ID   A0A0A0MRT6_HUMAN        Unreviewed;       475 AA.
AC   A0A0A0MRT6;
DT   07-JAN-2015, integrated into UniProtKB/TrEMBL.
DT   07-JAN-2015, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Abl interactor 1 {ECO:0000313|Ensembl:ENSP00000365330};
GN   Name=ABI1 {ECO:0000313|Ensembl:ENSP00000365330};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000365330, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000365330, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [7] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [8] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [9] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [10] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [11] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [13] {ECO:0000313|Ensembl:ENSP00000365330}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (NOV-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL139404; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_005252390.1; XM_005252333.3.
DR   jPOST; A0A0A0MRT6; -.
DR   MaxQB; A0A0A0MRT6; -.
DR   PeptideAtlas; A0A0A0MRT6; -.
DR   PRIDE; A0A0A0MRT6; -.
DR   Antibodypedia; 3646; 331 antibodies.
DR   Ensembl; ENST00000376160; ENSP00000365330; ENSG00000136754.
DR   GeneID; 10006; -.
DR   UCSC; uc057sjb.1; human.
DR   CTD; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   HGNC; HGNC:11320; ABI1.
DR   OpenTargets; ENSG00000136754; -.
DR   GeneTree; ENSGT00940000154811; -.
DR   ChiTaRS; ABI1; human.
DR   GenomeRNAi; 10006; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000136754; Expressed in mouth mucosa and 231 other tissues.
DR   ExpressionAtlas; A0A0A0MRT6; baseline and differential.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   Proteomics identification {ECO:0000213|EPD:A0A0A0MRT6,
KW   ECO:0000213|MaxQB:A0A0A0MRT6, ECO:0000213|PeptideAtlas:A0A0A0MRT6,
KW   ECO:0000213|ProteomicsDB:A0A0A0MRT6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN          45..107
FT                   /note="T-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000259|PROSITE:PS50192"
FT   DOMAIN          413..472
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          150..342
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          355..388
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        210..256
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        275..326
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        327..341
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        358..388
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   475 AA;  51770 MW;  198820E31BB455D4 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKHGNNQP ARTGTLSRTN PPTQKPPSPP
     MSGRGTLGRN TPYKTLEPVK PPTVPNDYMT SPARLGSQHS PGRTASLNQR PRTHSGSSGG
     SGSRENSGSS SIGIPIAVPT PSPPTIGPAP GSAPGSQYGT MTRQISRHNS TTSSTSSGGY
     RRTPSVTAQF SAQPHVNGGP LYSQNSISIA PPPPPMPQLT PQIPLTGFVA RVQENIADSP
     TPPPPPPPDD IPMFDDSPPP PPPPPVDYED EEAAVVQYND PYADGDPAWA PKNYIEKVVA
     IYDYTKDKDD ELSFMEGAII YVIKKNDDGW YEGVCNRVTG LFPGNYVESI MHYTD
//
ID   B6VEX3_HUMAN            Unreviewed;       422 AA.
AC   B6VEX3;
DT   16-DEC-2008, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 1.
DT   22-APR-2020, entry version 64.
DE   SubName: Full=Abl-interactor 1 variant 41 {ECO:0000313|EMBL:ACJ12783.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ12783.1};
RN   [1] {ECO:0000313|EMBL:ACJ12783.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gautreau A.;
RT   "The Wave complex is intrinsically inactive.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ380057; ACJ12783.1; -; mRNA.
DR   RefSeq; NP_001171593.1; NM_001178122.1.
DR   SMR; B6VEX3; -.
DR   PRIDE; B6VEX3; -.
DR   Antibodypedia; 3646; 331 antibodies.
DR   GeneID; 10006; -.
DR   CTD; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   PharmGKB; PA36144; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   GenomeRNAi; 10006; -.
DR   Bgee; ENSG00000136754; Expressed in mouth mucosa and 231 other tissues.
DR   ExpressionAtlas; B6VEX3; baseline and differential.
DR   Genevisible; B6VEX3; HS.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN          45..107
FT                   /note="T-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000259|PROSITE:PS50192"
FT   DOMAIN          360..419
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          159..289
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          302..335
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..261
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        262..288
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        305..335
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   422 AA;  46386 MW;  16FAAB5B29D7E506 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKWLKAKH GNNQPARTGT LSRTNPPTQK
     PPSPPMSGRG TLGRNTPYKT LEPVKPPTVP NDYMTSPARL GSQHSPGRTA SLNQRPRTHS
     GSSGGSGSRE NSGSSSIGIP IAVPTPSPPT IGPVSIAPPP PPMPQLTPQI PLTGFVARVQ
     ENIADSPTPP PPPPPDDIPM FDDSPPPPPP PPVDYEDEEA AVVQYNDPYA DGDPAWAPKN
     YIEKVVAIYD YTKDKDDELS FMEGAIIYVI KKNDDGWYEG VCNRVTGLFP GNYVESIMHY
     TD
//
ID   B6VEX4_HUMAN            Unreviewed;       393 AA.
AC   B6VEX4; F5H1G9;
DT   16-DEC-2008, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 1.
DT   22-APR-2020, entry version 85.
DE   SubName: Full=Abl interactor 1 {ECO:0000313|Ensembl:ENSP00000439646};
DE   SubName: Full=Abl-interactor 1 variant 21 {ECO:0000313|EMBL:ACJ12784.1};
GN   Name=ABI1 {ECO:0000313|Ensembl:ENSP00000439646};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ12784.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000439646, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [2] {ECO:0000213|PubMed:17081983}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [3] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000313|EMBL:ACJ12784.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gautreau A.;
RT   "The Wave complex is intrinsically inactive.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [10] {ECO:0000313|Ensembl:ENSP00000439646}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [11] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL139404; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390961; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; FJ380058; ACJ12784.1; -; mRNA.
DR   RefSeq; NP_001171594.1; NM_001178123.1.
DR   ProteomicsDB; 25653; -.
DR   Antibodypedia; 3646; 331 antibodies.
DR   Ensembl; ENST00000536334; ENSP00000439646; ENSG00000136754.
DR   GeneID; 10006; -.
DR   UCSC; uc010qdk.2; human.
DR   CTD; 10006; -.
DR   EuPathDB; HostDB:ENSG00000136754.16; -.
DR   HGNC; HGNC:11320; ABI1.
DR   OpenTargets; ENSG00000136754; -.
DR   PharmGKB; PA36144; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   GeneTree; ENSGT00940000154811; -.
DR   HOGENOM; CLU_035421_0_0_1; -.
DR   ChiTaRS; ABI1; human.
DR   GenomeRNAi; 10006; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   Bgee; ENSG00000136754; Expressed in mouth mucosa and 231 other tissues.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   Proteomics identification {ECO:0000213|EPD:B6VEX4,
KW   ECO:0000213|MaxQB:B6VEX4, ECO:0000213|PeptideAtlas:B6VEX4,
KW   ECO:0000213|ProteomicsDB:B6VEX4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN          45..107
FT                   /note="T-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000259|PROSITE:PS50192"
FT   DOMAIN          331..390
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          159..306
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        215..261
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        262..306
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   393 AA;  43295 MW;  4230F3E09401E859 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKWLKAKH GNNQPARTGT LSRTNPPTQK
     PPSPPMSGRG TLGRNTPYKT LEPVKPPTVP NDYMTSPARL GSQHSPGRTA SLNQRPRTHS
     GSSGGSGSRE NSGSSSIGIP IAVPTPSPPT IGPVADSPTP PPPPPPDDIP MFDDSPPPPP
     PPPVDYEDEE AAVVQYNDPY ADGDPAWAPK NYIEKVVAIY DYTKDKDDEL SFMEGAIIYV
     IKKNDDGWYE GVCNRVTGLF PGNYVESIMH YTD
//
ID   B6VEX5_HUMAN            Unreviewed;       388 AA.
AC   B6VEX5;
DT   16-DEC-2008, integrated into UniProtKB/TrEMBL.
DT   16-DEC-2008, sequence version 1.
DT   22-APR-2020, entry version 50.
DE   SubName: Full=Abl-interactor 1 variant 72 {ECO:0000313|EMBL:ACJ12785.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ12785.1};
RN   [1] {ECO:0000313|EMBL:ACJ12785.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Gautreau A.;
RT   "The Wave complex is intrinsically inactive.";
RL   Submitted (OCT-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; FJ380059; ACJ12785.1; -; mRNA.
DR   RefSeq; NP_001171595.1; NM_001178124.1.
DR   PeptideAtlas; B6VEX5; -.
DR   PRIDE; B6VEX5; -.
DR   GeneID; 10006; -.
DR   CTD; 10006; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   GenomeRNAi; 10006; -.
DR   Genevisible; B6VEX5; HS.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:InterPro.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; IEA:InterPro.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 2.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 2.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|PROSITE-ProRule:PRU00202};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192}.
FT   DOMAIN          45..107
FT                   /note="T-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000259|PROSITE:PS50192"
FT   DOMAIN          326..385
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          150..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        210..256
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        257..301
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   388 AA;  42638 MW;  8BFFDB219C618E57 CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKHGNNQP ARTGTLSRTN PPTQKPPSPP
     MSGRGTLGRN TPYKTLEPVK PPTVPNDYMT SPARLGSQHS PGRTASLNQR PRTHGGSSGG
     SGSRENSGSS SIGIPIAVPT PSPPTIGPVA DSPTPPPPPP PDDIPMFDDS PPPPPPPPVD
     YEDEEAAVVQ YNDPYADGDP AWAPKNYIEK VVAIYDYTKD KDDELSFMEG AIIYVIKKND
     DGWYEGVCNR VTGLFPGNYV ESIMHYTD
//
ID   ABI1_HUMAN              Reviewed;         508 AA.
AC   Q8IZP0; A9Z1Y6; B3KX62; B4DQ58; H7BXI6; O15147; O76049; O95060; Q5T2R3;
AC   Q5T2R4; Q5T2R6; Q5T2R7; Q5T2R9; Q5W070; Q5W072; Q8TB63; Q96S81; Q9NXZ9;
AC   Q9NYB8;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-APR-2020, entry version 183.
DE   RecName: Full=Abl interactor 1;
DE   AltName: Full=Abelson interactor 1;
DE            Short=Abi-1;
DE   AltName: Full=Abl-binding protein 4;
DE            Short=AblBP4;
DE   AltName: Full=Eps8 SH3 domain-binding protein;
DE            Short=Eps8-binding protein;
DE   AltName: Full=Nap1-binding protein;
DE            Short=Nap1BP;
DE   AltName: Full=Spectrin SH3 domain-binding protein 1;
DE   AltName: Full=e3B1;
GN   Name=ABI1 {ECO:0000312|HGNC:HGNC:11320}; Synonyms=SSH3BP1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6), PHOSPHORYLATION, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH EPS8 AND ABL1.
RX   PubMed=9010225; DOI=10.1038/sj.onc.1200822;
RA   Biesova Z., Piccoli C., Wong W.T.;
RT   "Isolation and characterization of e3B1, an eps8 binding protein that
RT   regulates cell growth.";
RL   Oncogene 14:233-241(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), ALTERNATIVE SPLICING (ISOFORMS 3;
RP   7; 8 AND 9), AND INTERACTION WITH SPTA1.
RX   PubMed=9593709; DOI=10.1074/jbc.273.22.13681;
RA   Ziemnicka-Kotula D., Xu J., Gu H., Potempska A., Kim K.S., Jenkins E.C.,
RA   Trenkner E., Kotula L.;
RT   "Identification of a candidate human spectrin Src homology 3 domain-binding
RT   protein suggests a general mechanism of association of tyrosine kinases
RT   with the spectrin-based membrane skeleton.";
RL   J. Biol. Chem. 273:13681-13692(1998).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND INTERACTION
RP   WITH ABL1; NAP1 AND NCK1.
RX   PubMed=11418237; DOI=10.1016/s0378-1119(01)00521-2;
RA   Yamamoto A., Suzuki T., Sakaki Y.;
RT   "Isolation of hNap1BP which interacts with human Nap 1 (NCKAP1) whose
RT   expression is down-regulated in Alzheimer's disease.";
RL   Gene 271:159-169(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5), AND INTERACTION WITH NCF1.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=12681507; DOI=10.1016/s0014-5793(03)00262-x;
RA   Gu Y., Souza R.F., Wu R.F., Xu Y.C., Terada L.S.;
RT   "Induction of colonic epithelial cell apoptosis by p47-dependent
RT   oxidants(1).";
RL   FEBS Lett. 540:195-200(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4).
RC   TISSUE=T-cell;
RA   Wilson L.A., Fields D., Cruz L., Friesen J., Siminovitch K.A.;
RT   "A new member of the Abl interactor protein family, AblBP4.";
RL   Submitted (APR-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Chikri M.M., Boutin M.P., Vaxillaire M.M., Froguel M.P.;
RT   "In silico cloning of the human SSH3BP1/e3B1 gene.";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Quackenbush R.C., Pendergast A.M.;
RL   Submitted (APR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2; 11 AND 12).
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 5).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PROTEIN SEQUENCE OF 2-17.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [13]
RP   PROTEIN SEQUENCE OF 2-17; 139-154; 229-237 AND 451-477, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Hepatoma;
RA   Bienvenut W.V., Boldt K., von Kriegsheim A.F., Kolch W.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [14]
RP   FUNCTION, AND INTERACTION WITH SOS1; SOS2 AND GRB2.
RX   PubMed=11003655; DOI=10.1128/mcb.20.20.7591-7601.2000;
RA   Fan P.-D., Goff S.P.;
RT   "Abl interactor 1 binds to sos and inhibits epidermal growth factor- and v-
RT   Abl-induced activation of extracellular signal-regulated kinases.";
RL   Mol. Cell. Biol. 20:7591-7601(2000).
RN   [15]
RP   ALTERNATIVE SPLICING (ISOFORMS 2 AND 10), AND CHROMOSOMAL TRANSLOCATION
RP   WITH KMT2A.
RX   PubMed=9694699;
RA   Taki T., Shibuya N., Taniwaki M., Hanada R., Morishita K., Bessho F.,
RA   Yanagisawa M., Hayashi Y.;
RT   "ABI-1, a human homolog to mouse Abl-interactor 1, fuses the MLL gene in
RT   acute myeloid leukemia with t(10;11)(p11.2;q23).";
RL   Blood 92:1125-1130(1998).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   IDENTIFICATION IN THE WAVE2 COMPLEX.
RX   PubMed=16417406; DOI=10.1371/journal.pbio.0040038;
RA   Weiner O.D., Rentel M.C., Ott A., Brown G.E., Jedrychowski M., Yaffe M.B.,
RA   Gygi S.P., Cantley L.C., Bourne H.R., Kirschner M.W.;
RT   "Hem-1 complexes are essential for Rac activation, actin polymerization,
RT   and myosin regulation during neutrophil chemotaxis.";
RL   PLoS Biol. 4:E38-E38(2006).
RN   [18]
RP   FUNCTION, AND PHOSPHORYLATION AT TYR-213.
RX   PubMed=18328268; DOI=10.1016/j.bbamcr.2008.01.028;
RA   Xiong X., Cui P., Hossain S., Xu R., Warner B., Guo X., An X.,
RA   Debnath A.K., Cowburn D., Kotula L.;
RT   "Allosteric inhibition of the nonMyristoylated c-Abl tyrosine kinase by
RT   phosphopeptides derived from Abi1/Hssh3bp1.";
RL   Biochim. Biophys. Acta 1783:737-747(2008).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183 AND SER-216, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [22]
RP   INTERACTION WITH FNBP1L; WASF2 AND CDC42.
RX   PubMed=19798448; DOI=10.1371/journal.pgen.1000675;
RA   Giuliani C., Troglio F., Bai Z., Patel F.B., Zucconi A., Malabarba M.G.,
RA   Disanza A., Stradal T.B., Cassata G., Confalonieri S., Hardin J.D.,
RA   Soto M.C., Grant B.D., Scita G.;
RT   "Requirements for F-BAR proteins TOCA-1 and TOCA-2 in actin dynamics and
RT   membrane trafficking during Caenorhabditis elegans oocyte growth and
RT   embryonic epidermal morphogenesis.";
RL   PLoS Genet. 5:E1000675-E1000675(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-225 AND THR-507, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-222; SER-225 AND SER-323, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; TYR-213; SER-225;
RP   SER-319 AND SER-323, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [29]
RP   INTERACTION WITH HUMAN CYTOMEGALOVIRUS PROTEIN UL135 (MICROBIAL INFECTION).
RX   PubMed=25121749; DOI=10.1016/j.chom.2014.07.005;
RA   Stanton R.J., Prod'homme V., Purbhoo M.A., Moore M., Aicheler R.J.,
RA   Heinzmann M., Bailer S.M., Haas J., Antrobus R., Weekes M.P., Lehner P.J.,
RA   Vojtesek B., Miners K.L., Man S., Wilkie G.S., Davison A.J., Wang E.C.,
RA   Tomasec P., Wilkinson G.W.;
RT   "HCMV pUL135 remodels the actin cytoskeleton to impair immune recognition
RT   of infected cells.";
RL   Cell Host Microbe 16:201-214(2014).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-174; THR-178; SER-183;
RP   SER-187; SER-222 AND SER-225, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: May act in negative regulation of cell growth and
CC       transformation by interacting with nonreceptor tyrosine kinases ABL1
CC       and/or ABL2. May play a role in regulation of EGF-induced Erk pathway
CC       activation. Involved in cytoskeletal reorganization and EGFR signaling.
CC       Together with EPS8 participates in transduction of signals from Ras to
CC       Rac. In vitro, a trimeric complex of ABI1, EPS8 and SOS1 exhibits Rac
CC       specific guanine nucleotide exchange factor (GEF) activity and ABI1
CC       seems to act as an adapter in the complex. Regulates ABL1/c-Abl-
CC       mediated phosphorylation of ENAH. Recruits WASF1 to lamellipodia and
CC       there seems to regulate WASF1 protein level. In brain, seems to
CC       regulate the dendritic outgrowth and branching as well as to determine
CC       the shape and number of synaptic contacts of developing neurons.
CC       {ECO:0000269|PubMed:11003655, ECO:0000269|PubMed:18328268}.
CC   -!- SUBUNIT: Interacts with ABL1, ENAH, STX1A, SNAP25, VAMP2, EPS8, and
CC       through its N-terminus with WASF1. Part of a complex consisting of
CC       ABI1, STX1A and SNAP25. Part of a complex consisting of ABI1, EPS8 and
CC       SOS1 (By similarity). Interacts with SOS1, SOS2, GRB2, SPTA1 and the
CC       first SH3 domain of NCK1. Isoform 6 does not interact with NCK1.
CC       Component of the WAVE2 complex composed of ABI1, CYFIP1/SRA1,
CC       NCKAP1/NAP1 (NCKAP1l/HEM1 in hematopoietic cells) and WASF2/WAVE2
CC       (PubMed:16417406). Interacts (via SH3 domain) with SHANK2 and SHANK3,
CC       but not SHANK1; the interaction is direct. Interacts with the
CC       heterodimer MYC:MAX; the interaction may enhance MYC:MAX
CC       transcriptional activity. Interacts with FNBP1L (via the SH3 domain),
CC       WASF2, and CDC42, but only in the presence of FNBP1L (PubMed:19798448).
CC       {ECO:0000250, ECO:0000269|PubMed:11003655, ECO:0000269|PubMed:11418237,
CC       ECO:0000269|PubMed:12681507, ECO:0000269|PubMed:16417406,
CC       ECO:0000269|PubMed:19798448, ECO:0000269|PubMed:9010225,
CC       ECO:0000269|PubMed:9593709}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human
CC       cytomegalovirus/HHV-5 protein UL135. {ECO:0000269|PubMed:25121749}.
CC   -!- INTERACTION:
CC       Q8IZP0-5; Q9NYB9-2: ABI2; NbExp=3; IntAct=EBI-11743294, EBI-11096309;
CC       Q8IZP0; P00519: ABL1; NbExp=11; IntAct=EBI-375446, EBI-375543;
CC       Q8IZP0-4; P00520-4: Abl1; Xeno; NbExp=5; IntAct=EBI-8593095, EBI-8593082;
CC       Q8IZP0; P42684: ABL2; NbExp=2; IntAct=EBI-375446, EBI-1102694;
CC       Q8IZP0-5; Q8WYQ4-2: C22orf15; NbExp=3; IntAct=EBI-11743294, EBI-12030460;
CC       Q8IZP0; O00555: CACNA1A; NbExp=2; IntAct=EBI-375446, EBI-766279;
CC       Q8IZP0-2; P22681: CBL; NbExp=3; IntAct=EBI-7358775, EBI-518228;
CC       Q8IZP0; Q13191: CBLB; NbExp=2; IntAct=EBI-375446, EBI-744027;
CC       Q8IZP0-5; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-11743294, EBI-10961624;
CC       Q8IZP0-5; Q8TD31-3: CCHCR1; NbExp=5; IntAct=EBI-11743294, EBI-10175300;
CC       Q8IZP0-5; O60941-5: DTNB; NbExp=3; IntAct=EBI-11743294, EBI-11984733;
CC       Q8IZP0-5; O15372: EIF3H; NbExp=3; IntAct=EBI-11743294, EBI-709735;
CC       Q8IZP0-5; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-11743294, EBI-744099;
CC       Q8IZP0; Q08509: Eps8; Xeno; NbExp=2; IntAct=EBI-375446, EBI-375596;
CC       Q8IZP0-5; Q9H5Z6-2: FAM124B; NbExp=3; IntAct=EBI-11743294, EBI-11986315;
CC       Q8IZP0-5; Q6PCT2-2: FBXL19; NbExp=3; IntAct=EBI-11743294, EBI-11959077;
CC       Q8IZP0-5; Q14192: FHL2; NbExp=3; IntAct=EBI-11743294, EBI-701903;
CC       Q8IZP0-5; Q03014: HHEX; NbExp=3; IntAct=EBI-11743294, EBI-747421;
CC       Q8IZP0-5; P61978-2: HNRNPK; NbExp=3; IntAct=EBI-11743294, EBI-7060731;
CC       Q8IZP0-5; Q86YM7: HOMER1; NbExp=3; IntAct=EBI-11743294, EBI-746815;
CC       Q8IZP0-5; Q9NSC5: HOMER3; NbExp=3; IntAct=EBI-11743294, EBI-748420;
CC       Q8IZP0-2; P13612: ITGA4; NbExp=2; IntAct=EBI-7358775, EBI-703044;
CC       Q8IZP0-5; Q5T5P2-6: KIAA1217; NbExp=3; IntAct=EBI-11743294, EBI-10188326;
CC       Q8IZP0-5; P25800: LMO1; NbExp=3; IntAct=EBI-11743294, EBI-8639312;
CC       Q8IZP0-5; Q9Y586: MAB21L2; NbExp=3; IntAct=EBI-11743294, EBI-6659161;
CC       Q8IZP0; P14598: NCF1; NbExp=5; IntAct=EBI-375446, EBI-395044;
CC       Q8IZP0; Q9Y2A7: NCKAP1; NbExp=5; IntAct=EBI-375446, EBI-389845;
CC       Q8IZP0-5; O94856-3: NFASC; NbExp=3; IntAct=EBI-11743294, EBI-12035911;
CC       Q8IZP0-5; Q5HYW2: NHSL2; NbExp=3; IntAct=EBI-11743294, EBI-2859639;
CC       Q8IZP0; P27986: PIK3R1; NbExp=8; IntAct=EBI-375446, EBI-79464;
CC       Q8IZP0; P26450: Pik3r1; Xeno; NbExp=3; IntAct=EBI-375446, EBI-641764;
CC       Q8IZP0; Q92569: PIK3R3; NbExp=2; IntAct=EBI-375446, EBI-79893;
CC       Q8IZP0-5; P54646: PRKAA2; NbExp=3; IntAct=EBI-11743294, EBI-1383852;
CC       Q8IZP0; P20936: RASA1; NbExp=2; IntAct=EBI-375446, EBI-1026476;
CC       Q8IZP0-5; Q96T37-3: RBM15; NbExp=3; IntAct=EBI-11743294, EBI-12041043;
CC       Q8IZP0-5; Q9P2K3-2: RCOR3; NbExp=3; IntAct=EBI-11743294, EBI-1504830;
CC       Q8IZP0-5; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-11743294, EBI-358489;
CC       Q8IZP0; O14512: SOCS7; NbExp=2; IntAct=EBI-375446, EBI-1539606;
CC       Q8IZP0-5; O94875-10: SORBS2; NbExp=3; IntAct=EBI-11743294, EBI-12037893;
CC       Q8IZP0; P02549: SPTA1; NbExp=2; IntAct=EBI-375446, EBI-375617;
CC       Q8IZP0-5; Q15642-2: TRIP10; NbExp=3; IntAct=EBI-11743294, EBI-6550597;
CC       Q8IZP0-5; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-11743294, EBI-9090990;
CC       Q8IZP0-5; Q5ST30: VARS2; NbExp=3; IntAct=EBI-11743294, EBI-2116622;
CC       Q8IZP0-5; P50552: VASP; NbExp=3; IntAct=EBI-11743294, EBI-748201;
CC       Q8IZP0; P15498: VAV1; NbExp=2; IntAct=EBI-375446, EBI-625518;
CC       Q8IZP0; P52735: VAV2; NbExp=2; IntAct=EBI-375446, EBI-297549;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Nucleus {ECO:0000250}.
CC       Cell projection, lamellipodium {ECO:0000250}. Cell projection,
CC       filopodium {ECO:0000250}. Cell projection, growth cone {ECO:0000250}.
CC       Cell junction, synapse, postsynaptic density {ECO:0000250}. Cytoplasm,
CC       cytoskeleton {ECO:0000250}. Note=Localized to protruding lamellipodia
CC       and filopodia tips. Also localized to neuronal growth cones and
CC       synaptosomes. May shuttle from the postsynaptic densities to the
CC       nucleus (By similarity). {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1;
CC         IsoId=Q8IZP0-1; Sequence=Displayed;
CC       Name=2; Synonyms=long, B48;
CC         IsoId=Q8IZP0-2; Sequence=VSP_010749, VSP_010750, VSP_010751,
CC                                  VSP_010752;
CC       Name=3;
CC         IsoId=Q8IZP0-3; Sequence=VSP_010750, VSP_010752;
CC       Name=4;
CC         IsoId=Q8IZP0-4; Sequence=VSP_010750, VSP_010751, VSP_010752;
CC       Name=5;
CC         IsoId=Q8IZP0-5; Sequence=VSP_010749, VSP_010750;
CC       Name=6;
CC         IsoId=Q8IZP0-6; Sequence=VSP_010750, VSP_010751;
CC       Name=7; Synonyms=4;
CC         IsoId=Q8IZP0-7; Sequence=VSP_010750, VSP_010751, VSP_010754,
CC                                  VSP_010755;
CC       Name=8; Synonyms=5;
CC         IsoId=Q8IZP0-8; Sequence=VSP_010750, VSP_010751, VSP_010754,
CC                                  VSP_010752;
CC       Name=9; Synonyms=2;
CC         IsoId=Q8IZP0-9; Sequence=VSP_010750;
CC       Name=10; Synonyms=B30;
CC         IsoId=Q8IZP0-10; Sequence=VSP_010749, VSP_010750, VSP_010751,
CC                                   VSP_010754, VSP_010752, VSP_010753;
CC       Name=11;
CC         IsoId=Q8IZP0-11; Sequence=VSP_043403, VSP_010750, VSP_010751,
CC                                   VSP_010754, VSP_010752, VSP_010753;
CC       Name=12;
CC         IsoId=Q8IZP0-12; Sequence=VSP_044604, VSP_010752;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in brain.
CC       {ECO:0000269|PubMed:11418237}.
CC   -!- DOMAIN: The t-SNARE coiled-coil homology domain is necessary and
CC       sufficient for interaction with STX1A. {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine residues after serum stimulation or
CC       induction by v-Abl. Seems to be phosphorylated at Tyr-53 by ABL1,
CC       required for nuclear but not for synaptic localization.
CC       {ECO:0000269|PubMed:18328268, ECO:0000269|PubMed:9010225}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ABI1 is a cause of
CC       acute leukemias. Translocation t(10;11)(p11.2;q23) with KMT2A/MLL1.
CC       ABI1 isoform 2 was found to be present in acute leukemia KMT2A/MLL1-
CC       ABI1 fusion transcript. {ECO:0000269|PubMed:9694699}.
CC   -!- SIMILARITY: Belongs to the ABI family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ABI1ID233.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF006516; AAB62569.1; -; mRNA.
DR   EMBL; U87166; AAC39757.1; -; mRNA.
DR   EMBL; AB040151; BAB55675.1; -; mRNA.
DR   EMBL; AF540955; AAN28379.1; -; mRNA.
DR   EMBL; AF001628; AAD00897.1; -; mRNA.
DR   EMBL; AJ277065; CAB88006.1; -; Genomic_DNA.
DR   EMBL; AJ277066; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277067; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277068; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277069; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277070; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277071; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277072; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277073; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AJ277074; CAB88006.1; JOINED; Genomic_DNA.
DR   EMBL; AF260262; AAF70309.1; -; mRNA.
DR   EMBL; AK126803; BAG54374.1; -; mRNA.
DR   EMBL; AK298646; BAG60820.1; -; mRNA.
DR   EMBL; AK291823; BAF84512.1; -; mRNA.
DR   EMBL; AL139404; CAH73112.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73112.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73113.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73113.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73114.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73114.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73115.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73115.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73116.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73116.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73117.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73117.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73118.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73118.1; JOINED; Genomic_DNA.
DR   EMBL; AL139404; CAH73119.1; -; Genomic_DNA.
DR   EMBL; AL390961; CAH73119.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17272.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17272.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17273.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17273.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17274.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17274.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17275.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17275.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17276.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17276.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17277.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17277.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17278.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17278.1; JOINED; Genomic_DNA.
DR   EMBL; AL390961; CAI17279.1; -; Genomic_DNA.
DR   EMBL; AL139404; CAI17279.1; JOINED; Genomic_DNA.
DR   EMBL; CH471072; EAW86079.1; -; Genomic_DNA.
DR   EMBL; CH471072; EAW86080.1; -; Genomic_DNA.
DR   EMBL; BC024254; AAH24254.1; -; mRNA.
DR   CCDS; CCDS31169.1; -. [Q8IZP0-5]
DR   CCDS; CCDS31170.1; -. [Q8IZP0-3]
DR   CCDS; CCDS31171.1; -. [Q8IZP0-9]
DR   CCDS; CCDS53497.1; -. [Q8IZP0-11]
DR   CCDS; CCDS53498.1; -. [Q8IZP0-2]
DR   CCDS; CCDS53499.1; -. [Q8IZP0-4]
DR   CCDS; CCDS53500.1; -. [Q8IZP0-6]
DR   CCDS; CCDS53501.1; -. [Q8IZP0-12]
DR   CCDS; CCDS7150.1; -. [Q8IZP0-1]
DR   CCDS; CCDS73077.1; -. [Q8IZP0-8]
DR   CCDS; CCDS73078.1; -. [Q8IZP0-7]
DR   RefSeq; NP_001012768.1; NM_001012750.2. [Q8IZP0-9]
DR   RefSeq; NP_001012769.1; NM_001012751.2. [Q8IZP0-3]
DR   RefSeq; NP_001012770.1; NM_001012752.2. [Q8IZP0-5]
DR   RefSeq; NP_001171587.1; NM_001178116.1. [Q8IZP0-12]
DR   RefSeq; NP_001171590.1; NM_001178119.1. [Q8IZP0-6]
DR   RefSeq; NP_001171591.1; NM_001178120.1. [Q8IZP0-4]
DR   RefSeq; NP_001171592.1; NM_001178121.1. [Q8IZP0-2]
DR   RefSeq; NP_001171593.1; NM_001178122.1. [Q8IZP0-7]
DR   RefSeq; NP_001171594.1; NM_001178123.1.
DR   RefSeq; NP_001171595.1; NM_001178124.1. [Q8IZP0-10]
DR   RefSeq; NP_001171596.1; NM_001178125.1. [Q8IZP0-11]
DR   RefSeq; NP_005461.2; NM_005470.3. [Q8IZP0-1]
DR   SMR; Q8IZP0; -.
DR   BioGrid; 115324; 77.
DR   CORUM; Q8IZP0; -.
DR   DIP; DIP-31118N; -.
DR   ELM; Q8IZP0; -.
DR   IntAct; Q8IZP0; 153.
DR   MINT; Q8IZP0; -.
DR   STRING; 9606.ENSP00000365312; -.
DR   iPTMnet; Q8IZP0; -.
DR   PhosphoSitePlus; Q8IZP0; -.
DR   BioMuta; ABI1; -.
DR   DMDM; 50400546; -.
DR   EPD; Q8IZP0; -.
DR   jPOST; Q8IZP0; -.
DR   MassIVE; Q8IZP0; -.
DR   MaxQB; Q8IZP0; -.
DR   PaxDb; Q8IZP0; -.
DR   PeptideAtlas; Q8IZP0; -.
DR   PRIDE; Q8IZP0; -.
DR   ProteomicsDB; 43294; -.
DR   ProteomicsDB; 71380; -. [Q8IZP0-1]
DR   ProteomicsDB; 71381; -. [Q8IZP0-10]
DR   ProteomicsDB; 71382; -. [Q8IZP0-11]
DR   ProteomicsDB; 71383; -. [Q8IZP0-2]
DR   ProteomicsDB; 71384; -. [Q8IZP0-3]
DR   ProteomicsDB; 71385; -. [Q8IZP0-4]
DR   ProteomicsDB; 71386; -. [Q8IZP0-5]
DR   ProteomicsDB; 71387; -. [Q8IZP0-6]
DR   ProteomicsDB; 71388; -. [Q8IZP0-7]
DR   ProteomicsDB; 71389; -. [Q8IZP0-8]
DR   ProteomicsDB; 71390; -. [Q8IZP0-9]
DR   Antibodypedia; 3646; 331 antibodies.
DR   Ensembl; ENST00000346832; ENSP00000279599; ENSG00000136754. [Q8IZP0-12]
DR   Ensembl; ENST00000359188; ENSP00000352114; ENSG00000136754. [Q8IZP0-6]
DR   Ensembl; ENST00000376137; ENSP00000365307; ENSG00000136754. [Q8IZP0-7]
DR   Ensembl; ENST00000376138; ENSP00000365308; ENSG00000136754. [Q8IZP0-3]
DR   Ensembl; ENST00000376139; ENSP00000365309; ENSG00000136754. [Q8IZP0-5]
DR   Ensembl; ENST00000376140; ENSP00000365310; ENSG00000136754. [Q8IZP0-9]
DR   Ensembl; ENST00000376142; ENSP00000365312; ENSG00000136754. [Q8IZP0-1]
DR   Ensembl; ENST00000376166; ENSP00000365336; ENSG00000136754. [Q8IZP0-2]
DR   Ensembl; ENST00000376170; ENSP00000365340; ENSG00000136754. [Q8IZP0-4]
DR   Ensembl; ENST00000490841; ENSP00000440101; ENSG00000136754. [Q8IZP0-11]
DR   GeneID; 10006; -.
DR   KEGG; hsa:10006; -.
DR   UCSC; uc001isx.4; human. [Q8IZP0-1]
DR   CTD; 10006; -.
DR   DisGeNET; 10006; -.
DR   GeneCards; ABI1; -.
DR   HGNC; HGNC:11320; ABI1.
DR   HPA; ENSG00000136754; Low tissue specificity.
DR   MIM; 603050; gene.
DR   neXtProt; NX_Q8IZP0; -.
DR   OpenTargets; ENSG00000136754; -.
DR   PharmGKB; PA36144; -.
DR   eggNOG; ENOG410IPCV; Eukaryota.
DR   eggNOG; ENOG410XQ3Y; LUCA.
DR   GeneTree; ENSGT00940000154811; -.
DR   InParanoid; Q8IZP0; -.
DR   KO; K23649; -.
DR   OMA; VGHGVKE; -.
DR   OrthoDB; 1478981at2759; -.
DR   PhylomeDB; Q8IZP0; -.
DR   TreeFam; TF314303; -.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-4420097; VEGFA-VEGFR2 Pathway.
DR   Reactome; R-HSA-5663213; RHO GTPases Activate WASPs and WAVEs.
DR   SignaLink; Q8IZP0; -.
DR   SIGNOR; Q8IZP0; -.
DR   ChiTaRS; ABI1; human.
DR   GeneWiki; ABI1; -.
DR   GenomeRNAi; 10006; -.
DR   Pharos; Q8IZP0; Tbio.
DR   PRO; PR:Q8IZP0; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8IZP0; protein.
DR   Bgee; ENSG00000136754; Expressed in mouth mucosa and 231 other tissues.
DR   ExpressionAtlas; Q8IZP0; baseline and differential.
DR   Genevisible; Q8IZP0; HS.
DR   GO; GO:0016235; C:aggresome; IDA:HPA.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005783; C:endoplasmic reticulum; TAS:ProtInc.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0032433; C:filopodium tip; IDA:UniProtKB.
DR   GO; GO:0030426; C:growth cone; IEA:UniProtKB-SubCell.
DR   GO; GO:0030027; C:lamellipodium; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0014069; C:postsynaptic density; IEA:UniProtKB-SubCell.
DR   GO; GO:0031209; C:SCAR complex; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0008092; F:cytoskeletal protein binding; TAS:ProtInc.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IEA:Ensembl.
DR   GO; GO:0017124; F:SH3 domain binding; IPI:UniProtKB.
DR   GO; GO:0008154; P:actin polymerization or depolymerization; NAS:UniProtKB.
DR   GO; GO:0048813; P:dendrite morphogenesis; IEA:Ensembl.
DR   GO; GO:0038096; P:Fc-gamma receptor signaling pathway involved in phagocytosis; TAS:Reactome.
DR   GO; GO:0072673; P:lamellipodium morphogenesis; IEA:Ensembl.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; TAS:ProtInc.
DR   GO; GO:0018108; P:peptidyl-tyrosine phosphorylation; IDA:MGI.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; TAS:ProtInc.
DR   GO; GO:0048010; P:vascular endothelial growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd11971; SH3_Abi1; 1.
DR   InterPro; IPR028457; ABI.
DR   InterPro; IPR028456; ABI1.
DR   InterPro; IPR035725; Abi1_SH3.
DR   InterPro; IPR012849; Abl-interactor_HHR_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   InterPro; IPR000727; T_SNARE_dom.
DR   PANTHER; PTHR10460; PTHR10460; 1.
DR   PANTHER; PTHR10460:SF2; PTHR10460:SF2; 1.
DR   Pfam; PF07815; Abi_HHR; 1.
DR   Pfam; PF00018; SH3_1; 1.
DR   PRINTS; PR00452; SH3DOMAIN.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50002; SH3; 1.
DR   PROSITE; PS50192; T_SNARE; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell junction; Cell projection;
KW   Chromosomal rearrangement; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Host-virus interaction; Nucleus; Phosphoprotein;
KW   Polymorphism; Reference proteome; SH3 domain; Synapse.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378, ECO:0000269|PubMed:12665801,
FT                   ECO:0000269|Ref.13"
FT   CHAIN           2..508
FT                   /note="Abl interactor 1"
FT                   /id="PRO_0000191787"
FT   DOMAIN          45..107
FT                   /note="t-SNARE coiled-coil homology"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00202"
FT   DOMAIN          446..505
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   REGION          18..79
FT                   /note="Required for binding to WASF1"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        260..418
FT                   /note="Pro-rich"
FT   SITE            95..96
FT                   /note="Breakpoint for translocation to form KMT2A/MLL1-
FT                   ABI1"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378, ECO:0000269|Ref.13"
FT   MOD_RES         53
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZM5"
FT   MOD_RES         174
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         178
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         183
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         187
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         213
FT                   /note="Phosphotyrosine; by ABL1"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:18328268"
FT   MOD_RES         215
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CBW3"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         222
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         225
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18691976,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         455
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CBW3"
FT   MOD_RES         466
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9QZM5"
FT   MOD_RES         507
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   VAR_SEQ         38
FT                   /note="I -> IQRHGFAVLLCLLSNSWP (in isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_044604"
FT   VAR_SEQ         96..159
FT                   /note="Missing (in isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043403"
FT   VAR_SEQ         154..158
FT                   /note="Missing (in isoform 2, isoform 5 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:12681507,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.7"
FT                   /id="VSP_010749"
FT   VAR_SEQ         274..300
FT                   /note="Missing (in isoform 2, isoform 3, isoform 4, isoform
FT                   5, isoform 6, isoform 7, isoform 8, isoform 9, isoform 10
FT                   and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:11418237,
FT                   ECO:0000303|PubMed:12681507, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:9010225,
FT                   ECO:0000303|Ref.5, ECO:0000303|Ref.7"
FT                   /id="VSP_010750"
FT   VAR_SEQ         301
FT                   /note="Missing (in isoform 2, isoform 4, isoform 6, isoform
FT                   7, isoform 8, isoform 10 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:12681507,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9010225, ECO:0000303|Ref.5,
FT                   ECO:0000303|Ref.7"
FT                   /id="VSP_010751"
FT   VAR_SEQ         302..359
FT                   /note="Missing (in isoform 7, isoform 8, isoform 10 and
FT                   isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:12681507,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_010754"
FT   VAR_SEQ         360..388
FT                   /note="Missing (in isoform 2, isoform 3, isoform 4, isoform
FT                   8, isoform 10, isoform 11 and isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:11418237,
FT                   ECO:0000303|PubMed:12681507, ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.5,
FT                   ECO:0000303|Ref.7"
FT                   /id="VSP_010752"
FT   VAR_SEQ         360
FT                   /note="I -> V (in isoform 7)"
FT                   /evidence="ECO:0000303|Ref.5"
FT                   /id="VSP_010755"
FT   VAR_SEQ         389
FT                   /note="I -> V (in isoform 10 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010753"
FT   VARIANT         331
FT                   /note="G -> A (in dbSNP:rs2306236)"
FT                   /id="VAR_048159"
FT   CONFLICT        177
FT                   /note="P -> L (in Ref. 2; AAC39757)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        410
FT                   /note="S -> F (in Ref. 2; AAC39757 and 4; AAN28379)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        437
FT                   /note="D -> G (in Ref. 8; BAG54374)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   508 AA;  55081 MW;  2D76F305934127CB CRC64;
     MAELQMLLEE EIPSGKRALI ESYQNLTRVA DYCENNYIQA TDKRKALEET KAYTTQSLAS
     VAYQINALAN NVLQLLDIQA SQLRRMESSI NHISQTVDIH KEKVARREIG ILTTNKNTSR
     THKIIAPANM ERPVRYIRKP IDYTVLDDVG HGVKWLKAKH GNNQPARTGT LSRTNPPTQK
     PPSPPMSGRG TLGRNTPYKT LEPVKPPTVP NDYMTSPARL GSQHSPGRTA SLNQRPRTHS
     GSSGGSGSRE NSGSSSIGIP IAVPTPSPPT IGPENISVPP PSGAPPAPPL APLLPVSTVI
     AAPGSAPGSQ YGTMTRQISR HNSTTSSTSS GGYRRTPSVT AQFSAQPHVN GGPLYSQNSI
     SIAPPPPPMP QLTPQIPLTG FVARVQENIA DSPTPPPPPP PDDIPMFDDS PPPPPPPPVD
     YEDEEAAVVQ YNDPYADGDP AWAPKNYIEK VVAIYDYTKD KDDELSFMEG AIIYVIKKND
     DGWYEGVCNR VTGLFPGNYV ESIMHYTD
//
ID   A0A0S2Z536_HUMAN        Unreviewed;       759 AA.
AC   A0A0S2Z536;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 27.
DE   SubName: Full=Rho GTPase activating protein 26 isoform 1 {ECO:0000313|EMBL:ALQ34019.1};
DE   Flags: Fragment;
GN   Name=ARHGAP26 {ECO:0000313|EMBL:ALQ34019.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ34019.1};
RN   [1] {ECO:0000313|EMBL:ALQ34019.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178561; ALQ34019.1; -; mRNA.
DR   RefSeq; NP_001129080.1; NM_001135608.1.
DR   SMR; A0A0S2Z536; -.
DR   PRIDE; A0A0S2Z536; -.
DR   Antibodypedia; 27437; 243 antibodies.
DR   GeneID; 23092; -.
DR   CTD; 23092; -.
DR   ChiTaRS; ARHGAP26; human.
DR   GenomeRNAi; 23092; -.
DR   ExpressionAtlas; A0A0S2Z536; baseline and differential.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0030036; P:actin cytoskeleton organization; IEA:InterPro.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd07636; BAR_GRAF; 1.
DR   CDD; cd12064; SH3_GRAF; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030061; GRAF.
DR   InterPro; IPR035483; GRAF_BAR.
DR   InterPro; IPR035481; GRAF_SH3.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR12552:SF4; PTHR12552:SF4; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   GTPase activation {ECO:0000256|SAAS:SAAS00805150};
KW   SH3 domain {ECO:0000256|PROSITE-ProRule:PRU00192,
KW   ECO:0000256|SAAS:SAAS00989295}.
FT   DOMAIN          265..369
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   DOMAIN          383..568
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000259|PROSITE:PS50238"
FT   DOMAIN          701..759
FT                   /note="SH3"
FT                   /evidence="ECO:0000259|PROSITE:PS50002"
FT   REGION          624..699
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          22..42
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          232..252
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        624..651
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        660..682
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        683..699
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         759
FT                   /evidence="ECO:0000313|EMBL:ALQ34019.1"
SQ   SEQUENCE   759 AA;  86165 MW;  8FA48FDF1DCAFB7F CRC64;
     MGLPALEFSD CCLDSPHFRE TLKSHEAELD KTNKFIKELI KDGKSLISAL KNLSSAKRKF
     ADSLNEFKFQ CIGDAETDDE MCIARSLQEF ATVLRNLEDE RIRMIENASE VLITPLEKFR
     KEQIGAAKEA KKKYDKETEK YCGILEKHLN LSSKKKESQL QEADSQVDLV RQHFYEVSLE
     YVFKVQEVQE RKMFEFVEPL LAFLQGLFTF YHHGYELAKD FGDFKTQLTI SIQNTRNRFE
     GTRSEVESLM KKMKENPLEH KTISPYTMEG YLYVQEKRHF GTSWVKHYCT YQRDSKQITM
     VPFDQKSGGK GGEDESVILK SCTRRKTDSI EKRFCFDVEA VDRPGVITMQ ALSEEDRRLW
     MEAMDGREPV YNSNKDSQSE GTAQLDSIGF SIIRKCIHAV ETRGINEQGL YRIVGVNSRV
     QKLLSVLMDP KTASETETDI CAEWEIKTIT SALKTYLRML PGPLMMYQFQ RSFIKAAKLE
     NQESRVSEIH SLVHRLPEKN RQMLQLLMNH LANVANNHKQ NLMTVANLGV VFGPTLLRPQ
     EETVAAIMDI KFQNIVIEIL IENHEKIFNT VPDMPLTNAQ LHLSRKKSSD SKPPSCSERP
     LTLFHTVQST EKQEQRNSII NSSLESVSSN PNSILNSSSS LQPNMNSSDP DLAVVKPTRP
     NSLPPNPSPT SPLSPSWPMF SAPSSPMPTS STSSDSSPVS TPFRKAKALY ACKAEHDSEL
     SFTAGTVFDN VHPSQEPGWL EGTLNGKTGL IPENYVEFL
//
ID   RHG26_HUMAN             Reviewed;         814 AA.
AC   Q9UNA1; O75117; Q5D035; Q9BYS6; Q9BYS7; Q9UJ00;
DT   11-JUL-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2000, sequence version 1.
DT   22-APR-2020, entry version 192.
DE   RecName: Full=Rho GTPase-activating protein 26;
DE   AltName: Full=GTPase regulator associated with focal adhesion kinase;
DE   AltName: Full=Oligophrenin-1-like protein;
DE   AltName: Full=Rho-type GTPase-activating protein 26;
GN   Name=ARHGAP26; Synonyms=GRAF, KIAA0621, OPHN1L;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart, Liver, and Placenta;
RA   Xia J.H., Tang X.X., Yu K.P., Pan Q., Dai H.P.;
RT   "Molecular cloning of human oligophrenin-1 like (OPHN1L) gene, complete
RT   CDS.";
RL   Submitted (APR-1999) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 2), DISEASE, AND VARIANT JMML
RP   SER-417.
RX   PubMed=10908648; DOI=10.1073/pnas.150079597;
RA   Borkhardt A., Bojesen S., Haas O.A., Fuchs U., Bartelheimer D.,
RA   Loncarevic I.F., Bohle R.M., Harbott J., Repp R., Jaeger U., Viehmann S.,
RA   Henn T., Korth P., Scharr D., Lampert F.;
RT   "The human GRAF gene is fused to MLL in a unique t(5;11)(q31;q23) and both
RT   alleles are disrupted in three cases of myelodysplastic syndrome/acute
RT   myeloid leukemia with a deletion 5q.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:9168-9173(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 53-785.
RA   Bojesen S.E., Link C., Borkhardt A.;
RT   "Genomic structure of the human GRAF gene.";
RL   Submitted (JAN-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 62-814 (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [8]
RP   STRUCTURE BY NMR OF 754-814.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the SH3 domain of human oligophrenin-1-like protein
RT   (KIAA0621).";
RL   Submitted (DEC-2003) to the PDB data bank.
CC   -!- FUNCTION: GTPase-activating protein for RHOA and CDC42.
CC   -!- SUBUNIT: Interacts with NYAP1, NYAP2 and MYO16 (By similarity). Binds
CC       to the C-terminus of PTK2/FAK1. {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q9UNA1; O14613: CDC42EP2; NbExp=3; IntAct=EBI-1390913, EBI-3438291;
CC       Q9UNA1-2; O14613: CDC42EP2; NbExp=3; IntAct=EBI-16430964, EBI-3438291;
CC       Q9UNA1; Q6P5Z2: PKN3; NbExp=4; IntAct=EBI-1390913, EBI-1384335;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion {ECO:0000250}.
CC       Cytoplasm, cytoskeleton {ECO:0000250}. Note=Colocalizes with actin
CC       stress fibers and cortical actin structures. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UNA1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UNA1-2; Sequence=VSP_001659;
CC   -!- DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An
CC       aggressive pediatric myelodysplastic syndrome/myeloproliferative
CC       disorder characterized by malignant transformation in the hematopoietic
CC       stem cell compartment with proliferation of differentiated progeny.
CC       Patients have splenomegaly, enlarged lymph nodes, rashes, and
CC       hemorrhages. Note=The gene represented in this entry is involved in
CC       disease pathogenesis. A chromosomal translocation t(5;11)(q31;q23) with
CC       KMT2A/MLL1 has been found in leukemic cells from JMML patients, also
CC       carrying inactivating mutations on the second allele (PubMed:10908648).
CC       {ECO:0000269|PubMed:10908648}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/GRAFID291.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Graf1 entry;
CC       URL="https://en.wikipedia.org/wiki/Graf1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF141884; AAD39482.1; -; mRNA.
DR   EMBL; Y10388; CAA71414.2; -; Genomic_DNA.
DR   EMBL; CH471062; EAW61876.1; -; Genomic_DNA.
DR   EMBL; BC068555; AAH68555.1; -; mRNA.
DR   EMBL; AJ309466; CAC29145.2; -; Genomic_DNA.
DR   EMBL; AJ309467; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309468; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309469; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309470; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309471; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309472; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309473; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309474; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309475; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309476; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309477; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309478; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309479; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309480; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309481; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309482; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309483; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309484; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309485; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309486; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309487; CAC29145.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309466; CAC29146.2; -; Genomic_DNA.
DR   EMBL; AJ309467; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309468; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309469; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309470; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309471; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309472; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309473; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309474; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309475; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309476; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309477; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309478; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309479; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309480; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309481; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309482; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309483; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309484; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309485; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AJ309487; CAC29146.2; JOINED; Genomic_DNA.
DR   EMBL; AB014521; BAA31596.1; -; mRNA.
DR   CCDS; CCDS4277.1; -. [Q9UNA1-1]
DR   CCDS; CCDS47297.1; -. [Q9UNA1-2]
DR   PIR; F59430; F59430.
DR   RefSeq; NP_001129080.1; NM_001135608.1. [Q9UNA1-2]
DR   RefSeq; NP_055886.1; NM_015071.4. [Q9UNA1-1]
DR   PDB; 1UGV; NMR; -; A=756-814.
DR   PDBsum; 1UGV; -.
DR   SMR; Q9UNA1; -.
DR   BioGrid; 116720; 25.
DR   IntAct; Q9UNA1; 31.
DR   MINT; Q9UNA1; -.
DR   STRING; 9606.ENSP00000274498; -.
DR   iPTMnet; Q9UNA1; -.
DR   PhosphoSitePlus; Q9UNA1; -.
DR   SwissPalm; Q9UNA1; -.
DR   BioMuta; ARHGAP26; -.
DR   DMDM; 21759332; -.
DR   EPD; Q9UNA1; -.
DR   jPOST; Q9UNA1; -.
DR   MassIVE; Q9UNA1; -.
DR   PaxDb; Q9UNA1; -.
DR   PeptideAtlas; Q9UNA1; -.
DR   PRIDE; Q9UNA1; -.
DR   ProteomicsDB; 85274; -. [Q9UNA1-1]
DR   ProteomicsDB; 85275; -. [Q9UNA1-2]
DR   Antibodypedia; 27437; 243 antibodies.
DR   Ensembl; ENST00000274498; ENSP00000274498; ENSG00000145819. [Q9UNA1-1]
DR   Ensembl; ENST00000645722; ENSP00000495131; ENSG00000145819. [Q9UNA1-2]
DR   GeneID; 23092; -.
DR   KEGG; hsa:23092; -.
DR   UCSC; uc003lmt.4; human. [Q9UNA1-1]
DR   CTD; 23092; -.
DR   DisGeNET; 23092; -.
DR   GeneCards; ARHGAP26; -.
DR   HGNC; HGNC:17073; ARHGAP26.
DR   HPA; ENSG00000145819; Low tissue specificity.
DR   MalaCards; ARHGAP26; -.
DR   MIM; 605370; gene.
DR   MIM; 607785; phenotype.
DR   neXtProt; NX_Q9UNA1; -.
DR   OpenTargets; ENSG00000145819; -.
DR   PharmGKB; PA134946198; -.
DR   eggNOG; KOG1451; Eukaryota.
DR   eggNOG; ENOG410YJPS; LUCA.
DR   GeneTree; ENSGT00940000157254; -.
DR   HOGENOM; CLU_011532_2_0_1; -.
DR   InParanoid; Q9UNA1; -.
DR   KO; K20071; -.
DR   OMA; ETETEIC; -.
DR   OrthoDB; 693048at2759; -.
DR   PhylomeDB; Q9UNA1; -.
DR   TreeFam; TF316851; -.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   ChiTaRS; ARHGAP26; human.
DR   EvolutionaryTrace; Q9UNA1; -.
DR   GeneWiki; ARHGAP26; -.
DR   GenomeRNAi; 23092; -.
DR   Pharos; Q9UNA1; Tbio.
DR   PRO; PR:Q9UNA1; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9UNA1; protein.
DR   Bgee; ENSG00000145819; Expressed in blood and 207 other tissues.
DR   ExpressionAtlas; Q9UNA1; baseline and differential.
DR   Genevisible; Q9UNA1; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005096; F:GTPase activator activity; IBA:GO_Central.
DR   GO; GO:0005543; F:phospholipid binding; IDA:FlyBase.
DR   GO; GO:0030036; P:actin cytoskeleton organization; NAS:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; NAS:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007165; P:signal transduction; IEA:InterPro.
DR   CDD; cd07636; BAR_GRAF; 1.
DR   CDD; cd12064; SH3_GRAF; 1.
DR   Gene3D; 1.10.555.10; -; 1.
DR   Gene3D; 1.20.1270.60; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR027267; AH/BAR_dom_sf.
DR   InterPro; IPR030061; GRAF.
DR   InterPro; IPR035483; GRAF_BAR.
DR   InterPro; IPR035481; GRAF_SH3.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   InterPro; IPR000198; RhoGAP_dom.
DR   InterPro; IPR036028; SH3-like_dom_sf.
DR   InterPro; IPR001452; SH3_domain.
DR   PANTHER; PTHR12552:SF4; PTHR12552:SF4; 1.
DR   Pfam; PF00169; PH; 1.
DR   Pfam; PF00620; RhoGAP; 1.
DR   Pfam; PF14604; SH3_9; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00324; RhoGAP; 1.
DR   SMART; SM00326; SH3; 1.
DR   SUPFAM; SSF103657; SSF103657; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF50044; SSF50044; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
DR   PROSITE; PS50238; RHOGAP; 1.
DR   PROSITE; PS50002; SH3; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction;
KW   Chromosomal rearrangement; Cytoplasm; Cytoskeleton; Disease mutation;
KW   GTPase activation; Proto-oncogene; Reference proteome; SH3 domain.
FT   CHAIN           1..814
FT                   /note="Rho GTPase-activating protein 26"
FT                   /id="PRO_0000056718"
FT   DOMAIN          265..369
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   DOMAIN          383..568
FT                   /note="Rho-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00172"
FT   DOMAIN          756..814
FT                   /note="SH3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00192"
FT   COMPBIAS        584..701
FT                   /note="Ser-rich"
FT   VAR_SEQ         700..754
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_001659"
FT   VARIANT         417
FT                   /note="N -> S (in JMML; somatic mutation;
FT                   dbSNP:rs121918546)"
FT                   /evidence="ECO:0000269|PubMed:10908648"
FT                   /id="VAR_013623"
FT   CONFLICT        355
FT                   /note="E -> G (in Ref. 2; CAA71414 and 3; CAC29145/
FT                   CAC29146)"
FT                   /evidence="ECO:0000305"
FT   STRAND          761..765
FT                   /evidence="ECO:0000244|PDB:1UGV"
FT   STRAND          771..774
FT                   /evidence="ECO:0000244|PDB:1UGV"
FT   STRAND          782..785
FT                   /evidence="ECO:0000244|PDB:1UGV"
FT   STRAND          794..801
FT                   /evidence="ECO:0000244|PDB:1UGV"
FT   STRAND          803..807
FT                   /evidence="ECO:0000244|PDB:1UGV"
FT   HELIX           808..810
FT                   /evidence="ECO:0000244|PDB:1UGV"
FT   STRAND          811..813
FT                   /evidence="ECO:0000244|PDB:1UGV"
SQ   SEQUENCE   814 AA;  92235 MW;  5C81DBDECB32B18A CRC64;
     MGLPALEFSD CCLDSPHFRE TLKSHEAELD KTNKFIKELI KDGKSLISAL KNLSSAKRKF
     ADSLNEFKFQ CIGDAETDDE MCIARSLQEF ATVLRNLEDE RIRMIENASE VLITPLEKFR
     KEQIGAAKEA KKKYDKETEK YCGILEKHLN LSSKKKESQL QEADSQVDLV RQHFYEVSLE
     YVFKVQEVQE RKMFEFVEPL LAFLQGLFTF YHHGYELAKD FGDFKTQLTI SIQNTRNRFE
     GTRSEVESLM KKMKENPLEH KTISPYTMEG YLYVQEKRHF GTSWVKHYCT YQRDSKQITM
     VPFDQKSGGK GGEDESVILK SCTRRKTDSI EKRFCFDVEA VDRPGVITMQ ALSEEDRRLW
     MEAMDGREPV YNSNKDSQSE GTAQLDSIGF SIIRKCIHAV ETRGINEQGL YRIVGVNSRV
     QKLLSVLMDP KTASETETDI CAEWEIKTIT SALKTYLRML PGPLMMYQFQ RSFIKAAKLE
     NQESRVSEIH SLVHRLPEKN RQMLQLLMNH LANVANNHKQ NLMTVANLGV VFGPTLLRPQ
     EETVAAIMDI KFQNIVIEIL IENHEKIFNT VPDMPLTNAQ LHLSRKKSSD SKPPSCSERP
     LTLFHTVQST EKQEQRNSII NSSLESVSSN PNSILNSSSS LQPNMNSSDP DLAVVKPTRP
     NSLPPNPSPT SPLSPSWPMF SAPSSPMPTS STSSDSSPVR SVAGFVWFSV AAVVLSLARS
     SLHAVFSLLV NFVPCHPNLH LLFDRPEEAV HEDSSTPFRK AKALYACKAE HDSELSFTAG
     TVFDNVHPSQ EPGWLEGTLN GKTGLIPENY VEFL
//
ID   B4E2K6_HUMAN            Unreviewed;      1278 AA.
AC   B4E2K6;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 82.
DE   SubName: Full=cDNA FLJ60405, highly similar to Rho guanine nucleotide exchange factor 12 {ECO:0000313|EMBL:BAG65168.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65168.1};
RN   [1] {ECO:0000313|EMBL:BAG65168.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65168.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK304316; BAG65168.1; -; mRNA.
DR   RefSeq; NP_001185594.1; NM_001198665.1.
DR   RefSeq; NP_056128.1; NM_015313.2.
DR   PeptideAtlas; B4E2K6; -.
DR   PRIDE; B4E2K6; -.
DR   DNASU; 23365; -.
DR   GeneID; 23365; -.
DR   KEGG; hsa:23365; -.
DR   CTD; 23365; -.
DR   eggNOG; KOG3520; Eukaryota.
DR   eggNOG; COG5422; LUCA.
DR   KO; K07532; -.
DR   OrthoDB; 319635at2759; -.
DR   GenomeRNAi; 23365; -.
DR   Genevisible; B4E2K6; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:InterPro.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007266; P:Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd13390; PH_LARG; 1.
DR   CDD; cd08754; RGS_LARG; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037801; ARHGEF12_PH.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR037884; LARG_RGS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR041489; PDZ_6.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR041020; PH_16.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015212; RGS-like_dom.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF17820; PDZ_6; 1.
DR   Pfam; PF17838; PH_16; 1.
DR   Pfam; PF09128; RGS-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          53..117
FT                   /note="PDZ"
FT                   /evidence="ECO:0000259|PROSITE:PS50106"
FT   DOMAIN          768..958
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   DOMAIN          1000..1113
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   REGION          229..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          549..688
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1119..1160
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          187..207
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          474..494
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        231..245
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        291..310
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        549..577
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        609..631
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        641..687
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1278
FT                   /evidence="ECO:0000313|EMBL:BAG65168.1"
SQ   SEQUENCE   1278 AA;  143947 MW;  A6279845201B370A CRC64;
     MSGTQSTITD RFPLKKPIRH GSILNRESPT DKKQKVERIA SHDFDPTGLV QRCVIIQKDD
     NGFGLTVSGD NPVFVQSVKE DGAAMRAGVQ TGDRIIKVNG TLVTHSNHLE VVKLIKSGSY
     VALTVQGRPP GSPQIPLADS EVEPSVIGHM SPIMTSPHSP GASGNMERIT SPVLMGEENN
     VVHNQKVEIL RKMLQKEQER LQLLQEDYNR TPAQRLLKEI QEAKKHIPQL QEQLSKATGS
     AQDGAVVTPS RPLGDTLTVS EAETDPGDVL GRTDCSSGDA SRPSSDNADS PKSGPKERIY
     LEENPEKSET IQDTDTQSLV GSPSTRIAPH IIGAEDDDFG TEHEQINGQC SCFQSIELLK
     SRPAHLAVFL HHVVSQFDPA TLLCYLYSDL YKHTNSKETR RIFLEFHQFF LDRSAHLKVS
     VPDEMSADLE KRRPELIPED LHRHYIQTMQ ERVHPEVQRH LEDFRQKRSM GLTLAESELT
     KLDAERDKDR LTLEKERTCA EQIVAKIEEV LMTAQAVEED KSSTMQYVIL MYMKHLGVKV
     KEPRNLEHKR GRIGFLPKIK QSMKKDKEGE EKGKRRGFPS ILGPPRRPSR HDNSAIGRAM
     ELQKARHPKH LSTPSSVSPE PQDSAKLRQS GLANEGTDAG YLPANSMSSV ASGASFSQEG
     GKENDTGSKQ VGETSAPGDT LDGTPRTLNT VFDFPPPPLD QVQEEECEVE RVTEHGTPKP
     FRKFDSVAFG ESQSEDEQFE NDLETDPPNW QQLVSREVLL GLKPCEIKRQ EVINELFYTE
     RAHVRTLKVL DQVFYQRVSR EGILSPSELR KIFSNLEDIL QLHIGLNEQM KAVRKRNETS
     VIDQIGEDLL TWFSGPGEEK LKHAAATFCS NQPFALEMIK SRQKKDSRFQ TFVQDAESNP
     LCRRLQLKDI IPTQMQRLTK YPLLLDNIAK YTEWPTEREK VKKAADHCRQ ILNYVNQAVK
     EAENKQRLED YQRRLDTSSL KLSEYPNVEE LRNLDLTKRK MIHEGPLVWK VNRDKTIDLY
     TLLLEDILVL LQKQDDRLVL RCHSKILAST ADSKHTFSPV IKLSTVLVRQ VATDNKALFV
     ISMSDNGAQI YELVAQTVSE KTVWQDLICR MAASVKEQST KPIPLPQSTP GEGDNDEEDP
     SKLKEEQHGI SVTGLQSPDR DLGLESTLIS SKPQSHSLST SGKSEVRDLF VAERQFAKEQ
     HTDGTLKEVG EDYQIAIPDS HLPVSEERWA LDALRNLGLL KQLLVQQLGL TEKSVQEDWQ
     HFPRYRTASQ GPQTDSVI
//
ID   E9PMR6_HUMAN            Unreviewed;      1441 AA.
AC   E9PMR6;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-APR-2011, sequence version 1.
DT   22-APR-2020, entry version 76.
DE   SubName: Full=Rho guanine nucleotide exchange factor 12 {ECO:0000313|Ensembl:ENSP00000432984};
GN   Name=ARHGEF12 {ECO:0000313|Ensembl:ENSP00000432984};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000432984, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000432984, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18088087}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schutz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [4] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [5] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [6] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [7] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [9] {ECO:0000313|Ensembl:ENSP00000432984}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [10] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [11] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AP000659; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP000758; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP001150; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001288013.1; NM_001301084.1.
DR   RefSeq; XP_011541022.1; XM_011542720.2.
DR   RefSeq; XP_016872910.1; XM_017017421.1.
DR   EPD; E9PMR6; -.
DR   jPOST; E9PMR6; -.
DR   MaxQB; E9PMR6; -.
DR   PeptideAtlas; E9PMR6; -.
DR   PRIDE; E9PMR6; -.
DR   ProteomicsDB; 22191; -.
DR   Antibodypedia; 9144; 151 antibodies.
DR   Ensembl; ENST00000532993; ENSP00000432984; ENSG00000196914.
DR   GeneID; 23365; -.
DR   UCSC; uc009zau.2; human.
DR   CTD; 23365; -.
DR   EuPathDB; HostDB:ENSG00000196914.8; -.
DR   HGNC; HGNC:14193; ARHGEF12.
DR   OpenTargets; ENSG00000196914; -.
DR   eggNOG; KOG3520; Eukaryota.
DR   eggNOG; COG5422; LUCA.
DR   GeneTree; ENSGT00940000157662; -.
DR   HOGENOM; CLU_003962_1_1_1; -.
DR   ChiTaRS; ARHGEF12; human.
DR   GenomeRNAi; 23365; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000196914; Expressed in visceral pleura and 234 other tissues.
DR   ExpressionAtlas; E9PMR6; baseline and differential.
DR   GO; GO:0005737; C:cytoplasm; IEA:InterPro.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IEA:InterPro.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:InterPro.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IEA:InterPro.
DR   GO; GO:0007266; P:Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd13390; PH_LARG; 1.
DR   CDD; cd08754; RGS_LARG; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037801; ARHGEF12_PH.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR037884; LARG_RGS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR041489; PDZ_6.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR041020; PH_16.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015212; RGS-like_dom.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF17820; PDZ_6; 1.
DR   Pfam; PF17838; PH_16; 1.
DR   Pfam; PF09128; RGS-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Guanine-nucleotide releasing factor {ECO:0000256|SAAS:SAAS01163629};
KW   Proteomics identification {ECO:0000213|MaxQB:E9PMR6,
KW   ECO:0000213|PeptideAtlas:E9PMR6, ECO:0000213|ProteomicsDB:E9PMR6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          1..33
FT                   /note="PDZ"
FT                   /evidence="ECO:0000259|PROSITE:PS50106"
FT   DOMAIN          684..874
FT                   /note="DH"
FT                   /evidence="ECO:0000259|PROSITE:PS50010"
FT   DOMAIN          916..1029
FT                   /note="PH"
FT                   /evidence="ECO:0000259|PROSITE:PS50003"
FT   REGION          144..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          465..604
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1035..1076
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          103..123
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          390..410
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        147..161
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..226
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        465..493
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        525..547
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        557..603
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1441 AA;  161909 MW;  7343555DCD901EDD CRC64;
     MRAGVQTGDR IIKVNGTLVT HSNHLEVVKL IKSGSYVALT VQGRPPGSPQ IPLADSEVEP
     SVIGHMSPIM TSPHSPGASG NMERITSPVL MGEENNVVHN QKVEILRKML QKEQERLQLL
     QEDYNRTPAQ RLLKEIQEAK KHIPQLQEQL SKATGSAQDG AVVTPSRPLG DTLTVSEAET
     DPGDVLGRTD CSSGDASRPS SDNADSPKSG PKERIYLEEN PEKSETIQDT DTQSLVGSPS
     TRIAPHIIGA EDDDFGTEHE QINGQCSCFQ SIELLKSRPA HLAVFLHHVV SQFDPATLLC
     YLYSDLYKHT NSKETRRIFL EFHQFFLDRS AHLKVSVPDE MSADLEKRRP ELIPEDLHRH
     YIQTMQERVH PEVQRHLEDF RQKRSMGLTL AESELTKLDA ERDKDRLTLE KERTCAEQIV
     AKIEEVLMTA QAVEEDKSST MQYVILMYMK HLGVKVKEPR NLEHKRGRIG FLPKIKQSMK
     KDKEGEEKGK RRGFPSILGP PRRPSRHDNS AIGRAMELQK ARHPKHLSTP SSVSPEPQDS
     AKLRQSGLAN EGTDAGYLPA NSMSSVASGA SFSQEGGKEN DTGSKQVGET SAPGDTLDGT
     PRTLNTVFDF PPPPLDQVQE EECEVERVTE HGTPKPFRKF DSVAFGESQS EDEQFENDLE
     TDPPNWQQLV SREVLLGLKP CEIKRQEVIN ELFYTERAHV RTLKVLDQVF YQRVSREGIL
     SPSELRKIFS NLEDILQLHI GLNEQMKAVR KRNETSVIDQ IGEDLLTWFS GPGEEKLKHA
     AATFCSNQPF ALEMIKSRQK KDSRFQTFVQ DAESNPLCRR LQLKDIIPTQ MQRLTKYPLL
     LDNIAKYTEW PTEREKVKKA ADHCRQILNY VNQAVKEAEN KQRLEDYQRR LDTSSLKLSE
     YPNVEELRNL DLTKRKMIHE GPLVWKVNRD KTIDLYTLLL EDILVLLQKQ DDRLVLRCHS
     KILASTADSK HTFSPVIKLS TVLVRQVATD NKALFVISMS DNGAQIYELV AQTVSEKTVW
     QDLICRMAAS VKEQSTKPIP LPQSTPGEGD NDEEDPSKLK EEQHGISVTG LQSPDRDLGL
     ESTLISSKPQ SHSLSTSGKS EVRDLFVAER QFAKEQHTDG TLKEVGEDYQ IAIPDSHLPV
     SEERWALDAL RNLGLLKQLL VQQLGLTEKS VQEDWQHFPR YRTASQGPQT DSVIQNSENI
     KAYHSGEGHM PFRTGTGDIA TCYSPRTSTE SFAPRDSVGL APQDSQASNI LVMDHMIMTP
     EMPTMEPEGG LDDSGEHFFD AREAHSDENP SEGDGAVNKE EKDVNLRISG NYLILDGYDP
     VQESSTDEEV ASSLTLQPMT GIPAVESTHQ QQHSPQNTHS DGAISPFTPE FLVQQRWGAM
     EYSCFEIQSP SSCADSQSQI MEYIHKIEAD LEHLKKVEES YTILCQRLAG SALTDKHSDK
     S
//
ID   ARHGC_HUMAN             Reviewed;        1544 AA.
AC   Q9NZN5; O15086; Q6P526;
DT   29-AUG-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 178.
DE   RecName: Full=Rho guanine nucleotide exchange factor 12;
DE   AltName: Full=Leukemia-associated RhoGEF;
GN   Name=ARHGEF12; Synonyms=KIAA0382, LARG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND CHROMOSOMAL
RP   TRANSLOCATION.
RC   TISSUE=Prostate;
RX   PubMed=10681437; DOI=10.1073/pnas.040569197;
RA   Kourlas P.J., Strout M.P., Becknell B., Veronese M.L., Croce C.M.,
RA   Theil K.S., Krahe R., Ruutu T., Knuutila S., Bloomfield C.D.,
RA   Caligiuri M.A.;
RT   "Identification of a gene at 11q23 encoding a guanine nucleotide exchange
RT   factor: evidence for its fusion with MLL in acute myeloid leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:2145-2150(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-584 (ISOFORM 2).
RC   TISSUE=Thyroid;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 102-1544, AND VARIANT PHE-973.
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [4]
RP   SEQUENCE REVISION.
RA   Ohara O., Nagase T., Kikuno R., Nomura N.;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   FUNCTION, AND INTERACTION WITH RHOA; GNA12 AND GNA13.
RX   PubMed=11094164; DOI=10.1016/s0014-5793(00)02224-9;
RA   Fukuhara S., Chikumi H., Gutkind J.S.;
RT   "Leukemia-associated Rho guanine nucleotide exchange factor (LARG) links
RT   heterotrimeric G proteins of the G(12) family to Rho.";
RL   FEBS Lett. 485:183-188(2000).
RN   [6]
RP   INTERACTION WITH IGF1R.
RX   PubMed=11724822; DOI=10.1083/jcb.200106139;
RA   Taya S., Inagaki N., Sengiku H., Makino H., Iwamatsu A., Urakawa I.,
RA   Nagao K., Kataoka S., Kaibuchi K.;
RT   "Direct interaction of insulin-like growth factor-1 receptor with leukemia-
RT   associated RhoGEF.";
RL   J. Cell Biol. 155:809-820(2001).
RN   [7]
RP   INTERACTION WITH PLXNB1 AND PLXNB2.
RX   PubMed=12372594; DOI=10.1016/s0014-5793(02)03323-9;
RA   Driessens M.H.E., Olivo C., Nagata K., Inagaki M., Collard J.G.;
RT   "B plexins activate Rho through PDZ-RhoGEF.";
RL   FEBS Lett. 529:168-172(2002).
RN   [8]
RP   INTERACTION WITH PLXNB1 AND PLXNB2.
RX   PubMed=12183458; DOI=10.1074/jbc.m206005200;
RA   Perrot V., Vazquez-Prado J., Gutkind J.S.;
RT   "Plexin B regulates Rho through the guanine nucleotide exchange factors
RT   leukemia-associated Rho GEF (LARG) and PDZ-RhoGEF.";
RL   J. Biol. Chem. 277:43115-43120(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-736, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-341, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-41 (ISOFORM 2), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   INTERACTION WITH GCSAM.
RX   PubMed=20844236; DOI=10.1182/blood-2010-04-281568;
RA   Jiang X., Lu X., McNamara G., Liu X., Cubedo E., Sarosiek K.A.,
RA   Sanchez-Garcia I., Helfman D.M., Lossos I.S.;
RT   "HGAL, a germinal center specific protein, decreases lymphoma cell motility
RT   by modulation of the RhoA signaling pathway.";
RL   Blood 116:5217-5227(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-41; SER-309; SER-341;
RP   SER-637; THR-736 AND SER-1288, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309; SER-637; SER-1327;
RP   SER-1377; SER-1457 AND SER-1541, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT
RP   SER-41 (ISOFORM 2), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.13 ANGSTROMS) OF 766-1138 IN COMPLEX WITH RHOA,
RP   AND SUBUNIT.
RX   PubMed=15331592; DOI=10.1074/jbc.m406056200;
RA   Kristelly R., Gao G., Tesmer J.J.;
RT   "Structural determinants of RhoA binding and nucleotide exchange in
RT   leukemia-associated Rho guanine-nucleotide exchange factor.";
RL   J. Biol. Chem. 279:47352-47362(2004).
RN   [21]
RP   STRUCTURE BY NMR OF 67-151 IN COMPLEX WITH PLXNB1, AND SUBUNIT.
RX   PubMed=18411422; DOI=10.1110/ps.073416508;
RA   Liu J., Zhang J., Yang Y., Huang H., Shen W., Hu Q., Wang X., Wu J.,
RA   Shi Y.;
RT   "Conformational change upon ligand binding and dynamics of the PDZ domain
RT   from leukemia-associated Rho guanine nucleotide exchange factor.";
RL   Protein Sci. 17:1003-1014(2008).
CC   -!- FUNCTION: May play a role in the regulation of RhoA GTPase by guanine
CC       nucleotide-binding alpha-12 (GNA12) and alpha-13 (GNA13). Acts as
CC       guanine nucleotide exchange factor (GEF) for RhoA GTPase and may act as
CC       GTPase-activating protein (GAP) for GNA12 and GNA13.
CC       {ECO:0000269|PubMed:11094164}.
CC   -!- SUBUNIT: Interacts with GNA12 and GNA13, probably through the RGS-like
CC       domain. Interacts with RHOA, PLXNB1 and PLXNB2. Interacts through its
CC       PDZ domain with IGF1R beta subunit. Interacts with GCSAM.
CC       {ECO:0000269|PubMed:11094164, ECO:0000269|PubMed:11724822,
CC       ECO:0000269|PubMed:12183458, ECO:0000269|PubMed:12372594,
CC       ECO:0000269|PubMed:15331592, ECO:0000269|PubMed:18411422,
CC       ECO:0000269|PubMed:20844236}.
CC   -!- INTERACTION:
CC       Q9NZN5; P08069: IGF1R; NbExp=7; IntAct=EBI-821440, EBI-475981;
CC       Q9NZN5; P61793: Lpar1; Xeno; NbExp=3; IntAct=EBI-821440, EBI-7512335;
CC       Q9NZN5-1; Q96PX9: PLEKHG4B; NbExp=3; IntAct=EBI-9640168, EBI-11741362;
CC       Q9NZN5; P61586: RHOA; NbExp=2; IntAct=EBI-821440, EBI-446668;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000305}. Membrane {ECO:0000305}.
CC       Note=Translocated to the membrane upon stimulation. {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9NZN5-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9NZN5-2; Sequence=VSP_008131;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Isoform 2 is found in
CC       jejunum and testis.
CC   -!- DISEASE: Note=A chromosomal aberration involving ARHGEF12 may be a
CC       cause of acute leukemia. Translocation t(11;11)(q23;23) with
CC       KMT2A/MLL1. {ECO:0000269|PubMed:10681437}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63117.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/LARGID243.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF180681; AAF36817.1; -; mRNA.
DR   EMBL; AB002380; BAA20836.2; -; mRNA.
DR   EMBL; BC063117; AAH63117.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS41727.1; -. [Q9NZN5-1]
DR   CCDS; CCDS55794.1; -. [Q9NZN5-2]
DR   RefSeq; NP_001185594.1; NM_001198665.1. [Q9NZN5-2]
DR   RefSeq; NP_001288013.1; NM_001301084.1.
DR   RefSeq; NP_056128.1; NM_015313.2. [Q9NZN5-1]
DR   RefSeq; XP_011541022.1; XM_011542720.2.
DR   RefSeq; XP_016872910.1; XM_017017421.1.
DR   PDB; 1TXD; X-ray; 2.13 A; A=766-1138.
DR   PDB; 1X86; X-ray; 3.22 A; A/C/E/G=766-1138.
DR   PDB; 2OMJ; NMR; -; A=67-151.
DR   PDB; 2OS6; NMR; -; A=67-151.
DR   PDBsum; 1TXD; -.
DR   PDBsum; 1X86; -.
DR   PDBsum; 2OMJ; -.
DR   PDBsum; 2OS6; -.
DR   SMR; Q9NZN5; -.
DR   BioGrid; 116945; 47.
DR   DIP; DIP-37887N; -.
DR   IntAct; Q9NZN5; 29.
DR   MINT; Q9NZN5; -.
DR   STRING; 9606.ENSP00000380942; -.
DR   iPTMnet; Q9NZN5; -.
DR   PhosphoSitePlus; Q9NZN5; -.
DR   BioMuta; ARHGEF12; -.
DR   DMDM; 34395525; -.
DR   EPD; Q9NZN5; -.
DR   jPOST; Q9NZN5; -.
DR   MassIVE; Q9NZN5; -.
DR   MaxQB; Q9NZN5; -.
DR   PaxDb; Q9NZN5; -.
DR   PeptideAtlas; Q9NZN5; -.
DR   PRIDE; Q9NZN5; -.
DR   ProteomicsDB; 83460; -. [Q9NZN5-1]
DR   ProteomicsDB; 83461; -. [Q9NZN5-2]
DR   Antibodypedia; 9144; 151 antibodies.
DR   DNASU; 23365; -.
DR   Ensembl; ENST00000356641; ENSP00000349056; ENSG00000196914. [Q9NZN5-2]
DR   Ensembl; ENST00000397843; ENSP00000380942; ENSG00000196914. [Q9NZN5-1]
DR   GeneID; 23365; -.
DR   KEGG; hsa:23365; -.
DR   UCSC; uc001pxl.3; human. [Q9NZN5-1]
DR   CTD; 23365; -.
DR   DisGeNET; 23365; -.
DR   GeneCards; ARHGEF12; -.
DR   HGNC; HGNC:14193; ARHGEF12.
DR   HPA; ENSG00000196914; Low tissue specificity.
DR   MIM; 604763; gene.
DR   neXtProt; NX_Q9NZN5; -.
DR   OpenTargets; ENSG00000196914; -.
DR   PharmGKB; PA24969; -.
DR   eggNOG; KOG3520; Eukaryota.
DR   eggNOG; COG5422; LUCA.
DR   GeneTree; ENSGT00940000157662; -.
DR   HOGENOM; CLU_003962_1_0_1; -.
DR   InParanoid; Q9NZN5; -.
DR   KO; K07532; -.
DR   OMA; ERKTWFK; -.
DR   PhylomeDB; Q9NZN5; -.
DR   TreeFam; TF106495; -.
DR   Reactome; R-HSA-193648; NRAGE signals death through JNK.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   Reactome; R-HSA-416482; G alpha (12/13) signalling events.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   SIGNOR; Q9NZN5; -.
DR   ChiTaRS; ARHGEF12; human.
DR   EvolutionaryTrace; Q9NZN5; -.
DR   GeneWiki; ARHGEF12; -.
DR   GenomeRNAi; 23365; -.
DR   Pharos; Q9NZN5; Tbio.
DR   PRO; PR:Q9NZN5; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q9NZN5; protein.
DR   Bgee; ENSG00000196914; Expressed in visceral pleura and 234 other tissues.
DR   ExpressionAtlas; Q9NZN5; baseline and differential.
DR   Genevisible; Q9NZN5; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0001664; F:G protein-coupled receptor binding; IDA:MGI.
DR   GO; GO:0005096; F:GTPase activator activity; IEA:UniProtKB-KW.
DR   GO; GO:0005089; F:Rho guanyl-nucleotide exchange factor activity; IEA:InterPro.
DR   GO; GO:0007186; P:G protein-coupled receptor signaling pathway; IDA:MGI.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0007266; P:Rho protein signal transduction; IEA:InterPro.
DR   CDD; cd13390; PH_LARG; 1.
DR   CDD; cd08754; RGS_LARG; 1.
DR   CDD; cd00160; RhoGEF; 1.
DR   Gene3D; 1.20.900.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   InterPro; IPR037801; ARHGEF12_PH.
DR   InterPro; IPR035899; DBL_dom_sf.
DR   InterPro; IPR000219; DH-domain.
DR   InterPro; IPR001331; GDS_CDC24_CS.
DR   InterPro; IPR037884; LARG_RGS.
DR   InterPro; IPR001478; PDZ.
DR   InterPro; IPR041489; PDZ_6.
DR   InterPro; IPR036034; PDZ_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR041020; PH_16.
DR   InterPro; IPR001849; PH_domain.
DR   InterPro; IPR015212; RGS-like_dom.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF17820; PDZ_6; 1.
DR   Pfam; PF17838; PH_16; 1.
DR   Pfam; PF09128; RGS-like; 1.
DR   Pfam; PF00621; RhoGEF; 1.
DR   SMART; SM00228; PDZ; 1.
DR   SMART; SM00233; PH; 1.
DR   SMART; SM00325; RhoGEF; 1.
DR   SUPFAM; SSF48065; SSF48065; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF50156; SSF50156; 1.
DR   PROSITE; PS00741; DH_1; 1.
DR   PROSITE; PS50010; DH_2; 1.
DR   PROSITE; PS50106; PDZ; 1.
DR   PROSITE; PS50003; PH_DOMAIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromosomal rearrangement;
KW   Coiled coil; Cytoplasm; GTPase activation;
KW   Guanine-nucleotide releasing factor; Membrane; Phosphoprotein;
KW   Polymorphism; Proto-oncogene; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..1544
FT                   /note="Rho guanine nucleotide exchange factor 12"
FT                   /id="PRO_0000080930"
FT   DOMAIN          72..151
FT                   /note="PDZ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00143"
FT   DOMAIN          367..558
FT                   /note="RGSL"
FT   DOMAIN          787..977
FT                   /note="DH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00062"
FT   DOMAIN          1019..1132
FT                   /note="PH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00145"
FT   COILED          194..262
FT                   /evidence="ECO:0000255"
FT   SITE            308..309
FT                   /note="Breakpoint for translocation to form KMT2A/MLL1-
FT                   ARHGEF12 oncogene"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         41
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         309
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         341
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         736
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1288
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1327
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1377
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1457
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         1541
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         48..66
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10681437,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_008131"
FT   VARIANT         973
FT                   /note="Y -> F (in dbSNP:rs2305013)"
FT                   /evidence="ECO:0000269|PubMed:9205841"
FT                   /id="VAR_020191"
FT   STRAND          70..76
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   STRAND          85..87
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   STRAND          89..91
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   STRAND          93..96
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   HELIX           102..106
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   STRAND          112..119
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   TURN            122..124
FT                   /evidence="ECO:0000244|PDB:2OS6"
FT   HELIX           127..135
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   STRAND          137..145
FT                   /evidence="ECO:0000244|PDB:2OMJ"
FT   HELIX           769..772
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           775..778
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           783..812
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           814..820
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           825..832
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           835..853
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          857..860
FT                   /evidence="ECO:0000244|PDB:1X86"
FT   HELIX           865..872
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           875..889
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           891..904
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           906..917
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           919..921
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           926..929
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           932..949
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           954..993
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1001..1003
FT                   /evidence="ECO:0000244|PDB:1X86"
FT   HELIX           1005..1007
FT                   /evidence="ECO:0000244|PDB:1X86"
FT   HELIX           1008..1011
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           1015..1017
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1020..1033
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1038..1053
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1056..1058
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1078..1081
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           1082..1084
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1085..1089
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1091..1093
FT                   /evidence="ECO:0000244|PDB:1X86"
FT   STRAND          1096..1102
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   STRAND          1107..1113
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   HELIX           1117..1137
FT                   /evidence="ECO:0000244|PDB:1TXD"
FT   MOD_RES         Q9NZN5-2:41
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:24275569"
SQ   SEQUENCE   1544 AA;  173232 MW;  0B7E319CF7C7A224 CRC64;
     MSGTQSTITD RFPLKKPIRH GSILNRESPT DKKQKVERIA SHDFDPTDSS SKKTKSSSEE
     SRSEIYGLVQ RCVIIQKDDN GFGLTVSGDN PVFVQSVKED GAAMRAGVQT GDRIIKVNGT
     LVTHSNHLEV VKLIKSGSYV ALTVQGRPPG SPQIPLADSE VEPSVIGHMS PIMTSPHSPG
     ASGNMERITS PVLMGEENNV VHNQKVEILR KMLQKEQERL QLLQEDYNRT PAQRLLKEIQ
     EAKKHIPQLQ EQLSKATGSA QDGAVVTPSR PLGDTLTVSE AETDPGDVLG RTDCSSGDAS
     RPSSDNADSP KSGPKERIYL EENPEKSETI QDTDTQSLVG SPSTRIAPHI IGAEDDDFGT
     EHEQINGQCS CFQSIELLKS RPAHLAVFLH HVVSQFDPAT LLCYLYSDLY KHTNSKETRR
     IFLEFHQFFL DRSAHLKVSV PDEMSADLEK RRPELIPEDL HRHYIQTMQE RVHPEVQRHL
     EDFRQKRSMG LTLAESELTK LDAERDKDRL TLEKERTCAE QIVAKIEEVL MTAQAVEEDK
     SSTMQYVILM YMKHLGVKVK EPRNLEHKRG RIGFLPKIKQ SMKKDKEGEE KGKRRGFPSI
     LGPPRRPSRH DNSAIGRAME LQKARHPKHL STPSSVSPEP QDSAKLRQSG LANEGTDAGY
     LPANSMSSVA SGASFSQEGG KENDTGSKQV GETSAPGDTL DGTPRTLNTV FDFPPPPLDQ
     VQEEECEVER VTEHGTPKPF RKFDSVAFGE SQSEDEQFEN DLETDPPNWQ QLVSREVLLG
     LKPCEIKRQE VINELFYTER AHVRTLKVLD QVFYQRVSRE GILSPSELRK IFSNLEDILQ
     LHIGLNEQMK AVRKRNETSV IDQIGEDLLT WFSGPGEEKL KHAAATFCSN QPFALEMIKS
     RQKKDSRFQT FVQDAESNPL CRRLQLKDII PTQMQRLTKY PLLLDNIAKY TEWPTEREKV
     KKAADHCRQI LNYVNQAVKE AENKQRLEDY QRRLDTSSLK LSEYPNVEEL RNLDLTKRKM
     IHEGPLVWKV NRDKTIDLYT LLLEDILVLL QKQDDRLVLR CHSKILASTA DSKHTFSPVI
     KLSTVLVRQV ATDNKALFVI SMSDNGAQIY ELVAQTVSEK TVWQDLICRM AASVKEQSTK
     PIPLPQSTPG EGDNDEEDPS KLKEEQHGIS VTGLQSPDRD LGLESTLISS KPQSHSLSTS
     GKSEVRDLFV AERQFAKEQH TDGTLKEVGE DYQIAIPDSH LPVSEERWAL DALRNLGLLK
     QLLVQQLGLT EKSVQEDWQH FPRYRTASQG PQTDSVIQNS ENIKAYHSGE GHMPFRTGTG
     DIATCYSPRT STESFAPRDS VGLAPQDSQA SNILVMDHMI MTPEMPTMEP EGGLDDSGEH
     FFDAREAHSD ENPSEGDGAV NKEEKDVNLR ISGNYLILDG YDPVQESSTD EEVASSLTLQ
     PMTGIPAVES THQQQHSPQN THSDGAISPF TPEFLVQQRW GAMEYSCFEI QSPSSCADSQ
     SQIMEYIHKI EADLEHLKKV EESYTILCQR LAGSALTDKH SDKS
//
ID   ARI1A_HUMAN             Reviewed;        2285 AA.
AC   O14497; D3DPL1; Q53FK9; Q5T0W1; Q5T0W2; Q5T0W3; Q8NFD6; Q96T89; Q9BY33;
AC   Q9HBJ5; Q9UPZ1;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   30-AUG-2005, sequence version 3.
DT   22-APR-2020, entry version 203.
DE   RecName: Full=AT-rich interactive domain-containing protein 1A;
DE            Short=ARID domain-containing protein 1A;
DE   AltName: Full=B120;
DE   AltName: Full=BRG1-associated factor 250;
DE            Short=BAF250;
DE   AltName: Full=BRG1-associated factor 250a;
DE            Short=BAF250A;
DE   AltName: Full=Osa homolog 1;
DE            Short=hOSA1;
DE   AltName: Full=SWI-like protein;
DE   AltName: Full=SWI/SNF complex protein p270;
DE   AltName: Full=SWI/SNF-related, matrix-associated, actin-dependent regulator of chromatin subfamily F member 1;
DE   AltName: Full=hELD;
GN   Name=ARID1A; Synonyms=BAF250, BAF250A, C1orf4, OSA1, SMARCF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), PARTIAL PROTEIN SEQUENCE, TISSUE
RP   SPECIFICITY, AND IDENTIFICATION IN THE BAF COMPLEX.
RX   PubMed=11073988; DOI=10.1128/mcb.20.23.8879-8888.2000;
RA   Nie Z., Xue Y., Yang D., Zhou S., Deroo B.J., Archer T.K., Wang W.;
RT   "A specificity and targeting subunit of a human SWI/SNF family-related
RT   chromatin-remodeling complex.";
RL   Mol. Cell. Biol. 20:8879-8888(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 287-2285 (ISOFORM 1), TISSUE SPECIFICITY,
RP   INTERACTION WITH SMARCA2 AND SMARCA4, AND IDENTIFICATION IN A SWI/SNF
RP   COMPLEX WITH ARID1B.
RX   PubMed=12200431; DOI=10.1074/jbc.m205961200;
RA   Inoue H., Furukawa T., Giannakopoulos S., Zhou S., King D.S., Tanese N.;
RT   "Largest subunits of the human SWI/SNF chromatin-remodeling complex promote
RT   transcriptional activation by steroid hormone receptors.";
RL   J. Biol. Chem. 277:41674-41685(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 347-2285 (ISOFORM 1), IDENTIFICATION BY MASS
RP   SPECTROMETRY, AND IDENTIFICATION IN THE BAF COMPLEX.
RC   TISSUE=Brain;
RX   PubMed=11734557; DOI=10.1074/jbc.m108702200;
RA   Kato H., Tjernberg A., Zhang W., Krutchinsky A.N., An W., Takeuchi T.,
RA   Ohtsuki Y., Sugano S., de Bruijn D.R., Chait B.T., Roeder R.G.;
RT   "SYT associates with human SNF/SWI complexes and the C-terminal region of
RT   its fusion partner SSX1 targets histones.";
RL   J. Biol. Chem. 277:5498-5505(2002).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 358-2285 (ISOFORM 1), AND MUTAGENESIS OF
RP   TRP-1073 AND TYR-1096.
RX   PubMed=10757798; DOI=10.1128/mcb.20.9.3137-3146.2000;
RA   Dallas P.B., Pacchione S., Wilsker D., Bowrin V., Kobayashi R., Moran E.;
RT   "The human SWI-SNF complex protein p270 is an ARID family member with non-
RT   sequence-specific DNA binding activity.";
RL   Mol. Cell. Biol. 20:3137-3146(2000).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1585 (ISOFORM 3).
RX   PubMed=9434167; DOI=10.1016/s0378-1119(97)00525-8;
RA   Takeuchi T., Chen B.-K., Qiu Y., Sonobe H., Ohtsuki Y.;
RT   "Molecular cloning and expression of a novel human cDNA containing CAG
RT   repeats.";
RL   Gene 204:71-77(1997).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 380-1515.
RA   Takeuchi T., Misaki A.;
RL   Submitted (FEB-1999) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 384-2285 (ISOFORM 2), ALTERNATIVE SPLICING
RP   (ISOFORM 1), SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=11318604; DOI=10.1006/geno.2001.6477;
RA   Kozmik Z., Machon O., Kralova J., Kreslova J., Paces J., Vlcek C.;
RT   "Characterization of mammalian orthologues of the Drosophila osa gene: cDNA
RT   cloning, expression, chromosomal localization, and direct physical
RT   interaction with Brahma chromatin-remodeling complex.";
RL   Genomics 73:140-148(2001).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1104-2285 (ISOFORM 1).
RC   TISSUE=Gastric mucosa;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   IDENTIFICATION IN SWI/SNF COMPLEXES.
RX   PubMed=8804307; DOI=10.1101/gad.10.17.2117;
RA   Wang W., Xue Y., Zhou S., Kuo A., Cairns B.R., Crabtree G.R.;
RT   "Diversity and specialization of mammalian SWI/SNF complexes.";
RL   Genes Dev. 10:2117-2130(1996).
RN   [12]
RP   IDENTIFICATION IN A SWI/SNF COMPLEX.
RX   PubMed=11780067; DOI=10.1038/414924a;
RA   Lemon B., Inouye C., King D.S., Tjian R.;
RT   "Selectivity of chromatin-remodelling cofactors for ligand-activated
RT   transcription.";
RL   Nature 414:924-928(2001).
RN   [13]
RP   IDENTIFICATION IN A SWI/SNF-LIKE COMPLEX WITH ARID1A.
RX   PubMed=11988099; DOI=10.1042/bj3640255;
RA   Hurlstone A.F., Olave I.A., Barker N., van Noort M., Clevers H.;
RT   "Cloning and characterization of hELD/OSA1, a novel BRG1 interacting
RT   protein.";
RL   Biochem. J. 364:255-264(2002).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-696; SER-698 AND SER-702, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-772, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-286; SER-301; SER-696;
RP   SER-698; SER-764; SER-772 AND SER-1944, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-79; THR-286; SER-363;
RP   SER-604; SER-696; SER-698; SER-702; SER-772 AND SER-1184, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1612 AND LYS-1905, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-772, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363; SER-696; SER-702 AND
RP   SER-1604, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [25]
RP   INVOLVEMENT IN CSS2.
RX   PubMed=22426308; DOI=10.1038/ng.2219;
RA   Tsurusaki Y., Okamoto N., Ohashi H., Kosho T., Imai Y., Hibi-Ko Y.,
RA   Kaname T., Naritomi K., Kawame H., Wakui K., Fukushima Y., Homma T.,
RA   Kato M., Hiraki Y., Yamagata T., Yano S., Mizuno S., Sakazume S., Ishii T.,
RA   Nagai T., Shiina M., Ogata K., Ohta T., Niikawa N., Miyatake S., Okada I.,
RA   Mizuguchi T., Doi H., Saitsu H., Miyake N., Matsumoto N.;
RT   "Mutations affecting components of the SWI/SNF complex cause Coffin-Siris
RT   syndrome.";
RL   Nat. Genet. 44:376-378(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-58; SER-233; SER-363;
RP   SER-382; SER-604; SER-696; SER-698; SER-702; SER-764; SER-772; SER-1184;
RP   SER-1235; SER-1604; SER-1751; SER-1754; THR-1888; SER-1929 AND SER-1944,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-363; SER-696 AND SER-1751,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [29]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-429 AND ARG-1276, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [30]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=12672490; DOI=10.1016/s0959-437x(03)00022-4;
RA   Martens J.A., Winston F.;
RT   "Recent advances in understanding chromatin remodeling by SWI/SNF
RT   complexes.";
RL   Curr. Opin. Genet. Dev. 13:136-142(2003).
RN   [31]
RP   IDENTIFICATION IN A SWI/SNF-LIKE EBAFA COMPLEX, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=12665591; DOI=10.1128/mcb.23.8.2942-2952.2003;
RA   Nie Z., Yan Z., Chen E.H., Sechi S., Ling C., Zhou S., Xue Y., Yang D.,
RA   Murray D., Kanakubo E., Cleary M.L., Wang W.;
RT   "Novel SWI/SNF chromatin-remodeling complexes contain a mixed-lineage
RT   leukemia chromosomal translocation partner.";
RL   Mol. Cell. Biol. 23:2942-2952(2003).
RN   [32]
RP   IDENTIFICATION IN SWI/SNF COMPLEXES, AND INTERACTION WITH SMARCA2; SMARCA4
RP   AND SMARCC1.
RX   PubMed=15170388; DOI=10.1042/bj20040524;
RA   Wang X., Nagl N.G., Wilsker D., Van Scoy M., Pacchione S., Yaciuk P.,
RA   Dallas P.B., Moran E.;
RT   "Two related ARID family proteins are alternative subunits of human SWI/SNF
RT   complexes.";
RL   Biochem. J. 383:319-325(2004).
RN   [33]
RP   IDENTIFICATION IN THE BAF COMPLEX, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=18765789; DOI=10.1101/gad.471408;
RA   Lange M., Kaynak B., Forster U.B., Toenjes M., Fischer J.J., Grimm C.,
RA   Schlesinger J., Just S., Dunkel I., Krueger T., Mebus S., Lehrach H.,
RA   Lurz R., Gobom J., Rottbauer W., Abdelilah-Seyfried S., Sperling S.;
RT   "Regulation of muscle development by DPF3, a novel histone acetylation and
RT   methylation reader of the BAF chromatin remodeling complex.";
RL   Genes Dev. 22:2370-2384(2008).
RN   [34]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=22952240; DOI=10.1074/jbc.r111.309302;
RA   Euskirchen G., Auerbach R.K., Snyder M.;
RT   "SWI/SNF chromatin-remodeling factors: multiscale analyses and diverse
RT   functions.";
RL   J. Biol. Chem. 287:30897-30905(2012).
RN   [35]
RP   REVIEW ON SWI/SNF CHROMATIN REMODELING COMPLEXES.
RX   PubMed=26601204; DOI=10.1126/sciadv.1500447;
RA   Kadoch C., Crabtree G.R.;
RT   "Mammalian SWI/SNF chromatin remodeling complexes and cancer: Mechanistic
RT   insights gained from human genomics.";
RL   Sci. Adv. 1:E1500447-E1500447(2015).
RN   [36]
RP   SUBCELLULAR LOCATION, NUCLEAR LOCALIZATION SIGNAL, AND MUTAGENESIS OF
RP   1370-LYS-ARG-1371; ARG-1383 AND 1656-ARG--ARG-1658.
RX   PubMed=26614907; DOI=10.1016/j.bbrc.2015.11.080;
RA   Bateman N.W., Shoji Y., Conrads K.A., Stroop K.D., Hamilton C.A.,
RA   Darcy K.M., Maxwell G.L., Risinger J.I., Conrads T.P.;
RT   "Identification and functional characterization of a novel bipartite
RT   nuclear localization sequence in ARID1A.";
RL   Biochem. Biophys. Res. Commun. 469:114-119(2016).
RN   [37]
RP   STRUCTURE BY NMR OF 1000-1159.
RX   PubMed=14722072; DOI=10.1074/jbc.m312115200;
RA   Kim S., Zhang Z., Upchurch S., Isern N., Chen Y.;
RT   "Structure and DNA-binding sites of the SWI1 AT-rich interaction domain
RT   (ARID) suggest determinants for sequence-specific DNA recognition.";
RL   J. Biol. Chem. 279:16670-16676(2004).
RN   [38]
RP   VARIANTS LYS-1020 AND PRO-2089.
RX   PubMed=21248752; DOI=10.1038/nature09639;
RA   Varela I., Tarpey P., Raine K., Huang D., Ong C.K., Stephens P., Davies H.,
RA   Jones D., Lin M.L., Teague J., Bignell G., Butler A., Cho J.,
RA   Dalgliesh G.L., Galappaththige D., Greenman C., Hardy C., Jia M.,
RA   Latimer C., Lau K.W., Marshall J., McLaren S., Menzies A., Mudie L.,
RA   Stebbings L., Largaespada D.A., Wessels L.F.A., Richard S., Kahnoski R.J.,
RA   Anema J., Tuveson D.A., Perez-Mancera P.A., Mustonen V., Fischer A.,
RA   Adams D.J., Rust A., Chan-On W., Subimerb C., Dykema K., Furge K.,
RA   Campbell P.J., Teh B.T., Stratton M.R., Futreal P.A.;
RT   "Exome sequencing identifies frequent mutation of the SWI/SNF complex gene
RT   PBRM1 in renal carcinoma.";
RL   Nature 469:539-542(2011).
RN   [39]
RP   VARIANTS TRP-1658; PHE-1907 AND ARG-2087.
RX   PubMed=22009941; DOI=10.1002/humu.21633;
RA   Jones S., Li M., Parsons D.W., Zhang X., Wesseling J., Kristel P.,
RA   Schmidt M.K., Markowitz S., Yan H., Bigner D., Hruban R.H., Eshleman J.R.,
RA   Iacobuzio-Donahue C.A., Goggins M., Maitra A., Malek S.N., Powell S.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E., Papadopoulos N.;
RT   "Somatic mutations in the chromatin remodeling gene ARID1A occur in several
RT   tumor types.";
RL   Hum. Mutat. 33:100-103(2012).
RN   [40]
RP   VARIANT SER-120.
RX   PubMed=23906836; DOI=10.1093/hmg/ddt366;
RA   Wieczorek D., Boegershausen N., Beleggia F., Steiner-Haldenstaett S.,
RA   Pohl E., Li Y., Milz E., Martin M., Thiele H., Altmueller J., Alanay Y.,
RA   Kayserili H., Klein-Hitpass L., Boehringer S., Wollstein A., Albrecht B.,
RA   Boduroglu K., Caliebe A., Chrzanowska K., Cogulu O., Cristofoli F.,
RA   Czeschik J.C., Devriendt K., Dotti M.T., Elcioglu N., Gener B.,
RA   Goecke T.O., Krajewska-Walasek M., Guillen-Navarro E., Hayek J., Houge G.,
RA   Kilic E., Simsek-Kiper P.O., Lopez-Gonzalez V., Kuechler A., Lyonnet S.,
RA   Mari F., Marozza A., Mathieu Dramard M., Mikat B., Morin G.,
RA   Morice-Picard F., Ozkinay F., Rauch A., Renieri A., Tinschert S.,
RA   Utine G.E., Vilain C., Vivarelli R., Zweier C., Nuernberg P., Rahmann S.,
RA   Vermeesch J., Luedecke H.J., Zeschnigk M., Wollnik B.;
RT   "A comprehensive molecular study on Coffin-Siris and Nicolaides-Baraitser
RT   syndromes identifies a broad molecular and clinical spectrum converging on
RT   altered chromatin remodeling.";
RL   Hum. Mol. Genet. 22:5121-5135(2013).
CC   -!- FUNCTION: Involved in transcriptional activation and repression of
CC       select genes by chromatin remodeling (alteration of DNA-nucleosome
CC       topology). Component of SWI/SNF chromatin remodeling complexes that
CC       carry out key enzymatic activities, changing chromatin structure by
CC       altering DNA-histone contacts within a nucleosome in an ATP-dependent
CC       manner. Binds DNA non-specifically. Belongs to the neural progenitors-
CC       specific chromatin remodeling complex (npBAF complex) and the neuron-
CC       specific chromatin remodeling complex (nBAF complex). During neural
CC       development a switch from a stem/progenitor to a postmitotic chromatin
CC       remodeling mechanism occurs as neurons exit the cell cycle and become
CC       committed to their adult state. The transition from proliferating
CC       neural stem/progenitor cells to postmitotic neurons requires a switch
CC       in subunit composition of the npBAF and nBAF complexes. As neural
CC       progenitors exit mitosis and differentiate into neurons, npBAF
CC       complexes which contain ACTL6A/BAF53A and PHF10/BAF45A, are exchanged
CC       for homologous alternative ACTL6B/BAF53B and DPF1/BAF45B or DPF3/BAF45C
CC       subunits in neuron-specific complexes (nBAF). The npBAF complex is
CC       essential for the self-renewal/proliferative capacity of the
CC       multipotent neural stem cells. The nBAF complex along with CREST plays
CC       a role regulating the activity of genes essential for dendrite growth
CC       (By similarity). {ECO:0000250|UniProtKB:A2BH40,
CC       ECO:0000303|PubMed:12672490, ECO:0000303|PubMed:22952240,
CC       ECO:0000303|PubMed:26601204}.
CC   -!- SUBUNIT: Component of SWI/SNF chromatin remodeling complexes, in some
CC       of which it can be mutually exclusive with ARID1B/BAF250B. The
CC       canonical complex contains a catalytic subunit (either
CC       SMARCA4/BRG1/BAF190A or SMARCA2/BRM/BAF190B) and at least SMARCE1,
CC       ACTL6A/BAF53, SMARCC1/BAF155, SMARCC2/BAF170, and SMARCB1/SNF5/BAF47.
CC       Other subunits specific to each of the complexes may also be present
CC       permitting several possible combinations developmentally and tissue
CC       specific (PubMed:22952240, PubMed:26601204, PubMed:12200431,
CC       PubMed:8804307, PubMed:11780067, PubMed:11988099, PubMed:15170388).
CC       Component of the BAF (SWI/SNF-A) complex, which includes at least actin
CC       (ACTB), ARID1A/BAF250A, ARID1B/BAF250B, SMARCA2/BRM,
CC       SMARCA4/BRG1/BAF190A, ACTL6A/BAF53, ACTL6B/BAF53B, SMARCE1/BAF57,
CC       SMARCC1/BAF155, SMARCC2/BAF170, SMARCB1/SNF5/INI1, and one or more
CC       SMARCD1/BAF60A, SMARCD2/BAF60B, or SMARCD3/BAF60C (PubMed:12200431,
CC       PubMed:11734557, PubMed:18765789,). In muscle cells, the BAF complex
CC       also contains DPF3. Component of neural progenitors-specific chromatin
CC       remodeling complex (npBAF complex) composed of at least, ARID1A/BAF250A
CC       or ARID1B/BAF250B, SMARCD1/BAF60A, SMARCD3/BAF60C, SMARCA2/BRM/BAF190B,
CC       SMARCA4/BRG1/BAF190A, SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57,
CC       SMARCC2/BAF170, PHF10/BAF45A, ACTL6A/BAF53A and actin. Component of
CC       neuron-specific chromatin remodeling complex (nBAF complex) composed of
CC       at least, ARID1A/BAF250A or ARID1B/BAF250B, SMARCD1/BAF60A,
CC       SMARCD3/BAF60C, SMARCA2/BRM/BAF190B, SMARCA4/BRG1/BAF190A,
CC       SMARCB1/BAF47, SMARCC1/BAF155, SMARCE1/BAF57, SMARCC2/BAF170,
CC       DPF1/BAF45B, DPF3/BAF45C, ACTL6B/BAF53B and actin (By similarity).
CC       Component of a SWI/SNF-like EBAFa complex, at least composed of
CC       SMARCA4/BRG1/BAF190A, SMARCB1/BAF47/SNF5, ACTL6A/BAF53A, SMARCE1/BAF57,
CC       SMARCD1/BAF60A, SMARCC1/BAF155, SMARCC2/BAF170, BAF250A and MLLT1/ENL
CC       (PubMed:12665591). Interacts through its C-terminus with
CC       SMARCA2/BRM/BAF190B and SMARCA4/BRG1/BAF190A (PubMed:12200431,
CC       PubMed:15170388). Interacts with SMARCC1/BAF155 (PubMed:15170388).
CC       {ECO:0000250|UniProtKB:A2BH40, ECO:0000269|PubMed:11734557,
CC       ECO:0000269|PubMed:11780067, ECO:0000269|PubMed:11988099,
CC       ECO:0000269|PubMed:12200431, ECO:0000269|PubMed:12665591,
CC       ECO:0000269|PubMed:15170388, ECO:0000269|PubMed:18765789,
CC       ECO:0000269|PubMed:8804307, ECO:0000303|PubMed:12672490,
CC       ECO:0000303|PubMed:22952240, ECO:0000303|PubMed:26601204}.
CC   -!- INTERACTION:
CC       O14497; Q14526: HIC1; NbExp=2; IntAct=EBI-637887, EBI-2507362;
CC       O14497; P51531: SMARCA2; NbExp=3; IntAct=EBI-637887, EBI-679562;
CC       O14497; P51532: SMARCA4; NbExp=22; IntAct=EBI-637887, EBI-302489;
CC       O14497-1; P11388: TOP2A; NbExp=2; IntAct=EBI-15956509, EBI-539628;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|PROSITE-ProRule:PRU00355,
CC       ECO:0000269|PubMed:11318604, ECO:0000269|PubMed:26614907}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O14497-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O14497-2; Sequence=VSP_015225;
CC       Name=3;
CC         IsoId=O14497-3; Sequence=VSP_037157;
CC   -!- TISSUE SPECIFICITY: Highly expressed in spleen, thymus, prostate,
CC       testis, ovary, small intestine, colon, and PBL, and at a much lower
CC       level in heart, brain, placenta, lung, liver, skeletal muscle, kidney,
CC       and pancreas. {ECO:0000269|PubMed:11073988,
CC       ECO:0000269|PubMed:11318604, ECO:0000269|PubMed:12200431}.
CC   -!- DISEASE: Coffin-Siris syndrome 2 (CSS2) [MIM:614607]: A form of Coffin-
CC       Siris syndrome, a congenital multiple malformation syndrome with broad
CC       phenotypic and genetic variability. Cardinal features are intellectual
CC       disability, coarse facial features, hypertrichosis, and hypoplastic or
CC       absent fifth digit nails or phalanges. Additional features include
CC       malformations of the cardiac, gastrointestinal, genitourinary, and/or
CC       central nervous systems. Sucking/feeding difficulties, poor growth,
CC       ophthalmologic abnormalities, hearing impairment, and spinal anomalies
CC       are common findings. Both autosomal dominant and autosomal recessive
CC       inheritance patterns have been reported. {ECO:0000269|PubMed:22426308}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF75765.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAG33967.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA23269.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA83073.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAA83073.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF231056; AAG33967.1; ALT_FRAME; mRNA.
DR   EMBL; AL512408; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL034380; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07795.1; -; Genomic_DNA.
DR   EMBL; CH471059; EAX07796.1; -; Genomic_DNA.
DR   EMBL; AF521670; AAN03446.1; -; mRNA.
DR   EMBL; AF219114; AAG17549.2; -; mRNA.
DR   EMBL; AF265208; AAF75765.1; ALT_FRAME; mRNA.
DR   EMBL; AB001895; BAA23269.1; ALT_FRAME; mRNA.
DR   EMBL; AB024075; BAA83073.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AF268913; AAK54505.1; -; mRNA.
DR   EMBL; AK223275; BAD96995.1; -; mRNA.
DR   CCDS; CCDS285.1; -. [O14497-1]
DR   CCDS; CCDS44091.1; -. [O14497-2]
DR   PIR; T00022; T00022.
DR   RefSeq; NP_006006.3; NM_006015.4. [O14497-1]
DR   RefSeq; NP_624361.1; NM_139135.2. [O14497-2]
DR   PDB; 1RYU; NMR; -; A=1000-1119.
DR   PDBsum; 1RYU; -.
DR   SMR; O14497; -.
DR   BioGrid; 113894; 97.
DR   ComplexPortal; CPX-1164; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1194; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1195; Embryonic stem cell-specific SWI/SNF ATP-dependent chromatin remodeling complex.
DR   ComplexPortal; CPX-1201; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1202; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1203; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1204; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1207; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1209; SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1212; Neural progenitor-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1216; Neuron-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1219; Brain-specific SWI/SNF ATP-dependent chromatin remodeling complex, ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1222; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6A-ARID1A-SMARCA4 variant.
DR   ComplexPortal; CPX-1225; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA2 variant.
DR   ComplexPortal; CPX-1226; Muscle cell-specific SWI/SNF ATP-dependent chromatin remodeling complex, ACTL6B-ARID1A-SMARCA4 variant.
DR   CORUM; O14497; -.
DR   DIP; DIP-33016N; -.
DR   IntAct; O14497; 32.
DR   MINT; O14497; -.
DR   STRING; 9606.ENSP00000320485; -.
DR   iPTMnet; O14497; -.
DR   MetOSite; O14497; -.
DR   PhosphoSitePlus; O14497; -.
DR   SwissPalm; O14497; -.
DR   BioMuta; ARID1A; -.
DR   EPD; O14497; -.
DR   jPOST; O14497; -.
DR   MassIVE; O14497; -.
DR   MaxQB; O14497; -.
DR   PaxDb; O14497; -.
DR   PeptideAtlas; O14497; -.
DR   PRIDE; O14497; -.
DR   ProteomicsDB; 48041; -. [O14497-1]
DR   ProteomicsDB; 48042; -. [O14497-2]
DR   ProteomicsDB; 48043; -. [O14497-3]
DR   Antibodypedia; 1691; 204 antibodies.
DR   Ensembl; ENST00000324856; ENSP00000320485; ENSG00000117713. [O14497-1]
DR   Ensembl; ENST00000374152; ENSP00000363267; ENSG00000117713. [O14497-3]
DR   Ensembl; ENST00000457599; ENSP00000387636; ENSG00000117713. [O14497-2]
DR   GeneID; 8289; -.
DR   KEGG; hsa:8289; -.
DR   UCSC; uc001bmu.2; human. [O14497-1]
DR   CTD; 8289; -.
DR   DisGeNET; 8289; -.
DR   GeneCards; ARID1A; -.
DR   GeneReviews; ARID1A; -.
DR   HGNC; HGNC:11110; ARID1A.
DR   HPA; ENSG00000117713; Low tissue specificity.
DR   MalaCards; ARID1A; -.
DR   MIM; 603024; gene.
DR   MIM; 614607; phenotype.
DR   neXtProt; NX_O14497; -.
DR   OpenTargets; ENSG00000117713; -.
DR   Orphanet; 1465; Coffin-Siris syndrome.
DR   PharmGKB; PA35960; -.
DR   eggNOG; KOG2510; Eukaryota.
DR   eggNOG; ENOG410Y034; LUCA.
DR   GeneTree; ENSGT00940000155194; -.
DR   HOGENOM; CLU_000974_1_1_1; -.
DR   InParanoid; O14497; -.
DR   KO; K11653; -.
DR   OMA; PMDQVGK; -.
DR   OrthoDB; 256110at2759; -.
DR   PhylomeDB; O14497; -.
DR   TreeFam; TF320364; -.
DR   Reactome; R-HSA-3214858; RMTs methylate histone arginines.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   SIGNOR; O14497; -.
DR   ChiTaRS; ARID1A; human.
DR   EvolutionaryTrace; O14497; -.
DR   GeneWiki; ARID1A; -.
DR   GenomeRNAi; 8289; -.
DR   Pharos; O14497; Tbio.
DR   PRO; PR:O14497; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O14497; protein.
DR   Bgee; ENSG00000117713; Expressed in cerebral cortex and 236 other tissues.
DR   ExpressionAtlas; O14497; baseline and differential.
DR   Genevisible; O14497; HS.
DR   GO; GO:0035060; C:brahma complex; IEA:InterPro.
DR   GO; GO:0071565; C:nBAF complex; ISS:UniProtKB.
DR   GO; GO:0071564; C:npBAF complex; ISS:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; TAS:UniProtKB.
DR   GO; GO:0016514; C:SWI/SNF complex; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0016922; F:nuclear receptor binding; IPI:BHF-UCL.
DR   GO; GO:0031491; F:nucleosome binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; NAS:BHF-UCL.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043044; P:ATP-dependent chromatin remodeling; IBA:GO_Central.
DR   GO; GO:0003205; P:cardiac chamber development; IEA:Ensembl.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0006338; P:chromatin remodeling; IDA:BHF-UCL.
DR   GO; GO:0048096; P:chromatin-mediated maintenance of transcription; TAS:UniProtKB.
DR   GO; GO:0007566; P:embryo implantation; IEA:Ensembl.
DR   GO; GO:0030900; P:forebrain development; IEA:Ensembl.
DR   GO; GO:0001704; P:formation of primary germ layer; IEA:Ensembl.
DR   GO; GO:0042921; P:glucocorticoid receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0030520; P:intracellular estrogen receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0006344; P:maintenance of chromatin silencing; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0001843; P:neural tube closure; IEA:Ensembl.
DR   GO; GO:0006337; P:nucleosome disassembly; IDA:BHF-UCL.
DR   GO; GO:0042766; P:nucleosome mobilization; TAS:UniProtKB.
DR   GO; GO:0003408; P:optic cup formation involved in camera-type eye development; IEA:Ensembl.
DR   GO; GO:0060674; P:placenta blood vessel development; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0019827; P:stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   Gene3D; 1.10.150.60; -; 1.
DR   Gene3D; 1.25.10.10; -; 1.
DR   InterPro; IPR001606; ARID_dom.
DR   InterPro; IPR036431; ARID_dom_sf.
DR   InterPro; IPR011989; ARM-like.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR021906; BAF250/Osa.
DR   InterPro; IPR033388; BAF250_C.
DR   InterPro; IPR030094; BAF250a.
DR   PANTHER; PTHR12656; PTHR12656; 1.
DR   PANTHER; PTHR12656:SF12; PTHR12656:SF12; 1.
DR   Pfam; PF01388; ARID; 1.
DR   Pfam; PF12031; BAF250_C; 1.
DR   SMART; SM00501; BRIGHT; 1.
DR   SUPFAM; SSF46774; SSF46774; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS51011; ARID; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Chromatin regulator;
KW   Direct protein sequencing; DNA-binding; Mental retardation; Methylation;
KW   Neurogenesis; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Transcription; Transcription regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378"
FT   CHAIN           2..2285
FT                   /note="AT-rich interactive domain-containing protein 1A"
FT                   /id="PRO_0000200575"
FT   DOMAIN          1017..1108
FT                   /note="ARID"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00355"
FT   MOTIF           295..299
FT                   /note="LXXLL"
FT   MOTIF           1368..1387
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000269|PubMed:26614907"
FT   MOTIF           1709..1713
FT                   /note="LXXLL"
FT   MOTIF           1967..1971
FT                   /note="LXXLL"
FT   MOTIF           2085..2089
FT                   /note="LXXLL"
FT   COMPBIAS        479..482
FT                   /note="Poly-Gln"
FT   COMPBIAS        561..567
FT                   /note="Poly-Gln"
FT   COMPBIAS        998..1001
FT                   /note="Poly-Ser"
FT   COMPBIAS        1327..1404
FT                   /note="Gln-rich"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         58
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         79
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         233
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         286
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         301
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         382
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         429
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         604
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         696
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         698
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         702
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         730
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:A2BH40"
FT   MOD_RES         764
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         772
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1184
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1235
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1276
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         1604
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1612
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1751
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1754
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1888
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1905
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1929
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1944
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..383
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:9434167"
FT                   /id="VSP_037157"
FT   VAR_SEQ         1367..1583
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11318604"
FT                   /id="VSP_015225"
FT   VARIANT         120
FT                   /note="P -> S (in dbSNP:rs571264557)"
FT                   /evidence="ECO:0000269|PubMed:23906836"
FT                   /id="VAR_076938"
FT   VARIANT         1020
FT                   /note="R -> K (found in a clear cell renal carcinoma;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21248752"
FT                   /id="VAR_064695"
FT   VARIANT         1658
FT                   /note="R -> W (found in a gastric cancer sample; somatic
FT                   mutation; dbSNP:rs1442666063)"
FT                   /evidence="ECO:0000269|PubMed:22009941"
FT                   /id="VAR_068021"
FT   VARIANT         1907
FT                   /note="I -> F (found in a breast cancer sample; somatic
FT                   mutation; dbSNP:rs139230162)"
FT                   /evidence="ECO:0000269|PubMed:22009941"
FT                   /id="VAR_068022"
FT   VARIANT         2087
FT                   /note="G -> R (found in a breast cancer sample; somatic
FT                   mutation; dbSNP:rs1553153748)"
FT                   /evidence="ECO:0000269|PubMed:22009941"
FT                   /id="VAR_068023"
FT   VARIANT         2089
FT                   /note="L -> P (found in a clear cell renal carcinoma case;
FT                   somatic mutation)"
FT                   /evidence="ECO:0000269|PubMed:21248752"
FT                   /id="VAR_064696"
FT   MUTAGEN         1073
FT                   /note="W->A: Partial loss of DNA-binding activity. Complete
FT                   loss of activity; when associated with A-1096."
FT                   /evidence="ECO:0000269|PubMed:10757798"
FT   MUTAGEN         1096
FT                   /note="Y->A: Partial loss of DNA-binding activity. Complete
FT                   loss of activity; when associated with A-1073."
FT                   /evidence="ECO:0000269|PubMed:10757798"
FT   MUTAGEN         1370..1371
FT                   /note="KR->TT: Displays nucleocytoplasmic localization and
FT                   increased stability; when associated with T-1383."
FT                   /evidence="ECO:0000269|PubMed:26614907"
FT   MUTAGEN         1383
FT                   /note="R->T: Displays nucleocytoplasmic localization and
FT                   increased stability; when associated with 1370-T-T-1371."
FT                   /evidence="ECO:0000269|PubMed:26614907"
FT   MUTAGEN         1656..1658
FT                   /note="RRR->TTT: No effect on subcellular localization."
FT                   /evidence="ECO:0000269|PubMed:26614907"
FT   CONFLICT        410
FT                   /note="G -> D (in Ref. 1; AAG33967, 7; BAA23269 and 8;
FT                   BAA83073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        434
FT                   /note="M -> V (in Ref. 1; AAG33967, 7; BAA23269 and 8;
FT                   BAA83073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        636
FT                   /note="P -> T (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        732
FT                   /note="Q -> S (in Ref. 1; AAG33967, 5; AAG17549 and 7;
FT                   BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        750
FT                   /note="R -> RG (in Ref. 8; BAA83073)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        757
FT                   /note="P -> S (in Ref. 1; AAG33967, 5; AAG17549 and 7;
FT                   BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        776
FT                   /note="P -> L (in Ref. 1; AAG33967, 5; AAG17549 and 7;
FT                   BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        858
FT                   /note="M -> V (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        871
FT                   /note="N -> T (in Ref. 7; BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        875
FT                   /note="M -> I (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1017
FT                   /note="E -> G (in Ref. 1; AAG33967, 5; AAG17549 and 7;
FT                   BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1180
FT                   /note="Missing (in Ref. 10; BAD96995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1307
FT                   /note="P -> S (in Ref. 1; AAG33967, 5; AAG17549 and 7;
FT                   BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1389
FT                   /note="Y -> F (in Ref. 5; AAG17549)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1399
FT                   /note="Q -> L (in Ref. 1; AAG33967 and 7; BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1416
FT                   /note="Q -> P (in Ref. 1; AAG33967 and 7; BAA23269)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1532
FT                   /note="M -> V (in Ref. 1; AAG33967)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1638
FT                   /note="D -> A (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1789
FT                   /note="A -> T (in Ref. 10; BAD96995)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1839
FT                   /note="S -> R (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2131
FT                   /note="N -> D (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2143
FT                   /note="R -> H (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2159
FT                   /note="K -> E (in Ref. 9; AAK54505)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2182
FT                   /note="A -> T (in Ref. 10; BAD96995)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1010..1012
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   STRAND          1014..1016
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   HELIX           1018..1033
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   STRAND          1045..1048
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   HELIX           1051..1061
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   HELIX           1066..1068
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   HELIX           1072..1079
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   HELIX           1087..1099
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   TURN            1100..1107
FT                   /evidence="ECO:0000244|PDB:1RYU"
FT   TURN            1109..1111
FT                   /evidence="ECO:0000244|PDB:1RYU"
SQ   SEQUENCE   2285 AA;  242045 MW;  85BC5B6061625D8E CRC64;
     MAAQVAPAAA SSLGNPPPPP PSELKKAEQQ QREEAGGEAA AAAAAERGEM KAAAGQESEG
     PAVGPPQPLG KELQDGAESN GGGGGGGAGS GGGPGAEPDL KNSNGNAGPR PALNNNLTEP
     PGGGGGGSSD GVGAPPHSAA AALPPPAYGF GQPYGRSPSA VAAAAAAVFH QQHGGQQSPG
     LAALQSGGGG GLEPYAGPQQ NSHDHGFPNH QYNSYYPNRS AYPPPAPAYA LSSPRGGTPG
     SGAAAAAGSK PPPSSSASAS SSSSSFAQQR FGAMGGGGPS AAGGGTPQPT ATPTLNQLLT
     SPSSARGYQG YPGGDYSGGP QDGGAGKGPA DMASQCWGAA AAAAAAAAAS GGAQQRSHHA
     PMSPGSSGGG GQPLARTPQP SSPMDQMGKM RPQPYGGTNP YSQQQGPPSG PQQGHGYPGQ
     PYGSQTPQRY PMTMQGRAQS AMGGLSYTQQ IPPYGQQGPS GYGQQGQTPY YNQQSPHPQQ
     QQPPYSQQPP SQTPHAQPSY QQQPQSQPPQ LQSSQPPYSQ QPSQPPHQQS PAPYPSQQST
     TQQHPQSQPP YSQPQAQSPY QQQQPQQPAP STLSQQAAYP QPQSQQSQQT AYSQQRFPPP
     QELSQDSFGS QASSAPSMTS SKGGQEDMNL SLQSRPSSLP DLSGSIDDLP MGTEGALSPG
     VSTSGISSSQ GEQSNPAQSP FSPHTSPHLP GIRGPSPSPV GSPASVAQSR SGPLSPAAVP
     GNQMPPRPPS GQSDSIMHPS MNQSSIAQDR GYMQRNPQMP QYSSPQPGSA LSPRQPSGGQ
     IHTGMGSYQQ NSMGSYGPQG GQYGPQGGYP RQPNYNALPN ANYPSAGMAG GINPMGAGGQ
     MHGQPGIPPY GTLPPGRMSH ASMGNRPYGP NMANMPPQVG SGMCPPPGGM NRKTQETAVA
     MHVAANSIQN RPPGYPNMNQ GGMMGTGPPY GQGINSMAGM INPQGPPYSM GGTMANNSAG
     MAASPEMMGL GDVKLTPATK MNNKADGTPK TESKSKKSSS STTTNEKITK LYELGGEPER
     KMWVDRYLAF TEEKAMGMTN LPAVGRKPLD LYRLYVSVKE IGGLTQVNKN KKWRELATNL
     NVGTSSSAAS SLKKQYIQCL YAFECKIERG EDPPPDIFAA ADSKKSQPKI QPPSPAGSGS
     MQGPQTPQST SSSMAEGGDL KPPTPASTPH SQIPPLPGMS RSNSVGIQDA FNDGSDSTFQ
     KRNSMTPNPG YQPSMNTSDM MGRMSYEPNK DPYGSMRKAP GSDPFMSSGQ GPNGGMGDPY
     SRAAGPGLGN VAMGPRQHYP YGGPYDRVRT EPGIGPEGNM STGAPQPNLM PSNPDSGMYS
     PSRYPPQQQQ QQQQRHDSYG NQFSTQGTPS GSPFPSQQTT MYQQQQQNYK RPMDGTYGPP
     AKRHEGEMYS VPYSTGQGQP QQQQLPPAQP QPASQQQAAQ PSPQQDVYNQ YGNAYPATAT
     AATERRPAGG PQNQFPFQFG RDRVSAPPGT NAQQNMPPQM MGGPIQASAE VAQQGTMWQG
     RNDMTYNYAN RQSTGSAPQG PAYHGVNRTD EMLHTDQRAN HEGSWPSHGT RQPPYGPSAP
     VPPMTRPPPS NYQPPPSMQN HIPQVSSPAP LPRPMENRTS PSKSPFLHSG MKMQKAGPPV
     PASHIAPAPV QPPMIRRDIT FPPGSVEATQ PVLKQRRRLT MKDIGTPEAW RVMMSLKSGL
     LAESTWALDT INILLYDDNS IMTFNLSQLP GLLELLVEYF RRCLIEIFGI LKEYEVGDPG
     QRTLLDPGRF SKVSSPAPME GGEEEEELLG PKLEEEEEEE VVENDEEIAF SGKDKPASEN
     SEEKLISKFD KLPVKIVQKN DPFVVDCSDK LGRVQEFDSG LLHWRIGGGD TTEHIQTHFE
     SKTELLPSRP HAPCPPAPRK HVTTAEGTPG TTDQEGPPPD GPPEKRITAT MDDMLSTRSS
     TLTEDGAKSS EAIKESSKFP FGISPAQSHR NIKILEDEPH SKDETPLCTL LDWQDSLAKR
     CVCVSNTIRS LSFVPGNDFE MSKHPGLLLI LGKLILLHHK HPERKQAPLT YEKEEEQDQG
     VSCNKVEWWW DCLEMLRENT LVTLANISGQ LDLSPYPESI CLPVLDGLLH WAVCPSAEAQ
     DPFSTLGPNA VLSPQRLVLE TLSKLSIQDN NVDLILATPP FSRLEKLYST MVRFLSDRKN
     PVCREMAVVL LANLAQGDSL AARAIAVQKG SIGNLLGFLE DSLAATQFQQ SQASLLHMQN
     PPFEPTSVDM MRRAARALLA LAKVDENHSE FTLYESRLLD ISVSPLMNSL VSQVICDVLF
     LIGQS
//
ID   A0A087WWW9_HUMAN        Unreviewed;       222 AA.
AC   A0A087WWW9;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 2.
DT   22-APR-2020, entry version 39.
DE   SubName: Full=B-cell lymphoma/leukemia 10 {ECO:0000313|Ensembl:ENSP00000480561};
GN   Name=BCL10 {ECO:0000313|Ensembl:ENSP00000480561};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000480561, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000480561, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:19413330}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000213|PubMed:21406692}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [5] {ECO:0000313|Ensembl:ENSP00000480561}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL590113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001307644.1; NM_001320715.1.
DR   jPOST; A0A087WWW9; -.
DR   PeptideAtlas; A0A087WWW9; -.
DR   Antibodypedia; 4526; 1229 antibodies.
DR   Ensembl; ENST00000620248; ENSP00000480561; ENSG00000142867.
DR   GeneID; 8915; -.
DR   UCSC; uc057iab.1; human.
DR   CTD; 8915; -.
DR   EuPathDB; HostDB:ENSG00000142867.12; -.
DR   HGNC; HGNC:989; BCL10.
DR   OpenTargets; ENSG00000142867; -.
DR   GeneTree; ENSGT00490000043442; -.
DR   HOGENOM; CLU_103803_1_0_1; -.
DR   ChiTaRS; BCL10; human.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000142867; Expressed in epithelial cell of pancreas and 223 other tissues.
DR   ExpressionAtlas; A0A087WWW9; baseline and differential.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:InterPro.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   CDD; cd08810; CARD_BCL10; 1.
DR   InterPro; IPR033238; BCL10/E10.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR042143; CARD_BCL10.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   PANTHER; PTHR34920; PTHR34920; 1.
DR   Pfam; PF00619; CARD; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50209; CARD; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:A0A087WWW9,
KW   ECO:0000213|MaxQB:A0A087WWW9, ECO:0000213|PeptideAtlas:A0A087WWW9,
KW   ECO:0000213|ProteomicsDB:A0A087WWW9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          13..87
FT                   /note="CARD"
FT                   /evidence="ECO:0000259|PROSITE:PS50209"
FT   REGION          176..222
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        201..222
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   222 AA;  25102 MW;  82781C1DB8C2414E CRC64;
     MEPTAPSLTE EDLTEVKKDA LENLRVYLCE KIIAERHFDH LRAKKILSRE DTEEISCRTS
     SRKRAGKLLD YLQENPKGLD TLVESIRREK TQNFLIQKIT DEVLKLRNIK LEHLKDGATN
     NLSRSNSDES NFSEKLRAST VMYHPEGESS TTPFFSTNSS LNLPVLEVGR TENTIFSSTT
     LPRPGDPGAP PLPPDLQLEE EGTCANSSEM FLPLRSRTVS RQ
//
ID   A2TDT2_HUMAN            Unreviewed;       157 AA.
AC   A2TDT2;
DT   06-MAR-2007, integrated into UniProtKB/TrEMBL.
DT   06-MAR-2007, sequence version 1.
DT   11-DEC-2019, entry version 55.
DE   SubName: Full=Mutant B-cell CLL/lymphoma 10 {ECO:0000313|EMBL:ABN09569.1};
GN   Name=BCL10 {ECO:0000313|EMBL:ABN09569.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABN09569.1};
RN   [1] {ECO:0000313|EMBL:ABN09569.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Ocular adnexal MALT lymphomas {ECO:0000313|EMBL:ABN09569.1};
RX   PubMed=23661444; DOI=10.4238/2013.April.12.6;
RA   Zhu J., Wei R.L., Pi Y.L., Guo Q.;
RT   "Significance of Bcl10 gene mutations in the clinical diagnosis of MALT-
RT   type ocular adnexal lymphoma in the Chinese population.";
RL   Genet. Mol. Res. 12:1194-1204(2013).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF189176; ABN09569.1; -; mRNA.
DR   RefSeq; NP_001307644.1; NM_001320715.1.
DR   PeptideAtlas; A2TDT2; -.
DR   PRIDE; A2TDT2; -.
DR   GeneID; 8915; -.
DR   CTD; 8915; -.
DR   OrthoDB; 1472514at2759; -.
DR   ChiTaRS; BCL10; human.
DR   GenomeRNAi; 8915; -.
DR   GO; GO:0006915; P:apoptotic process; IEA:InterPro.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IEA:InterPro.
DR   GO; GO:0042981; P:regulation of apoptotic process; IEA:InterPro.
DR   InterPro; IPR033238; BCL10/E10.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   PANTHER; PTHR34920; PTHR34920; 1.
DR   Pfam; PF00619; CARD; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50209; CARD; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          13..87
FT                   /note="CARD"
FT                   /evidence="ECO:0000259|PROSITE:PS50209"
SQ   SEQUENCE   157 AA;  18221 MW;  CD0AE33364933B1F CRC64;
     MEPTAPSLTE EDLTEVKKDA LENLRVYLCE KIIAERHFDH LRAKKILSRE DTEEISCRTS
     SRKRAGKLLD YLQENPKGLD TLVESIRREK TQNFLIQKIT DEVLKLRNIK LEHLKDGATN
     NLSRSNSDES NFSEKLRAST VMYHPEGESS TTPFFFY
//
ID   BCL10_HUMAN             Reviewed;         233 AA.
AC   O95999; Q5VUF1;
DT   02-MAY-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-1999, sequence version 1.
DT   22-APR-2020, entry version 182.
DE   RecName: Full=B-cell lymphoma/leukemia 10;
DE   AltName: Full=B-cell CLL/lymphoma 10;
DE            Short=Bcl-10;
DE   AltName: Full=CARD-containing molecule enhancing NF-kappa-B;
DE   AltName: Full=CARD-like apoptotic protein;
DE            Short=hCLAP;
DE   AltName: Full=CED-3/ICH-1 prodomain homologous E10-like regulator;
DE            Short=CIPER;
DE   AltName: Full=Cellular homolog of vCARMEN;
DE            Short=cCARMEN;
DE   AltName: Full=Cellular-E10;
DE            Short=c-E10;
DE   AltName: Full=Mammalian CARD-containing adapter molecule E10;
DE            Short=mE10;
GN   Name=BCL10; Synonyms=CIPER, CLAP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INVOLVEMENT IN MALTOMA, AND VARIANTS ILE-52;
RP   GLY-58; GLU-210 DEL AND PHE-218.
RC   TISSUE=Lymphoma;
RX   PubMed=9989495; DOI=10.1016/s0092-8674(00)80957-5;
RA   Willis T.G., Jadayel D.M., Du M.-Q., Peng H., Perry A.R., Abdul-Rauf M.,
RA   Price H., Karran L., Majekodunmi O., Wlodarska I., Pan L., Crook T.,
RA   Hamoudi R., Isaacson P., Dyer M.J.S.;
RT   "Bcl10 is involved in t(1;14)(p22;q32) of MALT B cell lymphoma and mutated
RT   in multiple tumor types.";
RL   Cell 96:35-45(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF LEU-41 AND GLY-78.
RX   PubMed=10187770; DOI=10.1074/jbc.274.15.9955;
RA   Koseki T., Inohara N., Chen S., Carrio R., Merino J., Hottiger M.O.,
RA   Nabel G.J., Nunez G.;
RT   "CIPER, a novel NF kappaB-activating protein containing a caspase
RT   recruitment domain with homology to Herpesvirus-2 protein E10.";
RL   J. Biol. Chem. 274:9955-9961(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10187771; DOI=10.1074/jbc.274.15.9962;
RA   Thome M., Martinon F., Hofmann K., Rubio V., Steiner V., Schneider P.,
RA   Mattmann C., Tschopp J.;
RT   "Equine herpesvirus-2 E10 gene product, but not its cellular homologue,
RT   activates NF-kappaB transcription factor and c-Jun N-terminal kinase.";
RL   J. Biol. Chem. 274:9962-9968(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND MUTAGENESIS OF LEU-28; LEU-41; ILE-46;
RP   LEU-47; GLU-53 AND ILE-55.
RX   PubMed=10187815; DOI=10.1074/jbc.274.15.10287;
RA   Yan M., Lee J., Schilbach S., Goddard A., Dixit V.M.;
RT   "mE10, a novel caspase recruitment domain-containing proapoptotic
RT   molecule.";
RL   J. Biol. Chem. 274:10287-10292(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10364242; DOI=10.1074/jbc.274.25.17946;
RA   Srinivasula S.M., Ahmad M., Lin J.-H., Poyet J.-L., Fernandes-Alnemri T.,
RA   Tsichlis P.N., Alnemri E.S.;
RT   "CLAP, a novel caspase recruitment domain-containing protein in the tumor
RT   necrosis factor receptor pathway, regulates NF-kappaB activation and
RT   apoptosis.";
RL   J. Biol. Chem. 274:17946-17954(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Spleen;
RX   PubMed=10400625; DOI=10.1074/jbc.274.29.20127;
RA   Costanzo A., Guiet C., Vito P.;
RT   "c-E10 is a caspase-recruiting domain-containing protein that interacts
RT   with components of death receptors signaling pathway and activates nuclear
RT   factor-kappaB.";
RL   J. Biol. Chem. 274:20127-20132(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA], AND VARIANTS SER-5; GLU-16;
RP   GLU-31; ARG-57; LYS-64; GLU-101; PRO-134; ALA-168; SER-174; GLU-213 AND
RP   ILE-230.
RX   PubMed=10319863; DOI=10.1038/8767;
RA   Zhang Q., Siebert R., Yan M., Hinzmann B., Cui X., Xue L., Rakestraw K.M.,
RA   Naeve C.W., Beckmann G., Weisenburger D.D., Sanger W.G., Nowotny H.,
RA   Vesely M., Callet-Bauchu E., Salles G., Dixit V.M., Rosenthal A.,
RA   Schlegelberger B., Morris S.W.;
RT   "Inactivating mutations and overexpression of BCL10, a caspase recruitment
RT   domain-containing gene, in MALT lymphoma with t(1;14)(p22;q32).";
RL   Nat. Genet. 22:63-68(1999).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   PHOSPHORYLATION.
RX   PubMed=11466612; DOI=10.1038/sj.onc.1204576;
RA   Yui D., Yoneda T., Oono K., Katayama T., Imaizumi K., Tohyama M.;
RT   "Interchangeable binding of Bcl10 to TRAF2 and cIAPs regulates apoptosis
RT   signaling.";
RL   Oncogene 20:4317-4323(2001).
RN   [13]
RP   IDENTIFICATION IN A MEMBRANE RAFT COMPLEX, AND SUBCELLULAR LOCATION.
RX   PubMed=17287217; DOI=10.1074/jbc.m609157200;
RA   Ohnuma K., Uchiyama M., Yamochi T., Nishibashi K., Hosono O., Takahashi N.,
RA   Kina S., Tanaka H., Lin X., Dang N.H., Morimoto C.;
RT   "Caveolin-1 triggers T-cell activation via CD26 in association with
RT   CARMA1.";
RL   J. Biol. Chem. 282:10117-10131(2007).
RN   [14]
RP   PHOSPHORYLATION BY IKBKB/IKKB, AND MUTAGENESIS OF 81-THR--SER-85.
RX   PubMed=17213322; DOI=10.1073/pnas.0606982104;
RA   Lobry C., Lopez T., Israel A., Weil R.;
RT   "Negative feedback loop in T cell activation through IkappaB kinase-induced
RT   phosphorylation and degradation of Bcl10.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:908-913(2007).
RN   [15]
RP   FUNCTION, AND MUTAGENESIS OF ARG-228.
RX   PubMed=18264101; DOI=10.1038/ni1568;
RA   Rebeaud F., Hailfinger S., Posevitz-Fejfar A., Tapernoux M., Moser R.,
RA   Rueda D., Gaide O., Guzzardi M., Iancu E.M., Rufer N., Fasel N., Thome M.;
RT   "The proteolytic activity of the paracaspase MALT1 is key in T cell
RT   activation.";
RL   Nat. Immunol. 9:272-281(2008).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-138, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   FUNCTION, AND INVOLVEMENT IN IMD37.
RX   PubMed=25365219; DOI=10.1172/jci77493;
RA   Torres J.M., Martinez-Barricarte R., Garcia-Gomez S., Mazariegos M.S.,
RA   Itan Y., Boisson B., Rholvarez R., Jimenez-Reinoso A., Del Pino L.,
RA   Rodriguez-Pena R., Ferreira A., Hernandez-Jimenez E., Toledano V.,
RA   Cubillos-Zapata C., Diaz-Almiron M., Lopez-Collazo E., Unzueta-Roch J.L.,
RA   Sanchez-Ramon S., Regueiro J.R., Lopez-Granados E., Casanova J.L.,
RA   Perez de Diego R.;
RT   "Inherited BCL10 deficiency impairs hematopoietic and nonhematopoietic
RT   immunity.";
RL   J. Clin. Invest. 124:5239-5248(2014).
RN   [20]
RP   SUBUNIT.
RX   PubMed=27113748; DOI=10.15252/embr.201642109;
RA   Afonina I.S., Van Nuffel E., Baudelet G., Driege Y., Kreike M., Staal J.,
RA   Beyaert R.;
RT   "The paracaspase MALT1 mediates CARD14-induced signaling in
RT   keratinocytes.";
RL   EMBO Rep. 17:914-927(2016).
RN   [21]
RP   INTERACTION WITH CARD11 AND MALT1.
RX   PubMed=28628108; DOI=10.1038/ng.3898;
RA   Ma C.A., Stinson J.R., Zhang Y., Abbott J.K., Weinreich M.A., Hauk P.J.,
RA   Reynolds P.R., Lyons J.J., Nelson C.G., Ruffo E., Dorjbal B., Glauzy S.,
RA   Yamakawa N., Arjunaraja S., Voss K., Stoddard J., Niemela J., Zhang Y.,
RA   Rosenzweig S.D., McElwee J.J., DiMaggio T., Matthews H.F., Jones N.,
RA   Stone K.D., Palma A., Oleastro M., Prieto E., Bernasconi A.R., Dubra G.,
RA   Danielian S., Zaiat J., Marti M.A., Kim B., Cooper M.A., Romberg N.,
RA   Meffre E., Gelfand E.W., Snow A.L., Milner J.D.;
RT   "Germline hypomorphic CARD11 mutations in severe atopic disease.";
RL   Nat. Genet. 49:1192-1201(2017).
RN   [22]
RP   VARIANTS SER-5; MET-162 AND GLU-213.
RX   PubMed=10582682;
RA   Lee S.H., Shin M.S., Kim H.S., Park W.S., Kim S.Y., Lee H.K., Park J.Y.,
RA   Oh R.R., Jang J.J., Park K.M., Han J.Y., Kang C.S., Lee J.Y., Yoo N.J.;
RT   "Point mutations and deletions of the Bcl10 gene in solid tumors and
RT   malignant lymphomas.";
RL   Cancer Res. 59:5674-5677(1999).
RN   [23]
RP   VARIANTS SER-5; GLN-45; GLN-58; SER-93; VAL-153; GLU-213 AND PHE-218.
RX   PubMed=10380921; DOI=10.1016/s0092-8674(02)09765-9;
RA   Apostolou S., de Rienzo A., Murthy S.S., Jhanwar S.C., Testa J.R.;
RT   "Absence of BCL10 mutations in human malignant mesothelioma.";
RL   Cell 97:684-686(1999).
CC   -!- FUNCTION: Involved in adaptive immune response (PubMed:25365219).
CC       Promotes apoptosis, pro-caspase-9 maturation and activation of NF-
CC       kappa-B via NIK and IKK. May be an adapter protein between upstream
CC       TNFR1-TRADD-RIP complex and the downstream NIK-IKK-IKAP complex. Is a
CC       substrate for MALT1 (PubMed:18264101). {ECO:0000269|PubMed:18264101,
CC       ECO:0000269|PubMed:25365219}.
CC   -!- SUBUNIT: Found in a membrane raft complex, at least composed of BCL10,
CC       CARD11, DPP4 and IKBKB. Self-associates by CARD-CARD interaction and
CC       forms a tight complex with MALT1. Interacts with other CARD-proteins
CC       such as CARD9, CARD10, CARD11 and CARD14. Forms a complex with CARD14
CC       and MALT1; resulting in the formation of a CBM (CARD14-BCL10-MALT1)
CC       complex (PubMed:27113748). Binds caspase-9 with its C-terminal domain.
CC       Interacts with TRAF2 and BIRC2/c-IAP2. Interacts with PELI2 and SOCS3;
CC       these interactions may be mutually exclusive (By similarity). Interacts
CC       with CARD11 and MALT1; as part of a CBM (CARD11-BCL10-MALT1) complex
CC       involved in NF-kappa-B activation. {ECO:0000250|UniProtKB:Q9Z0H7,
CC       ECO:0000269|PubMed:27113748}.
CC   -!- INTERACTION:
CC       O95999; O95999; NbExp=5; IntAct=EBI-958922, EBI-958922;
CC       O95999; P31749: AKT1; NbExp=5; IntAct=EBI-958922, EBI-296087;
CC       O95999; P20749: BCL3; NbExp=3; IntAct=EBI-958922, EBI-958997;
CC       O95999; Q9BXL7: CARD11; NbExp=7; IntAct=EBI-958922, EBI-7006141;
CC       O95999; Q9H257: CARD9; NbExp=6; IntAct=EBI-958922, EBI-751319;
CC       O95999; Q9Y2V7: COG6; NbExp=5; IntAct=EBI-958922, EBI-3866319;
CC       O95999; Q66677: E10; Xeno; NbExp=2; IntAct=EBI-958922, EBI-11709474;
CC       O95999; Q9Y6K9: IKBKG; NbExp=7; IntAct=EBI-958922, EBI-81279;
CC       O95999; Q9UDY8: MALT1; NbExp=18; IntAct=EBI-958922, EBI-1047372;
CC       O95999; Q05513: PRKCZ; NbExp=3; IntAct=EBI-958922, EBI-295351;
CC       O95999; Q12933: TRAF2; NbExp=9; IntAct=EBI-958922, EBI-355744;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, perinuclear region
CC       {ECO:0000269|PubMed:17287217}. Membrane raft
CC       {ECO:0000269|PubMed:17287217}. Note=Appears to have a perinuclear,
CC       compact and filamentous pattern of expression. Also found in the
CC       nucleus of several types of tumor cells. Colocalized with DPP4 in
CC       membrane rafts.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylated. Phosphorylation results in dissociation from TRAF2
CC       and binding to BIRC2/c-IAP2. Phosphorylated by IKBKB/IKKB.
CC       {ECO:0000269|PubMed:11466612, ECO:0000269|PubMed:17213322}.
CC   -!- DISEASE: Note=A chromosomal aberration involving BCL10 is recurrent in
CC       low-grade mucosa-associated lymphoid tissue (MALT lymphoma).
CC       Translocation t(1;14)(p22;q32). Although the BCL10/IgH translocation
CC       leaves the coding region of BCL10 intact, frequent BCL10 mutations
CC       could be attributed to the Ig somatic hypermutation mechanism resulting
CC       in nucleotide transitions.
CC   -!- DISEASE: Immunodeficiency 37 (IMD37) [MIM:616098]: A form of primary
CC       combined immunodeficiency, a group of disorders characterized by severe
CC       recurrent infections, with normal numbers or an absence of T and B
CC       lymphocytes, and impaired cellular and humoral immunity. IMD37 is
CC       characterized by hypogammaglobulinemia without lymphopenia, but with
CC       profoundly reduced memory B cells and memory T cells, and increased
CC       numbers of circulating naive lymphocytes. Inheritance is autosomal
CC       recessive. {ECO:0000269|PubMed:25365219}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Lymphoma, mucosa-associated lymphoid type (MALTOMA)
CC       [MIM:137245]: A subtype of non-Hodgkin lymphoma, originating in mucosa-
CC       associated lymphoid tissue. MALT lymphomas occur most commonly in the
CC       gastro-intestinal tract but have been described in a variety of
CC       extranodal sites including the ocular adnexa, salivary gland, thyroid,
CC       lung, thymus, and breast. Histologically, they are characterized by an
CC       infiltrate of small to medium-sized lymphocytes with abundant cytoplasm
CC       and irregularly shaped nuclei. Scattered transformed blasts (large
CC       cells) also are present. Non-malignant reactive follicles are observed
CC       frequently. A pivotal feature is the presence of lymphoepithelial
CC       lesions, with invasion and partial destruction of mucosal glands and
CC       crypts by aggregates of tumor cells. {ECO:0000269|PubMed:9989495}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/BCL10ID222ch1p22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AJ006288; CAA06955.1; -; mRNA.
DR   EMBL; AF057700; AAD15800.1; -; mRNA.
DR   EMBL; AF100338; AAD16428.1; -; mRNA.
DR   EMBL; AF127386; AAD32597.1; -; mRNA.
DR   EMBL; AF134395; AAD39147.1; -; mRNA.
DR   EMBL; AF105066; AAF06894.1; -; mRNA.
DR   EMBL; AF082283; AAC99767.1; -; mRNA.
DR   EMBL; AF097732; AAD24918.1; -; Genomic_DNA.
DR   EMBL; AK291346; BAF84035.1; -; mRNA.
DR   EMBL; AL590113; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471097; EAW73208.1; -; Genomic_DNA.
DR   EMBL; BC053617; AAH53617.1; -; mRNA.
DR   CCDS; CCDS704.1; -.
DR   RefSeq; NP_003912.1; NM_003921.4.
DR   PDB; 2MB9; NMR; -; A=1-115.
DR   PDB; 6BZE; EM; 4.00 A; A/B/C/D/E/F/G/H=10-115.
DR   PDB; 6GK2; EM; 4.90 A; H=10-115.
DR   PDBsum; 2MB9; -.
DR   PDBsum; 6BZE; -.
DR   PDBsum; 6GK2; -.
DR   SMR; O95999; -.
DR   BioGrid; 114429; 67.
DR   CORUM; O95999; -.
DR   DIP; DIP-29740N; -.
DR   IntAct; O95999; 39.
DR   MINT; O95999; -.
DR   STRING; 9606.ENSP00000359612; -.
DR   iPTMnet; O95999; -.
DR   PhosphoSitePlus; O95999; -.
DR   SwissPalm; O95999; -.
DR   BioMuta; BCL10; -.
DR   EPD; O95999; -.
DR   jPOST; O95999; -.
DR   MassIVE; O95999; -.
DR   PaxDb; O95999; -.
DR   PeptideAtlas; O95999; -.
DR   PRIDE; O95999; -.
DR   ProteomicsDB; 51178; -.
DR   Antibodypedia; 4526; 1229 antibodies.
DR   DNASU; 8915; -.
DR   Ensembl; ENST00000648566; ENSP00000498104; ENSG00000142867.
DR   GeneID; 8915; -.
DR   KEGG; hsa:8915; -.
DR   UCSC; uc021opd.3; human.
DR   CTD; 8915; -.
DR   DisGeNET; 8915; -.
DR   GeneCards; BCL10; -.
DR   HGNC; HGNC:989; BCL10.
DR   HPA; ENSG00000142867; Low tissue specificity.
DR   MalaCards; BCL10; -.
DR   MIM; 137245; phenotype.
DR   MIM; 603517; gene.
DR   MIM; 616098; phenotype.
DR   neXtProt; NX_O95999; -.
DR   OpenTargets; ENSG00000142867; -.
DR   Orphanet; 52417; MALT lymphoma.
DR   PharmGKB; PA25299; -.
DR   eggNOG; ENOG410IVMM; Eukaryota.
DR   eggNOG; ENOG4111JRA; LUCA.
DR   GeneTree; ENSGT00490000043442; -.
DR   HOGENOM; CLU_103803_0_0_1; -.
DR   InParanoid; O95999; -.
DR   KO; K07368; -.
DR   OMA; RHYLCDK; -.
DR   OrthoDB; 1472514at2759; -.
DR   PhylomeDB; O95999; -.
DR   TreeFam; TF328636; -.
DR   Reactome; R-HSA-1169091; Activation of NF-kappaB in B cells.
DR   Reactome; R-HSA-202424; Downstream TCR signaling.
DR   Reactome; R-HSA-2871837; FCERI mediated NF-kB activation.
DR   Reactome; R-HSA-5607764; CLEC7A (Dectin-1) signaling.
DR   Reactome; R-HSA-8866654; E3 ubiquitin ligases ubiquitinate target proteins.
DR   SignaLink; O95999; -.
DR   SIGNOR; O95999; -.
DR   ChiTaRS; BCL10; human.
DR   GeneWiki; BCL10; -.
DR   GenomeRNAi; 8915; -.
DR   Pharos; O95999; Tbio.
DR   PRO; PR:O95999; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; O95999; protein.
DR   Bgee; ENSG00000142867; Expressed in epithelial cell of pancreas and 223 other tissues.
DR   ExpressionAtlas; O95999; baseline and differential.
DR   Genevisible; O95999; HS.
DR   GO; GO:0032449; C:CBM complex; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005881; C:cytoplasmic microtubule; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005764; C:lysosome; IDA:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0002096; C:polkadots; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0050700; F:CARD domain binding; IPI:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IDA:UniProtKB.
DR   GO; GO:0002020; F:protease binding; IPI:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0043422; F:protein kinase B binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IDA:UniProtKB.
DR   GO; GO:0043621; F:protein self-association; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IMP:UniProtKB.
DR   GO; GO:0001783; P:B cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0008219; P:cell death; IDA:UniProtKB.
DR   GO; GO:0006968; P:cellular defense response; IEA:Ensembl.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IEP:UniProtKB.
DR   GO; GO:0071260; P:cellular response to mechanical stimulus; IEP:UniProtKB.
DR   GO; GO:0038095; P:Fc-epsilon receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0007249; P:I-kappaB kinase/NF-kappaB signaling; IBA:GO_Central.
DR   GO; GO:0016064; P:immunoglobulin mediated immune response; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; IEP:UniProtKB.
DR   GO; GO:0042226; P:interleukin-6 biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0031663; P:lipopolysaccharide-mediated signaling pathway; IDA:UniProtKB.
DR   GO; GO:0042109; P:lymphotoxin A biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0002906; P:negative regulation of mature B cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0001843; P:neural tube closure; ISS:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IDA:UniProtKB.
DR   GO; GO:0043280; P:positive regulation of cysteine-type endopeptidase activity involved in apoptotic process; IMP:ARUK-UCL.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IDA:UniProtKB.
DR   GO; GO:0043123; P:positive regulation of I-kappaB kinase/NF-kappaB signaling; IEP:UniProtKB.
DR   GO; GO:0045416; P:positive regulation of interleukin-8 biosynthetic process; IMP:UniProtKB.
DR   GO; GO:0033674; P:positive regulation of kinase activity; IEA:GOC.
DR   GO; GO:0032765; P:positive regulation of mast cell cytokine production; NAS:UniProtKB.
DR   GO; GO:0051092; P:positive regulation of NF-kappaB transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0042327; P:positive regulation of phosphorylation; IDA:UniProtKB.
DR   GO; GO:0031398; P:positive regulation of protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0050870; P:positive regulation of T cell activation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; TAS:Reactome.
DR   GO; GO:0050856; P:regulation of T cell receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0032094; P:response to food; IDA:UniProtKB.
DR   GO; GO:0009620; P:response to fungus; IEA:Ensembl.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0070231; P:T cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0050852; P:T cell receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0002224; P:toll-like receptor signaling pathway; IDA:UniProtKB.
DR   CDD; cd08810; CARD_BCL10; 1.
DR   InterPro; IPR033238; BCL10/E10.
DR   InterPro; IPR001315; CARD.
DR   InterPro; IPR042143; CARD_BCL10.
DR   InterPro; IPR011029; DEATH-like_dom_sf.
DR   PANTHER; PTHR34920; PTHR34920; 1.
DR   Pfam; PF00619; CARD; 1.
DR   SUPFAM; SSF47986; SSF47986; 1.
DR   PROSITE; PS50209; CARD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Apoptosis; Chromosomal rearrangement; Cytoplasm;
KW   Disease mutation; Immunity; Membrane; Phosphoprotein; Reference proteome;
KW   Tumor suppressor.
FT   CHAIN           1..233
FT                   /note="B-cell lymphoma/leukemia 10"
FT                   /id="PRO_0000144074"
FT   DOMAIN          13..101
FT                   /note="CARD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00046"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         138
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   VARIANT         5
FT                   /note="A -> S (found in a MALT lymphoma sample; unknown
FT                   pathological significance; dbSNP:rs12037217)"
FT                   /evidence="ECO:0000269|PubMed:10319863,
FT                   ECO:0000269|PubMed:10380921, ECO:0000269|PubMed:10582682"
FT                   /id="VAR_013208"
FT   VARIANT         16
FT                   /note="V -> E (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013209"
FT   VARIANT         31
FT                   /note="K -> E (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013210"
FT   VARIANT         45
FT                   /note="K -> Q"
FT                   /evidence="ECO:0000269|PubMed:10380921"
FT                   /id="VAR_013211"
FT   VARIANT         52
FT                   /note="T -> I (found in a mesothelioma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:9989495"
FT                   /id="VAR_013212"
FT   VARIANT         57
FT                   /note="C -> R (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013213"
FT   VARIANT         58
FT                   /note="R -> G (found in a germ cell tumor sample; unknown
FT                   pathological significance; dbSNP:rs121918314)"
FT                   /evidence="ECO:0000269|PubMed:9989495"
FT                   /id="VAR_013214"
FT   VARIANT         58
FT                   /note="R -> Q"
FT                   /evidence="ECO:0000269|PubMed:10380921"
FT                   /id="VAR_013215"
FT   VARIANT         64
FT                   /note="R -> K (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013216"
FT   VARIANT         93
FT                   /note="N -> S"
FT                   /evidence="ECO:0000269|PubMed:10380921"
FT                   /id="VAR_013217"
FT   VARIANT         101
FT                   /note="D -> E (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013218"
FT   VARIANT         134
FT                   /note="S -> P (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013219"
FT   VARIANT         153
FT                   /note="M -> V"
FT                   /evidence="ECO:0000269|PubMed:10380921"
FT                   /id="VAR_013220"
FT   VARIANT         162
FT                   /note="T -> M (found in a testicular teratoma sample;
FT                   somatic mutation; dbSNP:rs200837308)"
FT                   /evidence="ECO:0000269|PubMed:10582682"
FT                   /id="VAR_077898"
FT   VARIANT         168
FT                   /note="T -> A (found in a MALT lymphoma sample; unknown
FT                   pathological significance; dbSNP:rs1384278393)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013221"
FT   VARIANT         174
FT                   /note="L -> S (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013222"
FT   VARIANT         210
FT                   /note="Missing (found in a follicular lymphoma sample;
FT                   unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:9989495"
FT                   /id="VAR_013223"
FT   VARIANT         213
FT                   /note="G -> E (found in a MALT lymphoma sample; unknown
FT                   pathological significance; dbSNP:rs3768235)"
FT                   /evidence="ECO:0000269|PubMed:10319863,
FT                   ECO:0000269|PubMed:10380921, ECO:0000269|PubMed:10582682"
FT                   /id="VAR_013224"
FT   VARIANT         218
FT                   /note="S -> F (found in a germ cell tumor and other cancer
FT                   cell lines; unknown pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10380921,
FT                   ECO:0000269|PubMed:9989495"
FT                   /id="VAR_013225"
FT   VARIANT         230
FT                   /note="V -> I (found in a MALT lymphoma sample; unknown
FT                   pathological significance)"
FT                   /evidence="ECO:0000269|PubMed:10319863"
FT                   /id="VAR_013226"
FT   MUTAGEN         28
FT                   /note="L->A: Abolishes cell death-inducing capability."
FT                   /evidence="ECO:0000269|PubMed:10187815"
FT   MUTAGEN         41
FT                   /note="L->A: Abolishes cell death-inducing capability."
FT                   /evidence="ECO:0000269|PubMed:10187770,
FT                   ECO:0000269|PubMed:10187815"
FT   MUTAGEN         41
FT                   /note="L->Q: Abolishes NF-kappa-B activation and
FT                   homo/heterodimerization."
FT                   /evidence="ECO:0000269|PubMed:10187770,
FT                   ECO:0000269|PubMed:10187815"
FT   MUTAGEN         46
FT                   /note="I->A: Abolishes cell death-inducing capability."
FT                   /evidence="ECO:0000269|PubMed:10187815"
FT   MUTAGEN         47
FT                   /note="L->A: Abolishes cell death-inducing capability."
FT                   /evidence="ECO:0000269|PubMed:10187815"
FT   MUTAGEN         53
FT                   /note="E->A: Abolishes cell death-inducing capability."
FT                   /evidence="ECO:0000269|PubMed:10187815"
FT   MUTAGEN         55
FT                   /note="I->A: Abolishes cell death-inducing capability."
FT                   /evidence="ECO:0000269|PubMed:10187815"
FT   MUTAGEN         78
FT                   /note="G->R: Abolishes NF-kappa-B activation."
FT                   /evidence="ECO:0000269|PubMed:10187770"
FT   MUTAGEN         81..85
FT                   /note="TLVES->ALVEA: Complete loss of IKBKB/IKKB-mediated
FT                   phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:17213322"
FT   MUTAGEN         228
FT                   /note="R->G: Abolishes MALT1-mediated cleavage."
FT                   /evidence="ECO:0000269|PubMed:18264101"
FT   MUTAGEN         231
FT                   /note="S->A: Promotes NF-kappa-B activation."
FT   HELIX           11..14
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           17..28
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   TURN            29..31
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   STRAND          32..38
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           39..42
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           49..53
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   TURN            54..57
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           61..72
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   TURN            76..79
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           80..86
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   STRAND          89..92
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           94..105
FT                   /evidence="ECO:0000244|PDB:2MB9"
FT   HELIX           107..113
FT                   /evidence="ECO:0000244|PDB:2MB9"
SQ   SEQUENCE   233 AA;  26252 MW;  F87C97F2B784BA4B CRC64;
     MEPTAPSLTE EDLTEVKKDA LENLRVYLCE KIIAERHFDH LRAKKILSRE DTEEISCRTS
     SRKRAGKLLD YLQENPKGLD TLVESIRREK TQNFLIQKIT DEVLKLRNIK LEHLKGLKCS
     SCEPFPDGAT NNLSRSNSDE SNFSEKLRAS TVMYHPEGES STTPFFSTNS SLNLPVLEVG
     RTENTIFSST TLPRPGDPGA PPLPPDLQLE EEGTCANSSE MFLPLRSRTV SRQ
//
ID   BCOR_HUMAN              Reviewed;        1755 AA.
AC   Q6W2J9; D3DWB3; D3DWB4; Q29RF6; Q6P4B6; Q7Z2K7; Q8TEB4; Q96DB3; Q9H232;
AC   Q9H233; Q9HCJ7; Q9NXF2;
DT   04-JAN-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 159.
DE   RecName: Full=BCL-6 corepressor;
DE            Short=BCoR;
GN   Name=BCOR; Synonyms=KIAA1575;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 3), FUNCTION, INTERACTION WITH
RP   BCL6; HDAC1; HDAC3 AND HDAC5, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Frontal cortex;
RX   PubMed=10898795;
RA   Huynh K.D., Fischle W., Verdin E., Bardwell V.J.;
RT   "BCoR, a novel corepressor involved in BCL-6 repression.";
RL   Genes Dev. 14:1810-1823(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, AND VARIANT MCOPS2
RP   LEU-85.
RX   PubMed=15004558; DOI=10.1038/ng1321;
RA   Ng D., Thakker N., Corcoran C.M., Donnai D., Perveen R., Schneider A.,
RA   Hadley D.W., Tifft C., Zhang L., Wilkie A.O., van der Smagt J.J.,
RA   Gorlin R.J., Burgess S.M., Bardwell V.J., Black G.C.M., Biesecker L.G.;
RT   "Oculofaciocardiodental and Lenz microphthalmia syndromes result from
RT   distinct classes of mutations in BCOR.";
RL   Nat. Genet. 36:411-416(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), AND NUCLEOTIDE SEQUENCE
RP   [LARGE SCALE MRNA] OF 1395-1755 (ISOFORM 1).
RC   TISSUE=Liver, Lymph, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 217-1755 (ISOFORM 4), AND
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1328-1755.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [8]
RP   INTERACTION WITH PCGF1 AND KDM2B, AND IDENTIFICATION IN A COMPLEX WITH
RP   RYBP; PCGF1; RING1; RNF2; KDM2B AND SKP1.
RX   PubMed=16943429; DOI=10.1128/mcb.00630-06;
RA   Gearhart M.D., Corcoran C.M., Wamstad J.A., Bardwell V.J.;
RT   "Polycomb group and SCF ubiquitin ligases are found in a novel BCOR complex
RT   that is recruited to BCL6 targets.";
RL   Mol. Cell. Biol. 26:6880-6889(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423 AND SER-1410, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   FUNCTION.
RX   PubMed=19578371; DOI=10.1038/ncb1913;
RA   Fan Z., Yamaza T., Lee J.S., Yu J., Wang S., Fan G., Shi S., Wang C.-Y.;
RT   "BCOR regulates mesenchymal stem cell function by epigenetic mechanisms.";
RL   Nat. Cell Biol. 11:1002-1009(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1139, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [13]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-392, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-336; SER-340; SER-365;
RP   SER-367 AND SER-423, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [17]
RP   FUNCTION AS COREPRESSOR, INTERACTION WITH BCL6, AND IDENTIFICATION IN A
RP   COMPLEX WITH BCL6 AND SMRT.
RX   PubMed=23911289; DOI=10.1016/j.celrep.2013.06.016;
RA   Hatzi K., Jiang Y., Huang C., Garrett-Bakelman F., Gearhart M.D.,
RA   Giannopoulou E.G., Zumbo P., Kirouac K., Bhaskara S., Polo J.M.,
RA   Kormaksson M., Mackerell A.D. Jr., Xue F., Mason C.E., Hiebert S.W.,
RA   Prive G.G., Cerchietti L., Bardwell V.J., Elemento O., Melnick A.;
RT   "A hybrid mechanism of action for BCL6 in B cells defined by formation of
RT   functionally distinct complexes at enhancers and promoters.";
RL   Cell Rep. 4:578-588(2013).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-423; SER-1139; SER-1290 AND
RP   SER-1410, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY, AND INTERACTION WITH PCGF1.
RX   PubMed=26687479; DOI=10.1038/srep18388;
RA   Oliviero G., Munawar N., Watson A., Streubel G., Manning G., Bardwell V.,
RA   Bracken A.P., Cagney G.;
RT   "The variant Polycomb Repressor Complex 1 component PCGF1 interacts with a
RT   pluripotency sub-network that includes DPPA4, a regulator of
RT   embryogenesis.";
RL   Sci. Rep. 5:18388-18388(2015).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-786; LYS-872; LYS-1256 AND
RP   LYS-1413, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.00 ANGSTROMS) OF 1634-1748 IN COMPLEX WITH PCGF1,
RP   INTERACTION WITH PCGF1, AND MUTAGENESIS OF LEU-1706.
RX   PubMed=23523425; DOI=10.1016/j.str.2013.02.013;
RA   Junco S.E., Wang R., Gaipa J.C., Taylor A.B., Schirf V., Gearhart M.D.,
RA   Bardwell V.J., Demeler B., Hart P.J., Kim C.A.;
RT   "Structure of the polycomb group protein PCGF1 in complex with BCOR reveals
RT   basis for binding selectivity of PCGF homologs.";
RL   Structure 21:665-671(2013).
RN   [22]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 498-514 IN COMPLEX WITH BCL6,
RP   FUNCTION, AND MUTAGENESIS OF SER-507; SER-508; TRP-509 AND VAL-511.
RX   PubMed=18280243; DOI=10.1016/j.molcel.2007.12.026;
RA   Ghetu A.F., Corcoran C.M., Cerchietti L., Bardwell V.J., Melnick A.,
RA   Prive G.G.;
RT   "Structure of a BCOR corepressor peptide in complex with the BCL6 BTB
RT   domain dimer.";
RL   Mol. Cell 29:384-391(2008).
CC   -!- FUNCTION: Transcriptional corepressor. May specifically inhibit gene
CC       expression when recruited to promoter regions by sequence-specific DNA-
CC       binding proteins such as BCL6 and MLLT3. This repression may be
CC       mediated at least in part by histone deacetylase activities which can
CC       associate with this corepressor. Involved in the repression of TFAP2A;
CC       impairs binding of BCL6 and KDM2B to TFAP2A promoter regions. Via
CC       repression of TFAP2A acts as a negative regulator of osteo-dentiogenic
CC       capacity in adult stem cells; the function implies inhibition of
CC       methylation on histone H3 'Lys-4' (H3K4me3) and 'Lys-36' (H3K36me2).
CC       {ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:15004558,
CC       ECO:0000269|PubMed:18280243, ECO:0000269|PubMed:19578371,
CC       ECO:0000269|PubMed:23911289}.
CC   -!- SUBUNIT: Interacts with BCL6; the interaction is direct
CC       (PubMed:10898795). Forms ternary complexes with BCL6 and SMRT/NCOR2 on
CC       selected target genes promoters; potently repress expression
CC       (PubMed:23911289, PubMed:18280243). Can interact with HDAC1, HDAC3 and
CC       HDAC5 (PubMed:10898795). Interacts with PCGF1; the interaction is
CC       direct (PubMed:16943429, PubMed:23523425, PubMed:26687479). Interacts
CC       with KDM2B. Component of an approximately 800 kDa repressive BCOR
CC       complex at least composed of BCOR, RYBP, PCGF1, RING1, RNF2/RING2,
CC       KDM2B and SKP1 (PubMed:16943429). Interacts with CPNE4 (via VWFA
CC       domain) (By similarity). Isoform 1 may interact with MLLT3/AF9 (By
CC       similarity). {ECO:0000250|UniProtKB:Q8CGN4,
CC       ECO:0000269|PubMed:10898795, ECO:0000269|PubMed:16943429,
CC       ECO:0000269|PubMed:18280243, ECO:0000269|PubMed:23523425,
CC       ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:26687479}.
CC   -!- INTERACTION:
CC       Q6W2J9; Q9HC52: CBX8; NbExp=9; IntAct=EBI-950027, EBI-712912;
CC       Q6W2J9; Q8NHM5: KDM2B; NbExp=4; IntAct=EBI-950027, EBI-3955564;
CC       Q6W2J9-1; P42568: MLLT3; NbExp=2; IntAct=EBI-16028932, EBI-716132;
CC       Q6W2J9-4; P41227: NAA10; NbExp=3; IntAct=EBI-10208579, EBI-747693;
CC       Q6W2J9; Q9BSM1: PCGF1; NbExp=13; IntAct=EBI-950027, EBI-749901;
CC       Q6W2J9-1; Q9BSM1-1: PCGF1; NbExp=7; IntAct=EBI-16028932, EBI-16041863;
CC       Q6W2J9-4; Q3KNV8: PCGF3; NbExp=3; IntAct=EBI-10208579, EBI-2339807;
CC       Q6W2J9-4; Q86SE9: PCGF5; NbExp=3; IntAct=EBI-10208579, EBI-2827999;
CC       Q6W2J9; Q93009: USP7; NbExp=3; IntAct=EBI-950027, EBI-302474;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10898795}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=Long;
CC         IsoId=Q6W2J9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6W2J9-2; Sequence=VSP_012557;
CC       Name=3; Synonyms=Short;
CC         IsoId=Q6W2J9-3; Sequence=VSP_012554, VSP_012556;
CC       Name=4;
CC         IsoId=Q6W2J9-4; Sequence=VSP_012555, VSP_012557;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC       {ECO:0000269|PubMed:10898795}.
CC   -!- DISEASE: Microphthalmia, syndromic, 2 (MCOPS2) [MIM:300166]: A very
CC       rare multiple congenital anomaly syndrome characterized by eye
CC       anomalies (congenital cataract, microphthalmia, or secondary glaucoma),
CC       facial abnormalities (long narrow face, high nasal bridge, pointed nose
CC       with cartilages separated at the tip, cleft palate, or submucous cleft
CC       palate), cardiac anomalies (atrial septal defect, ventricular septal
CC       defect, or floppy mitral valve) and dental abnormalities (canine
CC       radiculomegaly, delayed dentition, oligodontia, persistent primary
CC       teeth, or variable root length). Microphthalmia is a disorder of eye
CC       formation, ranging from small size of a single eye to complete
CC       bilateral absence of ocular tissues (anophthalmia). In many cases,
CC       microphthalmia/anophthalmia occurs in association with syndromes that
CC       include non-ocular abnormalities. {ECO:0000269|PubMed:15004558}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the BCOR family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH63536.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Presence of complementary strand sequence in the clone.; Evidence={ECO:0000305};
CC       Sequence=BAA91061.1; Type=Miscellaneous discrepancy; Note=Intron retention.; Evidence={ECO:0000305};
CC       Sequence=BAB13401.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB85037.1; Type=Frameshift; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF317391; AAG41429.1; -; mRNA.
DR   EMBL; AF317392; AAG41430.1; -; mRNA.
DR   EMBL; AY316592; AAR08265.1; -; mRNA.
DR   EMBL; AB046795; BAB13401.2; ALT_INIT; mRNA.
DR   EMBL; CH471141; EAW59425.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59427.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59428.1; -; Genomic_DNA.
DR   EMBL; CH471141; EAW59430.1; -; Genomic_DNA.
DR   EMBL; BC009675; AAH09675.2; -; mRNA.
DR   EMBL; BC063536; AAH63536.1; ALT_SEQ; mRNA.
DR   EMBL; BC114220; AAI14221.1; -; mRNA.
DR   EMBL; AK000292; BAA91061.1; ALT_SEQ; mRNA.
DR   EMBL; AK074286; BAB85037.1; ALT_FRAME; mRNA.
DR   CCDS; CCDS14250.1; -. [Q6W2J9-2]
DR   CCDS; CCDS48092.1; -. [Q6W2J9-4]
DR   CCDS; CCDS48093.1; -. [Q6W2J9-1]
DR   RefSeq; NP_001116855.1; NM_001123383.1. [Q6W2J9-2]
DR   RefSeq; NP_001116856.1; NM_001123384.1. [Q6W2J9-4]
DR   RefSeq; NP_001116857.1; NM_001123385.1. [Q6W2J9-1]
DR   RefSeq; NP_060215.4; NM_017745.5. [Q6W2J9-2]
DR   RefSeq; XP_005272673.1; XM_005272616.1. [Q6W2J9-1]
DR   RefSeq; XP_005272675.1; XM_005272618.3. [Q6W2J9-1]
DR   RefSeq; XP_005272677.1; XM_005272620.3. [Q6W2J9-4]
DR   RefSeq; XP_006724599.1; XM_006724536.3. [Q6W2J9-1]
DR   RefSeq; XP_011542231.1; XM_011543929.2. [Q6W2J9-1]
DR   RefSeq; XP_011542232.1; XM_011543930.1. [Q6W2J9-1]
DR   RefSeq; XP_011542233.1; XM_011543931.2. [Q6W2J9-1]
DR   RefSeq; XP_016885104.1; XM_017029615.1. [Q6W2J9-2]
DR   PDB; 2N1L; NMR; -; A=1634-1748.
DR   PDB; 3BIM; X-ray; 2.60 A; I/J/K/L/M/N/O/P=498-514.
DR   PDB; 4HPL; X-ray; 2.00 A; A=1634-1748.
DR   PDB; 6B7G; NMR; -; B=1176-1207.
DR   PDBsum; 2N1L; -.
DR   PDBsum; 3BIM; -.
DR   PDBsum; 4HPL; -.
DR   PDBsum; 6B7G; -.
DR   SMR; Q6W2J9; -.
DR   BioGrid; 120228; 157.
DR   CORUM; Q6W2J9; -.
DR   DIP; DIP-50009N; -.
DR   IntAct; Q6W2J9; 84.
DR   STRING; 9606.ENSP00000367705; -.
DR   iPTMnet; Q6W2J9; -.
DR   PhosphoSitePlus; Q6W2J9; -.
DR   BioMuta; BCOR; -.
DR   EPD; Q6W2J9; -.
DR   jPOST; Q6W2J9; -.
DR   MassIVE; Q6W2J9; -.
DR   MaxQB; Q6W2J9; -.
DR   PaxDb; Q6W2J9; -.
DR   PeptideAtlas; Q6W2J9; -.
DR   PRIDE; Q6W2J9; -.
DR   ProteomicsDB; 67737; -. [Q6W2J9-1]
DR   ProteomicsDB; 67738; -. [Q6W2J9-2]
DR   ProteomicsDB; 67739; -. [Q6W2J9-3]
DR   ProteomicsDB; 67740; -. [Q6W2J9-4]
DR   Antibodypedia; 24949; 252 antibodies.
DR   DNASU; 54880; -.
DR   Ensembl; ENST00000342274; ENSP00000345923; ENSG00000183337. [Q6W2J9-2]
DR   Ensembl; ENST00000378444; ENSP00000367705; ENSG00000183337. [Q6W2J9-1]
DR   Ensembl; ENST00000378455; ENSP00000367716; ENSG00000183337. [Q6W2J9-4]
DR   Ensembl; ENST00000397354; ENSP00000380512; ENSG00000183337. [Q6W2J9-2]
DR   Ensembl; ENST00000673391; ENSP00000500446; ENSG00000183337. [Q6W2J9-2]
DR   GeneID; 54880; -.
DR   KEGG; hsa:54880; -.
DR   UCSC; uc004dem.5; human. [Q6W2J9-1]
DR   CTD; 54880; -.
DR   DisGeNET; 54880; -.
DR   GeneCards; BCOR; -.
DR   GeneReviews; BCOR; -.
DR   HGNC; HGNC:20893; BCOR.
DR   HPA; ENSG00000183337; Low tissue specificity.
DR   MalaCards; BCOR; -.
DR   MIM; 300166; phenotype.
DR   MIM; 300485; gene.
DR   neXtProt; NX_Q6W2J9; -.
DR   OpenTargets; ENSG00000183337; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   Orphanet; 457246; Clear cell sarcoma of kidney.
DR   Orphanet; 568; Microphthalmia, Lenz type.
DR   Orphanet; 2712; Oculofaciocardiodental syndrome.
DR   PharmGKB; PA134921737; -.
DR   eggNOG; ENOG410IHDH; Eukaryota.
DR   eggNOG; ENOG410YT00; LUCA.
DR   GeneTree; ENSGT00940000153737; -.
DR   HOGENOM; CLU_003863_0_0_1; -.
DR   InParanoid; Q6W2J9; -.
DR   KO; K23215; -.
DR   OMA; VPGHTRK; -.
DR   OrthoDB; 85469at2759; -.
DR   PhylomeDB; Q6W2J9; -.
DR   TreeFam; TF333317; -.
DR   SIGNOR; Q6W2J9; -.
DR   ChiTaRS; BCOR; human.
DR   EvolutionaryTrace; Q6W2J9; -.
DR   GeneWiki; BCOR; -.
DR   GenomeRNAi; 54880; -.
DR   Pharos; Q6W2J9; Tbio.
DR   PRO; PR:Q6W2J9; -.
DR   Proteomes; UP000005640; Chromosome X.
DR   RNAct; Q6W2J9; protein.
DR   Bgee; ENSG00000183337; Expressed in forebrain and 204 other tissues.
DR   ExpressionAtlas; Q6W2J9; baseline and differential.
DR   Genevisible; Q6W2J9; HS.
DR   GO; GO:0140261; C:BCOR complex; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0031072; F:heat shock protein binding; IDA:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003714; F:transcription corepressor activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IMP:UniProtKB.
DR   GO; GO:0001835; P:blastocyst hatching; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; IMP:UniProtKB.
DR   GO; GO:0035518; P:histone H2A monoubiquitination; IDA:UniProtKB.
DR   GO; GO:0030502; P:negative regulation of bone mineralization; IMP:UniProtKB.
DR   GO; GO:0000415; P:negative regulation of histone H3-K36 methylation; IMP:UniProtKB.
DR   GO; GO:0051572; P:negative regulation of histone H3-K4 methylation; IMP:UniProtKB.
DR   GO; GO:0070171; P:negative regulation of tooth mineralization; IMP:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0042476; P:odontogenesis; IMP:UniProtKB.
DR   GO; GO:0060021; P:roof of mouth development; IMP:UniProtKB.
DR   GO; GO:0065001; P:specification of axis polarity; IMP:UniProtKB.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 3.10.260.40; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR031628; BCOR.
DR   InterPro; IPR032365; PUFD.
DR   InterPro; IPR038227; PUFD_som_sf.
DR   Pfam; PF12796; Ank_2; 1.
DR   Pfam; PF15808; BCOR; 1.
DR   Pfam; PF16553; PUFD; 1.
DR   SMART; SM00248; ANK; 3.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ANK repeat;
KW   Chromatin regulator; Disease mutation; Isopeptide bond; Microphthalmia;
KW   Nucleus; Phosphoprotein; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation.
FT   CHAIN           1..1755
FT                   /note="BCL-6 corepressor"
FT                   /id="PRO_0000066978"
FT   REPEAT          1462..1495
FT                   /note="ANK 1"
FT   REPEAT          1496..1525
FT                   /note="ANK 2"
FT   REPEAT          1529..1558
FT                   /note="ANK 3"
FT   REGION          498..514
FT                   /note="Interaction with BCL6"
FT   REGION          1634..1748
FT                   /note="Necessary and sufficient for interaction with PCGF1"
FT   COMPBIAS        634..711
FT                   /note="Pro-rich"
FT   COMPBIAS        1625..1631
FT                   /note="Poly-Asp"
FT   MOD_RES         336
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         365
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         392
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         423
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1127
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN4"
FT   MOD_RES         1139
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1345
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8CGN4"
FT   MOD_RES         1410
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        786
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        872
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1256
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1413
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1000..1017
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012555"
FT   VAR_SEQ         1000..1004
FT                   /note="MEGLQ -> VSPPT (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10898795,
FT                   ECO:0000303|PubMed:10997877"
FT                   /id="VSP_012554"
FT   VAR_SEQ         1005..1755
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10898795,
FT                   ECO:0000303|PubMed:10997877"
FT                   /id="VSP_012556"
FT   VAR_SEQ         1168..1201
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10898795,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012557"
FT   VARIANT         85
FT                   /note="P -> L (in MCOPS2; dbSNP:rs121434618)"
FT                   /evidence="ECO:0000269|PubMed:15004558"
FT                   /id="VAR_020921"
FT   MUTAGEN         507
FT                   /note="S->A: Abolishes interaction with BCL6 and inhibits
FT                   BCL6 corepression activity; when associated with A-509 and
FT                   A-511."
FT                   /evidence="ECO:0000269|PubMed:18280243"
FT   MUTAGEN         508
FT                   /note="S->A: Diminishes interaction with BCL6."
FT                   /evidence="ECO:0000269|PubMed:18280243"
FT   MUTAGEN         509
FT                   /note="W->A: Abolishes interaction with BCL6 and inhibits
FT                   BCL6 corepression activity; when associated with A-507 and
FT                   A-511."
FT                   /evidence="ECO:0000269|PubMed:18280243"
FT   MUTAGEN         511
FT                   /note="V->A: Abolishes interaction with BCL6 and inhibits
FT                   BCL6 corepression activity; when associated with A-507 and
FT                   A-509."
FT                   /evidence="ECO:0000269|PubMed:18280243"
FT   MUTAGEN         1706
FT                   /note="L->D,R: Slightly inhibits interaction with PCGF1."
FT                   /evidence="ECO:0000269|PubMed:23523425"
FT   CONFLICT        406
FT                   /note="V -> A (in Ref. 6; BAB85037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        596
FT                   /note="Q -> L (in Ref. 6; BAB85037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1459
FT                   /note="N -> S (in Ref. 6; BAA91061)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1577
FT                   /note="K -> R (in Ref. 6; BAA91061)"
FT                   /evidence="ECO:0000305"
FT   STRAND          500..503
FT                   /evidence="ECO:0000244|PDB:3BIM"
FT   STRAND          1190..1193
FT                   /evidence="ECO:0000244|PDB:6B7G"
FT   STRAND          1195..1199
FT                   /evidence="ECO:0000244|PDB:6B7G"
FT   TURN            1200..1202
FT                   /evidence="ECO:0000244|PDB:6B7G"
FT   STRAND          1637..1644
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   STRAND          1650..1653
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   TURN            1656..1658
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   STRAND          1660..1665
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   HELIX           1666..1673
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   HELIX           1677..1683
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   STRAND          1689..1693
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   HELIX           1694..1702
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   HELIX           1705..1707
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   HELIX           1710..1712
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   TURN            1713..1715
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   STRAND          1723..1728
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   HELIX           1731..1736
FT                   /evidence="ECO:0000244|PDB:4HPL"
FT   STRAND          1740..1744
FT                   /evidence="ECO:0000244|PDB:4HPL"
SQ   SEQUENCE   1755 AA;  192189 MW;  A80CFCD5618EE717 CRC64;
     MLSATPLYGN VHSWMNSERV RMCGASEDRK ILVNDGDASK ARLELREENP LNHNVVDAST
     AHRIDGLAAL SMDRTGLIRE GLRVPGNIVY SSLCGLGSEK GREAATSTLG GLGFSSERNP
     EMQFKPNTPE TVEASAVSGK PPNGFSAIYK TPPGIQKSAV ATAEALGLDR PASDKQSPLN
     INGASYLRLP WVNPYMEGAT PAIYPFLDSP NKYSLNMYKA LLPQQSYSLA QPLYSPVCTN
     GERFLYLPPP HYVGPHIPSS LASPMRLSTP SASPAIPPLV HCADKSLPWK MGVSPGNPVD
     SHAYPHIQNS KQPRVPSAKA VTSGLPGDTA LLLPPSPRPS PRVHLPTQPA ADTYSEFHKH
     YARISTSPSV ALSKPYMTVS SEFPAARLSN GKYPKAPEGG EGAQPVPGHA RKTAVQDRKD
     GSSPPLLEKQ TVTKDVTDKP LDLSSKVVDV DASKADHMKK MAPTVLVHSR AGSGLVLSGS
     EIPKETLSPP GNGCAIYRSE IISTAPSSWV VPGPSPNEEN NGKSMSLKNK ALDWAIPQQR
     SSSCPRMGGT DAVITNVSGS VSSAGRPASA SPAPNANADG TKTSRSSVET TPSVIQHVGQ
     PPATPAKHSS STSSKGAKAS NPEPSFKANE NGLPPSSIFL SPNEAFRSPP IPYPRSYLPY
     PAPEGIAVSP LSLHGKGPVY PHPVLLPNGS LFPGHLAPKP GLPYGLPTGR PEFVTYQDAL
     GLGMVHPMLI PHTPIEITKE EKPERRSRSH ERARYEDPTL RNRFSEILET SSTKLHPDVP
     TDKNLKPNPN WNQGKTVVKS DKLVYVDLLR EEPDAKTDTN VSKPSFAAES VGQSAEPPKP
     SVEPALQQHR DFIALREELG RISDFHETYT FKQPVFTVSK DSVLAGTNKE NLGLPVSTPF
     LEPPLGSDGP AVTFGKTQED PKPFCVGSAP PSVDVTPTYT KDGADEAESN DGKVLKPKPS
     KLAKRIANSA GYVGDRFKCV TTELYADSSQ LSREQRALQM EGLQEDSILC LPAAYCERAM
     MRFSELEMKE REGGHPATKD SEMCKFSPAD WERLKGNQDK KPKSVTLEEA IAEQNESERC
     EYSVGNKHRD PFEAPEDKDL PVEKYFVERQ PVSEPPADQV ASDMPHSPTL RVDRKRKVSG
     DSSHTETTAE EVPEDPLLKA KRRRVSKDDW PEREMTNSSS NHLEDPHYSE LTNLKVCIEL
     TGLHPKKQRH LLHLRERWEQ QVSAADGKPG RQSRKEVTQA TQPEAIPQGT NITEEKPGRK
     RAEAKGNRSW SEESLKPSDN EQGLPVFSGS PPMKSLSSTS AGGKKQAQPS CAPASRPPAK
     QQKIKENQKT DVLCADEEED CQAASLLQKY TDNSEKPSGK RLCKTKHLIP QESRRGLPLT
     GEYYVENADG KVTVRRFRKR PEPSSDYDLS PAKQEPKPFD RLQQLLPASQ STQLPCSSSP
     QETTQSRPMP PEARRLIVNK NAGETLLQRA ARLGYEEVVL YCLENKICDV NHRDNAGYCA
     LHEACARGWL NIVRHLLEYG ADVNCSAQDG TRPLHDAVEN DHLEIVRLLL SYGADPTLAT
     YSGRTIMKMT HSELMEKFLT DYLNDLQGRN DDDASGTWDF YGSSVCEPDD ESGYDVLANP
     PGPEDQDDDD DAYSDVFEFE FSETPLLPCY NIQVSVAQGP RNWLLLSDVL KKLKMSSRIF
     RCNFPNVEIV TIAEAEFYRQ VSASLLFSCS KDLEAFNPES KELLDLVEFT NEIQTLLGSS
     VEWLHPSDLA SDNYW
//
ID   BTG1_HUMAN              Reviewed;         171 AA.
AC   P62324; P31607;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 131.
DE   RecName: Full=Protein BTG1;
DE   AltName: Full=B-cell translocation gene 1 protein;
GN   Name=BTG1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Lymphoblastoma;
RX   PubMed=1373383; DOI=10.1002/j.1460-2075.1992.tb05213.x;
RA   Rouault J.-P., Rimokh R., Tessa C., Paranhos G., Ffrench M., Duret L.,
RA   Garoccio M., Germain D., Samarut J., Magaud J.-P.;
RT   "BTG1, a member of a new family of antiproliferative genes.";
RL   EMBO J. 11:1663-1670(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-139 AND GLU-141.
RG   NIEHS SNPs program;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon, and Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   INTERACTION WITH CNOT7.
RX   PubMed=9712883; DOI=10.1074/jbc.273.35.22563;
RA   Rouault J.P., Prevot D., Berthet C., Birot A.M., Billaud M., Magaud J.P.,
RA   Corbo L.;
RT   "Interaction of BTG1 and p53-regulated BTG2 gene products with mCaf1, the
RT   murine homolog of a component of the yeast CCR4 transcriptional regulatory
RT   complex.";
RL   J. Biol. Chem. 273:22563-22569(1998).
RN   [6]
RP   INTERACTION WITH CNOT8.
RX   PubMed=11136725; DOI=10.1074/jbc.m008201200;
RA   Prevot D., Morel A.P., Voeltzel T., Rostan M.C., Rimokh R., Magaud J.P.,
RA   Corbo L.;
RT   "Relationships of the antiproliferative proteins BTG1 and BTG2 with CAF1,
RT   the human homolog of a component of the yeast CCR4 transcriptional complex:
RT   involvement in estrogen receptor alpha signaling pathway.";
RL   J. Biol. Chem. 276:9640-9648(2001).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH MYC.
RX   PubMed=2069907; DOI=10.1002/gcc.2870030106;
RA   Rimokh R., Rouault J.P., Wahbi K., Gadoux M., Lafage M., Archimbaud E.,
RA   Charrin C., Gentilhomme O., Germain D., Samarut J.;
RT   "A chromosome 12 coding region is juxtaposed to the MYC protooncogene locus
RT   in a t(8;12)(q24;q22) translocation in a case of B-cell chronic lymphocytic
RT   leukemia.";
RL   Genes Chromosomes Cancer 3:24-36(1991).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Anti-proliferative protein. {ECO:0000269|PubMed:1373383}.
CC   -!- SUBUNIT: Interacts with CNOT7 and CNOT8. {ECO:0000269|PubMed:11136725,
CC       ECO:0000269|PubMed:9712883}.
CC   -!- INTERACTION:
CC       P62324; Q9UIV1: CNOT7; NbExp=4; IntAct=EBI-742279, EBI-2105113;
CC       P62324; Q60809: Cnot7; Xeno; NbExp=5; IntAct=EBI-742279, EBI-2104739;
CC       P62324; Q9UFF9: CNOT8; NbExp=5; IntAct=EBI-742279, EBI-742299;
CC       P62324; Q13158: FADD; NbExp=5; IntAct=EBI-742279, EBI-494804;
CC       P62324; P62993: GRB2; NbExp=3; IntAct=EBI-742279, EBI-401755;
CC       P62324; O43639: NCK2; NbExp=3; IntAct=EBI-742279, EBI-713635;
CC   -!- DEVELOPMENTAL STAGE: Its expression is associated with the early G1
CC       phase of the cell cycle. {ECO:0000269|PubMed:1373383}.
CC   -!- DISEASE: Note=A chromosomal aberration involving BTG1 may be a cause of
CC       a form of B-cell chronic lymphocytic leukemia. Translocation
CC       t(8;12)(q24;q22) with MYC. {ECO:0000269|PubMed:2069907}.
CC   -!- SIMILARITY: Belongs to the BTG family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/btg1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X61123; CAA43435.1; -; mRNA.
DR   EMBL; BT019840; AAV38643.1; -; mRNA.
DR   EMBL; AY850133; AAV97814.1; -; Genomic_DNA.
DR   EMBL; BC016759; AAH16759.1; -; mRNA.
DR   EMBL; BC064953; AAH64953.1; -; mRNA.
DR   CCDS; CCDS9043.1; -.
DR   PIR; S20947; S20947.
DR   RefSeq; NP_001722.1; NM_001731.2.
DR   SMR; P62324; -.
DR   BioGrid; 107159; 19.
DR   IntAct; P62324; 10.
DR   MINT; P62324; -.
DR   STRING; 9606.ENSP00000256015; -.
DR   iPTMnet; P62324; -.
DR   PhosphoSitePlus; P62324; -.
DR   BioMuta; BTG1; -.
DR   DMDM; 59799172; -.
DR   EPD; P62324; -.
DR   MassIVE; P62324; -.
DR   PaxDb; P62324; -.
DR   PeptideAtlas; P62324; -.
DR   PRIDE; P62324; -.
DR   ProteomicsDB; 57394; -.
DR   Antibodypedia; 1186; 216 antibodies.
DR   DNASU; 694; -.
DR   Ensembl; ENST00000256015; ENSP00000256015; ENSG00000133639.
DR   GeneID; 694; -.
DR   KEGG; hsa:694; -.
DR   CTD; 694; -.
DR   DisGeNET; 694; -.
DR   GeneCards; BTG1; -.
DR   HGNC; HGNC:1130; BTG1.
DR   HPA; ENSG00000133639; Tissue enhanced (lymphoid).
DR   MIM; 109580; gene.
DR   neXtProt; NX_P62324; -.
DR   OpenTargets; ENSG00000133639; -.
DR   PharmGKB; PA25450; -.
DR   eggNOG; KOG4006; Eukaryota.
DR   eggNOG; ENOG410ZZC0; LUCA.
DR   GeneTree; ENSGT00950000182952; -.
DR   HOGENOM; CLU_079660_4_0_1; -.
DR   InParanoid; P62324; -.
DR   KO; K14443; -.
DR   OMA; GHVNDRQ; -.
DR   OrthoDB; 1439942at2759; -.
DR   PhylomeDB; P62324; -.
DR   TreeFam; TF105272; -.
DR   Reactome; R-HSA-9617828; FOXO-mediated transcription of cell cycle genes.
DR   SIGNOR; P62324; -.
DR   ChiTaRS; BTG1; human.
DR   GeneWiki; BTG1; -.
DR   GenomeRNAi; 694; -.
DR   Pharos; P62324; Tbio.
DR   PRO; PR:P62324; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P62324; protein.
DR   Bgee; ENSG00000133639; Expressed in upper lobe of lung and 243 other tissues.
DR   ExpressionAtlas; P62324; baseline and differential.
DR   Genevisible; P62324; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; NAS:UniProtKB.
DR   GO; GO:0003712; F:transcription coregulator activity; NAS:UniProtKB.
DR   GO; GO:0016477; P:cell migration; NAS:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; NAS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IBA:GO_Central.
DR   GO; GO:0045766; P:positive regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0045603; P:positive regulation of endothelial cell differentiation; IMP:UniProtKB.
DR   GO; GO:2000271; P:positive regulation of fibroblast apoptotic process; IMP:UniProtKB.
DR   GO; GO:0045663; P:positive regulation of myoblast differentiation; IDA:MGI.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   Gene3D; 1.20.120.1120; -; 1.
DR   InterPro; IPR002087; Anti_prolifrtn.
DR   InterPro; IPR036054; BTG-like_sf.
DR   InterPro; IPR033330; BTG1.
DR   PANTHER; PTHR22978:SF30; PTHR22978:SF30; 1.
DR   Pfam; PF07742; BTG; 1.
DR   PRINTS; PR00310; ANTIPRLFBTG1.
DR   SMART; SM00099; btg1; 1.
DR   SUPFAM; SSF160696; SSF160696; 1.
DR   PROSITE; PS00960; BTG_1; 1.
DR   PROSITE; PS01203; BTG_2; 1.
PE   1: Evidence at protein level;
KW   Chromosomal rearrangement; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome.
FT   CHAIN           1..171
FT                   /note="Protein BTG1"
FT                   /id="PRO_0000143800"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VARIANT         139
FT                   /note="N -> S (in dbSNP:rs28399541)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_021345"
FT   VARIANT         141
FT                   /note="Q -> E (in dbSNP:rs28399542)"
FT                   /evidence="ECO:0000269|Ref.3"
FT                   /id="VAR_021346"
SQ   SEQUENCE   171 AA;  19209 MW;  EFED8BE09013BE60 CRC64;
     MHPFYTRAAT MIGEIAAAVS FISKFLRTKG LTSERQLQTF SQSLQELLAE HYKHHWFPEK
     PCKGSGYRCI RINHKMDPLI GQAAQRIGLS SQELFRLLPS ELTLWVDPYE VSYRIGEDGS
     ICVLYEASPA GGSTQNSTNV QMVDSRISCK EELLLGRTSP SKNYNMMTVS G
//
ID   Q6IBC8_HUMAN            Unreviewed;       171 AA.
AC   Q6IBC8;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 133.
DE   SubName: Full=B-cell translocation gene 1, anti-proliferative {ECO:0000313|EMBL:AAV38642.1};
DE   SubName: Full=B-cell translocation gene 1, anti-proliferative, isoform CRA_b {ECO:0000313|EMBL:EAW97467.1};
DE   SubName: Full=BTG1 {ECO:0000313|EMBL:AAA08538.1};
DE   SubName: Full=BTG1 protein {ECO:0000313|EMBL:CAG33157.1};
DE   SubName: Full=cDNA, FLJ93822, Homo sapiens B-cell translocation gene 1, anti-proliferative(BTG1), mRNA {ECO:0000313|EMBL:BAG36114.1};
GN   Name=BTG1 {ECO:0000313|EMBL:CAG33157.1};
GN   ORFNames=hCG_21188 {ECO:0000313|EMBL:EAW97467.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33157.1};
RN   [1] {ECO:0000313|EMBL:AAA08538.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=1373383;
RA   Rouault J.-P., Rimokh R., Tessa C., Paranhos G., Ffrench M., Duret L.,
RA   Garoccio M., Germain D., Samarut J., Magaud J.-P.;
RT   "BTG1, a member of a new family of antiproliferative genes.";
RL   EMBO J. 11:1663-1670(1992).
RN   [2] {ECO:0000313|EMBL:EAW97467.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [3] {ECO:0000313|EMBL:CAG33157.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:CAG46581.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Halleck A., Ebert L., Mkoundinya M., Schick M., Eisenstein S., Neubert P.,
RA   Kstrang K., Schatten R., Shen B., Henze S., Mar W., Korn B., Zuo D., Hu Y.,
RA   LaBaer J.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:AAV38642.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:EAW97467.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7] {ECO:0000313|EMBL:BAG36114.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Stomach {ECO:0000313|EMBL:BAG36114.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AH000334; AAA08538.1; -; Genomic_DNA.
DR   EMBL; S38424; AAA08538.1; JOINED; Genomic_DNA.
DR   EMBL; BT019839; AAV38642.1; -; mRNA.
DR   EMBL; BT019841; AAV38644.1; -; mRNA.
DR   EMBL; AK313309; BAG36114.1; -; mRNA.
DR   EMBL; CR456876; CAG33157.1; -; mRNA.
DR   EMBL; CR541782; CAG46581.1; -; mRNA.
DR   EMBL; CH471054; EAW97467.1; -; Genomic_DNA.
DR   RefSeq; NP_001722.1; NM_001731.2.
DR   IntAct; Q6IBC8; 2.
DR   Antibodypedia; 1186; 216 antibodies.
DR   DNASU; 694; -.
DR   GeneID; 694; -.
DR   KEGG; hsa:694; -.
DR   UCSC; uc001tby.3; human.
DR   CTD; 694; -.
DR   EuPathDB; HostDB:ENSG00000133639.4; -.
DR   PharmGKB; PA25450; -.
DR   eggNOG; KOG4006; Eukaryota.
DR   eggNOG; ENOG410ZZC0; LUCA.
DR   HOGENOM; CLU_079660_4_0_1; -.
DR   KO; K14443; -.
DR   OMA; GHVNDRQ; -.
DR   OrthoDB; 1439942at2759; -.
DR   ChiTaRS; BTG1; human.
DR   GenomeRNAi; 694; -.
DR   Bgee; ENSG00000133639; Expressed in upper lobe of lung and 243 other tissues.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:InterPro.
DR   Gene3D; 1.20.120.1120; -; 1.
DR   InterPro; IPR002087; Anti_prolifrtn.
DR   InterPro; IPR036054; BTG-like_sf.
DR   InterPro; IPR033330; BTG1.
DR   PANTHER; PTHR22978:SF30; PTHR22978:SF30; 1.
DR   Pfam; PF07742; BTG; 1.
DR   PRINTS; PR00310; ANTIPRLFBTG1.
DR   SMART; SM00099; btg1; 1.
DR   SUPFAM; SSF160696; SSF160696; 1.
DR   PROSITE; PS00960; BTG_1; 1.
DR   PROSITE; PS01203; BTG_2; 1.
PE   1: Evidence at protein level;
FT   DOMAIN          52..72
FT                   /note="Anti_prolifrtn"
FT                   /evidence="ECO:0000259|PROSITE:PS00960"
FT   DOMAIN          98..117
FT                   /note="Anti_prolifrtn"
FT                   /evidence="ECO:0000259|PROSITE:PS01203"
SQ   SEQUENCE   171 AA;  19209 MW;  EFED8BE09013BE60 CRC64;
     MHPFYTRAAT MIGEIAAAVS FISKFLRTKG LTSERQLQTF SQSLQELLAE HYKHHWFPEK
     PCKGSGYRCI RINHKMDPLI GQAAQRIGLS SQELFRLLPS ELTLWVDPYE VSYRIGEDGS
     ICVLYEASPA GGSTQNSTNV QMVDSRISCK EELLLGRTSP SKNYNMMTVS G
//
ID   CMTA1_HUMAN             Reviewed;        1673 AA.
AC   Q9Y6Y1; A7MBM4; G3V3Z7; Q5VUE1; Q6V701; Q8WYI3; Q96S92;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   16-MAY-2006, sequence version 4.
DT   22-APR-2020, entry version 161.
DE   RecName: Full=Calmodulin-binding transcription activator 1;
GN   Name=CAMTA1; Synonyms=KIAA0833; ORFNames=MSTP023;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=10048485; DOI=10.1093/dnares/5.6.355;
RA   Nagase T., Ishikawa K., Suyama M., Kikuno R., Hirosawa M., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 5:355-364(1998).
RN   [2]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Li N., Zhang M., Wan T., Zhang W., Cao X.;
RL   Submitted (MAY-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3 AND 4).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1422-1673 (ISOFORM 2).
RC   TISSUE=Heart;
RA   Xu Y.Y., Sun L.Z., Wu Q.Y., Liu Y.Q., Liu B., Zhao B., Wang X.Y., Song L.,
RA   Ye J., Sheng H., Gao Y., Zhang C.L., Zhang J., Wei Y.J., Sun Y.H.,
RA   Jiang Y.X., Zhao X.W., Liu S., Liu L.S., Ding J.F., Gao R.L., Qiang B.Q.,
RA   Yuan J.G., Liew C.C., Zhao M.S., Hui R.T.;
RL   Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1437-1673 (ISOFORM 2).
RA   Li H., Li S., Yu R., Shen C., Zhou G., Ke R., Lin L., Yang S.;
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   FUNCTION, SUBUNIT, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=11925432; DOI=10.1074/jbc.m200268200;
RA   Bouche N., Scharlat A., Snedden W., Bouchez D., Fromm H.;
RT   "A novel family of calmodulin-binding transcription activators in
RT   multicellular organisms.";
RL   J. Biol. Chem. 277:21851-21861(2002).
RN   [10]
RP   INDUCTION, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=15138581;
RA   Nakatani K., Nishioka J., Itakura T., Nakanishi Y., Horinouchi J., Abe Y.,
RA   Wada H., Nobori T.;
RT   "Cell cycle-dependent transcriptional regulation of calmodulin-binding
RT   transcription activator 1 in neuroblastoma cells.";
RL   Int. J. Oncol. 24:1407-1412(2004).
RN   [11]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=15709179;
RA   Barbashina V., Salazar P., Holland E.C., Rosenblum M.K., Ladanyi M.;
RT   "Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic
RT   classification, definition of a 150-kb minimal deleted region on 1p36, and
RT   evaluation of CAMTA1 as a candidate tumor suppressor gene.";
RL   Clin. Cancer Res. 11:1119-1128(2005).
RN   [12]
RP   INVOLVEMENT IN CANPMR.
RX   PubMed=22693284; DOI=10.1136/jmedgenet-2012-100856;
RA   Thevenon J., Lopez E., Keren B., Heron D., Mignot C., Altuzarra C.,
RA   Beri-Dexheimer M., Bonnet C., Magnin E., Burglen L., Minot D., Vigneron J.,
RA   Morle S., Anheim M., Charles P., Brice A., Gallagher L., Amiel J.,
RA   Haffen E., Mach C., Depienne C., Doummar D., Bonnet M., Duplomb L.,
RA   Carmignac V., Callier P., Marle N., Mosca-Boidron A.L., Roze V., Aral B.,
RA   Razavi F., Jonveaux P., Faivre L., Thauvin-Robinet C.;
RT   "Intragenic CAMTA1 rearrangements cause non-progressive congenital ataxia
RT   with or without intellectual disability.";
RL   J. Med. Genet. 49:400-408(2012).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 872-953.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Crystal structure of the TIG domain of human calmodulin-binding
RT   transcription activator 1 (CAMTA1).";
RL   Submitted (DEC-2005) to the PDB data bank.
RN   [14]
RP   VARIANTS LYS-1177; THR-1218 AND ILE-1336.
RX   PubMed=17222547; DOI=10.1016/j.ejca.2006.09.023;
RA   Henrich K.-O., Claas A., Praml C., Benner A., Mollenhauer J., Poustka A.,
RA   Schwab M., Westermann F.;
RT   "Allelic variants of CAMTA1 and FLJ10737 within a commonly deleted region
RT   at 1p36 in neuroblastoma.";
RL   Eur. J. Cancer 43:607-616(2007).
CC   -!- FUNCTION: Transcriptional activator. May act as a tumor suppressor.
CC       {ECO:0000269|PubMed:11925432, ECO:0000269|PubMed:15709179}.
CC   -!- SUBUNIT: May interact with calmodulin. {ECO:0000305}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}. Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q9Y6Y1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9Y6Y1-2; Sequence=VSP_035936, VSP_035937;
CC       Name=3;
CC         IsoId=Q9Y6Y1-3; Sequence=VSP_043842, VSP_043843;
CC       Name=4;
CC         IsoId=Q9Y6Y1-4; Sequence=VSP_046358, VSP_046359;
CC   -!- TISSUE SPECIFICITY: Normally expressed in non-neoplastic adult central
CC       nervous system tissues: detected in whole brain, cerebellum, brain
CC       cortex, occipital lobe, frontal lobe, temporal lobe, putamen.
CC       Expression levels are low in oligodendroglial tumors, and are reduced
CC       by half in oligodendroglioma and astrocytoma cases with 1p loss of
CC       heterozygosity. Detected in neuroblastic-type cultured neuroblastoma
CC       cells. Expressed in heart and kidney. {ECO:0000269|PubMed:11925432,
CC       ECO:0000269|PubMed:15138581, ECO:0000269|PubMed:15709179}.
CC   -!- INDUCTION: Detected at low levels at interphase and in resting cells.
CC       Up-regulated during S phase and mitosis. Levels decrease at the end of
CC       mitosis. {ECO:0000269|PubMed:15138581}.
CC   -!- DISEASE: Cerebellar ataxia, non-progressive, with mental retardation
CC       (CANPMR) [MIM:614756]: A neurodevelopmental disorder characterized by
CC       mildly delayed psychomotor development, early onset of cerebellar
CC       ataxia, and intellectual disability later in childhood and adult life.
CC       Other features may include neonatal hypotonia, dysarthria, and
CC       dysmetria. Brain imaging in some patients shows cerebellar atrophy.
CC       Dysmorphic facial features are variable. {ECO:0000269|PubMed:22693284}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- MISCELLANEOUS: A very small segment of 1p36 located within CAMTA1 is
CC       deleted in all oligodendroglial tumors with 1p LOH. This minimal
CC       deleted region (MDR) also overlaps the neuroblastoma 1p36 MDR. CAMTA1
CC       shows no evidence of inactivation by somatic mutations.
CC   -!- SIMILARITY: Belongs to the CAMTA family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAL39006.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA74856.3; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=EAW71580.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CAMTA1ID908ch1p36.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB020640; BAA74856.3; ALT_INIT; mRNA.
DR   EMBL; AY037153; AAK67633.1; -; mRNA.
DR   EMBL; AL359881; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL365194; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590128; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL596210; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z97635; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98052; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; Z98884; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471130; EAW71580.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC116457; AAI16458.1; -; mRNA.
DR   EMBL; BC151835; AAI51836.1; -; mRNA.
DR   EMBL; CD103791; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AF111804; AAL39006.1; ALT_INIT; mRNA.
DR   EMBL; AY349360; AAQ56724.1; -; mRNA.
DR   CCDS; CCDS30576.1; -. [Q9Y6Y1-1]
DR   CCDS; CCDS55574.1; -. [Q9Y6Y1-3]
DR   CCDS; CCDS55575.1; -. [Q9Y6Y1-4]
DR   RefSeq; NP_001182492.1; NM_001195563.1. [Q9Y6Y1-3]
DR   RefSeq; NP_001229630.1; NM_001242701.1. [Q9Y6Y1-4]
DR   RefSeq; NP_056030.1; NM_015215.3. [Q9Y6Y1-1]
DR   PDB; 2CXK; X-ray; 1.85 A; A/B/C/D/E=872-953.
DR   PDBsum; 2CXK; -.
DR   SMR; Q9Y6Y1; -.
DR   BioGrid; 116863; 4.
DR   IntAct; Q9Y6Y1; 1.
DR   STRING; 9606.ENSP00000306522; -.
DR   iPTMnet; Q9Y6Y1; -.
DR   PhosphoSitePlus; Q9Y6Y1; -.
DR   BioMuta; CAMTA1; -.
DR   DMDM; 97046872; -.
DR   jPOST; Q9Y6Y1; -.
DR   MassIVE; Q9Y6Y1; -.
DR   PaxDb; Q9Y6Y1; -.
DR   PeptideAtlas; Q9Y6Y1; -.
DR   PRIDE; Q9Y6Y1; -.
DR   ProteomicsDB; 33093; -.
DR   ProteomicsDB; 86825; -. [Q9Y6Y1-1]
DR   ProteomicsDB; 86826; -. [Q9Y6Y1-2]
DR   ProteomicsDB; 86827; -. [Q9Y6Y1-3]
DR   Antibodypedia; 49059; 55 antibodies.
DR   Ensembl; ENST00000303635; ENSP00000306522; ENSG00000171735. [Q9Y6Y1-1]
DR   Ensembl; ENST00000473578; ENSP00000451388; ENSG00000171735. [Q9Y6Y1-3]
DR   Ensembl; ENST00000557126; ENSP00000451510; ENSG00000171735. [Q9Y6Y1-4]
DR   GeneID; 23261; -.
DR   KEGG; hsa:23261; -.
DR   UCSC; uc001aoh.4; human. [Q9Y6Y1-1]
DR   CTD; 23261; -.
DR   DisGeNET; 23261; -.
DR   GeneCards; CAMTA1; -.
DR   HGNC; HGNC:18806; CAMTA1.
DR   HPA; ENSG00000171735; Low tissue specificity.
DR   MalaCards; CAMTA1; -.
DR   MIM; 611501; gene.
DR   MIM; 614756; phenotype.
DR   neXtProt; NX_Q9Y6Y1; -.
DR   OpenTargets; ENSG00000171735; -.
DR   Orphanet; 157791; Epithelioid hemangioendothelioma.
DR   Orphanet; 314647; Non-progressive cerebellar ataxia with intellectual disability.
DR   PharmGKB; PA38688; -.
DR   eggNOG; KOG0520; Eukaryota.
DR   eggNOG; ENOG410XS5M; LUCA.
DR   GeneTree; ENSGT00940000155203; -.
DR   HOGENOM; CLU_003170_1_0_1; -.
DR   InParanoid; Q9Y6Y1; -.
DR   KO; K21596; -.
DR   OMA; GKNEHSH; -.
DR   OrthoDB; 315169at2759; -.
DR   PhylomeDB; Q9Y6Y1; -.
DR   TreeFam; TF323452; -.
DR   SIGNOR; Q9Y6Y1; -.
DR   ChiTaRS; CAMTA1; human.
DR   EvolutionaryTrace; Q9Y6Y1; -.
DR   GeneWiki; CAMTA1; -.
DR   GenomeRNAi; 23261; -.
DR   Pharos; Q9Y6Y1; Tbio.
DR   PRO; PR:Q9Y6Y1; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9Y6Y1; protein.
DR   Bgee; ENSG00000171735; Expressed in caudate nucleus and 217 other tissues.
DR   ExpressionAtlas; Q9Y6Y1; baseline and differential.
DR   Genevisible; Q9Y6Y1; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0050885; P:neuromuscular process controlling balance; IEA:Ensembl.
DR   GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IMP:BHF-UCL.
DR   GO; GO:0035307; P:positive regulation of protein dephosphorylation; IMP:BHF-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   Gene3D; 1.25.40.20; -; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR002110; Ankyrin_rpt.
DR   InterPro; IPR020683; Ankyrin_rpt-contain_dom.
DR   InterPro; IPR036770; Ankyrin_rpt-contain_sf.
DR   InterPro; IPR039033; Camta1.
DR   InterPro; IPR005559; CG-1_dom.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   PANTHER; PTHR23335:SF11; PTHR23335:SF11; 1.
DR   Pfam; PF03859; CG-1; 1.
DR   Pfam; PF00612; IQ; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM01076; CG-1; 1.
DR   SUPFAM; SSF48403; SSF48403; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS50297; ANK_REP_REGION; 1.
DR   PROSITE; PS50088; ANK_REPEAT; 1.
DR   PROSITE; PS51437; CG_1; 1.
DR   PROSITE; PS50096; IQ; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; ANK repeat; Cytoplasm;
KW   Mental retardation; Nucleus; Polymorphism; Reference proteome; Repeat;
KW   Transcription; Transcription regulation.
FT   CHAIN           1..1673
FT                   /note="Calmodulin-binding transcription activator 1"
FT                   /id="PRO_0000235820"
FT   DOMAIN          873..953
FT                   /note="IPT/TIG"
FT   REPEAT          1064..1093
FT                   /note="ANK 1"
FT   REPEAT          1109..1129
FT                   /note="ANK 2"
FT   REPEAT          1143..1172
FT                   /note="ANK 3"
FT   DOMAIN          1547..1576
FT                   /note="IQ 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1577..1599
FT                   /note="IQ 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DOMAIN          1600..1622
FT                   /note="IQ 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   DNA_BIND        63..188
FT                   /note="CG-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00767"
FT   MOTIF           112..119
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00767"
FT   COMPBIAS        499..502
FT                   /note="Poly-Gly"
FT   COMPBIAS        1038..1041
FT                   /note="Poly-Val"
FT   VAR_SEQ         79..101
FT                   /note="EIAAYLITFEKHEEWLTTSPKTR -> ALTTHLFMGAAKKRDPQSWSHEG
FT                   (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046358"
FT   VAR_SEQ         79..80
FT                   /note="EI -> RS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_043842"
FT   VAR_SEQ         81..1673
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3"
FT                   /id="VSP_043843"
FT   VAR_SEQ         102..1673
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_046359"
FT   VAR_SEQ         1458..1471
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.7, ECO:0000303|Ref.8"
FT                   /id="VSP_035936"
FT   VAR_SEQ         1653..1673
FT                   /note="SPLVDHRLYKRSERIEKGQGT -> RVKELKKAKELEDIQQHPLAM (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|Ref.7, ECO:0000303|Ref.8"
FT                   /id="VSP_035937"
FT   VARIANT         1177
FT                   /note="N -> K (in dbSNP:rs41278952)"
FT                   /evidence="ECO:0000269|PubMed:17222547"
FT                   /id="VAR_047824"
FT   VARIANT         1218
FT                   /note="N -> T (in dbSNP:rs41278954)"
FT                   /evidence="ECO:0000269|PubMed:17222547"
FT                   /id="VAR_047825"
FT   VARIANT         1336
FT                   /note="T -> I (in dbSNP:rs137974312)"
FT                   /evidence="ECO:0000269|PubMed:17222547"
FT                   /id="VAR_047826"
FT   STRAND          875..877
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          879..881
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          888..894
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          902..906
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          909..912
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          914..917
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          920..924
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          930..939
FT                   /evidence="ECO:0000244|PDB:2CXK"
FT   STRAND          948..952
FT                   /evidence="ECO:0000244|PDB:2CXK"
SQ   SEQUENCE   1673 AA;  183672 MW;  008AA6A906374C00 CRC64;
     MWRAEGKWLP KTSRKSVSQS VFCGTSTYCV LNTVPPIEDD HGNSNSSHVK IFLPKKLLEC
     LPKCSSLPKE RHRWNTNEEI AAYLITFEKH EEWLTTSPKT RPQNGSMILY NRKKVKYRKD
     GYCWKKRKDG KTTREDHMKL KVQGVECLYG CYVHSSIIPT FHRRCYWLLQ NPDIVLVHYL
     NVPAIEDCGK PCGPILCSIN TDKKEWAKWT KEELIGQLKP MFHGIKWTCS NGNSSSGFSV
     EQLVQQILDS HQTKPQPRTH NCLCTGSLGA GGSVHHKCNS AKHRIISPKV EPRTGGYGSH
     SEVQHNDVSE GKHEHSHSKG SSREKRNGKV AKPVLLHQSS TEVSSTNQVE VPDTTQSSPV
     SISSGLNSDP DMVDSPVVTG VSGMAVASVM GSLSQSATVF MSEVTNEAVY TMSPTAGPNH
     HLLSPDASQG LVLAVSSDGH KFAFPTTGSS ESLSMLPTNV SEELVLSTTL DGGRKIPETT
     MNFDPDCFLN NPKQGQTYGG GGLKAEMVSS NIRHSPPGER SFSFTTVLTK EIKTEDTSFE
     QQMAKEAYSS SAAAVAASSL TLTAGSSLLP SGGGLSPSTT LEQMDFSAID SNKDYTSSFS
     QTGHSPHIHQ TPSPSFFLQD ASKPLPVEQN THSSLSDSGG TFVMPTVKTE ASSQTSSCSG
     HVETRIESTS SLHLMQFQAN FQAMTAEGEV TMETSQAAEG SEVLLKSGEL QACSSEHYLQ
     PETNGVIRSA GGVPILPGNV VQGLYPVAQP SLGNASNMEL SLDHFDISFS NQFSDLINDF
     ISVEGGSSTI YGHQLVSGDS TALSQSEDGA RAPFTQAEMC LPCCSPQQGS LQLSSSEGGA
     STMAYMHVAE VVSAASAQGT LGMLQQSGRV FMVTDYSPEW SYPEGGVKVL ITGPWQEASN
     NYSCLFDQIS VPASLIQPGV LRCYCPAHDT GLVTLQVAFN NQIISNSVVF EYKARALPTL
     PSSQHDWLSL DDNQFRMSIL ERLEQMERRM AEMTGSQQHK QASGGGSSGG GSGSGNGGSQ
     AQCASGTGAL GSCFESRVVV VCEKMMSRAC WAKSKHLIHS KTFRGMTLLH LAAAQGYATL
     IQTLIKWRTK HADSIDLELE VDPLNVDHFS CTPLMWACAL GHLEAAVVLY KWDRRAISIP
     DSLGRLPLGI ARSRGHVKLA ECLEHLQRDE QAQLGQNPRI HCPASEEPST ESWMAQWHSE
     AISSPEIPKG VTVIASTNPE LRRPRSEPSN YYSSESHKDY PAPKKHKLNP EYFQTRQEKL
     LPTALSLEEP NIRKQSPSSK QSVPETLSPS EGVRDFSREL SPPTPETAAF QASGSQPVGK
     WNSKDLYIGV STVQVTGNPK GTSVGKEAAP SQVRPREPMS VLMMANREVV NTELGSYRDS
     AENEECGQPM DDIQVNMMTL AEHIIEATPD RIKQENFVPM ESSGLERTDP ATISSTMSWL
     ASYLADADCL PSAAQIRSAY NEPLTPSSNT SLSPVGSPVS EIAFEKPNLP SAADWSEFLS
     ASTSEKVENE FAQLTLSDHE QRELYEAARL VQTAFRKYKG RPLREQQEVA AAVIQRCYRK
     YKQYALYKKM TQAAILIQSK FRSYYEQKKF QQSRRAAVLI QKYYRSYKKC GKRRQARRTA
     VIVQQKLRSS LLTKKQDQAA RKIMRFLRRC RHSPLVDHRL YKRSERIEKG QGT
//
ID   A0A024RCG3_HUMAN        Unreviewed;       748 AA.
AC   A0A024RCG3;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Cysteinyl-tRNA synthetase, isoform CRA_a {ECO:0000313|EMBL:EAX02540.1};
GN   Name=CARS {ECO:0000313|EMBL:EAX02540.1};
GN   ORFNames=hCG_16441 {ECO:0000313|EMBL:EAX02540.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAX02540.1};
RN   [1] {ECO:0000313|EMBL:EAX02540.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAX02540.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471158; EAX02536.1; -; Genomic_DNA.
DR   EMBL; CH471158; EAX02540.1; -; Genomic_DNA.
DR   RefSeq; NP_001742.1; NM_001751.5.
DR   Antibodypedia; 1044; 222 antibodies.
DR   GeneID; 833; -.
DR   KEGG; hsa:833; -.
DR   CTD; 833; -.
DR   EuPathDB; HostDB:ENSG00000110619.16; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   HOGENOM; CLU_013528_3_3_1; -.
DR   KO; K01883; -.
DR   OrthoDB; 528822at2759; -.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   Bgee; ENSG00000110619; Expressed in endothelial cell and 229 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   3: Inferred from homology;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:EAX02540.1};
KW   Ligase {ECO:0000313|EMBL:EAX02540.1}.
FT   DOMAIN          44..452
FT                   /note="tRNA-synt_1e"
FT                   /evidence="ECO:0000259|Pfam:PF01406"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          653..686
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..22
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        653..679
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   748 AA;  85473 MW;  D0B7A29EC03AA87F CRC64;
     MADSSGQQGK GRRVQPQWSP PAGTQPCRLH LYNSLTRNKE VFIPQDGKKV TWYCCGPTVY
     DASHMGHARS YISFDILRRV LKDYFKFDVF YCMNITDIDD KIIKRARQNH LFEQYREKRP
     EAAQLLEDVQ AALKPFSVKL NETTDPDKKQ MLERIQHAVQ LATEPLEKAV QSRLTGEEVN
     SCVEVLLEEA KDLLSDWLDS TLGCDVTDNS IFSKLPKFWE GDFHRDMEAL NVLPPDVLTR
     VSEYVPEIVN FVQKIVDNGY GYVSNGSVYF DTAKFASSEK HSYGKLVPEA VGDQKALQEG
     EGDLSISADR LSEKRSPNDF ALWKASKPGE PSWPCPWGKG RPGWHIECSA MAGTLLGASM
     DIHGGGFDLR FPHHDNELAQ SEAYFENDCW VRYFLHTGHL TIAGCKMSKS LKNFITIKDA
     LKKHSARQLR LAFLMHSWKD TLDYSSNTME SALQYEKFLN EFFLNVKDIL RAPVDITGQF
     EKWGEEEAEL NKNFYDKKTA IHKALCDNVD TRTVMEEMRA LVSQCNLYMA ARKAVRKRPN
     QALLENIALY LTHMLKIFGA VEEDSSLGFP VGGPGTSLSL EATVMPYLQV LSEFREGVRK
     IAREQKVPEI LQLSDALRDN ILPELGVRFE DHEGLPTVVK LVDRNTLLKE REEKRRVEEE
     KRKKKEEAAR RKQEQEAAKL AKMKIPPSEM FLSETDKYSK FDENGLPTHD MEGKELSKGQ
     AKKLKKLFEA QEKLYKEYLQ MAQNGSFQ
//
ID   A8MVQ3_HUMAN            Unreviewed;       738 AA.
AC   A8MVQ3;
DT   04-DEC-2007, integrated into UniProtKB/TrEMBL.
DT   04-DEC-2007, sequence version 1.
DT   22-APR-2020, entry version 103.
DE   SubName: Full=Cysteinyl-tRNA synthetase, isoform CRA_b {ECO:0000313|EMBL:EAX02537.1};
DE   SubName: Full=cDNA FLJ38994 fis, clone NT2RI2009259, highly similar to Cysteinyl-tRNA synthetase {ECO:0000313|EMBL:BAG53256.1};
GN   Name=CARS {ECO:0000313|EMBL:EAX02537.1};
GN   ORFNames=hCG_16441 {ECO:0000313|EMBL:EAX02537.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53256.1};
RN   [1] {ECO:0000313|EMBL:EAX02537.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:BAG53256.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3] {ECO:0000313|EMBL:EAX02537.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK096313; BAG53256.1; -; mRNA.
DR   EMBL; CH471158; EAX02537.1; -; Genomic_DNA.
DR   RefSeq; XP_006718404.1; XM_006718341.3.
DR   ProteomicsDB; 2196; -.
DR   GeneID; 833; -.
DR   CTD; 833; -.
DR   PharmGKB; PA26079; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   OrthoDB; 528822at2759; -.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   2: Evidence at transcript level;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:BAG53256.1};
KW   Ligase {ECO:0000313|EMBL:BAG53256.1}.
FT   DOMAIN          34..442
FT                   /note="tRNA-synt_1e"
FT                   /evidence="ECO:0000259|Pfam:PF01406"
FT   REGION          643..676
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        643..669
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   738 AA;  84472 MW;  D193831EAB32F00E CRC64;
     MQTPPLQQPH QEQVFLAFLV IVIPSFLTKE VFIPQDGKKV TWYCCGPTVY DASHMGHARS
     YISFDILRRV LKDYFKFDVF YCMNITDIDD KIIKRARQNH LFEQYREKRP EAAQLLEDVQ
     AALKPFSVKL NETTDPDKKQ MLERIQHAVQ LATEPLEKAV QSRLTGEEVN SCVEVLLEEA
     KDLLSDWLDS TLGCDVTDNS IFSKLPKFWE GDFHRDMEAL NVLPPDVLTR VSEYVPEIVN
     FVQKIVDNGY GYVSNGSVYF DTAKFASSEK HSYGKLVPEA VGDQKALQEG EGDLSISADR
     LSEKRSPNDF ALWKASKPGE PSWPCPWGKG RPGWHIECSA MAGTLLGASM DIHGGGFDLR
     FPHHDNELAQ SEAYFENDCW VRYFLHTGHL TIAGCKMSKS LKNFITIKDA LKKHSARQLR
     LAFLMHSWKD TLDYSSNTME SALQYEKFLN EFFLNVKDIL RAPVDITGQF EKWGEEEAEL
     NKNFYDKKTA IHKALCDNVD TRTVMEEMRA LVSQCNLYMA ARKAVRKRPN QALLENIALY
     LTHMLKIFGA VEEDSSLGFP VGGPGTSLSL EATVMPYLQV LSEFREGVRK IAREQKVPEI
     LQLSDALRDN ILPELGVRFE DHEGLPTVVK LVDRNTLLKE REEKRRVEEE KRKKKEEAAR
     RKQEQEAAKL AKMKIPPSEM FLSETDKYSK FDENGLPTHD MEGKELSKGQ AKKLKKLFEA
     QEKLYKEYLQ MAQNGSFQ
//
ID   B4DKY1_HUMAN            Unreviewed;       739 AA.
AC   B4DKY1; E9PPK8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 95.
DE   SubName: Full=Cysteine--tRNA ligase, cytoplasmic {ECO:0000313|Ensembl:ENSP00000432619};
DE   SubName: Full=cDNA FLJ59563, highly similar to Cysteinyl-tRNA synthetase {ECO:0000313|EMBL:BAG59343.1};
GN   Name=CARS1 {ECO:0000313|Ensembl:ENSP00000432619};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG59343.1};
RN   [1] {ECO:0000213|PubMed:15592455}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [2] {ECO:0000313|Ensembl:ENSP00000432619, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [3] {ECO:0000313|EMBL:BAG59343.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Tongue {ECO:0000313|EMBL:BAG59343.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [5] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [6] {ECO:0000313|Ensembl:ENSP00000432619}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [8] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [9] {ECO:0000313|Ensembl:ENSP00000488062}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (AUG-2015) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC001228; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108448; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AK296763; BAG59343.1; -; mRNA.
DR   RefSeq; XP_016873881.1; XM_017018392.1.
DR   ProteomicsDB; 22749; -.
DR   ProteomicsDB; 4495; -.
DR   Antibodypedia; 1044; 222 antibodies.
DR   Ensembl; ENST00000529772; ENSP00000432619; ENSG00000110619.
DR   Ensembl; ENST00000633563; ENSP00000488062; ENSG00000278191.
DR   GeneID; 833; -.
DR   UCSC; uc010qxp.3; human.
DR   CTD; 833; -.
DR   EuPathDB; HostDB:ENSG00000110619.16; -.
DR   HGNC; HGNC:1493; CARS1.
DR   OpenTargets; ENSG00000110619; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   GeneTree; ENSGT00390000006347; -.
DR   OrthoDB; 528822at2759; -.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   Bgee; ENSG00000110619; Expressed in endothelial cell and 229 other tissues.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   1: Evidence at protein level;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:BAG59343.1};
KW   Ligase {ECO:0000313|EMBL:BAG59343.1};
KW   Proteomics identification {ECO:0000213|EPD:B4DKY1,
KW   ECO:0000213|MaxQB:B4DKY1, ECO:0000213|PeptideAtlas:B4DKY1,
KW   ECO:0000213|ProteomicsDB:B4DKY1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          57..465
FT                   /note="tRNA-synt_1e"
FT                   /evidence="ECO:0000259|Pfam:PF01406"
FT   REGION          667..697
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        667..692
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   739 AA;  84278 MW;  E15B22AA0661A14E CRC64;
     MEPTSGPFRT DLGYHLVGCS SGKGRRVQPQ WSPPAGTQPC RLHLYNSLTR NKEVFIPQDG
     KKVTWYCCGP TVYDASHMGH ARSYISFDIL RRVLKDYFKF DVFYCMNITD IDDKIIKRAR
     QNHLFEQYRE KRPEAAQLLE DVQAALKPFS VKLNETTDPD KKQMLERIQH AVQLATEPLE
     KAVQSRLTGE EVNSCVEVLL EEAKDLLSDW LDSTLGCDVT DNSIFSKLPK FWEGDFHRDM
     EALNVLPPDV LTRVSEYVPE IVNFVQKIVD NGYGYVSNGS VYFDTAKFAS SEKHSYGKLV
     PEAVGDQKAL QEGEGDLSIS ADRLSEKRSP NDFALWKASK PGEPSWPCPW GKGRPGWHIE
     CSAMAGTLLG ASMDIHGGGF DLRFPHHDNE LAQSEAYFEN DCWVRYFLHT GHLTIAGCKM
     SKSLKNFITI KDALKKHSAR QLRLAFLMHS WKDTLDYSSN TMESALQYEK FLNEFFLNVK
     DILRAPVDIT GQFEKWGEEE AELNKNFYDK KTAIHKALCD NVDTRTVMEE MRALVSQCNL
     YMAARKAVRK RPNQALLENI ALYLTHMLKI FGAVEEDSSL GFPVGGPGTS LSLEATVMPY
     LQVLSEFREG VRKIAREQKV PEILQLSDAL RDNILPELGV RFEDHEGLPT VVKLVDRNTL
     LKEREEKRRV EEEKRKKKEE AARRKQEQEA AKLAKMKIPP SEMFLSETDK YSKFDENVSM
     VCPHMTWRAK SSAKGKPRS
//
ID   B4DPV7_HUMAN            Unreviewed;       809 AA.
AC   B4DPV7;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 67.
DE   SubName: Full=cDNA FLJ54534, highly similar to Homo sapiens cysteinyl-tRNA synthetase (CARS), transcript variant 3, mRNA {ECO:0000313|EMBL:BAG60719.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60719.1};
RN   [1] {ECO:0000313|EMBL:BAG60719.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK298514; BAG60719.1; -; mRNA.
DR   RefSeq; NP_001181926.1; NM_001194997.1.
DR   PeptideAtlas; B4DPV7; -.
DR   PRIDE; B4DPV7; -.
DR   DNASU; 833; -.
DR   GeneID; 833; -.
DR   CTD; 833; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   OrthoDB; 528822at2759; -.
DR   GenomeRNAi; 833; -.
DR   Genevisible; B4DPV7; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IEA:InterPro.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IEA:InterPro.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR036282; Glutathione-S-Trfase_C_sf.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   SUPFAM; SSF47616; SSF47616; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   2: Evidence at transcript level;
KW   Aminoacyl-tRNA synthetase {ECO:0000313|EMBL:BAG60719.1};
KW   Ligase {ECO:0000313|EMBL:BAG60719.1}.
FT   DOMAIN          127..535
FT                   /note="tRNA-synt_1e"
FT                   /evidence="ECO:0000259|Pfam:PF01406"
FT   REGION          738..767
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        738..762
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   809 AA;  92019 MW;  C05376F3F04FD266 CRC64;
     MADSSGQQAP DYRSILSISD EAARAQALNE HLSTRSYVQG YSLSQADVDA FRQLSAPPAD
     PQLFHVARWF RHIEALLGSP CGKGQPCRLQ ASKGRRVQPQ WSPPAGTQPC RLHLYNSLTR
     NKEVFIPQDG KKVTWYCCGP TVYDASHMGH ARSYISFDIL RRVLKDYFKF DVFYCMNITD
     IDDKIIKRAR QNHLFEQYRE KRPEAAQLLE DVQAALKPFS VKLNETTDPD KKQMLERIQH
     AVQLATEPLE KAVQSRLTGE EVNSCVEVLL EEAKDLLSDW LDSTFGCDVT DNSIFSKLPK
     FWEGDFHRDM EALNVLPPDV LTRVSEYVPE IVNFVQKIVD NGYGYVSNGS VYFDTAKFAS
     SEKHSYGKLV PEAVGDQKAL QEGEGDLSIS ADRLSEKRSP NDFALWKASK PGEPSWPCPW
     GKGRPGWHIE CSAMAGTLLG ASMDIHGGGF DLRFPHHDNE LAQSEAYFEN DCWVRYFLHT
     GHLTIAGCKM SKSLKNFITI KDALKKHSAR QLRLAFLMHS WKDTLDYSSN TMESALQYEK
     FLNEFFLNVK DILRAPVDIT GQFEKWGEEE AELNKNFYDK KTAIHKALCD NVDTRTVMEE
     MRASVSQCNL YMAARKAVRK RPNQALLENI ALYLTHMLKI FGAVEEDSSL GFPVGGPGTS
     LSLEATVMPY LQVLSEFREG VRKIAREQKV PEILQLSDAL RDNILPELGV RFEDHEGLPT
     VVKLVDRNTL LKEREEKRRV EEEKRKKKEE AARRKQEQEA AKLAKMKIPP SEMFLSETDK
     YSKFDENVSM VCPHMTWRAK SSAKGKPRS
//
ID   SYCC_HUMAN              Reviewed;         748 AA.
AC   P49589; Q53XI8; Q5HYE4; Q9HD24; Q9HD25;
DT   01-FEB-1996, integrated into UniProtKB/Swiss-Prot.
DT   31-JAN-2002, sequence version 3.
DT   22-APR-2020, entry version 186.
DE   RecName: Full=Cysteine--tRNA ligase, cytoplasmic;
DE            EC=6.1.1.16;
DE   AltName: Full=Cysteinyl-tRNA synthetase;
DE            Short=CysRS;
GN   Name=CARS1 {ECO:0000312|HGNC:HGNC:1493}; Synonyms=CARS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=7987009; DOI=10.3109/10425179409020847;
RA   Cruzen M.E., Arfin S.M.;
RT   "Nucleotide and deduced amino acid sequence of human cysteinyl-tRNA
RT   synthetase.";
RL   DNA Seq. 4:243-248(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=11347887; DOI=10.1515/bc.2001.049;
RA   Davidson E., Caffarella J., Vitseva O., Hou Y.M., King M.P.;
RT   "Isolation of two cDNAs encoding functional human cytoplasmic cysteinyl-
RT   tRNA synthetase.";
RL   Biol. Chem. 382:399-406(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Cervix;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16554811; DOI=10.1038/nature04632;
RA   Taylor T.D., Noguchi H., Totoki Y., Toyoda A., Kuroki Y., Dewar K.,
RA   Lloyd C., Itoh T., Takeda T., Kim D.-W., She X., Barlow K.F., Bloom T.,
RA   Bruford E., Chang J.L., Cuomo C.A., Eichler E., FitzGerald M.G.,
RA   Jaffe D.B., LaButti K., Nicol R., Park H.-S., Seaman C., Sougnez C.,
RA   Yang X., Zimmer A.R., Zody M.C., Birren B.W., Nusbaum C., Fujiyama A.,
RA   Hattori M., Rogers J., Lander E.S., Sakaki Y.;
RT   "Human chromosome 11 DNA sequence and analysis including novel gene
RT   identification.";
RL   Nature 440:497-500(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH ALK.
RX   PubMed=12112524; DOI=10.1002/gcc.10033;
RA   Cools J., Wlodarska I., Somers R., Mentens N., Pedeutour F., Maes B.,
RA   De Wolf-Peeters C., Pauwels P., Hagemeijer A., Marynen P.;
RT   "Identification of novel fusion partners of ALK, the anaplastic lymphoma
RT   kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic
RT   tumor.";
RL   Genes Chromosomes Cancer 34:354-362(2002).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=15592455; DOI=10.1038/nbt1046;
RA   Rush J., Moritz A., Lee K.A., Guo A., Goss V.L., Spek E.J., Zhang H.,
RA   Zha X.-M., Polakiewicz R.D., Comb M.J.;
RT   "Immunoaffinity profiling of tyrosine phosphorylation in cancer cells.";
RL   Nat. Biotechnol. 23:94-101(2005).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [12]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-503, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-746, PHOSPHORYLATION [LARGE
RP   SCALE ANALYSIS] AT SER-79 (ISOFORM 3), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [15]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19 AND SER-307, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-19; SER-305 AND SER-307, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-cysteine + tRNA(Cys) = AMP + diphosphate + L-
CC         cysteinyl-tRNA(Cys); Xref=Rhea:RHEA:17773, Rhea:RHEA-COMP:9661,
CC         Rhea:RHEA-COMP:9679, ChEBI:CHEBI:30616, ChEBI:CHEBI:33019,
CC         ChEBI:CHEBI:35235, ChEBI:CHEBI:78442, ChEBI:CHEBI:78517,
CC         ChEBI:CHEBI:456215; EC=6.1.1.16;
CC   -!- COFACTOR:
CC       Name=Zn(2+); Xref=ChEBI:CHEBI:29105; Evidence={ECO:0000250};
CC       Note=Binds 1 zinc ion per subunit. {ECO:0000250};
CC   -!- SUBUNIT: Monomer. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=P49589-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P49589-2; Sequence=VSP_006312;
CC       Name=3;
CC         IsoId=P49589-3; Sequence=VSP_043571;
CC   -!- DISEASE: Note=A chromosomal aberration involving CARS is associated
CC       with inflammatory myofibroblastic tumors (IMTs). Translocation
CC       t(2;11)(p23;p15) with ALK.
CC   -!- MISCELLANEOUS: [Isoform 2]: Found in 20% of the mRNAs. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the class-I aminoacyl-tRNA synthetase family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA73901.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CARSID484.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L06845; AAA73901.1; ALT_FRAME; mRNA.
DR   EMBL; AF288206; AAG00578.1; -; mRNA.
DR   EMBL; AF288207; AAG00579.1; -; mRNA.
DR   EMBL; BT009913; AAP88915.1; -; mRNA.
DR   EMBL; AK302644; BAG63885.1; -; mRNA.
DR   EMBL; BX647906; CAI46108.1; -; mRNA.
DR   EMBL; AC108448; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC131971; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471158; EAX02541.1; -; Genomic_DNA.
DR   EMBL; BC002880; AAH02880.1; -; mRNA.
DR   CCDS; CCDS41600.1; -. [P49589-3]
DR   CCDS; CCDS41602.1; -. [P49589-2]
DR   CCDS; CCDS7742.1; -. [P49589-1]
DR   RefSeq; NP_001014437.1; NM_001014437.2. [P49589-3]
DR   RefSeq; NP_001742.1; NM_001751.5. [P49589-1]
DR   RefSeq; NP_644802.1; NM_139273.3. [P49589-2]
DR   SMR; P49589; -.
DR   BioGrid; 107283; 66.
DR   IntAct; P49589; 20.
DR   MINT; P49589; -.
DR   STRING; 9606.ENSP00000369897; -.
DR   ChEMBL; CHEMBL4105937; -.
DR   DrugBank; DB00151; Cysteine.
DR   iPTMnet; P49589; -.
DR   MetOSite; P49589; -.
DR   PhosphoSitePlus; P49589; -.
DR   SwissPalm; P49589; -.
DR   BioMuta; CARS; -.
DR   DMDM; 20141641; -.
DR   EPD; P49589; -.
DR   jPOST; P49589; -.
DR   MassIVE; P49589; -.
DR   MaxQB; P49589; -.
DR   PaxDb; P49589; -.
DR   PeptideAtlas; P49589; -.
DR   PRIDE; P49589; -.
DR   ProteomicsDB; 56023; -. [P49589-1]
DR   ProteomicsDB; 56024; -. [P49589-2]
DR   ProteomicsDB; 56025; -. [P49589-3]
DR   Antibodypedia; 1044; 222 antibodies.
DR   DNASU; 833; -.
DR   Ensembl; ENST00000278224; ENSP00000278224; ENSG00000110619. [P49589-2]
DR   Ensembl; ENST00000380525; ENSP00000369897; ENSG00000110619. [P49589-3]
DR   Ensembl; ENST00000397111; ENSP00000380300; ENSG00000110619. [P49589-1]
DR   Ensembl; ENST00000612826; ENSP00000482336; ENSG00000278191. [P49589-3]
DR   Ensembl; ENST00000632612; ENSP00000487923; ENSG00000278191. [P49589-2]
DR   Ensembl; ENST00000633248; ENSP00000488657; ENSG00000278191. [P49589-1]
DR   GeneID; 833; -.
DR   KEGG; hsa:833; -.
DR   UCSC; uc001lxf.4; human. [P49589-1]
DR   CTD; 833; -.
DR   DisGeNET; 833; -.
DR   GeneCards; CARS1; -.
DR   HGNC; HGNC:1493; CARS1.
DR   HPA; ENSG00000110619; Low tissue specificity.
DR   MalaCards; CARS1; -.
DR   MIM; 123859; gene.
DR   neXtProt; NX_P49589; -.
DR   OpenTargets; ENSG00000110619; -.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   PharmGKB; PA26079; -.
DR   eggNOG; KOG2007; Eukaryota.
DR   eggNOG; COG0215; LUCA.
DR   GeneTree; ENSGT00390000006347; -.
DR   HOGENOM; CLU_013528_3_3_1; -.
DR   InParanoid; P49589; -.
DR   KO; K01883; -.
DR   OMA; FHNDMKS; -.
DR   OrthoDB; 528822at2759; -.
DR   PhylomeDB; P49589; -.
DR   TreeFam; TF300384; -.
DR   Reactome; R-HSA-379716; Cytosolic tRNA aminoacylation.
DR   ChiTaRS; CARS; human.
DR   GenomeRNAi; 833; -.
DR   Pharos; P49589; Tbio.
DR   PRO; PR:P49589; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; P49589; protein.
DR   Bgee; ENSG00000110619; Expressed in endothelial cell and 229 other tissues.
DR   ExpressionAtlas; P49589; baseline and differential.
DR   Genevisible; P49589; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IDA:UniProtKB.
DR   GO; GO:0004817; F:cysteine-tRNA ligase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000049; F:tRNA binding; IDA:UniProtKB.
DR   GO; GO:0006423; P:cysteinyl-tRNA aminoacylation; IDA:UniProtKB.
DR   GO; GO:0006418; P:tRNA aminoacylation for protein translation; TAS:Reactome.
DR   CDD; cd00672; CysRS_core; 1.
DR   Gene3D; 3.40.50.620; -; 2.
DR   HAMAP; MF_00041; Cys_tRNA_synth; 1.
DR   InterPro; IPR015803; Cys-tRNA-ligase.
DR   InterPro; IPR024909; Cys-tRNA/MSH_ligase.
DR   InterPro; IPR014729; Rossmann-like_a/b/a_fold.
DR   InterPro; IPR032678; tRNA-synt_1_cat_dom.
DR   InterPro; IPR009080; tRNAsynth_Ia_anticodon-bd.
DR   PANTHER; PTHR10890; PTHR10890; 1.
DR   Pfam; PF01406; tRNA-synt_1e; 1.
DR   PRINTS; PR00983; TRNASYNTHCYS.
DR   SUPFAM; SSF47323; SSF47323; 1.
DR   TIGRFAMs; TIGR00435; cysS; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Aminoacyl-tRNA synthetase; ATP-binding;
KW   Chromosomal rearrangement; Cytoplasm; Ligase; Metal-binding;
KW   Nucleotide-binding; Phosphoprotein; Protein biosynthesis; Proto-oncogene;
KW   Reference proteome; Zinc.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..748
FT                   /note="Cysteine--tRNA ligase, cytoplasmic"
FT                   /id="PRO_0000159550"
FT   MOTIF           57..67
FT                   /note="'HIGH' region"
FT   MOTIF           406..410
FT                   /note="'KMSKS' region"
FT   METAL           55
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           348
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           373
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   METAL           377
FT                   /note="Zinc"
FT                   /evidence="ECO:0000250"
FT   BINDING         409
FT                   /note="ATP"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         19
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         305
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         307
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         503
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         746
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231"
FT   VAR_SEQ         9
FT                   /note="G -> APDYRSILSISDEAARAQALNEHLSTRSYVQGYSLSQADVDAFRQLS
FT                   APPADPQLFHVARWFRHIEALLGSPCGKGQPCRLQAS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:17974005"
FT                   /id="VSP_043571"
FT   VAR_SEQ         705..748
FT                   /note="GLPTHDMEGKELSKGQAKKLKKLFEAQEKLYKEYLQMAQNGSFQ -> VSMV
FT                   CPHMTWRAKSSAKGKPRS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:11347887,
FT                   ECO:0000303|PubMed:7987009"
FT                   /id="VSP_006312"
FT   MOD_RES         P49589-3:79
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
SQ   SEQUENCE   748 AA;  85473 MW;  D0B7A29EC03AA87F CRC64;
     MADSSGQQGK GRRVQPQWSP PAGTQPCRLH LYNSLTRNKE VFIPQDGKKV TWYCCGPTVY
     DASHMGHARS YISFDILRRV LKDYFKFDVF YCMNITDIDD KIIKRARQNH LFEQYREKRP
     EAAQLLEDVQ AALKPFSVKL NETTDPDKKQ MLERIQHAVQ LATEPLEKAV QSRLTGEEVN
     SCVEVLLEEA KDLLSDWLDS TLGCDVTDNS IFSKLPKFWE GDFHRDMEAL NVLPPDVLTR
     VSEYVPEIVN FVQKIVDNGY GYVSNGSVYF DTAKFASSEK HSYGKLVPEA VGDQKALQEG
     EGDLSISADR LSEKRSPNDF ALWKASKPGE PSWPCPWGKG RPGWHIECSA MAGTLLGASM
     DIHGGGFDLR FPHHDNELAQ SEAYFENDCW VRYFLHTGHL TIAGCKMSKS LKNFITIKDA
     LKKHSARQLR LAFLMHSWKD TLDYSSNTME SALQYEKFLN EFFLNVKDIL RAPVDITGQF
     EKWGEEEAEL NKNFYDKKTA IHKALCDNVD TRTVMEEMRA LVSQCNLYMA ARKAVRKRPN
     QALLENIALY LTHMLKIFGA VEEDSSLGFP VGGPGTSLSL EATVMPYLQV LSEFREGVRK
     IAREQKVPEI LQLSDALRDN ILPELGVRFE DHEGLPTVVK LVDRNTLLKE REEKRRVEEE
     KRKKKEEAAR RKQEQEAAKL AKMKIPPSEM FLSETDKYSK FDENGLPTHD MEGKELSKGQ
     AKKLKKLFEA QEKLYKEYLQ MAQNGSFQ
//
ID   MTG16_HUMAN             Reviewed;         653 AA.
AC   O75081; D3DX78; O60615; O60616; O60617; O75082; O75107; O75108; Q0P5Z6;
AC   Q6P5W6;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   23-OCT-2007, sequence version 2.
DT   22-APR-2020, entry version 152.
DE   RecName: Full=Protein CBFA2T3;
DE   AltName: Full=MTG8-related protein 2;
DE   AltName: Full=Myeloid translocation gene on chromosome 16 protein;
DE            Short=hMTG16;
DE   AltName: Full=Zinc finger MYND domain-containing protein 4;
GN   Name=CBFA2T3; Synonyms=MTG16, MTGR2, ZMYND4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORMS 1 AND 2), CHROMOSOMAL
RP   TRANSLOCATION WITH RUNX1, TISSUE SPECIFICITY, AND VARIANT GLY-429.
RC   TISSUE=Brain;
RX   PubMed=9596646;
RA   Gamou T., Kitamura E., Hosoda F., Shimuzu K., Hayashi Y., Nagase T.,
RA   Yokoyama Y., Ohki M.;
RT   "The partner gene of AML1 in t(16;21) myeloid malignancies is a novel
RT   member of the MTG8(ETO) family.";
RL   Blood 91:4028-4037(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung, and Pancreas;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 128-297 AND 492-604, NUCLEOTIDE
RP   SEQUENCE [MRNA] OF 341-431, AND TISSUE SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9790752; DOI=10.1006/geno.1998.5429;
RA   Calabi F., Cilli V.;
RT   "CBFA2T1, a gene rearranged in human leukemia, is a member of a multigene
RT   family.";
RL   Genomics 52:332-341(1998).
RN   [5]
RP   CHROMOSOMAL TRANSLOCATION WITH RUNX1.
RX   PubMed=10995019; DOI=10.1038/sj.leu.2401885;
RA   Salomon-Nguyen F., Busson-Le Coniat M., Lafage Pochitaloff M.,
RA   Mozziconacci J., Berger R., Bernard O.A.;
RT   "AML1-MTG16 fusion gene in therapy-related acute leukemia with
RT   t(16;21)(q24;q22): two new cases.";
RL   Leukemia 14:1704-1705(2000).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH RUNX1.
RX   PubMed=11224496;
RA   La Starza R., Sambani C., Crescenzi B., Matteucci C., Martelli M.F.,
RA   Mecucci C.;
RT   "AML1/MTG16 fusion gene from a t(16;21)(q24;q22) translocation in
RT   treatment-induced leukemia after breast cancer.";
RL   Haematologica 86:212-213(2001).
RN   [7]
RP   INTERACTION WITH HDAC1; HDAC2; HDAC3; HDAC6; HDAC8; NCOR1 AND NCOR2.
RX   PubMed=11533236; DOI=10.1128/mcb.21.19.6470-6483.2001;
RA   Amann J.M., Nip J., Strom D.K., Lutterbach B., Harada H., Lenny N.,
RA   Downing J.R., Meyers S., Hiebert S.W.;
RT   "ETO, a target of t(8;21) in acute leukemia, makes distinct contacts with
RT   multiple histone deacetylases and binds mSin3A through its oligomerization
RT   domain.";
RL   Mol. Cell. Biol. 21:6470-6483(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=12183414;
RA   Kochetkova M., McKenzie O.L.D., Bais A.J., Martin J.M., Secker G.A.,
RA   Seshadri R., Powell J.A., Hinze S.J., Gardner A.E., Spendlove H.E.,
RA   O'Callaghan N.J., Cleton-Jansen A.-M., Cornelisse C., Whitmore S.A.,
RA   Crawford J., Kremmidiotis G., Sutherland G.R., Callen D.F.;
RT   "CBFA2T3 (MTG16) is a putative breast tumor suppressor gene from the breast
RT   cancer loss of heterozygosity region at 16q24.3.";
RL   Cancer Res. 62:4599-4604(2002).
RN   [9]
RP   FUNCTION (ISOFORM 2), INTERACTION WITH PRKAR2A, MUTAGENESIS OF VAL-494, AND
RP   SUBCELLULAR LOCATION (ISOFORM 2).
RX   PubMed=11823486; DOI=10.4049/jimmunol.168.4.1590;
RA   Schillace R.V., Andrews S.F., Liberty G.A., Davey M.P., Carr D.W.;
RT   "Identification and characterization of myeloid translocation gene 16b as a
RT   novel a kinase anchoring protein in T lymphocytes.";
RL   J. Immunol. 168:1590-1599(2002).
RN   [10]
RP   ALTERNATIVE SPLICING (ISOFORMS 3 AND 4), SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH CBFA2T2; HDAC1; HDAC3 AND RUNX1T1.
RX   PubMed=12242670; DOI=10.1038/sj.onc.1205882;
RA   Hoogeveen A.T., Rossetti S., Stoyanova V., Schonkeren J., Fenaroli A.,
RA   Schiaffonati L., van Unen L., Sacchi N.;
RT   "The transcriptional corepressor MTG16a contains a novel nucleolar
RT   targeting sequence deranged in t(16; 21)-positive myeloid malignancies.";
RL   Oncogene 21:6703-6712(2002).
RN   [11]
RP   REVIEW.
RX   PubMed=12559562; DOI=10.1016/s0378-1119(02)01172-1;
RA   Davis J.N., McGhee L., Meyers S.;
RT   "The ETO (MTG8) gene family.";
RL   Gene 303:1-10(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH NCOR1, AND TISSUE SPECIFICITY.
RX   PubMed=15231665; DOI=10.1158/0008-5472.can-03-3689;
RA   Ibanez V., Sharma A., Buonamici S., Verma A., Kalakonda S., Wang J.,
RA   Kadkol S., Saunthararajah Y.;
RT   "AML1-ETO decreases ETO-2 (MTG16) interactions with nuclear receptor
RT   corepressor, an effect that impairs granulocyte differentiation.";
RL   Cancer Res. 64:4547-4554(2004).
RN   [13]
RP   REVIEW.
RX   PubMed=15203199; DOI=10.1016/j.ygeno.2004.02.011;
RA   Rossetti S., Hoogeveen A.T., Sacchi N.;
RT   "The MTG proteins: chromatin repression players with a passion for
RT   networking.";
RL   Genomics 84:1-9(2004).
RN   [14]
RP   INTERACTION WITH PDE4A AND PDE7A.
RX   PubMed=15470020; DOI=10.4049/jimmunol.173.8.4806;
RA   Asirvatham A.L., Galligan S.G., Schillace R.V., Davey M.P., Vasta V.,
RA   Beavo J.A., Carr D.W.;
RT   "A-kinase anchoring proteins interact with phosphodiesterases in T
RT   lymphocyte cell lines.";
RL   J. Immunol. 173:4806-4814(2004).
RN   [15]
RP   INDUCTION.
RX   PubMed=15676213; DOI=10.1016/j.exphem.2004.10.011;
RA   Lindberg S.R., Olsson A., Persson A.-M., Olsson I.;
RT   "The leukemia-associated ETO homologues are differently expressed during
RT   hematopoietic differentiation.";
RL   Exp. Hematol. 33:189-198(2005).
RN   [16]
RP   INTERACTION WITH AML1-MTG8/ETO.
RX   PubMed=16616331; DOI=10.1016/j.ccr.2006.03.012;
RA   Liu Y., Cheney M.D., Gaudet J.J., Chruszcz M., Lukasik S.M., Sugiyama D.,
RA   Lary J., Cole J., Dauter Z., Minor W., Speck N.A., Bushweller J.H.;
RT   "The tetramer structure of the Nervy homology two domain, NHR2, is critical
RT   for AML1/ETO's activity.";
RL   Cancer Cell 9:249-260(2006).
RN   [17]
RP   INTERACTION WITH ERBB4.
RX   PubMed=16815842; DOI=10.1074/jbc.m603998200;
RA   Linggi B., Carpenter G.;
RT   "ErbB-4 s80 intracellular domain abrogates ETO2-dependent transcriptional
RT   repression.";
RL   J. Biol. Chem. 281:25373-25380(2006).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH ZNF652.
RX   PubMed=16966434; DOI=10.1158/1541-7786.mcr-05-0249;
RA   Kumar R., Manning J., Spendlove H.E., Kremmidiotis G., McKirdy R., Lee J.,
RA   Millband D.N., Cheney K.M., Stampfer M.R., Dwivedi P.P., Morris H.A.,
RA   Callen D.F.;
RT   "ZNF652, a novel zinc finger protein, interacts with the putative breast
RT   tumor suppressor CBFA2T3 to repress transcription.";
RL   Mol. Cancer Res. 4:655-665(2006).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [20]
RP   INTERACTION WITH PLXNA1; PLXNA3 AND PRKAR1A.
RX   PubMed=20138877; DOI=10.1016/j.febslet.2010.02.007;
RA   Fiedler S.E., Schillace R.V., Daniels C.J., Andrews S.F., Carr D.W.;
RT   "Myeloid translocation gene 16b is a dual A-kinase anchoring protein that
RT   interacts selectively with plexins in a phospho-regulated manner.";
RL   FEBS Lett. 584:873-877(2010).
RN   [21]
RP   FUNCTION, AND INTERACTION WITH ZBTB4; ZBTB33 AND ZBTB38.
RX   PubMed=23251453; DOI=10.1371/journal.pone.0051205;
RA   Barrett C.W., Smith J.J., Lu L.C., Markham N., Stengel K.R., Short S.P.,
RA   Zhang B., Hunt A.A., Fingleton B.M., Carnahan R.H., Engel M.E., Chen X.,
RA   Beauchamp R.D., Wilson K.T., Hiebert S.W., Reynolds A.B., Williams C.S.;
RT   "Kaiso directs the transcriptional corepressor MTG16 to the Kaiso binding
RT   site in target promoters.";
RL   PLoS ONE 7:E51205-E51205(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-457; SER-459 AND THR-479, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   FUNCTION, AND REGIONS NHR2 AND NHR3.
RX   PubMed=23840896; DOI=10.1371/journal.pone.0068502;
RA   Kumar P., Sharoyko V.V., Spegel P., Gullberg U., Mulder H., Olsson I.,
RA   Ajore R.;
RT   "The transcriptional co-repressor myeloid translocation gene 16 inhibits
RT   glycolysis and stimulates mitochondrial respiration.";
RL   PLoS ONE 8:E68502-E68502(2013).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-637; SER-641 AND THR-650, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   FUNCTION, AND INTERACTION WITH HIF1A AND EGLN1.
RX   PubMed=25974097; DOI=10.1371/journal.pone.0123725;
RA   Kumar P., Gullberg U., Olsson I., Ajore R.;
RT   "Myeloid translocation gene-16 co-repressor promotes degradation of
RT   hypoxia-inducible factor 1.";
RL   PLoS ONE 10:E0123725-E0123725(2015).
RN   [26]
RP   VARIANTS [LARGE SCALE ANALYSIS] HIS-306; LYS-518 AND VAL-534.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Transcriptional corepressor which facilitates transcriptional
CC       repression via its association with DNA-binding transcription factors
CC       and recruitment of other corepressors and histone-modifying enzymes
CC       (PubMed:12559562, PubMed:15203199). Can repress the expression of MMP7
CC       in a ZBTB33-dependent manner (PubMed:23251453). Reduces the protein
CC       levels and stability of the transcriptinal regulator HIF1A; interacts
CC       with EGLN1 and promotes the HIF1A prolyl hydroxylation-dependent
CC       ubiquitination and proteasomal degradation pathway (PubMed:25974097).
CC       Contributes to inhibition of glycolysis and stimulation of
CC       mitochondrial respiration by down-regulating the expression of
CC       glycolytic genes including PFKFB3, PFKFB4, PDK1, PFKP, LDHA and HK1
CC       which are direct targets of HIF1A (PubMed:23840896, PubMed:25974097).
CC       Regulates the proliferation and the differentiation of erythroid
CC       progenitors by repressing the expression of TAL1 target genes (By
CC       similarity). Plays a role in granulocyte differentiation
CC       (PubMed:15231665). {ECO:0000250|UniProtKB:O54972,
CC       ECO:0000269|PubMed:12183414, ECO:0000269|PubMed:15231665,
CC       ECO:0000269|PubMed:16966434, ECO:0000269|PubMed:23251453,
CC       ECO:0000269|PubMed:23840896, ECO:0000269|PubMed:25974097,
CC       ECO:0000303|PubMed:12559562, ECO:0000303|PubMed:15203199}.
CC   -!- FUNCTION: Isoform 2 functions as an A-kinase-anchoring protein
CC       (PubMed:11823486). {ECO:0000269|PubMed:11823486}.
CC   -!- SUBUNIT: Homooligomer. Homotetramerization is mediated by nervy
CC       homology region 2 (NRH2) (By similarity). Can interact with RUNX1T1 and
CC       CBFA2T2; heterotetramerization between members of the CBFA2T family is
CC       proposed (PubMed:12242670). Component of a TAL-1 complex composed at
CC       least of CBFA2T3, LDB1, TAL1 and TCF3 (By similarity). Interacts with
CC       ERBB4, HDAC1, HDAC2, HDAC3, HDAC6, HDAC8, NCOR1, NCOR2, and ZNF652.
CC       According to PubMed:12242670, may not interact with HDAC6. Interacts
CC       with PLXNA1, PLXNA3 and PRKAR1A. Isoform 2 interacts with PRKAR2A,
CC       PDE7A and probably PDE4A. Interacts with ZBTB4, ZBTB38 and ZBTB33.
CC       Interacts with HIF1A and EGLN1. Interacts with the AML1-MTG8/ETO fusion
CC       protein. {ECO:0000250|UniProtKB:O54972, ECO:0000250|UniProtKB:Q06455,
CC       ECO:0000269|PubMed:11533236, ECO:0000269|PubMed:11823486,
CC       ECO:0000269|PubMed:12242670, ECO:0000269|PubMed:15231665,
CC       ECO:0000269|PubMed:15470020, ECO:0000269|PubMed:16616331,
CC       ECO:0000269|PubMed:16815842, ECO:0000269|PubMed:16966434,
CC       ECO:0000269|PubMed:20138877, ECO:0000269|PubMed:23251453,
CC       ECO:0000269|PubMed:25974097}.
CC   -!- INTERACTION:
CC       O75081; P51805: PLXNA3; NbExp=2; IntAct=EBI-1190217, EBI-7135904;
CC       O75081; Q9Y2D9: ZNF652; NbExp=2; IntAct=EBI-1190217, EBI-1190229;
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Nucleus, nucleolus. Note=The RUNX1-
CC       CBFA2T3 fusion protein localizes to the nucleoplasm.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Nucleus, nucleoplasm
CC       {ECO:0000269|PubMed:11823486}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:11823486}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=CBFA2T3A, MTG16a;
CC         IsoId=O75081-1; Sequence=Displayed;
CC       Name=2; Synonyms=CBFA2T3B, MTG16b;
CC         IsoId=O75081-2; Sequence=VSP_028620, VSP_028624;
CC       Name=3; Synonyms=MTG16c;
CC         IsoId=O75081-4; Sequence=VSP_028621;
CC       Name=4; Synonyms=MTG16HEL;
CC         IsoId=O75081-5; Sequence=VSP_028622, VSP_028623;
CC   -!- TISSUE SPECIFICITY: Widely expressed with higher expression in heart,
CC       pancreas, skeletal muscle, spleen, thymus and peripheral blood
CC       leukocytes. Expressed in hematopoietic cells (at protein level).
CC       {ECO:0000269|PubMed:15231665, ECO:0000269|PubMed:9596646,
CC       ECO:0000269|PubMed:9790752}.
CC   -!- INDUCTION: Down-regulated by all-trans retinoic acid (ATRA).
CC       {ECO:0000269|PubMed:15676213}.
CC   -!- DOMAIN: Nervy homology region 2 (NHR2) mediates homo- and possibly
CC       heterotypic oligomerization by forming a four-helix bundle tetrameric
CC       structure. {ECO:0000250|UniProtKB:Q06455}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CBFA2T3 is found in
CC       therapy-related myeloid malignancies. Translocation t(16;21)(q24;q22)
CC       that forms a RUNX1-CBFA2T3 fusion protein.
CC       {ECO:0000269|PubMed:10995019, ECO:0000269|PubMed:11224496,
CC       ECO:0000269|PubMed:9596646}.
CC   -!- SIMILARITY: Belongs to the CBFA2T family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAH62624.1; Type=Miscellaneous discrepancy; Note=Aberrant splicing.; Evidence={ECO:0000305};
CC       Sequence=BAA31276.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAA31277.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CBFA2T3ID428ch16q24.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB010419; BAA29061.1; -; mRNA.
DR   EMBL; AB010420; BAA29062.1; -; mRNA.
DR   EMBL; AB013286; BAA31276.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; AB013286; BAA31277.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; CH471184; EAW66748.1; -; Genomic_DNA.
DR   EMBL; CH471184; EAW66752.1; -; Genomic_DNA.
DR   EMBL; BC047019; AAH47019.1; -; mRNA.
DR   EMBL; BC062624; AAH62624.1; ALT_SEQ; mRNA.
DR   EMBL; AF052217; AAC64701.1; -; Genomic_DNA.
DR   EMBL; AF052216; AAC64701.1; JOINED; Genomic_DNA.
DR   EMBL; AF052215; AAC64702.1; -; Genomic_DNA.
DR   EMBL; AF052213; AAC64702.1; JOINED; Genomic_DNA.
DR   EMBL; AF052214; AAC64702.1; JOINED; Genomic_DNA.
DR   EMBL; AF052220; AAC64698.1; -; mRNA.
DR   CCDS; CCDS10972.1; -. [O75081-1]
DR   CCDS; CCDS10973.1; -. [O75081-2]
DR   RefSeq; NP_005178.4; NM_005187.5. [O75081-1]
DR   RefSeq; NP_787127.1; NM_175931.2. [O75081-2]
DR   SMR; O75081; -.
DR   BioGrid; 107311; 48.
DR   DIP; DIP-48898N; -.
DR   IntAct; O75081; 16.
DR   MINT; O75081; -.
DR   STRING; 9606.ENSP00000268679; -.
DR   iPTMnet; O75081; -.
DR   PhosphoSitePlus; O75081; -.
DR   BioMuta; CBFA2T3; -.
DR   EPD; O75081; -.
DR   jPOST; O75081; -.
DR   MassIVE; O75081; -.
DR   MaxQB; O75081; -.
DR   PaxDb; O75081; -.
DR   PeptideAtlas; O75081; -.
DR   PRIDE; O75081; -.
DR   ProteomicsDB; 49745; -. [O75081-1]
DR   ProteomicsDB; 49746; -. [O75081-2]
DR   ProteomicsDB; 49747; -. [O75081-4]
DR   ProteomicsDB; 49748; -. [O75081-5]
DR   Antibodypedia; 30813; 119 antibodies.
DR   DNASU; 863; -.
DR   Ensembl; ENST00000268679; ENSP00000268679; ENSG00000129993. [O75081-1]
DR   Ensembl; ENST00000327483; ENSP00000332122; ENSG00000129993. [O75081-2]
DR   GeneID; 863; -.
DR   KEGG; hsa:863; -.
DR   UCSC; uc002fml.3; human. [O75081-1]
DR   CTD; 863; -.
DR   DisGeNET; 863; -.
DR   GeneCards; CBFA2T3; -.
DR   HGNC; HGNC:1537; CBFA2T3.
DR   HPA; ENSG00000129993; Tissue enhanced (lymphoid).
DR   MalaCards; CBFA2T3; -.
DR   MIM; 603870; gene.
DR   neXtProt; NX_O75081; -.
DR   OpenTargets; ENSG00000129993; -.
DR   Orphanet; 329469; Acute megakaryoblastic leukemia without Down syndrome.
DR   PharmGKB; PA26113; -.
DR   eggNOG; ENOG410IG1Z; Eukaryota.
DR   eggNOG; ENOG410XR30; LUCA.
DR   GeneTree; ENSGT00950000183176; -.
DR   HOGENOM; CLU_022077_2_0_1; -.
DR   InParanoid; O75081; -.
DR   KO; K22752; -.
DR   OMA; AHREFMP; -.
DR   OrthoDB; 334242at2759; -.
DR   PhylomeDB; O75081; -.
DR   TreeFam; TF106303; -.
DR   SIGNOR; O75081; -.
DR   ChiTaRS; CBFA2T3; human.
DR   GeneWiki; CBFA2T3; -.
DR   GenomeRNAi; 863; -.
DR   Pharos; O75081; Tbio.
DR   PRO; PR:O75081; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; O75081; protein.
DR   Bgee; ENSG00000129993; Expressed in cerebellar hemisphere and 153 other tissues.
DR   ExpressionAtlas; O75081; baseline and differential.
DR   Genevisible; O75081; HS.
DR   GO; GO:0000139; C:Golgi membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003714; F:transcription corepressor activity; IBA:GO_Central.
DR   GO; GO:0030851; P:granulocyte differentiation; IDA:MGI.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0045820; P:negative regulation of glycolytic process; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0032436; P:positive regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1903715; P:regulation of aerobic respiration; IDA:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   Gene3D; 1.20.120.1110; -; 1.
DR   InterPro; IPR013289; CBFA2T1/2/3.
DR   InterPro; IPR013292; CBFA2T3.
DR   InterPro; IPR014896; NHR2.
DR   InterPro; IPR037249; TAFH/NHR1_dom_sf.
DR   InterPro; IPR003894; TAFH_NHR1.
DR   InterPro; IPR002893; Znf_MYND.
DR   PANTHER; PTHR10379; PTHR10379; 1.
DR   Pfam; PF08788; NHR2; 1.
DR   Pfam; PF07531; TAFH; 1.
DR   Pfam; PF01753; zf-MYND; 1.
DR   PRINTS; PR01875; ETOFAMILY.
DR   PRINTS; PR01878; MTG16PROTEIN.
DR   SMART; SM00549; TAFH; 1.
DR   SUPFAM; SSF158553; SSF158553; 1.
DR   PROSITE; PS51119; TAFH; 1.
DR   PROSITE; PS01360; ZF_MYND_1; 1.
DR   PROSITE; PS50865; ZF_MYND_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Chromosomal rearrangement; Coiled coil;
KW   Differentiation; Golgi apparatus; Membrane; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   CHAIN           1..653
FT                   /note="Protein CBFA2T3"
FT                   /id="PRO_0000307173"
FT   DOMAIN          171..266
FT                   /note="TAFH"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00440"
FT   ZN_FING         556..592
FT                   /note="MYND-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00134"
FT   REGION          1..435
FT                   /note="Mediates localization to the nucleus"
FT                   /evidence="ECO:0000250"
FT   REGION          1..430
FT                   /note="Mediates interaction with PDE7A (in isoform 2)"
FT   REGION          1..127
FT                   /note="Required for nucleolar targeting (in isoform 1)"
FT   REGION          145..242
FT                   /note="Interaction with ZBTB33"
FT                   /evidence="ECO:0000269|PubMed:23251453"
FT   REGION          176..268
FT                   /note="Interaction with HIF1A"
FT                   /evidence="ECO:0000269|PubMed:25974097"
FT   REGION          394..412
FT                   /note="Nervy homology region 2 (NHR2); essential for down-
FT                   regulation of PFKFB3, PFKFB4 and PDK1 expression"
FT                   /evidence="ECO:0000269|PubMed:23840896"
FT   REGION          485..533
FT                   /note="Nervy homology region 3 (NHR3); essential for down-
FT                   regulation of PFKFB3, PFKFB4 and PDK1 expression"
FT                   /evidence="ECO:0000269|PubMed:23840896"
FT   REGION          485..506
FT                   /note="Mediates interaction with PRKAR2A"
FT                   /evidence="ECO:0000269|PubMed:11823486"
FT   COILED          488..543
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        42..99
FT                   /note="Pro-rich"
FT   SITE            51..52
FT                   /note="Breakpoint for translocation to form type-1 RUNX1-
FT                   CBFA2T3 fusion protein"
FT   SITE            127..128
FT                   /note="Breakpoint for translocation to form type-2 RUNX1-
FT                   CBFA2T3 fusion protein"
FT   MOD_RES         457
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         459
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         479
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         637
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         641
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         650
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         1..61
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9596646"
FT                   /id="VSP_028620"
FT   VAR_SEQ         51..127
FT                   /note="APVDRKAKASAMPDSPAEVKTQPRSTPPSMPPPPPAASQGATRPPSFTPHTH
FT                   REDGPATLPHGRFHGCLKWSMVCLL -> V (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_028621"
FT   VAR_SEQ         51
FT                   /note="A -> GKPALAAAGAPALCTPGQADARPVLGPA (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_028622"
FT   VAR_SEQ         52..653
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_028623"
FT   VAR_SEQ         102..126
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9596646"
FT                   /id="VSP_028624"
FT   VARIANT         306
FT                   /note="R -> H (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs745972870)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035447"
FT   VARIANT         429
FT                   /note="E -> G (in dbSNP:rs1053526)"
FT                   /evidence="ECO:0000269|PubMed:9596646"
FT                   /id="VAR_035374"
FT   VARIANT         518
FT                   /note="E -> K (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs774310781)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035448"
FT   VARIANT         534
FT                   /note="A -> V (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs553618592)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035449"
FT   MUTAGEN         494
FT                   /note="V->P,A: Loss of interaction with PRKAR2A."
FT                   /evidence="ECO:0000269|PubMed:11823486"
FT   CONFLICT        231
FT                   /note="F -> L (in Ref. 3; AAH47019)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        295
FT                   /note="T -> S (in Ref. 4; AAC64702)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305
FT                   /note="D -> E (in Ref. 1; BAA29061)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        370
FT                   /note="R -> P (in Ref. 4; AAC64698)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420
FT                   /note="L -> V (in Ref. 4; AAC64698)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        542
FT                   /note="A -> D (in Ref. 4; AAC64701)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   653 AA;  71192 MW;  0B72B602120FA5DE CRC64;
     MPASRLRDRA ASSASGSTCG SMSQTHPVLE SGLLASAGCS APRGPRKGGP APVDRKAKAS
     AMPDSPAEVK TQPRSTPPSM PPPPPAASQG ATRPPSFTPH THREDGPATL PHGRFHGCLK
     WSMVCLLMNG SSHSPTAING APCTPNGFSN GPATSSTASL STQHLPPACG ARQLSKLKRF
     LTTLQQFGSD ISPEIGERVR TLVLGLVNST LTIEEFHSKL QEATNFPLRP FVIPFLKANL
     PLLQRELLHC ARLAKQTPAQ YLAQHEQLLL DASASSPIDS SELLLEVNEN GKRRTPDRTK
     ENGSDRDPLH PEHLSKRPCT LNPAQRYSPS NGPPQPTPPP HYRLEDIAMA HHFRDAYRHP
     DPRELRERHR PLVVPGSRQE EVIDHKLTER EWAEEWKHLN NLLNCIMDMV EKTRRSLTVL
     RRCQEADREE LNHWARRYSD AEDTKKGPAP AAARPRSSSA GPEGPQLDVP REFLPRTLTG
     YVPEDIWRKA EEAVNEVKRQ AMSELQKAVS DAERKAHELI TTERAKMERA LAEAKRQASE
     DALTVINQQE DSSESCWNCG RKASETCSGC NAARYCGSFC QHRDWEKHHH VCGQSLQGPT
     AVVADPVPGP PEAAHSLGPS LPVGAASPSE AGSAGPSRPG SPSPPGPLDT VPR
//
ID   A0A024R6X2_HUMAN        Unreviewed;       182 AA.
AC   A0A024R6X2;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 28.
DE   SubName: Full=Core-binding factor, beta subunit, isoform CRA_b {ECO:0000313|EMBL:EAW83069.1};
GN   Name=CBFB {ECO:0000313|EMBL:EAW83069.1};
GN   ORFNames=hCG_28838 {ECO:0000313|EMBL:EAW83069.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW83069.1};
RN   [1] {ECO:0000313|EMBL:EAW83069.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW83069.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471092; EAW83069.1; -; Genomic_DNA.
DR   RefSeq; NP_001746.1; NM_001755.2.
DR   SMR; A0A024R6X2; -.
DR   PRIDE; A0A024R6X2; -.
DR   Antibodypedia; 15619; 390 antibodies.
DR   GeneID; 865; -.
DR   KEGG; hsa:865; -.
DR   CTD; 865; -.
DR   EuPathDB; HostDB:ENSG00000067955.13; -.
DR   eggNOG; KOG4785; Eukaryota.
DR   eggNOG; ENOG410Z04Q; LUCA.
DR   PhylomeDB; A0A024R6X2; -.
DR   ChiTaRS; CBFB; human.
DR   GenomeRNAi; 865; -.
DR   Bgee; ENSG00000067955; Expressed in epithelium of mammary gland and 231 other tissues.
DR   ExpressionAtlas; A0A024R6X2; baseline and differential.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   Gene3D; 2.40.250.10; -; 1.
DR   InterPro; IPR003417; CBF_beta.
DR   InterPro; IPR036552; CBF_bsu_sf.
DR   PANTHER; PTHR10276; PTHR10276; 1.
DR   Pfam; PF02312; CBF_beta; 1.
DR   SUPFAM; SSF50723; SSF50723; 1.
PE   4: Predicted;
SQ   SEQUENCE   182 AA;  21508 MW;  20FB1CC05FBFE4FB CRC64;
     MPRVVPDQRS KFENEEFFRK LSRECEIKYT GFRDRPHEER QARFQNACRD GRSEIAFVAT
     GTNLSLQFFP ASWQGEQRQT PSREYVDLER EAGKVYLKAP MILNGVCVIW KGWIDLQRLD
     GMGCLEFDEE RAQQEDALAQ QAFEEARRRT REFEDRDRSH REEMEVRVSQ LLAVTGKKTT
     RP
//
ID   PEBB_HUMAN              Reviewed;         182 AA.
AC   Q13951; A8K347; Q13124; Q9HCT2;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   22-APR-2020, entry version 183.
DE   RecName: Full=Core-binding factor subunit beta;
DE            Short=CBF-beta;
DE   AltName: Full=Polyomavirus enhancer-binding protein 2 beta subunit;
DE            Short=PEA2-beta;
DE            Short=PEBP2-beta;
DE   AltName: Full=SL3-3 enhancer factor 1 subunit beta;
DE   AltName: Full=SL3/AKV core-binding factor beta subunit;
GN   Name=CBFB;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RA   Liu P.P.;
RL   Submitted (AUG-2000) to the EMBL/GenBank/DDBJ databases.
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 8-182 (ISOFORM 1), AND CHROMOSOMAL INVERSION.
RC   TISSUE=Brain;
RX   PubMed=8351518; DOI=10.1126/science.8351518;
RA   Liu P., Tarle S.A., Hajra A., Claxton D.F., Marlton P., Freedman M.,
RA   Siciliano M.J., Collins F.S.;
RT   "Fusion between transcription factor CBF beta/PEBP2 beta and a myosin heavy
RT   chain in acute myeloid leukemia.";
RL   Science 261:1041-1044(1993).
RN   [7]
RP   RETRACTED PAPER.
RX   PubMed=7607682; DOI=10.1016/0888-7543(95)80177-n;
RA   Hajra A., Collins F.S.;
RT   "Structure of the leukemia-associated human CBFB gene.";
RL   Genomics 26:571-579(1995).
RN   [8]
RP   RETRACTION NOTICE OF PUBMED:7607682.
RX   PubMed=9064279; DOI=10.1006/geno.1996.0603;
RA   Hajra A., Collins F.S.;
RL   Genomics 38:107-107(1996).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-173 (ISOFORM 2), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [12]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 2-135 IN COMPLEX WITH RUNX1.
RX   PubMed=10856244; DOI=10.1093/emboj/19.12.3004;
RA   Warren A.J., Bravo J., Williams R.L., Rabbitts T.H.;
RT   "Structural basis for the heterodimeric interaction between the acute
RT   leukaemia-associated transcription factors AML1 and CBFbeta.";
RL   EMBO J. 19:3004-3015(2000).
RN   [14]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 2-135 IN COMPLEX WITH RUNX1 AND
RP   DNA.
RX   PubMed=11276260; DOI=10.1038/86264;
RA   Bravo J., Li Z., Speck N.A., Warren A.J.;
RT   "The leukemia-associated AML1 (Runx1) -- CBF beta complex functions as a
RT   DNA-induced molecular clamp.";
RL   Nat. Struct. Biol. 8:371-378(2001).
RN   [15]
RP   STRUCTURE BY NMR OF 4-141.
RX   PubMed=10404215; DOI=10.1038/10664;
RA   Goger M., Gupta V., Kim W.Y., Shigesada K., Ito Y., Werner M.H.;
RT   "Molecular insights into PEBP2/CBF beta-SMMHC associated acute leukemia
RT   revealed from the structure of PEBP2/CBF beta.";
RL   Nat. Struct. Biol. 6:620-623(1999).
RN   [16]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-100.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Forms the heterodimeric complex core-binding factor (CBF)
CC       with RUNX family proteins (RUNX1, RUNX2, and RUNX3). RUNX members
CC       modulate the transcription of their target genes through recognizing
CC       the core consensus binding sequence 5'-TGTGGT-3', or very rarely, 5'-
CC       TGCGGT-3', within their regulatory regions via their runt domain, while
CC       CBFB is a non-DNA-binding regulatory subunit that allosterically
CC       enhances the sequence-specific DNA-binding capacity of RUNX. The
CC       heterodimers bind to the core site of a number of enhancers and
CC       promoters, including murine leukemia virus, polyomavirus enhancer, T-
CC       cell receptor enhancers, LCK, IL3 and GM-CSF promoters. CBF complexes
CC       repress ZBTB7B transcription factor during cytotoxic (CD8+) T cell
CC       development. They bind to RUNX-binding sequence within the ZBTB7B locus
CC       acting as transcriptional silencer and allowing for cytotoxic T cell
CC       differentiation. {ECO:0000250|UniProtKB:Q08024}.
CC   -!- SUBUNIT: Heterodimer with RUNX1, RUNX2 and RUNX3. Interacts with COPRS.
CC       Found in a complex with PRMT5 and RUNX1.
CC       {ECO:0000250|UniProtKB:Q08024}.
CC   -!- INTERACTION:
CC       Q13951; Q9NVM9: INTS13; NbExp=2; IntAct=EBI-718750, EBI-741429;
CC       Q13951; P11137: MAP2; NbExp=2; IntAct=EBI-718750, EBI-2682460;
CC       Q13951; Q01196: RUNX1; NbExp=3; IntAct=EBI-718750, EBI-925904;
CC       Q13951; Q01196-8: RUNX1; NbExp=3; IntAct=EBI-718750, EBI-12001422;
CC       Q13951; Q13761-2: RUNX3; NbExp=3; IntAct=EBI-718750, EBI-12145465;
CC       Q13951; P12504: vif; Xeno; NbExp=10; IntAct=EBI-718750, EBI-779991;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13951-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13951-2; Sequence=VSP_036044;
CC   -!- DISEASE: Note=A chromosomal aberration involving CBFB is associated
CC       with acute myeloid leukemia of M4EO subtype. Pericentric inversion
CC       inv(16)(p13;q22). The inversion produces a fusion protein that consists
CC       of the 165 N-terminal residues of CBF-beta (PEPB2) with the tail region
CC       of MYH11. {ECO:0000269|PubMed:8351518}.
CC   -!- SIMILARITY: Belongs to the CBF-beta family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CBFbID45.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF294326; AAG01553.1; -; mRNA.
DR   EMBL; BT006862; AAP35508.1; -; mRNA.
DR   EMBL; AK290462; BAF83151.1; -; mRNA.
DR   EMBL; CH471092; EAW83067.1; -; Genomic_DNA.
DR   EMBL; CH471092; EAW83068.1; -; Genomic_DNA.
DR   EMBL; BC018509; AAH18509.1; -; mRNA.
DR   EMBL; L20298; AAA02868.1; -; mRNA.
DR   CCDS; CCDS10827.1; -. [Q13951-1]
DR   CCDS; CCDS45508.1; -. [Q13951-2]
DR   PIR; A56840; A56840.
DR   PIR; I59579; I59579.
DR   RefSeq; NP_001746.1; NM_001755.2. [Q13951-1]
DR   RefSeq; NP_074036.1; NM_022845.2. [Q13951-2]
DR   PDB; 1CL3; NMR; -; A=4-141.
DR   PDB; 1E50; X-ray; 2.60 A; B/D/F/H=2-135.
DR   PDB; 1H9D; X-ray; 2.60 A; B/D=2-135.
DR   PDB; 4N9F; X-ray; 3.30 A; 0/6/F/L/N/R/a/c/i/k/o/u=1-170.
DR   PDB; 6NIL; EM; 3.90 A; B/E/H/K=1-151.
DR   PDB; 6P59; X-ray; 2.94 A; A/C=1-165.
DR   PDBsum; 1CL3; -.
DR   PDBsum; 1E50; -.
DR   PDBsum; 1H9D; -.
DR   PDBsum; 4N9F; -.
DR   PDBsum; 6NIL; -.
DR   PDBsum; 6P59; -.
DR   SMR; Q13951; -.
DR   BioGrid; 107313; 35.
DR   CORUM; Q13951; -.
DR   DIP; DIP-36772N; -.
DR   IntAct; Q13951; 35.
DR   MINT; Q13951; -.
DR   STRING; 9606.ENSP00000415151; -.
DR   BindingDB; Q13951; -.
DR   ChEMBL; CHEMBL1615386; -.
DR   iPTMnet; Q13951; -.
DR   MetOSite; Q13951; -.
DR   PhosphoSitePlus; Q13951; -.
DR   BioMuta; CBFB; -.
DR   DMDM; 2498753; -.
DR   EPD; Q13951; -.
DR   jPOST; Q13951; -.
DR   MassIVE; Q13951; -.
DR   MaxQB; Q13951; -.
DR   PaxDb; Q13951; -.
DR   PeptideAtlas; Q13951; -.
DR   PRIDE; Q13951; -.
DR   ProteomicsDB; 59770; -. [Q13951-1]
DR   ProteomicsDB; 59771; -. [Q13951-2]
DR   Antibodypedia; 15619; 390 antibodies.
DR   DNASU; 865; -.
DR   Ensembl; ENST00000290858; ENSP00000290858; ENSG00000067955. [Q13951-1]
DR   Ensembl; ENST00000412916; ENSP00000415151; ENSG00000067955. [Q13951-2]
DR   GeneID; 865; -.
DR   KEGG; hsa:865; -.
DR   UCSC; uc002era.4; human. [Q13951-1]
DR   CTD; 865; -.
DR   DisGeNET; 865; -.
DR   GeneCards; CBFB; -.
DR   HGNC; HGNC:1539; CBFB.
DR   HPA; ENSG00000067955; Low tissue specificity.
DR   MalaCards; CBFB; -.
DR   MIM; 121360; gene.
DR   neXtProt; NX_Q13951; -.
DR   OpenTargets; ENSG00000067955; -.
DR   Orphanet; 98829; Acute myeloid leukemia with abnormal bone marrow eosinophils inv(16)(p13q22) or t(16;16)(p13;q22).
DR   PharmGKB; PA26114; -.
DR   eggNOG; KOG4785; Eukaryota.
DR   eggNOG; ENOG410Z04Q; LUCA.
DR   GeneTree; ENSGT00390000018132; -.
DR   HOGENOM; CLU_074992_1_0_1; -.
DR   InParanoid; Q13951; -.
DR   OMA; PVVSKIW; -.
DR   OrthoDB; 1254153at2759; -.
DR   PhylomeDB; Q13951; -.
DR   TreeFam; TF314675; -.
DR   Reactome; R-HSA-8877330; RUNX1 and FOXP3 control the development of regulatory T lymphocytes (Tregs).
DR   Reactome; R-HSA-8878166; Transcriptional regulation by RUNX2.
DR   Reactome; R-HSA-8931987; RUNX1 regulates estrogen receptor mediated transcription.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8935964; RUNX1 regulates expression of components of tight junctions.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939236; RUNX1 regulates transcription of genes involved in differentiation of HSCs.
DR   Reactome; R-HSA-8939242; RUNX1 regulates transcription of genes involved in differentiation of keratinocytes.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   Reactome; R-HSA-8939245; RUNX1 regulates transcription of genes involved in BCR signaling.
DR   Reactome; R-HSA-8939246; RUNX1 regulates transcription of genes involved in differentiation of myeloid cells.
DR   Reactome; R-HSA-8939247; RUNX1 regulates transcription of genes involved in interleukin signaling.
DR   Reactome; R-HSA-8939256; RUNX1 regulates transcription of genes involved in WNT signaling.
DR   Reactome; R-HSA-8939902; Regulation of RUNX2 expression and activity.
DR   Reactome; R-HSA-8940973; RUNX2 regulates osteoblast differentiation.
DR   Reactome; R-HSA-8941284; RUNX2 regulates chondrocyte maturation.
DR   Reactome; R-HSA-8941326; RUNX2 regulates bone development.
DR   Reactome; R-HSA-8941332; RUNX2 regulates genes involved in cell migration.
DR   Reactome; R-HSA-8941333; RUNX2 regulates genes involved in differentiation of myeloid cells.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8949275; RUNX3 Regulates Immune Response and Cell Migration.
DR   Reactome; R-HSA-8951911; RUNX3 regulates RUNX1-mediated transcription.
DR   Reactome; R-HSA-8951936; RUNX3 regulates p14-ARF.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   SIGNOR; Q13951; -.
DR   ChiTaRS; CBFB; human.
DR   EvolutionaryTrace; Q13951; -.
DR   GeneWiki; CBFB; -.
DR   GenomeRNAi; 865; -.
DR   Pharos; Q13951; Tchem.
DR   PRO; PR:Q13951; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q13951; protein.
DR   Bgee; ENSG00000067955; Expressed in epithelium of mammary gland and 231 other tissues.
DR   ExpressionAtlas; Q13951; baseline and differential.
DR   Genevisible; Q13951; HS.
DR   GO; GO:0016513; C:core-binding factor complex; IBA:GO_Central.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IBA:GO_Central.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0048469; P:cell maturation; IEA:Ensembl.
DR   GO; GO:0060216; P:definitive hemopoiesis; IEA:Ensembl.
DR   GO; GO:0030098; P:lymphocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030099; P:myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0043371; P:negative regulation of CD4-positive, alpha-beta T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0043378; P:positive regulation of CD8-positive, alpha-beta T cell differentiation; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0000209; P:protein polyubiquitination; IMP:CACAO.
DR   GO; GO:0050855; P:regulation of B cell receptor signaling pathway; TAS:Reactome.
DR   GO; GO:2000810; P:regulation of bicellular tight junction assembly; TAS:Reactome.
DR   GO; GO:0001959; P:regulation of cytokine-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:1902036; P:regulation of hematopoietic stem cell differentiation; TAS:Reactome.
DR   GO; GO:0033146; P:regulation of intracellular estrogen receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0045616; P:regulation of keratinocyte differentiation; TAS:Reactome.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0045637; P:regulation of myeloid cell differentiation; TAS:Reactome.
DR   GO; GO:0045589; P:regulation of regulatory T cell differentiation; TAS:Reactome.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0030111; P:regulation of Wnt signaling pathway; TAS:Reactome.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 2.40.250.10; -; 1.
DR   InterPro; IPR003417; CBF_beta.
DR   InterPro; IPR036552; CBF_bsu_sf.
DR   PANTHER; PTHR10276; PTHR10276; 1.
DR   Pfam; PF02312; CBF_beta; 1.
DR   SUPFAM; SSF50723; SSF50723; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome.
FT   CHAIN           1..182
FT                   /note="Core-binding factor subunit beta"
FT                   /id="PRO_0000058301"
FT   SITE            165..166
FT                   /note="Breakpoint for translocation to form CBF-beta-MYH11
FT                   oncogene in AML, subtype M4EO"
FT   VAR_SEQ         166..182
FT                   /note="VRVSQLLAVTGKKTTRP -> ARRQQDPSPGSNLGGGDDLKLR (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|Ref.1"
FT                   /id="VSP_036044"
FT   VARIANT         100
FT                   /note="P -> A (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs1280921900)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036226"
FT   HELIX           8..14
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   HELIX           16..19
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          25..29
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          33..35
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   HELIX           37..49
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          52..57
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   TURN            58..61
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          65..67
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   HELIX           71..73
FT                   /evidence="ECO:0000244|PDB:4N9F"
FT   TURN            83..85
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          86..91
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          94..103
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          106..115
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   TURN            116..118
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   STRAND          119..127
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   HELIX           129..134
FT                   /evidence="ECO:0000244|PDB:1E50"
FT   HELIX           137..148
FT                   /evidence="ECO:0000244|PDB:4N9F"
FT   MOD_RES         Q13951-2:173
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231"
SQ   SEQUENCE   182 AA;  21508 MW;  20FB1CC05FBFE4FB CRC64;
     MPRVVPDQRS KFENEEFFRK LSRECEIKYT GFRDRPHEER QARFQNACRD GRSEIAFVAT
     GTNLSLQFFP ASWQGEQRQT PSREYVDLER EAGKVYLKAP MILNGVCVIW KGWIDLQRLD
     GMGCLEFDEE RAQQEDALAQ QAFEEARRRT REFEDRDRSH REEMEVRVSQ LLAVTGKKTT
     RP
//
ID   Q05CP8_HUMAN            Unreviewed;       334 AA.
AC   Q05CP8;
DT   14-NOV-2006, integrated into UniProtKB/TrEMBL.
DT   14-NOV-2006, sequence version 1.
DT   26-FEB-2020, entry version 61.
DE   SubName: Full=CCDC6 protein {ECO:0000313|EMBL:AAH22284.1};
DE   Flags: Fragment;
GN   Name=CCDC6 {ECO:0000313|EMBL:AAH22284.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH22284.1};
RN   [1] {ECO:0000313|EMBL:AAH22284.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung {ECO:0000313|EMBL:AAH22284.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC022284; AAH22284.1; -; mRNA.
DR   RefSeq; NP_005427.2; NM_005436.4.
DR   SMR; Q05CP8; -.
DR   MaxQB; Q05CP8; -.
DR   PeptideAtlas; Q05CP8; -.
DR   PRIDE; Q05CP8; -.
DR   GeneID; 8030; -.
DR   KEGG; hsa:8030; -.
DR   CTD; 8030; -.
DR   PharmGKB; PA134904022; -.
DR   KO; K09288; -.
DR   OrthoDB; 1142037at2759; -.
DR   ChiTaRS; CCDC6; human.
DR   GenomeRNAi; 8030; -.
DR   Genevisible; Q05CP8; HS.
DR   InterPro; IPR019152; DUF2046.
DR   PANTHER; PTHR15276; PTHR15276; 1.
DR   Pfam; PF09755; DUF2046; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   REGION          1..47
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          287..334
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          56..104
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          120..140
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          142..212
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          214..234
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1..33
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        287..306
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        307..334
FT                   /note="Basic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         334
FT                   /evidence="ECO:0000313|EMBL:AAH22284.1"
SQ   SEQUENCE   334 AA;  38164 MW;  4DA022DF2550140D CRC64;
     MADSASESDT DGAGGNSSSS AAMQSSCSST SGGGGGGGGG GGGGKSGGIV ISPFRLEELT
     NRLASLQQEN KVLKIELETY KLKCKALQEE NRDLRKASVT IQARAEQEEE FISNTLFKKI
     QALQKEKETL AVNYEKEEEF LTNELSRKLM QLQHEKAELE QHLEQEQEFQ VNKLMKKIKK
     LENDTISKQL TLEQLRREKI DLENTLEQEQ EALVNRLWKR MDKLEAEKRI LQEKLDQPVS
     APPSPRDISM EIDSPENMMR HIRFLKNEVE RLKKQLRAAQ LQHSEKMAQY LEEERHMREE
     RGRRGKMAAT KRKRRGGFAV QAKKPKKKKK KKKK
//
ID   CCDC6_HUMAN             Reviewed;         474 AA.
AC   Q16204; Q15250; Q6GSG7;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   23-MAR-2010, sequence version 2.
DT   22-APR-2020, entry version 180.
DE   RecName: Full=Coiled-coil domain-containing protein 6;
DE   AltName: Full=Papillary thyroid carcinoma-encoded protein;
DE   AltName: Full=Protein H4;
GN   Name=CCDC6; Synonyms=D10S170, TST1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT THR-470.
RC   TISSUE=Thyroid;
RX   PubMed=8058316;
RA   Grieco M., Cerrato A., Santoro M., Fusco A., Melillo R.M., Vecchio G.;
RT   "Cloning and characterization of H4 (D10S170), a gene involved in RET
RT   rearrangements in vivo.";
RL   Oncogene 9:2531-2535(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-470.
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT THR-470.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT THR-470.
RC   TISSUE=Blood, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-101, AND CHROMOSOMAL TRANSLOCATION WITH
RP   RET.
RC   TISSUE=Thyroid papillary carcinoma;
RX   PubMed=2406025; DOI=10.1016/0092-8674(90)90659-3;
RA   Grieco M., Santoro M., Berlingieri M.T., Melillo R.M., Donghi R.,
RA   Bongarzone I., Pierotti M.A., Della Porta G., Fusco A., Vecchio G.;
RT   "PTC is a novel rearranged form of the ret proto-oncogene and is frequently
RT   detected in vivo in human thyroid papillary carcinomas.";
RL   Cell 60:557-563(1990).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17924679; DOI=10.1021/pr070152u;
RA   Yu L.R., Zhu Z., Chan K.C., Issaq H.J., Dimitrov D.S., Veenstra T.D.;
RT   "Improved titanium dioxide enrichment of phosphopeptides from HeLa cells
RT   and high confident phosphopeptide identification by cross-validation of
RT   MS/MS and MS/MS/MS spectra.";
RL   J. Proteome Res. 6:4150-4162(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-244, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; THR-349; SER-363 AND
RP   SER-367, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [14]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240; SER-244; SER-254
RP   AND SER-367, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240; SER-244;
RP   SER-249; SER-254; SER-284 AND SER-323, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240; SER-244 AND SER-323, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-52; SER-240; SER-244;
RP   SER-254; SER-323; SER-395 AND SER-413, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-240 AND SER-244, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- INTERACTION:
CC       Q16204; Q16204; NbExp=3; IntAct=EBI-1045350, EBI-1045350;
CC       Q16204; Q86SG2: ANKRD23; NbExp=3; IntAct=EBI-1045350, EBI-5661893;
CC       Q16204; Q9Y2D1: ATF5; NbExp=3; IntAct=EBI-1045350, EBI-492509;
CC       Q16204; Q7L2Z9: CENPQ; NbExp=3; IntAct=EBI-1045350, EBI-2350265;
CC       Q16204; Q9UIA0: CYTH4; NbExp=3; IntAct=EBI-1045350, EBI-11521003;
CC       Q16204; Q969H0: FBXW7; NbExp=9; IntAct=EBI-1045350, EBI-359574;
CC       Q16204; O95995: GAS8; NbExp=3; IntAct=EBI-1045350, EBI-1052570;
CC       Q16204; Q9NP66: HMG20A; NbExp=3; IntAct=EBI-1045350, EBI-740641;
CC       Q16204; Q9UBR4-2: LHX3; NbExp=3; IntAct=EBI-1045350, EBI-12039345;
CC       Q16204; Q6UWE0: LRSAM1; NbExp=3; IntAct=EBI-1045350, EBI-720984;
CC       Q16204; Q9P127: LUZP4; NbExp=3; IntAct=EBI-1045350, EBI-10198848;
CC       Q16204; Q13164: MAPK7; NbExp=3; IntAct=EBI-1045350, EBI-1213983;
CC       Q16204; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-1045350, EBI-16439278;
CC       Q16204; Q5JR59-3: MTUS2; NbExp=4; IntAct=EBI-1045350, EBI-11522433;
CC       Q16204; P26367: PAX6; NbExp=3; IntAct=EBI-1045350, EBI-747278;
CC       Q16204; Q13526: PIN1; NbExp=6; IntAct=EBI-1045350, EBI-714158;
CC       Q16204; Q15311: RALBP1; NbExp=7; IntAct=EBI-1045350, EBI-749285;
CC       Q16204; Q16533: SNAPC1; NbExp=3; IntAct=EBI-1045350, EBI-11915024;
CC       Q16204; O60504: SORBS3; NbExp=3; IntAct=EBI-1045350, EBI-741237;
CC       Q16204; Q9UBB9: TFIP11; NbExp=3; IntAct=EBI-1045350, EBI-1105213;
CC       Q16204; Q14142: TRIM14; NbExp=3; IntAct=EBI-1045350, EBI-2820256;
CC       Q16204; P15622-3: ZNF250; NbExp=3; IntAct=EBI-1045350, EBI-10177272;
CC       Q16204; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-1045350, EBI-4395669;
CC       Q16204; Q6NX45: ZNF774; NbExp=3; IntAct=EBI-1045350, EBI-10251462;
CC       Q16204; Q9Y2P0: ZNF835; NbExp=3; IntAct=EBI-1045350, EBI-5667516;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cytoplasm, cytoskeleton {ECO:0000305}.
CC       Note=May be a cytoskeletal protein.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: The protein has mostly an alpha helical conformation similar to
CC       myosin heavy-chain tail that might adopt a coiled-coil conformation.
CC   -!- DISEASE: Note=A chromosomal aberration involving CCDC6 is found in
CC       papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q21)
CC       generates the RET/CCDC6 (PTC1) oncogene. {ECO:0000269|PubMed:2406025}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAC60637.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/H4ID280.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S72869; AAC60637.1; ALT_FRAME; mRNA.
DR   EMBL; AK292593; BAF85282.1; -; mRNA.
DR   EMBL; AC060231; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023904; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471083; EAW54196.1; -; Genomic_DNA.
DR   EMBL; BC036757; AAH36757.2; -; mRNA.
DR   EMBL; BC064391; AAH64391.1; -; mRNA.
DR   EMBL; M31213; AAA36524.1; ALT_TERM; mRNA.
DR   CCDS; CCDS7257.1; -.
DR   PIR; I58403; I58403.
DR   RefSeq; NP_005427.2; NM_005436.4.
DR   SMR; Q16204; -.
DR   BioGrid; 113725; 76.
DR   IntAct; Q16204; 70.
DR   MINT; Q16204; -.
DR   STRING; 9606.ENSP00000263102; -.
DR   BindingDB; Q16204; -.
DR   iPTMnet; Q16204; -.
DR   PhosphoSitePlus; Q16204; -.
DR   BioMuta; CCDC6; -.
DR   DMDM; 292494979; -.
DR   EPD; Q16204; -.
DR   jPOST; Q16204; -.
DR   MassIVE; Q16204; -.
DR   MaxQB; Q16204; -.
DR   PaxDb; Q16204; -.
DR   PeptideAtlas; Q16204; -.
DR   PRIDE; Q16204; -.
DR   ProteomicsDB; 60837; -.
DR   Antibodypedia; 14268; 212 antibodies.
DR   Ensembl; ENST00000263102; ENSP00000263102; ENSG00000108091.
DR   GeneID; 8030; -.
DR   KEGG; hsa:8030; -.
DR   UCSC; uc001jks.5; human.
DR   CTD; 8030; -.
DR   DisGeNET; 8030; -.
DR   GeneCards; CCDC6; -.
DR   HGNC; HGNC:18782; CCDC6.
DR   HPA; ENSG00000108091; Low tissue specificity.
DR   MalaCards; CCDC6; -.
DR   MIM; 601985; gene.
DR   neXtProt; NX_Q16204; -.
DR   OpenTargets; ENSG00000108091; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   PharmGKB; PA134904022; -.
DR   eggNOG; KOG2129; Eukaryota.
DR   eggNOG; ENOG410XR5H; LUCA.
DR   GeneTree; ENSGT00390000013594; -.
DR   HOGENOM; CLU_033433_2_0_1; -.
DR   InParanoid; Q16204; -.
DR   KO; K09288; -.
DR   OMA; QNRCYAC; -.
DR   OrthoDB; 1142037at2759; -.
DR   PhylomeDB; Q16204; -.
DR   TreeFam; TF321211; -.
DR   SIGNOR; Q16204; -.
DR   ChiTaRS; CCDC6; human.
DR   GeneWiki; CCDC6; -.
DR   GenomeRNAi; 8030; -.
DR   Pharos; Q16204; Tbio.
DR   PRO; PR:Q16204; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q16204; protein.
DR   Bgee; ENSG00000108091; Expressed in secondary oocyte and 214 other tissues.
DR   Genevisible; Q16204; HS.
DR   GO; GO:0005856; C:cytoskeleton; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0005200; F:structural constituent of cytoskeleton; TAS:ProtInc.
DR   InterPro; IPR019152; DUF2046.
DR   PANTHER; PTHR15276; PTHR15276; 1.
DR   Pfam; PF09755; DUF2046; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Chromosomal rearrangement; Coiled coil; Cytoplasm;
KW   Cytoskeleton; Methylation; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; SH3-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..474
FT                   /note="Coiled-coil domain-containing protein 6"
FT                   /id="PRO_0000089398"
FT   REPEAT          106..134
FT                   /note="1"
FT   REPEAT          135..163
FT                   /note="2"
FT   REPEAT          164..192
FT                   /note="3"
FT   REPEAT          193..206
FT                   /note="4; approximate"
FT   REPEAT          207..235
FT                   /note="5"
FT   REGION          106..235
FT                   /note="5 X 29 AA tandem repeats"
FT   COILED          53..237
FT                   /evidence="ECO:0000255"
FT   COILED          253..332
FT                   /evidence="ECO:0000255"
FT   MOTIF           442..451
FT                   /note="SH3-binding"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        17..20
FT                   /note="Poly-Ser"
FT   COMPBIAS        32..44
FT                   /note="Poly-Gly"
FT   COMPBIAS        440..448
FT                   /note="Poly-Pro"
FT   SITE            101..102
FT                   /note="Breakpoint for translocation to form RET-CCDC6
FT                   oncogene"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         52
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17924679,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         240
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:15144186,
FT                   ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18220336, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         244
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:15144186,
FT                   ECO:0000244|PubMed:16964243, ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         254
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         284
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         349
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         363
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         367
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332"
FT   MOD_RES         387
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:D3YZP9"
FT   MOD_RES         395
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         413
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VARIANT         470
FT                   /note="P -> T (in dbSNP:rs1053266)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:8058316,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_062971"
FT   CONFLICT        157
FT                   /note="A -> G (in Ref. 1; AAC60637)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228
FT                   /note="K -> T (in Ref. 1; AAC60637)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   474 AA;  53291 MW;  DF055DBF20304D26 CRC64;
     MADSASESDT DGAGGNSSSS AAMQSSCSST SGGGGGGGGG GGGGKSGGIV ISPFRLEELT
     NRLASLQQEN KVLKIELETY KLKCKALQEE NRDLRKASVT IQARAEQEEE FISNTLFKKI
     QALQKEKETL AVNYEKEEEF LTNELSRKLM QLQHEKAELE QHLEQEQEFQ VNKLMKKIKK
     LENDTISKQL TLEQLRREKI DLENTLEQEQ EALVNRLWKR MDKLEAEKRI LQEKLDQPVS
     APPSPRDISM EIDSPENMMR HIRFLKNEVE RLKKQLRAAQ LQHSEKMAQY LEEERHMREE
     NLRLQRKLQR EMERREALCR QLSESESSLE MDDERYFNEM SAQGLRPRTV SSPIPYTPSP
     SSSRPISPGL SYASHTVGFT PPTSLTRAGM SYYNSPGLHV QHMGTSHGIT RPSPRRSNSP
     DKFKRPTPPP SPNTQTPVQP PPPPPPPPMQ PTVPSAATSQ PTPSQHSAHP SSQP
//
ID   A0A384MR52_HUMAN        Unreviewed;       277 AA.
AC   A0A384MR52;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Cyclin B1 interacting protein 1 {ECO:0000313|EMBL:EAW66479.1};
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22511.1};
GN   Name=CCNB1IP1 {ECO:0000313|EMBL:EAW66479.1};
GN   ORFNames=hCG_40484 {ECO:0000313|EMBL:EAW66479.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22511.1};
RN   [1] {ECO:0000313|EMBL:EAW66479.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW66479.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ADO22511.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ900994; ADO22511.1; -; mRNA.
DR   EMBL; CH471078; EAW66479.1; -; Genomic_DNA.
DR   RefSeq; NP_067001.3; NM_021178.4.
DR   RefSeq; NP_878269.1; NM_182849.2.
DR   RefSeq; NP_878272.1; NM_182852.3.
DR   Antibodypedia; 22006; 220 antibodies.
DR   GeneID; 57820; -.
DR   KEGG; hsa:57820; -.
DR   CTD; 57820; -.
DR   KO; K10639; -.
DR   OMA; DGDFHFR; -.
DR   ChiTaRS; CCNB1IP1; human.
DR   GO; GO:0000795; C:synaptonemal complex; IEA:Ensembl.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:InterPro.
DR   GO; GO:0001825; P:blastocyst formation; IEA:Ensembl.
DR   GO; GO:0051026; P:chiasma assembly; IEA:Ensembl.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   InterPro; IPR042448; CCNB1IP1.
DR   InterPro; IPR001841; Znf_RING.
DR   PANTHER; PTHR14305; PTHR14305; 1.
DR   Pfam; PF14634; zf-RING_5; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          10..52
FT                   /note="RING-type"
FT                   /evidence="ECO:0000259|Pfam:PF14634"
FT   COILED          136..170
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   277 AA;  31544 MW;  885723B01A35225A CRC64;
     MSLCEDMLLC NYRKCRIKLS GYAWVTACSH IFCDQHGSGE FSRSPAICPA CNSTLSGKLD
     IVRTELSPSE EYKAMVLAGL RPEIVLDISS RALAFWTYQV HQERLYQEYN FSKAEGHLKQ
     MEKIYTQQIQ SKDVELTSMK GEVTSMKKVL EEYKKKFSDI SEKLMERNRQ YQKLQGLYDS
     LRLRNITIAN HEGTLEPSMI AQSGVLGFPL GNNSKFPLDN TPVRNRGDGD GDFQFRPFFA
     GSPTAPEPSN SFFSFVSPSR ELEQQQVSSR AFKVKRI
//
ID   CIP1_HUMAN              Reviewed;         277 AA.
AC   Q9NPC3;
DT   26-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 166.
DE   RecName: Full=E3 ubiquitin-protein ligase CCNB1IP1;
DE            EC=2.3.2.27 {ECO:0000269|PubMed:12612082};
DE   AltName: Full=Cyclin-B1-interacting protein 1;
DE   AltName: Full=Human enhancer of invasion 10;
DE   AltName: Full=RING-type E3 ubiquitin transferase CCNB1IP1 {ECO:0000305};
GN   Name=CCNB1IP1; Synonyms=C14orf18, HEI10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], MUTAGENESIS OF CYS-28; HIS-30 AND CYS-33,
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH UBE2L3 AND CCNB1,
RP   UBIQUITINATION, PHOSPHORYLATION, AND TISSUE SPECIFICITY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=12612082; DOI=10.1128/mcb.23.6.2109-2122.2003;
RA   Toby G.G., Gherraby W., Coleman T.R., Golemis E.A.;
RT   "A novel RING finger protein, human enhancer of invasion 10, alters mitotic
RT   progression through regulation of cyclin B levels.";
RL   Mol. Cell. Biol. 23:2109-2122(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Small intestine;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Fetal brain, and Placenta;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   INTERACTION WITH NF2.
RX   PubMed=16532029; DOI=10.1038/sj.onc.1209475;
RA   Gronholm M., Muranen T., Toby G.G., Utermark T., Hanemann C.O.,
RA   Golemis E.A., Carpen O.;
RT   "A functional association between merlin and HEI10, a cell cycle
RT   regulator.";
RL   Oncogene 25:4389-4398(2006).
RN   [7]
RP   FUNCTION.
RX   PubMed=17297447; DOI=10.1038/sj.onc.1210282;
RA   Singh M.K., Nicolas E., Gherraby W., Dadke D., Lessin S., Golemis E.A.;
RT   "HEI10 negatively regulates cell invasion by inhibiting cyclin B/Cdk1 and
RT   other promotility proteins.";
RL   Oncogene 26:4825-4832(2007).
CC   -!- FUNCTION: Ubiquitin E3 ligase that acts as a limiting factor for
CC       crossing-over during meiosis: required during zygonema to limit the
CC       colocalization of RNF212 with MutS-gamma-associated recombination sites
CC       and thereby establish early differentiation of crossover and non-
CC       crossover sites. Later, it is directed by MutL-gamma to stably
CC       accumulate at designated crossover sites. Probably promotes the
CC       dissociation of RNF212 and MutS-gamma to allow the progression of
CC       recombination and the implementation of the final steps of crossing
CC       over (By similarity). Modulates cyclin-B levels and participates in the
CC       regulation of cell cycle progression through the G2 phase.
CC       Overexpression causes delayed entry into mitosis. {ECO:0000250,
CC       ECO:0000269|PubMed:12612082, ECO:0000269|PubMed:17297447}.
CC   -!- FUNCTION: E3 ubiquitin-protein ligase. Modulates cyclin B levels and
CC       participates in the regulation of cell cycle progression through the G2
CC       phase. Overexpression causes delayed entry into mitosis.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27; Evidence={ECO:0000269|PubMed:12612082};
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Interacts with CCNB1, UBE2L3 and NF2.
CC       {ECO:0000269|PubMed:12612082, ECO:0000269|PubMed:16532029}.
CC   -!- INTERACTION:
CC       Q9NPC3; P62972; Xeno; NbExp=2; IntAct=EBI-745269, EBI-412964;
CC       Q9NPC3; Q9NPC3; NbExp=3; IntAct=EBI-745269, EBI-745269;
CC       Q9NPC3; P14635: CCNB1; NbExp=2; IntAct=EBI-745269, EBI-495332;
CC       Q9NPC3; Q93034: CUL5; NbExp=3; IntAct=EBI-745269, EBI-1057139;
CC       Q9NPC3; Q7L775: EPM2AIP1; NbExp=4; IntAct=EBI-745269, EBI-6255981;
CC       Q9NPC3; Q14145: KEAP1; NbExp=4; IntAct=EBI-745269, EBI-751001;
CC       Q9NPC3; P19012: KRT15; NbExp=4; IntAct=EBI-745269, EBI-739566;
CC       Q9NPC3; P54646: PRKAA2; NbExp=4; IntAct=EBI-745269, EBI-1383852;
CC       Q9NPC3; Q9BSW7: SYT17; NbExp=3; IntAct=EBI-745269, EBI-745392;
CC       Q9NPC3; Q96HA8: WDYHV1; NbExp=3; IntAct=EBI-745269, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome. Note=Associates to the
CC       synaptonemal complex.
CC   -!- TISSUE SPECIFICITY: Highly expressed in heart. Detected at intermediate
CC       levels in liver and kidney, and at low levels in placenta, brain and
CC       lung. {ECO:0000269|PubMed:12612082}.
CC   -!- PTM: Ubiquitinated; autoubiquitinated. {ECO:0000269|PubMed:12612082}.
CC   -!- PTM: Phosphorylated by CDK1 on serine or threonine residues (in vitro).
CC       {ECO:0000269|PubMed:12612082}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF216381; AAF36386.1; -; mRNA.
DR   EMBL; AL161994; CAB82326.1; -; mRNA.
DR   EMBL; AK026233; BAB15403.1; -; mRNA.
DR   EMBL; BX161423; CAD61896.1; -; mRNA.
DR   EMBL; BX161424; CAD61897.1; -; mRNA.
DR   EMBL; BX247978; CAD62312.1; -; mRNA.
DR   EMBL; BC000369; AAH00369.1; -; mRNA.
DR   EMBL; BC001218; AAH01218.1; -; mRNA.
DR   EMBL; BC004435; AAH04435.1; -; mRNA.
DR   CCDS; CCDS9547.1; -.
DR   PIR; T47153; T47153.
DR   RefSeq; NP_067001.3; NM_021178.4.
DR   RefSeq; NP_878269.1; NM_182849.2.
DR   RefSeq; NP_878272.1; NM_182852.3.
DR   SMR; Q9NPC3; -.
DR   BioGrid; 121779; 13.
DR   IntAct; Q9NPC3; 12.
DR   STRING; 9606.ENSP00000409896; -.
DR   iPTMnet; Q9NPC3; -.
DR   PhosphoSitePlus; Q9NPC3; -.
DR   BioMuta; CCNB1IP1; -.
DR   DMDM; 37078756; -.
DR   MassIVE; Q9NPC3; -.
DR   PaxDb; Q9NPC3; -.
DR   PeptideAtlas; Q9NPC3; -.
DR   PRIDE; Q9NPC3; -.
DR   ProteomicsDB; 81965; -.
DR   Antibodypedia; 22006; 220 antibodies.
DR   DNASU; 57820; -.
DR   Ensembl; ENST00000353689; ENSP00000337396; ENSG00000100814.
DR   Ensembl; ENST00000358932; ENSP00000351810; ENSG00000100814.
DR   Ensembl; ENST00000398160; ENSP00000381226; ENSG00000100814.
DR   Ensembl; ENST00000398163; ENSP00000381229; ENSG00000100814.
DR   Ensembl; ENST00000398169; ENSP00000381235; ENSG00000100814.
DR   Ensembl; ENST00000437553; ENSP00000409896; ENSG00000100814.
DR   GeneID; 57820; -.
DR   KEGG; hsa:57820; -.
DR   UCSC; uc001vwv.5; human.
DR   CTD; 57820; -.
DR   DisGeNET; 57820; -.
DR   GeneCards; CCNB1IP1; -.
DR   HGNC; HGNC:19437; CCNB1IP1.
DR   HPA; ENSG00000100814; Low tissue specificity.
DR   MIM; 608249; gene.
DR   neXtProt; NX_Q9NPC3; -.
DR   OpenTargets; ENSG00000100814; -.
DR   PharmGKB; PA134863884; -.
DR   eggNOG; ENOG410IE9K; Eukaryota.
DR   eggNOG; ENOG410XTEP; LUCA.
DR   GeneTree; ENSGT00390000002849; -.
DR   HOGENOM; CLU_049340_3_0_1; -.
DR   InParanoid; Q9NPC3; -.
DR   KO; K10639; -.
DR   OMA; DGDFHFR; -.
DR   OrthoDB; 1383870at2759; -.
DR   PhylomeDB; Q9NPC3; -.
DR   TreeFam; TF328863; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; CCNB1IP1; human.
DR   GeneWiki; CCNB1IP1; -.
DR   GenomeRNAi; 57820; -.
DR   Pharos; Q9NPC3; Tbio.
DR   PRO; PR:Q9NPC3; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; Q9NPC3; protein.
DR   Bgee; ENSG00000100814; Expressed in right ovary and 225 other tissues.
DR   ExpressionAtlas; Q9NPC3; baseline and differential.
DR   Genevisible; Q9NPC3; HS.
DR   GO; GO:0000795; C:synaptonemal complex; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0061630; F:ubiquitin protein ligase activity; IEA:InterPro.
DR   GO; GO:0001825; P:blastocyst formation; IEA:Ensembl.
DR   GO; GO:0051026; P:chiasma assembly; ISS:UniProtKB.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; ISS:UniProtKB.
DR   GO; GO:0007286; P:spermatid development; IEA:Ensembl.
DR   InterPro; IPR042448; CCNB1IP1.
DR   InterPro; IPR001841; Znf_RING.
DR   PANTHER; PTHR14305; PTHR14305; 1.
DR   Pfam; PF14634; zf-RING_5; 1.
PE   1: Evidence at protein level;
KW   Chromosome; Coiled coil; Meiosis; Metal-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transferase; Ubl conjugation; Ubl conjugation pathway;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..277
FT                   /note="E3 ubiquitin-protein ligase CCNB1IP1"
FT                   /id="PRO_0000055874"
FT   ZN_FING         4..51
FT                   /note="RING-type; atypical"
FT   COILED          127..182
FT                   /evidence="ECO:0000255"
FT   MUTAGEN         28
FT                   /note="C->A: Abrogates induction of filamentous growth in
FT                   yeast; when associated with A-30 and A-33."
FT                   /evidence="ECO:0000269|PubMed:12612082"
FT   MUTAGEN         30
FT                   /note="H->A: Abrogates induction of filamentous growth in
FT                   yeast; when associated with A-28 and A-33."
FT                   /evidence="ECO:0000269|PubMed:12612082"
FT   MUTAGEN         33
FT                   /note="C->A: Abrogates induction of filamentous growth in
FT                   yeast; when associated with A-28 and A-30."
FT                   /evidence="ECO:0000269|PubMed:12612082"
SQ   SEQUENCE   277 AA;  31544 MW;  885723B01A35225A CRC64;
     MSLCEDMLLC NYRKCRIKLS GYAWVTACSH IFCDQHGSGE FSRSPAICPA CNSTLSGKLD
     IVRTELSPSE EYKAMVLAGL RPEIVLDISS RALAFWTYQV HQERLYQEYN FSKAEGHLKQ
     MEKIYTQQIQ SKDVELTSMK GEVTSMKKVL EEYKKKFSDI SEKLMERNRQ YQKLQGLYDS
     LRLRNITIAN HEGTLEPSMI AQSGVLGFPL GNNSKFPLDN TPVRNRGDGD GDFQFRPFFA
     GSPTAPEPSN SFFSFVSPSR ELEQQQVSSR AFKVKRI
//
ID   Q0GN75_HUMAN            Unreviewed;       127 AA.
AC   Q0GN75;
DT   03-OCT-2006, integrated into UniProtKB/TrEMBL.
DT   03-OCT-2006, sequence version 1.
DT   22-APR-2020, entry version 57.
DE   SubName: Full=CD274 {ECO:0000313|EMBL:ABI16084.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABI16084.1};
RN   [1] {ECO:0000313|EMBL:ABI16084.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Huang G., Zhang L., Zhang L., Song M., Bai Y.;
RL   Submitted (JUL-2006) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; DQ836393; ABI16084.1; -; mRNA.
DR   RefSeq; NP_001254635.1; NM_001267706.1.
DR   RefSeq; NP_001300958.1; NM_001314029.1.
DR   PeptideAtlas; Q0GN75; -.
DR   GeneID; 29126; -.
DR   CTD; 29126; -.
DR   eggNOG; ENOG410IIBU; Eukaryota.
DR   eggNOG; ENOG4111V14; LUCA.
DR   GenomeRNAi; 29126; -.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF07686; V-set; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           19..127
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004172848"
FT   DOMAIN          33..127
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   NON_TER         127
FT                   /evidence="ECO:0000313|EMBL:ABI16084.1"
SQ   SEQUENCE   127 AA;  14775 MW;  7BE13D4ADE4884BE CRC64;
     MRIFAVFIFM TYWHLLNAFT VTVPKDLYVV EYGSNMTIEC KFPVEKQLDL AALIVYWEME
     DKNIIQFVHG EEDLKVQHSS YRQRARLLKD QLSLGNAALQ ITDVKLQDAG VFRCMISYGG
     ADYKRIT
//
ID   PD1L1_HUMAN             Reviewed;         290 AA.
AC   Q9NZQ7; B2RBA2; B4DU27; Q14CJ2; Q2V8D5; Q66RK1; Q6WEX4; Q9NUZ5;
DT   10-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 177.
DE   RecName: Full=Programmed cell death 1 ligand 1 {ECO:0000303|PubMed:28813417};
DE            Short=PD-L1 {ECO:0000303|PubMed:28813410, ECO:0000303|PubMed:28813417};
DE            Short=PDCD1 ligand 1;
DE            Short=Programmed death ligand 1;
DE            Short=hPD-L1 {ECO:0000303|PubMed:26602187};
DE   AltName: Full=B7 homolog 1 {ECO:0000303|PubMed:10581077};
DE            Short=B7-H1 {ECO:0000303|PubMed:10581077};
DE   AltName: CD_antigen=CD274;
DE   Flags: Precursor;
GN   Name=CD274 {ECO:0000312|HGNC:HGNC:17635};
GN   Synonyms=B7H1, PDCD1L1, PDCD1LG1, PDL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, TISSUE SPECIFICITY, AND
RP   INDUCTION.
RX   PubMed=10581077; DOI=10.1038/70932;
RA   Dong H., Zhu G., Tamada K., Chen L.;
RT   "B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation
RT   and interleukin-10 secretion.";
RL   Nat. Med. 5:1365-1369(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), FUNCTION, INTERACTION WITH PDCD1,
RP   TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Placenta;
RX   PubMed=11015443; DOI=10.1084/jem.192.7.1027;
RA   Freeman G.J., Long A.J., Iwai Y., Bourque K., Chernova T., Nishimura H.,
RA   Fitz L.J., Malenkovich N., Okazaki T., Byrne M.C., Horton H.F., Fouser L.,
RA   Carter L., Ling V., Bowman M.R., Carreno B.M., Collins M., Wood C.R.,
RA   Honjo T.;
RT   "Engagement of the PD-1 immunoinhibitory receptor by a novel B7-family
RT   member leads to negative regulation of lymphocyte activation.";
RL   J. Exp. Med. 192:1027-1034(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), AND SUBCELLULAR LOCATION
RP   (ISOFORMS 1 AND 2).
RX   PubMed=15780196; DOI=10.1111/j.1745-7254.2005.00086.x;
RA   He X.-H., Xu L.-H., Liu Y.;
RT   "Identification of a novel splice variant of human PD-L1 mRNA encoding an
RT   isoform-lacking Igv-like domain.";
RL   Acta Pharmacol. Sin. 26:462-468(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Gastric carcinoma;
RA   Chi X.-Y., Zha Q.-B., Xu L.-H., Jia Q.-T., Li F.-Y., He X.-H.;
RT   "Expression and significance of PD-L1 variant within tissues of human
RT   gastric carcinoma.";
RL   Submitted (NOV-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164053; DOI=10.1038/nature02465;
RA   Humphray S.J., Oliver K., Hunt A.R., Plumb R.W., Loveland J.E., Howe K.L.,
RA   Andrews T.D., Searle S., Hunt S.E., Scott C.E., Jones M.C., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Ashwell R.I.S., Babbage A.K., Babbage S.,
RA   Bagguley C.L., Bailey J., Banerjee R., Barker D.J., Barlow K.F., Bates K.,
RA   Beasley H., Beasley O., Bird C.P., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D., Burrill W., Burton J., Carder C., Carter N.P., Chapman J.C.,
RA   Chen Y., Clarke G., Clark S.Y., Clee C.M., Clegg S., Collier R.E.,
RA   Corby N., Crosier M., Cummings A.T., Davies J., Dhami P., Dunn M.,
RA   Dutta I., Dyer L.W., Earthrowl M.E., Faulkner L., Fleming C.J.,
RA   Frankish A., Frankland J.A., French L., Fricker D.G., Garner P.,
RA   Garnett J., Ghori J., Gilbert J.G.R., Glison C., Grafham D.V., Gribble S.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Guy J., Hall R.E.,
RA   Hammond S., Harley J.L., Harrison E.S.I., Hart E.A., Heath P.D.,
RA   Henderson C.D., Hopkins B.L., Howard P.J., Howden P.J., Huckle E.,
RA   Johnson C., Johnson D., Joy A.A., Kay M., Keenan S., Kershaw J.K.,
RA   Kimberley A.M., King A., Knights A., Laird G.K., Langford C., Lawlor S.,
RA   Leongamornlert D.A., Leversha M., Lloyd C., Lloyd D.M., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., Matthews L., McLaren S., McLay K.E.,
RA   McMurray A., Milne S., Nickerson T., Nisbett J., Nordsiek G., Pearce A.V.,
RA   Peck A.I., Porter K.M., Pandian R., Pelan S., Phillimore B., Povey S.,
RA   Ramsey Y., Rand V., Scharfe M., Sehra H.K., Shownkeen R., Sims S.K.,
RA   Skuce C.D., Smith M., Steward C.A., Swarbreck D., Sycamore N., Tester J.,
RA   Thorpe A., Tracey A., Tromans A., Thomas D.W., Wall M., Wallis J.M.,
RA   West A.P., Whitehead S.L., Willey D.L., Williams S.A., Wilming L.,
RA   Wray P.W., Young L., Ashurst J.L., Coulson A., Blocker H., Durbin R.M.,
RA   Sulston J.E., Hubbard T., Jackson M.J., Bentley D.R., Beck S., Rogers J.,
RA   Dunham I.;
RT   "DNA sequence and analysis of human chromosome 9.";
RL   Nature 429:369-374(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-192.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CMTM6, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=28813417; DOI=10.1038/nature23643;
RA   Burr M.L., Sparbier C.E., Chan Y.C., Williamson J.C., Woods K.,
RA   Beavis P.A., Lam E.Y.N., Henderson M.A., Bell C.C., Stolzenburg S.,
RA   Gilan O., Bloor S., Noori T., Morgens D.W., Bassik M.C., Neeson P.J.,
RA   Behren A., Darcy P.K., Dawson S.J., Voskoboinik I., Trapani J.A., Cebon J.,
RA   Lehner P.J., Dawson M.A.;
RT   "CMTM6 maintains the expression of PD-L1 and regulates anti-tumour
RT   immunity.";
RL   Nature 549:101-105(2017).
RN   [11]
RP   INVOLVEMENT IN CANCERS.
RX   PubMed=27281199; DOI=10.1038/nature18294;
RA   Kataoka K., Shiraishi Y., Takeda Y., Sakata S., Matsumoto M., Nagano S.,
RA   Maeda T., Nagata Y., Kitanaka A., Mizuno S., Tanaka H., Chiba K., Ito S.,
RA   Watatani Y., Kakiuchi N., Suzuki H., Yoshizato T., Yoshida K., Sanada M.,
RA   Itonaga H., Imaizumi Y., Totoki Y., Munakata W., Nakamura H., Hama N.,
RA   Shide K., Kubuki Y., Hidaka T., Kameda T., Masuda K., Minato N.,
RA   Kashiwase K., Izutsu K., Takaori-Kondo A., Miyazaki Y., Takahashi S.,
RA   Shibata T., Kawamoto H., Akatsuka Y., Shimoda K., Takeuchi K., Seya T.,
RA   Miyano S., Ogawa S.;
RT   "Aberrant PD-L1 expression through 3'-UTR disruption in multiple cancers.";
RL   Nature 534:402-406(2016).
RN   [12]
RP   FUNCTION, INDUCTION BY IFNG, SUBCELLULAR LOCATION, INTERACTION WITH CMTM4
RP   AND CMTM6, IDENTIFICATION BY MASS SPECTROMETRY, AND UBIQUITINATION.
RX   PubMed=28813410; DOI=10.1038/nature23669;
RA   Mezzadra R., Sun C., Jae L.T., Gomez-Eerland R., de Vries E., Wu W.,
RA   Logtenberg M.E.W., Slagter M., Rozeman E.A., Hofland I., Broeks A.,
RA   Horlings H.M., Wessels L.F.A., Blank C.U., Xiao Y., Heck A.J.R., Borst J.,
RA   Brummelkamp T.R., Schumacher T.N.M.;
RT   "Identification of CMTM6 and CMTM4 as PD-L1 protein regulators.";
RL   Nature 549:106-110(2017).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.64 ANGSTROMS) OF 18-239 IN COMPLEX WITH MOUSE
RP   PDCD1, AND DISULFIDE BONDS.
RX   PubMed=18287011; DOI=10.1073/pnas.0712278105;
RA   Lin D.Y., Tanaka Y., Iwasaki M., Gittis A.G., Su H.P., Mikami B.,
RA   Okazaki T., Honjo T., Minato N., Garboczi D.N.;
RT   "The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of
RT   antibodies and T cell receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:3011-3016(2008).
RN   [14] {ECO:0000244|PDB:4ZQK, ECO:0000244|PDB:5C3T}
RP   X-RAY CRYSTALLOGRAPHY (1.80 ANGSTROMS) OF 18-134 IN COMPLEX WITH PDCD1, AND
RP   DISULFIDE BOND.
RX   PubMed=26602187; DOI=10.1016/j.str.2015.09.010;
RA   Zak K.M., Kitel R., Przetocka S., Golik P., Guzik K., Musielak B.,
RA   Domling A., Dubin G., Holak T.A.;
RT   "Structure of the complex of human programmed death 1, PD-1, and its ligand
RT   PD-L1.";
RL   Structure 23:2341-2348(2015).
CC   -!- FUNCTION: Plays a critical role in induction and maintenance of immune
CC       tolerance to self (PubMed:11015443, PubMed:28813417, PubMed:28813410).
CC       As a ligand for the inhibitory receptor PDCD1/PD-1, modulates the
CC       activation threshold of T-cells and limits T-cell effector response
CC       (PubMed:11015443, PubMed:28813417, PubMed:28813410). Through a yet
CC       unknown activating receptor, may costimulate T-cell subsets that
CC       predominantly produce interleukin-10 (IL10) (PubMed:10581077).
CC       {ECO:0000269|PubMed:10581077, ECO:0000269|PubMed:11015443,
CC       ECO:0000269|PubMed:28813410, ECO:0000269|PubMed:28813417}.
CC   -!- FUNCTION: The PDCD1-mediated inhibitory pathway is exploited by tumors
CC       to attenuate anti-tumor immunity and escape destruction by the immune
CC       system, thereby facilitating tumor survival (PubMed:28813417,
CC       PubMed:28813410). The interaction with PDCD1/PD-1 inhibits cytotoxic T
CC       lymphocytes (CTLs) effector function (By similarity). The blockage of
CC       the PDCD1-mediated pathway results in the reversal of the exhausted T-
CC       cell phenotype and the normalization of the anti-tumor response,
CC       providing a rationale for cancer immunotherapy (By similarity).
CC       {ECO:0000250|UniProtKB:Q9EP73, ECO:0000269|PubMed:28813410,
CC       ECO:0000269|PubMed:28813417}.
CC   -!- SUBUNIT: Interacts with PDCD1 (PubMed:11015443, PubMed:18287011,
CC       PubMed:26602187). Interacts (via transmembrane domain) with CMTM4 and
CC       CMTM6 (PubMed:28813417, PubMed:28813410). {ECO:0000269|PubMed:11015443,
CC       ECO:0000269|PubMed:18287011, ECO:0000269|PubMed:26602187,
CC       ECO:0000269|PubMed:28813410, ECO:0000269|PubMed:28813417}.
CC   -!- INTERACTION:
CC       Q9NZQ7; P33681: CD80; NbExp=11; IntAct=EBI-4314282, EBI-1031024;
CC       Q9NZQ7; Q8IZR5: CMTM4; NbExp=3; IntAct=EBI-4314282, EBI-3925367;
CC       Q9NZQ7; Q9NX76: CMTM6; NbExp=11; IntAct=EBI-4314282, EBI-1054315;
CC       Q9NZQ7; Q15116: PDCD1; NbExp=17; IntAct=EBI-4314282, EBI-4314328;
CC       Q9NZQ7-1; Q15116: PDCD1; NbExp=2; IntAct=EBI-15686469, EBI-4314328;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:28813410,
CC       ECO:0000269|PubMed:28813417}; Single-pass type I membrane protein
CC       {ECO:0000255}. Early endosome membrane {ECO:0000269|PubMed:28813417};
CC       Single-pass type I membrane protein {ECO:0000255}. Recycling endosome
CC       membrane {ECO:0000269|PubMed:28813417}; Single-pass type I membrane
CC       protein {ECO:0000255}. Note=Associates with CMTM6 at recycling
CC       endosomes, where it is protected from being targeted for lysosomal
CC       degradation. {ECO:0000269|PubMed:28813417}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 1]: Cell membrane
CC       {ECO:0000269|PubMed:15780196}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Endomembrane system
CC       {ECO:0000269|PubMed:15780196}; Single-pass type I membrane protein
CC       {ECO:0000255}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=PD-L1I;
CC         IsoId=Q9NZQ7-1; Sequence=Displayed;
CC       Name=2; Synonyms=PD-L1II;
CC         IsoId=Q9NZQ7-2; Sequence=VSP_013735;
CC       Name=3;
CC         IsoId=Q9NZQ7-3; Sequence=VSP_013736, VSP_013737;
CC   -!- TISSUE SPECIFICITY: Highly expressed in the heart, skeletal muscle,
CC       placenta and lung. Weakly expressed in the thymus, spleen, kidney and
CC       liver. Expressed on activated T- and B-cells, dendritic cells,
CC       keratinocytes and monocytes. {ECO:0000269|PubMed:10581077,
CC       ECO:0000269|PubMed:11015443}.
CC   -!- INDUCTION: Up-regulated on T- and B-cells, dendritic cells,
CC       keratinocytes and monocytes after LPS and IFNG activation. Up-regulated
CC       in B-cells activated by surface Ig cross-linking.
CC       {ECO:0000269|PubMed:10581077, ECO:0000269|PubMed:11015443,
CC       ECO:0000269|PubMed:28813410}.
CC   -!- PTM: Ubiquitinated; STUB1 likely mediates polyubiquitination of PD-
CC       L1/CD274 triggering its degradation. {ECO:0000269|PubMed:28813410}.
CC   -!- DISEASE: Note=Truncation of the 3'-untranslated (3'-UTR) region of
CC       CD274 transcripts leads to elevated expression of CD274 in multiple
CC       cancers including T-cell leukemia, diffuse large B-cell lymphoma and
CC       stomach adenocarcinoma (PubMed:27281199). Disruption of 3'-UTR region
CC       is caused by structural variants that stabilize CD274 transcripts,
CC       leading to overexpression (PubMed:27281199). Increased expression in
CC       tumors promotes immune evasion and tumor cell growth by allowing
CC       malignant cells to escape destruction by the immune system
CC       (PubMed:27281199). {ECO:0000269|PubMed:27281199}.
CC   -!- MISCELLANEOUS: [Isoform 3]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the immunoglobulin superfamily. BTN/MOG family.
CC       {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA91966.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF177937; AAF25807.1; -; mRNA.
DR   EMBL; AF233516; AAG18508.1; -; mRNA.
DR   EMBL; AY254342; AAP13470.1; -; mRNA.
DR   EMBL; AY291313; AAP42144.1; -; mRNA.
DR   EMBL; AY714881; AAU09634.1; -; mRNA.
DR   EMBL; DQ286582; ABB90152.1; -; mRNA.
DR   EMBL; AK001894; BAA91966.1; ALT_INIT; mRNA.
DR   EMBL; AK300470; BAG62189.1; -; mRNA.
DR   EMBL; AK314567; BAG37149.1; -; mRNA.
DR   EMBL; AL162253; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471071; EAW58763.1; -; Genomic_DNA.
DR   EMBL; BC069381; AAH69381.1; -; mRNA.
DR   EMBL; BC074984; AAH74984.1; -; mRNA.
DR   EMBL; BC113734; AAI13735.1; -; mRNA.
DR   EMBL; BC113736; AAI13737.1; -; mRNA.
DR   CCDS; CCDS59118.1; -. [Q9NZQ7-2]
DR   CCDS; CCDS6464.1; -. [Q9NZQ7-1]
DR   RefSeq; NP_001254635.1; NM_001267706.1. [Q9NZQ7-2]
DR   RefSeq; NP_054862.1; NM_014143.3. [Q9NZQ7-1]
DR   PDB; 3BIK; X-ray; 2.65 A; A=18-239.
DR   PDB; 3BIS; X-ray; 2.64 A; A/B=18-239.
DR   PDB; 3FN3; X-ray; 2.70 A; A/B=19-238.
DR   PDB; 3SBW; X-ray; 2.28 A; C=19-239.
DR   PDB; 4Z18; X-ray; 1.95 A; A/B=19-239.
DR   PDB; 4ZQK; X-ray; 2.45 A; A=18-132.
DR   PDB; 5C3T; X-ray; 1.80 A; A=18-134.
DR   PDB; 5GGT; X-ray; 2.80 A; A=18-134.
DR   PDB; 5GRJ; X-ray; 3.21 A; A=18-238.
DR   PDB; 5IUS; X-ray; 2.89 A; C/D=18-239.
DR   PDB; 5J89; X-ray; 2.20 A; A/B/C/D=2-134.
DR   PDB; 5J8O; X-ray; 2.30 A; A/B=18-134.
DR   PDB; 5JDR; X-ray; 2.70 A; A/B=18-239.
DR   PDB; 5JDS; X-ray; 1.70 A; A=18-132.
DR   PDB; 5N2D; X-ray; 2.35 A; A/B/C/D=2-134.
DR   PDB; 5N2F; X-ray; 1.70 A; A/B=18-134.
DR   PDB; 5NIU; X-ray; 2.01 A; A/B/C/D=18-134.
DR   PDB; 5O45; X-ray; 0.99 A; A=17-134.
DR   PDB; 5O4Y; X-ray; 2.30 A; B/C/E=18-132.
DR   PDB; 5X8L; X-ray; 3.10 A; A/B/C/D/E=18-134.
DR   PDB; 5X8M; X-ray; 2.66 A; A=18-134.
DR   PDB; 5XJ4; X-ray; 2.30 A; A=19-238.
DR   PDB; 5XXY; X-ray; 2.90 A; A=18-133.
DR   PDB; 6NM7; X-ray; 2.43 A; A/B=19-134.
DR   PDB; 6NM8; X-ray; 2.79 A; A/B=19-134.
DR   PDB; 6NNV; X-ray; 1.92 A; A/B/C/D=18-134.
DR   PDB; 6NOJ; X-ray; 2.33 A; A/B=18-134.
DR   PDB; 6NOS; X-ray; 2.70 A; A/B=18-134.
DR   PDB; 6NP9; X-ray; 1.27 A; A=18-134.
DR   PDB; 6PV9; X-ray; 2.00 A; A=19-239.
DR   PDB; 6R3K; X-ray; 2.20 A; A/B/C/D=18-134.
DR   PDB; 6RPG; X-ray; 2.70 A; A/B=18-134.
DR   PDBsum; 3BIK; -.
DR   PDBsum; 3BIS; -.
DR   PDBsum; 3FN3; -.
DR   PDBsum; 3SBW; -.
DR   PDBsum; 4Z18; -.
DR   PDBsum; 4ZQK; -.
DR   PDBsum; 5C3T; -.
DR   PDBsum; 5GGT; -.
DR   PDBsum; 5GRJ; -.
DR   PDBsum; 5IUS; -.
DR   PDBsum; 5J89; -.
DR   PDBsum; 5J8O; -.
DR   PDBsum; 5JDR; -.
DR   PDBsum; 5JDS; -.
DR   PDBsum; 5N2D; -.
DR   PDBsum; 5N2F; -.
DR   PDBsum; 5NIU; -.
DR   PDBsum; 5O45; -.
DR   PDBsum; 5O4Y; -.
DR   PDBsum; 5X8L; -.
DR   PDBsum; 5X8M; -.
DR   PDBsum; 5XJ4; -.
DR   PDBsum; 5XXY; -.
DR   PDBsum; 6NM7; -.
DR   PDBsum; 6NM8; -.
DR   PDBsum; 6NNV; -.
DR   PDBsum; 6NOJ; -.
DR   PDBsum; 6NOS; -.
DR   PDBsum; 6NP9; -.
DR   PDBsum; 6PV9; -.
DR   PDBsum; 6R3K; -.
DR   PDBsum; 6RPG; -.
DR   SMR; Q9NZQ7; -.
DR   BioGrid; 118891; 54.
DR   DIP; DIP-29731N; -.
DR   IntAct; Q9NZQ7; 34.
DR   STRING; 9606.ENSP00000370989; -.
DR   BindingDB; Q9NZQ7; -.
DR   ChEMBL; CHEMBL3580522; -.
DR   DrugBank; DB11595; Atezolizumab.
DR   DrugBank; DB11945; Avelumab.
DR   DrugBank; DB11714; Durvalumab.
DR   DrugCentral; Q9NZQ7; -.
DR   iPTMnet; Q9NZQ7; -.
DR   PhosphoSitePlus; Q9NZQ7; -.
DR   SwissPalm; Q9NZQ7; -.
DR   BioMuta; CD274; -.
DR   DMDM; 83287884; -.
DR   EPD; Q9NZQ7; -.
DR   jPOST; Q9NZQ7; -.
DR   MassIVE; Q9NZQ7; -.
DR   MaxQB; Q9NZQ7; -.
DR   PaxDb; Q9NZQ7; -.
DR   PeptideAtlas; Q9NZQ7; -.
DR   PRIDE; Q9NZQ7; -.
DR   ProteomicsDB; 83483; -. [Q9NZQ7-1]
DR   ProteomicsDB; 83484; -. [Q9NZQ7-2]
DR   ProteomicsDB; 83485; -. [Q9NZQ7-3]
DR   ABCD; Q9NZQ7; -.
DR   Antibodypedia; 24139; 1683 antibodies.
DR   Ensembl; ENST00000381573; ENSP00000370985; ENSG00000120217. [Q9NZQ7-2]
DR   Ensembl; ENST00000381577; ENSP00000370989; ENSG00000120217. [Q9NZQ7-1]
DR   GeneID; 29126; -.
DR   KEGG; hsa:29126; -.
DR   UCSC; uc003zje.4; human. [Q9NZQ7-1]
DR   CTD; 29126; -.
DR   DisGeNET; 29126; -.
DR   GeneCards; CD274; -.
DR   HGNC; HGNC:17635; CD274.
DR   HPA; ENSG00000120217; Tissue enhanced (lung, placenta).
DR   MIM; 605402; gene.
DR   neXtProt; NX_Q9NZQ7; -.
DR   OpenTargets; ENSG00000120217; -.
DR   PharmGKB; PA134915280; -.
DR   eggNOG; ENOG410IIBU; Eukaryota.
DR   eggNOG; ENOG4111V14; LUCA.
DR   GeneTree; ENSGT00940000161430; -.
DR   HOGENOM; CLU_1744717_0_0_1; -.
DR   InParanoid; Q9NZQ7; -.
DR   KO; K06745; -.
DR   OMA; AGVYCCM; -.
DR   OrthoDB; 892262at2759; -.
DR   PhylomeDB; Q9NZQ7; -.
DR   TreeFam; TF331083; -.
DR   Reactome; R-HSA-389948; PD-1 signaling.
DR   SIGNOR; Q9NZQ7; -.
DR   ChiTaRS; CD274; human.
DR   EvolutionaryTrace; Q9NZQ7; -.
DR   GeneWiki; PD-L1; -.
DR   GenomeRNAi; 29126; -.
DR   Pharos; Q9NZQ7; Tclin.
DR   PRO; PR:Q9NZQ7; -.
DR   Proteomes; UP000005640; Chromosome 9.
DR   RNAct; Q9NZQ7; protein.
DR   Bgee; ENSG00000120217; Expressed in chorionic villus and 151 other tissues.
DR   Genevisible; Q9NZQ7; HS.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0031901; C:early endosome membrane; IDA:UniProtKB.
DR   GO; GO:0009897; C:external side of plasma membrane; IBA:GO_Central.
DR   GO; GO:0070062; C:extracellular exosome; IDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0007166; P:cell surface receptor signaling pathway; IDA:UniProtKB.
DR   GO; GO:0071222; P:cellular response to lipopolysaccharide; IBA:GO_Central.
DR   GO; GO:0006955; P:immune response; IDA:UniProtKB.
DR   GO; GO:0046007; P:negative regulation of activated T cell proliferation; IMP:UniProtKB.
DR   GO; GO:2000562; P:negative regulation of CD4-positive, alpha-beta T cell proliferation; IDA:UniProtKB.
DR   GO; GO:2001186; P:negative regulation of CD8-positive, alpha-beta T cell activation; IMP:UniProtKB.
DR   GO; GO:0032689; P:negative regulation of interferon-gamma production; IMP:UniProtKB.
DR   GO; GO:0032693; P:negative regulation of interleukin-10 production; IMP:UniProtKB.
DR   GO; GO:0042130; P:negative regulation of T cell proliferation; IBA:GO_Central.
DR   GO; GO:1903556; P:negative regulation of tumor necrosis factor superfamily cytokine production; IMP:UniProtKB.
DR   GO; GO:1905404; P:positive regulation of activated CD8-positive, alpha-beta T cell apoptotic process; IDA:UniProtKB.
DR   GO; GO:0030335; P:positive regulation of cell migration; IEA:Ensembl.
DR   GO; GO:2001181; P:positive regulation of interleukin-10 secretion; IDA:UniProtKB.
DR   GO; GO:0042102; P:positive regulation of T cell proliferation; IBA:GO_Central.
DR   GO; GO:0002845; P:positive regulation of tolerance induction to tumor cell; IMP:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; IDA:AgBase.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0031295; P:T cell costimulation; IDA:UniProtKB.
DR   GO; GO:1901998; P:toxin transport; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 2.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR013106; Ig_V-set.
DR   Pfam; PF08205; C2-set_2; 1.
DR   Pfam; PF07686; V-set; 1.
DR   SMART; SM00409; IG; 2.
DR   SUPFAM; SSF48726; SSF48726; 2.
DR   PROSITE; PS50835; IG_LIKE; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell membrane;
KW   Disulfide bond; Endosome; Glycoprotein; Immunity; Immunoglobulin domain;
KW   Membrane; Receptor; Reference proteome; Repeat; Signal; Transmembrane;
KW   Transmembrane helix; Ubl conjugation.
FT   SIGNAL          1..18
FT                   /evidence="ECO:0000255"
FT   CHAIN           19..290
FT                   /note="Programmed cell death 1 ligand 1"
FT                   /id="PRO_0000014553"
FT   TOPO_DOM        19..238
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        239..259
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        260..290
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          19..127
FT                   /note="Ig-like V-type"
FT   DOMAIN          133..225
FT                   /note="Ig-like C2-type"
FT   CARBOHYD        35
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        192
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218"
FT   CARBOHYD        200
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        219
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        40..114
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:18287011, ECO:0000269|PubMed:26602187"
FT   DISULFID        155..209
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0000269|PubMed:18287011"
FT   VAR_SEQ         19..132
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15780196, ECO:0000303|Ref.4"
FT                   /id="VSP_013735"
FT   VAR_SEQ         178
FT                   /note="K -> D (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15780196"
FT                   /id="VSP_013736"
FT   VAR_SEQ         179..290
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15780196"
FT                   /id="VSP_013737"
FT   STRAND          26..31
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          36..41
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          45..47
FT                   /evidence="ECO:0000244|PDB:5C3T"
FT   HELIX           50..52
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          54..59
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          62..68
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          71..73
FT                   /evidence="ECO:0000244|PDB:6NP9"
FT   HELIX           74..76
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   HELIX           79..81
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   TURN            82..84
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          85..87
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   HELIX           89..94
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          96..103
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   HELIX           106..108
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          110..131
FT                   /evidence="ECO:0000244|PDB:5O45"
FT   STRAND          138..145
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   TURN            146..149
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          150..161
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          164..169
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          177..183
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          185..187
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          191..200
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          206..213
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   TURN            214..217
FT                   /evidence="ECO:0000244|PDB:4Z18"
FT   STRAND          218..225
FT                   /evidence="ECO:0000244|PDB:4Z18"
SQ   SEQUENCE   290 AA;  33275 MW;  FE957086E62A31A8 CRC64;
     MRIFAVFIFM TYWHLLNAFT VTVPKDLYVV EYGSNMTIEC KFPVEKQLDL AALIVYWEME
     DKNIIQFVHG EEDLKVQHSS YRQRARLLKD QLSLGNAALQ ITDVKLQDAG VYRCMISYGG
     ADYKRITVKV NAPYNKINQR ILVVDPVTSE HELTCQAEGY PKAEVIWTSS DHQVLSGKTT
     TTNSKREEKL FNVTSTLRIN TTTNEIFYCT FRRLDPEENH TAELVIPELP LAHPPNERTH
     LVILGAILLC LGVALTFIFR LRKGRMMDVK KCGIQDTNSK KQSDTHLEET
//
ID   H3BUU9_HUMAN            Unreviewed;       670 AA.
AC   H3BUU9;
DT   18-APR-2012, integrated into UniProtKB/TrEMBL.
DT   18-APR-2012, sequence version 1.
DT   22-APR-2020, entry version 63.
DE   SubName: Full=Cadherin-11 {ECO:0000313|Ensembl:ENSP00000457812};
GN   Name=CDH11 {ECO:0000313|Ensembl:ENSP00000457812};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000457812, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000457812, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000457812}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       {ECO:0000256|RuleBase:RU004357}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000256|RuleBase:RU003318,
CC       ECO:0000256|SAAS:SAAS00544042}; Single-pass type I membrane protein
CC       {ECO:0000256|RuleBase:RU003318, ECO:0000256|SAAS:SAAS00544042}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC010533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC137643; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001317505.1; NM_001330576.1.
DR   DrugBank; DB00482; Celecoxib.
DR   jPOST; H3BUU9; -.
DR   MaxQB; H3BUU9; -.
DR   PeptideAtlas; H3BUU9; -.
DR   PRIDE; H3BUU9; -.
DR   ProteomicsDB; 43032; -.
DR   Antibodypedia; 4584; 800 antibodies.
DR   Ensembl; ENST00000566827; ENSP00000457812; ENSG00000140937.
DR   GeneID; 1009; -.
DR   UCSC; uc010vin.3; human.
DR   CTD; 1009; -.
DR   EuPathDB; HostDB:ENSG00000140937.13; -.
DR   HGNC; HGNC:1750; CDH11.
DR   OpenTargets; ENSG00000140937; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00940000153691; -.
DR   HOGENOM; CLU_005284_3_1_1; -.
DR   ChiTaRS; CDH11; human.
DR   GenomeRNAi; 1009; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000140937; Expressed in placenta and 218 other tissues.
DR   ExpressionAtlas; H3BUU9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 3.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 4.
DR   SUPFAM; SSF49313; SSF49313; 4.
DR   PROSITE; PS00232; CADHERIN_1; 3.
PE   1: Evidence at protein level;
KW   Calcium {ECO:0000256|RuleBase:RU003318, ECO:0000256|SAAS:SAAS00020193};
KW   Cell adhesion {ECO:0000256|RuleBase:RU003318,
KW   ECO:0000256|SAAS:SAAS00307165};
KW   Cell membrane {ECO:0000256|SAAS:SAAS00307127};
KW   Membrane {ECO:0000256|SAAS:SAAS00307127, ECO:0000256|SAAS:SAAS00554877,
KW   ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:H3BUU9,
KW   ECO:0000213|PeptideAtlas:H3BUU9, ECO:0000213|ProteomicsDB:H3BUU9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00226229};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00554877, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00554877,
KW   ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        493..514
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          55..140
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          164..256
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          279..360
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
FT   DOMAIN          387..474
FT                   /note="CA"
FT                   /evidence="ECO:0000259|SMART:SM00112"
SQ   SEQUENCE   670 AA;  73793 MW;  F8CBF4E3BD77712D CRC64;
     MAQAVDRDTN RPLEPPSEFI VKVQDINDNP PEFLHETYHA NVPERSNVGT SVIQVTASDA
     DDPTYGNSAK LVYSILEGQP YFSVEAQTGI IRTALPNMDR EAKEEYHVVI QAKDMGGHMG
     GLSGTTKVTI TLTDVNDNPP KFPQSVYQMS VSEAAVPGEE VGRVKAKDPD IGENGLVTYN
     IVDGDGMESF EITTDYETQE GVIKLKKPVD FETKRAYSLK VEAANVHIDP KFISNGPFKD
     TVTVKISVED ADEPPMFLAP SYIHEVQENA AAGTVVGRVH AKDPDAANSP IRYSIDRHTD
     LDRFFTINPE DGFIKTTKPL DREETAWLNI TVFAAEIHNR HQEAKVPVAI RVLDVNDNAP
     KFAAPYEGFI CESDQTKPLS NQPIVTISAD DKDDTANGPR FIFSLPPEII HNPNFTVRDN
     RDNTAGVYAR RGGFSRQKQD LYLLPIVISD GGIPPMSSTN TLTIKVCGCD VNGALLSCNA
     EAYILNAGLS TGALIAILAC IVILLVIVVL FVTLRRQKKE PLIVFEEEDV RENIITYDDE
     GGGEEDTEAF DIATLQNPDG INGFIPRKDI KPEYQYMPRP GLRPAPNSVD VDDFINTRIQ
     EADNDPTAPP YDSIQIYGYE GRGSVAGSLS SLESATTDSD LDYDYLQNWG PRFKKLADLY
     GSKDTFDDDS
//
ID   CAD11_HUMAN             Reviewed;         796 AA.
AC   P55287; A8K5D6; A8MZC8; B7WP28; Q15065; Q15066; Q9UQ93; Q9UQ94;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   22-APR-2020, entry version 168.
DE   RecName: Full=Cadherin-11;
DE   AltName: Full=OSF-4;
DE   AltName: Full=Osteoblast cadherin;
DE            Short=OB-cadherin;
DE   Flags: Precursor;
GN   Name=CDH11;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=7982033; DOI=10.3109/15419069409014199;
RA   Tanihara H., Sano K., Heimark R.L., St John T., Suzuki S.;
RT   "Cloning of five human cadherins clarifies characteristic features of
RT   cadherin extracellular domain and provides further evidence for two
RT   structurally different types of cadherin.";
RL   Cell Adhes. Commun. 2:15-26(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANTS ILE-275 AND
RP   ALA-373.
RC   TISSUE=Osteosarcoma;
RX   PubMed=8163513;
RA   Okazaki M., Takeshita S., Kawai S., Kikuno R., Tsujimura A., Kudo A.,
RA   Amann E.;
RT   "Molecular cloning and characterization of OB-cadherin, a new member of
RT   cadherin family expressed in osteoblasts.";
RL   J. Biol. Chem. 269:12092-12098(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT ALA-373.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 269-796 (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=2059658; DOI=10.1091/mbc.2.4.261;
RA   Suzuki S., Sano K., Tanihara H.;
RT   "Diversity of the cadherin family: evidence for eight new cadherins in
RT   nervous tissue.";
RL   Cell Regul. 2:261-270(1991).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 600-668.
RA   Kools P.F.J., Hogendoorn P.C.W., Bovee J.V.M.G., van Roy F.;
RT   "Alternative cadherin-11 transcripts encoding truncated adhesion molecules
RT   are detectable in both human cancer and normal cells.";
RL   Submitted (APR-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH USP6.
RX   PubMed=15026324; DOI=10.1158/0008-5472.can-03-2827;
RA   Oliveira A.M., Hsi B.L., Weremowicz S., Rosenberg A.E., Dal Cin P.,
RA   Joseph N., Bridge J.A., Perez-Atayde A.R., Fletcher J.A.;
RT   "USP6 (Tre2) fusion oncogenes in aneurysmal bone cyst.";
RL   Cancer Res. 64:1920-1923(2004).
RN   [8]
RP   INVOLVEMENT IN ESWS.
RX   PubMed=28988429; DOI=10.1002/ajmg.a.38495;
RA   Taskiran E.Z., Karaosmanoglu B., Kosukcu C., Dogan O.A.,
RA   Taylan-Sekeroglu H., Simsek-Kiper P.O., Utine E.G., Boduroglu K.,
RA   Alikasifoglu M.;
RT   "Homozygous indel mutation in CDH11 as the probable cause of Elsahy-Waters
RT   syndrome.";
RL   Am. J. Med. Genet. A 173:3143-3152(2017).
RN   [9]
RP   INVOLVEMENT IN ESWS, AND VARIANT ESWS 232-TYR--SER-796 DEL.
RX   PubMed=29271567; DOI=10.1002/ajmg.a.38568;
RA   Harms F.L., Nampoothiri S., Anazi S., Yesodharan D., Alawi M., Kutsche K.,
RA   Alkuraya F.S.;
RT   "Elsahy-Waters syndrome is caused by biallelic mutations in CDH11.";
RL   Am. J. Med. Genet. A 176:477-482(2018).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins. They
CC       preferentially interact with themselves in a homophilic manner in
CC       connecting cells; cadherins may thus contribute to the sorting of
CC       heterogeneous cell types.
CC   -!- SUBUNIT: Interacts with PCDH8. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane; Single-pass type I membrane
CC       protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P55287-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P55287-2; Sequence=VSP_000640, VSP_000641;
CC   -!- TISSUE SPECIFICITY: Expressed mainly in brain but also found in other
CC       tissues. Expressed in neuroblasts.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of each
CC       cadherin domain and rigidify the connections, imparting a strong
CC       curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving CDH11 is a common
CC       genetic feature of aneurysmal bone cyst, a benign osseous neoplasm.
CC       Translocation t(16;17)(q22;p13) with USP6. The translocation generates
CC       a fusion gene in which the strong CDH11 promoter is fused to the entire
CC       USP6 coding sequence, resulting in USP6 transcriptional up-regulation.
CC   -!- DISEASE: Elsahy-Waters syndrome (ESWS) [MIM:211380]: An autosomal
CC       recessive syndrome characterized by moderate mental retardation,
CC       hypospadias and characteristic craniofacial morphology, which includes
CC       brachycephaly, facial asymmetry, exotropia, hypertelorism, telechantus,
CC       broad nose, concave nasal ridge, underdeveloped mid-face, prognathism,
CC       and radicular dentin dysplasia. {ECO:0000269|PubMed:28988429,
CC       ECO:0000269|PubMed:29271567}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L34056; AAA35622.1; -; mRNA.
DR   EMBL; D21254; BAA04798.1; -; mRNA.
DR   EMBL; D21255; BAA04799.1; -; mRNA.
DR   EMBL; AK291251; BAF83940.1; -; mRNA.
DR   EMBL; AC010533; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF060370; AAD27755.1; -; Genomic_DNA.
DR   EMBL; AF060369; AAD27755.1; JOINED; Genomic_DNA.
DR   EMBL; AF060370; AAD27756.1; -; Genomic_DNA.
DR   EMBL; AF060369; AAD27756.1; JOINED; Genomic_DNA.
DR   CCDS; CCDS10803.1; -. [P55287-1]
DR   CCDS; CCDS81993.1; -. [P55287-2]
DR   PIR; A38992; A38992.
DR   RefSeq; NP_001295321.1; NM_001308392.1. [P55287-2]
DR   RefSeq; NP_001788.2; NM_001797.3. [P55287-1]
DR   RefSeq; XP_005255818.1; XM_005255761.3.
DR   RefSeq; XP_005255819.1; XM_005255762.2. [P55287-1]
DR   RefSeq; XP_005255820.1; XM_005255763.2. [P55287-1]
DR   RefSeq; XP_011521105.1; XM_011522803.2. [P55287-1]
DR   SMR; P55287; -.
DR   BioGrid; 107444; 5.
DR   CORUM; P55287; -.
DR   IntAct; P55287; 5.
DR   MINT; P55287; -.
DR   STRING; 9606.ENSP00000268603; -.
DR   iPTMnet; P55287; -.
DR   PhosphoSitePlus; P55287; -.
DR   BioMuta; CDH11; -.
DR   DMDM; 146345381; -.
DR   jPOST; P55287; -.
DR   MassIVE; P55287; -.
DR   MaxQB; P55287; -.
DR   PaxDb; P55287; -.
DR   PeptideAtlas; P55287; -.
DR   PRIDE; P55287; -.
DR   ProteomicsDB; 56837; -. [P55287-1]
DR   ProteomicsDB; 56838; -. [P55287-2]
DR   ABCD; P55287; -.
DR   Antibodypedia; 4584; 800 antibodies.
DR   Ensembl; ENST00000268603; ENSP00000268603; ENSG00000140937. [P55287-1]
DR   Ensembl; ENST00000394156; ENSP00000377711; ENSG00000140937. [P55287-2]
DR   GeneID; 1009; -.
DR   KEGG; hsa:1009; -.
DR   UCSC; uc002eoi.4; human. [P55287-1]
DR   CTD; 1009; -.
DR   DisGeNET; 1009; -.
DR   GeneCards; CDH11; -.
DR   HGNC; HGNC:1750; CDH11.
DR   HPA; ENSG00000140937; Tissue enhanced (ovary).
DR   MalaCards; CDH11; -.
DR   MIM; 211380; phenotype.
DR   MIM; 600023; gene.
DR   neXtProt; NX_P55287; -.
DR   OpenTargets; ENSG00000140937; -.
DR   Orphanet; 1299; Branchioskeletogenital syndrome.
DR   PharmGKB; PA26284; -.
DR   eggNOG; KOG3594; Eukaryota.
DR   eggNOG; ENOG410XQHI; LUCA.
DR   GeneTree; ENSGT00940000153691; -.
DR   HOGENOM; CLU_005284_4_3_1; -.
DR   InParanoid; P55287; -.
DR   KO; K06803; -.
DR   OMA; HENYHAN; -.
DR   OrthoDB; 188978at2759; -.
DR   PhylomeDB; P55287; -.
DR   TreeFam; TF329887; -.
DR   Reactome; R-HSA-418990; Adherens junctions interactions.
DR   SIGNOR; P55287; -.
DR   ChiTaRS; CDH11; human.
DR   GeneWiki; CDH11; -.
DR   GenomeRNAi; 1009; -.
DR   Pharos; P55287; Tbio.
DR   PRO; PR:P55287; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P55287; protein.
DR   Bgee; ENSG00000140937; Expressed in placenta and 218 other tissues.
DR   ExpressionAtlas; P55287; baseline and differential.
DR   Genevisible; P55287; HS.
DR   GO; GO:0005912; C:adherens junction; IBA:GO_Central.
DR   GO; GO:0016342; C:catenin complex; IBA:GO_Central.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0098685; C:Schaffer collateral - CA1 synapse; IEA:Ensembl.
DR   GO; GO:0045296; F:cadherin binding; IBA:GO_Central.
DR   GO; GO:0005509; F:calcium ion binding; IBA:GO_Central.
DR   GO; GO:0008092; F:cytoskeletal protein binding; IBA:GO_Central.
DR   GO; GO:0034332; P:adherens junction organization; IBA:GO_Central.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; IBA:GO_Central.
DR   GO; GO:0007155; P:cell adhesion; TAS:ProtInc.
DR   GO; GO:0000902; P:cell morphogenesis; IBA:GO_Central.
DR   GO; GO:0098609; P:cell-cell adhesion; IBA:GO_Central.
DR   GO; GO:0044331; P:cell-cell adhesion mediated by cadherin; IBA:GO_Central.
DR   GO; GO:0007043; P:cell-cell junction assembly; IBA:GO_Central.
DR   GO; GO:0021957; P:corticospinal tract morphogenesis; IEA:Ensembl.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IBA:GO_Central.
DR   GO; GO:0050804; P:modulation of chemical synaptic transmission; IEA:Ensembl.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0001503; P:ossification; NAS:UniProtKB.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   Gene3D; 4.10.900.10; -; 1.
DR   InterPro; IPR039808; Cadherin.
DR   InterPro; IPR002126; Cadherin-like_dom.
DR   InterPro; IPR015919; Cadherin-like_sf.
DR   InterPro; IPR020894; Cadherin_CS.
DR   InterPro; IPR000233; Cadherin_cytoplasmic-dom.
DR   InterPro; IPR027397; Catenin_binding_dom_sf.
DR   PANTHER; PTHR24027; PTHR24027; 1.
DR   Pfam; PF00028; Cadherin; 4.
DR   Pfam; PF01049; Cadherin_C; 1.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 5.
DR   SUPFAM; SSF49313; SSF49313; 5.
DR   PROSITE; PS00232; CADHERIN_1; 3.
DR   PROSITE; PS50268; CADHERIN_2; 5.
PE   1: Evidence at protein level;
KW   Alternative splicing; Calcium; Cell adhesion; Cell membrane;
KW   Chromosomal rearrangement; Cleavage on pair of basic residues; Deafness;
KW   Disease mutation; Glycoprotein; Membrane; Mental retardation;
KW   Metal-binding; Phosphoprotein; Polymorphism; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..22
FT                   /evidence="ECO:0000255"
FT   PROPEP          23..53
FT                   /evidence="ECO:0000255"
FT                   /id="PRO_0000003785"
FT   CHAIN           54..796
FT                   /note="Cadherin-11"
FT                   /id="PRO_0000003786"
FT   TOPO_DOM        54..617
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        618..640
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        641..796
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          54..159
FT                   /note="Cadherin 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          160..268
FT                   /note="Cadherin 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          269..383
FT                   /note="Cadherin 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          384..486
FT                   /note="Cadherin 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   DOMAIN          487..612
FT                   /note="Cadherin 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00043"
FT   MOD_RES         788
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P55288"
FT   MOD_RES         791
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P55288"
FT   CARBOHYD        455
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        540
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         632..693
FT                   /note="VIVVLFVTLRRQKKEPLIVFEEEDVRENIITYDDEGGGEEDTEAFDIATLQN
FT                   PDGINGFIPR -> GCPSLMEPPSPREDMRLLYLGFQLMLFSYVKVNRRFCLLGVFIKL
FT                   PFLYVVATESPTTLTSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8163513"
FT                   /id="VSP_000640"
FT   VAR_SEQ         694..796
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8163513"
FT                   /id="VSP_000641"
FT   VARIANT         232..796
FT                   /note="Missing (in ESWS)"
FT                   /evidence="ECO:0000269|PubMed:29271567"
FT                   /id="VAR_080481"
FT   VARIANT         255
FT                   /note="T -> M (in dbSNP:rs35195)"
FT                   /id="VAR_031945"
FT   VARIANT         275
FT                   /note="M -> I (in dbSNP:rs1130821)"
FT                   /evidence="ECO:0000269|PubMed:8163513"
FT                   /id="VAR_031946"
FT   VARIANT         373
FT                   /note="S -> A (in dbSNP:rs35213)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:8163513"
FT                   /id="VAR_031947"
FT   CONFLICT        271..272
FT                   /note="SV -> RL (in Ref. 1; AAA35622 and 5; no nucleotide
FT                   entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        340
FT                   /note="K -> E (in Ref. 1; AAA35622 and 5; no nucleotide
FT                   entry)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        471
FT                   /note="K -> Q (in Ref. 1; AAA35622 and 5; no nucleotide
FT                   entry)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   796 AA;  87965 MW;  E17090EC95C59936 CRC64;
     MKENYCLQAA LVCLGMLCHS HAFAPERRGH LRPSFHGHHE KGKEGQVLQR SKRGWVWNQF
     FVIEEYTGPD PVLVGRLHSD IDSGDGNIKY ILSGEGAGTI FVIDDKSGNI HATKTLDREE
     RAQYTLMAQA VDRDTNRPLE PPSEFIVKVQ DINDNPPEFL HETYHANVPE RSNVGTSVIQ
     VTASDADDPT YGNSAKLVYS ILEGQPYFSV EAQTGIIRTA LPNMDREAKE EYHVVIQAKD
     MGGHMGGLSG TTKVTITLTD VNDNPPKFPQ SVYQMSVSEA AVPGEEVGRV KAKDPDIGEN
     GLVTYNIVDG DGMESFEITT DYETQEGVIK LKKPVDFETK RAYSLKVEAA NVHIDPKFIS
     NGPFKDTVTV KISVEDADEP PMFLAPSYIH EVQENAAAGT VVGRVHAKDP DAANSPIRYS
     IDRHTDLDRF FTINPEDGFI KTTKPLDREE TAWLNITVFA AEIHNRHQEA KVPVAIRVLD
     VNDNAPKFAA PYEGFICESD QTKPLSNQPI VTISADDKDD TANGPRFIFS LPPEIIHNPN
     FTVRDNRDNT AGVYARRGGF SRQKQDLYLL PIVISDGGIP PMSSTNTLTI KVCGCDVNGA
     LLSCNAEAYI LNAGLSTGAL IAILACIVIL LVIVVLFVTL RRQKKEPLIV FEEEDVRENI
     ITYDDEGGGE EDTEAFDIAT LQNPDGINGF IPRKDIKPEY QYMPRPGLRP APNSVDVDDF
     INTRIQEADN DPTAPPYDSI QIYGYEGRGS VAGSLSSLES ATTDSDLDYD YLQNWGPRFK
     KLADLYGSKD TFDDDS
//
ID   CDX2_HUMAN              Reviewed;         313 AA.
AC   Q99626; O00503; Q5VTU7; Q969L8; Q9UD92;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2010, sequence version 3.
DT   22-APR-2020, entry version 185.
DE   RecName: Full=Homeobox protein CDX-2;
DE   AltName: Full=CDX-3;
DE   AltName: Full=Caudal-type homeobox protein 2;
GN   Name=CDX2; Synonyms=CDX3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-293.
RX   PubMed=9459001; DOI=10.1046/j.1469-1809.1997.6150393.x;
RA   Drummond F.J., Putt W., Fox M., Edwards Y.H.;
RT   "Cloning and chromosome assignment of the human CDX2 gene.";
RL   Ann. Hum. Genet. 61:393-400(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT SER-293.
RC   TISSUE=Colon carcinoma;
RX   PubMed=9036867;
RX   DOI=10.1002/(sici)1097-0215(19970220)74:1<35::aid-ijc7>3.0.co;2-1;
RA   Mallo G.V., Rechreche H., Frigerio J.-M., Rocha D., Zweibaum A., Lacasa M.,
RA   Jordan B.R., Dusetti N.J., Dagorn J.-C., Iovanna J.L.;
RT   "Molecular cloning, sequencing and expression of the mRNA encoding human
RT   Cdx1 and Cdx2 homeobox. Down-regulation of Cdx1 and Cdx2 mRNA expression
RT   during colorectal carcinogenesis.";
RL   Int. J. Cancer 74:35-44(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-293.
RX   PubMed=11161380; DOI=10.1054/bjoc.2000.1544;
RA   Sivagnanasundaram S., Islam I., Talbot I., Drummond F., Walters J.R.,
RA   Edwards Y.H.;
RT   "The homeobox gene CDX2 in colorectal carcinoma: a genetic analysis.";
RL   Br. J. Cancer 84:218-225(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT SER-293.
RA   Tanizawa Y., Ueda K., Inoue H., Ayame H., Aoki M., Kuwano A., German M.S.,
RA   Liu L., Donis-Keller H., Permutt M.A., Oka Y.;
RT   "Isolation, characterization, and linkage mapping of the human caudal-type
RT   homeobox gene, CDX2/3.";
RL   Submitted (JUN-1997) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057823; DOI=10.1038/nature02379;
RA   Dunham A., Matthews L.H., Burton J., Ashurst J.L., Howe K.L.,
RA   Ashcroft K.J., Beare D.M., Burford D.C., Hunt S.E., Griffiths-Jones S.,
RA   Jones M.C., Keenan S.J., Oliver K., Scott C.E., Ainscough R., Almeida J.P.,
RA   Ambrose K.D., Andrews D.T., Ashwell R.I.S., Babbage A.K., Bagguley C.L.,
RA   Bailey J., Bannerjee R., Barlow K.F., Bates K., Beasley H., Bird C.P.,
RA   Bray-Allen S., Brown A.J., Brown J.Y., Burrill W., Carder C., Carter N.P.,
RA   Chapman J.C., Clamp M.E., Clark S.Y., Clarke G., Clee C.M., Clegg S.C.,
RA   Cobley V., Collins J.E., Corby N., Coville G.J., Deloukas P., Dhami P.,
RA   Dunham I., Dunn M., Earthrowl M.E., Ellington A.G., Faulkner L.,
RA   Frankish A.G., Frankland J., French L., Garner P., Garnett J.,
RA   Gilbert J.G.R., Gilson C.J., Ghori J., Grafham D.V., Gribble S.M.,
RA   Griffiths C., Hall R.E., Hammond S., Harley J.L., Hart E.A., Heath P.D.,
RA   Howden P.J., Huckle E.J., Hunt P.J., Hunt A.R., Johnson C., Johnson D.,
RA   Kay M., Kimberley A.M., King A., Laird G.K., Langford C.J., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Lloyd C., Loveland J.E., Lovell J.,
RA   Martin S., Mashreghi-Mohammadi M., McLaren S.J., McMurray A., Milne S.,
RA   Moore M.J.F., Nickerson T., Palmer S.A., Pearce A.V., Peck A.I., Pelan S.,
RA   Phillimore B., Porter K.M., Rice C.M., Searle S., Sehra H.K., Shownkeen R.,
RA   Skuce C.D., Smith M., Steward C.A., Sycamore N., Tester J., Thomas D.W.,
RA   Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., West A.P.,
RA   Whitehead S.L., Willey D.L., Wilming L., Wray P.W., Wright M.W., Young L.,
RA   Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Beck S., Bentley D.R.,
RA   Rogers J., Ross M.T.;
RT   "The DNA sequence and analysis of human chromosome 13.";
RL   Nature 428:522-528(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT SER-293.
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 205-232.
RC   TISSUE=T-cell;
RX   PubMed=8105782; DOI=10.1006/bbrc.1993.2235;
RA   Inamori K., Takeshita K., Chiba S., Yazaki Y., Hirai H.;
RT   "Identification of homeobox genes expressed in human T-lymphocytes.";
RL   Biochem. Biophys. Res. Commun. 196:203-208(1993).
RN   [8] {ECO:0000244|PDB:5LTY}
RP   X-RAY CRYSTALLOGRAPHY (2.66 ANGSTROMS) OF 185-255 IN COMPLEX WITH
RP   METHYLATED DNA, AND DNA-BINDING.
RX   PubMed=28473536; DOI=10.1126/science.aaj2239;
RA   Yin Y., Morgunova E., Jolma A., Kaasinen E., Sahu B., Khund-Sayeed S.,
RA   Das P.K., Kivioja T., Dave K., Zhong F., Nitta K.R., Taipale M., Popov A.,
RA   Ginno P.A., Domcke S., Yan J., Schubeler D., Vinson C., Taipale J.;
RT   "Impact of cytosine methylation on DNA binding specificities of human
RT   transcription factors.";
RL   Science 356:0-0(2017).
CC   -!- FUNCTION: Involved in the transcriptional regulation of multiple genes
CC       expressed in the intestinal epithelium. Important in broad range of
CC       functions from early differentiation to maintenance of the intestinal
CC       epithelial lining of both the small and large intestine. Binds
CC       preferentially to methylated DNA (PubMed:28473536).
CC       {ECO:0000269|PubMed:28473536}.
CC   -!- INTERACTION:
CC       Q99626; Q8IYR0: CFAP206; NbExp=3; IntAct=EBI-10899513, EBI-749051;
CC       Q99626; Q9BQ66: KRTAP4-12; NbExp=3; IntAct=EBI-10899513, EBI-739863;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- PTM: Phosphorylation of Ser-60 mediates the transactivation capacity.
CC       {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the Caudal homeobox family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CDX2ID326.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Y13709; CAA74038.1; -; mRNA.
DR   EMBL; U51096; AAB40603.1; -; mRNA.
DR   EMBL; AJ278431; CAB94779.1; -; Genomic_DNA.
DR   EMBL; AJ278432; CAB94779.1; JOINED; Genomic_DNA.
DR   EMBL; AJ278434; CAB94779.1; JOINED; Genomic_DNA.
DR   EMBL; AF007886; AAD05200.1; -; Genomic_DNA.
DR   EMBL; AF007884; AAD05200.1; JOINED; Genomic_DNA.
DR   EMBL; AF007885; AAD05200.1; JOINED; Genomic_DNA.
DR   EMBL; AL591024; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC014461; AAH14461.1; -; mRNA.
DR   CCDS; CCDS9328.1; -.
DR   PIR; PN0625; PN0625.
DR   RefSeq; NP_001256.3; NM_001265.4.
DR   PDB; 5LTY; X-ray; 2.66 A; K/M=185-255.
DR   PDB; 6ES2; X-ray; 2.95 A; K/L=186-256.
DR   PDB; 6ES3; X-ray; 2.57 A; K/M=184-255.
DR   PDBsum; 5LTY; -.
DR   PDBsum; 6ES2; -.
DR   PDBsum; 6ES3; -.
DR   SMR; Q99626; -.
DR   BioGrid; 107475; 17.
DR   CORUM; Q99626; -.
DR   IntAct; Q99626; 4.
DR   MINT; Q99626; -.
DR   STRING; 9606.ENSP00000370408; -.
DR   iPTMnet; Q99626; -.
DR   PhosphoSitePlus; Q99626; -.
DR   BioMuta; CDX2; -.
DR   DMDM; 311033469; -.
DR   jPOST; Q99626; -.
DR   MassIVE; Q99626; -.
DR   MaxQB; Q99626; -.
DR   PaxDb; Q99626; -.
DR   PeptideAtlas; Q99626; -.
DR   PRIDE; Q99626; -.
DR   ProteomicsDB; 78366; -.
DR   Antibodypedia; 3700; 1049 antibodies.
DR   DNASU; 1045; -.
DR   Ensembl; ENST00000381020; ENSP00000370408; ENSG00000165556.
DR   GeneID; 1045; -.
DR   KEGG; hsa:1045; -.
DR   UCSC; uc001urv.5; human.
DR   CTD; 1045; -.
DR   DisGeNET; 1045; -.
DR   GeneCards; CDX2; -.
DR   HGNC; HGNC:1806; CDX2.
DR   HPA; ENSG00000165556; Tissue enriched (intestine).
DR   MIM; 600297; gene.
DR   neXtProt; NX_Q99626; -.
DR   OpenTargets; ENSG00000165556; -.
DR   PharmGKB; PA26352; -.
DR   eggNOG; KOG0848; Eukaryota.
DR   eggNOG; ENOG4111W2J; LUCA.
DR   GeneTree; ENSGT00940000161261; -.
DR   HOGENOM; CLU_073177_1_0_1; -.
DR   InParanoid; Q99626; -.
DR   KO; K22234; -.
DR   OMA; YHVAAAN; -.
DR   OrthoDB; 1380804at2759; -.
DR   PhylomeDB; Q99626; -.
DR   TreeFam; TF351605; -.
DR   Reactome; R-HSA-381771; Synthesis, secretion, and inactivation of Glucagon-like Peptide-1 (GLP-1).
DR   SIGNOR; Q99626; -.
DR   ChiTaRS; CDX2; human.
DR   GeneWiki; CDX2; -.
DR   GenomeRNAi; 1045; -.
DR   Pharos; Q99626; Tbio.
DR   PRO; PR:Q99626; -.
DR   Proteomes; UP000005640; Chromosome 13.
DR   RNAct; Q99626; protein.
DR   Bgee; ENSG00000165556; Expressed in mucosa of transverse colon and 35 other tissues.
DR   Genevisible; Q99626; HS.
DR   GO; GO:0000794; C:condensed nuclear chromosome; IEA:Ensembl.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0017053; C:transcriptional repressor complex; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0008327; F:methyl-CpG binding; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0003714; F:transcription corepressor activity; IEA:Ensembl.
DR   GO; GO:0009887; P:animal organ morphogenesis; IBA:GO_Central.
DR   GO; GO:0009948; P:anterior/posterior axis specification; IBA:GO_Central.
DR   GO; GO:0001568; P:blood vessel development; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0008333; P:endosome to lysosome transport; IEA:Ensembl.
DR   GO; GO:0045197; P:establishment or maintenance of epithelial cell apical/basal polarity; IEA:Ensembl.
DR   GO; GO:0060575; P:intestinal epithelial cell differentiation; ISS:UniProtKB.
DR   GO; GO:0060711; P:labyrinthine layer development; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045597; P:positive regulation of cell differentiation; IEA:Ensembl.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0014807; P:regulation of somitogenesis; ISS:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0035019; P:somatic stem cell population maintenance; IEA:Ensembl.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:ProtInc.
DR   GO; GO:0001829; P:trophectodermal cell differentiation; IEA:Ensembl.
DR   CDD; cd00086; homeodomain; 1.
DR   InterPro; IPR006820; Caudal_activation_dom.
DR   InterPro; IPR009057; Homeobox-like_sf.
DR   InterPro; IPR017970; Homeobox_CS.
DR   InterPro; IPR001356; Homeobox_dom.
DR   InterPro; IPR020479; Homeobox_metazoa.
DR   InterPro; IPR000047; HTH_motif.
DR   Pfam; PF04731; Caudal_act; 1.
DR   Pfam; PF00046; Homeodomain; 1.
DR   PRINTS; PR00024; HOMEOBOX.
DR   PRINTS; PR00031; HTHREPRESSR.
DR   SMART; SM00389; HOX; 1.
DR   SUPFAM; SSF46689; SSF46689; 1.
DR   PROSITE; PS00027; HOMEOBOX_1; 1.
DR   PROSITE; PS50071; HOMEOBOX_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Developmental protein; DNA-binding; Homeobox;
KW   Nucleus; Phosphoprotein; Polymorphism; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..313
FT                   /note="Homeobox protein CDX-2"
FT                   /id="PRO_0000048849"
FT   DNA_BIND        186..245
FT                   /note="Homeobox"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00108"
FT   REGION          186..216
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000305|PubMed:28473536"
FT   REGION          228..242
FT                   /note="Interaction with 5-mCpG DNA"
FT                   /evidence="ECO:0000305|PubMed:28473536"
FT   COMPBIAS        46..53
FT                   /note="Poly-Ala"
FT   COMPBIAS        85..92
FT                   /note="Poly-Ala"
FT   COMPBIAS        250..256
FT                   /note="Poly-Gln"
FT   COMPBIAS        257..270
FT                   /note="Poly-Pro"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P43241"
FT   VARIANT         293
FT                   /note="P -> S (in dbSNP:rs1805107)"
FT                   /evidence="ECO:0000269|PubMed:11161380,
FT                   ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:9036867,
FT                   ECO:0000269|PubMed:9459001, ECO:0000269|Ref.4"
FT                   /id="VAR_014530"
FT   CONFLICT        52..53
FT                   /note="AA -> Q (in Ref. 2; AAB40603)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        89
FT                   /note="Missing (in Ref. 2; AAB40603)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        95
FT                   /note="G -> A (in Ref. 2; AAB40603)"
FT                   /evidence="ECO:0000305"
FT   STRAND          187..189
FT                   /evidence="ECO:0000244|PDB:6ES3"
FT   HELIX           195..207
FT                   /evidence="ECO:0000244|PDB:6ES3"
FT   HELIX           213..223
FT                   /evidence="ECO:0000244|PDB:6ES3"
FT   HELIX           227..254
FT                   /evidence="ECO:0000244|PDB:6ES3"
SQ   SEQUENCE   313 AA;  33520 MW;  B5724F1F7CA569AF CRC64;
     MYVSYLLDKD VSMYPSSVRH SGGLNLAPQN FVSPPQYPDY GGYHVAAAAA AAANLDSAQS
     PGPSWPAAYG APLREDWNGY APGGAAAAAN AVAHGLNGGS PAAAMGYSSP ADYHPHHHPH
     HHPHHPAAAP SCASGLLQTL NPGPPGPAAT AAAEQLSPGG QRRNLCEWMR KPAQQSLGSQ
     VKTRTKDKYR VVYTDHQRLE LEKEFHYSRY ITIRRKAELA ATLGLSERQV KIWFQNRRAK
     ERKINKKKLQ QQQQQQPPQP PPPPPQPPQP QPGPLRSVPE PLSPVSSLQA SVPGSVPGVL
     GPTGGVLNPT VTQ
//
ID   A0A087X2I7_HUMAN        Unreviewed;      1131 AA.
AC   A0A087X2I7;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=MHC class II transactivator {ECO:0000313|Ensembl:ENSP00000485010};
GN   Name=CIITA {ECO:0000313|Ensembl:ENSP00000485010};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000485010, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000485010, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000485010}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC133065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459560; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001273331.1; NM_001286402.1.
DR   RefSeq; XP_011520794.1; XM_011522492.2.
DR   jPOST; A0A087X2I7; -.
DR   PeptideAtlas; A0A087X2I7; -.
DR   PRIDE; A0A087X2I7; -.
DR   Antibodypedia; 4234; 178 antibodies.
DR   Ensembl; ENST00000618327; ENSP00000485010; ENSG00000179583.
DR   GeneID; 4261; -.
DR   UCSC; uc002daj.4; human.
DR   CTD; 4261; -.
DR   EuPathDB; HostDB:ENSG00000179583.17; -.
DR   HGNC; HGNC:7067; CIITA.
DR   OpenTargets; ENSG00000179583; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   GeneTree; ENSGT00940000161578; -.
DR   HOGENOM; CLU_010691_1_0_1; -.
DR   OMA; ARGQLPQ; -.
DR   OrthoDB; 28098at2759; -.
DR   ChiTaRS; CIITA; human.
DR   GenomeRNAi; 4261; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000179583; Expressed in tendon and 145 other tissues.
DR   ExpressionAtlas; A0A087X2I7; baseline and differential.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0007568; P:aging; IEA:Ensembl.
DR   GO; GO:0071257; P:cellular response to electrical stimulus; IEA:Ensembl.
DR   GO; GO:0071360; P:cellular response to exogenous dsRNA; IEA:Ensembl.
DR   GO; GO:0071346; P:cellular response to interferon-gamma; IEA:Ensembl.
DR   GO; GO:0006954; P:inflammatory response; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   GO; GO:0045348; P:positive regulation of MHC class II biosynthetic process; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:Ensembl.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR041267; NLRC_HD2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   Pfam; PF05729; NACHT; 1.
DR   Pfam; PF17776; NLRC4_HD2; 1.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS01046498};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS01046498};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A087X2I7};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS01046485}.
FT   DOMAIN          415..725
FT                   /note="NACHT"
FT                   /evidence="ECO:0000259|PROSITE:PS50837"
FT   REGION          271..304
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        281..295
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1131 AA;  123529 MW;  75EF94F4CEC4AB3A CRC64;
     MRCLAPRPAG SYLSEPQGSS QCATMELGPL EGGYLELLNS DADPLCLYHF YDQMDLAGEE
     EIELYSEPDT DTINCDQFSR LLCDMEGDEE TREAYANIAE LDQYVFQDSQ LEGLSKDIFI
     EHIGPDEVIG ESMEMPAEVG QKSQKRPFPE ELPADLKHWK PAEPPTVVTG SLLVGPVSDC
     STLPCLPLPA LFNQEPASGQ MRLEKTDQIP MPFSSSSLSC LNLPEGPIQF VPTISTLPHG
     LWQISEAGTG VSSIFIYHGE VPQASQVPPP SGFTVHGLPT SPDRPGSTSP FAPSATDLPS
     MPEPALTSRA NMTEHKTSPT QCPAAGEVSN KLPKWPEPVE QFYRSLQDTY GAEPAGPDGI
     LVEVDLVQAR LERSSSKSLE RELATPDWAE RQLAQGGLAE VLLAAKEHRR PRETRVIAVL
     GKAGQGKSYW AGAVSRAWAC GRLPQYDFVF SVPCHCLNRP GDAYGLQDLL FSLGPQPLVA
     ADEVFSHILK RPDRVLLILD GFEELEAQDG FLHSTCGPAP AEPCSLRGLL AGLFQKKLLR
     GCTLLLTARP RGRLVQSLSK ADALFELSGF SMEQAQAYVM RYFESSGMTE HQDRALTLLR
     DRPLLLSHSH SPTLCRAVCQ LSEALLELGE DAKLPSTLTG LYVGLLGRAA LDSPPGALAE
     LAKLAWELGR RHQSTLQEDQ FPSADVRTWA MAKGLVQHPP RAAESELAFP SFLLQCFLGA
     LWLALSGEIK DKELPQYLAL TPRKKRPYDN WLEGVPRFLA GLIFQPPARC LGALLGPSAA
     ASVDRKQKVL ARYLKRLQPG TLRARQLLEL LHCAHEAEEA GIWQHVVQEL PGRLSFLGTR
     LTPPDAHVLG KALEAAGQDF SLDLRSTGIC PSGLGSLVGL SCVTRFRAAL SDTVALWESL
     QQHGETKLLQ AAEEKFTIEP FKAKSLKDVE DLGKLVQTQR TRSSSEDTAG ELPAVRDLKK
     LEFALGPVSG PQAFPKLVRI LTAFSSLQHL DLDALSENKI GDEGVSQLSA TFPQLKSLET
     LNLSQNNITD LGAYKLAEAL PSLAASLLRL SLYNNCICDV GAESLARVLP DMVSLRVMDV
     QYNKFTAAGA QQLAASLRRC PHVETLAMWT PTIPFSVQEH LQQQDSRISL R
//
ID   A0A0B4J1S1_HUMAN        Unreviewed;      1130 AA.
AC   A0A0B4J1S1;
DT   04-MAR-2015, integrated into UniProtKB/TrEMBL.
DT   04-MAR-2015, sequence version 1.
DT   22-APR-2020, entry version 43.
DE   SubName: Full=MHC class II transactivator {ECO:0000313|Ensembl:ENSP00000316328};
GN   Name=CIITA {ECO:0000313|Ensembl:ENSP00000316328};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000316328, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000316328, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [2] {ECO:0000313|Ensembl:ENSP00000316328}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JAN-2015) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC133065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF459560; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_000237.2; NM_000246.3.
DR   RefSeq; XP_011520795.1; XM_011522493.2.
DR   jPOST; A0A0B4J1S1; -.
DR   PRIDE; A0A0B4J1S1; -.
DR   Antibodypedia; 4234; 178 antibodies.
DR   Ensembl; ENST00000324288; ENSP00000316328; ENSG00000179583.
DR   GeneID; 4261; -.
DR   KEGG; hsa:4261; -.
DR   CTD; 4261; -.
DR   EuPathDB; HostDB:ENSG00000179583.17; -.
DR   HGNC; HGNC:7067; CIITA.
DR   OpenTargets; ENSG00000179583; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   GeneTree; ENSGT00940000161578; -.
DR   KO; K08060; -.
DR   OrthoDB; 28098at2759; -.
DR   PhylomeDB; A0A0B4J1S1; -.
DR   ChiTaRS; CIITA; human.
DR   GenomeRNAi; 4261; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   Bgee; ENSG00000179583; Expressed in tendon and 145 other tissues.
DR   ExpressionAtlas; A0A0B4J1S1; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR041267; NLRC_HD2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   Pfam; PF05729; NACHT; 1.
DR   Pfam; PF17776; NLRC4_HD2; 1.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   1: Evidence at protein level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS01046498};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS01046498};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A0B4J1S1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS01046485}.
FT   DOMAIN          414..724
FT                   /note="NACHT"
FT                   /evidence="ECO:0000259|PROSITE:PS50837"
FT   REGION          270..303
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        280..294
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1130 AA;  123415 MW;  D698094576546509 CRC64;
     MRCLAPRPAG SYLSEPQGSS QCATMELGPL EGGYLELLNS DADPLCLYHF YDQMDLAGEE
     EIELYSEPDT DTINCDQFSR LLCDMEGDEE TREAYANIAE LDQYVFQDSQ LEGLSKDIFK
     HIGPDEVIGE SMEMPAEVGQ KSQKRPFPEE LPADLKHWKP AEPPTVVTGS LLVGPVSDCS
     TLPCLPLPAL FNQEPASGQM RLEKTDQIPM PFSSSSLSCL NLPEGPIQFV PTISTLPHGL
     WQISEAGTGV SSIFIYHGEV PQASQVPPPS GFTVHGLPTS PDRPGSTSPF APSATDLPSM
     PEPALTSRAN MTEHKTSPTQ CPAAGEVSNK LPKWPEPVEQ FYRSLQDTYG AEPAGPDGIL
     VEVDLVQARL ERSSSKSLER ELATPDWAER QLAQGGLAEV LLAAKEHRRP RETRVIAVLG
     KAGQGKSYWA GAVSRAWACG RLPQYDFVFS VPCHCLNRPG DAYGLQDLLF SLGPQPLVAA
     DEVFSHILKR PDRVLLILDG FEELEAQDGF LHSTCGPAPA EPCSLRGLLA GLFQKKLLRG
     CTLLLTARPR GRLVQSLSKA DALFELSGFS MEQAQAYVMR YFESSGMTEH QDRALTLLRD
     RPLLLSHSHS PTLCRAVCQL SEALLELGED AKLPSTLTGL YVGLLGRAAL DSPPGALAEL
     AKLAWELGRR HQSTLQEDQF PSADVRTWAM AKGLVQHPPR AAESELAFPS FLLQCFLGAL
     WLALSGEIKD KELPQYLALT PRKKRPYDNW LEGVPRFLAG LIFQPPARCL GALLGPSAAA
     SVDRKQKVLA RYLKRLQPGT LRARQLLELL HCAHEAEEAG IWQHVVQELP GRLSFLGTRL
     TPPDAHVLGK ALEAAGQDFS LDLRSTGICP SGLGSLVGLS CVTRFRAALS DTVALWESLQ
     QHGETKLLQA AEEKFTIEPF KAKSLKDVED LGKLVQTQRT RSSSEDTAGE LPAVRDLKKL
     EFALGPVSGP QAFPKLVRIL TAFSSLQHLD LDALSENKIG DEGVSQLSAT FPQLKSLETL
     NLSQNNITDL GAYKLAEALP SLAASLLRLS LYNNCICDVG AESLARVLPD MVSLRVMDVQ
     YNKFTAAGAQ QLAASLRRCP HVETLAMWTP TIPFSVQEHL QQQDSRISLR
//
ID   C2TA_HUMAN              Reviewed;        1130 AA.
AC   P33076; A0N0N9; D3DUG0; E9PFE0; Q29675; Q8SNB8; Q96KL4;
DT   01-OCT-1993, integrated into UniProtKB/Swiss-Prot.
DT   11-JAN-2011, sequence version 3.
DT   22-APR-2020, entry version 192.
DE   RecName: Full=MHC class II transactivator;
DE            Short=CIITA;
DE            EC=2.3.1.-;
DE            EC=2.7.11.1;
GN   Name=CIITA; Synonyms=MHC2TA;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANTS BLS2 LYS-120 DEL ILE-GLU
RP   INS AND 940-THR--ALA-963 DEL, AND VARIANTS GLY-174; ALA-500 AND ARG-900.
RX   PubMed=8402893; DOI=10.1016/s0092-8674(05)80090-x;
RA   Steimle V., Otten L.A., Zufferey M., Mach B.;
RT   "Complementation cloning of an MHC class II transactivator mutated in
RT   hereditary MHC class II deficiency (or bare lymphocyte syndrome).";
RL   Cell 75:135-146(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), VARIANTS BLS2 LYS-120 DEL
RP   ILE-GLU INS; GLY-174; ALA-500 AND ARG-900, AND ALTERNATIVE SPLICING.
RX   PubMed=7749984; DOI=10.1016/1074-7613(95)90033-0;
RA   Riley J.L., Westerheide S.D., Price J.A., Brown J.A., Boss J.M.;
RT   "Activation of class II MHC genes requires both the X box region and the
RT   class II transactivator (CIITA).";
RL   Immunity 2:533-543(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), VARIANT ARG-900, AND ALTERNATIVE
RP   SPLICING.
RX   PubMed=12919287; DOI=10.1046/j.1365-2370.2003.00397.x;
RA   Quinn G., Bower R., Dos-Santos Cruz G., Giovino M., Xu Y., Patience C.,
RA   Schuurman H.J.;
RT   "Structural and functional characteristics of a dominant-negative isoform
RT   of porcine MHC class II transactivator.";
RL   Eur. J. Immunogenet. 30:259-270(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), VARIANTS GLY-174 AND ALA-500, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=12859996; DOI=10.1016/s0145-2126(03)00072-9;
RA   Day N.E., Ugai H., Yokoyama K.K., Ichiki A.T.;
RT   "K-562 cells lack MHC class II expression due to an alternatively spliced
RT   CIITA transcript with a truncated coding region.";
RL   Leuk. Res. 27:1027-1038(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLY-174 AND ARG-900.
RA   Livingston R.J., Shaffer T., McFarland I., Nguyen C.P., Stanaway I.B.,
RA   Rajkumar N., Johnson E.J., da Ponte S.H., Willa H., Ahearn M.O.,
RA   Bertucci C., Acklestad J., Carroll A., Swanson J., Gildersleeve H.I.,
RA   Nickerson D.A.;
RL   Submitted (OCT-2006) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   GTP-BINDING, AND MUTAGENESIS OF 420-GLY-LYS-421 AND ASP-561.
RX   PubMed=10464099; DOI=10.1126/science.285.5432.1402;
RA   Harton J.A., Cressman D.E., Chin K.C., Der C.J., Ting J.P.;
RT   "GTP binding by class II transactivator: role in nuclear import.";
RL   Science 285:1402-1405(1999).
RN   [9]
RP   FUNCTION AS ACETYLTRANSFERASE, GTP-BINDING, AND ACETYLTRANSFERASE REGION.
RX   PubMed=11172716; DOI=10.1016/s1097-2765(01)00159-9;
RA   Raval A., Howcroft T.K., Weissman J.D., Kirshner S., Zhu X.S., Yokoyama K.,
RA   Ting J., Singer D.S.;
RT   "Transcriptional coactivator, CIITA, is an acetyltransferase that bypasses
RT   a promoter requirement for TAF(II)250.";
RL   Mol. Cell 7:105-115(2001).
RN   [10]
RP   FUNCTION, AND INTERACTION WITH ZXDA AND ZXDC.
RX   PubMed=17493635; DOI=10.1016/j.jmb.2007.04.033;
RA   Al-Kandari W., Koneni R., Navalgund V., Aleksandrova A., Jambunathan S.,
RA   Fontes J.D.;
RT   "The zinc finger proteins ZXDA and ZXDC form a complex that binds CIITA and
RT   regulates MHC II gene transcription.";
RL   J. Mol. Biol. 369:1175-1187(2007).
RN   [11]
RP   FUNCTION, AND INTERACTION WITH ZXDC.
RX   PubMed=16600381; DOI=10.1016/j.molimm.2006.02.029;
RA   Al-Kandari W., Jambunathan S., Navalgund V., Koneni R., Freer M.,
RA   Parimi N., Mudhasani R., Fontes J.D.;
RT   "ZXDC, a novel zinc finger protein that binds CIITA and activates MHC gene
RT   transcription.";
RL   Mol. Immunol. 44:311-321(2007).
RN   [12]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH PML.
RX   PubMed=23007646; DOI=10.1083/jcb.201112015;
RA   Ulbricht T., Alzrigat M., Horch A., Reuter N., von Mikecz A., Steimle V.,
RA   Schmitt E., Kraemer O.H., Stamminger T., Hemmerich P.;
RT   "PML promotes MHC class II gene expression by stabilizing the class II
RT   transactivator.";
RL   J. Cell Biol. 199:49-63(2012).
RN   [13]
RP   FUNCTION AS KINASE, CATALYTIC ACTIVITY, AND AUTOPHOSPHORYLATION.
RX   PubMed=24036077; DOI=10.1016/j.bbagrm.2013.09.001;
RA   Soe K.C., Devaiah B.N., Singer D.S.;
RT   "Transcriptional coactivator CIITA, a functional homolog of TAF1, has
RT   kinase activity.";
RL   Biochim. Biophys. Acta 1829:1184-1190(2013).
RN   [14]
RP   VARIANT BLS2 GROUP A SER-962.
RX   PubMed=10501838; DOI=10.1007/s002510050579;
RA   Quan V., Towey M., Sacks S., Kelly A.P.;
RT   "Absence of MHC class II gene expression in a patient with a single amino
RT   acid substitution in the class II transactivator protein CIITA.";
RL   Immunogenetics 49:957-963(1999).
RN   [15]
RP   VARIANT BLS2 GROUP A PRO-469.
RX   PubMed=11466404; DOI=10.4049/jimmunol.167.3.1787;
RA   Wiszniewski W., Fondaneche M.-C., Le Deist F., Kanariou M., Selz F.,
RA   Brousse N., Steimle V., Barbieri G., Alcaide-Loridan C., Charron D.,
RA   Fischer A., Lisowska-Grospierre B.;
RT   "Mutation in the class II trans-activator leading to a mild
RT   immunodeficiency.";
RL   J. Immunol. 167:1787-1794(2001).
RN   [16]
RP   ERRATUM OF PUBMED:11466404.
RA   Wiszniewski W., Fondaneche M.-C., Le Deist F., Kanariou M., Selz F.,
RA   Brousse N., Steimle V., Barbieri G., Alcaide-Loridan C., Charron D.,
RA   Fischer A., Lisowska-Grospierre B.;
RL   J. Immunol. 169:607-607(2002).
RN   [17]
RP   VARIANTS BLS2 GROUP A 964-LEU--ASP-991 DEL AND ILE-1027 DEL.
RX   PubMed=11862382; DOI=10.1007/s00251-001-0395-7;
RA   Dziembowska M., Fondaneche M.-C., Vedrenne J., Barbieri G., Wiszniewski W.,
RA   Picard C., Cant A.J., Steimle V., Charron D., Alcaide-Loridan C.,
RA   Fischer A., Lisowska-Grospierre B.;
RT   "Three novel mutations of the CIITA gene in MHC class II-deficient patients
RT   with a severe immunodeficiency.";
RL   Immunogenetics 53:821-829(2002).
CC   -!- FUNCTION: Essential for transcriptional activity of the HLA class II
CC       promoter; activation is via the proximal promoter. No DNA binding of in
CC       vitro translated CIITA was detected. May act in a coactivator-like
CC       fashion through protein-protein interactions by contacting factors
CC       binding to the proximal MHC class II promoter, to elements of the
CC       transcription machinery, or both. Alternatively it may activate HLA
CC       class II transcription by modifying proteins that bind to the MHC class
CC       II promoter. Also mediates enhanced MHC class I transcription; the
CC       promoter element requirements for CIITA-mediated transcription are
CC       distinct from those of constitutive MHC class I transcription, and
CC       CIITA can functionally replace TAF1 at these genes. Exhibits intrinsic
CC       GTP-stimulated acetyltransferase activity. Exhibits serine/threonine
CC       protein kinase activity: can phosphorylate the TFIID component TAF7,
CC       the RAP74 subunit of the general transcription factor TFIIF, histone
CC       H2B at 'Ser-37' and other histones (in vitro).
CC       {ECO:0000269|PubMed:11172716, ECO:0000269|PubMed:16600381,
CC       ECO:0000269|PubMed:17493635, ECO:0000269|PubMed:24036077}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-seryl-[protein] = ADP + H(+) + O-phospho-L-seryl-
CC         [protein]; Xref=Rhea:RHEA:17989, Rhea:RHEA-COMP:9863, Rhea:RHEA-
CC         COMP:11604, ChEBI:CHEBI:15378, ChEBI:CHEBI:29999, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:83421, ChEBI:CHEBI:456216; EC=2.7.11.1;
CC         Evidence={ECO:0000269|PubMed:24036077};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + L-threonyl-[protein] = ADP + H(+) + O-phospho-L-
CC         threonyl-[protein]; Xref=Rhea:RHEA:46608, Rhea:RHEA-COMP:11060,
CC         Rhea:RHEA-COMP:11605, ChEBI:CHEBI:15378, ChEBI:CHEBI:30013,
CC         ChEBI:CHEBI:30616, ChEBI:CHEBI:61977, ChEBI:CHEBI:456216;
CC         EC=2.7.11.1; Evidence={ECO:0000269|PubMed:24036077};
CC   -!- SUBUNIT: Interacts with ZXDA and ZXDC. Interacts with PML (isoform PML-
CC       2). {ECO:0000269|PubMed:16600381, ECO:0000269|PubMed:17493635,
CC       ECO:0000269|PubMed:23007646}.
CC   -!- INTERACTION:
CC       P33076; Q96EB6: SIRT1; NbExp=4; IntAct=EBI-1538819, EBI-1802965;
CC       P33076; P98168: ZXDA; NbExp=4; IntAct=EBI-1538819, EBI-1538980;
CC       P33076; Q2QGD7: ZXDC; NbExp=6; IntAct=EBI-1538819, EBI-1538838;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:23007646}. Nucleus,
CC       PML body {ECO:0000269|PubMed:23007646}. Note=Recruited to PML body by
CC       PML.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=P33076-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P33076-2; Sequence=VSP_055099, VSP_055102, VSP_055103;
CC       Name=3; Synonyms=hCIITA';
CC         IsoId=P33076-3; Sequence=VSP_055099, VSP_055100, VSP_055101;
CC       Name=4;
CC         IsoId=P33076-4; Sequence=VSP_055102, VSP_055103;
CC   -!- DOMAIN: The acetyltransferase domain is necessary for activation of
CC       both class I and class II transcription.
CC   -!- DOMAIN: The GTP-binding motif doesn't confer GTPase activity but
CC       promotes nuclear localization.
CC   -!- PTM: Autophosphorylated, affecting interaction with TAF7.
CC   -!- DISEASE: Bare lymphocyte syndrome 2 (BLS2) [MIM:209920]: A severe
CC       combined immunodeficiency disease with early onset. It is characterized
CC       by a profound defect in constitutive and interferon-gamma induced MHC
CC       II expression, absence of cellular and humoral T-cell response to
CC       antigen challenge, hypogammaglobulinemia and impaired antibody
CC       production. The consequence include extreme susceptibility to viral,
CC       bacterial and fungal infections. {ECO:0000269|PubMed:10501838,
CC       ECO:0000269|PubMed:11466404, ECO:0000269|PubMed:11862382,
CC       ECO:0000269|PubMed:7749984, ECO:0000269|PubMed:8402893}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- MISCELLANEOUS: [Isoform 3]: Exhibits dominant-negative suppression of
CC       MHC class II gene expression. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=CIITAbase; Note=CIITA mutation db;
CC       URL="http://structure.bmc.lu.se/idbase/CIITAbase/";
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MHC2TAID260.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X74301; CAA52354.1; -; mRNA.
DR   EMBL; U18259; AAA88861.1; -; mRNA.
DR   EMBL; U18288; AAA88862.1; -; mRNA.
DR   EMBL; AY084054; AAM15723.1; -; mRNA.
DR   EMBL; AF410154; AAL04118.1; -; mRNA.
DR   EMBL; EF064747; ABK41930.1; -; Genomic_DNA.
DR   EMBL; AC133065; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85169.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85172.1; -; Genomic_DNA.
DR   EMBL; CH471112; EAW85173.1; -; Genomic_DNA.
DR   CCDS; CCDS10544.1; -. [P33076-1]
DR   CCDS; CCDS66943.1; -. [P33076-3]
DR   PIR; A48843; A48843.
DR   RefSeq; NP_000237.2; NM_000246.3.
DR   RefSeq; NP_001273332.1; NM_001286403.1. [P33076-3]
DR   BioGrid; 110416; 28.
DR   ELM; P33076; -.
DR   IntAct; P33076; 3.
DR   STRING; 9606.ENSP00000485010; -.
DR   iPTMnet; P33076; -.
DR   PhosphoSitePlus; P33076; -.
DR   BioMuta; CIITA; -.
DR   DMDM; 317373472; -.
DR   jPOST; P33076; -.
DR   MassIVE; P33076; -.
DR   MaxQB; P33076; -.
DR   PaxDb; P33076; -.
DR   PeptideAtlas; P33076; -.
DR   PRIDE; P33076; -.
DR   ProteomicsDB; 20081; -.
DR   ProteomicsDB; 54897; -. [P33076-1]
DR   Antibodypedia; 4234; 178 antibodies.
DR   DNASU; 4261; -.
DR   Ensembl; ENST00000381835; ENSP00000371257; ENSG00000179583. [P33076-3]
DR   GeneID; 4261; -.
DR   KEGG; hsa:4261; -.
DR   UCSC; uc002dak.5; human. [P33076-1]
DR   CTD; 4261; -.
DR   DisGeNET; 4261; -.
DR   GeneCards; CIITA; -.
DR   HGNC; HGNC:7067; CIITA.
DR   HPA; ENSG00000179583; Tissue enhanced (lymphoid).
DR   MalaCards; CIITA; -.
DR   MIM; 209920; phenotype.
DR   MIM; 600005; gene.
DR   neXtProt; NX_P33076; -.
DR   OpenTargets; ENSG00000179583; -.
DR   Orphanet; 572; Immunodeficiency by defective expression of MHC class II.
DR   PharmGKB; PA30795; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   GeneTree; ENSGT00940000161578; -.
DR   HOGENOM; CLU_498699_0_0_1; -.
DR   InParanoid; P33076; -.
DR   KO; K08060; -.
DR   OrthoDB; 28098at2759; -.
DR   PhylomeDB; P33076; -.
DR   TreeFam; TF352118; -.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   SIGNOR; P33076; -.
DR   ChiTaRS; CIITA; human.
DR   GeneWiki; CIITA; -.
DR   GenomeRNAi; 4261; -.
DR   Pharos; P33076; Tbio.
DR   PRO; PR:P33076; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P33076; protein.
DR   Bgee; ENSG00000179583; Expressed in tendon and 145 other tissues.
DR   ExpressionAtlas; P33076; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0016301; F:kinase activity; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IPI:UniProtKB.
DR   GO; GO:0044877; F:protein-containing complex binding; IDA:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IEA:UniProtKB-KW.
DR   GO; GO:0006955; P:immune response; TAS:ProtInc.
DR   GO; GO:0006954; P:inflammatory response; IBA:GO_Central.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IC:BHF-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IMP:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0045345; P:positive regulation of MHC class I biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0045348; P:positive regulation of MHC class II biosynthetic process; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0046677; P:response to antibiotic; IDA:MGI.
DR   GO; GO:0034341; P:response to interferon-gamma; IDA:BHF-UCL.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR041267; NLRC_HD2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   Pfam; PF05729; NACHT; 1.
DR   Pfam; PF17776; NLRC4_HD2; 1.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   1: Evidence at protein level;
KW   Activator; Acyltransferase; Alternative splicing; ATP-binding;
KW   Disease mutation; GTP-binding; Kinase; Leucine-rich repeat;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; SCID; Transcription; Transcription regulation;
KW   Transferase.
FT   CHAIN           1..1130
FT                   /note="MHC class II transactivator"
FT                   /id="PRO_0000089241"
FT   DOMAIN          414..724
FT                   /note="NACHT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00136"
FT   REPEAT          985..1008
FT                   /note="LRR 1"
FT   REPEAT          1016..1037
FT                   /note="LRR 2"
FT   REPEAT          1045..1066
FT                   /note="LRR 3"
FT   REPEAT          1073..1093
FT                   /note="LRR 4"
FT   NP_BIND         420..427
FT                   /note="GTP"
FT   REGION          94..132
FT                   /note="Required for acetyltransferase activity"
FT   COMPBIAS        52..137
FT                   /note="Asp/Glu-rich (acidic)"
FT   VAR_SEQ         161..210
FT                   /note="AEPPTVVTGSLLVRPVSDCSTLPCLPLPALFNQEPASGQMRLEKTDQIPM
FT                   -> V (in isoform 2 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12919287,
FT                   ECO:0000303|PubMed:7749984"
FT                   /id="VSP_055099"
FT   VAR_SEQ         336..350
FT                   /note="EPVEQFYRSLQDTYG -> GLAWSPCLGLRPSLH (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12919287"
FT                   /id="VSP_055100"
FT   VAR_SEQ         351..885
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12919287"
FT                   /id="VSP_055101"
FT   VAR_SEQ         887..930
FT                   /note="AALSDTVALWESLQQHGETKLLQAAEEKFTIEPFKAKSLKDVED -> WGEG
FT                   LGRDILVLGINCGLGAKPSALWGPFSMQSSRVGQNGFSPF (in isoform 2 and
FT                   isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:12859996,
FT                   ECO:0000303|PubMed:7749984"
FT                   /id="VSP_055102"
FT   VAR_SEQ         931..1128
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:12859996,
FT                   ECO:0000303|PubMed:7749984"
FT                   /id="VSP_055103"
FT   VARIANT         45
FT                   /note="L -> V (in dbSNP:rs2229317)"
FT                   /id="VAR_029270"
FT   VARIANT         120
FT                   /note="K -> IE (in BLS2)"
FT                   /id="VAR_005127"
FT   VARIANT         174
FT                   /note="R -> G (in dbSNP:rs8046121)"
FT                   /evidence="ECO:0000269|PubMed:12859996,
FT                   ECO:0000269|PubMed:7749984, ECO:0000269|PubMed:8402893,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_047907"
FT   VARIANT         469
FT                   /note="L -> P (in BLS2; mild immunodeficiency; has residual
FT                   MHC class II trans activation activity)"
FT                   /evidence="ECO:0000269|PubMed:11466404"
FT                   /id="VAR_015551"
FT   VARIANT         500
FT                   /note="G -> A (in dbSNP:rs4774)"
FT                   /evidence="ECO:0000269|PubMed:12859996,
FT                   ECO:0000269|PubMed:7749984, ECO:0000269|PubMed:8402893"
FT                   /id="VAR_005128"
FT   VARIANT         658
FT                   /note="A -> G (in dbSNP:rs2229319)"
FT                   /id="VAR_015552"
FT   VARIANT         781
FT                   /note="S -> L (in dbSNP:rs13330686)"
FT                   /id="VAR_060104"
FT   VARIANT         782
FT                   /note="V -> A (in dbSNP:rs13336804)"
FT                   /id="VAR_057711"
FT   VARIANT         900
FT                   /note="Q -> R (in dbSNP:rs7197779)"
FT                   /evidence="ECO:0000269|PubMed:12919287,
FT                   ECO:0000269|PubMed:7749984, ECO:0000269|PubMed:8402893,
FT                   ECO:0000269|Ref.5"
FT                   /id="VAR_047908"
FT   VARIANT         940..963
FT                   /note="Missing (in BLS2)"
FT                   /evidence="ECO:0000269|PubMed:8402893"
FT                   /id="VAR_005129"
FT   VARIANT         962
FT                   /note="F -> S (in BLS2)"
FT                   /evidence="ECO:0000269|PubMed:10501838"
FT                   /id="VAR_015553"
FT   VARIANT         964..991
FT                   /note="Missing (in BLS2)"
FT                   /id="VAR_015554"
FT   VARIANT         1027
FT                   /note="Missing (in BLS2)"
FT                   /evidence="ECO:0000269|PubMed:11862382"
FT                   /id="VAR_015555"
FT   MUTAGEN         420..421
FT                   /note="Missing: Strongly reduces GTP-binding and abolishes
FT                   transactivation at MHC promoters."
FT                   /evidence="ECO:0000269|PubMed:10464099"
FT   MUTAGEN         561
FT                   /note="D->A: Strongly reduces GTP-binding and abolishes
FT                   transactivation at MHC promoters."
FT                   /evidence="ECO:0000269|PubMed:10464099"
FT   CONFLICT        1020..1021
FT                   /note="LN -> RS (in Ref. 4; ABK41930)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1130 AA;  123514 MW;  7A61CAA4F3FFECE0 CRC64;
     MRCLAPRPAG SYLSEPQGSS QCATMELGPL EGGYLELLNS DADPLCLYHF YDQMDLAGEE
     EIELYSEPDT DTINCDQFSR LLCDMEGDEE TREAYANIAE LDQYVFQDSQ LEGLSKDIFK
     HIGPDEVIGE SMEMPAEVGQ KSQKRPFPEE LPADLKHWKP AEPPTVVTGS LLVRPVSDCS
     TLPCLPLPAL FNQEPASGQM RLEKTDQIPM PFSSSSLSCL NLPEGPIQFV PTISTLPHGL
     WQISEAGTGV SSIFIYHGEV PQASQVPPPS GFTVHGLPTS PDRPGSTSPF APSATDLPSM
     PEPALTSRAN MTEHKTSPTQ CPAAGEVSNK LPKWPEPVEQ FYRSLQDTYG AEPAGPDGIL
     VEVDLVQARL ERSSSKSLER ELATPDWAER QLAQGGLAEV LLAAKEHRRP RETRVIAVLG
     KAGQGKSYWA GAVSRAWACG RLPQYDFVFS VPCHCLNRPG DAYGLQDLLF SLGPQPLVAA
     DEVFSHILKR PDRVLLILDG FEELEAQDGF LHSTCGPAPA EPCSLRGLLA GLFQKKLLRG
     CTLLLTARPR GRLVQSLSKA DALFELSGFS MEQAQAYVMR YFESSGMTEH QDRALTLLRD
     RPLLLSHSHS PTLCRAVCQL SEALLELGED AKLPSTLTGL YVGLLGRAAL DSPPGALAEL
     AKLAWELGRR HQSTLQEDQF PSADVRTWAM AKGLVQHPPR AAESELAFPS FLLQCFLGAL
     WLALSGEIKD KELPQYLALT PRKKRPYDNW LEGVPRFLAG LIFQPPARCL GALLGPSAAA
     SVDRKQKVLA RYLKRLQPGT LRARQLLELL HCAHEAEEAG IWQHVVQELP GRLSFLGTRL
     TPPDAHVLGK ALEAAGQDFS LDLRSTGICP SGLGSLVGLS CVTRFRAALS DTVALWESLQ
     QHGETKLLQA AEEKFTIEPF KAKSLKDVED LGKLVQTQRT RSSSEDTAGE LPAVRDLKKL
     EFALGPVSGP QAFPKLVRIL TAFSSLQHLD LDALSENKIG DEGVSQLSAT FPQLKSLETL
     NLSQNNITDL GAYKLAEALP SLAASLLRLS LYNNCICDVG AESLARVLPD MVSLRVMDVQ
     YNKFTAAGAQ QLAASLRRCP HVETLAMWTP TIPFSVQEHL QQQDSRISLR
//
ID   Q66X48_HUMAN            Unreviewed;      1107 AA.
AC   Q66X48;
DT   11-OCT-2004, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2004, sequence version 1.
DT   26-FEB-2020, entry version 95.
DE   SubName: Full=CIITA IV {ECO:0000313|EMBL:AAU06586.1};
GN   Name=MHC2TA {ECO:0000313|EMBL:AAU06586.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAU06586.1};
RN   [1] {ECO:0000313|EMBL:AAU06586.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Jiang Y., Chou K., Song L., Gong W., Zhou Y., Wang B., Xin L., Lu L.,
RA   Ding Q., Jiao Z.;
RT   "CIITA IV from THP1 cell line.";
RL   Submitted (JUL-2004) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY699071; AAU06586.1; -; mRNA.
DR   RefSeq; NP_000237.2; NM_000246.3.
DR   PRIDE; Q66X48; -.
DR   DNASU; 4261; -.
DR   GeneID; 4261; -.
DR   KEGG; hsa:4261; -.
DR   CTD; 4261; -.
DR   PharmGKB; PA30795; -.
DR   eggNOG; KOG4308; Eukaryota.
DR   eggNOG; ENOG410ZBX3; LUCA.
DR   KO; K08060; -.
DR   OrthoDB; 28098at2759; -.
DR   ChiTaRS; CIITA; human.
DR   GenomeRNAi; 4261; -.
DR   Genevisible; Q66X48; HS.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   InterPro; IPR008095; MHC_II_transact.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR041267; NLRC_HD2.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   Pfam; PF13516; LRR_6; 3.
DR   Pfam; PF05729; NACHT; 1.
DR   Pfam; PF17776; NLRC4_HD2; 1.
DR   PRINTS; PR01719; MHCIIACTVATR.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS51450; LRR; 4.
DR   PROSITE; PS50837; NACHT; 1.
PE   2: Evidence at transcript level;
KW   ATP-binding {ECO:0000256|SAAS:SAAS01046498};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS01046498};
KW   Repeat {ECO:0000256|SAAS:SAAS01046485}.
FT   DOMAIN          391..701
FT                   /note="NACHT"
FT                   /evidence="ECO:0000259|PROSITE:PS50837"
FT   REGION          248..279
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        257..271
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1107 AA;  120936 MW;  16A1103F13FC3663 CRC64;
     MELGPLEGGY LEPLNSDADP LCLYHFYDQM DLAGEEEIEL YSEPDTDTIN CDQFSRLLCD
     MEGDEETREA YANIAELDQY VFQDSQLEGL SKDIFIEHIG PDEVIGESME MPAEVGQKSQ
     KRPFPEELPA DLKHWKPAEP PTVVAGSLLV GPVSDCSTLS CLPLPALFNQ EPASGQMRLE
     KTDQIPMPFS SSSLSCLNLP EGPIQFVPTI STLPHGLWQI SEAGTGVSSI FIYHGEVPQA
     SQVPPPSGFT VHGLPTSPDR PGSTSPFAPS ATDLPSMPEP ALTSRANMTE HKTSPTQCPA
     AGEVSNKLPK WPEPVEQFYR SLQDTYGAEP AGPDGILVEV DLVQARLERS SSKGLERELA
     TPDWAERQLA QGGLAEVLLA AKEHRRPRET RVIAVLGKAG QGKSYWAGAV SRAWACGRLP
     QYDFVFSVPC HCLNRPGDAY GLQDLLFSLG PQPLVAADEV FSHILKRPDR VLLILDGFEE
     LEAQDGFLHS TCGPAPAEPC SLRGLLAGLF QKKLLRGCTL LLTARPRGRL VQSLSKADAL
     FELSGFSMEQ AQAYVMRYFE SSGMTEHQDR ALTLLRDRPL LLSHSHSPTL CRAVCQLSEA
     LLELGEDAKL PSTLTGLYVG LLGRAALGSP PGALAELAKL AWELGRRHQS TLQEDQFPSA
     DVRTWAMAKG LVQHPPRAAE SELAFPSFLL QCFLGALWLA LSGEIKDKEL PQYLALTPRK
     KRPYDNWLEG VPRFLAGLIF QPPARCLGAL LGPSAAASVD RKQKVLARYL KRLQPGTLRA
     RQLLELLHCA HEAEEAGIWQ HVVQELPGRL SFLGTRLTPL DAHVLGKALE AAGQDFSLDL
     RSTGICPSGL GSLVGLSCVT RFRAALSDTV ALWESLRQHG ETKLLQAAEE KFTIEPFKAK
     SLKDVEDLGK LVQTQRTRSS SEDTAGELPA VRDLKKLEFA LGPVSGPQAF PKLVRILTAF
     SSLQHLDLDA LSENKIGDEG VSQLSATFPQ LKSLETLNLS QNNITDLGAY KLAEALPSLA
     ASLLRLSLYN NCICDVGAES LARVLPDMVS LRVMDVQYNK FTAAGAQQLA ASLRRCPHVE
     TLAMWTPTIP FSVQEHLQQQ DSRISLR
//
ID   A0A087WVQ6_HUMAN        Unreviewed;      1679 AA.
AC   A0A087WVQ6;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 55.
DE   RecName: Full=Clathrin heavy chain {ECO:0000256|PIRNR:PIRNR002290};
GN   Name=CLTC {ECO:0000313|EMBL:EAW94397.1,
GN   ECO:0000313|Ensembl:ENSP00000479606};
GN   ORFNames=hCG_1818599 {ECO:0000313|EMBL:EAW94397.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000479606, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:EAW94397.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW94397.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000479606, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [4] {ECO:0000213|PubMed:18691976}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [5] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [6] {ECO:0000213|PubMed:19369195}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [7] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [8] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [9] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11] {ECO:0000213|PubMed:22223895}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.M111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [12] {ECO:0000213|PubMed:22814378}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [13] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [15] {ECO:0000313|Ensembl:ENSP00000479606}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [16] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. {ECO:0000256|PIRNR:PIRNR002290}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000256|PIRNR:PIRNR002290}; Peripheral membrane protein
CC       {ECO:0000256|PIRNR:PIRNR002290}; Cytoplasmic side
CC       {ECO:0000256|PIRNR:PIRNR002290}. Membrane, coated pit
CC       {ECO:0000256|PIRNR:PIRNR002290}; Peripheral membrane protein
CC       {ECO:0000256|PIRNR:PIRNR002290}; Cytoplasmic side
CC       {ECO:0000256|PIRNR:PIRNR002290}.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family.
CC       {ECO:0000256|PIRNR:PIRNR002290}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC091271; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471109; EAW94397.1; -; Genomic_DNA.
DR   RefSeq; NP_001275582.1; NM_001288653.1.
DR   IntAct; A0A087WVQ6; 1.
DR   Antibodypedia; 4164; 478 antibodies.
DR   Ensembl; ENST00000621829; ENSP00000479606; ENSG00000141367.
DR   GeneID; 1213; -.
DR   UCSC; uc002ixr.1; human.
DR   CTD; 1213; -.
DR   EuPathDB; HostDB:ENSG00000141367.11; -.
DR   HGNC; HGNC:2092; CLTC.
DR   OpenTargets; ENSG00000141367; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   eggNOG; ENOG410XPH1; LUCA.
DR   GeneTree; ENSGT00950000183166; -.
DR   OMA; NLMSAPQ; -.
DR   OrthoDB; 17940at2759; -.
DR   ChiTaRS; CLTC; human.
DR   GenomeRNAi; 1213; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   Bgee; ENSG00000141367; Expressed in dorsolateral prefrontal cortex and 239 other tissues.
DR   GO; GO:0030132; C:clathrin coat of coated pit; IEA:InterPro.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IEA:InterPro.
DR   GO; GO:0005768; C:endosome; IDA:HPA.
DR   GO; GO:0005764; C:lysosome; IDA:HPA.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:0098684; C:photoreceptor ribbon synapse; IEA:Ensembl.
DR   GO; GO:0098835; C:presynaptic endocytic zone membrane; IEA:Ensembl.
DR   GO; GO:0032051; F:clathrin light chain binding; IEA:InterPro.
DR   GO; GO:0019901; F:protein kinase binding; IEA:Ensembl.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:UniProtKB-UniRule.
DR   GO; GO:0016192; P:vesicle-mediated transport; IEA:InterPro.
DR   Gene3D; 1.25.40.10; -; 4.
DR   Gene3D; 2.130.10.110; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR016025; Clathrin_H-chain_N.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF01394; Clathrin_propel; 5.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; SSF48371; 6.
DR   SUPFAM; SSF50989; SSF50989; 1.
DR   PROSITE; PS50236; CHCR; 7.
PE   1: Evidence at protein level;
KW   Coated pit {ECO:0000256|PIRNR:PIRNR002290};
KW   Cytoplasmic vesicle {ECO:0000256|PIRNR:PIRNR002290};
KW   Membrane {ECO:0000256|PIRNR:PIRNR002290};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WVQ6,
KW   ECO:0000213|MaxQB:A0A087WVQ6, ECO:0000213|PeptideAtlas:A0A087WVQ6,
KW   ECO:0000213|ProteomicsDB:A0A087WVQ6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          335..358
FT                   /note="Clathrin-link"
FT                   /evidence="ECO:0000259|Pfam:PF09268"
FT   REPEAT          541..687
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
FT   REPEAT          690..832
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
FT   REPEAT          837..976
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
FT   REPEAT          983..1128
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
FT   REPEAT          1132..1273
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
FT   REPEAT          1278..1424
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
FT   REPEAT          1427..1570
FT                   /note="CHCR"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01006"
SQ   SEQUENCE   1679 AA;  192058 MW;  9E4E36D1E25FB0DA CRC64;
     MAQILPIRFQ EHLQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV VIIDMNDPSN
     PIRRPISADS AIMNPASKVI ALKGIKESGK TLQIFNIEMK SKMKAHTMTD DVTFWKWISL
     NTVALVTDNA VYHWSMEGES QPVKMFDRHS SLAGCQIINY RTDAKQKWLL LTGISAQQNR
     VVGAMQLYSV DRKVSQPIEG HAASFAQFKM EGNAEESTLF CFAVRGQAGG KLHIIEVGTP
     PTGNQPFPKK AVDVFFPPEA QNDFPVAMQI SEKHDVVFLI TKYGYIHLYD LETGTCIYMN
     RISGETIFVT APHEATAGII GVNRKGQVLS VCVEEENIIP YITNVLQNPD LALRMAVRNN
     LAGAEELFAR KFNALFAQGN YSEAAKVAAN APKGILRTPD TIRRFQSVPA QPGQTSPLLQ
     YFGILLDQGQ LNKYESLELC RPVLQQGRKQ LLEKWLKEDK LECSEELGDL VKSVDPTLAL
     SVYLRANVPN KVIQCFAETG QVQKIVLYAK KVGYTPDWIF LLRNVMRISP DQGQQFAQML
     VQDEEPLADI TQIVDVFMEY NLIQQCTAFL LDALKNNRPS EGPLQTRLLE MNLMHAPQVA
     DAILGNQMFT HYDRAHIAQL CEKAGLLQRA LEHFTDLYDI KRAVVHTHLL NPEWLVNYFG
     SLSVEDSLEC LRAMLSANIR QNLQICVQVA SKYHEQLSTQ SLIELFESFK SFEGLFYFLG
     SIVNFSQDPD VHFKYIQAAC KTGQIKEVER ICRESNCYDP ERVKNFLKEA KLTDQLPLII
     VCDRFDFVHD LVLYLYRNNL QKYIEIYVQK VNPSRLPVVI GGLLDVDCSE DVIKNLILVV
     RGQFSTDELV AEVEKRNRLK LLLPWLEARI HEGCEEPATH NALAKIYIDS NNNPERFLRE
     NPYYDSRVVG KYCEKRDPHL ACVAYERGQC DLELINVCNE NSLFKSLSRY LVRRKDPELW
     GSVLLESNPY RRPLIDQVVQ TALSETQDPE EVSVTVKAFM TADLPNELIE LLEKIVLDNS
     VFSEHRNLQN LLILTAIKAD RTRVMEYINR LDNYDAPDIA NIAISNELFE EAFAIFRKFD
     VNTSAVQVLI EHIGNLDRAY EFAERCNEPA VWSQLAKAQL QKGMVKEAID SYIKADDPSS
     YMEVVQAANT SGNWEELVKY LQMARKKARE SYVETELIFA LAKTNRLAEL EEFINGPNNA
     HIQQVGDRCY DEKMYDAAKL LYNNVSNFGR LASTLVHLGE YQAAVDGARK ANSTRTWKEV
     CFACVDGKEF RLAQMCGLHI VVHADELEEL INYYQDRGYF EELITMLEAA LGLERAHMGM
     FTELAILYSK FKPQKMREHL ELFWSRVNIP KVLRAAEQAH LWAELVFLYD KYEEYDNAII
     TMMNHPTDAW KEGQFKDIIT KVANVELYYR AIQFYLEFKP LLLNDLLMVL SPRLDHTRAV
     NYFSKVKQLP LVKPYLRSVQ NHNNKSVNES LNNLFITEED YQALRTSIDA YDNFDNISLA
     QRLEKHELIE FRRIAAYLFK GNNRWKQSVE LCKKDSLYKD AMQYASESKD TELAEELLQW
     FLQEEKRECF GACLFTCYDL LRPDVVLETA WRHNIMDFAM PYFIQVMKEY LTKVDKLDAS
     ESLRKEEEQA TETQPIVYGQ PQLMLTAGPS VAVPPQAPFG YGYTAPPYGQ PQPGFGYSM
//
ID   CLH1_HUMAN              Reviewed;        1675 AA.
AC   Q00610; D3DU00; Q6N0A0; Q86TF2;
DT   01-DEC-1992, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 5.
DT   22-APR-2020, entry version 209.
DE   RecName: Full=Clathrin heavy chain 1 {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083};
DE   AltName: Full=Clathrin heavy chain on chromosome 17;
DE            Short=CLH-17;
GN   Name=CLTC {ECO:0000303|PubMed:26822784, ECO:0000303|PubMed:29100083,
GN   ECO:0000312|HGNC:HGNC:2092}; Synonyms=CLH17, CLTCL2, KIAA0034;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7584026; DOI=10.1093/dnares/1.1.27;
RA   Nomura N., Miyajima N., Sazuka T., Tanaka A., Kawarabayasi Y., Sato S.,
RA   Nagase T., Seki N., Ishikawa K., Tabata S.;
RT   "Prediction of the coding sequences of unidentified human genes. I. The
RT   coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of
RT   randomly sampled cDNA clones from human immature myeloid cell line KG-1.";
RL   DNA Res. 1:27-35(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Fetal kidney;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=PNS, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 560-864 (ISOFORMS 1/2).
RC   TISSUE=Colon;
RX   PubMed=1765375; DOI=10.1016/0888-7543(91)90115-u;
RA   Dodge G.R., Kovalszky I., McBride O.W., Yi H.F., Chu M.-L., Saitta B.,
RA   Stokes D.G., Iozzo R.V.;
RT   "Human clathrin heavy chain (CLTC): partial molecular cloning, expression,
RT   and mapping of the gene to human chromosome 17q11-qter.";
RL   Genomics 11:174-178(1991).
RN   [6]
RP   PROTEIN SEQUENCE OF 2-8.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [7]
RP   PROTEIN SEQUENCE OF 2-8; 64-78; 87-96; 164-205; 228-245; 270-278; 298-320;
RP   355-382; 469-481; 507-519; 572-610; 626-638; 799-806; 831-852; 855-865;
RP   882-903; 1011-1037; 1074-1101; 1123-1130; 1166-1179; 1183-1204; 1216-1245;
RP   1312-1326; 1398-1406; 1435-1453; 1482-1498; 1502-1508; 1510-1516 AND
RP   1610-1620, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma, Hepatoma, and Mammary carcinoma;
RA   Bienvenut W.V., Calvo F., Matallanas D., Cooper W.N., Boldt K.,
RA   von Kriegsheim A.F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [8]
RP   INTERACTION WITH HIP1.
RX   PubMed=11532990; DOI=10.1093/hmg/10.17.1807;
RA   Waelter S., Scherzinger E., Hasenbank R., Nordhoff E., Lurz R., Goehler H.,
RA   Gauss C., Sathasivam K., Bates G.P., Lehrach H., Wanker E.E.;
RT   "The huntingtin interacting protein HIP1 is a clathrin and alpha-adaptin-
RT   binding protein involved in receptor-mediated endocytosis.";
RL   Hum. Mol. Genet. 10:1807-1817(2001).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [10]
RP   INTERACTION WITH ERBB2.
RX   PubMed=16314522; DOI=10.1128/mcb.25.24.11005-11018.2005;
RA   Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G.,
RA   Wang S.C., Hung M.C.;
RT   "Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell
RT   surface receptor.";
RL   Mol. Cell. Biol. 25:11005-11018(2005).
RN   [11]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15858577; DOI=10.1038/nature03502;
RA   Royle S.J., Bright N.A., Lagnado L.;
RT   "Clathrin is required for the function of the mitotic spindle.";
RL   Nature 434:1152-1157(2005).
RN   [12]
RP   FUNCTION, SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=16968737; DOI=10.1242/jcs.03192;
RA   Royle S.J., Lagnado L.;
RT   "Trimerisation is important for the function of clathrin at the mitotic
RT   spindle.";
RL   J. Cell Sci. 119:4071-4078(2006).
RN   [13]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [14]
RP   INTERACTION WITH FKBP6.
RX   PubMed=18529014; DOI=10.1021/bi8001506;
RA   Jarczowski F., Fischer G., Edlich F.;
RT   "FKBP36 forms complexes with clathrin and Hsp72 in spermatocytes.";
RL   Biochemistry 47:6946-6952(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1494, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-634 AND TYR-1477, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [19]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-856; LYS-1441 AND LYS-1501, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH ATG16L1.
RX   PubMed=20639872; DOI=10.1038/ncb2078;
RA   Ravikumar B., Moreau K., Jahreiss L., Puri C., Rubinsztein D.C.;
RT   "Plasma membrane contributes to the formation of pre-autophagosomal
RT   structures.";
RL   Nat. Cell Biol. 12:747-757(2010).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [23]
RP   SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=21297582; DOI=10.1038/emboj.2011.15;
RA   Booth D.G., Hood F.E., Prior I.A., Royle S.J.;
RT   "A TACC3/ch-TOG/clathrin complex stabilises kinetochore fibres by inter-
RT   microtubule bridging.";
RL   EMBO J. 30:906-919(2011).
RN   [24]
RP   INTERACTION WITH RFTN1.
RX   PubMed=21266579; DOI=10.1074/jbc.m110.185793;
RA   Watanabe A., Tatematsu M., Saeki K., Shibata S., Shime H., Yoshimura A.,
RA   Obuse C., Seya T., Matsumoto M.;
RT   "Raftlin is involved in the nucleocapture complex to induce poly(I:C)-
RT   mediated TLR3 activation.";
RL   J. Biol. Chem. 286:10702-10711(2011).
RN   [25]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [27]
RP   INTERACTION WITH TACC3, SUBCELLULAR LOCATION, AND MUTAGENESIS OF PRO-65;
RP   SER-67; THR-87; GLN-89; LYS-96; LYS-98 AND 480-LYS--VAL-484.
RX   PubMed=23918938; DOI=10.1083/jcb.201211127;
RA   Hood F.E., Williams S.J., Burgess S.G., Richards M.W., Roth D., Straube A.,
RA   Pfuhl M., Bayliss R., Royle S.J.;
RT   "Coordination of adjacent domains mediates TACC3-ch-TOG-clathrin assembly
RT   and mitotic spindle binding.";
RL   J. Cell Biol. 202:463-478(2013).
RN   [28]
RP   FUNCTION OF THE TACC3/CH-TOG/CLATHRIN COMPLEX.
RX   PubMed=23532825; DOI=10.1242/jcs.124834;
RA   Cheeseman L.P., Harry E.F., McAinsh A.D., Prior I.A., Royle S.J.;
RT   "Specific removal of TACC3-ch-TOG-clathrin at metaphase deregulates
RT   kinetochore fiber tension.";
RL   J. Cell Sci. 126:2102-2113(2013).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-67; THR-394; SER-1229 AND
RP   SER-1494, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-394 AND SER-1494, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [31]
RP   SUBCELLULAR LOCATION.
RX   PubMed=25596274; DOI=10.1242/bio.201410843;
RA   Gutierrez-Caballero C., Burgess S.G., Bayliss R., Royle S.J.;
RT   "TACC3-ch-TOG track the growing tips of microtubules independently of
RT   clathrin and Aurora-A phosphorylation.";
RL   Biol. Open 4:170-179(2015).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [33]
RP   INTERACTION WITH RFTN1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=27022195; DOI=10.4049/jimmunol.1501734;
RA   Tatematsu M., Yoshida R., Morioka Y., Ishii N., Funami K., Watanabe A.,
RA   Saeki K., Seya T., Matsumoto M.;
RT   "Raftlin controls lipopolysaccharide-induced TLR4 internalization and
RT   TICAM-1 signaling in a cell type-specific manner.";
RL   J. Immunol. 196:3865-3876(2016).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (1.69 ANGSTROMS) OF 1-364 IN COMPLEX WITH INHIBITORS,
RP   AND WD40-LIKE REPEATS.
RX   PubMed=21816279; DOI=10.1016/j.cell.2011.06.025;
RA   von Kleist L., Stahlschmidt W., Bulut H., Gromova K., Puchkov D.,
RA   Robertson M.J., MacGregor K.A., Tomilin N., Pechstein A., Chau N.,
RA   Chircop M., Sakoff J., von Kries J.P., Saenger W., Krausslich H.G.,
RA   Shupliakov O., Robinson P.J., McCluskey A., Haucke V.;
RT   "Role of the clathrin terminal domain in regulating coated pit dynamics
RT   revealed by small molecule inhibition.";
RL   Cell 146:471-484(2011).
RN   [35]
RP   INTERACTION WITH USP2.
RX   PubMed=26756164; DOI=10.1371/journal.pone.0145155;
RA   Pouly D., Chenaux S., Martin V., Babis M., Koch R., Nagoshi E.,
RA   Katanaev V.L., Gachon F., Staub O.;
RT   "USP2-45 is a circadian clock output effector regulating calcium absorption
RT   at the post-translational level.";
RL   PLoS ONE 11:E0145155-E0145155(2016).
RN   [36]
RP   INVOLVEMENT IN MRD56.
RX   PubMed=26822784; DOI=10.1002/ajmg.a.37506;
RA   DeMari J., Mroske C., Tang S., Nimeh J., Miller R., Lebel R.R.;
RT   "CLTC as a clinically novel gene associated with multiple malformations and
RT   developmental delay.";
RL   Am. J. Med. Genet. A 170A:958-966(2016).
RN   [37]
RP   INVOLVEMENT IN MRD56, AND VARIANTS MRD56 554-MET--TYR-556 DEL; LEU-890;
RP   PRO-1047; ARG-1108; 1199-GLN--MET-1675 DEL; ASP-1207 DEL;
RP   1555-GLN--MET-1675 DEL AND 1556-TRP--MET-1675 DEL.
RX   PubMed=29100083; DOI=10.1016/j.ajhg.2017.09.008;
RG   Deciphering Developmental Disorders Study;
RA   Hamdan F.F., Myers C.T., Cossette P., Lemay P., Spiegelman D.,
RA   Laporte A.D., Nassif C., Diallo O., Monlong J., Cadieux-Dion M.,
RA   Dobrzeniecka S., Meloche C., Retterer K., Cho M.T., Rosenfeld J.A., Bi W.,
RA   Massicotte C., Miguet M., Brunga L., Regan B.M., Mo K., Tam C.,
RA   Schneider A., Hollingsworth G., FitzPatrick D.R., Donaldson A., Canham N.,
RA   Blair E., Kerr B., Fry A.E., Thomas R.H., Shelagh J., Hurst J.A.,
RA   Brittain H., Blyth M., Lebel R.R., Gerkes E.H., Davis-Keppen L., Stein Q.,
RA   Chung W.K., Dorison S.J., Benke P.J., Fassi E., Corsten-Janssen N.,
RA   Kamsteeg E.J., Mau-Them F.T., Bruel A.L., Verloes A., Ounap K.,
RA   Wojcik M.H., Albert D.V.F., Venkateswaran S., Ware T., Jones D., Liu Y.C.,
RA   Mohammad S.S., Bizargity P., Bacino C.A., Leuzzi V., Martinelli S.,
RA   Dallapiccola B., Tartaglia M., Blumkin L., Wierenga K.J., Purcarin G.,
RA   O'Byrne J.J., Stockler S., Lehman A., Keren B., Nougues M.C., Mignot C.,
RA   Auvin S., Nava C., Hiatt S.M., Bebin M., Shao Y., Scaglia F., Lalani S.R.,
RA   Frye R.E., Jarjour I.T., Jacques S., Boucher R.M., Riou E., Srour M.,
RA   Carmant L., Lortie A., Major P., Diadori P., Dubeau F., D'Anjou G.,
RA   Bourque G., Berkovic S.F., Sadleir L.G., Campeau P.M., Kibar Z.,
RA   Lafreniere R.G., Girard S.L., Mercimek-Mahmutoglu S., Boelman C.,
RA   Rouleau G.A., Scheffer I.E., Mefford H.C., Andrade D.M., Rossignol E.,
RA   Minassian B.A., Michaud J.L.;
RT   "High rate of recurrent de novo mutations in developmental and epileptic
RT   encephalopathies.";
RL   Am. J. Hum. Genet. 101:664-685(2017).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. Two different adapter protein complexes link
CC       the clathrin lattice either to the plasma membrane or to the trans-
CC       Golgi network. Acts as component of the TACC3/ch-TOG/clathrin complex
CC       proposed to contribute to stabilization of kinetochore fibers of the
CC       mitotic spindle by acting as inter-microtubule bridge (PubMed:15858577,
CC       PubMed:16968737, PubMed:21297582). The TACC3/ch-TOG/clathrin complex is
CC       required for the maintenance of kinetochore fiber tension
CC       (PubMed:23532825). Plays a role in early autophagosome formation
CC       (PubMed:20639872). {ECO:0000269|PubMed:15858577,
CC       ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:20639872,
CC       ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:23532825}.
CC   -!- SUBUNIT: Clathrin triskelions, composed of 3 heavy chains and 3 light
CC       chains, are the basic subunits of the clathrin coat (PubMed:16968737).
CC       In the presence of light chains, hub assembly is influenced by both the
CC       pH and the concentration of calcium. Interacts with HIP1
CC       (PubMed:11532990). Interacts with DENND1A, DENND1B and DENND1C (By
CC       similarity). May interact with OCRL (By similarity). Interacts with
CC       ERBB2 (PubMed:16314522). Interacts with FKBP6 (PubMed:18529014).
CC       Interacts with CKAP5 and TACC3 forming the TACC3/ch-TOG/clathrin
CC       complex located at spindle inter-microtubules bridges; the complex
CC       implicates clathrin triskelions; TACC3 and CLTC are proposed to form a
CC       composite microtubule interaction surface (PubMed:21297582). Interacts
CC       with ATG16L1 (via N-terminus) (PubMed:20639872). Interacts with RFTN1;
CC       the interaction occurs in response to pathogens (PubMed:27022195,
CC       PubMed:21266579). Interacts with USP2 isoform 4 (PubMed:26756164).
CC       {ECO:0000250|UniProtKB:P49951, ECO:0000250|UniProtKB:Q68FD5,
CC       ECO:0000269|PubMed:11532990, ECO:0000269|PubMed:16314522,
CC       ECO:0000269|PubMed:16968737, ECO:0000269|PubMed:18529014,
CC       ECO:0000269|PubMed:20639872, ECO:0000269|PubMed:21266579,
CC       ECO:0000269|PubMed:21297582, ECO:0000269|PubMed:26756164,
CC       ECO:0000269|PubMed:27022195}.
CC   -!- INTERACTION:
CC       Q00610; P09496: CLTA; NbExp=2; IntAct=EBI-354967, EBI-1171169;
CC       Q00610; O00291: HIP1; NbExp=2; IntAct=EBI-354967, EBI-473886;
CC       Q00610; P10242: MYB; NbExp=4; IntAct=EBI-354967, EBI-298355;
CC       Q00610; Q01968: OCRL; NbExp=10; IntAct=EBI-354967, EBI-6148898;
CC       Q00610; Q07912: TNK2; NbExp=2; IntAct=EBI-354967, EBI-603457;
CC       Q00610; O75674: TOM1L1; NbExp=4; IntAct=EBI-354967, EBI-712991;
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane
CC       {ECO:0000269|PubMed:17081065}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17081065}; Cytoplasmic side
CC       {ECO:0000269|PubMed:17081065}. Membrane, coated pit
CC       {ECO:0000269|PubMed:17081065}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:17081065}; Cytoplasmic side
CC       {ECO:0000269|PubMed:17081065}. Melanosome
CC       {ECO:0000269|PubMed:17081065}. Cytoplasm, cytoskeleton, spindle
CC       {ECO:0000269|PubMed:15858577, ECO:0000269|PubMed:16968737,
CC       ECO:0000269|PubMed:23918938}. Note=Cytoplasmic face of coated pits and
CC       vesicles. Identified by mass spectrometry in melanosome fractions from
CC       stage I to stage IV. In complex with TACC3 and CKAP5 (forming the
CC       TACC3/ch-TOG/clathrin complex) localized to inter-microtubule bridges
CC       in mitotic spindles. {ECO:0000269|PubMed:25596274}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q00610-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q00610-2; Sequence=VSP_011570, VSP_011571;
CC   -!- DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40-
CC       like repeats, and projects inward from the polyhedral outer clathrin
CC       coat. It constitutes a major protein-protein interaction node.
CC   -!- DISEASE: Mental retardation, autosomal dominant 56 (MRD56)
CC       [MIM:617854]: A form of mental retardation, a disorder characterized by
CC       significantly below average general intellectual functioning associated
CC       with impairments in adaptive behavior and manifested during the
CC       developmental period. {ECO:0000269|PubMed:26822784,
CC       ECO:0000269|PubMed:29100083}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA04801.2; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLTCID360.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Clathrin entry;
CC       URL="https://en.wikipedia.org/wiki/Clathrin";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D21260; BAA04801.2; ALT_INIT; mRNA.
DR   EMBL; BX640615; CAE45761.1; -; mRNA.
DR   EMBL; CH471109; EAW94396.1; -; Genomic_DNA.
DR   EMBL; CH471109; EAW94399.1; -; Genomic_DNA.
DR   EMBL; BC051800; AAH51800.1; -; mRNA.
DR   EMBL; BC054489; AAH54489.1; -; mRNA.
DR   EMBL; X55878; CAA39363.1; -; mRNA.
DR   CCDS; CCDS32696.1; -. [Q00610-1]
DR   PIR; A40573; A40573.
DR   RefSeq; NP_004850.1; NM_004859.3. [Q00610-1]
DR   PDB; 2XZG; X-ray; 1.70 A; A=1-364.
DR   PDB; 4G55; X-ray; 1.69 A; A=1-364.
DR   PDB; 6E4L; X-ray; 1.60 A; A=1-364.
DR   PDB; 6QNN; X-ray; 2.03 A; A=1-364.
DR   PDB; 6QNP; X-ray; 2.70 A; A/B/C/D=1-364.
DR   PDBsum; 2XZG; -.
DR   PDBsum; 4G55; -.
DR   PDBsum; 6E4L; -.
DR   PDBsum; 6QNN; -.
DR   PDBsum; 6QNP; -.
DR   SMR; Q00610; -.
DR   BioGrid; 107623; 374.
DR   CORUM; Q00610; -.
DR   ELM; Q00610; -.
DR   IntAct; Q00610; 226.
DR   MINT; Q00610; -.
DR   STRING; 9606.ENSP00000479606; -.
DR   BindingDB; Q00610; -.
DR   ChEMBL; CHEMBL3108634; -.
DR   MoonDB; Q00610; Curated.
DR   iPTMnet; Q00610; -.
DR   MetOSite; Q00610; -.
DR   PhosphoSitePlus; Q00610; -.
DR   SwissPalm; Q00610; -.
DR   BioMuta; CLTC; -.
DR   DMDM; 1705916; -.
DR   CPTAC; CPTAC-182; -.
DR   CPTAC; CPTAC-183; -.
DR   EPD; Q00610; -.
DR   jPOST; Q00610; -.
DR   MassIVE; Q00610; -.
DR   MaxQB; Q00610; -.
DR   PaxDb; Q00610; -.
DR   PeptideAtlas; Q00610; -.
DR   PRIDE; Q00610; -.
DR   ProteomicsDB; 57862; -. [Q00610-1]
DR   ProteomicsDB; 57863; -. [Q00610-2]
DR   ABCD; Q00610; -.
DR   Antibodypedia; 4164; 478 antibodies.
DR   DNASU; 1213; -.
DR   Ensembl; ENST00000269122; ENSP00000269122; ENSG00000141367. [Q00610-1]
DR   Ensembl; ENST00000393043; ENSP00000376763; ENSG00000141367. [Q00610-2]
DR   GeneID; 1213; -.
DR   KEGG; hsa:1213; -.
DR   UCSC; uc002ixp.4; human. [Q00610-1]
DR   CTD; 1213; -.
DR   DisGeNET; 1213; -.
DR   GeneCards; CLTC; -.
DR   HGNC; HGNC:2092; CLTC.
DR   HPA; ENSG00000141367; Low tissue specificity.
DR   MalaCards; CLTC; -.
DR   MIM; 118955; gene.
DR   MIM; 617854; phenotype.
DR   neXtProt; NX_Q00610; -.
DR   OpenTargets; ENSG00000141367; -.
DR   Orphanet; 178469; Autosomal dominant non-syndromic intellectual disability.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   Orphanet; 319308; MiT family translocation renal cell carcinoma.
DR   Orphanet; 442835; Undetermined early-onset epileptic encephalopathy.
DR   PharmGKB; PA26618; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   eggNOG; ENOG410XPH1; LUCA.
DR   GeneTree; ENSGT00950000183166; -.
DR   HOGENOM; CLU_002136_0_0_1; -.
DR   InParanoid; Q00610; -.
DR   KO; K04646; -.
DR   OrthoDB; 17940at2759; -.
DR   PhylomeDB; Q00610; -.
DR   TreeFam; TF300059; -.
DR   Reactome; R-HSA-168275; Entry of Influenza Virion into Host Cell via Endocytosis.
DR   Reactome; R-HSA-177504; Retrograde neurotrophin signalling.
DR   Reactome; R-HSA-190873; Gap junction degradation.
DR   Reactome; R-HSA-196025; Formation of annular gap junctions.
DR   Reactome; R-HSA-2132295; MHC class II antigen presentation. [Q00610-1]
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-432720; Lysosome Vesicle Biogenesis. [Q00610-1]
DR   Reactome; R-HSA-432722; Golgi Associated Vesicle Biogenesis. [Q00610-1]
DR   Reactome; R-HSA-437239; Recycling pathway of L1.
DR   Reactome; R-HSA-5099900; WNT5A-dependent internalization of FZD4.
DR   Reactome; R-HSA-5140745; WNT5A-dependent internalization of FZD2, FZD5 and ROR2.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8866427; VLDLR internalisation and degradation.
DR   Reactome; R-HSA-8964038; LDL clearance.
DR   SignaLink; Q00610; -.
DR   SIGNOR; Q00610; -.
DR   ChiTaRS; CLTC; human.
DR   EvolutionaryTrace; Q00610; -.
DR   GeneWiki; CLTC; -.
DR   GenomeRNAi; 1213; -.
DR   Pharos; Q00610; Tbio.
DR   PRO; PR:Q00610; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; Q00610; protein.
DR   Bgee; ENSG00000141367; Expressed in dorsolateral prefrontal cortex and 239 other tissues.
DR   ExpressionAtlas; Q00610; baseline and differential.
DR   Genevisible; Q00610; HS.
DR   GO; GO:0030118; C:clathrin coat; IMP:CAFA.
DR   GO; GO:0030132; C:clathrin coat of coated pit; IEA:InterPro.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IDA:FlyBase.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; IBA:GO_Central.
DR   GO; GO:0030669; C:clathrin-coated endocytic vesicle membrane; TAS:Reactome.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0036020; C:endolysosome membrane; TAS:Reactome.
DR   GO; GO:0005768; C:endosome; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:1903561; C:extracellular vesicle; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005764; C:lysosome; IDA:HPA.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0072686; C:mitotic spindle; IDA:HPA.
DR   GO; GO:1990498; C:mitotic spindle microtubule; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0032588; C:trans-Golgi network membrane; TAS:Reactome.
DR   GO; GO:0032051; F:clathrin light chain binding; IPI:FlyBase.
DR   GO; GO:0097718; F:disordered domain specific binding; IPI:CAFA.
DR   GO; GO:0003725; F:double-stranded RNA binding; IDA:MGI.
DR   GO; GO:0050750; F:low-density lipoprotein particle receptor binding; IPI:ARUK-UCL.
DR   GO; GO:0019901; F:protein kinase binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0005198; F:structural molecule activity; NAS:UniProtKB.
DR   GO; GO:1990381; F:ubiquitin-specific protease binding; IPI:UniProtKB.
DR   GO; GO:0150093; P:amyloid-beta clearance by transcytosis; IMP:ARUK-UCL.
DR   GO; GO:0019886; P:antigen processing and presentation of exogenous peptide antigen via MHC class II; TAS:Reactome.
DR   GO; GO:0006914; P:autophagy; IEA:UniProtKB-KW.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0048268; P:clathrin coat assembly; IMP:CAFA.
DR   GO; GO:0072583; P:clathrin-dependent endocytosis; IMP:ARUK-UCL.
DR   GO; GO:0006886; P:intracellular protein transport; NAS:UniProtKB.
DR   GO; GO:0034383; P:low-density lipoprotein particle clearance; TAS:Reactome.
DR   GO; GO:0032802; P:low-density lipoprotein particle receptor catabolic process; TAS:Reactome.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000278; P:mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:1900126; P:negative regulation of hyaluronan biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1903077; P:negative regulation of protein localization to plasma membrane; IMP:UniProtKB.
DR   GO; GO:0001649; P:osteoblast differentiation; HDA:UniProtKB.
DR   GO; GO:0031623; P:receptor internalization; IMP:BHF-UCL.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IMP:UniProtKB.
DR   GO; GO:0060236; P:regulation of mitotic spindle organization; IMP:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   GO; GO:0033572; P:transferrin transport; IMP:BHF-UCL.
DR   GO; GO:0060071; P:Wnt signaling pathway, planar cell polarity pathway; TAS:Reactome.
DR   Gene3D; 1.25.40.10; -; 4.
DR   Gene3D; 2.130.10.110; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR016025; Clathrin_H-chain_N.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF01394; Clathrin_propel; 5.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; SSF48371; 6.
DR   SUPFAM; SSF50989; SSF50989; 1.
DR   PROSITE; PS50236; CHCR; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Autophagy; Cell cycle;
KW   Cell division; Coated pit; Cytoplasm; Cytoplasmic vesicle; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; Membrane; Mental retardation;
KW   Mitosis; Phosphoprotein; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712,
FT                   ECO:0000269|PubMed:12665801, ECO:0000269|Ref.7"
FT   CHAIN           2..1675
FT                   /note="Clathrin heavy chain 1"
FT                   /id="PRO_0000205778"
FT   REPEAT          537..683
FT                   /note="CHCR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          686..828
FT                   /note="CHCR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          833..972
FT                   /note="CHCR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          979..1124
FT                   /note="CHCR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          1128..1269
FT                   /note="CHCR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          1274..1420
FT                   /note="CHCR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REPEAT          1423..1566
FT                   /note="CHCR 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01006,
FT                   ECO:0000269|PubMed:21816279"
FT   REGION          2..479
FT                   /note="Globular terminal domain"
FT   REGION          24..67
FT                   /note="WD40-like repeat 1"
FT   REGION          68..107
FT                   /note="WD40-like repeat 2"
FT   REGION          108..149
FT                   /note="WD40-like repeat 3"
FT   REGION          150..195
FT                   /note="WD40-like repeat 4"
FT   REGION          196..257
FT                   /note="WD40-like repeat 5"
FT   REGION          258..301
FT                   /note="WD40-like repeat 6"
FT   REGION          302..330
FT                   /note="WD40-like repeat 7"
FT   REGION          449..465
FT                   /note="Binding site for the uncoating ATPase, involved in
FT                   lattice disassembly"
FT                   /evidence="ECO:0000255"
FT   REGION          457..507
FT                   /note="Involved in spindle localization and interaction
FT                   with TACC3"
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   REGION          480..523
FT                   /note="Flexible linker"
FT   REGION          524..1675
FT                   /note="Heavy chain arm"
FT   REGION          524..634
FT                   /note="Distal segment"
FT   REGION          639..1675
FT                   /note="Proximal segment"
FT   REGION          1213..1522
FT                   /note="Involved in binding clathrin light chain"
FT                   /evidence="ECO:0000250"
FT   REGION          1550..1675
FT                   /note="Trimerization"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22223895,
FT                   ECO:0000244|PubMed:22814378, ECO:0000244|PubMed:25944712,
FT                   ECO:0000269|Ref.7"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         105
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         184
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         394
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         634
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         737
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         856
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         899
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1206
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1441
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1441
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1477
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         1487
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19369195,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1501
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   VAR_SEQ         1636..1639
FT                   /note="QPQL -> NLSL (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011570"
FT   VAR_SEQ         1640..1675
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_011571"
FT   VARIANT         554..556
FT                   /note="Missing (in MRD56; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080721"
FT   VARIANT         890
FT                   /note="P -> L (in MRD56; dbSNP:rs1555606635)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080722"
FT   VARIANT         1047
FT                   /note="L -> P (in MRD56; unknown pathological significance;
FT                   dbSNP:rs1555607159)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080723"
FT   VARIANT         1108
FT                   /note="W -> R (in MRD56; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080724"
FT   VARIANT         1199..1675
FT                   /note="Missing (in MRD56)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080725"
FT   VARIANT         1207
FT                   /note="Missing (in MRD56; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080726"
FT   VARIANT         1555..1675
FT                   /note="Missing (in MRD56)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080727"
FT   VARIANT         1556..1675
FT                   /note="Missing (in MRD56)"
FT                   /evidence="ECO:0000269|PubMed:29100083"
FT                   /id="VAR_080728"
FT   MUTAGEN         65
FT                   /note="P->N: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         67
FT                   /note="S->G: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         87
FT                   /note="T->A: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         89
FT                   /note="Q->A: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         96
FT                   /note="K->E: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         98
FT                   /note="K->E: Disrupts spindle localization."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         444
FT                   /note="R->E: Disrupts spindle localization; when associated
FT                   with E-445, E-500 E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         445
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-500, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         480..484
FT                   /note="LRANV->ERGQC: Disrupts spindle localization and
FT                   interaction with TACC3."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         481
FT                   /note="R->E: Disrupts spindle localization; when associated
FT                   with E-487, E-500, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         487
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-500, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         500
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-445, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         500
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-487, E-506 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         506
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-445, E-500 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         506
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-487, E-500 and E-507."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         507
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-444, E-445, E-500 and E-506."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   MUTAGEN         507
FT                   /note="K->E: Disrupts spindle localization; when associated
FT                   with E-481, E-487, E-500 and E-506."
FT                   /evidence="ECO:0000269|PubMed:23918938"
FT   CONFLICT        560
FT                   /note="Q -> R (in Ref. 5; CAA39363)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        817
FT                   /note="G -> V (in Ref. 5; CAA39363)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        923
FT                   /note="R -> H (in Ref. 2; CAE45761)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1563
FT                   /note="R -> G (in Ref. 2; CAE45761)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1652
FT                   /note="Q -> R (in Ref. 2; CAE45761)"
FT                   /evidence="ECO:0000305"
FT   STRAND          6..14
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   HELIX           15..18
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   HELIX           22..24
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            27..29
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          30..34
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          37..44
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          47..54
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          62..64
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          69..73
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          75..84
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          87..92
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            93..96
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          97..103
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          108..113
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          115..135
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          139..143
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   HELIX           146..148
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          152..158
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          164..173
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          176..185
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            186..189
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          190..194
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          197..204
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          213..222
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          225..232
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          246..249
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   HELIX           254..256
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          261..267
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            268..271
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          272..277
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          280..286
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            287..289
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          292..297
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          303..309
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            310..313
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          314..319
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   STRAND          323..329
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   TURN            331..333
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   HELIX           334..340
FT                   /evidence="ECO:0000244|PDB:6E4L"
FT   HELIX           345..354
FT                   /evidence="ECO:0000244|PDB:6E4L"
SQ   SEQUENCE   1675 AA;  191615 MW;  6C4F2D54950079E2 CRC64;
     MAQILPIRFQ EHLQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV VIIDMNDPSN
     PIRRPISADS AIMNPASKVI ALKAGKTLQI FNIEMKSKMK AHTMTDDVTF WKWISLNTVA
     LVTDNAVYHW SMEGESQPVK MFDRHSSLAG CQIINYRTDA KQKWLLLTGI SAQQNRVVGA
     MQLYSVDRKV SQPIEGHAAS FAQFKMEGNA EESTLFCFAV RGQAGGKLHI IEVGTPPTGN
     QPFPKKAVDV FFPPEAQNDF PVAMQISEKH DVVFLITKYG YIHLYDLETG TCIYMNRISG
     ETIFVTAPHE ATAGIIGVNR KGQVLSVCVE EENIIPYITN VLQNPDLALR MAVRNNLAGA
     EELFARKFNA LFAQGNYSEA AKVAANAPKG ILRTPDTIRR FQSVPAQPGQ TSPLLQYFGI
     LLDQGQLNKY ESLELCRPVL QQGRKQLLEK WLKEDKLECS EELGDLVKSV DPTLALSVYL
     RANVPNKVIQ CFAETGQVQK IVLYAKKVGY TPDWIFLLRN VMRISPDQGQ QFAQMLVQDE
     EPLADITQIV DVFMEYNLIQ QCTAFLLDAL KNNRPSEGPL QTRLLEMNLM HAPQVADAIL
     GNQMFTHYDR AHIAQLCEKA GLLQRALEHF TDLYDIKRAV VHTHLLNPEW LVNYFGSLSV
     EDSLECLRAM LSANIRQNLQ ICVQVASKYH EQLSTQSLIE LFESFKSFEG LFYFLGSIVN
     FSQDPDVHFK YIQAACKTGQ IKEVERICRE SNCYDPERVK NFLKEAKLTD QLPLIIVCDR
     FDFVHDLVLY LYRNNLQKYI EIYVQKVNPS RLPVVIGGLL DVDCSEDVIK NLILVVRGQF
     STDELVAEVE KRNRLKLLLP WLEARIHEGC EEPATHNALA KIYIDSNNNP ERFLRENPYY
     DSRVVGKYCE KRDPHLACVA YERGQCDLEL INVCNENSLF KSLSRYLVRR KDPELWGSVL
     LESNPYRRPL IDQVVQTALS ETQDPEEVSV TVKAFMTADL PNELIELLEK IVLDNSVFSE
     HRNLQNLLIL TAIKADRTRV MEYINRLDNY DAPDIANIAI SNELFEEAFA IFRKFDVNTS
     AVQVLIEHIG NLDRAYEFAE RCNEPAVWSQ LAKAQLQKGM VKEAIDSYIK ADDPSSYMEV
     VQAANTSGNW EELVKYLQMA RKKARESYVE TELIFALAKT NRLAELEEFI NGPNNAHIQQ
     VGDRCYDEKM YDAAKLLYNN VSNFGRLAST LVHLGEYQAA VDGARKANST RTWKEVCFAC
     VDGKEFRLAQ MCGLHIVVHA DELEELINYY QDRGYFEELI TMLEAALGLE RAHMGMFTEL
     AILYSKFKPQ KMREHLELFW SRVNIPKVLR AAEQAHLWAE LVFLYDKYEE YDNAIITMMN
     HPTDAWKEGQ FKDIITKVAN VELYYRAIQF YLEFKPLLLN DLLMVLSPRL DHTRAVNYFS
     KVKQLPLVKP YLRSVQNHNN KSVNESLNNL FITEEDYQAL RTSIDAYDNF DNISLAQRLE
     KHELIEFRRI AAYLFKGNNR WKQSVELCKK DSLYKDAMQY ASESKDTELA EELLQWFLQE
     EKRECFGACL FTCYDLLRPD VVLETAWRHN IMDFAMPYFI QVMKEYLTKV DKLDASESLR
     KEEEQATETQ PIVYGQPQLM LTAGPSVAVP PQAPFGYGYT APPYGQPQPG FGYSM
//
ID   CLH2_HUMAN              Reviewed;        1640 AA.
AC   P53675; B7Z7U5; Q14017; Q15808; Q15809;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 2.
DT   22-APR-2020, entry version 188.
DE   RecName: Full=Clathrin heavy chain 2;
DE   AltName: Full=Clathrin heavy chain on chromosome 22;
DE            Short=CLH-22;
GN   Name=CLTCL1; Synonyms=CLH22, CLTCL, CLTD;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Fetal brain;
RX   PubMed=8733128; DOI=10.1093/hmg/5.5.617;
RA   Sirotkin H., Morrow B., Dasgupta R., Goldberg R., Patangali S.R., Shi G.,
RA   Cannizzaro L., Shprintzen R., Weissman S., Kucherlapati R.;
RT   "Isolation of a new clathrin heavy chain gene with muscle-specific
RT   expression from the region commonly deleted in velo-cardio-facial
RT   syndrome.";
RL   Hum. Mol. Genet. 5:617-624(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND NUCLEOTIDE SEQUENCE [MRNA] OF
RP   1451-1640 (ISOFORM 2).
RC   TISSUE=Fetal brain, and Skeletal muscle;
RX   PubMed=8733129; DOI=10.1093/hmg/5.5.625;
RA   Kedra D., Peyrard M., Fransson I., Collins J.E., Dunham I., Roe B.A.,
RA   Dumanski J.P.;
RT   "Characterization of a second human clathrin heavy chain polypeptide gene
RT   (CLH-22) from chromosome 22q11.";
RL   Hum. Mol. Genet. 5:625-631(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), AND VARIANT LYS-691.
RX   PubMed=8844170; DOI=10.1006/geno.1996.0386;
RA   Long K.R., Trofatter J.A., Ramesh V., McCormick M.K., Buckler A.J.;
RT   "Cloning and characterization of a novel human clathrin heavy chain gene
RT   (CLTCL).";
RL   Genomics 35:466-472(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
CC   -!- FUNCTION: Clathrin is the major protein of the polyhedral coat of
CC       coated pits and vesicles. Two different adapter protein complexes link
CC       the clathrin lattice either to the plasma membrane or to the trans-
CC       Golgi network (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Clathrin triskelions, composed of 3 heavy chains and 3 light
CC       chains, are the basic subunits of the clathrin coat. In the presence of
CC       light chains, hub assembly is influenced by both the pH and the
CC       concentration of calcium (By similarity). May interact with OCRL (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasmic vesicle membrane {ECO:0000250};
CC       Peripheral membrane protein {ECO:0000250}; Cytoplasmic side
CC       {ECO:0000250}. Membrane, coated pit {ECO:0000250}; Peripheral membrane
CC       protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Cytoplasmic
CC       face of coated pits and vesicles. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=Long, Brain;
CC         IsoId=P53675-1; Sequence=Displayed;
CC       Name=2; Synonyms=Short, Muscle;
CC         IsoId=P53675-2; Sequence=VSP_001100;
CC   -!- TISSUE SPECIFICITY: Maximal levels in skeletal muscle. High levels in
CC       heart and testis. Low expression detected in all other tissues.
CC   -!- DOMAIN: The C-terminal third of the heavy chains forms the hub of the
CC       triskelion. This region contains the trimerization domain and the
CC       light-chain binding domain involved in the assembly of the clathrin
CC       lattice.
CC   -!- DOMAIN: The N-terminal seven-bladed beta-propeller is formed by WD40-
CC       like repeats, and projects inward from the polyhedral outer clathrin
CC       coat. It constitutes a major protein-protein interaction node (By
CC       similarity). {ECO:0000250}.
CC   -!- SIMILARITY: Belongs to the clathrin heavy chain family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/CLTCL1ID361.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U41763; AAC50494.1; -; mRNA.
DR   EMBL; X95486; CAA64752.1; -; mRNA.
DR   EMBL; X95487; CAA64753.1; -; mRNA.
DR   EMBL; U60802; AAB40908.1; -; mRNA.
DR   EMBL; U60803; AAB40909.1; -; mRNA.
DR   EMBL; AK302506; BAH13731.1; -; mRNA.
DR   EMBL; CH471176; EAX03047.1; -; Genomic_DNA.
DR   CCDS; CCDS46662.2; -. [P53675-1]
DR   CCDS; CCDS54497.2; -. [P53675-2]
DR   PIR; G02757; G02757.
DR   PIR; T09522; T09522.
DR   RefSeq; NP_001826.3; NM_001835.3. [P53675-2]
DR   RefSeq; NP_009029.3; NM_007098.3. [P53675-1]
DR   SMR; P53675; -.
DR   BioGrid; 113854; 95.
DR   IntAct; P53675; 67.
DR   MINT; P53675; -.
DR   STRING; 9606.ENSP00000441158; -.
DR   MoonDB; P53675; Curated.
DR   iPTMnet; P53675; -.
DR   MetOSite; P53675; -.
DR   PhosphoSitePlus; P53675; -.
DR   SwissPalm; P53675; -.
DR   BioMuta; CLTCL1; -.
DR   DMDM; 2506298; -.
DR   EPD; P53675; -.
DR   jPOST; P53675; -.
DR   MassIVE; P53675; -.
DR   MaxQB; P53675; -.
DR   PaxDb; P53675; -.
DR   PeptideAtlas; P53675; -.
DR   PRIDE; P53675; -.
DR   ProteomicsDB; 56608; -. [P53675-1]
DR   ProteomicsDB; 56609; -. [P53675-2]
DR   Antibodypedia; 50558; 68 antibodies.
DR   DNASU; 8218; -.
DR   Ensembl; ENST00000427926; ENSP00000441158; ENSG00000070371. [P53675-1]
DR   Ensembl; ENST00000621271; ENSP00000485020; ENSG00000070371. [P53675-2]
DR   GeneID; 8218; -.
DR   KEGG; hsa:8218; -.
DR   UCSC; uc032qgb.2; human. [P53675-1]
DR   CTD; 8218; -.
DR   DisGeNET; 8218; -.
DR   GeneCards; CLTCL1; -.
DR   GeneReviews; CLTCL1; -.
DR   HGNC; HGNC:2093; CLTCL1.
DR   HPA; ENSG00000070371; Tissue enhanced (skeletal).
DR   MalaCards; CLTCL1; -.
DR   MIM; 601273; gene.
DR   neXtProt; NX_P53675; -.
DR   OpenTargets; ENSG00000070371; -.
DR   Orphanet; 453510; Congenital insensitivity to pain with severe intellectual disability.
DR   PharmGKB; PA26619; -.
DR   eggNOG; KOG0985; Eukaryota.
DR   eggNOG; ENOG410XPH1; LUCA.
DR   GeneTree; ENSGT00950000183166; -.
DR   InParanoid; P53675; -.
DR   KO; K04646; -.
DR   OMA; GKQECFA; -.
DR   OrthoDB; 17940at2759; -.
DR   PhylomeDB; P53675; -.
DR   TreeFam; TF300059; -.
DR   Reactome; R-HSA-190873; Gap junction degradation.
DR   Reactome; R-HSA-196025; Formation of annular gap junctions.
DR   Reactome; R-HSA-3928665; EPH-ephrin mediated repulsion of cells.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   SIGNOR; P53675; -.
DR   ChiTaRS; CLTCL1; human.
DR   GenomeRNAi; 8218; -.
DR   Pharos; P53675; Tbio.
DR   PRO; PR:P53675; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P53675; protein.
DR   Bgee; ENSG00000070371; Expressed in gastrocnemius and 152 other tissues.
DR   ExpressionAtlas; P53675; baseline and differential.
DR   Genevisible; P53675; HS.
DR   GO; GO:0030130; C:clathrin coat of trans-Golgi network vesicle; IEA:InterPro.
DR   GO; GO:0071439; C:clathrin complex; IBA:GO_Central.
DR   GO; GO:0045334; C:clathrin-coated endocytic vesicle; IBA:GO_Central.
DR   GO; GO:0005905; C:clathrin-coated pit; IDA:UniProtKB.
DR   GO; GO:0030136; C:clathrin-coated vesicle; IDA:UniProtKB.
DR   GO; GO:0030135; C:coated vesicle; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005770; C:late endosome; IDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0097443; C:sorting endosome; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IDA:UniProtKB.
DR   GO; GO:0005802; C:trans-Golgi network; IDA:UniProtKB.
DR   GO; GO:0032051; F:clathrin light chain binding; IBA:GO_Central.
DR   GO; GO:0005198; F:structural molecule activity; IEA:InterPro.
DR   GO; GO:0009653; P:anatomical structure morphogenesis; TAS:ProtInc.
DR   GO; GO:0006886; P:intracellular protein transport; IEA:InterPro.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0000278; P:mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0046326; P:positive regulation of glucose import; IMP:UniProtKB.
DR   GO; GO:0006898; P:receptor-mediated endocytosis; IDA:UniProtKB.
DR   GO; GO:0042147; P:retrograde transport, endosome to Golgi; IMP:UniProtKB.
DR   Gene3D; 1.25.40.10; -; 4.
DR   Gene3D; 2.130.10.110; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR000547; Clathrin_H-chain/VPS_repeat.
DR   InterPro; IPR015348; Clathrin_H-chain_linker_core.
DR   InterPro; IPR016025; Clathrin_H-chain_N.
DR   InterPro; IPR022365; Clathrin_H-chain_propeller_rpt.
DR   InterPro; IPR016341; Clathrin_heavy_chain.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   Pfam; PF00637; Clathrin; 7.
DR   Pfam; PF09268; Clathrin-link; 1.
DR   Pfam; PF01394; Clathrin_propel; 4.
DR   PIRSF; PIRSF002290; Clathrin_H_chain; 1.
DR   SMART; SM00299; CLH; 7.
DR   SUPFAM; SSF48371; SSF48371; 6.
DR   SUPFAM; SSF50989; SSF50989; 1.
DR   PROSITE; PS50236; CHCR; 7.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Coated pit; Cytoplasmic vesicle;
KW   Membrane; Phosphoprotein; Polymorphism; Reference proteome; Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   CHAIN           2..1640
FT                   /note="Clathrin heavy chain 2"
FT                   /id="PRO_0000205786"
FT   REPEAT          537..683
FT                   /note="CHCR 1"
FT   REPEAT          686..828
FT                   /note="CHCR 2"
FT   REPEAT          833..972
FT                   /note="CHCR 3"
FT   REPEAT          979..1124
FT                   /note="CHCR 4"
FT   REPEAT          1128..1269
FT                   /note="CHCR 5"
FT   REPEAT          1274..1420
FT                   /note="CHCR 6"
FT   REPEAT          1423..1566
FT                   /note="CHCR 7"
FT   REGION          2..479
FT                   /note="Globular terminal domain"
FT   REGION          24..67
FT                   /note="WD40-like repeat 1"
FT   REGION          68..107
FT                   /note="WD40-like repeat 2"
FT   REGION          108..149
FT                   /note="WD40-like repeat 3"
FT   REGION          150..195
FT                   /note="WD40-like repeat 4"
FT   REGION          196..257
FT                   /note="WD40-like repeat 5"
FT   REGION          258..301
FT                   /note="WD40-like repeat 6"
FT   REGION          302..330
FT                   /note="WD40-like repeat 7"
FT   REGION          449..465
FT                   /note="Binding site for the uncoating ATPase, involved in
FT                   lattice disassembly"
FT                   /evidence="ECO:0000255"
FT   REGION          480..523
FT                   /note="Flexible linker"
FT   REGION          524..1640
FT                   /note="Heavy chain arm"
FT   REGION          524..634
FT                   /note="Distal segment"
FT   REGION          639..1640
FT                   /note="Proximal segment"
FT   REGION          1213..1522
FT                   /note="Involved in binding clathrin light chain"
FT                   /evidence="ECO:0000250"
FT   REGION          1551..1640
FT                   /note="Trimerization"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         67
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         184
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         394
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         634
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         737
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         856
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         899
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1167
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1206
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1229
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         1441
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         1441
FT                   /note="N6-succinyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1477
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         1487
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:Q68FD5"
FT   MOD_RES         1494
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   MOD_RES         1501
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q00610"
FT   VAR_SEQ         1479..1535
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:8733129, ECO:0000303|PubMed:8844170"
FT                   /id="VSP_001100"
FT   VARIANT         61
FT                   /note="P -> L (in dbSNP:rs3747059)"
FT                   /id="VAR_055653"
FT   VARIANT         205
FT                   /note="K -> R (in dbSNP:rs5746697)"
FT                   /id="VAR_055654"
FT   VARIANT         279
FT                   /note="Y -> C (in dbSNP:rs807459)"
FT                   /id="VAR_055655"
FT   VARIANT         691
FT                   /note="E -> K (in dbSNP:rs1060374)"
FT                   /evidence="ECO:0000269|PubMed:8844170"
FT                   /id="VAR_055656"
FT   VARIANT         941
FT                   /note="K -> R (in dbSNP:rs35398725)"
FT                   /id="VAR_055657"
FT   VARIANT         945
FT                   /note="R -> H (in dbSNP:rs36077768)"
FT                   /id="VAR_055658"
FT   VARIANT         1046
FT                   /note="R -> C (in dbSNP:rs712952)"
FT                   /id="VAR_055659"
FT   VARIANT         1195
FT                   /note="N -> S (in dbSNP:rs807547)"
FT                   /id="VAR_059214"
FT   VARIANT         1316
FT                   /note="M -> V (in dbSNP:rs1061325)"
FT                   /id="VAR_059215"
FT   VARIANT         1394
FT                   /note="I -> T (in dbSNP:rs1633399)"
FT                   /id="VAR_059216"
FT   VARIANT         1592
FT                   /note="V -> M (in dbSNP:rs2073738)"
FT                   /id="VAR_059217"
FT   VARIANT         1620
FT                   /note="R -> H (in dbSNP:rs5748024)"
FT                   /id="VAR_059218"
FT   CONFLICT        193
FT                   /note="P -> H (in Ref. 1; AAC50494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        215
FT                   /note="L -> H (in Ref. 1; AAC50494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        320
FT                   /note="K -> T (in Ref. 2; CAA64752)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        530
FT                   /note="L -> Q (in Ref. 1; AAC50494)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1474
FT                   /note="E -> K (in Ref. 3; AAB40908/AAB40909)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1620..1640
FT                   /note="RKQEEHVTEPAPLVFDFDGHE -> PPSKRSM (in Ref. 3;
FT                   AAB40908/AAB40909)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1640 AA;  187030 MW;  C661E1AB989D8E7F CRC64;
     MAQILPVRFQ EHFQLQNLGI NPANIGFSTL TMESDKFICI REKVGEQAQV TIIDMSDPMA
     PIRRPISAES AIMNPASKVI ALKAGKTLQI FNIEMKSKMK AHTMAEEVIF WKWVSVNTVA
     LVTETAVYHW SMEGDSQPMK MFDRHTSLVG CQVIHYRTDE YQKWLLLVGI SAQQNRVVGA
     MQLYSVDRKV SQPIEGHAAA FAEFKMEGNA KPATLFCFAV RNPTGGKLHI IEVGQPAAGN
     QPFVKKAVDV FFPPEAQNDF PVAMQIGAKH GVIYLITKYG YLHLYDLESG VCICMNRISA
     DTIFVTAPHK PTSGIIGVNK KGQVLSVCVE EDNIVNYATN VLQNPDLGLR LAVRSNLAGA
     EKLFVRKFNT LFAQGSYAEA AKVAASAPKG ILRTRETVQK FQSIPAQSGQ ASPLLQYFGI
     LLDQGQLNKL ESLELCHLVL QQGRKQLLEK WLKEDKLECS EELGDLVKTT DPMLALSVYL
     RANVPSKVIQ CFAETGQFQK IVLYAKKVGY TPDWIFLLRG VMKISPEQGL QFSRMLVQDE
     EPLANISQIV DIFMENSLIQ QCTSFLLDAL KNNRPAEGLL QTWLLEMNLV HAPQVADAIL
     GNKMFTHYDR AHIAQLCEKA GLLQQALEHY TDLYDIKRAV VHTHLLNPEW LVNFFGSLSV
     EDSVECLHAM LSANIRQNLQ LCVQVASKYH EQLGTQALVE LFESFKSYKG LFYFLGSIVN
     FSQDPDVHLK YIQAACKTGQ IKEVERICRE SSCYNPERVK NFLKEAKLTD QLPLIIVCDR
     FGFVHDLVLY LYRNNLQRYI EIYVQKVNPS RTPAVIGGLL DVDCSEEVIK HLIMAVRGQF
     STDELVAEVE KRNRLKLLLP WLESQIQEGC EEPATHNALA KIYIDSNNSP ECFLRENAYY
     DSSVVGRYCE KRDPHLACVA YERGQCDLEL IKVCNENSLF KSEARYLVCR KDPELWAHVL
     EETNPSRRQL IDQVVQTALS ETRDPEEISV TVKAFMTADL PNELIELLEK IVLDNSVFSE
     HRNLQNLLIL TAIKADRTRV MEYISRLDNY DALDIASIAV SSALYEEAFT VFHKFDMNAS
     AIQVLIEHIG NLDRAYEFAE RCNEPAVWSQ LAQAQLQKDL VKEAINSYIR GDDPSSYLEV
     VQSASRSNNW EDLVKFLQMA RKKGRESYIE TELIFALAKT SRVSELEDFI NGPNNAHIQQ
     VGDRCYEEGM YEAAKLLYSN VSNFARLAST LVHLGEYQAA VDNSRKASST RTWKEVCFAC
     MDGQEFRFAQ LCGLHIVIHA DELEELMCYY QDRGYFEELI LLLEAALGLE RAHMGMFTEL
     AILYSKFKPQ KMLEHLELFW SRVNIPKVLR AAEQAHLWAE LVFLYDKYEE YDNAVLTMMS
     HPTEAWKEGQ FKDIITKVAN VELCYRALQF YLDYKPLLIN DLLLVLSPRL DHTWTVSFFS
     KAGQLPLVKP YLRSVQSHNN KSVNEALNHL LTEEEDYQGL RASIDAYDNF DNISLAQQLE
     KHQLMEFRCI AAYLYKGNNW WAQSVELCKK DHLYKDAMQH AAESRDAELA QKLLQWFLEE
     GKRECFAACL FTCYDLLRPD MVLELAWRHN LVDLAMPYFI QVMREYLSKV DKLDALESLR
     KQEEHVTEPA PLVFDFDGHE
//
ID   A0A0S2Z4K2_HUMAN        Unreviewed;       177 AA.
AC   A0A0S2Z4K2;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 20.
DE   SubName: Full=CCHC-type zinc finger nucleic acid binding protein isoform 3 {ECO:0000313|EMBL:ALQ33857.1};
DE   Flags: Fragment;
GN   Name=CNBP {ECO:0000313|EMBL:ALQ33857.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33857.1};
RN   [1] {ECO:0000313|EMBL:ALQ33857.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178399; ALQ33857.1; -; mRNA.
DR   RefSeq; NP_003409.1; NM_003418.4.
DR   SMR; A0A0S2Z4K2; -.
DR   PRIDE; A0A0S2Z4K2; -.
DR   Antibodypedia; 33233; 317 antibodies.
DR   GeneID; 7555; -.
DR   KEGG; hsa:7555; -.
DR   CTD; 7555; -.
DR   KO; K09250; -.
DR   PhylomeDB; A0A0S2Z4K2; -.
DR   ChiTaRS; CNBP; human.
DR   GenomeRNAi; 7555; -.
DR   ExpressionAtlas; A0A0S2Z4K2; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; SSF57756; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00047}.
FT   DOMAIN          6..20
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          54..67
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          74..89
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          98..111
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          118..134
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          136..152
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          158..171
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   NON_TER         177
FT                   /evidence="ECO:0000313|EMBL:ALQ33857.1"
SQ   SEQUENCE   177 AA;  19463 MW;  996F398285F52618 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGGFTSD RGFQFVSSSL PDICYRCGES
     GHLAKDCDLQ EDACYNCGRG GHIAKDCKEP KREREQCCYN CGKPGHLARD CDHADEQKCY
     SCGEFGHIQK DCTKVKCYRC GETGHVAINC SKTSEVNCYR CGESGHLARE CTIEATA
//
ID   A0A0S2Z4Q3_HUMAN        Unreviewed;       170 AA.
AC   A0A0S2Z4Q3;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 19.
DE   SubName: Full=CCHC-type zinc finger nucleic acid binding protein isoform 1 {ECO:0000313|EMBL:ALQ33855.1};
DE   Flags: Fragment;
GN   Name=CNBP {ECO:0000313|EMBL:ALQ33855.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33855.1};
RN   [1] {ECO:0000313|EMBL:ALQ33855.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178397; ALQ33855.1; -; mRNA.
DR   RefSeq; NP_001120668.1; NM_001127196.1.
DR   SMR; A0A0S2Z4Q3; -.
DR   PRIDE; A0A0S2Z4Q3; -.
DR   Antibodypedia; 33233; 317 antibodies.
DR   GeneID; 7555; -.
DR   CTD; 7555; -.
DR   ChiTaRS; CNBP; human.
DR   GenomeRNAi; 7555; -.
DR   ExpressionAtlas; A0A0S2Z4Q3; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; SSF57756; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00047};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00047}.
FT   DOMAIN          6..20
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          47..60
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          67..82
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          91..104
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          111..127
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          129..145
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   DOMAIN          151..164
FT                   /note="CCHC-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50158"
FT   NON_TER         170
FT                   /evidence="ECO:0000313|EMBL:ALQ33855.1"
SQ   SEQUENCE   170 AA;  18742 MW;  152BEC42881358E8 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGFQFVS SSLPDICYRC GESGHLAKDC
     DLQEDACYNC GRGGHIAKDC KEPKREREQC CYNCGKPGHL ARDCDHADEQ KCYSCGEFGH
     IQKDCTKVKC YRCGETGHVA INCSKTSEVN CYRCGESGHL ARECTIEATA
//
ID   CNBP_HUMAN              Reviewed;         177 AA.
AC   P62633; A8K7V4; B2RAV9; B4DP17; D3DNB9; D3DNC0; D3DNC1; E9PDR7; P20694;
AC   Q4JGY0; Q4JGY1; Q5QJR0; Q5U0E9; Q6PJI7; Q96NV3;
DT   19-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   19-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 160.
DE   RecName: Full=Cellular nucleic acid-binding protein;
DE            Short=CNBP;
DE   AltName: Full=Zinc finger protein 9;
GN   Name=CNBP; Synonyms=RNF163, ZNF9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2562787; DOI=10.1126/science.2562787;
RA   Rajavashisth T.B., Taylor A.K., Andalibi A., Svenson K.L., Lusis A.J.;
RT   "Identification of a zinc finger protein that binds to the sterol
RT   regulatory element.";
RL   Science 245:640-643(1989).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RC   TISSUE=Placenta;
RX   PubMed=7590281; DOI=10.1016/0378-1119(95)00421-2;
RA   Flink I.L., Morkin E.;
RT   "Organization of the gene encoding cellular nucleic acid-binding protein.";
RL   Gene 163:279-282(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND DISEASE.
RX   PubMed=11486088; DOI=10.1126/science.1062125;
RA   Liquori C.L., Ricker K., Moseley M.L., Jacobsen J.F., Kress W.,
RA   Naylor S.L., Day J.W., Ranum L.P.;
RT   "Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of
RT   ZNF9.";
RL   Science 293:864-867(2001).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 4; 5 AND 8).
RA   Yang F., Yan H., Zhang S.;
RT   "Cloning of novel transcript variants of human cellular nucleic acid
RT   binding protein.";
RL   Submitted (JUN-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 3; 6 AND 7).
RC   TISSUE=Placenta, and Synovium;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (OCT-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, Lung, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [12]
RP   METHYLATION AT ARG-25 AND ARG-27, AND MUTAGENESIS OF ARG-25 AND ARG-27.
RX   PubMed=24726729; DOI=10.1016/j.febslet.2014.03.052;
RA   Wei H.M., Hu H.H., Chang G.Y., Lee Y.J., Li Y.C., Chang H.H., Li C.;
RT   "Arginine methylation of the cellular nucleic acid binding protein does not
RT   affect its subcellular localization but impedes RNA binding.";
RL   FEBS Lett. 588:1542-1548(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-79, METHYLATION [LARGE SCALE
RP   ANALYSIS] AT ARG-32 AND ARG-34 (ISOFORMS 2; 5 AND 8), METHYLATION [LARGE
RP   SCALE ANALYSIS] AT ARG-80 (ISOFORM 4), METHYLATION [LARGE SCALE ANALYSIS]
RP   AT ARG-73 (ISOFORM 8), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   -!- FUNCTION: Single-stranded DNA-binding protein, with specificity to the
CC       sterol regulatory element (SRE). Involved in sterol-mediated
CC       repression.
CC   -!- INTERACTION:
CC       P62633; Q63009: Prmt1; Xeno; NbExp=2; IntAct=EBI-1047529, EBI-78708;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250}. Endoplasmic reticulum
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=1;
CC         IsoId=P62633-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P62633-2; Sequence=VSP_010981;
CC       Name=3;
CC         IsoId=P62633-3; Sequence=VSP_010982;
CC       Name=4;
CC         IsoId=P62633-4; Sequence=VSP_043304;
CC       Name=5;
CC         IsoId=P62633-5; Sequence=VSP_010981, VSP_043424;
CC       Name=6;
CC         IsoId=P62633-6; Sequence=VSP_043424;
CC       Name=7;
CC         IsoId=P62633-7; Sequence=VSP_055084;
CC       Name=8;
CC         IsoId=P62633-8; Sequence=VSP_010981, VSP_043304;
CC   -!- TISSUE SPECIFICITY: Present in all tissues examined.
CC   -!- PTM: Arginine methylation by PRMT1 in the Arg/Gly-rich region impedes
CC       RNA binding. {ECO:0000269|PubMed:24726729}.
CC   -!- DISEASE: Dystrophia myotonica 2 (DM2) [MIM:602668]: A multisystem
CC       disease characterized by the association of proximal muscle weakness
CC       with myotonia, cardiac manifestations and cataract. Additional features
CC       can include hyperhidrosis, testicular atrophy, insulin resistance and
CC       diabetes and central nervous system anomalies in rare cases. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry. The causative mutation is a CCTG expansion (mean approximately
CC       5000 repeats) located in intron 1 of the CNBP gene.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M28372; AAA61975.1; -; mRNA.
DR   EMBL; U19765; AAA91782.1; -; Genomic_DNA.
DR   EMBL; AY329622; AAR89462.1; -; Genomic_DNA.
DR   EMBL; DQ092366; AAY96754.1; -; mRNA.
DR   EMBL; DQ092367; AAY96755.1; -; mRNA.
DR   EMBL; DQ091187; AAY89856.1; -; mRNA.
DR   EMBL; AK054592; BAB70769.1; -; mRNA.
DR   EMBL; AK298154; BAG60429.1; -; mRNA.
DR   EMBL; AK292119; BAF84808.1; -; mRNA.
DR   EMBL; AK314380; BAG37006.1; -; mRNA.
DR   EMBL; BT019613; AAV38419.1; -; mRNA.
DR   EMBL; AC108673; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135587; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW79271.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79272.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79273.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79274.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79275.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW79277.1; -; Genomic_DNA.
DR   EMBL; BC000288; AAH00288.1; -; mRNA.
DR   EMBL; BC014911; AAH14911.1; -; mRNA.
DR   EMBL; BC093058; AAH93058.1; -; mRNA.
DR   CCDS; CCDS3056.1; -. [P62633-1]
DR   CCDS; CCDS46906.1; -. [P62633-6]
DR   CCDS; CCDS46907.1; -. [P62633-4]
DR   CCDS; CCDS46908.1; -. [P62633-5]
DR   CCDS; CCDS54637.1; -. [P62633-2]
DR   PIR; A32760; A32760.
DR   RefSeq; NP_001120664.1; NM_001127192.1. [P62633-6]
DR   RefSeq; NP_001120665.1; NM_001127193.1. [P62633-4]
DR   RefSeq; NP_001120666.1; NM_001127194.1. [P62633-5]
DR   RefSeq; NP_001120667.1; NM_001127195.1. [P62633-8]
DR   RefSeq; NP_001120668.1; NM_001127196.1. [P62633-2]
DR   RefSeq; NP_003409.1; NM_003418.4. [P62633-1]
DR   SMR; P62633; -.
DR   BioGrid; 113387; 168.
DR   IntAct; P62633; 111.
DR   MINT; P62633; -.
DR   STRING; 9606.ENSP00000410769; -.
DR   iPTMnet; P62633; -.
DR   PhosphoSitePlus; P62633; -.
DR   SwissPalm; P62633; -.
DR   BioMuta; CNBP; -.
DR   DMDM; 50401852; -.
DR   CPTAC; CPTAC-480; -.
DR   CPTAC; CPTAC-481; -.
DR   EPD; P62633; -.
DR   jPOST; P62633; -.
DR   MassIVE; P62633; -.
DR   MaxQB; P62633; -.
DR   PaxDb; P62633; -.
DR   PeptideAtlas; P62633; -.
DR   PRIDE; P62633; -.
DR   ProteomicsDB; 19732; -.
DR   ProteomicsDB; 4742; -.
DR   ProteomicsDB; 57408; -. [P62633-1]
DR   ProteomicsDB; 57409; -. [P62633-2]
DR   ProteomicsDB; 57410; -. [P62633-3]
DR   ProteomicsDB; 57411; -. [P62633-4]
DR   ProteomicsDB; 57412; -. [P62633-5]
DR   Antibodypedia; 33233; 317 antibodies.
DR   DNASU; 7555; -.
DR   Ensembl; ENST00000422453; ENSP00000410619; ENSG00000169714. [P62633-1]
DR   Ensembl; ENST00000441626; ENSP00000410769; ENSG00000169714. [P62633-6]
DR   Ensembl; ENST00000446936; ENSP00000400444; ENSG00000169714. [P62633-5]
DR   Ensembl; ENST00000451728; ENSP00000399488; ENSG00000169714. [P62633-4]
DR   Ensembl; ENST00000500450; ENSP00000426223; ENSG00000169714. [P62633-7]
DR   Ensembl; ENST00000502976; ENSP00000421323; ENSG00000169714. [P62633-2]
DR   Ensembl; ENST00000504813; ENSP00000422110; ENSG00000169714. [P62633-3]
DR   GeneID; 7555; -.
DR   KEGG; hsa:7555; -.
DR   UCSC; uc003elq.5; human. [P62633-1]
DR   CTD; 7555; -.
DR   DisGeNET; 7555; -.
DR   GeneCards; CNBP; -.
DR   GeneReviews; CNBP; -.
DR   HGNC; HGNC:13164; CNBP.
DR   HPA; ENSG00000169714; Low tissue specificity.
DR   MalaCards; CNBP; -.
DR   MIM; 116955; gene.
DR   MIM; 602668; phenotype.
DR   neXtProt; NX_P62633; -.
DR   OpenTargets; ENSG00000169714; -.
DR   Orphanet; 606; Proximal myotonic myopathy.
DR   PharmGKB; PA37737; -.
DR   eggNOG; KOG4400; Eukaryota.
DR   eggNOG; COG5082; LUCA.
DR   GeneTree; ENSGT00950000183041; -.
DR   HOGENOM; CLU_058879_4_0_1; -.
DR   InParanoid; P62633; -.
DR   KO; K09250; -.
DR   OMA; RRECDEK; -.
DR   OrthoDB; 1535084at2759; -.
DR   PhylomeDB; P62633; -.
DR   TreeFam; TF316974; -.
DR   SIGNOR; P62633; -.
DR   ChiTaRS; CNBP; human.
DR   GeneWiki; CNBP; -.
DR   GenomeRNAi; 7555; -.
DR   Pharos; P62633; Tbio.
DR   PRO; PR:P62633; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P62633; protein.
DR   Bgee; ENSG00000169714; Expressed in skeletal muscle tissue of rectus abdominis and 229 other tissues.
DR   ExpressionAtlas; P62633; baseline and differential.
DR   Genevisible; P62633; HS.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0005783; C:endoplasmic reticulum; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0003729; F:mRNA binding; IBA:GO_Central.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0003697; F:single-stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0003727; F:single-stranded RNA binding; IBA:GO_Central.
DR   GO; GO:0045182; F:translation regulator activity; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; TAS:ProtInc.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; ISS:UniProtKB.
DR   GO; GO:2000767; P:positive regulation of cytoplasmic translation; IBA:GO_Central.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:ProtInc.
DR   InterPro; IPR001878; Znf_CCHC.
DR   InterPro; IPR036875; Znf_CCHC_sf.
DR   Pfam; PF00098; zf-CCHC; 7.
DR   SMART; SM00343; ZnF_C2HC; 7.
DR   SUPFAM; SSF57756; SSF57756; 4.
DR   PROSITE; PS50158; ZF_CCHC; 7.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cytoplasm; DNA-binding;
KW   Endoplasmic reticulum; Metal-binding; Methylation; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..177
FT                   /note="Cellular nucleic acid-binding protein"
FT                   /id="PRO_0000089965"
FT   ZN_FING         4..21
FT                   /note="CCHC-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         52..69
FT                   /note="CCHC-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         72..89
FT                   /note="CCHC-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         96..113
FT                   /note="CCHC-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         117..134
FT                   /note="CCHC-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         135..152
FT                   /note="CCHC-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   ZN_FING         156..173
FT                   /note="CCHC-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00047"
FT   COMPBIAS        22..42
FT                   /note="Arg/Gly-rich"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P53996"
FT   MOD_RES         25
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   MOD_RES         27
FT                   /note="Omega-N-methylarginine; by PRMT1"
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   MOD_RES         49
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P53996"
FT   MOD_RES         79
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   VAR_SEQ         35..51
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_055084"
FT   VAR_SEQ         36..42
FT                   /note="Missing (in isoform 2, isoform 5 and isoform 8)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.4"
FT                   /id="VSP_010981"
FT   VAR_SEQ         42..51
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_010982"
FT   VAR_SEQ         72
FT                   /note="D -> DE (in isoform 4 and isoform 8)"
FT                   /evidence="ECO:0000303|Ref.4, ECO:0000303|Ref.6"
FT                   /id="VSP_043304"
FT   VAR_SEQ         72
FT                   /note="D -> DVE (in isoform 5 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.4"
FT                   /id="VSP_043424"
FT   MUTAGEN         25
FT                   /note="R->K: Significantly reduces methylation; when
FT                   associated with K-27."
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   MUTAGEN         27
FT                   /note="R->K: Significantly reduces methylation; when
FT                   associated with K-25."
FT                   /evidence="ECO:0000269|PubMed:24726729"
FT   CONFLICT        6
FT                   /note="C -> R (in Ref. 5; BAF84808)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P62633-2:32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-2:34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-4:80
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-5:32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-5:34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-8:32
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-8:34
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         P62633-8:73
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
SQ   SEQUENCE   177 AA;  19463 MW;  996F398285F52618 CRC64;
     MSSNECFKCG RSGHWARECP TGGGRGRGMR SRGRGGFTSD RGFQFVSSSL PDICYRCGES
     GHLAKDCDLQ EDACYNCGRG GHIAKDCKEP KREREQCCYN CGKPGHLARD CDHADEQKCY
     SCGEFGHIQK DCTKVKCYRC GETGHVAINC SKTSEVNCYR CGESGHLARE CTIEATA
//
ID   B2RA75_HUMAN            Unreviewed;       519 AA.
AC   B2RA75;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   11-DEC-2019, entry version 71.
DE   SubName: Full=cDNA, FLJ94739, highly similar to Homo sapiens cAMP responsive element binding protein 3-like 1 (CREB3L1), mRNA {ECO:0000313|EMBL:BAG36772.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG36772.1};
RN   [1] {ECO:0000313|EMBL:BAG36772.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG36772.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK314072; BAG36772.1; -; mRNA.
DR   RefSeq; NP_443086.1; NM_052854.3.
DR   PeptideAtlas; B2RA75; -.
DR   PRIDE; B2RA75; -.
DR   GeneID; 90993; -.
DR   KEGG; hsa:90993; -.
DR   CTD; 90993; -.
DR   eggNOG; KOG0709; Eukaryota.
DR   eggNOG; ENOG410ZZQM; LUCA.
DR   KO; K09048; -.
DR   OrthoDB; 644485at2759; -.
DR   GenomeRNAi; 90993; -.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0035497; F:cAMP response element binding; IEA:InterPro.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; IEA:InterPro.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IEA:InterPro.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR001630; Leuzip_CREB.
DR   InterPro; IPR029805; OASIS.
DR   PANTHER; PTHR46004:SF1; PTHR46004:SF1; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PRINTS; PR00041; LEUZIPPRCREB.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils}.
FT   DOMAIN          290..353
FT                   /note="BZIP"
FT                   /evidence="ECO:0000259|PROSITE:PS50217"
FT   REGION          71..98
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          200..259
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          478..519
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          336..359
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        82..96
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        207..251
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   519 AA;  57063 MW;  3D37E8B9195453D0 CRC64;
     MDAVLEPFPA DRLFPGSSFL DLGDLNESDF LNNAHFPEHL DHFTENMEDF SNDLFSSFFD
     DPVLDEKSPL LDMELDSPTP GIQAEHSYSL SGDSAPQSPL VPIKMEDTTQ DAEHGAWALG
     HKLCSIMVKQ EQSPELPVDP LAAPSAMAAA AAMATTPLLG LSPLSRLPIP HQAPGEMTQL
     PVIKAEPLEV NQFLKVTPED LVQMPPTPPS SHGSDSDGSQ SPRSLPPSSP VRPMARSSTA
     ISTSPLLTAP HKLQGTSGPL LLTEEEKRTL IAEGYPIPTK LPLTKAEEKA LKRVRRKIKN
     KISAQESRRK KKEYVECLEK KVETFTSENN ELWKKVETLE NANRTLLQQL QKLQTLVTNK
     ISRPYKMAAT QTGTCLMVAA LCFVLVLGSL VPCLPEFSSG SQTVKEDPLV ADGVYTASQM
     PSRSLLFYDD GAGLWEDGRS TLLPMEPPDG WEINPGGPAE QRPRDHLQHD HLDSTHETTK
     YLSEAWPKDS GNGTSPDFSH SKEWFHDRDL GPNTTIKLS
//
ID   CR3L1_HUMAN             Reviewed;         519 AA.
AC   Q96BA8; Q8N2D5; Q96CP0;
DT   29-MAY-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-DEC-2001, sequence version 1.
DT   22-APR-2020, entry version 162.
DE   RecName: Full=Cyclic AMP-responsive element-binding protein 3-like protein 1;
DE            Short=cAMP-responsive element-binding protein 3-like protein 1;
DE   AltName: Full=Old astrocyte specifically-induced substance;
DE            Short=OASIS;
DE   Contains:
DE     RecName: Full=Processed cyclic AMP-responsive element-binding protein 3-like protein 1;
GN   Name=CREB3L1; Synonyms=OASIS; ORFNames=PSEC0238;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), DNA-BINDING, ALTERNATIVE SPLICING
RP   (ISOFORM 2), SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12054625; DOI=10.1016/s0006-291x(02)00253-x;
RA   Omori Y., Imai J., Suzuki Y., Watanabe S., Tanigami A., Sugano S.;
RT   "OASIS is a transcriptional activator of CREB/ATF family with a
RT   transmembrane domain.";
RL   Biochem. Biophys. Res. Commun. 293:470-477(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 253-519.
RC   TISSUE=Embryo;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   SUBCELLULAR LOCATION, MUTAGENESIS OF PRO-392; ARG-423 AND LEU-426, AND
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=16417584; DOI=10.1111/j.1471-4159.2005.03596.x;
RA   Murakami T., Kondo S., Ogata M., Kanemoto S., Saito A., Wanaka A.,
RA   Imaizumi K.;
RT   "Cleavage of the membrane-bound transcription factor OASIS in response to
RT   endoplasmic reticulum stress.";
RL   J. Neurochem. 96:1090-1100(2006).
RN   [5]
RP   FUNCTION IN VIRAL INFECTIONS, IDENTIFICATION OF TARGET GENES, SUBCELLULAR
RP   LOCATION, PROTEOLYTIC CLEAVAGE, AND MUTAGENESIS OF PRO-392; PRO-395 AND
RP   ARG-423.
RX   PubMed=21767813; DOI=10.1016/j.chom.2011.06.006;
RA   Denard B., Seemann J., Chen Q., Gay A., Huang H., Chen Y., Ye J.;
RT   "The membrane-bound transcription factor CREB3L1 is activated in response
RT   to virus infection to inhibit proliferation of virus-infected cells.";
RL   Cell Host Microbe 10:65-74(2011).
RN   [6]
RP   UBIQUITINATION.
RX   PubMed=22705851; DOI=10.1038/cdd.2012.77;
RA   Kondo S., Hino S.I., Saito A., Kanemoto S., Kawasaki N., Asada R.,
RA   Izumi S., Iwamoto H., Oki M., Miyagi H., Kaneko M., Nomura Y., Urano F.,
RA   Imaizumi K.;
RT   "Activation of OASIS family, ER stress transducers, is dependent on its
RT   stabilization.";
RL   Cell Death Differ. 19:1939-1949(2012).
RN   [7]
RP   FUNCTION, SUBCELLULAR LOCATION, PROTEOLYTIC PROCESSING, AND INTERACTION
RP   WITH SMAD4.
RX   PubMed=25310401; DOI=10.1371/journal.pone.0108528;
RA   Chen Q., Lee C.E., Denard B., Ye J.;
RT   "Sustained induction of collagen synthesis by TGF-beta requires regulated
RT   intramembrane proteolysis of CREB3L1.";
RL   PLoS ONE 9:E108528-E108528(2014).
RN   [8]
RP   PROTEOLYTIC PROCESSING.
RX   PubMed=27499293; DOI=10.1016/j.molcel.2016.06.032;
RA   Chen Q., Denard B., Lee C.E., Han S., Ye J.S., Ye J.;
RT   "Inverting the topology of a transmembrane protein by regulating the
RT   translocation of the first transmembrane helix.";
RL   Mol. Cell 63:567-578(2016).
RN   [9]
RP   POSSIBLE INVOLVEMENT IN OI16, AND SUBCELLULAR LOCATION.
RX   PubMed=24079343; DOI=10.1186/1750-1172-8-154;
RA   Symoens S., Malfait F., D'hondt S., Callewaert B., Dheedene A.,
RA   Steyaert W., Baechinger H.P., De Paepe A., Kayserili H., Coucke P.J.;
RT   "Deficiency for the ER-stress transducer OASIS causes severe recessive
RT   osteogenesis imperfecta in humans.";
RL   Orphanet J. Rare Dis. 8:154-154(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-184, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Transcription factor involved in unfolded protein response
CC       (UPR). Binds the DNA consensus sequence 5'-GTGXGCXGC-3'
CC       (PubMed:21767813). In the absence of endoplasmic reticulum (ER) stress,
CC       inserted into ER membranes, with N-terminal DNA-binding and
CC       transcription activation domains oriented toward the cytosolic face of
CC       the membrane. In response to ER stress, transported to the Golgi, where
CC       it is cleaved in a site-specific manner by resident proteases
CC       S1P/MBTPS1 and S2P/MBTPS2. The released N-terminal cytosolic domain is
CC       translocated to the nucleus to effect transcription of specific target
CC       genes. Plays a critical role in bone formation through the
CC       transcription of COL1A1, and possibly COL1A2, and the secretion of bone
CC       matrix proteins. Directly binds to the UPR element (UPRE)-like sequence
CC       in an osteoblast-specific COL1A1 promoter region and induces its
CC       transcription. Does not regulate COL1A1 in other tissues, such as skin
CC       (By similarity). Required to protect astrocytes from ER stress-induced
CC       cell death. In astrocytes, binds to the cAMP response element (CRE) of
CC       the BiP/HSPA5 promoter and participate in its transcriptional
CC       activation (By similarity). Required for TGFB1 to activate genes
CC       involved in the assembly of collagen extracellular matrix
CC       (PubMed:25310401). {ECO:0000250|UniProtKB:Q9Z125,
CC       ECO:0000269|PubMed:12054625, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:25310401}.
CC   -!- FUNCTION: (Microbial infection) May play a role in limiting virus
CC       spread by inhibiting proliferation of virus-infected cells. Upon
CC       infection with diverse DNA and RNA viruses, inhibits cell-cycle
CC       progression by binding to promoters and activating transcription of
CC       genes encoding cell-cycle inhibitors, such as p21/CDKN1A
CC       (PubMed:21767813). {ECO:0000269|PubMed:21767813}.
CC   -!- SUBUNIT: Interacts with SMAD4, the interaction takes place upon TGFB1
CC       induction and SMAD4 acts as CREB3L1 coactivator to induce the
CC       expression of genes involved in assembly of collagen extracellular
CC       matrix. {ECO:0000269|PubMed:25310401}.
CC   -!- INTERACTION:
CC       Q96BA8; Q08AM2: ADAM33; NbExp=3; IntAct=EBI-6942903, EBI-10225815;
CC       Q96BA8; Q9UHX3: ADGRE2; NbExp=3; IntAct=EBI-6942903, EBI-11277970;
CC       Q96BA8; Q15848: ADIPOQ; NbExp=3; IntAct=EBI-6942903, EBI-10827839;
CC       Q96BA8; Q9NRZ7: AGPAT3; NbExp=3; IntAct=EBI-6942903, EBI-2803601;
CC       Q96BA8; Q9NRZ5: AGPAT4; NbExp=3; IntAct=EBI-6942903, EBI-1754287;
CC       Q96BA8; Q9NUQ2: AGPAT5; NbExp=3; IntAct=EBI-6942903, EBI-6916385;
CC       Q96BA8; Q9BVK2: ALG8; NbExp=3; IntAct=EBI-6942903, EBI-3921603;
CC       Q96BA8; Q86W74-2: ANKRD46; NbExp=3; IntAct=EBI-6942903, EBI-12109402;
CC       Q96BA8; Q16853: AOC3; NbExp=3; IntAct=EBI-6942903, EBI-3921628;
CC       Q96BA8; P05090: APOD; NbExp=3; IntAct=EBI-6942903, EBI-715495;
CC       Q96BA8; Q96PS8: AQP10; NbExp=3; IntAct=EBI-6942903, EBI-12820279;
CC       Q96BA8; P41181: AQP2; NbExp=3; IntAct=EBI-6942903, EBI-12701138;
CC       Q96BA8; Q9H2C2: ARV1; NbExp=3; IntAct=EBI-6942903, EBI-11724186;
CC       Q96BA8; P07306: ASGR1; NbExp=3; IntAct=EBI-6942903, EBI-1172335;
CC       Q96BA8; O15155: BET1; NbExp=3; IntAct=EBI-6942903, EBI-749204;
CC       Q96BA8; O95393: BMP10; NbExp=3; IntAct=EBI-6942903, EBI-3922513;
CC       Q96BA8; Q12983: BNIP3; NbExp=3; IntAct=EBI-6942903, EBI-749464;
CC       Q96BA8; Q6PL45-2: BRICD5; NbExp=3; IntAct=EBI-6942903, EBI-12244618;
CC       Q96BA8; Q96F05: C11orf24; NbExp=3; IntAct=EBI-6942903, EBI-2836238;
CC       Q96BA8; Q96GQ5: C16orf58; NbExp=3; IntAct=EBI-6942903, EBI-8636004;
CC       Q96BA8; Q8WVX3-2: C4orf3; NbExp=3; IntAct=EBI-6942903, EBI-12003442;
CC       Q96BA8; P01031: C5; NbExp=3; IntAct=EBI-6942903, EBI-8558308;
CC       Q96BA8; Q8NHW4: CCL4L2; NbExp=3; IntAct=EBI-6942903, EBI-10271156;
CC       Q96BA8; P19397: CD53; NbExp=5; IntAct=EBI-6942903, EBI-6657396;
CC       Q96BA8; P21854: CD72; NbExp=5; IntAct=EBI-6942903, EBI-307924;
CC       Q96BA8; A0A0S2Z5R8: CD99L2; NbExp=3; IntAct=EBI-6942903, EBI-16434925;
CC       Q96BA8; Q9BXR6: CFHR5; NbExp=6; IntAct=EBI-6942903, EBI-11579371;
CC       Q96BA8; Q9H5X1: CIAO2A; NbExp=5; IntAct=EBI-6942903, EBI-752069;
CC       Q96BA8; Q9NWW5: CLN6; NbExp=5; IntAct=EBI-6942903, EBI-6165897;
CC       Q96BA8; Q96MX0: CMTM3; NbExp=3; IntAct=EBI-6942903, EBI-7247651;
CC       Q96BA8; Q96FZ5: CMTM7; NbExp=3; IntAct=EBI-6942903, EBI-2807956;
CC       Q96BA8; Q6PI25: CNIH2; NbExp=3; IntAct=EBI-6942903, EBI-12815321;
CC       Q96BA8; Q4VAQ0: COL8A2; NbExp=3; IntAct=EBI-6942903, EBI-10241815;
CC       Q96BA8; P21964: COMT; NbExp=3; IntAct=EBI-6942903, EBI-372265;
CC       Q96BA8; Q5RI15: COX20; NbExp=3; IntAct=EBI-6942903, EBI-2834035;
CC       Q96BA8; Q8N6G5: CSGALNACT2; NbExp=3; IntAct=EBI-6942903, EBI-10267100;
CC       Q96BA8; Q4LDR2: CTXN3; NbExp=3; IntAct=EBI-6942903, EBI-12019274;
CC       Q96BA8; O14569: CYB561D2; NbExp=3; IntAct=EBI-6942903, EBI-717654;
CC       Q96BA8; P78329: CYP4F2; NbExp=3; IntAct=EBI-6942903, EBI-1752413;
CC       Q96BA8; Q9UPQ8: DOLK; NbExp=3; IntAct=EBI-6942903, EBI-8645574;
CC       Q96BA8; Q15125: EBP; NbExp=5; IntAct=EBI-6942903, EBI-3915253;
CC       Q96BA8; P54852: EMP3; NbExp=3; IntAct=EBI-6942903, EBI-3907816;
CC       Q96BA8; O75355-2: ENTPD3; NbExp=3; IntAct=EBI-6942903, EBI-12279764;
CC       Q96BA8; Q9UKR5: ERG28; NbExp=3; IntAct=EBI-6942903, EBI-711490;
CC       Q96BA8; Q7Z2K6: ERMP1; NbExp=3; IntAct=EBI-6942903, EBI-10976398;
CC       Q96BA8; Q7L5A8: FA2H; NbExp=3; IntAct=EBI-6942903, EBI-11337888;
CC       Q96BA8; Q92520: FAM3C; NbExp=4; IntAct=EBI-6942903, EBI-2876774;
CC       Q96BA8; Q96IV6: FAXDC2; NbExp=3; IntAct=EBI-6942903, EBI-12142299;
CC       Q96BA8; Q9UGM5: FETUB; NbExp=3; IntAct=EBI-6942903, EBI-13049494;
CC       Q96BA8; Q14802-3: FXYD3; NbExp=3; IntAct=EBI-6942903, EBI-12175685;
CC       Q96BA8; Q9H0Q3: FXYD6; NbExp=6; IntAct=EBI-6942903, EBI-713304;
CC       Q96BA8; P01350: GAST; NbExp=5; IntAct=EBI-6942903, EBI-3436637;
CC       Q96BA8; Q8WWP7: GIMAP1; NbExp=3; IntAct=EBI-6942903, EBI-11991950;
CC       Q96BA8; Q96F15: GIMAP5; NbExp=3; IntAct=EBI-6942903, EBI-6166686;
CC       Q96BA8; Q9Y3E0: GOLT1B; NbExp=3; IntAct=EBI-6942903, EBI-4402607;
CC       Q96BA8; O14653: GOSR2; NbExp=5; IntAct=EBI-6942903, EBI-4401517;
CC       Q96BA8; Q8TDV0: GPR151; NbExp=3; IntAct=EBI-6942903, EBI-11955647;
CC       Q96BA8; O00155: GPR25; NbExp=7; IntAct=EBI-6942903, EBI-10178951;
CC       Q96BA8; O60883: GPR37L1; NbExp=3; IntAct=EBI-6942903, EBI-2927498;
CC       Q96BA8; Q6Y1H2: HACD2; NbExp=3; IntAct=EBI-6942903, EBI-530257;
CC       Q96BA8; Q01638-2: IL1RL1; NbExp=3; IntAct=EBI-6942903, EBI-12838366;
CC       Q96BA8; Q9Y5U4: INSIG2; NbExp=3; IntAct=EBI-6942903, EBI-8503746;
CC       Q96BA8; P11215: ITGAM; NbExp=3; IntAct=EBI-6942903, EBI-2568251;
CC       Q96BA8; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-6942903, EBI-10266796;
CC       Q96BA8; O00180: KCNK1; NbExp=5; IntAct=EBI-6942903, EBI-3914675;
CC       Q96BA8; O95214: LEPROTL1; NbExp=3; IntAct=EBI-6942903, EBI-750776;
CC       Q96BA8; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-6942903, EBI-2820517;
CC       Q96BA8; Q9UBY5: LPAR3; NbExp=5; IntAct=EBI-6942903, EBI-12033434;
CC       Q96BA8; Q16873: LTC4S; NbExp=5; IntAct=EBI-6942903, EBI-12241118;
CC       Q96BA8; P21145: MAL; NbExp=3; IntAct=EBI-6942903, EBI-3932027;
CC       Q96BA8; Q969L2: MAL2; NbExp=3; IntAct=EBI-6942903, EBI-944295;
CC       Q96BA8; Q13021: MALL; NbExp=3; IntAct=EBI-6942903, EBI-750078;
CC       Q96BA8; Q9Y2E5: MAN2B2; NbExp=3; IntAct=EBI-6942903, EBI-12243024;
CC       Q96BA8; Q9P0N8: MARCH2; NbExp=3; IntAct=EBI-6942903, EBI-10317612;
CC       Q96BA8; Q6N075: MFSD5; NbExp=6; IntAct=EBI-6942903, EBI-3920969;
CC       Q96BA8; O43451: MGAM; NbExp=3; IntAct=EBI-6942903, EBI-2829774;
CC       Q96BA8; Q99735: MGST2; NbExp=3; IntAct=EBI-6942903, EBI-11324706;
CC       Q96BA8; O14880: MGST3; NbExp=3; IntAct=EBI-6942903, EBI-724754;
CC       Q96BA8; Q8IY49-2: MMD2; NbExp=3; IntAct=EBI-6942903, EBI-13349813;
CC       Q96BA8; P11836: MS4A1; NbExp=3; IntAct=EBI-6942903, EBI-2808234;
CC       Q96BA8; Q5J8X5: MS4A13; NbExp=3; IntAct=EBI-6942903, EBI-12070086;
CC       Q96BA8; Q9H115: NAPB; NbExp=3; IntAct=EBI-6942903, EBI-3921185;
CC       Q96BA8; Q9UHE5: NAT8; NbExp=3; IntAct=EBI-6942903, EBI-2863634;
CC       Q96BA8; Q99519: NEU1; NbExp=5; IntAct=EBI-6942903, EBI-721517;
CC       Q96BA8; Q92982: NINJ1; NbExp=3; IntAct=EBI-6942903, EBI-2802124;
CC       Q96BA8; Q9NZG7: NINJ2; NbExp=3; IntAct=EBI-6942903, EBI-10317425;
CC       Q96BA8; Q8IXM6: NRM; NbExp=3; IntAct=EBI-6942903, EBI-10262547;
CC       Q96BA8; P42857: NSG1; NbExp=3; IntAct=EBI-6942903, EBI-6380741;
CC       Q96BA8; Q6UX06: OLFM4; NbExp=3; IntAct=EBI-6942903, EBI-2804156;
CC       Q96BA8; Q8NH19: OR10AG1; NbExp=3; IntAct=EBI-6942903, EBI-13339917;
CC       Q96BA8; Q9P0S3: ORMDL1; NbExp=3; IntAct=EBI-6942903, EBI-1054848;
CC       Q96BA8; Q53FV1: ORMDL2; NbExp=3; IntAct=EBI-6942903, EBI-11075081;
CC       Q96BA8; Q6TCH4: PAQR6; NbExp=3; IntAct=EBI-6942903, EBI-17265310;
CC       Q96BA8; Q9Y5Y5: PEX16; NbExp=3; IntAct=EBI-6942903, EBI-981985;
CC       Q96BA8; E9PRZ2: PGAP2; NbExp=3; IntAct=EBI-6942903, EBI-16438210;
CC       Q96BA8; Q9UHJ9: PGAP2; NbExp=3; IntAct=EBI-6942903, EBI-10321427;
CC       Q96BA8; Q9UHJ9-5: PGAP2; NbExp=6; IntAct=EBI-6942903, EBI-12092917;
CC       Q96BA8; Q6IB11: PGRMC1; NbExp=3; IntAct=EBI-6942903, EBI-10249941;
CC       Q96BA8; P26678: PLN; NbExp=3; IntAct=EBI-6942903, EBI-692836;
CC       Q96BA8; P60201: PLP1; NbExp=3; IntAct=EBI-6942903, EBI-8653150;
CC       Q96BA8; P60201-2: PLP1; NbExp=16; IntAct=EBI-6942903, EBI-12188331;
CC       Q96BA8; Q04941: PLP2; NbExp=3; IntAct=EBI-6942903, EBI-608347;
CC       Q96BA8; Q5VZY2: PLPP4; NbExp=3; IntAct=EBI-6942903, EBI-10485931;
CC       Q96BA8; Q8IY26: PLPP6; NbExp=5; IntAct=EBI-6942903, EBI-11721828;
CC       Q96BA8; Q96GM1: PLPPR2; NbExp=3; IntAct=EBI-6942903, EBI-12955265;
CC       Q96BA8; Q01453: PMP22; NbExp=3; IntAct=EBI-6942903, EBI-2845982;
CC       Q96BA8; Q59EV6: PPGB; NbExp=3; IntAct=EBI-6942903, EBI-14210385;
CC       Q96BA8; O43741: PRKAB2; NbExp=4; IntAct=EBI-6942903, EBI-1053424;
CC       Q96BA8; P43378: PTPN9; NbExp=3; IntAct=EBI-6942903, EBI-742898;
CC       Q96BA8; Q96AA3: RFT1; NbExp=3; IntAct=EBI-6942903, EBI-6269616;
CC       Q96BA8; Q8TEB9: RHBDD1; NbExp=3; IntAct=EBI-6942903, EBI-9916444;
CC       Q96BA8; Q02161-2: RHD; NbExp=3; IntAct=EBI-6942903, EBI-17249212;
CC       Q96BA8; Q5GAN6: RNASE10; NbExp=3; IntAct=EBI-6942903, EBI-12423312;
CC       Q96BA8; Q06455-4: RUNX1T1; NbExp=3; IntAct=EBI-6942903, EBI-10224192;
CC       Q96BA8; Q9NTJ5: SACM1L; NbExp=6; IntAct=EBI-6942903, EBI-3917235;
CC       Q96BA8; Q14162: SCARF1; NbExp=3; IntAct=EBI-6942903, EBI-12056025;
CC       Q96BA8; O00767: SCD; NbExp=3; IntAct=EBI-6942903, EBI-2684237;
CC       Q96BA8; O95968: SCGB1D1; NbExp=3; IntAct=EBI-6942903, EBI-12825395;
CC       Q96BA8; Q96IW7: SEC22A; NbExp=3; IntAct=EBI-6942903, EBI-8652744;
CC       Q96BA8; O75396: SEC22B; NbExp=3; IntAct=EBI-6942903, EBI-1058865;
CC       Q96BA8; P60059: SEC61G; NbExp=5; IntAct=EBI-6942903, EBI-4402709;
CC       Q96BA8; Q9NTN9-2: SEMA4G; NbExp=5; IntAct=EBI-6942903, EBI-12913124;
CC       Q96BA8; Q8TD22: SFXN5; NbExp=3; IntAct=EBI-6942903, EBI-17274136;
CC       Q96BA8; Q13183: SLC13A2; NbExp=3; IntAct=EBI-6942903, EBI-17460043;
CC       Q96BA8; Q8WWT9: SLC13A3; NbExp=3; IntAct=EBI-6942903, EBI-12938720;
CC       Q96BA8; Q7RTY0: SLC16A13; NbExp=3; IntAct=EBI-6942903, EBI-12243266;
CC       Q96BA8; P11169: SLC2A3; NbExp=3; IntAct=EBI-6942903, EBI-725116;
CC       Q96BA8; Q8IWU4: SLC30A8; NbExp=9; IntAct=EBI-6942903, EBI-10262251;
CC       Q96BA8; Q96G79: SLC35A4; NbExp=3; IntAct=EBI-6942903, EBI-12363689;
CC       Q96BA8; P78383: SLC35B1; NbExp=3; IntAct=EBI-6942903, EBI-12147661;
CC       Q96BA8; Q8TB61: SLC35B2; NbExp=5; IntAct=EBI-6942903, EBI-1054782;
CC       Q96BA8; Q969S0: SLC35B4; NbExp=8; IntAct=EBI-6942903, EBI-10281213;
CC       Q96BA8; Q9NQQ7-3: SLC35C2; NbExp=3; IntAct=EBI-6942903, EBI-17295964;
CC       Q96BA8; Q9NP94: SLC39A2; NbExp=3; IntAct=EBI-6942903, EBI-12898013;
CC       Q96BA8; Q9NUM3: SLC39A9; NbExp=3; IntAct=EBI-6942903, EBI-2823239;
CC       Q96BA8; Q9NWF4: SLC52A1; NbExp=3; IntAct=EBI-6942903, EBI-12904614;
CC       Q96BA8; P30825: SLC7A1; NbExp=5; IntAct=EBI-6942903, EBI-4289564;
CC       Q96BA8; Q9NRQ5: SMCO4; NbExp=3; IntAct=EBI-6942903, EBI-8640191;
CC       Q96BA8; B2RUZ4: SMIM1; NbExp=3; IntAct=EBI-6942903, EBI-12188413;
CC       Q96BA8; Q08629: SPOCK1; NbExp=3; IntAct=EBI-6942903, EBI-2682560;
CC       Q96BA8; Q14534: SQLE; NbExp=3; IntAct=EBI-6942903, EBI-3905171;
CC       Q96BA8; Q13277: STX3; NbExp=3; IntAct=EBI-6942903, EBI-1394295;
CC       Q96BA8; O15400: STX7; NbExp=5; IntAct=EBI-6942903, EBI-3221827;
CC       Q96BA8; Q9UNK0: STX8; NbExp=5; IntAct=EBI-6942903, EBI-727240;
CC       Q96BA8; O43759-2: SYNGR1; NbExp=3; IntAct=EBI-6942903, EBI-12187159;
CC       Q96BA8; P57105: SYNJ2BP; NbExp=3; IntAct=EBI-6942903, EBI-1049004;
CC       Q96BA8; Q9NZ01: TECR; NbExp=3; IntAct=EBI-6942903, EBI-2877718;
CC       Q96BA8; Q9Y6I9: TEX264; NbExp=3; IntAct=EBI-6942903, EBI-10329860;
CC       Q96BA8; P02786: TFRC; NbExp=3; IntAct=EBI-6942903, EBI-355727;
CC       Q96BA8; O14925: TIMM23; NbExp=3; IntAct=EBI-6942903, EBI-1047996;
CC       Q96BA8; Q9NPL8: TIMMDC1; NbExp=3; IntAct=EBI-6942903, EBI-6268651;
CC       Q96BA8; Q96CP7: TLCD1; NbExp=3; IntAct=EBI-6942903, EBI-11337932;
CC       Q96BA8; P55061: TMBIM6; NbExp=3; IntAct=EBI-6942903, EBI-1045825;
CC       Q96BA8; P17152: TMEM11; NbExp=6; IntAct=EBI-6942903, EBI-723946;
CC       Q96BA8; A0PK00: TMEM120B; NbExp=5; IntAct=EBI-6942903, EBI-10171534;
CC       Q96BA8; Q9BVK8: TMEM147; NbExp=9; IntAct=EBI-6942903, EBI-348587;
CC       Q96BA8; Q9Y6G1: TMEM14A; NbExp=5; IntAct=EBI-6942903, EBI-2800360;
CC       Q96BA8; Q9NUH8: TMEM14B; NbExp=3; IntAct=EBI-6942903, EBI-8638294;
CC       Q96BA8; Q9P0S9: TMEM14C; NbExp=5; IntAct=EBI-6942903, EBI-2339195;
CC       Q96BA8; I3L0A0: TMEM189-UBE2V1; NbExp=3; IntAct=EBI-6942903, EBI-12213001;
CC       Q96BA8; Q96HH6: TMEM19; NbExp=3; IntAct=EBI-6942903, EBI-741829;
CC       Q96BA8; Q969S6: TMEM203; NbExp=3; IntAct=EBI-6942903, EBI-12274070;
CC       Q96BA8; Q9BTX3: TMEM208; NbExp=3; IntAct=EBI-6942903, EBI-12876824;
CC       Q96BA8; A2RU14: TMEM218; NbExp=7; IntAct=EBI-6942903, EBI-10173151;
CC       Q96BA8; Q9H0R3: TMEM222; NbExp=3; IntAct=EBI-6942903, EBI-347385;
CC       Q96BA8; Q8NBD8: TMEM229B; NbExp=3; IntAct=EBI-6942903, EBI-12195227;
CC       Q96BA8; Q8WY98: TMEM234; NbExp=3; IntAct=EBI-6942903, EBI-8642211;
CC       Q96BA8; Q8WW34-2: TMEM239; NbExp=3; IntAct=EBI-6942903, EBI-11528917;
CC       Q96BA8; P56557: TMEM50B; NbExp=3; IntAct=EBI-6942903, EBI-12366453;
CC       Q96BA8; Q8N2M4: TMEM86A; NbExp=3; IntAct=EBI-6942903, EBI-12015604;
CC       Q96BA8; P01375: TNF; NbExp=3; IntAct=EBI-6942903, EBI-359977;
CC       Q96BA8; O14798: TNFRSF10C; NbExp=3; IntAct=EBI-6942903, EBI-717441;
CC       Q96BA8; Q9H2S6-2: TNMD; NbExp=3; IntAct=EBI-6942903, EBI-12003398;
CC       Q96BA8; Q8N609: TRAM1L1; NbExp=3; IntAct=EBI-6942903, EBI-11996766;
CC       Q96BA8; O60636: TSPAN2; NbExp=3; IntAct=EBI-6942903, EBI-3914288;
CC       Q96BA8; P30536: TSPO; NbExp=7; IntAct=EBI-6942903, EBI-6623146;
CC       Q96BA8; Q5TGU0: TSPO2; NbExp=5; IntAct=EBI-6942903, EBI-12195249;
CC       Q96BA8; Q9Y5Z9: UBIAD1; NbExp=3; IntAct=EBI-6942903, EBI-2819725;
CC       Q96BA8; Q9H1C4: UNC93B1; NbExp=3; IntAct=EBI-6942903, EBI-4401271;
CC       Q96BA8; P23763-3: VAMP1; NbExp=3; IntAct=EBI-6942903, EBI-12097582;
CC       Q96BA8; P63027: VAMP2; NbExp=3; IntAct=EBI-6942903, EBI-520113;
CC       Q96BA8; Q9BQB6: VKORC1; NbExp=3; IntAct=EBI-6942903, EBI-6256462;
CC       Q96BA8; Q14508: WFDC2; NbExp=3; IntAct=EBI-6942903, EBI-723529;
CC       Q96BA8; Q96EC8: YIPF6; NbExp=3; IntAct=EBI-6942903, EBI-751210;
CC       Q96BA8; Q96MV8: ZDHHC15; NbExp=5; IntAct=EBI-6942903, EBI-12837904;
CC       Q96BA8; Q8N966: ZDHHC22; NbExp=3; IntAct=EBI-6942903, EBI-10268111;
CC       Q96BA8; O95159: ZFPL1; NbExp=5; IntAct=EBI-6942903, EBI-718439;
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:12054625, ECO:0000269|PubMed:16417584,
CC       ECO:0000269|PubMed:25310401}; Single-pass type II membrane protein.
CC       Note=ER membrane resident protein. Upon ER stress, translocated to the
CC       Golgi apparatus where it is cleaved. The cytosolic N-terminal fragment
CC       (processed cyclic AMP-responsive element-binding protein 3-like protein
CC       1) is transported into the nucleus. {ECO:0000269|PubMed:12054625,
CC       ECO:0000269|PubMed:16417584, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:25310401}.
CC   -!- SUBCELLULAR LOCATION: [Processed cyclic AMP-responsive element-binding
CC       protein 3-like protein 1]: Nucleus {ECO:0000269|PubMed:24079343,
CC       ECO:0000269|PubMed:25310401}. Note=Upon ER stress, transported into the
CC       nucleus. {ECO:0000269|PubMed:12054625, ECO:0000269|PubMed:21767813,
CC       ECO:0000269|PubMed:24079343, ECO:0000269|PubMed:25310401}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96BA8-1; Sequence=Displayed;
CC       Name=2; Synonyms=OASISv1;
CC         IsoId=Q96BA8-2; Sequence=VSP_025632;
CC   -!- TISSUE SPECIFICITY: Expressed in several tissues, with highest levels
CC       in pancreas and prostate. Expressed at relatively lower levels in
CC       brain. {ECO:0000269|PubMed:12054625}.
CC   -!- PTM: Upon ER stress, translocated to the Golgi apparatus, where it is
CC       processed by regulated intramembrane proteolysis (RIP) to release the
CC       cytosol-facing N-terminal transcription factor domain. The cleavage is
CC       performed sequentially by site-1 and site-2 proteases (S1P/MBTPS1 and
CC       S2P/MBTPS2). RIP is induced by TGFB1 and ceramide (PubMed:25310401,
CC       PubMed:27499293). {ECO:0000269|PubMed:16417584,
CC       ECO:0000269|PubMed:21767813, ECO:0000269|PubMed:25310401,
CC       ECO:0000269|PubMed:27499293}.
CC   -!- PTM: N-glycosylated. {ECO:0000250|UniProtKB:Q9Z125}.
CC   -!- PTM: Ubiquitinated by HRD1/SYVN1; undergoes 'Lys-48'-linked
CC       ubiquitination, followed by rapid proteasomal degradation under normal
CC       conditions. Upon ER stress, SYVN1 E3 ubiquitin-protein ligase
CC       dissociates from its substrate, ubiquitination does not occur and
CC       CREB3L1 is stabilized. {ECO:0000269|PubMed:22705851}.
CC   -!- DISEASE: Osteogenesis imperfecta 16 (OI16) [MIM:616229]: An autosomal
CC       recessive form of osteogenesis imperfecta, a connective tissue disorder
CC       characterized by low bone mass, bone fragility and susceptibility to
CC       fractures after minimal trauma. Disease severity ranges from very mild
CC       forms without fractures to intrauterine fractures and perinatal
CC       lethality. Extraskeletal manifestations, which affect a variable number
CC       of patients, are dentinogenesis imperfecta, hearing loss, and blue
CC       sclerae. OI16 is a severe form. {ECO:0000269|PubMed:24079343}. Note=The
CC       disease may be caused by mutations affecting the gene represented in
CC       this entry. OI16 affected patients show a genomic deletion encompassing
CC       CREB3L1 and the first exon of DGKZ. The absence of this exon does not
CC       affect all DGKZ isoforms, some are still produced at normal level. It
CC       cannot be ruled out that DGKZ could contribute to the phenotype, but in
CC       view of its role in bone formation, CREB3L1 is a strong OI16-causing
CC       candidate (PubMed:24079343). This hypothesis is corroborated by the
CC       observation of CREB3L1 knockout mice which exhibit features reminiscent
CC       of severe human osteogenesis imperfecta. {ECO:0000269|PubMed:24079343}.
CC   -!- SIMILARITY: Belongs to the bZIP family. ATF subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11681.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB063321; BAC01278.1; -; mRNA.
DR   EMBL; BC014097; AAH14097.1; -; mRNA.
DR   EMBL; BC015781; AAH15781.1; -; mRNA.
DR   EMBL; AK075538; BAC11681.1; ALT_INIT; mRNA.
DR   CCDS; CCDS53620.1; -. [Q96BA8-1]
DR   RefSeq; NP_443086.1; NM_052854.3. [Q96BA8-1]
DR   SMR; Q96BA8; -.
DR   BioGrid; 124786; 79.
DR   IntAct; Q96BA8; 194.
DR   MINT; Q96BA8; -.
DR   STRING; 9606.ENSP00000481956; -.
DR   iPTMnet; Q96BA8; -.
DR   PhosphoSitePlus; Q96BA8; -.
DR   BioMuta; CREB3L1; -.
DR   DMDM; 74751763; -.
DR   MassIVE; Q96BA8; -.
DR   MaxQB; Q96BA8; -.
DR   PaxDb; Q96BA8; -.
DR   PeptideAtlas; Q96BA8; -.
DR   PRIDE; Q96BA8; -.
DR   ProteomicsDB; 76059; -. [Q96BA8-1]
DR   ProteomicsDB; 76060; -. [Q96BA8-2]
DR   Antibodypedia; 6395; 263 antibodies.
DR   DNASU; 90993; -.
DR   Ensembl; ENST00000621158; ENSP00000481956; ENSG00000157613. [Q96BA8-1]
DR   GeneID; 90993; -.
DR   KEGG; hsa:90993; -.
DR   UCSC; uc021qik.3; human. [Q96BA8-1]
DR   CTD; 90993; -.
DR   DisGeNET; 90993; -.
DR   GeneCards; CREB3L1; -.
DR   HGNC; HGNC:18856; CREB3L1.
DR   HPA; ENSG00000157613; Tissue enhanced (pancreas).
DR   MalaCards; CREB3L1; -.
DR   MIM; 616215; gene.
DR   MIM; 616229; phenotype.
DR   neXtProt; NX_Q96BA8; -.
DR   OpenTargets; ENSG00000157613; -.
DR   Orphanet; 79105; Myxofibrosarcoma.
DR   Orphanet; 216812; Osteogenesis imperfecta type 3.
DR   PharmGKB; PA134960108; -.
DR   eggNOG; KOG0709; Eukaryota.
DR   eggNOG; ENOG410ZZQM; LUCA.
DR   GeneTree; ENSGT00940000159848; -.
DR   HOGENOM; CLU_037638_1_0_1; -.
DR   InParanoid; Q96BA8; -.
DR   KO; K09048; -.
DR   OMA; HLDHFVE; -.
DR   PhylomeDB; Q96BA8; -.
DR   TreeFam; TF316079; -.
DR   Reactome; R-HSA-8874211; CREB3 factors activate genes.
DR   SIGNOR; Q96BA8; -.
DR   ChiTaRS; CREB3L1; human.
DR   GenomeRNAi; 90993; -.
DR   Pharos; Q96BA8; Tbio.
DR   PRO; PR:Q96BA8; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q96BA8; protein.
DR   Bgee; ENSG00000157613; Expressed in nasal cavity epithelium and 184 other tissues.
DR   ExpressionAtlas; Q96BA8; baseline and differential.
DR   Genevisible; Q96BA8; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0016020; C:membrane; IDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035497; F:cAMP response element binding; ISS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:BHF-UCL.
DR   GO; GO:0046332; F:SMAD binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0030968; P:endoplasmic reticulum unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0070278; P:extracellular matrix constituent secretion; ISS:UniProtKB.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:1902236; P:negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0040037; P:negative regulation of fibroblast growth factor receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0010629; P:negative regulation of gene expression; IDA:BHF-UCL.
DR   GO; GO:1903671; P:negative regulation of sprouting angiogenesis; IGI:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:BHF-UCL.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:UniProtKB.
DR   GO; GO:0032967; P:positive regulation of collagen biosynthetic process; IDA:UniProtKB.
DR   GO; GO:1990440; P:positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress; ISS:ParkinsonsUK-UCL.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   InterPro; IPR004827; bZIP.
DR   InterPro; IPR001630; Leuzip_CREB.
DR   InterPro; IPR029805; OASIS.
DR   PANTHER; PTHR46004:SF1; PTHR46004:SF1; 1.
DR   Pfam; PF00170; bZIP_1; 1.
DR   PRINTS; PR00041; LEUZIPPRCREB.
DR   SMART; SM00338; BRLZ; 1.
DR   PROSITE; PS50217; BZIP; 1.
DR   PROSITE; PS00036; BZIP_BASIC; 1.
PE   1: Evidence at protein level;
KW   Activator; Alternative splicing; Developmental protein; DNA-binding;
KW   Endoplasmic reticulum; Glycoprotein; Host-virus interaction;
KW   Isopeptide bond; Membrane; Nucleus; Osteogenesis imperfecta; Polymorphism;
KW   Reference proteome; Signal-anchor; Transcription; Transcription regulation;
KW   Transmembrane; Transmembrane helix; Ubl conjugation;
KW   Unfolded protein response.
FT   CHAIN           1..519
FT                   /note="Cyclic AMP-responsive element-binding protein 3-like
FT                   protein 1"
FT                   /id="PRO_0000288064"
FT   CHAIN           1..?
FT                   /note="Processed cyclic AMP-responsive element-binding
FT                   protein 3-like protein 1"
FT                   /id="PRO_0000296206"
FT   TOPO_DOM        1..374
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        375..395
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        396..519
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          290..353
FT                   /note="bZIP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          1..60
FT                   /note="Required for transcriptional activation"
FT   REGION          292..321
FT                   /note="Basic motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   REGION          332..353
FT                   /note="Leucine-zipper"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00978"
FT   MOTIF           392..395
FT                   /note="S2P recognition"
FT                   /evidence="ECO:0000303|PubMed:21767813"
FT   MOTIF           423..426
FT                   /note="S1P recognition"
FT                   /evidence="ECO:0000303|PubMed:21767813"
FT   COMPBIAS        146..154
FT                   /note="Poly-Ala"
FT   SITE            426..427
FT                   /note="Cleavage; by S1P"
FT                   /evidence="ECO:0000250"
FT   CARBOHYD        492
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        513
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CROSSLNK        184
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         111..198
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_025632"
FT   VARIANT         411
FT                   /note="A -> T (in dbSNP:rs35652107)"
FT                   /id="VAR_032392"
FT   MUTAGEN         392
FT                   /note="P->A: Abolishes proteolytic cleavage by S2P; when
FT                   associated with A-395."
FT                   /evidence="ECO:0000269|PubMed:21767813"
FT   MUTAGEN         392
FT                   /note="P->L: Abolishes proteolytic cleavage by S2P."
FT                   /evidence="ECO:0000269|PubMed:16417584"
FT   MUTAGEN         395
FT                   /note="P->A: Abolishes proteolytic cleavage by S2P; when
FT                   associated with A-392."
FT                   /evidence="ECO:0000269|PubMed:21767813"
FT   MUTAGEN         423
FT                   /note="R->A: Abolishes proteolytic cleavage by S1P."
FT                   /evidence="ECO:0000269|PubMed:16417584,
FT                   ECO:0000269|PubMed:21767813"
FT   MUTAGEN         426
FT                   /note="L->V: Abolishes proteolytic cleavage by S1P."
FT                   /evidence="ECO:0000269|PubMed:16417584"
FT   CONFLICT        249
FT                   /note="A -> P (in Ref. 2; AAH14097)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   519 AA;  57005 MW;  D08133CD8B02A3AC CRC64;
     MDAVLEPFPA DRLFPGSSFL DLGDLNESDF LNNAHFPEHL DHFTENMEDF SNDLFSSFFD
     DPVLDEKSPL LDMELDSPTP GIQAEHSYSL SGDSAPQSPL VPIKMEDTTQ DAEHGAWALG
     HKLCSIMVKQ EQSPELPVDP LAAPSAMAAA AAMATTPLLG LSPLSRLPIP HQAPGEMTQL
     PVIKAEPLEV NQFLKVTPED LVQMPPTPPS SHGSDSDGSQ SPRSLPPSSP VRPMARSSTA
     ISTSPLLTAP HKLQGTSGPL LLTEEEKRTL IAEGYPIPTK LPLTKAEEKA LKRVRRKIKN
     KISAQESRRK KKEYVECLEK KVETFTSENN ELWKKVETLE NANRTLLQQL QKLQTLVTNK
     ISRPYKMAAT QTGTCLMVAA LCFVLVLGSL VPCLPEFSSG SQTVKEDPLA ADGVYTASQM
     PSRSLLFYDD GAGLWEDGRS TLLPMEPPDG WEINPGGPAE QRPRDHLQHD HLDSTHETTK
     YLSEAWPKDG GNGTSPDFSH SKEWFHDRDL GPNTTIKLS
//
ID   DDX10_HUMAN             Reviewed;         875 AA.
AC   Q13206; B2RCQ3; Q5BJD8;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   27-SEP-2005, sequence version 2.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=Probable ATP-dependent RNA helicase DDX10;
DE            EC=3.6.4.13;
DE   AltName: Full=DEAD box protein 10;
GN   Name=DDX10;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8660968; DOI=10.1006/geno.1996.0184;
RA   Savitsky K., Ziv Y., Bar-Shira A., Gilad S., Tagle D.A., Smith S.,
RA   Uziel T., Sfez S., Nahmias J., Sartiel A., Eddy R.L., Shows T.B.,
RA   Collins F.S., Shiloh Y., Rotman G.;
RT   "A human gene (DDX10) encoding a putative DEAD-box RNA helicase at 11q22-
RT   q23.";
RL   Genomics 33:199-206(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RA   Arai Y., Kaneko Y., Kubo T., Arai K., Hosoda F., Ohki M.;
RT   "Molecular analysis of the chromosomal breakpoints and identification of
RT   the repetitive sequences near the breakpoints of NUP98 in therapy-related
RT   leukemia with inv(11)(p15q22).";
RL   Submitted (MAR-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Cerebellum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-4, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [7]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-539 AND SER-831, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-539, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-539, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-780, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7; SER-539; THR-577 AND
RP   SER-831, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-649, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [13]
RP   X-RAY CRYSTALLOGRAPHY (2.15 ANGSTROMS) OF 47-280 IN COMPLEX WITH ADP.
RX   PubMed=20941364; DOI=10.1371/journal.pone.0012791;
RA   Schutz P., Karlberg T., van den Berg S., Collins R., Lehtio L., Hogbom M.,
RA   Holmberg-Schiavone L., Tempel W., Park H.W., Hammarstrom M., Moche M.,
RA   Thorsell A.G., Schuler H.;
RT   "Comparative structural analysis of human DEAD-box RNA helicases.";
RL   PLoS ONE 5:E12791-E12791(2010).
RN   [14]
RP   VARIANT [LARGE SCALE ANALYSIS] VAL-566.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Putative ATP-dependent RNA helicase.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=ATP + H2O = ADP + H(+) + phosphate; Xref=Rhea:RHEA:13065,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:30616,
CC         ChEBI:CHEBI:43474, ChEBI:CHEBI:456216; EC=3.6.4.13;
CC   -!- TISSUE SPECIFICITY: High in testis but widely expressed.
CC   -!- DOMAIN: The Q motif is unique to and characteristic of the DEAD box
CC       family of RNA helicases and controls ATP binding and hydrolysis.
CC   -!- SIMILARITY: Belongs to the DEAD box helicase family. DDX10/DBP4
CC       subfamily. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/DDX10ID35.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U28042; AAC50823.1; -; mRNA.
DR   EMBL; AB040537; BAB18536.1; -; mRNA.
DR   EMBL; AK315216; BAG37650.1; -; mRNA.
DR   EMBL; CH471065; EAW67122.1; -; Genomic_DNA.
DR   EMBL; BC091521; AAH91521.1; -; mRNA.
DR   EMBL; BC093654; AAH93654.1; -; mRNA.
DR   EMBL; BC093656; AAH93656.1; -; mRNA.
DR   CCDS; CCDS8342.1; -.
DR   RefSeq; NP_004389.2; NM_004398.3.
DR   PDB; 2PL3; X-ray; 2.15 A; A=47-280.
DR   PDBsum; 2PL3; -.
DR   SMR; Q13206; -.
DR   BioGrid; 108027; 57.
DR   IntAct; Q13206; 39.
DR   STRING; 9606.ENSP00000314348; -.
DR   iPTMnet; Q13206; -.
DR   PhosphoSitePlus; Q13206; -.
DR   BioMuta; DDX10; -.
DR   DMDM; 76803554; -.
DR   SWISS-2DPAGE; Q13206; -.
DR   EPD; Q13206; -.
DR   jPOST; Q13206; -.
DR   MassIVE; Q13206; -.
DR   MaxQB; Q13206; -.
DR   PaxDb; Q13206; -.
DR   PeptideAtlas; Q13206; -.
DR   PRIDE; Q13206; -.
DR   ProteomicsDB; 59224; -.
DR   Antibodypedia; 1401; 40 antibodies.
DR   Ensembl; ENST00000322536; ENSP00000314348; ENSG00000178105.
DR   GeneID; 1662; -.
DR   KEGG; hsa:1662; -.
DR   UCSC; uc001pkm.4; human.
DR   CTD; 1662; -.
DR   DisGeNET; 1662; -.
DR   GeneCards; DDX10; -.
DR   HGNC; HGNC:2735; DDX10.
DR   HPA; ENSG00000178105; Low tissue specificity.
DR   MIM; 601235; gene.
DR   neXtProt; NX_Q13206; -.
DR   OpenTargets; ENSG00000178105; -.
DR   PharmGKB; PA27200; -.
DR   eggNOG; KOG0342; Eukaryota.
DR   eggNOG; COG0513; LUCA.
DR   GeneTree; ENSGT00550000074980; -.
DR   InParanoid; Q13206; -.
DR   KO; K14776; -.
DR   OMA; YGTLHQD; -.
DR   OrthoDB; 973872at2759; -.
DR   PhylomeDB; Q13206; -.
DR   TreeFam; TF315215; -.
DR   ChiTaRS; DDX10; human.
DR   EvolutionaryTrace; Q13206; -.
DR   GeneWiki; DDX10; -.
DR   GenomeRNAi; 1662; -.
DR   Pharos; Q13206; Tbio.
DR   PRO; PR:Q13206; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q13206; protein.
DR   Bgee; ENSG00000178105; Expressed in testis and 200 other tissues.
DR   ExpressionAtlas; Q13206; baseline and differential.
DR   Genevisible; Q13206; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003724; F:RNA helicase activity; IBA:GO_Central.
DR   GO; GO:0097065; P:anterior head development; IEA:Ensembl.
DR   GO; GO:0006364; P:rRNA processing; IBA:GO_Central.
DR   InterPro; IPR011545; DEAD/DEAH_box_helicase_dom.
DR   InterPro; IPR025313; DUF4217.
DR   InterPro; IPR014001; Helicase_ATP-bd.
DR   InterPro; IPR001650; Helicase_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR000629; RNA-helicase_DEAD-box_CS.
DR   InterPro; IPR014014; RNA_helicase_DEAD_Q_motif.
DR   Pfam; PF00270; DEAD; 1.
DR   Pfam; PF13959; DUF4217; 1.
DR   Pfam; PF00271; Helicase_C; 1.
DR   SMART; SM00487; DEXDc; 1.
DR   SMART; SM01178; DUF4217; 1.
DR   SMART; SM00490; HELICc; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS00039; DEAD_ATP_HELICASE; 1.
DR   PROSITE; PS51192; HELICASE_ATP_BIND_1; 1.
DR   PROSITE; PS51194; HELICASE_CTER; 1.
DR   PROSITE; PS51195; Q_MOTIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; ATP-binding; Helicase; Hydrolase;
KW   Isopeptide bond; Nucleotide-binding; Phosphoprotein; Polymorphism;
KW   Reference proteome; RNA-binding; Ubl conjugation.
FT   CHAIN           1..875
FT                   /note="Probable ATP-dependent RNA helicase DDX10"
FT                   /id="PRO_0000055083"
FT   DOMAIN          100..274
FT                   /note="Helicase ATP-binding"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00541"
FT   DOMAIN          287..448
FT                   /note="Helicase C-terminal"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00542"
FT   NP_BIND         89..91
FT                   /note="ATP"
FT   NP_BIND         113..120
FT                   /note="ATP"
FT   MOTIF           69..97
FT                   /note="Q motif"
FT   MOTIF           222..225
FT                   /note="DEAD box"
FT   BINDING         96
FT                   /note="ATP"
FT   MOD_RES         4
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18220336"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         539
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         555
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q80Y44"
FT   MOD_RES         577
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         780
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         831
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        649
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VARIANT         566
FT                   /note="L -> V (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035840"
FT   CONFLICT        647
FT                   /note="D -> A (in Ref. 1; AAC50823)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        658
FT                   /note="E -> D (in Ref. 1; AAC50823)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        661
FT                   /note="K -> N (in Ref. 1; AAC50823)"
FT                   /evidence="ECO:0000305"
FT   HELIX           47..58
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   TURN            59..62
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           65..67
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           71..73
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           78..86
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           94..104
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          109..112
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           119..133
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           138..140
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          144..147
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           151..164
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   TURN            165..167
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          172..175
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           182..188
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          192..196
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           198..207
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          218..221
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           224..229
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   TURN            230..232
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           233..241
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          247..255
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   HELIX           258..266
FT                   /evidence="ECO:0000244|PDB:2PL3"
FT   STRAND          272..275
FT                   /evidence="ECO:0000244|PDB:2PL3"
SQ   SEQUENCE   875 AA;  100888 MW;  B61BF325921C62FD CRC64;
     MGKTANSPGS GARPDPVRSF NRWKKKHSHR QNKKKQLRKQ LKKPEWQVER ESISRLMQNY
     EKINVNEITR FSDFPLSKKT LKGLQEAQYR LVTEIQKQTI GLALQGKDVL GAAKTGSGKT
     LAFLVPVLEA LYRLQWTSTD GLGVLIISPT RELAYQTFEV LRKVGKNHDF SAGLIIGGKD
     LKHEAERINN INILVCTPGR LLQHMDETVS FHATDLQMLV LDEADRILDM GFADTMNAVI
     ENLPKKRQTL LFSATQTKSV KDLARLSLKN PEYVWVHEKA KYSTPATLEQ NYIVCELQQK
     ISVLYSFLRS HLKKKSIVFF SSCKEVQYLY RVFCRLRPGV SILALHGRQQ QMRRMEVYNE
     FVRKRAAVLF ATDIAARGLD FPAVNWVLQF DCPEDANTYI HRAGRTARYK EDGEALLILL
     PSEKAMVQQL LQKKVPVKEI KINPEKLIDV QKKLESILAQ DQDLKERAQR CFVSYVRSVY
     LMKDKEVFDV SKLPIPEYAL SLGLAVAPRV RFLQKMQKQP TKELVRSQAD KVIEPRAPSL
     TNDEVEEFRA YFNEKMSILQ KGGKRLEGTE HRQDNDTGNE EQEEEEDDEE EMEEKLAKAK
     GSQAPSLPNT SEAQKIKEVP TQFLDRDEEE EDADFLKVKR HNVFGLDLKD EKTLQKKEPS
     KSSIKKKMTK VAEAKKVMKR NFKVNKKITF TDEGELVQQW PQMQKSAIKD AEEDDDTGGI
     NLHKAKERLQ EEDKFDKEEY RKKIKAKHRE KRLKEREARR EANKRQAKAK DEEEAFLDWS
     DDDDDDDDGF DPSTLPDPDK YRSSEDSDSE DMENKISDTK KKQGMKKRSN SEVEDVGPTS
     HNRKKARWDT LEPLDTGLSL AEDEELVLHL LRSQS
//
ID   B4E2U8_HUMAN            Unreviewed;       578 AA.
AC   B4E2U8;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 68.
DE   SubName: Full=cDNA FLJ54478, highly similar to Transcription factor COE1 {ECO:0000313|EMBL:BAG65260.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG65260.1};
RN   [1] {ECO:0000313|EMBL:BAG65260.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Trachea {ECO:0000313|EMBL:BAG65260.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU004489}.
CC   -!- SIMILARITY: Belongs to the COE family. {ECO:0000256|RuleBase:RU004489}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK304438; BAG65260.1; -; mRNA.
DR   RefSeq; NP_001277289.1; NM_001290360.2.
DR   PeptideAtlas; B4E2U8; -.
DR   PRIDE; B4E2U8; -.
DR   GeneID; 1879; -.
DR   CTD; 1879; -.
DR   eggNOG; KOG3836; Eukaryota.
DR   eggNOG; ENOG410XQ9Z; LUCA.
DR   OrthoDB; 817293at2759; -.
DR   GenomeRNAi; 1879; -.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:InterPro.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   CDD; cd11606; COE_DBD; 1.
DR   CDD; cd01175; IPT_COE; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 2.60.40.3180; -; 1.
DR   Gene3D; 4.10.280.10; -; 2.
DR   InterPro; IPR032200; COE_DBD.
DR   InterPro; IPR038173; COE_DBD_sf.
DR   InterPro; IPR032201; COE_HLH.
DR   InterPro; IPR038006; COE_IPT.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR003523; Transcription_factor_COE.
DR   InterPro; IPR018350; Transcription_factor_COE_CS.
DR   PANTHER; PTHR10747; PTHR10747; 1.
DR   Pfam; PF16422; COE1_DBD; 1.
DR   Pfam; PF16423; COE1_HLH; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS01345; COE; 1.
PE   2: Evidence at transcript level;
KW   Developmental protein {ECO:0000256|RuleBase:RU004489};
KW   DNA-binding {ECO:0000256|RuleBase:RU004489};
KW   Metal-binding {ECO:0000256|RuleBase:RU004489};
KW   Nucleus {ECO:0000256|RuleBase:RU004489};
KW   Transcription {ECO:0000256|RuleBase:RU004489};
KW   Transcription regulation {ECO:0000256|RuleBase:RU004489};
KW   Zinc {ECO:0000256|RuleBase:RU004489};
KW   Zinc-finger {ECO:0000256|RuleBase:RU004489}.
FT   DOMAIN          248..332
FT                   /note="IPT/TIG"
FT                   /evidence="ECO:0000259|SMART:SM00429"
FT   REGION          444..467
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   578 AA;  63026 MW;  F617F7E252D128C5 CRC64;
     MKEEPLGSGM NAVRTWMQGA GVLDANTAAQ SGVGLARAHF EKQPPSNLRK SNFFHFVLAL
     YDRQGQPVEI ERTAFVGFVE KEKEANSEKT NNGIHYRLQL LYSNGIRTEQ DFYVRLIDSM
     TKQAIVYEGQ DKNPEMCRVL LTHEIMCSRC CDKKSCGNRN ETPSDPVIID RFFLKFFLKC
     NQNCLKNAGN PRDMRRFQVV VSTTVNVDGH VLAVSDNMFV HNNSKHGRRA RRLDPSEGTP
     SYLEHAATPC IKAISPSEGW TTGGATVIII GDNFFDGLQV IFGTMLVWSE LITPHAIRVQ
     TPPRHIPGVV EVTLSYKSKQ FCKGTPGRFI YTALNEPTID YGFQRLQKVI PRHPGDPERL
     PKEVILKRAA DLVEALYGMP HNNQEIILKR AADIAEALYS VPRNHNQLPA LANTSVHAGM
     MGVNSFSGQL AVNVSEASQA TNQGFTRNSS SVSPHGYVPS TTPQQTNYNS VTTSMNGYGS
     AAMSNLGGSP TFLNGSAANS PYAIVPSSPT MASSTSLPSN CSSSSGIFSF SPANMVSAVK
     QKSAFAPVVR PQTSPPPTCT STNGNSLQAI SGMIVPPM
//
ID   COE1_HUMAN              Reviewed;         591 AA.
AC   Q9UH73; Q8IW11;
DT   28-NOV-2002, integrated into UniProtKB/Swiss-Prot.
DT   10-MAY-2004, sequence version 2.
DT   22-APR-2020, entry version 165.
DE   RecName: Full=Transcription factor COE1;
DE            Short=O/E-1;
DE            Short=OE-1;
DE   AltName: Full=Early B-cell factor;
GN   Name=EBF1; Synonyms=COE1, EBF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 6-591 (ISOFORM 1).
RX   PubMed=10942392;
RA   Gisler R., Jacobsen S.E., Sigvardsson M.;
RT   "Cloning of human early B-cell factor and identification of target genes
RT   suggest a conserved role in B-cell development in man and mouse.";
RL   Blood 96:1457-1464(2000).
RN   [3]
RP   INTERACTION WITH ZNF521.
RX   PubMed=14630787; DOI=10.1182/blood-2003-07-2388;
RA   Bond H.M., Mesuraca M., Carbone E., Bonelli P., Agosti V., Amodio N.,
RA   De Rosa G., Di Nicola M., Gianni A.M., Moore M.A., Hata A., Grieco M.,
RA   Morrone G., Venuta S.;
RT   "Early hematopoietic zinc finger protein (EHZF), the human homolog to mouse
RT   Evi3, is highly expressed in primitive human hematopoietic cells.";
RL   Blood 103:2062-2070(2004).
RN   [4]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-16, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [6]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-16, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 10-351 IN COMPLEX WITH ZINC IONS.
RX   PubMed=20592035; DOI=10.1074/jbc.c110.150482;
RA   Siponen M.I., Wisniewska M., Lehtio L., Johansson I., Svensson L.,
RA   Raszewski G., Nilsson L., Sigvardsson M., Berglund H.;
RT   "Structural determination of functional domains in early B-cell factor
RT   (EBF) family of transcription factors reveals similarities to Rel DNA-
RT   binding proteins and a novel dimerization motif.";
RL   J. Biol. Chem. 285:25875-25879(2010).
CC   -!- FUNCTION: Transcriptional activator which recognizes variations of the
CC       palindromic sequence 5'-ATTCCCNNGGGAATT-3'. {ECO:0000250}.
CC   -!- SUBUNIT: Forms either a homodimer or a heterodimer with a related
CC       family member (By similarity). Interacts with ZNF423 and ZNF521,
CC       leading to prevent EBF1 to bind DNA and activate target genes.
CC       {ECO:0000250, ECO:0000269|PubMed:14630787,
CC       ECO:0000269|PubMed:20592035}.
CC   -!- INTERACTION:
CC       Q9UH73; Q8N5M1: ATPAF2; NbExp=10; IntAct=EBI-765426, EBI-1166928;
CC       Q9UH73; Q8IX15-3: HOMEZ; NbExp=3; IntAct=EBI-765426, EBI-10172004;
CC       Q9UH73; P78424: POU6F2; NbExp=3; IntAct=EBI-765426, EBI-12029004;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q9UH73-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q9UH73-2; Sequence=VSP_012304, VSP_012305;
CC   -!- SIMILARITY: Belongs to the COE family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC038805; AAH38805.1; -; mRNA.
DR   EMBL; BC041178; AAH41178.1; -; mRNA.
DR   EMBL; AF208502; AAF19643.1; -; mRNA.
DR   CCDS; CCDS4343.1; -. [Q9UH73-1]
DR   CCDS; CCDS78081.1; -. [Q9UH73-2]
DR   RefSeq; NP_076870.1; NM_024007.4. [Q9UH73-1]
DR   RefSeq; NP_874367.1; NM_182708.2. [Q9UH73-2]
DR   PDB; 3LYR; X-ray; 2.51 A; A=10-250.
DR   PDB; 3MQI; X-ray; 2.30 A; A/B/C=258-351.
DR   PDBsum; 3LYR; -.
DR   PDBsum; 3MQI; -.
DR   SMR; Q9UH73; -.
DR   BioGrid; 108211; 11.
DR   IntAct; Q9UH73; 6.
DR   STRING; 9606.ENSP00000322898; -.
DR   iPTMnet; Q9UH73; -.
DR   PhosphoSitePlus; Q9UH73; -.
DR   SwissPalm; Q9UH73; -.
DR   BioMuta; EBF1; -.
DR   DMDM; 47117917; -.
DR   MassIVE; Q9UH73; -.
DR   PaxDb; Q9UH73; -.
DR   PeptideAtlas; Q9UH73; -.
DR   PRIDE; Q9UH73; -.
DR   ProteomicsDB; 84280; -. [Q9UH73-1]
DR   ProteomicsDB; 84281; -. [Q9UH73-2]
DR   Antibodypedia; 28482; 178 antibodies.
DR   DNASU; 1879; -.
DR   Ensembl; ENST00000313708; ENSP00000322898; ENSG00000164330. [Q9UH73-1]
DR   Ensembl; ENST00000380654; ENSP00000370029; ENSG00000164330. [Q9UH73-2]
DR   GeneID; 1879; -.
DR   KEGG; hsa:1879; -.
DR   UCSC; uc003lxl.7; human. [Q9UH73-1]
DR   CTD; 1879; -.
DR   DisGeNET; 1879; -.
DR   GeneCards; EBF1; -.
DR   HGNC; HGNC:3126; EBF1.
DR   HPA; ENSG00000164330; Low tissue specificity.
DR   MIM; 164343; gene.
DR   neXtProt; NX_Q9UH73; -.
DR   OpenTargets; ENSG00000164330; -.
DR   PharmGKB; PA162384225; -.
DR   eggNOG; KOG3836; Eukaryota.
DR   eggNOG; ENOG410XQ9Z; LUCA.
DR   GeneTree; ENSGT00950000182859; -.
DR   InParanoid; Q9UH73; -.
DR   KO; K09103; -.
DR   OMA; RNGIHYR; -.
DR   OrthoDB; 817293at2759; -.
DR   PhylomeDB; Q9UH73; -.
DR   TreeFam; TF313391; -.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   SIGNOR; Q9UH73; -.
DR   ChiTaRS; EBF1; human.
DR   EvolutionaryTrace; Q9UH73; -.
DR   GeneWiki; EBF1; -.
DR   GenomeRNAi; 1879; -.
DR   Pharos; Q9UH73; Tbio.
DR   PRO; PR:Q9UH73; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   RNAct; Q9UH73; protein.
DR   Bgee; ENSG00000164330; Expressed in forebrain and 204 other tissues.
DR   ExpressionAtlas; Q9UH73; baseline and differential.
DR   Genevisible; Q9UH73; HS.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0070742; F:C2H2 zinc finger domain binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0046983; F:protein dimerization activity; IEA:InterPro.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   CDD; cd11606; COE_DBD; 1.
DR   CDD; cd01175; IPT_COE; 1.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 2.60.40.3180; -; 1.
DR   Gene3D; 4.10.280.10; -; 2.
DR   InterPro; IPR032200; COE_DBD.
DR   InterPro; IPR038173; COE_DBD_sf.
DR   InterPro; IPR032201; COE_HLH.
DR   InterPro; IPR038006; COE_IPT.
DR   InterPro; IPR036638; HLH_DNA-bd_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR014756; Ig_E-set.
DR   InterPro; IPR002909; IPT_dom.
DR   InterPro; IPR003523; Transcription_factor_COE.
DR   InterPro; IPR018350; Transcription_factor_COE_CS.
DR   PANTHER; PTHR10747; PTHR10747; 1.
DR   Pfam; PF16422; COE1_DBD; 1.
DR   Pfam; PF16423; COE1_HLH; 1.
DR   Pfam; PF01833; TIG; 1.
DR   SMART; SM00429; IPT; 1.
DR   SUPFAM; SSF81296; SSF81296; 1.
DR   PROSITE; PS01345; COE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Developmental protein; DNA-binding; Isopeptide bond; Metal-binding;
KW   Nucleus; Reference proteome; Transcription; Transcription regulation;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..591
FT                   /note="Transcription factor COE1"
FT                   /id="PRO_0000107825"
FT   DOMAIN          262..345
FT                   /note="IPT/TIG"
FT   ZN_FING         151..170
FT                   /note="C5-type"
FT                   /evidence="ECO:0000250|UniProtKB:Q07802"
FT   REGION          63..66
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q07802"
FT   REGION          197..204
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q07802"
FT   REGION          236..239
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q07802"
FT   COMPBIAS        462..550
FT                   /note="Pro/Ser/Thr-rich"
FT   SITE            163
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q07802"
FT   SITE            172
FT                   /note="Interaction with DNA"
FT                   /evidence="ECO:0000250|UniProtKB:Q07802"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        16
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         162..184
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012304"
FT   VAR_SEQ         252..259
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_012305"
FT   CONFLICT        112
FT                   /note="L -> I (in Ref. 2; AAF19643)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        147
FT                   /note="N -> S (in Ref. 2; AAF19643)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        228..229
FT                   /note="VS -> AP (in Ref. 2; AAF19643)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        305..306
FT                   /note="IT -> TG (in Ref. 2; AAF19643)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        309
FT                   /note="A -> S (in Ref. 2; AAF19643)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        347
FT                   /note="L -> R (in Ref. 2; AAF19643)"
FT                   /evidence="ECO:0000305"
FT   HELIX           25..31
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          36..38
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   HELIX           39..43
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   TURN            44..46
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          49..56
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          60..63
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          66..76
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          83..93
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   HELIX           95..97
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   HELIX           99..101
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          108..115
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          121..132
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   TURN            133..135
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          152..155
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   HELIX           158..160
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   HELIX           162..165
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   TURN            171..175
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          181..183
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   TURN            184..186
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          187..194
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          211..219
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          223..228
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          232..235
FT                   /evidence="ECO:0000244|PDB:3LYR"
FT   STRAND          263..268
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          271..273
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          279..286
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          292..295
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          298..300
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          302..306
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          309..313
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          321..329
FT                   /evidence="ECO:0000244|PDB:3MQI"
FT   STRAND          340..345
FT                   /evidence="ECO:0000244|PDB:3MQI"
SQ   SEQUENCE   591 AA;  64464 MW;  E47797B6FC1E5071 CRC64;
     MFGIQESIQR SGSSMKEEPL GSGMNAVRTW MQGAGVLDAN TAAQSGVGLA RAHFEKQPPS
     NLRKSNFFHF VLALYDRQGQ PVEIERTAFV GFVEKEKEAN SEKTNNGIHY RLQLLYSNGI
     RTEQDFYVRL IDSMTKQAIV YEGQDKNPEM CRVLLTHEIM CSRCCDKKSC GNRNETPSDP
     VIIDRFFLKF FLKCNQNCLK NAGNPRDMRR FQVVVSTTVN VDGHVLAVSD NMFVHNNSKH
     GRRARRLDPS EGTPSYLEHA TPCIKAISPS EGWTTGGATV IIIGDNFFDG LQVIFGTMLV
     WSELITPHAI RVQTPPRHIP GVVEVTLSYK SKQFCKGTPG RFIYTALNEP TIDYGFQRLQ
     KVIPRHPGDP ERLPKEVILK RAADLVEALY GMPHNNQEII LKRAADIAEA LYSVPRNHNQ
     LPALANTSVH AGMMGVNSFS GQLAVNVSEA SQATNQGFTR NSSSVSPHGY VPSTTPQQTN
     YNSVTTSMNG YGSAAMSNLG GSPTFLNGSA ANSPYAIVPS SPTMASSTSL PSNCSSSSGI
     FSFSPANMVS AVKQKSAFAP VVRPQTSPPP TCTSTNGNSL QAISGMIVPP M
//
ID   EIF3E_HUMAN             Reviewed;         445 AA.
AC   P60228; O43902; Q64058; Q64059; Q64252; Q6FG33; Q8WVK4;
DT   16-JAN-2004, integrated into UniProtKB/Swiss-Prot.
DT   16-JAN-2004, sequence version 1.
DT   22-APR-2020, entry version 180.
DE   RecName: Full=Eukaryotic translation initiation factor 3 subunit E {ECO:0000255|HAMAP-Rule:MF_03004};
DE            Short=eIF3e {ECO:0000255|HAMAP-Rule:MF_03004};
DE   AltName: Full=Eukaryotic translation initiation factor 3 subunit 6 {ECO:0000255|HAMAP-Rule:MF_03004};
DE   AltName: Full=Viral integration site protein INT-6 homolog;
DE   AltName: Full=eIF-3 p48 {ECO:0000255|HAMAP-Rule:MF_03004};
GN   Name=EIF3E {ECO:0000255|HAMAP-Rule:MF_03004};
GN   Synonyms=EIF3S6 {ECO:0000255|HAMAP-Rule:MF_03004},
GN   INT6 {ECO:0000255|HAMAP-Rule:MF_03004};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PROTEIN SEQUENCE OF 280-289 AND 427-436,
RP   INTERACTION WITH EIF3A, IDENTIFICATION IN THE EIF-3 COMPLEX, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Liver;
RX   PubMed=9295280; DOI=10.1074/jbc.272.38.23477;
RA   Asano K., Merrick W.C., Hershey J.W.B.;
RT   "The translation initiation factor eIF3-p48 subunit is encoded by int-6, a
RT   site of frequent integration by the mouse mammary tumor virus genome.";
RL   J. Biol. Chem. 272:23477-23480(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RC   TISSUE=Lung;
RX   PubMed=9403073; DOI=10.1006/geno.1997.4996;
RA   Miyazaki S., Imatani A., Ballard L., Marchetti A., Buttitta F.,
RA   Albertsen H., Nevanlinna H.A., Gallahan D., Callahan R.;
RT   "The chromosome location of the human homolog of the mouse mammary tumor-
RT   associated gene INT6 and its status in human breast carcinomas.";
RL   Genomics 46:155-158(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH TAX-1, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=8688078; DOI=10.1126/science.273.5277.951;
RA   Desbois C., Rousset R., Bantignies F., Jalinot P.;
RT   "Exclusion of Int-6 from PML nuclear bodies by binding to the HTLV-I Tax
RT   oncoprotein.";
RL   Science 273:951-953(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH TAX-1, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=12386384; DOI=10.1007/bf02253422;
RA   Neuvert C., Jin D.-Y., Semmes O.J., Diella F., Callahan R., Jeang K.-T.;
RT   "Divergent subcellular locations of HTLV-I Tax and Int-6: a contrast
RT   between in vitro protein-protein binding and intracellular protein
RT   colocalization.";
RL   J. Biomed. Sci. 4:229-234(1997).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT VAL-185.
RC   TISSUE=Bone marrow, Brain, Lung, and Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PROTEIN SEQUENCE OF 2-9; 60-71; 164-172; 256-265 AND 370-376, CLEAVAGE OF
RP   INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Colon carcinoma, and Mammary carcinoma;
RA   Bienvenut W.V., Heiserich L., Gottlieb E., Matallanas D., Cooper W.N.,
RA   Kolch W.;
RL   Submitted (MAR-2008) to UniProtKB.
RN   [9]
RP   INTERACTION WITH EIF3C AND TRIM27, AND SUBCELLULAR LOCATION.
RX   PubMed=10504338;
RA   Morris-Desbois C., Bochard V., Reynaud C., Jalinot P.;
RT   "Interaction between the Ret finger protein and the Int-6 gene product and
RT   co-localisation into nuclear bodies.";
RL   J. Cell Sci. 112:3331-3342(1999).
RN   [10]
RP   INTERACTION WITH EIF3B.
RX   PubMed=11457827; DOI=10.1074/jbc.m102161200;
RA   Shalev A., Valasek L., Pise-Masison C.A., Radonovich M., Phan L.,
RA   Clayton J., He H., Brady J.N., Hinnebusch A.G., Asano K.;
RT   "Saccharomyces cerevisiae protein Pci8p and human protein eIF3e/Int-6
RT   interact with the eIF3 core complex by binding to cognate eIF3b subunits.";
RL   J. Biol. Chem. 276:34948-34957(2001).
RN   [11]
RP   INTERACTION WITH EIF3L.
RX   PubMed=11590142; DOI=10.1074/jbc.m104966200;
RA   Morris-Desbois C., Rety S., Ferro M., Garin J., Jalinot P.;
RT   "The human protein HSPC021 interacts with Int-6 and is associated with
RT   eukaryotic translation initiation factor 3.";
RL   J. Biol. Chem. 276:45988-45995(2001).
RN   [12]
RP   INTERACTION WITH COPS3; COPS6; COPS7 AND PSMC6.
RX   PubMed=12220626; DOI=10.1016/s0014-5793(02)03147-2;
RA   Hoareau Alves K., Bochard V., Rety S., Jalinot P.;
RT   "Association of the mammalian proto-oncoprotein Int-6 with the three
RT   protein complexes eIF3, COP9 signalosome and 26S proteasome.";
RL   FEBS Lett. 527:15-21(2002).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [14]
RP   CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=15703437; DOI=10.1261/rna.7215305;
RA   Kolupaeva V.G., Unbehaun A., Lomakin I.B., Hellen C.U.T., Pestova T.V.;
RT   "Binding of eukaryotic initiation factor 3 to ribosomal 40S subunits and
RT   its role in ribosomal dissociation and anti-association.";
RL   RNA 11:470-486(2005).
RN   [15]
RP   INTERACTION WITH IFIT1.
RX   PubMed=16023166; DOI=10.1016/j.virol.2005.06.011;
RA   Terenzi F., Pal S., Sen G.C.;
RT   "Induction and mode of action of the viral stress-inducible murine
RT   proteins, P56 and P54.";
RL   Virology 340:116-124(2005).
RN   [16]
RP   INTERACTION WITH EIF4G1, IDENTIFICATION IN THE EIF-3 COMPLEX, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16766523; DOI=10.1074/jbc.m605418200;
RA   LeFebvre A.K., Korneeva N.L., Trutschl M., Cvek U., Duzan R.D.,
RA   Bradley C.A., Hershey J.W.B., Rhoads R.E.;
RT   "Translation initiation factor eIF4G-1 binds to eIF3 through the eIF3e
RT   subunit.";
RL   J. Biol. Chem. 281:22917-22932(2006).
RN   [17]
RP   INTERACTION WITH IFIT2.
RX   PubMed=16973618; DOI=10.1074/jbc.m605771200;
RA   Terenzi F., Hui D.J., Merrick W.C., Sen G.C.;
RT   "Distinct induction patterns and functions of two closely related
RT   interferon-inducible human genes, ISG54 and ISG56.";
RL   J. Biol. Chem. 281:34064-34071(2006).
RN   [18]
RP   FUNCTION, AND CHARACTERIZATION OF THE EIF-3 COMPLEX.
RX   PubMed=17581632; DOI=10.1038/sj.emboj.7601765;
RA   Masutani M., Sonenberg N., Yokoyama S., Imataka H.;
RT   "Reconstitution reveals the functional core of mammalian eIF3.";
RL   EMBO J. 26:3373-3383(2007).
RN   [19]
RP   FUNCTION, AND INTERACTION WITH EIF3A; EIF3B; EIF3C; EIF4G1; NCBP1 AND UPF2.
RX   PubMed=17468741; DOI=10.1038/sj.embor.7400955;
RA   Morris C., Wittmann J., Jaeck H.-M., Jalinot P.;
RT   "Human INT6/eIF3e is required for nonsense-mediated mRNA decay.";
RL   EMBO Rep. 8:596-602(2007).
RN   [20]
RP   FUNCTION, AND INTERACTION WITH EPAS1.
RX   PubMed=17324924; DOI=10.1074/jbc.m700423200;
RA   Chen L., Uchida K., Endler A., Shibasaki F.;
RT   "Mammalian tumor suppressor Int6 specifically targets hypoxia inducible
RT   factor 2 alpha for degradation by hypoxia- and pVHL-independent
RT   regulation.";
RL   J. Biol. Chem. 282:12707-12716(2007).
RN   [21]
RP   SUBCELLULAR LOCATION, AND MUTAGENESIS OF LEU-312.
RX   PubMed=17761670; DOI=10.1074/jbc.m706276200;
RA   Sha Z., Yen H.-C.S., Scheel H., Suo J., Hofmann K., Chang E.C.;
RT   "Isolation of the Schizosaccharomyces pombe proteasome subunit Rpn7 and a
RT   structure-function study of the proteasome-COP9-initiation factor domain.";
RL   J. Biol. Chem. 282:32414-32423(2007).
RN   [22]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3 COMPLEX,
RP   CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND MASS
RP   SPECTROMETRY.
RX   PubMed=17322308; DOI=10.1074/mcp.m600399-mcp200;
RA   Damoc E., Fraser C.S., Zhou M., Videler H., Mayeur G.L., Hershey J.W.B.,
RA   Doudna J.A., Robinson C.V., Leary J.A.;
RT   "Structural characterization of the human eukaryotic initiation factor 3
RT   protein complex by mass spectrometry.";
RL   Mol. Cell. Proteomics 6:1135-1146(2007).
RN   [23]
RP   FUNCTION, AND INTERACTION WITH MCM7.
RX   PubMed=17310990; DOI=10.1038/sj.onc.1210314;
RA   Buchsbaum S., Morris C., Bochard V., Jalinot P.;
RT   "Human INT6 interacts with MCM7 and regulates its stability during S phase
RT   of the cell cycle.";
RL   Oncogene 26:5132-5144(2007).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   IDENTIFICATION IN THE EIF-3 COMPLEX, CHARACTERIZATION OF THE EIF-3 COMPLEX,
RP   MASS SPECTROMETRY, AND INTERACTION WITH EIF3B.
RX   PubMed=18599441; DOI=10.1073/pnas.0801313105;
RA   Zhou M., Sandercock A.M., Fraser C.S., Ridlova G., Stephens E.,
RA   Schenauer M.R., Yokoi-Fong T., Barsky D., Leary J.A., Hershey J.W.B.,
RA   Doudna J.A., Robinson C.V.;
RT   "Mass spectrometry reveals modularity and a complete subunit interaction
RT   map of the eukaryotic translation factor eIF3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:18139-18144(2008).
RN   [27]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [31]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-399, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-442, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   FUNCTION, AND IDENTIFICATION IN THE EIF-3 COMPLEX.
RX   PubMed=25849773; DOI=10.1038/nature14267;
RA   Lee A.S., Kranzusch P.J., Cate J.H.;
RT   "eIF3 targets cell-proliferation messenger RNAs for translational
RT   activation or repression.";
RL   Nature 522:111-114(2015).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [36]
RP   FUNCTION.
RX   PubMed=27462815; DOI=10.1038/nature18954;
RA   Lee A.S., Kranzusch P.J., Doudna J.A., Cate J.H.;
RT   "eIF3d is an mRNA cap-binding protein that is required for specialized
RT   translation initiation.";
RL   Nature 536:96-99(2016).
RN   [37]
RP   3D-STRUCTURE MODELING, AND ELECTRON MICROSCOPY.
RX   PubMed=16322461; DOI=10.1126/science.1118977;
RA   Siridechadilok B., Fraser C.S., Hall R.J., Doudna J.A., Nogales E.;
RT   "Structural roles for human translation factor eIF3 in initiation of
RT   protein synthesis.";
RL   Science 310:1513-1515(2005).
CC   -!- FUNCTION: Component of the eukaryotic translation initiation factor 3
CC       (eIF-3) complex, which is required for several steps in the initiation
CC       of protein synthesis (PubMed:17581632, PubMed:25849773,
CC       PubMed:27462815). The eIF-3 complex associates with the 40S ribosome
CC       and facilitates the recruitment of eIF-1, eIF-1A, eIF-2:GTP:methionyl-
CC       tRNAi and eIF-5 to form the 43S pre-initiation complex (43S PIC). The
CC       eIF-3 complex stimulates mRNA recruitment to the 43S PIC and scanning
CC       of the mRNA for AUG recognition. The eIF-3 complex is also required for
CC       disassembly and recycling of post-termination ribosomal complexes and
CC       subsequently prevents premature joining of the 40S and 60S ribosomal
CC       subunits prior to initiation (PubMed:17581632). The eIF-3 complex
CC       specifically targets and initiates translation of a subset of mRNAs
CC       involved in cell proliferation, including cell cycling, differentiation
CC       and apoptosis, and uses different modes of RNA stem-loop binding to
CC       exert either translational activation or repression (PubMed:25849773).
CC       Required for nonsense-mediated mRNA decay (NMD); may act in conjunction
CC       with UPF2 to divert mRNAs from translation to the NMD pathway
CC       (PubMed:17468741). May interact with MCM7 and EPAS1 and regulate the
CC       proteasome-mediated degradation of these proteins (PubMed:17310990,
CC       PubMed:17324924). {ECO:0000255|HAMAP-Rule:MF_03004,
CC       ECO:0000269|PubMed:17310990, ECO:0000269|PubMed:17324924,
CC       ECO:0000269|PubMed:17468741, ECO:0000269|PubMed:17581632,
CC       ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:27462815}.
CC   -!- SUBUNIT: Component of the eukaryotic translation initiation factor 3
CC       (eIF-3) complex, which is composed of 13 subunits: EIF3A, EIF3B, EIF3C,
CC       EIF3D, EIF3E, EIF3F, EIF3G, EIF3H, EIF3I, EIF3J, EIF3K, EIF3L and
CC       EIF3M. The eIF-3 complex appears to include 3 stable modules: module A
CC       is composed of EIF3A, EIF3B, EIF3G and EIF3I; module B is composed of
CC       EIF3F, EIF3H, and EIF3M; and module C is composed of EIF3C, EIF3D,
CC       EIF3E, EIF3K and EIF3L. EIF3C of module C binds EIF3B of module A and
CC       EIF3H of module B, thereby linking the three modules. EIF3J is a labile
CC       subunit that binds to the eIF-3 complex via EIF3B. The eIF-3 complex
CC       interacts with RPS6KB1 under conditions of nutrient depletion.
CC       Mitogenic stimulation leads to binding and activation of a complex
CC       composed of MTOR and RPTOR, leading to phosphorylation and release of
CC       RPS6KB1 and binding of EIF4B to eIF-3. Interacts with COPS3, COPS6,
CC       COPS7 (COPS7A or COPS7B), EIF4G1, EPAS1, MCM7, NCBP1, PSMC6, TRIM27 and
CC       UPF2. Interacts with the HTLV-1 protein Tax-1. Interacts with IFIT1 and
CC       IFIT2. {ECO:0000255|HAMAP-Rule:MF_03004, ECO:0000269|PubMed:10504338,
CC       ECO:0000269|PubMed:11457827, ECO:0000269|PubMed:11590142,
CC       ECO:0000269|PubMed:12220626, ECO:0000269|PubMed:12386384,
CC       ECO:0000269|PubMed:16023166, ECO:0000269|PubMed:16766523,
CC       ECO:0000269|PubMed:16973618, ECO:0000269|PubMed:17310990,
CC       ECO:0000269|PubMed:17322308, ECO:0000269|PubMed:17324924,
CC       ECO:0000269|PubMed:17468741, ECO:0000269|PubMed:18599441,
CC       ECO:0000269|PubMed:25849773, ECO:0000269|PubMed:8688078,
CC       ECO:0000269|PubMed:9295280}.
CC   -!- INTERACTION:
CC       P60228; Q8IY42: C4orf19; NbExp=4; IntAct=EBI-347740, EBI-10216552;
CC       P60228; P04233: CD74; NbExp=2; IntAct=EBI-347740, EBI-2622890;
CC       P60228; Q8IY21: DDX60; NbExp=2; IntAct=EBI-347740, EBI-2807346;
CC       P60228; P55884: EIF3B; NbExp=6; IntAct=EBI-347740, EBI-366696;
CC       P60228; Q99613: EIF3C; NbExp=14; IntAct=EBI-347740, EBI-353741;
CC       P60228; O15371: EIF3D; NbExp=6; IntAct=EBI-347740, EBI-353818;
CC       P60228; Q9UBQ5: EIF3K; NbExp=6; IntAct=EBI-347740, EBI-354344;
CC       P60228; Q9Y262: EIF3L; NbExp=7; IntAct=EBI-347740, EBI-373519;
CC       P60228; Q99814: EPAS1; NbExp=10; IntAct=EBI-347740, EBI-447470;
CC       P60228; O95208-2: EPN2; NbExp=3; IntAct=EBI-347740, EBI-12135243;
CC       P60228; Q86U28: ISCA2; NbExp=3; IntAct=EBI-347740, EBI-10258659;
CC       P60228; Q5T749: KPRP; NbExp=3; IntAct=EBI-347740, EBI-10981970;
CC       P60228; Q5JXC2: MIIP; NbExp=3; IntAct=EBI-347740, EBI-2801965;
CC       P60228; Q6NTE8: MRNIP; NbExp=3; IntAct=EBI-347740, EBI-2857471;
CC       P60228; Q9Q2G4: ORF; Xeno; NbExp=5; IntAct=EBI-347740, EBI-6248094;
CC       P60228; Q59EK9: RUNDC3A; NbExp=4; IntAct=EBI-347740, EBI-747225;
CC       P60228; Q59EK9-3: RUNDC3A; NbExp=3; IntAct=EBI-347740, EBI-11957366;
CC       P60228; P14373: TRIM27; NbExp=7; IntAct=EBI-347740, EBI-719493;
CC       P60228; Q8IUH5: ZDHHC17; NbExp=2; IntAct=EBI-347740, EBI-524753;
CC       P60228; Q96MX3: ZNF48; NbExp=3; IntAct=EBI-347740, EBI-12006434;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Nucleus, PML body.
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed. Expressed at highest levels
CC       in appendix, lymph, pancreas, skeletal muscle, spleen and thymus.
CC       {ECO:0000269|PubMed:8688078, ECO:0000269|PubMed:9295280}.
CC   -!- MASS SPECTROMETRY: Mass=52131.8; Method=Unknown;
CC       Evidence={ECO:0000269|PubMed:17322308};
CC   -!- MASS SPECTROMETRY: Mass=52133.4; Mass_error=0.2; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:18599441};
CC   -!- SIMILARITY: Belongs to the eIF-3 subunit E family. {ECO:0000255|HAMAP-
CC       Rule:MF_03004}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U54562; AAC51760.1; -; mRNA.
DR   EMBL; U94174; AAC51917.1; -; Genomic_DNA.
DR   EMBL; U94162; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94163; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94164; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94165; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94166; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94167; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94168; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94169; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94170; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94171; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94172; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94173; AAC51917.1; JOINED; Genomic_DNA.
DR   EMBL; U94175; AAC51919.1; -; mRNA.
DR   EMBL; U62962; AAB58251.1; -; mRNA.
DR   EMBL; U85947; AAB88873.1; -; mRNA.
DR   EMBL; CR542275; CAG47071.1; -; mRNA.
DR   EMBL; CH471060; EAW91918.1; -; Genomic_DNA.
DR   EMBL; BC000734; AAH00734.1; -; mRNA.
DR   EMBL; BC008419; AAH08419.1; -; mRNA.
DR   EMBL; BC016706; AAH16706.1; -; mRNA.
DR   EMBL; BC017887; AAH17887.1; -; mRNA.
DR   EMBL; BC021679; AAH21679.1; -; mRNA.
DR   CCDS; CCDS6308.1; -.
DR   RefSeq; NP_001559.1; NM_001568.2.
DR   PDB; 3J8B; EM; -; E=1-395.
DR   PDB; 3J8C; EM; -; E=1-395.
DR   PDB; 6FEC; EM; 6.30 A; 3=1-445.
DR   PDBsum; 3J8B; -.
DR   PDBsum; 3J8C; -.
DR   PDBsum; 6FEC; -.
DR   SMR; P60228; -.
DR   BioGrid; 109857; 145.
DR   CORUM; P60228; -.
DR   DIP; DIP-32691N; -.
DR   IntAct; P60228; 76.
DR   MINT; P60228; -.
DR   STRING; 9606.ENSP00000220849; -.
DR   iPTMnet; P60228; -.
DR   MetOSite; P60228; -.
DR   PhosphoSitePlus; P60228; -.
DR   SwissPalm; P60228; -.
DR   BioMuta; EIF3E; -.
DR   DMDM; 41019126; -.
DR   EPD; P60228; -.
DR   jPOST; P60228; -.
DR   MassIVE; P60228; -.
DR   MaxQB; P60228; -.
DR   PaxDb; P60228; -.
DR   PeptideAtlas; P60228; -.
DR   PRIDE; P60228; -.
DR   ProteomicsDB; 57190; -.
DR   Antibodypedia; 13407; 281 antibodies.
DR   DNASU; 3646; -.
DR   Ensembl; ENST00000220849; ENSP00000220849; ENSG00000104408.
DR   GeneID; 3646; -.
DR   KEGG; hsa:3646; -.
DR   UCSC; uc003ymu.4; human.
DR   CTD; 3646; -.
DR   DisGeNET; 3646; -.
DR   GeneCards; EIF3E; -.
DR   HGNC; HGNC:3277; EIF3E.
DR   HPA; ENSG00000104408; Low tissue specificity.
DR   MIM; 602210; gene.
DR   neXtProt; NX_P60228; -.
DR   OpenTargets; ENSG00000104408; -.
DR   PharmGKB; PA27705; -.
DR   eggNOG; KOG2758; Eukaryota.
DR   eggNOG; ENOG410XQK5; LUCA.
DR   GeneTree; ENSGT00390000002661; -.
DR   InParanoid; P60228; -.
DR   KO; K03250; -.
DR   OMA; HRTWLIH; -.
DR   OrthoDB; 1151808at2759; -.
DR   PhylomeDB; P60228; -.
DR   TreeFam; TF101518; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-72649; Translation initiation complex formation.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72695; Formation of the ternary complex, and subsequently, the 43S complex.
DR   Reactome; R-HSA-72702; Ribosomal scanning and start codon recognition.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   SIGNOR; P60228; -.
DR   ChiTaRS; EIF3E; human.
DR   GeneWiki; EIF3S6; -.
DR   GenomeRNAi; 3646; -.
DR   Pharos; P60228; Tbio.
DR   PRO; PR:P60228; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; P60228; protein.
DR   Bgee; ENSG00000104408; Expressed in epithelium of mammary gland and 235 other tissues.
DR   ExpressionAtlas; P60228; baseline and differential.
DR   Genevisible; P60228; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016282; C:eukaryotic 43S preinitiation complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0033290; C:eukaryotic 48S preinitiation complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0005852; C:eukaryotic translation initiation factor 3 complex; IDA:UniProtKB.
DR   GO; GO:0071540; C:eukaryotic translation initiation factor 3 complex, eIF3e; IEA:UniProtKB-UniRule.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IEA:UniProtKB-SubCell.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0047485; F:protein N-terminus binding; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003743; F:translation initiation factor activity; IC:UniProtKB.
DR   GO; GO:0001732; P:formation of cytoplasmic translation initiation complex; IEA:UniProtKB-UniRule.
DR   GO; GO:0045947; P:negative regulation of translational initiation; NAS:UniProtKB.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; IMP:UniProtKB.
DR   GO; GO:1902416; P:positive regulation of mRNA binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0045727; P:positive regulation of translation; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0006446; P:regulation of translational initiation; NAS:UniProtKB.
DR   GO; GO:0006413; P:translational initiation; IDA:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 1.
DR   HAMAP; MF_03004; eIF3e; 1.
DR   InterPro; IPR016650; eIF3e.
DR   InterPro; IPR019010; eIF3e_N.
DR   InterPro; IPR000717; PCI_dom.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR10317; PTHR10317; 1.
DR   Pfam; PF09440; eIF3_N; 1.
DR   Pfam; PF01399; PCI; 1.
DR   PIRSF; PIRSF016255; eIF3e_su6; 1.
DR   SMART; SM01186; eIF3_N; 1.
DR   SMART; SM00088; PINT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   PROSITE; PS50250; PCI; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Cytoplasm; Direct protein sequencing;
KW   Initiation factor; Nucleus; Phosphoprotein; Polymorphism;
KW   Protein biosynthesis; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000255|HAMAP-Rule:MF_03004,
FT                   ECO:0000269|PubMed:17322308, ECO:0000269|Ref.8"
FT   CHAIN           2..445
FT                   /note="Eukaryotic translation initiation factor 3 subunit
FT                   E"
FT                   /id="PRO_0000123515"
FT   DOMAIN          221..398
FT                   /note="PCI"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01185"
FT   REGION          4..128
FT                   /note="Sufficient for interaction with EPAS1"
FT                   /evidence="ECO:0000269|PubMed:17324924"
FT   REGION          9..195
FT                   /note="Sufficient for interaction with TRIM27"
FT                   /evidence="ECO:0000269|PubMed:10504338"
FT   REGION          351..445
FT                   /note="Sufficient for interaction with MCM7"
FT                   /evidence="ECO:0000269|PubMed:17310990"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378,
FT                   ECO:0000255|HAMAP-Rule:MF_03004,
FT                   ECO:0000269|PubMed:17322308, ECO:0000269|Ref.8"
FT   MOD_RES         399
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         439
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P60229"
FT   MOD_RES         442
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         445
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P60229"
FT   VARIANT         185
FT                   /note="A -> V (in dbSNP:rs17856554)"
FT                   /evidence="ECO:0000269|PubMed:15489334"
FT                   /id="VAR_046480"
FT   MUTAGEN         312
FT                   /note="L->D: Promotes nuclear accumulation."
FT                   /evidence="ECO:0000269|PubMed:17761670"
FT   HELIX           6..12
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           16..19
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           21..29
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           35..45
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           51..58
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           67..92
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           124..140
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           144..152
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           161..165
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           166..179
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           182..194
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   STRAND          200..202
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           205..218
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           232..236
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   STRAND          246..248
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           250..262
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   TURN            265..267
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           270..273
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           274..278
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           281..289
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           291..301
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           305..319
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   TURN            323..325
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           326..328
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           329..347
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   STRAND          349..352
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           353..359
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   STRAND          360..362
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   HELIX           364..376
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   TURN            386..389
FT                   /evidence="ECO:0000244|PDB:3J8B"
FT   STRAND          390..392
FT                   /evidence="ECO:0000244|PDB:3J8B"
SQ   SEQUENCE   445 AA;  52221 MW;  A5368651DD0DDD0C CRC64;
     MAEYDLTTRI AHFLDRHLVF PLLEFLSVKE IYNEKELLQG KLDLLSDTNM VDFAMDVYKN
     LYSDDIPHAL REKRTTVVAQ LKQLQAETEP IVKMFEDPET TRQMQSTRDG RMLFDYLADK
     HGFRQEYLDT LYRYAKFQYE CGNYSGAAEY LYFFRVLVPA TDRNALSSLW GKLASEILMQ
     NWDAAMEDLT RLKETIDNNS VSSPLQSLQQ RTWLIHWSLF VFFNHPKGRD NIIDLFLYQP
     QYLNAIQTMC PHILRYLTTA VITNKDVRKR RQVLKDLVKV IQQESYTYKD PITEFVECLY
     VNFDFDGAQK KLRECESVLV NDFFLVACLE DFIENARLFI FETFCRIHQC ISINMLADKL
     NMTPEEAERW IVNLIRNARL DAKIDSKLGH VVMGNNAVSP YQQVIEKTKS LSFRSQMLAM
     NIEKKLNQNS RSEAPNWATQ DSGFY
//
ID   ELL_HUMAN               Reviewed;         621 AA.
AC   P55199;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 1.
DT   22-APR-2020, entry version 171.
DE   RecName: Full=RNA polymerase II elongation factor ELL;
DE   AltName: Full=Eleven-nineteen lysine-rich leukemia protein;
GN   Name=ELL; Synonyms=C19orf17;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Fetal brain;
RX   PubMed=7991593; DOI=10.1073/pnas.91.25.12110;
RA   Thirman M.J., Levitan D.A., Kobayashi H., Simon M.C., Rowley J.D.;
RT   "Cloning of ELL, a gene that fuses to MLL in a t(11;19)(q23;p13.1) in acute
RT   myeloid leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 91:12110-12114(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   FUNCTION IN TRANSCRIPTION ELONGATION.
RX   PubMed=8596958; DOI=10.1126/science.271.5257.1873;
RA   Shilatifard A., Lane W.S., Jackson K.W., Conaway R.C., Conaway J.W.;
RT   "An RNA polymerase II elongation factor encoded by the human ELL gene.";
RL   Science 271:1873-1876(1996).
RN   [4]
RP   INTERACTION WITH EAF1, AND SUBCELLULAR LOCATION.
RX   PubMed=11418481; DOI=10.1182/blood.v98.1.201;
RA   Simone F., Polak P.E., Kaberlein J.J., Luo R.T., Levitan D.A.,
RA   Thirman M.J.;
RT   "EAF1, a novel ELL-associated factor that is delocalized by expression of
RT   the MLL-ELL fusion protein.";
RL   Blood 98:201-209(2001).
RN   [5]
RP   INTERACTION WITH EAF2, AND SUBCELLULAR LOCATION.
RX   PubMed=12446457; DOI=10.1182/blood-2002-06-1664;
RA   Simone F., Luo R.T., Polak P.E., Kaberlein J.J., Thirman M.J.;
RT   "ELL-associated factor 2 (EAF2), a functional homolog of EAF1 with
RT   alternative ELL binding properties.";
RL   Blood 101:2355-2362(2003).
RN   [6]
RP   SUBCELLULAR LOCATION.
RX   PubMed=12686606; DOI=10.1091/mbc.e02-07-0394;
RA   Polak P.E., Simone F., Kaberlein J.J., Luo R.T., Thirman M.J.;
RT   "ELL and EAF1 are Cajal body components that are disrupted in MLL-ELL
RT   leukemia.";
RL   Mol. Biol. Cell 14:1517-1528(2003).
RN   [7]
RP   FUNCTION IN TRANSCRIPTION.
RX   PubMed=16006523; DOI=10.1073/pnas.0503017102;
RA   Kong S.E., Banks C.A., Shilatifard A., Conaway J.W., Conaway R.C.;
RT   "ELL-associated factors 1 and 2 are positive regulators of RNA polymerase
RT   II elongation factor ELL.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:10094-10098(2005).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-561, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20471948; DOI=10.1016/j.molcel.2010.04.013;
RA   He N., Liu M., Hsu J., Xue Y., Chou S., Burlingame A., Krogan N.J.,
RA   Alber T., Zhou Q.;
RT   "HIV-1 Tat and host AFF4 recruit two transcription elongation factors into
RT   a bifunctional complex for coordinated activation of HIV-1 transcription.";
RL   Mol. Cell 38:428-438(2010).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE SEC COMPLEX.
RX   PubMed=20159561; DOI=10.1016/j.molcel.2010.01.026;
RA   Lin C., Smith E.R., Takahashi H., Lai K.C., Martin-Brown S., Florens L.,
RA   Washburn M.P., Conaway J.W., Conaway R.C., Shilatifard A.;
RT   "AFF4, a component of the ELL/P-TEFb elongation complex and a shared
RT   subunit of MLL chimeras, can link transcription elongation to leukemia.";
RL   Mol. Cell 37:429-437(2010).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-309, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN THE SEC COMPLEX,
RP   IDENTIFICATION IN THE LEC COMPLEX, AND INTERACTION WITH ICE1 AND ICE2.
RX   PubMed=22195968; DOI=10.1016/j.molcel.2011.12.008;
RA   Smith E.R., Lin C., Garrett A.S., Thornton J., Mohaghegh N., Hu D.,
RA   Jackson J., Saraf A., Swanson S.K., Seidel C., Florens L., Washburn M.P.,
RA   Eissenberg J.C., Shilatifard A.;
RT   "The little elongation complex regulates small nuclear RNA transcription.";
RL   Mol. Cell 44:954-965(2011).
RN   [14]
RP   FUNCTION.
RX   PubMed=22252557; DOI=10.1038/ncomms1652;
RA   Byun J.S., Fufa T.D., Wakano C., Fernandez A., Haggerty C.M., Sung M.H.,
RA   Gardner K.;
RT   "ELL facilitates RNA polymerase II pause site entry and release.";
RL   Nat. Commun. 3:633-633(2012).
RN   [15]
RP   REVIEW ON THE SUPER ELONGATION COMPLEX.
RX   PubMed=22895430; DOI=10.1038/nrm3417;
RA   Luo Z., Lin C., Shilatifard A.;
RT   "The super elongation complex (SEC) family in transcriptional control.";
RL   Nat. Rev. Mol. Cell Biol. 13:543-547(2012).
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-180 AND SER-309, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [18]
RP   FUNCTION, SUBCELLULAR LOCATION, IDENTIFICATION IN THE LEC COMPLEX, AND
RP   INTERACTION WITH ICE1.
RX   PubMed=23932780; DOI=10.1016/j.molcel.2013.07.003;
RA   Hu D., Smith E.R., Garruss A.S., Mohaghegh N., Varberg J.M., Lin C.,
RA   Jackson J., Gao X., Saraf A., Florens L., Washburn M.P., Eissenberg J.C.,
RA   Shilatifard A.;
RT   "The little elongation complex functions at initiation and elongation
RT   phases of snRNA gene transcription.";
RL   Mol. Cell 51:493-505(2013).
RN   [19]
RP   INTERACTION WITH USPL1.
RX   PubMed=24413172; DOI=10.1242/jcs.141788;
RA   Hutten S., Chachami G., Winter U., Melchior F., Lamond A.I.;
RT   "A role for the Cajal-body-associated SUMO isopeptidase USPL1 in snRNA
RT   transcription mediated by RNA polymerase II.";
RL   J. Cell Sci. 127:1065-1078(2014).
RN   [20]
RP   STRUCTURE BY NMR OF 197-297.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the helical domain in human eleven-nineteen lysine-
RT   rich leukemia protein ELL.";
RL   Submitted (MAY-2007) to the PDB data bank.
CC   -!- FUNCTION: Elongation factor component of the super elongation complex
CC       (SEC), a complex required to increase the catalytic rate of RNA
CC       polymerase II transcription by suppressing transient pausing by the
CC       polymerase at multiple sites along the DNA. Elongation factor component
CC       of the little elongation complex (LEC), a complex required to regulate
CC       small nuclear RNA (snRNA) gene transcription by RNA polymerase II and
CC       III (PubMed:22195968, PubMed:23932780). Specifically required for
CC       stimulating the elongation step of RNA polymerase II- and III-dependent
CC       snRNA gene transcription (PubMed:23932780). ELL also plays an early
CC       role before its assembly into in the SEC complex by stabilizing RNA
CC       polymerase II recruitment/initiation and entry into the pause site.
CC       Required to stabilize the pre-initiation complex and early elongation.
CC       {ECO:0000269|PubMed:16006523, ECO:0000269|PubMed:20159561,
CC       ECO:0000269|PubMed:20471948, ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:22252557, ECO:0000269|PubMed:23932780,
CC       ECO:0000269|PubMed:8596958}.
CC   -!- SUBUNIT: Component of the super elongation complex (SEC), at least
CC       composed of EAF1, EAF2, CDK9, MLLT3/AF9, AFF (AFF1 or AFF4), the P-TEFb
CC       complex and ELL (ELL, ELL2 or ELL3). Component of the little elongation
CC       complex (LEC), at least composed of ELL (ELL, ELL2 or ELL3), ZC3H8,
CC       ICE1 and ICE2. Interacts with AFF4; the interaction is direct.
CC       Interacts with EAF1 and EAF2. Interacts with ICE1 (via N-terminus
CC       domain). Interacts with ICE2. Interacts with USPL1 (PubMed:24413172).
CC       {ECO:0000269|PubMed:11418481, ECO:0000269|PubMed:12446457,
CC       ECO:0000269|PubMed:20159561, ECO:0000269|PubMed:20471948,
CC       ECO:0000269|PubMed:22195968, ECO:0000269|PubMed:23932780,
CC       ECO:0000269|PubMed:24413172}.
CC   -!- INTERACTION:
CC       P55199; P62136: PPP1CA; NbExp=2; IntAct=EBI-1245868, EBI-357253;
CC       P55199; Q96H20: SNF8; NbExp=3; IntAct=EBI-1245868, EBI-747719;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:11418481,
CC       ECO:0000269|PubMed:12446457}. Nucleus speckle
CC       {ECO:0000269|PubMed:11418481, ECO:0000269|PubMed:12446457}. Nucleus,
CC       Cajal body {ECO:0000269|PubMed:12686606, ECO:0000269|PubMed:22195968,
CC       ECO:0000269|PubMed:23932780}. Note=Colocalizes with EAF2 to nuclear
CC       speckles (PubMed:12446457). Colocalizes with coilin in subnuclear cajal
CC       and histone locus bodies (PubMed:12686606). Translocates in the LEC
CC       complex to cajal and histone locus bodies at snRNA genes in a ICE1-
CC       dependent manner. Associates to transcriptionally active chromatin at
CC       snRNA genes(PubMed:23932780). {ECO:0000269|PubMed:12446457,
CC       ECO:0000269|PubMed:12686606, ECO:0000269|PubMed:23932780}.
CC   -!- TISSUE SPECIFICITY: Expressed in all tissues tested. Highest levels
CC       found in placenta, skeletal muscle, testis and peripheral blood
CC       leukocytes.
CC   -!- DISEASE: Note=A chromosomal aberration involving ELL is found in acute
CC       leukemias. Translocation t(11;19)(q23;p13.1) with KMT2A/MLL1. The
CC       result is a rogue activator protein. {ECO:0000269|PubMed:7991593}.
CC   -!- SIMILARITY: Belongs to the ELL/occludin family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ELLID10.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U16282; AAA57120.1; -; mRNA.
DR   EMBL; BC049195; AAH49195.1; -; mRNA.
DR   CCDS; CCDS12380.1; -.
DR   PIR; I38880; I38880.
DR   RefSeq; NP_006523.1; NM_006532.3.
DR   PDB; 2DOA; NMR; -; A=200-292.
DR   PDBsum; 2DOA; -.
DR   SMR; P55199; -.
DR   BioGrid; 113828; 55.
DR   CORUM; P55199; -.
DR   IntAct; P55199; 35.
DR   MINT; P55199; -.
DR   STRING; 9606.ENSP00000262809; -.
DR   iPTMnet; P55199; -.
DR   PhosphoSitePlus; P55199; -.
DR   BioMuta; ELL; -.
DR   DMDM; 1706635; -.
DR   EPD; P55199; -.
DR   jPOST; P55199; -.
DR   MassIVE; P55199; -.
DR   MaxQB; P55199; -.
DR   PaxDb; P55199; -.
DR   PeptideAtlas; P55199; -.
DR   PRIDE; P55199; -.
DR   ProteomicsDB; 56805; -.
DR   Antibodypedia; 15081; 364 antibodies.
DR   Ensembl; ENST00000262809; ENSP00000262809; ENSG00000105656.
DR   GeneID; 8178; -.
DR   KEGG; hsa:8178; -.
DR   UCSC; uc002njh.3; human.
DR   CTD; 8178; -.
DR   DisGeNET; 8178; -.
DR   GeneCards; ELL; -.
DR   HGNC; HGNC:23114; ELL.
DR   HPA; ENSG00000105656; Low tissue specificity.
DR   MIM; 600284; gene.
DR   neXtProt; NX_P55199; -.
DR   OpenTargets; ENSG00000105656; -.
DR   PharmGKB; PA134939610; -.
DR   eggNOG; KOG4796; Eukaryota.
DR   eggNOG; ENOG410ZNGU; LUCA.
DR   GeneTree; ENSGT00940000155914; -.
DR   HOGENOM; CLU_021268_0_0_1; -.
DR   InParanoid; P55199; -.
DR   KO; K15183; -.
DR   OMA; IQFQGSQ; -.
DR   OrthoDB; 335949at2759; -.
DR   PhylomeDB; P55199; -.
DR   TreeFam; TF326161; -.
DR   Reactome; R-HSA-112382; Formation of RNA Pol II elongation complex.
DR   Reactome; R-HSA-167152; Formation of HIV elongation complex in the absence of HIV Tat.
DR   Reactome; R-HSA-167200; Formation of HIV-1 elongation complex containing HIV-1 Tat.
DR   Reactome; R-HSA-167238; Pausing and recovery of Tat-mediated HIV elongation.
DR   Reactome; R-HSA-167243; Tat-mediated HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167246; Tat-mediated elongation of the HIV-1 transcript.
DR   Reactome; R-HSA-167287; HIV elongation arrest and recovery.
DR   Reactome; R-HSA-167290; Pausing and recovery of HIV elongation.
DR   Reactome; R-HSA-674695; RNA Polymerase II Pre-transcription Events.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6796648; TP53 Regulates Transcription of DNA Repair Genes.
DR   Reactome; R-HSA-6807505; RNA polymerase II transcribes snRNA genes.
DR   Reactome; R-HSA-75955; RNA Polymerase II Transcription Elongation.
DR   SIGNOR; P55199; -.
DR   ChiTaRS; ELL; human.
DR   EvolutionaryTrace; P55199; -.
DR   GeneWiki; ELL_(gene); -.
DR   GenomeRNAi; 8178; -.
DR   Pharos; P55199; Tbio.
DR   PRO; PR:P55199; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; P55199; protein.
DR   Bgee; ENSG00000105656; Expressed in testis and 130 other tissues.
DR   ExpressionAtlas; P55199; baseline and differential.
DR   Genevisible; P55199; HS.
DR   GO; GO:0015030; C:Cajal body; IDA:UniProtKB.
DR   GO; GO:0035363; C:histone locus body; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0008023; C:transcription elongation factor complex; IDA:UniProtKB.
DR   GO; GO:0035327; C:transcriptionally active chromatin; IDA:UniProtKB.
DR   GO; GO:0019902; F:phosphatase binding; IDA:UniProtKB.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0032786; P:positive regulation of DNA-templated transcription, elongation; TAS:ProtInc.
DR   GO; GO:0045945; P:positive regulation of transcription by RNA polymerase III; IMP:UniProtKB.
DR   GO; GO:0032968; P:positive regulation of transcription elongation from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0042795; P:snRNA transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0042796; P:snRNA transcription by RNA polymerase III; IMP:UniProtKB.
DR   GO; GO:0006366; P:transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; TAS:Reactome.
DR   Gene3D; 1.10.10.2670; -; 1.
DR   InterPro; IPR042065; E3_ELL-like.
DR   InterPro; IPR031184; ELL.
DR   InterPro; IPR031176; ELL/occludin.
DR   InterPro; IPR019464; ELL_N.
DR   InterPro; IPR010844; Occludin_ELL.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR23288; PTHR23288; 1.
DR   PANTHER; PTHR23288:SF9; PTHR23288:SF9; 1.
DR   Pfam; PF10390; ELL; 1.
DR   Pfam; PF07303; Occludin_ELL; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome;
KW   Transcription; Transcription regulation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   CHAIN           2..621
FT                   /note="RNA polymerase II elongation factor ELL"
FT                   /id="PRO_0000146733"
FT   MOTIF           445..459
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   SITE            46
FT                   /note="KMT2A/MLL1 fusion point (in acute myeloid leukemia
FT                   patient)"
FT                   /evidence="ECO:0000269|PubMed:7991593"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:22814378"
FT   MOD_RES         180
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         309
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         561
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332"
FT   VARIANT         297
FT                   /note="S -> N (in dbSNP:rs2303694)"
FT                   /id="VAR_053072"
FT   VARIANT         387
FT                   /note="R -> W (in dbSNP:rs35245196)"
FT                   /id="VAR_053073"
FT   HELIX           207..217
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   HELIX           222..232
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   HELIX           236..248
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   STRAND          249..252
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   STRAND          254..256
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   STRAND          258..260
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   HELIX           265..268
FT                   /evidence="ECO:0000244|PDB:2DOA"
FT   HELIX           279..291
FT                   /evidence="ECO:0000244|PDB:2DOA"
SQ   SEQUENCE   621 AA;  68265 MW;  EB4A3F94CA8A411F CRC64;
     MAALKEDRSY GLSCGRVSDG SKVSVFHVKL TDSALRAFES YRARQDSVSL RPSIRFQGSQ
     GHISIPQPDC PAEARTFSFY LSNIGRDNPQ GSFDCIQQYV SSHGEVHLDC LGSIQDKITV
     CATDDSYQKA RQSMAQAEEE TRSRSAIVIK AGGRYLGKKV QFRKPAPGAT DAVPSRKRAT
     PINLASAIRK SGASAVSGGS GVSQRPFRDR VLHLLALRPY RKAELLLRLQ KDGLTQADKD
     ALDGLLQQVA NMSAKDGTCT LQDCMYKDVQ KDWPGYSEGD QQLLKRVLVR KLCQPQSTGS
     LLGDPAASSP PGERGRSASP PQKRLQPPDF IDPLANKKPR ISHFTQRAQP AVNGKLGVPN
     GREALLPTPG PPASTDTLSS STHLPPRLEP PRAHDPLADV SNDLGHSGRD CEHGEAAAPA
     PTVRLGLPLL TDCAQPSRPH GSPSRSKPKK KSKKHKDKER AAEDKPRAQL PDCAPATHAT
     PGAPADTPGL NGTCSVSSVP TSTSETPDYL LKYAAISSSE QRQSYKNDFN AEYSEYRDLH
     ARIERITRRF TQLDAQLRQL SQGSEEYETT RGQILQEYRK IKKTNTNYSQ EKHRCEYLHS
     KLAHIKRLIA EYDQRQLQAW P
//
ID   U3KQ90_HUMAN            Unreviewed;       488 AA.
AC   U3KQ90;
DT   13-NOV-2013, integrated into UniProtKB/TrEMBL.
DT   19-FEB-2014, sequence version 2.
DT   22-APR-2020, entry version 49.
DE   SubName: Full=RNA polymerase II elongation factor ELL {ECO:0000313|Ensembl:ENSP00000475648};
GN   Name=ELL {ECO:0000313|Ensembl:ENSP00000475648};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000475648, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000475648, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [2] {ECO:0000213|PubMed:17525332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R., Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [3] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [4] {ECO:0000213|PubMed:20068231}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000313|Ensembl:ENSP00000475648}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2013) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC010335; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016882824.1; XM_017027335.1.
DR   jPOST; U3KQ90; -.
DR   PeptideAtlas; U3KQ90; -.
DR   PRIDE; U3KQ90; -.
DR   Antibodypedia; 15081; 364 antibodies.
DR   Ensembl; ENST00000596124; ENSP00000475648; ENSG00000105656.
DR   GeneID; 8178; -.
DR   UCSC; uc002njg.4; human.
DR   CTD; 8178; -.
DR   EuPathDB; HostDB:ENSG00000105656.12; -.
DR   HGNC; HGNC:23114; ELL.
DR   OpenTargets; ENSG00000105656; -.
DR   eggNOG; KOG4796; Eukaryota.
DR   eggNOG; ENOG410ZNGU; LUCA.
DR   GeneTree; ENSGT00940000155914; -.
DR   ChiTaRS; ELL; human.
DR   GenomeRNAi; 8178; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000105656; Expressed in testis and 130 other tissues.
DR   ExpressionAtlas; U3KQ90; baseline and differential.
DR   GO; GO:0008023; C:transcription elongation factor complex; IEA:InterPro.
DR   GO; GO:0042795; P:snRNA transcription by RNA polymerase II; IEA:InterPro.
DR   GO; GO:0006368; P:transcription elongation from RNA polymerase II promoter; IEA:InterPro.
DR   Gene3D; 1.10.10.2670; -; 1.
DR   InterPro; IPR042065; E3_ELL-like.
DR   InterPro; IPR031184; ELL.
DR   InterPro; IPR031176; ELL/occludin.
DR   InterPro; IPR019464; ELL_N.
DR   InterPro; IPR010844; Occludin_ELL.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   PANTHER; PTHR23288; PTHR23288; 1.
DR   PANTHER; PTHR23288:SF9; PTHR23288:SF9; 1.
DR   Pfam; PF10390; ELL; 1.
DR   Pfam; PF07303; Occludin_ELL; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:U3KQ90,
KW   ECO:0000213|MaxQB:U3KQ90, ECO:0000213|PeptideAtlas:U3KQ90,
KW   ECO:0000213|ProteomicsDB:U3KQ90};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          1..159
FT                   /note="ELL"
FT                   /evidence="ECO:0000259|Pfam:PF10390"
FT   DOMAIN          380..481
FT                   /note="Occludin_ELL"
FT                   /evidence="ECO:0000259|Pfam:PF07303"
FT   REGION          163..284
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          298..371
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        357..371
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   488 AA;  53600 MW;  4EC28927F531E6E6 CRC64;
     MAQAEEETRS RSAIVIKAGG RYLGKKVQFR KPAPGATDAV PSRKRATPIN LASAIRKSGA
     SAVSGGSGVS QRPFRDRVLH LLALRPYRKA ELLLRLQKDG LTQADKDALD GLLQQVANMS
     AKDGTCTLQD CMYKDVQKDW PGYSEGDQQL LKRVLVRKLC QPQSTGSLLG DPAASSPPGE
     RGRSASPPQK RLQPPDFIDP LANKKPRISH FTQRAQPAVN GKLGVPNGRE ALLPTPGPPA
     STDTLSSSTH LPPRLEPPRA HDPLADVSND LGHSGRDCEH GEAAAPAPTV RLGLPLLTDC
     AQPSRPHGSP SRSKPKKKSK KHKDKERAAE DKPRAQLPDC APATHATPGA PADTPGLNGT
     CSVSSVPTST SETPDYLLKY AAISSSEQRQ SYKNDFNAEY SEYRDLHARI ERITRRFTQL
     DAQLRQLSQG SEEYETTRGQ ILQEYRKIKK TNTNYSQEKH RCEYLHSKLA HIKRLIAEYD
     QRQLQAWP
//
ID   EP300_HUMAN             Reviewed;        2414 AA.
AC   Q09472; B1AKC2;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 2.
DT   22-APR-2020, entry version 250.
DE   RecName: Full=Histone acetyltransferase p300;
DE            Short=p300 HAT;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:23415232, ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:8945521};
DE   AltName: Full=E1A-associated protein p300;
DE   AltName: Full=Histone butyryltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:17267393};
DE   AltName: Full=Histone crotonyltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:25818647};
DE   AltName: Full=Protein 2-hydroxyisobutyryltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:29775581};
DE   AltName: Full=Protein propionyltransferase p300;
DE            EC=2.3.1.- {ECO:0000269|PubMed:17267393};
GN   Name=EP300; Synonyms=P300;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND VARIANT PRO-2223.
RX   PubMed=7523245; DOI=10.1101/gad.8.8.869;
RA   Eckner R., Ewen M.E., Newsome D., Gerdes M., Decaprio J.A., Lawrence J.B.,
RA   Livingston D.M.;
RT   "Molecular cloning and functional analysis of the adenovirus E1A-associated
RT   300-kD protein (p300) reveals a protein with properties of a
RT   transcriptional adaptor.";
RL   Genes Dev. 8:869-884(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 27-42, AND CHROMOSOMAL TRANSLOCATION WITH
RP   KAT6A.
RX   PubMed=10824998;
RX   DOI=10.1002/(sici)1098-2264(200006)28:2<138::aid-gcc2>3.0.co;2-2;
RA   Chaffanet M., Gressin L., Preudhomme C., Soenen-Cornu V., Birnbaum D.,
RA   Pebusque M.-J.;
RT   "MOZ is fused to p300 in an acute monocytic leukemia with t(8;22).";
RL   Genes Chromosomes Cancer 28:138-144(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 552-660.
RX   PubMed=7870179; DOI=10.1038/374085a0;
RA   Lundblad J.R., Kwok R.P.S., Laurance M.E., Harter M.L., Goodman R.H.;
RT   "Adenoviral E1A-associated protein p300 as a functional homologue of the
RT   transcriptional co-activator CBP.";
RL   Nature 374:85-88(1995).
RN   [6]
RP   PARTIAL PROTEIN SEQUENCE, INTERACTION WITH CARM1, METHYLATION AT ARG-580
RP   AND ARG-604, AND FUNCTION.
RX   PubMed=11701890; DOI=10.1126/science.1065961;
RA   Xu W., Chen H., Du K., Asahara H., Tini M., Emerson B.M., Montminy M.,
RA   Evans R.M.;
RT   "A transcriptional switch mediated by cofactor methylation.";
RL   Science 294:2507-2511(2001).
RN   [7]
RP   CATALYTIC ACTIVITY, AND FUNCTION.
RX   PubMed=8945521; DOI=10.1016/s0092-8674(00)82001-2;
RA   Ogryzko V.V., Schiltz R.L., Russanova V., Howard B.H., Nakatani Y.;
RT   "The transcriptional coactivators p300 and CBP are histone
RT   acetyltransferases.";
RL   Cell 87:953-959(1996).
RN   [8]
RP   INTERACTION WITH PCAF.
RX   PubMed=8684459; DOI=10.1038/382319a0;
RA   Yang X.-J., Ogryzko V.V., Nishikawa J., Howard B.H., Nakatani Y.;
RT   "A p300/CBP-associated factor that competes with the adenoviral oncoprotein
RT   E1A.";
RL   Nature 382:319-324(1996).
RN   [9]
RP   INTERACTION WITH HIF1A AND CREBBP.
RX   PubMed=8917528; DOI=10.1073/pnas.93.23.12969;
RA   Arany Z., Huang L.E., Eckner R., Bhattacharya S., Jiang C., Goldberg M.A.,
RA   Bunn H.F., Livingston D.M.;
RT   "An essential role for p300/CBP in the cellular response to hypoxia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:12969-12973(1996).
RN   [10]
RP   INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION).
RX   PubMed=9528808; DOI=10.1128/mcb.18.4.2392;
RA   Bex F., Yin M.-J., Burny A., Gaynor R.B.;
RT   "Differential transcriptional activation by human T-cell leukemia virus
RT   type 1 Tax mutants is mediated by distinct interactions with CREB binding
RT   protein and p300.";
RL   Mol. Cell. Biol. 18:2392-2405(1998).
RN   [11]
RP   INTERACTION WITH NR3C1.
RX   PubMed=9590696; DOI=10.1038/30032;
RA   Fryer C.J., Archer T.K.;
RT   "Chromatin remodelling by the glucocorticoid receptor requires the BRG1
RT   complex.";
RL   Nature 393:88-91(1998).
RN   [12]
RP   INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL
RP   INFECTION).
RX   PubMed=10545121; DOI=10.1093/emboj/18.21.6106;
RA   Kiernan R.E., Vanhulle C., Schiltz L., Adam E., Xiao H., Maudoux F.,
RA   Calomme C., Burny A., Nakatani Y., Jeang K.-T., Benkirane M., Van Lint C.;
RT   "HIV-1 tat transcriptional activity is regulated by acetylation.";
RL   EMBO J. 18:6106-6118(1999).
RN   [13]
RP   INTERACTION WITH CITED2 AND HIF1A, AND MUTAGENESIS OF 371-THR--LEU-376 AND
RP   413-VAL--LYS-418.
RX   PubMed=9887100; DOI=10.1101/gad.13.1.64;
RA   Bhattacharya S., Michels C.M., Leung M.K., Arany Z.P., Kung A.L.,
RA   Livingston D.M.;
RT   "Functional role of p35srj, a novel p300/CBP binding protein, during
RT   transactivation by HIF-1.";
RL   Genes Dev. 13:64-75(1999).
RN   [14]
RP   INTERACTION WITH RORA.
RX   PubMed=9862959; DOI=10.1093/nar/27.2.411;
RA   Lau P., Bailey P., Dowhan D.H., Muscat G.E.;
RT   "Exogenous expression of a dominant negative RORalpha1 vector in muscle
RT   cells impairs differentiation: RORalpha1 directly interacts with p300 and
RT   myoD.";
RL   Nucleic Acids Res. 27:411-420(1999).
RN   [15]
RP   INTERACTION WITH CITED1.
RX   PubMed=10722728; DOI=10.1074/jbc.275.12.8825;
RA   Yahata T., de Caestecker M.P., Lechleider R.J., Andriole S., Roberts A.B.,
RA   Isselbacher K.J., Shioda T.;
RT   "The MSG1 non-DNA-binding transactivator binds to the p300/CBP
RT   coactivators, enhancing their functional link to the Smad transcription
RT   factors.";
RL   J. Biol. Chem. 275:8825-8834(2000).
RN   [16]
RP   FUNCTION IN TRANSCRIPTIONAL REPRESSION.
RX   PubMed=10733570; DOI=10.1128/mcb.20.8.2676-2686.2000;
RA   Snowden A.W., Anderson L.A., Webster G.A., Perkins N.D.;
RT   "A novel transcriptional repression domain mediates p21(WAF1/CIP1)
RT   induction of p300 transactivation.";
RL   Mol. Cell. Biol. 20:2676-2686(2000).
RN   [17]
RP   ERRATUM OF PUBMED:10733570.
RA   Snowden A.W., Anderson L.A., Webster G.A., Perkins N.D.;
RL   Mol. Cell. Biol. 20:5360-5360(2000).
RN   [18]
RP   INTERACTION WITH EID1.
RX   PubMed=11073989; DOI=10.1128/mcb.20.23.8889-8902.2000;
RA   Miyake S., Sellers W.R., Safran M., Li X., Zhao W., Grossman S.R., Gan J.,
RA   DeCaprio J.A., Adams P.D., Kaelin W.G. Jr.;
RT   "Cells degrade a novel inhibitor of differentiation with E1A-like
RT   properties upon exiting the cell cycle.";
RL   Mol. Cell. Biol. 20:8889-8902(2000).
RN   [19]
RP   INTERACTION WITH EID1.
RX   PubMed=11073990; DOI=10.1128/mcb.20.23.8903-8915.2000;
RA   MacLellan W.R., Xiao G., Abdellatif M., Schneider M.D.;
RT   "A novel Rb- and p300-binding protein inhibits transactivation by MyoD.";
RL   Mol. Cell. Biol. 20:8903-8915(2000).
RN   [20]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10823961; DOI=10.1073/pnas.97.11.6212;
RA   Ko L., Cardona G.R., Chin W.W.;
RT   "Thyroid hormone receptor-binding protein, an LXXLL motif-containing
RT   protein, functions as a general coactivator.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:6212-6217(2000).
RN   [21]
RP   INTERACTION WITH HIV-1 TAT (MICROBIAL INFECTION), AND FUNCTION (MICROBIAL
RP   INFECTION).
RX   PubMed=11080476; DOI=10.1006/viro.2000.0593;
RA   Deng L., de la Fuente C., Fu P., Wang L., Donnelly R., Wade J.D.,
RA   Lambert P., Li H., Lee C.-G., Kashanchi F.;
RT   "Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated
RT   HIV-1 genome and enhances binding to core histones.";
RL   Virology 277:278-295(2000).
RN   [22]
RP   INTERACTION WITH ESR1.
RX   PubMed=11581164; DOI=10.1101/gad.906301;
RA   Yahata T., Shao W., Endoh H., Hur J., Coser K.R., Sun H., Ueda Y., Kato S.,
RA   Isselbacher K.J., Brown M., Shioda T.;
RT   "Selective coactivation of estrogen-dependent transcription by CITED1
RT   CBP/p300-binding protein.";
RL   Genes Dev. 15:2598-2612(2001).
RN   [23]
RP   PHOSPHORYLATION AT SER-89, MUTAGENESIS OF SER-89, AND INTERACTION WITH
RP   PPARG.
RX   PubMed=11518699; DOI=10.1074/jbc.c100316200;
RA   Yang W., Hong Y.H., Shen X.Q., Frankowski C., Camp H.S., Leff T.;
RT   "Regulation of transcription by AMP-activated protein kinase:
RT   phosphorylation of p300 blocks its interaction with nuclear receptors.";
RL   J. Biol. Chem. 276:38341-38344(2001).
RN   [24]
RP   INTERACTION WITH SRCAP.
RX   PubMed=11581372; DOI=10.1128/jvi.75.21.10033-10040.2001;
RA   Xu X., Chackalaparampil I., Monroy M.A., Cannella M.T., Pesek E.,
RA   Chrivia J., Yaciuk P.;
RT   "Adenovirus DNA binding protein interacts with the SNF2-related CBP
RT   activator protein (SrCap) and inhibits SrCap-mediated transcription.";
RL   J. Virol. 75:10033-10040(2001).
RN   [25]
RP   INTERACTION WITH HTLV-1 TAX (MICROBIAL INFECTION).
RX   PubMed=11463834; DOI=10.1128/mcb.21.16.5520-5530.2001;
RA   Scoggin K.E.S., Ulloa A., Nyborg J.K.;
RT   "The oncoprotein Tax binds the SRC-1-interacting domain of CBP/p300 to
RT   mediate transcriptional activation.";
RL   Mol. Cell. Biol. 21:5520-5530(2001).
RN   [26]
RP   INTERACTION WITH HTLV-1 ACCESSORY PROTEIN P30II (MICROBIAL INFECTION).
RX   PubMed=11559821; DOI=10.1128/jvi.75.20.9885-9895.2001;
RA   Zhang W., Nisbet J.W., Albrecht B., Ding W., Kashanchi F., Bartoe J.T.,
RA   Lairmore M.D.;
RT   "Human T-lymphotropic virus type 1 p30(II) regulates gene transcription by
RT   binding CREB binding protein/p300.";
RL   J. Virol. 75:9885-9895(2001).
RN   [27]
RP   INTERACTION WITH TRERF1.
RX   PubMed=11349124; DOI=10.1074/jbc.m100113200;
RA   Gizard F., Lavallee B., DeWitte F., Hum D.W.;
RT   "A novel zinc finger protein TReP-132 interacts with CBP/p300 to regulate
RT   human CYP11A1 gene expression.";
RL   J. Biol. Chem. 276:33881-33892(2001).
RN   [28]
RP   INTERACTION WITH PELP1.
RX   PubMed=11481323; DOI=10.1074/jbc.m103783200;
RA   Vadlamudi R.K., Wang R.-A., Mazumdar A., Kim Y.-S., Shin J., Sahin A.,
RA   Kumar R.;
RT   "Molecular cloning and characterization of PELP1, a novel human coregulator
RT   of estrogen receptor alpha.";
RL   J. Biol. Chem. 276:38272-38279(2001).
RN   [29]
RP   INTERACTION WITH DTX1.
RX   PubMed=11564735; DOI=10.1074/jbc.m105245200;
RA   Yamamoto N., Yamamoto S., Inagaki F., Kawaichi M., Fukamizu A., Kishi N.,
RA   Matsuno K., Nakamura K., Weinmaster G., Okano H., Nakafuku M.;
RT   "Role of Deltex-1 as a transcriptional regulator downstream of the Notch
RT   receptor.";
RL   J. Biol. Chem. 276:45031-45040(2001).
RN   [30]
RP   FUNCTION, AND INTERACTION WITH FEN1.
RX   PubMed=11430825; DOI=10.1016/s1097-2765(01)00272-6;
RA   Hasan S., Stucki M., Hassa P.O., Imhof R., Gehrig P., Hunziker P.,
RA   Hubscher U., Hottiger M.O.;
RT   "Regulation of human flap endonuclease-1 activity by acetylation through
RT   the transcriptional coactivator p300.";
RL   Mol. Cell 7:1221-1231(2001).
RN   [31]
RP   INTERACTION WITH HADV5 E1A (MICROBIAL INFECTION).
RX   PubMed=11433299; DOI=10.1038/35083062;
RA   Chan H.M., Krstic-Demonacos M., Smith L., Demonacos C., La Thangue N.B.;
RT   "Acetylation control of the retinoblastoma tumour-suppressor protein.";
RL   Nat. Cell Biol. 3:667-674(2001).
RN   [32]
RP   INTERACTION WITH SPIB.
RX   PubMed=11864910;
RA   Yamamoto H., Kihara-Negishi F., Yamada T., Suzuki M., Nakano T., Oikawa T.;
RT   "Interaction between the hematopoietic Ets transcription factor Spi-B and
RT   the coactivator CREB-binding protein associated with negative cross-talk
RT   with c-Myb.";
RL   Cell Growth Differ. 13:69-75(2002).
RN   [33]
RP   INTERACTION WITH CITED4.
RX   PubMed=11744733; DOI=10.1074/jbc.m110850200;
RA   Braganca J., Swingler T., Marques F.I.R., Jones T., Eloranta J.J.,
RA   Hurst H.C., Shioda T., Bhattacharya S.;
RT   "Human CREB-binding protein/p300-interacting transactivator with ED-rich
RT   tail (CITED) 4, a new member of the CITED family, functions as a co-
RT   activator for transcription factor AP-2.";
RL   J. Biol. Chem. 277:8559-8565(2002).
RN   [34]
RP   INTERACTION WITH NUPR1.
RX   PubMed=11940591; DOI=10.1074/jbc.m201657200;
RA   Hoffmeister A., Ropolo A., Vasseur S., Mallo G.V., Bodeker H.,
RA   Ritz-Laser B., Dressler G.R., Vaccaro M.I., Dagorn J.C., Moreno S.,
RA   Iovanna J.L.;
RT   "The HMG-I/Y-related protein p8 binds to p300 and Pax2 trans-activation
RT   domain-interacting protein to regulate the trans-activation activity of the
RT   Pax2A and Pax2B transcription factors on the glucagon gene promoter.";
RL   J. Biol. Chem. 277:22314-22319(2002).
RN   [35]
RP   INTERACTION WITH HNRNPU.
RX   PubMed=11909954; DOI=10.1128/mcb.22.8.2598-2606.2002;
RA   Martens J.H., Verlaan M., Kalkhoven E., Dorsman J.C., Zantema A.;
RT   "Scaffold/matrix attachment region elements interact with a p300-scaffold
RT   attachment factor A complex and are bound by acetylated nucleosomes.";
RL   Mol. Cell. Biol. 22:2598-2606(2002).
RN   [36]
RP   IDENTIFICATION IN A COMPLEX WITH CARM1 AND NCOA2.
RX   PubMed=11997499; DOI=10.1128/mcb.22.11.3621-3632.2002;
RA   Lee Y.-H., Koh S.S., Zhang X., Cheng X., Stallcup M.R.;
RT   "Synergy among nuclear receptor coactivators: selective requirement for
RT   protein methyltransferase and acetyltransferase activities.";
RL   Mol. Cell. Biol. 22:3621-3632(2002).
RN   [37]
RP   FUNCTION IN BCL6 ACETYLATION.
RX   PubMed=12402037; DOI=10.1038/ng1018;
RA   Bereshchenko O.R., Gu W., Dalla-Favera R.;
RT   "Acetylation inactivates the transcriptional repressor BCL6.";
RL   Nat. Genet. 32:606-613(2002).
RN   [38]
RP   INTERACTION WITH ING4 AND ING5.
RX   PubMed=12750254;
RA   Shiseki M., Nagashima M., Pedeux R.M., Kitahama-Shiseki M., Miura K.,
RA   Okamura S., Onogi H., Higashimoto Y., Appella E., Yokota J., Harris C.C.;
RT   "p29ING4 and p28ING5 bind to p53 and p300, and enhance p53 activity.";
RL   Cancer Res. 63:2373-2378(2003).
RN   [39]
RP   PHOSPHORYLATION, AND INTERACTION WITH TCF7L2 AND LEF1.
RX   PubMed=12446687; DOI=10.1074/jbc.m210081200;
RA   Hecht A., Stemmler M.P.;
RT   "Identification of a promoter-specific transcriptional activation domain at
RT   the C-terminus of the Wnt effector protein T-cell factor 4.";
RL   J. Biol. Chem. 278:3776-3785(2003).
RN   [40]
RP   FUNCTION, INTERACTION WITH CITED2 AND TFAP2A, AND MUTAGENESIS OF ASP-1399.
RX   PubMed=12586840; DOI=10.1074/jbc.m208144200;
RA   Braganca J., Eloranta J.J., Bamforth S.D., Ibbitt J.C., Hurst H.C.,
RA   Bhattacharya S.;
RT   "Physical and functional interactions among AP-2 transcription factors,
RT   p300/CREB-binding protein, and CITED2.";
RL   J. Biol. Chem. 278:16021-16029(2003).
RN   [41]
RP   INTERACTION WITH SP3.
RX   PubMed=12837748; DOI=10.1074/jbc.m305961200;
RA   Ammanamanchi S., Freeman J.W., Brattain M.G.;
RT   "Acetylated SP3 is a transcriptional activator.";
RL   J. Biol. Chem. 278:35775-35780(2003).
RN   [42]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH ALX1, AND REGION.
RX   PubMed=12929931; DOI=10.1359/jbmr.2003.18.8.1419;
RA   Iioka T., Furukawa K., Yamaguchi A., Shindo H., Yamashita S., Tsukazaki T.;
RT   "P300/CBP acts as a coactivator to cartilage homeoprotein-1 (Cart1),
RT   paired-like homeoprotein, through acetylation of the conserved lysine
RT   residue adjacent to the homeodomain.";
RL   J. Bone Miner. Res. 18:1419-1429(2003).
RN   [43]
RP   INTERACTION WITH SATB1.
RX   PubMed=14605447; DOI=10.1111/j.1348-0421.2003.tb03438.x;
RA   Fujii Y., Kumatori A., Nakamura M.;
RT   "SATB1 makes a complex with p300 and represses gp91(phox) promoter
RT   activity.";
RL   Microbiol. Immunol. 47:803-811(2003).
RN   [44]
RP   SUMOYLATION AT LYS-1020 AND LYS-1024, AND MUTAGENESIS OF LYS-1020 AND
RP   LYS-1024.
RX   PubMed=12718889; DOI=10.1016/s1097-2765(03)00141-2;
RA   Girdwood D., Bumpass D., Vaughan O.A., Thain A., Anderson L.A.,
RA   Snowden A.W., Garcia-Wilson E., Perkins N.D., Hay R.T.;
RT   "P300 transcriptional repression is mediated by SUMO modification.";
RL   Mol. Cell 11:1043-1054(2003).
RN   [45]
RP   INTERACTION WITH DDX5.
RX   PubMed=12527917; DOI=10.1038/sj.onc.1206067;
RA   Rossow K.L., Janknecht R.;
RT   "Synergism between p68 RNA helicase and the transcriptional coactivators
RT   CBP and p300.";
RL   Oncogene 22:151-156(2003).
RN   [46]
RP   INTERACTION WITH TP53, AND FUNCTION.
RX   PubMed=15186775; DOI=10.1016/j.cell.2004.05.009;
RA   An W., Kim J., Roeder R.G.;
RT   "Ordered cooperative functions of PRMT1, p300, and CARM1 in transcriptional
RT   activation by p53.";
RL   Cell 117:735-748(2004).
RN   [47]
RP   INTERACTION WITH SRY.
RX   PubMed=15297880; DOI=10.1038/sj.emboj.7600352;
RA   Thevenet L., Mejean C., Moniot B., Bonneaud N., Galeotti N.,
RA   Aldrian-Herrada G., Poulat F., Berta P., Benkirane M., Boizet-Bonhoure B.;
RT   "Regulation of human SRY subcellular distribution by its
RT   acetylation/deacetylation.";
RL   EMBO J. 23:3336-3345(2004).
RN   [48]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH NPAS2; ARNTL/BMAL1 AND
RP   CLOCK.
RX   PubMed=14645221; DOI=10.1074/jbc.m311973200;
RA   Curtis A.M., Seo S.B., Westgate E.J., Rudic R.D., Smyth E.M.,
RA   Chakravarti D., FitzGerald G.A., McNamara P.;
RT   "Histone acetyltransferase-dependent chromatin remodeling and the vascular
RT   clock.";
RL   J. Biol. Chem. 279:7091-7097(2004).
RN   [49]
RP   INTERACTION WITH ELF3.
RX   PubMed=15075319; DOI=10.1074/jbc.m401356200;
RA   Wang H., Fang R., Cho J.-Y., Libermann T.A., Oettgen P.;
RT   "Positive and negative modulation of the transcriptional activity of the
RT   ETS factor ESE-1 through interaction with p300, CREB-binding protein, and
RT   Ku 70/86.";
RL   J. Biol. Chem. 279:25241-25250(2004).
RN   [50]
RP   INTERACTION WITH IRF1.
RX   PubMed=15509808; DOI=10.1128/mcb.24.22.10083-10098.2004;
RA   Dornan D., Eckert M., Wallace M., Shimizu H., Ramsay E., Hupp T.R.,
RA   Ball K.L.;
RT   "Interferon regulatory factor 1 binding to p300 stimulates DNA-dependent
RT   acetylation of p53.";
RL   Mol. Cell. Biol. 24:10083-10098(2004).
RN   [51]
RP   ACETYLATION AT LYS-1499; LYS-1549; LYS-1554; LYS-1558 AND LYS-1560.
RX   PubMed=15004546; DOI=10.1038/nsmb740;
RA   Thompson P.R., Wang D., Wang L., Fulco M., Pediconi N., Zhang D., An W.,
RA   Ge Q., Roeder R.G., Wong J., Levrero M., Sartorelli V., Cotter R.J.,
RA   Cole P.A.;
RT   "Regulation of the p300 HAT domain via a novel activation loop.";
RL   Nat. Struct. Mol. Biol. 11:308-315(2004).
RN   [52]
RP   INTERACTION WITH NEUROD1 AND TCF3.
RX   PubMed=14752053; DOI=10.1210/me.2003-0311;
RA   Kim J.Y., Chu K., Kim H.J., Seong H.A., Park K.C., Sanyal S., Takeda J.,
RA   Ha H., Shong M., Tsai M.J., Choi H.S.;
RT   "Orphan nuclear receptor small heterodimer partner, a novel corepressor for
RT   a basic helix-loop-helix transcription factor BETA2/neuroD.";
RL   Mol. Endocrinol. 18:776-790(2004).
RN   [53]
RP   INTERACTION WITH SS18L1/CREST.
RX   PubMed=14716005; DOI=10.1126/science.1089845;
RA   Aizawa H., Hu S.-C., Bobb K., Balakrishnan K., Ince G., Gurevich I.,
RA   Cowan M., Ghosh A.;
RT   "Dendrite development regulated by CREST, a calcium-regulated
RT   transcriptional activator.";
RL   Science 303:197-202(2004).
RN   [54]
RP   INVOLVEMENT IN RSTS2.
RX   PubMed=15706485; DOI=10.1086/429130;
RA   Roelfsema J.H., White S.J., Ariyuerek Y., Bartholdi D., Niedrist D.,
RA   Papadia F., Bacino C.A., den Dunnen J.T., van Ommen G.-J.B., Breuning M.H.,
RA   Hennekam R.C., Peters D.J.M.;
RT   "Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the
RT   CBP and EP300 genes cause disease.";
RL   Am. J. Hum. Genet. 76:572-580(2005).
RN   [55]
RP   DEACETYLATION BY SIRT1, ACETYLATION AT LYS-1020 AND LYS-1024, AND
RP   MUTAGENESIS OF LYS-1020 AND LYS-1024.
RX   PubMed=15632193; DOI=10.1074/jbc.m408748200;
RA   Bouras T., Fu M., Sauve A.A., Wang F., Quong A.A., Perkins N.D., Hay R.T.,
RA   Gu W., Pestell R.G.;
RT   "SIRT1 deacetylation and repression of p300 involves lysine residues
RT   1020/1024 within the cell cycle regulatory domain 1.";
RL   J. Biol. Chem. 280:10264-10276(2005).
RN   [56]
RP   INTERACTION WITH FOXO1, FUNCTION, AND MUTAGENESIS OF ASP-1399.
RX   PubMed=15890677; DOI=10.1210/me.2004-0292;
RA   Perrot V., Rechler M.M.;
RT   "The coactivator p300 directly acetylates the forkhead transcription factor
RT   Foxo1 and stimulates Foxo1-induced transcription.";
RL   Mol. Endocrinol. 19:2283-2298(2005).
RN   [57]
RP   METHYLATION AT ARG-2142, CITRULLINATION AT ARG-2142, INTERACTION WITH
RP   NCOA2, AND MUTAGENESIS OF ARG-2056; ARG-2088 AND ARG-2142.
RX   PubMed=15731352; DOI=10.1073/pnas.0407159102;
RA   Lee Y.-H., Coonrod S.A., Kraus W.L., Jelinek M.A., Stallcup M.R.;
RT   "Regulation of coactivator complex assembly and function by protein
RT   arginine methylation and demethylimination.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:3611-3616(2005).
RN   [58]
RP   INTERACTION WITH BCL11B.
RX   PubMed=16809611; DOI=10.1182/blood-2006-05-021790;
RA   Cismasiu V.B., Ghanta S., Duque J., Albu D.I., Chen H.M., Kasturi R.,
RA   Avram D.;
RT   "BCL11B participates in the activation of IL2 gene expression in CD4+ T
RT   lymphocytes.";
RL   Blood 108:2695-2702(2006).
RN   [59]
RP   SUBCELLULAR LOCATION, INTERACTION WITH ROCK2, AND PHOSPHORYLATION AT
RP   SER-89.
RX   PubMed=16574662; DOI=10.1074/jbc.m510954200;
RA   Tanaka T., Nishimura D., Wu R.C., Amano M., Iso T., Kedes L., Nishida H.,
RA   Kaibuchi K., Hamamori Y.;
RT   "Nuclear Rho kinase, ROCK2, targets p300 acetyltransferase.";
RL   J. Biol. Chem. 281:15320-15329(2006).
RN   [60]
RP   INTERACTION WITH CITED1.
RX   PubMed=16864582; DOI=10.1074/jbc.m602631200;
RA   Shi G., Boyle S.C., Sparrow D.B., Dunwoodie S.L., Shioda T.,
RA   de Caestecker M.P.;
RT   "The transcriptional activity of CITED1 is regulated by phosphorylation in
RT   a cell cycle-dependent manner.";
RL   J. Biol. Chem. 281:27426-27435(2006).
RN   [61]
RP   ACETYLATION AT LYS-1336 AND LYS-1473, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=17065153; DOI=10.1074/jbc.m608813200;
RA   Karanam B., Jiang L., Wang L., Kelleher N.L., Cole P.A.;
RT   "Kinetic and mass spectrometric analysis of p300 histone acetyltransferase
RT   domain autoacetylation.";
RL   J. Biol. Chem. 281:40292-40301(2006).
RN   [62]
RP   FUNCTION IN ACETYLATION OF HDAC1.
RX   PubMed=16762839; DOI=10.1016/j.molcel.2006.04.019;
RA   Qiu Y., Zhao Y., Becker M., John S., Parekh B.S., Huang S., Hendarwanto A.,
RA   Martinez E.D., Chen Y., Lu H., Adkins N.L., Stavreva D.A., Wiench M.,
RA   Georgel P.T., Schiltz R.L., Hager G.L.;
RT   "HDAC1 acetylation is linked to progressive modulation of steroid receptor-
RT   induced gene transcription.";
RL   Mol. Cell 22:669-679(2006).
RN   [63]
RP   INTERACTION WITH SP1.
RX   PubMed=16478997; DOI=10.1128/mcb.26.5.1770-1785.2006;
RA   Hung J.J., Wang Y.T., Chang W.C.;
RT   "Sp1 deacetylation induced by phorbol ester recruits p300 to activate
RT   12(S)-lipoxygenase gene transcription.";
RL   Mol. Cell. Biol. 26:1770-1785(2006).
RN   [64]
RP   FUNCTION, AND INTERACTION WITH MTA1.
RX   PubMed=16617102; DOI=10.1073/pnas.0601989103;
RA   Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P., Zhang H.,
RA   Balasenthil S., Talukder A.H., Landberg G., Kumar R.;
RT   "MTA1, a transcriptional activator of breast cancer amplified sequence 3.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:6670-6675(2006).
RN   [65]
RP   ERRATUM OF PUBMED:16617102.
RA   Gururaj A.E., Singh R.R., Rayala S.K., Holm C., den Hollander P., Zhang H.,
RA   Balasenthil S., Talukder A.H., Landberg G., Kumar R.;
RL   Proc. Natl. Acad. Sci. U.S.A. 110:4147-4148(2013).
RN   [66]
RP   INTERACTION WITH DDIT3.
RX   PubMed=17872950; DOI=10.1074/jbc.m703735200;
RA   Ohoka N., Hattori T., Kitagawa M., Onozaki K., Hayashi H.;
RT   "Critical and functional regulation of CHOP (C/EBP homologous protein)
RT   through the N-terminal portion.";
RL   J. Biol. Chem. 282:35687-35694(2007).
RN   [67]
RP   INTERACTION WITH DDX17.
RX   PubMed=17226766; DOI=10.1002/jcb.21250;
RA   Shin S., Janknecht R.;
RT   "Concerted activation of the Mdm2 promoter by p72 RNA helicase and the
RT   coactivators p300 and P/CAF.";
RL   J. Cell. Biochem. 101:1252-1265(2007).
RN   [68]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=17267393; DOI=10.1074/mcp.m700021-mcp200;
RA   Chen Y., Sprung R., Tang Y., Ball H., Sangras B., Kim S.C., Falck J.R.,
RA   Peng J., Gu W., Zhao Y.;
RT   "Lysine propionylation and butyrylation are novel post-translational
RT   modifications in histones.";
RL   Mol. Cell. Proteomics 6:812-819(2007).
RN   [69]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH RXRA, SUBCELLULAR LOCATION,
RP   AND MUTAGENESIS OF ASP-1399.
RX   PubMed=17761950; DOI=10.1210/me.2007-0107;
RA   Zhao W.X., Tian M., Zhao B.X., Li G.D., Liu B., Zhan Y.Y., Chen H.Z.,
RA   Wu Q.;
RT   "Orphan receptor TR3 attenuates the p300-induced acetylation of retinoid X
RT   receptor-alpha.";
RL   Mol. Endocrinol. 21:2877-2889(2007).
RN   [70]
RP   FUNCTION IN ACETYLATION OF SIRT2.
RX   PubMed=18722353; DOI=10.1016/j.bbrc.2008.08.042;
RA   Han Y., Jin Y.H., Kim Y.J., Kang B.Y., Choi H.J., Kim D.W., Yeo C.Y.,
RA   Lee K.Y.;
RT   "Acetylation of Sirt2 by p300 attenuates its deacetylase activity.";
RL   Biochem. Biophys. Res. Commun. 375:576-580(2008).
RN   [71]
RP   PHOSPHORYLATION BY HIPK2.
RX   PubMed=18695000; DOI=10.1182/blood-2008-01-134122;
RA   Wee H.-J., Voon D.C.-C., Bae S.-C., Ito Y.;
RT   "PEBP2-beta/CBF-beta-dependent phosphorylation of RUNX1 and p300 by HIPK2:
RT   implications for leukemogenesis.";
RL   Blood 112:3777-3787(2008).
RN   [72]
RP   INTERACTION WITH HUMAN T-CELL LEUKEMIA VIRUS 1/HTLV-1 PROTEIN HBZ.
RX   PubMed=18599479; DOI=10.1074/jbc.m803116200;
RA   Clerc I., Polakowski N., Andre-Arpin C., Cook P., Barbeau B., Mesnard J.M.,
RA   Lemasson I.;
RT   "An interaction between the human T cell leukemia virus type 1 basic
RT   leucine zipper factor (HBZ) and the KIX domain of p300/CBP contributes to
RT   the down-regulation of tax-dependent viral transcription by HBZ.";
RL   J. Biol. Chem. 283:23903-23913(2008).
RN   [73]
RP   FBXO3-MEDIATED DEGRADATION.
RX   PubMed=18809579; DOI=10.1128/mcb.00897-08;
RA   Shima Y., Shima T., Chiba T., Irimura T., Pandolfi P.P., Kitabayashi I.;
RT   "PML activates transcription by protecting HIPK2 and p300 from SCFFbx3-
RT   mediated degradation.";
RL   Mol. Cell. Biol. 28:7126-7138(2008).
RN   [74]
RP   ACETYLATION AT LYS-418; LYS-423; LYS-1542; LYS-1546; LYS-1549; LYS-1699;
RP   LYS-1704 AND LYS-1707, DEACETYLATION BY SIRT2, AND FUNCTION IN
RP   TRANSCRIPTIONAL REGULATION.
RX   PubMed=18995842; DOI=10.1016/j.molcel.2008.09.018;
RA   Black J.C., Mosley A., Kitada T., Washburn M., Carey M.;
RT   "The SIRT2 deacetylase regulates autoacetylation of p300.";
RL   Mol. Cell 32:449-455(2008).
RN   [75]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [76]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [77]
RP   INTERACTION WITH SENP3, AND SUMOYLATION.
RX   PubMed=19680224; DOI=10.1038/emboj.2009.210;
RA   Huang C., Han Y., Wang Y., Sun X., Yan S., Yeh E.T.H., Chen Y., Cang H.,
RA   Li H., Shi G., Cheng J., Tang X., Yi J.;
RT   "SENP3 is responsible for HIF-1 transactivation under mild oxidative stress
RT   via p300 de-SUMOylation.";
RL   EMBO J. 28:2748-2762(2009).
RN   [78]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [79]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-636; LYS-977; LYS-1542; LYS-1546;
RP   LYS-1554; LYS-1555; LYS-1558; LYS-1560 AND LYS-1583, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [80]
RP   SUBCELLULAR LOCATION.
RX   PubMed=20940255; DOI=10.1242/jcs.068924;
RA   Pickard A., Wong P.P., McCance D.J.;
RT   "Acetylation of Rb by PCAF is required for nuclear localization and
RT   keratinocyte differentiation.";
RL   J. Cell Sci. 123:3718-3726(2010).
RN   [81]
RP   FUNCTION IN ACETYLATION OF ZBTB7B.
RX   PubMed=20810990; DOI=10.4049/jimmunol.1001462;
RA   Zhang M., Zhang J., Rui J., Liu X.;
RT   "p300-mediated acetylation stabilizes the Th-inducing POK factor.";
RL   J. Immunol. 185:3960-3969(2010).
RN   [82]
RP   IDENTIFICATION IN COMPLEX WITH CCNT1; CDK9 AND GATA4.
RX   PubMed=20081228; DOI=10.1074/jbc.m109.070458;
RA   Sunagawa Y., Morimoto T., Takaya T., Kaichi S., Wada H., Kawamura T.,
RA   Fujita M., Shimatsu A., Kita T., Hasegawa K.;
RT   "Cyclin-dependent kinase-9 is a component of the p300/GATA4 complex
RT   required for phenylephrine-induced hypertrophy in cardiomyocytes.";
RL   J. Biol. Chem. 285:9556-9568(2010).
RN   [83]
RP   FUNCTION IN ACETYLATION OF MEF2D.
RX   PubMed=21030595; DOI=10.1074/jbc.m110.153270;
RA   Chini C.C., Escande C., Nin V., Chini E.N.;
RT   "HDAC3 is negatively regulated by the nuclear protein DBC1.";
RL   J. Biol. Chem. 285:40830-40837(2010).
RN   [84]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [85]
RP   FUNCTION IN ACETYLATION OF XBP1.
RX   PubMed=20955178; DOI=10.1042/bj20101293;
RA   Wang F.M., Chen Y.J., Ouyang H.J.;
RT   "Regulation of unfolded protein response modulator XBP1s by acetylation and
RT   deacetylation.";
RL   Biochem. J. 433:245-252(2011).
RN   [86]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [87]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [88]
RP   INTERACTION WITH ALKBH4.
RX   PubMed=23145062; DOI=10.1371/journal.pone.0049045;
RA   Bjornstad L.G., Meza T.J., Otterlei M., Olafsrud S.M., Meza-Zepeda L.A.,
RA   Falnes P.O.;
RT   "Human ALKBH4 interacts with proteins associated with transcription.";
RL   PLoS ONE 7:E49045-E49045(2012).
RN   [89]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=23415232; DOI=10.1016/j.cell.2013.01.032;
RA   Tropberger P., Pott S., Keller C., Kamieniarz-Gdula K., Caron M.,
RA   Richter F., Li G., Mittler G., Liu E.T., Buhler M., Margueron R.,
RA   Schneider R.;
RT   "Regulation of transcription through acetylation of H3K122 on the lateral
RT   surface of the histone octamer.";
RL   Cell 152:859-872(2013).
RN   [90]
RP   FUNCTION AS ACETYLTRANSFERASE OF H3K27.
RX   PubMed=23911289; DOI=10.1016/j.celrep.2013.06.016;
RA   Hatzi K., Jiang Y., Huang C., Garrett-Bakelman F., Gearhart M.D.,
RA   Giannopoulou E.G., Zumbo P., Kirouac K., Bhaskara S., Polo J.M.,
RA   Kormaksson M., Mackerell A.D. Jr., Xue F., Mason C.E., Hiebert S.W.,
RA   Prive G.G., Cerchietti L., Bardwell V.J., Elemento O., Melnick A.;
RT   "A hybrid mechanism of action for BCL6 in B cells defined by formation of
RT   functionally distinct complexes at enhancers and promoters.";
RL   Cell Rep. 4:578-588(2013).
RN   [91]
RP   INTERACTION WITH KLF15.
RX   PubMed=23999430; DOI=10.1172/jci68552;
RA   Lu Y., Zhang L., Liao X., Sangwung P., Prosdocimo D.A., Zhou G.,
RA   Votruba A.R., Brian L., Han Y.J., Gao H., Wang Y., Shimizu K.,
RA   Weinert-Stein K., Khrestian M., Simon D.I., Freedman N.J., Jain M.K.;
RT   "Kruppel-like factor 15 is critical for vascular inflammation.";
RL   J. Clin. Invest. 123:4232-4241(2013).
RN   [92]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038 AND SER-1726, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [93]
RP   INTERACTION WITH HDAC4 AND HDAC5.
RX   PubMed=24413532; DOI=10.1158/0008-5472.can-13-2020;
RA   Kang H.J., Lee M.H., Kang H.L., Kim S.H., Ahn J.R., Na H., Na T.Y.,
RA   Kim Y.N., Seong J.K., Lee M.O.;
RT   "Differential regulation of estrogen receptor alpha expression in breast
RT   cancer cells by metastasis-associated protein 1.";
RL   Cancer Res. 74:1484-1494(2014).
RN   [94]
RP   INTERACTION WITH ZNF451, AND FUNCTION.
RX   PubMed=24324267; DOI=10.1074/jbc.m113.526905;
RA   Feng Y., Wu H., Xu Y., Zhang Z., Liu T., Lin X., Feng X.H.;
RT   "Zinc finger protein 451 is a novel Smad corepressor in transforming growth
RT   factor-beta signaling.";
RL   J. Biol. Chem. 289:2072-2083(2014).
RN   [95]
RP   INTERACTION WITH ZBTB48.
RX   PubMed=24382891; DOI=10.1074/jbc.m113.526855;
RA   Yoon J.H., Choi W.I., Jeon B.N., Koh D.I., Kim M.K., Kim M.H., Kim J.,
RA   Hur S.S., Kim K.S., Hur M.W.;
RT   "Human Kruppel-related 3 (HKR3) is a novel transcription activator of
RT   alternate reading frame (ARF) gene.";
RL   J. Biol. Chem. 289:4018-4031(2014).
RN   [96]
RP   ACETYLATION, DEACETYLATION BY SIRT2, AND INTERACTION WITH EP300.
RX   PubMed=24177535; DOI=10.1016/j.jmb.2013.10.027;
RA   Rack J.G., Vanlinden M.R., Lutter T., Aasland R., Ziegler M.;
RT   "Constitutive nuclear localization of an alternatively spliced sirtuin-2
RT   isoform.";
RL   J. Mol. Biol. 426:1677-1691(2014).
RN   [97]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1038, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [98]
RP   INTERACTION WITH TRIP4.
RX   PubMed=25219498; DOI=10.1016/j.molcel.2014.08.007;
RA   Yoo H.M., Kang S.H., Kim J.Y., Lee J.E., Seong M.W., Lee S.W., Ka S.H.,
RA   Sou Y.S., Komatsu M., Tanaka K., Lee S.T., Noh D.Y., Baek S.H., Jeon Y.J.,
RA   Chung C.H.;
RT   "Modification of ASC1 by UFM1 is crucial for ERalpha transactivation and
RT   breast cancer development.";
RL   Mol. Cell 56:261-274(2014).
RN   [99]
RP   FUNCTION AS ACETYLTRANSFERASE OF PCNA, AND INTERACTION WITH PCNA.
RX   PubMed=24939902; DOI=10.1093/nar/gku533;
RA   Cazzalini O., Sommatis S., Tillhon M., Dutto I., Bachi A., Rapp A.,
RA   Nardo T., Scovassi A.I., Necchi D., Cardoso M.C., Stivala L.A.,
RA   Prosperi E.;
RT   "CBP and p300 acetylate PCNA to link its degradation with nucleotide
RT   excision repair synthesis.";
RL   Nucleic Acids Res. 42:8433-8448(2014).
RN   [100]
RP   INTERACTION WITH ZBTB49.
RX   PubMed=25245946; DOI=10.1093/nar/gku857;
RA   Jeon B.N., Kim M.K., Yoon J.H., Kim M.Y., An H., Noh H.J., Choi W.I.,
RA   Koh D.I., Hur M.W.;
RT   "Two ZNF509 (ZBTB49) isoforms induce cell-cycle arrest by activating
RT   transcription of p21/CDKN1A and RB upon exposure to genotoxic stress.";
RL   Nucleic Acids Res. 42:11447-11461(2014).
RN   [101]
RP   FUNCTION, AND INTERACTION WITH SMAD4.
RX   PubMed=25514493; DOI=10.1016/j.bbagrm.2014.12.008;
RA   Yang Y., Cui J., Xue F., Zhang C., Mei Z., Wang Y., Bi M., Shan D.,
RA   Meredith A., Li H., Xu Z.Q.;
RT   "Pokemon (FBI-1) interacts with Smad4 to repress TGF-beta-induced
RT   transcriptional responses.";
RL   Biochim. Biophys. Acta 1849:270-281(2015).
RN   [102]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION.
RX   PubMed=25818647; DOI=10.1016/j.molcel.2015.02.029;
RA   Sabari B.R., Tang Z., Huang H., Yong-Gonzalez V., Molina H., Kong H.E.,
RA   Dai L., Shimada M., Cross J.R., Zhao Y., Roeder R.G., Allis C.D.;
RT   "Intracellular crotonyl-CoA stimulates transcription through p300-catalyzed
RT   histone crotonylation.";
RL   Mol. Cell 58:203-215(2015).
RN   [103]
RP   INTERACTION WITH STAT1.
RX   PubMed=26479788; DOI=10.1038/ni.3279;
RA   Zhang Y., Mao D., Roswit W.T., Jin X., Patel A.C., Patel D.A., Agapov E.,
RA   Wang Z., Tidwell R.M., Atkinson J.J., Huang G., McCarthy R., Yu J.,
RA   Yun N.E., Paessler S., Lawson T.G., Omattage N.S., Brett T.J.,
RA   Holtzman M.J.;
RT   "PARP9-DTX3L ubiquitin ligase targets host histone H2BJ and viral 3C
RT   protease to enhance interferon signaling and control viral infection.";
RL   Nat. Immunol. 16:1215-1227(2015).
RN   [104]
RP   INTERACTION WITH BCL11B.
RX   PubMed=27959755; DOI=10.1056/nejmoa1509164;
RA   Punwani D., Zhang Y., Yu J., Cowan M.J., Rana S., Kwan A., Adhikari A.N.,
RA   Lizama C.O., Mendelsohn B.A., Fahl S.P., Chellappan A., Srinivasan R.,
RA   Brenner S.E., Wiest D.L., Puck J.M.;
RT   "Multisystem anomalies in severe combined immunodeficiency with mutant
RT   BCL11B.";
RL   N. Engl. J. Med. 375:2165-2176(2016).
RN   [105]
RP   INTERACTION WITH DUX4.
RX   PubMed=26951377; DOI=10.1093/nar/gkw141;
RA   Choi S.H., Gearhart M.D., Cui Z., Bosnakovski D., Kim M., Schennum N.,
RA   Kyba M.;
RT   "DUX4 recruits p300/CBP through its C-terminus and induces global H3K27
RT   acetylation changes.";
RL   Nucleic Acids Res. 44:5161-5173(2016).
RN   [106]
RP   INTERACTION WITH HSF1.
RX   PubMed=27189267; DOI=10.1038/srep26294;
RA   Pan X.Y., Zhao W., Zeng X.Y., Lin J., Li M.M., Shen X.T., Liu S.W.;
RT   "Heat shock factor 1 mediates latent HIV reactivation.";
RL   Sci. Rep. 6:26294-26294(2016).
RN   [107]
RP   INTERACTION WITH DDX3X.
RX   PubMed=28128295; DOI=10.1038/srep41452;
RA   Tsai T.Y., Wang W.T., Li H.K., Chen W.J., Tsai Y.H., Chao C.H.,
RA   Wu Lee Y.H.;
RT   "RNA helicase DDX3 maintains lipid homeostasis through upregulation of the
RT   microsomal triglyceride transfer protein by interacting with HNF4 and
RT   SHP.";
RL   Sci. Rep. 7:41452-41452(2017).
RN   [108]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ASP-1399.
RX   PubMed=29775581; DOI=10.1016/j.molcel.2018.04.011;
RA   Huang H., Tang S., Ji M., Tang Z., Shimada M., Liu X., Qi S.,
RA   Locasale J.W., Roeder R.G., Zhao Y., Li X.;
RT   "p300-mediated lysine 2-hydroxyisobutyrylation regulates glycolysis.";
RL   Mol. Cell 70:663-678(2018).
RN   [109]
RP   FUNCTION IN ACETYLATION OF PCK1.
RX   PubMed=30193097; DOI=10.1016/j.molcel.2018.07.031;
RA   Latorre-Muro P., Baeza J., Armstrong E.A., Hurtado-Guerrero R., Corzana F.,
RA   Wu L.E., Sinclair D.A., Lopez-Buesa P., Carrodeguas J.A., Denu J.M.;
RT   "Dynamic acetylation of phosphoenolpyruvate carboxykinase toggles enzyme
RT   activity between gluconeogenic and anaplerotic reactions.";
RL   Mol. Cell 71:718-732(2018).
RN   [110]
RP   STRUCTURE BY NMR OF 302-418 IN COMPLEX WITH HIF1A PEPTIDE AND ZINC IONS.
RX   PubMed=11959990; DOI=10.1073/pnas.082117899;
RA   Freedman S.J., Sun Z.-Y.J., Poy F., Kung A.L., Livingston D.M., Wagner G.,
RA   Eck M.J.;
RT   "Structural basis for recruitment of CBP/p300 by hypoxia-inducible factor-1
RT   alpha.";
RL   Proc. Natl. Acad. Sci. U.S.A. 99:5367-5372(2002).
RN   [111]
RP   STRUCTURE BY NMR OF 323-423 IN COMPLEX WITH 216-259 OF CITED2 AND ZINC
RP   IONS, INTERACTION WITH CITED2, AND MUTAGENESIS OF LEU-344 AND LEU-345.
RX   PubMed=12778114; DOI=10.1038/nsb936;
RA   Freedman S.J., Sun Z.Y., Kung A.L., France D.S., Wagner G., Eck M.J.;
RT   "Structural basis for negative regulation of hypoxia-inducible factor-
RT   1alpha by CITED2.";
RL   Nat. Struct. Biol. 10:504-512(2003).
RN   [112]
RP   X-RAY CRYSTALLOGRAPHY (1.7 ANGSTROMS) OF 1287-1666 IN COMPLEX WITH LYS-COA,
RP   AND MUTAGENESIS OF THR-1357; SER-1396; TYR-1397; GLU-1505; ASP-1625 AND
RP   ASP-1628.
RX   PubMed=18273021; DOI=10.1038/nature06546;
RA   Liu X., Wang L., Zhao K., Thompson P.R., Hwang Y., Marmorstein R.,
RA   Cole P.A.;
RT   "The structural basis of protein acetylation by the p300/CBP
RT   transcriptional coactivator.";
RL   Nature 451:846-850(2008).
RN   [113]
RP   STRUCTURE BY NMR OF 1723-1812, AND INTERACTION WITH TP53.
RX   PubMed=19217391; DOI=10.1016/j.str.2008.12.009;
RA   Feng H., Jenkins L.M.M., Durell S.R., Hayashi R., Mazur S.J., Cherry S.,
RA   Tropea J.E., Miller M., Wlodawer A., Appella E., Bai Y.;
RT   "Structural basis for p300 Taz2-p53 TAD1 binding and modulation by
RT   phosphorylation.";
RL   Structure 17:202-210(2009).
RN   [114]
RP   X-RAY CRYSTALLOGRAPHY (2.33 ANGSTROMS) OF 1040-1161.
RX   PubMed=22464331; DOI=10.1016/j.cell.2012.02.013;
RA   Filippakopoulos P., Picaud S., Mangos M., Keates T., Lambert J.P.,
RA   Barsyte-Lovejoy D., Felletar I., Volkmer R., Muller S., Pawson T.,
RA   Gingras A.C., Arrowsmith C.H., Knapp S.;
RT   "Histone recognition and large-scale structural analysis of the human
RT   bromodomain family.";
RL   Cell 149:214-231(2012).
RN   [115]
RP   X-RAY CRYSTALLOGRAPHY (2.80 ANGSTROMS) OF 1043-1519 AND 1581-1666 OF MUTANT
RP   PHE-1467 IN COMPLEX WITH ZINC, CATALYTIC ACTIVITY, FUNCTION,
RP   AUTOACETYLATION, AND MUTAGENESIS OF PHE-1170; CYS-1204; GLU-1242; ASP-1399;
RP   TYR-1467 AND 1645-ARG-ARG-1646.
RX   PubMed=23934153; DOI=10.1038/nsmb.2642;
RA   Delvecchio M., Gaucher J., Aguilar-Gurrieri C., Ortega E., Panne D.;
RT   "Structure of the p300 catalytic core and implications for chromatin
RT   targeting and HAT regulation.";
RL   Nat. Struct. Mol. Biol. 20:1040-1046(2013).
RN   [116]
RP   X-RAY CRYSTALLOGRAPHY (1.94 ANGSTROMS) OF 1287-1664 OF MUTANT PHE-1467 IN
RP   COMPLEX WITH ACETYL-COA AND COENZYME A.
RX   PubMed=24819397; DOI=10.1021/bi500380f;
RA   Maksimoska J., Segura-Pena D., Cole P.A., Marmorstein R.;
RT   "Structure of the p300 histone acetyltransferase bound to acetyl-coenzyme A
RT   and its analogues.";
RL   Biochemistry 53:3415-3422(2014).
RN   [117]
RP   VARIANTS PRO-827; GLY-1013; TYR-1650 AND GLN-2221, AND POSSIBLE INVOLVEMENT
RP   IN CANCER.
RX   PubMed=10700188; DOI=10.1038/73536;
RA   Gayther S.A., Batley S.J., Linger L., Bannister A., Thorpe K., Chin S.-F.,
RA   Daigo Y., Russell P., Wilson A., Sowter H.M., Delhanty J.D.A.,
RA   Ponder B.A.J., Kouzarides T., Caldas C.;
RT   "Mutations truncating the EP300 acetylase in human cancers.";
RL   Nat. Genet. 24:300-303(2000).
RN   [118]
RP   VARIANT ILE-1511.
RX   PubMed=24476420; DOI=10.1111/cge.12348;
RA   Negri G., Milani D., Colapietro P., Forzano F., Della Monica M.,
RA   Rusconi D., Consonni L., Caffi L.G., Finelli P., Scarano G., Magnani C.,
RA   Selicorni A., Spena S., Larizza L., Gervasini C.;
RT   "Clinical and molecular characterization of Rubinstein-Taybi syndrome
RT   patients carrying distinct novel mutations of the EP300 gene.";
RL   Clin. Genet. 87:148-154(2015).
RN   [119]
RP   VARIANT ARG-2007.
RX   PubMed=29053796; DOI=10.1093/brain/awx251;
RA   Nibbeling E.A.R., Duarri A., Verschuuren-Bemelmans C.C., Fokkens M.R.,
RA   Karjalainen J.M., Smeets C.J.L.M., de Boer-Bergsma J.J., van der Vries G.,
RA   Dooijes D., Bampi G.B., van Diemen C., Brunt E., Ippel E., Kremer B.,
RA   Vlak M., Adir N., Wijmenga C., van de Warrenburg B.P.C., Franke L.,
RA   Sinke R.J., Verbeek D.S.;
RT   "Exome sequencing and network analysis identifies shared mechanisms
RT   underlying spinocerebellar ataxia.";
RL   Brain 140:2860-2878(2017).
RN   [120]
RP   VARIANTS MKHK2 PRO-1824 AND ARG-1831 DEL, AND INVOLVEMENT IN MKHK2.
RX   PubMed=29460469; DOI=10.1002/ajmg.a.38626;
RG   DDD study;
RA   Menke L.A., Gardeitchik T., Hammond P., Heimdal K.R., Houge G.,
RA   Hufnagel S.B., Ji J., Johansson S., Kant S.G., Kinning E., Leon E.L.,
RA   Newbury-Ecob R., Paolacci S., Pfundt R., Ragge N.K., Rinne T.,
RA   Ruivenkamp C., Saitta S.C., Sun Y., Tartaglia M., Terhal P.A.,
RA   van Essen A.J., Vigeland M.D., Xiao B., Hennekam R.C.;
RT   "Further delineation of an entity caused by CREBBP and EP300 mutations but
RT   not resembling Rubinstein-Taybi syndrome.";
RL   Am. J. Med. Genet. A 176:862-876(2018).
CC   -!- FUNCTION: Functions as histone acetyltransferase and regulates
CC       transcription via chromatin remodeling (PubMed:23415232,
CC       PubMed:23934153, PubMed:8945521). Acetylates all four core histones in
CC       nucleosomes. Histone acetylation gives an epigenetic tag for
CC       transcriptional activation (PubMed:23415232, PubMed:23934153,
CC       PubMed:8945521). Mediates cAMP-gene regulation by binding specifically
CC       to phosphorylated CREB protein. Mediates acetylation of histone H3 at
CC       'Lys-122' (H3K122ac), a modification that localizes at the surface of
CC       the histone octamer and stimulates transcription, possibly by promoting
CC       nucleosome instability. Mediates acetylation of histone H3 at 'Lys-27'
CC       (H3K27ac) (PubMed:23911289). Also functions as acetyltransferase for
CC       non-histone targets, such as ALX1, HDAC1, PRMT1 or SIRT2
CC       (PubMed:12929931, PubMed:16762839, PubMed:18722353). Acetylates 'Lys-
CC       131' of ALX1 and acts as its coactivator (PubMed:12929931). Acetylates
CC       SIRT2 and is proposed to indirectly increase the transcriptional
CC       activity of TP53 through acetylation and subsequent attenuation of
CC       SIRT2 deacetylase function (PubMed:18722353). Acetylates HDAC1 leading
CC       to its inactivation and modulation of transcription (PubMed:16762839).
CC       Acts as a TFAP2A-mediated transcriptional coactivator in presence of
CC       CITED2 (PubMed:12586840). Plays a role as a coactivator of NEUROD1-
CC       dependent transcription of the secretin and p21 genes and controls
CC       terminal differentiation of cells in the intestinal epithelium.
CC       Promotes cardiac myocyte enlargement. Can also mediate transcriptional
CC       repression. Acetylates FOXO1 and enhances its transcriptional activity
CC       (PubMed:15890677). Acetylates BCL6 wich disrupts its ability to recruit
CC       histone deacetylases and hinders its transcriptional repressor activity
CC       (PubMed:12402037). Participates in CLOCK or NPAS2-regulated rhythmic
CC       gene transcription; exhibits a circadian association with CLOCK or
CC       NPAS2, correlating with increase in PER1/2 mRNA and histone H3
CC       acetylation on the PER1/2 promoter (PubMed:14645221). Acetylates MTA1
CC       at 'Lys-626' which is essential for its transcriptional coactivator
CC       activity (PubMed:16617102). Acetylates XBP1 isoform 2; acetylation
CC       increases protein stability of XBP1 isoform 2 and enhances its
CC       transcriptional activity (PubMed:20955178). Acetylates PCNA;
CC       acetylation promotes removal of chromatin-bound PCNA and its
CC       degradation during nucleotide excision repair (NER) (PubMed:24939902).
CC       Acetylates MEF2D (PubMed:21030595). Acetylates and stabilizes ZBTB7B
CC       protein by antagonizing ubiquitin conjugation and degragation, this
CC       mechanism may be involved in CD4/CD8 lineage differentiation
CC       (PubMed:20810990). Acetylates GABPB1, impairing GABPB1
CC       heterotetramerization and activity (By similarity). In addition to
CC       protein acetyltransferase, can use different acyl-CoA substrates, such
CC       as (2E)-butenoyl-CoA (crotonyl-CoA), butanoyl-CoA (butyryl-CoA), 2-
CC       hydroxyisobutanoyl-CoA (2-hydroxyisobutyryl-CoA) or propanoyl-CoA
CC       (propionyl-CoA), and is able to mediate protein crotonylation,
CC       butyrylation, 2-hydroxyisobutyrylation or propionylation, respectively
CC       (PubMed:17267393, PubMed:25818647, PubMed:29775581). Acts as a histone
CC       crotonyltransferase; crotonylation marks active promoters and enhancers
CC       and confers resistance to transcriptional repressors (PubMed:25818647).
CC       Histone crotonyltransferase activity is dependent on the concentration
CC       of (2E)-butenoyl-CoA (crotonyl-CoA) substrate and such activity is weak
CC       when (2E)-butenoyl-CoA (crotonyl-CoA) concentration is low
CC       (PubMed:25818647). Also acts as a histone butyryltransferase;
CC       butyrylation marks active promoters (PubMed:17267393). Acts as a
CC       protein-lysine 2-hydroxyisobutyryltransferase; regulates glycolysis by
CC       mediating 2-hydroxyisobutyrylation of glycolytic enzymes
CC       (PubMed:29775581). Functions as a transcriptional coactivator for SMAD4
CC       in the TGF-beta signaling pathway (PubMed:25514493). Acetylates PCK1
CC       and promotes PCK1 anaplerotic activity (PubMed:30193097). Acetylates
CC       RXRA and RXRG (PubMed:17761950). {ECO:0000250|UniProtKB:B2RWS6,
CC       ECO:0000269|PubMed:10733570, ECO:0000269|PubMed:11430825,
CC       ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:12402037,
CC       ECO:0000269|PubMed:12586840, ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:15186775,
CC       ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:16617102,
CC       ECO:0000269|PubMed:16762839, ECO:0000269|PubMed:17267393,
CC       ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:18722353,
CC       ECO:0000269|PubMed:18995842, ECO:0000269|PubMed:20810990,
CC       ECO:0000269|PubMed:21030595, ECO:0000269|PubMed:23415232,
CC       ECO:0000269|PubMed:23911289, ECO:0000269|PubMed:23934153,
CC       ECO:0000269|PubMed:24939902, ECO:0000269|PubMed:25514493,
CC       ECO:0000269|PubMed:25818647, ECO:0000269|PubMed:29775581,
CC       ECO:0000269|PubMed:30193097, ECO:0000269|PubMed:8945521,
CC       ECO:0000305|PubMed:20955178}.
CC   -!- FUNCTION: (Microbial infection) In case of HIV-1 infection, it is
CC       recruited by the viral protein Tat. Regulates Tat's transactivating
CC       activity and may help inducing chromatin remodeling of proviral genes.
CC       Binds to and may be involved in the transforming capacity of the
CC       adenovirus E1A protein. {ECO:0000269|PubMed:10545121,
CC       ECO:0000269|PubMed:11080476}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:23415232,
CC         ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:8945521};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=(2E)-butenoyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-
CC         (2E)-butenoyl-L-lysyl-[protein]; Xref=Rhea:RHEA:53908, Rhea:RHEA-
CC         COMP:9752, Rhea:RHEA-COMP:13707, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57332,
CC         ChEBI:CHEBI:137954; Evidence={ECO:0000269|PubMed:25818647};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=butanoyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-butanoyl-
CC         L-lysyl-[protein]; Xref=Rhea:RHEA:53912, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:13708, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57371, ChEBI:CHEBI:137955;
CC         Evidence={ECO:0000250|UniProtKB:B2RWS6};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=L-lysyl-[protein] + propanoyl-CoA = CoA + H(+) + N(6)-
CC         propanoyl-L-lysyl-[protein]; Xref=Rhea:RHEA:54020, Rhea:RHEA-
CC         COMP:9752, Rhea:RHEA-COMP:13758, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:57392,
CC         ChEBI:CHEBI:138019; Evidence={ECO:0000269|PubMed:17267393};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-hydroxyisobutanoyl-CoA + L-lysyl-[protein] = CoA + H(+) +
CC         N(6)-(2-hydroxyisobutanoyl)-L-lysyl-[protein]; Xref=Rhea:RHEA:24180,
CC         Rhea:RHEA-COMP:9752, Rhea:RHEA-COMP:15921, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:29969, ChEBI:CHEBI:57287, ChEBI:CHEBI:131780,
CC         ChEBI:CHEBI:144968; Evidence={ECO:0000269|PubMed:29775581};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:24181;
CC         Evidence={ECO:0000269|PubMed:29775581};
CC   -!- SUBUNIT: Interacts with phosphorylated CREB1. Interacts with HIF1A; the
CC       interaction is stimulated in response to hypoxia and inhibited by
CC       CITED2. Interacts (via N-terminus) with TFAP2A (via N-terminus); the
CC       interaction requires CITED2. Interacts (via CH1 domain) with CITED2
CC       (via C-terminus). Interacts with CITED1 (unphosphorylated form
CC       preferentially and via C-terminus). Interacts with ESR1; the
CC       interaction is estrogen-dependent and enhanced by CITED1. Interacts
CC       with DTX1, EID1, ELF3, FEN1, LEF1, NCOA1, NCOA6, NR3C1, PCAF, PELP1,
CC       PRDM6, SP1, SP3, SPIB, SRY, TCF7L2, TP53, DDX5, DDX17, SATB1, SRCAP,
CC       TTC5, JMY and TRERF1. The TAZ-type 1 domain interacts with HIF1A.
CC       Probably part of a complex with HIF1A and CREBBP. Part of a complex
CC       containing CARM1 and NCOA2/GRIP1. Interacts with ING4 and this
CC       interaction may be indirect. Interacts with ING5. Interacts with the C-
CC       terminal region of CITED4. Non-sumoylated EP300 preferentially
CC       interacts with SENP3. Interacts with SS18L1/CREST. Interacts with ALX1
CC       (via homeobox domain). Interacts with NEUROD1; the interaction is
CC       inhibited by NR0B2. Interacts with TCF3. Interacts (via CREB-binding
CC       domain) with MYOCD (via C-terminus). Binds to HIPK2. Interacts with
CC       ROCK2 and PPARG. Forms a complex made of CDK9, CCNT1/cyclin-T1, EP300
CC       and GATA4 that stimulates hypertrophy in cardiomyocytes. Interacts with
CC       IRF1 and this interaction enhances acetylation of p53/TP53 and
CC       stimulation of its activity. Interacts with FOXO1; the interaction
CC       acetylates FOXO1 and enhances its transcriptional activity. Interacts
CC       with ALKBH4 and DDIT3/CHOP. Interacts with KLF15. Interacts with CEBPB
CC       and RORA. Interacts with p30II. Interacts with NPAS2, ARNTL/BMAL1 and
CC       CLOCK. Interacts with SIRT2 isoform 1, isoform 2 and isoform 5.
CC       Interacts with MTA1. Interacts with HDAC4 and HDAC5 in the presence of
CC       TFAP2C (PubMed:10722728, PubMed:10823961, PubMed:11073989,
CC       PubMed:11073990, PubMed:11349124, PubMed:11430825, PubMed:11481323,
CC       PubMed:11518699, PubMed:11559821, PubMed:11564735, PubMed:11581164,
CC       PubMed:11581372, PubMed:11701890, PubMed:11744733, PubMed:11864910,
CC       PubMed:11959990, PubMed:11997499, PubMed:12446687, PubMed:12527917,
CC       PubMed:12586840, PubMed:12750254, PubMed:12778114, PubMed:12837748,
CC       PubMed:12929931, PubMed:14605447, PubMed:14645221, PubMed:14716005,
CC       PubMed:14752053, PubMed:15075319, PubMed:15186775, PubMed:15297880,
CC       PubMed:15509808, PubMed:15731352, PubMed:15890677, PubMed:16478997,
CC       PubMed:16574662, PubMed:16617102, PubMed:16864582, PubMed:17226766,
CC       PubMed:17872950, PubMed:18273021, PubMed:19217391, PubMed:19680224,
CC       PubMed:20081228, PubMed:23145062, PubMed:23999430, PubMed:24177535,
CC       PubMed:24413532, PubMed:8684459, PubMed:8917528, PubMed:9528808,
CC       PubMed:9590696, PubMed:9862959, PubMed:9887100). Interacts with TRIP4
CC       (PubMed:25219498). Directly interacts with ZBTB49; this interaction
CC       leads to synergistic transactivation of CDKN1A (PubMed:25245946).
CC       Interacts with NR4A3 (By similarity). Interacts with ZNF451
CC       (PubMed:24324267). Interacts with ATF5; EP300 is required for ATF5 and
CC       CEBPB interaction and DNA binding (By similarity). Interacts with HSF1
CC       (PubMed:27189267). Interacts with ZBTB48/TZAP (PubMed:24382891).
CC       Interacts with STAT1; the interaction is enhanced upon IFN-gamma
CC       stimulation (PubMed:26479788). Interacts with HNRNPU (via C-terminus);
CC       this interaction enhances DNA-binding of HNRNPU to nuclear
CC       scaffold/matrix attachment region (S/MAR) elements (PubMed:11909954).
CC       Interacts with BCL11B (PubMed:27959755, PubMed:16809611). Interacts
CC       with SMAD4; negatively regulated by ZBTB7A (PubMed:25514493). Interacts
CC       with DUX4 (via C-terminus) (PubMed:26951377). Interacts with NUPR1;
CC       this interaction enhances the effect of EP300 on PAX2 transcription
CC       factor activity (PubMed:11940591). Interacts with RXRA; the interaction
CC       is decreased by 9-cis retinoic acid (PubMed:17761950). NR4A1 competes
CC       with EP300 for interaction with RXRA and thereby attenuates EP300
CC       mediated acetylation of RXRA (PubMed:17761950). Interacts with RB1 (By
CC       similarity). Interacts with DDX3X; this interaction may facilitate
CC       HNF4A acetylation (PubMed:28128295). {ECO:0000250|UniProtKB:B2RWS6,
CC       ECO:0000269|PubMed:10722728, ECO:0000269|PubMed:10823961,
CC       ECO:0000269|PubMed:11073989, ECO:0000269|PubMed:11073990,
CC       ECO:0000269|PubMed:11349124, ECO:0000269|PubMed:11430825,
CC       ECO:0000269|PubMed:11481323, ECO:0000269|PubMed:11518699,
CC       ECO:0000269|PubMed:11559821, ECO:0000269|PubMed:11564735,
CC       ECO:0000269|PubMed:11581164, ECO:0000269|PubMed:11581372,
CC       ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:11744733,
CC       ECO:0000269|PubMed:11864910, ECO:0000269|PubMed:11909954,
CC       ECO:0000269|PubMed:11940591, ECO:0000269|PubMed:11959990,
CC       ECO:0000269|PubMed:11997499, ECO:0000269|PubMed:12446687,
CC       ECO:0000269|PubMed:12527917, ECO:0000269|PubMed:12586840,
CC       ECO:0000269|PubMed:12750254, ECO:0000269|PubMed:12778114,
CC       ECO:0000269|PubMed:12837748, ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:14605447, ECO:0000269|PubMed:14645221,
CC       ECO:0000269|PubMed:14716005, ECO:0000269|PubMed:14752053,
CC       ECO:0000269|PubMed:15075319, ECO:0000269|PubMed:15186775,
CC       ECO:0000269|PubMed:15297880, ECO:0000269|PubMed:15509808,
CC       ECO:0000269|PubMed:15731352, ECO:0000269|PubMed:15890677,
CC       ECO:0000269|PubMed:16478997, ECO:0000269|PubMed:16574662,
CC       ECO:0000269|PubMed:16617102, ECO:0000269|PubMed:16809611,
CC       ECO:0000269|PubMed:16864582, ECO:0000269|PubMed:17226766,
CC       ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:17872950,
CC       ECO:0000269|PubMed:18273021, ECO:0000269|PubMed:19217391,
CC       ECO:0000269|PubMed:19680224, ECO:0000269|PubMed:20081228,
CC       ECO:0000269|PubMed:23145062, ECO:0000269|PubMed:23999430,
CC       ECO:0000269|PubMed:24177535, ECO:0000269|PubMed:24382891,
CC       ECO:0000269|PubMed:24413532, ECO:0000269|PubMed:25219498,
CC       ECO:0000269|PubMed:25245946, ECO:0000269|PubMed:25514493,
CC       ECO:0000269|PubMed:26479788, ECO:0000269|PubMed:26951377,
CC       ECO:0000269|PubMed:27189267, ECO:0000269|PubMed:27959755,
CC       ECO:0000269|PubMed:28128295, ECO:0000269|PubMed:8684459,
CC       ECO:0000269|PubMed:8917528, ECO:0000269|PubMed:9590696,
CC       ECO:0000269|PubMed:9862959, ECO:0000269|PubMed:9887100}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with human adenovirus 5 E1A
CC       protein; this interaction stimulates the acetylation of RB1 by
CC       recruiting EP300 and RB1 into a multimeric-protein complex.
CC       {ECO:0000269|PubMed:11433299}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with and acetylates HIV-1 Tat.
CC       {ECO:0000269|PubMed:10545121, ECO:0000269|PubMed:11080476,
CC       ECO:0000269|PubMed:9528808}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HTLV-1 proteins Tax,
CC       p30II and HBZ. {ECO:0000269|PubMed:11463834,
CC       ECO:0000269|PubMed:11559821, ECO:0000269|PubMed:18599479}.
CC   -!- INTERACTION:
CC       Q09472; P03070; Xeno; NbExp=2; IntAct=EBI-447295, EBI-617698;
CC       Q09472; P03255; Xeno; NbExp=3; IntAct=EBI-447295, EBI-2603114;
CC       Q09472; P03255-2; Xeno; NbExp=3; IntAct=EBI-447295, EBI-6859460;
CC       Q09472; P03259; Xeno; NbExp=3; IntAct=EBI-447295, EBI-6947456;
CC       Q09472; Q9NXW9: ALKBH4; NbExp=4; IntAct=EBI-447295, EBI-8637516;
CC       Q09472; P27695: APEX1; NbExp=8; IntAct=EBI-447295, EBI-1048805;
CC       Q09472; Q9UBL3: ASH2L; NbExp=5; IntAct=EBI-447295, EBI-540797;
CC       Q09472; Q8WXX7: AUTS2; NbExp=3; IntAct=EBI-447295, EBI-2875359;
CC       Q09472; K4P3M7: BICP0; Xeno; NbExp=4; IntAct=EBI-447295, EBI-11296047;
CC       Q09472; Q9NPI1: BRD7; NbExp=3; IntAct=EBI-447295, EBI-711221;
CC       Q09472; P24941: CDK2; NbExp=6; IntAct=EBI-447295, EBI-375096;
CC       Q09472; Q99967: CITED2; NbExp=3; IntAct=EBI-447295, EBI-937732;
CC       Q09472; P61201: COPS2; NbExp=2; IntAct=EBI-447295, EBI-1050386;
CC       Q09472; P16220: CREB1; NbExp=2; IntAct=EBI-447295, EBI-711855;
CC       Q09472; Q01147: Creb1; Xeno; NbExp=2; IntAct=EBI-447295, EBI-2291098;
CC       Q09472; P17844: DDX5; NbExp=4; IntAct=EBI-447295, EBI-351962;
CC       Q09472; P03122: E2; Xeno; NbExp=3; IntAct=EBI-447295, EBI-7028618;
CC       Q09472; P06422: E2; Xeno; NbExp=7; IntAct=EBI-447295, EBI-7136851;
CC       Q09472; P06790: E2; Xeno; NbExp=6; IntAct=EBI-447295, EBI-7010629;
CC       Q09472; P03372: ESR1; NbExp=2; IntAct=EBI-447295, EBI-78473;
CC       Q09472; Q01844: EWSR1; NbExp=2; IntAct=EBI-447295, EBI-739737;
CC       Q09472; P35637: FUS; NbExp=4; IntAct=EBI-447295, EBI-400434;
CC       Q09472; Q00403: GTF2B; NbExp=2; IntAct=EBI-447295, EBI-389564;
CC       Q09472; Q16665: HIF1A; NbExp=20; IntAct=EBI-447295, EBI-447269;
CC       Q09472; Q61221: Hif1a; Xeno; NbExp=2; IntAct=EBI-447295, EBI-298954;
CC       Q09472; Q9H2X6: HIPK2; NbExp=4; IntAct=EBI-447295, EBI-348345;
CC       Q09472; Q9QXM1: Jmy; Xeno; NbExp=16; IntAct=EBI-447295, EBI-866001;
CC       Q09472; Q92831: KAT2B; NbExp=2; IntAct=EBI-447295, EBI-477430;
CC       Q09472; P55209: NAP1L1; NbExp=3; IntAct=EBI-447295, EBI-356392;
CC       Q09472; O60934: NBN; NbExp=5; IntAct=EBI-447295, EBI-494844;
CC       Q09472; Q9Y6Q9: NCOA3; NbExp=2; IntAct=EBI-447295, EBI-81196;
CC       Q09472; P20265: POU3F2; NbExp=3; IntAct=EBI-447295, EBI-1167176;
CC       Q09472; Q96KQ4: PPP1R13B; NbExp=2; IntAct=EBI-447295, EBI-1105153;
CC       Q09472; Q8WUF5: PPP1R13L; NbExp=2; IntAct=EBI-447295, EBI-5550163;
CC       Q09472; Q13761: RUNX3; NbExp=7; IntAct=EBI-447295, EBI-925990;
CC       Q09472; Q96EB6: SIRT1; NbExp=4; IntAct=EBI-447295, EBI-1802965;
CC       Q09472; Q13309: SKP2; NbExp=3; IntAct=EBI-447295, EBI-456291;
CC       Q09472; O95863: SNAI1; NbExp=3; IntAct=EBI-447295, EBI-1045459;
CC       Q09472; P42226: STAT6; NbExp=2; IntAct=EBI-447295, EBI-1186478;
CC       Q09472; P04608: tat; Xeno; NbExp=3; IntAct=EBI-447295, EBI-6164389;
CC       Q09472; Q9UL17: TBX21; NbExp=5; IntAct=EBI-447295, EBI-3922312;
CC       Q09472; P56279: TCL1A; NbExp=4; IntAct=EBI-447295, EBI-749995;
CC       Q09472; P05549: TFAP2A; NbExp=7; IntAct=EBI-447295, EBI-347351;
CC       Q09472; P04637: TP53; NbExp=20; IntAct=EBI-447295, EBI-366083;
CC       Q09472; Q13625: TP53BP2; NbExp=2; IntAct=EBI-447295, EBI-77642;
CC       Q09472; O15350: TP73; NbExp=2; IntAct=EBI-447295, EBI-389606;
CC       Q09472; P11473: VDR; NbExp=3; IntAct=EBI-447295, EBI-286357;
CC       Q09472; P67809: YBX1; NbExp=2; IntAct=EBI-447295, EBI-354065;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:20940255}. Nucleus {ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:16574662,
CC       ECO:0000269|PubMed:17761950, ECO:0000269|PubMed:20940255}. Chromosome
CC       {ECO:0000269|PubMed:14645221, ECO:0000269|PubMed:25818647}.
CC       Note=Localizes to active chromatin: Colocalizes with histone H3
CC       acetylated and/or crotonylated at 'Lys-18' (H3K18ac and H3K18cr,
CC       respectively) (PubMed:25818647). In the presence of ALX1 relocalizes
CC       from the cytoplasm to the nucleus. Colocalizes with ROCK2 in the
CC       nucleus (PubMed:12929931). {ECO:0000269|PubMed:12929931,
CC       ECO:0000269|PubMed:25818647}.
CC   -!- DOMAIN: The CRD1 domain (cell cycle regulatory domain 1) mediates
CC       transcriptional repression of a subset of p300 responsive genes; it can
CC       be de-repressed by CDKN1A/p21WAF1 at least at some promoters. It
CC       conatins sumoylation and acetylation sites and the same lysine residues
CC       may be targeted for the respective modifications. It is proposed that
CC       deacetylation by SIRT1 allows sumoylation leading to suppressed
CC       activity.
CC   -!- PTM: Acetylated on Lys at up to 17 positions by intermolecular
CC       autocatalysis. Deacetylated in the transcriptional repression domain
CC       (CRD1) by SIRT1, preferentially at Lys-1020. Deacetylated by SIRT2,
CC       preferentially at Lys-418, Lys-423, Lys-1542, Lys-1546, Lys-1549, Lys-
CC       1699, Lys-1704 and Lys-1707. {ECO:0000269|PubMed:15004546,
CC       ECO:0000269|PubMed:15632193, ECO:0000269|PubMed:17065153,
CC       ECO:0000269|PubMed:18995842, ECO:0000269|PubMed:23934153,
CC       ECO:0000269|PubMed:24177535}.
CC   -!- PTM: Citrullinated at Arg-2142 by PADI4, which impairs methylation by
CC       CARM1 and promotes interaction with NCOA2/GRIP1.
CC       {ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:15731352}.
CC   -!- PTM: Methylated at Arg-580 and Arg-604 in the KIX domain by CARM1,
CC       which blocks association with CREB, inhibits CREB signaling and
CC       activates apoptotic response. Also methylated at Arg-2142 by CARM1,
CC       which impairs interaction with NCOA2/GRIP1.
CC       {ECO:0000269|PubMed:11701890, ECO:0000269|PubMed:15731352}.
CC   -!- PTM: Sumoylated; sumoylation in the transcriptional repression domain
CC       (CRD1) mediates transcriptional repression. Desumoylated by SENP3
CC       through the removal of SUMO2 and SUMO3. {ECO:0000269|PubMed:12718889,
CC       ECO:0000269|PubMed:19680224}.
CC   -!- PTM: Probable target of ubiquitination by FBXO3, leading to rapid
CC       proteasome-dependent degradation.
CC   -!- PTM: Phosphorylated by HIPK2 in a RUNX1-dependent manner. This
CC       phosphorylation that activates EP300 happens when RUNX1 is associated
CC       with DNA and CBFB. Phosphorylated by ROCK2 and this enhances its
CC       activity. Phosphorylation at Ser-89 by AMPK reduces interaction with
CC       nuclear receptors, such as PPARG. {ECO:0000269|PubMed:11518699,
CC       ECO:0000269|PubMed:12446687, ECO:0000269|PubMed:16574662,
CC       ECO:0000269|PubMed:18695000}.
CC   -!- DISEASE: Note=Defects in EP300 may play a role in epithelial cancer.
CC   -!- DISEASE: Note=Chromosomal aberrations involving EP300 may be a cause of
CC       acute myeloid leukemias. Translocation t(8;22)(p11;q13) with KAT6A.
CC   -!- DISEASE: Rubinstein-Taybi syndrome 2 (RSTS2) [MIM:613684]: A disorder
CC       characterized by craniofacial abnormalities, postnatal growth
CC       deficiency, broad thumbs, broad big toes, mental retardation and a
CC       propensity for development of malignancies. Some individuals with RSTS2
CC       have less severe mental impairment, more severe microcephaly, and a
CC       greater degree of changes in facial bone structure than RSTS1 patients.
CC       {ECO:0000269|PubMed:15706485}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Menke-Hennekam syndrome 2 (MKHK2) [MIM:618333]: A form of
CC       Menke-Hennekam syndrome, a congenital autosomal dominant disease
CC       characterized by developmental delay, growth retardation, and
CC       craniofacial dysmorphism. Patients have intellectual disability of
CC       variable severity, speech delay, autistic behavior, short stature and
CC       microcephaly. Main facial characteristics include short palpebral
CC       fissures, telecanthi, depressed nasal ridge, short nose, anteverted
CC       nares, short columella and long philtrum.
CC       {ECO:0000269|PubMed:29460469}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/P300ID97.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=P300/CBP entry;
CC       URL="https://en.wikipedia.org/wiki/P300/CBP";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U01877; AAA18639.1; -; mRNA.
DR   EMBL; AL080243; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL096765; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035658; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60408.1; -; Genomic_DNA.
DR   CCDS; CCDS14010.1; -.
DR   PIR; A54277; A54277.
DR   RefSeq; NP_001420.2; NM_001429.3.
DR   PDB; 1L3E; NMR; -; B=323-423.
DR   PDB; 1P4Q; NMR; -; B=323-423.
DR   PDB; 2K8F; NMR; -; A=1723-1812.
DR   PDB; 2MH0; NMR; -; B=1723-1812.
DR   PDB; 2MZD; NMR; -; A=1723-1812.
DR   PDB; 3BIY; X-ray; 1.70 A; A=1287-1666.
DR   PDB; 3I3J; X-ray; 2.33 A; A/B/C/D/E/F/G/H/I/J/K/L=1040-1161.
DR   PDB; 3IO2; X-ray; 2.50 A; A=1723-1836.
DR   PDB; 3P57; X-ray; 2.19 A; P=1726-1835.
DR   PDB; 3T92; X-ray; 1.50 A; A=1723-1818.
DR   PDB; 4BHW; X-ray; 2.80 A; A/B=1043-1519, A/B=1581-1666.
DR   PDB; 4PZR; X-ray; 2.10 A; A=1287-1664.
DR   PDB; 4PZS; X-ray; 1.94 A; A=1287-1664.
DR   PDB; 4PZT; X-ray; 2.80 A; A=1287-1664.
DR   PDB; 5BT3; X-ray; 1.05 A; A=1048-1161.
DR   PDB; 5KJ2; X-ray; 1.95 A; A=1287-1522, A=1555-1666.
DR   PDB; 5LKT; X-ray; 2.04 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LKU; X-ray; 3.50 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LKX; X-ray; 2.52 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LKZ; X-ray; 2.50 A; A=1043-1519, A=1581-1666.
DR   PDB; 5LPK; X-ray; 2.10 A; A/B/C/D/E/F/G=1040-1161.
DR   PDB; 5LPM; X-ray; 1.50 A; A/B=1048-1161.
DR   PDB; 5NU5; X-ray; 1.60 A; A/B=1048-1161.
DR   PDB; 5XZC; EM; 10.70 A; A=1046-1664.
DR   PDB; 6DS6; X-ray; 1.95 A; A=1661-1713.
DR   PDB; 6FGN; NMR; -; A=1723-1812.
DR   PDB; 6FGS; NMR; -; A=1723-1812.
DR   PDB; 6GYR; X-ray; 3.10 A; A/B/C/D=1046-1664.
DR   PDB; 6GYT; X-ray; 2.50 A; A/B=1047-1168.
DR   PDB; 6K4N; EM; 9.80 A; A=1046-1664.
DR   PDB; 6PF1; X-ray; 2.32 A; A/B=1287-1663.
DR   PDB; 6PGU; X-ray; 1.72 A; A/B=1287-1519, A/B=1582-1663.
DR   PDBsum; 1L3E; -.
DR   PDBsum; 1P4Q; -.
DR   PDBsum; 2K8F; -.
DR   PDBsum; 2MH0; -.
DR   PDBsum; 2MZD; -.
DR   PDBsum; 3BIY; -.
DR   PDBsum; 3I3J; -.
DR   PDBsum; 3IO2; -.
DR   PDBsum; 3P57; -.
DR   PDBsum; 3T92; -.
DR   PDBsum; 4BHW; -.
DR   PDBsum; 4PZR; -.
DR   PDBsum; 4PZS; -.
DR   PDBsum; 4PZT; -.
DR   PDBsum; 5BT3; -.
DR   PDBsum; 5KJ2; -.
DR   PDBsum; 5LKT; -.
DR   PDBsum; 5LKU; -.
DR   PDBsum; 5LKX; -.
DR   PDBsum; 5LKZ; -.
DR   PDBsum; 5LPK; -.
DR   PDBsum; 5LPM; -.
DR   PDBsum; 5NU5; -.
DR   PDBsum; 5XZC; -.
DR   PDBsum; 6DS6; -.
DR   PDBsum; 6FGN; -.
DR   PDBsum; 6FGS; -.
DR   PDBsum; 6GYR; -.
DR   PDBsum; 6GYT; -.
DR   PDBsum; 6K4N; -.
DR   PDBsum; 6PF1; -.
DR   PDBsum; 6PGU; -.
DR   SMR; Q09472; -.
DR   BioGrid; 108347; 571.
DR   CORUM; Q09472; -.
DR   DIP; DIP-257N; -.
DR   IntAct; Q09472; 205.
DR   MINT; Q09472; -.
DR   STRING; 9606.ENSP00000263253; -.
DR   BindingDB; Q09472; -.
DR   ChEMBL; CHEMBL3784; -.
DR   GuidetoPHARMACOLOGY; 2735; -.
DR   MoonDB; Q09472; Predicted.
DR   iPTMnet; Q09472; -.
DR   MetOSite; Q09472; -.
DR   PhosphoSitePlus; Q09472; -.
DR   BioMuta; EP300; -.
DR   DMDM; 223590203; -.
DR   CPTAC; CPTAC-1240; -.
DR   EPD; Q09472; -.
DR   jPOST; Q09472; -.
DR   MassIVE; Q09472; -.
DR   MaxQB; Q09472; -.
DR   PaxDb; Q09472; -.
DR   PeptideAtlas; Q09472; -.
DR   PRIDE; Q09472; -.
DR   ProteomicsDB; 58723; -.
DR   Antibodypedia; 296; 995 antibodies.
DR   Ensembl; ENST00000263253; ENSP00000263253; ENSG00000100393.
DR   GeneID; 2033; -.
DR   KEGG; hsa:2033; -.
DR   UCSC; uc003azl.5; human.
DR   CTD; 2033; -.
DR   DisGeNET; 2033; -.
DR   GeneCards; EP300; -.
DR   GeneReviews; EP300; -.
DR   HGNC; HGNC:3373; EP300.
DR   HPA; ENSG00000100393; Low tissue specificity.
DR   MalaCards; EP300; -.
DR   MIM; 602700; gene.
DR   MIM; 613684; phenotype.
DR   MIM; 618333; phenotype.
DR   neXtProt; NX_Q09472; -.
DR   OpenTargets; ENSG00000100393; -.
DR   Orphanet; 353284; Rubinstein-Taybi syndrome due to EP300 haploinsufficiency.
DR   PharmGKB; PA27807; -.
DR   eggNOG; KOG1778; Eukaryota.
DR   eggNOG; COG5076; LUCA.
DR   GeneTree; ENSGT00940000155497; -.
DR   HOGENOM; CLU_000162_2_0_1; -.
DR   InParanoid; Q09472; -.
DR   KO; K04498; -.
DR   OMA; QQALHQN; -.
DR   OrthoDB; 236283at2759; -.
DR   PhylomeDB; Q09472; -.
DR   TreeFam; TF101097; -.
DR   BRENDA; 2.3.1.48; 2681.
DR   Reactome; R-HSA-1234158; Regulation of gene expression by Hypoxia-inducible Factor.
DR   Reactome; R-HSA-1368082; RORA activates gene expression.
DR   Reactome; R-HSA-156711; Polo-like kinase mediated events.
DR   Reactome; R-HSA-1912408; Pre-NOTCH Transcription and Translation.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-201722; Formation of the beta-catenin:TCF transactivating complex.
DR   Reactome; R-HSA-210744; Regulation of gene expression in late stage (branching morphogenesis) pancreatic bud precursor cells.
DR   Reactome; R-HSA-2122947; NOTCH1 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-2197563; NOTCH2 intracellular domain regulates transcription.
DR   Reactome; R-HSA-2644606; Constitutive Signaling by NOTCH1 PEST Domain Mutants.
DR   Reactome; R-HSA-2894862; Constitutive Signaling by NOTCH1 HD+PEST Domain Mutants.
DR   Reactome; R-HSA-3134973; LRR FLII-interacting protein 1 (LRRFIP1) activates type I IFN production.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   Reactome; R-HSA-3371568; Attenuation phase.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-3899300; SUMOylation of transcription cofactors.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   Reactome; R-HSA-5250924; B-WICH complex positively regulates rRNA expression.
DR   Reactome; R-HSA-5617472; Activation of anterior HOX genes in hindbrain development during early embryogenesis.
DR   Reactome; R-HSA-5621575; CD209 (DC-SIGN) signaling.
DR   Reactome; R-HSA-5689901; Metalloprotease DUBs.
DR   Reactome; R-HSA-6781823; Formation of TC-NER Pre-Incision Complex.
DR   Reactome; R-HSA-6781827; Transcription-Coupled Nucleotide Excision Repair (TC-NER).
DR   Reactome; R-HSA-6782135; Dual incision in TC-NER.
DR   Reactome; R-HSA-6782210; Gap-filling DNA repair synthesis and ligation in TC-NER.
DR   Reactome; R-HSA-6804114; TP53 Regulates Transcription of Genes Involved in G2 Cell Cycle Arrest.
DR   Reactome; R-HSA-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-HSA-6804760; Regulation of TP53 Activity through Methylation.
DR   Reactome; R-HSA-6811555; PI5P Regulates TP53 Acetylation.
DR   Reactome; R-HSA-8866907; Activation of the TFAP2 (AP-2) family of transcription factors.
DR   Reactome; R-HSA-8936459; RUNX1 regulates genes involved in megakaryocyte differentiation and platelet function.
DR   Reactome; R-HSA-8939243; RUNX1 interacts with co-factors whose precise effect on RUNX1 targets is not known.
DR   Reactome; R-HSA-8941856; RUNX3 regulates NOTCH signaling.
DR   Reactome; R-HSA-8941858; Regulation of RUNX3 expression and activity.
DR   Reactome; R-HSA-8951936; RUNX3 regulates p14-ARF.
DR   Reactome; R-HSA-9013508; NOTCH3 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-9013695; NOTCH4 Intracellular Domain Regulates Transcription.
DR   Reactome; R-HSA-9018519; Estrogen-dependent gene expression.
DR   Reactome; R-HSA-9029569; NR1H3 & NR1H2 regulate gene expression linked to cholesterol transport and efflux.
DR   Reactome; R-HSA-918233; TRAF3-dependent IRF activation pathway.
DR   Reactome; R-HSA-933541; TRAF6 mediated IRF7 activation.
DR   Reactome; R-HSA-9614657; FOXO-mediated transcription of cell death genes.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis.
DR   Reactome; R-HSA-9617629; Regulation of FOXO transcriptional activity by acetylation.
DR   SignaLink; Q09472; -.
DR   SIGNOR; Q09472; -.
DR   ChiTaRS; EP300; human.
DR   EvolutionaryTrace; Q09472; -.
DR   GeneWiki; EP300; -.
DR   GenomeRNAi; 2033; -.
DR   Pharos; Q09472; Tchem.
DR   PRO; PR:Q09472; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q09472; protein.
DR   Bgee; ENSG00000100393; Expressed in kidney and 232 other tissues.
DR   ExpressionAtlas; Q09472; baseline and differential.
DR   Genevisible; Q09472; HS.
DR   GO; GO:0005694; C:chromosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032993; C:protein-DNA complex; ISS:ARUK-UCL.
DR   GO; GO:0005667; C:transcription factor complex; IEA:Ensembl.
DR   GO; GO:0016407; F:acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0033613; F:activating transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0050681; F:androgen receptor binding; IPI:BHF-UCL.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0031490; F:chromatin DNA binding; IEA:Ensembl.
DR   GO; GO:0003684; F:damaged DNA binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0140069; F:histone butyryltransferase activity; IEA:Ensembl.
DR   GO; GO:0140068; F:histone crotonyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0004468; F:lysine N-acetyltransferase activity, acting on acetyl phosphate as donor; IDA:UniProtKB.
DR   GO; GO:0051059; F:NF-kappaB binding; IPI:ARUK-UCL.
DR   GO; GO:0035257; F:nuclear hormone receptor binding; IPI:UniProtKB.
DR   GO; GO:0002039; F:p53 binding; IEA:Ensembl.
DR   GO; GO:0140065; F:peptide butyryltransferase activity; IDA:UniProtKB.
DR   GO; GO:0061733; F:peptide-lysine-N-acetyltransferase activity; TAS:Reactome.
DR   GO; GO:0097157; F:pre-mRNA intronic binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IDA:MGI.
DR   GO; GO:0061920; F:protein propionyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0001102; F:RNA polymerase II activating transcription factor binding; IPI:BHF-UCL.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0001085; F:RNA polymerase II transcription factor binding; IEA:Ensembl.
DR   GO; GO:0097677; F:STAT family protein binding; IPI:UniProtKB.
DR   GO; GO:0048156; F:tau protein binding; NAS:ARUK-UCL.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0016746; F:transferase activity, transferring acyl groups; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0009887; P:animal organ morphogenesis; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IMP:UniProtKB.
DR   GO; GO:0030183; P:B cell differentiation; IEA:Ensembl.
DR   GO; GO:0002209; P:behavioral defense response; IEA:Ensembl.
DR   GO; GO:1904837; P:beta-catenin-TCF complex assembly; TAS:Reactome.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; TAS:Reactome.
DR   GO; GO:0060325; P:face morphogenesis; IEA:Ensembl.
DR   GO; GO:0045444; P:fat cell differentiation; ISS:UniProtKB.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0043969; P:histone H2B acetylation; IDA:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IMP:UniProtKB.
DR   GO; GO:0018393; P:internal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0006475; P:internal protein amino acid acetylation; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; IDA:UniProtKB.
DR   GO; GO:0007611; P:learning or memory; IEA:Ensembl.
DR   GO; GO:0030324; P:lung development; IEA:Ensembl.
DR   GO; GO:0010742; P:macrophage derived foam cell differentiation; IDA:UniProtKB.
DR   GO; GO:0035855; P:megakaryocyte development; IEA:Ensembl.
DR   GO; GO:0035264; P:multicellular organism growth; IEA:Ensembl.
DR   GO; GO:0018076; P:N-terminal peptidyl-lysine acetylation; IDA:UniProtKB.
DR   GO; GO:0045721; P:negative regulation of gluconeogenesis; IDA:UniProtKB.
DR   GO; GO:0031333; P:negative regulation of protein-containing complex assembly; IDA:ARUK-UCL.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0007399; P:nervous system development; TAS:ARUK-UCL.
DR   GO; GO:0007219; P:Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0018394; P:peptidyl-lysine acetylation; IDA:ARUK-UCL.
DR   GO; GO:0140067; P:peptidyl-lysine butyrylation; IDA:UniProtKB.
DR   GO; GO:0140066; P:peptidyl-lysine crotonylation; IDA:UniProtKB.
DR   GO; GO:0061921; P:peptidyl-lysine propionylation; IDA:UniProtKB.
DR   GO; GO:0030220; P:platelet formation; IEA:Ensembl.
DR   GO; GO:0043923; P:positive regulation by host of viral transcription; IDA:BHF-UCL.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:UniProtKB.
DR   GO; GO:0045815; P:positive regulation of gene expression, epigenetic; IDA:UniProtKB.
DR   GO; GO:0010976; P:positive regulation of neuron projection development; IDA:ARUK-UCL.
DR   GO; GO:1901224; P:positive regulation of NIK/NF-kappaB signaling; IDA:ARUK-UCL.
DR   GO; GO:0045747; P:positive regulation of Notch signaling pathway; TAS:Reactome.
DR   GO; GO:0032092; P:positive regulation of protein binding; IEA:Ensembl.
DR   GO; GO:1905636; P:positive regulation of RNA polymerase II regulatory region sequence-specific DNA binding; IDA:ARUK-UCL.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006990; P:positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response; ISS:UniProtKB.
DR   GO; GO:0007221; P:positive regulation of transcription of Notch receptor target; TAS:Reactome.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; TAS:ARUK-UCL.
DR   GO; GO:0030511; P:positive regulation of transforming growth factor beta receptor signaling pathway; IMP:UniProtKB.
DR   GO; GO:0032481; P:positive regulation of type I interferon production; TAS:Reactome.
DR   GO; GO:0006473; P:protein acetylation; IDA:UniProtKB.
DR   GO; GO:0031648; P:protein destabilization; IMP:UniProtKB.
DR   GO; GO:0016579; P:protein deubiquitination; TAS:Reactome.
DR   GO; GO:0050821; P:protein stabilization; ISS:UniProtKB.
DR   GO; GO:0060765; P:regulation of androgen receptor signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0010506; P:regulation of autophagy; TAS:ParkinsonsUK-UCL.
DR   GO; GO:0051726; P:regulation of cell cycle; TAS:Reactome.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0006110; P:regulation of glycolytic process; IDA:UniProtKB.
DR   GO; GO:0045652; P:regulation of megakaryocyte differentiation; TAS:Reactome.
DR   GO; GO:0010821; P:regulation of mitochondrion organization; ISS:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0061418; P:regulation of transcription from RNA polymerase II promoter in response to hypoxia; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0090043; P:regulation of tubulin deacetylation; IDA:UniProtKB.
DR   GO; GO:0043627; P:response to estrogen; IDA:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0001756; P:somitogenesis; IEA:Ensembl.
DR   GO; GO:0002223; P:stimulatory C-type lectin receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0036268; P:swimming; IEA:Ensembl.
DR   GO; GO:0001966; P:thigmotaxis; IEA:Ensembl.
DR   GO; GO:0006283; P:transcription-coupled nucleotide-excision repair; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   CDD; cd15802; RING_CBP-p300; 1.
DR   DisProt; DP00633; -.
DR   Gene3D; 1.10.1630.10; -; 1.
DR   Gene3D; 1.10.246.20; -; 1.
DR   Gene3D; 1.20.1020.10; -; 2.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 2.10.110.40; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR031162; CBP_P300_HAT.
DR   InterPro; IPR013178; Histone_AcTrfase_Rtt109/CBP.
DR   InterPro; IPR003101; KIX_dom.
DR   InterPro; IPR036529; KIX_dom_sf.
DR   InterPro; IPR009110; Nuc_rcpt_coact.
DR   InterPro; IPR014744; Nuc_rcpt_coact_CREBbp.
DR   InterPro; IPR037073; Nuc_rcpt_coact_CREBbp_sf.
DR   InterPro; IPR010303; RING_CBP-p300.
DR   InterPro; IPR038547; RING_CBP-p300_sf.
DR   InterPro; IPR035898; TAZ_dom_sf.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000197; Znf_TAZ.
DR   InterPro; IPR000433; Znf_ZZ.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF09030; Creb_binding; 1.
DR   Pfam; PF06001; DUF902; 1.
DR   Pfam; PF08214; HAT_KAT11; 1.
DR   Pfam; PF02172; KIX; 1.
DR   Pfam; PF02135; zf-TAZ; 2.
DR   Pfam; PF00569; ZZ; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM01250; KAT11; 1.
DR   SMART; SM00551; ZnF_TAZ; 2.
DR   SMART; SM00291; ZnF_ZZ; 1.
DR   SUPFAM; SSF47040; SSF47040; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57933; SSF57933; 2.
DR   SUPFAM; SSF69125; SSF69125; 1.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS51727; CBP_P300_HAT; 1.
DR   PROSITE; PS50952; KIX; 1.
DR   PROSITE; PS50134; ZF_TAZ; 2.
DR   PROSITE; PS01357; ZF_ZZ_1; 1.
DR   PROSITE; PS50135; ZF_ZZ_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Acyltransferase; Biological rhythms;
KW   Bromodomain; Cell cycle; Chromosomal rearrangement; Chromosome;
KW   Citrullination; Cytoplasm; Direct protein sequencing; Disease mutation;
KW   Host-virus interaction; Isopeptide bond; Mental retardation; Metal-binding;
KW   Methylation; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Transferase;
KW   Ubl conjugation; Zinc; Zinc-finger.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895"
FT   CHAIN           2..2414
FT                   /note="Histone acetyltransferase p300"
FT                   /id="PRO_0000211193"
FT   DOMAIN          566..645
FT                   /note="KIX"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00311"
FT   DOMAIN          1067..1139
FT                   /note="Bromo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   DOMAIN          1287..1663
FT                   /note="CBP/p300-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01065"
FT   ZN_FING         331..417
FT                   /note="TAZ-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00203"
FT   ZN_FING         1664..1707
FT                   /note="ZZ-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00228"
FT   ZN_FING         1728..1809
FT                   /note="TAZ-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00203"
FT   REGION          2..149
FT                   /note="Interaction with RORA"
FT                   /evidence="ECO:0000269|PubMed:9862959"
FT   REGION          2..139
FT                   /note="Interaction with ALX1"
FT                   /evidence="ECO:0000269|PubMed:12929931"
FT   REGION          1017..1029
FT                   /note="CRD1; mediates transcriptional repression"
FT   REGION          1397..1399
FT                   /note="Interaction with histone"
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   REGION          1398..1400
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:24819397"
FT   REGION          1410..1411
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000269|PubMed:24819397"
FT   REGION          1572..1818
FT                   /note="Binding region for E1A adenovirus"
FT   REGION          2003..2212
FT                   /note="Interaction with HTLV-1 Tax"
FT   REGION          2041..2240
FT                   /note="Interaction with NCOA2"
FT                   /evidence="ECO:0000269|PubMed:15731352"
FT   MOTIF           11..17
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        797..800
FT                   /note="Poly-Ser"
FT   COMPBIAS        1519..1526
FT                   /note="Poly-Glu"
FT   COMPBIAS        2066..2069
FT                   /note="Poly-Gln"
FT   COMPBIAS        2190..2195
FT                   /note="Poly-Gln"
FT   METAL           347
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           351
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           364
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           369
FT                   /note="Zinc 1"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           378
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           382
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           388
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           393
FT                   /note="Zinc 2"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           402
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           406
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           411
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   METAL           414
FT                   /note="Zinc 3"
FT                   /evidence="ECO:0000269|PubMed:11959990,
FT                   ECO:0000269|PubMed:12778114"
FT   BINDING         1457
FT                   /note="Acetyl-CoA; via carbonyl oxygen"
FT                   /evidence="ECO:0000269|PubMed:24819397"
FT   BINDING         1462
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:24819397"
FT   BINDING         1466
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000269|PubMed:24819397"
FT   SITE            31..32
FT                   /note="Breakpoint for translocation to form KAT6A-EP300 and
FT                   EP300-KAT6A"
FT   SITE            2088
FT                   /note="Interaction with NCOA2"
FT   SITE            2142
FT                   /note="Interaction with NCOA2"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895"
FT   MOD_RES         89
FT                   /note="Phosphoserine; by AMPK"
FT                   /evidence="ECO:0000269|PubMed:11518699,
FT                   ECO:0000269|PubMed:16574662"
FT   MOD_RES         418
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:18995842"
FT   MOD_RES         423
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:18995842"
FT   MOD_RES         499
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RWS6"
FT   MOD_RES         580
FT                   /note="Omega-N-methylated arginine; by CARM1"
FT                   /evidence="ECO:0000269|PubMed:11701890"
FT   MOD_RES         604
FT                   /note="Omega-N-methylated arginine; by CARM1"
FT                   /evidence="ECO:0000269|PubMed:11701890"
FT   MOD_RES         636
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         977
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1020
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15632193"
FT   MOD_RES         1024
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:15632193"
FT   MOD_RES         1038
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1180
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:B2RWS6"
FT   MOD_RES         1336
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:17065153"
FT   MOD_RES         1473
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:17065153"
FT   MOD_RES         1499
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15004546"
FT   MOD_RES         1542
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:18995842"
FT   MOD_RES         1546
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:18995842"
FT   MOD_RES         1549
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000269|PubMed:15004546,
FT                   ECO:0000269|PubMed:18995842"
FT   MOD_RES         1554
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:15004546"
FT   MOD_RES         1555
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1558
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:15004546"
FT   MOD_RES         1560
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000244|PubMed:19608861,
FT                   ECO:0000269|PubMed:15004546"
FT   MOD_RES         1583
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1699
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:18995842"
FT   MOD_RES         1704
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:18995842"
FT   MOD_RES         1707
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000269|PubMed:18995842"
FT   MOD_RES         1726
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2142
FT                   /note="Asymmetric dimethylarginine; by CARM1; alternate"
FT                   /evidence="ECO:0000269|PubMed:15731352"
FT   MOD_RES         2142
FT                   /note="Citrulline; by PADI4; alternate"
FT                   /evidence="ECO:0000269|PubMed:15731352"
FT   CROSSLNK        1020
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:12718889"
FT   CROSSLNK        1024
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:12718889"
FT   VARIANT         289
FT                   /note="M -> V (in dbSNP:rs2230111)"
FT                   /id="VAR_055554"
FT   VARIANT         827
FT                   /note="L -> P (in a breast cancer sample)"
FT                   /evidence="ECO:0000269|PubMed:10700188"
FT                   /id="VAR_014428"
FT   VARIANT         997
FT                   /note="I -> V (in dbSNP:rs20551)"
FT                   /id="VAR_020425"
FT   VARIANT         1013
FT                   /note="E -> G (in a breast cancer sample;
FT                   dbSNP:rs1234168115)"
FT                   /evidence="ECO:0000269|PubMed:10700188"
FT                   /id="VAR_014429"
FT   VARIANT         1511
FT                   /note="N -> I"
FT                   /evidence="ECO:0000269|PubMed:24476420"
FT                   /id="VAR_074021"
FT   VARIANT         1650
FT                   /note="S -> Y (in a pancreatic cancer sample)"
FT                   /evidence="ECO:0000269|PubMed:10700188"
FT                   /id="VAR_014430"
FT   VARIANT         1824
FT                   /note="Q -> P (in MKHK2)"
FT                   /evidence="ECO:0000269|PubMed:29460469"
FT                   /id="VAR_081986"
FT   VARIANT         1831
FT                   /note="Missing (in MKHK2)"
FT                   /evidence="ECO:0000269|PubMed:29460469"
FT                   /id="VAR_081987"
FT   VARIANT         2007
FT                   /note="Q -> R (found in a patient with spinocerebellar
FT                   ataxia; unknown pathological significance;
FT                   dbSNP:rs763892493)"
FT                   /evidence="ECO:0000269|PubMed:29053796"
FT                   /id="VAR_080731"
FT   VARIANT         2174
FT                   /note="T -> S (in dbSNP:rs5758252)"
FT                   /id="VAR_038376"
FT   VARIANT         2221
FT                   /note="P -> Q (in a colorectal cancer sample;
FT                   dbSNP:rs28937578)"
FT                   /evidence="ECO:0000269|PubMed:10700188"
FT                   /id="VAR_014431"
FT   VARIANT         2223
FT                   /note="Q -> P (in dbSNP:rs1046088)"
FT                   /evidence="ECO:0000269|PubMed:7523245"
FT                   /id="VAR_038377"
FT   MUTAGEN         89
FT                   /note="S->A: Abolishes AMPK-mediated phosphorylation."
FT                   /evidence="ECO:0000269|PubMed:11518699"
FT   MUTAGEN         89
FT                   /note="S->D: Phosphomimetic mutant that leads to descreased
FT                   interaction with nuclear receptors."
FT                   /evidence="ECO:0000269|PubMed:11518699"
FT   MUTAGEN         344
FT                   /note="L->A: Inhibits interaction with HIF1A and
FT                   transcription activation; when associated with A-345."
FT                   /evidence="ECO:0000269|PubMed:12778114"
FT   MUTAGEN         345
FT                   /note="L->A: Inhibits interaction with HIF1A and
FT                   transcription activation; when associated with A-344."
FT                   /evidence="ECO:0000269|PubMed:12778114"
FT   MUTAGEN         371..376
FT                   /note="TMKNVL->NAAIRS: Inhibits interaction with HIF1A.
FT                   Reduces interaction with CITED2."
FT                   /evidence="ECO:0000269|PubMed:9887100"
FT   MUTAGEN         413..418
FT                   /note="VCLPLK->NAAIRS: Inhibits interaction with HIF1A.
FT                   Does not inhibit interaction with CITED2."
FT                   /evidence="ECO:0000269|PubMed:9887100"
FT   MUTAGEN         1020
FT                   /note="K->A: Abolishes sumoylation and transcriptional
FT                   repression when associated with A-1024."
FT                   /evidence="ECO:0000269|PubMed:12718889,
FT                   ECO:0000269|PubMed:15632193"
FT   MUTAGEN         1020
FT                   /note="K->R: Abolishes sumoylation and transcriptional
FT                   repression; when associated with R-1024."
FT                   /evidence="ECO:0000269|PubMed:12718889,
FT                   ECO:0000269|PubMed:15632193"
FT   MUTAGEN         1024
FT                   /note="K->A: Abolishes sumoylation and transcriptional
FT                   repression; when associated with A-1020."
FT                   /evidence="ECO:0000269|PubMed:12718889,
FT                   ECO:0000269|PubMed:15632193"
FT   MUTAGEN         1024
FT                   /note="K->R: Abolishes sumoylation and transcriptional
FT                   repression; when associated with R-1020."
FT                   /evidence="ECO:0000269|PubMed:12718889,
FT                   ECO:0000269|PubMed:15632193"
FT   MUTAGEN         1170
FT                   /note="F->E: Increased acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:23934153"
FT   MUTAGEN         1204
FT                   /note="C->R: Increased acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:23934153"
FT   MUTAGEN         1242
FT                   /note="E->K: Increased acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:23934153"
FT   MUTAGEN         1357
FT                   /note="T->L: 40% decrease in activity."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1357
FT                   /note="T->R: 40% decrease in activity. 90% decrease in
FT                   activity; when associated with R-1505; R-1625 and R-1628."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1396
FT                   /note="S->R: Loss of activity; when associated with R-
FT                   1397."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1396
FT                   /note="S->W: Loss of activity; when associated with W-
FT                   1396."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1397
FT                   /note="Y->R: Loss of activity; when associated with R-
FT                   1396."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1397
FT                   /note="Y->W: Loss of activity; when associated with W-
FT                   1397."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1399
FT                   /note="D->Y: Abolished acetyltransferase and
FT                   acyltransferase activities. Abolishes autoacetylation. Does
FT                   not interact with TFAP2A and inhibits transcriptional
FT                   coactivation of TFAP2A by CITED2. Does not inhibit
FT                   interaction with CITED2, DNA-binding of TFAP2A or nuclear
FT                   localization of TFAP2A or CITED2. No enhancement of FOXO1-
FT                   mediated transcriptional activity. No inhibition of
FT                   insulin-mediated translocation to the cytoplasm. No
FT                   acetylation of RXRA."
FT                   /evidence="ECO:0000269|PubMed:12586840,
FT                   ECO:0000269|PubMed:15890677, ECO:0000269|PubMed:17761950,
FT                   ECO:0000269|PubMed:23934153, ECO:0000269|PubMed:29775581"
FT   MUTAGEN         1467
FT                   /note="Y->F: Abolishes autoacetylation. Loss of
FT                   acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:23934153"
FT   MUTAGEN         1505
FT                   /note="E->R: 90% decrease in activity; when associated with
FT                   R-1625 and R-1628. 90% decrease in activity; when
FT                   associated with R-1357; R-1625 and R-1628."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1625
FT                   /note="D->R: 70% decrease in activity; when associated with
FT                   R-1628. 90% decrease in activity; when associated with R-
FT                   1505 and R-1628. 90% decrease in activity; when associated
FT                   with R-1357; R-1505 and R-1628."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1628
FT                   /note="D->R: 70% decrease in activity; when associated with
FT                   R-1625. 90% decrease in activity; when associated with E-
FT                   1505 and R-1625. 90% decrease in activity; when associated
FT                   with R-1357; R-1505 and R-1625."
FT                   /evidence="ECO:0000269|PubMed:18273021"
FT   MUTAGEN         1645..1646
FT                   /note="RR->EE: Increased acetyltransferase activity."
FT                   /evidence="ECO:0000269|PubMed:23934153"
FT   MUTAGEN         2056
FT                   /note="R->K: No effect on interaction with NCOA2."
FT                   /evidence="ECO:0000269|PubMed:15731352"
FT   MUTAGEN         2088
FT                   /note="R->K: Abolishes interaction with NCOA2."
FT                   /evidence="ECO:0000269|PubMed:15731352"
FT   MUTAGEN         2142
FT                   /note="R->K: Strongly reduces interaction with NCOA2."
FT                   /evidence="ECO:0000269|PubMed:15731352"
FT   CONFLICT        169
FT                   /note="M -> T (in Ref. 1; AAA18639)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        204
FT                   /note="N -> D (in Ref. 1; AAA18639)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        928
FT                   /note="T -> N (in Ref. 1; AAA18639)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1924
FT                   /note="A -> T (in Ref. 1; AAA18639)"
FT                   /evidence="ECO:0000305"
FT   HELIX           332..334
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   HELIX           335..355
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   TURN            356..358
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   HELIX           367..379
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   STRAND          386..389
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   HELIX           391..405
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   STRAND          408..410
FT                   /evidence="ECO:0000244|PDB:1P4Q"
FT   HELIX           414..418
FT                   /evidence="ECO:0000244|PDB:1L3E"
FT   HELIX           1051..1066
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   TURN            1069..1072
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   HELIX           1073..1075
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   HELIX           1081..1084
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   HELIX           1089..1092
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   HELIX           1099..1107
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   HELIX           1114..1131
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   HELIX           1137..1160
FT                   /evidence="ECO:0000244|PDB:5BT3"
FT   STRAND          1175..1177
FT                   /evidence="ECO:0000244|PDB:6GYR"
FT   STRAND          1180..1182
FT                   /evidence="ECO:0000244|PDB:5LKX"
FT   STRAND          1189..1194
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   TURN            1195..1197
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   STRAND          1198..1201
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   HELIX           1202..1207
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   STRAND          1210..1215
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   STRAND          1218..1221
FT                   /evidence="ECO:0000244|PDB:4BHW"
FT   STRAND          1224..1227
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   HELIX           1228..1230
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   STRAND          1231..1236
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   STRAND          1244..1246
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   TURN            1248..1250
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   STRAND          1253..1255
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   HELIX           1256..1259
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   TURN            1263..1265
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   HELIX           1273..1278
FT                   /evidence="ECO:0000244|PDB:5LKT"
FT   HELIX           1290..1292
FT                   /evidence="ECO:0000244|PDB:5KJ2"
FT   HELIX           1297..1313
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1321..1334
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1339..1342
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   TURN            1343..1347
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1351..1366
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1369..1381
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1383..1385
FT                   /evidence="ECO:0000244|PDB:6PF1"
FT   STRAND          1392..1400
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1407..1409
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1410..1428
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1432..1436
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1446..1450
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1460..1476
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1482..1485
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1486..1493
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1498..1500
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1508..1517
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1582..1590
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1592..1594
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1595..1601
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1603..1606
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1622..1624
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   STRAND          1625..1627
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1628..1636
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   HELIX           1644..1662
FT                   /evidence="ECO:0000244|PDB:3BIY"
FT   TURN            1671..1673
FT                   /evidence="ECO:0000244|PDB:6DS6"
FT   STRAND          1676..1688
FT                   /evidence="ECO:0000244|PDB:6DS6"
FT   HELIX           1693..1696
FT                   /evidence="ECO:0000244|PDB:6DS6"
FT   STRAND          1705..1708
FT                   /evidence="ECO:0000244|PDB:6DS6"
FT   TURN            1726..1728
FT                   /evidence="ECO:0000244|PDB:2MZD"
FT   HELIX           1730..1747
FT                   /evidence="ECO:0000244|PDB:3T92"
FT   STRAND          1750..1752
FT                   /evidence="ECO:0000244|PDB:6FGN"
FT   HELIX           1756..1770
FT                   /evidence="ECO:0000244|PDB:3T92"
FT   TURN            1774..1778
FT                   /evidence="ECO:0000244|PDB:3T92"
FT   HELIX           1780..1793
FT                   /evidence="ECO:0000244|PDB:3T92"
FT   STRAND          1799..1802
FT                   /evidence="ECO:0000244|PDB:2MZD"
FT   HELIX           1806..1818
FT                   /evidence="ECO:0000244|PDB:3T92"
SQ   SEQUENCE   2414 AA;  264161 MW;  8E869E1F174A6FEB CRC64;
     MAENVVEPGP PSAKRPKLSS PALSASASDG TDFGSLFDLE HDLPDELINS TELGLTNGGD
     INQLQTSLGM VQDAASKHKQ LSELLRSGSS PNLNMGVGGP GQVMASQAQQ SSPGLGLINS
     MVKSPMTQAG LTSPNMGMGT SGPNQGPTQS TGMMNSPVNQ PAMGMNTGMN AGMNPGMLAA
     GNGQGIMPNQ VMNGSIGAGR GRQNMQYPNP GMGSAGNLLT EPLQQGSPQM GGQTGLRGPQ
     PLKMGMMNNP NPYGSPYTQN PGQQIGASGL GLQIQTKTVL SNNLSPFAMD KKAVPGGGMP
     NMGQQPAPQV QQPGLVTPVA QGMGSGAHTA DPEKRKLIQQ QLVLLLHAHK CQRREQANGE
     VRQCNLPHCR TMKNVLNHMT HCQSGKSCQV AHCASSRQII SHWKNCTRHD CPVCLPLKNA
     GDKRNQQPIL TGAPVGLGNP SSLGVGQQSA PNLSTVSQID PSSIERAYAA LGLPYQVNQM
     PTQPQVQAKN QQNQQPGQSP QGMRPMSNMS ASPMGVNGGV GVQTPSLLSD SMLHSAINSQ
     NPMMSENASV PSLGPMPTAA QPSTTGIRKQ WHEDITQDLR NHLVHKLVQA IFPTPDPAAL
     KDRRMENLVA YARKVEGDMY ESANNRAEYY HLLAEKIYKI QKELEEKRRT RLQKQNMLPN
     AAGMVPVSMN PGPNMGQPQP GMTSNGPLPD PSMIRGSVPN QMMPRITPQS GLNQFGQMSM
     AQPPIVPRQT PPLQHHGQLA QPGALNPPMG YGPRMQQPSN QGQFLPQTQF PSQGMNVTNI
     PLAPSSGQAP VSQAQMSSSS CPVNSPIMPP GSQGSHIHCP QLPQPALHQN SPSPVPSRTP
     TPHHTPPSIG AQQPPATTIP APVPTPPAMP PGPQSQALHP PPRQTPTPPT TQLPQQVQPS
     LPAAPSADQP QQQPRSQQST AASVPTPTAP LLPPQPATPL SQPAVSIEGQ VSNPPSTSST
     EVNSQAIAEK QPSQEVKMEA KMEVDQPEPA DTQPEDISES KVEDCKMEST ETEERSTELK
     TEIKEEEDQP STSATQSSPA PGQSKKKIFK PEELRQALMP TLEALYRQDP ESLPFRQPVD
     PQLLGIPDYF DIVKSPMDLS TIKRKLDTGQ YQEPWQYVDD IWLMFNNAWL YNRKTSRVYK
     YCSKLSEVFE QEIDPVMQSL GYCCGRKLEF SPQTLCCYGK QLCTIPRDAT YYSYQNRYHF
     CEKCFNEIQG ESVSLGDDPS QPQTTINKEQ FSKRKNDTLD PELFVECTEC GRKMHQICVL
     HHEIIWPAGF VCDGCLKKSA RTRKENKFSA KRLPSTRLGT FLENRVNDFL RRQNHPESGE
     VTVRVVHASD KTVEVKPGMK ARFVDSGEMA ESFPYRTKAL FAFEEIDGVD LCFFGMHVQE
     YGSDCPPPNQ RRVYISYLDS VHFFRPKCLR TAVYHEILIG YLEYVKKLGY TTGHIWACPP
     SEGDDYIFHC HPPDQKIPKP KRLQEWYKKM LDKAVSERIV HDYKDIFKQA TEDRLTSAKE
     LPYFEGDFWP NVLEESIKEL EQEEEERKRE ENTSNESTDV TKGDSKNAKK KNNKKTSKNK
     SSLSRGNKKK PGMPNVSNDL SQKLYATMEK HKEVFFVIRL IAGPAANSLP PIVDPDPLIP
     CDLMDGRDAF LTLARDKHLE FSSLRRAQWS TMCMLVELHT QSQDRFVYTC NECKHHVETR
     WHCTVCEDYD LCITCYNTKN HDHKMEKLGL GLDDESNNQQ AAATQSPGDS RRLSIQRCIQ
     SLVHACQCRN ANCSLPSCQK MKRVVQHTKG CKRKTNGGCP ICKQLIALCC YHAKHCQENK
     CPVPFCLNIK QKLRQQQLQH RLQQAQMLRR RMASMQRTGV VGQQQGLPSP TPATPTTPTG
     QQPTTPQTPQ PTSQPQPTPP NSMPPYLPRT QAAGPVSQGK AAGQVTPPTP PQTAQPPLPG
     PPPAAVEMAM QIQRAAETQR QMAHVQIFQR PIQHQMPPMT PMAPMGMNPP PMTRGPSGHL
     EPGMGPTGMQ QQPPWSQGGL PQPQQLQSGM PRPAMMSVAQ HGQPLNMAPQ PGLGQVGISP
     LKPGTVSQQA LQNLLRTLRS PSSPLQQQQV LSILHANPQL LAAFIKQRAA KYANSNPQPI
     PGQPGMPQGQ PGLQPPTMPG QQGVHSNPAM QNMNPMQAGV QRAGLPQQQP QQQLQPPMGG
     MSPQAQQMNM NHNTMPSQFR DILRRQQMMQ QQQQQGAGPG IGPGMANHNQ FQQPQGVGYP
     PQQQQRMQHH MQQMQQGNMG QIGQLPQALG AEAGASLQAY QQRLLQQQMG SPVQPNPMSP
     QQHMLPNQAQ SPHLQGQQIP NSLSNQVRSP QPVPSPRPQS QPPHSSPSPR MQPQPSPHHV
     SPQTSSPHPG LVAAQANPME QGHFASPDQN SMLSQLASNP GMANLHGASA TDLGLSTDNS
     DLNSNLSQST LDIH
//
ID   Q7Z6C1_HUMAN            Unreviewed;      1553 AA.
AC   Q7Z6C1;
DT   01-OCT-2003, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2003, sequence version 1.
DT   11-DEC-2019, entry version 105.
DE   SubName: Full=EP300 protein {ECO:0000313|EMBL:AAH53889.1};
DE   Flags: Fragment;
GN   Name=EP300 {ECO:0000313|EMBL:AAH53889.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH53889.1};
RN   [1] {ECO:0000313|EMBL:AAH53889.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Skin {ECO:0000313|EMBL:AAH53889.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC053889; AAH53889.1; -; mRNA.
DR   RefSeq; NP_001420.2; NM_001429.3.
DR   SMR; Q7Z6C1; -.
DR   PeptideAtlas; Q7Z6C1; -.
DR   PRIDE; Q7Z6C1; -.
DR   GeneID; 2033; -.
DR   KEGG; hsa:2033; -.
DR   CTD; 2033; -.
DR   PharmGKB; PA27807; -.
DR   eggNOG; KOG1778; Eukaryota.
DR   eggNOG; COG5076; LUCA.
DR   KO; K04498; -.
DR   OrthoDB; 236283at2759; -.
DR   ChiTaRS; EP300; human.
DR   GenomeRNAi; 2033; -.
DR   Genevisible; Q7Z6C1; HS.
DR   GO; GO:0005634; C:nucleus; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0003712; F:transcription coregulator activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd15802; RING_CBP-p300; 1.
DR   Gene3D; 1.10.246.20; -; 1.
DR   Gene3D; 1.20.1020.10; -; 1.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 2.10.110.40; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR018359; Bromodomain_CS.
DR   InterPro; IPR031162; CBP_P300_HAT.
DR   InterPro; IPR013178; Histone_AcTrfase_Rtt109/CBP.
DR   InterPro; IPR003101; KIX_dom.
DR   InterPro; IPR036529; KIX_dom_sf.
DR   InterPro; IPR010303; RING_CBP-p300.
DR   InterPro; IPR038547; RING_CBP-p300_sf.
DR   InterPro; IPR035898; TAZ_dom_sf.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR000197; Znf_TAZ.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF06001; DUF902; 1.
DR   Pfam; PF08214; HAT_KAT11; 1.
DR   Pfam; PF02172; KIX; 1.
DR   Pfam; PF02135; zf-TAZ; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM01250; KAT11; 1.
DR   SMART; SM00551; ZnF_TAZ; 1.
DR   SUPFAM; SSF47040; SSF47040; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57933; SSF57933; 1.
DR   PROSITE; PS00633; BROMODOMAIN_1; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS51727; CBP_P300_HAT; 1.
DR   PROSITE; PS50952; KIX; 1.
DR   PROSITE; PS50134; ZF_TAZ; 1.
PE   2: Evidence at transcript level;
KW   Acyltransferase {ECO:0000256|PROSITE-ProRule:PRU01065};
KW   Bromodomain {ECO:0000256|PROSITE-ProRule:PRU00035};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00203};
KW   Transferase {ECO:0000256|PROSITE-ProRule:PRU01065};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00203};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00203}.
FT   DOMAIN          331..417
FT                   /note="TAZ-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50134"
FT   DOMAIN          566..645
FT                   /note="KIX"
FT                   /evidence="ECO:0000259|PROSITE:PS50952"
FT   DOMAIN          1067..1139
FT                   /note="Bromo"
FT                   /evidence="ECO:0000259|PROSITE:PS50014"
FT   DOMAIN          1287..1553
FT                   /note="CBP/p300-type HAT"
FT                   /evidence="ECO:0000259|PROSITE:PS51727"
FT   ZN_FING         331..417
FT                   /note="TAZ-type"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00203"
FT   REGION          1..29
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          133..157
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          196..235
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          482..518
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          729..1050
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1398..1400
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01065"
FT   REGION          1410..1411
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01065"
FT   REGION          1519..1553
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        196..234
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        753..811
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        827..849
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        857..895
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        896..926
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        941..971
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        974..1029
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1519..1546
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         1457
FT                   /note="Acetyl-CoA; via carbonyl oxygen"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01065"
FT   BINDING         1462
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01065"
FT   BINDING         1466
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU01065"
FT   NON_TER         1553
FT                   /evidence="ECO:0000313|EMBL:AAH53889.1"
SQ   SEQUENCE   1553 AA;  170081 MW;  BEFFB9C8206AD891 CRC64;
     MAENVVEPGP PSAKRPKLSS PALSASASDG TDFGSLFDLE HDLPDELINS TELGLTNGGD
     INQLQTSLGM VQDAASKHKQ LSELLRSGSS PNLNMGVGGP GQVMASQAQQ SSPGLGLINS
     MVKSPMTQAG LTSPNMGMGT SGPNQGPTQS TGMMNSPVNQ PAMGMNTGMN AGMNPGMLAA
     GNGQGIMPNQ VMNGSIGAGR GRQNMQYPNP GMGSAGNLLT EPLQQGSPQM GGQTGLRGPQ
     PLKMGMMNNP NPYGSPYTQN PGQQIGASGL GLQIQTKTVL SNNLSPFAMD KKAVPGGGMP
     NMGQQPAPQV QQPGLVTPVA QGMGSGAHTA DPEKRKLIQQ QLVLLLHAHK CQRREQANGE
     VRQCNLPHCR TMKNVLNHMT HCQSGKSCQV AHCASSRQII SHWKNCTRHD CPVCLPLKNA
     GDKRNQQPIL TGAPVGLGNP SSLGVGQQSA PNLSTVSQID PSSIERAYAA LGLPYQVNQM
     PTQPQVQAKN QQNQQPGQSP QGMRPMSNMS ASPMGVNGGV GVQTPSLLSD SMLHSAINSQ
     NPMMSENASV PSLGPMPTAA QPSTTGIRKQ WHEDITQDLR NHLVHKLVQA IFPTPDPAAL
     KDRRMENLVA YARKVEGDMY ESANNRAEYY HLLAEKIYKI QKELEEKRRT RLQKQNMLPN
     AAGMVPVSMN PGPNMGQPQP GMTSNGPLPD PSMIRGSVPN QMMPRITPQS GLNQFGQMSM
     AQPPIVPRQT PPLQHHGQLA QPGALNPPMG YGPRMQQPSN QGQFLPQTQF PSQGMNVTNI
     PLAPSSGQAP VSQAQMSSSS CPVNSPIMPP GSQGSHIHCP QLPQPALHQN SPSPVPSRTP
     TPHHTPPSIG AQQPPATTIP APVPTPPAMP PGPQSQALHP PPRQTPTPPT TQLPQQVQPS
     LPAAPSADQP QQQPRSQQST AASVPTPTAP LLPPQPATPL SQPAVSIEGQ VSNPPSTSST
     EVNSQAIAEK QPSQEVKMEA KMEVDQPEPA DTQPEDISES KVEDCKMEST ETEERSTELK
     TEIKEEEDQP STSATQSSPA PGQSKKKIFK PEELRQALMP TLEALYRQDP ESLPFRQPVD
     PQLLGIPDYF DIVKSPMDLS TIKRKLDTGQ YQEPWQYVDD IWLMFNNAWL YNRKTSRVYK
     YCSKLSEVFE QEIDPVMQSL GYCCGRKLEF SPQTLCCYGK QLCTIPRDAT YYSYQNRYHF
     CEKCFNEIQG ESVSLGDDPS QPQTTINKEQ FSKRKNDTLD PELFVECTEC GRKMHQICVL
     HHEIIWPAGF VCDGCLKKSA RTRKENKFSA KRLPSTRLGT FLENRVNDFL RRQNHPESGE
     VTVRVVHASD KTVEVKPGMK ARFVDSGEMA ESFPYRTKAL FAFEEIDGVD LCFFGMHVQE
     YGSDCPPPNQ RRVYISYLDS VHFFRPKCLR TAVYHEILIG YLEYVKKLGY TTGHIWACPP
     SEGDDYIFHC HPPDQKIPKP KRLQEWYKKM LDKAVSERIV HDYKDIFKQA TEDRLTSAKE
     LPYFEGDFWP NVLEESIKEL EQEEEERKRE ENTSNESTDV TKGDSKNAKK KKK
//
ID   B7Z240_HUMAN            Unreviewed;       573 AA.
AC   B7Z240;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   26-FEB-2020, entry version 45.
DE   SubName: Full=cDNA FLJ55050, highly similar to Epidermal growth factor receptor substrate 15 {ECO:0000313|EMBL:BAH11726.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11726.1};
RN   [1] {ECO:0000313|EMBL:BAH11726.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAH11726.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK294297; BAH11726.1; -; mRNA.
DR   RefSeq; NP_001153441.1; NM_001159969.1.
DR   PeptideAtlas; B7Z240; -.
DR   PRIDE; B7Z240; -.
DR   GeneID; 2060; -.
DR   CTD; 2060; -.
DR   PharmGKB; PA27838; -.
DR   eggNOG; KOG0998; Eukaryota.
DR   eggNOG; ENOG410XTDR; LUCA.
DR   OrthoDB; 597979at2759; -.
DR   GenomeRNAi; 2060; -.
DR   Genevisible; B7Z240; HS.
DR   InterPro; IPR003903; UIM_dom.
DR   SMART; SM00726; UIM; 3.
DR   PROSITE; PS50330; UIM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Receptor {ECO:0000313|EMBL:BAH11726.1}.
FT   REGION          9..54
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          219..283
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          437..498
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          159..179
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          537..558
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        9..53
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        219..263
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        264..278
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        448..462
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   573 AA;  63622 MW;  7C74EA492335003C CRC64;
     MILMVRDCLK SQHRDPHCDP SDKREKNNVE QDLKEKEDTI KQRTSEVQDL QDEVQRENTN
     LQKLQAQKQQ VQELLDELDE QKAQLEEQLK EVRKKCAEEA QLISSLKAEL TSQESQISTY
     EEELAKAREE LSRLQQETAE LEESVESGKA QLEPLQQHLQ DSQQEISSMQ MKLMEMKDLE
     NHNSQLNWCS SPHSILVNGA TDYCSLSTSS SETANLNEHV EGQSNLESEP IHQESPARSS
     PELLPSGVTD ENEVTTAVTE KVCSELDNNR HSKEEDPFNV DSSSLTGPVA DTNLDFFQSD
     PFVGSDPFKD DPFGKIDPFG GDPFKGSDPF ASDCFFRQST DPFATSSTDP FSAANNSSIT
     SVETLKHNDP FAPGGTVVAA SDSATDPFAS VFGNESFGGG FADFSTLSKV NNEDPFRSAT
     SSSVSNVVIT KNVFEETSVK SEDEPPALPP KIGTPTRPCP LPPGKRSINK LDSPDPFKLN
     DPFQPFPGND SPKEIDPEIF CDPFTSATTT TNKEADPSNF ANFSAYPSEE DMIEWAKRES
     EREEEQRLAR LNQQEQEDLE LAIALSKSEI SEA
//
ID   EPS15_HUMAN             Reviewed;         896 AA.
AC   P42566; B2R8J7; D3DPJ2; Q5SRH4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   07-JUN-2005, sequence version 2.
DT   22-APR-2020, entry version 215.
DE   RecName: Full=Epidermal growth factor receptor substrate 15;
DE            Short=Protein Eps15;
DE   AltName: Full=Protein AF-1p;
GN   Name=EPS15; Synonyms=AF1P;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND VARIANT MET-822.
RC   TISSUE=Melanoma;
RX   PubMed=8183552;
RA   Wong W.T., Kraus M.H., Carlomagno F., Zelano A., Druck T., Croce C.M.,
RA   Huebner K., di Fiore P.P.;
RT   "The human eps15 gene, encoding a tyrosine kinase substrate, is conserved
RT   in evolution and maps to 1p31-p32.";
RL   Oncogene 9:1591-1597(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8134107;
RA   Bernard O.A., Mauchauffe M., Mecucci C., van den Berghe H., Berger R.;
RT   "A novel gene, AF-1p, fused to HRX in t(1;11)(p32;q23), is not related to
RT   AF-4, AF-9 nor ENL.";
RL   Oncogene 9:1039-1045(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Kronstein R., Grossklaus S., Schnittler H.-J.;
RT   "Eps15 in human umbilical vein endothelial cells.";
RL   Submitted (JAN-2006) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   INTERACTION WITH CRK.
RX   PubMed=8662907; DOI=10.1074/jbc.271.24.14468;
RA   Matsuda M., Ota S., Tanimura R., Nakamura H., Matuoka K., Takenawa T.,
RA   Nagashima K., Kurata T.;
RT   "Interaction between the amino-terminal SH3 domain of CRK and its natural
RT   target proteins.";
RL   J. Biol. Chem. 271:14468-14472(1996).
RN   [9]
RP   INTERACTION WITH EPN1.
RX   PubMed=9723620; DOI=10.1038/29555;
RA   Chen H., Fre S., Slepnev V.I., Capua M.R., Takei K., Butler M.H.,
RA   Di Fiore P.P., De Camilli P.;
RT   "Epsin is an EH-domain-binding protein implicated in clathrin-mediated
RT   endocytosis.";
RL   Nature 394:793-797(1998).
RN   [10]
RP   INTERACTION WITH HGS AND STAM2.
RX   PubMed=12551915; DOI=10.1074/jbc.m210843200;
RA   Bache K.G., Raiborg C., Mehlum A., Stenmark H.;
RT   "STAM and Hrs are subunits of a multivalent ubiquitin-binding complex on
RT   early endosomes.";
RL   J. Biol. Chem. 278:12513-12521(2003).
RN   [11]
RP   INTERACTION WITH SH3BP4.
RX   PubMed=16325581; DOI=10.1016/j.cell.2005.10.021;
RA   Tosoni D., Puri C., Confalonieri S., Salcini A.E., De Camilli P.,
RA   Tacchetti C., Di Fiore P.P.;
RT   "TTP specifically regulates the internalization of the transferrin
RT   receptor.";
RL   Cell 123:875-888(2005).
RN   [12]
RP   INTERACTION WITH UBQLN1, AND SUBCELLULAR LOCATION.
RX   PubMed=16159959; DOI=10.1242/jcs.02571;
RA   Regan-Klapisz E., Sorokina I., Voortman J., de Keizer P., Roovers R.C.,
RA   Verheesen P., Urbe S., Fallon L., Fon E.A., Verkleij A., Benmerah A.,
RA   van Bergen en Henegouwen P.M.;
RT   "Ubiquilin recruits Eps15 into ubiquitin-rich cytoplasmic aggregates via a
RT   UIM-UBL interaction.";
RL   J. Cell Sci. 118:4437-4450(2005).
RN   [13]
RP   INTERACTION WITH ERBB2.
RX   PubMed=16314522; DOI=10.1128/mcb.25.24.11005-11018.2005;
RA   Giri D.K., Ali-Seyed M., Li L.Y., Lee D.F., Ling P., Bartholomeusz G.,
RA   Wang S.C., Hung M.C.;
RT   "Endosomal transport of ErbB-2: mechanism for nuclear entry of the cell
RT   surface receptor.";
RL   Mol. Cell. Biol. 25:11005-11018(2005).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-323, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-485, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [16]
RP   FUNCTION, ALTERNATIVE SPLICING (ISOFORM 2), SUBCELLULAR LOCATION (ISOFORM
RP   2), AND INTERACTION WITH HSG AND AP2A2.
RX   PubMed=18362181; DOI=10.1083/jcb.200708115;
RA   Roxrud I., Raiborg C., Pedersen N.M., Stang E., Stenmark H.;
RT   "An endosomally localized isoform of Eps15 interacts with Hrs to mediate
RT   degradation of epidermal growth factor receptor.";
RL   J. Cell Biol. 180:1205-1218(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-796 AND SER-814, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [18]
RP   INTERACTION WITH UBQLN1 AND UBQLN2.
RX   PubMed=18199683; DOI=10.1091/mbc.e07-08-0775;
RA   N'Diaye E.N., Hanyaloglu A.C., Kajihara K.K., Puthenveedu M.A., Wu P.,
RA   von Zastrow M., Brown E.J.;
RT   "The ubiquitin-like protein PLIC-2 is a negative regulator of G protein-
RT   coupled receptor endocytosis.";
RL   Mol. Biol. Cell 19:1252-1260(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-140; SER-323; SER-485 AND
RP   SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [22]
RP   FUNCTION.
RX   PubMed=19458185; DOI=10.1091/mbc.e09-03-0256;
RA   Mettlen M., Stoeber M., Loerke D., Antonescu C.N., Danuser G., Schmid S.L.;
RT   "Endocytic accessory proteins are functionally distinguished by their
RT   differential effects on the maturation of clathrin-coated pits.";
RL   Mol. Biol. Cell 20:3251-3260(2009).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-108; SER-323; SER-324;
RP   SER-814 AND TYR-849, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-467; SER-470;
RP   SER-790; SER-796 AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [25]
RP   INTERACTION WITH FCHO2.
RX   PubMed=20448150; DOI=10.1126/science.1188462;
RA   Henne W.M., Boucrot E., Meinecke M., Evergren E., Vallis Y., Mittal R.,
RA   McMahon H.T.;
RT   "FCHo proteins are nucleators of clathrin-mediated endocytosis.";
RL   Science 328:1281-1284(2010).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [27]
RP   INTERACTION WITH FCHO2.
RX   PubMed=21762413; DOI=10.1111/j.1365-2443.2011.01536.x;
RA   Uezu A., Umeda K., Tsujita K., Suetsugu S., Takenawa T., Nakanishi H.;
RT   "Characterization of the EFC/F-BAR domain protein, FCHO2.";
RL   Genes Cells 16:868-878(2011).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-485; SER-790;
RP   SER-796 AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH DAB2.
RX   PubMed=22648170; DOI=10.1091/mbc.e11-12-1007;
RA   Teckchandani A., Mulkearns E.E., Randolph T.W., Toida N., Cooper J.A.;
RT   "The clathrin adaptor Dab2 recruits EH domain scaffold proteins to regulate
RT   integrin beta1 endocytosis.";
RL   Mol. Biol. Cell 23:2905-2916(2012).
RN   [30]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22223895; DOI=10.1074/mcp.m111.015131;
RA   Bienvenut W.V., Sumpton D., Martinez A., Lilla S., Espagne C., Meinnel T.,
RA   Giglione C.;
RT   "Comparative large-scale characterisation of plant vs. mammal proteins
RT   reveals similar and idiosyncratic N-alpha acetylation features.";
RL   Mol. Cell. Proteomics 11:M111.015131-M111.015131(2012).
RN   [31]
RP   INTERACTION WITH FCHO1.
RX   PubMed=22484487; DOI=10.1038/ncb2473;
RA   Umasankar P.K., Sanker S., Thieman J.R., Chakraborty S., Wendland B.,
RA   Tsang M., Traub L.M.;
RT   "Distinct and separable activities of the endocytic clathrin-coat
RT   components Fcho1/2 and AP-2 in developmental patterning.";
RL   Nat. Cell Biol. 14:488-501(2012).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; SER-746; THR-777;
RP   SER-790; SER-796 AND SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-324; THR-777; SER-796 AND
RP   SER-814, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [35]
RP   INTERACTION WITH CORO7.
RX   PubMed=24768539; DOI=10.1016/j.molcel.2014.03.035;
RA   Yuan W.C., Lee Y.R., Lin S.Y., Chang L.Y., Tan Y.P., Hung C.C., Kuo J.C.,
RA   Liu C.H., Lin M.Y., Xu M., Chen Z.J., Chen R.H.;
RT   "K33-linked polyubiquitination of coronin 7 by Cul3-KLHL20 ubiquitin E3
RT   ligase regulates protein trafficking.";
RL   Mol. Cell 54:586-600(2014).
RN   [36]
RP   INTERACTION WITH VACCINIA VIRUS PROTEIN A36 (MICROBIAL INFECTION).
RX   PubMed=27670116; DOI=10.1038/nmicrobiol.2016.141;
RA   Snetkov X., Weisswange I., Pfanzelter J., Humphries A.C., Way M.;
RT   "NPF motifs in the vaccinia virus protein A36 recruit intersectin-1 to
RT   promote Cdc42:N-WASP-mediated viral release from infected cells.";
RL   Nat. Microbiol. 1:16141-16141(2016).
RN   [37]
RP   STRUCTURE BY NMR OF 121-215 IN COMPLEX WITH CALCIUM IONS.
RX   PubMed=9721102; DOI=10.1126/science.281.5381.1357;
RA   de Beer T., Carter R.E., Lobel-Rice K.E., Sorkin A., Overduin M.;
RT   "Structure and Asn-Pro-Phe binding pocket of the Eps15 homology domain.";
RL   Science 281:1357-1360(1998).
RN   [38]
RP   STRUCTURE BY NMR OF 217-311 IN COMPLEX WITH CALCIUM IONS.
RX   PubMed=10757979; DOI=10.1021/bi9927383;
RA   Enmon J.L., de Beer T., Overduin M.;
RT   "Solution structure of Eps15's third EH domain reveals coincident Phe-Trp
RT   and Asn-Pro-Phe binding sites.";
RL   Biochemistry 39:4309-4319(2000).
RN   [39]
RP   STRUCTURE BY NMR OF 121-215 IN COMPLEX WITH PEPTIDE LIGAND AND CALCIUM
RP   IONS, AND DOMAIN.
RX   PubMed=11062555; DOI=10.1038/80924;
RA   de Beer T., Hoofnagle A.N., Enmon J.L., Bowers R.C., Yamabhai M., Kay B.K.,
RA   Overduin M.;
RT   "Molecular mechanism of NPF recognition by EH domains.";
RL   Nat. Struct. Biol. 7:1018-1022(2000).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 719-730 IN COMPLEX WITH AP2B1,
RP   IDENTIFICATION BY MASS SPECTROMETRY, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=16903783; DOI=10.1371/journal.pbio.0040262;
RA   Schmid E.M., Ford M.G.J., Burtey A., Praefcke G.J.K., Peak-Chew S.-Y.,
RA   Mills I.G., Benmerah A., McMahon H.T.;
RT   "Role of the AP2 beta-appendage hub in recruiting partners for clathrin-
RT   coated vesicle assembly.";
RL   PLoS Biol. 4:E262-E262(2006).
RN   [41]
RP   STRUCTURE BY NMR OF 121-215 IN COMPLEX WITH STON2 AND CALCIUM IONS,
RP   MUTAGENESIS OF VAL-154 AND TRP-169, AND SUBCELLULAR LOCATION.
RX   PubMed=18200045; DOI=10.1038/sj.emboj.7601980;
RA   Rumpf J., Simon B., Jung N., Maritzen T., Haucke V., Sattler M.,
RA   Groemping Y.;
RT   "Structure of the Eps15-stonin2 complex provides a molecular explanation
RT   for EH-domain ligand specificity.";
RL   EMBO J. 27:558-569(2008).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (2.70 ANGSTROMS) OF 645-654, AND INTERACTION WITH
RP   SGIP1.
RX   PubMed=26822536; DOI=10.1038/srep19565;
RA   Shimada A., Yamaguchi A., Kohda D.;
RT   "Structural basis for the recognition of two consecutive mutually
RT   interacting DPF motifs by the SGIP1 mu homology domain.";
RL   Sci. Rep. 6:19565-19565(2016).
CC   -!- FUNCTION: Involved in cell growth regulation. May be involved in the
CC       regulation of mitogenic signals and control of cell proliferation.
CC       Involved in the internalization of ligand-inducible receptors of the
CC       receptor tyrosine kinase (RTK) type, in particular EGFR. Plays a role
CC       in the assembly of clathrin-coated pits (CCPs). Acts as a clathrin
CC       adapter required for post-Golgi trafficking. Seems to be involved in
CC       CCPs maturation including invagination or budding. Involved in
CC       endocytosis of integrin beta-1 (ITGB1) and transferrin receptor (TFR);
CC       internalization of ITGB1 as DAB2-dependent cargo but not TFR seems to
CC       require association with DAB2. {ECO:0000269|PubMed:16903783,
CC       ECO:0000269|PubMed:18362181, ECO:0000269|PubMed:19458185,
CC       ECO:0000269|PubMed:22648170}.
CC   -!- SUBUNIT: Interacts with SGIP1 (PubMed:26822536). Interacts with HGS;
CC       the interaction bridges the interaction of STAM or STAM2 with EPS15.
CC       Isoform 2 interacts with HGS and AP2A2. Part of a complex at least
CC       composed of EPS15, HGS, and either STAM or STAM2. Binds AP2A2.
CC       Interacts with AP2B1; clathrin competes with EPS15. Binds STON2 and
CC       EPN1. Interacts (via its SH3-binding sites) with CRK. Interacts with
CC       SH3BP4/TTP. Interacts with ERBB2. Interacts with FCHO1. Interacts with
CC       FCHO2. Interacts (via EH domains) with DAB2. Interacts (via UIM
CC       repeats) with CORO7 (when ubiquitinated at 'Lys-472'). Interacts (via
CC       UIM domains) with UBQLN1 (via ubiquitin-like domain) and can interact
CC       with both the ubiquitinated and the non-ubiquitinated forms of UBQLN1.
CC       Interacts with UBQLN2 (By similarity) (PubMed:10757979,
CC       PubMed:11062555, PubMed:12551915, PubMed:16159959, PubMed:16314522,
CC       PubMed:16325581, PubMed:16903783, PubMed:18199683, PubMed:18200045,
CC       PubMed:18362181, PubMed:20448150, PubMed:21762413, PubMed:22484487,
CC       PubMed:22648170, PubMed:24768539, PubMed:8662907, PubMed:9721102,
CC       PubMed:9723620). {ECO:0000250|UniProtKB:P42567,
CC       ECO:0000269|PubMed:10757979, ECO:0000269|PubMed:11062555,
CC       ECO:0000269|PubMed:12551915, ECO:0000269|PubMed:16159959,
CC       ECO:0000269|PubMed:16314522, ECO:0000269|PubMed:16325581,
CC       ECO:0000269|PubMed:16903783, ECO:0000269|PubMed:18199683,
CC       ECO:0000269|PubMed:18200045, ECO:0000269|PubMed:18362181,
CC       ECO:0000269|PubMed:20448150, ECO:0000269|PubMed:21762413,
CC       ECO:0000269|PubMed:22484487, ECO:0000269|PubMed:22648170,
CC       ECO:0000269|PubMed:24768539, ECO:0000269|PubMed:26822536,
CC       ECO:0000269|PubMed:8662907, ECO:0000269|PubMed:9721102,
CC       ECO:0000269|PubMed:9723620}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with vaccinia virus protein
CC       A36. {ECO:0000269|PubMed:27670116}.
CC   -!- INTERACTION:
CC       P42566; Q0JRZ9: FCHO2; NbExp=3; IntAct=EBI-396684, EBI-2609756;
CC       P42566; Q3UQN2: Fcho2; Xeno; NbExp=3; IntAct=EBI-396684, EBI-6094986;
CC       P42566; Q15811: ITSN1; NbExp=3; IntAct=EBI-396684, EBI-602041;
CC       P42566; P16333: NCK1; NbExp=2; IntAct=EBI-396684, EBI-389883;
CC       P42566; Q9QZS3-1: Numb; Xeno; NbExp=3; IntAct=EBI-396684, EBI-9547433;
CC       P42566; Q9QZS3-2: Numb; Xeno; NbExp=3; IntAct=EBI-396684, EBI-3896014;
CC       P42566-1; P26045: PTPN3; NbExp=4; IntAct=EBI-15895294, EBI-1047946;
CC       P42566; Q8WXE9: STON2; NbExp=17; IntAct=EBI-396684, EBI-539742;
CC       P42566; Q9UMX0: UBQLN1; NbExp=5; IntAct=EBI-396684, EBI-741480;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Cell membrane; Peripheral membrane
CC       protein; Cytoplasmic side. Membrane, clathrin-coated pit.
CC       Note=Recruited to the plasma membrane upon EGFR activation and
CC       localizes to coated pits. Colocalizes with UBQLN1 in ubiquitin-rich
CC       cytoplasmic aggregates that are not endocytic compartments and in
CC       cytoplasmic juxtanuclear structures called aggresomes.
CC       {ECO:0000269|PubMed:16159959}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 2]: Early endosome membrane
CC       {ECO:0000269|PubMed:18362181}; Peripheral membrane protein
CC       {ECO:0000269|PubMed:18362181}; Cytoplasmic side
CC       {ECO:0000269|PubMed:18362181}. Note=Colocalizes with HGS on bilayered
CC       clathrin coats on endosomes.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P42566-1; Sequence=Displayed;
CC       Name=2; Synonyms=Eps15b;
CC         IsoId=P42566-2; Sequence=VSP_036168, VSP_036169;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed.
CC   -!- DOMAIN: The EH domain interacts with Asn-Pro-Phe (NPF) motifs of target
CC       proteins. {ECO:0000269|PubMed:11062555}.
CC   -!- DOMAIN: The UIM (ubiquitin-interacting motif) repeats specifically bind
CC       'Lys-33'-linked ubiquitin. {ECO:0000269|PubMed:11062555,
CC       ECO:0000269|PubMed:24768539}.
CC   -!- PTM: Phosphorylation on Tyr-849 is involved in the internalization of
CC       EGFR. Not required for membrane translocation after EGF treatment or
CC       for targeting to coated pits, but essential for a subsequent step in
CC       EGFR endocytosis (By similarity). Phosphorylated on serine upon DNA
CC       damage, probably by ATM or ATR. {ECO:0000250}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250|UniProtKB:P42567}.
CC   -!- DISEASE: Note=A chromosomal aberration involving EPS15 is found in
CC       acute leukemias. Translocation t(1;11)(p32;q23) with KMT2A/MLL1. The
CC       result is a rogue activator protein.
CC   -!- CAUTION: Studies in clathrin-mediated endocytosis of ITGB1 and TFR used
CC       a siRNA mixture of EPS15 and EPS15L1, and a Dab2 mutant with impaired
CC       binding to EH domain-containing proteins EPS15 and ITSN1 suggesting a
CC       partially overlapping role of the EH domain-containing proteins.
CC       {ECO:0000305|PubMed:22648170}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF1pID11.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U07707; AAA52101.1; -; mRNA.
DR   EMBL; Z29064; CAA82305.1; -; mRNA.
DR   EMBL; AK313396; BAG36194.1; -; mRNA.
DR   EMBL; DQ367924; ABD34786.1; -; mRNA.
DR   EMBL; BX647676; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC104170; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL671986; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX06823.1; -; Genomic_DNA.
DR   CCDS; CCDS557.1; -. [P42566-1]
DR   PIR; S43074; S43074.
DR   RefSeq; NP_001153441.1; NM_001159969.1. [P42566-2]
DR   RefSeq; NP_001972.1; NM_001981.2. [P42566-1]
DR   PDB; 1C07; NMR; -; A=217-311.
DR   PDB; 1EH2; NMR; -; A=121-218.
DR   PDB; 1F8H; NMR; -; A=121-215.
DR   PDB; 1FF1; NMR; -; A=121-215.
DR   PDB; 2IV9; X-ray; 1.90 A; P=723-730.
DR   PDB; 2JXC; NMR; -; A=121-215.
DR   PDB; 4RH5; X-ray; 1.60 A; B=846-854.
DR   PDB; 4RH9; X-ray; 1.60 A; B=846-854.
DR   PDB; 4RHG; X-ray; 1.58 A; B=846-854.
DR   PDB; 4S0G; X-ray; 1.72 A; B=846-854.
DR   PDB; 5AWT; X-ray; 2.70 A; B=640-649.
DR   PDB; 5AWU; X-ray; 2.70 A; B=645-654.
DR   PDB; 5JP2; X-ray; 2.40 A; E/F=615-637.
DR   PDBsum; 1C07; -.
DR   PDBsum; 1EH2; -.
DR   PDBsum; 1F8H; -.
DR   PDBsum; 1FF1; -.
DR   PDBsum; 2IV9; -.
DR   PDBsum; 2JXC; -.
DR   PDBsum; 4RH5; -.
DR   PDBsum; 4RH9; -.
DR   PDBsum; 4RHG; -.
DR   PDBsum; 4S0G; -.
DR   PDBsum; 5AWT; -.
DR   PDBsum; 5AWU; -.
DR   PDBsum; 5JP2; -.
DR   SMR; P42566; -.
DR   BioGrid; 108374; 166.
DR   CORUM; P42566; -.
DR   DIP; DIP-33064N; -.
DR   ELM; P42566; -.
DR   IntAct; P42566; 91.
DR   MINT; P42566; -.
DR   STRING; 9606.ENSP00000360798; -.
DR   MoonDB; P42566; Curated.
DR   MoonProt; P42566; -.
DR   iPTMnet; P42566; -.
DR   PhosphoSitePlus; P42566; -.
DR   BioMuta; EPS15; -.
DR   DMDM; 67476728; -.
DR   OGP; P42566; -.
DR   CPTAC; CPTAC-966; -.
DR   CPTAC; CPTAC-967; -.
DR   EPD; P42566; -.
DR   jPOST; P42566; -.
DR   MassIVE; P42566; -.
DR   MaxQB; P42566; -.
DR   PaxDb; P42566; -.
DR   PeptideAtlas; P42566; -.
DR   PRIDE; P42566; -.
DR   ProteomicsDB; 55515; -. [P42566-1]
DR   ProteomicsDB; 55516; -. [P42566-2]
DR   Antibodypedia; 1916; 232 antibodies.
DR   Ensembl; ENST00000371733; ENSP00000360798; ENSG00000085832. [P42566-1]
DR   GeneID; 2060; -.
DR   KEGG; hsa:2060; -.
DR   UCSC; uc001csq.2; human. [P42566-1]
DR   CTD; 2060; -.
DR   DisGeNET; 2060; -.
DR   GeneCards; EPS15; -.
DR   HGNC; HGNC:3419; EPS15.
DR   HPA; ENSG00000085832; Low tissue specificity.
DR   MIM; 600051; gene.
DR   neXtProt; NX_P42566; -.
DR   OpenTargets; ENSG00000085832; -.
DR   PharmGKB; PA27838; -.
DR   eggNOG; KOG0998; Eukaryota.
DR   eggNOG; ENOG410XTDR; LUCA.
DR   GeneTree; ENSGT00940000155751; -.
DR   InParanoid; P42566; -.
DR   KO; K12472; -.
DR   OMA; EQEQRIC; -.
DR   OrthoDB; 597979at2759; -.
DR   PhylomeDB; P42566; -.
DR   TreeFam; TF324293; -.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   Reactome; R-HSA-6807004; Negative regulation of MET activity.
DR   Reactome; R-HSA-8856825; Cargo recognition for clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8856828; Clathrin-mediated endocytosis.
DR   Reactome; R-HSA-8875360; InlB-mediated entry of Listeria monocytogenes into host cell.
DR   SignaLink; P42566; -.
DR   SIGNOR; P42566; -.
DR   ChiTaRS; EPS15; human.
DR   EvolutionaryTrace; P42566; -.
DR   GeneWiki; EPS15; -.
DR   GenomeRNAi; 2060; -.
DR   Pharos; P42566; Tbio.
DR   PRO; PR:P42566; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P42566; protein.
DR   Bgee; ENSG00000085832; Expressed in endothelial cell and 240 other tissues.
DR   ExpressionAtlas; P42566; baseline and differential.
DR   Genevisible; P42566; HS.
DR   GO; GO:0016235; C:aggresome; IDA:UniProtKB.
DR   GO; GO:0030122; C:AP-2 adaptor complex; IEA:Ensembl.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0009925; C:basal plasma membrane; IEA:Ensembl.
DR   GO; GO:0060170; C:ciliary membrane; IEA:Ensembl.
DR   GO; GO:0005905; C:clathrin-coated pit; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:HGNC-UCL.
DR   GO; GO:0098794; C:postsynapse; IEA:GOC.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042802; F:identical protein binding; IEA:Ensembl.
DR   GO; GO:0031593; F:polyubiquitin modification-dependent protein binding; IDA:UniProtKB.
DR   GO; GO:0017124; F:SH3 domain binding; IEA:UniProtKB-KW.
DR   GO; GO:0048268; P:clathrin coat assembly; IDA:BHF-UCL.
DR   GO; GO:0032456; P:endocytic recycling; IC:BHF-UCL.
DR   GO; GO:0006895; P:Golgi to endosome transport; IMP:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0042059; P:negative regulation of epidermal growth factor receptor signaling pathway; TAS:Reactome.
DR   GO; GO:0001921; P:positive regulation of receptor recycling; IEA:Ensembl.
DR   GO; GO:0098884; P:postsynaptic neurotransmitter receptor internalization; IEA:Ensembl.
DR   GO; GO:0019065; P:receptor-mediated endocytosis of virus by host cell; IMP:CACAO.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0016050; P:vesicle organization; TAS:UniProtKB.
DR   GO; GO:0046718; P:viral entry into host cell; IMP:CACAO.
DR   CDD; cd00052; EH; 3.
DR   InterPro; IPR011992; EF-hand-dom_pair.
DR   InterPro; IPR018247; EF_Hand_1_Ca_BS.
DR   InterPro; IPR002048; EF_hand_dom.
DR   InterPro; IPR000261; EH_dom.
DR   InterPro; IPR003903; UIM_dom.
DR   Pfam; PF12763; EF-hand_4; 3.
DR   SMART; SM00054; EFh; 3.
DR   SMART; SM00027; EH; 3.
DR   SMART; SM00726; UIM; 3.
DR   SUPFAM; SSF47473; SSF47473; 3.
DR   PROSITE; PS00018; EF_HAND_1; 2.
DR   PROSITE; PS50222; EF_HAND_2; 4.
DR   PROSITE; PS50031; EH; 3.
DR   PROSITE; PS50330; UIM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Calcium; Cell membrane;
KW   Chromosomal rearrangement; Coated pit; Cytoplasm; Endocytosis; Endosome;
KW   Host-virus interaction; Membrane; Metal-binding; Phosphoprotein;
KW   Polymorphism; Protein transport; Proto-oncogene; Reference proteome;
KW   Repeat; SH3-binding; Transport; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378"
FT   CHAIN           2..896
FT                   /note="Epidermal growth factor receptor substrate 15"
FT                   /id="PRO_0000146116"
FT   DOMAIN          15..104
FT                   /note="EH 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          128..216
FT                   /note="EH 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   DOMAIN          160..195
FT                   /note="EF-hand 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          223..258
FT                   /note="EF-hand 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00448"
FT   DOMAIN          224..314
FT                   /note="EH 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00077"
FT   REPEAT          599..601
FT                   /note="1"
FT   REPEAT          623..625
FT                   /note="2"
FT   REPEAT          629..631
FT                   /note="3"
FT   REPEAT          634..636
FT                   /note="4"
FT   REPEAT          640..642
FT                   /note="5"
FT   REPEAT          645..647
FT                   /note="6"
FT   REPEAT          651..653
FT                   /note="7"
FT   REPEAT          664..666
FT                   /note="8"
FT   REPEAT          672..674
FT                   /note="9"
FT   REPEAT          692..694
FT                   /note="10"
FT   REPEAT          709..711
FT                   /note="11"
FT   REPEAT          737..739
FT                   /note="12"
FT   REPEAT          798..800
FT                   /note="13"
FT   REPEAT          804..806
FT                   /note="14"
FT   REPEAT          825..827
FT                   /note="15"
FT   DOMAIN          851..870
FT                   /note="UIM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   DOMAIN          877..896
FT                   /note="UIM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00213"
FT   CA_BIND         173..184
FT                   /note="1"
FT   CA_BIND         236..247
FT                   /note="2"
FT   REGION          2..330
FT                   /note="Interaction with DAB2"
FT                   /evidence="ECO:0000250"
FT   REGION          599..827
FT                   /note="15 X 3 AA repeats of D-P-F"
FT   MOTIF           768..774
FT                   /note="SH3-binding"
FT   COMPBIAS        768..850
FT                   /note="Pro-rich"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:19413330,
FT                   ECO:0000244|PubMed:22223895, ECO:0000244|PubMed:22814378"
FT   MOD_RES         108
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         140
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332"
FT   MOD_RES         324
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         470
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         485
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17525332,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:21406692"
FT   MOD_RES         562
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42567"
FT   MOD_RES         563
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P42567"
FT   MOD_RES         746
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         777
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         779
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P42567"
FT   MOD_RES         790
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         796
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         814
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18088087,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         849
FT                   /note="Phosphotyrosine; by EGFR"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   VAR_SEQ         1..314
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_036168"
FT   VAR_SEQ         315..346
FT                   /note="SLQKNIIGSSPVADFSAIKELDTLNNEIVDLQ -> MYLKSDSGLGGWITIP
FT                   AVADVLKYSCIVCWSS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_036169"
FT   VARIANT         822
FT                   /note="I -> M (in dbSNP:rs17567)"
FT                   /evidence="ECO:0000269|PubMed:8183552"
FT                   /id="VAR_016142"
FT   MUTAGEN         154
FT                   /note="V->E: Loss of interaction with STON2 NPF motifs."
FT                   /evidence="ECO:0000269|PubMed:18200045"
FT   MUTAGEN         169
FT                   /note="W->A: Loss of interaction with STON2 NPF motifs."
FT                   /evidence="ECO:0000269|PubMed:18200045"
FT   CONFLICT        446
FT                   /note="Missing (in Ref. 5; BX647676)"
FT                   /evidence="ECO:0000305"
FT   HELIX           126..136
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   STRAND          142..144
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   STRAND          145..147
FT                   /evidence="ECO:0000244|PDB:2JXC"
FT   HELIX           148..156
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   TURN            157..159
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   HELIX           162..172
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   STRAND          177..179
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   HELIX           182..197
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   TURN            207..209
FT                   /evidence="ECO:0000244|PDB:1EH2"
FT   HELIX           212..214
FT                   /evidence="ECO:0000244|PDB:1F8H"
FT   HELIX           223..235
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   STRAND          240..243
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   HELIX           245..253
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   TURN            254..256
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   HELIX           259..269
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   STRAND          274..278
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   TURN            279..281
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   HELIX           282..293
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   TURN            305..307
FT                   /evidence="ECO:0000244|PDB:1C07"
FT   TURN            624..627
FT                   /evidence="ECO:0000244|PDB:5JP2"
FT   TURN            630..633
FT                   /evidence="ECO:0000244|PDB:5JP2"
FT   HELIX           723..726
FT                   /evidence="ECO:0000244|PDB:2IV9"
SQ   SEQUENCE   896 AA;  98656 MW;  A1B9FE15B47ABAFF CRC64;
     MAAAAQLSLT QLSSGNPVYE KYYRQVDTGN TGRVLASDAA AFLKKSGLPD LILGKIWDLA
     DTDGKGILNK QEFFVALRLV ACAQNGLEVS LSSLNLAVPP PRFHDTSSPL LISGTSAAEL
     PWAVKPEDKA KYDAIFDSLS PVNGFLSGDK VKPVLLNSKL PVDILGRVWE LSDIDHDGML
     DRDEFAVAMF LVYCALEKEP VPMSLPPALV PPSKRKTWVV SPAEKAKYDE IFLKTDKDMD
     GFVSGLEVRE IFLKTGLPST LLAHIWSLCD TKDCGKLSKD QFALAFHLIS QKLIKGIDPP
     HVLTPEMIPP SDRASLQKNI IGSSPVADFS AIKELDTLNN EIVDLQREKN NVEQDLKEKE
     DTIKQRTSEV QDLQDEVQRE NTNLQKLQAQ KQQVQELLDE LDEQKAQLEE QLKEVRKKCA
     EEAQLISSLK AELTSQESQI STYEEELAKA REELSRLQQE TAELEESVES GKAQLEPLQQ
     HLQDSQQEIS SMQMKLMEMK DLENHNSQLN WCSSPHSILV NGATDYCSLS TSSSETANLN
     EHVEGQSNLE SEPIHQESPA RSSPELLPSG VTDENEVTTA VTEKVCSELD NNRHSKEEDP
     FNVDSSSLTG PVADTNLDFF QSDPFVGSDP FKDDPFGKID PFGGDPFKGS DPFASDCFFR
     QSTDPFATSS TDPFSAANNS SITSVETLKH NDPFAPGGTV VAASDSATDP FASVFGNESF
     GGGFADFSTL SKVNNEDPFR SATSSSVSNV VITKNVFEET SVKSEDEPPA LPPKIGTPTR
     PCPLPPGKRS INKLDSPDPF KLNDPFQPFP GNDSPKEKDP EIFCDPFTSA TTTTNKEADP
     SNFANFSAYP SEEDMIEWAK RESEREEEQR LARLNQQEQE DLELAIALSK SEISEA
//
ID   A0A0S2Z3C9_HUMAN        Unreviewed;       452 AA.
AC   A0A0S2Z3C9;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 28.
DE   SubName: Full=Ets variant 6 isoform 1 {ECO:0000313|EMBL:ALQ33507.1};
DE   Flags: Fragment;
GN   Name=ETV6 {ECO:0000313|EMBL:ALQ33507.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33507.1};
RN   [1] {ECO:0000313|EMBL:ALQ33507.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU004019,
CC       ECO:0000256|SAAS:SAAS00594387}.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000256|RuleBase:RU004019,
CC       ECO:0000256|SAAS:SAAS00594391}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178049; ALQ33507.1; -; mRNA.
DR   RefSeq; NP_001978.1; NM_001987.4.
DR   SMR; A0A0S2Z3C9; -.
DR   PRIDE; A0A0S2Z3C9; -.
DR   Antibodypedia; 634; 370 antibodies.
DR   GeneID; 2120; -.
DR   KEGG; hsa:2120; -.
DR   CTD; 2120; -.
DR   KO; K03211; -.
DR   OMA; IENNHCP; -.
DR   OrthoDB; 827924at2759; -.
DR   PhylomeDB; A0A0S2Z3C9; -.
DR   ChiTaRS; ETV6; human.
DR   GenomeRNAi; 2120; -.
DR   ExpressionAtlas; A0A0S2Z3C9; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0097152; P:mesenchymal cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0022008; P:neurogenesis; IEA:Ensembl.
DR   GO; GO:0007296; P:vitellogenesis; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.150.50; -; 1.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS00346; ETS_DOMAIN_2; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   2: Evidence at transcript level;
KW   DNA-binding {ECO:0000256|RuleBase:RU004019, ECO:0000256|SAAS:SAAS00594397};
KW   Nucleus {ECO:0000256|RuleBase:RU004019, ECO:0000256|SAAS:SAAS00594400}.
FT   DOMAIN          40..124
FT                   /note="PNT"
FT                   /evidence="ECO:0000259|PROSITE:PS51433"
FT   DOMAIN          339..420
FT                   /note="ETS"
FT                   /evidence="ECO:0000259|PROSITE:PS50061"
FT   REGION          1..30
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          158..262
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..16
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        225..262
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         452
FT                   /evidence="ECO:0000313|EMBL:ALQ33507.1"
SQ   SEQUENCE   452 AA;  53000 MW;  DEC45682ECADECBB CRC64;
     MSETPAQCSI KQERISYTPP ESPVPSYASS TPLHVPVPRA LRMEEDSIRL PAHLRLQPIY
     WSRDDVAQWL KWAENEFSLR PIDSNTFEMN GKALLLLTKE DFRYRSPHSG DVLYELLQHI
     LKQRKPRILF SPFFHPGNSI HTQPEVILHQ NHEEDNCVQR TPRPSVDNVH HNPPTIELLH
     RSRSPITTNH RPSPDPEQRP LRSPLDNMIR RLSPAERAQG PRPHQENNHQ ESYPLSVSPM
     ENNHCPASSE SHPKPSSPRQ ESTRVIQLMP SPIMHPLILN PRHSVDFKQS RLSEDGLHRE
     GKPINLSHRE DLAYMNHIMV SVSPPEEHAM PIGRIADCRL LWDYVYQLLS DSRYENFIRW
     EDKESKIFRI VDPNGLARLW GNHKNRTNMT YEKMSRALRH YYKLNIIRKE PGQRLLFRFM
     KTPDEIMSGR TDRLEHLESQ ELDEQIYQED EC
//
ID   ETV6_HUMAN              Reviewed;         452 AA.
AC   P41212; A3QVP6; A8K076; Q9UMF6; Q9UMF7; Q9UMG0;
DT   01-FEB-1995, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1995, sequence version 1.
DT   22-APR-2020, entry version 208.
DE   RecName: Full=Transcription factor ETV6;
DE   AltName: Full=ETS translocation variant 6;
DE   AltName: Full=ETS-related protein Tel1;
DE            Short=Tel;
GN   Name=ETV6; Synonyms=TEL, TEL1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=8168137; DOI=10.1016/0092-8674(94)90322-0;
RA   Golub T.R., Barker G.F., Lovett M., Gilliland D.G.;
RT   "Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic
RT   myelomonocytic leukemia with t(5;12) chromosomal translocation.";
RL   Cell 77:307-316(1994).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Urinary bladder;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 56-109; 111-336 AND 338-452.
RX   PubMed=8743990; DOI=10.1101/gr.6.5.404;
RA   Baens M., Peeters P., Guo C., Aerssens J., Marynen P.;
RT   "Genomic organization of TEL: the human ETS-variant gene 6.";
RL   Genome Res. 6:404-413(1996).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 56-452, AND CHROMOSOMAL TRANSLOCATION WITH
RP   PAX5.
RX   PubMed=17344859; DOI=10.1038/nature05690;
RA   Mullighan C.G., Goorha S., Radtke I., Miller C.B., Coustan-Smith E.,
RA   Dalton J.D., Girtman K., Mathew S., Ma J., Pounds S.B., Su X., Pui C.-H.,
RA   Relling M.V., Evans W.E., Shurtleff S.A., Downing J.R.;
RT   "Genome-wide analysis of genetic alterations in acute lymphoblastic
RT   leukaemia.";
RL   Nature 446:758-764(2007).
RN   [7]
RP   CHROMOSOMAL TRANSLOCATION WITH MN1.
RX   PubMed=7731705;
RA   Buijs A., Sherr S., van Baal S., van Bezouw S., van der Plas D.,
RA   Geurts van Kessel A., Riegman P., Lekanne Deprez R., Zwarthoff E.,
RA   Hagemeijer A.;
RT   "Translocation (12;22) (p13;q11) in myeloproliferative disorders results in
RT   fusion of the ETS-like TEL gene on 12p13 to the MN1 gene on 22q11.";
RL   Oncogene 10:1511-1519(1995).
RN   [8]
RP   CHROMOSOMAL TRANSLOCATION WITH AML1.
RX   PubMed=7761424; DOI=10.1073/pnas.92.11.4917;
RA   Golub T.R., Barker G.F., Bohlander S.K., Hiebert S.W., Ward D.C.,
RA   Bray-Ward P., Morgan E., Raimondi S.C., Rowley J.D., Gilliland D.G.;
RT   "Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute
RT   lymphoblastic leukemia.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:4917-4921(1995).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH AML1.
RX   PubMed=7780150;
RA   Romana S.P., Mauchauffe M., le Coniat M., Chumakov I., le Paslier D.,
RA   Berger R., Bernard O.A.;
RT   "The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene
RT   fusion.";
RL   Blood 85:3662-3670(1995).
RN   [10]
RP   CHROMOSOMAL TRANSLOCATIONS WITH JAK2.
RX   PubMed=9326218;
RA   Peeters P., Raynaud S.D., Cools J., Wlodarska I., Grosgeorge J., Philip P.,
RA   Monpoux F., Van Rompaey L., Baens M., Van Den Berghe H., Marynen P.;
RT   "Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated
RT   kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a
RT   myeloid leukemia.";
RL   Blood 90:2535-2540(1997).
RN   [11]
RP   CHROMOSOMAL TRANSLOCATION WITH ACSL6.
RX   PubMed=10502316;
RX   DOI=10.1002/(sici)1098-2264(199911)26:3<192::aid-gcc2>3.0.co;2-e;
RA   Yagasaki F., Jinnai I., Yoshida S., Yokoyama Y., Matsuda A., Kusumoto S.,
RA   Kobayashi H., Terasaki H., Ohyashiki K., Asou N., Murohashi I., Bessho M.,
RA   Hirashima K.;
RT   "Fusion of TEL/ETV6 to a novel ACS2 in myelodysplastic syndrome and acute
RT   myelogenous leukemia with t(5;12)(q31;p13).";
RL   Genes Chromosomes Cancer 26:192-202(1999).
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH CHIC2.
RX   PubMed=10477709;
RA   Cools J., Bilhou-Nabera C., Wlodarska I., Cabrol C., Talmant P.,
RA   Bernard P., Hagemeijer A., Marynen P.;
RT   "Fusion of a novel gene, BTL, to ETV6 in acute myeloid leukemias with a
RT   t(4;12)(q11-q12;p13).";
RL   Blood 94:1820-1824(1999).
RN   [13]
RP   PHOSPHORYLATION AT SER-22 AND SER-257, AND MUTAGENESIS OF SER-213; SER-238
RP   AND SER-257.
RX   PubMed=12435397; DOI=10.1016/s0006-291x(02)02588-3;
RA   Arai H., Maki K., Waga K., Sasaki K., Nakamura Y., Imai Y., Kurokawa M.,
RA   Hirai H., Mitani K.;
RT   "Functional regulation of TEL by p38-induced phosphorylation.";
RL   Biochem. Biophys. Res. Commun. 299:116-125(2002).
RN   [14]
RP   CHROMOSOMAL TRANSLOCATION WITH MDS2.
RX   PubMed=12203785; DOI=10.1002/gcc.10090;
RA   Odero M.D., Vizmanos J.L., Roman J.P., Lahortiga I., Panizo C.,
RA   Calasanz M.J., Zeleznik-Le N.J., Rowley J.D., Novo F.J.;
RT   "A novel gene, MDS2, is fused to ETV6/TEL in a t(1;12)(p36.1;p13) in a
RT   patient with myelodysplastic syndrome.";
RL   Genes Chromosomes Cancer 35:11-19(2002).
RN   [15]
RP   INVOLVEMENT IN MPE, AND CHROMOSOMAL TRANSLOCATION WITH PDGFRB.
RX   PubMed=12181402; DOI=10.1056/nejmoa020150;
RA   Apperley J.F., Gardembas M., Melo J.V., Russell-Jones R., Bain B.J.,
RA   Baxter E.J., Chase A., Chessells J.M., Colombat M., Dearden C.E.,
RA   Dimitrijevic S., Mahon F.-X., Marin D., Nikolova Z., Olavarria E.,
RA   Silberman S., Schultheis B., Cross N.C.P., Goldman J.M.;
RT   "Response to imatinib mesylate in patients with chronic myeloproliferative
RT   diseases with rearrangements of the platelet-derived growth factor receptor
RT   beta.";
RL   N. Engl. J. Med. 347:481-487(2002).
RN   [16]
RP   INTERACTION WITH L3MBTL1.
RX   PubMed=12588862; DOI=10.1074/jbc.m300592200;
RA   Boccuni P., MacGrogan D., Scandura J.M., Nimer S.D.;
RT   "The human L(3)MBT Polycomb group protein is a transcriptional repressor
RT   and interacts physically and functionally with TEL (ETV6).";
RL   J. Biol. Chem. 278:15412-15420(2003).
RN   [17]
RP   INTERACTION WITH HDAC9.
RX   PubMed=12590135; DOI=10.1074/jbc.m212935200;
RA   Petrie K., Guidez F., Howell L., Healy L., Waxman S., Greaves M.,
RA   Zelent A.;
RT   "The histone deacetylase 9 gene encodes multiple protein isoforms.";
RL   J. Biol. Chem. 278:16059-16072(2003).
RN   [18]
RP   INVOLVEMENT IN AML, VARIANT GLY-344 INS, AND CHARACTERIZATION OF VARIANT
RP   GLY-344 INS.
RX   PubMed=15806161; DOI=10.1038/sj.onc.1208588;
RA   Barjesteh van Waalwijk van Doorn-Khosrovani S., Spensberger D.,
RA   de Knegt Y., Tang M., Loewenberg B., Delwel R.;
RT   "Somatic heterozygous mutations in ETV6 (TEL) and frequent absence of ETV6
RT   protein in acute myeloid leukemia.";
RL   Oncogene 24:4129-4137(2005).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-18 AND SER-22, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-302, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-22 AND SER-213, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [26]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [27]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [28]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11 AND LYS-288, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [29]
RP   FUNCTION, INVOLVEMENT IN THC5, VARIANTS THC5 LEU-214; GLN-369 AND CYS-399,
RP   AND CHARACTERIZATION OF VARIANTS THC5 LEU-214; GLN-369 AND CYS-399.
RX   PubMed=25581430; DOI=10.1038/ng.3177;
RA   Zhang M.Y., Churpek J.E., Keel S.B., Walsh T., Lee M.K., Loeb K.R.,
RA   Gulsuner S., Pritchard C.C., Sanchez-Bonilla M., Delrow J.J., Basom R.S.,
RA   Forouhar M., Gyurkocza B., Schwartz B.S., Neistadt B., Marquez R.,
RA   Mariani C.J., Coats S.A., Hofmann I., Lindsley R.C., Williams D.A.,
RA   Abkowitz J.L., Horwitz M.S., King M.C., Godley L.A., Shimamura A.;
RT   "Germline ETV6 mutations in familial thrombocytopenia and hematologic
RT   malignancy.";
RL   Nat. Genet. 47:180-185(2015).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-11; LYS-288; LYS-302; LYS-403 AND
RP   LYS-421, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [31]
RP   STRUCTURE BY NMR OF 338-442.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of ets domain transcriptional factor ETV6 protein.";
RL   Submitted (DEC-2006) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional repressor; binds to the DNA sequence 5'-
CC       CCGGAAGT-3'. Plays a role in hematopoiesis and malignant
CC       transformation. {ECO:0000269|PubMed:25581430}.
CC   -!- SUBUNIT: Can form homodimers or heterodimers with TEL2 or FLI1.
CC       Interacts with L3MBTL1 and HDAC9. {ECO:0000269|PubMed:12588862,
CC       ECO:0000269|PubMed:12590135}.
CC   -!- INTERACTION:
CC       P41212; Q9BXS5: AP1M1; NbExp=3; IntAct=EBI-1372759, EBI-541426;
CC       P41212; A0A0S2Z4M1: AXIN1; NbExp=3; IntAct=EBI-1372759, EBI-16429430;
CC       P41212; Q9UKV0-3: HDAC9; NbExp=3; IntAct=EBI-1372759, EBI-765476;
CC       P41212; Q13526: PIN1; NbExp=3; IntAct=EBI-1372759, EBI-714158;
CC       P41212; Q96HA8: WDYHV1; NbExp=3; IntAct=EBI-1372759, EBI-741158;
CC   -!- SUBCELLULAR LOCATION: Nucleus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Phosphorylation of Ser-257 by MAPK14 (p38) inhibits ETV6
CC       transcriptional repression. {ECO:0000269|PubMed:12435397}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in a
CC       form of chronic myelomonocytic leukemia (CMML). Translocation
CC       t(5;12)(q33;p13) with PDGFRB. It is characterized by abnormal clonal
CC       myeloid proliferation and by progression to acute myelogenous leukemia
CC       (AML). {ECO:0000269|PubMed:8168137}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving ETV6 are found in acute
CC       myeloid leukemia (AML). Translocation t(12;22)(p13;q11) with MN1
CC       (PubMed:7731705). Translocation t(4;12)(q12;p13) with CHIC2
CC       (PubMed:10477709). {ECO:0000269|PubMed:10477709,
CC       ECO:0000269|PubMed:7731705}.
CC   -!- DISEASE: Note=Chromosomal aberrations involving ETV6 are found in
CC       childhood acute lymphoblastic leukemia (ALL). Translocations
CC       t(12;21)(p12;q22) and t(12;21)(p13;q22) with RUNX1/AML1.
CC       {ECO:0000269|PubMed:7761424}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in a
CC       form of pre-B acute lymphoid leukemia. Translocation t(9;12)(p24;p13)
CC       with JAK2. {ECO:0000269|PubMed:9326218}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 and JAK2 is found
CC       in an atypical chronic myelogenous leukemia. Translocation
CC       t(9;15;12)(p24;q15;p13). {ECO:0000269|PubMed:9326218}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       myelodysplastic syndrome (MDS) with basophilia. Translocation
CC       t(5;12)(q31;p13) with ACSL6. {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in acute
CC       eosinophilic leukemia (AEL). Translocation t(5;12)(q31;p13) with ACSL6.
CC       {ECO:0000269|PubMed:10502316}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in
CC       myelodysplastic syndrome (MDS). Translocation t(1;12)(p36.1;p13) with
CC       MDS2. {ECO:0000269|PubMed:12203785}.
CC   -!- DISEASE: Note=A chromosomal aberration involving ETV6 is found in acute
CC       lymphoblastic leukemia. Translocation t(9;12)(p13;p13) with PAX5.
CC       {ECO:0000269|PubMed:17344859}.
CC   -!- DISEASE: Myeloproliferative disorder chronic with eosinophilia (MPE)
CC       [MIM:131440]: A hematologic disorder characterized by malignant
CC       eosinophils proliferation. {ECO:0000269|PubMed:12181402}. Note=The gene
CC       represented in this entry is involved in disease pathogenesis. A
CC       chromosomal aberration involving ETV6 is found in many instances of
CC       myeloproliferative disorder chronic with eosinophilia. Translocation
CC       t(5;12) with PDGFRB on chromosome 5 creating an ETV6-PDGFRB fusion
CC       protein. {ECO:0000269|PubMed:12181402}.
CC   -!- DISEASE: Leukemia, acute myelogenous (AML) [MIM:601626]: A subtype of
CC       acute leukemia, a cancer of the white blood cells. AML is a malignant
CC       disease of bone marrow characterized by maturational arrest of
CC       hematopoietic precursors at an early stage of development. Clonal
CC       expansion of myeloid blasts occurs in bone marrow, blood, and other
CC       tissue. Myelogenous leukemias develop from changes in cells that
CC       normally produce neutrophils, basophils, eosinophils and monocytes.
CC       {ECO:0000269|PubMed:15806161}. Note=The gene represented in this entry
CC       is involved in disease pathogenesis.
CC   -!- DISEASE: Thrombocytopenia 5 (THC5) [MIM:616216]: Thrombocytopenia is
CC       defined by a decrease in the number of platelets in circulating blood,
CC       resulting in the potential for increased bleeding and decreased ability
CC       for clotting. THC5 is an autosomal dominant disorder, associated with
CC       an increased susceptibility to the development of hematologic and solid
CC       malignancies. {ECO:0000269|PubMed:25581430}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the ETS family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=ABI30005.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/ETV6ID38.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U11732; AAA19786.1; -; mRNA.
DR   EMBL; AK289441; BAF82130.1; -; mRNA.
DR   EMBL; CH471094; EAW96240.1; -; Genomic_DNA.
DR   EMBL; BC043399; AAH43399.1; -; mRNA.
DR   EMBL; U61375; AAC50690.1; -; Genomic_DNA.
DR   EMBL; U63312; AAB17134.1; -; Genomic_DNA.
DR   EMBL; U63313; AAB17135.1; -; Genomic_DNA.
DR   EMBL; DQ841178; ABI30005.1; ALT_INIT; mRNA.
DR   CCDS; CCDS8643.1; -.
DR   RefSeq; NP_001978.1; NM_001987.4.
DR   PDB; 1JI7; X-ray; 1.45 A; A/B/C=47-123.
DR   PDB; 1LKY; X-ray; 2.30 A; A/B/C/D/E/F=47-123.
DR   PDB; 2DAO; NMR; -; A=338-442.
DR   PDB; 2QAR; X-ray; 2.40 A; A/B/D/E=47-124.
DR   PDB; 2QB0; X-ray; 2.56 A; A/C=47-123.
DR   PDB; 2QB1; X-ray; 2.61 A; A/B=47-121.
DR   PDB; 5L0P; X-ray; 2.30 A; A=47-356.
DR   PDBsum; 1JI7; -.
DR   PDBsum; 1LKY; -.
DR   PDBsum; 2DAO; -.
DR   PDBsum; 2QAR; -.
DR   PDBsum; 2QB0; -.
DR   PDBsum; 2QB1; -.
DR   PDBsum; 5L0P; -.
DR   SMR; P41212; -.
DR   BioGrid; 108421; 44.
DR   DIP; DIP-17028N; -.
DR   ELM; P41212; -.
DR   IntAct; P41212; 24.
DR   MINT; P41212; -.
DR   STRING; 9606.ENSP00000379658; -.
DR   BindingDB; P41212; -.
DR   ChEMBL; CHEMBL2401606; -.
DR   DrugCentral; P41212; -.
DR   iPTMnet; P41212; -.
DR   PhosphoSitePlus; P41212; -.
DR   BioMuta; ETV6; -.
DR   DMDM; 730927; -.
DR   EPD; P41212; -.
DR   jPOST; P41212; -.
DR   MassIVE; P41212; -.
DR   MaxQB; P41212; -.
DR   PaxDb; P41212; -.
DR   PeptideAtlas; P41212; -.
DR   PRIDE; P41212; -.
DR   ProteomicsDB; 55416; -.
DR   Antibodypedia; 634; 370 antibodies.
DR   DNASU; 2120; -.
DR   Ensembl; ENST00000396373; ENSP00000379658; ENSG00000139083.
DR   GeneID; 2120; -.
DR   KEGG; hsa:2120; -.
DR   UCSC; uc001qzz.4; human.
DR   CTD; 2120; -.
DR   DisGeNET; 2120; -.
DR   GeneCards; ETV6; -.
DR   HGNC; HGNC:3495; ETV6.
DR   HPA; ENSG00000139083; Low tissue specificity.
DR   MalaCards; ETV6; -.
DR   MIM; 131440; phenotype.
DR   MIM; 600618; gene.
DR   MIM; 601626; phenotype.
DR   MIM; 616216; phenotype.
DR   neXtProt; NX_P41212; -.
DR   OpenTargets; ENSG00000139083; -.
DR   Orphanet; 98823; Chronic myelomonocytic leukemia.
DR   Orphanet; 2665; Congenital mesoblastic nephroma.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   Orphanet; 71290; Familial platelet disorder with associated myeloid malignancy.
DR   Orphanet; 2030; Fibrosarcoma.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   Orphanet; 314950; Primary hypereosinophilic syndrome.
DR   PharmGKB; PA27909; -.
DR   eggNOG; KOG3804; Eukaryota.
DR   eggNOG; ENOG4111K4J; LUCA.
DR   GeneTree; ENSGT00940000159508; -.
DR   HOGENOM; CLU_037998_1_0_1; -.
DR   InParanoid; P41212; -.
DR   KO; K03211; -.
DR   OMA; IENNHCP; -.
DR   OrthoDB; 559763at2759; -.
DR   PhylomeDB; P41212; -.
DR   TreeFam; TF318679; -.
DR   SIGNOR; P41212; -.
DR   ChiTaRS; ETV6; human.
DR   EvolutionaryTrace; P41212; -.
DR   GeneWiki; ETV6; -.
DR   GenomeRNAi; 2120; -.
DR   Pharos; P41212; Tbio.
DR   PRO; PR:P41212; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; P41212; protein.
DR   Bgee; ENSG00000139083; Expressed in mammary gland and 192 other tissues.
DR   ExpressionAtlas; P41212; baseline and differential.
DR   Genevisible; P41212; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; TAS:ProtInc.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0071425; P:hematopoietic stem cell proliferation; IMP:UniProtKB.
DR   GO; GO:0097152; P:mesenchymal cell apoptotic process; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0022008; P:neurogenesis; IEA:Ensembl.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0007296; P:vitellogenesis; IEA:Ensembl.
DR   Gene3D; 1.10.10.10; -; 1.
DR   Gene3D; 1.10.150.50; -; 1.
DR   InterPro; IPR000418; Ets_dom.
DR   InterPro; IPR003118; Pointed_dom.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   Pfam; PF00178; Ets; 1.
DR   Pfam; PF02198; SAM_PNT; 1.
DR   PRINTS; PR00454; ETSDOMAIN.
DR   SMART; SM00413; ETS; 1.
DR   SMART; SM00251; SAM_PNT; 1.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF47769; SSF47769; 1.
DR   PROSITE; PS00346; ETS_DOMAIN_2; 1.
DR   PROSITE; PS50061; ETS_DOMAIN_3; 1.
DR   PROSITE; PS51433; PNT; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Chromosomal rearrangement; Disease mutation;
KW   DNA-binding; Isopeptide bond; Nucleus; Phosphoprotein; Proto-oncogene;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..452
FT                   /note="Transcription factor ETV6"
FT                   /id="PRO_0000204121"
FT   DOMAIN          40..124
FT                   /note="PNT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00762"
FT   DNA_BIND        339..420
FT                   /note="ETS"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00237"
FT   SITE            11..12
FT                   /note="Breakpoint for translocation to form CHIC2-ETV6 in
FT                   AML"
FT   SITE            54..55
FT                   /note="Breakpoint for translocation to form ETV6-MDS2 in
FT                   MDS"
FT   SITE            55..56
FT                   /note="Breakpoint for translocation to form PAX5-ETV6"
FT   SITE            336..337
FT                   /note="Breakpoint for translocation to form ETV6-AML1 in
FT                   ALL"
FT   MOD_RES         11
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         18
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         22
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000269|PubMed:12435397"
FT   MOD_RES         213
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         238
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97360"
FT   MOD_RES         257
FT                   /note="Phosphoserine; by MAPK14"
FT                   /evidence="ECO:0000269|PubMed:12435397"
FT   MOD_RES         302
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         323
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P97360"
FT   CROSSLNK        11
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        288
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        302
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        403
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        421
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VARIANT         214
FT                   /note="P -> L (in THC5; abrogates DNA binding; alters
FT                   subcellular location; decreases transcriptional repression
FT                   in a dominant-negative fashion; dbSNP:rs724159947)"
FT                   /evidence="ECO:0000269|PubMed:25581430"
FT                   /id="VAR_073322"
FT   VARIANT         344
FT                   /note="Y -> YG (in one individual with AML; somatic
FT                   mutation; unable to repress transcription)"
FT                   /evidence="ECO:0000269|PubMed:15806161"
FT                   /id="VAR_034600"
FT   VARIANT         369
FT                   /note="R -> Q (in THC5; abrogates DNA binding; alters
FT                   subcellular location; decreases transcriptional repression
FT                   in a dominant-negative fashion; dbSNP:rs724159946)"
FT                   /evidence="ECO:0000269|PubMed:25581430"
FT                   /id="VAR_073323"
FT   VARIANT         399
FT                   /note="R -> C (in THC5; abrogates DNA binding; alters
FT                   subcellular location; decreases transcriptional repression
FT                   in a dominant-negative fashion; dbSNP:rs724159945)"
FT                   /evidence="ECO:0000269|PubMed:25581430"
FT                   /id="VAR_073324"
FT   MUTAGEN         22
FT                   /note="S->A: No effect."
FT   MUTAGEN         213
FT                   /note="S->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:12435397"
FT   MUTAGEN         238
FT                   /note="S->A: No effect."
FT                   /evidence="ECO:0000269|PubMed:12435397"
FT   MUTAGEN         257
FT                   /note="S->A: No phosphorylation by MAPK14."
FT                   /evidence="ECO:0000269|PubMed:12435397"
FT   HELIX           12..18
FT                   /evidence="ECO:0000244|PDB:5L0P"
FT   TURN            20..22
FT                   /evidence="ECO:0000244|PDB:5L0P"
FT   HELIX           23..27
FT                   /evidence="ECO:0000244|PDB:5L0P"
FT   HELIX           30..38
FT                   /evidence="ECO:0000244|PDB:5L0P"
FT   HELIX           52..54
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   HELIX           58..60
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   HELIX           63..76
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   TURN            84..87
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   HELIX           91..94
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   HELIX           99..105
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   TURN            107..109
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   HELIX           110..122
FT                   /evidence="ECO:0000244|PDB:1JI7"
FT   HELIX           341..350
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   HELIX           352..354
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   TURN            355..357
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   STRAND          358..362
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   HELIX           363..365
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   STRAND          367..371
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   HELIX           373..383
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   HELIX           391..403
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   STRAND          406..408
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   STRAND          411..419
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   HELIX           424..426
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   STRAND          430..432
FT                   /evidence="ECO:0000244|PDB:2DAO"
FT   HELIX           434..438
FT                   /evidence="ECO:0000244|PDB:2DAO"
SQ   SEQUENCE   452 AA;  53000 MW;  DEC45682ECADECBB CRC64;
     MSETPAQCSI KQERISYTPP ESPVPSYASS TPLHVPVPRA LRMEEDSIRL PAHLRLQPIY
     WSRDDVAQWL KWAENEFSLR PIDSNTFEMN GKALLLLTKE DFRYRSPHSG DVLYELLQHI
     LKQRKPRILF SPFFHPGNSI HTQPEVILHQ NHEEDNCVQR TPRPSVDNVH HNPPTIELLH
     RSRSPITTNH RPSPDPEQRP LRSPLDNMIR RLSPAERAQG PRPHQENNHQ ESYPLSVSPM
     ENNHCPASSE SHPKPSSPRQ ESTRVIQLMP SPIMHPLILN PRHSVDFKQS RLSEDGLHRE
     GKPINLSHRE DLAYMNHIMV SVSPPEEHAM PIGRIADCRL LWDYVYQLLS DSRYENFIRW
     EDKESKIFRI VDPNGLARLW GNHKNRTNMT YEKMSRALRH YYKLNIIRKE PGQRLLFRFM
     KTPDEIMSGR TDRLEHLESQ ELDEQIYQED EC
//
ID   EXT1_HUMAN              Reviewed;         746 AA.
AC   Q16394; B2R7V2; Q9BVI9;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   27-MAR-2002, sequence version 2.
DT   22-APR-2020, entry version 200.
DE   RecName: Full=Exostosin-1;
DE            EC=2.4.1.224;
DE            EC=2.4.1.225;
DE   AltName: Full=Glucuronosyl-N-acetylglucosaminyl-proteoglycan/N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase;
DE   AltName: Full=Multiple exostoses protein 1;
DE   AltName: Full=Putative tumor suppressor protein EXT1;
GN   Name=EXT1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Placenta;
RX   PubMed=7550340; DOI=10.1038/ng1095-137;
RA   Ahn J., Luedecke H.-J., Lindow S., Horton W.A., Lee B., Wagner M.J.,
RA   Horsthemke B., Wells D.E.;
RT   "Cloning of the putative tumour suppressor gene for hereditary multiple
RT   exostoses (EXT1).";
RL   Nat. Genet. 11:137-143(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-320.
RC   TISSUE=Lung;
RX   PubMed=9119404; DOI=10.1006/geno.1996.4577;
RA   Luedecke H.-J., Ahn J., Lin X., Hill A., Wagner M.J., Schomburg L.,
RA   Horsthemke B., Wells D.E.;
RT   "Genomic organization and promoter structure of the human EXT1 gene.";
RL   Genomics 40:351-354(1997).
RN   [6]
RP   SUBUNIT, AND SUBCELLULAR LOCATION.
RX   PubMed=10679296; DOI=10.1006/bbrc.2000.2219;
RA   Kobayashi S., Morimoto K., Shimizu T., Takahashi M., Kurosawa H.,
RA   Shirasawa T.;
RT   "Association of EXT1 and EXT2, hereditary multiple exostoses gene products,
RT   in Golgi apparatus.";
RL   Biochem. Biophys. Res. Commun. 268:860-867(2000).
RN   [7]
RP   FUNCTION.
RX   PubMed=11518722; DOI=10.1172/jci13737;
RA   Duncan G., McCormick C., Tufaro F.;
RT   "The link between heparan sulfate and hereditary bone disease: finding a
RT   function for the EXT family of putative tumor suppressor proteins.";
RL   J. Clin. Invest. 108:511-516(2001).
RN   [8]
RP   FUNCTION.
RX   PubMed=22660413; DOI=10.1038/ncb2502;
RA   Baietti M.F., Zhang Z., Mortier E., Melchior A., Degeest G., Geeraerts A.,
RA   Ivarsson Y., Depoortere F., Coomans C., Vermeiren E., Zimmermann P.,
RA   David G.;
RT   "Syndecan-syntenin-ALIX regulates the biogenesis of exosomes.";
RL   Nat. Cell Biol. 14:677-685(2012).
RN   [9]
RP   REVIEW ON VARIANTS.
RX   PubMed=10679937;
RX   DOI=10.1002/(sici)1098-1004(200003)15:3<220::aid-humu2>3.0.co;2-k;
RA   Wuyts W., Van Hul W.;
RT   "Molecular basis of multiple exostoses: mutations in the EXT1 and EXT2
RT   genes.";
RL   Hum. Mutat. 15:220-227(2000).
RN   [10]
RP   VARIANTS EXT1 GLY-280 AND HIS-340.
RA   Raskind W.H., Matsushita M., Conrad E.U. III, Wells D.E., Sandell L.J.,
RA   Wagner M.J., Houck J.;
RT   "Spectrum of EXT1 mutations in hereditary multiple exostoses.";
RL   Am. J. Hum. Genet. 59:A280-A280(1996).
RN   [11]
RP   VARIANT EXT1 LEU-340.
RX   PubMed=8981950;
RA   Hecht J.T., Hogue D.A., Wang Y., Blanton S.H., Wagner M.J., Strong L.C.,
RA   Raskind W.H., Hansen M.F., Wells D.E.;
RT   "Hereditary multiple exostoses (EXT): mutational studies of familial EXT1
RT   cases and EXT-associated malignancies.";
RL   Am. J. Hum. Genet. 60:80-86(1997).
RN   [12]
RP   VARIANTS EXT1 ASP-339 AND CYS-340.
RX   PubMed=9326317; DOI=10.1086/515505;
RA   Philippe C., Porter D.E., Emerton M.E., Wells D.E., Simpson A.H.R.W.,
RA   Monaco A.P.;
RT   "Mutation screening of the EXT1 and EXT2 genes in patients with hereditary
RT   multiple exostoses.";
RL   Am. J. Hum. Genet. 61:520-528(1997).
RN   [13]
RP   VARIANTS EXT1 GLY-280 AND SER-340.
RX   PubMed=9463333; DOI=10.1086/301726;
RA   Wuyts W., van Hul W., de Boulle K., Hendrickx J., Bakker E.,
RA   Vanhoenacker F., Mollica F., Luedecke H.-J., Sayli B.S., Pazzaglia U.E.,
RA   Mortier G., Hamel B.C.J., Conrad E.U. III, Matsushita M., Raskind W.H.,
RA   Willems P.J.;
RT   "Mutations in the EXT1 and EXT2 genes in hereditary multiple exostoses.";
RL   Am. J. Hum. Genet. 62:346-354(1998).
RN   [14]
RP   VARIANTS EXT1 GLY-280; SER-280; HIS-340 AND HIS-627 DEL.
RX   PubMed=9521425;
RX   DOI=10.1002/(sici)1098-1004(1998)11:3<231::aid-humu8>3.0.co;2-k;
RA   Raskind W.H., Conrad E.U. III, Matsushita M., Wijsman E.M., Wells D.E.,
RA   Chapman N., Sandell L.J., Wagner M.J., Houck J.;
RT   "Evaluation of locus heterogeneity and EXT1 mutations in 34 families with
RT   hereditary multiple exostoses.";
RL   Hum. Mutat. 11:231-239(1998).
RN   [15]
RP   VARIANTS EXT1 HIS-164; 235-PRO--LYS-239 DEL AND SER-316.
RX   PubMed=10441575; DOI=10.1086/302532;
RA   Bovee J.V.M.G., Cleton-Jansen A.-M., Wuyts W., Caethoven G.,
RA   Taminiau A.H.M., Bakker E., van Hul W., Cornelisse C.J., Hogendoorn P.C.W.;
RT   "EXT-mutation analysis and loss of heterozygosity in sporadic and
RT   hereditary osteochondromas and secondary chondrosarcomas.";
RL   Am. J. Hum. Genet. 65:689-698(1999).
RN   [16]
RP   VARIANTS EXT1 VAL-486 AND LEU-496.
RX   PubMed=10480354; DOI=10.1007/s004399900058;
RA   Xu L., Xia J., Jiang H., Zhou J., Li H., Wang D., Pan Q., Long Z., Fan C.,
RA   Deng H.-X.;
RT   "Mutation analysis of hereditary multiple exostoses in the Chinese.";
RL   Hum. Genet. 105:45-50(1999).
RN   [17]
RP   VARIANT EXT1 215-MET--SER-221 DEL, AND VARIANT OSTEOCHONDROMA
RP   215-MET--SER-222 DELINS ILE.
RX   PubMed=11169766;
RX   DOI=10.1002/1097-0169(200102)48:2<149::aid-cm1005>3.0.co;2-3;
RA   Bernard M.A., Hall C.E., Hogue D.A., Cole W.G., Scott A., Snuggs M.B.,
RA   Clines G.A., Luedecke H.-J., Lovett M., Van Winkle W.B., Hecht J.T.;
RT   "Diminished levels of the putative tumor suppressor proteins EXT1 and EXT2
RT   in exostosis chondrocytes.";
RL   Cell Motil. Cytoskeleton 48:149-162(2001).
RN   [18]
RP   CHARACTERIZATION OF VARIANTS, AND MUTAGENESIS OF GLN-27; ASP-164; ASN-316;
RP   ALA-486 AND PRO-496.
RX   PubMed=11391482; DOI=10.1086/321278;
RA   Cheung P.K., McCormick C., Crawford B.E., Esko J.D., Tufaro F., Duncan G.;
RT   "Etiological point mutations in the hereditary multiple exostoses gene
RT   EXT1: a functional analysis of heparan sulfate polymerase activity.";
RL   Am. J. Hum. Genet. 69:55-66(2001).
CC   -!- FUNCTION: Glycosyltransferase required for the biosynthesis of heparan-
CC       sulfate. The EXT1/EXT2 complex possesses substantially higher
CC       glycosyltransferase activity than EXT1 or EXT2 alone. Appears to be a
CC       tumor suppressor. Required for the exosomal release of SDCBP, CD63 and
CC       syndecan (PubMed:22660413). {ECO:0000269|PubMed:11518722,
CC       ECO:0000269|PubMed:22660413}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-{[(1->4)-beta-D-GlcA-(1->4)-alpha-D-GlcNAc](n)-(1->4)-
CC         beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl}-L-
CC         seryl-[protein] + UDP-N-acetyl-alpha-D-glucosamine = 3-O-{alpha-D-
CC         GlcNAc-[(1->4)-beta-D-GlcA-(1->4)-alpha-D-GlcNAc](n)-(1->4)-beta-D-
CC         GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl}-L-seryl-
CC         [protein] + H(+) + UDP; Xref=Rhea:RHEA:16213, Rhea:RHEA-COMP:12621,
CC         Rhea:RHEA-COMP:12623, ChEBI:CHEBI:15378, ChEBI:CHEBI:57705,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:132415, ChEBI:CHEBI:132416;
CC         EC=2.4.1.224;
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=3-O-{alpha-D-GlcNAc-[(1->4)-beta-D-GlcA-(1->4)-alpha-D-
CC         GlcNAc](n)-(1->4)-beta-D-GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-
CC         (1->4)-beta-D-Xyl}-L-seryl-[protein] + UDP-alpha-D-glucuronate = 3-
CC         O-{[(1->4)-beta-D-GlcA-(1->4)-alpha-D-GlcNAc](n+1)-(1->4)-beta-D-
CC         GlcA-(1->3)-beta-D-Gal-(1->3)-beta-D-Gal-(1->4)-beta-D-Xyl}-L-seryl-
CC         [protein] + H(+) + UDP; Xref=Rhea:RHEA:20908, Rhea:RHEA-COMP:12623,
CC         Rhea:RHEA-COMP:14295, ChEBI:CHEBI:15378, ChEBI:CHEBI:58052,
CC         ChEBI:CHEBI:58223, ChEBI:CHEBI:132415, ChEBI:CHEBI:132416;
CC         EC=2.4.1.225;
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000250|UniProtKB:Q9ES89};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC   -!- SUBUNIT: Forms a homo/hetero-oligomeric complex with EXT2.
CC       {ECO:0000269|PubMed:10679296}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:10679296}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:10679296}. Golgi apparatus membrane
CC       {ECO:0000269|PubMed:10679296}; Single-pass type II membrane protein
CC       {ECO:0000269|PubMed:10679296}. Note=The EXT1/EXT2 complex is localized
CC       in the Golgi apparatus.
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Hereditary multiple exostoses 1 (EXT1) [MIM:133700]: EXT is a
CC       genetically heterogeneous bone disorder caused by genes segregating on
CC       human chromosomes 8, 11, and 19 and designated EXT1, EXT2 and EXT3
CC       respectively. EXT is a dominantly inherited skeletal disorder primarily
CC       affecting endochondral bone during growth. The disease is characterized
CC       by formation of numerous cartilage-capped, benign bone tumors
CC       (osteocartilaginous exostoses or osteochondromas) that are often
CC       accompanied by skeletal deformities and short stature. In a small
CC       percentage of cases exostoses have exhibited malignant transformation
CC       resulting in an osteosarcoma or chondrosarcoma. Osteochondromas
CC       development can also occur as a sporadic event.
CC       {ECO:0000269|PubMed:10441575, ECO:0000269|PubMed:10480354,
CC       ECO:0000269|PubMed:11169766, ECO:0000269|PubMed:8981950,
CC       ECO:0000269|PubMed:9326317, ECO:0000269|PubMed:9463333,
CC       ECO:0000269|PubMed:9521425, ECO:0000269|Ref.10}. Note=The disease is
CC       caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Tricho-rhino-phalangeal syndrome 2 (TRPS2) [MIM:150230]: A
CC       syndrome that combines the clinical features of tricho-rhino-phalangeal
CC       syndrome type 1 and multiple exostoses type 1. Affected individuals
CC       manifest multiple dysmorphic facial features including large, laterally
CC       protruding ears, a bulbous nose, an elongated upper lip, as well as
CC       sparse scalp hair, winged scapulae, multiple cartilaginous exostoses,
CC       redundant skin, and mental retardation. Note=The gene represented in
CC       this entry is involved in disease pathogenesis. A chromosomal
CC       aberration resulting in the loss of functional copies of TRPS1 and EXT1
CC       has been found in TRPS2 patients.
CC   -!- DISEASE: Chondrosarcoma (CHDSA) [MIM:215300]: A malignant neoplasm
CC       derived from cartilage cells. Chondrosarcomas range from slow-growing
CC       non-metastasizing lesions to highly aggressive metastasizing sarcomas.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the glycosyltransferase 47 family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/EXT1ID212.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S79639; AAB62283.1; -; mRNA.
DR   EMBL; AK313129; BAG35949.1; -; mRNA.
DR   EMBL; CH471060; EAW91972.1; -; Genomic_DNA.
DR   EMBL; BC001174; AAH01174.1; -; mRNA.
DR   EMBL; U70539; AAC51154.1; -; Genomic_DNA.
DR   CCDS; CCDS6324.1; -.
DR   RefSeq; NP_000118.2; NM_000127.2.
DR   SMR; Q16394; -.
DR   BioGrid; 108432; 31.
DR   CORUM; Q16394; -.
DR   IntAct; Q16394; 20.
DR   STRING; 9606.ENSP00000367446; -.
DR   CAZy; GT47; Glycosyltransferase Family 47.
DR   CAZy; GT64; Glycosyltransferase Family 64.
DR   iPTMnet; Q16394; -.
DR   PhosphoSitePlus; Q16394; -.
DR   BioMuta; EXT1; -.
DR   DMDM; 20141422; -.
DR   EPD; Q16394; -.
DR   MassIVE; Q16394; -.
DR   MaxQB; Q16394; -.
DR   PaxDb; Q16394; -.
DR   PeptideAtlas; Q16394; -.
DR   PRIDE; Q16394; -.
DR   ProteomicsDB; 60869; -.
DR   Antibodypedia; 26732; 231 antibodies.
DR   DNASU; 2131; -.
DR   Ensembl; ENST00000378204; ENSP00000367446; ENSG00000182197.
DR   GeneID; 2131; -.
DR   KEGG; hsa:2131; -.
DR   UCSC; uc003yok.3; human.
DR   CTD; 2131; -.
DR   DisGeNET; 2131; -.
DR   GeneCards; EXT1; -.
DR   GeneReviews; EXT1; -.
DR   HGNC; HGNC:3512; EXT1.
DR   HPA; ENSG00000182197; Tissue enhanced (liver).
DR   MalaCards; EXT1; -.
DR   MIM; 133700; phenotype.
DR   MIM; 150230; phenotype.
DR   MIM; 215300; phenotype.
DR   MIM; 608177; gene.
DR   neXtProt; NX_Q16394; -.
DR   OpenTargets; ENSG00000182197; -.
DR   Orphanet; 55880; Chondrosarcoma.
DR   Orphanet; 321; Multiple osteochondromas.
DR   Orphanet; 502; Trichorhinophalangeal syndrome type 2.
DR   PharmGKB; PA27924; -.
DR   eggNOG; KOG1021; Eukaryota.
DR   eggNOG; ENOG410XTFH; LUCA.
DR   GeneTree; ENSGT00940000155321; -.
DR   HOGENOM; CLU_013906_4_0_1; -.
DR   InParanoid; Q16394; -.
DR   KO; K02366; -.
DR   OMA; SHYWDDS; -.
DR   OrthoDB; 436779at2759; -.
DR   PhylomeDB; Q16394; -.
DR   TreeFam; TF314231; -.
DR   BioCyc; MetaCyc:HS00012-MONOMER; -.
DR   BRENDA; 2.4.1.224; 2681.
DR   BRENDA; 2.4.1.225; 2681.
DR   Reactome; R-HSA-2022928; HS-GAG biosynthesis.
DR   Reactome; R-HSA-3656237; Defective EXT2 causes exostoses 2.
DR   Reactome; R-HSA-3656253; Defective EXT1 causes exostoses 1, TRPS2 and CHDS.
DR   SIGNOR; Q16394; -.
DR   UniPathway; UPA00378; -.
DR   ChiTaRS; EXT1; human.
DR   GeneWiki; EXT1; -.
DR   GenomeRNAi; 2131; -.
DR   Pharos; Q16394; Tbio.
DR   PRO; PR:Q16394; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q16394; protein.
DR   Bgee; ENSG00000182197; Expressed in thoracic aorta and 233 other tissues.
DR   ExpressionAtlas; Q16394; baseline and differential.
DR   Genevisible; Q16394; HS.
DR   GO; GO:0005783; C:endoplasmic reticulum; IDA:BHF-UCL.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; TAS:ProtInc.
DR   GO; GO:0005794; C:Golgi apparatus; IDA:BHF-UCL.
DR   GO; GO:0000139; C:Golgi membrane; TAS:BHF-UCL.
DR   GO; GO:0030176; C:integral component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; TAS:ProtInc.
DR   GO; GO:0008375; F:acetylglucosaminyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0050508; F:glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0015020; F:glucuronosyltransferase activity; IDA:BHF-UCL.
DR   GO; GO:0042328; F:heparan sulfate N-acetylglucosaminyltransferase activity; NAS:BHF-UCL.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0050509; F:N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:BHF-UCL.
DR   GO; GO:0016757; F:transferase activity, transferring glycosyl groups; IDA:BHF-UCL.
DR   GO; GO:0007411; P:axon guidance; IEA:Ensembl.
DR   GO; GO:0033692; P:cellular polysaccharide biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0072498; P:embryonic skeletal joint development; IEA:Ensembl.
DR   GO; GO:0007492; P:endoderm development; IEA:Ensembl.
DR   GO; GO:0007369; P:gastrulation; IEA:Ensembl.
DR   GO; GO:0006024; P:glycosaminoglycan biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015012; P:heparan sulfate proteoglycan biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0015014; P:heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process; IMP:BHF-UCL.
DR   GO; GO:0007498; P:mesoderm development; IEA:Ensembl.
DR   GO; GO:0021772; P:olfactory bulb development; IEA:Ensembl.
DR   GO; GO:0001503; P:ossification; IMP:BHF-UCL.
DR   GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0001501; P:skeletal system development; TAS:ProtInc.
DR   Gene3D; 3.90.550.10; -; 1.
DR   InterPro; IPR004263; Exostosin.
DR   InterPro; IPR027670; Exostosin-1.
DR   InterPro; IPR040911; Exostosin_GT47.
DR   InterPro; IPR015338; GT64.
DR   InterPro; IPR029044; Nucleotide-diphossugar_trans.
DR   PANTHER; PTHR11062; PTHR11062; 1.
DR   PANTHER; PTHR11062:SF97; PTHR11062:SF97; 1.
DR   Pfam; PF03016; Exostosin; 1.
DR   Pfam; PF09258; Glyco_transf_64; 1.
DR   SUPFAM; SSF53448; SSF53448; 1.
PE   1: Evidence at protein level;
KW   Disease mutation; Disulfide bond; Endoplasmic reticulum; Glycoprotein;
KW   Glycosyltransferase; Golgi apparatus; Hereditary multiple exostoses;
KW   Manganese; Membrane; Metal-binding; Reference proteome; Signal-anchor;
KW   Transferase; Transmembrane; Transmembrane helix; Tumor suppressor.
FT   CHAIN           1..746
FT                   /note="Exostosin-1"
FT                   /id="PRO_0000149648"
FT   TOPO_DOM        1..7
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        8..28
FT                   /note="Helical; Signal-anchor for type II membrane protein"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        29..746
FT                   /note="Lumenal"
FT                   /evidence="ECO:0000255"
FT   REGION          544..549
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   REGION          565..567
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   REGION          650..654
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   REGION          688..701
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   ACT_SITE        654
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   METAL           567
FT                   /note="Manganese; catalytic"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   BINDING         518
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   BINDING         595
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   CARBOHYD        89
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        330
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        652..704
FT                   /evidence="ECO:0000250|UniProtKB:Q9ES89"
FT   VARIANT         27
FT                   /note="Q -> K (in EXT1; no loss of activity)"
FT                   /id="VAR_012815"
FT   VARIANT         164
FT                   /note="D -> H (in EXT1; loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:10441575"
FT                   /id="VAR_012816"
FT   VARIANT         215..222
FT                   /note="MLAKASIS -> I (in isolated osteochondroma; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:11169766"
FT                   /id="VAR_012818"
FT   VARIANT         215..221
FT                   /note="Missing (in EXT1)"
FT                   /id="VAR_012817"
FT   VARIANT         235..239
FT                   /note="Missing (in multiple osteochondromas)"
FT                   /evidence="ECO:0000269|PubMed:10441575"
FT                   /id="VAR_012819"
FT   VARIANT         280
FT                   /note="R -> G (in EXT1; loss of activity;
FT                   dbSNP:rs1554601483)"
FT                   /evidence="ECO:0000269|PubMed:9463333,
FT                   ECO:0000269|PubMed:9521425, ECO:0000269|Ref.10"
FT                   /id="VAR_002370"
FT   VARIANT         280
FT                   /note="R -> S (in EXT1; loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:9521425"
FT                   /id="VAR_002371"
FT   VARIANT         316
FT                   /note="N -> S (in chondrosarcoma; no loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:10441575"
FT                   /id="VAR_012820"
FT   VARIANT         339
FT                   /note="G -> D (in EXT1; loss of activity;
FT                   dbSNP:rs119103288)"
FT                   /evidence="ECO:0000269|PubMed:9326317"
FT                   /id="VAR_002372"
FT   VARIANT         340
FT                   /note="R -> C (in EXT1; loss of activity; still able to
FT                   form an oligomeric complex; dbSNP:rs119103290)"
FT                   /evidence="ECO:0000269|PubMed:9326317"
FT                   /id="VAR_002373"
FT   VARIANT         340
FT                   /note="R -> H (in EXT1; loss of activity;
FT                   dbSNP:rs119103287)"
FT                   /evidence="ECO:0000269|PubMed:9521425, ECO:0000269|Ref.10"
FT                   /id="VAR_002374"
FT   VARIANT         340
FT                   /note="R -> L (in EXT1; loss of activity;
FT                   dbSNP:rs119103287)"
FT                   /evidence="ECO:0000269|PubMed:8981950"
FT                   /id="VAR_002375"
FT   VARIANT         340
FT                   /note="R -> S (in EXT1; loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:9463333"
FT                   /id="VAR_002376"
FT   VARIANT         486
FT                   /note="A -> V (in EXT1; no loss of activity;
FT                   dbSNP:rs188859975)"
FT                   /evidence="ECO:0000269|PubMed:10480354"
FT                   /id="VAR_012821"
FT   VARIANT         496
FT                   /note="P -> L (in EXT1; no loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:10480354"
FT                   /id="VAR_012822"
FT   VARIANT         627
FT                   /note="Missing (in EXT1; loss of activity)"
FT                   /evidence="ECO:0000269|PubMed:9521425"
FT                   /id="VAR_002377"
FT   MUTAGEN         27
FT                   /note="Q->A,P: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         27
FT                   /note="Missing: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         164
FT                   /note="D->E: Abolishes heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         164
FT                   /note="Missing: Abolishes heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         316
FT                   /note="N->A: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         316
FT                   /note="Missing: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         486
FT                   /note="A->H: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         486
FT                   /note="Missing: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         496
FT                   /note="P->H: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   MUTAGEN         496
FT                   /note="Missing: No effect on heparan-sulfate biosynthesis."
FT                   /evidence="ECO:0000269|PubMed:11391482"
FT   CONFLICT        60..61
FT                   /note="DA -> EP (in Ref. 1 and 3)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   746 AA;  86255 MW;  842CD7E6C1312C1A CRC64;
     MQAKKRYFIL LSAGSCLALL FYFGGLQFRA SRSHSRREEH SGRNGLHHPS PDHFWPRFPD
     ALRPFVPWDQ LENEDSSVHI SPRQKRDANS SIYKGKKCRM ESCFDFTLCK KNGFKVYVYP
     QQKGEKIAES YQNILAAIEG SRFYTSDPSQ ACLFVLSLDT LDRDQLSPQY VHNLRSKVQS
     LHLWNNGRNH LIFNLYSGTW PDYTEDVGFD IGQAMLAKAS ISTENFRPNF DVSIPLFSKD
     HPRTGGERGF LKFNTIPPLR KYMLVFKGKR YLTGIGSDTR NALYHVHNGE DVVLLTTCKH
     GKDWQKHKDS RCDRDNTEYE KYDYREMLHN ATFCLVPRGR RLGSFRFLEA LQAACVPVML
     SNGWELPFSE VINWNQAAVI GDERLLLQIP STIRSIHQDK ILALRQQTQF LWEAYFSSVE
     KIVLTTLEII QDRIFKHISR NSLIWNKHPG GLFVLPQYSS YLGDFPYYYA NLGLKPPSKF
     TAVIHAVTPL VSQSQPVLKL LVAAAKSQYC AQIIVLWNCD KPLPAKHRWP ATAVPVVVIE
     GESKVMSSRF LPYDNIITDA VLSLDEDTVL STTEVDFAFT VWQSFPERIV GYPARSHFWD
     NSKERWGYTS KWTNDYSMVL TGAAIYHKYY HYLYSHYLPA SLKNMVDQLA NCEDILMNFL
     VSAVTKLPPI KVTQKKQYKE TMMGQTSRAS RWADPDHFAQ RQSCMNTFAS WFGYMPLIHS
     QMRLDPVLFK DQVSILRKKY RDIERL
//
ID   A0A024R366_HUMAN        Unreviewed;       147 AA.
AC   A0A024R366;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 39.
DE   RecName: Full=Bis(5'-adenosyl)-triphosphatase {ECO:0000256|RuleBase:RU366076};
DE            EC=3.6.1.29 {ECO:0000256|RuleBase:RU366076};
GN   Name=FHIT {ECO:0000313|EMBL:EAW65394.1};
GN   ORFNames=hCG_1997982 {ECO:0000313|EMBL:EAW65394.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW65394.1};
RN   [1] {ECO:0000313|EMBL:EAW65394.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW65394.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + P(1),P(3)-bis(5'-adenosyl) triphosphate = ADP + AMP + 2
CC         H(+); Xref=Rhea:RHEA:13893, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:58529, ChEBI:CHEBI:456215, ChEBI:CHEBI:456216;
CC         EC=3.6.1.29; Evidence={ECO:0000256|RuleBase:RU366076};
CC   -!- COFACTOR:
CC       Name=Mn(2+); Xref=ChEBI:CHEBI:29035;
CC         Evidence={ECO:0000256|RuleBase:RU366076};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471055; EAW65394.1; -; Genomic_DNA.
DR   RefSeq; NP_001159715.1; NM_001166243.2.
DR   RefSeq; NP_001307828.1; NM_001320899.1.
DR   RefSeq; NP_001307829.1; NM_001320900.1.
DR   RefSeq; NP_002003.1; NM_002012.3.
DR   SMR; A0A024R366; -.
DR   PRIDE; A0A024R366; -.
DR   Antibodypedia; 3636; 581 antibodies.
DR   GeneID; 2272; -.
DR   KEGG; hsa:2272; -.
DR   CTD; 2272; -.
DR   EuPathDB; HostDB:ENSG00000189283.9; -.
DR   eggNOG; KOG3379; Eukaryota.
DR   eggNOG; COG0537; LUCA.
DR   HOGENOM; CLU_056776_7_1_1; -.
DR   KO; K01522; -.
DR   OMA; VHTHIIP; -.
DR   OrthoDB; 1198291at2759; -.
DR   PhylomeDB; A0A024R366; -.
DR   ChiTaRS; FHIT; human.
DR   GenomeRNAi; 2272; -.
DR   Bgee; ENSG00000189283; Expressed in pigmented layer of retina and 130 other tissues.
DR   ExpressionAtlas; A0A024R366; baseline and differential.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0047710; F:bis(5'-adenosyl)-triphosphatase activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   CDD; cd01275; FHIT; 1.
DR   Gene3D; 3.30.428.10; -; 1.
DR   InterPro; IPR039383; FHIT.
DR   InterPro; IPR019808; Histidine_triad_CS.
DR   InterPro; IPR001310; Histidine_triad_HIT.
DR   InterPro; IPR011146; HIT-like.
DR   InterPro; IPR036265; HIT-like_sf.
DR   Pfam; PF01230; HIT; 1.
DR   SUPFAM; SSF54197; SSF54197; 1.
DR   PROSITE; PS00892; HIT_1; 1.
DR   PROSITE; PS51084; HIT_2; 1.
PE   4: Predicted;
KW   Hydrolase {ECO:0000256|RuleBase:RU366076};
KW   Nucleotide-binding {ECO:0000256|RuleBase:RU366076}.
FT   DOMAIN          2..109
FT                   /note="HIT"
FT                   /evidence="ECO:0000259|PROSITE:PS51084"
FT   MOTIF           94..98
FT                   /note="Histidine triad motif"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00464"
SQ   SEQUENCE   147 AA;  16858 MW;  14D85961A19ECF3E CRC64;
     MSFRFGQHLI KPSVVFLKTE LSFALVNRKP VVPGHVLVCP LRPVERFHDL RPDEVADLFQ
     TTQRVGTVVE KHFHGTSLTF SMQDGPEAGQ TVKHVHVHVL PRKAGDFHRN DSIYEELQKH
     DKEDFPASWR SEEEMAAEAA ALRVYFQ
//
ID   FHIT_HUMAN              Reviewed;         147 AA.
AC   P49789; A2IAS9; A2IAT0; A2IAT6; A8K1A9; Q45QG9; Q6IU12;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-APR-2020, entry version 182.
DE   RecName: Full=Bis(5'-adenosyl)-triphosphatase;
DE            EC=3.6.1.29;
DE   AltName: Full=AP3A hydrolase;
DE            Short=AP3Aase;
DE   AltName: Full=Diadenosine 5',5'''-P1,P3-triphosphate hydrolase;
DE   AltName: Full=Dinucleosidetriphosphatase;
DE   AltName: Full=Fragile histidine triad protein;
GN   Name=FHIT;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA].
RX   PubMed=8598045; DOI=10.1016/s0092-8674(00)81034-x;
RA   Ohta M., Inoue H., Cotticelli M.G., Kastury K., Baffa R., Palazzo J.,
RA   Siprashvili Z., Mori M., McCue P., Druck T., Croce C.M., Huebner K.;
RT   "The FHIT gene, spanning the chromosome 3p14.2 fragile site and renal
RT   carcinoma-associated t(3;8) breakpoint, is abnormal in digestive tract
RT   cancers.";
RL   Cell 84:587-597(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=9012482;
RA   Druck T., Hadaczek P., Fu T.B., Ohta M., Siprashvili Z., Baffa R.,
RA   Negrini M., Kastury K., Veronese M.L., Rosen D., Rothstein J., McCue P.,
RA   Cotticelli M.G., Inoue H., Croce C.M., Huebner K.;
RT   "Structure and expression of the human FHIT gene in normal and tumor
RT   cells.";
RL   Cancer Res. 57:504-512(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=24722188; DOI=10.1038/ncomms4650;
RA   Corominas R., Yang X., Lin G.N., Kang S., Shen Y., Ghamsari L., Broly M.,
RA   Rodriguez M., Tam S., Wanamaker S.A., Fan C., Yi S., Tasan M., Lemmens I.,
RA   Kuang X., Zhao N., Malhotra D., Michaelson J.J., Vacic V., Calderwood M.A.,
RA   Roth F.P., Tavernier J., Horvath S., Salehi-Ashtiani K., Korkin D.,
RA   Sebat J., Hill D.E., Hao T., Vidal M., Iakoucheva L.M.;
RT   "Protein interaction network of alternatively spliced isoforms from brain
RT   links genetic risk factors for autism.";
RL   Nat. Commun. 5:3650-3650(2014).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF
RP   94-146.
RA   Naqvi S.R.A., Malik A., Kukreti H., Chaudhary A., Anand R., Deo S.S.,
RA   Shukla N.K., Husain S.A., Pasha S.T.;
RT   "Mutational analysis of FHIT gene.";
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-35; HIS-94; HIS-96 AND
RP   HIS-98.
RX   PubMed=8794732; DOI=10.1021/bi961415t;
RA   Barnes L.D., Garrison P.N., Siprashvili Z., Guranowski A., Robinson A.K.,
RA   Ingram S.W., Croce C.M., Ohta M., Huebner K.;
RT   "Fhit, a putative tumor suppressor in humans, is a dinucleoside 5',5''-
RT   P1,P3-triphosphate hydrolase.";
RL   Biochemistry 35:11529-11535(1996).
RN   [9]
RP   CHROMOSOMAL TRANSLOCATION WITH RNF139.
RX   PubMed=9689122; DOI=10.1073/pnas.95.16.9572;
RA   Gemmill R.M., West J.D., Boldog F., Tanaka N., Robinson L.J., Smith D.I.,
RA   Li F., Drabkin H.A.;
RT   "The hereditary renal cell carcinoma 3;8 translocation fuses FHIT to a
RT   patched-related gene, TRC8.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:9572-9577(1998).
RN   [10]
RP   INTERACTION WITH UBE2I.
RX   PubMed=11085938; DOI=10.1042/bj3520443;
RA   Shi Y., Zou M., Farid N.R., Paterson M.C.;
RT   "Association of FHIT (fragile histidine triad), a candidate tumour
RT   suppressor gene, with the ubiquitin-conjugating enzyme hUBC9.";
RL   Biochem. J. 352:443-448(2000).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, AND MUTAGENESIS OF ILE-10; LEU-25 AND HIS-96.
RX   PubMed=12574506; DOI=10.1073/pnas.0437915100;
RA   Trapasso F., Krakowiak A., Cesari R., Arkles J., Yendamuri S., Ishii H.,
RA   Vecchione A., Kuroki T., Bieganowski P., Pace H.C., Huebner K., Croce C.M.,
RA   Brenner C.;
RT   "Designed FHIT alleles establish that Fhit-induced apoptosis in cancer
RT   cells is limited by substrate binding.";
RL   Proc. Natl. Acad. Sci. U.S.A. 100:1592-1597(2003).
RN   [12]
RP   ACTIVE SITE, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-96.
RX   PubMed=15182206; DOI=10.1021/bi049762n;
RA   Huang K., Arabshahi A., Wei Y., Frey P.A.;
RT   "The mechanism of action of the fragile histidine triad, Fhit: isolation of
RT   a covalent adenylyl enzyme and chemical rescue of H96G-Fhit.";
RL   Biochemistry 43:7637-7642(2004).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH MDM2.
RX   PubMed=15313915; DOI=10.1158/0008-5472.can-04-0195;
RA   Nishizaki M., Sasaki J., Fang B., Atkinson E.N., Minna J.D., Roth J.A.,
RA   Ji L.;
RT   "Synergistic tumor suppression by coexpression of FHIT and p53 coincides
RT   with FHIT-mediated MDM2 inactivation and p53 stabilization in human non-
RT   small cell lung cancer cells.";
RL   Cancer Res. 64:5745-5752(2004).
RN   [14]
RP   PHOSPHORYLATION BY SRC, SUBUNIT, SUBCELLULAR LOCATION, MASS SPECTROMETRY,
RP   DISEASE, PHOSPHORYLATION AT TYR-114 AND TYR-145, AND MUTAGENESIS OF TYR-114
RP   AND TYR-145.
RX   PubMed=15007172; DOI=10.1073/pnas.0400481101;
RA   Pekarsky Y., Garrison P.N., Palamarchuk A., Zanesi N., Aqeilan R.I.,
RA   Huebner K., Barnes L.D., Croce C.M.;
RT   "Fhit is a physiological target of the protein kinase Src.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:3775-3779(2004).
RN   [15]
RP   MUTAGENESIS OF TYR-114, AND FUNCTION.
RX   PubMed=16407838; DOI=10.1038/sj.onc.1209323;
RA   Semba S., Trapasso F., Fabbri M., McCorkell K.A., Volinia S., Druck T.,
RA   Iliopoulos D., Pekarsky Y., Ishii H., Garrison P.N., Barnes L.D.,
RA   Croce C.M., Huebner K.;
RT   "Fhit modulation of the Akt-survivin pathway in lung cancer cells: Fhit-
RT   tyrosine 114 (Y114) is essential.";
RL   Oncogene 25:2860-2872(2006).
RN   [16]
RP   INTERACTION WITH CTNNB1, IDENTIFICATION IN A COMPLEX WITH CTNNB1 AND LEF1,
RP   AND FUNCTION.
RX   PubMed=18077326; DOI=10.1073/pnas.0703664105;
RA   Weiske J., Albring K.F., Huber O.;
RT   "The tumor suppressor Fhit acts as a repressor of beta-catenin
RT   transcriptional activity.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20344-20349(2007).
RN   [17]
RP   SUBCELLULAR LOCATION, AND FUNCTION IN APOPTOSIS.
RX   PubMed=19622739; DOI=10.1073/pnas.0906484106;
RA   Rimessi A., Marchi S., Fotino C., Romagnoli A., Huebner K., Croce C.M.,
RA   Pinton P., Rizzuto R.;
RT   "Intramitochondrial calcium regulation by the FHIT gene product sensitizes
RT   to apoptosis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:12753-12758(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS).
RX   PubMed=9261067; DOI=10.1016/s0969-2126(97)00231-1;
RA   Lima C.D., D'Amico K.L., Naday I., Rosenbaum G., Westbrook E.M.,
RA   Hendrickson W.A.;
RT   "MAD analysis of FHIT, a putative human tumor suppressor from the HIT
RT   protein family.";
RL   Structure 5:763-774(1997).
RN   [20]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) IN COMPLEXES WITH SUBSTRATES,
RP   CATALYTIC ACTIVITY, FUNCTION, SUBUNIT, AND ACTIVE SITE.
RX   PubMed=9323207; DOI=10.1126/science.278.5336.286;
RA   Lima C.D., Klein M.G., Hendrickson W.A.;
RT   "Structure-based analysis of catalysis and substrate definition in the HIT
RT   protein family.";
RL   Science 278:286-290(1997).
RN   [21]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) IN COMPLEXES WITH SUBSTRATE ANALOGS,
RP   SUBUNIT, CATALYTIC ACTIVITY, AND MUTAGENESIS OF HIS-96.
RX   PubMed=9576908; DOI=10.1073/pnas.95.10.5484;
RA   Pace H.C., Garrison P.N., Robinson A.K., Barnes L.D., Draganescu A.,
RA   Roesler A., Blackburn G.M., Siprashvili Z., Croce C.M., Huebner K.,
RA   Brenner C.;
RT   "Genetic, biochemical, and crystallographic characterization of Fhit-
RT   substrate complexes as the active signaling form of Fhit.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:5484-5489(1998).
CC   -!- FUNCTION: Cleaves P(1)-P(3)-bis(5'-adenosyl) triphosphate (Ap3A) to
CC       yield AMP and ADP. Can also hydrolyze P(1)-P(4)-bis(5'-adenosyl)
CC       tetraphosphate (Ap4A), but has extremely low activity with ATP.
CC       Modulates transcriptional activation by CTNNB1 and thereby contributes
CC       to regulate the expression of genes essential for cell proliferation
CC       and survival, such as CCND1 and BIRC5. Plays a role in the induction of
CC       apoptosis via SRC and AKT1 signaling pathways. Inhibits MDM2-mediated
CC       proteasomal degradation of p53/TP53 and thereby plays a role in
CC       p53/TP53-mediated apoptosis. Induction of apoptosis depends on the
CC       ability of FHIT to bind P(1)-P(3)-bis(5'-adenosyl) triphosphate or
CC       related compounds, but does not require its catalytic activity, it may
CC       in part come from the mitochondrial form, which sensitizes the low-
CC       affinity Ca(2+) transporters, enhancing mitochondrial calcium uptake.
CC       Functions as tumor suppressor. {ECO:0000269|PubMed:12574506,
CC       ECO:0000269|PubMed:15313915, ECO:0000269|PubMed:16407838,
CC       ECO:0000269|PubMed:18077326, ECO:0000269|PubMed:19622739,
CC       ECO:0000269|PubMed:8794732, ECO:0000269|PubMed:9323207}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + P(1),P(3)-bis(5'-adenosyl) triphosphate = ADP + AMP + 2
CC         H(+); Xref=Rhea:RHEA:13893, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:58529, ChEBI:CHEBI:456215, ChEBI:CHEBI:456216;
CC         EC=3.6.1.29; Evidence={ECO:0000269|PubMed:12574506,
CC         ECO:0000269|PubMed:15182206, ECO:0000269|PubMed:8794732,
CC         ECO:0000269|PubMed:9323207, ECO:0000269|PubMed:9576908};
CC   -!- SUBUNIT: Homodimer. Interacts with UBE2I. Interacts with MDM2.
CC       Interacts with CTNNB1. Identified in a complex with CTNNB1 and LEF1.
CC       {ECO:0000269|PubMed:11085938, ECO:0000269|PubMed:15007172,
CC       ECO:0000269|PubMed:15313915, ECO:0000269|PubMed:18077326,
CC       ECO:0000269|PubMed:9323207, ECO:0000269|PubMed:9576908}.
CC   -!- INTERACTION:
CC       P49789; P49789; NbExp=13; IntAct=EBI-741760, EBI-741760;
CC       P49789; P35222: CTNNB1; NbExp=4; IntAct=EBI-741760, EBI-491549;
CC       P49789; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-741760, EBI-742054;
CC       P49789; Q9UJU2: LEF1; NbExp=2; IntAct=EBI-741760, EBI-926131;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm. Mitochondrion. Nucleus.
CC   -!- TISSUE SPECIFICITY: Low levels expressed in all tissues tested.
CC       Phospho-FHIT observed in liver and kidney, but not in brain and lung.
CC       Phospho-FHIT undetected in all tested human tumor cell lines.
CC   -!- PTM: Phosphorylation at Tyr-114 by SRC is required for induction of
CC       apoptosis. {ECO:0000269|PubMed:15007172}.
CC   -!- MASS SPECTROMETRY: Mass=16733; Method=MALDI;
CC       Evidence={ECO:0000269|PubMed:15007172};
CC   -!- DISEASE: Note=A chromosomal aberration involving FHIT has been found in
CC       a lymphoblastoid cell line established from a family with renal cell
CC       carcinoma and thyroid carcinoma. Translocation t(3;8)(p14.2;q24.1) with
CC       RNF139. Although the 3p14.2 breakpoint has been shown to interrupt FHIT
CC       in its 5-prime non-coding region, it is unlikely that FHIT is causally
CC       related to renal or other malignancies. {ECO:0000269|PubMed:15007172}.
CC   -!- DISEASE: Note=Associated with digestive tract cancers. Numerous tumor
CC       types are found to have aberrant forms of FHIT protein due to deletions
CC       in a coding region of chromosome 3p14.2 including the fragile site
CC       locus FRA3B. {ECO:0000269|PubMed:15007172}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FHITID192ch3p14.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U46922; AAA99013.1; -; mRNA.
DR   EMBL; U76271; AAB52539.1; -; Genomic_DNA.
DR   EMBL; U76267; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; U76268; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; U76269; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; U76270; AAB52539.1; JOINED; Genomic_DNA.
DR   EMBL; KJ534835; AHW56475.1; -; mRNA.
DR   EMBL; AY625256; AAT37530.1; -; Genomic_DNA.
DR   EMBL; DQ120721; AAZ23623.1; -; mRNA.
DR   EMBL; EF186677; ABM65879.1; -; Genomic_DNA.
DR   EMBL; EF183457; ABM66086.1; -; Genomic_DNA.
DR   EMBL; EF183458; ABM66087.1; -; Genomic_DNA.
DR   EMBL; EF183459; ABM66088.1; -; Genomic_DNA.
DR   EMBL; EF183461; ABM66090.1; -; Genomic_DNA.
DR   EMBL; EF183464; ABM66093.1; -; Genomic_DNA.
DR   EMBL; AK289824; BAF82513.1; -; mRNA.
DR   EMBL; CH471055; EAW65393.1; -; Genomic_DNA.
DR   EMBL; BC032336; AAH32336.1; -; mRNA.
DR   CCDS; CCDS2894.1; -.
DR   PIR; A58802; A58802.
DR   RefSeq; NP_001159715.1; NM_001166243.2.
DR   RefSeq; NP_001307828.1; NM_001320899.1.
DR   RefSeq; NP_001307829.1; NM_001320900.1.
DR   RefSeq; NP_002003.1; NM_002012.3.
DR   PDB; 1FHI; X-ray; 3.10 A; A=1-147.
DR   PDB; 1FIT; X-ray; 1.85 A; A=1-147.
DR   PDB; 2FHI; X-ray; 2.60 A; A=1-147.
DR   PDB; 2FIT; X-ray; 1.90 A; A=1-147.
DR   PDB; 3FIT; X-ray; 2.40 A; A=1-147.
DR   PDB; 4FIT; X-ray; 2.50 A; A=1-147.
DR   PDB; 5FIT; X-ray; 2.30 A; A=1-147.
DR   PDB; 6FIT; X-ray; 2.60 A; A=1-147.
DR   PDBsum; 1FHI; -.
DR   PDBsum; 1FIT; -.
DR   PDBsum; 2FHI; -.
DR   PDBsum; 2FIT; -.
DR   PDBsum; 3FIT; -.
DR   PDBsum; 4FIT; -.
DR   PDBsum; 5FIT; -.
DR   PDBsum; 6FIT; -.
DR   SMR; P49789; -.
DR   BioGrid; 108563; 14.
DR   DIP; DIP-29947N; -.
DR   IntAct; P49789; 9.
DR   STRING; 9606.ENSP00000417480; -.
DR   BindingDB; P49789; -.
DR   ChEMBL; CHEMBL1795151; -.
DR   DrugBank; DB02373; Adenosine monotungstate.
DR   DrugBank; DB04389; Ado-P-Ch2-P-Ps-Ado.
DR   DrugBank; DB04173; Fructose.
DR   iPTMnet; P49789; -.
DR   PhosphoSitePlus; P49789; -.
DR   BioMuta; FHIT; -.
DR   DMDM; 1706794; -.
DR   EPD; P49789; -.
DR   jPOST; P49789; -.
DR   MassIVE; P49789; -.
DR   PaxDb; P49789; -.
DR   PeptideAtlas; P49789; -.
DR   PRIDE; P49789; -.
DR   ProteomicsDB; 56119; -.
DR   Antibodypedia; 3636; 581 antibodies.
DR   DNASU; 2272; -.
DR   Ensembl; ENST00000468189; ENSP00000417480; ENSG00000189283.
DR   Ensembl; ENST00000476844; ENSP00000417557; ENSG00000189283.
DR   Ensembl; ENST00000492590; ENSP00000418582; ENSG00000189283.
DR   GeneID; 2272; -.
DR   KEGG; hsa:2272; -.
DR   UCSC; uc003dkx.5; human.
DR   CTD; 2272; -.
DR   DisGeNET; 2272; -.
DR   GeneCards; FHIT; -.
DR   HGNC; HGNC:3701; FHIT.
DR   HPA; ENSG00000189283; Low tissue specificity.
DR   MalaCards; FHIT; -.
DR   MIM; 601153; gene.
DR   neXtProt; NX_P49789; -.
DR   OpenTargets; ENSG00000189283; -.
DR   Orphanet; 422526; Hereditary clear cell renal cell carcinoma.
DR   PharmGKB; PA28140; -.
DR   eggNOG; KOG3379; Eukaryota.
DR   eggNOG; COG0537; LUCA.
DR   GeneTree; ENSGT00510000047967; -.
DR   HOGENOM; CLU_056776_7_1_1; -.
DR   KO; K01522; -.
DR   OMA; VHTHIIP; -.
DR   OrthoDB; 1198291at2759; -.
DR   PhylomeDB; P49789; -.
DR   TreeFam; TF105432; -.
DR   BRENDA; 3.6.1.29; 2681.
DR   SABIO-RK; P49789; -.
DR   SIGNOR; P49789; -.
DR   ChiTaRS; FHIT; human.
DR   EvolutionaryTrace; P49789; -.
DR   GeneWiki; FHIT; -.
DR   GenomeRNAi; 2272; -.
DR   Pharos; P49789; Tchem.
DR   PRO; PR:P49789; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P49789; protein.
DR   Bgee; ENSG00000189283; Expressed in pigmented layer of retina and 130 other tissues.
DR   ExpressionAtlas; P49789; baseline and differential.
DR   Genevisible; P49789; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0001650; C:fibrillar center; IDA:HPA.
DR   GO; GO:0005739; C:mitochondrion; IEA:UniProtKB-SubCell.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0047710; F:bis(5'-adenosyl)-triphosphatase activity; IDA:UniProtKB.
DR   GO; GO:0003824; F:catalytic activity; TAS:ProtInc.
DR   GO; GO:0016787; F:hydrolase activity; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0000166; F:nucleotide binding; IEA:UniProtKB-KW.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0072332; P:intrinsic apoptotic signaling pathway by p53 class mediator; IMP:UniProtKB.
DR   GO; GO:0032435; P:negative regulation of proteasomal ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:0009117; P:nucleotide metabolic process; TAS:ProtInc.
DR   GO; GO:0006163; P:purine nucleotide metabolic process; IDA:UniProtKB.
DR   CDD; cd01275; FHIT; 1.
DR   Gene3D; 3.30.428.10; -; 1.
DR   InterPro; IPR039383; FHIT.
DR   InterPro; IPR019808; Histidine_triad_CS.
DR   InterPro; IPR001310; Histidine_triad_HIT.
DR   InterPro; IPR011146; HIT-like.
DR   InterPro; IPR036265; HIT-like_sf.
DR   Pfam; PF01230; HIT; 1.
DR   SUPFAM; SSF54197; SSF54197; 1.
DR   PROSITE; PS00892; HIT_1; 1.
DR   PROSITE; PS51084; HIT_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Apoptosis; Chromosomal rearrangement; Cytoplasm; Hydrolase;
KW   Manganese; Mitochondrion; Nucleotide-binding; Nucleus; Phosphoprotein;
KW   Reference proteome; Transcription; Transcription regulation;
KW   Tumor suppressor.
FT   CHAIN           1..147
FT                   /note="Bis(5'-adenosyl)-triphosphatase"
FT                   /id="PRO_0000109789"
FT   DOMAIN          2..109
FT                   /note="HIT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00464"
FT   NP_BIND         89..92
FT                   /note="Substrate"
FT                   /evidence="ECO:0000244|PDB:5FIT,
FT                   ECO:0000269|PubMed:9323207"
FT   MOTIF           94..98
FT                   /note="Histidine triad motif"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00464"
FT   ACT_SITE        96
FT                   /note="Tele-AMP-histidine intermediate"
FT                   /evidence="ECO:0000269|PubMed:15182206,
FT                   ECO:0000269|PubMed:9323207"
FT   BINDING         8
FT                   /note="Substrate"
FT                   /evidence="ECO:0000244|PDB:3FIT,
FT                   ECO:0000269|PubMed:9261067"
FT   BINDING         27
FT                   /note="Substrate"
FT                   /evidence="ECO:0000244|PDB:5FIT,
FT                   ECO:0000269|PubMed:9323207"
FT   BINDING         83
FT                   /note="Substrate"
FT                   /evidence="ECO:0000244|PDB:5FIT,
FT                   ECO:0000269|PubMed:9323207"
FT   BINDING         98
FT                   /note="Substrate"
FT                   /evidence="ECO:0000244|PDB:5FIT,
FT                   ECO:0000269|PubMed:9323207"
FT   SITE            114
FT                   /note="Important for induction of apoptosis"
FT   MOD_RES         114
FT                   /note="Phosphotyrosine; by SRC"
FT                   /evidence="ECO:0000269|PubMed:15007172"
FT   MOD_RES         145
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000269|PubMed:15007172"
FT   MUTAGEN         10
FT                   /note="I->W: Strongly reduces affinity for substrates and
FT                   impairs apoptosis; when associated with W-25."
FT                   /evidence="ECO:0000269|PubMed:12574506"
FT   MUTAGEN         25
FT                   /note="L->W: Reduces affinity for substrates and impairs
FT                   apoptosis. Strongly reduces affinity for substrates and
FT                   impairs apoptosis; when associated with W-10."
FT                   /evidence="ECO:0000269|PubMed:12574506"
FT   MUTAGEN         35
FT                   /note="H->N: 50% decrease in catalytic activity. No loss in
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8794732"
FT   MUTAGEN         94
FT                   /note="H->N: 75% decrease in catalytic activity. No loss in
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:8794732"
FT   MUTAGEN         96
FT                   /note="H->D: Loss of catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:12574506,
FT                   ECO:0000269|PubMed:15182206, ECO:0000269|PubMed:8794732,
FT                   ECO:0000269|PubMed:9576908"
FT   MUTAGEN         96
FT                   /note="H->G: Total loss of catalytic activity. Rescuable
FT                   with free imidazole."
FT                   /evidence="ECO:0000269|PubMed:12574506,
FT                   ECO:0000269|PubMed:15182206, ECO:0000269|PubMed:8794732,
FT                   ECO:0000269|PubMed:9576908"
FT   MUTAGEN         96
FT                   /note="H->N: Total loss of catalytic activity. No loss in
FT                   substrate binding."
FT                   /evidence="ECO:0000269|PubMed:12574506,
FT                   ECO:0000269|PubMed:15182206, ECO:0000269|PubMed:8794732,
FT                   ECO:0000269|PubMed:9576908"
FT   MUTAGEN         98
FT                   /note="H->N: 98% decrease in catalytic activity."
FT                   /evidence="ECO:0000269|PubMed:8794732"
FT   MUTAGEN         114
FT                   /note="Y->A: Impairs induction of apoptosis. Strongly
FT                   reduced affinity for substrates."
FT                   /evidence="ECO:0000269|PubMed:15007172,
FT                   ECO:0000269|PubMed:16407838"
FT   MUTAGEN         114
FT                   /note="Y->D: Impairs induction of apoptosis. Reduces
FT                   affinity for substrates."
FT                   /evidence="ECO:0000269|PubMed:15007172,
FT                   ECO:0000269|PubMed:16407838"
FT   MUTAGEN         114
FT                   /note="Y->F: Loss of phosphorylation by SRC. Impairs
FT                   induction of apoptosis."
FT                   /evidence="ECO:0000269|PubMed:15007172,
FT                   ECO:0000269|PubMed:16407838"
FT   MUTAGEN         145
FT                   /note="Y->F: No effect on phosphorylation by SRC."
FT                   /evidence="ECO:0000269|PubMed:15007172"
FT   CONFLICT        146
FT                   /note="F -> S (in Ref. 5; BAF82513)"
FT                   /evidence="ECO:0000305"
FT   STRAND          3..5
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          8..10
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   HELIX           12..14
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          15..18
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          20..26
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          36..42
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   HELIX           47..49
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   HELIX           52..72
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          76..82
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   HELIX           86..88
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          92..94
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   STRAND          97..102
FT                   /evidence="ECO:0000244|PDB:1FIT"
FT   HELIX           132..144
FT                   /evidence="ECO:0000244|PDB:1FIT"
SQ   SEQUENCE   147 AA;  16858 MW;  14D85961A19ECF3E CRC64;
     MSFRFGQHLI KPSVVFLKTE LSFALVNRKP VVPGHVLVCP LRPVERFHDL RPDEVADLFQ
     TTQRVGTVVE KHFHGTSLTF SMQDGPEAGQ TVKHVHVHVL PRKAGDFHRN DSIYEELQKH
     DKEDFPASWR SEEEMAAEAA ALRVYFQ
//
ID   FUS_HUMAN               Reviewed;         526 AA.
AC   P35637; Q9H4A8;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 1.
DT   22-APR-2020, entry version 222.
DE   RecName: Full=RNA-binding protein FUS;
DE   AltName: Full=75 kDa DNA-pairing protein;
DE   AltName: Full=Oncogene FUS;
DE   AltName: Full=Oncogene TLS;
DE   AltName: Full=POMp75;
DE   AltName: Full=Translocated in liposarcoma protein;
GN   Name=FUS; Synonyms=TLS;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM LONG).
RX   PubMed=8510758; DOI=10.1038/363640a0;
RA   Crozat A., Aman P., Mandahl N., Ron D.;
RT   "Fusion of CHOP to a novel RNA-binding protein in human myxoid
RT   liposarcoma.";
RL   Nature 363:640-644(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SHORT), AND CHROMOSOMAL TRANSLOCATION
RP   WITH DDIT3.
RX   PubMed=7503811; DOI=10.1038/ng0693-175;
RA   Rabbitts T.H., Forster A., Larson R., Nathan P.;
RT   "Fusion of the dominant negative transcription regulator CHOP with a novel
RT   gene FUS by translocation t(12;16) in malignant liposarcoma.";
RL   Nat. Genet. 4:175-180(1993).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS LONG AND SHORT).
RX   PubMed=9795213; DOI=10.1016/s0378-1119(98)00463-6;
RA   Morohoshi F., Ootsuka Y., Arai K., Ichikawa H., Mitani S., Munakata N.,
RA   Ohki M.;
RT   "Genomic structure of the human RBP56/hTAFII68 and FUS/TLS genes.";
RL   Gene 221:191-198(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM LONG).
RC   TISSUE=Lung, and Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 85-310, CHROMOSOMAL TRANSLOCATION WITH ATF1,
RP   AND INVOLVEMENT IN AFH.
RX   PubMed=11063792; DOI=10.1016/s0165-4608(00)00237-5;
RA   Waters B.L., Panagopoulos I., Allen E.F.;
RT   "Genetic characterization of angiomatoid fibrous histiocytoma identifies
RT   fusion of the FUS and ATF-1 genes induced by a chromosomal translocation
RT   involving bands 12q13 and 16p11.";
RL   Cancer Genet. Cytogenet. 121:109-116(2000).
RN   [7]
RP   PROTEIN SEQUENCE OF 235-244; 307-312; 335-345 AND 349-357, FUNCTION, AND
RP   DNA-BINDING.
RX   PubMed=10567410; DOI=10.1074/jbc.274.48.34337;
RA   Baechtold H., Kuroda M., Sok J., Ron D., Lopez B.S., Akhmedov A.T.;
RT   "Human 75-kDa DNA-pairing protein is identical to the pro-oncoprotein
RT   TLS/FUS and is able to promote D-loop formation.";
RL   J. Biol. Chem. 274:34337-34342(1999).
RN   [8]
RP   PROTEIN SEQUENCE OF 265-276; 317-331 AND 335-357, AND IDENTIFICATION.
RX   PubMed=10442642; DOI=10.1038/sj.onc.1203048;
RA   Bertrand P., Akhmedov A.T., Delacote F., Durrbach A., Lopez B.S.;
RT   "Human POMp75 is identified as the pro-oncoprotein TLF/FUS: both POMp75 and
RT   POMp100 DNA homologous pairing activities are associated to cell
RT   proliferation.";
RL   Oncogene 18:4515-4521(1999).
RN   [9]
RP   PROTEIN SEQUENCE OF 349-357, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [10]
RP   CHROMOSOMAL TRANSLOCATION WITH ERG.
RX   PubMed=8187069;
RA   Ichikawa H., Shimizu K., Hayashi Y., Ohki M.;
RT   "An RNA-binding protein gene, TLS/FUS, is fused to ERG in human myeloid
RT   leukemia with t(16;21) chromosomal translocation.";
RL   Cancer Res. 54:2865-2868(1994).
RN   [11]
RP   INTERACTION WITH SF1.
RX   PubMed=9660765; DOI=10.1074/jbc.273.29.18086;
RA   Zhang D., Paley A.J., Childs G.;
RT   "The transcriptional repressor ZFM1 interacts with and modulates the
RT   ability of EWS to activate transcription.";
RL   J. Biol. Chem. 273:18086-18091(1998).
RN   [12]
RP   INTERACTION WITH SFRS13A.
RX   PubMed=9774382; DOI=10.1074/jbc.273.43.27761;
RA   Yang L., Embree L.J., Tsai S., Hickstein D.D.;
RT   "Oncoprotein TLS interacts with serine-arginine proteins involved in RNA
RT   splicing.";
RL   J. Biol. Chem. 273:27761-27764(1998).
RN   [13]
RP   METHYLATION AT ARG-242; ARG-244; ARG-248; ARG-251; ARG-259; ARG-377;
RP   ARG-383; ARG-386; ARG-388; ARG-394; ARG-407; ARG-473; ARG-476; ARG-481;
RP   ARG-485; ARG-487; ARG-491; ARG-495; ARG-498 AND ARG-503, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY.
RX   PubMed=12964758; DOI=10.1021/ac026283q;
RA   Rappsilber J., Friesen W.J., Paushkin S., Dreyfuss G., Mann M.;
RT   "Detection of arginine dimethylated peptides by parallel precursor ion
RT   scanning mass spectrometry in positive ion mode.";
RL   Anal. Chem. 75:3107-3114(2003).
RN   [14]
RP   INTERACTION WITH SARNP.
RX   PubMed=17196963; DOI=10.1016/j.yexcr.2006.11.014;
RA   Sugiura T., Sakurai K., Nagano Y.;
RT   "Intracellular characterization of DDX39, a novel growth-associated RNA
RT   helicase.";
RL   Exp. Cell Res. 313:782-790(2007).
RN   [15]
RP   INTERACTION WITH TDRD3.
RX   PubMed=18632687; DOI=10.1093/hmg/ddn203;
RA   Goulet I., Boisvenue S., Mokas S., Mazroui R., Cote J.;
RT   "TDRD3, a novel Tudor domain-containing protein, localizes to cytoplasmic
RT   stress granules.";
RL   Hum. Mol. Genet. 17:3055-3074(2008).
RN   [16]
RP   PHOSPHORYLATION AT SER-42.
RX   PubMed=18620545; DOI=10.1042/bj20081135;
RA   Gardiner M., Toth R., Vandermoere F., Morrice N.A., Rouse J.;
RT   "Identification and characterization of FUS/TLS as a new target of ATM.";
RL   Biochem. J. 415:297-307(2008).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-277 AND THR-286, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-221, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-340, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [22]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=24204307; DOI=10.1371/journal.pgen.1003895;
RA   Zhou Y., Liu S., Liu G., Oztuerk A., Hicks G.G.;
RT   "ALS-associated FUS mutations result in compromised FUS alternative
RT   splicing and autoregulation.";
RL   PLoS Genet. 9:E1003895-E1003895(2013).
RN   [23]
RP   FUNCTION, SUBCELLULAR LOCATION, SUBUNIT, AND RNA-BINDING.
RX   PubMed=25453086; DOI=10.1073/pnas.1414004111;
RA   Yang L., Gal J., Chen J., Zhu H.;
RT   "Self-assembled FUS binds active chromatin and regulates gene
RT   transcription.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:17809-17814(2014).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [25]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-216; ARG-218 AND ARG-503, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [26]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [27]
RP   INTERACTION WITH LRSAM1.
RX   PubMed=27615052; DOI=10.1002/ana.24776;
RA   Hu B., Arpag S., Zuchner S., Li J.;
RT   "A novel missense mutation of CMT2P alters transcription machinery.";
RL   Ann. Neurol. 80:834-845(2016).
RN   [28]
RP   FUNCTION, AND INTERACTION WITH SNRNP70 AND POLR2A.
RX   PubMed=26124092; DOI=10.1073/pnas.1506282112;
RA   Yu Y., Reed R.;
RT   "FUS functions in coupling transcription to splicing by mediating an
RT   interaction between RNAP II and U1 snRNP.";
RL   Proc. Natl. Acad. Sci. U.S.A. 112:8608-8613(2015).
RN   [29]
RP   FUNCTION, AND INTERACTION WITH SAFB AND MATR3.
RX   PubMed=27731383; DOI=10.1038/srep35195;
RA   Yamaguchi A., Takanashi K.;
RT   "FUS interacts with nuclear matrix-associated protein SAFB1 as well as
RT   Matrin3 to regulate splicing and ligand-mediated transcription.";
RL   Sci. Rep. 6:35195-35195(2016).
RN   [30]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-334, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [31]
RP   PHOSPHORYLATION AT SER-26 AND SER-30, AND SUBCELLULAR LOCATION.
RX   PubMed=29897835; DOI=10.1091/mbc.e17-12-0735;
RA   Rhoads S.N., Monahan Z.T., Yee D.S., Leung A.Y., Newcombe C.G.,
RA   O'Meally R.N., Cole R.N., Shewmaker F.P.;
RT   "The prionlike domain of FUS is multiphosphorylated following DNA damage
RT   without altering nuclear localization.";
RL   Mol. Biol. Cell 29:1786-1797(2018).
RN   [32]
RP   INTERACTION WITH RALY, AND SUBCELLULAR LOCATION.
RX   PubMed=30354839; DOI=10.1091/mbc.e18-02-0108;
RA   Gasperini L., Rossi A., Cornella N., Peroni D., Zuccotti P., Potrich V.,
RA   Quattrone A., Macchi P.;
RT   "The hnRNP raly regulates PRMT1 expression and interacts with the ALS-
RT   linked protein FUS: implication for reciprocal cellular localization.";
RL   Mol. Biol. Cell 2018:MBCE18020108-MBCE18020108(2018).
RN   [33]
RP   STRUCTURE BY NMR OF 282-370.
RG   Northeast structural genomics consortium (NESG);
RT   "Northeast structural genomics consortium target HR6430A.";
RL   Submitted (MAY-2011) to the PDB data bank.
RN   [34]
RP   VARIANT [LARGE SCALE ANALYSIS] GLN-312.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [35]
RP   VARIANTS ALS6 CYS-244; SER-514; CYS-515; LYS-518; CYS-521; GLY-521;
RP   HIS-521; GLY-522; SER-524; THR-524 AND LEU-525, VARIANT GLN-517,
RP   SUBCELLULAR LOCATION, CHARACTERIZATION OF VARIANT ALS6 GLY-521, AND
RP   CHARACTERIZATION OF VARIANT GLN-517.
RX   PubMed=19251627; DOI=10.1126/science.1166066;
RA   Kwiatkowski T.J. Jr., Bosco D.A., Leclerc A.L., Tamrazian E.,
RA   Vanderburg C.R., Russ C., Davis A., Gilchrist J., Kasarskis E.J.,
RA   Munsat T., Valdmanis P., Rouleau G.A., Hosler B.A., Cortelli P.,
RA   de Jong P.J., Yoshinaga Y., Haines J.L., Pericak-Vance M.A., Yan J.,
RA   Ticozzi N., Siddique T., McKenna-Yasek D., Sapp P.C., Horvitz H.R.,
RA   Landers J.E., Brown R.H. Jr.;
RT   "Mutations in the FUS/TLS gene on chromosome 16 cause familial amyotrophic
RT   lateral sclerosis.";
RL   Science 323:1205-1208(2009).
RN   [36]
RP   VARIANTS ALS6 GLY-514; CYS-521 AND HIS-521, SUBCELLULAR LOCATION, AND
RP   CHARACTERIZATION OF VARIANTS ALS6 CYS-521 AND HIS-521.
RX   PubMed=19251628; DOI=10.1126/science.1165942;
RA   Vance C., Rogelj B., Hortobagyi T., De Vos K.J., Nishimura A.L.,
RA   Sreedharan J., Hu X., Smith B., Ruddy D., Wright P., Ganesalingam J.,
RA   Williams K.L., Tripathi V., Al-Saraj S., Al-Chalabi A., Leigh P.N.,
RA   Blair I.P., Nicholson G., de Belleroche J., Gallo J.M., Miller C.C.,
RA   Shaw C.E.;
RT   "Mutations in FUS, an RNA processing protein, cause familial amyotrophic
RT   lateral sclerosis type 6.";
RL   Science 323:1208-1211(2009).
RN   [37]
RP   VARIANTS ALS6 SER-191; CYS-216; VAL-225; CYS-230; CYS-234; ASP-507 AND
RP   CYS-521.
RX   PubMed=19861302; DOI=10.1136/jmg.2009.071027;
RA   Corrado L., Del Bo R., Castellotti B., Ratti A., Cereda C., Penco S.,
RA   Soraru G., Carlomagno Y., Ghezzi S., Pensato V., Colombrita C.,
RA   Gagliardi S., Cozzi L., Orsetti V., Mancuso M., Siciliano G., Mazzini L.,
RA   Comi G.P., Gellera C., Ceroni M., D'Alfonso S., Silani V.;
RT   "Mutations of FUS gene in sporadic amyotrophic lateral sclerosis.";
RL   J. Med. Genet. 47:190-194(2010).
RN   [38]
RP   VARIANT ALS6 HIS-521, AND VARIANT VAL-254.
RX   PubMed=20124201; DOI=10.1212/wnl.0b013e3181ccc732;
RA   Van Langenhove T., van der Zee J., Sleegers K., Engelborghs S.,
RA   Vandenberghe R., Gijselinck I., Van den Broeck M., Mattheijssens M.,
RA   Peeters K., De Deyn P.P., Cruts M., Van Broeckhoven C.;
RT   "Genetic contribution of FUS to frontotemporal lobar degeneration.";
RL   Neurology 74:366-371(2010).
RN   [39]
RP   VARIANTS ETM4 CYS-216 AND LEU-431.
RX   PubMed=22863194; DOI=10.1016/j.ajhg.2012.07.002;
RA   Merner N.D., Girard S.L., Catoire H., Bourassa C.V., Belzil V.V.,
RA   Riviere J.B., Hince P., Levert A., Dionne-Laporte A., Spiegelman D.,
RA   Noreau A., Diab S., Szuto A., Fournier H., Raelson J., Belouchi M.,
RA   Panisset M., Cossette P., Dupre N., Bernard G., Chouinard S., Dion P.A.,
RA   Rouleau G.A.;
RT   "Exome sequencing identifies fus mutations as a cause of essential
RT   tremor.";
RL   Am. J. Hum. Genet. 91:313-319(2012).
RN   [40]
RP   VARIANTS ALS6 HIS-521 AND TYR-526 EXT.
RX   PubMed=27604643; DOI=10.1038/srep32478;
RA   Hou L., Jiao B., Xiao T., Zhou L., Zhou Z., Du J., Yan X., Wang J.,
RA   Tang B., Shen L.;
RT   "Screening of SOD1, FUS and TARDBP genes in patients with amyotrophic
RT   lateral sclerosis in central-southern China.";
RL   Sci. Rep. 6:32478-32478(2016).
CC   -!- FUNCTION: DNA/RNA-binding protein that plays a role in various cellular
CC       processes such as transcription regulation, RNA splicing, RNA
CC       transport, DNA repair and damage response (PubMed:27731383). Binds to
CC       nascent pre-mRNAs and acts as a molecular mediator between RNA
CC       polymerase II and U1 small nuclear ribonucleoprotein thereby coupling
CC       transcription and splicing (PubMed:26124092). Binds also its own pre-
CC       mRNA and autoregulates its expression; this autoregulation mechanism is
CC       mediated by non-sense-mediated decay (PubMed:24204307). Plays a role in
CC       DNA repair mechanisms by promoting D-loop formation and homologous
CC       recombination during DNA double-strand break repair (PubMed:10567410).
CC       In neuronal cells, plays crucial roles in dendritic spine formation and
CC       stability, RNA transport, mRNA stability and synaptic homeostasis (By
CC       similarity). {ECO:0000250|UniProtKB:P56959,
CC       ECO:0000269|PubMed:10567410, ECO:0000269|PubMed:24204307,
CC       ECO:0000269|PubMed:26124092, ECO:0000269|PubMed:27731383}.
CC   -!- SUBUNIT: Self-oligomerizes (via N-terminal region) (PubMed:25453086).
CC       Oligomerization is essential for chromatin binding (PubMed:25453086).
CC       Component of nuclear riboprotein complexes. Interacts with ILF3, TDRD3
CC       and SF1 (PubMed:9660765). Interacts through its C-terminus with SFRS13A
CC       (PubMed:9774382). Interacts with OTUB1 and SARNP. Interacts with LRSAM1
CC       (PubMed:27615052). Interacts with SAFB1 in a DNA-dependent manner; this
CC       interaction tethers FUS to chromatin (PubMed:27731383). Interacts with
CC       MATR3 (PubMed:27731383). Interacts with SNRNP70 and POLR2A; these
CC       interactions couple RNA transcription and splicing (PubMed:26124092).
CC       Interacts (through its RNA-binding domain) with RALY (through its RNA-
CC       binding domain); both are components of the same RNPs
CC       (PubMed:30354839). {ECO:0000269|PubMed:17196963,
CC       ECO:0000269|PubMed:18632687, ECO:0000269|PubMed:25453086,
CC       ECO:0000269|PubMed:26124092, ECO:0000269|PubMed:27615052,
CC       ECO:0000269|PubMed:27731383, ECO:0000269|PubMed:30354839,
CC       ECO:0000269|PubMed:9660765, ECO:0000269|PubMed:9774382}.
CC   -!- INTERACTION:
CC       P35637; P35637; NbExp=6; IntAct=EBI-400434, EBI-400434;
CC       P35637; P45481: Crebbp; Xeno; NbExp=4; IntAct=EBI-400434, EBI-296306;
CC       P35637; Q9NRR4: DROSHA; NbExp=2; IntAct=EBI-400434, EBI-528367;
CC       P35637; Q09472: EP300; NbExp=4; IntAct=EBI-400434, EBI-447295;
CC       P35637; Q01844: EWSR1; NbExp=5; IntAct=EBI-400434, EBI-739737;
CC       P35637; Q92993: KAT5; NbExp=2; IntAct=EBI-400434, EBI-399080;
CC       P35637; Q15149: PLEC; NbExp=4; IntAct=EBI-400434, EBI-297903;
CC       P35637; Q99873: PRMT1; NbExp=5; IntAct=EBI-400434, EBI-78738;
CC       P35637; Q99873-3: PRMT1; NbExp=3; IntAct=EBI-400434, EBI-17165527;
CC       P35637; Q9UKM9: RALY; NbExp=5; IntAct=EBI-400434, EBI-714796;
CC       P35637; P38159: RBMX; NbExp=5; IntAct=EBI-400434, EBI-743526;
CC       P35637; Q15424: SAFB; NbExp=7; IntAct=EBI-400434, EBI-348298;
CC       P35637; Q92804: TAF15; NbExp=7; IntAct=EBI-400434, EBI-2255091;
CC       P35637; Q92973-2: TNPO1; NbExp=2; IntAct=EBI-400434, EBI-11022821;
CC       P35637; Q9H3D4: TP63; NbExp=2; IntAct=EBI-400434, EBI-2337775;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:19251627,
CC       ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:24204307,
CC       ECO:0000269|PubMed:25453086, ECO:0000269|PubMed:30354839}.
CC       Note=Displays a punctate pattern inside the nucleus and is excluded
CC       from nucleoli. {ECO:0000269|PubMed:25453086}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Long;
CC         IsoId=P35637-1; Sequence=Displayed;
CC       Name=Short;
CC         IsoId=P35637-2; Sequence=VSP_005798;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- PTM: Arg-216 and Arg-218 are dimethylated, probably to asymmetric
CC       dimethylarginine.
CC   -!- PTM: Phosphorylated in its N-terminal serine residues upon induced DNA
CC       damage. ATM and DNA-PK are able to phosphorylate FUS N-terminal region.
CC       {ECO:0000269|PubMed:18620545, ECO:0000269|PubMed:29897835}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FUS is found in a
CC       patient with malignant myxoid liposarcoma. Translocation
CC       t(12;16)(q13;p11) with DDIT3. {ECO:0000269|PubMed:7503811}.
CC   -!- DISEASE: Note=A chromosomal aberration involving FUS is a cause of
CC       acute myeloid leukemia (AML). Translocation t(16;21)(p11;q22) with ERG.
CC       {ECO:0000269|PubMed:8187069}.
CC   -!- DISEASE: Angiomatoid fibrous histiocytoma (AFH) [MIM:612160]: A
CC       distinct variant of malignant fibrous histiocytoma that typically
CC       occurs in children and adolescents and is manifest by nodular
CC       subcutaneous growth. Characteristic microscopic features include
CC       lobulated sheets of histiocyte-like cells intimately associated with
CC       areas of hemorrhage and cystic pseudovascular spaces, as well as a
CC       striking cuffing of inflammatory cells, mimicking a lymph node
CC       metastasis. {ECO:0000269|PubMed:11063792}. Note=The gene represented in
CC       this entry is involved in disease pathogenesis. A chromosomal
CC       aberration involving FUS is found in a patient with angiomatoid fibrous
CC       histiocytoma. Translocation t(12;16)(q13;p11.2) with ATF1 generates a
CC       chimeric FUS/ATF1 protein. {ECO:0000269|PubMed:11063792}.
CC   -!- DISEASE: Amyotrophic lateral sclerosis 6, with or without
CC       frontotemporal dementia (ALS6) [MIM:608030]: A neurodegenerative
CC       disorder affecting upper motor neurons in the brain and lower motor
CC       neurons in the brain stem and spinal cord, resulting in fatal
CC       paralysis. Sensory abnormalities are absent. The pathologic hallmarks
CC       of the disease include pallor of the corticospinal tract due to loss of
CC       motor neurons, presence of ubiquitin-positive inclusions within
CC       surviving motor neurons, and deposition of pathologic aggregates. The
CC       etiology of amyotrophic lateral sclerosis is likely to be
CC       multifactorial, involving both genetic and environmental factors. The
CC       disease is inherited in 5-10% of the cases.
CC       {ECO:0000269|PubMed:19251627, ECO:0000269|PubMed:19251628,
CC       ECO:0000269|PubMed:19861302, ECO:0000269|PubMed:20124201,
CC       ECO:0000269|PubMed:27604643}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Tremor, hereditary essential 4 (ETM4) [MIM:614782]: A common
CC       movement disorder mainly characterized by postural tremor of the arms.
CC       Head, legs, trunk, voice, jaw, and facial muscles also may be involved.
CC       The condition can be aggravated by emotions, hunger, fatigue and
CC       temperature extremes, and may cause a functional disability or even
CC       incapacitation. Inheritance is autosomal dominant.
CC       {ECO:0000269|PubMed:22863194}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the RRM TET family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/FUSID44.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S62140; AAB27102.1; -; mRNA.
DR   EMBL; S62138; AAB27103.1; ALT_SEQ; mRNA.
DR   EMBL; X71427; CAA50558.1; ALT_SEQ; mRNA.
DR   EMBL; X71428; CAA50559.1; ALT_SEQ; mRNA.
DR   EMBL; AF071213; AAC35285.1; -; Genomic_DNA.
DR   EMBL; AF071213; AAC35284.1; -; Genomic_DNA.
DR   EMBL; AC009088; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000402; AAH00402.1; -; mRNA.
DR   EMBL; BC002459; AAH02459.1; -; mRNA.
DR   EMBL; AJ295163; CAC15058.1; ALT_TERM; mRNA.
DR   CCDS; CCDS10707.1; -. [P35637-1]
DR   CCDS; CCDS58454.1; -. [P35637-2]
DR   PIR; S33798; S33798.
DR   PIR; S33799; S33799.
DR   RefSeq; NP_001164105.1; NM_001170634.1. [P35637-2]
DR   RefSeq; NP_004951.1; NM_004960.3. [P35637-1]
DR   PDB; 2LA6; NMR; -; A=282-370.
DR   PDB; 2LCW; NMR; -; A=278-385.
DR   PDB; 4FDD; X-ray; 2.30 A; B=498-526.
DR   PDB; 4FQ3; X-ray; 3.00 A; B=495-526.
DR   PDB; 5W3N; NMR; -; A/B/C/D/E/F/G/H/I=2-214.
DR   PDB; 5XRR; X-ray; 1.50 A; A=54-59.
DR   PDB; 5XSG; EM; 0.73 A; A=37-42.
DR   PDB; 5YVG; X-ray; 4.05 A; X/Y=1-526.
DR   PDB; 5YVH; X-ray; 3.15 A; B=371-526.
DR   PDB; 5YVI; X-ray; 2.90 A; B=456-526.
DR   PDB; 6BWZ; X-ray; 1.10 A; A=37-42.
DR   PDB; 6BXV; X-ray; 1.10 A; A=54-61.
DR   PDB; 6BZP; EM; 1.10 A; A/B=77-82.
DR   PDB; 6G99; NMR; -; B=419-454.
DR   PDB; 6GBM; NMR; -; B=280-377.
DR   PDB; 6KJ1; EM; 0.65 A; A=37-42.
DR   PDB; 6KJ2; EM; 0.67 A; A=37-42.
DR   PDB; 6KJ3; EM; 0.60 A; A=37-42.
DR   PDB; 6KJ4; EM; 0.65 A; A=37-42.
DR   PDBsum; 2LA6; -.
DR   PDBsum; 2LCW; -.
DR   PDBsum; 4FDD; -.
DR   PDBsum; 4FQ3; -.
DR   PDBsum; 5W3N; -.
DR   PDBsum; 5XRR; -.
DR   PDBsum; 5XSG; -.
DR   PDBsum; 5YVG; -.
DR   PDBsum; 5YVH; -.
DR   PDBsum; 5YVI; -.
DR   PDBsum; 6BWZ; -.
DR   PDBsum; 6BXV; -.
DR   PDBsum; 6BZP; -.
DR   PDBsum; 6G99; -.
DR   PDBsum; 6GBM; -.
DR   PDBsum; 6KJ1; -.
DR   PDBsum; 6KJ2; -.
DR   PDBsum; 6KJ3; -.
DR   PDBsum; 6KJ4; -.
DR   SMR; P35637; -.
DR   BioGrid; 108797; 466.
DR   CORUM; P35637; -.
DR   DIP; DIP-29857N; -.
DR   IntAct; P35637; 207.
DR   MINT; P35637; -.
DR   STRING; 9606.ENSP00000254108; -.
DR   iPTMnet; P35637; -.
DR   MetOSite; P35637; -.
DR   PhosphoSitePlus; P35637; -.
DR   SwissPalm; P35637; -.
DR   BioMuta; FUS; -.
DR   DMDM; 544357; -.
DR   EPD; P35637; -.
DR   jPOST; P35637; -.
DR   MassIVE; P35637; -.
DR   PaxDb; P35637; -.
DR   PeptideAtlas; P35637; -.
DR   PRIDE; P35637; -.
DR   ProteomicsDB; 55119; -. [P35637-1]
DR   ProteomicsDB; 55120; -. [P35637-2]
DR   TopDownProteomics; P35637-1; -. [P35637-1]
DR   TopDownProteomics; P35637-2; -. [P35637-2]
DR   Antibodypedia; 1307; 416 antibodies.
DR   DNASU; 2521; -.
DR   Ensembl; ENST00000254108; ENSP00000254108; ENSG00000089280. [P35637-1]
DR   Ensembl; ENST00000380244; ENSP00000369594; ENSG00000089280. [P35637-2]
DR   GeneID; 2521; -.
DR   KEGG; hsa:2521; -.
DR   UCSC; uc002ebh.4; human. [P35637-1]
DR   CTD; 2521; -.
DR   DisGeNET; 2521; -.
DR   GeneCards; FUS; -.
DR   GeneReviews; FUS; -.
DR   HGNC; HGNC:4010; FUS.
DR   HPA; ENSG00000089280; Low tissue specificity.
DR   MalaCards; FUS; -.
DR   MIM; 137070; gene.
DR   MIM; 608030; phenotype.
DR   MIM; 612160; phenotype.
DR   MIM; 614782; phenotype.
DR   neXtProt; NX_P35637; -.
DR   OpenTargets; ENSG00000089280; -.
DR   Orphanet; 803; Amyotrophic lateral sclerosis.
DR   Orphanet; 275872; Frontotemporal dementia with motor neuron disease.
DR   Orphanet; 300605; Juvenile amyotrophic lateral sclerosis.
DR   Orphanet; 79105; Myxofibrosarcoma.
DR   Orphanet; 99967; Myxoid/round cell liposarcoma.
DR   Orphanet; 862; NON RARE IN EUROPE: Hereditary essential tremor.
DR   PharmGKB; PA28425; -.
DR   eggNOG; ENOG410IP58; Eukaryota.
DR   eggNOG; ENOG4111GEG; LUCA.
DR   GeneTree; ENSGT00940000157290; -.
DR   InParanoid; P35637; -.
DR   KO; K13098; -.
DR   PhylomeDB; P35637; -.
DR   TreeFam; TF322599; -.
DR   Reactome; R-HSA-72163; mRNA Splicing - Major Pathway.
DR   SIGNOR; P35637; -.
DR   ChiTaRS; FUS; human.
DR   GeneWiki; FUS; -.
DR   GenomeRNAi; 2521; -.
DR   Pharos; P35637; Tbio.
DR   PRO; PR:P35637; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; P35637; protein.
DR   Bgee; ENSG00000089280; Expressed in right testis and 237 other tissues.
DR   ExpressionAtlas; P35637; baseline and differential.
DR   Genevisible; P35637; HS.
DR   GO; GO:0044327; C:dendritic spine head; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005844; C:polysome; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:Ensembl.
DR   GO; GO:0031489; F:myosin V binding; IEA:Ensembl.
DR   GO; GO:0046965; F:retinoid X receptor binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IDA:MGI.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; IEA:Ensembl.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:CACAO.
DR   GO; GO:0003712; F:transcription coregulator activity; IBA:GO_Central.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; TAS:Reactome.
DR   GO; GO:0048255; P:mRNA stabilization; IDA:MGI.
DR   GO; GO:1905168; P:positive regulation of double-strand break repair via homologous recombination; IDA:UniProtKB.
DR   GO; GO:0051260; P:protein homooligomerization; IDA:UniProtKB.
DR   GO; GO:0043484; P:regulation of RNA splicing; IDA:UniProtKB.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0008380; P:RNA splicing; IDA:UniProtKB.
DR   DisProt; DP01102; -.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR034459; FUS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034870; TET_fam.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR23238; PTHR23238; 1.
DR   PANTHER; PTHR23238:SF5; PTHR23238:SF5; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Amyotrophic lateral sclerosis;
KW   Chromosomal rearrangement; Direct protein sequencing; Disease mutation;
KW   DNA-binding; Isopeptide bond; Metal-binding; Methylation;
KW   Neurodegeneration; Nucleus; Phosphoprotein; Polymorphism; Proto-oncogene;
KW   Reference proteome; Repeat; RNA-binding; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..526
FT                   /note="RNA-binding protein FUS"
FT                   /id="PRO_0000081591"
FT   DOMAIN          285..371
FT                   /note="RRM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   ZN_FING         422..453
FT                   /note="RanBP2-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   COMPBIAS        1..165
FT                   /note="Gln/Gly/Ser/Tyr-rich"
FT   COMPBIAS        166..267
FT                   /note="Gly-rich"
FT   COMPBIAS        371..526
FT                   /note="Arg/Gly-rich"
FT   SITE            175
FT                   /note="Breakpoint for translocation to form chimeric
FT                   FUS/ATF1 protein"
FT   SITE            266..267
FT                   /note="Breakpoint for translocation to form FUS/TLS-CHOP
FT                   oncogene"
FT   MOD_RES         26
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:29897835"
FT   MOD_RES         30
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:29897835"
FT   MOD_RES         42
FT                   /note="Phosphoserine; by ATM"
FT                   /evidence="ECO:0000269|PubMed:18620545"
FT   MOD_RES         216
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         216
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         218
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         218
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         221
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692"
FT   MOD_RES         242
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         244
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         248
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         251
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         259
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         277
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         286
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         340
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         377
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         383
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         386
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         388
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         394
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         407
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         407
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:P56959"
FT   MOD_RES         473
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         476
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         481
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         485
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         487
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         491
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         495
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         498
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         503
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000269|PubMed:12964758"
FT   MOD_RES         503
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   CROSSLNK        334
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         64..65
FT                   /note="TG -> S (in isoform Short)"
FT                   /evidence="ECO:0000303|PubMed:7503811"
FT                   /id="VSP_005798"
FT   VARIANT         191
FT                   /note="G -> S (in ALS6; dbSNP:rs148758737)"
FT                   /evidence="ECO:0000269|PubMed:19861302"
FT                   /id="VAR_068918"
FT   VARIANT         216
FT                   /note="R -> C (in ALS6 and ETM4; dbSNP:rs267606832)"
FT                   /evidence="ECO:0000269|PubMed:19861302,
FT                   ECO:0000269|PubMed:22863194"
FT                   /id="VAR_068919"
FT   VARIANT         225
FT                   /note="G -> V (in ALS6)"
FT                   /evidence="ECO:0000269|PubMed:19861302"
FT                   /id="VAR_068920"
FT   VARIANT         230
FT                   /note="G -> C (in ALS6; dbSNP:rs748374535)"
FT                   /evidence="ECO:0000269|PubMed:19861302"
FT                   /id="VAR_068921"
FT   VARIANT         234
FT                   /note="R -> C (in ALS6; dbSNP:rs777819849)"
FT                   /evidence="ECO:0000269|PubMed:19861302"
FT                   /id="VAR_068922"
FT   VARIANT         244
FT                   /note="R -> C (in ALS6; dbSNP:rs1165095258)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054837"
FT   VARIANT         254
FT                   /note="M -> V (found in a patient with frontotemporal lobar
FT                   degeneration; dbSNP:rs752076094)"
FT                   /evidence="ECO:0000269|PubMed:20124201"
FT                   /id="VAR_065229"
FT   VARIANT         312
FT                   /note="K -> Q (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035481"
FT   VARIANT         431
FT                   /note="P -> L (in ETM4; dbSNP:rs186547381)"
FT                   /evidence="ECO:0000269|PubMed:22863194"
FT                   /id="VAR_068923"
FT   VARIANT         507
FT                   /note="G -> D (in ALS6; dbSNP:rs267606831)"
FT                   /evidence="ECO:0000269|PubMed:19861302"
FT                   /id="VAR_068924"
FT   VARIANT         514
FT                   /note="R -> G (in ALS6)"
FT                   /evidence="ECO:0000269|PubMed:19251628"
FT                   /id="VAR_054838"
FT   VARIANT         514
FT                   /note="R -> S (in ALS6)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054839"
FT   VARIANT         515
FT                   /note="G -> C (in ALS6)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054840"
FT   VARIANT         517
FT                   /note="H -> Q (does not affect protein nuclear
FT                   localization; dbSNP:rs121909667)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054841"
FT   VARIANT         518
FT                   /note="R -> K (in ALS6; dbSNP:rs121909669)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054842"
FT   VARIANT         521
FT                   /note="R -> C (in ALS6; results in aberrant trafficking and
FT                   cytoplasmic retention of the protein; dbSNP:rs121909668)"
FT                   /evidence="ECO:0000269|PubMed:19251627,
FT                   ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:19861302"
FT                   /id="VAR_054843"
FT   VARIANT         521
FT                   /note="R -> G (in ALS6; results in aberrant trafficking and
FT                   cytoplasmic retention of the protein; dbSNP:rs121909668)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054844"
FT   VARIANT         521
FT                   /note="R -> H (in ALS6; results in aberrant trafficking and
FT                   cytoplasmic retention of the protein; dbSNP:rs121909671)"
FT                   /evidence="ECO:0000269|PubMed:19251627,
FT                   ECO:0000269|PubMed:19251628, ECO:0000269|PubMed:20124201,
FT                   ECO:0000269|PubMed:27604643"
FT                   /id="VAR_054845"
FT   VARIANT         522
FT                   /note="R -> G (in ALS6; dbSNP:rs1555509693)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054846"
FT   VARIANT         524
FT                   /note="R -> S (in ALS6; dbSNP:rs886041389)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054847"
FT   VARIANT         524
FT                   /note="R -> T (in ALS6)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054848"
FT   VARIANT         525
FT                   /note="P -> L (in ALS6; dbSNP:rs886041390)"
FT                   /evidence="ECO:0000269|PubMed:19251627"
FT                   /id="VAR_054849"
FT   VARIANT         526
FT                   /note="Y -> YY (in ALS6; unknown pathological
FT                   significance)"
FT                   /evidence="ECO:0000269|PubMed:27604643"
FT                   /id="VAR_077328"
FT   CONFLICT        338
FT                   /note="T -> N (in Ref. 7; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   STRAND          38..40
FT                   /evidence="ECO:0000244|PDB:5W3N"
FT   STRAND          47..49
FT                   /evidence="ECO:0000244|PDB:5W3N"
FT   STRAND          59..64
FT                   /evidence="ECO:0000244|PDB:5W3N"
FT   STRAND          67..70
FT                   /evidence="ECO:0000244|PDB:5W3N"
FT   STRAND          73..75
FT                   /evidence="ECO:0000244|PDB:5W3N"
FT   STRAND          93..95
FT                   /evidence="ECO:0000244|PDB:5W3N"
FT   STRAND          285..290
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   HELIX           298..305
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   TURN            306..308
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   TURN            315..318
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   STRAND          319..326
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   TURN            328..330
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   STRAND          332..343
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   HELIX           344..354
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   STRAND          358..363
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   STRAND          365..368
FT                   /evidence="ECO:0000244|PDB:2LA6"
FT   HELIX           372..375
FT                   /evidence="ECO:0000244|PDB:6GBM"
FT   STRAND          379..381
FT                   /evidence="ECO:0000244|PDB:2LCW"
FT   TURN            431..433
FT                   /evidence="ECO:0000244|PDB:6G99"
FT   TURN            445..447
FT                   /evidence="ECO:0000244|PDB:6G99"
FT   STRAND          450..452
FT                   /evidence="ECO:0000244|PDB:6G99"
FT   HELIX           514..521
FT                   /evidence="ECO:0000244|PDB:4FDD"
SQ   SEQUENCE   526 AA;  53426 MW;  88C8E263B7905549 CRC64;
     MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTSGY GQSSYSSYGQ
     SQNTGYGTQS TPQGYGSTGG YGSSQSSQSS YGQQSSYPGY GQQPAPSSTS GSYGSSSQSS
     SYGQPQSGSY SQQPSYGGQQ QSYGQQQSYN PPQGYGQQNQ YNSSSGGGGG GGGGGNYGQD
     QSSMSSGGGS GGGYGNQDQS GGGGSGGYGQ QDRGGRGRGG SGGGGGGGGG GYNRSSGGYE
     PRGRGGGRGG RGGMGGSDRG GFNKFGGPRD QGSRHDSEQD NSDNNTIFVQ GLGENVTIES
     VADYFKQIGI IKTNKKTGQP MINLYTDRET GKLKGEATVS FDDPPSAKAA IDWFDGKEFS
     GNPIKVSFAT RRADFNRGGG NGRGGRGRGG PMGRGGYGGG GSGGGGRGGF PSGGGGGGGQ
     QRAGDWKCPN PTCENMNFSW RNECNQCKAP KPDGPGGGPG GSHMGGNYGD DRRGGRGGYD
     RGGYRGRGGD RGGFRGGRGG GDRGGFGPGK MDSRGEHRQD RRERPY
//
ID   Q13344_HUMAN            Unreviewed;       528 AA.
AC   Q13344;
DT   01-NOV-1996, integrated into UniProtKB/TrEMBL.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 105.
DE   SubName: Full=Fus-like protein {ECO:0000313|EMBL:AAA79948.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAA79948.1};
RN   [1] {ECO:0000313|EMBL:AAA79948.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Itoh K., Kawase M.;
RL   Submitted (SEP-1995) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U36561; AAA79948.1; -; mRNA.
DR   PIR; G02127; G02127.
DR   RefSeq; NP_001164408.1; NM_001170937.1.
DR   IntAct; Q13344; 2.
DR   MINT; Q13344; -.
DR   MaxQB; Q13344; -.
DR   PeptideAtlas; Q13344; -.
DR   PRIDE; Q13344; -.
DR   DNASU; 2521; -.
DR   GeneID; 2521; -.
DR   CTD; 2521; -.
DR   PharmGKB; PA28425; -.
DR   eggNOG; ENOG410IP58; Eukaryota.
DR   eggNOG; ENOG4111GEG; LUCA.
DR   GenomeRNAi; 2521; -.
DR   Genevisible; Q13344; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR034459; FUS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034870; TET_fam.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR23238; PTHR23238; 1.
DR   PANTHER; PTHR23238:SF5; PTHR23238:SF5; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00322, ECO:0000256|SAAS:SAAS00581830};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830}.
FT   DOMAIN          288..374
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          425..456
FT                   /note="RanBP2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50199"
FT   REGION          1..289
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          378..427
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          447..528
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..181
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        472..495
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        512..528
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         528
FT                   /evidence="ECO:0000313|EMBL:AAA79948.1"
SQ   SEQUENCE   528 AA;  53377 MW;  43CFD6CBDA57A258 CRC64;
     MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTGYG QSSYSSYGQS
     QNTGYGTQSA PQGYGSTGGY GSSQSSQSSY GQQSSYPGYG PQPTPSSTSG SYGSSSQTSS
     YGQPPSYGQQ PSYGGQQQSY GQQQSYNPSG YGQQNQYNSS SSGSGGGGSY GQDQSSMSGS
     GGGGGGGGGG GSGGGGGYGN QDQSGGGGGG YGQQDRGGRG RGRSSGGGGG SGGGYNRSSG
     GYEPRGRGGG RGGRGGMGGS DRGGFNKFGG PRDQGSRHDS EQDNSDNNTI FVQGLGENVT
     IESVADYFKQ IGIIKTNKKT GQPMINLYTD RETGKLKGEA TVSFDDPPSA KAAIDWFDGK
     EFSGNPIKVS FATRRADFNR GGGNGRGGRG RGGPMGRGGY GGGGSGGGGR GGFPSGGGGG
     GGQQRAGDWK CPNPTCENMN FSWRNECNQC KAPKPDGPGG GPGGSHMGGN YGDDRRGGRG
     GYDRGGYRGR GGDRGGFRGG RGGGDRGGFG PGKMDSRGEH RQDRRERP
//
ID   Q6IBQ5_HUMAN            Unreviewed;       526 AA.
AC   Q6IBQ5;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 132.
DE   SubName: Full=FUS protein {ECO:0000313|EMBL:CAG33028.1};
DE   SubName: Full=Fusion (Involved in t(1216) in malignant liposarcoma), isoform CRA_a {ECO:0000313|EMBL:EAW52150.1};
DE   SubName: Full=Fusion, derived from t(12;16) malignant liposarcoma {ECO:0000313|EMBL:AAP35795.1};
GN   Name=FUS {ECO:0000313|EMBL:CAG33028.1};
GN   ORFNames=hCG_21147 {ECO:0000313|EMBL:EAW52150.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG33028.1};
RN   [1] {ECO:0000313|EMBL:EAW52150.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:AAP35795.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) System Donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:CAG33028.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:EAW52150.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BT007131; AAP35795.1; -; mRNA.
DR   EMBL; CR456747; CAG33028.1; -; mRNA.
DR   EMBL; CH471192; EAW52150.1; -; Genomic_DNA.
DR   RefSeq; NP_004951.1; NM_004960.3.
DR   Antibodypedia; 1307; 416 antibodies.
DR   DNASU; 2521; -.
DR   GeneID; 2521; -.
DR   KEGG; hsa:2521; -.
DR   UCSC; uc002ebf.3; human.
DR   CTD; 2521; -.
DR   EuPathDB; HostDB:ENSG00000089280.18; -.
DR   PharmGKB; PA28425; -.
DR   eggNOG; ENOG410IP58; Eukaryota.
DR   eggNOG; ENOG4111GEG; LUCA.
DR   KO; K13098; -.
DR   OrthoDB; 1539664at2759; -.
DR   ChiTaRS; FUS; human.
DR   GenomeRNAi; 2521; -.
DR   Bgee; ENSG00000089280; Expressed in right testis and 237 other tissues.
DR   GO; GO:0044327; C:dendritic spine head; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0043204; C:perikaryon; IEA:Ensembl.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0005844; C:polysome; IEA:Ensembl.
DR   GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
DR   GO; GO:0035255; F:ionotropic glutamate receptor binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003730; F:mRNA 3'-UTR binding; IEA:Ensembl.
DR   GO; GO:0031489; F:myosin V binding; IEA:Ensembl.
DR   GO; GO:0046965; F:retinoid X receptor binding; IEA:Ensembl.
DR   GO; GO:0046966; F:thyroid hormone receptor binding; IEA:Ensembl.
DR   GO; GO:0071277; P:cellular response to calcium ion; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   GO; GO:0008380; P:RNA splicing; IEA:Ensembl.
DR   Gene3D; 3.30.70.330; -; 1.
DR   InterPro; IPR034459; FUS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   InterPro; IPR034870; TET_fam.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   PANTHER; PTHR23238; PTHR23238; 1.
DR   PANTHER; PTHR23238:SF5; PTHR23238:SF5; 1.
DR   Pfam; PF00076; RRM_1; 1.
DR   Pfam; PF00641; zf-RanBP; 1.
DR   SMART; SM00360; RRM; 1.
DR   SMART; SM00547; ZnF_RBZ; 1.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   SUPFAM; SSF90209; SSF90209; 1.
DR   PROSITE; PS50102; RRM; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 1.
DR   PROSITE; PS50199; ZF_RANBP2_2; 1.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00322, ECO:0000256|SAAS:SAAS00581830};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00322,
KW   ECO:0000256|SAAS:SAAS00581830}.
FT   DOMAIN          285..371
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          422..453
FT                   /note="RanBP2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50199"
FT   REGION          1..286
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          375..424
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          444..526
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1..169
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        176..206
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        469..492
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        509..526
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   526 AA;  53426 MW;  88C8E263B7905549 CRC64;
     MASNDYTQQA TQSYGAYPTQ PGQGYSQQSS QPYGQQSYSG YSQSTDTSGY GQSSYSSYGQ
     SQNTGYGTQS TPQGYGSTGG YGSSQSSQSS YGQQSSYPGY GQQPAPSSTS GSYGSSSQSS
     SYGQPQSGSY SQQPSYGGQQ QSYGQQQSYN PPQGYGQQNQ YNSSSGGGGG GGGGGNYGQD
     QSSMSSGGGS GGGYGNQDQS GGGGSGGYGQ QDRGGRGRGG SGGGGGGGGG GYNRSSGGYE
     PRGRGGGRGG RGGMGGSDRG GFNKFGGPRD QGSRHDSEQD NSDNNTIFVQ GLGENVTIES
     VADYFKQIGI IKTNKKTGQP MINLYTDRET GKLKGEATVS FDDPPSAKAA IDWFDGKEFS
     GNPIKVSFAT RRADFNRGGG NGRGGRGRGG PMGRGGYGGG GSGGGGRGGF PSGGGGGGGQ
     QRAGDWKCPN PTCENMNFSW RNECNQCKAP KPDGPGGGPG GSHMGGNYGD DRRGGRGGYD
     RGGYRGRGGD RGGFRGGRGG GDRGGFGPGK MDSRGEHRQD RRERPY
//
ID   A0A2R8Y4D3_HUMAN        Unreviewed;        77 AA.
AC   A0A2R8Y4D3;
DT   20-JUN-2018, integrated into UniProtKB/TrEMBL.
DT   20-JUN-2018, sequence version 1.
DT   22-APR-2020, entry version 13.
DE   SubName: Full=DNA-binding protein Ikaros {ECO:0000313|Ensembl:ENSP00000493696};
GN   Name=IKZF1 {ECO:0000313|Ensembl:ENSP00000493696};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000493696, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000493696, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000493696}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2018) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AUXG01000057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278775.1; NM_001291846.1.
DR   RefSeq; NP_001278776.1; NM_001291847.1.
DR   Antibodypedia; 3980; 526 antibodies.
DR   Ensembl; ENST00000492782; ENSP00000494180; ENSG00000185811.
DR   Ensembl; ENST00000646110; ENSP00000493696; ENSG00000185811.
DR   GeneID; 10320; -.
DR   CTD; 10320; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   OpenTargets; ENSG00000185811; -.
DR   GeneTree; ENSGT00940000156782; -.
DR   ChiTaRS; IKZF1; human.
DR   Proteomes; UP000005640; Chromosome 7.
DR   ExpressionAtlas; A0A2R8Y4D3; baseline and differential.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:A0A2R8Y4D3,
KW   ECO:0000213|MaxQB:A0A2R8Y4D3, ECO:0000213|PeptideAtlas:A0A2R8Y4D3,
KW   ECO:0000213|ProteomicsDB:A0A2R8Y4D3};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REGION          1..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        37..51
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   77 AA;  8289 MW;  ECF99C94A1A5F05C CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVVTYGADD
     FRDFHAIIPK SFSLLEL
//
ID   C9JTB0_HUMAN            Unreviewed;       174 AA.
AC   C9JTB0;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   22-APR-2020, entry version 60.
DE   SubName: Full=DNA-binding protein Ikaros {ECO:0000313|Ensembl:ENSP00000388478};
GN   Name=IKZF1 {ECO:0000313|Ensembl:ENSP00000388478};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000388478, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000388478, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000388478}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AUXG01000057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001278774.1; NM_001291845.1.
DR   EPD; C9JTB0; -.
DR   MaxQB; C9JTB0; -.
DR   PeptideAtlas; C9JTB0; -.
DR   PRIDE; C9JTB0; -.
DR   ProteomicsDB; 11572; -.
DR   Antibodypedia; 3980; 526 antibodies.
DR   Ensembl; ENST00000413698; ENSP00000388478; ENSG00000185811.
DR   GeneID; 10320; -.
DR   UCSC; uc003tov.2; human.
DR   CTD; 10320; -.
DR   EuPathDB; HostDB:ENSG00000185811.16; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   OpenTargets; ENSG00000185811; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000156782; -.
DR   HOGENOM; CLU_1539499_0_0_1; -.
DR   OrthoDB; 385551at2759; -.
DR   ChiTaRS; IKZF1; human.
DR   GenomeRNAi; 10320; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000185811; Expressed in leukocyte and 183 other tissues.
DR   ExpressionAtlas; C9JTB0; baseline and differential.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:C9JTB0,
KW   ECO:0000213|MaxQB:C9JTB0, ECO:0000213|PeptideAtlas:C9JTB0,
KW   ECO:0000213|ProteomicsDB:C9JTB0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   REGION          1..49
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   174 AA;  19628 MW;  A4F62FEE7226F3D5 CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVVTYGADD
     FRDFHAIIPK SFSRKYMPCF WKTKACLHLL SCKYRTCMFL HQPPRYIKYS LFYSLDTYHI
     IFGYLYHKVQ NEGLGSCAVS WEHGSGVTVR VGVTVALMGL LLRRCCWTAL RLLL
//
ID   IKZF1_HUMAN             Reviewed;         519 AA.
AC   Q13422; A4D260; B4E0Z1; D3DVM5; O00598; Q53XL2; Q69BM4; Q8WVA3;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 195.
DE   RecName: Full=DNA-binding protein Ikaros;
DE   AltName: Full=Ikaros family zinc finger protein 1;
DE   AltName: Full=Lymphoid transcription factor LyF-1;
GN   Name=IKZF1; Synonyms=IK1, IKAROS, LYF1, ZNFN1A1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RC   TISSUE=Bone marrow;
RX   PubMed=8964602; DOI=10.1016/0165-2478(95)02479-4;
RA   Nietfeld W., Meyerhans A.;
RT   "Cloning and sequencing of hIk-1, a cDNA encoding a human homologue of
RT   mouse Ikaros/LyF-1.";
RL   Immunol. Lett. 49:139-141(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND TISSUE SPECIFICITY.
RX   PubMed=8543809;
RA   Molnar A., Wu P., Largespada D.A., Vortkamp A., Scherer S., Copeland N.G.,
RA   Jenkins N.A., Bruns G., Georgopoulos K.;
RT   "The Ikaros gene encodes a family of lymphocyte-restricted zinc finger DNA
RT   binding proteins, highly conserved in human and mouse.";
RL   J. Immunol. 156:585-592(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM IKX).
RA   Sanchez-Tapia E.M., Rodriguez R.E., Gonzalez-Sarmiento R.;
RT   "Molecular misreading is involved in generation of Ikaros diversity.";
RL   Submitted (SEP-2003) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IK2).
RC   TISSUE=Thymus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IK7).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12690205; DOI=10.1126/science.1083423;
RA   Scherer S.W., Cheung J., MacDonald J.R., Osborne L.R., Nakabayashi K.,
RA   Herbrick J.-A., Carson A.R., Parker-Katiraee L., Skaug J., Khaja R.,
RA   Zhang J., Hudek A.K., Li M., Haddad M., Duggan G.E., Fernandez B.A.,
RA   Kanematsu E., Gentles S., Christopoulos C.C., Choufani S., Kwasnicka D.,
RA   Zheng X.H., Lai Z., Nusskern D.R., Zhang Q., Gu Z., Lu F., Zeesman S.,
RA   Nowaczyk M.J., Teshima I., Chitayat D., Shuman C., Weksberg R.,
RA   Zackai E.H., Grebe T.A., Cox S.R., Kirkpatrick S.J., Rahman N.,
RA   Friedman J.M., Heng H.H.Q., Pelicci P.G., Lo-Coco F., Belloni E.,
RA   Shaffer L.G., Pober B., Morton C.C., Gusella J.F., Bruns G.A.P., Korf B.R.,
RA   Quade B.J., Ligon A.H., Ferguson H., Higgins A.W., Leach N.T.,
RA   Herrick S.R., Lemyre E., Farra C.G., Kim H.-G., Summers A.M., Gripp K.W.,
RA   Roberts W., Szatmari P., Winsor E.J.T., Grzeschik K.-H., Teebi A.,
RA   Minassian B.A., Kere J., Armengol L., Pujana M.A., Estivill X.,
RA   Wilson M.D., Koop B.F., Tosi S., Moore G.E., Boright A.P., Zlotorynski E.,
RA   Kerem B., Kroisel P.M., Petek E., Oscier D.G., Mould S.J., Doehner H.,
RA   Doehner K., Rommens J.M., Vincent J.B., Venter J.C., Li P.W., Mural R.J.,
RA   Adams M.D., Tsui L.-C.;
RT   "Human chromosome 7: DNA sequence and biology.";
RL   Science 300:767-772(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM IK7).
RC   TISSUE=Lymph;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   IDENTIFICATION IN THE NURD COMPLEX, INTERACTION WITH SMARCA4 AND CHD4, AND
RP   FUNCTION.
RX   PubMed=10204490; DOI=10.1016/s1074-7613(00)80034-5;
RA   Kim J., Sif S., Jones B., Jackson A., Koipally J., Heller E., Winandy S.,
RA   Viel A., Sawyer A., Ikeda T., Kingston R., Georgopoulos K.;
RT   "Ikaros DNA-binding proteins direct formation of chromatin remodeling
RT   complexes in lymphocytes.";
RL   Immunity 10:345-355(1999).
RN   [11]
RP   INVOLVEMENT IN B-CELL NON-HODGKIN LYMPHOMA, AND CHROMOSOMAL TRANSLOCATION
RP   WITH BCL6.
RX   PubMed=10753856;
RA   Hosokawa Y., Maeda Y., Ichinohasama R., Miura I., Taniwaki M., Seto M.;
RT   "The Ikaros gene, a central regulator of lymphoid differentiation, fuses to
RT   the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient
RT   with diffuse large B-cell lymphoma.";
RL   Blood 95:2719-2721(2000).
RN   [12]
RP   INTERACTION WITH IKZF4 AND IKZF5.
RX   PubMed=10978333; DOI=10.1074/jbc.m005457200;
RA   Perdomo J., Holmes M., Chong B., Crossley M.;
RT   "Eos and pegasus, two members of the Ikaros family of proteins with
RT   distinct DNA binding activities.";
RL   J. Biol. Chem. 275:38347-38354(2000).
RN   [13]
RP   FUNCTION, ALTERNATIVE SPLICING, SUBCELLULAR LOCATION, AND SUBUNIT.
RX   PubMed=17135265; DOI=10.1074/jbc.m605627200;
RA   Ronni T., Payne K.J., Ho S., Bradley M.N., Dorsam G., Dovat S.;
RT   "Human Ikaros function in activated T cells is regulated by coordinated
RT   expression of its largest isoforms.";
RL   J. Biol. Chem. 282:2538-2547(2007).
RN   [14]
RP   FUNCTION, AND ALTERNATIVE SPLICING.
RX   PubMed=17934067; DOI=10.1182/blood-2007-07-098202;
RA   Dijon M., Bardin F., Murati A., Batoz M., Chabannon C., Tonnelle C.;
RT   "The role of Ikaros in human erythroid differentiation.";
RL   Blood 111:1138-1146(2008).
RN   [15]
RP   FUNCTION IN GAMMA SATELLITE DNA-BINDING.
RX   PubMed=19141594; DOI=10.1101/gr.086496.108;
RA   Kim J.-H., Ebersole T., Kouprina N., Noskov V.N., Ohzeki J.-I.,
RA   Masumoto H., Mravinac B., Sullivan B.A., Pavlicek A., Dovat S., Pack S.D.,
RA   Kwon Y.-W., Flanagan P.T., Loukinov D., Lobanenkov V., Larionov V.;
RT   "Human gamma-satellite DNA maintains open chromatin structure and protects
RT   a transgene from epigenetic silencing.";
RL   Genome Res. 19:533-544(2009).
RN   [16]
RP   INVOLVEMENT IN ACUTE LYMPHOBLASIC LEUKEMIA.
RX   PubMed=19129520; DOI=10.1056/nejmoa0808253;
RA   Mullighan C.G., Su X., Zhang J., Radtke I., Phillips L.A., Miller C.B.,
RA   Ma J., Liu W., Cheng C., Schulman B.A., Harvey R.C., Chen I.-M.,
RA   Clifford R.J., Carroll W.L., Reaman G., Bowman W.P., Devidas M.,
RA   Gerhard D.S., Yang W., Relling M.V., Shurtleff S.A., Campana D.,
RA   Borowitz M.J., Pui C.H., Smith M., Hunger S.P., Willman C.L., Downing J.R.;
RT   "Deletion of IKZF1 and prognosis in acute lymphoblastic leukemia.";
RL   N. Engl. J. Med. 360:470-480(2009).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-258; SER-361 AND
RP   SER-364, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   FUNCTION IN DNA-BINDING, SUBCELLULAR LOCATION, PHOSPHORYLATION, AND
RP   ALTERNATIVE SPLICING.
RX   PubMed=22106042; DOI=10.1002/pbc.23406;
RA   Li Z., Song C., Ouyang H., Lai L., Payne K.J., Dovat S.;
RT   "Cell cycle-specific function of Ikaros in human leukemia.";
RL   Pediatr. Blood Cancer 59:69-76(2012).
RN   [20]
RP   PHOSPHORYLATION AT SER-361 AND SER-364 BY SYK, AND SUBCELLULAR LOCATION.
RX   PubMed=23071339; DOI=10.1073/pnas.1209828109;
RA   Uckun F.M., Ma H., Zhang J., Ozer Z., Dovat S., Mao C., Ishkhanian R.,
RA   Goodman P., Qazi S.;
RT   "Serine phosphorylation by SYK is critical for nuclear localization and
RT   transcription factor function of Ikaros.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:18072-18077(2012).
RN   [21]
RP   INVOLVEMENT IN CVID13, VARIANT CVID13 CYS-210, CHARACTERIZATION OF VARIANT
RP   CVID13 CYS-210, AND SUBCELLULAR LOCATION.
RX   PubMed=21548011; DOI=10.1002/pbc.23160;
RA   Goldman F.D., Gurel Z., Al-Zubeidi D., Fried A.J., Icardi M., Song C.,
RA   Dovat S.;
RT   "Congenital pancytopenia and absence of B lymphocytes in a neonate with a
RT   mutation in the Ikaros gene.";
RL   Pediatr. Blood Cancer 58:591-597(2012).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-63; SER-261; SER-289;
RP   SER-298; SER-364; SER-368; SER-427 AND SER-445, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-445, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [24]
RP   VARIANTS CVID13 GLN-162; LEU-162; ARG-167 AND GLN-184, CHARACTERIZATION OF
RP   VARIANTS CVID13 GLN-162; LEU-162; ARG-167; GLN-184 AND CYS-210, AND
RP   MUTAGENESIS OF ASN-159 AND HIS-191.
RX   PubMed=26981933; DOI=10.1056/nejmoa1512234;
RA   Kuehn H.S., Boisson B., Cunningham-Rundles C., Reichenbach J.,
RA   Stray-Pedersen A., Gelfand E.W., Maffucci P., Pierce K.R., Abbott J.K.,
RA   Voelkerding K.V., South S.T., Augustine N.H., Bush J.S., Dolen W.K.,
RA   Wray B.B., Itan Y., Cobat A., Sorte H.S., Ganesan S., Prader S.,
RA   Martins T.B., Lawrence M.G., Orange J.S., Calvo K.R., Niemela J.E.,
RA   Casanova J.L., Fleisher T.A., Hill H.R., Kumanovics A., Conley M.E.,
RA   Rosenzweig S.D.;
RT   "Loss of B Cells in Patients with Heterozygous Mutations in IKAROS.";
RL   N. Engl. J. Med. 374:1032-1043(2016).
CC   -!- FUNCTION: Transcription regulator of hematopoietic cell differentiation
CC       (PubMed:17934067). Binds gamma-satellite DNA (PubMed:17135265,
CC       PubMed:19141594). Plays a role in the development of lymphocytes,
CC       B- and T-cells. Binds and activates the enhancer (delta-A element) of
CC       the CD3-delta gene. Repressor of the TDT (fikzfterminal
CC       deoxynucleotidyltransferase) gene during thymocyte differentiation.
CC       Regulates transcription through association with both HDAC-dependent
CC       and HDAC-independent complexes. Targets the 2 chromatin-remodeling
CC       complexes, NuRD and BAF (SWI/SNF), in a single complex (PYR complex),
CC       to the beta-globin locus in adult erythrocytes. Increases normal
CC       apoptosis in adult erythroid cells. Confers early temporal competence
CC       to retinal progenitor cells (RPCs) (By similarity). Function is
CC       isoform-specific and is modulated by dominant-negative inactive
CC       isoforms (PubMed:17135265, PubMed:17934067).
CC       {ECO:0000250|UniProtKB:Q03267, ECO:0000269|PubMed:10204490,
CC       ECO:0000269|PubMed:17135265, ECO:0000269|PubMed:17934067,
CC       ECO:0000269|PubMed:19141594}.
CC   -!- SUBUNIT: Heterodimer formed by the various isoforms; this modulates
CC       transcription regulator activity (PubMed:17135265, PubMed:17934067).
CC       Heterodimer with other IKAROS family members. Interacts with IKZF4 AND
CC       IKZF5 (PubMed:10978333). Component of the chromatin-remodeling NuRD
CC       repressor complex which includes at least HDAC1, HDAC2, RBBP4, RBBP7,
CC       IKZF1, MTA2, MBD2, MBD3, MTA1L1, CHD3 and CHD4. Interacts directly with
CC       the CHD4 component of the NuRD complex. Interacts directly with
CC       SMARCA4; the interaction associates IKFZ1 with the BAF complex
CC       (PubMed:10204490). Interacts with SUMO1; the interaction sumoylates
CC       IKAROS, promoted by PIAS2 and PIAS3. Interacts with PIAS2 (isoform
CC       alpha); the interaction promotes sumoylation and reduces transcription
CC       repression. Interacts, to a lesser extent, with PIAS3. Interacts with
CC       PPP1CC; the interaction targets PPP1CC to pericentromeric
CC       heterochromatin, dephosphorylates IKAROS, stabilizes it and prevents it
CC       from degradation. Interacts with IKZF3 (By similarity). {ECO:0000250,
CC       ECO:0000269|PubMed:10204490, ECO:0000269|PubMed:10978333,
CC       ECO:0000305|PubMed:17135265, ECO:0000305|PubMed:17934067}.
CC   -!- INTERACTION:
CC       Q13422; A8K932; NbExp=3; IntAct=EBI-745305, EBI-10174671;
CC       Q13422-7; Q13422-7; NbExp=3; IntAct=EBI-11522367, EBI-11522367;
CC       Q13422; Q8WTP8: AEN; NbExp=3; IntAct=EBI-745305, EBI-8637627;
CC       Q13422; Q96Q83: ALKBH3; NbExp=5; IntAct=EBI-745305, EBI-6658697;
CC       Q13422-7; A1A5B0: ANKRD36; NbExp=3; IntAct=EBI-11522367, EBI-14100900;
CC       Q13422; Q9BXS5: AP1M1; NbExp=3; IntAct=EBI-745305, EBI-541426;
CC       Q13422-7; Q9BXS5: AP1M1; NbExp=3; IntAct=EBI-11522367, EBI-541426;
CC       Q13422; Q9H6L4: ARMC7; NbExp=3; IntAct=EBI-745305, EBI-742909;
CC       Q13422-7; Q99728: BARD1; NbExp=3; IntAct=EBI-11522367, EBI-473181;
CC       Q13422; Q13895: BYSL; NbExp=5; IntAct=EBI-745305, EBI-358049;
CC       Q13422-7; Q13895: BYSL; NbExp=3; IntAct=EBI-11522367, EBI-358049;
CC       Q13422; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-745305, EBI-8643161;
CC       Q13422-7; Q9NX04: C1orf109; NbExp=3; IntAct=EBI-11522367, EBI-8643161;
CC       Q13422; Q8IYL3: C1orf174; NbExp=4; IntAct=EBI-745305, EBI-715898;
CC       Q13422-7; Q8IYL3: C1orf174; NbExp=3; IntAct=EBI-11522367, EBI-715898;
CC       Q13422; Q9H7E9: C8orf33; NbExp=3; IntAct=EBI-745305, EBI-715389;
CC       Q13422-7; Q9H7E9: C8orf33; NbExp=3; IntAct=EBI-11522367, EBI-715389;
CC       Q13422; Q9HC52: CBX8; NbExp=3; IntAct=EBI-745305, EBI-712912;
CC       Q13422-7; Q9HC52: CBX8; NbExp=3; IntAct=EBI-11522367, EBI-712912;
CC       Q13422-7; Q8N715: CCDC185; NbExp=3; IntAct=EBI-11522367, EBI-740814;
CC       Q13422-7; O00311: CDC7; NbExp=3; IntAct=EBI-11522367, EBI-374980;
CC       Q13422-7; Q8IVW4: CDKL3; NbExp=3; IntAct=EBI-11522367, EBI-3919850;
CC       Q13422; Q8IYX8-2: CEP57L1; NbExp=3; IntAct=EBI-745305, EBI-10181988;
CC       Q13422; P61024: CKS1B; NbExp=3; IntAct=EBI-745305, EBI-456371;
CC       Q13422-7; P61024: CKS1B; NbExp=3; IntAct=EBI-11522367, EBI-456371;
CC       Q13422-7; Q96SW2-2: CRBN; NbExp=2; IntAct=EBI-11522367, EBI-10693561;
CC       Q13422; Q13363-2: CTBP1; NbExp=3; IntAct=EBI-745305, EBI-10171858;
CC       Q13422-7; Q13363-2: CTBP1; NbExp=5; IntAct=EBI-11522367, EBI-10171858;
CC       Q13422; P56545: CTBP2; NbExp=5; IntAct=EBI-745305, EBI-741533;
CC       Q13422; P56545-3: CTBP2; NbExp=3; IntAct=EBI-745305, EBI-10171902;
CC       Q13422-7; P56545-3: CTBP2; NbExp=3; IntAct=EBI-11522367, EBI-10171902;
CC       Q13422-7; Q2TBE0: CWF19L2; NbExp=3; IntAct=EBI-11522367, EBI-5453285;
CC       Q13422; O43602: DCX; NbExp=4; IntAct=EBI-745305, EBI-8646694;
CC       Q13422-7; O43602-2: DCX; NbExp=3; IntAct=EBI-11522367, EBI-14148644;
CC       Q13422; P26196: DDX6; NbExp=3; IntAct=EBI-745305, EBI-351257;
CC       Q13422-7; P26196: DDX6; NbExp=3; IntAct=EBI-11522367, EBI-351257;
CC       Q13422; Q92630: DYRK2; NbExp=3; IntAct=EBI-745305, EBI-749432;
CC       Q13422; Q3B820: FAM161A; NbExp=3; IntAct=EBI-745305, EBI-719941;
CC       Q13422; Q7L5A3: FAM214B; NbExp=6; IntAct=EBI-745305, EBI-745689;
CC       Q13422-7; Q7L5A3: FAM214B; NbExp=3; IntAct=EBI-11522367, EBI-745689;
CC       Q13422; Q9Y247: FAM50B; NbExp=4; IntAct=EBI-745305, EBI-742802;
CC       Q13422; Q5TZK3: FAM74A6; NbExp=3; IntAct=EBI-745305, EBI-10247271;
CC       Q13422; P61328: FGF12; NbExp=3; IntAct=EBI-745305, EBI-6657662;
CC       Q13422-7; Q14192: FHL2; NbExp=3; IntAct=EBI-11522367, EBI-701903;
CC       Q13422; Q96NE9: FRMD6; NbExp=3; IntAct=EBI-745305, EBI-741729;
CC       Q13422-7; Q96NE9-2: FRMD6; NbExp=3; IntAct=EBI-11522367, EBI-13213391;
CC       Q13422; O76003: GLRX3; NbExp=3; IntAct=EBI-745305, EBI-374781;
CC       Q13422; Q8NEA9: GMCL2; NbExp=3; IntAct=EBI-745305, EBI-745707;
CC       Q13422; Q9H1K1: ISCU; NbExp=3; IntAct=EBI-745305, EBI-1047335;
CC       Q13422-7; A0A0S2Z5S9: LHX4; NbExp=3; IntAct=EBI-11522367, EBI-16429099;
CC       Q13422-7; P25800: LMO1; NbExp=3; IntAct=EBI-11522367, EBI-8639312;
CC       Q13422-7; P25791-3: LMO2; NbExp=3; IntAct=EBI-11522367, EBI-11959475;
CC       Q13422; Q8TAP4: LMO3; NbExp=3; IntAct=EBI-745305, EBI-742259;
CC       Q13422-7; Q8TAP4-4: LMO3; NbExp=3; IntAct=EBI-11522367, EBI-11742507;
CC       Q13422-7; P61968: LMO4; NbExp=3; IntAct=EBI-11522367, EBI-2798728;
CC       Q13422; Q9Y4Z0: LSM4; NbExp=3; IntAct=EBI-745305, EBI-372521;
CC       Q13422; Q9UI95: MAD2L2; NbExp=3; IntAct=EBI-745305, EBI-77889;
CC       Q13422-7; Q96A72: MAGOHB; NbExp=3; IntAct=EBI-11522367, EBI-746778;
CC       Q13422-7; Q9UPY8: MAPRE3; NbExp=3; IntAct=EBI-11522367, EBI-726739;
CC       Q13422; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-745305, EBI-348259;
CC       Q13422-7; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-11522367, EBI-348259;
CC       Q13422-7; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-11522367, EBI-16439278;
CC       Q13422; Q9UBU8: MORF4L1; NbExp=3; IntAct=EBI-745305, EBI-399246;
CC       Q13422; Q15014: MORF4L2; NbExp=3; IntAct=EBI-745305, EBI-399257;
CC       Q13422-7; P00540: MOS; NbExp=3; IntAct=EBI-11522367, EBI-1757866;
CC       Q13422; Q13330: MTA1; NbExp=3; IntAct=EBI-745305, EBI-714236;
CC       Q13422; Q9HC98: NEK6; NbExp=3; IntAct=EBI-745305, EBI-740364;
CC       Q13422-7; Q9Y5B8: NME7; NbExp=6; IntAct=EBI-11522367, EBI-744782;
CC       Q13422; Q9BVI4: NOC4L; NbExp=3; IntAct=EBI-745305, EBI-395927;
CC       Q13422-7; O43809: NUDT21; NbExp=3; IntAct=EBI-11522367, EBI-355720;
CC       Q13422-7; O75928-2: PIAS2; NbExp=3; IntAct=EBI-11522367, EBI-348567;
CC       Q13422; Q13526: PIN1; NbExp=3; IntAct=EBI-745305, EBI-714158;
CC       Q13422-7; Q13526: PIN1; NbExp=3; IntAct=EBI-11522367, EBI-714158;
CC       Q13422; Q96T60: PNKP; NbExp=3; IntAct=EBI-745305, EBI-1045072;
CC       Q13422-7; Q96T60: PNKP; NbExp=3; IntAct=EBI-11522367, EBI-1045072;
CC       Q13422-7; O60437: PPL; NbExp=3; IntAct=EBI-11522367, EBI-368321;
CC       Q13422-7; P54646: PRKAA2; NbExp=3; IntAct=EBI-11522367, EBI-1383852;
CC       Q13422; O43741: PRKAB2; NbExp=3; IntAct=EBI-745305, EBI-1053424;
CC       Q13422-7; Q99633: PRPF18; NbExp=3; IntAct=EBI-11522367, EBI-2798416;
CC       Q13422; P25786: PSMA1; NbExp=3; IntAct=EBI-745305, EBI-359352;
CC       Q13422; P25789: PSMA4; NbExp=3; IntAct=EBI-745305, EBI-359310;
CC       Q13422-7; P25789: PSMA4; NbExp=3; IntAct=EBI-11522367, EBI-359310;
CC       Q13422-7; P47897: QARS; NbExp=3; IntAct=EBI-11522367, EBI-347462;
CC       Q13422; O75771: RAD51D; NbExp=5; IntAct=EBI-745305, EBI-1055693;
CC       Q13422-7; O75771: RAD51D; NbExp=3; IntAct=EBI-11522367, EBI-1055693;
CC       Q13422-7; Q6ZSC3: RBM43; NbExp=3; IntAct=EBI-11522367, EBI-2880658;
CC       Q13422-7; P78317: RNF4; NbExp=3; IntAct=EBI-11522367, EBI-2340927;
CC       Q13422-7; A0A0S2Z4G9: RNF6; NbExp=3; IntAct=EBI-11522367, EBI-16428950;
CC       Q13422; P57060: RWDD2B; NbExp=4; IntAct=EBI-745305, EBI-724442;
CC       Q13422; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-745305, EBI-748391;
CC       Q13422-7; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-11522367, EBI-748391;
CC       Q13422; O00560: SDCBP; NbExp=3; IntAct=EBI-745305, EBI-727004;
CC       Q13422; Q9H788: SH2D4A; NbExp=3; IntAct=EBI-745305, EBI-747035;
CC       Q13422; Q9NUL5: SHFL; NbExp=3; IntAct=EBI-745305, EBI-10313866;
CC       Q13422-7; P09661: SNRPA1; NbExp=3; IntAct=EBI-11522367, EBI-876439;
CC       Q13422; P62306: SNRPF; NbExp=3; IntAct=EBI-745305, EBI-356900;
CC       Q13422-7; P62306: SNRPF; NbExp=3; IntAct=EBI-11522367, EBI-356900;
CC       Q13422; Q13573: SNW1; NbExp=3; IntAct=EBI-745305, EBI-632715;
CC       Q13422; Q9H0A9: SPATC1L; NbExp=3; IntAct=EBI-745305, EBI-372911;
CC       Q13422; Q9BSW7: SYT17; NbExp=3; IntAct=EBI-745305, EBI-745392;
CC       Q13422-7; Q15560: TCEA2; NbExp=3; IntAct=EBI-11522367, EBI-710310;
CC       Q13422-7; Q5T7W7: TSTD2; NbExp=3; IntAct=EBI-11522367, EBI-8994397;
CC       Q13422-7; P42681: TXK; NbExp=3; IntAct=EBI-11522367, EBI-7877438;
CC       Q13422; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-745305, EBI-10180829;
CC       Q13422-7; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-11522367, EBI-10180829;
CC       Q13422; Q15007: WTAP; NbExp=3; IntAct=EBI-745305, EBI-751647;
CC       Q13422-7; Q15007: WTAP; NbExp=7; IntAct=EBI-11522367, EBI-751647;
CC       Q13422; Q96NC0: ZMAT2; NbExp=3; IntAct=EBI-745305, EBI-2682299;
CC       Q13422; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-745305, EBI-740727;
CC       Q13422-7; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-11522367, EBI-740727;
CC       Q13422-7; Q9UK33: ZNF580; NbExp=3; IntAct=EBI-11522367, EBI-746277;
CC       Q13422; Q9P0T4: ZNF581; NbExp=3; IntAct=EBI-745305, EBI-745520;
CC       Q13422-7; Q96SQ5: ZNF587; NbExp=3; IntAct=EBI-11522367, EBI-6427977;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:17135265,
CC       ECO:0000269|PubMed:21548011, ECO:0000269|PubMed:22106042,
CC       ECO:0000269|PubMed:23071339}. Note=In resting lymphocytes, distributed
CC       diffusely throughout the nucleus. Localizes to pericentromeric
CC       heterochromatin in proliferating cells. This localization requires DNA
CC       binding which is regulated by phosphorylation / dephosphorylation
CC       events. {ECO:0000269|PubMed:17135265, ECO:0000269|PubMed:22106042}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Ik2]: Nucleus. Note=In resting
CC       lymphocytes, distributed diffusely throughout the nucleus. Localizes to
CC       pericentromeric heterochromatin in proliferating cells. This
CC       localization requires DNA binding which is regulated by phosphorylation
CC       / dephosphorylation events (By similarity). {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: [Isoform Ik6]: Cytoplasm {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=8;
CC       Name=Ik1;
CC         IsoId=Q13422-1; Sequence=Displayed;
CC       Name=Ik2;
CC         IsoId=Q13422-2; Sequence=VSP_006848;
CC       Name=Ik3;
CC         IsoId=Q13422-3; Sequence=VSP_006850;
CC       Name=Ik4;
CC         IsoId=Q13422-4; Sequence=VSP_006847, VSP_006850;
CC       Name=Ik5;
CC         IsoId=Q13422-5; Sequence=VSP_006852;
CC       Name=Ik6;
CC         IsoId=Q13422-6; Sequence=VSP_006849;
CC       Name=Ik7;
CC         IsoId=Q13422-7; Sequence=VSP_006851;
CC       Name=Ikx;
CC         IsoId=Q13422-8; Sequence=VSP_006851, VSP_053404, VSP_053405;
CC   -!- TISSUE SPECIFICITY: Abundantly expressed in thymus, spleen and
CC       peripheral blood Leukocytes and lymph nodes. Lower expression in bone
CC       marrow and small intestine. {ECO:0000269|PubMed:8543809,
CC       ECO:0000269|PubMed:8964602}.
CC   -!- DOMAIN: The N-terminal zinc-fingers 2 and 3 are required for DNA
CC       binding as well as for targeting IKFZ1 to pericentromeric
CC       heterochromatin. {ECO:0000250}.
CC   -!- DOMAIN: The C-terminal zinc-finger domain is required for dimerization.
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylation controls cell-cycle progression from late G(1)
CC       stage to S stage. Hyperphosphorylated during G2/M phase.
CC       Dephosphorylated state during late G(1) phase. Phosphorylation on Thr-
CC       140 is required for DNA and pericentromeric location during mitosis.
CC       CK2 is the main kinase, in vitro. GSK3 and CDK may also contribute to
CC       phosphorylation of the C-terminal serine and threonine residues.
CC       Phosphorylation on these C-terminal residues reduces the DNA-binding
CC       ability. Phosphorylation/dephosphorylation events on Ser-13 and Ser-295
CC       regulate TDT expression during thymocyte differentiation.
CC       Dephosphorylation by protein phosphatase 1 regulates stability and
CC       pericentromeric heterochromatin location. Phosphorylated in both
CC       lymphoid and non-lymphoid tissues (By similarity). Phosphorylation at
CC       Ser-361 and Ser-364 downstream of SYK induces nuclear translocation.
CC       {ECO:0000250, ECO:0000269|PubMed:22106042,
CC       ECO:0000269|PubMed:23071339}.
CC   -!- PTM: Sumoylated. Simulataneous sumoylation on the 2 sites results in a
CC       loss of both HDAC-dependent and HDAC-independent repression. Has no
CC       effect on pericentromeric heterochromatin location. Desumoylated by
CC       SENP1 (By similarity). {ECO:0000250}.
CC   -!- PTM: Polyubiquitinated. {ECO:0000250}.
CC   -!- DISEASE: Note=Defects in IKZF1 are frequent occurrences (28.6%) in
CC       acute lymphoblasic leukemia (ALL). Such alterations or deletions lead
CC       to poor prognosis for ALL.
CC   -!- DISEASE: Note=Chromosomal aberrations involving IKZF1 are a cause of B-
CC       cell non-Hodgkin lymphomas (B-cell NHL). Translocation t(3;7)(q27;p12),
CC       with BCL6.
CC   -!- DISEASE: Immunodeficiency, common variable, 13 (CVID13) [MIM:616873]: A
CC       primary immunodeficiency characterized by antibody deficiency,
CC       hypogammaglobulinemia, recurrent bacterial infections and an inability
CC       to mount an antibody response to antigen. CVID13 is an autosomal
CC       dominant disease associated with a striking decrease in B-cell numbers.
CC       {ECO:0000269|PubMed:21548011, ECO:0000269|PubMed:26981933}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- SIMILARITY: Belongs to the Ikaros C2H2-type zinc-finger protein family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/IkarosID258.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U40462; AAC50459.1; -; mRNA.
DR   EMBL; S80876; AAB50683.1; -; mRNA.
DR   EMBL; AY377974; AAR84585.1; -; mRNA.
DR   EMBL; AK303586; BAG64603.1; -; mRNA.
DR   EMBL; BT009836; AAP88838.1; -; mRNA.
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471128; EAW60977.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW60978.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW60981.1; -; Genomic_DNA.
DR   EMBL; CH236955; EAL23900.1; -; Genomic_DNA.
DR   EMBL; CH471128; EAW60979.1; -; Genomic_DNA.
DR   EMBL; BC018349; AAH18349.1; -; mRNA.
DR   CCDS; CCDS59055.1; -. [Q13422-7]
DR   CCDS; CCDS69299.1; -. [Q13422-5]
DR   CCDS; CCDS75596.1; -. [Q13422-1]
DR   CCDS; CCDS75597.1; -. [Q13422-3]
DR   CCDS; CCDS78233.1; -. [Q13422-2]
DR   RefSeq; NP_001207694.1; NM_001220765.2. [Q13422-7]
DR   RefSeq; NP_001207696.1; NM_001220767.2.
DR   RefSeq; NP_001207697.1; NM_001220768.2. [Q13422-3]
DR   RefSeq; NP_001207699.1; NM_001220770.2.
DR   RefSeq; NP_001207700.1; NM_001220771.2. [Q13422-5]
DR   RefSeq; NP_001278766.1; NM_001291837.1. [Q13422-7]
DR   RefSeq; NP_001278767.1; NM_001291838.1. [Q13422-2]
DR   RefSeq; NP_001278768.1; NM_001291839.1.
DR   RefSeq; NP_001278769.1; NM_001291840.1. [Q13422-6]
DR   RefSeq; NP_001278770.1; NM_001291841.1.
DR   RefSeq; NP_001278771.1; NM_001291842.1.
DR   RefSeq; NP_001278772.1; NM_001291843.1.
DR   RefSeq; NP_001278773.1; NM_001291844.1.
DR   RefSeq; NP_006051.1; NM_006060.5. [Q13422-1]
DR   RefSeq; XP_011513370.1; XM_011515068.2. [Q13422-1]
DR   RefSeq; XP_011513371.1; XM_011515069.2. [Q13422-1]
DR   RefSeq; XP_011513377.1; XM_011515075.2. [Q13422-2]
DR   RefSeq; XP_011513378.1; XM_011515076.2. [Q13422-2]
DR   RefSeq; XP_016867157.1; XM_017011668.1. [Q13422-2]
DR   PDB; 6H0F; X-ray; 3.25 A; C/F/I/L=141-174.
DR   PDBsum; 6H0F; -.
DR   SMR; Q13422; -.
DR   BioGrid; 115604; 153.
DR   DIP; DIP-41110N; -.
DR   ELM; Q13422; -.
DR   IntAct; Q13422; 133.
DR   MINT; Q13422; -.
DR   STRING; 9606.ENSP00000331614; -.
DR   iPTMnet; Q13422; -.
DR   MetOSite; Q13422; -.
DR   PhosphoSitePlus; Q13422; -.
DR   BioMuta; IKZF1; -.
DR   DMDM; 3913926; -.
DR   EPD; Q13422; -.
DR   jPOST; Q13422; -.
DR   MassIVE; Q13422; -.
DR   MaxQB; Q13422; -.
DR   PaxDb; Q13422; -.
DR   PeptideAtlas; Q13422; -.
DR   PRIDE; Q13422; -.
DR   ProteomicsDB; 59401; -. [Q13422-1]
DR   ProteomicsDB; 59402; -. [Q13422-2]
DR   ProteomicsDB; 59403; -. [Q13422-3]
DR   ProteomicsDB; 59404; -. [Q13422-4]
DR   ProteomicsDB; 59405; -. [Q13422-5]
DR   ProteomicsDB; 59406; -. [Q13422-6]
DR   ProteomicsDB; 59407; -. [Q13422-7]
DR   ProteomicsDB; 66152; -.
DR   Antibodypedia; 3980; 526 antibodies.
DR   DNASU; 10320; -.
DR   Ensembl; ENST00000331340; ENSP00000331614; ENSG00000185811. [Q13422-1]
DR   Ensembl; ENST00000343574; ENSP00000342750; ENSG00000185811. [Q13422-2]
DR   Ensembl; ENST00000349824; ENSP00000342485; ENSG00000185811. [Q13422-5]
DR   Ensembl; ENST00000357364; ENSP00000349928; ENSG00000185811. [Q13422-3]
DR   Ensembl; ENST00000359197; ENSP00000352123; ENSG00000185811. [Q13422-7]
DR   Ensembl; ENST00000438033; ENSP00000396554; ENSG00000185811. [Q13422-2]
DR   Ensembl; ENST00000439701; ENSP00000413025; ENSG00000185811. [Q13422-7]
DR   GeneID; 10320; -.
DR   KEGG; hsa:10320; -.
DR   UCSC; uc003tow.5; human. [Q13422-1]
DR   CTD; 10320; -.
DR   DisGeNET; 10320; -.
DR   GeneCards; IKZF1; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   HPA; ENSG00000185811; Tissue enhanced (blood, bone marrow, lymphoid tissue).
DR   MalaCards; IKZF1; -.
DR   MIM; 603023; gene.
DR   MIM; 616873; phenotype.
DR   neXtProt; NX_Q13422; -.
DR   OpenTargets; ENSG00000185811; -.
DR   Orphanet; 317473; Pancytopenia due to IKZF1 mutations.
DR   Orphanet; 99860; Precursor B-cell acute lymphoblastic leukemia.
DR   Orphanet; 36426; Stevens-Johnson syndrome.
DR   PharmGKB; PA37748; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000156782; -.
DR   HOGENOM; CLU_025502_2_0_1; -.
DR   InParanoid; Q13422; -.
DR   KO; K09220; -.
DR   OMA; HARNGIS; -.
DR   OrthoDB; 385551at2759; -.
DR   PhylomeDB; Q13422; -.
DR   TreeFam; TF331189; -.
DR   Reactome; R-HSA-9013508; NOTCH3 Intracellular Domain Regulates Transcription. [Q13422-1]
DR   SignaLink; Q13422; -.
DR   SIGNOR; Q13422; -.
DR   ChiTaRS; IKZF1; human.
DR   GeneWiki; IKZF1; -.
DR   GenomeRNAi; 10320; -.
DR   Pharos; Q13422; Tbio.
DR   PRO; PR:Q13422; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   RNAct; Q13422; protein.
DR   Bgee; ENSG00000185811; Expressed in leukocyte and 183 other tissues.
DR   ExpressionAtlas; Q13422; baseline and differential.
DR   Genevisible; Q13422; HS.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0031618; C:nuclear pericentric heterochromatin; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IBA:GO_Central.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:CAFA.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IBA:GO_Central.
DR   GO; GO:0007049; P:cell cycle; IEA:UniProtKB-KW.
DR   GO; GO:0006325; P:chromatin organization; IEA:UniProtKB-KW.
DR   GO; GO:0030218; P:erythrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0030098; P:lymphocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0007498; P:mesoderm development; TAS:ProtInc.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Cell cycle;
KW   Chromatin regulator; Chromosomal rearrangement; Cytoplasm;
KW   Developmental protein; Disease mutation; DNA-binding; Isopeptide bond;
KW   Metal-binding; Nucleus; Phosphoprotein; Reference proteome; Repeat;
KW   Repressor; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..519
FT                   /note="DNA-binding protein Ikaros"
FT                   /id="PRO_0000047094"
FT   ZN_FING         117..139
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         145..167
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         173..195
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         201..224
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         462..484
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         490..514
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   REGION          154..163
FT                   /note="Required for both high-affinity DNA binding and
FT                   pericentromeric heterochromatin localization"
FT                   /evidence="ECO:0000250"
FT   REGION          180..195
FT                   /note="Required for both high-affinity DNA binding and
FT                   pericentromeric heterochromatin localization"
FT                   /evidence="ECO:0000250"
FT   REGION          468..471
FT                   /note="Required for binding PP1CC"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        373..376
FT                   /note="Poly-Leu"
FT   SITE            159
FT                   /note="Required for both pericentromeric heterochromatin
FT                   localization and complete DNA binding"
FT                   /evidence="ECO:0000250"
FT   SITE            162
FT                   /note="Required for both pericentromeric heterochromatin
FT                   localization and complete DNA binding"
FT                   /evidence="ECO:0000250"
FT   SITE            188
FT                   /note="Required for both pericentromeric heterochromatin
FT                   localization and DNA binding"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         13
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         23
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         63
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         101
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         140
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         168
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         196
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         258
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         261
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         289
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         295
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         298
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         361
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000269|PubMed:23071339"
FT   MOD_RES         364
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:23071339"
FT   MOD_RES         368
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         389
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         391
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         393
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         397
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         398
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         402
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q03267"
FT   MOD_RES         427
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         445
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   CROSSLNK        58
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   CROSSLNK        241
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         10..53
FT                   /note="Missing (in isoform Ik4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006847"
FT   VAR_SEQ         54..283
FT                   /note="Missing (in isoform Ik6)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006849"
FT   VAR_SEQ         54..140
FT                   /note="Missing (in isoform Ik2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_006848"
FT   VAR_SEQ         141..283
FT                   /note="Missing (in isoform Ik5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006852"
FT   VAR_SEQ         197..283
FT                   /note="Missing (in isoform Ik3 and isoform Ik4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006850"
FT   VAR_SEQ         197..238
FT                   /note="Missing (in isoform Ik7 and isoform Ikx)"
FT                   /evidence="ECO:0000303|PubMed:15489334, ECO:0000303|Ref.3,
FT                   ECO:0000303|Ref.5"
FT                   /id="VSP_006851"
FT   VAR_SEQ         260..268
FT                   /note="RSLVLDRLA -> ISRAGQTSK (in isoform Ikx)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_053404"
FT   VAR_SEQ         269..519
FT                   /note="Missing (in isoform Ikx)"
FT                   /evidence="ECO:0000303|Ref.3"
FT                   /id="VSP_053405"
FT   VARIANT         162
FT                   /note="R -> L (in CVID13; abolishes binding to DNA; has
FT                   diffuse nuclear localization; dbSNP:rs770551610)"
FT                   /evidence="ECO:0000269|PubMed:26981933"
FT                   /id="VAR_076401"
FT   VARIANT         162
FT                   /note="R -> Q (in CVID13; abolishes binding to DNA; has
FT                   diffuse nuclear localization; dbSNP:rs770551610)"
FT                   /evidence="ECO:0000269|PubMed:26981933"
FT                   /id="VAR_076402"
FT   VARIANT         167
FT                   /note="H -> R (in CVID13; abolishes binding to DNA; has
FT                   diffuse nuclear localization; dbSNP:rs869312884)"
FT                   /evidence="ECO:0000269|PubMed:26981933"
FT                   /id="VAR_076403"
FT   VARIANT         184
FT                   /note="R -> Q (in CVID13; abolishes binding to DNA; has
FT                   diffuse nuclear localization; dbSNP:rs869312885)"
FT                   /evidence="ECO:0000269|PubMed:26981933"
FT                   /id="VAR_076404"
FT   VARIANT         210
FT                   /note="Y -> C (in CVID13; decreases binding to
FT                   pericentromeric heterochromatin DNA; has diffuse nuclear
FT                   localization; dbSNP:rs869312883)"
FT                   /evidence="ECO:0000269|PubMed:21548011,
FT                   ECO:0000269|PubMed:26981933"
FT                   /id="VAR_076405"
FT   MUTAGEN         159
FT                   /note="N->A: Abolishes binding to DNA and has diffuse
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:26981933"
FT   MUTAGEN         191
FT                   /note="H->R: Abolishes binding to DNA and has diffuse
FT                   nuclear localization."
FT                   /evidence="ECO:0000269|PubMed:26981933"
FT   CONFLICT        11..12
FT                   /note="QV -> FS (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        214
FT                   /note="S -> T (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        245
FT                   /note="N -> K (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        296
FT                   /note="Missing (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        298
FT                   /note="S -> T (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        352..355
FT                   /note="KPLA -> RRS (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        372
FT                   /note="N -> Y (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        420..426
FT                   /note="PHARNGL -> RRAQRV (in Ref. 2; AAB50683)"
FT                   /evidence="ECO:0000305"
FT   TURN            148..150
FT                   /evidence="ECO:0000244|PDB:6H0F"
FT   STRAND          153..156
FT                   /evidence="ECO:0000244|PDB:6H0F"
FT   HELIX           157..168
FT                   /evidence="ECO:0000244|PDB:6H0F"
SQ   SEQUENCE   519 AA;  57528 MW;  7B0129C4E3FE41A8 CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVASNVKVE
     TQSDEENGRA CEMNGEECAE DLRMLDASGE KMNGSHRDQG SSALSGVGGI RLPNGKLKCD
     ICGIICIGPN VLMVHKRSHT GERPFQCNQC GASFTQKGNL LRHIKLHSGE KPFKCHLCNY
     ACRRRDALTG HLRTHSVGKP HKCGYCGRSY KQRSSLEEHK ERCHNYLESM GLPGTLYPVI
     KEETNHSEMA EDLCKIGSER SLVLDRLASN VAKRKSSMPQ KFLGDKGLSD TPYDSSASYE
     KENEMMKSHV MDQAINNAIN YLGAESLRPL VQTPPGGSEV VPVISPMYQL HKPLAEGTPR
     SNHSAQDSAV ENLLLLSKAK LVPSEREASP SNSCQDSTDT ESNNEEQRSG LIYLTNHIAP
     HARNGLSLKE EHRAYDLLRA ASENSQDALR VVSTSGEQMK VYKCEHCRVL FLDHVMYTIH
     MGCHGFRDPF ECNMCGYHSQ DRYEFSSHIT RGEHRFHMS
//
ID   R9R4D9_HUMAN            Unreviewed;       268 AA.
AC   R9R4D9;
DT   18-SEP-2013, integrated into UniProtKB/TrEMBL.
DT   18-SEP-2013, sequence version 1.
DT   22-APR-2020, entry version 59.
DE   SubName: Full=DNA-binding protein Ikaros {ECO:0000313|Ensembl:ENSP00000483016};
DE   SubName: Full=IKAROS family zinc finger 1 isoform 14 {ECO:0000313|EMBL:AGI59420.1};
GN   Name=IKZF1 {ECO:0000313|EMBL:AGI59420.1,
GN   ECO:0000313|Ensembl:ENSP00000483016};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AGI59420.1};
RN   [1] {ECO:0000313|Ensembl:ENSP00000483016, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12853948; DOI=10.1038/nature01782;
RA   Hillier L.W., Fulton R.S., Fulton L.A., Graves T.A., Pepin K.H.,
RA   Wagner-McPherson C., Layman D., Maas J., Jaeger S., Walker R., Wylie K.,
RA   Sekhon M., Becker M.C., O'Laughlin M.D., Schaller M.E., Fewell G.A.,
RA   Delehaunty K.D., Miner T.L., Nash W.E., Cordes M., Du H., Sun H.,
RA   Edwards J., Bradshaw-Cordum H., Ali J., Andrews S., Isak A., Vanbrunt A.,
RA   Nguyen C., Du F., Lamar B., Courtney L., Kalicki J., Ozersky P.,
RA   Bielicki L., Scott K., Holmes A., Harkins R., Harris A., Strong C.M.,
RA   Hou S., Tomlinson C., Dauphin-Kohlberg S., Kozlowicz-Reilly A., Leonard S.,
RA   Rohlfing T., Rock S.M., Tin-Wollam A.-M., Abbott A., Minx P., Maupin R.,
RA   Strowmatt C., Latreille P., Miller N., Johnson D., Murray J.,
RA   Woessner J.P., Wendl M.C., Yang S.-P., Schultz B.R., Wallis J.W.,
RA   Spieth J., Bieri T.A., Nelson J.O., Berkowicz N., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Bedell J.A.,
RA   Mardis E.R., Clifton S.W., Chissoe S.L., Marra M.A., Raymond C., Haugen E.,
RA   Gillett W., Zhou Y., James R., Phelps K., Iadanoto S., Bubb K., Simms E.,
RA   Levy R., Clendenning J., Kaul R., Kent W.J., Furey T.S., Baertsch R.A.,
RA   Brent M.R., Keibler E., Flicek P., Bork P., Suyama M., Bailey J.A.,
RA   Portnoy M.E., Torrents D., Chinwalla A.T., Gish W.R., Eddy S.R.,
RA   McPherson J.D., Olson M.V., Eichler E.E., Green E.D., Waterston R.H.,
RA   Wilson R.K.;
RT   "The DNA sequence of human chromosome 7.";
RL   Nature 424:157-164(2003).
RN   [2] {ECO:0000213|PubMed:19690332}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [3] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [4] {ECO:0000313|EMBL:AGI59420.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Capece D., Zazzeroni F., Mancarelli M.M., Verzella D., Fischietti M.,
RA   Di Tommaso A., Plebani S., Di Ianni M., Gulino A., Alesse E.;
RT   "A novel, non-canonical splice variant of Ikaros gene is aberrantly
RT   expressed in B-cell lymphoproliferative disorders.";
RL   Submitted (AUG-2012) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [6] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [7] {ECO:0000313|Ensembl:ENSP00000483016}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC124014; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC233268; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AUXG01000057; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; JX459579; AGI59420.1; -; mRNA.
DR   RefSeq; NP_001207694.1; NM_001220765.2.
DR   RefSeq; NP_001207696.1; NM_001220767.2.
DR   RefSeq; NP_001207697.1; NM_001220768.2.
DR   RefSeq; NP_001207699.1; NM_001220770.2.
DR   RefSeq; NP_001207700.1; NM_001220771.2.
DR   RefSeq; NP_001278766.1; NM_001291837.1.
DR   RefSeq; NP_001278767.1; NM_001291838.1.
DR   RefSeq; NP_001278768.1; NM_001291839.1.
DR   RefSeq; NP_001278769.1; NM_001291840.1.
DR   RefSeq; NP_001278770.1; NM_001291841.1.
DR   RefSeq; NP_001278771.1; NM_001291842.1.
DR   RefSeq; NP_001278772.1; NM_001291843.1.
DR   RefSeq; NP_001278773.1; NM_001291844.1.
DR   RefSeq; NP_006051.1; NM_006060.5.
DR   Antibodypedia; 3980; 526 antibodies.
DR   Ensembl; ENST00000612658; ENSP00000483016; ENSG00000185811.
DR   GeneID; 10320; -.
DR   KEGG; hsa:10320; -.
DR   UCSC; uc064dpn.1; human.
DR   CTD; 10320; -.
DR   EuPathDB; HostDB:ENSG00000185811.16; -.
DR   HGNC; HGNC:13176; IKZF1.
DR   OpenTargets; ENSG00000185811; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000156782; -.
DR   KO; K09220; -.
DR   OrthoDB; 385551at2759; -.
DR   ChiTaRS; IKZF1; human.
DR   GenomeRNAi; 10320; -.
DR   Proteomes; UP000005640; Chromosome 7.
DR   Bgee; ENSG00000185811; Expressed in leukocyte and 183 other tissues.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00096; zf-C2H2; 1.
DR   SMART; SM00355; ZnF_C2H2; 3.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 2.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 1.
PE   1: Evidence at protein level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Proteomics identification {ECO:0000213|EPD:R9R4D9,
KW   ECO:0000213|MaxQB:R9R4D9, ECO:0000213|PeptideAtlas:R9R4D9,
KW   ECO:0000213|ProteomicsDB:R9R4D9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          78..100
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          130..155
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        135..155
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   268 AA;  30031 MW;  3A4F6647250035C0 CRC64;
     MDADEGQDMS QVSGKESPPV SDTPDEGDEP MPIPEDLSTT SGGQQSSKSD RVVVTYGADD
     FRDFHAIIPK SFSRERPFQC NQCGASFTQK GNLLRHIKLH KPLAEGTPRS NHSAQDSAVE
     NLLLLSKAKL VPSEREASPS NSCQDSTDTE SNNEEQRSGL IYLTNHIAPH ARNGLSLKEE
     HRAYDLLRAA SENSQDALRV VSTSGEQMKV YKCEHCRVLF LDHVMYTIHM GCHGFRDPFE
     CNMCGYHSQD RYEFSSHITR GEHRFHMS
//
ID   B2RWN8_HUMAN            Unreviewed;      2073 AA.
AC   B2RWN8;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   11-DEC-2019, entry version 80.
DE   RecName: Full=Histone acetyltransferase {ECO:0000256|RuleBase:RU361211};
DE            EC=2.3.1.48 {ECO:0000256|RuleBase:RU361211};
GN   Name=MYST4 {ECO:0000313|EMBL:AAI50619.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAI50619.1};
RN   [1] {ECO:0000313|EMBL:AAI50619.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAI50619.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000256|RuleBase:RU361211};
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000256|RuleBase:RU361211}.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family.
CC       {ECO:0000256|RuleBase:RU361211}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC150618; AAI50619.1; -; mRNA.
DR   RefSeq; NP_001243397.1; NM_001256468.1.
DR   RefSeq; NP_001243398.1; NM_001256469.1.
DR   RefSeq; NP_036462.2; NM_012330.3.
DR   PeptideAtlas; B2RWN8; -.
DR   PRIDE; B2RWN8; -.
DR   GeneID; 23522; -.
DR   KEGG; hsa:23522; -.
DR   CTD; 23522; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   KO; K11306; -.
DR   OrthoDB; 629545at2759; -.
DR   ChiTaRS; KAT6B; human.
DR   GenomeRNAi; 23522; -.
DR   GO; GO:0000786; C:nucleosome; IEA:InterPro.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IEA:UniProtKB-EC.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0006334; P:nucleosome assembly; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   Gene3D; 1.10.10.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF00628; PHD; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SMART; SM00526; H15; 1.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51504; H15; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077}; Nucleus {ECO:0000256|RuleBase:RU361211};
KW   Transferase {ECO:0000313|EMBL:AAI50619.1};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00146, ECO:0000256|SAAS:SAAS01007077};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077}.
FT   DOMAIN          103..176
FT                   /note="H15"
FT                   /evidence="ECO:0000259|PROSITE:PS51504"
FT   DOMAIN          213..272
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50016"
FT   DOMAIN          269..320
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50016"
FT   DOMAIN          715..989
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000259|PROSITE:PS51726"
FT   REGION          72..97
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          360..409
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          442..531
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          553..583
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          639..663
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1022..1452
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1484..1538
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1580..1619
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          994..1021
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        471..488
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        503..531
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        569..583
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1028..1048
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1067..1105
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1124..1139
FT                   /note="Basic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1143..1157
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1160..1190
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1197..1216
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1286..1329
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1347..1377
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1378..1404
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1405..1436
FT                   /note="Acidic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1437..1452
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1507..1533
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        891
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000256|PIRSR:PIRSR602717-51"
SQ   SEQUENCE   2073 AA;  231390 MW;  1BBC7262B7F3D81D CRC64;
     MVKLANPLYI EWILEAIQKI KKQKQRPSEE RICHAVSTSH GLDKKTVSEQ LELSVQDGSV
     LKVTNKGLAS YKDPDNPGRF SSVKPGTFPK SAKGSRGSCN DLRNVDWNKL LRRAIEGLEE
     PNGSSLKNIE KYLRSQSDLT STTNNPAFQQ RLRLGAKRAV NNGRLLKDGP QYRVNYGSLD
     GKGAPQYPSA FPSSLPPVSL LPHEKDQPRA DPIPICSFCL GTKESNREKK PEELLSCADC
     GSSGHPSCLK FCPELTTNVK ALRWQCIECK TCSACRVQGR NADNMLFCDS CDRGFHMECC
     DPPLSRMPKG MWICQVCRPK KKGRKLLHEK AAQIKRRYAK PIGRPKNKLK QRLLSVTSDE
     GSMNAFTGRG SPGRGQKTKV CTTPSSGHAA SGKDSSSRLA VTDPTRPGAT TKITTTSTYI
     SASTLKVNKK TKGLIDGLTK FFTPSPDGRR SRGEIIDFSK HYRPRKKVSQ KQSCTSHVLA
     TGTTQKLKPP PSSLPPPTPI SGQSPSSQKS STATSSPSPQ SSSSQCSVPS LSSLTTNSQL
     KALFDGLSHI YTTQGQSRKK GHPSYAPPKR MRRKTELSST AKSKAHFFGK RDIRSRFISH
     SSSSSWGMAR GSIFKAIAHF KRTTFLKKHR MLGRLKYKVT PQMGTPSPGK GSLTDGRIKP
     DQDDDTEIKI NIKQESADVN VIGNKDVVTE EDLDVFKQAQ ELSWEKIECE SGVEDCGRYP
     SVIEFGKYEI QTWYSSPYPQ EYARLPKLYL CEFCLKYMKS KNILLRHSKK CGWFHPPANE
     IYRRKDLSVF EVDGNMSKIY CQNLCLLAKL FLDHKTLYYD VEPFLFYVLT KNDEKGCHLV
     GYFSKEKLCQ QKYNVSCIMI MPQHQRQGFG RFLIDFSYLL SRREGQAGSP EKPLSDLGRL
     SYLAYWKSVI LEYLYHHHER HISIKAISRA TGMCPHDIAT TLQHLHMIDK RDGRFVIIRR
     EKLILSHMEK LKTCSRANEL DPDSLRWTPI LISNAAVSEE EREAEKEAER LMEQASCWEK
     EEQEILSTRA NSRQSPAKVQ SKNKYLHSPE SRPVTGERGQ LLELSKESSE EEEEEEDEEE
     EEEEEEEEED EEEEEEEEEE EEEENIQSSP PRLTKPQSVA IKRKRPFVLK KKRGRKRRRI
     NSSVTTETIS ETTEVLNEPF DNSDEERPMP QLEPTCEIEV EEDGRKPVLR KAFQHQPGKK
     RQTEEEEGKD NHCFKNADPC RNNMNDDSSN LKEGSKDNPE PLKCKQVWPK GTKRGLSKWR
     QNKERKTGFK LNLYTPPETP MEPDEQVTVE EQKETSEGKT SPSPIRIEEE VKETGEALLP
     QEENRREETC APVSPNTSPG EKPEDDLIKP EEEEEEEEEE EEEEEEEEGE EEEGGGNVEK
     DPDGAKSQEK EEPEISTEKE DSARLDDHEE EEEEDEEPSH NEDHDADDED DSHMESAEVE
     KEELPRESFK EVLENQETFL DLNVQPGHSN PEVLMDCGVD LTASCNSEPK ELAGDPEAVP
     ESDEEPPPGE QAQKQDQKNS KEVDTEFKEG NPATMEIDSE TVQAVQSLTQ ESSEQDDTFQ
     DCAETQEACR SLQNYTRADQ SPQIATTLDD CQQSDHSSPV SSVHSHPGQS VRSVNSPSVP
     ALENSYAQIS PDQSAISVPS LQNMETSPMM DVPSVSDHSQ QVVDSGFSDL GSIESTTENY
     ENPSSYDSTM GGSICGNGSS QNSCSYSNLT SSSLTQSSCA VTQQMSNISG SCSMLQQTSI
     SSPPTCSVKS PQGCVVERPP SSSQQLAQCS MAANFTPPMQ LAEIPETSNA NIGLYERMGQ
     SDFGAGHYPQ PSATFSLAKL QQLTNTLIDH SLPYSHSAAV TSYANSASLS TPLSNTGLVQ
     LSQSPHSVPG GPQAQATMTP PPNLTPPPMN LPPPLLQRNM AASNIGISHS QRLQTQIASK
     GHISMRTKSA SLSPAAATHQ SQIYGRSQTV AMQGPARTLT MQRGMNMSVN LMPAPAYNVN
     SVNMNMNTLN AMNGYSMSQP MMNSGYHSNH GYMNQTPQYP MQMQMGMMGT QPYAQQPMQT
     PPHGNMMYTA PGHHGYMNTG MSKQSLNGSY MRR
//
ID   KAT6B_HUMAN             Reviewed;        2073 AA.
AC   Q8WYB5; O15087; Q86Y05; Q8WU81; Q9UKW2; Q9UKW3; Q9UKX0;
DT   05-JUL-2005, integrated into UniProtKB/Swiss-Prot.
DT   03-APR-2007, sequence version 3.
DT   22-APR-2020, entry version 172.
DE   RecName: Full=Histone acetyltransferase KAT6B;
DE            EC=2.3.1.48 {ECO:0000269|PubMed:10497217};
DE   AltName: Full=Histone acetyltransferase MOZ2;
DE   AltName: Full=MOZ, YBF2/SAS3, SAS2 and TIP60 protein 4;
DE            Short=MYST-4;
DE   AltName: Full=Monocytic leukemia zinc finger protein-related factor;
GN   Name=KAT6B; Synonyms=KIAA0383, MORF, MOZ2, MYST4;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2 AND 3), TISSUE SPECIFICITY,
RP   AUTOACETYLATION, CATALYTIC ACTIVITY, DOMAIN, AND FUNCTION.
RC   TISSUE=Bone marrow;
RX   PubMed=10497217; DOI=10.1074/jbc.274.40.28528;
RA   Champagne N., Bertos N.R., Pelletier N., Wang A.H., Vezmar M., Yang Y.,
RA   Heng H.H., Yang X.-J.;
RT   "Identification of a human histone acetyltransferase related to monocytic
RT   leukemia zinc finger protein.";
RL   J. Biol. Chem. 274:28528-28536(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RA   Borrow J., Housman D.E.;
RT   "Structure and function of the human MYST family: MOZ2, MYST1 and MYST2.";
RL   Submitted (DEC-1999) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RC   TISSUE=Brain;
RX   PubMed=9205841; DOI=10.1093/dnares/4.2.141;
RA   Nagase T., Ishikawa K., Nakajima D., Ohira M., Seki N., Miyajima N.,
RA   Tanaka A., Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. VII. The
RT   complete sequences of 100 new cDNA clones from brain which can code for
RT   large proteins in vitro.";
RL   DNA Res. 4:141-150(1997).
RN   [4]
RP   SEQUENCE REVISION.
RX   PubMed=12168954; DOI=10.1093/dnares/9.3.99;
RA   Nakajima D., Okazaki N., Yamakawa H., Kikuno R., Ohara O., Nagase T.;
RT   "Construction of expression-ready cDNA clones for KIAA genes: manual
RT   curation of 330 KIAA cDNA clones.";
RL   DNA Res. 9:99-106(2002).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-322 AND 1187-2073.
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1136-1287, AND CHROMOSOMAL TRANSLOCATION WITH
RP   CREBBP.
RX   PubMed=11157802; DOI=10.1093/hmg/10.4.395;
RA   Panagopoulos I., Fioretos T., Isaksson M., Samuelsson U., Billstroem R.,
RA   Stroembeck B., Mitelman F., Johansson B.;
RT   "Fusion of the MORF and CBP genes in acute myeloid leukemia with the
RT   t(10;16)(q22;p13).";
RL   Hum. Mol. Genet. 10:395-404(2001).
RN   [7]
RP   INTERACTION WITH RUNX1 AND RUNX2, AUTOACETYLATION, AND FUNCTION.
RX   PubMed=11965546; DOI=10.1038/sj.onc.1205367;
RA   Pelletier N., Champagne N., Stifani S., Yang X.-J.;
RT   "MOZ and MORF histone acetyltransferases interact with the Runt-domain
RT   transcription factor Runx2.";
RL   Oncogene 21:2729-2740(2002).
RN   [8]
RP   FUNCTION, AND IDENTIFICATION IN THE MOZ/MORF COMPLEX.
RX   PubMed=16387653; DOI=10.1016/j.molcel.2005.12.007;
RA   Doyon Y., Cayrou C., Ullah M., Landry A.-J., Cote V., Selleck W.,
RA   Lane W.S., Tan S., Yang X.-J., Cote J.;
RT   "ING tumor suppressor proteins are critical regulators of chromatin
RT   acetylation required for genome expression and perpetuation.";
RL   Mol. Cell 21:51-64(2006).
RN   [9]
RP   IDENTIFICATION IN THE MOZ/MORF COMPLEX, AND INTERACTION WITH BRPF1.
RX   PubMed=18794358; DOI=10.1128/mcb.01297-08;
RA   Ullah M., Pelletier N., Xiao L., Zhao S.P., Wang K., Degerny C.,
RA   Tahmasebi S., Cayrou C., Doyon Y., Goh S.-L., Champagne N., Cote J.,
RA   Yang X.-J.;
RT   "Molecular architecture of quartet MOZ/MORF histone acetyltransferase
RT   complexes.";
RL   Mol. Cell. Biol. 28:6828-6843(2008).
RN   [10]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-1038; LYS-1042 AND LYS-1044, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [11]
RP   INVOLVEMENT IN SBBYSS, AND VARIANT LYS-360.
RX   PubMed=22077973; DOI=10.1016/j.ajhg.2011.10.008;
RA   Clayton-Smith J., O'Sullivan J., Daly S., Bhaskar S., Day R., Anderson B.,
RA   Voss A.K., Thomas T., Biesecker L.G., Smith P., Fryer A., Chandler K.E.,
RA   Kerr B., Tassabehji M., Lynch S.A., Krajewska-Walasek M., McKee S.,
RA   Smith J., Sweeney E., Mansour S., Mohammed S., Donnai D., Black G.;
RT   "Whole-exome-sequencing identifies mutations in histone acetyltransferase
RT   gene KAT6B in individuals with the Say-Barber-Biesecker variant of Ohdo
RT   syndrome.";
RL   Am. J. Hum. Genet. 89:675-681(2011).
RN   [12]
RP   INVOLVEMENT IN GTPTS.
RX   PubMed=22265014; DOI=10.1016/j.ajhg.2011.11.023;
RA   Campeau P.M., Kim J.C., Lu J.T., Schwartzentruber J.A., Abdul-Rahman O.A.,
RA   Schlaubitz S., Murdock D.M., Jiang M.M., Lammer E.J., Enns G.M.,
RA   Rhead W.J., Rowland J., Robertson S.P., Cormier-Daire V., Bainbridge M.N.,
RA   Yang X.J., Gingras M.C., Gibbs R.A., Rosenblatt D.S., Majewski J.,
RA   Lee B.H.;
RT   "Mutations in KAT6B, encoding a histone acetyltransferase, cause
RT   Genitopatellar syndrome.";
RL   Am. J. Hum. Genet. 90:282-289(2012).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-355; SER-647 AND SER-1048,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [14]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-673, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [15]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-673, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-673, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] ALA-483.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Histone acetyltransferase which may be involved in both
CC       positive and negative regulation of transcription. Required for RUNX2-
CC       dependent transcriptional activation. May be involved in cerebral
CC       cortex development. Component of the MOZ/MORF complex which has a
CC       histone H3 acetyltransferase activity. {ECO:0000269|PubMed:10497217,
CC       ECO:0000269|PubMed:11965546, ECO:0000269|PubMed:16387653}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=acetyl-CoA + L-lysyl-[protein] = CoA + H(+) + N(6)-acetyl-L-
CC         lysyl-[protein]; Xref=Rhea:RHEA:45948, Rhea:RHEA-COMP:9752,
CC         Rhea:RHEA-COMP:10731, ChEBI:CHEBI:15378, ChEBI:CHEBI:29969,
CC         ChEBI:CHEBI:57287, ChEBI:CHEBI:57288, ChEBI:CHEBI:61930; EC=2.3.1.48;
CC         Evidence={ECO:0000269|PubMed:10497217};
CC   -!- SUBUNIT: Component of the MOZ/MORF complex composed at least of ING5,
CC       KAT6A, KAT6B, MEAF6 and one of BRPF1, BRD1/BRPF2 and BRPF3. Interacts
CC       with RUNX1 and RUNX2. {ECO:0000269|PubMed:11965546,
CC       ECO:0000269|PubMed:16387653, ECO:0000269|PubMed:18794358}.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1; Synonyms=Beta;
CC         IsoId=Q8WYB5-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha;
CC         IsoId=Q8WYB5-2; Sequence=VSP_014587;
CC       Name=3;
CC         IsoId=Q8WYB5-3; Sequence=VSP_014586;
CC   -!- TISSUE SPECIFICITY: Ubiquitously expressed, with high levels in heart,
CC       pancreas, testis and ovary. {ECO:0000269|PubMed:10497217}.
CC   -!- DOMAIN: The N-terminus is involved in transcriptional activation while
CC       the C-terminus is involved in transcriptional repression.
CC       {ECO:0000269|PubMed:10497217}.
CC   -!- PTM: Autoacetylated (PubMed:10497217 and PubMed:11965546).
CC       Autoacetylation at Lys-815 is required for proper function.
CC       {ECO:0000250|UniProtKB:Q9H7Z6, ECO:0000269|PubMed:10497217,
CC       ECO:0000269|PubMed:11965546}.
CC   -!- DISEASE: Note=A chromosomal aberration involving KAT6B may be a cause
CC       acute myeloid leukemias. Translocation t(10;16)(q22;p13) with CREBBP.
CC       {ECO:0000269|PubMed:11157802}.
CC   -!- DISEASE: Ohdo syndrome, SBBYS variant (SBBYSS) [MIM:603736]: A syndrome
CC       characterized by distinctive facial appearance with severe
CC       blepharophimosis, an immobile mask-like face, a bulbous nasal tip, and
CC       a small mouth with a thin upper lip. The condition presents in infancy
CC       with severe hypotonia and feeding problems. Associated skeletal
CC       problems include joint laxity, abnormally long thumbs and great toes,
CC       and dislocated or hypoplastic patellae. Structural cardiac defects are
CC       present in around 50% of cases, and dental anomalies, including small
CC       and pointed teeth, are common. Optic atrophy and conductive or
CC       sensorineural deafness are repeatedly reported. Many affected
CC       individuals have abnormalities of thyroid structure or function. SBBYSS
CC       is usually associated with severe mental retardation, delayed motor
CC       milestones, and significantly impaired speech.
CC       {ECO:0000269|PubMed:22077973}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Genitopatellar syndrome (GTPTS) [MIM:606170]: A rare disorder
CC       consisting of microcephaly, severe psychomotor retardation, and
CC       characteristic coarse facial features, including broad nose and small
CC       or retracted chin, associated with congenital flexion contractures of
CC       the lower extremities, abnormal or missing patellae, and urogenital
CC       anomalies. {ECO:0000269|PubMed:22265014}. Note=The disease is caused by
CC       mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the MYST (SAS/MOZ) family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAF00100.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=AAH14143.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC       Sequence=AAH48199.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Potential poly-A sequence.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYST4ID41488ch10q22.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF113514; AAF00095.1; -; mRNA.
DR   EMBL; AF119230; AAF00099.1; -; mRNA.
DR   EMBL; AF119231; AAF00100.1; ALT_FRAME; mRNA.
DR   EMBL; AF217500; AAL56647.1; -; mRNA.
DR   EMBL; AB002381; BAA20837.2; -; mRNA.
DR   EMBL; BC014143; AAH14143.1; ALT_SEQ; mRNA.
DR   EMBL; BC021128; AAH21128.1; -; mRNA.
DR   EMBL; BC048199; AAH48199.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS58084.1; -. [Q8WYB5-3]
DR   CCDS; CCDS58085.1; -. [Q8WYB5-2]
DR   CCDS; CCDS7345.1; -. [Q8WYB5-1]
DR   RefSeq; NP_001243397.1; NM_001256468.1. [Q8WYB5-2]
DR   RefSeq; NP_001243398.1; NM_001256469.1. [Q8WYB5-3]
DR   RefSeq; NP_036462.2; NM_012330.3. [Q8WYB5-1]
DR   RefSeq; XP_005269721.1; XM_005269664.2. [Q8WYB5-1]
DR   RefSeq; XP_016871489.1; XM_017016000.1.
DR   RefSeq; XP_016871490.1; XM_017016001.1.
DR   RefSeq; XP_016871491.1; XM_017016002.1.
DR   RefSeq; XP_016871492.1; XM_017016003.1. [Q8WYB5-1]
DR   RefSeq; XP_016871494.1; XM_017016005.1.
DR   RefSeq; XP_016871495.1; XM_017016006.1.
DR   RefSeq; XP_016871496.1; XM_017016007.1.
DR   RefSeq; XP_016871497.1; XM_017016008.1.
DR   PDB; 5U2J; X-ray; 1.60 A; A/B=211-320.
DR   PDB; 6OIE; X-ray; 2.08 A; A/B=211-322.
DR   PDBsum; 5U2J; -.
DR   PDBsum; 6OIE; -.
DR   SMR; Q8WYB5; -.
DR   BioGrid; 117069; 13.
DR   ComplexPortal; CPX-738; MORF1 histone acetyltransferase complex.
DR   ComplexPortal; CPX-739; MORF2 histone acetyltransferase complex.
DR   ComplexPortal; CPX-740; MORF3 histone acetyltransferase complex.
DR   CORUM; Q8WYB5; -.
DR   IntAct; Q8WYB5; 10.
DR   STRING; 9606.ENSP00000287239; -.
DR   ChEMBL; CHEMBL3774300; -.
DR   MoonDB; Q8WYB5; Predicted.
DR   iPTMnet; Q8WYB5; -.
DR   PhosphoSitePlus; Q8WYB5; -.
DR   BioMuta; KAT6B; -.
DR   DMDM; 143811424; -.
DR   EPD; Q8WYB5; -.
DR   jPOST; Q8WYB5; -.
DR   MassIVE; Q8WYB5; -.
DR   MaxQB; Q8WYB5; -.
DR   PaxDb; Q8WYB5; -.
DR   PeptideAtlas; Q8WYB5; -.
DR   PRIDE; Q8WYB5; -.
DR   ProteomicsDB; 75154; -. [Q8WYB5-1]
DR   ProteomicsDB; 75155; -. [Q8WYB5-2]
DR   ProteomicsDB; 75156; -. [Q8WYB5-3]
DR   Antibodypedia; 1807; 78 antibodies.
DR   Ensembl; ENST00000287239; ENSP00000287239; ENSG00000156650. [Q8WYB5-1]
DR   Ensembl; ENST00000372711; ENSP00000361796; ENSG00000156650. [Q8WYB5-2]
DR   Ensembl; ENST00000372714; ENSP00000361799; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000372724; ENSP00000361809; ENSG00000156650. [Q8WYB5-2]
DR   Ensembl; ENST00000372725; ENSP00000361810; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000628038; ENSP00000485896; ENSG00000281813. [Q8WYB5-3]
DR   Ensembl; ENST00000628523; ENSP00000487238; ENSG00000281813. [Q8WYB5-2]
DR   Ensembl; ENST00000629233; ENSP00000487219; ENSG00000281813. [Q8WYB5-3]
DR   Ensembl; ENST00000629879; ENSP00000486731; ENSG00000281813. [Q8WYB5-2]
DR   Ensembl; ENST00000630001; ENSP00000486595; ENSG00000281813. [Q8WYB5-1]
DR   Ensembl; ENST00000647630; ENSP00000497352; ENSG00000281813. [Q8WYB5-1]
DR   Ensembl; ENST00000648605; ENSP00000497718; ENSG00000281813. [Q8WYB5-1]
DR   Ensembl; ENST00000648725; ENSP00000497841; ENSG00000156650. [Q8WYB5-1]
DR   Ensembl; ENST00000648892; ENSP00000497048; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000649006; ENSP00000498139; ENSG00000156650. [Q8WYB5-3]
DR   Ensembl; ENST00000649463; ENSP00000497166; ENSG00000156650. [Q8WYB5-1]
DR   Ensembl; ENST00000649574; ENSP00000497416; ENSG00000281813. [Q8WYB5-3]
DR   Ensembl; ENST00000650575; ENSP00000497453; ENSG00000281813. [Q8WYB5-3]
DR   GeneID; 23522; -.
DR   KEGG; hsa:23522; -.
DR   UCSC; uc001jwm.3; human. [Q8WYB5-1]
DR   CTD; 23522; -.
DR   DisGeNET; 23522; -.
DR   GeneCards; KAT6B; -.
DR   GeneReviews; KAT6B; -.
DR   HGNC; HGNC:17582; KAT6B.
DR   HPA; ENSG00000156650; Low tissue specificity.
DR   MalaCards; KAT6B; -.
DR   MIM; 603736; phenotype.
DR   MIM; 605880; gene.
DR   MIM; 606170; phenotype.
DR   neXtProt; NX_Q8WYB5; -.
DR   OpenTargets; ENSG00000156650; -.
DR   Orphanet; 3047; Blepharophimosis-intellectual disability syndrome, SBBYS type.
DR   Orphanet; 85201; Genitopatellar syndrome.
DR   Orphanet; 648; Noonan syndrome.
DR   PharmGKB; PA134880712; -.
DR   eggNOG; KOG2747; Eukaryota.
DR   eggNOG; COG5027; LUCA.
DR   GeneTree; ENSGT00940000157372; -.
DR   HOGENOM; CLU_001232_1_1_1; -.
DR   InParanoid; Q8WYB5; -.
DR   KO; K11306; -.
DR   OMA; KQGWPKG; -.
DR   PhylomeDB; Q8WYB5; -.
DR   TreeFam; TF106483; -.
DR   BRENDA; 2.3.1.48; 2681.
DR   Reactome; R-HSA-3214847; HATs acetylate histones.
DR   SIGNOR; Q8WYB5; -.
DR   ChiTaRS; KAT6B; human.
DR   GeneWiki; MYST4; -.
DR   GenomeRNAi; 23522; -.
DR   Pharos; Q8WYB5; Tbio.
DR   PRO; PR:Q8WYB5; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q8WYB5; protein.
DR   Bgee; ENSG00000156650; Expressed in forebrain and 242 other tissues.
DR   ExpressionAtlas; Q8WYB5; baseline and differential.
DR   Genevisible; Q8WYB5; HS.
DR   GO; GO:0000123; C:histone acetyltransferase complex; IBA:GO_Central.
DR   GO; GO:0070776; C:MOZ/MORF histone acetyltransferase complex; IDA:UniProtKB.
DR   GO; GO:0000790; C:nuclear chromatin; IBA:GO_Central.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0000786; C:nucleosome; NAS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0016407; F:acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0004402; F:histone acetyltransferase activity; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008134; F:transcription factor binding; IDA:UniProtKB.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0016573; P:histone acetylation; IDA:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006334; P:nucleosome assembly; NAS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   Gene3D; 1.10.10.10; -; 2.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR016181; Acyl_CoA_acyltransferase.
DR   InterPro; IPR002717; HAT_MYST-type.
DR   InterPro; IPR005818; Histone_H1/H5_H15.
DR   InterPro; IPR036388; WH-like_DNA-bd_sf.
DR   InterPro; IPR036390; WH_DNA-bd_sf.
DR   InterPro; IPR040706; Zf-MYST.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF01853; MOZ_SAS; 1.
DR   Pfam; PF00628; PHD; 1.
DR   Pfam; PF17772; zf-MYST; 1.
DR   SMART; SM00526; H15; 1.
DR   SMART; SM00249; PHD; 2.
DR   SUPFAM; SSF46785; SSF46785; 1.
DR   SUPFAM; SSF55729; SSF55729; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS51504; H15; 1.
DR   PROSITE; PS51726; MYST_HAT; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Acyltransferase;
KW   Alternative splicing; Chromatin regulator; Chromosomal rearrangement;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..2073
FT                   /note="Histone acetyltransferase KAT6B"
FT                   /id="PRO_0000051575"
FT   DOMAIN          103..176
FT                   /note="H15"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00837"
FT   DOMAIN          715..989
FT                   /note="MYST-type HAT"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   ZN_FING         213..272
FT                   /note="PHD-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   ZN_FING         269..320
FT                   /note="PHD-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   ZN_FING         748..773
FT                   /note="C2HC MYST-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01063"
FT   REGION          361..717
FT                   /note="Negatively regulates HAT activity"
FT   REGION          718..1008
FT                   /note="Catalytic"
FT   REGION          752..1008
FT                   /note="Interaction with BRPF1"
FT                   /evidence="ECO:0000269|PubMed:18794358"
FT   REGION          856..860
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q92794"
FT   REGION          865..871
FT                   /note="Acetyl-CoA binding"
FT                   /evidence="ECO:0000250|UniProtKB:Q92794"
FT   REGION          1560..2073
FT                   /note="Interaction with RUNX1 and RUNX2"
FT                   /evidence="ECO:0000269|PubMed:11965546"
FT   COMPBIAS        492..533
FT                   /note="Ser-rich"
FT   COMPBIAS        521..524
FT                   /note="Poly-Ser"
FT   COMPBIAS        599..605
FT                   /note="Poly-Ser"
FT   COMPBIAS        1070..1104
FT                   /note="Poly-Glu"
FT   COMPBIAS        1204..1207
FT                   /note="Poly-Glu"
FT   COMPBIAS        1351..1373
FT                   /note="Poly-Glu"
FT   COMPBIAS        1409..1417
FT                   /note="Poly-Glu"
FT   COMPBIAS        1594..1763
FT                   /note="Ser-rich"
FT   COMPBIAS        1961..2061
FT                   /note="Met-rich"
FT   ACT_SITE        891
FT                   /note="Proton donor/acceptor"
FT                   /evidence="ECO:0000250|UniProtKB:Q9H7Z6"
FT   BINDING         895
FT                   /note="Acetyl-CoA"
FT                   /evidence="ECO:0000250|UniProtKB:Q92794"
FT   SITE            1222..1223
FT                   /note="Breakpoint for translocation to form KAT6B-CREBBP"
FT   MOD_RES         355
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         647
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         815
FT                   /note="N6-acetyllysine; by autocatalysis"
FT                   /evidence="ECO:0000250|UniProtKB:Q92794"
FT   MOD_RES         1038
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1042
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1044
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1048
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        673
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         373..664
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10497217,
FT                   ECO:0000303|PubMed:9205841"
FT                   /id="VSP_014586"
FT   VAR_SEQ         482..664
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10497217"
FT                   /id="VSP_014587"
FT   VARIANT         360
FT                   /note="E -> K"
FT                   /evidence="ECO:0000269|PubMed:22077973"
FT                   /id="VAR_067315"
FT   VARIANT         483
FT                   /note="T -> A (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036361"
FT   VARIANT         1217
FT                   /note="A -> S (in dbSNP:rs57372986)"
FT                   /id="VAR_061367"
FT   VARIANT         1499
FT                   /note="V -> I (in dbSNP:rs3740321)"
FT                   /id="VAR_050217"
FT   CONFLICT        123
FT                   /note="G -> R (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        231
FT                   /note="P -> A (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        843
FT                   /note="F -> L (in Ref. 1; AAF00095/AAF00099/AAF00100 and 3;
FT                   BAA20837)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        931..933
FT                   /note="TGM -> RHV (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        934
FT                   /note="Missing (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1152
FT                   /note="T -> S (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1625
FT                   /note="S -> T (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1731
FT                   /note="S -> T (in Ref. 2; AAL56647)"
FT                   /evidence="ECO:0000305"
FT   STRAND          214..216
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   TURN            217..219
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   TURN            238..240
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   HELIX           246..249
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   HELIX           253..260
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   TURN            267..269
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   TURN            273..275
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   HELIX           282..284
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   TURN            289..291
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   HELIX           297..299
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   STRAND          300..302
FT                   /evidence="ECO:0000244|PDB:5U2J"
FT   TURN            315..317
FT                   /evidence="ECO:0000244|PDB:5U2J"
SQ   SEQUENCE   2073 AA;  231378 MW;  AEE267B9DA444B08 CRC64;
     MVKLANPLYT EWILEAIQKI KKQKQRPSEE RICHAVSTSH GLDKKTVSEQ LELSVQDGSV
     LKVTNKGLAS YKDPDNPGRF SSVKPGTFPK SAKGSRGSCN DLRNVDWNKL LRRAIEGLEE
     PNGSSLKNIE KYLRSQSDLT STTNNPAFQQ RLRLGAKRAV NNGRLLKDGP QYRVNYGSLD
     GKGAPQYPSA FPSSLPPVSL LPHEKDQPRA DPIPICSFCL GTKESNREKK PEELLSCADC
     GSSGHPSCLK FCPELTTNVK ALRWQCIECK TCSACRVQGR NADNMLFCDS CDRGFHMECC
     DPPLSRMPKG MWICQVCRPK KKGRKLLHEK AAQIKRRYAK PIGRPKNKLK QRLLSVTSDE
     GSMNAFTGRG SPGRGQKTKV CTTPSSGHAA SGKDSSSRLA VTDPTRPGAT TKITTTSTYI
     SASTLKVNKK TKGLIDGLTK FFTPSPDGRR SRGEIIDFSK HYRPRKKVSQ KQSCTSHVLA
     TGTTQKLKPP PSSLPPPTPI SGQSPSSQKS STATSSPSPQ SSSSQCSVPS LSSLTTNSQL
     KALFDGLSHI YTTQGQSRKK GHPSYAPPKR MRRKTELSST AKSKAHFFGK RDIRSRFISH
     SSSSSWGMAR GSIFKAIAHF KRTTFLKKHR MLGRLKYKVT PQMGTPSPGK GSLTDGRIKP
     DQDDDTEIKI NIKQESADVN VIGNKDVVTE EDLDVFKQAQ ELSWEKIECE SGVEDCGRYP
     SVIEFGKYEI QTWYSSPYPQ EYARLPKLYL CEFCLKYMKS KNILLRHSKK CGWFHPPANE
     IYRRKDLSVF EVDGNMSKIY CQNLCLLAKL FLDHKTLYYD VEPFLFYVLT KNDEKGCHLV
     GYFSKEKLCQ QKYNVSCIMI MPQHQRQGFG RFLIDFSYLL SRREGQAGSP EKPLSDLGRL
     SYLAYWKSVI LEYLYHHHER HISIKAISRA TGMCPHDIAT TLQHLHMIDK RDGRFVIIRR
     EKLILSHMEK LKTCSRANEL DPDSLRWTPI LISNAAVSEE EREAEKEAER LMEQASCWEK
     EEQEILSTRA NSRQSPAKVQ SKNKYLHSPE SRPVTGERGQ LLELSKESSE EEEEEEDEEE
     EEEEEEEEED EEEEEEEEEE EEEENIQSSP PRLTKPQSVA IKRKRPFVLK KKRGRKRRRI
     NSSVTTETIS ETTEVLNEPF DNSDEERPMP QLEPTCEIEV EEDGRKPVLR KAFQHQPGKK
     RQTEEEEGKD NHCFKNADPC RNNMNDDSSN LKEGSKDNPE PLKCKQVWPK GTKRGLSKWR
     QNKERKTGFK LNLYTPPETP MEPDEQVTVE EQKETSEGKT SPSPIRIEEE VKETGEALLP
     QEENRREETC APVSPNTSPG EKPEDDLIKP EEEEEEEEEE EEEEEEEEGE EEEGGGNVEK
     DPDGAKSQEK EEPEISTEKE DSARLDDHEE EEEEDEEPSH NEDHDADDED DSHMESAEVE
     KEELPRESFK EVLENQETFL DLNVQPGHSN PEVLMDCGVD LTASCNSEPK ELAGDPEAVP
     ESDEEPPPGE QAQKQDQKNS KEVDTEFKEG NPATMEIDSE TVQAVQSLTQ ESSEQDDTFQ
     DCAETQEACR SLQNYTRADQ SPQIATTLDD CQQSDHSSPV SSVHSHPGQS VRSVNSPSVP
     ALENSYAQIS PDQSAISVPS LQNMETSPMM DVPSVSDHSQ QVVDSGFSDL GSIESTTENY
     ENPSSYDSTM GGSICGNGSS QNSCSYSNLT SSSLTQSSCA VTQQMSNISG SCSMLQQTSI
     SSPPTCSVKS PQGCVVERPP SSSQQLAQCS MAANFTPPMQ LAEIPETSNA NIGLYERMGQ
     SDFGAGHYPQ PSATFSLAKL QQLTNTLIDH SLPYSHSAAV TSYANSASLS TPLSNTGLVQ
     LSQSPHSVPG GPQAQATMTP PPNLTPPPMN LPPPLLQRNM AASNIGISHS QRLQTQIASK
     GHISMRTKSA SLSPAAATHQ SQIYGRSQTV AMQGPARTLT MQRGMNMSVN LMPAPAYNVN
     SVNMNMNTLN AMNGYSMSQP MMNSGYHSNH GYMNQTPQYP MQMQMGMMGT QPYAQQPMQT
     PPHGNMMYTA PGHHGYMNTG MSKQSLNGSY MRR
//
ID   KNL1_HUMAN              Reviewed;        2342 AA.
AC   Q8NG31; Q8NHE1; Q8WXA6; Q9HCK2; Q9NR92;
DT   24-MAY-2005, integrated into UniProtKB/Swiss-Prot.
DT   10-FEB-2009, sequence version 3.
DT   22-APR-2020, entry version 150.
DE   RecName: Full=Kinetochore scaffold 1;
DE   AltName: Full=ALL1-fused gene from chromosome 15q14 protein;
DE            Short=AF15q14;
DE   AltName: Full=Bub-linking kinetochore protein;
DE            Short=Blinkin;
DE   AltName: Full=Cancer susceptibility candidate gene 5 protein;
DE   AltName: Full=Cancer/testis antigen 29;
DE            Short=CT29;
DE   AltName: Full=Kinetochore-null protein 1;
DE   AltName: Full=Protein CASC5;
DE   AltName: Full=Protein D40/AF15q14;
GN   Name=KNL1 {ECO:0000312|HGNC:HGNC:24054}; Synonyms=CASC5, KIAA1570;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 4), CHROMOSOMAL TRANSLOCATION
RP   WITH KMT2A/MLL1, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND VARIANTS
RP   SER-486; THR-598; GLY-936; GLU-1285 AND ALA-1473.
RX   PubMed=10980622; DOI=10.1038/sj.onc.1203789;
RA   Hayette S., Tigaud I., Vanier A., Martel S., Corbo L., Charrin C.,
RA   Beillard E., Deleage G., Magaud J.-P., Rimokh R.;
RT   "AF15q14, a novel partner gene fused to the MLL gene in an acute myeloid
RT   leukaemia with a t(11;15)(q23;q14).";
RL   Oncogene 19:4446-4450(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), TISSUE SPECIFICITY, AND VARIANTS
RP   THR-43; ALA-113; SER-486; THR-598 AND GLY-936.
RC   TISSUE=Testis;
RX   PubMed=12087463; DOI=10.1038/sj.bjc.6600328;
RA   Takimoto M., Wei G., Dosaka-Akita H., Mao P., Kondo S., Sakuragi N.,
RA   Chiba I., Miura T., Itoh N., Sasao T., Koya R.C., Tsukamoto T.,
RA   Fujimoto S., Kato H., Kuzumaki N.;
RT   "Frequent expression of new cancer/testis gene D40/AF15q14 in lung cancer
RT   of smokers.";
RL   Br. J. Cancer 86:1757-1762(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), CHROMOSOMAL TRANSLOCATION WITH
RP   KMT2A/MLL1, TISSUE SPECIFICITY, AND VARIANTS THR-598 AND GLY-936.
RX   PubMed=12618768; DOI=10.1038/sj.onc.1206272;
RA   Kuefer M.U., Chinwalla V., Zeleznik-Le N.J., Behm F.G., Naeve C.W.,
RA   Rakestraw K.M., Mukatira S.T., Raimondi S.C., Morris S.W.;
RT   "Characterization of the MLL partner gene AF15q14 involved in
RT   t(11;15)(q23;q14).";
RL   Oncogene 22:1418-1424(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 983-2342.
RC   TISSUE=Brain;
RX   PubMed=10997877; DOI=10.1093/dnares/7.4.271;
RA   Nagase T., Kikuno R., Nakayama M., Hirosawa M., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XVIII. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 7:273-281(2000).
RN   [6]
RP   CHROMOSOMAL TRANSLOCATION WITH KMT2A.
RX   PubMed=12618766; DOI=10.1038/sj.onc.1206273;
RA   Chinwalla V., Chien A., Odero M., Neilly M.B., Zeleznik-Le N.J.,
RA   Rowley J.D.;
RT   "A t(11;15) fuses MLL to two different genes, AF15q14 and a novel gene
RT   MPFYVE on chromosome 15.";
RL   Oncogene 22:1400-1410(2003).
RN   [7]
RP   INTERACTION WITH DSN1 AND MIS12, IDENTIFICATION BY MASS SPECTROMETRY, AND
RP   FUNCTION.
RX   PubMed=15502821; DOI=10.1038/ncb1187;
RA   Obuse C., Iwasaki O., Kiyomitsu T., Goshima G., Toyoda Y., Yanagida M.;
RT   "A conserved Mis12 centromere complex is linked to heterochromatic HP1 and
RT   outer kinetochore protein Zwint-1.";
RL   Nat. Cell Biol. 6:1135-1141(2004).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15579588; DOI=10.1530/rep.1.00312;
RA   Sasao T., Itoh N., Takano H., Watanabe S., Wei G., Tsukamoto T.,
RA   Kuzumaki N., Takimoto M.;
RT   "The protein encoded by cancer/testis gene D40/AF15q14 is localized in
RT   spermatocytes, acrosomes of spermatids and ejaculated spermatozoa.";
RL   Reproduction 128:709-716(2004).
RN   [9]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH BUB1; BUB1B; NSL1;
RP   DSN1 AND ZWINT.
RX   PubMed=17981135; DOI=10.1016/j.devcel.2007.09.005;
RA   Kiyomitsu T., Obuse C., Yanagida M.;
RT   "Human Blinkin/AF15q14 is required for chromosome alignment and the mitotic
RT   checkpoint through direct interaction with Bub1 and BubR1.";
RL   Dev. Cell 13:663-676(2007).
RN   [10]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18045986; DOI=10.1091/mbc.e07-10-1051;
RA   Cheeseman I.M., Hori T., Fukagawa T., Desai A.;
RT   "KNL1 and the CENP-H/I/K complex coordinately direct kinetochore assembly
RT   in vertebrates.";
RL   Mol. Biol. Cell 19:587-594(2008).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1076, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-60; SER-1076;
RP   SER-1773 AND SER-1845, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [13]
RP   SUBCELLULAR LOCATION.
RX   PubMed=19450515; DOI=10.1016/j.cell.2009.03.035;
RA   Wan X., O'Quinn R.P., Pierce H.L., Joglekar A.P., Gall W.E., DeLuca J.G.,
RA   Carroll C.W., Liu S.-T., Yen T.J., McEwen B.F., Stukenberg P.T., Desai A.,
RA   Salmon E.D.;
RT   "Protein architecture of the human kinetochore microtubule attachment
RT   site.";
RL   Cell 137:672-684(2009).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1076, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-539; SER-956; SER-1076 AND
RP   SER-1831, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-32; SER-60; THR-539; SER-578;
RP   SER-584; THR-586; SER-767; SER-956; SER-1039; SER-1076; SER-1088; SER-1448;
RP   SER-1675; SER-1845 AND SER-1860, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [17]
RP   VARIANT [LARGE SCALE ANALYSIS] THR-598.
RX   PubMed=18987736; DOI=10.1038/nature07485;
RA   Ley T.J., Mardis E.R., Ding L., Fulton B., McLellan M.D., Chen K.,
RA   Dooling D., Dunford-Shore B.H., McGrath S., Hickenbotham M., Cook L.,
RA   Abbott R., Larson D.E., Koboldt D.C., Pohl C., Smith S., Hawkins A.,
RA   Abbott S., Locke D., Hillier L.W., Miner T., Fulton L., Magrini V.,
RA   Wylie T., Glasscock J., Conyers J., Sander N., Shi X., Osborne J.R.,
RA   Minx P., Gordon D., Chinwalla A., Zhao Y., Ries R.E., Payton J.E.,
RA   Westervelt P., Tomasson M.H., Watson M., Baty J., Ivanovich J., Heath S.,
RA   Shannon W.D., Nagarajan R., Walter M.J., Link D.C., Graubert T.A.,
RA   DiPersio J.F., Wilson R.K.;
RT   "DNA sequencing of a cytogenetically normal acute myeloid leukaemia
RT   genome.";
RL   Nature 456:66-72(2008).
RN   [18]
RP   VARIANT MCPH4 ILE-2041.
RX   PubMed=22983954; DOI=10.1093/hmg/dds386;
RA   Genin A., Desir J., Lambert N., Biervliet M., Van Der Aa N., Pierquin G.,
RA   Killian A., Tosi M., Urbina M., Lefort A., Libert F., Pirson I.,
RA   Abramowicz M.;
RT   "Kinetochore KMN network gene CASC5 mutated in primary microcephaly.";
RL   Hum. Mol. Genet. 21:5306-5317(2012).
RN   [19]
RP   VARIANT MCPH4 ILE-2041.
RX   PubMed=26626498; DOI=10.1007/s10048-015-0468-7;
RA   Saadi A., Verny F., Siquier-Pernet K., Bole-Feysot C., Nitschke P.,
RA   Munnich A., Abada-Dendib M., Chaouch M., Abramowicz M., Colleaux L.;
RT   "Refining the phenotype associated with CASC5 mutation.";
RL   Neurogenetics 17:71-78(2016).
CC   -!- FUNCTION: Performs two crucial functions during mitosis: it is
CC       essential for spindle-assembly checkpoint signaling and for correct
CC       chromosome alignment. Required for attachment of the kinetochores to
CC       the spindle microtubules. Directly links BUB1 and BUB1B to
CC       kinetochores. Part of the MIS12 complex, which may be fundamental for
CC       kinetochore formation and proper chromosome segregation during mitosis.
CC       Acts in coordination with CENPK to recruit the NDC80 complex to the
CC       outer kinetochore. {ECO:0000269|PubMed:15502821,
CC       ECO:0000269|PubMed:17981135, ECO:0000269|PubMed:18045986}.
CC   -!- SUBUNIT: Interacts with DSN1, MIS12, BUB1, BUB1B, NSL1 and ZWINT.
CC       {ECO:0000269|PubMed:15502821, ECO:0000269|PubMed:17981135}.
CC   -!- INTERACTION:
CC       Q8NG31; O43683: BUB1; NbExp=2; IntAct=EBI-1001161, EBI-748936;
CC       Q8NG31-2; O43683: BUB1; NbExp=3; IntAct=EBI-10973816, EBI-748936;
CC       Q8NG31-2; O60566: BUB1B; NbExp=10; IntAct=EBI-10973816, EBI-1001438;
CC       Q8NG31; P62136: PPP1CA; NbExp=2; IntAct=EBI-1001161, EBI-357253;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Chromosome, centromere, kinetochore.
CC       Note=Weakly expressed in interphase nuclei. Expression increases from
CC       prophase to late anaphase, but greatly diminishes from the telophase
CC       and cytokinesis to early G1 phase of cell cycle.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q8NG31-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8NG31-2; Sequence=VSP_013795;
CC       Name=3;
CC         IsoId=Q8NG31-3; Sequence=VSP_013795, VSP_013796, VSP_013797;
CC       Name=4;
CC         IsoId=Q8NG31-4; Sequence=VSP_013795, VSP_018524, VSP_018525;
CC   -!- TISSUE SPECIFICITY: Highly expressed in testis, where it is localized
CC       in germ cells, in particular in spermatocytes and in the pre-acrosome
CC       of round spermatids. Detected in the acrosome of ejaculated
CC       spermatozoa. Detected in adult thymus, bone marrow, colon, small
CC       intestine, appendix and placenta, and in fetal liver and thymus.
CC       {ECO:0000269|PubMed:10980622, ECO:0000269|PubMed:12087463,
CC       ECO:0000269|PubMed:12618768}.
CC   -!- DISEASE: Note=A chromosomal aberration involving KNL1 is associated
CC       with acute myeloblastic leukemia (AML). Translocation t(11;15)(q23;q14)
CC       with KMT2A. May give rise to a KMT2A-KNL1 fusion protein.
CC       {ECO:0000269|PubMed:12618766}.
CC   -!- DISEASE: Microcephaly 4, primary, autosomal recessive (MCPH4)
CC       [MIM:604321]: A disease defined as a head circumference more than 3
CC       standard deviations below the age-related mean. Brain weight is
CC       markedly reduced and the cerebral cortex is disproportionately small.
CC       Despite this marked reduction in size, the gyral pattern is relatively
CC       well preserved, with no major abnormality in cortical architecture.
CC       Affected individuals are mentally retarded. Primary microcephaly is
CC       further defined by the absence of other syndromic features or
CC       significant neurological deficits due to degenerative brain disorder.
CC       {ECO:0000269|PubMed:22983954, ECO:0000269|PubMed:26626498}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/AF15q14ID318.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF248041; AAF97513.1; -; mRNA.
DR   EMBL; AF461041; AAL67803.1; -; mRNA.
DR   EMBL; AB022190; BAC05691.1; -; mRNA.
DR   EMBL; AF173994; AAM45143.1; -; mRNA.
DR   EMBL; AC022405; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AB046790; BAB13396.1; -; mRNA.
DR   CCDS; CCDS42023.1; -. [Q8NG31-1]
DR   CCDS; CCDS42024.1; -. [Q8NG31-2]
DR   RefSeq; NP_653091.3; NM_144508.4. [Q8NG31-2]
DR   RefSeq; NP_733468.3; NM_170589.4. [Q8NG31-1]
DR   PDB; 3SI5; X-ray; 2.20 A; X/Y=234-252.
DR   PDB; 4A1G; X-ray; 2.60 A; E/F/G/H=176-226.
DR   PDB; 4NF9; X-ray; 2.80 A; A/B=2117-2337.
DR   PDB; 4NFA; X-ray; 2.50 A; A=2131-2337.
DR   PDBsum; 3SI5; -.
DR   PDBsum; 4A1G; -.
DR   PDBsum; 4NF9; -.
DR   PDBsum; 4NFA; -.
DR   SMR; Q8NG31; -.
DR   BioGrid; 121354; 58.
DR   CORUM; Q8NG31; -.
DR   DIP; DIP-36474N; -.
DR   ELM; Q8NG31; -.
DR   IntAct; Q8NG31; 56.
DR   MINT; Q8NG31; -.
DR   STRING; 9606.ENSP00000335463; -.
DR   iPTMnet; Q8NG31; -.
DR   PhosphoSitePlus; Q8NG31; -.
DR   BioMuta; KNL1; -.
DR   DMDM; 223590239; -.
DR   EPD; Q8NG31; -.
DR   jPOST; Q8NG31; -.
DR   MassIVE; Q8NG31; -.
DR   MaxQB; Q8NG31; -.
DR   PaxDb; Q8NG31; -.
DR   PeptideAtlas; Q8NG31; -.
DR   PRIDE; Q8NG31; -.
DR   ProteomicsDB; 73413; -. [Q8NG31-1]
DR   ProteomicsDB; 73414; -. [Q8NG31-2]
DR   ProteomicsDB; 73415; -. [Q8NG31-3]
DR   ProteomicsDB; 73416; -. [Q8NG31-4]
DR   Antibodypedia; 23122; 108 antibodies.
DR   DNASU; 57082; -.
DR   Ensembl; ENST00000346991; ENSP00000335463; ENSG00000137812. [Q8NG31-1]
DR   Ensembl; ENST00000399668; ENSP00000382576; ENSG00000137812. [Q8NG31-2]
DR   GeneID; 57082; -.
DR   KEGG; hsa:57082; -.
DR   UCSC; uc010bbs.2; human. [Q8NG31-1]
DR   CTD; 57082; -.
DR   DisGeNET; 57082; -.
DR   GeneCards; KNL1; -.
DR   HGNC; HGNC:24054; KNL1.
DR   HPA; ENSG00000137812; Group enriched (lymphoid tissue, testis).
DR   MalaCards; KNL1; -.
DR   MIM; 604321; phenotype.
DR   MIM; 609173; gene.
DR   neXtProt; NX_Q8NG31; -.
DR   OpenTargets; ENSG00000137812; -.
DR   Orphanet; 2512; Autosomal recessive primary microcephaly.
DR   PharmGKB; PA142672201; -.
DR   eggNOG; ENOG410IF9C; Eukaryota.
DR   eggNOG; ENOG410XZXJ; LUCA.
DR   GeneTree; ENSGT00410000025918; -.
DR   InParanoid; Q8NG31; -.
DR   KO; K11542; -.
DR   OMA; DNMEVSK; -.
DR   OrthoDB; 1249457at2759; -.
DR   PhylomeDB; Q8NG31; -.
DR   TreeFam; TF335517; -.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-606279; Deposition of new CENPA-containing nucleosomes at the centromere.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   SIGNOR; Q8NG31; -.
DR   ChiTaRS; KNL1; human.
DR   EvolutionaryTrace; Q8NG31; -.
DR   GeneWiki; CASC5; -.
DR   GenomeRNAi; 57082; -.
DR   Pharos; Q8NG31; Tbio.
DR   PRO; PR:Q8NG31; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; Q8NG31; protein.
DR   Bgee; ENSG00000137812; Expressed in testis and 124 other tissues.
DR   ExpressionAtlas; Q8NG31; baseline and differential.
DR   Genevisible; Q8NG31; HS.
DR   GO; GO:0001669; C:acrosomal vesicle; IDA:UniProtKB.
DR   GO; GO:0000777; C:condensed chromosome kinetochore; IDA:WormBase.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016604; C:nuclear body; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0001675; P:acrosome assembly; NAS:UniProtKB.
DR   GO; GO:0008608; P:attachment of spindle microtubules to kinetochore; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0034080; P:CENP-A containing nucleosome assembly; TAS:Reactome.
DR   GO; GO:0010923; P:negative regulation of phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0034501; P:protein localization to kinetochore; IDA:MGI.
DR   DisProt; DP01269; -.
DR   InterPro; IPR037388; Blinkin.
DR   InterPro; IPR040850; Knl1_RWD_C.
DR   PANTHER; PTHR16520; PTHR16520; 1.
DR   Pfam; PF18210; Knl1_RWD_C; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division; Centromere;
KW   Chromosomal rearrangement; Chromosome; Chromosome partition; Coiled coil;
KW   Disease mutation; Kinetochore; Mental retardation; Mitosis; Nucleus;
KW   Phosphoprotein; Polymorphism; Primary microcephaly; Reference proteome;
KW   Repeat.
FT   CHAIN           1..2342
FT                   /note="Kinetochore scaffold 1"
FT                   /id="PRO_0000089327"
FT   REPEAT          885..989
FT                   /note="1"
FT   REPEAT          1099..1201
FT                   /note="2"
FT   REGION          1..728
FT                   /note="Interaction with BUB1 and BUB1B"
FT                   /evidence="ECO:0000269|PubMed:17981135"
FT   REGION          855..1201
FT                   /note="2 X 104 AA approximate repeats"
FT   REGION          1834..2316
FT                   /note="Necessary for kinetochore localization and for
FT                   interaction with NSL1 and DSN1"
FT                   /evidence="ECO:0000269|PubMed:17981135"
FT   COILED          1942..2133
FT                   /evidence="ECO:0000255"
FT   MOTIF           1789..1803
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000255"
FT   SITE            1818..1819
FT                   /note="Breakpoint for translocation to form KMT2A-KNL1"
FT                   /evidence="ECO:0000269|PubMed:12618766"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         60
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         539
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         578
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         584
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         586
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         767
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         956
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1039
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1076
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:18691976, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1088
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1448
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1675
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1773
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1831
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         1845
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1860
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         84..109
FT                   /note="Missing (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10980622,
FT                   ECO:0000303|PubMed:12087463"
FT                   /id="VSP_013795"
FT   VAR_SEQ         1764..1772
FT                   /note="LIETYQKEI -> VGTRRRRYS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12087463"
FT                   /id="VSP_013796"
FT   VAR_SEQ         1773..2342
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:12087463"
FT                   /id="VSP_013797"
FT   VAR_SEQ         1819..1859
FT                   /note="IFDHHTEEDIDKSANSVLIKNLSRTPSSCSSSLDSIKADGT -> VSSVLNQ
FT                   RMFLNFGFCFVFLNCGYSQILILVSGRQKIIIST (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10980622"
FT                   /id="VSP_018524"
FT   VAR_SEQ         1860..2342
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10980622"
FT                   /id="VSP_018525"
FT   VARIANT         43
FT                   /note="R -> T (in dbSNP:rs7177192)"
FT                   /evidence="ECO:0000269|PubMed:12087463"
FT                   /id="VAR_026428"
FT   VARIANT         70
FT                   /note="T -> A (in dbSNP:rs16970874)"
FT                   /id="VAR_026429"
FT   VARIANT         113
FT                   /note="T -> A (in dbSNP:rs12911738)"
FT                   /evidence="ECO:0000269|PubMed:12087463"
FT                   /id="VAR_026430"
FT   VARIANT         177
FT                   /note="M -> V (in dbSNP:rs35146555)"
FT                   /id="VAR_061568"
FT   VARIANT         486
FT                   /note="A -> S (in dbSNP:rs2412541)"
FT                   /evidence="ECO:0000269|PubMed:10980622,
FT                   ECO:0000269|PubMed:12087463"
FT                   /id="VAR_026431"
FT   VARIANT         598
FT                   /note="M -> T (in dbSNP:rs11858113)"
FT                   /evidence="ECO:0000269|PubMed:10980622,
FT                   ECO:0000269|PubMed:12087463, ECO:0000269|PubMed:12618768,
FT                   ECO:0000269|PubMed:18987736"
FT                   /id="VAR_054342"
FT   VARIANT         936
FT                   /note="R -> G (in dbSNP:rs8040502)"
FT                   /evidence="ECO:0000269|PubMed:10980622,
FT                   ECO:0000269|PubMed:12087463, ECO:0000269|PubMed:12618768"
FT                   /id="VAR_026432"
FT   VARIANT         1190
FT                   /note="L -> V (in dbSNP:rs58614880)"
FT                   /id="VAR_061569"
FT   VARIANT         1285
FT                   /note="K -> E (in dbSNP:rs17747633)"
FT                   /evidence="ECO:0000269|PubMed:10980622"
FT                   /id="VAR_026433"
FT   VARIANT         1473
FT                   /note="T -> A (in dbSNP:rs16970911)"
FT                   /evidence="ECO:0000269|PubMed:10980622"
FT                   /id="VAR_026434"
FT   VARIANT         2041
FT                   /note="M -> I (in MCPH4; may inactivate an exonic splicing
FT                   enhancer and result in abnormal splicing;
FT                   dbSNP:rs763915472)"
FT                   /evidence="ECO:0000269|PubMed:22983954,
FT                   ECO:0000269|PubMed:26626498"
FT                   /id="VAR_069085"
FT   VARIANT         2338
FT                   /note="C -> Y (in dbSNP:rs61164860)"
FT                   /id="VAR_061570"
FT   CONFLICT        37
FT                   /note="L -> H (in Ref. 3; AAM45143)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1332
FT                   /note="P -> A (in Ref. 2; BAC05691)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1357
FT                   /note="N -> H (in Ref. 2; BAC05691)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1756
FT                   /note="N -> Y (in Ref. 2; BAC05691)"
FT                   /evidence="ECO:0000305"
FT   HELIX           205..211
FT                   /evidence="ECO:0000244|PDB:4A1G"
FT   HELIX           241..250
FT                   /evidence="ECO:0000244|PDB:3SI5"
FT   HELIX           2123..2130
FT                   /evidence="ECO:0000244|PDB:4NF9"
FT   STRAND          2136..2140
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   STRAND          2146..2151
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   STRAND          2154..2162
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   TURN            2168..2170
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   HELIX           2172..2174
FT                   /evidence="ECO:0000244|PDB:4NF9"
FT   STRAND          2177..2184
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   TURN            2188..2190
FT                   /evidence="ECO:0000244|PDB:4NF9"
FT   HELIX           2193..2210
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   TURN            2213..2215
FT                   /evidence="ECO:0000244|PDB:4NF9"
FT   HELIX           2219..2221
FT                   /evidence="ECO:0000244|PDB:4NF9"
FT   HELIX           2222..2249
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   HELIX           2250..2253
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   STRAND          2255..2261
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   STRAND          2264..2271
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   TURN            2272..2275
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   STRAND          2276..2283
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   TURN            2286..2289
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   STRAND          2295..2302
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   HELIX           2306..2315
FT                   /evidence="ECO:0000244|PDB:4NFA"
FT   HELIX           2322..2334
FT                   /evidence="ECO:0000244|PDB:4NFA"
SQ   SEQUENCE   2342 AA;  265391 MW;  8E29150CA4F5B5C1 CRC64;
     MDGVSSEANE ENDNIERPVR RRHSSILKPP RSPLQDLRGG NERVQESNAL RNKKNSRRVS
     FADTIKVFQT ESHMKIVRKS EMEGCSAMVP SQLQLLPPGF KRFSCLSLPE TETGENLLLI
     QNKKLEDNYC EITGMNTLLS APIHTQMQQK EFSIIEHTRE RKHANDQTVI FSDENQMDLT
     SSHTVMITKG LLDNPISEKS TKIDTTSFLA NLKLHTEDSR MKKEVNFSVD QNTSSENKID
     FNDFIKRLKT GKCSAFPDVP DKENFEIPIY SKEPNSASST HQMHVSLKED ENNSNITRLF
     REKDDGMNFT QCHTANIQTL IPTSSETNSR ESKGNDITIY GNDFMDLTFN HTLQILPATG
     NFSEIENQTQ NAMDVTTGYG TKASGNKTVF KSKQNTAFQD LSINSADKIH ITRSHIMGAE
     THIVSQTCNQ DARILAMTPE SIYSNPSIQG CKTVFYSSCN DAMEMTKCLS NMREEKNLLK
     HDSNYAKMYC NPDAMSSLTE KTIYSGEENM DITKSHTVAI DNQIFKQDQS NVQIAAAPTP
     EKEMMLQNLM TTSEDGKMNV NCNSVPHVSK ERIQQSLSNP LSISLTDRKT ELLSGENMDL
     TESHTSNLGS QVPLAAYNLA PESTSESHSQ SKSSSDECEE ITKSRNEPFQ RSDIIAKNSL
     TDTWNKDKDW VLKILPYLDK DSPQSADCNQ EIATSHNIVY CGGVLDKQIT NRNTVSWEQS
     LFSTTKPLFS SGQFSMKNHD TAISSHTVKS VLGQNSKLAE PLRKSLSNPT PDYCHDKMII
     CSEEEQNMDL TKSHTVVIGF GPSELQELGK TNLEHTTGQL TTMNRQIAVK VEKCGKSPIE
     KSGVLKSNCI MDVLEDESVQ KPKFPKEKQN VKIWGRKSVG GPKIDKTIVF SEDDKNDMDI
     TKSYTIEINH RPLLEKRDCH LVPLAGTSET ILYTCRQDDM EITRSHTTAL ECKTVSPDEI
     TTRPMDKTVV FVDNHVELEM TESHTVFIDY QEKERTDRPN FELSQRKSLG TPTVICTPTE
     ESVFFPGNGE SDRLVANDSQ LTPLEEWSNN RGPVEVADNM ELSKSATCKN IKDVQSPGFL
     NEPLSSKSQR RKSLKLKNDK TIVFSENHKN DMDITQSCMV EIDNESALED KEDFHLAGAS
     KTILYSCGQD DMEITRSHTT ALECKTLLPN EIAIRPMDKT VLFTDNYSDL EVTDSHTVFI
     DCQATEKILE ENPKFGIGKG KNLGVSFPKD NSCVQEIAEK QALAVGNKIV LHTEQKQQLF
     AATNRTTNEI IKFHSAAMDE KVIGKVVDQA CTLEKAQVES CQLNNRDRRN VDFTSSHATA
     VCGSSDNYSC LPNVISCTDN LEGSAMLLCD KDEEKANYCP VQNDLAYAND FASEYYLESE
     GQPLSAPCPL LEKEEVIQTS TKGQLDCVIT LHKDQDLIKD PRNLLANQTL VYSQDLGEMT
     KLNSKRVSFK LPKDQMKVYV DDIYVIPQPH FSTDQPPLPK KGQSSINKEE VILSKAGNKS
     LNIIENSSAP ICENKPKILN SEEWFAAACK KELKENIQTT NYNTALDFHS NSDVTKQVIQ
     THVNAGEAPD PVITSNVPCF HSIKPNLNNL NGKTGEFLAF QTVHLPPLPE QLLELGNKAH
     NDMHIVQATE IHNINIISSN AKDSRDEENK KSHNGAETTS LPPKTVFKDK VRRCSLGIFL
     PRLPNKRNCS VTGIDDLEQI PADTTDINHL ETQPVSSKDS GIGSVAGKLN LSPSQYINEE
     NLPVYPDEIN SSDSINIETE EKALIETYQK EISPYENKMG KTCNSQKRTW VQEEEDIHKE
     KKIRKNEIKF SDTTQDREIF DHHTEEDIDK SANSVLIKNL SRTPSSCSSS LDSIKADGTS
     LDFSTYRSSQ MESQFLRDTI CEESLREKLQ DGRITIREFF ILLQVHILIQ KPRQSNLPGN
     FTVNTPPTPE DLMLSQYVYR PKIQIYREDC EARRQKIEEL KLSASNQDKL LVDINKNLWE
     KMRHCSDKEL KAFGIYLNKI KSCFTKMTKV FTHQGKVALY GKLVQSAQNE REKLQIKIDE
     MDKILKKIDN CLTEMETETK NLEDEEKNNP VEEWDSEMRA AEKELEQLKT EEEELQRNLL
     ELEVQKEQTL AQIDFMQKQR NRTEELLDQL SLSEWDVVEW SDDQAVFTFV YDTIQLTITF
     EESVVGFPFL DKRYRKIVDV NFQSLLDEDQ APPSSLLVHK LIFQYVEEKE SWKKTCTTQH
     QLPKMLEEFS LVVHHCRLLG EEIEYLKRWG PNYNLMNIDI NNNELRLLFS SSAAFAKFEI
     TLFLSAYYPS VPLPSTIQNH VGNTSQDDIA TILSKVPLEN NYLKNVVKQI YQDLFQDCHF
     YH
//
ID   C9K080_HUMAN            Unreviewed;       623 AA.
AC   C9K080;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   21-SEP-2011, sequence version 2.
DT   22-APR-2020, entry version 85.
DE   SubName: Full=Leucine-rich repeats and immunoglobulin-like domains protein 3 {ECO:0000313|Ensembl:ENSP00000413143};
GN   Name=LRIG3 {ECO:0000313|Ensembl:ENSP00000413143};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000413143, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000413143, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16541075; DOI=10.1038/nature04569;
RG   Baylor College of Medicine Human Genome Sequencing Center Sequence Production Team;
RA   Scherer S.E., Muzny D.M., Buhay C.J., Chen R., Cree A., Ding Y.,
RA   Dugan-Rocha S., Gill R., Gunaratne P., Harris R.A., Hawes A.C.,
RA   Hernandez J., Hodgson A.V., Hume J., Jackson A., Khan Z.M., Kovar-Smith C.,
RA   Lewis L.R., Lozado R.J., Metzker M.L., Milosavljevic A., Miner G.R.,
RA   Montgomery K.T., Morgan M.B., Nazareth L.V., Scott G., Sodergren E.,
RA   Song X.Z., Steffen D., Lovering R.C., Wheeler D.A., Worley K.C., Yuan Y.,
RA   Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M., Brown M.J., Chen G.,
RA   Chen Z., Clerc-Blankenburg K.P., Davis C., Delgado O., Dinh H.H.,
RA   Draper H., Gonzalez-Garay M.L., Havlak P., Jackson L.R., Jacob L.S.,
RA   Kelly S.H., Li L., Li Z., Liu J., Liu W., Lu J., Maheshwari M.,
RA   Nguyen B.V., Okwuonu G.O., Pasternak S., Perez L.M., Plopper F.J.,
RA   Santibanez J., Shen H., Tabor P.E., Verduzco D., Waldron L., Wang Q.,
RA   Williams G.A., Zhang J., Zhou J., Allen C.C., Amin A.G., Anyalebechi V.,
RA   Bailey M., Barbaria J.A., Bimage K.E., Bryant N.P., Burch P.E.,
RA   Burkett C.E., Burrell K.L., Calderon E., Cardenas V., Carter K., Casias K.,
RA   Cavazos I., Cavazos S.R., Ceasar H., Chacko J., Chan S.N., Chavez D.,
RA   Christopoulos C., Chu J., Cockrell R., Cox C.D., Dang M., Dathorne S.R.,
RA   David R., Davis C.M., Davy-Carroll L., Deshazo D.R., Donlin J.E.,
RA   D'Souza L., Eaves K.A., Egan A., Emery-Cohen A.J., Escotto M., Flagg N.,
RA   Forbes L.D., Gabisi A.M., Garza M., Hamilton C., Henderson N.,
RA   Hernandez O., Hines S., Hogues M.E., Huang M., Idlebird D.G., Johnson R.,
RA   Jolivet A., Jones S., Kagan R., King L.M., Leal B., Lebow H., Lee S.,
RA   LeVan J.M., Lewis L.C., London P., Lorensuhewa L.M., Loulseged H.,
RA   Lovett D.A., Lucier A., Lucier R.L., Ma J., Madu R.C., Mapua P.,
RA   Martindale A.D., Martinez E., Massey E., Mawhiney S., Meador M.G.,
RA   Mendez S., Mercado C., Mercado I.C., Merritt C.E., Miner Z.L., Minja E.,
RA   Mitchell T., Mohabbat F., Mohabbat K., Montgomery B., Moore N., Morris S.,
RA   Munidasa M., Ngo R.N., Nguyen N.B., Nickerson E., Nwaokelemeh O.O.,
RA   Nwokenkwo S., Obregon M., Oguh M., Oragunye N., Oviedo R.J., Parish B.J.,
RA   Parker D.N., Parrish J., Parks K.L., Paul H.A., Payton B.A., Perez A.,
RA   Perrin W., Pickens A., Primus E.L., Pu L.L., Puazo M., Quiles M.M.,
RA   Quiroz J.B., Rabata D., Reeves K., Ruiz S.J., Shao H., Sisson I.,
RA   Sonaike T., Sorelle R.P., Sutton A.E., Svatek A.F., Svetz L.A.,
RA   Tamerisa K.S., Taylor T.R., Teague B., Thomas N., Thorn R.D., Trejos Z.Y.,
RA   Trevino B.K., Ukegbu O.N., Urban J.B., Vasquez L.I., Vera V.A.,
RA   Villasana D.M., Wang L., Ward-Moore S., Warren J.T., Wei X., White F.,
RA   Williamson A.L., Wleczyk R., Wooden H.S., Wooden S.H., Yen J., Yoon L.,
RA   Yoon V., Zorrilla S.E., Nelson D., Kucherlapati R., Weinstock G.,
RA   Gibbs R.A., null.;
RT   "The finished DNA sequence of human chromosome 12.";
RL   Nature 440:346-351(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000413143}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC078963; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF511180; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_016874279.1; XM_017018790.1.
DR   MaxQB; C9K080; -.
DR   PeptideAtlas; C9K080; -.
DR   PRIDE; C9K080; -.
DR   ProteomicsDB; 12499; -.
DR   Ensembl; ENST00000433272; ENSP00000413143; ENSG00000139263.
DR   GeneID; 121227; -.
DR   UCSC; uc058qes.1; human.
DR   CTD; 121227; -.
DR   EuPathDB; HostDB:ENSG00000139263.11; -.
DR   HGNC; HGNC:30991; LRIG3.
DR   OpenTargets; ENSG00000139263; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG4194; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00940000157098; -.
DR   HOGENOM; CLU_000288_18_24_1; -.
DR   ChiTaRS; LRIG3; human.
DR   GenomeRNAi; 121227; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   Bgee; ENSG00000139263; Expressed in stomach and 163 other tissues.
DR   ExpressionAtlas; C9K080; baseline and differential.
DR   Gene3D; 2.60.40.10; -; 1.
DR   Gene3D; 3.80.10.10; -; 4.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF13855; LRR_8; 4.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00369; LRR_TYP; 14.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS51450; LRR; 15.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|SAAS:SAAS01010727};
KW   Immunoglobulin domain {ECO:0000256|SAAS:SAAS01010457};
KW   Leucine-rich repeat {ECO:0000256|SAAS:SAAS00488662};
KW   Proteomics identification {ECO:0000213|MaxQB:C9K080,
KW   ECO:0000213|PeptideAtlas:C9K080, ECO:0000213|ProteomicsDB:C9K080};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00597472}; Signal {ECO:0000256|SAM:SignalP}.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           25..623
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002997948"
FT   DOMAIN          499..598
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
SQ   SEQUENCE   623 AA;  69407 MW;  FAE71746C0CEA045 CRC64;
     MSAPSLRARA AGLGLLLCAV LGRAGRSDSG GRGELGQPSG VAAERPCPTT CRCLGDLLDC
     SRKRLARLPE PLPSWVARLD LSHNRLSFIK ASSMSHLQSL REVKLNNNEL ETIPNLGPVS
     ANITLLSLAG NRIVEILPEH LKEFQSLETL DLSSNNISEL QTAFPALQLK YLYLNSNRVT
     SMEPGYFDNL ANTLLVLKLN RNRISAIPPK MFKLPQLQHL ELNRNKIKNV DGLTFQGLGA
     LKSLKMQRNG VTKLMDGAFW GLSNMEILQL DHNNLTEITK GWLYGLLMLQ ELHLSQNAIN
     RISPDAWEFC QKLSELDLTF NHLSRLDDSS FLGLSLLNTL HIGNNRVSYI ADCAFRGLSS
     LKTLDLKNNE ISWTIEDMNG AFSGLDKLRR LILQGNRIRS ITKKAFTGLD ALEHLDLSDN
     AIMSLQGNAF SQMKKLQQLH LNTSSLLCDC QLKWLPQWVA ENNFQSFVNA SCAHPQLLKG
     RSIFAVSPDG FVCDDFPKPQ ITVQPETQSA IKGSNLSFIC SAASSSDSPM TFAWKKDNEL
     LHDAEMENYA HLRAQGGEVM EYTTILRLRE VEFASEGKYQ CVISNHFGSS YSVKAKLTVN
     IPHLTLPFPT FHSTKLRFLV ICI
//
ID   LRIG3_HUMAN             Reviewed;        1119 AA.
AC   Q6UXM1; Q6UXL7; Q8NC72;
DT   16-AUG-2005, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 142.
DE   RecName: Full=Leucine-rich repeats and immunoglobulin-like domains protein 3;
DE            Short=LIG-3;
DE   Flags: Precursor;
GN   Name=LRIG3; Synonyms=LIG3; ORFNames=UNQ287/PRO326/PRO335;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=15203213; DOI=10.1016/j.ygeno.2004.01.013;
RA   Guo D., Holmlund C., Henriksson R., Hedman H.;
RT   "The LRIG gene family has three vertebrate paralogs widely expressed in
RT   human and mouse tissues and a homolog in Ascidiacea.";
RL   Genomics 84:157-165(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 400-1119.
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   -!- FUNCTION: May play a role in craniofacial and inner ear morphogenesis
CC       during embryonic development. May act within the otic vesicle
CC       epithelium to control formation of the lateral semicircular canal in
CC       the inner ear, possibly by restricting the expression of NTN1 (By
CC       similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Interacts with EGFR, ERBB2 and ERBB4 (in vitro).
CC       {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass type I
CC       membrane protein {ECO:0000250}. Cytoplasmic vesicle membrane
CC       {ECO:0000250}; Single-pass type I membrane protein {ECO:0000250}.
CC       Note=Detected in cytoplasmic vesicles when coexpressed with ERBB4.
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q6UXM1-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UXM1-2; Sequence=VSP_015097;
CC   -!- TISSUE SPECIFICITY: Widely expressed. {ECO:0000269|PubMed:15203213}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11295.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY505340; AAR98629.1; -; mRNA.
DR   EMBL; AY358288; AAQ88655.1; -; mRNA.
DR   EMBL; AY358295; AAQ88662.1; -; mRNA.
DR   EMBL; AK074921; BAC11295.1; ALT_INIT; mRNA.
DR   CCDS; CCDS44933.1; -. [Q6UXM1-2]
DR   CCDS; CCDS8960.1; -. [Q6UXM1-1]
DR   RefSeq; NP_001129523.1; NM_001136051.2. [Q6UXM1-2]
DR   RefSeq; NP_700356.2; NM_153377.4. [Q6UXM1-1]
DR   SMR; Q6UXM1; -.
DR   BioGrid; 125712; 25.
DR   IntAct; Q6UXM1; 6.
DR   STRING; 9606.ENSP00000326759; -.
DR   iPTMnet; Q6UXM1; -.
DR   PhosphoSitePlus; Q6UXM1; -.
DR   BioMuta; LRIG3; -.
DR   DMDM; 73621176; -.
DR   EPD; Q6UXM1; -.
DR   jPOST; Q6UXM1; -.
DR   MassIVE; Q6UXM1; -.
DR   MaxQB; Q6UXM1; -.
DR   PaxDb; Q6UXM1; -.
DR   PeptideAtlas; Q6UXM1; -.
DR   PRIDE; Q6UXM1; -.
DR   ProteomicsDB; 67636; -. [Q6UXM1-1]
DR   ProteomicsDB; 67637; -. [Q6UXM1-2]
DR   Antibodypedia; 2484; 143 antibodies.
DR   Ensembl; ENST00000320743; ENSP00000326759; ENSG00000139263. [Q6UXM1-1]
DR   Ensembl; ENST00000379141; ENSP00000368436; ENSG00000139263. [Q6UXM1-2]
DR   GeneID; 121227; -.
DR   KEGG; hsa:121227; -.
DR   UCSC; uc001sqr.5; human. [Q6UXM1-1]
DR   CTD; 121227; -.
DR   DisGeNET; 121227; -.
DR   GeneCards; LRIG3; -.
DR   HGNC; HGNC:30991; LRIG3.
DR   HPA; ENSG00000139263; Low tissue specificity.
DR   MIM; 608870; gene.
DR   neXtProt; NX_Q6UXM1; -.
DR   OpenTargets; ENSG00000139263; -.
DR   PharmGKB; PA134864136; -.
DR   eggNOG; KOG0619; Eukaryota.
DR   eggNOG; KOG4194; Eukaryota.
DR   eggNOG; COG4886; LUCA.
DR   GeneTree; ENSGT00940000157098; -.
DR   InParanoid; Q6UXM1; -.
DR   OMA; NPNCDSG; -.
DR   OrthoDB; 161719at2759; -.
DR   PhylomeDB; Q6UXM1; -.
DR   TreeFam; TF325380; -.
DR   SIGNOR; Q6UXM1; -.
DR   ChiTaRS; LRIG3; human.
DR   GenomeRNAi; 121227; -.
DR   Pharos; Q6UXM1; Tbio.
DR   PRO; PR:Q6UXM1; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q6UXM1; protein.
DR   Bgee; ENSG00000139263; Expressed in stomach and 163 other tissues.
DR   ExpressionAtlas; Q6UXM1; baseline and differential.
DR   Genevisible; Q6UXM1; HS.
DR   GO; GO:0030659; C:cytoplasmic vesicle membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0031012; C:extracellular matrix; IBA:GO_Central.
DR   GO; GO:0005615; C:extracellular space; HDA:UniProtKB.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032474; P:otolith morphogenesis; IEA:Ensembl.
DR   Gene3D; 2.60.40.10; -; 3.
DR   Gene3D; 3.80.10.10; -; 2.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF07679; I-set; 2.
DR   Pfam; PF13855; LRR_8; 4.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00369; LRR_TYP; 14.
DR   SMART; SM00082; LRRCT; 1.
DR   SUPFAM; SSF48726; SSF48726; 3.
DR   PROSITE; PS50835; IG_LIKE; 3.
DR   PROSITE; PS51450; LRR; 15.
PE   2: Evidence at transcript level;
KW   Alternative splicing; Cell membrane; Cytoplasmic vesicle;
KW   Developmental protein; Disulfide bond; Glycoprotein; Immunoglobulin domain;
KW   Leucine-rich repeat; Membrane; Reference proteome; Repeat; Signal;
KW   Transmembrane; Transmembrane helix.
FT   SIGNAL          1..24
FT                   /evidence="ECO:0000255"
FT   CHAIN           25..1119
FT                   /note="Leucine-rich repeats and immunoglobulin-like domains
FT                   protein 3"
FT                   /id="PRO_0000014831"
FT   TRANSMEM        810..830
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          38..74
FT                   /note="LRRNT"
FT   REPEAT          75..96
FT                   /note="LRR 1"
FT   REPEAT          99..120
FT                   /note="LRR 2"
FT   REPEAT          122..142
FT                   /note="LRR 3"
FT   REPEAT          146..167
FT                   /note="LRR 4"
FT   REPEAT          168..189
FT                   /note="LRR 5"
FT   REPEAT          193..214
FT                   /note="LRR 6"
FT   REPEAT          216..237
FT                   /note="LRR 7"
FT   REPEAT          240..261
FT                   /note="LRR 8"
FT   REPEAT          264..285
FT                   /note="LRR 9"
FT   REPEAT          288..309
FT                   /note="LRR 10"
FT   REPEAT          312..333
FT                   /note="LRR 11"
FT   REPEAT          336..357
FT                   /note="LRR 12"
FT   REPEAT          360..382
FT                   /note="LRR 13"
FT   REPEAT          387..408
FT                   /note="LRR 14"
FT   REPEAT          411..432
FT                   /note="LRR 15"
FT   DOMAIN          444..495
FT                   /note="LRRCT"
FT   DOMAIN          499..598
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          603..692
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          697..783
FT                   /note="Ig-like C2-type 3"
FT   CARBOHYD        122
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        156
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        274
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        442
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        469
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        515
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        688
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        729
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        905
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        987
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        999
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        1016
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        520..581
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        624..676
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        718..767
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..79
FT                   /note="MSAPSLRARAAGLGLLLCAVLGRAGRSDSGGRGELGQPSGVAAERPCPTTCR
FT                   CLGDLLDCSRKRLARLPEPLPSWVARL -> MVDVLLLFSLCLLFHISRP (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309"
FT                   /id="VSP_015097"
SQ   SEQUENCE   1119 AA;  123434 MW;  EB3B6A391F3C8713 CRC64;
     MSAPSLRARA AGLGLLLCAV LGRAGRSDSG GRGELGQPSG VAAERPCPTT CRCLGDLLDC
     SRKRLARLPE PLPSWVARLD LSHNRLSFIK ASSMSHLQSL REVKLNNNEL ETIPNLGPVS
     ANITLLSLAG NRIVEILPEH LKEFQSLETL DLSSNNISEL QTAFPALQLK YLYLNSNRVT
     SMEPGYFDNL ANTLLVLKLN RNRISAIPPK MFKLPQLQHL ELNRNKIKNV DGLTFQGLGA
     LKSLKMQRNG VTKLMDGAFW GLSNMEILQL DHNNLTEITK GWLYGLLMLQ ELHLSQNAIN
     RISPDAWEFC QKLSELDLTF NHLSRLDDSS FLGLSLLNTL HIGNNRVSYI ADCAFRGLSS
     LKTLDLKNNE ISWTIEDMNG AFSGLDKLRR LILQGNRIRS ITKKAFTGLD ALEHLDLSDN
     AIMSLQGNAF SQMKKLQQLH LNTSSLLCDC QLKWLPQWVA ENNFQSFVNA SCAHPQLLKG
     RSIFAVSPDG FVCDDFPKPQ ITVQPETQSA IKGSNLSFIC SAASSSDSPM TFAWKKDNEL
     LHDAEMENYA HLRAQGGEVM EYTTILRLRE VEFASEGKYQ CVISNHFGSS YSVKAKLTVN
     MLPSFTKTPM DLTIRAGAMA RLECAAVGHP APQIAWQKDG GTDFPAARER RMHVMPEDDV
     FFIVDVKIED IGVYSCTAQN SAGSISANAT LTVLETPSFL RPLLDRTVTK GETAVLQCIA
     GGSPPPKLNW TKDDSPLVVT ERHFFAAGNQ LLIIVDSDVS DAGKYTCEMS NTLGTERGNV
     RLSVIPTPTC DSPQMTAPSL DDDGWATVGV VIIAVVCCVV GTSLVWVVII YHTRRRNEDC
     SITNTDETNL PADIPSYLSS QGTLADRQDG YVSSESGSHH QFVTSSGAGF FLPQHDSSGT
     CHIDNSSEAD VEAATDLFLC PFLGSTGPMY LKGNVYGSDP FETYHTGCSP DPRTVLMDHY
     EPSYIKKKEC YPCSHPSEES CERSFSNISW PSHVRKLLNT SYSHNEGPGM KNLCLNKSSL
     DFSANPEPAS VASSNSFMGT FGKALRRPHL DAYSSFGQPS DCQPRAFYLK AHSSPDLDSG
     SEEDGKERTD FQEENHICTF KQTLENYRTP NFQSYDLDT
//
ID   A0A0S2Z4U8_HUMAN        Unreviewed;       268 AA.
AC   A0A0S2Z4U8;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 32.
DE   SubName: Full=Myeloid leukemia factor 1 isoform 1 {ECO:0000313|EMBL:ALQ33644.1};
DE   SubName: Full=Myeloid leukemia factor 1, isoform CRA_a {ECO:0000313|EMBL:EAW78685.1};
DE   Flags: Fragment;
GN   Name=MLF1 {ECO:0000313|EMBL:ALQ33644.1};
GN   ORFNames=hCG_16019 {ECO:0000313|EMBL:EAW78685.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33644.1};
RN   [1] {ECO:0000313|EMBL:EAW78685.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW78685.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33644.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178186; ALQ33644.1; -; mRNA.
DR   EMBL; CH471052; EAW78685.1; -; Genomic_DNA.
DR   RefSeq; NP_071888.1; NM_022443.4.
DR   Antibodypedia; 18436; 513 antibodies.
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   CTD; 4291; -.
DR   KO; K15622; -.
DR   ChiTaRS; MLF1; human.
DR   GenomeRNAi; 4291; -.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   REGION          44..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          209..268
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        45..64
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        223..254
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         268
FT                   /evidence="ECO:0000313|EMBL:ALQ33644.1"
SQ   SEQUENCE   268 AA;  30627 MW;  08774217329F737A CRC64;
     MFRMLNSSFE DDPFFSESIL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTHTDVS SFQTMDQMVS NMRNYMQKLE RNFGQLSVDP NGHSFCSSSV MTYSKIGDEP
     PKVFQASTQT RRAPGGIKET RKAMRDSDSG LEKMAIGHHI HDRAHVIKKS KNKKTGDEEV
     NQEFINMNES DAHAFDEEWQ SEVLKYKPGR HNLGNTRMRS VGHENPGSRE LKRREKPQQS
     PAIEHGRRSN VLGDKLHIKG SSVKSNKK
//
ID   A0A140VKD2_HUMAN        Unreviewed;       243 AA.
AC   A0A140VKD2;
DT   08-JUN-2016, integrated into UniProtKB/TrEMBL.
DT   08-JUN-2016, sequence version 1.
DT   22-APR-2020, entry version 18.
DE   SubName: Full=Testis tissue sperm-binding protein Li 49e {ECO:0000313|EMBL:AEE61269.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AEE61269.1};
RN   [1] {ECO:0000313|EMBL:AEE61269.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y.;
RT   "Human testis protein.";
RL   Submitted (MAR-2010) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HM005672; AEE61269.1; -; mRNA.
DR   RefSeq; NP_001123628.1; NM_001130156.2.
DR   RefSeq; NP_001123629.1; NM_001130157.2.
DR   RefSeq; XP_011511155.1; XM_011512853.2.
DR   SMR; A0A140VKD2; -.
DR   PRIDE; A0A140VKD2; -.
DR   Antibodypedia; 18436; 513 antibodies.
DR   GeneID; 4291; -.
DR   CTD; 4291; -.
DR   GenomeRNAi; 4291; -.
DR   ExpressionAtlas; A0A140VKD2; baseline and differential.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   REGION          19..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          184..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..39
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        198..229
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   243 AA;  27625 MW;  061E87A385C3E063 CRC64;
     MRQMIRSFSE PFGRDLLSIS DGRGRAHNRR GHNDGEDSLT HTDVSSFQTM DQMVSNMRNY
     MQKLERNFGQ LSVDPNGHSF CSSSVMTYSK IGDEPPKVFQ ASTQTRRAPG GIKETRKAMR
     DSDSGLEKMA IGHHIHDRAH VIKKSKNKKT GDEEVNQEFI NMNESDAHAF DEEWQSEVLK
     YKPGRHNLGN TRMRSVGHEN PGSRELKRRE KPQQSPAIEH GRRSNVLGDK LHIKGSSVKS
     NKK
//
ID   B2RD48_HUMAN            Unreviewed;       268 AA.
AC   B2RD48;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 44.
DE   SubName: Full=cDNA, FLJ96451, highly similar to Homo sapiens myeloid leukemia factor 1 (MLF1), mRNA {ECO:0000313|EMBL:BAG37795.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG37795.1};
RN   [1] {ECO:0000313|EMBL:BAG37795.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Colon {ECO:0000313|EMBL:BAG37795.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK315402; BAG37795.1; -; mRNA.
DR   RefSeq; NP_071888.1; NM_022443.4.
DR   SMR; B2RD48; -.
DR   PeptideAtlas; B2RD48; -.
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   CTD; 4291; -.
DR   KO; K15622; -.
DR   GenomeRNAi; 4291; -.
DR   Genevisible; B2RD48; HS.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   REGION          44..66
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          209..268
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        45..64
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        223..254
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   268 AA;  30615 MW;  08706B173293837A CRC64;
     MFRMLNSSFE DDPFFSESTL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTHTDVS SFQTMDQMVS NMRNYMQKLE RNFGQLSVDP NGHSFCSSSV MTYSKIGDEP
     PKVFQASTQT RRAPGGIKET RKAMRDSDSG LEKMAIGHHI HDRAHVIKKS KNKKTGDEEV
     NQEFINMNES DAHAFDEEWQ SEVLKYKPGR HNLGNTRMRS VGHENPGSRE LKRREKPQQS
     PAIEHGRRSN VLGDKLHIKG SSVKSNKK
//
ID   MLF1_HUMAN              Reviewed;         268 AA.
AC   P58340; E9PEU9; Q2TLE3; Q2TLE5; Q8N8F8; Q96MH1;
DT   02-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   02-NOV-2001, sequence version 1.
DT   22-APR-2020, entry version 153.
DE   RecName: Full=Myeloid leukemia factor 1;
DE   AltName: Full=Myelodysplasia-myeloid leukemia factor 1;
GN   Name=MLF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND CHROMOSOMAL TRANSLOCATION.
RC   TISSUE=Skeletal muscle, and Testis;
RX   PubMed=8570204;
RA   Yoneda-Kato N., Look A.T., Kirstein M.N., Valentine M.B., Raimondi S.C.,
RA   Cohen K.J., Carroll A.J., Morris S.W.;
RT   "The t(3;5)(q25.1;q34) of myelodysplastic syndrome and acute myeloid
RT   leukemia produces a novel fusion gene, NPM-MLF1.";
RL   Oncogene 12:265-275(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2 AND 5).
RA   Feng X., Ling S., Zhang H., Song X., Wang G., Chen K., Zhu C.;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3; 4 AND 5).
RC   TISSUE=Brain, and Skeletal muscle;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Urinary bladder;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   INTERACTION WITH CENPU.
RX   PubMed=15116101; DOI=10.1038/sj.onc.1207448;
RA   Hanissian S.H., Akbar U., Teng B., Janjetovic Z., Hoffmann A.,
RA   Hitzler J.K., Iscove N., Hamre K., Du X., Tong Y., Mukatira S.,
RA   Robertson J.H., Morris S.W.;
RT   "cDNA cloning and characterization of a novel gene encoding the MLF1-
RT   interacting protein MLF1IP.";
RL   Oncogene 23:3700-3707(2004).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH COPS3.
RX   PubMed=15861129; DOI=10.1038/sj.emboj.7600656;
RA   Yoneda-Kato N., Tomoda K., Umehara M., Arata Y., Kato J.-Y.;
RT   "Myeloid leukemia factor 1 regulates p53 by suppressing COP1 via COP9
RT   signalosome subunit 3.";
RL   EMBO J. 24:1739-1749(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8 AND SER-32, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 29-42 IN COMPLEX WITH YWHAE, AND
RP   PHOSPHORYLATION AT SER-34.
RX   PubMed=22151054; DOI=10.1111/j.1742-4658.2011.08445.x;
RA   Molzan M., Weyand M., Rose R., Ottmann C.;
RT   "Structural insights of the MLF1/14-3-3 interaction.";
RL   FEBS J. 279:563-571(2012).
CC   -!- FUNCTION: Involved in lineage commitment of primary hemopoietic
CC       progenitors by restricting erythroid formation and enhancing myeloid
CC       formation. Interferes with erythropoietin-induced erythroid terminal
CC       differentiation by preventing cells from exiting the cell cycle through
CC       suppression of CDKN1B/p27Kip1 levels. Suppresses COP1 activity via CSN3
CC       which activates p53 and induces cell cycle arrest. Binds DNA and
CC       affects the expression of a number of genes so may function as a
CC       transcription factor in the nucleus. {ECO:0000269|PubMed:15861129}.
CC   -!- SUBUNIT: Interacts with CENPU. Also interacts with NRBP1/MADM,
CC       YWHAZ/14-3-3-zeta and HNRPUL2/MANP. NRBP1 recruits a serine kinase
CC       which phosphorylates both itself and MLF1. Phosphorylated MLF1 then
CC       binds to YWHAZ and is retained in the cytoplasm. Retained in the
CC       nucleus by binding to HNRPUL2. Binds to COPS3/CSN3 which is required
CC       for suppression of COP1 and activation of p53.
CC       {ECO:0000269|PubMed:15116101, ECO:0000269|PubMed:15861129,
CC       ECO:0000269|PubMed:22151054}.
CC   -!- INTERACTION:
CC       P58340; A8K1F4; NbExp=2; IntAct=EBI-721328, EBI-9357094;
CC       P58340; Q9BTE6-2: AARSD1; NbExp=2; IntAct=EBI-721328, EBI-9357295;
CC       P58340; O75190: DNAJB6; NbExp=2; IntAct=EBI-721328, EBI-1053164;
CC       P58340; P43364: MAGEA11; NbExp=5; IntAct=EBI-721328, EBI-739552;
CC       P58340; Q13200: PSMD2; NbExp=2; IntAct=EBI-721328, EBI-357648;
CC       P58340; P62258: YWHAE; NbExp=3; IntAct=EBI-721328, EBI-356498;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000250|UniProtKB:Q9QWV4}. Nucleus
CC       {ECO:0000250|UniProtKB:Q9QWV4}. Cell projection, cilium
CC       {ECO:0000250|UniProtKB:Q9QWV4}. Cytoplasm, cytoskeleton, cilium basal
CC       body {ECO:0000250|UniProtKB:Q9QWV4}. Note=Shuttles between the
CC       cytoplasm and nucleus. {ECO:0000250|UniProtKB:Q9QWV4}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=P58340-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P58340-2; Sequence=VSP_043130, VSP_043131;
CC       Name=3;
CC         IsoId=P58340-3; Sequence=VSP_043725, VSP_043726;
CC       Name=5;
CC         IsoId=P58340-5; Sequence=VSP_043130;
CC       Name=4;
CC         IsoId=P58340-4; Sequence=VSP_043130, VSP_043726;
CC   -!- TISSUE SPECIFICITY: Most abundant in testis, ovary, skeletal muscle,
CC       heart, kidney and colon. Low expression in spleen, thymus and
CC       peripheral blood leukocytes.
CC   -!- PTM: Phosphorylation is required for binding to YWHAZ. {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving MLF1 is a cause of
CC       myelodysplastic syndrome (MDS). Translocation t(3;5)(q25.1;q34) with
CC       NPM1/NPM. {ECO:0000269|PubMed:8570204}.
CC   -!- SIMILARITY: Belongs to the MLF family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MLF1ID18.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L49054; AAA99997.1; -; mRNA.
DR   EMBL; AY848700; AAX46015.1; -; mRNA.
DR   EMBL; AY848702; AAX46017.1; -; mRNA.
DR   EMBL; AK056948; BAB71320.1; -; mRNA.
DR   EMBL; AK096889; BAC04885.1; -; mRNA.
DR   EMBL; AK297488; BAG59906.1; -; mRNA.
DR   EMBL; AC025033; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC106707; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471052; EAW78689.1; -; Genomic_DNA.
DR   EMBL; CH471052; EAW78690.1; -; Genomic_DNA.
DR   EMBL; BC007045; AAH07045.1; -; mRNA.
DR   CCDS; CCDS3182.1; -. [P58340-1]
DR   CCDS; CCDS46945.1; -. [P58340-5]
DR   CCDS; CCDS56286.1; -. [P58340-3]
DR   CCDS; CCDS56287.1; -. [P58340-4]
DR   CCDS; CCDS56288.1; -. [P58340-2]
DR   RefSeq; NP_001123628.1; NM_001130156.2. [P58340-5]
DR   RefSeq; NP_001123629.1; NM_001130157.2. [P58340-5]
DR   RefSeq; NP_001182361.1; NM_001195432.1. [P58340-3]
DR   RefSeq; NP_001182362.1; NM_001195433.1. [P58340-2]
DR   RefSeq; NP_001182363.1; NM_001195434.1. [P58340-4]
DR   RefSeq; NP_071888.1; NM_022443.4. [P58340-1]
DR   RefSeq; XP_005247537.1; XM_005247480.2.
DR   RefSeq; XP_011511154.1; XM_011512852.2. [P58340-4]
DR   RefSeq; XP_011511155.1; XM_011512853.2.
DR   PDB; 3UAL; X-ray; 1.80 A; P=29-42.
DR   PDB; 3UBW; X-ray; 1.90 A; P=29-42.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   SMR; P58340; -.
DR   BioGrid; 110437; 79.
DR   ELM; P58340; -.
DR   IntAct; P58340; 130.
DR   MINT; P58340; -.
DR   STRING; 9606.ENSP00000376568; -.
DR   MoonDB; P58340; Predicted.
DR   iPTMnet; P58340; -.
DR   PhosphoSitePlus; P58340; -.
DR   BioMuta; MLF1; -.
DR   DMDM; 17368170; -.
DR   EPD; P58340; -.
DR   jPOST; P58340; -.
DR   MassIVE; P58340; -.
DR   MaxQB; P58340; -.
DR   PeptideAtlas; P58340; -.
DR   PRIDE; P58340; -.
DR   ProteomicsDB; 57064; -. [P58340-1]
DR   ProteomicsDB; 57065; -. [P58340-2]
DR   ProteomicsDB; 57066; -. [P58340-3]
DR   ProteomicsDB; 57067; -. [P58340-4]
DR   ProteomicsDB; 61497; -.
DR   Antibodypedia; 18436; 513 antibodies.
DR   Ensembl; ENST00000355893; ENSP00000348157; ENSG00000178053. [P58340-1]
DR   Ensembl; ENST00000359117; ENSP00000352025; ENSG00000178053. [P58340-5]
DR   Ensembl; ENST00000392822; ENSP00000376568; ENSG00000178053. [P58340-3]
DR   Ensembl; ENST00000469452; ENSP00000418595; ENSG00000178053. [P58340-2]
DR   Ensembl; ENST00000471745; ENSP00000420134; ENSG00000178053. [P58340-4]
DR   Ensembl; ENST00000477042; ENSP00000419637; ENSG00000178053. [P58340-4]
DR   Ensembl; ENST00000478894; ENSP00000417777; ENSG00000178053. [P58340-3]
DR   Ensembl; ENST00000482628; ENSP00000417141; ENSG00000178053. [P58340-5]
DR   Ensembl; ENST00000484955; ENSP00000417835; ENSG00000178053. [P58340-5]
DR   Ensembl; ENST00000618075; ENSP00000484169; ENSG00000178053. [P58340-2]
DR   Ensembl; ENST00000651874; ENSP00000498363; ENSG00000178053. [P58340-5]
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   UCSC; uc003fbx.4; human. [P58340-1]
DR   CTD; 4291; -.
DR   DisGeNET; 4291; -.
DR   GeneCards; MLF1; -.
DR   HGNC; HGNC:7125; MLF1.
DR   HPA; ENSG00000178053; Tissue enhanced (heart muscle, skeletal muscle, testis).
DR   MalaCards; MLF1; -.
DR   MIM; 601402; gene.
DR   neXtProt; NX_P58340; -.
DR   OpenTargets; ENSG00000178053; -.
DR   PharmGKB; PA30843; -.
DR   GeneTree; ENSGT00390000005023; -.
DR   InParanoid; P58340; -.
DR   KO; K15622; -.
DR   OMA; MAVGHHL; -.
DR   PhylomeDB; P58340; -.
DR   TreeFam; TF317561; -.
DR   SIGNOR; P58340; -.
DR   ChiTaRS; MLF1; human.
DR   GeneWiki; MLF1; -.
DR   GenomeRNAi; 4291; -.
DR   Pharos; P58340; Tbio.
DR   PRO; PR:P58340; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P58340; protein.
DR   Bgee; ENSG00000178053; Expressed in right testis and 224 other tissues.
DR   ExpressionAtlas; P58340; baseline and differential.
DR   Genevisible; P58340; HS.
DR   GO; GO:0036064; C:ciliary basal body; ISS:UniProtKB.
DR   GO; GO:0005929; C:cilium; ISS:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; HDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; ISS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IDA:UniProtKB.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0002318; P:myeloid progenitor cell differentiation; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0006351; P:transcription, DNA-templated; ISS:UniProtKB.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell projection;
KW   Chromosomal rearrangement; Cytoplasm; Cytoskeleton; Developmental protein;
KW   Differentiation; DNA-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome.
FT   CHAIN           1..268
FT                   /note="Myeloid leukemia factor 1"
FT                   /id="PRO_0000220752"
FT   REGION          50..125
FT                   /note="Interaction with COPS3"
FT                   /evidence="ECO:0000269|PubMed:15861129"
FT   SITE            16..17
FT                   /note="Breakpoint for translocation to form NPM-MLF1"
FT   MOD_RES         8
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         32
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         34
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000269|PubMed:22151054"
FT   VAR_SEQ         1..25
FT                   /note="Missing (in isoform 2, isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.2"
FT                   /id="VSP_043130"
FT   VAR_SEQ         1..15
FT                   /note="MFRMLNSSFEDDPFF -> MLKEVLQREGKSYKSETLMYIKKARASENKL
FT                   (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043725"
FT   VAR_SEQ         65
FT                   /note="T -> TATSCSLVPFGDFGGM (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_043726"
FT   VAR_SEQ         94..136
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|Ref.2"
FT                   /id="VSP_043131"
FT   VARIANT         226
FT                   /note="P -> T (in dbSNP:rs15967)"
FT                   /id="VAR_022070"
SQ   SEQUENCE   268 AA;  30627 MW;  08774217329F737A CRC64;
     MFRMLNSSFE DDPFFSESIL AHRENMRQMI RSFSEPFGRD LLSISDGRGR AHNRRGHNDG
     EDSLTHTDVS SFQTMDQMVS NMRNYMQKLE RNFGQLSVDP NGHSFCSSSV MTYSKIGDEP
     PKVFQASTQT RRAPGGIKET RKAMRDSDSG LEKMAIGHHI HDRAHVIKKS KNKKTGDEEV
     NQEFINMNES DAHAFDEEWQ SEVLKYKPGR HNLGNTRMRS VGHENPGSRE LKRREKPQQS
     PAIEHGRRSN VLGDKLHIKG SSVKSNKK
//
ID   Q2TLE4_HUMAN            Unreviewed;       243 AA.
AC   Q2TLE4;
DT   24-JAN-2006, integrated into UniProtKB/TrEMBL.
DT   24-JAN-2006, sequence version 1.
DT   22-APR-2020, entry version 59.
DE   SubName: Full=Myeloid leukemia factor 1 variant 2 {ECO:0000313|EMBL:AAX46016.1};
GN   Name=MLF1 {ECO:0000313|EMBL:AAX46016.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAX46016.1};
RN   [1] {ECO:0000313|EMBL:AAX46016.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Feng X., Ling S., Zhang H., Song X., Wang G., Chen K., Zhu C.;
RL   Submitted (DEC-2004) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY848701; AAX46016.1; -; mRNA.
DR   RefSeq; NP_001123629.1; NM_001130157.2.
DR   SMR; Q2TLE4; -.
DR   PeptideAtlas; Q2TLE4; -.
DR   PRIDE; Q2TLE4; -.
DR   GeneID; 4291; -.
DR   CTD; 4291; -.
DR   PharmGKB; PA30843; -.
DR   ChiTaRS; MLF1; human.
DR   GenomeRNAi; 4291; -.
DR   Genevisible; Q2TLE4; HS.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   REGION          19..41
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          184..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        20..39
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        198..229
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   243 AA;  27615 MW;  05D187A3860CE17C CRC64;
     MRQMIRSFSE PFGRDLLSIS DGRGRAHNRR GHNDGEDSLT HTDVSSFQTM DQMVSNMRNY
     MQKLERNFGQ LSVDPNGHSF CSSSVMTYSK IGDEPPKVFQ ASTQTRRASG GIKETRKAMR
     DSDSGLEKMA IGHHIHDRAH VIKKSKNKKT GDEEVNQEFI NMNESDAHAF DEEWQSEVLK
     YKPGRHNLGN TRMRSVGHEN PGSRELKRRE KPQQSPAIEH GRRSNVLGDK LHIKGSSVKS
     NKK
//
ID   Q5HYH4_HUMAN            Unreviewed;       256 AA.
AC   Q5HYH4;
DT   15-FEB-2005, integrated into UniProtKB/TrEMBL.
DT   15-FEB-2005, sequence version 1.
DT   26-FEB-2020, entry version 65.
DE   SubName: Full=Uncharacterized protein DKFZp313B1621 {ECO:0000313|EMBL:CAI46058.1};
GN   Name=DKFZp313B1621 {ECO:0000313|EMBL:CAI46058.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAI46058.1};
RN   [1] {ECO:0000313|EMBL:CAI46058.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Adipose {ECO:0000313|EMBL:CAI46058.1};
RG   The German cDNA Consortium;
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (JAN-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BX647666; CAI46058.1; -; mRNA.
DR   RefSeq; NP_001123628.1; NM_001130156.2.
DR   RefSeq; NP_001123629.1; NM_001130157.2.
DR   RefSeq; NP_001182361.1; NM_001195432.1.
DR   RefSeq; NP_001182362.1; NM_001195433.1.
DR   RefSeq; NP_001182363.1; NM_001195434.1.
DR   RefSeq; NP_071888.1; NM_022443.4.
DR   SMR; Q5HYH4; -.
DR   PeptideAtlas; Q5HYH4; -.
DR   GeneID; 4291; -.
DR   KEGG; hsa:4291; -.
DR   CTD; 4291; -.
DR   PharmGKB; PA30843; -.
DR   eggNOG; KOG4049; Eukaryota.
DR   eggNOG; ENOG4111J7M; LUCA.
DR   KO; K15622; -.
DR   OrthoDB; 1471165at2759; -.
DR   GenomeRNAi; 4291; -.
DR   Genevisible; Q5HYH4; HS.
DR   InterPro; IPR019376; Myeloid_leukemia_factor.
DR   PANTHER; PTHR13105; PTHR13105; 1.
DR   Pfam; PF10248; Mlf1IP; 1.
PE   2: Evidence at transcript level;
FT   REGION          197..256
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        211..242
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   256 AA;  28808 MW;  63B188D3DFA82062 CRC64;
     MRQMIRSFSE PFGRDLLSIS DGRGRAHNRR GHNDGEDSLT ATSCSLVPFG DFGHTDVSSF
     QTMDQMVSNM RNYMQKLERN FGQLSVDPNG HSFCSSSVMT YSKIGDEPPK VFQASTQTRR
     APGGIKETRK AMRDSDSGLE KMAIGHHIHD RAHVIKKSKN KKTGDEEVNQ EFINMNESDA
     HAFDEEWQSE VLKYKPGRHN LGNTRMRSVG HENPGSRELK RGEKPQQSPA IEHGRRSNVL
     GDKLHIKGSS VKSNKK
//
ID   A0A024R1N1_HUMAN        Unreviewed;      1960 AA.
AC   A0A024R1N1;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Myosin, heavy polypeptide 9, non-muscle, isoform CRA_a {ECO:0000313|EMBL:EAW60098.1};
GN   Name=MYH9 {ECO:0000313|EMBL:EAW60098.1};
GN   ORFNames=hCG_41454 {ECO:0000313|EMBL:EAW60098.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW60098.1};
RN   [1] {ECO:0000313|EMBL:EAW60098.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW60098.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000256|PROSITE-ProRule:PRU00782,
CC       ECO:0000256|SAAS:SAAS00572438}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471095; EAW60098.1; -; Genomic_DNA.
DR   RefSeq; NP_002464.1; NM_002473.5.
DR   RefSeq; XP_011528499.1; XM_011530197.2.
DR   RefSeq; XP_016884292.1; XM_017028803.1.
DR   RefSeq; XP_016884293.1; XM_017028804.1.
DR   RefSeq; XP_016884294.1; XM_017028805.1.
DR   RefSeq; XP_016884295.1; XM_017028806.1.
DR   SMR; A0A024R1N1; -.
DR   PRIDE; A0A024R1N1; -.
DR   Antibodypedia; 887; 441 antibodies.
DR   GeneID; 4627; -.
DR   KEGG; hsa:4627; -.
DR   CTD; 4627; -.
DR   EuPathDB; HostDB:ENSG00000100345.20; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   HOGENOM; CLU_000192_4_0_1; -.
DR   KO; K10352; -.
DR   OMA; TDMRKKM; -.
DR   OrthoDB; 47111at2759; -.
DR   PhylomeDB; A0A024R1N1; -.
DR   ChiTaRS; MYH9; human.
DR   GenomeRNAi; 4627; -.
DR   Bgee; ENSG00000100345; Expressed in metanephric glomerulus and 218 other tissues.
DR   ExpressionAtlas; A0A024R1N1; baseline and differential.
DR   GO; GO:0005912; C:adherens junction; IEA:Ensembl.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0030863; C:cortical cytoskeleton; IEA:Ensembl.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0016460; C:myosin II complex; IEA:Ensembl.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005819; C:spindle; IEA:Ensembl.
DR   GO; GO:0001725; C:stress fiber; IEA:Ensembl.
DR   GO; GO:0001931; C:uropod; IEA:Ensembl.
DR   GO; GO:0051015; F:actin filament binding; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0003774; F:motor activity; IEA:UniProtKB-UniRule.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0000904; P:cell morphogenesis involved in differentiation; IEA:Ensembl.
DR   GO; GO:0098609; P:cell-cell adhesion; IEA:Ensembl.
DR   GO; GO:0051295; P:establishment of meiotic spindle localization; IEA:Ensembl.
DR   GO; GO:0001768; P:establishment of T cell polarity; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0000212; P:meiotic spindle organization; IEA:Ensembl.
DR   GO; GO:0007520; P:myoblast fusion; IEA:Ensembl.
DR   GO; GO:1903919; P:negative regulation of actin filament severing; IEA:Ensembl.
DR   GO; GO:0006911; P:phagocytosis, engulfment; IEA:Ensembl.
DR   GO; GO:1903923; P:positive regulation of protein processing in phagocytic vesicle; IEA:Ensembl.
DR   GO; GO:0008360; P:regulation of cell shape; IEA:Ensembl.
DR   GO; GO:0032796; P:uropod organization; IEA:Ensembl.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   Gene3D; 4.10.270.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027401; Myosin_IQ_contain_sf.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   3: Inferred from homology;
KW   Actin-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01238310};
KW   ATP-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240};
KW   Coiled coil {ECO:0000256|SAAS:SAAS01040361, ECO:0000256|SAM:Coils};
KW   Motor protein {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Myosin {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS01033784};
KW   Nucleotide-binding {ECO:0000256|PROSITE-ProRule:PRU00782,
KW   ECO:0000256|SAAS:SAAS00875240}.
FT   DOMAIN          27..77
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000259|PROSITE:PS51844"
FT   DOMAIN          81..776
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000259|PROSITE:PS51456"
FT   NP_BIND         174..181
FT                   /note="ATP"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          654..676
FT                   /note="Actin-binding"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00782"
FT   REGION          1035..1057
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1118..1137
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          1877..1960
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          840..986
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          994..1014
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1166..1235
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1240..1267
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1303..1372
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1380..1435
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1450..1568
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1577..1758
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          1766..1800
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        1877..1908
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1915..1930
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        1937..1960
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   1960 AA;  226532 MW;  588F84BB8C106E6F CRC64;
     MAQQAADKYL YVDKNFINNP LAQADWAAKK LVWVPSDKSG FEPASLKEEV GEEAIVELVE
     NGKKVKVNKD DIQKMNPPKF SKVEDMAELT CLNEASVLHN LKERYYSGLI YTYSGLFCVV
     INPYKNLPIY SEEIVEMYKG KKRHEMPPHI YAITDTAYRS MMQDREDQSI LCTGESGAGK
     TENTKKVIQY LAYVASSHKS KKDQGELERQ LLQANPILEA FGNAKTVKND NSSRFGKFIR
     INFDVNGYIV GANIETYLLE KSRAIRQAKE ERTFHIFYYL LSGAGEHLKT DLLLEPYNKY
     RFLSNGHVTI PGQQDKDMFQ ETMEAMRIMG IPEEEQMGLL RVISGVLQLG NIVFKKERNT
     DQASMPDNTA AQKVSHLLGI NVTDFTRGIL TPRIKVGRDY VQKAQTKEQA DFAIEALAKA
     TYERMFRWLV LRINKALDKT KRQGASFIGI LDIAGFEIFD LNSFEQLCIN YTNEKLQQLF
     NHTMFILEQE EYQREGIEWN FIDFGLDLQP CIDLIEKPAG PPGILALLDE ECWFPKATDK
     SFVEKVMQEQ GTHPKFQKPK QLKDKADFCI IHYAGKVDYK ADEWLMKNMD PLNDNIATLL
     HQSSDKFVSE LWKDVDRIIG LDQVAGMSET ALPGAFKTRK GMFRTVGQLY KEQLAKLMAT
     LRNTNPNFVR CIIPNHEKKA GKLDPHLVLD QLRCNGVLEG IRICRQGFPN RVVFQEFRQR
     YEILTPNSIP KGFMDGKQAC VLMIKALELD SNLYRIGQSK VFFRAGVLAH LEEERDLKIT
     DVIIGFQACC RGYLARKAFA KRQQQLTAMK VLQRNCAAYL KLRNWQWWRL FTKVKPLLQV
     SRQEEEMMAK EEELVKVREK QLAAENRLTE METLQSQLMA EKLQLQEQLQ AETELCAEAE
     ELRARLTAKK QELEEICHDL EARVEEEEER CQHLQAEKKK MQQNIQELEE QLEEEESARQ
     KLQLEKVTTE AKLKKLEEEQ IILEDQNCKL AKEKKLLEDR IAEFTTNLTE EEEKSKSLAK
     LKNKHEAMIT DLEERLRREE KQRQELEKTR RKLEGDSTDL SDQIAELQAQ IAELKMQLAK
     KEEELQAALA RVEEEAAQKN MALKKIRELE SQISELQEDL ESERASRNKA EKQKRDLGEE
     LEALKTELED TLDSTAAQQE LRSKREQEVN ILKKTLEEEA KTHEAQIQEM RQKHSQAVEE
     LAEQLEQTKR VKANLEKAKQ TLENERGELA NEVKVLLQGK GDSEHKRKKV EAQLQELQVK
     FNEGERVRTE LADKVTKLQV ELDNVTGLLS QSDSKSSKLT KDFSALESQL QDTQELLQEE
     NRQKLSLSTK LKQVEDEKNS FREQLEEEEE AKHNLEKQIA TLHAQVADMK KKMEDSVGCL
     ETAEEVKRKL QKDLEGLSQR HEEKVAAYDK LEKTKTRLQQ ELDDLLVDLD HQRQSACNLE
     KKQKKFDQLL AEEKTISAKY AEERDRAEAE AREKETKALS LARALEEAME QKAELERLNK
     QFRTEMEDLM SSKDDVGKSV HELEKSKRAL EQQVEEMKTQ LEELEDELQA TEDAKLRLEV
     NLQAMKAQFE RDLQGRDEQS EEKKKQLVRQ VREMEAELED ERKQRSMAVA ARKKLEMDLK
     DLEAHIDSAN KNRDEAIKQL RKLQAQMKDC MRELDDTRAS REEILAQAKE NEKKLKSMEA
     EMIQLQEELA AAERAKRQAQ QERDELADEI ANSSGKGALA LEEKRRLEAR IAQLEEELEE
     EQGNTELIND RLKKANLQID QINTDLNLER SHAQKNENAR QQLERQNKEL KVKLQEMEGT
     VKSKYKASIT ALEAKIAQLE EQLDNETKER QAACKQVRRT EKKLKDVLLQ VDDERRNAEQ
     YKDQADKAST RLKQLKRQLE EAEEEAQRAN ASRRKLQREL EDATETADAM NREVSSLKNK
     LRRGDLPFVV PRRMARKGAG DGSDEEVDGK ADGAEAKPAE
//
ID   MYH9_HUMAN              Reviewed;        1960 AA.
AC   P35579; A8K6E4; O60805; Q60FE2; Q86T83;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 4.
DT   22-APR-2020, entry version 234.
DE   RecName: Full=Myosin-9;
DE   AltName: Full=Cellular myosin heavy chain, type A;
DE   AltName: Full=Myosin heavy chain 9;
DE   AltName: Full=Myosin heavy chain, non-muscle IIa;
DE   AltName: Full=Non-muscle myosin heavy chain A;
DE            Short=NMMHC-A;
DE   AltName: Full=Non-muscle myosin heavy chain IIa;
DE            Short=NMMHC II-a;
DE            Short=NMMHC-IIA;
GN   Name=MYH9;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=16106752; DOI=10.1093/dnares/12.1.53;
RA   Kato S., Ohtoko K., Ohtake H., Kimura T.;
RT   "Vector-capping: a simple method for preparing a high-quality full-length
RT   cDNA library.";
RL   DNA Res. 12:53-62(2005).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Spinal cord;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Yamakawa H., Kikuno R.F., Nagase T., Ohara O.;
RT   "Multiplex amplification and cloning of 5'-ends of cDNA by ligase-free
RT   recombination: Preparation of full-lemgth cDNA clones encoding motor
RT   proteins.";
RL   Submitted (JAN-2007) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-1337, AND TISSUE SPECIFICITY.
RX   PubMed=1912569;
RA   Toothaker L.E., Gonzalez D.A., Tung N., Lemons R.S., le Beau M.M.,
RA   Arnaout M.A., Clayton L.K., Tenen D.G.;
RT   "Cellular myosin heavy chain in human leukocytes: isolation of 5' cDNA
RT   clones, characterization of the protein, chromosomal localization, and
RT   upregulation during myeloid differentiation.";
RL   Blood 78:1826-1833(1991).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1-1009.
RC   TISSUE=Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-715.
RX   PubMed=1860190; DOI=10.1161/01.res.69.2.530;
RA   Simons M., Wang M., McBride O.W., Kawamoto S., Yamakawa K., Gdula D.,
RA   Adelstein R.S., Weir L.;
RT   "Human nonmuscle myosin heavy chains are encoded by two genes located on
RT   different chromosomes.";
RL   Circ. Res. 69:530-539(1991).
RN   [10]
RP   PROTEIN SEQUENCE OF 2-47; 67-74; 126-139; 187-199; 203-225; 241-261;
RP   290-299; 328-355; 359-387; 408-419; 476-494; 546-555; 581-613; 618-637;
RP   645-651; 657-670; 683-693; 712-718; 721-731; 746-755; 765-775; 802-810;
RP   824-829; 834-842; 861-867; 924-930; 995-1014; 1042-1048; 1052-1075;
RP   1081-1099; 1136-1162; 1166-1191; 1261-1266; 1278-1295; 1302-1322;
RP   1393-1400; 1405-1413; 1418-1433; 1484-1492; 1504-1513; 1519-1525;
RP   1529-1555; 1558-1566; 1606-1612; 1614-1638; 1642-1648; 1662-1669;
RP   1704-1724; 1794-1802; 1807-1828; 1857-1867; 1899-1912; 1923-1932 AND
RP   1951-1960, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION AT ALA-2, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Platelet;
RA   Bienvenut W.V., Claeys R.;
RL   Submitted (AUG-2005) to UniProtKB.
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 714-1960.
RX   PubMed=1967836; DOI=10.1073/pnas.87.3.1164;
RA   Saez C.G., Myers J.C., Shows T.B., Leinwand L.A.;
RT   "Human nonmuscle myosin heavy chain mRNA: generation of diversity through
RT   alternative polyadenylylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 87:1164-1168(1990).
RN   [12]
RP   INTERACTION WITH SVIL.
RX   PubMed=12917436; DOI=10.1074/jbc.m305311200;
RA   Chen Y., Takizawa N., Crowley J.L., Oh S.W., Gatto C.L., Kambara T.,
RA   Sato O., Li X.-D., Ikebe M., Luna E.J.;
RT   "F-actin and myosin II binding domains in supervillin.";
RL   J. Biol. Chem. 278:46094-46106(2003).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [14]
RP   ISGYLATION.
RX   PubMed=16139798; DOI=10.1016/j.bbrc.2005.08.132;
RA   Giannakopoulos N.V., Luo J.K., Papov V., Zou W., Lenschow D.J.,
RA   Jacobs B.S., Borden E.C., Li J., Virgin H.W., Zhang D.E.;
RT   "Proteomic identification of proteins conjugated to ISG15 in mouse and
RT   human cells.";
RL   Biochem. Biophys. Res. Commun. 336:496-506(2005).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate cancer
RT   cells: identification of phosphoproteins in the LNCaP cell line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [18]
RP   INTERACTION WITH SVIL.
RX   PubMed=17925381; DOI=10.1242/jcs.008219;
RA   Takizawa N., Ikebe R., Ikebe M., Luna E.J.;
RT   "Supervillin slows cell spreading by facilitating myosin II activation at
RT   the cell periphery.";
RL   J. Cell Sci. 120:3792-3803(2007).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=T-cell;
RX   PubMed=19367720; DOI=10.1021/pr800500r;
RA   Carrascal M., Ovelleiro D., Casas V., Gay M., Abian J.;
RT   "Phosphorylation analysis of primary human T lymphocytes using sequential
RT   IMAC and titanium oxide enrichment.";
RL   J. Proteome Res. 7:5167-5176(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [21]
RP   ASSOCIATION WITH END STAGE RENAL DISEASE.
RX   PubMed=18794856; DOI=10.1038/ng.226;
RA   Kopp J.B., Smith M.W., Nelson G.W., Johnson R.C., Freedman B.I.,
RA   Bowden D.W., Oleksyk T., McKenzie L.M., Kajiyama H., Ahuja T.S.,
RA   Berns J.S., Briggs W., Cho M.E., Dart R.A., Kimmel P.L., Korbet S.M.,
RA   Michel D.M., Mokrzycki M.H., Schelling J.R., Simon E., Trachtman H.,
RA   Vlahov D., Winkler C.A.;
RT   "MYH9 is a major-effect risk gene for focal segmental glomerulosclerosis.";
RL   Nat. Genet. 40:1175-1184(2008).
RN   [22]
RP   ASSOCIATION WITH END STAGE RENAL DISEASE.
RX   PubMed=18794854; DOI=10.1038/ng.232;
RA   Kao W.H., Klag M.J., Meoni L.A., Reich D., Berthier-Schaad Y., Li M.,
RA   Coresh J., Patterson N., Tandon A., Powe N.R., Fink N.E., Sadler J.H.,
RA   Weir M.R., Abboud H.E., Adler S.G., Divers J., Iyengar S.K., Freedman B.I.,
RA   Kimmel P.L., Knowler W.C., Kohn O.F., Kramp K., Leehey D.J., Nicholas S.B.,
RA   Pahl M.V., Schelling J.R., Sedor J.R., Thornley-Brown D., Winkler C.A.,
RA   Smith M.W., Parekh R.S.;
RT   "MYH9 is associated with nondiabetic end-stage renal disease in African
RT   Americans.";
RL   Nat. Genet. 40:1185-1192(2008).
RN   [23]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [26]
RP   ASSOCIATION WITH END STAGE RENAL DISEASE.
RX   PubMed=19177153; DOI=10.1038/ki.2008.701;
RA   Freedman B.I., Hicks P.J., Bostrom M.A., Cunningham M.E., Liu Y.,
RA   Divers J., Kopp J.B., Winkler C.A., Nelson G.W., Langefeld C.D.,
RA   Bowden D.W.;
RT   "Polymorphisms in the non-muscle myosin heavy chain 9 gene (MYH9) are
RT   strongly associated with end-stage renal disease historically attributed to
RT   hypertension in African Americans.";
RL   Kidney Int. 75:736-745(2009).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-11 AND SER-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-8; LYS-102; LYS-299; LYS-1024;
RP   LYS-1357; LYS-1392; LYS-1404; LYS-1410; LYS-1459 AND LYS-1638, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [30]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=20052411; DOI=10.1371/journal.pone.0008560;
RA   Betapudi V.;
RT   "Myosin II motor proteins with different functions determine the fate of
RT   lamellipodia extension during cell spreading.";
RL   PLoS ONE 5:E8560-E8560(2010).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1714 AND SER-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [32]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1943, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [34]
RP   INTERACTION WITH HTRA3.
RX   PubMed=22229724; DOI=10.2144/000113798;
RA   Singh H., Makino S., Endo Y., Li Y., Stephens A.N., Nie G.;
RT   "Application of the wheat-germ cell-free translation system to produce high
RT   temperature requirement A3 (HtrA3) proteases.";
RL   BioTechniques 52:23-28(2012).
RN   [35]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-754; SER-1714 AND SER-1943,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-628 AND SER-1943, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [38]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [39]
RP   INTERACTION WITH RAB3A.
RX   PubMed=27325790; DOI=10.1083/jcb.201511093;
RA   Encarnacao M., Espada L., Escrevente C., Mateus D., Ramalho J.,
RA   Michelet X., Santarino I., Hsu V.W., Brenner M.B., Barral D.C.,
RA   Vieira O.V.;
RT   "A Rab3a-dependent complex essential for lysosome positioning and plasma
RT   membrane repair.";
RL   J. Cell Biol. 213:631-640(2016).
RN   [40]
RP   SUBCELLULAR LOCATION, AND UBIQUITINATION.
RX   PubMed=27331610; DOI=10.7554/elife.15258;
RA   Li T., Giagtzoglou N., Eberl D.F., Jaiswal S.N., Cai T., Godt D.,
RA   Groves A.K., Bellen H.J.;
RT   "The E3 ligase Ubr3 regulates Usher syndrome and MYH9 disorder proteins in
RT   the auditory organs of Drosophila and mammals.";
RL   Elife 5:E15258-E15258(2016).
RN   [41]
RP   INTERACTION WITH LIMCH1, AND REGION.
RX   PubMed=28228547; DOI=10.1091/mbc.e15-04-0218;
RA   Lin Y.H., Zhen Y.Y., Chien K.Y., Lee I.C., Lin W.C., Chen M.Y., Pai L.M.;
RT   "LIMCH1 regulates nonmuscle myosin-II activity and suppresses cell
RT   migration.";
RL   Mol. Biol. Cell 28:1054-1065(2017).
RN   [42]
RP   INTERACTION WITH C9ORF135.
RX   PubMed=28345668; DOI=10.1038/srep45311;
RA   Zhou S., Liu Y., Ma Y., Zhang X., Li Y., Wen J.;
RT   "C9ORF135 encodes a membrane protein whose expression is related to
RT   pluripotency in human embryonic stem cells.";
RL   Sci. Rep. 7:45311-45311(2017).
RN   [43]
RP   VARIANT DFNA17 HIS-705.
RX   PubMed=11023810; DOI=10.1086/321212;
RA   Lalwani A.K., Goldstein J.A., Kelley M.J., Luxford W., Castelein C.M.,
RA   Mhatre A.N.;
RT   "Human nonsyndromic hereditary deafness DFNA17 is due to a mutation in
RT   nonmuscle myosin MYH9.";
RL   Am. J. Hum. Genet. 67:1121-1128(2000).
RN   [44]
RP   VARIANTS MATINS LYS-93; CYS-702; CYS-1165; HIS-1424 AND LYS-1841.
RX   PubMed=10973259; DOI=10.1038/79063;
RA   Seri M., Cusano M., Gangarossa S., Caridi G., Bordo D., Lo Nigro C.,
RA   Ghiggeri G.M., Ravazzolo R., Savino M., Del Vecchio M., d'Apolito M.,
RA   Iolascon A., Zelante L.L., Savoia A., Balduini C.L., Noris P., Magrini U.,
RA   Belletti S., Heath K.E., Babcock M., Glucksman M.J., Aliprandis E.,
RA   Bizzaro N., Desnick R.J., Martignetti J.A.;
RT   "Mutations in MYH9 result in the May-Hegglin anomaly, and Fechtner and
RT   Sebastian syndromes.";
RL   Nat. Genet. 26:103-105(2000).
RN   [45]
RP   VARIANTS MATINS ILE-1155 AND LYS-1841.
RX   PubMed=10973260; DOI=10.1038/79069;
RA   Kelley M.J., Jawien W., Ortel T.L., Korczak J.F.;
RT   "Mutation of MYH9, encoding non-muscle myosin heavy chain A, in May-Hegglin
RT   anomaly.";
RL   Nat. Genet. 26:106-108(2000).
RN   [46]
RP   VARIANTS MATINS ASN-373; CYS-702; HIS-702; PRO-1114; ASN-1424; HIS-1424 AND
RP   LYS-1841.
RX   PubMed=11590545; DOI=10.1086/324267;
RA   Heath K.E., Campos-Barros A., Toren A., Rozenfeld-Granot G., Carlsson L.E.,
RA   Savige J., Denison J.C., Gregory M.C., White J.G., Barker D.F.,
RA   Greinacher A., Epstein C.J., Glucksman M.J., Martignetti J.A.;
RT   "Nonmuscle myosin heavy chain IIA mutations define a spectrum of autosomal
RT   dominant macrothrombocytopenias: May-Hegglin anomaly and Fechtner,
RT   Sebastian, Epstein, and Alport-like syndromes.";
RL   Am. J. Hum. Genet. 69:1033-1045(2001).
RN   [47]
RP   VARIANTS MATINS THR-95; CYS-1165; LEU-1165; 1205-LEU--GLN-1207 DEL;
RP   HIS-1424; ASN-1424; TYR-1424 AND LYS-1841, AND VARIANT VAL-1626.
RX   PubMed=11776386; DOI=10.1007/s100380170007;
RA   Kunishima S., Matsushita T., Kojima T., Amemiya N., Choi Y.M., Hosaka N.,
RA   Inoue M., Jung Y., Mamiya S., Matsumoto K., Miyajima Y., Zhang G., Ruan C.,
RA   Saito K., Song K.S., Yoon H.-J., Kamiya T., Saito H.;
RT   "Identification of six novel MYH9 mutations and genotype-phenotype
RT   relationships in autosomal dominant macrothrombocytopenia with leukocyte
RT   inclusions.";
RL   J. Hum. Genet. 46:722-729(2001).
RN   [48]
RP   VARIANT MATINS HIS-702.
RX   PubMed=11935325; DOI=10.1007/s00439-001-0659-1;
RA   Seri M., Savino M., Bordo D., Cusano R., Rocca B., Meloni I., Di Bari F.,
RA   Koivisto P.A., Bolognesi M., Ghiggeri G.M., Landolfi R., Balduini C.L.,
RA   Zelante L., Ravazzolo R., Renieri A., Savoia A.;
RT   "Epstein syndrome: another renal disorder with mutations in the nonmuscle
RT   myosin heavy chain 9 gene.";
RL   Hum. Genet. 110:182-186(2002).
RN   [49]
RP   VARIANTS MATINS LEU-96; LEU-1165; TRP-1400; ASN-1424 AND LYS-1841, AND
RP   TISSUE SPECIFICITY.
RX   PubMed=11752022;
RA   Arrondel C., Vodovar N., Knebelmann B., Gruenfeld J.-P., Gubler M.-C.,
RA   Antignac C., Heidet L.;
RT   "Expression of the nonmuscle myosin heavy chain IIA in the human kidney and
RT   screening for MYH9 mutations in Epstein and Fechtner syndromes.";
RL   J. Am. Soc. Nephrol. 13:65-74(2002).
RN   [50]
RP   CHARACTERIZATION OF VARIANT MATINS ASN-1424.
RX   PubMed=12649151; DOI=10.1182/blood-2002-09-2783;
RA   Deutsch S., Rideau A., Bochaton-Piallat M.-L., Merla G., Geinoz A.,
RA   Gabbiani G., Schwede T., Matthes T., Antonarakis S.E., Beris P.;
RT   "Asp1424Asn MYH9 mutation results in an unstable protein responsible for
RT   the phenotypes in May-Hegglin anomaly/Fechtner syndrome.";
RL   Blood 102:529-534(2003).
RN   [51]
RP   VARIANTS MATINS CYS-1165; LEU-1165; 1205-LEU--GLN-1207 DEL; HIS-1424;
RP   ASN-1424; TYR-1424; VAL-1816 AND LYS-1841.
RX   PubMed=12533692; DOI=10.1097/01.lab.0000050960.48774.17;
RA   Kunishima S., Matsushita T., Kojima T., Sako M., Kimura F., Jo E.-K.,
RA   Inoue C., Kamiya T., Saito H.;
RT   "Immunofluorescence analysis of neutrophil nonmuscle myosin heavy chain-A
RT   in MYH9 disorders: association of subcellular localization with MYH9
RT   mutations.";
RL   Lab. Invest. 83:115-122(2003).
RN   [52]
RP   VARIANTS MATINS CYS-702; HIS-702; GLN-910; 1066-GLU--ALA-1072 DEL;
RP   ILE-1155; ASN-1424 AND HIS-1424.
RX   PubMed=12792306; DOI=10.1097/01.md.0000076006.64510.5c;
RA   Seri M., Pecci A., Di Bari F., Cusano R., Savino M., Panza E., Nigro A.,
RA   Noris P., Gangarossa S., Rocca B., Gresele P., Bizzaro N., Malatesta P.,
RA   Koivisto P.A., Longo I., Musso R., Pecoraro C., Iolascon A., Magrini U.,
RA   Rodriguez Soriano J., Renieri A., Ghiggeri G.M., Ravazzolo R.,
RA   Balduini C.L., Savoia A.;
RT   "MYH9-related disease: may-Hegglin anomaly, Sebastian syndrome, Fechtner
RT   syndrome, and Epstein syndrome are not distinct entities but represent a
RT   variable expression of a single illness.";
RL   Medicine (Baltimore) 82:203-215(2003).
RN   [53]
RP   VARIANT MATINS ASN-1424.
RX   PubMed=12621333; DOI=10.1097/00129492-200303000-00013;
RA   Mhatre A.N., Kim Y., Brodie H.A., Lalwani A.K.;
RT   "Macrothrombocytopenia and progressive deafness is due to a mutation in
RT   MYH9.";
RL   Otol. Neurotol. 24:205-209(2003).
RN   [54]
RP   VARIANT MATINS LEU-96.
RX   PubMed=16969870; DOI=10.1002/ajmg.a.31454;
RA   Utsch B., DiFeo A., Kujat A., Karle S., Schuster V., Lenk H., Jacobs U.,
RA   Mueller M., Doetsch J., Rascher W., Reutter H., Martignetti J.A.,
RA   Ludwig M., Troebs R.-B.;
RT   "Bladder exstrophy and Epstein type congenital macrothrombocytopenia:
RT   evidence for a common cause?";
RL   Am. J. Med. Genet. A 140:2251-2253(2006).
RN   [55]
RP   VARIANT [LARGE SCALE ANALYSIS] ASN-810.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [56]
RP   POSITION OF MUTATIONS IN MYH9-RELATED DISEASE.
RX   PubMed=18059020; DOI=10.1002/humu.20661;
RA   Pecci A., Panza E., Pujol-Moix N., Klersy C., Di Bari F., Bozzi V.,
RA   Gresele P., Lethagen S., Fabris F., Dufour C., Granata A., Doubek M.,
RA   Pecoraro C., Koivisto P.A., Heller P.G., Iolascon A., Alvisi P.,
RA   Schwabe D., De Candia E., Rocca B., Russo U., Ramenghi U., Noris P.,
RA   Seri M., Balduini C.L., Savoia A.;
RT   "Position of nonmuscle myosin heavy chain IIA (NMMHC-IIA) mutations
RT   predicts the natural history of MYH9-related disease.";
RL   Hum. Mutat. 29:409-417(2008).
CC   -!- FUNCTION: Cellular myosin that appears to play a role in cytokinesis,
CC       cell shape, and specialized functions such as secretion and capping.
CC       During cell spreading, plays an important role in cytoskeleton
CC       reorganization, focal contacts formation (in the margins but not the
CC       central part of spreading cells), and lamellipodial retraction; this
CC       function is mechanically antagonized by MYH10.
CC       {ECO:0000269|PubMed:20052411}.
CC   -!- SUBUNIT: Myosin is a hexameric protein that consists of 2 heavy chain
CC       subunits (MHC), 2 alkali light chain subunits (MLC) and 2 regulatory
CC       light chain subunits (MLC-2). Interacts with RASIP1 (By similarity).
CC       Interacts with DDR1 (By similarity). Interacts with SLC6A4 (By
CC       similarity). Interacts with PDLIM2 (By similarity). Interacts with SVIL
CC       (PubMed:12917436, PubMed:17925381). Interacts with HTRA3
CC       (PubMed:22229724). Interacts with Myo7a (By similarity). Interacts with
CC       C9orf135 (PubMed:28345668). Interacts with LIMCH1; independently of the
CC       integration of MYH9 into the myosin complex (PubMed:28228547).
CC       Interacts with RAB3A (PubMed:27325790). {ECO:0000250|UniProtKB:Q62812,
CC       ECO:0000250|UniProtKB:Q8VDD5, ECO:0000269|PubMed:12917436,
CC       ECO:0000269|PubMed:17925381, ECO:0000269|PubMed:22229724,
CC       ECO:0000269|PubMed:27325790, ECO:0000269|PubMed:28228547,
CC       ECO:0000269|PubMed:28345668}.
CC   -!- INTERACTION:
CC       P35579; P61073: CXCR4; NbExp=5; IntAct=EBI-350338, EBI-489411;
CC       P35579; P62993: GRB2; NbExp=3; IntAct=EBI-350338, EBI-401755;
CC       P35579; O00255: MEN1; NbExp=3; IntAct=EBI-350338, EBI-592789;
CC       P35579; O00255-2: MEN1; NbExp=4; IntAct=EBI-350338, EBI-9869387;
CC       P35579; P19338: NCL; NbExp=3; IntAct=EBI-350338, EBI-346967;
CC       P35579; P26447: S100A4; NbExp=11; IntAct=EBI-350338, EBI-717058;
CC       P35579; O46385: SVIL; Xeno; NbExp=2; IntAct=EBI-350338, EBI-6995105;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton
CC       {ECO:0000250|UniProtKB:Q8VDD5}. Cytoplasm, cell cortex
CC       {ECO:0000250|UniProtKB:Q8VDD5}. Note=Colocalizes with actin filaments
CC       at lamellipodia margins and at the leading edge of migrating cells
CC       (PubMed:20052411). In retinal pigment epithelial cells, predominantly
CC       localized to stress fiber-like structures with some localization to
CC       cytoplasmic puncta (PubMed:27331610). {ECO:0000269|PubMed:20052411,
CC       ECO:0000269|PubMed:27331610}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P35579-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=P35579-2; Sequence=VSP_035409, VSP_035410;
CC   -!- TISSUE SPECIFICITY: In the kidney, expressed in the glomeruli. Also
CC       expressed in leukocytes. {ECO:0000269|PubMed:11752022,
CC       ECO:0000269|PubMed:1912569}.
CC   -!- DOMAIN: The rodlike tail sequence is highly repetitive, showing cycles
CC       of a 28-residue repeat pattern composed of 4 heptapeptides,
CC       characteristic for alpha-helical coiled coils.
CC   -!- PTM: ISGylated. {ECO:0000269|PubMed:16139798}.
CC   -!- PTM: Ubiquitination. {ECO:0000269|PubMed:27331610}.
CC   -!- DISEASE: Macrothrombocytopenia and granulocyte inclusions with or
CC       without nephritis or sensorineural hearing loss (MATINS) [MIM:155100]:
CC       An autosomal dominant disorder characterized by thrombocytopenia, giant
CC       platelets and Dohle body-like inclusions in peripheral blood leukocytes
CC       with variable ultrastructural appearance. Some affected individuals
CC       lack leukocyte inclusion bodies on classic staining of peripheral blood
CC       smears. Alport syndrome-like features of nephritis, hearing loss, and
CC       eye abnormalities are present in some patients.
CC       {ECO:0000269|PubMed:10973259, ECO:0000269|PubMed:10973260,
CC       ECO:0000269|PubMed:11590545, ECO:0000269|PubMed:11752022,
CC       ECO:0000269|PubMed:11776386, ECO:0000269|PubMed:11935325,
CC       ECO:0000269|PubMed:12533692, ECO:0000269|PubMed:12621333,
CC       ECO:0000269|PubMed:12649151, ECO:0000269|PubMed:12792306,
CC       ECO:0000269|PubMed:16969870}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Deafness, autosomal dominant, 17 (DFNA17) [MIM:603622]: A form
CC       of deafness characterized by progressive high frequency hearing
CC       impairment and cochleosaccular degeneration.
CC       {ECO:0000269|PubMed:11023810}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=Subjects with mutations in the motor domain of MYH9
CC       present with severe thrombocytopenia and develop nephritis and deafness
CC       before the age of 40 years, while those with mutations in the tail
CC       domain have a much lower risk of noncongenital complications and
CC       significantly higher platelet counts. The clinical course of patients
CC       with mutations in the four most frequently affected residues of MYH9
CC       (responsible for 70% of MYH9-related cases) were evaluated. Mutations
CC       at residue 1933 do not induce kidney damage or cataracts and cause
CC       deafness only in the elderly, those in position 702 result in severe
CC       thrombocytopenia and produce nephritis and deafness at a juvenile age,
CC       while alterations at residue 1424 or 1841 result in intermediate
CC       clinical pictures.
CC   -!- DISEASE: Note=Genetic variations in MYH9 are associated with non-
CC       diabetic end stage renal disease (ESRD).
CC   -!- SIMILARITY: Belongs to the TRAFAC class myosin-kinesin ATPase
CC       superfamily. Myosin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD89954.1; Type=Frameshift; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/MYH9ID481.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR456526; CAG30412.1; -; mRNA.
DR   EMBL; AB191263; BAD52439.1; -; mRNA.
DR   EMBL; AL832639; CAD89954.1; ALT_FRAME; mRNA.
DR   EMBL; AB290175; BAG06729.1; -; mRNA.
DR   EMBL; Z82215; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471095; EAW60096.1; -; Genomic_DNA.
DR   EMBL; M81105; AAA59888.1; -; mRNA.
DR   EMBL; AK291609; BAF84298.1; -; mRNA.
DR   EMBL; M69180; AAA61765.1; -; mRNA.
DR   EMBL; M31013; AAA36349.1; -; mRNA.
DR   CCDS; CCDS13927.1; -. [P35579-1]
DR   PIR; A61231; A61231.
DR   RefSeq; NP_002464.1; NM_002473.5. [P35579-1]
DR   RefSeq; XP_011528499.1; XM_011530197.2.
DR   RefSeq; XP_016884292.1; XM_017028803.1.
DR   RefSeq; XP_016884293.1; XM_017028804.1.
DR   RefSeq; XP_016884294.1; XM_017028805.1.
DR   RefSeq; XP_016884295.1; XM_017028806.1.
DR   PDB; 2LNK; NMR; -; C=1897-1935.
DR   PDB; 3ZWH; X-ray; 1.94 A; Q=1893-1937.
DR   PDB; 4CFQ; X-ray; 1.37 A; Q/R=1893-1937.
DR   PDB; 4CFR; X-ray; 1.40 A; Q=1893-1937.
DR   PDB; 4ETO; X-ray; 1.54 A; P=1908-1923.
DR   PDBsum; 2LNK; -.
DR   PDBsum; 3ZWH; -.
DR   PDBsum; 4CFQ; -.
DR   PDBsum; 4CFR; -.
DR   PDBsum; 4ETO; -.
DR   SMR; P35579; -.
DR   BioGrid; 110712; 380.
DR   CORUM; P35579; -.
DR   DIP; DIP-33103N; -.
DR   IntAct; P35579; 310.
DR   MINT; P35579; -.
DR   STRING; 9606.ENSP00000216181; -.
DR   ChEMBL; CHEMBL2189151; -.
DR   DrugBank; DB11638; Artenimol.
DR   CarbonylDB; P35579; -.
DR   iPTMnet; P35579; -.
DR   MetOSite; P35579; -.
DR   PhosphoSitePlus; P35579; -.
DR   SwissPalm; P35579; -.
DR   BioMuta; MYH9; -.
DR   DMDM; 6166599; -.
DR   EPD; P35579; -.
DR   jPOST; P35579; -.
DR   MassIVE; P35579; -.
DR   PaxDb; P35579; -.
DR   PeptideAtlas; P35579; -.
DR   PRIDE; P35579; -.
DR   ProteomicsDB; 55093; -. [P35579-1]
DR   ProteomicsDB; 55094; -. [P35579-2]
DR   TopDownProteomics; P35579-1; -. [P35579-1]
DR   ABCD; P35579; -.
DR   Antibodypedia; 887; 441 antibodies.
DR   DNASU; 4627; -.
DR   Ensembl; ENST00000216181; ENSP00000216181; ENSG00000100345. [P35579-1]
DR   GeneID; 4627; -.
DR   KEGG; hsa:4627; -.
DR   UCSC; uc003apg.4; human. [P35579-1]
DR   CTD; 4627; -.
DR   DisGeNET; 4627; -.
DR   GeneCards; MYH9; -.
DR   GeneReviews; MYH9; -.
DR   HGNC; HGNC:7579; MYH9.
DR   HPA; ENSG00000100345; Low tissue specificity.
DR   MalaCards; MYH9; -.
DR   MIM; 155100; phenotype.
DR   MIM; 160775; gene.
DR   MIM; 603622; phenotype.
DR   neXtProt; NX_P35579; -.
DR   OpenTargets; ENSG00000100345; -.
DR   Orphanet; 90635; Autosomal dominant non-syndromic sensorineural deafness type DFNA.
DR   Orphanet; 182050; MYH9-related disease.
DR   Orphanet; 477742; Nodular fasciitis.
DR   PharmGKB; PA31377; -.
DR   eggNOG; KOG0161; Eukaryota.
DR   eggNOG; COG5022; LUCA.
DR   GeneTree; ENSGT00940000155632; -.
DR   HOGENOM; CLU_000192_4_0_1; -.
DR   InParanoid; P35579; -.
DR   KO; K10352; -.
DR   OMA; TDMRKKM; -.
DR   PhylomeDB; P35579; -.
DR   TreeFam; TF333601; -.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-HSA-2029482; Regulation of actin dynamics for phagocytic cup formation.
DR   Reactome; R-HSA-3928663; EPHA-mediated growth cone collapse.
DR   Reactome; R-HSA-416572; Sema4D induced cell migration and growth-cone collapse.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5625900; RHO GTPases activate CIT.
DR   Reactome; R-HSA-5627117; RHO GTPases Activate ROCKs.
DR   Reactome; R-HSA-5627123; RHO GTPases activate PAKs.
DR   SIGNOR; P35579; -.
DR   ChiTaRS; MYH9; human.
DR   GeneWiki; MYH9; -.
DR   GenomeRNAi; 4627; -.
DR   Pharos; P35579; Tbio.
DR   PRO; PR:P35579; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; P35579; protein.
DR   Bgee; ENSG00000100345; Expressed in metanephric glomerulus and 218 other tissues.
DR   ExpressionAtlas; P35579; baseline and differential.
DR   Genevisible; P35579; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:UniProtKB.
DR   GO; GO:0042641; C:actomyosin; IDA:UniProtKB.
DR   GO; GO:0005826; C:actomyosin contractile ring; IDA:UniProtKB.
DR   GO; GO:0005912; C:adherens junction; IEA:Ensembl.
DR   GO; GO:0005903; C:brush border; IEA:Ensembl.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0031252; C:cell leading edge; IDA:UniProtKB.
DR   GO; GO:0032154; C:cleavage furrow; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; IEA:Ensembl.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0016460; C:myosin II complex; IDA:UniProtKB.
DR   GO; GO:0097513; C:myosin II filament; IDA:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IDA:UniProtKB.
DR   GO; GO:0001726; C:ruffle; IDA:UniProtKB.
DR   GO; GO:0005819; C:spindle; IEA:Ensembl.
DR   GO; GO:0001725; C:stress fiber; IDA:UniProtKB.
DR   GO; GO:0001931; C:uropod; IDA:MGI.
DR   GO; GO:0003779; F:actin binding; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0030898; F:actin-dependent ATPase activity; IDA:MGI.
DR   GO; GO:0043531; F:ADP binding; IDA:MGI.
DR   GO; GO:0005524; F:ATP binding; IDA:MGI.
DR   GO; GO:0016887; F:ATPase activity; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005516; F:calmodulin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005178; F:integrin binding; IDA:UniProtKB.
DR   GO; GO:0000146; F:microfilament motor activity; IDA:UniProtKB.
DR   GO; GO:0003774; F:motor activity; NAS:UniProtKB.
DR   GO; GO:0019904; F:protein domain specific binding; IPI:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0043495; F:protein membrane adaptor; IMP:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0031532; P:actin cytoskeleton reorganization; IMP:UniProtKB.
DR   GO; GO:0030048; P:actin filament-based movement; IDA:UniProtKB.
DR   GO; GO:0031032; P:actomyosin structure organization; IDA:UniProtKB.
DR   GO; GO:0001525; P:angiogenesis; IDA:UniProtKB.
DR   GO; GO:0043534; P:blood vessel endothelial cell migration; IMP:UniProtKB.
DR   GO; GO:0032506; P:cytokinetic process; IMP:UniProtKB.
DR   GO; GO:0051295; P:establishment of meiotic spindle localization; IEA:Ensembl.
DR   GO; GO:0001768; P:establishment of T cell polarity; IEA:Ensembl.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; NAS:UniProtKB.
DR   GO; GO:0050900; P:leukocyte migration; NAS:UniProtKB.
DR   GO; GO:0032418; P:lysosome localization; IMP:UniProtKB.
DR   GO; GO:0000212; P:meiotic spindle organization; IEA:Ensembl.
DR   GO; GO:0006509; P:membrane protein ectodomain proteolysis; IDA:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; IEP:UniProtKB.
DR   GO; GO:0007520; P:myoblast fusion; IEA:Ensembl.
DR   GO; GO:1903919; P:negative regulation of actin filament severing; IMP:UniProtKB.
DR   GO; GO:0006911; P:phagocytosis, engulfment; ISS:UniProtKB.
DR   GO; GO:0001778; P:plasma membrane repair; IDA:UniProtKB.
DR   GO; GO:0070527; P:platelet aggregation; HMP:UniProtKB.
DR   GO; GO:0030220; P:platelet formation; IMP:UniProtKB.
DR   GO; GO:1903923; P:positive regulation of protein processing in phagocytic vesicle; ISS:UniProtKB.
DR   GO; GO:0015031; P:protein transport; IMP:UniProtKB.
DR   GO; GO:0045055; P:regulated exocytosis; IMP:UniProtKB.
DR   GO; GO:0008360; P:regulation of cell shape; IMP:UniProtKB.
DR   GO; GO:1905684; P:regulation of plasma membrane repair; IMP:UniProtKB.
DR   GO; GO:0032796; P:uropod organization; IEA:Ensembl.
DR   Gene3D; 2.30.30.360; -; 1.
DR   Gene3D; 3.40.850.10; -; 1.
DR   Gene3D; 4.10.270.10; -; 1.
DR   InterPro; IPR000048; IQ_motif_EF-hand-BS.
DR   InterPro; IPR036961; Kinesin_motor_dom_sf.
DR   InterPro; IPR001609; Myosin_head_motor_dom.
DR   InterPro; IPR027401; Myosin_IQ_contain_sf.
DR   InterPro; IPR004009; Myosin_N.
DR   InterPro; IPR008989; Myosin_S1_N.
DR   InterPro; IPR002928; Myosin_tail.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR036305; RGS_sf.
DR   Pfam; PF00063; Myosin_head; 1.
DR   Pfam; PF02736; Myosin_N; 1.
DR   Pfam; PF01576; Myosin_tail_1; 1.
DR   PRINTS; PR00193; MYOSINHEAVY.
DR   SMART; SM00015; IQ; 1.
DR   SMART; SM00242; MYSc; 1.
DR   SUPFAM; SSF48097; SSF48097; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50096; IQ; 1.
DR   PROSITE; PS51456; MYOSIN_MOTOR; 1.
DR   PROSITE; PS51844; SH3_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alport syndrome;
KW   Alternative splicing; ATP-binding; Calmodulin-binding; Cataract;
KW   Cell adhesion; Cell shape; Coiled coil; Cytoplasm; Cytoskeleton; Deafness;
KW   Direct protein sequencing; Disease mutation; Methylation; Motor protein;
KW   Myosin; Non-syndromic deafness; Nucleotide-binding; Phosphoprotein;
KW   Polymorphism; Reference proteome; Ubl conjugation.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|Ref.10"
FT   CHAIN           2..1960
FT                   /note="Myosin-9"
FT                   /id="PRO_0000123416"
FT   DOMAIN          27..77
FT                   /note="Myosin N-terminal SH3-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01190"
FT   DOMAIN          81..776
FT                   /note="Myosin motor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00782"
FT   DOMAIN          779..808
FT                   /note="IQ"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00116"
FT   NP_BIND         174..181
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          2..838
FT                   /note="Mediates interaction with LIMCH1"
FT                   /evidence="ECO:0000269|PubMed:28228547"
FT   REGION          654..676
FT                   /note="Actin-binding"
FT   COILED          837..1926
FT                   /evidence="ECO:0000255"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000269|Ref.10"
FT   MOD_RES         8
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         11
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         102
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         299
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         435
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P35580"
FT   MOD_RES         613
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         628
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         754
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         850
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         860
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         975
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1024
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1114
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1234
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1249
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1357
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1392
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1404
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1410
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1459
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1638
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1669
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1714
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1793
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1802
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1845
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VDD5"
FT   MOD_RES         1923
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61879"
FT   MOD_RES         1943
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:17081983, ECO:0000244|PubMed:17487921,
FT                   ECO:0000244|PubMed:18088087, ECO:0000244|PubMed:18318008,
FT                   ECO:0000244|PubMed:19367720, ECO:0000244|PubMed:19369195,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         1..136
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_035409"
FT   VAR_SEQ         980..1421
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_035410"
FT   VARIANT         93
FT                   /note="N -> K (in MATINS; dbSNP:rs121913655)"
FT                   /evidence="ECO:0000269|PubMed:10973259"
FT                   /id="VAR_010791"
FT   VARIANT         95
FT                   /note="A -> T (in MATINS)"
FT                   /evidence="ECO:0000269|PubMed:11776386"
FT                   /id="VAR_018308"
FT   VARIANT         96
FT                   /note="S -> L (in MATINS; dbSNP:rs121913657)"
FT                   /evidence="ECO:0000269|PubMed:11752022,
FT                   ECO:0000269|PubMed:16969870"
FT                   /id="VAR_018309"
FT   VARIANT         373
FT                   /note="K -> N (in MATINS)"
FT                   /evidence="ECO:0000269|PubMed:11590545"
FT                   /id="VAR_018310"
FT   VARIANT         702
FT                   /note="R -> C (in MATINS; dbSNP:rs80338826)"
FT                   /evidence="ECO:0000269|PubMed:10973259,
FT                   ECO:0000269|PubMed:11590545, ECO:0000269|PubMed:12792306"
FT                   /id="VAR_010792"
FT   VARIANT         702
FT                   /note="R -> H (in MATINS; dbSNP:rs80338827)"
FT                   /evidence="ECO:0000269|PubMed:11590545,
FT                   ECO:0000269|PubMed:11935325, ECO:0000269|PubMed:12792306"
FT                   /id="VAR_018311"
FT   VARIANT         705
FT                   /note="R -> H (in DFNA17; dbSNP:rs80338828)"
FT                   /evidence="ECO:0000269|PubMed:11023810"
FT                   /id="VAR_010793"
FT   VARIANT         810
FT                   /note="K -> N (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036006"
FT   VARIANT         910
FT                   /note="K -> Q (in MATINS; dbSNP:rs554332083)"
FT                   /evidence="ECO:0000269|PubMed:12792306"
FT                   /id="VAR_044226"
FT   VARIANT         967
FT                   /note="V -> E (in dbSNP:rs16996652)"
FT                   /id="VAR_044227"
FT   VARIANT         1066..1072
FT                   /note="Missing (in MATINS)"
FT                   /evidence="ECO:0000269|PubMed:12792306"
FT                   /id="VAR_044228"
FT   VARIANT         1114
FT                   /note="S -> P (in MATINS; dbSNP:rs200901330)"
FT                   /evidence="ECO:0000269|PubMed:11590545"
FT                   /id="VAR_018312"
FT   VARIANT         1155
FT                   /note="T -> I (in MATINS; dbSNP:rs121913656)"
FT                   /evidence="ECO:0000269|PubMed:10973260,
FT                   ECO:0000269|PubMed:12792306"
FT                   /id="VAR_010794"
FT   VARIANT         1165
FT                   /note="R -> C (in MATINS; dbSNP:rs80338829)"
FT                   /evidence="ECO:0000269|PubMed:10973259,
FT                   ECO:0000269|PubMed:11776386, ECO:0000269|PubMed:12533692"
FT                   /id="VAR_010795"
FT   VARIANT         1165
FT                   /note="R -> L (in MATINS; dbSNP:rs80338830)"
FT                   /evidence="ECO:0000269|PubMed:11752022,
FT                   ECO:0000269|PubMed:11776386, ECO:0000269|PubMed:12533692"
FT                   /id="VAR_018313"
FT   VARIANT         1205..1207
FT                   /note="Missing (in MATINS)"
FT                   /evidence="ECO:0000269|PubMed:11776386,
FT                   ECO:0000269|PubMed:12533692"
FT                   /id="VAR_018314"
FT   VARIANT         1400
FT                   /note="R -> W (in MATINS; unknown pathological
FT                   significance; might contribute to pathogenicity when
FT                   associated with L-96; dbSNP:rs76368635)"
FT                   /evidence="ECO:0000269|PubMed:11752022"
FT                   /id="VAR_018315"
FT   VARIANT         1424
FT                   /note="D -> H (in MATINS; dbSNP:rs80338831)"
FT                   /evidence="ECO:0000269|PubMed:10973259,
FT                   ECO:0000269|PubMed:11590545, ECO:0000269|PubMed:11776386,
FT                   ECO:0000269|PubMed:12533692, ECO:0000269|PubMed:12792306"
FT                   /id="VAR_010796"
FT   VARIANT         1424
FT                   /note="D -> N (in MATINS; results in reduced protein
FT                   levels; dbSNP:rs80338831)"
FT                   /evidence="ECO:0000269|PubMed:11590545,
FT                   ECO:0000269|PubMed:11752022, ECO:0000269|PubMed:11776386,
FT                   ECO:0000269|PubMed:12533692, ECO:0000269|PubMed:12621333,
FT                   ECO:0000269|PubMed:12649151, ECO:0000269|PubMed:12792306"
FT                   /id="VAR_018316"
FT   VARIANT         1424
FT                   /note="D -> Y (in MATINS; dbSNP:rs80338831)"
FT                   /evidence="ECO:0000269|PubMed:11776386,
FT                   ECO:0000269|PubMed:12533692"
FT                   /id="VAR_018317"
FT   VARIANT         1626
FT                   /note="I -> V (in dbSNP:rs2269529)"
FT                   /evidence="ECO:0000269|PubMed:11776386"
FT                   /id="VAR_018318"
FT   VARIANT         1816
FT                   /note="I -> V (in MATINS; dbSNP:rs762773112)"
FT                   /evidence="ECO:0000269|PubMed:12533692"
FT                   /id="VAR_030385"
FT   VARIANT         1841
FT                   /note="E -> K (in MATINS; dbSNP:rs80338834)"
FT                   /evidence="ECO:0000269|PubMed:10973259,
FT                   ECO:0000269|PubMed:10973260, ECO:0000269|PubMed:11590545,
FT                   ECO:0000269|PubMed:11752022, ECO:0000269|PubMed:11776386,
FT                   ECO:0000269|PubMed:12533692"
FT                   /id="VAR_010797"
FT   CONFLICT        53..55
FT                   /note="EAI -> RGH (in Ref. 9)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        660
FT                   /note="T -> S (in Ref. 9)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        869
FT                   /note="T -> M (in Ref. 11; AAA36349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        931
FT                   /note="C -> Y (in Ref. 11; AAA36349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1000
FT                   /note="R -> I (in Ref. 8; BAF84298)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1240..1241
FT                   /note="KG -> GR (in Ref. 11; AAA36349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1350
FT                   /note="E -> EE (in Ref. 11)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1462
FT                   /note="E -> G (in Ref. 1; CAD89954)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1546
FT                   /note="D -> G (in Ref. 1; CAD89954)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1764
FT                   /note="T -> A (in Ref. 11; AAA36349)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1771
FT                   /note="S -> G (in Ref. 11; AAA36349)"
FT                   /evidence="ECO:0000305"
FT   STRAND          1895..1897
FT                   /evidence="ECO:0000244|PDB:4CFR"
FT   HELIX           1899..1903
FT                   /evidence="ECO:0000244|PDB:4CFR"
FT   HELIX           1904..1921
FT                   /evidence="ECO:0000244|PDB:4CFQ"
FT   STRAND          1922..1925
FT                   /evidence="ECO:0000244|PDB:2LNK"
SQ   SEQUENCE   1960 AA;  226532 MW;  588F84BB8C106E6F CRC64;
     MAQQAADKYL YVDKNFINNP LAQADWAAKK LVWVPSDKSG FEPASLKEEV GEEAIVELVE
     NGKKVKVNKD DIQKMNPPKF SKVEDMAELT CLNEASVLHN LKERYYSGLI YTYSGLFCVV
     INPYKNLPIY SEEIVEMYKG KKRHEMPPHI YAITDTAYRS MMQDREDQSI LCTGESGAGK
     TENTKKVIQY LAYVASSHKS KKDQGELERQ LLQANPILEA FGNAKTVKND NSSRFGKFIR
     INFDVNGYIV GANIETYLLE KSRAIRQAKE ERTFHIFYYL LSGAGEHLKT DLLLEPYNKY
     RFLSNGHVTI PGQQDKDMFQ ETMEAMRIMG IPEEEQMGLL RVISGVLQLG NIVFKKERNT
     DQASMPDNTA AQKVSHLLGI NVTDFTRGIL TPRIKVGRDY VQKAQTKEQA DFAIEALAKA
     TYERMFRWLV LRINKALDKT KRQGASFIGI LDIAGFEIFD LNSFEQLCIN YTNEKLQQLF
     NHTMFILEQE EYQREGIEWN FIDFGLDLQP CIDLIEKPAG PPGILALLDE ECWFPKATDK
     SFVEKVMQEQ GTHPKFQKPK QLKDKADFCI IHYAGKVDYK ADEWLMKNMD PLNDNIATLL
     HQSSDKFVSE LWKDVDRIIG LDQVAGMSET ALPGAFKTRK GMFRTVGQLY KEQLAKLMAT
     LRNTNPNFVR CIIPNHEKKA GKLDPHLVLD QLRCNGVLEG IRICRQGFPN RVVFQEFRQR
     YEILTPNSIP KGFMDGKQAC VLMIKALELD SNLYRIGQSK VFFRAGVLAH LEEERDLKIT
     DVIIGFQACC RGYLARKAFA KRQQQLTAMK VLQRNCAAYL KLRNWQWWRL FTKVKPLLQV
     SRQEEEMMAK EEELVKVREK QLAAENRLTE METLQSQLMA EKLQLQEQLQ AETELCAEAE
     ELRARLTAKK QELEEICHDL EARVEEEEER CQHLQAEKKK MQQNIQELEE QLEEEESARQ
     KLQLEKVTTE AKLKKLEEEQ IILEDQNCKL AKEKKLLEDR IAEFTTNLTE EEEKSKSLAK
     LKNKHEAMIT DLEERLRREE KQRQELEKTR RKLEGDSTDL SDQIAELQAQ IAELKMQLAK
     KEEELQAALA RVEEEAAQKN MALKKIRELE SQISELQEDL ESERASRNKA EKQKRDLGEE
     LEALKTELED TLDSTAAQQE LRSKREQEVN ILKKTLEEEA KTHEAQIQEM RQKHSQAVEE
     LAEQLEQTKR VKANLEKAKQ TLENERGELA NEVKVLLQGK GDSEHKRKKV EAQLQELQVK
     FNEGERVRTE LADKVTKLQV ELDNVTGLLS QSDSKSSKLT KDFSALESQL QDTQELLQEE
     NRQKLSLSTK LKQVEDEKNS FREQLEEEEE AKHNLEKQIA TLHAQVADMK KKMEDSVGCL
     ETAEEVKRKL QKDLEGLSQR HEEKVAAYDK LEKTKTRLQQ ELDDLLVDLD HQRQSACNLE
     KKQKKFDQLL AEEKTISAKY AEERDRAEAE AREKETKALS LARALEEAME QKAELERLNK
     QFRTEMEDLM SSKDDVGKSV HELEKSKRAL EQQVEEMKTQ LEELEDELQA TEDAKLRLEV
     NLQAMKAQFE RDLQGRDEQS EEKKKQLVRQ VREMEAELED ERKQRSMAVA ARKKLEMDLK
     DLEAHIDSAN KNRDEAIKQL RKLQAQMKDC MRELDDTRAS REEILAQAKE NEKKLKSMEA
     EMIQLQEELA AAERAKRQAQ QERDELADEI ANSSGKGALA LEEKRRLEAR IAQLEEELEE
     EQGNTELIND RLKKANLQID QINTDLNLER SHAQKNENAR QQLERQNKEL KVKLQEMEGT
     VKSKYKASIT ALEAKIAQLE EQLDNETKER QAACKQVRRT EKKLKDVLLQ VDDERRNAEQ
     YKDQADKAST RLKQLKRQLE EAEEEAQRAN ASRRKLQREL EDATETADAM NREVSSLKNK
     LRRGDLPFVV PRRMARKGAG DGSDEEVDGK ADGAEAKPAE
//
ID   NAB2_HUMAN              Reviewed;         525 AA.
AC   Q15742; B2RAK3; O76006; Q14797;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 166.
DE   RecName: Full=NGFI-A-binding protein 2;
DE   AltName: Full=EGR-1-binding protein 2;
DE   AltName: Full=Melanoma-associated delayed early response protein;
DE            Short=Protein MADER;
GN   Name=NAB2; Synonyms=MADER;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Placenta;
RX   PubMed=8668170; DOI=10.1128/mcb.16.7.3545;
RA   Svaren J., Sevetson B.R., Apel E.D., Zimonjic D.B., Popescu N.C.,
RA   Milbrandt J.;
RT   "NAB2, a corepressor of NGFI-A (Egr-1) and Krox20, is induced by
RT   proliferative and differentiative stimuli.";
RL   Mol. Cell. Biol. 16:3545-3553(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 1).
RA   Gerlinger M., Johnson J.P.;
RT   "Genomic organization of the Mader/NAB2 gene.";
RL   Submitted (MAY-2000) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Skin;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 50-525 (ISOFORM 1).
RX   PubMed=8649813;
RA   Kirsch K.H., Korradi Y., Johnson J.P.;
RT   "Mader: a novel nuclear protein over expressed in human melanomas.";
RL   Oncogene 12:963-971(1996).
RN   [7]
RP   PARTIAL NUCLEOTIDE SEQUENCE (ISOFORM 3).
RA   Johnson J.P.;
RL   Submitted (SEP-1998) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9126479; DOI=10.1006/geno.1997.4609;
RA   Svaren J., Apel E.D., Simburger K.S., Jenkins N.A., Gilbert D.J.,
RA   Copeland N.G., Milbrandt J.;
RT   "The Nab2 and Stat6 genes share a common transcription termination
RT   region.";
RL   Genomics 41:33-39(1997).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [12]
RP   SUMOYLATION AT LYS-379 AND LYS-517 BY EGR2.
RX   PubMed=21836637; DOI=10.1038/embor.2011.152;
RA   Garcia-Gutierrez P., Juarez-Vicente F., Gallardo-Chamizo F., Charnay P.,
RA   Garcia-Dominguez M.;
RT   "The transcription factor Krox20 is an E3 ligase that sumoylates its Nab
RT   coregulators.";
RL   EMBO Rep. 12:1018-1023(2011).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-159 AND SER-162, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6; SER-159; SER-162 AND
RP   SER-171, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-6 AND SER-171, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [16]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-517, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: Acts as a transcriptional repressor for zinc finger
CC       transcription factors EGR1 and EGR2. Isoform 2 lacks repression ability
CC       (By similarity). {ECO:0000250}.
CC   -!- SUBUNIT: Homomultimers may associate with EGR1 bound to DNA.
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q15742; Q15742; NbExp=4; IntAct=EBI-8641936, EBI-8641936;
CC       Q15742; Q12955-5: ANK3; NbExp=3; IntAct=EBI-8641936, EBI-12154305;
CC       Q15742; X5D778: ANKRD11; NbExp=3; IntAct=EBI-8641936, EBI-17183751;
CC       Q15742; Q9HC52: CBX8; NbExp=3; IntAct=EBI-8641936, EBI-712912;
CC       Q15742; Q2TAC2-2: CCDC57; NbExp=3; IntAct=EBI-8641936, EBI-10961624;
CC       Q15742; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-8641936, EBI-10175300;
CC       Q15742; Q9UJX2: CDC23; NbExp=3; IntAct=EBI-8641936, EBI-396137;
CC       Q15742; P78358: CTAG1B; NbExp=3; IntAct=EBI-8641936, EBI-1188472;
CC       Q15742; Q9UI47-2: CTNNA3; NbExp=3; IntAct=EBI-8641936, EBI-11962928;
CC       Q15742; Q2TBE0: CWF19L2; NbExp=6; IntAct=EBI-8641936, EBI-5453285;
CC       Q15742; P26196: DDX6; NbExp=3; IntAct=EBI-8641936, EBI-351257;
CC       Q15742; Q9BY27: DGCR6L; NbExp=3; IntAct=EBI-8641936, EBI-742953;
CC       Q15742; P55039: DRG2; NbExp=3; IntAct=EBI-8641936, EBI-750565;
CC       Q15742; Q14241: ELOA; NbExp=3; IntAct=EBI-8641936, EBI-742350;
CC       Q15742; Q9H0I2: ENKD1; NbExp=3; IntAct=EBI-8641936, EBI-744099;
CC       Q15742; Q8IYI6: EXOC8; NbExp=3; IntAct=EBI-8641936, EBI-742102;
CC       Q15742; Q8IZU1: FAM9A; NbExp=3; IntAct=EBI-8641936, EBI-8468186;
CC       Q15742; Q96CN9: GCC1; NbExp=3; IntAct=EBI-8641936, EBI-746252;
CC       Q15742; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-8641936, EBI-5916454;
CC       Q15742; O75031: HSF2BP; NbExp=3; IntAct=EBI-8641936, EBI-7116203;
CC       Q15742; Q96AA8: JAKMIP2; NbExp=3; IntAct=EBI-8641936, EBI-752007;
CC       Q15742; Q9HAQ2: KIF9; NbExp=3; IntAct=EBI-8641936, EBI-8472129;
CC       Q15742; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-8641936, EBI-14069005;
CC       Q15742; O76011: KRT34; NbExp=3; IntAct=EBI-8641936, EBI-1047093;
CC       Q15742; P60410: KRTAP10-8; NbExp=3; IntAct=EBI-8641936, EBI-10171774;
CC       Q15742; Q96BZ8: LENG1; NbExp=6; IntAct=EBI-8641936, EBI-726510;
CC       Q15742; Q8TBB1: LNX1; NbExp=3; IntAct=EBI-8641936, EBI-739832;
CC       Q15742; P33993: MCM7; NbExp=3; IntAct=EBI-8641936, EBI-355924;
CC       Q15742; Q96EZ8: MCRS1; NbExp=3; IntAct=EBI-8641936, EBI-348259;
CC       Q15742; Q8IVT4: MGC50722; NbExp=3; IntAct=EBI-8641936, EBI-14086479;
CC       Q15742; Q9UBU8: MORF4L1; NbExp=3; IntAct=EBI-8641936, EBI-399246;
CC       Q15742; Q9UBU8-2: MORF4L1; NbExp=3; IntAct=EBI-8641936, EBI-10288852;
CC       Q15742; Q15014: MORF4L2; NbExp=3; IntAct=EBI-8641936, EBI-399257;
CC       Q15742; Q9UHB4: NDOR1; NbExp=3; IntAct=EBI-8641936, EBI-10249760;
CC       Q15742; Q14511: NEDD9; NbExp=4; IntAct=EBI-8641936, EBI-2108053;
CC       Q15742; Q14511-2: NEDD9; NbExp=3; IntAct=EBI-8641936, EBI-11746523;
CC       Q15742; Q9Y5B8: NME7; NbExp=6; IntAct=EBI-8641936, EBI-744782;
CC       Q15742; Q7Z3S9: NOTCH2NLA; NbExp=3; IntAct=EBI-8641936, EBI-945833;
CC       Q15742; O43189: PHF1; NbExp=7; IntAct=EBI-8641936, EBI-530034;
CC       Q15742; Q8TCD6: PHOSPHO2; NbExp=6; IntAct=EBI-8641936, EBI-2861380;
CC       Q15742; Q92569: PIK3R3; NbExp=3; IntAct=EBI-8641936, EBI-79893;
CC       Q15742; Q13526: PIN1; NbExp=6; IntAct=EBI-8641936, EBI-714158;
CC       Q15742; O60568: PLOD3; NbExp=3; IntAct=EBI-8641936, EBI-741582;
CC       Q15742; P54646: PRKAA2; NbExp=3; IntAct=EBI-8641936, EBI-1383852;
CC       Q15742; O43741: PRKAB2; NbExp=3; IntAct=EBI-8641936, EBI-1053424;
CC       Q15742; P25786: PSMA1; NbExp=3; IntAct=EBI-8641936, EBI-359352;
CC       Q15742; P47897: QARS; NbExp=3; IntAct=EBI-8641936, EBI-347462;
CC       Q15742; P40937: RFC5; NbExp=8; IntAct=EBI-8641936, EBI-712376;
CC       Q15742; Q6NUQ1: RINT1; NbExp=3; IntAct=EBI-8641936, EBI-726876;
CC       Q15742; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-8641936, EBI-748391;
CC       Q15742; Q96GM5: SMARCD1; NbExp=3; IntAct=EBI-8641936, EBI-358489;
CC       Q15742; O60504: SORBS3; NbExp=3; IntAct=EBI-8641936, EBI-741237;
CC       Q15742; Q9NZD8: SPG21; NbExp=3; IntAct=EBI-8641936, EBI-742688;
CC       Q15742; G2XKQ0: SUMO1P1; NbExp=3; IntAct=EBI-8641936, EBI-10175576;
CC       Q15742; Q15560: TCEA2; NbExp=3; IntAct=EBI-8641936, EBI-710310;
CC       Q15742; Q8N8B7: TCEANC; NbExp=3; IntAct=EBI-8641936, EBI-954696;
CC       Q15742; Q8N8B7-2: TCEANC; NbExp=3; IntAct=EBI-8641936, EBI-11955057;
CC       Q15742; Q9BT92: TCHP; NbExp=7; IntAct=EBI-8641936, EBI-740781;
CC       Q15742; Q8IUE0: TGIF2LY; NbExp=6; IntAct=EBI-8641936, EBI-8063723;
CC       Q15742; Q08117: TLE5; NbExp=3; IntAct=EBI-8641936, EBI-717810;
CC       Q15742; Q08117-2: TLE5; NbExp=3; IntAct=EBI-8641936, EBI-11741437;
CC       Q15742; Q12933: TRAF2; NbExp=3; IntAct=EBI-8641936, EBI-355744;
CC       Q15742; P36406: TRIM23; NbExp=3; IntAct=EBI-8641936, EBI-740098;
CC       Q15742; Q9BZW7: TSGA10; NbExp=3; IntAct=EBI-8641936, EBI-744794;
CC       Q15742; Q3SY00: TSGA10IP; NbExp=3; IntAct=EBI-8641936, EBI-10241197;
CC       Q15742; Q6DKK2: TTC19; NbExp=3; IntAct=EBI-8641936, EBI-948354;
CC       Q15742; O75604: USP2; NbExp=3; IntAct=EBI-8641936, EBI-743272;
CC       Q15742; Q5TAP6: UTP14C; NbExp=3; IntAct=EBI-8641936, EBI-11737646;
CC       Q15742; Q96HA8: WDYHV1; NbExp=3; IntAct=EBI-8641936, EBI-741158;
CC       Q15742; Q8IZ13: ZBED8; NbExp=7; IntAct=EBI-8641936, EBI-7186123;
CC       Q15742; Q96NC0: ZMAT2; NbExp=3; IntAct=EBI-8641936, EBI-2682299;
CC       Q15742; Q9H0C1: ZMYND12; NbExp=3; IntAct=EBI-8641936, EBI-12030590;
CC       Q15742; Q96E35: ZMYND19; NbExp=7; IntAct=EBI-8641936, EBI-746595;
CC       Q15742; Q8TAU3: ZNF417; NbExp=3; IntAct=EBI-8641936, EBI-740727;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000250}. Note=Isoform 2 is not
CC       localized to the nucleus. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q15742-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15742-2; Sequence=VSP_003385, VSP_003386;
CC       Name=3;
CC         IsoId=Q15742-3; Sequence=VSP_003387;
CC   -!- TISSUE SPECIFICITY: Widely expressed at low levels. Highly expressed in
CC       melanoma cell lines.
CC   -!- INDUCTION: By serum and phorbol myristate acetate (PMA) stimulation.
CC   -!- DOMAIN: The NAB conserved domain 1 (NCD1) interacts with EGR1
CC       inhibitory domain and mediates multimerization.
CC   -!- DOMAIN: The NAB conserved domain 2 (NCD2) is necessary for
CC       transcriptional repression.
CC   -!- PTM: Sumoylation by EGR2 represses EGR2 transcriptional activity in
CC       hindbrain. {ECO:0000269|PubMed:21836637}.
CC   -!- SIMILARITY: Belongs to the NAB family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U48361; AAC50589.1; -; mRNA.
DR   EMBL; AF268380; AAF72545.1; -; Genomic_DNA.
DR   EMBL; AK314229; BAG36900.1; -; mRNA.
DR   EMBL; CH471054; EAW96989.1; -; Genomic_DNA.
DR   EMBL; BC065931; AAH65931.1; -; mRNA.
DR   EMBL; X70991; CAA50318.1; -; mRNA.
DR   EMBL; AJ011081; CAA09472.1; -; Genomic_DNA.
DR   CCDS; CCDS81701.1; -. [Q15742-3]
DR   CCDS; CCDS8930.1; -. [Q15742-1]
DR   RefSeq; NP_001317234.1; NM_001330305.1. [Q15742-3]
DR   RefSeq; NP_005958.1; NM_005967.3. [Q15742-1]
DR   SMR; Q15742; -.
DR   BioGrid; 110747; 46.
DR   IntAct; Q15742; 78.
DR   MINT; Q15742; -.
DR   STRING; 9606.ENSP00000300131; -.
DR   iPTMnet; Q15742; -.
DR   PhosphoSitePlus; Q15742; -.
DR   BioMuta; NAB2; -.
DR   DMDM; 12643729; -.
DR   EPD; Q15742; -.
DR   jPOST; Q15742; -.
DR   MassIVE; Q15742; -.
DR   MaxQB; Q15742; -.
DR   PaxDb; Q15742; -.
DR   PeptideAtlas; Q15742; -.
DR   PRIDE; Q15742; -.
DR   ProteomicsDB; 60728; -. [Q15742-1]
DR   ProteomicsDB; 60729; -. [Q15742-2]
DR   ProteomicsDB; 60730; -. [Q15742-3]
DR   Antibodypedia; 3858; 369 antibodies.
DR   Ensembl; ENST00000300131; ENSP00000300131; ENSG00000166886. [Q15742-1]
DR   Ensembl; ENST00000342556; ENSP00000341491; ENSG00000166886. [Q15742-3]
DR   GeneID; 4665; -.
DR   KEGG; hsa:4665; -.
DR   UCSC; uc001smz.3; human. [Q15742-1]
DR   CTD; 4665; -.
DR   DisGeNET; 4665; -.
DR   GeneCards; NAB2; -.
DR   HGNC; HGNC:7627; NAB2.
DR   HPA; ENSG00000166886; Low tissue specificity.
DR   MalaCards; NAB2; -.
DR   MIM; 602381; gene.
DR   neXtProt; NX_Q15742; -.
DR   OpenTargets; ENSG00000166886; -.
DR   Orphanet; 2126; Solitary fibrous tumour/hemangiopericytoma.
DR   PharmGKB; PA31432; -.
DR   eggNOG; KOG3835; Eukaryota.
DR   eggNOG; ENOG410YKFH; LUCA.
DR   GeneTree; ENSGT00390000006330; -.
DR   HOGENOM; CLU_029394_2_0_1; -.
DR   InParanoid; Q15742; -.
DR   KO; K22388; -.
DR   OMA; HARTNAD; -.
DR   OrthoDB; 1002244at2759; -.
DR   PhylomeDB; Q15742; -.
DR   TreeFam; TF315501; -.
DR   SIGNOR; Q15742; -.
DR   ChiTaRS; NAB2; human.
DR   GeneWiki; NAB2; -.
DR   GenomeRNAi; 4665; -.
DR   Pharos; Q15742; Tbio.
DR   PRO; PR:Q15742; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q15742; protein.
DR   Bgee; ENSG00000166886; Expressed in right ovary and 209 other tissues.
DR   Genevisible; Q15742; HS.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0003714; F:transcription corepressor activity; TAS:ProtInc.
DR   GO; GO:0008134; F:transcription factor binding; IEA:Ensembl.
DR   GO; GO:0001958; P:endochondral ossification; IEA:Ensembl.
DR   GO; GO:0042552; P:myelination; IEA:Ensembl.
DR   GO; GO:0016480; P:negative regulation of transcription by RNA polymerase III; IDA:MGI.
DR   GO; GO:1902949; P:positive regulation of tau-protein kinase activity; ISS:ARUK-UCL.
DR   GO; GO:0045682; P:regulation of epidermis development; IEA:Ensembl.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0014037; P:Schwann cell differentiation; IEA:Ensembl.
DR   Gene3D; 1.10.150.50; -; 1.
DR   Gene3D; 3.40.390.60; -; 1.
DR   InterPro; IPR006989; NAB_co-repressor_dom.
DR   InterPro; IPR039040; NAB_fam.
DR   InterPro; IPR006988; Nab_N.
DR   InterPro; IPR038398; NCD2_sf.
DR   InterPro; IPR013761; SAM/pointed_sf.
DR   PANTHER; PTHR12623; PTHR12623; 1.
DR   Pfam; PF04904; NCD1; 1.
DR   Pfam; PF04905; NCD2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Isopeptide bond; Nucleus; Phosphoprotein;
KW   Reference proteome; Repressor; Transcription; Transcription regulation;
KW   Ubl conjugation.
FT   CHAIN           1..525
FT                   /note="NGFI-A-binding protein 2"
FT                   /id="PRO_0000077042"
FT   REGION          35..113
FT                   /note="NCD1"
FT   REGION          267..356
FT                   /note="NCD2"
FT   REGION          353..384
FT                   /note="Necessary for nuclear localization"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         6
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         157
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61127"
FT   MOD_RES         159
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         162
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         171
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         479
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q61127"
FT   CROSSLNK        379
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1)"
FT                   /evidence="ECO:0000269|PubMed:21836637"
FT   CROSSLNK        517
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000269|PubMed:21836637"
FT   CROSSLNK        517
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         320..322
FT                   /note="LTI -> ASP (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8668170"
FT                   /id="VSP_003385"
FT   VAR_SEQ         323..525
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:8668170"
FT                   /id="VSP_003386"
FT   VAR_SEQ         426..489
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_003387"
FT   CONFLICT        257..258
FT                   /note="PR -> Q (in Ref. 6 and 7)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   525 AA;  56594 MW;  38CF6CFEFE3756F9 CRC64;
     MHRAPSPTAE QPPGGGDSAR RTLQPRLKPS ARAMALPRTL GELQLYRVLQ RANLLSYYET
     FIQQGGDDVQ QLCEAGEEEF LEIMALVGMA TKPLHVRRLQ KALREWATNP GLFSQPVPAV
     PVSSIPLFKI SETAGTRKGS MSNGHGSPGE KAGSARSFSP KSPLELGEKL SPLPGGPGAG
     DPRIWPGRST PESDVGAGGE EEAGSPPFSP PAGGGVPEGT GAGGLAAGGT GGGPDRLEPE
     MVRMVVESVE RIFRSFPRGD AGEVTSLLKL NKKLARSVGH IFEMDDNDSQ KEEEIRKYSI
     IYGRFDSKRR EGKQLSLHEL TINEAAAQFC MRDNTLLLRR VELFSLSRQV ARESTYLSSL
     KGSRLHPEEL GGPPLKKLKQ EVGEQSHPEI QQPPPGPESY VPPYRPSLEE DSASLSGESL
     DGHLQAVGSC PRLTPPPADL PLALPAHGLW SRHILQQTLM DEGLRLARLV SHDRVGRLSP
     CVPAKPPLAE FEEGLLDRCP APGPHPALVE GRRSSVKVEA EASRQ
//
ID   A0A024QZI5_HUMAN        Unreviewed;       614 AA.
AC   A0A024QZI5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Nuclear receptor coactivator 4, isoform CRA_a {ECO:0000313|EMBL:EAW53688.1};
GN   Name=NCOA4 {ECO:0000313|EMBL:EAW53688.1};
GN   ORFNames=hCG_1982904 {ECO:0000313|EMBL:EAW53688.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW53688.1};
RN   [1] {ECO:0000313|EMBL:EAW53688.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW53688.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471260; EAW53687.1; -; Genomic_DNA.
DR   EMBL; CH471260; EAW53688.1; -; Genomic_DNA.
DR   RefSeq; NP_001138734.1; NM_001145262.1.
DR   RefSeq; NP_001138735.1; NM_001145263.1.
DR   RefSeq; NP_005428.1; NM_005437.3.
DR   Antibodypedia; 72715; 383 antibodies.
DR   GeneID; 8031; -.
DR   KEGG; hsa:8031; -.
DR   CTD; 8031; -.
DR   EuPathDB; HostDB:ENSG00000266412.5; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   HOGENOM; CLU_034170_0_0_1; -.
DR   KO; K09289; -.
DR   ChiTaRS; NCOA4; human.
DR   GenomeRNAi; 8031; -.
DR   Bgee; ENSG00000266412; Expressed in trabecular bone tissue and 238 other tissues.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   InterPro; IPR022174; ARA70.
DR   InterPro; IPR039947; NCoA-4.
DR   PANTHER; PTHR17085; PTHR17085; 1.
DR   Pfam; PF12489; ARA70; 2.
PE   4: Predicted;
KW   Receptor {ECO:0000313|EMBL:EAW53688.1}.
FT   DOMAIN          35..165
FT                   /note="ARA70"
FT                   /evidence="ECO:0000259|Pfam:PF12489"
FT   DOMAIN          199..321
FT                   /note="ARA70"
FT                   /evidence="ECO:0000259|Pfam:PF12489"
FT   REGION          501..524
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   614 AA;  69726 MW;  36B6D97C7D072BFF CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
     LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
     VDKEKWLYRT PLQM
//
ID   B2R5V0_HUMAN            Unreviewed;       614 AA.
AC   B2R5V0;
DT   01-JUL-2008, integrated into UniProtKB/TrEMBL.
DT   01-JUL-2008, sequence version 1.
DT   22-APR-2020, entry version 46.
DE   SubName: Full=cDNA, FLJ92637, highly similar to Homo sapiens nuclear receptor coactivator 4 (NCOA4), mRNA {ECO:0000313|EMBL:BAG35247.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG35247.1};
RN   [1] {ECO:0000313|EMBL:BAG35247.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Cerebellum {ECO:0000313|EMBL:BAG35247.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK312325; BAG35247.1; -; mRNA.
DR   RefSeq; NP_001138735.1; NM_001145263.1.
DR   PeptideAtlas; B2R5V0; -.
DR   DNASU; 8031; -.
DR   GeneID; 8031; -.
DR   CTD; 8031; -.
DR   PharmGKB; PA31473; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   GenomeRNAi; 8031; -.
DR   Genevisible; B2R5V0; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   InterPro; IPR022174; ARA70.
DR   InterPro; IPR039947; NCoA-4.
DR   PANTHER; PTHR17085; PTHR17085; 1.
DR   Pfam; PF12489; ARA70; 2.
PE   2: Evidence at transcript level;
KW   Receptor {ECO:0000313|EMBL:BAG35247.1}.
FT   DOMAIN          35..165
FT                   /note="ARA70"
FT                   /evidence="ECO:0000259|Pfam:PF12489"
FT   DOMAIN          199..321
FT                   /note="ARA70"
FT                   /evidence="ECO:0000259|Pfam:PF12489"
FT   REGION          501..524
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   614 AA;  69779 MW;  781C7862CA0D4311 CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGRISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
     LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
     VDKEKWLYRT PLQM
//
ID   NCOA4_HUMAN             Reviewed;         614 AA.
AC   Q13772; A8K8W5; B4E260; E9PAV7; J3KQN8; Q14239;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1996, sequence version 1.
DT   22-APR-2020, entry version 195.
DE   RecName: Full=Nuclear receptor coactivator 4;
DE            Short=NCoA-4;
DE   AltName: Full=Androgen receptor coactivator 70 kDa protein;
DE            Short=70 kDa AR-activator;
DE            Short=70 kDa androgen receptor coactivator;
DE   AltName: Full=Androgen receptor-associated protein of 70 kDa;
DE   AltName: Full=Ret-activating protein ELE1;
GN   Name=NCOA4; Synonyms=ARA70, ELE1, RFG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Prostatic carcinoma;
RX   PubMed=8643607; DOI=10.1073/pnas.93.11.5517;
RA   Yeh S., Chang C.;
RT   "Cloning and characterization of a specific coactivator, ARA70, for the
RT   androgen receptor in human prostate cells.";
RL   Proc. Natl. Acad. Sci. U.S.A. 93:5517-5521(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND CHROMOSOMAL REARRANGEMENT WITH RET.
RC   TISSUE=Thyroid;
RX   PubMed=8290261;
RA   Santoro M., Dathan N.A., Berlingieri M.T., Bongarzone I., Paulin C.,
RA   Grieco M., Pierotti M.A., Vecchio G., Fusco A.;
RT   "Molecular characterization of RET/PTC3; a novel rearranged version of the
RT   RETproto-oncogene in a human thyroid papillary carcinoma.";
RL   Oncogene 9:509-516(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS ALPHA; 3 AND 4).
RC   TISSUE=Testis, and Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Melanoma;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15164054; DOI=10.1038/nature02462;
RA   Deloukas P., Earthrowl M.E., Grafham D.V., Rubenfield M., French L.,
RA   Steward C.A., Sims S.K., Jones M.C., Searle S., Scott C., Howe K.,
RA   Hunt S.E., Andrews T.D., Gilbert J.G.R., Swarbreck D., Ashurst J.L.,
RA   Taylor A., Battles J., Bird C.P., Ainscough R., Almeida J.P.,
RA   Ashwell R.I.S., Ambrose K.D., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Bates K., Beasley H., Bray-Allen S., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Cahill P., Camire D., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clarke G., Clee C.M., Clegg S., Corby N.,
RA   Coulson A., Dhami P., Dutta I., Dunn M., Faulkner L., Frankish A.,
RA   Frankland J.A., Garner P., Garnett J., Gribble S., Griffiths C.,
RA   Grocock R., Gustafson E., Hammond S., Harley J.L., Hart E., Heath P.D.,
RA   Ho T.P., Hopkins B., Horne J., Howden P.J., Huckle E., Hynds C.,
RA   Johnson C., Johnson D., Kana A., Kay M., Kimberley A.M., Kershaw J.K.,
RA   Kokkinaki M., Laird G.K., Lawlor S., Lee H.M., Leongamornlert D.A.,
RA   Laird G., Lloyd C., Lloyd D.M., Loveland J., Lovell J., McLaren S.,
RA   McLay K.E., McMurray A., Mashreghi-Mohammadi M., Matthews L., Milne S.,
RA   Nickerson T., Nguyen M., Overton-Larty E., Palmer S.A., Pearce A.V.,
RA   Peck A.I., Pelan S., Phillimore B., Porter K., Rice C.M., Rogosin A.,
RA   Ross M.T., Sarafidou T., Sehra H.K., Shownkeen R., Skuce C.D., Smith M.,
RA   Standring L., Sycamore N., Tester J., Thorpe A., Torcasso W., Tracey A.,
RA   Tromans A., Tsolas J., Wall M., Walsh J., Wang H., Weinstock K., West A.P.,
RA   Willey D.L., Whitehead S.L., Wilming L., Wray P.W., Young L., Chen Y.,
RA   Lovering R.C., Moschonas N.K., Siebert R., Fechtel K., Bentley D.,
RA   Durbin R.M., Hubbard T., Doucette-Stamm L., Beck S., Smith D.R., Rogers J.;
RT   "The DNA sequence and comparative analysis of human chromosome 10.";
RL   Nature 429:375-381(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-238, AND CHROMOSOMAL REARRANGEMENT WITH
RP   RET.
RC   TISSUE=Thyroid tumor;
RX   PubMed=8187085;
RA   Bongarzone I., Butti M.G., Coronelli S., Borrello M.G., Santoro M.,
RA   Mondellini P., Pilotti S., Fusco A., Della Porta G., Pierotti M.A.;
RT   "Frequent activation of ret protooncogene by fusion with a new activating
RT   gene in papillary thyroid carcinomas.";
RL   Cancer Res. 54:2979-2985(1994).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA), AND VARIANTS LEU-94;
RP   LEU-154; ARG-350 AND PRO-561.
RC   TISSUE=Cervix carcinoma, Mammary cancer, and Prostatic carcinoma;
RX   PubMed=9892017; DOI=10.1210/mend.13.1.0214;
RA   Alen P., Claessens F., Schoenmakers E., Swinnen J.V., Verhoeven G.,
RA   Rombauts W., Peeters B.;
RT   "Interaction of the putative androgen receptor-specific coactivator
RT   ARA70/ELE1alpha with multiple steroid receptors and identification of an
RT   internally deleted ELE1beta isoform.";
RL   Mol. Endocrinol. 13:117-128(1999).
RN   [10]
RP   FUNCTION.
RX   PubMed=10347167; DOI=10.1074/jbc.274.23.16147;
RA   Heinlein C.A., Ting H.-J., Yeh S., Chang C.;
RT   "Identification of ARA70 as a ligand-enhanced coactivator for the
RT   peroxisome proliferator-activated receptor gamma.";
RL   J. Biol. Chem. 274:16147-16152(1999).
CC   -!- FUNCTION: Enhances the androgen receptor transcriptional activity in
CC       prostate cancer cells. Ligand-independent coactivator of the peroxisome
CC       proliferator-activated receptor (PPAR) gamma.
CC       {ECO:0000269|PubMed:10347167}.
CC   -!- SUBUNIT: Interacts with the androgen receptor and the retinoid X
CC       receptor (RXR) in a ligand-dependent manner.
CC   -!- INTERACTION:
CC       Q13772-3; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-12054609, EBI-10172526;
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Alpha;
CC         IsoId=Q13772-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q13772-2; Sequence=VSP_003409;
CC       Name=3;
CC         IsoId=Q13772-3; Sequence=VSP_046348;
CC       Name=4;
CC         IsoId=Q13772-4; Sequence=VSP_046348, VSP_046349;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Also detected in adipose tissues
CC       and in different cell lines. Isoform Beta is only expressed in testis.
CC   -!- DISEASE: Note=A chromosomal aberration involving NCOA4 is found in
CC       papillary thyroid carcinomas (PTCs). Inversion inv(10)(q11.2;q11.2)
CC       generates the RET/NCOA4 (PTC3) oncogene. {ECO:0000269|PubMed:8187085,
CC       ECO:0000269|PubMed:8290261}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NCOA4ID218ch10q11.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L49399; AAC37591.1; -; mRNA.
DR   EMBL; X77548; CAA54673.1; -; mRNA.
DR   EMBL; AK292480; BAF85169.1; -; mRNA.
DR   EMBL; AK304123; BAG65022.1; -; mRNA.
DR   EMBL; AK310849; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AL162047; CAB82390.1; -; mRNA.
DR   EMBL; AL450342; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471260; EAW53686.1; -; Genomic_DNA.
DR   EMBL; BC001562; AAH01562.1; -; mRNA.
DR   EMBL; X71413; CAA50536.1; -; mRNA.
DR   CCDS; CCDS73092.1; -. [Q13772-1]
DR   CCDS; CCDS73093.1; -. [Q13772-3]
DR   CCDS; CCDS73094.1; -. [Q13772-4]
DR   PIR; S61532; S61532.
DR   RefSeq; NP_001138732.1; NM_001145260.1. [Q13772-4]
DR   RefSeq; NP_001138733.1; NM_001145261.1. [Q13772-3]
DR   RefSeq; NP_001138734.1; NM_001145262.1. [Q13772-1]
DR   RefSeq; NP_001138735.1; NM_001145263.1. [Q13772-1]
DR   RefSeq; NP_005428.1; NM_005437.3. [Q13772-1]
DR   PDB; 1T5Z; X-ray; 2.30 A; B=322-336.
DR   PDBsum; 1T5Z; -.
DR   SMR; Q13772; -.
DR   BioGrid; 113726; 37.
DR   DIP; DIP-5957N; -.
DR   IntAct; Q13772; 18.
DR   STRING; 9606.ENSP00000463027; -.
DR   iPTMnet; Q13772; -.
DR   PhosphoSitePlus; Q13772; -.
DR   BioMuta; NCOA4; -.
DR   DMDM; 8928226; -.
DR   EPD; Q13772; -.
DR   jPOST; Q13772; -.
DR   MassIVE; Q13772; -.
DR   MaxQB; Q13772; -.
DR   PaxDb; Q13772; -.
DR   PeptideAtlas; Q13772; -.
DR   PRIDE; Q13772; -.
DR   ProteomicsDB; 19088; -.
DR   ProteomicsDB; 59681; -. [Q13772-1]
DR   ProteomicsDB; 59682; -. [Q13772-2]
DR   Antibodypedia; 72715; 383 antibodies.
DR   DNASU; 8031; -.
DR   Ensembl; ENST00000578454; ENSP00000463027; ENSG00000266412. [Q13772-4]
DR   Ensembl; ENST00000579039; ENSP00000463455; ENSG00000266412. [Q13772-3]
DR   Ensembl; ENST00000581486; ENSP00000462943; ENSG00000266412. [Q13772-1]
DR   Ensembl; ENST00000583565; ENSP00000463476; ENSG00000266412. [Q13772-1]
DR   Ensembl; ENST00000585132; ENSP00000464054; ENSG00000266412. [Q13772-1]
DR   GeneID; 8031; -.
DR   KEGG; hsa:8031; -.
DR   UCSC; uc001jis.5; human. [Q13772-1]
DR   CTD; 8031; -.
DR   DisGeNET; 8031; -.
DR   GeneCards; NCOA4; -.
DR   HGNC; HGNC:7671; NCOA4.
DR   HPA; ENSG00000266412; Tissue enhanced (blood).
DR   MalaCards; NCOA4; -.
DR   MIM; 601984; gene.
DR   neXtProt; NX_Q13772; -.
DR   OpenTargets; ENSG00000266412; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   PharmGKB; PA31473; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   GeneTree; ENSGT00390000008403; -.
DR   HOGENOM; CLU_034170_0_0_1; -.
DR   InParanoid; Q13772; -.
DR   KO; K09289; -.
DR   OMA; DLFACMK; -.
DR   PhylomeDB; Q13772; -.
DR   TreeFam; TF333204; -.
DR   SIGNOR; Q13772; -.
DR   ChiTaRS; NCOA4; human.
DR   EvolutionaryTrace; Q13772; -.
DR   GeneWiki; NCOA4; -.
DR   GenomeRNAi; 8031; -.
DR   Pharos; Q13772; Tbio.
DR   PRO; PR:Q13772; -.
DR   Proteomes; UP000005640; Chromosome 10.
DR   RNAct; Q13772; protein.
DR   Bgee; ENSG00000266412; Expressed in trabecular bone tissue and 238 other tissues.
DR   ExpressionAtlas; Q13772; baseline and differential.
DR   Genevisible; Q13772; HS.
DR   GO; GO:0044754; C:autolysosome; IDA:MGI.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0050681; F:androgen receptor binding; NAS:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; TAS:ProtInc.
DR   GO; GO:0030521; P:androgen receptor signaling pathway; NAS:UniProtKB.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; TAS:ProtInc.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0006622; P:protein targeting to lysosome; IDA:MGI.
DR   InterPro; IPR022174; ARA70.
DR   InterPro; IPR039947; NCoA-4.
DR   PANTHER; PTHR17085; PTHR17085; 1.
DR   Pfam; PF12489; ARA70; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Chromosomal rearrangement;
KW   Polymorphism; Proto-oncogene; Reference proteome; Transcription;
KW   Transcription regulation.
FT   CHAIN           1..614
FT                   /note="Nuclear receptor coactivator 4"
FT                   /id="PRO_0000094410"
FT   SITE            238..239
FT                   /note="Breakpoint for rearrangement to form RET/PTC3
FT                   oncogene"
FT   VAR_SEQ         1
FT                   /note="M -> MGAQLTTFALAGAVRRM (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046348"
FT   VAR_SEQ         239..565
FT                   /note="Missing (in isoform Beta)"
FT                   /evidence="ECO:0000303|PubMed:9892017"
FT                   /id="VSP_003409"
FT   VAR_SEQ         614
FT                   /note="M -> AYFKMNFQDVTVGNFQIPCGF (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046349"
FT   VARIANT         94
FT                   /note="S -> L (in dbSNP:rs782517064)"
FT                   /evidence="ECO:0000269|PubMed:9892017"
FT                   /id="VAR_009190"
FT   VARIANT         154
FT                   /note="F -> L"
FT                   /evidence="ECO:0000269|PubMed:9892017"
FT                   /id="VAR_009191"
FT   VARIANT         350
FT                   /note="C -> R"
FT                   /evidence="ECO:0000269|PubMed:9892017"
FT                   /id="VAR_009192"
FT   VARIANT         474
FT                   /note="P -> R (in dbSNP:rs1132111)"
FT                   /id="VAR_014928"
FT   VARIANT         561
FT                   /note="L -> P"
FT                   /evidence="ECO:0000269|PubMed:9892017"
FT                   /id="VAR_009193"
FT   MUTAGEN         95..96
FT                   /note="LL->AA: Decreased interaction with PPAR and RXR."
FT   CONFLICT        71
FT                   /note="Y -> H (in Ref. 3; BAG65022)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        162
FT                   /note="I -> T (in Ref. 8; CAA50536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        183
FT                   /note="G -> S (in Ref. 8; CAA50536)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        271
FT                   /note="K -> R (in Ref. 3; AK310849)"
FT                   /evidence="ECO:0000305"
FT   HELIX           327..333
FT                   /evidence="ECO:0000244|PDB:1T5Z"
FT   CONFLICT        Q13772-3:8
FT                   /note="F -> V (in Ref. 3; BAG65022)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        Q13772-4:8
FT                   /note="F -> V (in Ref. 3; AK310849)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   614 AA;  69726 MW;  36B6D97C7D072BFF CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKFKSPMNTS WCSFNTADWV
     LPGKKMGNLS QLSSGEDKWL LRKKAQEVLL NSPLQEEHNF PPDHYGLPAV CDLFACMQLK
     VDKEKWLYRT PLQM
//
ID   Q96E88_HUMAN            Unreviewed;       575 AA.
AC   Q96E88;
DT   01-DEC-2001, integrated into UniProtKB/TrEMBL.
DT   01-DEC-2001, sequence version 1.
DT   26-FEB-2020, entry version 98.
DE   SubName: Full=NCOA4 protein {ECO:0000313|EMBL:AAH12736.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH12736.1};
RN   [1] {ECO:0000313|EMBL:AAH12736.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Placenta {ECO:0000313|EMBL:AAH12736.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC012736; AAH12736.1; -; mRNA.
DR   RefSeq; NP_001138732.1; NM_001145260.1.
DR   RefSeq; NP_001138733.1; NM_001145261.1.
DR   RefSeq; NP_001138734.1; NM_001145262.1.
DR   RefSeq; NP_001138735.1; NM_001145263.1.
DR   RefSeq; NP_005428.1; NM_005437.3.
DR   SMR; Q96E88; -.
DR   IntAct; Q96E88; 3.
DR   MaxQB; Q96E88; -.
DR   PeptideAtlas; Q96E88; -.
DR   PRIDE; Q96E88; -.
DR   ProteomicsDB; 76383; -.
DR   DNASU; 8031; -.
DR   GeneID; 8031; -.
DR   KEGG; hsa:8031; -.
DR   CTD; 8031; -.
DR   PharmGKB; PA31473; -.
DR   eggNOG; ENOG410IHT6; Eukaryota.
DR   eggNOG; ENOG410YJ5B; LUCA.
DR   KO; K09289; -.
DR   OrthoDB; 1397106at2759; -.
DR   GenomeRNAi; 8031; -.
DR   Genevisible; Q96E88; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0003713; F:transcription coactivator activity; IEA:InterPro.
DR   GO; GO:0006879; P:cellular iron ion homeostasis; IEA:InterPro.
DR   InterPro; IPR022174; ARA70.
DR   InterPro; IPR039947; NCoA-4.
DR   PANTHER; PTHR17085; PTHR17085; 1.
DR   Pfam; PF12489; ARA70; 2.
PE   2: Evidence at transcript level;
FT   DOMAIN          35..165
FT                   /note="ARA70"
FT                   /evidence="ECO:0000259|Pfam:PF12489"
FT   DOMAIN          199..321
FT                   /note="ARA70"
FT                   /evidence="ECO:0000259|Pfam:PF12489"
SQ   SEQUENCE   575 AA;  65295 MW;  E5E449EF7CED5F3D CRC64;
     MNTFQDQSGS SSNREPLLRC SDARRDLELA IGGVLRAEQQ IKDNLREVKA QIHSCISRHL
     ECLRSREVWL YEQVDLIYQL KEETLQQQAQ QLYSLLGQFN CLTHQLECTQ NKDLANQVSV
     CLERLGSLTL KPEDSTVLLF EADTITLRQT ITTFGSLKTI QIPEHLMAHA SSANIGPFLE
     KRGCISMPEQ KSASGIVAVP FSEWLLGSKP ASGYQAPYIP STDPQDWLTQ KQTLENSQTS
     SRACNFFNNV GGNLKGLENW LLKSEKSSYQ KCNSHSTTSS FSIEMEKVGD QELPDQDEMD
     LSDWLVTPQE SHKLRKPENG SRETSEKFKL LFQSYNVNDW LVKTDSCTNC QGNQPKGVEI
     ENLGNLKCLN DHLEAKKPLS TPSMVTEDWL VQNHQDPCKV EEVCRANEPC TSFAECVCDE
     NCEKEALYKW LLKKEGKDKN GMPVEPKPEP EKHKDSLNMW LCPRKEVIEQ TKAPKAMTPS
     RIADSFQVIK NSPLSEWLIR PPYKEGSPKE VPGTEDRAGK QKYYLIHLYR RNITSPQTIM
     ASLQFVISLP VCSLKLIKRS GYIELLYRCE GMDKS
//
ID   B3KWB2_HUMAN            Unreviewed;       205 AA.
AC   B3KWB2;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   11-DEC-2019, entry version 58.
DE   SubName: Full=cDNA FLJ42719 fis, clone BRAMY3010492, highly similar to Protein NDRG1 {ECO:0000313|EMBL:BAG54074.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG54074.1};
RN   [1] {ECO:0000313|EMBL:BAG54074.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Amygdala {ECO:0000313|EMBL:BAG54074.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK124709; BAG54074.1; -; mRNA.
DR   RefSeq; XP_011515094.1; XM_011516792.1.
DR   SMR; B3KWB2; -.
DR   ESTHER; human-NDRG1; Ndr_family.
DR   PeptideAtlas; B3KWB2; -.
DR   PRIDE; B3KWB2; -.
DR   GeneID; 10397; -.
DR   CTD; 10397; -.
DR   eggNOG; KOG2931; Eukaryota.
DR   eggNOG; ENOG410XSPF; LUCA.
DR   OrthoDB; 854690at2759; -.
DR   GenomeRNAi; 10397; -.
DR   GO; GO:0045576; P:mast cell activation; IEA:InterPro.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IEA:InterPro.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR004142; NDRG.
DR   InterPro; IPR030693; NDRG1.
DR   PANTHER; PTHR11034; PTHR11034; 1.
DR   PANTHER; PTHR11034:SF18; PTHR11034:SF18; 1.
DR   Pfam; PF03096; Ndr; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   2: Evidence at transcript level;
FT   REGION          136..205
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        136..154
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        155..179
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        180..205
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   205 AA;  22079 MW;  3F215ECBAAC88105 CRC64;
     MVVSHLFGKE EMQSNVEVVH TYRQHIVNDM NPGNLHLFIN AYNSRRDLEI ERPMPGTHTV
     TLQCPALLVV GDSSPAVDAV VECNSKLDPT KTTLLKMADC GGLPQISQPA KLAEAFKYFV
     QGMGYMPSAS MTRLMRSRTA SGSSVTSLDG TRSRSHTSEG TRSRSHTSEG TRSRSHTSEG
     AHLDITPNSG AAGNSAGPKS MEVSC
//
ID   Q8N959_HUMAN            Unreviewed;       323 AA.
AC   Q8N959;
DT   01-OCT-2002, integrated into UniProtKB/TrEMBL.
DT   01-OCT-2002, sequence version 1.
DT   11-DEC-2019, entry version 85.
DE   SubName: Full=cDNA FLJ38330 fis, clone FCBBF3025280, highly similar to NDRG1 PROTEIN {ECO:0000313|EMBL:BAC04597.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAC04597.1};
RN   [1] {ECO:0000313|EMBL:BAC04597.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAC04597.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK095649; BAC04597.1; -; mRNA.
DR   RefSeq; NP_001245361.1; NM_001258432.1.
DR   RefSeq; NP_001245362.1; NM_001258433.1.
DR   ESTHER; human-NDRG1; Ndr_family.
DR   PeptideAtlas; Q8N959; -.
DR   PRIDE; Q8N959; -.
DR   GeneID; 10397; -.
DR   CTD; 10397; -.
DR   eggNOG; KOG2931; Eukaryota.
DR   eggNOG; ENOG410XSPF; LUCA.
DR   OrthoDB; 854690at2759; -.
DR   GenomeRNAi; 10397; -.
DR   GO; GO:0045576; P:mast cell activation; IEA:InterPro.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; IEA:InterPro.
DR   GO; GO:0042127; P:regulation of cell population proliferation; IEA:InterPro.
DR   Gene3D; 3.40.50.1820; -; 2.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR004142; NDRG.
DR   InterPro; IPR030693; NDRG1.
DR   PANTHER; PTHR11034; PTHR11034; 2.
DR   PANTHER; PTHR11034:SF18; PTHR11034:SF18; 2.
DR   Pfam; PF03096; Ndr; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   2: Evidence at transcript level;
FT   REGION          254..323
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        254..272
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        273..297
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        298..323
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   323 AA;  35226 MW;  EA130D129F3B92E8 CRC64;
     MSREMQDVDL AEVKPLVEKG ETITGLLQEF DVQEQDIETL HGSVHVTLCG TPKGNRPVIL
     TYHDIGMNHK TCYILTRFAL NNPEMVEGLV LINVNPCAEG WMDWAASKIS GWTQALPDMV
     VSHLFGKEEM QSNVEVVHTY RQHIVNDMNP GNLHLFINAY NSRRDLEIER PMPGTHTVTL
     QCPALLVVGD SSPAVDAVVE CNSKLDPTKT TLLKMADCGG LPQISQPAKL AEAFKYFVQG
     MGYMPSASMT RLMRSRTASG SSVTSLDGTR SRSHTSEGTR SRSHTSEGTR SRSHTSEGAH
     LDITPNSGAA GNSAGPKSME VSC
//
ID   NDRG1_HUMAN             Reviewed;         394 AA.
AC   Q92597; B3KR80; B7Z446; O15207; Q6IBG2; Q9NYR6; Q9UK29;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   01-FEB-1997, sequence version 1.
DT   22-APR-2020, entry version 191.
DE   RecName: Full=Protein NDRG1;
DE   AltName: Full=Differentiation-related gene 1 protein;
DE            Short=DRG-1;
DE   AltName: Full=N-myc downstream-regulated gene 1 protein;
DE   AltName: Full=Nickel-specific induction protein Cap43;
DE   AltName: Full=Reducing agents and tunicamycin-responsive protein;
DE            Short=RTP;
DE   AltName: Full=Rit42;
GN   Name=NDRG1; Synonyms=CAP43, DRG1, RTP;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, AND TISSUE SPECIFICITY.
RC   TISSUE=Umbilical vein endothelial cell;
RX   PubMed=8939898; DOI=10.1074/jbc.271.47.29659;
RA   Kokame K., Kato H., Miyata T.;
RT   "Homocysteine-respondent genes in vascular endothelial cells identified by
RT   differential display analysis. GRP78/BiP and novel genes.";
RL   J. Biol. Chem. 271:29659-29665(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), INDUCTION, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=9251681;
RA   van Belzen N., Dinjens W.N.M., Diesveld M.P.G., Groen N.A.,
RA   van der Made A.C.J., Nozawa Y., Vlietstra R., Trapman J., Bosman F.T.;
RT   "A novel gene which is up-regulated during colon epithelial cell
RT   differentiation and down-regulated in colorectal neoplasms.";
RL   Lab. Invest. 77:85-92(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), TISSUE SPECIFICITY, AND INDUCTION.
RC   TISSUE=Lung;
RX   PubMed=9605764;
RA   Zhou D., Salnikow K., Costa M.;
RT   "Cap43, a novel gene specifically induced by Ni2+ compounds.";
RL   Cancer Res. 58:2182-2189(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND INDUCTION.
RX   PubMed=10395947; DOI=10.1016/s0167-4889(99)00056-7;
RA   Piquemal D., Joulia D., Balaguer P., Basset A., Marti J., Commes T.;
RT   "Differential expression of the RTP/Drg1/Ndr1 gene product in proliferating
RT   and growth arrested cells.";
RL   Biochim. Biophys. Acta 1450:364-373(1999).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 2 AND 3).
RC   TISSUE=Brain, and Tongue;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-21 (ISOFORM 1).
RC   TISSUE=Brain;
RA   Angelicheva D., Kalaydjieva L.;
RL   Submitted (FEB-2000) to the EMBL/GenBank/DDBJ databases.
RN   [11]
RP   PROTEIN SEQUENCE OF 4-19; 54-70; 133-148; 199-212; 286-300; 307-322;
RP   328-341 AND 364-388, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [12]
RP   FUNCTION, AND INDUCTION.
RX   PubMed=9766676;
RA   Kurdistani S.K., Arizti P., Reimer C.L., Sugrue M.M., Aaronson S.A.,
RA   Lee S.W.;
RT   "Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53
RT   and DNA damage.";
RL   Cancer Res. 58:4439-4444(1998).
RN   [13]
RP   INVOLVEMENT IN CMT4D.
RX   PubMed=10831399; DOI=10.1086/302978;
RA   Kalaydjieva L., Gresham D., Gooding R., Heather L., Baas F., de Jonge R.,
RA   Blechschmidt K., Angelicheva D., Chandler D., Worsley P., Rosenthal A.,
RA   King R.H.M., Thomas P.K.;
RT   "N-myc downstream-regulated gene 1 is mutated in hereditary motor and
RT   sensory neuropathy-Lom.";
RL   Am. J. Hum. Genet. 67:47-58(2000).
RN   [14]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=10860807; DOI=10.1006/bbrc.2000.2833;
RA   Agarwala K.L., Kokame K., Kato H., Miyata T.;
RT   "Phosphorylation of RTP, an ER stress-responsive cytoplasmic protein.";
RL   Biochem. Biophys. Res. Commun. 272:641-647(2000).
RN   [15]
RP   SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=12432451; DOI=10.1007/s00418-002-0460-9;
RA   Lachat P., Shaw P., Gebhard S., van Belzen N., Chaubert P., Bosman F.T.;
RT   "Expression of NDRG1, a differentiation-related gene, in human tissues.";
RL   Histochem. Cell Biol. 118:399-408(2002).
RN   [16]
RP   PHOSPHORYLATION AT THR-328; SER-330; THR-346; THR-356 AND THR-366.
RX   PubMed=15461589; DOI=10.1042/bj20041057;
RA   Murray J.T., Campbell D.G., Morrice N., Auld G.C., Shpiro N., Marquez R.,
RA   Peggie M., Bain J., Bloomberg G.B., Grahammer F., Lang F., Wulff P.,
RA   Kuhl D., Cohen P.;
RT   "Exploitation of KESTREL to identify NDRG family members as physiological
RT   substrates for SGK1 and GSK3.";
RL   Biochem. J. 384:477-488(2004).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15247272; DOI=10.1074/jbc.m400781200;
RA   Kim K.T., Ongusaha P.P., Hong Y.K., Kurdistani S.K., Nakamura M., Lu K.P.,
RA   Lee S.W.;
RT   "Function of Drg1/Rit42 in p53-dependent mitotic spindle checkpoint.";
RL   J. Biol. Chem. 279:38597-38602(2004).
RN   [18]
RP   FUNCTION.
RX   PubMed=15377670; DOI=10.1074/jbc.m400386200;
RA   Stein S., Thomas E.K., Herzog B., Westfall M.D., Rocheleau J.V.,
RA   Jackson R.S. II, Wang M., Liang P.;
RT   "NDRG1 is necessary for p53-dependent apoptosis.";
RL   J. Biol. Chem. 279:48930-48940(2004).
RN   [19]
RP   INTERACTION WITH APOA1; APOA2; PRA1 AND RTN1, AND POSSIBLE FUNCTION.
RX   PubMed=15922294; DOI=10.1016/j.bbrc.2005.05.050;
RA   Hunter M., Angelicheva D., Tournev I., Ingley E., Chan D.C., Watts G.F.,
RA   Kremensky I., Kalaydjieva L.;
RT   "NDRG1 interacts with APO A-I and A-II and is a functional candidate for
RT   the HDL-C QTL on 8q24.";
RL   Biochem. Biophys. Res. Commun. 332:982-992(2005).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-330 AND SER-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Prostate cancer;
RX   PubMed=17487921; DOI=10.1002/elps.200600782;
RA   Giorgianni F., Zhao Y., Desiderio D.M., Beranova-Giorgianni S.;
RT   "Toward a global characterization of the phosphoproteome in prostate cancer
RT   cells: identification of phosphoproteins in the LNCaP cell line.";
RL   Electrophoresis 28:2027-2034(2007).
RN   [23]
RP   SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=17316623; DOI=10.1016/j.febslet.2007.01.080;
RA   Sibold S., Roh V., Keogh A., Studer P., Tiffon C., Angst E.,
RA   Vorburger S.A., Weimann R., Candinas D., Stroka D.;
RT   "Hypoxia increases cytoplasmic expression of NDRG1, but is insufficient for
RT   its membrane localization in human hepatocellular carcinoma.";
RL   FEBS Lett. 581:989-994(2007).
RN   [24]
RP   INTERACTION WITH RAB4A, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=17786215; DOI=10.1371/journal.pone.0000844;
RA   Kachhap S.K., Faith D., Qian D.Z., Shabbeer S., Galloway N.L., Pili R.,
RA   Denmeade S.R., DeMarzo A.M., Carducci M.A.;
RT   "The N-Myc down regulated Gene1 (NDRG1) is a Rab4a effector involved in
RT   vesicular recycling of E-cadherin.";
RL   PLoS ONE 2:E844-E844(2007).
RN   [25]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-326; SER-330; SER-333;
RP   SER-336; SER-364 AND THR-375, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [26]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT SER-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [27]
RP   PHOSPHORYLATION AT THR-346; THR-356 AND THR-366.
RX   PubMed=18787837; DOI=10.1007/s00424-008-0587-1;
RA   Inglis S.K., Gallacher M., Brown S.G., McTavish N., Getty J., Husband E.M.,
RA   Murray J.T., Wilson S.M.;
RT   "SGK1 activity in Na+ absorbing airway epithelial cells monitored by
RT   assaying NDRG1-Thr346/356/366 phosphorylation.";
RL   Pflugers Arch. 457:1287-1301(2009).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-328 AND SER-330, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-333, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [31]
RP   PHOSPHORYLATION, AND SUBCELLULAR LOCATION.
RX   PubMed=21708134; DOI=10.1016/j.bbrc.2011.06.092;
RA   McCaig C., Potter L., Abramczyk O., Murray J.T.;
RT   "Phosphorylation of NDRG1 is temporally and spatially controlled during the
RT   cell cycle.";
RL   Biochem. Biophys. Res. Commun. 411:227-234(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2; THR-328; SER-330; SER-333;
RP   SER-336; SER-364; THR-366 AND THR-375, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-328; SER-332 AND SER-333, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
CC   -!- FUNCTION: Stress-responsive protein involved in hormone responses, cell
CC       growth, and differentiation. Acts as a tumor suppressor in many cell
CC       types. Necessary but not sufficient for p53/TP53-mediated caspase
CC       activation and apoptosis. Has a role in cell trafficking, notably of
CC       the Schwann cell, and is necessary for the maintenance and development
CC       of the peripheral nerve myelin sheath. Required for vesicular recycling
CC       of CDH1 and TF. May also function in lipid trafficking. Protects cells
CC       from spindle disruption damage. Functions in p53/TP53-dependent mitotic
CC       spindle checkpoint. Regulates microtubule dynamics and maintains
CC       euploidy. {ECO:0000269|PubMed:15247272, ECO:0000269|PubMed:15377670,
CC       ECO:0000269|PubMed:17786215, ECO:0000269|PubMed:9766676}.
CC   -!- SUBUNIT: Interacts with RAB4A (membrane-bound form); the interaction
CC       involves NDRG1 in vesicular recycling of CDH1.
CC       {ECO:0000269|PubMed:15922294, ECO:0000269|PubMed:17786215}.
CC   -!- INTERACTION:
CC       Q92597-3; Q9Y3D8: AK6; NbExp=3; IntAct=EBI-10278703, EBI-2896123;
CC       Q92597; P27824: CANX; NbExp=2; IntAct=EBI-716486, EBI-355947;
CC       Q92597; P35222: CTNNB1; NbExp=3; IntAct=EBI-716486, EBI-491549;
CC       Q92597; P12956: XRCC6; NbExp=2; IntAct=EBI-716486, EBI-353208;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol. Cytoplasm, cytoskeleton,
CC       microtubule organizing center, centrosome. Nucleus. Cell membrane.
CC       Note=Mainly cytoplasmic but differentially localized to other regions.
CC       Associates with the plasma membrane in intestinal epithelia and
CC       lactating mammary gland. Translocated to the nucleus in a p53/TP53-
CC       dependent manner. In prostate epithelium and placental chorion, located
CC       in both the cytoplasm and in the nucleus. No nuclear localization in
CC       colon epithelium cells. In intestinal mucosa, prostate and renal
CC       cortex, located predominantly adjacent to adherens junctions.
CC       Cytoplasmic with granular staining in proximal tubular cells of the
CC       kidney and salivary gland ducts. Recruits to the membrane of
CC       recycling/sorting and late endosomes via binding to
CC       phosphatidylinositol 4-phosphate. Associates with microtubules.
CC       Colocalizes with TUBG1 in the centrosome. Cytoplasmic location
CC       increased with hypoxia. Phosphorylated form found associated with
CC       centromeres during S-phase of mitosis and with the plasma membrane.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q92597-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q92597-2; Sequence=VSP_045038;
CC       Name=3;
CC         IsoId=Q92597-3; Sequence=VSP_045037;
CC   -!- TISSUE SPECIFICITY: Ubiquitous; expressed most prominently in placental
CC       membranes and prostate, kidney, small intestine, and ovary tissues.
CC       Also expressed in heart, brain, skeletal muscle, lung, liver and
CC       pancreas. Low levels in peripheral blood leukocytes and in tissues of
CC       the immune system. Expressed mainly in epithelial cells. Also found in
CC       Schwann cells of peripheral neurons. Reduced expression in
CC       adenocarcinomas compared to normal tissues. In colon, prostate and
CC       placental membranes, the cells that border the lumen show the highest
CC       expression. {ECO:0000269|PubMed:12432451, ECO:0000269|PubMed:8939898,
CC       ECO:0000269|PubMed:9251681, ECO:0000269|PubMed:9605764}.
CC   -!- INDUCTION: By homocysteine, 2-mercaptoethanol, tunicamycin in
CC       endothelial cells. Induced approximately 20-fold during in vitro
CC       differentiation of the colon carcinoma cell lines HT-29-D4 and Caco-2.
CC       Induced by oxidative stress in colon cancers. Decreased expression in
CC       colon adenomas and adenocarcinomas. Induced by nickel compounds in all
CC       tested cell lines. The primary signal for its induction is an elevation
CC       of free intracellular calcium ion caused by nickel ion exposure.
CC       Okadaic acid, a serine/threonine phosphatase inhibitor, induced its
CC       expression more rapidly and more efficiently than nickel.
CC       {ECO:0000269|PubMed:10395947, ECO:0000269|PubMed:17316623,
CC       ECO:0000269|PubMed:8939898, ECO:0000269|PubMed:9251681,
CC       ECO:0000269|PubMed:9605764, ECO:0000269|PubMed:9766676}.
CC   -!- PTM: Under stress conditions, phosphorylated in the C-terminal on many
CC       serine and threonine residues. Phosphorylated in vitro by PKA.
CC       Phosphorylation enhanced by increased intracellular cAMP levels.
CC       Homocysteine induces dephosphorylation. Phosphorylation by SGK1 is cell
CC       cycle dependent. {ECO:0000269|PubMed:10860807,
CC       ECO:0000269|PubMed:15461589, ECO:0000269|PubMed:18787837,
CC       ECO:0000269|PubMed:21708134}.
CC   -!- DISEASE: Charcot-Marie-Tooth disease 4D (CMT4D) [MIM:601455]: A
CC       recessive demyelinating form of Charcot-Marie-Tooth disease, a disorder
CC       of the peripheral nervous system, characterized by progressive weakness
CC       and atrophy, initially of the peroneal muscles and later of the distal
CC       muscles of the arms. Charcot-Marie-Tooth disease is classified in two
CC       main groups on the basis of electrophysiologic properties and
CC       histopathology: primary peripheral demyelinating neuropathies
CC       (designated CMT1 when they are dominantly inherited) and primary
CC       peripheral axonal neuropathies (CMT2). Demyelinating neuropathies are
CC       characterized by severely reduced nerve conduction velocities (less
CC       than 38 m/sec), segmental demyelination and remyelination with onion
CC       bulb formations on nerve biopsy, slowly progressive distal muscle
CC       atrophy and weakness, absent deep tendon reflexes, and hollow feet. By
CC       convention autosomal recessive forms of demyelinating Charcot-Marie-
CC       Tooth disease are designated CMT4. {ECO:0000269|PubMed:10831399}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- SIMILARITY: Belongs to the NDRG family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NDRG1ID41512ch8q24.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; D87953; BAA13505.1; -; mRNA.
DR   EMBL; X92845; CAA63430.1; -; mRNA.
DR   EMBL; AF004162; AAC13419.1; -; mRNA.
DR   EMBL; AF186190; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CR456842; CAG33123.1; -; mRNA.
DR   EMBL; AK091147; BAG52292.1; -; mRNA.
DR   EMBL; AK126924; BAG54400.1; -; mRNA.
DR   EMBL; AK296794; BAH12432.1; -; mRNA.
DR   EMBL; AF192304; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW92164.1; -; Genomic_DNA.
DR   EMBL; BC003175; AAH03175.1; -; mRNA.
DR   EMBL; AF230380; AAF71305.1; -; mRNA.
DR   CCDS; CCDS34945.1; -. [Q92597-1]
DR   CCDS; CCDS59112.1; -. [Q92597-3]
DR   CCDS; CCDS59113.1; -. [Q92597-2]
DR   RefSeq; NP_001128714.1; NM_001135242.1. [Q92597-1]
DR   RefSeq; NP_001245361.1; NM_001258432.1. [Q92597-2]
DR   RefSeq; NP_001245362.1; NM_001258433.1. [Q92597-3]
DR   RefSeq; NP_006087.2; NM_006096.3. [Q92597-1]
DR   SMR; Q92597; -.
DR   BioGrid; 115669; 137.
DR   IntAct; Q92597; 81.
DR   STRING; 9606.ENSP00000404854; -.
DR   ESTHER; human-NDRG1; Ndr_family.
DR   MEROPS; S33.988; -.
DR   iPTMnet; Q92597; -.
DR   MetOSite; Q92597; -.
DR   PhosphoSitePlus; Q92597; -.
DR   SwissPalm; Q92597; -.
DR   BioMuta; NDRG1; -.
DR   DMDM; 6166568; -.
DR   EPD; Q92597; -.
DR   jPOST; Q92597; -.
DR   MassIVE; Q92597; -.
DR   MaxQB; Q92597; -.
DR   PaxDb; Q92597; -.
DR   PeptideAtlas; Q92597; -.
DR   PRIDE; Q92597; -.
DR   ProteomicsDB; 3585; -.
DR   ProteomicsDB; 6569; -.
DR   ProteomicsDB; 75343; -. [Q92597-1]
DR   TopDownProteomics; Q92597-1; -. [Q92597-1]
DR   Antibodypedia; 1521; 604 antibodies.
DR   DNASU; 10397; -.
DR   Ensembl; ENST00000323851; ENSP00000319977; ENSG00000104419. [Q92597-1]
DR   Ensembl; ENST00000414097; ENSP00000404854; ENSG00000104419. [Q92597-1]
DR   Ensembl; ENST00000522476; ENSP00000427894; ENSG00000104419. [Q92597-2]
DR   Ensembl; ENST00000537882; ENSP00000437443; ENSG00000104419. [Q92597-3]
DR   GeneID; 10397; -.
DR   KEGG; hsa:10397; -.
DR   UCSC; uc003yug.3; human. [Q92597-1]
DR   CTD; 10397; -.
DR   DisGeNET; 10397; -.
DR   GeneCards; NDRG1; -.
DR   GeneReviews; NDRG1; -.
DR   HGNC; HGNC:7679; NDRG1.
DR   HPA; ENSG00000104419; Low tissue specificity.
DR   MalaCards; NDRG1; -.
DR   MIM; 601455; phenotype.
DR   MIM; 605262; gene.
DR   neXtProt; NX_Q92597; -.
DR   OpenTargets; ENSG00000104419; -.
DR   Orphanet; 99950; Charcot-Marie-Tooth disease type 4D.
DR   PharmGKB; PA31482; -.
DR   eggNOG; KOG2931; Eukaryota.
DR   eggNOG; ENOG410XSPF; LUCA.
DR   GeneTree; ENSGT00950000182872; -.
DR   HOGENOM; CLU_035361_1_0_1; -.
DR   InParanoid; Q92597; -.
DR   KO; K18266; -.
DR   OMA; MSTEFQD; -.
DR   OrthoDB; 854690at2759; -.
DR   PhylomeDB; Q92597; -.
DR   TreeFam; TF313168; -.
DR   Reactome; R-HSA-6803205; TP53 regulates transcription of several additional cell death genes whose specific roles in p53-dependent apoptosis remain uncertain.
DR   SIGNOR; Q92597; -.
DR   ChiTaRS; NDRG1; human.
DR   GeneWiki; NDRG1; -.
DR   GenomeRNAi; 10397; -.
DR   Pharos; Q92597; Tbio.
DR   PRO; PR:Q92597; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q92597; protein.
DR   Bgee; ENSG00000104419; Expressed in medial globus pallidus and 239 other tissues.
DR   ExpressionAtlas; Q92597; baseline and differential.
DR   Genevisible; Q92597; HS.
DR   GO; GO:0005912; C:adherens junction; IDA:UniProtKB.
DR   GO; GO:0005813; C:centrosome; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005874; C:microtubule; IDA:UniProtKB.
DR   GO; GO:0015630; C:microtubule cytoskeleton; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0055038; C:recycling endosome membrane; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; IDA:UniProtKB.
DR   GO; GO:0043015; F:gamma-tubulin binding; IDA:UniProtKB.
DR   GO; GO:0008017; F:microtubule binding; IDA:UniProtKB.
DR   GO; GO:0017137; F:Rab GTPase binding; IDA:UniProtKB.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEP:UniProtKB.
DR   GO; GO:0030330; P:DNA damage response, signal transduction by p53 class mediator; IEP:UniProtKB.
DR   GO; GO:0045576; P:mast cell activation; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0032287; P:peripheral nervous system myelin maintenance; IEA:Ensembl.
DR   GO; GO:0099173; P:postsynapse organization; IEA:Ensembl.
DR   GO; GO:0042981; P:regulation of apoptotic process; TAS:Reactome.
DR   GO; GO:0010038; P:response to metal ion; TAS:ProtInc.
DR   GO; GO:0007165; P:signal transduction; IBA:GO_Central.
DR   Gene3D; 3.40.50.1820; -; 1.
DR   InterPro; IPR029058; AB_hydrolase.
DR   InterPro; IPR004142; NDRG.
DR   InterPro; IPR030693; NDRG1.
DR   PANTHER; PTHR11034; PTHR11034; 1.
DR   PANTHER; PTHR11034:SF18; PTHR11034:SF18; 1.
DR   Pfam; PF03096; Ndr; 1.
DR   SUPFAM; SSF53474; SSF53474; 1.
PE   1: Evidence at protein level;
KW   Acetylation; Alternative splicing; Cell membrane;
KW   Charcot-Marie-Tooth disease; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Membrane; Microtubule; Neurodegeneration;
KW   Neuropathy; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Repeat.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   CHAIN           2..394
FT                   /note="Protein NDRG1"
FT                   /id="PRO_0000159573"
FT   REPEAT          339..348
FT                   /note="1"
FT   REPEAT          349..358
FT                   /note="2"
FT   REPEAT          359..368
FT                   /note="3"
FT   REGION          339..368
FT                   /note="3 X 10 AA tandem repeats of G-T-R-S-R-S-H-T-S-E"
FT   MOD_RES         2
FT                   /note="N-acetylserine"
FT                   /evidence="ECO:0000244|PubMed:19413330"
FT   MOD_RES         2
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         319
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62433"
FT   MOD_RES         326
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         328
FT                   /note="Phosphothreonine; by SGK1"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|PubMed:15461589"
FT   MOD_RES         330
FT                   /note="Phosphoserine; by SGK1"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:15461589"
FT   MOD_RES         332
FT                   /note="Phosphoserine; by SGK1"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   MOD_RES         333
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         335
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62433"
FT   MOD_RES         336
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         340
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62433"
FT   MOD_RES         342
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q62433"
FT   MOD_RES         346
FT                   /note="Phosphothreonine; by SGK1"
FT                   /evidence="ECO:0000269|PubMed:15461589,
FT                   ECO:0000269|PubMed:18787837"
FT   MOD_RES         352
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6JE36"
FT   MOD_RES         356
FT                   /note="Phosphothreonine; by SGK1"
FT                   /evidence="ECO:0000269|PubMed:15461589,
FT                   ECO:0000269|PubMed:18787837"
FT   MOD_RES         362
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q6JE36"
FT   MOD_RES         364
FT                   /note="Phosphoserine; by SGK1"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         366
FT                   /note="Phosphothreonine; by SGK1"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:15461589, ECO:0000269|PubMed:18787837"
FT   MOD_RES         375
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..81
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045037"
FT   VAR_SEQ         1..66
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_045038"
FT   VARIANT         67
FT                   /note="M -> V (in dbSNP:rs2233319)"
FT                   /id="VAR_050234"
FT   VARIANT         111
FT                   /note="M -> L (in dbSNP:rs2233328)"
FT                   /id="VAR_050235"
FT   CONFLICT        145
FT                   /note="I -> T (in Ref. 2; CAA63430)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   394 AA;  42835 MW;  4C816B9C85E3756F CRC64;
     MSREMQDVDL AEVKPLVEKG ETITGLLQEF DVQEQDIETL HGSVHVTLCG TPKGNRPVIL
     TYHDIGMNHK TCYNPLFNYE DMQEITQHFA VCHVDAPGQQ DGAASFPAGY MYPSMDQLAE
     MLPGVLQQFG LKSIIGMGTG AGAYILTRFA LNNPEMVEGL VLINVNPCAE GWMDWAASKI
     SGWTQALPDM VVSHLFGKEE MQSNVEVVHT YRQHIVNDMN PGNLHLFINA YNSRRDLEIE
     RPMPGTHTVT LQCPALLVVG DSSPAVDAVV ECNSKLDPTK TTLLKMADCG GLPQISQPAK
     LAEAFKYFVQ GMGYMPSASM TRLMRSRTAS GSSVTSLDGT RSRSHTSEGT RSRSHTSEGT
     RSRSHTSEGA HLDITPNSGA AGNSAGPKSM EVSC
//
ID   NF1_HUMAN               Reviewed;        2839 AA.
AC   P21359; O00662; Q14284; Q14930; Q14931; Q9UMK3;
DT   01-MAY-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-JUN-1994, sequence version 2.
DT   22-APR-2020, entry version 234.
DE   RecName: Full=Neurofibromin;
DE   AltName: Full=Neurofibromatosis-related protein NF-1;
DE   Contains:
DE     RecName: Full=Neurofibromin truncated;
GN   Name=NF1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RX   PubMed=1457041; DOI=10.1089/dna.1992.11.727;
RA   Bernards A., Haase V.H., Murthy A.E., Menon A., Hannigan G.E.,
RA   Gusella J.F.;
RT   "Complete human NF1 cDNA sequence: two alternatively spliced mRNAs and
RT   absence of expression in a neuroblastoma line.";
RL   DNA Cell Biol. 11:727-734(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=2134734; DOI=10.1126/science.2134734;
RA   Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Odeh H.M.,
RA   Saulino A.M., Fountain J.W., Brereton A., Nicholson J., Mitchell A.L.,
RA   Brownstein B.H., Collins F.S.;
RT   "Type 1 neurofibromatosis gene: identification of a large transcript
RT   disrupted in three NF1 patients.";
RL   Science 249:181-186(1990).
RN   [3]
RP   ERRATUM OF PUBMED:2134734.
RX   PubMed=2125369;
RA   Wallace M.R., Marchuk D.A., Andersen L.B., Letcher R., Odeh H.M.,
RA   Saulino A.M., Fountain J.W., Brereton A., Nicholson J., Mitchell A.L.,
RA   Brownstein B.H., Collins F.S.;
RL   Science 250:1749-1749(1990).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=1783401; DOI=10.1016/0888-7543(91)90017-9;
RA   Marchuk D.A., Saulino A.M., Tavakkol R., Swaroop M., Wallace M.R.,
RA   Andersen L.B., Mitchell A.L., Gutmann D.H., Boguski M.S., Collins F.S.;
RT   "cDNA cloning of the type 1 neurofibromatosis gene: complete sequence of
RT   the NF1 gene product.";
RL   Genomics 11:931-940(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), AND ALTERNATIVE SPLICING.
RC   TISSUE=Placenta;
RX   PubMed=1339276; DOI=10.1016/0006-291x(92)91294-z;
RA   Suzuki H., Takahashi K., Kubota Y., Shibahara S.;
RT   "Molecular cloning of a cDNA coding for neurofibromatosis type 1 protein
RT   isoform lacking the domain related to ras GTPase-activating protein.";
RL   Biochem. Biophys. Res. Commun. 187:984-990(1992).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 5).
RC   TISSUE=Kidney;
RX   PubMed=7570581; DOI=10.1620/tjem.175.225;
RA   Suzuki H., Takahashi K., Shibahara S.;
RT   "Evidence for the presence of two amino-terminal isoforms of neurofibromin,
RT   a gene product responsible for neurofibromatosis type 1.";
RL   Tohoku J. Exp. Med. 175:225-233(1995).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS CYS-80; LEU-678; HIS-1422
RP   AND LEU-2511.
RG   NIEHS SNPs program;
RL   Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] OF 335-2839 (ISOFORM 1), AND
RP   VARIANT NF1 PRO-1953.
RX   PubMed=2114220; DOI=10.1016/0092-8674(90)90253-b;
RA   Cawthon R.M., Weiss R., Xu G., Viskochil D., Culver M., Stevens J.,
RA   Robertson M., Dunn D., Gesteland R., O'Connell P., White R.;
RT   "A major segment of the neurofibromatosis type 1 gene: cDNA sequence,
RT   genomic structure, and point mutations.";
RL   Cell 62:193-201(1990).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 335-2839 (ISOFORMS 1 AND 6).
RX   PubMed=2116237; DOI=10.1016/0092-8674(90)90024-9;
RA   Xu G., O'Connell P., Viskochil D., Cawthon R.M., Robertson M., Culver M.,
RA   Dunn D., Stevens J., Gesteland R., White R., Weiss R.;
RT   "The neurofibromatosis type 1 gene encodes a protein related to GAP.";
RL   Cell 62:599-608(1990).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 707-782.
RX   PubMed=9002664; DOI=10.1093/hmg/6.1.9;
RA   Regnier V., Meddeb M., Lecointre G., Richard F., Duverger A., Nguyen V.C.,
RA   Dutrillaux B., Bernheim A., Danglot G.;
RT   "Emergence and scattering of multiple neurofibromatosis (NF1)-related
RT   sequences during hominoid evolution suggest a process of pericentromeric
RT   interchromosomal transposition.";
RL   Hum. Mol. Genet. 6:9-16(1997).
RN   [13]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 751-1611 (ISOFORMS 1 AND 2).
RX   PubMed=7774960; DOI=10.1016/0888-7543(95)80104-t;
RA   Li Y., O'Connell P., Breidenbach H.H., Cawthon R.M., Stevens J., Xu G.,
RA   Neil S., Robertson M., White R., Viskochil D.;
RT   "Genomic organization of the neurofibromatosis 1 gene (NF1).";
RL   Genomics 25:9-18(1995).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1090-1598 (ISOFORM 4).
RX   PubMed=2121370; DOI=10.1016/0092-8674(90)90150-d;
RA   Martin G.A., Viskochil D., Bollag G., McCabe P.C., Crosier W.J.,
RA   Haubruck H., Conroy L., Clark R., O'Connell P., Cawthon R.M., Innis M.,
RA   McCormick F.;
RT   "The GAP-related domain of the neurofibromatosis type 1 gene product
RT   interacts with ras p21.";
RL   Cell 63:843-849(1990).
RN   [15]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1168-1566 (ISOFORMS 1 AND 2).
RX   PubMed=1923522;
RA   Nishi T., Lee P.S., Oka K., Levin V.A., Tanase S., Morino Y., Saya H.;
RT   "Differential expression of two types of the neurofibromatosis type 1 (NF1)
RT   gene transcripts related to neuronal differentiation.";
RL   Oncogene 6:1555-1559(1991).
RN   [16]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1371-1391 (ISOFORM 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=8417346; DOI=10.1128/mcb.13.1.487;
RA   Andersen L.B., Ballester R., Marchuk D.A., Chang E., Gutmann D.H.,
RA   Saulino A.M., Camonis J., Wigler M., Collins F.S.;
RT   "A conserved alternative splice in the von Recklinghausen neurofibromatosis
RT   (NF1) gene produces two neurofibromin isoforms, both of which have GTPase-
RT   activating protein activity.";
RL   Mol. Cell. Biol. 13:487-495(1993).
RN   [17]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1371-1391 (ISOFORM 2).
RX   PubMed=1662505; DOI=10.1016/0006-291x(91)92029-j;
RA   Suzuki Y., Suzuki H., Kayama T., Yoshimoto T., Shibahara S.;
RT   "Brain tumors predominantly express the neurofibromatosis type 1 gene
RT   transcripts containing the 63 base insert in the region coding for GTPase
RT   activating protein-related domain.";
RL   Biochem. Biophys. Res. Commun. 181:955-961(1991).
RN   [18]
RP   FUNCTION.
RX   PubMed=2121371; DOI=10.1016/0092-8674(90)90151-4;
RA   Ballester R., Marchuk D.A., Boguski M.S., Saulino A.M., Letcher R.,
RA   Wigler M., Collins F.S.;
RT   "The NF1 locus encodes a protein functionally related to mammalian GAP and
RT   yeast IRA proteins.";
RL   Cell 63:851-859(1990).
RN   [19]
RP   RNA EDITING.
RX   PubMed=8602361; DOI=10.1093/nar/24.3.478;
RA   Skuse G.R., Cappione A.J., Sowden M., Metheny L.J., Smith H.C.;
RT   "The neurofibromatosis type I messenger RNA undergoes base-modification RNA
RT   editing.";
RL   Nucleic Acids Res. 24:478-485(1996).
RN   [20]
RP   RNA EDITING.
RX   PubMed=11727199; DOI=10.1086/337952;
RA   Mukhopadhyay D., Anant S., Lee R.M., Kennedy S., Viskochil D.,
RA   Davidson N.O.;
RT   "C-->U editing of neurofibromatosis 1 mRNA occurs in tumors that express
RT   both the type II transcript and apobec-1, the catalytic subunit of the
RT   apolipoprotein B mRNA-editing enzyme.";
RL   Am. J. Hum. Genet. 70:38-50(2002).
RN   [21]
RP   REVIEW ON VARIANTS.
RX   PubMed=7981724; DOI=10.1002/humu.1380040202;
RA   Upadhyaya M., Shaw D.J., Harper P.S.;
RT   "Molecular basis of neurofibromatosis type 1 (NF1): mutation analysis and
RT   polymorphisms in the NF1 gene.";
RL   Hum. Mutat. 4:83-101(1994).
RN   [22]
RP   REVIEW ON VARIANTS.
RX   PubMed=8825042; DOI=10.1136/jmg.33.1.2;
RA   Shen M.H., Harper P.S., Upadhyaya M.;
RT   "Molecular genetics of neurofibromatosis type 1 (NF1).";
RL   J. Med. Genet. 33:2-17(1996).
RN   [23]
RP   SUBCELLULAR LOCATION, AND NUCLEAR LOCALIZATION SIGNAL.
RX   PubMed=14988005; DOI=10.1016/s0014-5793(04)00078-x;
RA   Vandenbroucke I., Van Oostveldt P., Coene E., De Paepe A., Messiaen L.;
RT   "Neurofibromin is actively transported to the nucleus.";
RL   FEBS Lett. 560:98-102(2004).
RN   [24]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [26]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-2188; SER-2515;
RP   SER-2521 AND SER-2543, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.m800588-mcp200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-876 AND SER-2515,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864 AND SER-2817, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [31]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2543 AND SER-2817, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [33]
RP   INTERACTION WITH HTR6.
RX   PubMed=23027611; DOI=10.1002/emmm.201201410;
RA   Meffre J., Chaumont-Dubel S., Mannoury la Cour C., Loiseau F., Watson D.J.,
RA   Dekeyne A., Seveno M., Rivet J.M., Gaven F., Deleris P., Herve D.,
RA   Fone K.C., Bockaert J., Millan M.J., Marin P.;
RT   "5-HT(6) receptor recruitment of mTOR as a mechanism for perturbed
RT   cognition in schizophrenia.";
RL   EMBO Mol. Med. 4:1043-1056(2012).
RN   [34]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-864; SER-876; SER-2188;
RP   SER-2515; SER-2521; SER-2523; SER-2543; THR-2565; SER-2597 AND SER-2802,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-2543 AND SER-2817, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1198-1551.
RX   PubMed=9687500; DOI=10.1093/emboj/17.15.4313;
RA   Scheffzek K., Ahmadian M.R., Wiesmuller L., Kabsch W., Stege P.,
RA   Schmitz F., Wittinghofer A.;
RT   "Structural analysis of the GAP-related domain from neurofibromin and its
RT   implications.";
RL   EMBO J. 17:4313-4327(1998).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.30 ANGSTROMS) OF 1581-1837, LIPID-BINDING, DOMAIN,
RP   AND MUTAGENESIS OF LYS-1691; ARG-1695; ARG-1769 AND LYS-1771.
RX   PubMed=16397625; DOI=10.1038/sj.embor.7400602;
RA   D'Angelo I., Welti S., Bonneau F., Scheffzek K.;
RT   "A novel bipartite phospholipid-binding module in the neurofibromatosis
RT   type 1 protein.";
RL   EMBO Rep. 7:174-179(2006).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.50 ANGSTROMS) OF 1566-1837 IN COMPLEX WITH
RP   PHOSPHOLIPID, LIPID-BINDING, AND DOMAIN.
RX   PubMed=17187824; DOI=10.1016/j.jmb.2006.11.055;
RA   Welti S., Fraterman S., D'Angelo I., Wilm M., Scheffzek K.;
RT   "The sec14 homology module of neurofibromin binds cellular
RT   glycerophospholipids: mass spectrometry and structure of a lipid complex.";
RL   J. Mol. Biol. 366:551-562(2007).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.19 ANGSTROMS) OF 1581-1837 OF VARIANT NF1 VAL-1605
RP   AND MUTANT LYS-1771 DEL IN COMPLEX WITH LIPID, CHARACTERIZATION OF VARIANT
RP   NF1 VAL-1605, MUTAGENESIS OF LYS-1771, LIPID-BINDING, AND DOMAIN.
RX   PubMed=21089070; DOI=10.1002/humu.21405;
RA   Welti S., Kuhn S., D'Angelo I., Brugger B., Kaufmann D., Scheffzek K.;
RT   "Structural and biochemical consequences of NF1 associated nontruncating
RT   mutations in the Sec14-PH module of neurofibromin.";
RL   Hum. Mutat. 32:191-197(2011).
RN   [40]
RP   VARIANT GLU-1444.
RX   PubMed=1568247; DOI=10.1016/0092-8674(92)90408-5;
RA   Li Y., Bollag G., Clark R., Stevens J., Conroy L., Fults D., Ward K.,
RA   Friedman E., Samowitz W., Robertson M., Bradley P., McCormick F., White R.,
RA   Cawthon R.M.;
RT   "Somatic mutations in the neurofibromatosis 1 gene in human tumors.";
RL   Cell 69:275-281(1992).
RN   [41]
RP   VARIANTS NF1 MET-2164 AND ASN-2192.
RX   PubMed=1302608; DOI=10.1093/hmg/1.9.735;
RA   Upadhyaya M., Shen M.H., Cherryson A., Farnham J., Maynard J., Huson S.M.,
RA   Harper P.S.;
RT   "Analysis of mutations at the neurofibromatosis 1 (NF1) locus.";
RL   Hum. Mol. Genet. 1:735-740(1992).
RN   [42]
RP   VARIANT GLY-HIS-GLU-GLN-GLN-LYS-LEU-PRO-ALA-ALA-THR-LEU-ALA-LEU-1733 INS.
RX   PubMed=8317503;
RA   Tassabehji M., Strachan T., Sharland M., Colley A., Donnai D., Harris R.,
RA   Thakker N.;
RT   "Tandem duplication within a neurofibromatosis type 1 (NF1) gene exon in a
RT   family with features of Watson syndrome and Noonan syndrome.";
RL   Am. J. Hum. Genet. 53:90-95(1993).
RN   [43]
RP   VARIANT MET-991 DEL.
RX   PubMed=7904209; DOI=10.1093/hmg/2.11.1861;
RA   Shen M.H., Harper P.S., Upadhyaya M.;
RT   "Neurofibromatosis type 1 (NF1): the search for mutations by PCR-
RT   heteroduplex analysis on Hydrolink gels.";
RL   Hum. Mol. Genet. 2:1861-1864(1993).
RN   [44]
RP   VARIANTS NF1 ASP-1166 AND ARG-1440.
RX   PubMed=7981679; DOI=10.1093/hmg/3.7.1109;
RA   Purandare S.M., Lanyon W.G., Connor J.M.;
RT   "Characterisation of inherited and sporadic mutations in neurofibromatosis
RT   type-1.";
RL   Hum. Mol. Genet. 3:1109-1115(1994).
RN   [45]
RP   VARIANT NF1 2387-ASN-PHE-2388 DEL.
RX   PubMed=8081387; DOI=10.1002/humu.1380030404;
RA   Abernathy C.R., Colman S.D., Kousseff B.G., Wallace M.R.;
RT   "Two NF1 mutations: frameshift in the GAP-related domain, and loss of two
RT   codons toward the 3' end of the gene.";
RL   Hum. Mutat. 3:347-352(1994).
RN   [46]
RP   VARIANT NF1 ALA-2631.
RX   PubMed=8544190; DOI=10.1136/jmg.32.9.706;
RA   Upadhyaya M., Maynard J., Osborn M.J., Huson S.M., Ponder M.,
RA   Ponder B.A.J., Harper P.S.;
RT   "Characterisation of germline mutations in the neurofibromatosis type 1
RT   (NF1) gene.";
RL   J. Med. Genet. 32:706-710(1995).
RN   [47]
RP   VARIANT NF1 ARG-629.
RX   PubMed=8834249; DOI=10.1007/bf02267073;
RA   Gasparini P., D'Agruma L., de Cillis G.P., Balestrazzi P., Mingarelli R.,
RA   Zelante L.;
RT   "Scanning the first part of the neurofibromatosis type 1 gene by RNA-SSCP:
RT   identification of three novel mutations and of two new polymorphisms.";
RL   Hum. Genet. 97:492-495(1996).
RN   [48]
RP   VARIANT NF1 ARG-1035.
RX   PubMed=8807336;
RX   DOI=10.1002/(sici)1098-1004(1996)8:1<51::aid-humu7>3.0.co;2-s;
RA   Wu R., Legius E., Robberecht W., Dumoulin M., Cassiman J.-J., Fryns J.-P.;
RT   "Neurofibromatosis type I gene mutation in a patient with features of
RT   LEOPARD syndrome.";
RL   Hum. Mutat. 8:51-56(1996).
RN   [49]
RP   VARIANTS NF1 SER-1412; GLN-1440; GLU-1444 AND GLY-1489.
RX   PubMed=9003501; DOI=10.1007/s004390050317;
RA   Upadhyaya M., Osborn M.J., Maynard J., Kim M.R., Tamanoi F., Cooper D.N.;
RT   "Mutational and functional analysis of the neurofibromatosis type 1 (NF1)
RT   gene.";
RL   Hum. Genet. 99:88-92(1997).
RN   [50]
RP   VARIANTS NF1 ARG-844 AND PRO-898.
RX   PubMed=9150739; DOI=10.1007/s004390050427;
RA   Maynard J., Krawczak M., Upadhyaya M.;
RT   "Characterization and significance of nine novel mutations in exon 16 of
RT   the neurofibromatosis type 1 (NF1) gene.";
RL   Hum. Genet. 99:674-676(1997).
RN   [51]
RP   VARIANT NF1 ARG-1952.
RX   PubMed=9101300;
RX   DOI=10.1002/(sici)1098-1004(1997)9:4<366::aid-humu12>3.0.co;2-0;
RA   Hudson J., Wu C.L., Tassabehji M., Summers E.M., Simon S., Super M.,
RA   Donnai D., Thakker N.;
RT   "Novel and recurrent mutations in the neurofibromatosis type 1 (NF1)
RT   gene.";
RL   Hum. Mutat. 9:366-367(1997).
RN   [52]
RP   VARIANTS NF1 GLY-338 AND TRP-1611.
RX   PubMed=9298829;
RX   DOI=10.1002/(sici)1098-1004(1997)10:3<248::aid-humu14>3.0.co;2-#;
RA   Upadhyaya M., Maynard J., Osborn M.J., Harper P.S.;
RT   "Six novel mutations in the neurofibromatosis type 1 (NF1) gene.";
RL   Hum. Mutat. 10:248-250(1997).
RN   [53]
RP   VARIANT NF1 PRO-1276.
RX   PubMed=9668168; DOI=10.1093/hmg/7.8.1261;
RA   Klose A., Ahmadian M.R., Schuelke M., Scheffzek K., Hoffmeyer S.,
RA   Gewies A., Schmitz F., Kaufmann D., Peters H., Wittinghofer A.,
RA   Nuernberg P.;
RT   "Selective disactivation of neurofibromin GAP activity in neurofibromatosis
RT   type 1 (NF1).";
RL   Hum. Mol. Genet. 7:1261-1268(1998).
RN   [54]
RP   VARIANTS NF1 HIS-765 AND GLY-1204.
RX   PubMed=10336779;
RX   DOI=10.1002/(sici)1098-1004(1998)11:5<411::aid-humu11>3.0.co;2-2;
RA   Krkljus S., Abernathy C.R., Johnson J.S., Williams C.A., Driscoll D.J.,
RA   Zori R., Stalker H.J., Rasmussen S.A., Collins F.S., Kousseff B.G.,
RA   Baumbach L., Wallace M.R.;
RT   "Analysis of CpG C-to-T mutations in neurofibromatosis type 1.";
RL   Hum. Mutat. 11:411-411(1998).
RN   [55]
RP   VARIANT NF1 PRO-508.
RX   PubMed=11258625; DOI=10.1097/00125817-199909000-00002;
RA   Messiaen L.M., Callens T., Roux K.J., Mortier G.R., De Paepe A.,
RA   Abramowicz M., Pericak-Vance M.A., Vance J.M., Wallace M.R.;
RT   "Exon 10b of the NF1 gene represents a mutational hotspot and harbors a
RT   recurrent missense mutation Y489C associated with aberrant splicing.";
RL   Genet. Med. 1:248-253(1999).
RN   [56]
RP   VARIANT NF1 PRO-1446.
RX   PubMed=10220149;
RX   DOI=10.1002/(sici)1098-1004(1999)13:4<337::aid-humu12>3.0.co;2-f;
RA   Peters H., Hess D., Fahsold R., Schuelke M.;
RT   "A novel mutation L1425P in the GAP-region of the NF1 gene detected by
RT   temperature gradient gel electrophoresis (TGGE).";
RL   Hum. Mutat. 13:337-337(1999).
RN   [57]
RP   VARIANTS NF1 PRO-216; PRO-357; CYS-491; PRO-549; THR-581; ARG-583; PHE-665;
RP   PRO-695; PRO-763; SER-777; LYS-780; PRO-781; PRO-847; SER-1156; PRO-1250;
RP   GLN-1276; PRO-1276; PRO-1446; VAL-1605 AND ILE-2507, AND VARIANT GLU-176.
RX   PubMed=10712197; DOI=10.1086/302809;
RA   Fahsold R., Hoffmeyer S., Mischung C., Gille C., Ehlers C.,
RA   Kuecuekceylan N., Abdel-Nour M., Gewies A., Peters H., Kaufmann D.,
RA   Buske A., Tinschert S., Nuernberg P.;
RT   "Minor lesion mutational spectrum of the entire NF1 gene does not explain
RT   its high mutability but points to a functional domain upstream of the GAP-
RT   related domain.";
RL   Am. J. Hum. Genet. 66:790-818(2000).
RN   [58]
RP   VARIANTS NF1 SER-117; TRP-1204; PRO-1446 AND 2387-ASN-PHE-2388 DEL.
RX   PubMed=10607834; DOI=10.1093/hmg/9.2.237;
RA   Ars E., Serra E., Garcia J., Kruyer H., Gaona A., Lazaro C., Estivill X.;
RT   "Mutations affecting mRNA splicing are the most common molecular defects in
RT   patients with neurofibromatosis type 1.";
RL   Hum. Mol. Genet. 9:237-247(2000).
RN   [59]
RP   ERRATUM OF PUBMED:10607834.
RA   Ars E., Serra E., Garcia J., Kruyer H., Gaona A., Lazaro C., Estivill X.;
RL   Hum. Mol. Genet. 9:659-659(2000).
RN   [60]
RP   VARIANT NF1 PHE-844.
RX   PubMed=10980545;
RX   DOI=10.1002/1098-1004(200009)16:3<274::aid-humu21>3.3.co;2-6;
RA   Boulandet E.G., Pantel J., Cazeneuve C., Van Gijn M., Vidaud D., Lemay S.,
RA   Martin J., Zeller J., Revuz J., Goossens M., Amselem S., Wolkenstein P.;
RT   "NF1 gene analysis focused on CpG-rich exons in a cohort of 93 patients
RT   with neurofibromatosis type 1.";
RL   Hum. Mutat. 16:274-275(2000).
RN   [61]
RP   VARIANT SPINAL FSNF PRO-2088.
RX   PubMed=11704931; DOI=10.1086/324648;
RA   Kaufmann D., Mueller R., Bartelt B., Wolf M., Kunzi-Rapp K., Hanemann C.O.,
RA   Fahsold R., Hein C., Vogel W., Assum G.;
RT   "Spinal neurofibromatosis without cafe-au-lait macules in two families with
RT   null mutations of the NF1 gene.";
RL   Am. J. Hum. Genet. 69:1395-1400(2001).
RN   [62]
RP   VARIANTS NF1 LYS-780; CYS-784; PRO-1147; CYS-1193; ARG-1444; SER-1785;
RP   ASN-2012 AND LYS-2357.
RX   PubMed=11735023; DOI=10.1007/s004390100594;
RA   Han S.S., Cooper D.N., Upadhyaya M.N.;
RT   "Evaluation of denaturing high performance liquid chromatography (DHPLC)
RT   for the mutational analysis of the neurofibromatosis type 1 (NF1) gene.";
RL   Hum. Genet. 109:487-497(2001).
RN   [63]
RP   VARIANTS NF1 PHE-82; ARG-784 AND GLU-1444.
RX   PubMed=11857752; DOI=10.1002/humu.9018;
RA   Kluwe L., Friedrich R.E., Korf B., Fahsold R., Mautner V.-F.;
RT   "NF1 mutations in neurofibromatosis 1 patients with plexiform
RT   neurofibromas.";
RL   Hum. Mutat. 19:309-309(2002).
RN   [64]
RP   VARIANT NFNS GLU-1459 DEL.
RX   PubMed=12707950; DOI=10.1002/ajmg.a.20023;
RA   Baralle D., Mattocks C., Kalidas K., Elmslie F., Whittaker J., Lees M.,
RA   Ragge N., Patton M.A., Winter R.M., ffrench-Constant C.;
RT   "Different mutations in the NF1 gene are associated with neurofibromatosis-
RT   Noonan syndrome (NFNS).";
RL   Am. J. Med. Genet. A 119:1-8(2003).
RN   [65]
RP   VARIANTS NF1 TYR-93; VAL-604; ARG-844 AND PRO-898, AND VARIANTS ASP-74;
RP   GLU-176; ARG-712 AND GLN-1276.
RX   PubMed=12522551; DOI=10.1007/s00439-002-0858-4;
RA   Wang Q., Montmain G., Ruano E., Upadhyaya M., Dudley S., Liskay R.M.,
RA   Thibodeau S.N., Puisieux A.;
RT   "Neurofibromatosis type 1 gene as a mutational target in a mismatch repair-
RT   deficient cell type.";
RL   Hum. Genet. 112:117-123(2003).
RN   [66]
RP   VARIANTS NF1 LYS-780; PRO-847; GLU-848 AND ARG-968; ASN-1444; LEU-1953 DEL
RP   AND ARG-2001.
RX   PubMed=12552569; DOI=10.1002/humu.9111;
RA   De Luca A., Buccino A., Gianni D., Mangino M., Giustini S., Richetta A.,
RA   Divona L., Calvieri S., Mingarelli R., Dallapiccola B.;
RT   "NF1 gene analysis based on DHPLC.";
RL   Hum. Mutat. 21:171-172(2003).
RN   [67]
RP   VARIANTS NF1 ARG-578; PRO-920 AND ALA-2221.
RX   PubMed=12746402; DOI=10.1136/jmg.40.5.368;
RA   Kluwe L., Tatagiba M., Fuensterer C., Mautner V.F.;
RT   "NF1 mutations and clinical spectrum in patients with spinal
RT   neurofibromas.";
RL   J. Med. Genet. 40:368-371(2003).
RN   [68]
RP   VARIANT NF1 VAL-186, AND CHARACTERIZATION OF VARIANT NF1 VAL-186.
RX   PubMed=15523642; DOI=10.1002/humu.20103;
RA   Zatkova A., Messiaen L., Vandenbroucke I., Wieser R., Fonatsch C.,
RA   Krainer A.R., Wimmer K.;
RT   "Disruption of exonic splicing enhancer elements is the principal cause of
RT   exon skipping associated with seven nonsense or missense alleles of NF1.";
RL   Hum. Mutat. 24:491-501(2004).
RN   [69]
RP   VARIANTS NF1 ASN-157; ARG-629; SER-777; LYS-780; ARG-784; PRO-847; GLU-848;
RP   ARG-968; ASN-1444; LEU-1953 DEL AND ARG-2001, AND VARIANT GLU-176.
RX   PubMed=15146469; DOI=10.1002/humu.9245;
RA   De Luca A., Schirinzi A., Buccino A., Bottillo I., Sinibaldi L.,
RA   Torrente I., Ciavarella A., Dottorini T., Porciello R., Giustini S.,
RA   Calvieri S., Dallapiccola B.;
RT   "Novel and recurrent mutations in the NF1 gene in Italian patients with
RT   neurofibromatosis type 1.";
RL   Hum. Mutat. 23:629-629(2004).
RN   [70]
RP   VARIANTS NF1 ARG-31; PRO-145; ARG-324; VAL-337; CYS-489; PRO-532; ARG-574;
RP   ARG-629; PHE-665; PHE-844; PRO-844; MET-991 DEL; VAL-1073; ARG-1196;
RP   GLY-1276; GLN-1276; GLU-1430; GLU-1459 DEL AND GLY-1489, AND VARIANTS
RP   GLU-176 AND CYS-873.
RX   PubMed=15060124; DOI=10.1136/jmg.2003.011890;
RA   Mattocks C., Baralle D., Tarpey P., ffrench-Constant C., Bobrow M.,
RA   Whittaker J.;
RT   "Automated comparative sequence analysis identifies mutations in 89% of NF1
RT   patients and confirms a mutation cluster in exons 11-17 distinct from the
RT   GAP related domain.";
RL   J. Med. Genet. 41:E48-E48(2004).
RN   [71]
RP   VARIANT NF1 PRO-1243.
RX   PubMed=15520408; DOI=10.1136/jmg.2004.021683;
RA   Ferner R.E., Hughes R.A.C., Hall S.M., Upadhyaya M., Johnson M.R.;
RT   "Neurofibromatous neuropathy in neurofibromatosis 1 (NF1).";
RL   J. Med. Genet. 41:837-841(2004).
RN   [72]
RP   VARIANT NF1 ARG-844.
RX   PubMed=15948193; DOI=10.1002/ajmg.a.30813;
RA   Bertola D.R., Pereira A.C., Passetti F., de Oliveira P.S.L., Messiaen L.,
RA   Gelb B.D., Kim C.A., Krieger J.E.;
RT   "Neurofibromatosis-Noonan syndrome: molecular evidence of the concurrence
RT   of both disorders in a patient.";
RL   Am. J. Med. Genet. A 136:242-245(2005).
RN   [73]
RP   VARIANTS NFNS ARG-194; GLU-1444; THR-1451; LEU-1453 AND GLU-1459 DEL.
RX   PubMed=16380919; DOI=10.1086/498454;
RA   De Luca A., Bottillo I., Sarkozy A., Carta C., Neri C., Bellacchio E.,
RA   Schirinzi A., Conti E., Zampino G., Battaglia A., Majore S., Rinaldi M.M.,
RA   Carella M., Marino B., Pizzuti A., Digilio M.C., Tartaglia M.,
RA   Dallapiccola B.;
RT   "NF1 gene mutations represent the major molecular event underlying
RT   neurofibromatosis-Noonan syndrome.";
RL   Am. J. Hum. Genet. 77:1092-1101(2005).
RN   [74]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-1187; LEU-1951 AND ARG-2745.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [75]
RP   VARIANT NF1 MET-991 DEL.
RX   PubMed=17160901; DOI=10.1086/510781;
RA   Upadhyaya M., Huson S.M., Davies M., Thomas N., Chuzhanova N.,
RA   Giovannini S., Evans D.G., Howard E., Kerr B., Griffiths S., Consoli C.,
RA   Side L., Adams D., Pierpont M., Hachen R., Barnicoat A., Li H., Wallace P.,
RA   Van Biervliet J.P., Stevenson D., Viskochil D., Baralle D., Haan E.,
RA   Riccardi V., Turnpenny P., Lazaro C., Messiaen L.;
RT   "An absence of cutaneous neurofibromas associated with a 3-bp inframe
RT   deletion in exon 17 of the NF1 gene (c.2970-2972 delAAT): evidence of a
RT   clinically significant NF1 genotype-phenotype correlation.";
RL   Am. J. Hum. Genet. 80:140-151(2007).
RN   [76]
RP   VARIANT NFNS PHE-1411.
RX   PubMed=19845691; DOI=10.1111/j.1399-0004.2009.01233.x;
RA   Nystrom A.M., Ekvall S., Allanson J., Edeby C., Elinder M., Holmstrom G.,
RA   Bondeson M.L., Anneren G.;
RT   "Noonan syndrome and neurofibromatosis type I in a family with a novel
RT   mutation in NF1.";
RL   Clin. Genet. 76:524-534(2009).
RN   [77]
RP   VARIANT NF1 THR-160.
RX   PubMed=21838856; DOI=10.1186/1897-4287-9-6;
RA   Ponti G., Losi L., Martorana D., Priola M., Boni E., Pollio A., Neri T.M.,
RA   Seidenari S.;
RT   "Clinico-pathological and biomolecular findings in Italian patients with
RT   multiple cutaneous neurofibromas.";
RL   Hered. Cancer Clin. Pract. 9:6-6(2011).
RN   [78]
RP   VARIANTS GLU-176; THR-330; ASP-393; LEU-393; PRO-519; THR-776 AND PHE-1484.
RX   PubMed=22108604; DOI=10.1038/ejhg.2011.207;
RA   Thomas L., Spurlock G., Eudall C., Thomas N.S., Mort M., Hamby S.E.,
RA   Chuzhanova N., Brems H., Legius E., Cooper D.N., Upadhyaya M.;
RT   "Exploring the somatic NF1 mutational spectrum associated with NF1
RT   cutaneous neurofibromas.";
RL   Eur. J. Hum. Genet. 20:411-419(2012).
RN   [79]
RP   VARIANTS NF1 TRP-93; ARG-1048; ARG-1189; ARG-1661 (ISOFORM 1) AND THR-1918
RP   (ISOFORM 1).
RX   PubMed=23758643; DOI=10.1111/ahg.12026;
RA   Nemethova M., Bolcekova A., Ilencikova D., Durovcikova D., Hlinkova K.,
RA   Hlavata A., Kovacs L., Kadasi L., Zatkova A.;
RT   "Thirty-nine novel neurofibromatosis 1 (NF1) gene mutations identified in
RT   Slovak patients.";
RL   Ann. Hum. Genet. 77:364-379(2013).
RN   [80]
RP   VARIANT NF1 PRO-2125.
RX   PubMed=24413922; DOI=10.1007/s00381-013-2352-9;
RA   Ben-Salem S., Al-Shamsi A.M., Ali B.R., Al-Gazali L.;
RT   "The mutational spectrum of the NF1 gene in neurofibromatosis type I
RT   patients from UAE.";
RL   Childs Nerv. Syst. 30:1183-1189(2014).
CC   -!- FUNCTION: Stimulates the GTPase activity of Ras. NF1 shows greater
CC       affinity for Ras GAP, but lower specific activity. May be a regulator
CC       of Ras activity. {ECO:0000269|PubMed:2121371,
CC       ECO:0000269|PubMed:8417346}.
CC   -!- SUBUNIT: Interacts with HTR6 (PubMed:23027611).
CC       {ECO:0000269|PubMed:23027611}.
CC   -!- INTERACTION:
CC       P21359; P05067: APP; NbExp=3; IntAct=EBI-1172917, EBI-77613;
CC       P21359; P01112: HRAS; NbExp=2; IntAct=EBI-1172917, EBI-350145;
CC       P21359; P34741: SDC2; NbExp=4; IntAct=EBI-1172917, EBI-1172957;
CC       P21359; Q7Z699: SPRED1; NbExp=6; IntAct=EBI-1172917, EBI-5235340;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:14988005}. Nucleus,
CC       nucleolus {ECO:0000269|PubMed:14988005}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=6;
CC         Comment=Experimental confirmation may be lacking for some isoforms.;
CC       Name=2; Synonyms=Type II;
CC         IsoId=P21359-1; Sequence=Displayed;
CC       Name=1; Synonyms=Type I;
CC         IsoId=P21359-2; Sequence=VSP_001628;
CC       Name=3;
CC         IsoId=P21359-3; Sequence=VSP_001629, VSP_001630;
CC       Name=4;
CC         IsoId=P21359-4; Sequence=VSP_001631, VSP_001632;
CC       Name=5;
CC         IsoId=P21359-5; Sequence=VSP_043467, VSP_043468;
CC       Name=6;
CC         IsoId=P21359-6; Sequence=VSP_001628, VSP_053587;
CC   -!- TISSUE SPECIFICITY: Detected in brain, peripheral nerve, lung, colon
CC       and muscle. {ECO:0000269|PubMed:8417346}.
CC   -!- DOMAIN: Binds phospholipids via its C-terminal CRAL-TRIO domain. Binds
CC       primarily glycerophospholipids with monounsaturated C18:1 and/or C16:1
CC       fatty acid moieties and a phosphatidylethanolamine or
CC       phosphatidylcholine headgroup. Has lesser affinity for lipids
CC       containing phosphatidylserine and phosphatidylinositol.
CC       {ECO:0000269|PubMed:16397625, ECO:0000269|PubMed:17187824,
CC       ECO:0000269|PubMed:21089070}.
CC   -!- RNA EDITING: Modified_positions=1306 {ECO:0000269|PubMed:11727199,
CC       ECO:0000269|PubMed:8602361}; Note=The stop codon (UGA) at position 1306
CC       is created by RNA editing. Various levels of RNA editing occurs in
CC       peripheral nerve-sheath tumor samples (PNSTs) from patients with NF1.
CC       Preferentially observed in transcripts containing exon 23A.;
CC   -!- DISEASE: Neurofibromatosis 1 (NF1) [MIM:162200]: A disease
CC       characterized by patches of skin pigmentation (cafe-au-lait spots),
CC       Lisch nodules of the iris, tumors in the peripheral nervous system and
CC       fibromatous skin tumors. Individuals with the disorder have increased
CC       susceptibility to the development of benign and malignant tumors.
CC       {ECO:0000269|PubMed:10220149, ECO:0000269|PubMed:10336779,
CC       ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197,
CC       ECO:0000269|PubMed:10980545, ECO:0000269|PubMed:11258625,
CC       ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:11857752,
CC       ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:12552569,
CC       ECO:0000269|PubMed:12746402, ECO:0000269|PubMed:1302608,
CC       ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:15146469,
CC       ECO:0000269|PubMed:15520408, ECO:0000269|PubMed:15523642,
CC       ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:17160901,
CC       ECO:0000269|PubMed:21089070, ECO:0000269|PubMed:2114220,
CC       ECO:0000269|PubMed:21838856, ECO:0000269|PubMed:23758643,
CC       ECO:0000269|PubMed:24413922, ECO:0000269|PubMed:7981679,
CC       ECO:0000269|PubMed:8081387, ECO:0000269|PubMed:8544190,
CC       ECO:0000269|PubMed:8807336, ECO:0000269|PubMed:8834249,
CC       ECO:0000269|PubMed:9003501, ECO:0000269|PubMed:9101300,
CC       ECO:0000269|PubMed:9150739, ECO:0000269|PubMed:9298829,
CC       ECO:0000269|PubMed:9668168}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Leukemia, juvenile myelomonocytic (JMML) [MIM:607785]: An
CC       aggressive pediatric myelodysplastic syndrome/myeloproliferative
CC       disorder characterized by malignant transformation in the hematopoietic
CC       stem cell compartment with proliferation of differentiated progeny.
CC       Patients have splenomegaly, enlarged lymph nodes, rashes, and
CC       hemorrhages. Note=The disease is caused by mutations affecting the gene
CC       represented in this entry.
CC   -!- DISEASE: Watson syndrome (WTSN) [MIM:193520]: A syndrome characterized
CC       by the presence of pulmonary stenosis, cafe-au-lait spots, and mental
CC       retardation. It is considered as an atypical form of neurofibromatosis.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Familial spinal neurofibromatosis (FSNF) [MIM:162210]:
CC       Considered to be an alternative form of neurofibromatosis, showing
CC       multiple spinal tumors. {ECO:0000269|PubMed:11704931}. Note=The disease
CC       is caused by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Neurofibromatosis-Noonan syndrome (NFNS) [MIM:601321]:
CC       Characterized by manifestations of both NF1 and Noonan syndrome (NS).
CC       NS is a disorder characterized by dysmorphic facial features, short
CC       stature, hypertelorism, cardiac anomalies, deafness, motor delay, and a
CC       bleeding diathesis. {ECO:0000269|PubMed:12707950,
CC       ECO:0000269|PubMed:16380919, ECO:0000269|PubMed:19845691}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Colorectal cancer (CRC) [MIM:114500]: A complex disease
CC       characterized by malignant lesions arising from the inner wall of the
CC       large intestine (the colon) and the rectum. Genetic alterations are
CC       often associated with progression from premalignant lesion (adenoma) to
CC       invasive adenocarcinoma. Risk factors for cancer of the colon and
CC       rectum include colon polyps, long-standing ulcerative colitis, and
CC       genetic family history. Note=The gene represented in this entry may be
CC       involved in disease pathogenesis.
CC   -!- CAUTION: Was originally thought to be associated with LEOPARD (LS), an
CC       autosomal dominant syndrome. {ECO:0000305|PubMed:8807336}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA59923.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/NF1ID134.html";
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/nf1/";
CC   -!- WEB RESOURCE: Name=Mendelian genes neurofibromin 1 (NF1); Note=Leiden
CC       Open Variation Database (LOVD);
CC       URL="http://www.lovd.nl/NF1";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M89914; AAA59925.1; -; mRNA.
DR   EMBL; M82814; AAA59924.1; -; mRNA.
DR   EMBL; M60496; AAA59928.1; -; mRNA.
DR   EMBL; D12625; BAA02150.1; -; mRNA.
DR   EMBL; M38106; AAA74897.1; -; mRNA.
DR   EMBL; M38107; AAB59558.1; -; mRNA.
DR   EMBL; D42072; BAA07669.1; -; mRNA.
DR   EMBL; AY796305; AAV50004.1; -; Genomic_DNA.
DR   EMBL; AC004222; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079915; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC134669; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC135724; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC138207; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC139072; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471147; EAW80272.1; -; Genomic_DNA.
DR   EMBL; CH471147; EAW80275.1; -; Genomic_DNA.
DR   EMBL; AH000834; AAA18483.1; -; Genomic_DNA.
DR   EMBL; Y07853; CAA69179.1; -; Genomic_DNA.
DR   EMBL; U17690; AAB48380.1; -; Genomic_DNA.
DR   EMBL; U17680; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17681; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17682; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17683; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17684; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17685; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17686; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17687; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17688; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17689; AAB48380.1; JOINED; Genomic_DNA.
DR   EMBL; U17690; AAB48379.1; -; Genomic_DNA.
DR   EMBL; U17680; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17681; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17682; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17683; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17684; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17685; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17687; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17688; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17689; AAB48379.1; JOINED; Genomic_DNA.
DR   EMBL; U17656; AAB48373.1; -; Genomic_DNA.
DR   EMBL; U17659; AAB48374.1; -; Genomic_DNA.
DR   EMBL; U17662; AAB48375.1; -; Genomic_DNA.
DR   EMBL; U17668; AAB48376.1; -; Genomic_DNA.
DR   EMBL; U17667; AAB48376.1; JOINED; Genomic_DNA.
DR   EMBL; U17673; AAB48377.1; -; Genomic_DNA.
DR   EMBL; U17677; AAB48378.1; -; Genomic_DNA.
DR   EMBL; U17676; AAB48378.1; JOINED; Genomic_DNA.
DR   EMBL; M60915; AAA59921.1; -; mRNA.
DR   EMBL; M60915; AAA59922.1; -; mRNA.
DR   EMBL; M61213; AAA59923.1; ALT_INIT; mRNA.
DR   EMBL; S51751; AAB24636.1; -; mRNA.
DR   EMBL; D10490; BAA01371.1; -; mRNA.
DR   CCDS; CCDS11264.1; -. [P21359-2]
DR   CCDS; CCDS42292.1; -. [P21359-1]
DR   CCDS; CCDS45645.1; -. [P21359-5]
DR   PIR; B55282; B55282.
DR   PIR; I78852; I78852.
DR   RefSeq; NP_000258.1; NM_000267.3. [P21359-2]
DR   RefSeq; NP_001035957.1; NM_001042492.2. [P21359-1]
DR   RefSeq; NP_001121619.1; NM_001128147.2. [P21359-5]
DR   PDB; 1NF1; X-ray; 2.50 A; A=1198-1551.
DR   PDB; 2D4Q; X-ray; 2.30 A; A/B=1581-1837.
DR   PDB; 2E2X; X-ray; 2.50 A; A/B=1566-1837.
DR   PDB; 3P7Z; X-ray; 2.65 A; A/B=1566-1837.
DR   PDB; 3PEG; X-ray; 2.52 A; A=1566-1837.
DR   PDB; 3PG7; X-ray; 2.19 A; A/B=1581-1837.
DR   PDB; 6OB2; X-ray; 2.85 A; B/D=1209-1484.
DR   PDB; 6OB3; X-ray; 2.10 A; B/D=1209-1484.
DR   PDBsum; 1NF1; -.
DR   PDBsum; 2D4Q; -.
DR   PDBsum; 2E2X; -.
DR   PDBsum; 3P7Z; -.
DR   PDBsum; 3PEG; -.
DR   PDBsum; 3PG7; -.
DR   PDBsum; 6OB2; -.
DR   PDBsum; 6OB3; -.
DR   SMR; P21359; -.
DR   BioGrid; 110836; 120.
DR   IntAct; P21359; 30.
DR   MINT; P21359; -.
DR   STRING; 9606.ENSP00000351015; -.
DR   iPTMnet; P21359; -.
DR   PhosphoSitePlus; P21359; -.
DR   BioMuta; NF1; -.
DR   DMDM; 548350; -.
DR   EPD; P21359; -.
DR   jPOST; P21359; -.
DR   MassIVE; P21359; -.
DR   MaxQB; P21359; -.
DR   PaxDb; P21359; -.
DR   PeptideAtlas; P21359; -.
DR   PRIDE; P21359; -.
DR   ProteomicsDB; 53861; -. [P21359-1]
DR   ProteomicsDB; 53862; -. [P21359-2]
DR   ProteomicsDB; 53863; -. [P21359-3]
DR   ProteomicsDB; 53864; -. [P21359-4]
DR   ProteomicsDB; 53865; -. [P21359-5]
DR   Antibodypedia; 3471; 453 antibodies.
DR   Ensembl; ENST00000356175; ENSP00000348498; ENSG00000196712. [P21359-2]
DR   Ensembl; ENST00000358273; ENSP00000351015; ENSG00000196712. [P21359-1]
DR   Ensembl; ENST00000431387; ENSP00000412921; ENSG00000196712. [P21359-5]
DR   Ensembl; ENST00000487476; ENSP00000491589; ENSG00000196712. [P21359-3]
DR   GeneID; 4763; -.
DR   KEGG; hsa:4763; -.
DR   UCSC; uc002hgf.3; human. [P21359-1]
DR   CTD; 4763; -.
DR   DisGeNET; 4763; -.
DR   GeneCards; NF1; -.
DR   GeneReviews; NF1; -.
DR   HGNC; HGNC:7765; NF1.
DR   HPA; ENSG00000196712; Low tissue specificity.
DR   MalaCards; NF1; -.
DR   MIM; 114500; phenotype.
DR   MIM; 162200; phenotype.
DR   MIM; 162210; phenotype.
DR   MIM; 193520; phenotype.
DR   MIM; 601321; phenotype.
DR   MIM; 607785; phenotype.
DR   MIM; 613113; gene.
DR   neXtProt; NX_P21359; -.
DR   OpenTargets; ENSG00000196712; -.
DR   Orphanet; 97685; 17q11 microdeletion syndrome.
DR   Orphanet; 139474; 17q11.2 microduplication syndrome.
DR   Orphanet; 86834; Juvenile myelomonocytic leukemia.
DR   Orphanet; 363700; Neurofibromatosis type 1 due to NF1 mutation or intragenic deletion.
DR   Orphanet; 638; Neurofibromatosis-Noonan syndrome.
DR   PharmGKB; PA31572; -.
DR   eggNOG; KOG1826; Eukaryota.
DR   eggNOG; ENOG410XRPJ; LUCA.
DR   GeneTree; ENSGT00550000074797; -.
DR   HOGENOM; CLU_036305_0_0_1; -.
DR   InParanoid; P21359; -.
DR   KO; K08052; -.
DR   OMA; VITRMCR; -.
DR   OrthoDB; 9686at2759; -.
DR   PhylomeDB; P21359; -.
DR   TreeFam; TF300302; -.
DR   Reactome; R-HSA-5658442; Regulation of RAS by GAPs.
DR   Reactome; R-HSA-6802953; RAS signaling downstream of NF1 loss-of-function variants.
DR   SignaLink; P21359; -.
DR   SIGNOR; P21359; -.
DR   ChiTaRS; NF1; human.
DR   EvolutionaryTrace; P21359; -.
DR   GeneWiki; Neurofibromin_1; -.
DR   GenomeRNAi; 4763; -.
DR   Pharos; P21359; Tbio.
DR   PRO; PR:P21359; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P21359; protein.
DR   Bgee; ENSG00000196712; Expressed in kidney and 223 other tissues.
DR   ExpressionAtlas; P21359; baseline and differential.
DR   Genevisible; P21359; HS.
DR   GO; GO:0030424; C:axon; IDA:HGNC-UCL.
DR   GO; GO:0005737; C:cytoplasm; ISS:HGNC-UCL.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0030425; C:dendrite; IDA:HGNC-UCL.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; ISS:HGNC-UCL.
DR   GO; GO:0098793; C:presynapse; IEA:GOC.
DR   GO; GO:0005096; F:GTPase activator activity; IDA:UniProtKB.
DR   GO; GO:0031210; F:phosphatidylcholine binding; IDA:UniProtKB.
DR   GO; GO:0008429; F:phosphatidylethanolamine binding; IDA:UniProtKB.
DR   GO; GO:0030036; P:actin cytoskeleton organization; ISS:HGNC-UCL.
DR   GO; GO:0030325; P:adrenal gland development; ISS:HGNC-UCL.
DR   GO; GO:0021764; P:amygdala development; IEA:Ensembl.
DR   GO; GO:0048844; P:artery morphogenesis; ISS:HGNC-UCL.
DR   GO; GO:0007420; P:brain development; ISS:HGNC-UCL.
DR   GO; GO:0048593; P:camera-type eye morphogenesis; ISS:HGNC-UCL.
DR   GO; GO:0007154; P:cell communication; ISS:HGNC-UCL.
DR   GO; GO:0034605; P:cellular response to heat; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; ISS:HGNC-UCL.
DR   GO; GO:0050890; P:cognition; IMP:HGNC-UCL.
DR   GO; GO:0030199; P:collagen fibril organization; ISS:HGNC-UCL.
DR   GO; GO:0030198; P:extracellular matrix organization; ISS:HGNC-UCL.
DR   GO; GO:0008625; P:extrinsic apoptotic signaling pathway via death domain receptors; IEA:Ensembl.
DR   GO; GO:0021897; P:forebrain astrocyte development; ISS:HGNC-UCL.
DR   GO; GO:0048853; P:forebrain morphogenesis; ISS:HGNC-UCL.
DR   GO; GO:0061534; P:gamma-aminobutyric acid secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:0061535; P:glutamate secretion, neurotransmission; IEA:Ensembl.
DR   GO; GO:0048820; P:hair follicle maturation; IEA:Ensembl.
DR   GO; GO:0007507; P:heart development; ISS:HGNC-UCL.
DR   GO; GO:0001889; P:liver development; ISS:HGNC-UCL.
DR   GO; GO:0000165; P:MAPK cascade; ISS:HGNC-UCL.
DR   GO; GO:0001656; P:metanephros development; ISS:HGNC-UCL.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; ISS:HGNC-UCL.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IEA:Ensembl.
DR   GO; GO:0048712; P:negative regulation of astrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0030336; P:negative regulation of cell migration; IMP:MGI.
DR   GO; GO:0001953; P:negative regulation of cell-matrix adhesion; IEA:Ensembl.
DR   GO; GO:0001937; P:negative regulation of endothelial cell proliferation; IMP:HGNC-UCL.
DR   GO; GO:0048147; P:negative regulation of fibroblast proliferation; ISS:UniProtKB.
DR   GO; GO:0043407; P:negative regulation of MAP kinase activity; ISS:HGNC-UCL.
DR   GO; GO:0043409; P:negative regulation of MAPK cascade; IMP:MGI.
DR   GO; GO:0007406; P:negative regulation of neuroblast proliferation; ISS:HGNC-UCL.
DR   GO; GO:0046929; P:negative regulation of neurotransmitter secretion; IEA:Ensembl.
DR   GO; GO:0048715; P:negative regulation of oligodendrocyte differentiation; ISS:HGNC-UCL.
DR   GO; GO:0045671; P:negative regulation of osteoclast differentiation; IEA:Ensembl.
DR   GO; GO:0042308; P:negative regulation of protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0006469; P:negative regulation of protein kinase activity; ISS:HGNC-UCL.
DR   GO; GO:0035021; P:negative regulation of Rac protein signal transduction; IEA:Ensembl.
DR   GO; GO:0021915; P:neural tube development; IEA:Ensembl.
DR   GO; GO:0098597; P:observational learning; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; ISS:HGNC-UCL.
DR   GO; GO:0007422; P:peripheral nervous system development; ISS:HGNC-UCL.
DR   GO; GO:0014065; P:phosphatidylinositol 3-kinase signaling; ISS:HGNC-UCL.
DR   GO; GO:0043473; P:pigmentation; ISS:HGNC-UCL.
DR   GO; GO:0045762; P:positive regulation of adenylate cyclase activity; ISS:HGNC-UCL.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; ISS:HGNC-UCL.
DR   GO; GO:0001938; P:positive regulation of endothelial cell proliferation; IEA:Ensembl.
DR   GO; GO:2001241; P:positive regulation of extrinsic apoptotic signaling pathway in absence of ligand; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IDA:UniProtKB.
DR   GO; GO:0043525; P:positive regulation of neuron apoptotic process; ISS:HGNC-UCL.
DR   GO; GO:0007265; P:Ras protein signal transduction; ISS:HGNC-UCL.
DR   GO; GO:0045765; P:regulation of angiogenesis; IMP:HGNC-UCL.
DR   GO; GO:0043535; P:regulation of blood vessel endothelial cell migration; IMP:HGNC-UCL.
DR   GO; GO:0045124; P:regulation of bone resorption; ISS:HGNC-UCL.
DR   GO; GO:0001952; P:regulation of cell-matrix adhesion; ISS:HGNC-UCL.
DR   GO; GO:0010468; P:regulation of gene expression; IEA:Ensembl.
DR   GO; GO:0045685; P:regulation of glial cell differentiation; ISS:HGNC-UCL.
DR   GO; GO:0043087; P:regulation of GTPase activity; IMP:HGNC-UCL.
DR   GO; GO:0048169; P:regulation of long-term neuronal synaptic plasticity; IEA:Ensembl.
DR   GO; GO:1900271; P:regulation of long-term synaptic potentiation; IEA:Ensembl.
DR   GO; GO:0032228; P:regulation of synaptic transmission, GABAergic; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; ISS:HGNC-UCL.
DR   GO; GO:0014044; P:Schwann cell development; ISS:HGNC-UCL.
DR   GO; GO:0007519; P:skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0048745; P:smooth muscle tissue development; ISS:HGNC-UCL.
DR   GO; GO:0021510; P:spinal cord development; ISS:HGNC-UCL.
DR   GO; GO:0048485; P:sympathetic nervous system development; ISS:HGNC-UCL.
DR   GO; GO:0008542; P:visual learning; ISS:HGNC-UCL.
DR   GO; GO:0042060; P:wound healing; ISS:HGNC-UCL.
DR   CDD; cd00170; SEC14; 1.
DR   Gene3D; 2.30.29.30; -; 1.
DR   Gene3D; 3.40.525.10; -; 1.
DR   InterPro; IPR016024; ARM-type_fold.
DR   InterPro; IPR001251; CRAL-TRIO_dom.
DR   InterPro; IPR036865; CRAL-TRIO_dom_sf.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR039360; Ras_GTPase.
DR   InterPro; IPR023152; RasGAP_CS.
DR   InterPro; IPR001936; RasGAP_dom.
DR   InterPro; IPR008936; Rho_GTPase_activation_prot.
DR   PANTHER; PTHR10194; PTHR10194; 1.
DR   Pfam; PF13716; CRAL_TRIO_2; 1.
DR   Pfam; PF00616; RasGAP; 1.
DR   SMART; SM00323; RasGAP; 1.
DR   SMART; SM00516; SEC14; 1.
DR   SUPFAM; SSF48350; SSF48350; 1.
DR   SUPFAM; SSF48371; SSF48371; 1.
DR   PROSITE; PS50191; CRAL_TRIO; 1.
DR   PROSITE; PS00509; RAS_GTPASE_ACTIV_1; 1.
DR   PROSITE; PS50018; RAS_GTPASE_ACTIV_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Disease mutation;
KW   GTPase activation; Lipid-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; RNA editing; Tumor suppressor.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P97526"
FT   CHAIN           2..2839
FT                   /note="Neurofibromin"
FT                   /id="PRO_0000010773"
FT   CHAIN           2..1305
FT                   /note="Neurofibromin truncated"
FT                   /id="PRO_0000010774"
FT   DOMAIN          1235..1451
FT                   /note="Ras-GAP"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00167"
FT   DOMAIN          1580..1738
FT                   /note="CRAL-TRIO"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00056"
FT   REGION          1580..1837
FT                   /note="Lipid binding"
FT   MOTIF           2555..2571
FT                   /note="Bipartite nuclear localization signal"
FT   COMPBIAS        1352..1355
FT                   /note="Poly-Ser"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000250|UniProtKB:P97526"
FT   MOD_RES         864
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         876
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         2188
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         2467
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04690"
FT   MOD_RES         2514
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q04690"
FT   MOD_RES         2515
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         2521
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         2523
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2543
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         2565
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2597
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2802
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2817
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   VAR_SEQ         548..551
FT                   /note="ALLV -> VRGK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1339276"
FT                   /id="VSP_001629"
FT   VAR_SEQ         552..2839
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:1339276"
FT                   /id="VSP_001630"
FT   VAR_SEQ         574..593
FT                   /note="SSQMLFYICKKLTSHQMLSS -> RYMYFYFLNSTFKFYFVFLS (in
FT                   isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7570581"
FT                   /id="VSP_043467"
FT   VAR_SEQ         594..2839
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:7570581"
FT                   /id="VSP_043468"
FT   VAR_SEQ         1371..1391
FT                   /note="Missing (in isoform 1 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:1457041,
FT                   ECO:0000303|PubMed:1783401, ECO:0000303|PubMed:1923522,
FT                   ECO:0000303|PubMed:2114220, ECO:0000303|PubMed:2116237,
FT                   ECO:0000303|PubMed:2134734"
FT                   /id="VSP_001628"
FT   VAR_SEQ         1591..1598
FT                   /note="SIFYQAGT -> TPPPEPET (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:2121370"
FT                   /id="VSP_001631"
FT   VAR_SEQ         1599..2839
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:2121370"
FT                   /id="VSP_001632"
FT   VAR_SEQ         2792
FT                   /note="P -> PASLPCSNSAVFMQLFPHQ (in isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:2116237"
FT                   /id="VSP_053587"
FT   VARIANT         31
FT                   /note="H -> R (in NF1; dbSNP:rs199474725)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032459"
FT   VARIANT         74
FT                   /note="A -> D (in mismatch repair deficient cancer cells;
FT                   dbSNP:rs199474726)"
FT                   /evidence="ECO:0000269|PubMed:12522551"
FT                   /id="VAR_017550"
FT   VARIANT         80
FT                   /note="Y -> C (in dbSNP:rs4795581)"
FT                   /evidence="ECO:0000269|Ref.7"
FT                   /id="VAR_022254"
FT   VARIANT         80
FT                   /note="Y -> S (in dbSNP:rs4795581)"
FT                   /id="VAR_049135"
FT   VARIANT         82
FT                   /note="S -> F (in NF1; dbSNP:rs199474729)"
FT                   /evidence="ECO:0000269|PubMed:11857752"
FT                   /id="VAR_021730"
FT   VARIANT         93
FT                   /note="C -> W (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:23758643"
FT                   /id="VAR_071668"
FT   VARIANT         93
FT                   /note="C -> Y (in NF1; dbSNP:rs199474728)"
FT                   /evidence="ECO:0000269|PubMed:12522551"
FT                   /id="VAR_017551"
FT   VARIANT         117
FT                   /note="I -> S (in NF1; dbSNP:rs199474731)"
FT                   /evidence="ECO:0000269|PubMed:10607834"
FT                   /id="VAR_010989"
FT   VARIANT         145
FT                   /note="L -> P (in NF1; dbSNP:rs199474734)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032460"
FT   VARIANT         157
FT                   /note="I -> N (in NF1; dbSNP:rs199474744)"
FT                   /evidence="ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021731"
FT   VARIANT         160
FT                   /note="R -> T (in NF1; dbSNP:rs199474752)"
FT                   /evidence="ECO:0000269|PubMed:21838856"
FT                   /id="VAR_065888"
FT   VARIANT         176
FT                   /note="D -> E (found in mismatch repair deficient cancer
FT                   cells; also found in a cutaneous neurofibroma from a
FT                   patient with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs112306990)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:15060124,
FT                   ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:22108604"
FT                   /id="VAR_017552"
FT   VARIANT         186
FT                   /note="D -> V (in NF1; reduced splicing enhancement)"
FT                   /evidence="ECO:0000269|PubMed:15523642"
FT                   /id="VAR_032461"
FT   VARIANT         194
FT                   /note="L -> R (in NFNS; dbSNP:rs199474753)"
FT                   /evidence="ECO:0000269|PubMed:16380919"
FT                   /id="VAR_032462"
FT   VARIANT         216
FT                   /note="L -> P (in NF1; dbSNP:rs199474756)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021732"
FT   VARIANT         324
FT                   /note="C -> R (in NF1; dbSNP:rs199474735)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032463"
FT   VARIANT         330
FT                   /note="A -> T (in a cutaneous neurofibroma from a patient
FT                   with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs199474767)"
FT                   /evidence="ECO:0000269|PubMed:22108604"
FT                   /id="VAR_067201"
FT   VARIANT         337
FT                   /note="E -> V (in NF1; dbSNP:rs199474736)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032464"
FT   VARIANT         338
FT                   /note="D -> G (in NF1; dbSNP:rs199474773)"
FT                   /evidence="ECO:0000269|PubMed:9298829"
FT                   /id="VAR_010990"
FT   VARIANT         357
FT                   /note="L -> P (in NF1; dbSNP:rs137854563)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021733"
FT   VARIANT         393
FT                   /note="H -> D (in a cutaneous neurofibroma from a patient
FT                   with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs199474768)"
FT                   /evidence="ECO:0000269|PubMed:22108604"
FT                   /id="VAR_067202"
FT   VARIANT         393
FT                   /note="H -> L (in a cutaneous neurofibroma from a patient
FT                   with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs199474769)"
FT                   /evidence="ECO:0000269|PubMed:22108604"
FT                   /id="VAR_067203"
FT   VARIANT         489
FT                   /note="Y -> C (in NF1; dbSNP:rs137854557)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032465"
FT   VARIANT         491
FT                   /note="Y -> C (in NF1; dbSNP:rs199474757)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021734"
FT   VARIANT         508
FT                   /note="L -> P (in NF1; dbSNP:rs137854558)"
FT                   /evidence="ECO:0000269|PubMed:11258625"
FT                   /id="VAR_010991"
FT   VARIANT         519
FT                   /note="Q -> P (in a cutaneous neurofibroma from a patient
FT                   with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs199474770)"
FT                   /evidence="ECO:0000269|PubMed:22108604"
FT                   /id="VAR_067204"
FT   VARIANT         532
FT                   /note="L -> P (in NF1; dbSNP:rs199474737)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032466"
FT   VARIANT         549
FT                   /note="L -> P (in NF1; dbSNP:rs199474758)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021735"
FT   VARIANT         574
FT                   /note="S -> R (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032467"
FT   VARIANT         578
FT                   /note="L -> R (in NF1; dbSNP:rs199474774)"
FT                   /evidence="ECO:0000269|PubMed:12746402"
FT                   /id="VAR_021736"
FT   VARIANT         581
FT                   /note="I -> T (in NF1; dbSNP:rs199474759)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021737"
FT   VARIANT         583
FT                   /note="K -> R (in NF1; dbSNP:rs199474760)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021738"
FT   VARIANT         604
FT                   /note="L -> V (in NF1; dbSNP:rs142712751)"
FT                   /evidence="ECO:0000269|PubMed:12522551"
FT                   /id="VAR_017553"
FT   VARIANT         629
FT                   /note="G -> R (in NF1; affects splicing by creating a novel
FT                   splice acceptor site; dbSNP:rs199474738)"
FT                   /evidence="ECO:0000269|PubMed:15060124,
FT                   ECO:0000269|PubMed:15146469, ECO:0000269|PubMed:8834249"
FT                   /id="VAR_002653"
FT   VARIANT         665
FT                   /note="S -> F (in NF1; unknown pathological significance;
FT                   dbSNP:rs145891889)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:15060124"
FT                   /id="VAR_021739"
FT   VARIANT         678
FT                   /note="P -> L (in dbSNP:rs17881753)"
FT                   /evidence="ECO:0000269|Ref.7"
FT                   /id="VAR_022255"
FT   VARIANT         695
FT                   /note="L -> P (in NF1; dbSNP:rs199474761)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021740"
FT   VARIANT         712
FT                   /note="H -> R (in mismatch repair deficient cancer cells;
FT                   dbSNP:rs199474727)"
FT                   /evidence="ECO:0000269|PubMed:12522551"
FT                   /id="VAR_017554"
FT   VARIANT         763
FT                   /note="L -> P (in NF1; dbSNP:rs199474762)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021741"
FT   VARIANT         765
FT                   /note="R -> H (in NF1; unknown pathological significance;
FT                   dbSNP:rs199474777)"
FT                   /evidence="ECO:0000269|PubMed:10336779"
FT                   /id="VAR_021742"
FT   VARIANT         776
FT                   /note="A -> T (in a cutaneous neurofibroma from a patient
FT                   with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs199474771)"
FT                   /evidence="ECO:0000269|PubMed:22108604"
FT                   /id="VAR_067205"
FT   VARIANT         777
FT                   /note="W -> S (in NF1; dbSNP:rs199474745)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021743"
FT   VARIANT         780
FT                   /note="T -> K (in NF1; dbSNP:rs199474746)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:11735023, ECO:0000269|PubMed:12552569,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021744"
FT   VARIANT         781
FT                   /note="H -> P (in NF1; dbSNP:rs199474763)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021745"
FT   VARIANT         784
FT                   /note="W -> C (in NF1; dbSNP:rs199474778)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021746"
FT   VARIANT         784
FT                   /note="W -> R (in NF1; dbSNP:rs199474730)"
FT                   /evidence="ECO:0000269|PubMed:11857752,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021747"
FT   VARIANT         844
FT                   /note="L -> F (in NF1; dbSNP:rs199474785)"
FT                   /evidence="ECO:0000269|PubMed:10980545,
FT                   ECO:0000269|PubMed:15060124"
FT                   /id="VAR_010992"
FT   VARIANT         844
FT                   /note="L -> P (in NF1; dbSNP:rs137854566)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032468"
FT   VARIANT         844
FT                   /note="L -> R (in NF1; sporadic; dbSNP:rs137854566)"
FT                   /evidence="ECO:0000269|PubMed:12522551,
FT                   ECO:0000269|PubMed:15948193, ECO:0000269|PubMed:9150739"
FT                   /id="VAR_002654"
FT   VARIANT         847
FT                   /note="L -> P (in NF1; dbSNP:rs199474747)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:12552569, ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021748"
FT   VARIANT         848
FT                   /note="G -> E (in NF1; dbSNP:rs199474748)"
FT                   /evidence="ECO:0000269|PubMed:12552569,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021749"
FT   VARIANT         873
FT                   /note="R -> C (in dbSNP:rs199474739)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032469"
FT   VARIANT         898
FT                   /note="L -> P (in NF1; sporadic; dbSNP:rs199474786)"
FT                   /evidence="ECO:0000269|PubMed:12522551,
FT                   ECO:0000269|PubMed:9150739"
FT                   /id="VAR_002655"
FT   VARIANT         920
FT                   /note="L -> P (in NF1; patient with cafe-au-lait spots; may
FT                   be a distinct form of NF1; dbSNP:rs199474775)"
FT                   /evidence="ECO:0000269|PubMed:12746402"
FT                   /id="VAR_021750"
FT   VARIANT         968
FT                   /note="M -> R (in NF1; dbSNP:rs199474749)"
FT                   /evidence="ECO:0000269|PubMed:12552569,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021751"
FT   VARIANT         991
FT                   /note="Missing (in NF1; most patients carrying the mutation
FT                   do not manifest cutaneous neurofibromas)"
FT                   /evidence="ECO:0000269|PubMed:15060124,
FT                   ECO:0000269|PubMed:17160901, ECO:0000269|PubMed:7904209"
FT                   /id="VAR_002656"
FT   VARIANT         1035
FT                   /note="M -> R (in NF1; dbSNP:rs137854553)"
FT                   /evidence="ECO:0000269|PubMed:8807336"
FT                   /id="VAR_002657"
FT   VARIANT         1048
FT                   /note="W -> R (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:23758643"
FT                   /id="VAR_071669"
FT   VARIANT         1073
FT                   /note="M -> V (in NF1; dbSNP:rs199474740)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032470"
FT   VARIANT         1147
FT                   /note="L -> P (in NF1; dbSNP:rs199474779)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021752"
FT   VARIANT         1156
FT                   /note="N -> S (in NF1; dbSNP:rs199474764)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021753"
FT   VARIANT         1166
FT                   /note="G -> D (in NF1; dbSNP:rs199474787)"
FT                   /evidence="ECO:0000269|PubMed:7981679"
FT                   /id="VAR_010993"
FT   VARIANT         1187
FT                   /note="L -> I (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035543"
FT   VARIANT         1189
FT                   /note="Q -> R (in NF1; dbSNP:rs752039618)"
FT                   /evidence="ECO:0000269|PubMed:23758643"
FT                   /id="VAR_071670"
FT   VARIANT         1193
FT                   /note="F -> C (in NF1; dbSNP:rs199474780)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021754"
FT   VARIANT         1196
FT                   /note="L -> R (in NF1; dbSNP:rs199474741)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032471"
FT   VARIANT         1204
FT                   /note="R -> G (in NF1; dbSNP:rs199474732)"
FT                   /evidence="ECO:0000269|PubMed:10336779"
FT                   /id="VAR_021755"
FT   VARIANT         1204
FT                   /note="R -> W (in NF1; dbSNP:rs199474732)"
FT                   /evidence="ECO:0000269|PubMed:10607834"
FT                   /id="VAR_010994"
FT   VARIANT         1243
FT                   /note="L -> P (in NF1; with neurofibromatous neuropathy;
FT                   dbSNP:rs137854564)"
FT                   /evidence="ECO:0000269|PubMed:15520408"
FT                   /id="VAR_032472"
FT   VARIANT         1250
FT                   /note="R -> P (in NF1; dbSNP:rs199474765)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021756"
FT   VARIANT         1276
FT                   /note="R -> G (in NF1; dbSNP:rs199474742)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032473"
FT   VARIANT         1276
FT                   /note="R -> P (in NF1; complete loss of GAP activity;
FT                   dbSNP:rs137854556)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:9668168"
FT                   /id="VAR_010995"
FT   VARIANT         1276
FT                   /note="R -> Q (in NF1 and mismatch repair deficient cancer
FT                   cells; dbSNP:rs137854556)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:12522551, ECO:0000269|PubMed:15060124"
FT                   /id="VAR_017555"
FT   VARIANT         1411
FT                   /note="L -> F (in NFNS; dbSNP:rs199474789)"
FT                   /evidence="ECO:0000269|PubMed:19845691"
FT                   /id="VAR_065236"
FT   VARIANT         1412
FT                   /note="R -> S (in NF1; significant reduction of GAP
FT                   activity; dbSNP:rs137854554)"
FT                   /evidence="ECO:0000269|PubMed:9003501"
FT                   /id="VAR_010996"
FT   VARIANT         1422
FT                   /note="Y -> H (in dbSNP:rs17884349)"
FT                   /evidence="ECO:0000269|Ref.7"
FT                   /id="VAR_022256"
FT   VARIANT         1430
FT                   /note="K -> E (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:15060124"
FT                   /id="VAR_032474"
FT   VARIANT         1440
FT                   /note="K -> Q (in NF1; dbSNP:rs199474790)"
FT                   /evidence="ECO:0000269|PubMed:9003501"
FT                   /id="VAR_010997"
FT   VARIANT         1440
FT                   /note="K -> R (in NF1; dbSNP:rs199474788)"
FT                   /evidence="ECO:0000269|PubMed:7981679"
FT                   /id="VAR_002658"
FT   VARIANT         1444
FT                   /note="K -> E (in NF1 and NFNS; significant reduction of
FT                   intrinsic GAP activity; dbSNP:rs137854550)"
FT                   /evidence="ECO:0000269|PubMed:11857752,
FT                   ECO:0000269|PubMed:1568247, ECO:0000269|PubMed:16380919,
FT                   ECO:0000269|PubMed:9003501"
FT                   /id="VAR_002659"
FT   VARIANT         1444
FT                   /note="K -> N (in NF1; dbSNP:rs199474750)"
FT                   /evidence="ECO:0000269|PubMed:12552569,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021757"
FT   VARIANT         1444
FT                   /note="K -> R (in NF1; dbSNP:rs199474781)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021758"
FT   VARIANT         1446
FT                   /note="L -> P (in NF1; dbSNP:rs199474733)"
FT                   /evidence="ECO:0000269|PubMed:10220149,
FT                   ECO:0000269|PubMed:10607834, ECO:0000269|PubMed:10712197"
FT                   /id="VAR_008129"
FT   VARIANT         1451
FT                   /note="N -> T (in NFNS; dbSNP:rs199474754)"
FT                   /evidence="ECO:0000269|PubMed:16380919"
FT                   /id="VAR_032475"
FT   VARIANT         1453
FT                   /note="V -> L (in NFNS; dbSNP:rs199474755)"
FT                   /evidence="ECO:0000269|PubMed:16380919"
FT                   /id="VAR_032476"
FT   VARIANT         1459
FT                   /note="Missing (in NFNS)"
FT                   /evidence="ECO:0000269|PubMed:12707950,
FT                   ECO:0000269|PubMed:15060124, ECO:0000269|PubMed:16380919"
FT                   /id="VAR_032477"
FT   VARIANT         1484
FT                   /note="S -> F (in a cutaneous neurofibroma from a patient
FT                   with neurofibromatosis; somatic mutation;
FT                   dbSNP:rs199474772)"
FT                   /evidence="ECO:0000269|PubMed:22108604"
FT                   /id="VAR_067206"
FT   VARIANT         1489
FT                   /note="S -> G (in NF1; dbSNP:rs199474743)"
FT                   /evidence="ECO:0000269|PubMed:15060124,
FT                   ECO:0000269|PubMed:9003501"
FT                   /id="VAR_010998"
FT   VARIANT         1605
FT                   /note="I -> V (in NF1; reduces protein stability;
FT                   dbSNP:rs199474766)"
FT                   /evidence="ECO:0000269|PubMed:10712197,
FT                   ECO:0000269|PubMed:21089070"
FT                   /id="VAR_021759"
FT   VARIANT         1611
FT                   /note="R -> W (in NF1; dbSNP:rs1060500316)"
FT                   /evidence="ECO:0000269|PubMed:9298829"
FT                   /id="VAR_002660"
FT   VARIANT         1733
FT                   /note="L -> LGHEQQKLPAATLAL (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:8317503"
FT                   /id="VAR_002661"
FT   VARIANT         1785
FT                   /note="A -> S (in NF1; dbSNP:rs199474782)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021760"
FT   VARIANT         1951
FT                   /note="P -> L (in a colorectal cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035544"
FT   VARIANT         1952
FT                   /note="W -> R (in NF1; dbSNP:rs199474791)"
FT                   /evidence="ECO:0000269|PubMed:9101300"
FT                   /id="VAR_002662"
FT   VARIANT         1953
FT                   /note="L -> P (in NF1; dbSNP:rs199474792)"
FT                   /evidence="ECO:0000269|PubMed:2114220"
FT                   /id="VAR_002663"
FT   VARIANT         1953
FT                   /note="Missing (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:12552569,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021761"
FT   VARIANT         2001
FT                   /note="G -> R (in NF1; dbSNP:rs199474751)"
FT                   /evidence="ECO:0000269|PubMed:12552569,
FT                   ECO:0000269|PubMed:15146469"
FT                   /id="VAR_021762"
FT   VARIANT         2012
FT                   /note="D -> N (in NF1; dbSNP:rs199474783)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021763"
FT   VARIANT         2088
FT                   /note="L -> P (in FSNF; no cafe-au-lait macules; null
FT                   mutation; 50% reduction of protein level;
FT                   dbSNP:rs137854561)"
FT                   /evidence="ECO:0000269|PubMed:11704931"
FT                   /id="VAR_017669"
FT   VARIANT         2125
FT                   /note="L -> P (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:24413922"
FT                   /id="VAR_071671"
FT   VARIANT         2164
FT                   /note="L -> M (in NF1; dbSNP:rs137854551)"
FT                   /evidence="ECO:0000269|PubMed:1302608"
FT                   /id="VAR_002664"
FT   VARIANT         2192
FT                   /note="Y -> N (in NF1; dbSNP:rs267606598)"
FT                   /evidence="ECO:0000269|PubMed:1302608"
FT                   /id="VAR_002665"
FT   VARIANT         2221
FT                   /note="P -> A (in NF1; dbSNP:rs199474776)"
FT                   /evidence="ECO:0000269|PubMed:12746402"
FT                   /id="VAR_021764"
FT   VARIANT         2357
FT                   /note="E -> K (in NF1; dbSNP:rs199474784)"
FT                   /evidence="ECO:0000269|PubMed:11735023"
FT                   /id="VAR_021765"
FT   VARIANT         2387..2388
FT                   /note="Missing (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:10607834,
FT                   ECO:0000269|PubMed:8081387"
FT                   /id="VAR_002666"
FT   VARIANT         2507
FT                   /note="T -> I (in NF1; dbSNP:rs149055633)"
FT                   /evidence="ECO:0000269|PubMed:10712197"
FT                   /id="VAR_021766"
FT   VARIANT         2511
FT                   /note="V -> L (in dbSNP:rs2230850)"
FT                   /evidence="ECO:0000269|Ref.7"
FT                   /id="VAR_022257"
FT   VARIANT         2631
FT                   /note="T -> A (in NF1; dbSNP:rs199474793)"
FT                   /evidence="ECO:0000269|PubMed:8544190"
FT                   /id="VAR_002667"
FT   VARIANT         2745
FT                   /note="G -> R (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_035545"
FT   MUTAGEN         1691
FT                   /note="K->A: Reduces phospholipid binding; when associated
FT                   with A-1695; A-1769 and A-1771."
FT                   /evidence="ECO:0000269|PubMed:16397625"
FT   MUTAGEN         1695
FT                   /note="R->A: Reduces phospholipid binding; when associated
FT                   with A-1691; A-1769 and A-1771."
FT                   /evidence="ECO:0000269|PubMed:16397625"
FT   MUTAGEN         1769
FT                   /note="R->A: Reduces phospholipid binding; when associated
FT                   with A-1691; A-1695 and A-1771."
FT                   /evidence="ECO:0000269|PubMed:16397625"
FT   MUTAGEN         1771
FT                   /note="K->A: Reduces phospholipid binding; when associated
FT                   with A-1691; A-169 and A-1769."
FT                   /evidence="ECO:0000269|PubMed:16397625,
FT                   ECO:0000269|PubMed:21089070"
FT   MUTAGEN         1771
FT                   /note="Missing: Reduces protein stability."
FT                   /evidence="ECO:0000269|PubMed:16397625,
FT                   ECO:0000269|PubMed:21089070"
FT   CONFLICT        496
FT                   /note="M -> I (in Ref. 11; AAA74897/AAB59558)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1094..1095
FT                   /note="EL -> ST (in Ref. 14; AAA59923)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1576
FT                   /note="H -> HH (in Ref. 11; AAA74897/AAB59558)"
FT                   /evidence="ECO:0000305"
FT   HELIX           1208..1216
FT                   /evidence="ECO:0000244|PDB:1NF1"
FT   HELIX           1220..1228
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1233..1235
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1236..1249
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1253..1267
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1271..1273
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1280..1309
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1315..1317
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1323..1325
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   STRAND          1328..1330
FT                   /evidence="ECO:0000244|PDB:6OB2"
FT   HELIX           1332..1351
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1354..1356
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1359..1370
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1392..1394
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1398..1400
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1401..1411
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1414..1419
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   TURN            1421..1425
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1433..1451
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1459..1464
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1465..1483
FT                   /evidence="ECO:0000244|PDB:6OB3"
FT   HELIX           1510..1514
FT                   /evidence="ECO:0000244|PDB:1NF1"
FT   HELIX           1517..1520
FT                   /evidence="ECO:0000244|PDB:1NF1"
FT   HELIX           1535..1544
FT                   /evidence="ECO:0000244|PDB:1NF1"
FT   HELIX           1569..1578
FT                   /evidence="ECO:0000244|PDB:3P7Z"
FT   TURN            1582..1586
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1587..1590
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1592..1598
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1604..1609
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1610..1612
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   TURN            1615..1617
FT                   /evidence="ECO:0000244|PDB:2D4Q"
FT   HELIX           1620..1631
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   TURN            1632..1636
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1639..1644
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1650..1652
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1656..1661
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   TURN            1662..1664
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1668..1672
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1674..1681
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1684..1692
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1694..1697
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   TURN            1698..1702
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1706..1711
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1714..1717
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1721..1723
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1728..1732
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1738..1749
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1751..1757
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1759..1767
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1770..1772
FT                   /evidence="ECO:0000244|PDB:2D4Q"
FT   STRAND          1775..1777
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1780..1784
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1785..1787
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1788..1795
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1798..1803
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   STRAND          1810..1813
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   HELIX           1817..1833
FT                   /evidence="ECO:0000244|PDB:3PG7"
FT   VARIANT         P21359-2:1661
FT                   /note="C -> R (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:23758643"
FT                   /id="VAR_082822"
FT   VARIANT         P21359-2:1918
FT                   /note="I -> T (in NF1)"
FT                   /evidence="ECO:0000269|PubMed:23758643"
FT                   /id="VAR_082823"
SQ   SEQUENCE   2839 AA;  319372 MW;  C079475139DBD51E CRC64;
     MAAHRPVEWV QAVVSRFDEQ LPIKTGQQNT HTKVSTEHNK ECLINISKYK FSLVISGLTT
     ILKNVNNMRI FGEAAEKNLY LSQLIILDTL EKCLAGQPKD TMRLDETMLV KQLLPEICHF
     LHTCREGNQH AAELRNSASG VLFSLSCNNF NAVFSRISTR LQELTVCSED NVDVHDIELL
     QYINVDCAKL KRLLKETAFK FKALKKVAQL AVINSLEKAF WNWVENYPDE FTKLYQIPQT
     DMAECAEKLF DLVDGFAEST KRKAAVWPLQ IILLILCPEI IQDISKDVVD ENNMNKKLFL
     DSLRKALAGH GGSRQLTESA AIACVKLCKA STYINWEDNS VIFLLVQSMV VDLKNLLFNP
     SKPFSRGSQP ADVDLMIDCL VSCFRISPHN NQHFKICLAQ NSPSTFHYVL VNSLHRIITN
     SALDWWPKID AVYCHSVELR NMFGETLHKA VQGCGAHPAI RMAPSLTFKE KVTSLKFKEK
     PTDLETRSYK YLLLSMVKLI HADPKLLLCN PRKQGPETQG STAELITGLV QLVPQSHMPE
     IAQEAMEALL VLHQLDSIDL WNPDAPVETF WEISSQMLFY ICKKLTSHQM LSSTEILKWL
     REILICRNKF LLKNKQADRS SCHFLLFYGV GCDIPSSGNT SQMSMDHEEL LRTPGASLRK
     GKGNSSMDSA AGCSGTPPIC RQAQTKLEVA LYMFLWNPDT EAVLVAMSCF RHLCEEADIR
     CGVDEVSVHN LLPNYNTFME FASVSNMMST GRAALQKRVM ALLRRIEHPT AGNTEAWEDT
     HAKWEQATKL ILNYPKAKME DGQAAESLHK TIVKRRMSHV SGGGSIDLSD TDSLQEWINM
     TGFLCALGGV CLQQRSNSGL ATYSPPMGPV SERKGSMISV MSSEGNADTP VSKFMDRLLS
     LMVCNHEKVG LQIRTNVKDL VGLELSPALY PMLFNKLKNT ISKFFDSQGQ VLLTDTNTQF
     VEQTIAIMKN LLDNHTEGSS EHLGQASIET MMLNLVRYVR VLGNMVHAIQ IKTKLCQLVE
     VMMARRDDLS FCQEMKFRNK MVEYLTDWVM GTSNQAADDD VKCLTRDLDQ ASMEAVVSLL
     AGLPLQPEEG DGVELMEAKS QLFLKYFTLF MNLLNDCSEV EDESAQTGGR KRGMSRRLAS
     LRHCTVLAMS NLLNANVDSG LMHSIGLGYH KDLQTRATFM EVLTKILQQG TEFDTLAETV
     LADRFERLVE LVTMMGDQGE LPIAMALANV VPCSQWDELA RVLVTLFDSR HLLYQLLWNM
     FSKEVELADS MQTLFRGNSL ASKIMTFCFK VYGATYLQKL LDPLLRIVIT SSDWQHVSFE
     VDPTRLEPSE SLEENQRNLL QMTEKFFHAI ISSSSEFPPQ LRSVCHCLYQ ATCHSLLNKA
     TVKEKKENKK SVVSQRFPQN SIGAVGSAMF LRFINPAIVS PYEAGILDKK PPPRIERGLK
     LMSKILQSIA NHVLFTKEEH MRPFNDFVKS NFDAARRFFL DIASDCPTSD AVNHSLSFIS
     DGNVLALHRL LWNNQEKIGQ YLSSNRDHKA VGRRPFDKMA TLLAYLGPPE HKPVADTHWS
     SLNLTSSKFE EFMTRHQVHE KEEFKALKTL SIFYQAGTSK AGNPIFYYVA RRFKTGQING
     DLLIYHVLLT LKPYYAKPYE IVVDLTHTGP SNRFKTDFLS KWFVVFPGFA YDNVSAVYIY
     NCNSWVREYT KYHERLLTGL KGSKRLVFID CPGKLAEHIE HEQQKLPAAT LALEEDLKVF
     HNALKLAHKD TKVSIKVGST AVQVTSAERT KVLGQSVFLN DIYYASEIEE ICLVDENQFT
     LTIANQGTPL TFMHQECEAI VQSIIHIRTR WELSQPDSIP QHTKIRPKDV PGTLLNIALL
     NLGSSDPSLR SAAYNLLCAL TCTFNLKIEG QLLETSGLCI PANNTLFIVS ISKTLAANEP
     HLTLEFLEEC ISGFSKSSIE LKHLCLEYMT PWLSNLVRFC KHNDDAKRQR VTAILDKLIT
     MTINEKQMYP SIQAKIWGSL GQITDLLDVV LDSFIKTSAT GGLGSIKAEV MADTAVALAS
     GNVKLVSSKV IGRMCKIIDK TCLSPTPTLE QHLMWDDIAI LARYMLMLSF NNSLDVAAHL
     PYLFHVVTFL VATGPLSLRA STHGLVINII HSLCTCSQLH FSEETKQVLR LSLTEFSLPK
     FYLLFGISKV KSAAVIAFRS SYRDRSFSPG SYERETFALT SLETVTEALL EIMEACMRDI
     PTCKWLDQWT ELAQRFAFQY NPSLQPRALV VFGCISKRVS HGQIKQIIRI LSKALESCLK
     GPDTYNSQVL IEATVIALTK LQPLLNKDSP LHKALFWVAV AVLQLDEVNL YSAGTALLEQ
     NLHTLDSLRI FNDKSPEEVF MAIRNPLEWH CKQMDHFVGL NFNSNFNFAL VGHLLKGYRH
     PSPAIVARTV RILHTLLTLV NKHRNCDKFE VNTQSVAYLA ALLTVSEEVR SRCSLKHRKS
     LLLTDISMEN VPMDTYPIHH GDPSYRTLKE TQPWSSPKGS EGYLAATYPT VGQTSPRARK
     SMSLDMGQPS QANTKKLLGT RKSFDHLISD TKAPKRQEME SGITTPPKMR RVAETDYEME
     TQRISSSQQH PHLRKVSVSE SNVLLDEEVL TDPKIQALLL TVLATLVKYT TDEFDQRILY
     EYLAEASVVF PKVFPVVHNL LDSKINTLLS LCQDPNLLNP IHGIVQSVVY HEESPPQYQT
     SYLQSFGFNG LWRFAGPFSK QTQIPDYAEL IVKFLDALID TYLPGIDEET SEESLLTPTS
     PYPPALQSQL SITANLNLSN SMTSLATSQH SPGIDKENVE LSPTTGHCNS GRTRHGSASQ
     VQKQRSAGSF KRNSIKKIV
//
ID   A0A024QY88_HUMAN        Unreviewed;       241 AA.
AC   A0A024QY88;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 44.
DE   SubName: Full=Neuregulin 1 isoform HRG-beta3 {ECO:0000313|EMBL:DAA00043.1};
DE   SubName: Full=Neuregulin 1, isoform CRA_g {ECO:0000313|EMBL:EAW63413.1};
GN   Name=NRG1 {ECO:0000313|EMBL:DAA00043.1};
GN   ORFNames=hCG_14780 {ECO:0000313|EMBL:EAW63413.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:DAA00043.1};
RN   [1] {ECO:0000313|EMBL:EAW63413.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:DAA00043.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O.,
RA   Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G.,
RA   Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S.,
RA   Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V.,
RA   Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T.,
RA   Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A.,
RA   Gulcher J.R., Petursson H., Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [3] {ECO:0000313|EMBL:EAW63413.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BK000383; DAA00043.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63413.1; -; Genomic_DNA.
DR   RefSeq; NP_039252.2; NM_013958.3.
DR   Antibodypedia; 3706; 907 antibodies.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   4: Predicted;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN          37..128
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          178..222
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        212..221
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   241 AA;  26143 MW;  D2450DB340E6B64D CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY STSTPFLSLP
     E
//
ID   A0A494C0K4_HUMAN        Unreviewed;       459 AA.
AC   A0A494C0K4;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000498583};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000498583};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000498583, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000498583, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000498583}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153476.1; NM_001160004.2.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000650980; ENSP00000498583; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C0K4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A494C0K4,
KW   ECO:0000213|PeptideAtlas:A0A494C0K4, ECO:0000213|ProteomicsDB:A0A494C0K4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        240..262
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          37..128
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          178..222
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          331..357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          372..395
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..386
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        212..221
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   459 AA;  50686 MW;  0BB05971ECB36CC0 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY KAEELYQKRV
     LTITGICIAL LVVGIMCVVA YCKTKKQRKK LHDRLRQSLR SERNNMMNIA NGPHHPNPPP
     ENVQLVNQYV SKNVISSEHI VEREAETSFS TSHYTSTAHH STTVTQTPSH SWSNGHTESI
     LSESHSVIVM SSVENSRHSS PTGGPRGRLN GTGGPRECNS FLRHARETPD SYRDSPHSER
     HNLIAELRRN KAHRSKCMQI QLSATHLRSS SIPHLGFIL
//
ID   A0A494C0L9_HUMAN        Unreviewed;       522 AA.
AC   A0A494C0L9;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000498590};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000498590};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000498590, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000498590, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000498590}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001309135.1; NM_001322206.1.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000651333; ENSP00000498590; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C0L9; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A494C0L9,
KW   ECO:0000213|ProteomicsDB:A0A494C0L9};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        76..99
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        303..325
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          233..277
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          189..227
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          394..420
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..457
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..27
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..449
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        267..276
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   522 AA;  57187 MW;  10FC2FEC84D14F3D CRC64;
     MEIYSPDMSE VAAERSSSPS TQLSADPSLD GLPAAEDMPE PQTEDGRTPG LVGLAVPCCA
     CLEAERLRGC LNSEKICIVP ILACLVSLCL CIAGLKWVFV DKIFEYDSPT HLDPGGLGQD
     PIISLDATAA SAVWVSSEAY TSPVSRAQSE SEVQVTVQGD KAVVSFEPSA APTPKNRIFA
     FSFLPSTAPS FPSPTRNPEV RTPKSATQPQ TTETNLQTAP KLSTSTSTTG TSHLVKCAEK
     EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI EFMEAEELYQ
     KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM NIANGPHHPN
     PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT PSHSWSNGHT
     ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE TPDSYRDSPH
     SERHNLIAEL RRNKAHRSKC MQIQLSATHL RSSSIPHLGF IL
//
ID   A0A494C0Q4_HUMAN        Unreviewed;       700 AA.
AC   A0A494C0Q4;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000498646};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000498646};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000498646, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000498646, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000498646}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001309134.1; NM_001322205.1.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000652592; ENSP00000498646; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C0Q4; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A494C0Q4,
KW   ECO:0000213|PeptideAtlas:A0A494C0Q4, ECO:0000213|ProteomicsDB:A0A494C0Q4};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        76..99
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        303..325
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          233..277
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          189..227
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          394..420
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..459
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          493..521
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          584..648
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..27
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..449
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        619..633
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        267..276
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   700 AA;  76700 MW;  BBC65054BC493626 CRC64;
     MEIYSPDMSE VAAERSSSPS TQLSADPSLD GLPAAEDMPE PQTEDGRTPG LVGLAVPCCA
     CLEAERLRGC LNSEKICIVP ILACLVSLCL CIAGLKWVFV DKIFEYDSPT HLDPGGLGQD
     PIISLDATAA SAVWVSSEAY TSPVSRAQSE SEVQVTVQGD KAVVSFEPSA APTPKNRIFA
     FSFLPSTAPS FPSPTRNPEV RTPKSATQPQ TTETNLQTAP KLSTSTSTTG TSHLVKCAEK
     EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI EFMEAEELYQ
     KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM NIANGPHHPN
     PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT PSHSWSNGHT
     ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE TPDSYRDSPH
     SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP FMEEERPLLL
     VTPPRLREKK FDHHPQQFSS FHHNPAHDSN SLPASPLRIV EDEEYETTQE YEPAQEPVKK
     LANSRRAKRT KPNGHIANRL EVDSNTSSQS SNSESETEDE RVGEDTPFLG IQNPLAASLE
     ATPAFRLADS RTNPAGRFST QEEIQARLSS VIANQDPIAV
//
ID   A0A494C114_HUMAN        Unreviewed;       207 AA.
AC   A0A494C114;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000498833};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000498833};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000498833, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000498833, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000498833}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153477.1; NM_001160005.1.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000650967; ENSP00000498833; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C114; baseline and differential.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 2.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A494C114,
KW   ECO:0000213|ProteomicsDB:A0A494C114};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          37..128
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          144..188
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        178..187
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   207 AA;  22715 MW;  9E78DF98A10A2B5D CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCPN
     EFTGDRCQNY VMASFYSTST PFLSLPE
//
ID   A0A494C1B5_HUMAN        Unreviewed;       483 AA.
AC   A0A494C1B5;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000498946};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000498946};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000498946, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000498946, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000498946}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001309136.1; NM_001322207.1.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000650819; ENSP00000498946; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C1B5; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A494C1B5,
KW   ECO:0000213|ProteomicsDB:A0A494C1B5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        76..99
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   TRANSMEM        303..325
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          233..277
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..48
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          189..227
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          394..420
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          435..483
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        11..27
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        435..449
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        463..483
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        267..276
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   483 AA;  52726 MW;  D768F4D2616C1A05 CRC64;
     MEIYSPDMSE VAAERSSSPS TQLSADPSLD GLPAAEDMPE PQTEDGRTPG LVGLAVPCCA
     CLEAERLRGC LNSEKICIVP ILACLVSLCL CIAGLKWVFV DKIFEYDSPT HLDPGGLGQD
     PIISLDATAA SAVWVSSEAY TSPVSRAQSE SEVQVTVQGD KAVVSFEPSA APTPKNRIFA
     FSFLPSTAPS FPSPTRNPEV RTPKSATQPQ TTETNLQTAP KLSTSTSTTG TSHLVKCAEK
     EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI EFMEAEELYQ
     KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM NIANGPHHPN
     PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT PSHSWSNGHT
     ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE TPDSYRDSPH
     SER
//
ID   A0A494C1F5_HUMAN        Unreviewed;       624 AA.
AC   A0A494C1F5;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000499045};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000499045};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000499045, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000499045, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000499045}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000650866; ENSP00000499045; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C1F5; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A494C1F5,
KW   ECO:0000213|PeptideAtlas:A0A494C1F5, ECO:0000213|ProteomicsDB:A0A494C1F5};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        227..249
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          157..201
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          318..344
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          359..383
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          417..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          508..572
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        359..373
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        543..557
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        191..200
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         624
FT                   /evidence="ECO:0000313|Ensembl:ENSP00000499045"
SQ   SEQUENCE   624 AA;  68888 MW;  0AA7C095D1B3BC39 CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSE SPIRISVSTE GANTSSSTST STTGTSHLVK CAEKEKTFCV NGGECFMVKD
     LSNPSRYLCK CPNEFTGDRC QNYVMASFYK HLGIEFMEAE ELYQKRVLTI TGICIALLVV
     GIMCVVAYCK TKKQRKKLHD RLRQSLRSER NNMMNIANGP HHPNPPPENV QLVNQYVSKN
     VISSEHIVER EAETSFSTSH YTSTAHHSTT VTQTPSHSWS NGHTESILSE SHSVIVMSSV
     ENSRHSSPTG GPRGRLNGTG GPRECNSFLR HARETPDSYR DSPHSERYVS AMTTPARMSP
     VDFHTPSSPK SPPSEMSPPV SSMTVSMPSM AVSPFMEEER PLLLVTPPRL REKKFDHHPQ
     QFSSFHHNPA HDSNSLPASP LRIVEDEEYE TTQEYEPAQE PVKKLANSRR AKRTKPNGHI
     ANRLEVDSNT SSQSSNSESE TEDERVGEDT PFLGIQNPLA ASLEATPAFR LADSRTNPAG
     RFSTQEEIQA RLSSVIANQD PIAV
//
ID   A0A494C1F8_HUMAN        Unreviewed;       607 AA.
AC   A0A494C1F8;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 9.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000499008};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000499008};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000499008, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000499008, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000499008}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000652698; ENSP00000499008; ENSG00000157168.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   ChiTaRS; NRG1; human.
DR   Proteomes; UP000005640; Chromosome 8.
DR   ExpressionAtlas; A0A494C1F8; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|MaxQB:A0A494C1F8,
KW   ECO:0000213|PeptideAtlas:A0A494C1F8, ECO:0000213|ProteomicsDB:A0A494C1F8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        210..232
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          140..184
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          301..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          342..367
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          400..428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          491..555
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..356
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        526..540
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        174..183
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   607 AA;  67155 MW;  26201498D4F08462 CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSA TSTSTTGTSH LVKCAEKEKT FCVNGGECFM VKDLSNPSRY LCKCPNEFTG
     DRCQNYVMAS FYKHLGIEFM EAEELYQKRV LTITGICIAL LVVGIMCVVA YCKTKKQRKK
     LHDRLRQSLR SERNNMMNIA NGPHHPNPPP ENVQLVNQYV SKNVISSEHI VEREAETSFS
     TSHYTSTAHH STTVTQTPSH SWSNGHTESI LSESHSVIVM SSVENSRHSS PTGGPRGRLN
     GTGGPRECNS FLRHARETPD SYRDSPHSER YVSAMTTPAR MSPVDFHTPS SPKSPPSEMS
     PPVSSMTVSM PSMAVSPFME EERPLLLVTP PRLREKKFDH HPQQFSSFHH NPAHDSNSLP
     ASPLRIVEDE EYETTQEYEP AQEPVKKLAN SRRAKRTKPN GHIANRLEVD SNTSSQSSNS
     ESETEDERVG EDTPFLGIQN PLAASLEATP AFRLADSRTN PAGRFSTQEE IQARLSSVIA
     NQDPIAV
//
ID   A5YAK6_HUMAN            Unreviewed;       214 AA.
AC   A5YAK6;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   11-DEC-2019, entry version 46.
DE   SubName: Full=Neuregulin 1 variant fetal a IV 1 {ECO:0000313|EMBL:ABQ53541.1};
GN   Name=NRG1 {ECO:0000313|EMBL:ABQ53541.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ53541.1};
RN   [1] {ECO:0000313|EMBL:ABQ53541.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABQ53541.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R.,
RA   Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional promoter
RT   variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF372275; ABQ53541.1; -; mRNA.
DR   RefSeq; NP_001309130.1; NM_001322201.1.
DR   MaxQB; A5YAK6; -.
DR   PeptideAtlas; A5YAK6; -.
DR   PRIDE; A5YAK6; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          1..26
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   214 AA;  23059 MW;  2FE14468A5E76AB0 CRC64;
     MGKGRAGRVG TTALPPQLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSA TSTSTTGASH LVKCAEKEKT FCVNGGECFM VKDLSNPSRY LCKGGGAVPE
     ESADHNRHLH RPPCGRHHVF GGLLQNQETA EKAA
//
ID   A5YAK8_HUMAN            Unreviewed;       197 AA.
AC   A5YAK8;
DT   10-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   10-JUL-2007, sequence version 1.
DT   11-DEC-2019, entry version 47.
DE   SubName: Full=Neuregulin 1 variant fetal c IV 2 {ECO:0000313|EMBL:ABQ53543.1};
GN   Name=NRG1 {ECO:0000313|EMBL:ABQ53543.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABQ53543.1};
RN   [1] {ECO:0000313|EMBL:ABQ53543.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABQ53543.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R.,
RA   Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional promoter
RT   variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF372277; ABQ53543.1; -; mRNA.
DR   RefSeq; NP_001309131.1; NM_001322202.1.
DR   PeptideAtlas; A5YAK8; -.
DR   PRIDE; A5YAK8; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 2.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          1..25
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   197 AA;  21422 MW;  817A13843DF40CEE CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNATSTSTTG
     TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCKGGGA VPEESADHNR HLHRPPCGRH
     HVFGGLLQNQ ETAEKAA
//
ID   A6MW54_HUMAN            Unreviewed;       454 AA.
AC   A6MW54;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   26-FEB-2020, entry version 68.
DE   SubName: Full=Neuregulin 1 type IV fetal A beta 1a {ECO:0000313|EMBL:ABR13842.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABR13842.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABR13842.1};
RN   [1] {ECO:0000313|EMBL:ABR13842.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABR13842.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R.,
RA   Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional promoter
RT   variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF517295; ABR13842.1; -; mRNA.
DR   RefSeq; NP_001309134.1; NM_001322205.1.
DR   PeptideAtlas; A6MW54; -.
DR   PRIDE; A6MW54; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 2.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        193..215
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          123..167
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          284..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          325..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          383..411
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          433..454
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        325..339
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        157..166
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         454
FT                   /evidence="ECO:0000313|EMBL:ABR13842.1"
SQ   SEQUENCE   454 AA;  50514 MW;  129727D7A36393FF CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVIGKLGND SASANITIVE SNATSTSTTG
     TSHLVKCAEK EKAFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI
     EFMEAEELYQ KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM
     NIANGPHHPN PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT
     PSHSWSNGHT ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE
     TPDSYRDSPH SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP
     FMEEERPLLL VTPPRPREKK FDHHPQQFSS FHHN
//
ID   A6MW55_HUMAN            Unreviewed;       498 AA.
AC   A6MW55;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   26-FEB-2020, entry version 80.
DE   SubName: Full=Neuregulin 1 type IV fetal B beta 1a {ECO:0000313|EMBL:ABR13843.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABR13843.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABR13843.1};
RN   [1] {ECO:0000313|EMBL:ABR13843.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABR13843.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R.,
RA   Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional promoter
RT   variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF517296; ABR13843.1; -; mRNA.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   PeptideAtlas; A6MW55; -.
DR   PRIDE; A6MW55; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; A6MW55; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        227..249
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          157..201
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          313..346
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          359..387
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          412..445
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          473..498
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        315..346
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        359..373
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        482..498
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        191..200
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         498
FT                   /evidence="ECO:0000313|EMBL:ABR13843.1"
SQ   SEQUENCE   498 AA;  55035 MW;  90574C187B0C5E7C CRC64;
     MGKGRAGRVG TTALPPQLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKD
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSE SPIRISVSTE GANTSSSTST STTGTSHLVK CAEKEKTFCV NGGECFMVKD
     LSNPSRYLCK CPNEFTGDRC QNYVMASFYK HLGIEFMEAE ELYQKRVLTI TGICIALLVV
     GIMCVVAYCK TKKQRKKLHD RLRQSLRSER NNMMNIANGP HHPNPPPENV QLVNQYASKN
     VISSEHIVER EAETPFSTSH YTSTAHHSTT VTQTPSHSWS NEHTESILSE SHSVIVMSSV
     ENSRHSSPTG GPRGRLNGTG GPRECNSFLR HARETPDSYR DSPHSERYVS AMTTPARMSP
     VDFHTPSSPK SPPSEMSPPV SSMTVSMPSM AVSPFMEEER PLLLVTPPRL REKKFDHHPQ
     QFSSFHHNPA HDSNSLPA
//
ID   A6MW56_HUMAN            Unreviewed;       481 AA.
AC   A6MW56;
DT   24-JUL-2007, integrated into UniProtKB/TrEMBL.
DT   24-JUL-2007, sequence version 1.
DT   26-FEB-2020, entry version 77.
DE   SubName: Full=Neuregulin 1 type IV fetal C beta 1a {ECO:0000313|EMBL:ABR13844.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABR13844.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABR13844.1};
RN   [1] {ECO:0000313|EMBL:ABR13844.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABR13844.1};
RX   PubMed=17565985; DOI=10.1074/jbc.M702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R.,
RA   Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional promoter
RT   variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EF517297; ABR13844.1; -; mRNA.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   PeptideAtlas; A6MW56; -.
DR   PRIDE; A6MW56; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; A6MW56; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        210..232
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          140..184
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          241..273
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          296..327
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          342..368
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          402..428
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          455..481
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        298..327
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        342..356
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        465..481
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        174..183
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         481
FT                   /evidence="ECO:0000313|EMBL:ABR13844.1"
SQ   SEQUENCE   481 AA;  53253 MW;  0E5B8B7386B8A340 CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNEIITGMPA
     STEGAYVSSA ASTSTTGTSH LVKCAEKEKT FCVNGGECFM VKDLSNPSRY LCKCPNEFTG
     DRCQNYVMAS FYKHLGIEFM EAEELYQKRV LTITGICIAL LVVGIMCVVA YCKTKKQRKK
     LHDRLRQSPR SERNNTMNIA NGPHHPNPPP ENVQLVNQYV SKNVISSEHI VEREAETSFP
     TSHYTSTAHH STTVTQTPSH SWSNGHTESI LSESHSVIVM SSVENSRHSS PTGGPRGRLN
     GTGGPRECNS YLRHARETPD SYRDSPHSER YVSVMTTPAR MSPVDFHTPS SPKSPPSEMS
     PPVSSMTVSM PSMAVSPFME EERPLLLVTP PRLREKKFDH HPQQFSSFHH NPAHDSNSLP
     A
//
ID   B0FWZ3_HUMAN            Unreviewed;       206 AA.
AC   B0FWZ3;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   11-DEC-2019, entry version 65.
DE   SubName: Full=Heregulin-beta 3 protein isoform {ECO:0000313|EMBL:ABY70644.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY70644.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY70644.1};
RN   [1] {ECO:0000313|EMBL:ABY70644.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain hippocampus {ECO:0000313|EMBL:ABY70644.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU359055; ABY70644.1; -; mRNA.
DR   RefSeq; NP_001153477.1; NM_001160005.1.
DR   SMR; B0FWZ3; -.
DR   PeptideAtlas; B0FWZ3; -.
DR   PRIDE; B0FWZ3; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FWZ3; HS.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 2.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN          36..127
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          143..187
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        177..186
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:ABY70644.1"
SQ   SEQUENCE   206 AA;  22584 MW;  A564911EBD44BBBA CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNATSTSTTG TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE
     FTGDRCQNYV MASFYSTSTP FLSLPE
//
ID   B0FYA7_HUMAN            Unreviewed;       193 AA.
AC   B0FYA7;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   11-DEC-2019, entry version 67.
DE   SubName: Full=Heregulin-gamma protein isoform 1 {ECO:0000313|EMBL:ABY66348.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY66348.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY66348.1};
RN   [1] {ECO:0000313|EMBL:ABY66348.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABY66348.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU363508; ABY66348.1; -; mRNA.
DR   RefSeq; NP_001153474.1; NM_001160002.1.
DR   PeptideAtlas; B0FYA7; -.
DR   PRIDE; B0FYA7; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FYA7; HS.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          36..127
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:ABY66348.1"
SQ   SEQUENCE   193 AA;  20891 MW;  8403AAC43EE97A77 CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNEIITGMPA STEGAYVSSA TSTSTTGTSH LVKCAEKEKT FCVNGGECFM
     VKDLSNPSRY LCK
//
ID   B0FYA8_HUMAN            Unreviewed;       176 AA.
AC   B0FYA8;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   11-DEC-2019, entry version 61.
DE   SubName: Full=Heregulin-gamma protein isoform 2 {ECO:0000313|EMBL:ABY66349.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY66349.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY66349.1};
RN   [1] {ECO:0000313|EMBL:ABY66349.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ABY66349.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU363509; ABY66349.1; -; mRNA.
DR   RefSeq; NP_001153479.1; NM_001160007.1.
DR   PeptideAtlas; B0FYA8; -.
DR   PRIDE; B0FYA8; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FYA8; HS.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 2.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          36..127
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:ABY66349.1"
SQ   SEQUENCE   176 AA;  19196 MW;  4EEB2167FA7B0CB0 CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNATSTSTTG TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCK
//
ID   B0FYA9_HUMAN            Unreviewed;       458 AA.
AC   B0FYA9;
DT   26-FEB-2008, integrated into UniProtKB/TrEMBL.
DT   26-FEB-2008, sequence version 1.
DT   26-FEB-2020, entry version 76.
DE   SubName: Full=Neuregulin 1 isoform ndf43-beta2 {ECO:0000313|EMBL:ABY66350.1};
DE   Flags: Fragment;
GN   Name=NRG1 {ECO:0000313|EMBL:ABY66350.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ABY66350.1};
RN   [1] {ECO:0000313|EMBL:ABY66350.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain hippocampus {ECO:0000313|EMBL:ABY66350.1};
RA   Tan W., Dean M., Weinberger D.R., Law A.J.;
RL   Submitted (DEC-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU363510; ABY66350.1; -; mRNA.
DR   RefSeq; NP_001153476.1; NM_001160004.2.
DR   PeptideAtlas; B0FYA9; -.
DR   PRIDE; B0FYA9; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B0FYA9; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        239..261
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          36..127
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          177..221
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..50
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          330..356
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          371..393
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        371..385
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        211..220
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:ABY66350.1"
SQ   SEQUENCE   458 AA;  50555 MW;  F092E3E0F16F9BBB CRC64;
     SERKEGRGKG KGKKKERGSG KKPESAAGSQ SPALPPRLKE MKSQESAAGS KLVLRCETSS
     EYSSLRFKWF KNGNELNRKN KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND
     SASANITIVE SNEIITGMPA STEGAYVSSE SPIRISVSTE GANTSSSTST STTGTSHLVK
     CAEKEKTFCV NGGECFMVKD LSNPSRYLCK CPNEFTGDRC QNYVMASFYK AEELYQKRVL
     TITGICIALL VVGIMCVVAY CKTKKQRKKL HDRLRQSLRS ERNNMMNIAN GPHHPNPPPE
     NVQLVNQYVS KNVISSEHIV EREAETSFST SHYTSTAHHS TTVTQTPSHS WSNGHTESIL
     SESHSVIVMS SVENSRHSSP TGGPRGRLNG TGGPRECNSF LRHARETPDS YRDSPHSERH
     NLIAELRRNK AHRSKCMQIQ LSATHLRSSS IPHLGFIL
//
ID   B7Z1D7_HUMAN            Unreviewed;       308 AA.
AC   B7Z1D7;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   11-DEC-2019, entry version 54.
DE   SubName: Full=cDNA FLJ52471, highly similar to Homo sapiens neuregulin 1 (NRG1), transcript variant ndf43, mRNA {ECO:0000313|EMBL:BAH11473.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11473.1};
RN   [1] {ECO:0000313|EMBL:BAH11473.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK293240; BAH11473.1; -; mRNA.
DR   RefSeq; NP_001153468.1; NM_001159996.2.
DR   iPTMnet; B7Z1D7; -.
DR   PeptideAtlas; B7Z1D7; -.
DR   PRIDE; B7Z1D7; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   OrthoDB; 313400at2759; -.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; B7Z1D7; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        89..111
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          24..68
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          180..206
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          221..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        221..235
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        58..67
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   308 AA;  34403 MW;  99F17E85A38C99BC CRC64;
     MQIPKHISIE DITATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCQP
     GFTGARCTEN VPMKVQNQEK AEELYQKRVL TITGICIALL VVGIMCVVAY CKTKKQRKKL
     HDRLRQSLRS ERNNMMNIAN GPHHPNPPPE NVQLVNQYVS KNVISSEHIV EREAETSFST
     SHYTSTAHHS TTVTQTPSHS WSNGHTESIL SKSHSVIVMS SVENSRHSSP TGGPRGRLNG
     TGGPRECNSF LRHARETPDS YRDSPHSERH NLIAELRRNK AHRSKCMQIQ LSATHLRSSS
     IPHLGFIL
//
ID   B7Z1E3_HUMAN            Unreviewed;       483 AA.
AC   B7Z1E3;
DT   03-MAR-2009, integrated into UniProtKB/TrEMBL.
DT   03-MAR-2009, sequence version 1.
DT   11-DEC-2019, entry version 77.
DE   SubName: Full=cDNA FLJ53967, highly similar to Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|EMBL:BAH11479.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAH11479.1};
RN   [1] {ECO:0000313|EMBL:BAH11479.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK293270; BAH11479.1; -; mRNA.
DR   RefSeq; NP_001309126.1; NM_001322197.1.
DR   SMR; B7Z1E3; -.
DR   MaxQB; B7Z1E3; -.
DR   PeptideAtlas; B7Z1E3; -.
DR   PRIDE; B7Z1E3; -.
DR   ProteomicsDB; 6323; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   OrthoDB; 313400at2759; -.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        86..108
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          24..68
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          177..203
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          218..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          276..304
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          367..431
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        218..232
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        402..416
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        58..67
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   483 AA;  53725 MW;  39B94B909F1D3DE0 CRC64;
     MQIPKHISIE DITATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCPN
     EFTGDRCQNY VMASFYKAEE LYQKRVLTIT GICIALLVVG IMCVVAYCKT KKQRKKLHDR
     LRQSLRSERN NMMNIANGPH HPNPPPENVQ LVNQYVSKNV ISSEHIVERE AETSFSTSHY
     TSTAHHSTTV TQTPSHSWSN GHTESILSES HSVIVMSSVE NSRHSSPTGG PRGRLNGTGG
     PRECNSFLRH ARETPDSYRD SPHSERYVSA MTTPARMSPV DFHTPSSPKS PPSEMSPPVS
     SMTVSMPSMA VSPFMEEERP LLLVTPPRLR EKKFDHHPQQ FSSFHHNPAH DSNSLPASPL
     RIVEDEEYET TQEYEPAQEP VKKLANSRRA KRTKPNGHIA NRLEVDSNTS SQSSNSESET
     EDERVGEDTP FLGIQNPLAA SLEATPAFRL ADSRTNPAGR FSTQEEIQAR LSSVIANQDP
     IAV
//
ID   E3SFM9_HUMAN            Unreviewed;       590 AA.
AC   E3SFM9;
DT   11-JAN-2011, integrated into UniProtKB/TrEMBL.
DT   11-JAN-2011, sequence version 1.
DT   11-DEC-2019, entry version 39.
DE   SubName: Full=Neuregulin 1 type IV beta 1a {ECO:0000313|EMBL:ADN85612.1};
GN   Name=NRG1 {ECO:0000313|EMBL:ADN85612.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADN85612.1};
RN   [1] {ECO:0000313|EMBL:ADN85612.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:ADN85612.1};
RX   PubMed=20218976; DOI=10.1111/j.1471-4159.2010.06677.x;
RA   Shamir A., Buonanno A.;
RT   "Molecular and cellular characterization of Neuregulin-1 type IV
RT   isoforms.";
RL   J. Neurochem. 113:1163-1176(2010).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ983557; ADN85612.1; -; mRNA.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   RefSeq; NP_001153473.1; NM_001160001.2.
DR   RefSeq; NP_001309130.1; NM_001322201.1.
DR   RefSeq; NP_001309131.1; NM_001322202.1.
DR   PeptideAtlas; E3SFM9; -.
DR   PRIDE; E3SFM9; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 2.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        193..215
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          16..107
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          123..167
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          284..310
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          325..349
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          383..411
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          474..538
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        325..339
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        509..523
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        157..166
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   590 AA;  65446 MW;  FBC248D48892ADBD CRC64;
     MGKGRAGRVG TTALPPRLKE MKSQESAAGS KLVLRCETSS EYSSLRFKWF KNGNELNRKN
     KPQNIKIQKK PGKSELRINK ASLADSGEYM CKVISKLGND SASANITIVE SNATSTSTTG
     TSHLVKCAEK EKTFCVNGGE CFMVKDLSNP SRYLCKCPNE FTGDRCQNYV MASFYKHLGI
     EFMEAEELYQ KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM
     NIANGPHHPN PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT
     PSHSWSNGHT ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE
     TPDSYRDSPH SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP
     FMEEERPLLL VTPPRLREKK FDHHPQQFSS FHHNPAHDSN SLPASPLRIV EDEEYETTQE
     YEPAQEPVKK LANSRRAKRT KPNGHVANRL EVDSNTSSQS SNSESETEDE RVGEDTPFLG
     IQNPLAASLE ATPAFRLADS RTNPAGRFST QEEIQARLSS VIANQDPIAV
//
ID   F6RJN6_HUMAN            Unreviewed;       308 AA.
AC   F6RJN6;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 41.
DE   SubName: Full=Pro-neuregulin-1, membrane-bound isoform {ECO:0000313|Ensembl:ENSP00000439276};
GN   Name=NRG1 {ECO:0000313|Ensembl:ENSP00000439276};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000439276, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000439276, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Glockner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [2] {ECO:0000313|Ensembl:ENSP00000439276}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458727; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458729; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001153468.1; NM_001159996.2.
DR   PeptideAtlas; F6RJN6; -.
DR   PRIDE; F6RJN6; -.
DR   Antibodypedia; 3706; 907 antibodies.
DR   Ensembl; ENST00000539990; ENSP00000439276; ENSG00000157168.
DR   GeneID; 3084; -.
DR   UCSC; uc011lbg.2; human.
DR   CTD; 3084; -.
DR   EuPathDB; HostDB:ENSG00000157168.18; -.
DR   HGNC; HGNC:7997; NRG1.
DR   OpenTargets; ENSG00000157168; -.
DR   GeneTree; ENSGT00940000157326; -.
DR   HOGENOM; CLU_903033_0_0_1; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   Bgee; ENSG00000157168; Expressed in oocyte and 150 other tissues.
DR   ExpressionAtlas; F6RJN6; baseline and differential.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
PE   1: Evidence at protein level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:F6RJN6,
KW   ECO:0000213|ProteomicsDB:F6RJN6};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        89..111
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          24..68
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          180..206
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          221..243
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        221..235
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        58..67
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   308 AA;  34404 MW;  915B562729A4339C CRC64;
     MQIPKHISIE DITATSTSTT GTSHLVKCAE KEKTFCVNGG ECFMVKDLSN PSRYLCKCQP
     GFTGARCTEN VPMKVQNQEK AEELYQKRVL TITGICIALL VVGIMCVVAY CKTKKQRKKL
     HDRLRQSLRS ERNNMMNIAN GPHHPNPPPE NVQLVNQYVS KNVISSEHIV EREAETSFST
     SHYTSTAHHS TTVTQTPSHS WSNGHTESIL SESHSVIVMS SVENSRHSSP TGGPRGRLNG
     TGGPRECNSF LRHARETPDS YRDSPHSERH NLIAELRRNK AHRSKCMQIQ LSATHLRSSS
     IPHLGFIL
//
ID   NRG1_HUMAN              Reviewed;         640 AA.
AC   Q02297; A5YAK4; A5YAK5; A8K1L2; B7Z4Z3; E9PHH4; O14667; P98202; Q02298;
AC   Q02299; Q07110; Q07111; Q12779; Q12780; Q12781; Q12782; Q12783; Q12784;
AC   Q15491; Q7RTV9; Q7RTW0; Q7RTW1; Q7RTW2; Q8NFN1; Q8NFN2; Q8NFN3; Q9UPE3;
DT   01-DEC-2000, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 3.
DT   22-APR-2020, entry version 227.
DE   RecName: Full=Pro-neuregulin-1, membrane-bound isoform;
DE            Short=Pro-NRG1;
DE   Contains:
DE     RecName: Full=Neuregulin-1;
DE     AltName: Full=Acetylcholine receptor-inducing activity;
DE              Short=ARIA;
DE     AltName: Full=Breast cancer cell differentiation factor p45;
DE     AltName: Full=Glial growth factor;
DE     AltName: Full=Heregulin;
DE              Short=HRG;
DE     AltName: Full=Neu differentiation factor;
DE     AltName: Full=Sensory and motor neuron-derived factor;
DE   Flags: Precursor;
GN   Name=NRG1; Synonyms=GGF, HGL, HRGA, NDF, SMDF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 6; 7 AND 8), AND PARTIAL PROTEIN
RP   SEQUENCE.
RX   PubMed=1350381; DOI=10.1126/science.256.5060.1205;
RA   Holmes W.E., Sliwkowski M.X., Akita R.W., Henzel W.J., Lee J., Park J.W.,
RA   Yansura D., Abadi N., Raab H., Lewis G.D., Shepard H.M., Kuang W.-J.,
RA   Wood W.I., Goeddel D.V., Vandlen R.L.;
RT   "Identification of heregulin, a specific activator of p185erbB2.";
RL   Science 256:1205-1210(1992).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3; 4; 6; 7 AND 8).
RC   TISSUE=Kidney adenocarcinoma, and Pituitary;
RX   PubMed=7509448; DOI=10.1128/mcb.14.3.1909;
RA   Wen D., Suggs S.V., Karunagaran D., Liu N., Cupples R.L., Luo Y.,
RA   Janssen A.M., Ben-Baruch N., Trollinger D.B., Jacobsen V.L., Meng S.-Y.,
RA   Lu H.S., Hu S., Chang D., Yang W., Yanigahara D., Koski R.A., Yarden Y.;
RT   "Structural and functional aspects of the multiplicity of Neu
RT   differentiation factors.";
RL   Mol. Cell. Biol. 14:1909-1919(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 8 AND 9).
RC   TISSUE=Brain;
RX   PubMed=8096067; DOI=10.1038/362312a0;
RA   Marchionni M.A., Goodearl A.D.J., Chen M.S., Bermingham-McDonogh O.,
RA   Kirk C., Hendricks M., Danehy F., Misumi D., Sudhalter J., Kobayashi K.,
RA   Wroblewski D., Lynch C., Baldasarre M., Hiles I., Davis J.B., Hsuan J.J.,
RA   Totty N.F., Otsu M., McBurney R.N., Waterfield M.D., Stroobant P.,
RA   Gwynne D.;
RT   "Glial growth factors are alternatively spliced erbB2 ligands expressed in
RT   the nervous system.";
RL   Nature 362:312-318(1993).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 10).
RC   TISSUE=Brain stem, and Cerebellum;
RX   PubMed=7782315; DOI=10.1074/jbc.270.24.14523;
RA   Ho W.-H., Armanini M.P., Nuijens A., Phillips H.S., Osheroff P.L.;
RT   "Sensory and motor neuron-derived factor. A novel heregulin variant highly
RT   expressed in sensory and motor neurons.";
RL   J. Biol. Chem. 270:14523-14532(1995).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 10 AND 12), AND VARIANT
RP   THR-289.
RC   TISSUE=Hippocampus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF GAMMA-HEREGULIN FUSION PROTEIN.
RC   TISSUE=Mammary cancer;
RX   PubMed=9333014; DOI=10.1038/sj.onc.1201317;
RA   Schaefer G., Fitzpatrick V.D., Sliwkowski M.X.;
RT   "Gamma-heregulin: a novel heregulin isoform that is an autocrine growth
RT   factor for the human breast cancer cell line, MDA-MB-175.";
RL   Oncogene 15:1385-1394(1997).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORMS 1; 3; 8 AND 9), AND
RP   SUSCEPTIBILITY TO SCHIZOPHRENIA.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O.,
RA   Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G.,
RA   Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S.,
RA   Hardardottir H., Harvey R.P., Brunner D., Mutel V., Gonzalo A., Lemke G.,
RA   Sainz J., Johannesson G., Andresson T., Gudbjartsson D., Manolescu A.,
RA   Frigge M.L., Gurney M.E., Kong A., Gulcher J.R., Petursson H.,
RA   Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 11), ALTERNATIVE SPLICING, VARIANTS
RP   GLN-38 AND THR-289, TISSUE SPECIFICITY, AND DEVELOPMENTAL STAGE.
RC   TISSUE=Hippocampus, and Prefrontal cortex;
RX   PubMed=17565985; DOI=10.1074/jbc.m702953200;
RA   Tan W., Wang Y., Gold B., Chen J., Dean M., Harrison P.J., Weinberger D.R.,
RA   Law A.J.;
RT   "Molecular cloning of a brain-specific, developmentally regulated
RT   neuregulin 1 (NRG1) isoform and identification of a functional promoter
RT   variant associated with schizophrenia.";
RL   J. Biol. Chem. 282:24343-24351(2007).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 10).
RC   TISSUE=Brain, and Duodenum;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 1-211 (ISOFORM 1).
RA   Schoumacher F., Herzer S., Flury N., Kueng W., Mueller H., Eppenberger U.;
RL   Submitted (SEP-1997) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   PROTEIN SEQUENCE OF 20-28.
RX   PubMed=7689552;
RA   Culouscou J.-M., Plowman G.D., Carlton G.W., Green J.M., Shoyab M.;
RT   "Characterization of a breast cancer cell differentiation factor that
RT   specifically activates the HER4/p180erbB4 receptor.";
RL   J. Biol. Chem. 268:18407-18410(1993).
RN   [14]
RP   PARTIAL PROTEIN SEQUENCE (ISOFORM 1), FUNCTION, AND GLYCOSYLATION.
RX   PubMed=1348215; DOI=10.1016/0092-8674(92)90131-u;
RA   Peles E., Bacus S.S., Koski R.A., Lu H.S., Wen D., Ogden S.G., Levy R.B.,
RA   Yarden Y.;
RT   "Isolation of the neu/HER-2 stimulatory ligand: a 44 kd glycoprotein that
RT   induces differentiation of mammary tumor cells.";
RL   Cell 69:205-216(1992).
RN   [15]
RP   BINDING TO ERBB4, AND FUNCTION.
RX   PubMed=7902537; DOI=10.1038/366473a0;
RA   Plowman G.D., Green J.M., Culouscou J.M., Carlton G.W., Rothwell V.M.,
RA   Buckley S.;
RT   "Heregulin induces tyrosine phosphorylation of HER4/p180erbB4.";
RL   Nature 366:473-475(1993).
RN   [16]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10523851; DOI=10.1038/sj.onc.1202950;
RA   Wang X.-Z., Jolicoeur E.M., Conte N., Chaffanet M., Zhang Y.,
RA   Mozziconacci M.-J., Feiner H., Birnbaum D., Pebusque M.-J., Ron D.;
RT   "Gamma-heregulin is the product of a chromosomal translocation fusing the
RT   DOC4 and HGL/NRG1 genes in the MDA-MB-175 breast cancer cell line.";
RL   Oncogene 18:5718-5721(1999).
RN   [17]
RP   CHROMOSOMAL TRANSLOCATION.
RX   PubMed=10597312; DOI=10.1038/sj.onc.1203136;
RA   Liu X., Baker E., Eyre H.J., Sutherland G.R., Zhou M.;
RT   "Gamma-heregulin: a fusion gene of DOC-4 and neuregulin-1 derived from a
RT   chromosome translocation.";
RL   Oncogene 18:7110-7114(1999).
RN   [18]
RP   BINDING TO ERBB4.
RX   PubMed=10867024; DOI=10.1074/jbc.c901015199;
RA   Sweeney C., Lai C., Riese D.J. II, Diamonti A.J., Cantley L.C.,
RA   Carraway K.L. III;
RT   "Ligand discrimination in signaling through an ErbB4 receptor homodimer.";
RL   J. Biol. Chem. 275:19803-19807(2000).
RN   [19]
RP   FUNCTION, BINDING TO ERBB3 AND INTEGRINS, IDENTIFICATION IN A TERNARY
RP   COMPLEX WITH ERBB3 AND INTEGRINS, AND MUTAGENESIS OF LYS-181; LYS-185 AND
RP   LYS-187.
RX   PubMed=20682778; DOI=10.1074/jbc.m110.113878;
RA   Ieguchi K., Fujita M., Ma Z., Davari P., Taniguchi Y., Sekiguchi K.,
RA   Wang B., Takada Y.K., Takada Y.;
RT   "Direct binding of the EGF-like domain of neuregulin-1 to integrins
RT   ({alpha}v{beta}3 and {alpha}6{beta}4) is involved in neuregulin-1/ErbB
RT   signaling.";
RL   J. Biol. Chem. 285:31388-31398(2010).
RN   [20]
RP   STRUCTURE BY NMR OF 175-241 (ISOFORM 1).
RX   PubMed=8062828; DOI=10.1002/j.1460-2075.1994.tb06658.x;
RA   Nagata K., Kohda D., Hatanaka H., Ichikawa S., Matsuda S., Yamamoto T.,
RA   Suzuki A., Inagaki F.;
RT   "Solution structure of the epidermal growth factor-like domain of
RT   heregulin-alpha, a ligand for p180erbB-4.";
RL   EMBO J. 13:3517-3523(1994).
RN   [21]
RP   STRUCTURE BY NMR OF 177-239 (ISOFORM 1), AND DISULFIDE BONDS.
RX   PubMed=8639490; DOI=10.1021/bi952626l;
RA   Jacobsen N.E., Abadi N., Sliwkowski M.X., Reilly D., Skelton N.J.,
RA   Fairbrother W.J.;
RT   "High-resolution solution structure of the EGF-like domain of heregulin-
RT   alpha.";
RL   Biochemistry 35:3402-3417(1996).
CC   -!- FUNCTION: Direct ligand for ERBB3 and ERBB4 tyrosine kinase receptors.
CC       Concomitantly recruits ERBB1 and ERBB2 coreceptors, resulting in
CC       ligand-stimulated tyrosine phosphorylation and activation of the ERBB
CC       receptors. The multiple isoforms perform diverse functions such as
CC       inducing growth and differentiation of epithelial, glial, neuronal, and
CC       skeletal muscle cells; inducing expression of acetylcholine receptor in
CC       synaptic vesicles during the formation of the neuromuscular junction;
CC       stimulating lobuloalveolar budding and milk production in the mammary
CC       gland and inducing differentiation of mammary tumor cells; stimulating
CC       Schwann cell proliferation; implication in the development of the
CC       myocardium such as trabeculation of the developing heart. Isoform 10
CC       may play a role in motor and sensory neuron development. Binds to ERBB4
CC       (PubMed:10867024, PubMed:7902537). Binds to ERBB3 (PubMed:20682778).
CC       Acts as a ligand for integrins and binds (via EGF domain) to integrins
CC       ITGAV:ITGB3 or ITGA6:ITGB4. Its binding to integrins and subsequent
CC       ternary complex formation with integrins and ERRB3 are essential for
CC       NRG1-ERBB signaling. Induces the phosphorylation and activation of
CC       MAPK3/ERK1, MAPK1/ERK2 and AKT1 (PubMed:20682778). Ligand-dependent
CC       ERBB4 endocytosis is essential for the NRG1-mediated activation of
CC       these kinases in neurons (By similarity).
CC       {ECO:0000250|UniProtKB:P43322, ECO:0000269|PubMed:10867024,
CC       ECO:0000269|PubMed:1348215, ECO:0000269|PubMed:20682778,
CC       ECO:0000269|PubMed:7902537}.
CC   -!- SUBUNIT: The cytoplasmic domain interacts with the LIM domain region of
CC       LIMK1 (By similarity). Forms a ternary complex with ERBB3 and
CC       ITGAV:ITGB3 or ITGA6:ITGB4 (PubMed:20682778).
CC       {ECO:0000250|UniProtKB:P43322, ECO:0000269|PubMed:20682778}.
CC   -!- INTERACTION:
CC       Q02297-10; P07307-3: ASGR2; NbExp=3; IntAct=EBI-12842334, EBI-12808270;
CC       Q02297-10; P21854: CD72; NbExp=3; IntAct=EBI-12842334, EBI-307924;
CC       Q02297-7; P04626: ERBB2; NbExp=2; IntAct=EBI-2460927, EBI-641062;
CC       Q02297-7; P21860: ERBB3; NbExp=3; IntAct=EBI-2460927, EBI-720706;
CC       Q02297-10; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-12842334, EBI-10266796;
CC       Q02297-10; Q86VI4: LAPTM4B; NbExp=3; IntAct=EBI-12842334, EBI-3267258;
CC       Q02297-10; Q96JQ5: MS4A4A; NbExp=3; IntAct=EBI-12842334, EBI-12820341;
CC       Q02297-10; P60201-2: PLP1; NbExp=3; IntAct=EBI-12842334, EBI-12188331;
CC       Q02297-10; Q969K7: TMEM54; NbExp=3; IntAct=EBI-12842334, EBI-3922833;
CC   -!- SUBCELLULAR LOCATION: [Pro-neuregulin-1, membrane-bound isoform]: Cell
CC       membrane; Single-pass type I membrane protein. Note=Does not seem to be
CC       active.
CC   -!- SUBCELLULAR LOCATION: [Neuregulin-1]: Secreted.
CC   -!- SUBCELLULAR LOCATION: [Isoform 8]: Nucleus. Note=May be nuclear.
CC   -!- SUBCELLULAR LOCATION: [Isoform 9]: Secreted. Note=Has a signal peptide.
CC   -!- SUBCELLULAR LOCATION: [Isoform 10]: Membrane; Single-pass type I
CC       membrane protein. Note=May possess an internal uncleaved signal
CC       sequence.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=11;
CC         Comment=Additional isoforms seem to exist. Isoforms have been
CC         classified as type I NRGs (isoforms with an Ig domain and a
CC         glycosylation domain, isoforms 1-8), type II NRGs (isoforms with an
CC         Ig domain but no glycosylation domain, isoform 9), type III NRGs
CC         (isoforms with a Cys-rich domain, isoform 10) and type IV NRGs
CC         (isoforms with additional 5' exons, isoform 11). All these isoforms
CC         perform distinct tissue-specific functions.;
CC       Name=1; Synonyms=Alpha;
CC         IsoId=Q02297-1; Sequence=Displayed;
CC       Name=2; Synonyms=Alpha1A;
CC         IsoId=Q02297-2; Sequence=VSP_003431;
CC       Name=3; Synonyms=Alpha2B;
CC         IsoId=Q02297-3; Sequence=VSP_003434, VSP_003435;
CC       Name=4; Synonyms=Alpha3;
CC         IsoId=Q02297-4; Sequence=VSP_003432, VSP_003433;
CC       Name=6; Synonyms=Beta1, Beta1A;
CC         IsoId=Q02297-6; Sequence=VSP_003428;
CC       Name=7; Synonyms=Beta2;
CC         IsoId=Q02297-7; Sequence=VSP_003427;
CC       Name=8; Synonyms=Beta3, GGFHFB1;
CC         IsoId=Q02297-8; Sequence=VSP_003429, VSP_003430;
CC       Name=9; Synonyms=GGF2, GGFHPP2;
CC         IsoId=Q02297-9; Sequence=VSP_003425, VSP_003426, VSP_003429,
CC                                  VSP_003430;
CC       Name=10; Synonyms=SMDF;
CC         IsoId=Q02297-10; Sequence=VSP_037562, VSP_037565, VSP_003429,
CC                                   VSP_003430;
CC       Name=11; Synonyms=Type IV-beta1a;
CC         IsoId=Q02297-11; Sequence=VSP_037563, VSP_037564, VSP_003426,
CC                                   VSP_003428;
CC       Name=12;
CC         IsoId=Q02297-12; Sequence=VSP_003427, VSP_046417;
CC   -!- TISSUE SPECIFICITY: Type I isoforms are the predominant forms expressed
CC       in the endocardium. Isoform alpha is expressed in breast, ovary,
CC       testis, prostate, heart, skeletal muscle, lung, placenta liver, kidney,
CC       salivary gland, small intestine and brain, but not in uterus, stomach,
CC       pancreas, and spleen. Isoform 3 is the predominant form in mesenchymal
CC       cells and in non-neuronal organs, whereas isoform 6 is the major
CC       neuronal form. Isoform 8 is expressed in spinal cord and brain. Isoform
CC       9 is the major form in skeletal muscle cells; in the nervous system it
CC       is expressed in spinal cord and brain. Also detected in adult heart,
CC       placenta, lung, liver, kidney, and pancreas. Isoform 10 is expressed in
CC       nervous system: spinal cord motor neurons, dorsal root ganglion
CC       neurons, and brain. Predominant isoform expressed in sensory and motor
CC       neurons. Not detected in adult heart, placenta, lung, liver, skeletal
CC       muscle, kidney, and pancreas. Not expressed in fetal lung, liver and
CC       kidney. Type IV isoforms are brain-specific.
CC       {ECO:0000269|PubMed:17565985}.
CC   -!- DEVELOPMENTAL STAGE: Detectable at early embryonic ages. Isoform 10 is
CC       highly expressed in developing spinal motor neurons and in developing
CC       cranial nerve nuclei. Expression is maintained only in both adult motor
CC       neurons and dorsal root ganglion neurons. Type IV isoforms are
CC       expressed in fetal brain. {ECO:0000269|PubMed:17565985}.
CC   -!- DOMAIN: The cytoplasmic domain may be involved in the regulation of
CC       trafficking and proteolytic processing. Regulation of the proteolytic
CC       processing involves initial intracellular domain dimerization (By
CC       similarity). {ECO:0000250}.
CC   -!- DOMAIN: ERBB receptor binding is elicited entirely by the EGF-like
CC       domain.
CC   -!- PTM: Proteolytic cleavage close to the plasma membrane on the external
CC       face leads to the release of the soluble growth factor form.
CC   -!- PTM: N- and O-glycosylated. Extensive glycosylation precedes the
CC       proteolytic cleavage (By similarity). {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving NRG1 produces gamma-
CC       heregulin. Translocation t(8;11) with TENM4. The translocation fuses
CC       the 5'-end of TENM4 to NRG1 (isoform 8). The product of this
CC       translocation was first thought to be an alternatively spliced isoform.
CC       Gamma-heregulin is a soluble activating ligand for the ERBB2-ERBB3
CC       receptor complex and acts as an autocrine growth factor in a specific
CC       breast cancer cell line (MDA-MB-175). Not detected in breast carcinoma
CC       samples, including ductal, lobular, medullary, and mucinous
CC       histological types, neither in other breast cancer cell lines.
CC   -!- MISCELLANEOUS: [Isoform 10]: Potential internal signal sequence at
CC       positions 76-100. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the neuregulin family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA19955.1; Type=Miscellaneous discrepancy; Note=Contaminating sequence. Sequence of unknown origin in the N-terminal part.; Evidence={ECO:0000305};
CC       Sequence=AAC51756.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Protein Spotlight; Note=Tipping the mind - Issue 129
CC       of June 2011;
CC       URL="https://web.expasy.org/spotlight/back_issues/129";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; M94165; AAA58638.1; -; mRNA.
DR   EMBL; M94166; AAA58639.1; -; mRNA.
DR   EMBL; M94167; AAA58640.1; -; mRNA.
DR   EMBL; M94168; AAA58641.1; -; mRNA.
DR   EMBL; U02325; AAA19950.1; -; mRNA.
DR   EMBL; U02326; AAA19951.1; -; mRNA.
DR   EMBL; U02327; AAA19952.1; -; mRNA.
DR   EMBL; U02328; AAA19953.1; -; mRNA.
DR   EMBL; U02329; AAA19954.1; -; mRNA.
DR   EMBL; U02330; AAA19955.1; ALT_SEQ; mRNA.
DR   EMBL; L12260; AAB59622.1; -; mRNA.
DR   EMBL; L12261; AAB59358.1; -; mRNA.
DR   EMBL; L41827; AAC41764.1; -; mRNA.
DR   EMBL; AK289927; BAF82616.1; -; mRNA.
DR   EMBL; AK298132; BAH12729.1; -; mRNA.
DR   EMBL; AC021909; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022833; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC022850; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC023948; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068359; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC068931; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC083977; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC103675; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104000; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC104029; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC113209; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF009227; AAC51756.1; ALT_INIT; mRNA.
DR   EMBL; AF491780; AAM71137.1; -; Genomic_DNA.
DR   EMBL; AF491780; AAM71139.1; -; Genomic_DNA.
DR   EMBL; AF491780; AAM71140.1; -; Genomic_DNA.
DR   EMBL; EF372273; ABQ53539.1; -; mRNA.
DR   EMBL; EF372274; ABQ53540.1; -; mRNA.
DR   EMBL; CH471080; EAW63411.1; -; Genomic_DNA.
DR   EMBL; BC064587; AAH64587.1; -; mRNA.
DR   EMBL; BC073871; AAH73871.1; -; mRNA.
DR   EMBL; AF026146; AAD01795.1; -; mRNA.
DR   EMBL; BK000383; DAA00044.1; -; Genomic_DNA.
DR   EMBL; BK000383; DAA00045.1; -; Genomic_DNA.
DR   EMBL; BK000383; DAA00046.1; -; Genomic_DNA.
DR   EMBL; BK000383; DAA00047.1; -; Genomic_DNA.
DR   CCDS; CCDS47836.1; -. [Q02297-9]
DR   CCDS; CCDS55218.1; -. [Q02297-11]
DR   CCDS; CCDS55219.1; -. [Q02297-12]
DR   CCDS; CCDS6083.1; -. [Q02297-6]
DR   CCDS; CCDS6084.1; -. [Q02297-7]
DR   CCDS; CCDS6085.1; -. [Q02297-1]
DR   CCDS; CCDS6086.1; -. [Q02297-3]
DR   CCDS; CCDS6087.1; -. [Q02297-10]
DR   PIR; A43273; A43273.
DR   PIR; A56943; A56943.
DR   PIR; B43273; B43273.
DR   PIR; C43273; C43273.
DR   PIR; D43273; D43273.
DR   PIR; I38403; I38403.
DR   PIR; I38404; I38404.
DR   PIR; I38408; I38408.
DR   PIR; S32357; S32357.
DR   RefSeq; NP_001153467.1; NM_001159995.2.
DR   RefSeq; NP_001153471.1; NM_001159999.2.
DR   RefSeq; NP_001153473.1; NM_001160001.2. [Q02297-11]
DR   RefSeq; NP_001153477.1; NM_001160005.1.
DR   RefSeq; NP_001153480.1; NM_001160008.1. [Q02297-12]
DR   RefSeq; NP_001309134.1; NM_001322205.1.
DR   RefSeq; NP_001309135.1; NM_001322206.1.
DR   RefSeq; NP_001309136.1; NM_001322207.1.
DR   RefSeq; NP_039250.2; NM_013956.4. [Q02297-6]
DR   RefSeq; NP_039251.2; NM_013957.4. [Q02297-7]
DR   RefSeq; NP_039252.2; NM_013958.3. [Q02297-8]
DR   RefSeq; NP_039253.1; NM_013959.3. [Q02297-10]
DR   RefSeq; NP_039254.1; NM_013960.4. [Q02297-3]
DR   RefSeq; NP_039256.2; NM_013962.2. [Q02297-9]
DR   RefSeq; NP_039258.1; NM_013964.4. [Q02297-1]
DR   PDB; 1HAE; NMR; -; A=177-239.
DR   PDB; 1HAF; NMR; -; A=177-239.
DR   PDB; 1HRE; NMR; -; A=175-241.
DR   PDB; 1HRF; NMR; -; A=175-241.
DR   PDB; 3U7U; X-ray; 3.03 A; G/H/I/J/K/L=175-212.
DR   PDBsum; 1HAE; -.
DR   PDBsum; 1HAF; -.
DR   PDBsum; 1HRE; -.
DR   PDBsum; 1HRF; -.
DR   PDBsum; 3U7U; -.
DR   SMR; Q02297; -.
DR   BioGrid; 109332; 73.
DR   CORUM; Q02297; -.
DR   DIP; DIP-355N; -.
DR   IntAct; Q02297; 48.
DR   MINT; Q02297; -.
DR   STRING; 9606.ENSP00000384620; -.
DR   iPTMnet; Q02297; -.
DR   PhosphoSitePlus; Q02297; -.
DR   BioMuta; NRG1; -.
DR   DMDM; 9297018; -.
DR   jPOST; Q02297; -.
DR   MassIVE; Q02297; -.
DR   MaxQB; Q02297; -.
DR   PaxDb; Q02297; -.
DR   PeptideAtlas; Q02297; -.
DR   PRIDE; Q02297; -.
DR   ProteomicsDB; 20533; -.
DR   ProteomicsDB; 58070; -. [Q02297-1]
DR   ProteomicsDB; 58071; -. [Q02297-10]
DR   ProteomicsDB; 58072; -. [Q02297-11]
DR   ProteomicsDB; 58073; -. [Q02297-2]
DR   ProteomicsDB; 58074; -. [Q02297-3]
DR   ProteomicsDB; 58075; -. [Q02297-4]
DR   ProteomicsDB; 58076; -. [Q02297-6]
DR   ProteomicsDB; 58077; -. [Q02297-7]
DR   ProteomicsDB; 58078; -. [Q02297-8]
DR   ProteomicsDB; 58079; -. [Q02297-9]
DR   Antibodypedia; 3706; 907 antibodies.
DR   DNASU; 3084; -.
DR   Ensembl; ENST00000287842; ENSP00000287842; ENSG00000157168. [Q02297-6]
DR   Ensembl; ENST00000356819; ENSP00000349275; ENSG00000157168. [Q02297-7]
DR   Ensembl; ENST00000405005; ENSP00000384620; ENSG00000157168. [Q02297-1]
DR   Ensembl; ENST00000519301; ENSP00000429582; ENSG00000157168. [Q02297-11]
DR   Ensembl; ENST00000520407; ENSP00000434640; ENSG00000157168. [Q02297-9]
DR   Ensembl; ENST00000520502; ENSP00000433289; ENSG00000157168. [Q02297-10]
DR   Ensembl; ENST00000521670; ENSP00000428828; ENSG00000157168. [Q02297-3]
DR   Ensembl; ENST00000523079; ENSP00000430120; ENSG00000157168. [Q02297-12]
DR   Ensembl; ENST00000650919; ENSP00000498811; ENSG00000157168. [Q02297-8]
DR   GeneID; 3084; -.
DR   KEGG; hsa:3084; -.
DR   UCSC; uc003xip.4; human. [Q02297-1]
DR   CTD; 3084; -.
DR   DisGeNET; 3084; -.
DR   GeneCards; NRG1; -.
DR   HGNC; HGNC:7997; NRG1.
DR   HPA; ENSG00000157168; Tissue enhanced (brain).
DR   MalaCards; NRG1; -.
DR   MIM; 142445; gene.
DR   neXtProt; NX_Q02297; -.
DR   OpenTargets; ENSG00000157168; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   GeneTree; ENSGT00940000157326; -.
DR   HOGENOM; CLU_023628_1_0_1; -.
DR   InParanoid; Q02297; -.
DR   KO; K05455; -.
DR   OrthoDB; 313400at2759; -.
DR   PhylomeDB; Q02297; -.
DR   TreeFam; TF332469; -.
DR   Reactome; R-HSA-1227986; Signaling by ERBB2. [Q02297-10]
DR   Reactome; R-HSA-1236394; Signaling by ERBB4. [Q02297-10]
DR   Reactome; R-HSA-1250196; SHC1 events in ERBB2 signaling. [Q02297-10]
DR   Reactome; R-HSA-1250342; PI3K events in ERBB4 signaling.
DR   Reactome; R-HSA-1250347; SHC1 events in ERBB4 signaling.
DR   Reactome; R-HSA-1251985; Nuclear signaling by ERBB4.
DR   Reactome; R-HSA-1257604; PIP3 activates AKT signaling. [Q02297-10]
DR   Reactome; R-HSA-1306955; GRB7 events in ERBB2 signaling. [Q02297-10]
DR   Reactome; R-HSA-1358803; Downregulation of ERBB2:ERBB3 signaling. [Q02297-10]
DR   Reactome; R-HSA-1963640; GRB2 events in ERBB2 signaling.
DR   Reactome; R-HSA-1963642; PI3K events in ERBB2 signaling. [Q02297-10]
DR   Reactome; R-HSA-2219530; Constitutive Signaling by Aberrant PI3K in Cancer. [Q02297-10]
DR   Reactome; R-HSA-5673001; RAF/MAP kinase cascade. [Q02297-10]
DR   Reactome; R-HSA-6785631; ERBB2 Regulates Cell Motility. [Q02297-10]
DR   Reactome; R-HSA-6811558; PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling. [Q02297-10]
DR   Reactome; R-HSA-8847993; ERBB2 Activates PTK6 Signaling. [Q02297-10]
DR   Reactome; R-HSA-8863795; Downregulation of ERBB2 signaling. [Q02297-10]
DR   Reactome; R-HSA-9620244; Long-term potentiation.
DR   Reactome; R-HSA-9664565; Signaling by ERBB2 KD Mutants. [Q02297-10]
DR   SignaLink; Q02297; -.
DR   SIGNOR; Q02297; -.
DR   ChiTaRS; NRG1; human.
DR   EvolutionaryTrace; Q02297; -.
DR   GeneWiki; Neuregulin_1; -.
DR   GenomeRNAi; 3084; -.
DR   Pharos; Q02297; Tbio.
DR   PRO; PR:Q02297; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q02297; protein.
DR   Bgee; ENSG00000157168; Expressed in oocyte and 150 other tissues.
DR   ExpressionAtlas; Q02297; baseline and differential.
DR   Genevisible; Q02297; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:BHF-UCL.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IDA:BHF-UCL.
DR   GO; GO:0098982; C:GABA-ergic synapse; IEA:Ensembl.
DR   GO; GO:0098978; C:glutamatergic synapse; IDA:SynGO.
DR   GO; GO:0005887; C:integral component of plasma membrane; IEA:Ensembl.
DR   GO; GO:0099061; C:integral component of postsynaptic density membrane; IDA:SynGO.
DR   GO; GO:0099059; C:integral component of presynaptic active zone membrane; IDA:SynGO.
DR   GO; GO:0016020; C:membrane; NAS:UniProtKB.
DR   GO; GO:0031594; C:neuromuscular junction; IEA:Ensembl.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0045499; F:chemorepellent activity; IEA:Ensembl.
DR   GO; GO:0005125; F:cytokine activity; TAS:BHF-UCL.
DR   GO; GO:0005176; F:ErbB-2 class receptor binding; IEA:Ensembl.
DR   GO; GO:0043125; F:ErbB-3 class receptor binding; IDA:BHF-UCL.
DR   GO; GO:0008083; F:growth factor activity; IDA:BHF-UCL.
DR   GO; GO:0005178; F:integrin binding; IDA:UniProtKB.
DR   GO; GO:0030296; F:protein tyrosine kinase activator activity; IDA:BHF-UCL.
DR   GO; GO:0030971; F:receptor tyrosine kinase binding; NAS:UniProtKB.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:BHF-UCL.
DR   GO; GO:0003712; F:transcription coregulator activity; IDA:MGI.
DR   GO; GO:0030297; F:transmembrane receptor protein tyrosine kinase activator activity; NAS:UniProtKB.
DR   GO; GO:0000187; P:activation of MAPK activity; IMP:UniProtKB.
DR   GO; GO:0032148; P:activation of protein kinase B activity; IMP:UniProtKB.
DR   GO; GO:0007171; P:activation of transmembrane receptor protein tyrosine kinase activity; IDA:BHF-UCL.
DR   GO; GO:0048513; P:animal organ development; IBA:GO_Central.
DR   GO; GO:0003161; P:cardiac conduction system development; IEA:Ensembl.
DR   GO; GO:0055007; P:cardiac muscle cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0060379; P:cardiac muscle cell myoblast differentiation; IDA:BHF-UCL.
DR   GO; GO:0007154; P:cell communication; TAS:BHF-UCL.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0000902; P:cell morphogenesis; IEA:Ensembl.
DR   GO; GO:0008283; P:cell population proliferation; IDA:BHF-UCL.
DR   GO; GO:0043624; P:cellular protein complex disassembly; IGI:MGI.
DR   GO; GO:0021842; P:chemorepulsion involved in interneuron migration from the subpallium to the cortex; IEA:Ensembl.
DR   GO; GO:0060956; P:endocardial cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0038127; P:ERBB signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0038128; P:ERBB2 signaling pathway; TAS:Reactome.
DR   GO; GO:0038129; P:ERBB3 signaling pathway; IDA:CAFA.
DR   GO; GO:0038130; P:ERBB4 signaling pathway; IDA:UniProtKB.
DR   GO; GO:0021781; P:glial cell fate commitment; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0007626; P:locomotory behavior; IEA:Ensembl.
DR   GO; GO:0030879; P:mammary gland development; TAS:BHF-UCL.
DR   GO; GO:0000165; P:MAPK cascade; TAS:Reactome.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IEA:Ensembl.
DR   GO; GO:0010667; P:negative regulation of cardiac muscle cell apoptotic process; IDA:BHF-UCL.
DR   GO; GO:2001240; P:negative regulation of extrinsic apoptotic signaling pathway in absence of ligand; IDA:BHF-UCL.
DR   GO; GO:2001223; P:negative regulation of neuron migration; IEA:Ensembl.
DR   GO; GO:0042177; P:negative regulation of protein catabolic process; IEA:Ensembl.
DR   GO; GO:0051048; P:negative regulation of secretion; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:MGI.
DR   GO; GO:0007399; P:nervous system development; IBA:GO_Central.
DR   GO; GO:0014032; P:neural crest cell development; TAS:BHF-UCL.
DR   GO; GO:0048663; P:neuron fate commitment; IEA:Ensembl.
DR   GO; GO:0045213; P:neurotransmitter receptor metabolic process; IEA:Ensembl.
DR   GO; GO:0048709; P:oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0070886; P:positive regulation of calcineurin-NFAT signaling cascade; IEA:Ensembl.
DR   GO; GO:2000727; P:positive regulation of cardiac muscle cell differentiation; IEA:Ensembl.
DR   GO; GO:0060045; P:positive regulation of cardiac muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0045785; P:positive regulation of cell adhesion; IDA:BHF-UCL.
DR   GO; GO:0030307; P:positive regulation of cell growth; IDA:BHF-UCL.
DR   GO; GO:0008284; P:positive regulation of cell population proliferation; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IEA:Ensembl.
DR   GO; GO:1900086; P:positive regulation of peptidyl-tyrosine autophosphorylation; IDA:UniProtKB.
DR   GO; GO:0051897; P:positive regulation of protein kinase B signaling; TAS:Reactome.
DR   GO; GO:0031334; P:positive regulation of protein-containing complex assembly; IDA:BHF-UCL.
DR   GO; GO:0046579; P:positive regulation of Ras protein signal transduction; IEA:Ensembl.
DR   GO; GO:0051155; P:positive regulation of striated muscle cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0099527; P:postsynapse to nucleus signaling pathway; IEA:Ensembl.
DR   GO; GO:2000145; P:regulation of cell motility; TAS:Reactome.
DR   GO; GO:0099149; P:regulation of postsynaptic neurotransmitter receptor internalization; IDA:SynGO.
DR   GO; GO:0007416; P:synapse assembly; IEA:Ensembl.
DR   GO; GO:0099560; P:synaptic membrane adhesion; IDA:SynGO.
DR   GO; GO:0007169; P:transmembrane receptor protein tyrosine kinase signaling pathway; IDA:BHF-UCL.
DR   GO; GO:0055012; P:ventricular cardiac muscle cell differentiation; IDA:BHF-UCL.
DR   GO; GO:0003222; P:ventricular trabecula myocardium morphogenesis; IDA:BHF-UCL.
DR   GO; GO:0042060; P:wound healing; IDA:BHF-UCL.
DR   DisProt; DP01520; -. [Q02297-10]
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF00008; EGF; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell membrane;
KW   Chromosomal rearrangement; Direct protein sequencing; Disulfide bond;
KW   EGF-like domain; Glycoprotein; Growth factor; Immunoglobulin domain;
KW   Membrane; Nucleus; Polymorphism; Reference proteome; Secreted;
KW   Transmembrane; Transmembrane helix.
FT   PROPEP          1..19
FT                   /evidence="ECO:0000269|PubMed:7689552"
FT                   /id="PRO_0000019462"
FT   CHAIN           20..640
FT                   /note="Pro-neuregulin-1, membrane-bound isoform"
FT                   /id="PRO_0000019463"
FT   CHAIN           20..241
FT                   /note="Neuregulin-1"
FT                   /id="PRO_0000019464"
FT   TOPO_DOM        20..242
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        243..265
FT                   /note="Helical; Note=Internal signal sequence"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        266..640
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          37..128
FT                   /note="Ig-like C2-type"
FT   DOMAIN          178..222
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   COMPBIAS        165..177
FT                   /note="Ser/Thr-rich"
FT   SITE            34
FT                   /note="Breakpoint for translocation to form gamma-
FT                   heregulin"
FT   CARBOHYD        120
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        126
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        164
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        57..112
FT                   /evidence="ECO:0000250"
FT   DISULFID        182..196
FT                   /evidence="ECO:0000269|PubMed:8639490"
FT   DISULFID        190..210
FT                   /evidence="ECO:0000269|PubMed:8639490"
FT   DISULFID        212..221
FT                   /evidence="ECO:0000269|PubMed:8639490"
FT   VAR_SEQ         1..166
FT                   /note="Missing (in isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7782315"
FT                   /id="VSP_037562"
FT   VAR_SEQ         1..33
FT                   /note="MSERKEGRGKGKGKKKERGSGKKPESAAGSQSP -> MRWRRAPRRSGRPGP
FT                   RAQRPGSAARSSPPLPLLPLLLLLGTAALAPGAAAGNEAAPAGASVCYSSPPSVGSVQE
FT                   LAQRAAVVIEGKVHPQRRQQGALDRKAAAAAGEAGAWGGDREPPAAGPRALGPPAEEPL
FT                   LAANGTVPSWPTAPVPSAGEPGEEAPYLVKVHQVWAVKAGGLKKDSLLTVRLGTWGHPA
FT                   FPSCGRLKEDSRYIFFMEPDANSTSRAPAAFRASFPPLETGRNLKKEVSRVLCKRC
FT                   (in isoform 9)"
FT                   /evidence="ECO:0000303|PubMed:8096067"
FT                   /id="VSP_003425"
FT   VAR_SEQ         1..21
FT                   /note="Missing (in isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:17565985"
FT                   /id="VSP_037563"
FT   VAR_SEQ         22..33
FT                   /note="KKPESAAGSQSP -> MGKGRAGRVGTT (in isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:17565985"
FT                   /id="VSP_037564"
FT   VAR_SEQ         134..168
FT                   /note="EIITGMPASTEGAYVSSESPIRISVSTEGANTSSS -> A (in isoform
FT                   9 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:17565985,
FT                   ECO:0000303|PubMed:8096067"
FT                   /id="VSP_003426"
FT   VAR_SEQ         167
FT                   /note="S -> MEIYSPDMSEVAAERSSSPSTQLSADPSLDGLPAAEDMPEPQTEDGR
FT                   TPGLVGLAVPCCACLEAERLRGCLNSEKICIVPILACLVSLCLCIAGLKWVFVDKIFEY
FT                   DSPTHLDPGGLGQDPIISLDATAASAVWVSSEAYTSPVSRAQSESEVQVTVQGDKAVVS
FT                   FEPSAAPTPKNRIFAFSFLPSTAPSFPSPTRNPEVRTPKSATQPQTTETNLQTAPKL
FT                   (in isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:7782315"
FT                   /id="VSP_037565"
FT   VAR_SEQ         213..241
FT                   /note="QPGFTGARCTENVPMKVQNQEKAEELYQK -> PNEFTGDRCQNYVMASFYS
FT                   TSTPFLSLPE (in isoform 8, isoform 9 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:1350381,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7509448, ECO:0000303|PubMed:7782315,
FT                   ECO:0000303|PubMed:8096067"
FT                   /id="VSP_003429"
FT   VAR_SEQ         213..234
FT                   /note="QPGFTGARCTENVPMKVQNQEK -> PNEFTGDRCQNYVMASFYKHLGIEFM
FT                   E (in isoform 6 and isoform 11)"
FT                   /evidence="ECO:0000303|PubMed:1350381,
FT                   ECO:0000303|PubMed:17565985, ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003428"
FT   VAR_SEQ         213..233
FT                   /note="QPGFTGARCTENVPMKVQNQE -> PNEFTGDRCQNYVMASFY (in
FT                   isoform 7 and isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:1350381,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003427"
FT   VAR_SEQ         234..247
FT                   /note="KAEELYQKRVLTIT -> SAQMSLLVIAAKTT (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003432"
FT   VAR_SEQ         234
FT                   /note="K -> KHLGIEFIE (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003431"
FT   VAR_SEQ         242..640
FT                   /note="Missing (in isoform 8, isoform 9 and isoform 10)"
FT                   /evidence="ECO:0000303|PubMed:1350381,
FT                   ECO:0000303|PubMed:14702039, ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:7509448, ECO:0000303|PubMed:7782315,
FT                   ECO:0000303|PubMed:8096067"
FT                   /id="VSP_003430"
FT   VAR_SEQ         248..640
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003433"
FT   VAR_SEQ         424..640
FT                   /note="Missing (in isoform 12)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_046417"
FT   VAR_SEQ         424..462
FT                   /note="YVSAMTTPARMSPVDFHTPSSPKSPPSEMSPPVSSMTVS -> HNLIAELRR
FT                   NKAHRSKCMQIQLSATHLRSSSIPHLGFIL (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003434"
FT   VAR_SEQ         463..640
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:7509448"
FT                   /id="VSP_003435"
FT   VARIANT         38
FT                   /note="R -> Q (in dbSNP:rs3924999)"
FT                   /evidence="ECO:0000269|PubMed:17565985"
FT                   /id="VAR_009307"
FT   VARIANT         289
FT                   /note="M -> T (in dbSNP:rs10503929)"
FT                   /evidence="ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:17565985"
FT                   /id="VAR_053531"
FT   VARIANT         463
FT                   /note="M -> K"
FT                   /id="VAR_009308"
FT   MUTAGEN         181
FT                   /note="K->E: Defective in integrin-binding and in inducing
FT                   ERBB3 phosphorylation; when associated with or without E-
FT                   185 or E-187. No effect on ERBB3-binding, defective in
FT                   integrin-binding and in ternary complex formation with
FT                   ERBB3 and integrins, and defective in inducing NRG1-ERBB
FT                   signaling; when associated with E-185 and E-187."
FT                   /evidence="ECO:0000269|PubMed:20682778"
FT   MUTAGEN         185
FT                   /note="K->E: Defective in integrin-binding and in inducing
FT                   ERBB3 phosphorylation; when associated with or without E-
FT                   181 or E-187. No effect on ERBB3-binding, defective in
FT                   integrin-binding and in ternary complex formation with
FT                   ERBB3 and integrins, and defective in inducing NRG1-ERBB
FT                   signaling; when associated with E-181 and E-187."
FT                   /evidence="ECO:0000269|PubMed:20682778"
FT   MUTAGEN         187
FT                   /note="K->E: Defective in integrin-binding and in inducing
FT                   ERBB3 phosphorylation; when associated with or without E-
FT                   181 or E-185. No effect on ERBB3-binding, defective in
FT                   integrin-binding and in ternary complex formation with
FT                   ERBB3 and integrins, and defective in inducing NRG1-ERBB
FT                   signaling; when associated with E-181 and E-185."
FT                   /evidence="ECO:0000269|PubMed:20682778"
FT   CONFLICT        94
FT                   /note="K -> A (in Ref. 2; AAA19953)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        107
FT                   /note="S -> P (in Ref. 10; ABQ53539)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        261
FT                   /note="V -> L (in Ref. 10; ABQ53540)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        414
FT                   /note="S -> F (in Ref. 2; AAA19953)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        535
FT                   /note="Q -> R (in Ref. 2; AAA19951)"
FT                   /evidence="ECO:0000305"
FT   STRAND          179..181
FT                   /evidence="ECO:0000244|PDB:3U7U"
FT   TURN            185..189
FT                   /evidence="ECO:0000244|PDB:3U7U"
FT   STRAND          190..193
FT                   /evidence="ECO:0000244|PDB:1HRE"
FT   STRAND          195..199
FT                   /evidence="ECO:0000244|PDB:3U7U"
FT   STRAND          200..204
FT                   /evidence="ECO:0000244|PDB:1HRE"
FT   STRAND          208..212
FT                   /evidence="ECO:0000244|PDB:3U7U"
FT   STRAND          216..218
FT                   /evidence="ECO:0000244|PDB:3U7U"
FT   STRAND          233..235
FT                   /evidence="ECO:0000244|PDB:1HAF"
FT   VARIANT         Q02297-10:46
FT                   /note="G -> R (in dbSNP:rs3735774)"
FT                   /evidence="ECO:0000305"
FT                   /id="VAR_082866"
FT   VARIANT         Q02297-10:127
FT                   /note="A -> P (in dbSNP:rs34822181)"
FT                   /evidence="ECO:0000305"
FT                   /id="VAR_082867"
SQ   SEQUENCE   640 AA;  70392 MW;  C30D3F614AADFF62 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCQPGFTGAR CTENVPMKVQ NQEKAEELYQ
     KRVLTITGIC IALLVVGIMC VVAYCKTKKQ RKKLHDRLRQ SLRSERNNMM NIANGPHHPN
     PPPENVQLVN QYVSKNVISS EHIVEREAET SFSTSHYTST AHHSTTVTQT PSHSWSNGHT
     ESILSESHSV IVMSSVENSR HSSPTGGPRG RLNGTGGPRE CNSFLRHARE TPDSYRDSPH
     SERYVSAMTT PARMSPVDFH TPSSPKSPPS EMSPPVSSMT VSMPSMAVSP FMEEERPLLL
     VTPPRLREKK FDHHPQQFSS FHHNPAHDSN SLPASPLRIV EDEEYETTQE YEPAQEPVKK
     LANSRRAKRT KPNGHIANRL EVDSNTSSQS SNSESETEDE RVGEDTPFLG IQNPLAASLE
     ATPAFRLADS RTNPAGRFST QEEIQARLSS VIANQDPIAV
//
ID   Q6PK61_HUMAN            Unreviewed;       241 AA.
AC   Q6PK61;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   11-DEC-2019, entry version 96.
DE   SubName: Full=Neuregulin 1 {ECO:0000313|EMBL:AAH06492.1};
GN   Name=NRG1 {ECO:0000313|EMBL:AAH06492.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH06492.1};
RN   [1] {ECO:0000313|EMBL:AAH06492.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Ovary {ECO:0000313|EMBL:AAH06492.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC006492; AAH06492.1; -; mRNA.
DR   RefSeq; NP_001153480.1; NM_001160008.1.
DR   RefSeq; NP_039250.2; NM_013956.4.
DR   RefSeq; NP_039251.2; NM_013957.4.
DR   RefSeq; NP_039254.1; NM_013960.4.
DR   RefSeq; NP_039258.1; NM_013964.4.
DR   PeptideAtlas; Q6PK61; -.
DR   PRIDE; Q6PK61; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   KEGG; hsa:3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   KO; K05455; -.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   Genevisible; Q6PK61; HS.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076}.
FT   DOMAIN          37..128
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          178..222
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        212..221
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   241 AA;  26114 MW;  FE8B9FDF71B816B1 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPQLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY STSTPFLSLP
     E
//
ID   Q7RTW3_HUMAN            Unreviewed;       637 AA.
AC   Q7RTW3;
DT   15-DEC-2003, integrated into UniProtKB/TrEMBL.
DT   15-DEC-2003, sequence version 1.
DT   26-FEB-2020, entry version 113.
DE   SubName: Full=Neuregulin 1 isoform HRG-beta2 {ECO:0000313|EMBL:DAA00042.1};
DE   SubName: Full=Neuregulin 1, isoform CRA_j {ECO:0000313|EMBL:EAW63416.1};
DE   SubName: Full=cDNA FLJ77413, highly similar to Homo sapiens neuregulin 1 (NRG1), transcript variant HRG-beta2, mRNA {ECO:0000313|EMBL:BAF83419.1};
GN   Name=NRG1 {ECO:0000313|EMBL:DAA00042.1};
GN   ORFNames=hCG_14780 {ECO:0000313|EMBL:EAW63416.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:DAA00042.1};
RN   [1] {ECO:0000313|EMBL:EAW63416.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:DAA00042.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O.,
RA   Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G.,
RA   Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S.,
RA   Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V.,
RA   Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T.,
RA   Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A.,
RA   Gulcher J.R., Petursson H., Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [3] {ECO:0000313|EMBL:EAW63416.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAF83419.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- CAUTION: Lacks conserved residue(s) required for the propagation of
CC       feature annotation. {ECO:0000256|PROSITE-ProRule:PRU00076}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK290730; BAF83419.1; -; mRNA.
DR   EMBL; BK000383; DAA00042.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63416.1; -; Genomic_DNA.
DR   RefSeq; NP_039251.2; NM_013957.4.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR002154; Neuregulin_C.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF02158; Neuregulin; 1.
DR   PRINTS; PR01089; NEUREGULIN.
DR   SMART; SM00181; EGF; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS00022; EGF_1; 1.
DR   PROSITE; PS50026; EGF_3; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   2: Evidence at transcript level;
KW   Disulfide bond {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   EGF-like domain {ECO:0000256|PROSITE-ProRule:PRU00076};
KW   Membrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        240..261
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          37..128
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          178..222
FT                   /note="EGF-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50026"
FT   REGION          1..51
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          281..301
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          331..357
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          372..398
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          430..458
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          521..585
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        372..386
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        556..570
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   DISULFID        212..221
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00076"
SQ   SEQUENCE   637 AA;  70169 MW;  0B89DF6E2ED70333 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC KCPNEFTGDR CQNYVMASFY KAEELYQKRV
     LTITGICIAL LVVGIMCVVA YCKTKKQRKK LHDRLRQSLR SERNNTMNIA NGPHHPNPPP
     ENVQLVNQYV SKNVISSEHI VEREAETSFS TSHYTSTAHH STTVTQTPSH SWSNGHTESI
     LSESHSVIVM SSVENSRHSS PTGGPRGRLN GTGGPRECNS FLRHARETPD SYRDSPHSER
     YVSAMTTPAR MSPVDFHTPS SPKSPPSEMS PPVSSMTVSM PSMAVSPFME EERPLLLVTP
     PRLREKKFDH HPQQFSSFHH NPAHDSNSLP ASPLRIVEDE EYETTQEYEP AQEPVKKLAN
     SRRAKRTKPN GHIANRLEVD SNTSSQSSNS ESETEDERVG EDTPFLGIQN PLAASLEATP
     AFRLADSRTN PAGRFSTQEE IQARLSSVIA NQDPIAV
//
ID   Q7RTW5_HUMAN            Unreviewed;       211 AA.
AC   Q7RTW5;
DT   15-DEC-2003, integrated into UniProtKB/TrEMBL.
DT   15-DEC-2003, sequence version 1.
DT   11-DEC-2019, entry version 127.
DE   SubName: Full=Neuregulin 1 isoform HRG-gamma {ECO:0000313|EMBL:DAA00040.1};
DE   SubName: Full=Neuregulin 1, isoform CRA_l {ECO:0000313|EMBL:EAW63418.1};
GN   Name=NRG1 {ECO:0000313|EMBL:DAA00040.1};
GN   ORFNames=hCG_14780 {ECO:0000313|EMBL:EAW63418.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:DAA00040.1};
RN   [1] {ECO:0000313|EMBL:EAW63418.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:DAA00040.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=12145742; DOI=10.1086/342734;
RA   Stefansson H., Sigurdsson E., Steinthorsdottir V., Bjornsdottir S.,
RA   Sigmundsson T., Ghosh S., Brynjolfsson J., Gunnarsdottir S., Ivarsson O.,
RA   Chou T.T., Hjaltason O., Birgisdottir B., Jonsson H., Gudnadottir V.G.,
RA   Gudmundsdottir E., Bjornsson A., Ingvarsson B., Ingason A., Sigfusson S.,
RA   Hardardottir H., Harvey R.P., Lai D., Zhou M., Brunner D., Mutel V.,
RA   Gonzalo A., Lemke G., Sainz J., Johannesson G., Andresson T.,
RA   Gudbjartsson D., Manolescu A., Frigge M.L., Gurney M.E., Kong A.,
RA   Gulcher J.R., Petursson H., Stefansson K.;
RT   "Neuregulin 1 and susceptibility to Schizophrenia.";
RL   Am. J. Hum. Genet. 71:877-892(2002).
RN   [3] {ECO:0000313|EMBL:EAW63418.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BK000383; DAA00040.1; -; Genomic_DNA.
DR   EMBL; CH471080; EAW63418.1; -; Genomic_DNA.
DR   RefSeq; NP_004486.2; NM_004495.3.
DR   SMR; Q7RTW5; -.
DR   PeptideAtlas; Q7RTW5; -.
DR   PRIDE; Q7RTW5; -.
DR   DNASU; 3084; -.
DR   GeneID; 3084; -.
DR   CTD; 3084; -.
DR   PharmGKB; PA31776; -.
DR   eggNOG; ENOG410IEU9; Eukaryota.
DR   eggNOG; ENOG4110ST7; LUCA.
DR   OrthoDB; 313400at2759; -.
DR   ChiTaRS; NRG1; human.
DR   GenomeRNAi; 3084; -.
DR   GO; GO:0005102; F:signaling receptor binding; IEA:InterPro.
DR   GO; GO:0007399; P:nervous system development; IEA:InterPro.
DR   Gene3D; 2.60.40.10; -; 1.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR040180; Neuregulin.
DR   InterPro; IPR018250; NRG1.
DR   PANTHER; PTHR11100; PTHR11100; 1.
DR   PANTHER; PTHR11100:SF7; PTHR11100:SF7; 1.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00408; IGc2; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   PROSITE; PS50835; IG_LIKE; 1.
PE   4: Predicted;
FT   DOMAIN          37..128
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   REGION          1..53
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   211 AA;  22755 MW;  E9EA8BF45F2A1090 CRC64;
     MSERKEGRGK GKGKKKERGS GKKPESAAGS QSPALPPRLK EMKSQESAAG SKLVLRCETS
     SEYSSLRFKW FKNGNELNRK NKPQNIKIQK KPGKSELRIN KASLADSGEY MCKVISKLGN
     DSASANITIV ESNEIITGMP ASTEGAYVSS ESPIRISVST EGANTSSSTS TSTTGTSHLV
     KCAEKEKTFC VNGGECFMVK DLSNPSRYLC K
//
ID   A0A024R1F8_HUMAN        Unreviewed;       641 AA.
AC   A0A024R1F8;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Zinc finger protein 278, isoform CRA_d {ECO:0000313|EMBL:EAW59971.1};
GN   Name=ZNF278 {ECO:0000313|EMBL:EAW59971.1};
GN   ORFNames=hCG_41522 {ECO:0000313|EMBL:EAW59971.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59971.1};
RN   [1] {ECO:0000313|EMBL:EAW59971.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59971.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471095; EAW59968.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59971.1; -; Genomic_DNA.
DR   RefSeq; NP_114439.1; NM_032050.1.
DR   Antibodypedia; 25019; 162 antibodies.
DR   GeneID; 23598; -.
DR   CTD; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   HOGENOM; CLU_030477_1_0_1; -.
DR   ChiTaRS; PATZ1; human.
DR   GenomeRNAi; 23598; -.
DR   Bgee; ENSG00000100105; Expressed in oviduct epithelium and 221 other tissues.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 7.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 3.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 6.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 6.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          41..130
FT                   /note="BTB"
FT                   /evidence="ECO:0000259|PROSITE:PS50097"
FT   DOMAIN          292..314
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          355..382
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          383..410
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          413..441
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          442..469
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          559..582
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          250..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          332..351
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          511..557
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        511..542
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   641 AA;  69079 MW;  29515535E380F0CE CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NREGQKCSHQ DPIESSDSYG DLSDASDLKT PEKQSANGSF
     SCDMAVPKNK MESDGEKKYP CPECGSFFRS KSYLNKHIQK VHVRALGGPL GDLGPALGSP
     FSPQQNMSLL ESFGFQIVQS AFASSLVDPE VDQQPMGPEG K
//
ID   A0A024R1H7_HUMAN        Unreviewed;       537 AA.
AC   A0A024R1H7;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 51.
DE   SubName: Full=Zinc finger protein 278, isoform CRA_b {ECO:0000313|EMBL:EAW59970.1};
GN   Name=ZNF278 {ECO:0000313|EMBL:EAW59970.1};
GN   ORFNames=hCG_41522 {ECO:0000313|EMBL:EAW59970.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59970.1};
RN   [1] {ECO:0000313|EMBL:EAW59970.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59970.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471095; EAW59966.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59970.1; -; Genomic_DNA.
DR   RefSeq; NP_114441.1; NM_032052.1.
DR   Antibodypedia; 25019; 162 antibodies.
DR   GeneID; 23598; -.
DR   CTD; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   ChiTaRS; PATZ1; human.
DR   GenomeRNAi; 23598; -.
DR   Bgee; ENSG00000100105; Expressed in oviduct epithelium and 221 other tissues.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 6.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 2.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 5.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 5.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          41..130
FT                   /note="BTB"
FT                   /evidence="ECO:0000259|PROSITE:PS50097"
FT   DOMAIN          292..314
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          355..382
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          383..410
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          413..441
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          442..469
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          250..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          332..351
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   537 AA;  57995 MW;  950792413BF1F5DB CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NRGLQAPGAH PEWGSSVPLR QDLWQQRRPE MLTSGSD
//
ID   A0A024R1M5_HUMAN        Unreviewed;       687 AA.
AC   A0A024R1M5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 53.
DE   SubName: Full=Zinc finger protein 278, isoform CRA_c {ECO:0000313|EMBL:EAW59969.1};
GN   Name=ZNF278 {ECO:0000313|EMBL:EAW59969.1};
GN   ORFNames=hCG_41522 {ECO:0000313|EMBL:EAW59969.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW59969.1};
RN   [1] {ECO:0000313|EMBL:EAW59969.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW59969.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471095; EAW59967.1; -; Genomic_DNA.
DR   EMBL; CH471095; EAW59969.1; -; Genomic_DNA.
DR   RefSeq; NP_055138.2; NM_014323.2.
DR   Antibodypedia; 25019; 162 antibodies.
DR   GeneID; 23598; -.
DR   KEGG; hsa:23598; -.
DR   CTD; 23598; -.
DR   EuPathDB; HostDB:ENSG00000100105.17; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   OMA; HQESIPN; -.
DR   OrthoDB; 1318335at2759; -.
DR   ChiTaRS; PATZ1; human.
DR   GenomeRNAi; 23598; -.
DR   Bgee; ENSG00000100105; Expressed in oviduct epithelium and 221 other tissues.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 7.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          41..130
FT                   /note="BTB"
FT                   /evidence="ECO:0000259|PROSITE:PS50097"
FT   DOMAIN          292..314
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          355..382
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          383..410
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          413..441
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          442..469
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          495..519
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          605..628
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          250..278
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          332..351
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          549..603
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        557..588
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   687 AA;  74060 MW;  0F1C59A78C6D110A CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NRGFSSASYL KVHVKTHHGV PLPQVSRHQE PILNGGAAFH
     CARTYGNKEG QKCSHQDPIE SSDSYGDLSD ASDLKTPEKQ SANGSFSCDM AVPKNKMESD
     GEKKYPCPEC GSFFRSKSYL NKHIQKVHVR ALGGPLGDLG PALGSPFSPQ QNMSLLESFG
     FQIVQSAFAS SLVDPEVDQQ PMGPEGK
//
ID   PATZ1_HUMAN             Reviewed;         687 AA.
AC   Q9HBE1; Q9HBE2; Q9HBE3; Q9P1A9; Q9UDU0; Q9Y529;
DT   07-NOV-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   22-APR-2020, entry version 181.
DE   RecName: Full=POZ-, AT hook-, and zinc finger-containing protein 1;
DE   AltName: Full=BTB/POZ domain zinc finger transcription factor;
DE   AltName: Full=Protein kinase A RI subunit alpha-associated protein;
DE   AltName: Full=Zinc finger and BTB domain-containing protein 19;
DE   AltName: Full=Zinc finger protein 278;
DE   AltName: Full=Zinc finger sarcoma gene protein;
GN   Name=PATZ1; Synonyms=PATZ, RIAZ, ZBTB19, ZNF278, ZSG;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 4), SUBCELLULAR LOCATION, FUNCTION, AND
RP   INTERACTION WITH RNF4.
RX   PubMed=10713105; DOI=10.1074/jbc.275.11.7894;
RA   Fedele M., Benvenuto G., Pero R., Majello B., Battista S., Lembo F.,
RA   Vollono E., Day P.M., Santoro M., Lania L., Bruni C.B., Fusco A.,
RA   Chiatiotti L.;
RT   "A novel member of the BTB/POZ family, PATZ, associates with the RNF4 RING
RT   finger protein and acts as a transcriptional repressor.";
RL   J. Biol. Chem. 275:7894-7901(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1; 2; 3 AND 4), AND CHROMOSOMAL
RP   TRANSLOCATION WITH EWSR1.
RX   PubMed=10949935; DOI=10.1038/sj.onc.1203762;
RA   Mastrangelo T., Modena P., Tornielli S., Bullrich F., Testi A.,
RA   Mezzelani A., Radice P., Azzarelli A., Pilotti S., Croce C., Pierotti M.,
RA   Sozzi G.;
RT   "A novel zinc finger gene is fused to EWS in small round cell tumor.";
RL   Oncogene 19:3799-3804(2000).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 3).
RA   Chin K.-V., Yang W.-L., Kudoh K.;
RT   "Novel cAMP signalling via the regulatory subunit of the cAMP-dependent
RT   protein kinase.";
RL   Submitted (MAR-2001) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RA   Collins J.E., Huckle E.J.;
RL   Submitted (JUL-1999) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3).
RX   PubMed=15461802; DOI=10.1186/gb-2004-5-10-r84;
RA   Collins J.E., Wright C.L., Edwards C.A., Davis M.P., Grinham J.A.,
RA   Cole C.G., Goward M.E., Aguado B., Mallya M., Mokrab Y., Huckle E.J.,
RA   Beare D.M., Dunham I.;
RT   "A genome annotation-driven approach to cloning the human ORFeome.";
RL   Genome Biol. 5:R84.1-R84.11(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=10591208; DOI=10.1038/990031;
RA   Dunham I., Hunt A.R., Collins J.E., Bruskiewich R., Beare D.M., Clamp M.,
RA   Smink L.J., Ainscough R., Almeida J.P., Babbage A.K., Bagguley C.,
RA   Bailey J., Barlow K.F., Bates K.N., Beasley O.P., Bird C.P., Blakey S.E.,
RA   Bridgeman A.M., Buck D., Burgess J., Burrill W.D., Burton J., Carder C.,
RA   Carter N.P., Chen Y., Clark G., Clegg S.M., Cobley V.E., Cole C.G.,
RA   Collier R.E., Connor R., Conroy D., Corby N.R., Coville G.J., Cox A.V.,
RA   Davis J., Dawson E., Dhami P.D., Dockree C., Dodsworth S.J., Durbin R.M.,
RA   Ellington A.G., Evans K.L., Fey J.M., Fleming K., French L., Garner A.A.,
RA   Gilbert J.G.R., Goward M.E., Grafham D.V., Griffiths M.N.D., Hall C.,
RA   Hall R.E., Hall-Tamlyn G., Heathcott R.W., Ho S., Holmes S., Hunt S.E.,
RA   Jones M.C., Kershaw J., Kimberley A.M., King A., Laird G.K., Langford C.F.,
RA   Leversha M.A., Lloyd C., Lloyd D.M., Martyn I.D., Mashreghi-Mohammadi M.,
RA   Matthews L.H., Mccann O.T., Mcclay J., Mclaren S., McMurray A.A.,
RA   Milne S.A., Mortimore B.J., Odell C.N., Pavitt R., Pearce A.V., Pearson D.,
RA   Phillimore B.J.C.T., Phillips S.H., Plumb R.W., Ramsay H., Ramsey Y.,
RA   Rogers L., Ross M.T., Scott C.E., Sehra H.K., Skuce C.D., Smalley S.,
RA   Smith M.L., Soderlund C., Spragon L., Steward C.A., Sulston J.E.,
RA   Swann R.M., Vaudin M., Wall M., Wallis J.M., Whiteley M.N., Willey D.L.,
RA   Williams L., Williams S.A., Williamson H., Wilmer T.E., Wilming L.,
RA   Wright C.L., Hubbard T., Bentley D.R., Beck S., Rogers J., Shimizu N.,
RA   Minoshima S., Kawasaki K., Sasaki T., Asakawa S., Kudoh J., Shintani A.,
RA   Shibuya K., Yoshizaki Y., Aoki N., Mitsuyama S., Roe B.A., Chen F., Chu L.,
RA   Crabtree J., Deschamps S., Do A., Do T., Dorman A., Fang F., Fu Y., Hu P.,
RA   Hua A., Kenton S., Lai H., Lao H.I., Lewis J., Lewis S., Lin S.-P., Loh P.,
RA   Malaj E., Nguyen T., Pan H., Phan S., Qi S., Qian Y., Ray L., Ren Q.,
RA   Shaull S., Sloan D., Song L., Wang Q., Wang Y., Wang Z., White J.,
RA   Willingham D., Wu H., Yao Z., Zhan M., Zhang G., Chissoe S., Murray J.,
RA   Miller N., Minx P., Fulton R., Johnson D., Bemis G., Bentley D.,
RA   Bradshaw H., Bourne S., Cordes M., Du Z., Fulton L., Goela D., Graves T.,
RA   Hawkins J., Hinds K., Kemp K., Latreille P., Layman D., Ozersky P.,
RA   Rohlfing T., Scheet P., Walker C., Wamsley A., Wohldmann P., Pepin K.,
RA   Nelson J., Korf I., Bedell J.A., Hillier L.W., Mardis E., Waterston R.,
RA   Wilson R., Emanuel B.S., Shaikh T., Kurahashi H., Saitta S., Budarf M.L.,
RA   McDermid H.E., Johnson A., Wong A.C.C., Morrow B.E., Edelmann L., Kim U.J.,
RA   Shizuya H., Simon M.I., Dumanski J.P., Peyrard M., Kedra D., Seroussi E.,
RA   Fransson I., Tapia I., Bruder C.E., O'Brien K.P., Wilkinson P.,
RA   Bodenteich A., Hartman K., Hu X., Khan A.S., Lane L., Tilahun Y.,
RA   Wright H.;
RT   "The DNA sequence of human chromosome 22.";
RL   Nature 402:489-495(1999).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4).
RC   TISSUE=Colon;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-282, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-112 AND LYS-272, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [11]
RP   STRUCTURE BY NMR OF 359-437.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of zinc finger domains in zinc finger protein 278.";
RL   Submitted (APR-2008) to the PDB data bank.
CC   -!- FUNCTION: Transcriptional repressor. {ECO:0000269|PubMed:10713105}.
CC   -!- SUBUNIT: Interacts with RNF4. {ECO:0000269|PubMed:10713105}.
CC   -!- INTERACTION:
CC       Q9HBE1-4; G4XUV3; NbExp=3; IntAct=EBI-11022007, EBI-10177989;
CC       Q9HBE1-4; Q8NFV4-4: ABHD11; NbExp=3; IntAct=EBI-11022007, EBI-12318443;
CC       Q9HBE1-4; Q9ULX6: AKAP8L; NbExp=3; IntAct=EBI-11022007, EBI-357530;
CC       Q9HBE1-4; Q9NXR5-2: ANKRD10; NbExp=3; IntAct=EBI-11022007, EBI-12102070;
CC       Q9HBE1-4; Q8N9W6-4: BOLL; NbExp=3; IntAct=EBI-11022007, EBI-11983447;
CC       Q9HBE1-4; Q9NP55: BPIFA1; NbExp=3; IntAct=EBI-11022007, EBI-953896;
CC       Q9HBE1-4; Q9H5F2: C11orf1; NbExp=3; IntAct=EBI-11022007, EBI-718615;
CC       Q9HBE1-4; Q5BKX5-3: C19orf54; NbExp=3; IntAct=EBI-11022007, EBI-11976299;
CC       Q9HBE1-4; Q96HB5: CCDC120; NbExp=3; IntAct=EBI-11022007, EBI-744556;
CC       Q9HBE1-4; Q8TAP6: CEP76; NbExp=3; IntAct=EBI-11022007, EBI-742887;
CC       Q9HBE1-4; Q8N684-3: CPSF7; NbExp=3; IntAct=EBI-11022007, EBI-11523759;
CC       Q9HBE1-4; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-11022007, EBI-3867333;
CC       Q9HBE1-4; Q15038: DAZAP2; NbExp=3; IntAct=EBI-11022007, EBI-724310;
CC       Q9HBE1-4; Q92997: DVL3; NbExp=3; IntAct=EBI-11022007, EBI-739789;
CC       Q9HBE1-4; O00167-2: EYA2; NbExp=3; IntAct=EBI-11022007, EBI-12807776;
CC       Q9HBE1-4; Q92567-2: FAM168A; NbExp=3; IntAct=EBI-11022007, EBI-11978259;
CC       Q9HBE1-4; A1KXE4-2: FAM168B; NbExp=3; IntAct=EBI-11022007, EBI-12193763;
CC       Q9HBE1-4; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-11022007, EBI-5916454;
CC       Q9HBE1-4; O95872: GPANK1; NbExp=3; IntAct=EBI-11022007, EBI-751540;
CC       Q9HBE1-4; P52597: HNRNPF; NbExp=3; IntAct=EBI-11022007, EBI-352986;
CC       Q9HBE1-4; P31943: HNRNPH1; NbExp=6; IntAct=EBI-11022007, EBI-351590;
CC       Q9HBE1-4; Q16082: HSPB2; NbExp=3; IntAct=EBI-11022007, EBI-739395;
CC       Q9HBE1-4; Q8NA54: IQUB; NbExp=3; IntAct=EBI-11022007, EBI-10220600;
CC       Q9HBE1-4; Q13351: KLF1; NbExp=3; IntAct=EBI-11022007, EBI-8284732;
CC       Q9HBE1-4; Q96G42: KLHDC7B; NbExp=3; IntAct=EBI-11022007, EBI-9478422;
CC       Q9HBE1-4; Q14525: KRT33B; NbExp=3; IntAct=EBI-11022007, EBI-1049638;
CC       Q9HBE1-4; P59991: KRTAP12-2; NbExp=3; IntAct=EBI-11022007, EBI-10176379;
CC       Q9HBE1-4; Q52LG2: KRTAP13-2; NbExp=3; IntAct=EBI-11022007, EBI-11953846;
CC       Q9HBE1-4; Q3LI76: KRTAP15-1; NbExp=5; IntAct=EBI-11022007, EBI-11992140;
CC       Q9HBE1-4; Q8IUB9: KRTAP19-1; NbExp=3; IntAct=EBI-11022007, EBI-12811111;
CC       Q9HBE1-4; Q3LI72: KRTAP19-5; NbExp=5; IntAct=EBI-11022007, EBI-1048945;
CC       Q9HBE1-4; Q3LI70: KRTAP19-6; NbExp=3; IntAct=EBI-11022007, EBI-12805508;
CC       Q9HBE1-4; Q3SYF9: KRTAP19-7; NbExp=3; IntAct=EBI-11022007, EBI-10241353;
CC       Q9HBE1-4; Q9BYR8: KRTAP3-1; NbExp=3; IntAct=EBI-11022007, EBI-9996449;
CC       Q9HBE1-4; Q9BYR6: KRTAP3-3; NbExp=3; IntAct=EBI-11022007, EBI-3957694;
CC       Q9HBE1-4; Q3LI64: KRTAP6-1; NbExp=3; IntAct=EBI-11022007, EBI-12111050;
CC       Q9HBE1-4; Q3LI66: KRTAP6-2; NbExp=3; IntAct=EBI-11022007, EBI-11962084;
CC       Q9HBE1-4; P25791-3: LMO2; NbExp=3; IntAct=EBI-11022007, EBI-11959475;
CC       Q9HBE1-4; Q17RB8: LONRF1; NbExp=3; IntAct=EBI-11022007, EBI-2341787;
CC       Q9HBE1-4; Q8IV03: LURAP1L; NbExp=3; IntAct=EBI-11022007, EBI-12898559;
CC       Q9HBE1-4; Q9BRK4: LZTS2; NbExp=3; IntAct=EBI-11022007, EBI-741037;
CC       Q9HBE1-4; Q99750: MDFI; NbExp=3; IntAct=EBI-11022007, EBI-724076;
CC       Q9HBE1-4; P35548: MSX2; NbExp=3; IntAct=EBI-11022007, EBI-6447480;
CC       Q9HBE1-4; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-11022007, EBI-10271199;
CC       Q9HBE1-4; P0CG21: NHLRC4; NbExp=3; IntAct=EBI-11022007, EBI-12868744;
CC       Q9HBE1-4; O43482: OIP5; NbExp=3; IntAct=EBI-11022007, EBI-536879;
CC       Q9HBE1-4; Q99471: PFDN5; NbExp=3; IntAct=EBI-11022007, EBI-357275;
CC       Q9HBE1-4; O43189: PHF1; NbExp=3; IntAct=EBI-11022007, EBI-530034;
CC       Q9HBE1-4; Q96T49: PPP1R16B; NbExp=3; IntAct=EBI-11022007, EBI-10293968;
CC       Q9HBE1-4; O75864: PPP1R37; NbExp=3; IntAct=EBI-11022007, EBI-5235692;
CC       Q9HBE1-4; Q9GZV8: PRDM14; NbExp=3; IntAct=EBI-11022007, EBI-3957793;
CC       Q9HBE1-4; Q9NQX0: PRDM6; NbExp=3; IntAct=EBI-11022007, EBI-11320284;
CC       Q9HBE1-4; P86480: PRR20D; NbExp=3; IntAct=EBI-11022007, EBI-12754095;
CC       Q9HBE1-4; P98175: RBM10; NbExp=3; IntAct=EBI-11022007, EBI-721525;
CC       Q9HBE1-4; Q93062-3: RBPMS; NbExp=6; IntAct=EBI-11022007, EBI-740343;
CC       Q9HBE1-4; Q6ZRY4: RBPMS2; NbExp=3; IntAct=EBI-11022007, EBI-11987469;
CC       Q9HBE1-4; Q8HWS3: RFX6; NbExp=3; IntAct=EBI-11022007, EBI-746118;
CC       Q9HBE1-4; Q0D2K3: RIPPLY1; NbExp=3; IntAct=EBI-11022007, EBI-10226430;
CC       Q9HBE1-4; Q8ND83: SLAIN1; NbExp=3; IntAct=EBI-11022007, EBI-10269374;
CC       Q9HBE1-4; Q53HV7-2: SMUG1; NbExp=3; IntAct=EBI-11022007, EBI-12275818;
CC       Q9HBE1-4; Q8NB12: SMYD1; NbExp=3; IntAct=EBI-11022007, EBI-8463848;
CC       Q9HBE1-4; Q99932-2: SPAG8; NbExp=3; IntAct=EBI-11022007, EBI-11959123;
CC       Q9HBE1-4; Q08117-2: TLE5; NbExp=5; IntAct=EBI-11022007, EBI-11741437;
CC       Q9HBE1-4; Q63HR2: TNS2; NbExp=3; IntAct=EBI-11022007, EBI-949753;
CC       Q9HBE1-4; Q13077: TRAF1; NbExp=3; IntAct=EBI-11022007, EBI-359224;
CC       Q9HBE1-4; Q12933: TRAF2; NbExp=3; IntAct=EBI-11022007, EBI-355744;
CC       Q9HBE1-4; Q15654: TRIP6; NbExp=3; IntAct=EBI-11022007, EBI-742327;
CC       Q9HBE1-4; Q86WV8: TSC1; NbExp=3; IntAct=EBI-11022007, EBI-12806590;
CC       Q9HBE1-4; Q9NZC7-5: WWOX; NbExp=5; IntAct=EBI-11022007, EBI-12040603;
CC       Q9HBE1-4; O00308: WWP2; NbExp=3; IntAct=EBI-11022007, EBI-743923;
CC       Q9HBE1-4; A0A0C4DGF1: ZBTB32; NbExp=3; IntAct=EBI-11022007, EBI-10188476;
CC       Q9HBE1-4; Q15915: ZIC1; NbExp=3; IntAct=EBI-11022007, EBI-11963196;
CC       Q9HBE1-4; Q9NZV7: ZIM2; NbExp=3; IntAct=EBI-11022007, EBI-11962760;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:10713105}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1; Synonyms=C;
CC         IsoId=Q9HBE1-1; Sequence=Displayed;
CC       Name=2; Synonyms=B;
CC         IsoId=Q9HBE1-2; Sequence=VSP_008799, VSP_008800;
CC       Name=3; Synonyms=A;
CC         IsoId=Q9HBE1-3; Sequence=VSP_008801;
CC       Name=4; Synonyms=Short;
CC         IsoId=Q9HBE1-4; Sequence=VSP_008802, VSP_008800;
CC   -!- TISSUE SPECIFICITY: Ubiquitous.
CC   -!- DISEASE: Note=A chromosomal aberration involving PATZ1 is associated
CC       with small round cell sarcoma. Translocation t(1;22)(p36.1;q12) with
CC       EWSR1. {ECO:0000269|PubMed:10949935}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAB51404.1; Type=Erroneous initiation; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF119256; AAF32518.1; -; mRNA.
DR   EMBL; AF254082; AAG09031.1; -; mRNA.
DR   EMBL; AF254083; AAG09032.1; -; mRNA.
DR   EMBL; AF254084; AAG09033.1; -; mRNA.
DR   EMBL; AF254085; AAG09034.1; -; mRNA.
DR   EMBL; AY028384; AAK19024.1; -; mRNA.
DR   EMBL; AL096880; CAB51404.1; ALT_INIT; mRNA.
DR   EMBL; CR456613; CAG30499.1; -; mRNA.
DR   EMBL; AC005003; AAF01349.1; -; Genomic_DNA.
DR   EMBL; BC021091; AAH21091.1; -; mRNA.
DR   CCDS; CCDS13894.1; -. [Q9HBE1-1]
DR   CCDS; CCDS13895.1; -. [Q9HBE1-3]
DR   CCDS; CCDS13896.1; -. [Q9HBE1-4]
DR   CCDS; CCDS46691.1; -. [Q9HBE1-2]
DR   RefSeq; NP_055138.2; NM_014323.2. [Q9HBE1-1]
DR   RefSeq; NP_114439.1; NM_032050.1. [Q9HBE1-3]
DR   RefSeq; NP_114440.1; NM_032051.1. [Q9HBE1-4]
DR   RefSeq; NP_114441.1; NM_032052.1. [Q9HBE1-2]
DR   PDB; 2EPP; NMR; -; A=286-338.
DR   PDB; 2EPQ; NMR; -; A=380-411.
DR   PDB; 2EPR; NMR; -; A=350-384.
DR   PDB; 2EPS; NMR; -; A=408-445.
DR   PDB; 2YT9; NMR; -; A=355-436.
DR   PDBsum; 2EPP; -.
DR   PDBsum; 2EPQ; -.
DR   PDBsum; 2EPR; -.
DR   PDBsum; 2EPS; -.
DR   PDBsum; 2YT9; -.
DR   SMR; Q9HBE1; -.
DR   BioGrid; 117133; 45.
DR   IntAct; Q9HBE1; 94.
DR   MINT; Q9HBE1; -.
DR   STRING; 9606.ENSP00000266269; -.
DR   iPTMnet; Q9HBE1; -.
DR   PhosphoSitePlus; Q9HBE1; -.
DR   BioMuta; PATZ1; -.
DR   DMDM; 38258840; -.
DR   EPD; Q9HBE1; -.
DR   jPOST; Q9HBE1; -.
DR   MassIVE; Q9HBE1; -.
DR   MaxQB; Q9HBE1; -.
DR   PaxDb; Q9HBE1; -.
DR   PeptideAtlas; Q9HBE1; -.
DR   PRIDE; Q9HBE1; -.
DR   ProteomicsDB; 81529; -. [Q9HBE1-1]
DR   ProteomicsDB; 81530; -. [Q9HBE1-2]
DR   ProteomicsDB; 81531; -. [Q9HBE1-3]
DR   ProteomicsDB; 81532; -. [Q9HBE1-4]
DR   Antibodypedia; 25019; 162 antibodies.
DR   DNASU; 23598; -.
DR   Ensembl; ENST00000215919; ENSP00000215919; ENSG00000100105. [Q9HBE1-4]
DR   Ensembl; ENST00000266269; ENSP00000266269; ENSG00000100105. [Q9HBE1-1]
DR   Ensembl; ENST00000351933; ENSP00000337520; ENSG00000100105. [Q9HBE1-3]
DR   Ensembl; ENST00000405309; ENSP00000384173; ENSG00000100105. [Q9HBE1-2]
DR   GeneID; 23598; -.
DR   KEGG; hsa:23598; -.
DR   UCSC; uc003akp.4; human. [Q9HBE1-1]
DR   CTD; 23598; -.
DR   DisGeNET; 23598; -.
DR   GeneCards; PATZ1; -.
DR   HGNC; HGNC:13071; PATZ1.
DR   HPA; ENSG00000100105; Low tissue specificity.
DR   MIM; 605165; gene.
DR   neXtProt; NX_Q9HBE1; -.
DR   OpenTargets; ENSG00000100105; -.
DR   PharmGKB; PA162398806; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000159296; -.
DR   HOGENOM; CLU_030477_1_0_1; -.
DR   InParanoid; Q9HBE1; -.
DR   OMA; HQESIPN; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q9HBE1; -.
DR   TreeFam; TF331686; -.
DR   SIGNOR; Q9HBE1; -.
DR   ChiTaRS; PATZ1; human.
DR   EvolutionaryTrace; Q9HBE1; -.
DR   GeneWiki; PATZ1; -.
DR   GenomeRNAi; 23598; -.
DR   Pharos; Q9HBE1; Tbio.
DR   PRO; PR:Q9HBE1; -.
DR   Proteomes; UP000005640; Chromosome 22.
DR   RNAct; Q9HBE1; protein.
DR   Bgee; ENSG00000100105; Expressed in oviduct epithelium and 221 other tissues.
DR   ExpressionAtlas; Q9HBE1; baseline and differential.
DR   Genevisible; Q9HBE1; HS.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0003677; F:DNA binding; IBA:GO_Central.
DR   GO; GO:0001228; F:DNA-binding transcription activator activity, RNA polymerase II-specific; IEA:Ensembl.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISM:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IEA:Ensembl.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008584; P:male gonad development; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; TAS:UniProtKB.
DR   GO; GO:0007283; P:spermatogenesis; IEA:Ensembl.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR000637; HMGI/Y_DNA-bd_CS.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 4.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 8.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00354; HMGI_Y; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 7.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 7.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement; DNA-binding;
KW   Isopeptide bond; Metal-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Proto-oncogene; Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Ubl conjugation; Zinc; Zinc-finger.
FT   CHAIN           1..687
FT                   /note="POZ-, AT hook-, and zinc finger-containing protein
FT                   1"
FT                   /id="PRO_0000047504"
FT   DOMAIN          41..130
FT                   /note="BTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT   DNA_BIND        264..276
FT                   /note="A.T hook"
FT   ZN_FING         292..314
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         355..377
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         383..405
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         413..436
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         442..464
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         495..518
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         605..628
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   MOD_RES         282
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   CROSSLNK        112
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        272
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         446..537
FT                   /note="TCNASFATRDRLRSHLACHEDKVPCQVCGKYLRAAYMADHLKKHSEGPSNFC
FT                   SICNRGFSSASYLKVHVKTHHGVPLPQVSRHQEPILNGGA -> VWVGSSSGLPPLEPL
FT                   PSDLPSWDFAQPALWRSSHSVPDTAFSLSLKKSFPALENLGPAHSSNTLFCPAPPGYLR
FT                   QGWTTPEGSRAFTQWPVG (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10713105,
FT                   ECO:0000303|PubMed:10949935, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_008802"
FT   VAR_SEQ         503..548
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:10949935,
FT                   ECO:0000303|PubMed:15461802, ECO:0000303|Ref.4"
FT                   /id="VSP_008801"
FT   VAR_SEQ         504..537
FT                   /note="FSSASYLKVHVKTHHGVPLPQVSRHQEPILNGGA -> LQAPGAHPEWGSSV
FT                   PLRQDLWQQRRPEMLTSGSD (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10949935"
FT                   /id="VSP_008799"
FT   VAR_SEQ         538..687
FT                   /note="Missing (in isoform 2 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:10713105,
FT                   ECO:0000303|PubMed:10949935, ECO:0000303|PubMed:15489334"
FT                   /id="VSP_008800"
FT   VARIANT         685
FT                   /note="E -> D (in dbSNP:rs2240424)"
FT                   /id="VAR_052724"
FT   CONFLICT        63
FT                   /note="S -> N (in Ref. 1; AAF32518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        259
FT                   /note="P -> L (in Ref. 1; AAF32518)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        394
FT                   /note="R -> K (in Ref. 1; AAF32518)"
FT                   /evidence="ECO:0000305"
FT   TURN            295..297
FT                   /evidence="ECO:0000244|PDB:2EPP"
FT   HELIX           304..314
FT                   /evidence="ECO:0000244|PDB:2EPP"
FT   TURN            315..317
FT                   /evidence="ECO:0000244|PDB:2EPP"
FT   STRAND          354..357
FT                   /evidence="ECO:0000244|PDB:2EPR"
FT   TURN            358..361
FT                   /evidence="ECO:0000244|PDB:2EPR"
FT   STRAND          362..366
FT                   /evidence="ECO:0000244|PDB:2EPR"
FT   HELIX           367..373
FT                   /evidence="ECO:0000244|PDB:2EPR"
FT   HELIX           374..376
FT                   /evidence="ECO:0000244|PDB:2EPR"
FT   STRAND          382..385
FT                   /evidence="ECO:0000244|PDB:2EPQ"
FT   TURN            386..389
FT                   /evidence="ECO:0000244|PDB:2EPQ"
FT   STRAND          391..393
FT                   /evidence="ECO:0000244|PDB:2YT9"
FT   HELIX           395..405
FT                   /evidence="ECO:0000244|PDB:2EPQ"
FT   STRAND          411..413
FT                   /evidence="ECO:0000244|PDB:2YT9"
FT   STRAND          416..418
FT                   /evidence="ECO:0000244|PDB:2EPS"
FT   STRAND          421..424
FT                   /evidence="ECO:0000244|PDB:2EPS"
FT   HELIX           425..434
FT                   /evidence="ECO:0000244|PDB:2EPS"
SQ   SEQUENCE   687 AA;  74060 MW;  0F1C59A78C6D110A CRC64;
     MERVNDASCG PSGCYTYQVS RHSTEMLHNL NQQRKNGGRF CDVLLRVGDE SFPAHRAVLA
     ACSEYFESVF SAQLGDGGAA DGGPADVGGA TAAPGGGAGG SRELEMHTIS SKVFGDILDF
     AYTSRIVVRL ESFPELMTAA KFLLMRSVIE ICQEVIKQSN VQILVPPARA DIMLFRPPGT
     SDLGFPLDMT NGAALAANSN GIAGSMQPEE EAARAAGAAI AGQASLPVLP GVDRLPMVAG
     PLSPQLLTSP FPSVASSAPP LTGKRGRGRP RKANLLDSMF GSPGGLREAG ILPCGLCGKV
     FTDANRLRQH EAQHGVTSLQ LGYIDLPPPR LGENGLPISE DPDGPRKRSR TRKQVACEIC
     GKIFRDVYHL NRHKLSHSGE KPYSCPVCGL RFKRKDRMSY HVRSHDGSVG KPYICQSCGK
     GFSRPDHLNG HIKQVHTSER PHKCQTCNAS FATRDRLRSH LACHEDKVPC QVCGKYLRAA
     YMADHLKKHS EGPSNFCSIC NRGFSSASYL KVHVKTHHGV PLPQVSRHQE PILNGGAAFH
     CARTYGNKEG QKCSHQDPIE SSDSYGDLSD ASDLKTPEKQ SANGSFSCDM AVPKNKMESD
     GEKKYPCPEC GSFFRSKSYL NKHIQKVHVR ALGGPLGDLG PALGSPFSPQ QNMSLLESFG
     FQIVQSAFAS SLVDPEVDQQ PMGPEGK
//
ID   PER1_HUMAN              Reviewed;        1290 AA.
AC   O15534; B2RPA8; B4DI49; D3DTR3;
DT   15-JUL-1999, integrated into UniProtKB/Swiss-Prot.
DT   16-DEC-2008, sequence version 2.
DT   22-APR-2020, entry version 191.
DE   RecName: Full=Period circadian protein homolog 1;
DE            Short=hPER1;
DE   AltName: Full=Circadian clock protein PERIOD 1;
DE   AltName: Full=Circadian pacemaker protein Rigui;
GN   Name=PER1; Synonyms=KIAA0482, PER, RIGUI;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], ALTERNATIVE SPLICING, AND VARIANT PRO-962.
RC   TISSUE=Heart;
RX   PubMed=9323128; DOI=10.1016/s0092-8674(00)80366-9;
RA   Sun Z.S., Albrecht U., Zhuchenko O., Bailey J., Eichele G., Lee C.C.;
RT   "Rigui, a putative mammalian ortholog of the Drosophila period gene.";
RL   Cell 90:1003-1011(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND VARIANT PRO-962.
RC   TISSUE=Brain;
RX   PubMed=9333243; DOI=10.1038/39086;
RA   Tei H., Okamura H., Shigeyoshi Y., Fukuhara C., Ozawa R., Hirose M.,
RA   Sakaki Y.;
RT   "Circadian oscillation of a mammalian homologue of the Drosophila period
RT   gene.";
RL   Nature 389:512-516(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-962.
RX   PubMed=10940553; DOI=10.1016/s0378-1119(00)00248-1;
RA   Taruscio D., Zoraqi G.K., Falchi M., Iosi F., Paradisi S., Di Fiore B.,
RA   Lavia P., Falbo V.;
RT   "The human Per1 gene: genomic organization and promoter analysis of the
RT   first human orthologue of the Drosophila period gene.";
RL   Gene 253:161-170(2000).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT PRO-962.
RX   PubMed=10857746; DOI=10.1006/geno.2000.6166;
RA   Hida A., Koike N., Hirose M., Hattori M., Sakaki Y., Tei H.;
RT   "The human and mouse Period1 genes: five well-conserved E-boxes additively
RT   contribute to the enhancement of mPer1 transcription.";
RL   Genomics 65:224-233(2000).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-962.
RC   TISSUE=Brain;
RX   PubMed=9455484; DOI=10.1093/dnares/4.5.345;
RA   Seki N., Ohira M., Nagase T., Ishikawa K., Miyajima N., Nakajima D.,
RA   Nomura N., Ohara O.;
RT   "Characterization of cDNA clones in size-fractionated cDNA libraries from
RT   human brain.";
RL   DNA Res. 4:345-349(1997).
RN   [6]
RP   SEQUENCE REVISION.
RA   Nagase T., Kikuno R., Ohara O.;
RL   Submitted (JUL-2002) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Corpus callosum;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16625196; DOI=10.1038/nature04689;
RA   Zody M.C., Garber M., Adams D.J., Sharpe T., Harrow J., Lupski J.R.,
RA   Nicholson C., Searle S.M., Wilming L., Young S.K., Abouelleil A.,
RA   Allen N.R., Bi W., Bloom T., Borowsky M.L., Bugalter B.E., Butler J.,
RA   Chang J.L., Chen C.-K., Cook A., Corum B., Cuomo C.A., de Jong P.J.,
RA   DeCaprio D., Dewar K., FitzGerald M., Gilbert J., Gibson R., Gnerre S.,
RA   Goldstein S., Grafham D.V., Grocock R., Hafez N., Hagopian D.S., Hart E.,
RA   Norman C.H., Humphray S., Jaffe D.B., Jones M., Kamal M., Khodiyar V.K.,
RA   LaButti K., Laird G., Lehoczky J., Liu X., Lokyitsang T., Loveland J.,
RA   Lui A., Macdonald P., Major J.E., Matthews L., Mauceli E., McCarroll S.A.,
RA   Mihalev A.H., Mudge J., Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,
RA   Schwartz D.C., Shaw-Smith C., Stankiewicz P., Steward C., Swarbreck D.,
RA   Venkataraman V., Whittaker C.A., Yang X., Zimmer A.R., Bradley A.,
RA   Hubbard T., Birren B.W., Rogers J., Lander E.S., Nusbaum C.;
RT   "DNA sequence of human chromosome 17 and analysis of rearrangement in the
RT   human lineage.";
RL   Nature 440:1045-1049(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-962.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA], AND VARIANT PRO-962.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   TISSUE SPECIFICITY.
RX   PubMed=9427249; DOI=10.1016/s0896-6273(00)80417-1;
RA   Shearman L.P., Zylka M.J., Weaver D.R., Kolakowski L.F. Jr., Reppert S.M.;
RT   "Two period homologs: circadian expression and photic regulation in the
RT   suprachiasmatic nuclei.";
RL   Neuron 19:1261-1269(1997).
RN   [12]
RP   PHOSPHORYLATION BY CSNK1E.
RX   PubMed=10790862; DOI=10.1097/00001756-200004070-00011;
RA   Keesler G.A., Camacho F., Guo Y., Virshup D., Mondadori C., Yao Z.;
RT   "Phosphorylation and destabilization of human period I clock protein by
RT   human casein kinase I epsilon.";
RL   NeuroReport 11:951-955(2000).
RN   [13]
RP   PHOSPHORYLATION BY CSNK1D.
RX   PubMed=11165242; DOI=10.1016/s0014-5793(00)02434-0;
RA   Camacho F., Cilio M., Guo Y., Virshup D.M., Patel K., Khorkova O.,
RA   Styren S., Morse B., Yao Z., Keesler G.A.;
RT   "Human casein kinase Idelta phosphorylation of human circadian clock
RT   proteins period 1 and 2.";
RL   FEBS Lett. 489:159-165(2001).
RN   [14]
RP   PHOSPHORYLATION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INDUCTION.
RX   PubMed=14750904; DOI=10.1042/bj20031308;
RA   Miyazaki K., Nagase T., Mesaki M., Narukawa J., Ohara O., Ishida N.;
RT   "Phosphorylation of clock protein PER1 regulates its circadian degradation
RT   in normal human fibroblasts.";
RL   Biochem. J. 380:95-103(2004).
RN   [15]
RP   INTERACTION WITH BTRC AND FBXW11, PHOSPHORYLATION AT THR-121; SER-122 AND
RP   SER-126, UBIQUITINATION, AND MUTAGENESIS OF 210-SER--THR-213;
RP   714-SER--SER-726 AND 794-PHE--PHE-798.
RX   PubMed=15917222; DOI=10.1074/jbc.m502862200;
RA   Shirogane T., Jin J., Ang X.L., Harper J.W.;
RT   "SCFbeta-TRCP controls clock-dependent transcription via casein kinase 1-
RT   dependent degradation of the mammalian period-1 (Per1) protein.";
RL   J. Biol. Chem. 280:26863-26872(2005).
RN   [16]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-979 AND SER-980, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Embryonic kidney;
RX   PubMed=17525332; DOI=10.1126/science.1140321;
RA   Matsuoka S., Ballif B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,
RA   Luo J., Bakalarski C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,
RA   Gygi S.P., Elledge S.J.;
RT   "ATM and ATR substrate analysis reveals extensive protein networks
RT   responsive to DNA damage.";
RL   Science 316:1160-1166(2007).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704 AND SER-815, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-815, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [22]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-704 AND SER-815, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [23]
RP   REVIEW.
RX   PubMed=23303907; DOI=10.1152/physrev.00016.2012;
RA   Eckel-Mahan K., Sassone-Corsi P.;
RT   "Metabolism and the circadian clock converge.";
RL   Physiol. Rev. 93:107-135(2013).
RN   [24]
RP   FUNCTION IN HAIR GROWTH, SUBCELLULAR LOCATION, AND TISSUE SPECIFICITY.
RX   PubMed=24005054; DOI=10.1038/jid.2013.366;
RA   Al-Nuaimi Y., Hardman J.A., Biro T., Haslam I.S., Philpott M.P., Toth B.I.,
RA   Farjo N., Farjo B., Baier G., Watson R.E., Grimaldi B., Kloepper J.E.,
RA   Paus R.;
RT   "A meeting of two chronobiological systems: circadian proteins Period1 and
RT   BMAL1 modulate the human hair cycle clock.";
RL   J. Invest. Dermatol. 134:610-619(2014).
RN   [25]
RP   REVIEW.
RX   PubMed=23916625; DOI=10.1016/j.tcb.2013.07.002;
RA   Partch C.L., Green C.B., Takahashi J.S.;
RT   "Molecular architecture of the mammalian circadian clock.";
RL   Trends Cell Biol. 24:90-99(2014).
RN   [26]
RP   INTERACTION WITH HNF4A.
RX   PubMed=30530698; DOI=10.1073/pnas.1816411115;
RA   Qu M., Duffy T., Hirota T., Kay S.A.;
RT   "Nuclear receptor HNF4A transrepresses CLOCK:BMAL1 and modulates tissue-
RT   specific circadian networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 115:E12305-E12312(2018).
RN   [27]
RP   VARIANTS [LARGE SCALE ANALYSIS] GLN-696; SER-985 AND LEU-1060.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S., Buckhaults P.,
RA   Farrell C., Meeh P., Markowitz S.D., Willis J., Dawson D., Willson J.K.V.,
RA   Gazdar A.F., Hartigan J., Wu L., Liu C., Parmigiani G., Park B.H.,
RA   Bachman K.E., Papadopoulos N., Vogelstein B., Kinzler K.W.,
RA   Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal cancers.";
RL   Science 314:268-274(2006).
RN   [28]
RP   VARIANT GLN-422.
RX   PubMed=27717682; DOI=10.1016/j.jstrokecerebrovasdis.2016.09.003;
RA   Mukawa M., Nariai T., Onda H., Yoneyama T., Aihara Y., Hirota K., Kudo T.,
RA   Sumita K., Maehara T., Kawamata T., Kasuya H., Akagawa H.;
RT   "Exome sequencing identified CCER2 as a novel candidate gene for Moyamoya
RT   disease.";
RL   J. Stroke Cerebrovasc. Dis. 26:150-161(2017).
CC   -!- FUNCTION: Transcriptional repressor which forms a core component of the
CC       circadian clock. The circadian clock, an internal time-keeping system,
CC       regulates various physiological processes through the generation of
CC       approximately 24 hour circadian rhythms in gene expression, which are
CC       translated into rhythms in metabolism and behavior. It is derived from
CC       the Latin roots 'circa' (about) and 'diem' (day) and acts as an
CC       important regulator of a wide array of physiological functions
CC       including metabolism, sleep, body temperature, blood pressure,
CC       endocrine, immune, cardiovascular, and renal function. Consists of two
CC       major components: the central clock, residing in the suprachiasmatic
CC       nucleus (SCN) of the brain, and the peripheral clocks that are present
CC       in nearly every tissue and organ system. Both the central and
CC       peripheral clocks can be reset by environmental cues, also known as
CC       Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the
CC       central clock is light, which is sensed by retina and signals directly
CC       to the SCN. The central clock entrains the peripheral clocks through
CC       neuronal and hormonal signals, body temperature and feeding-related
CC       cues, aligning all clocks with the external light/dark cycle. Circadian
CC       rhythms allow an organism to achieve temporal homeostasis with its
CC       environment at the molecular level by regulating gene expression to
CC       create a peak of protein expression once every 24 hours to control when
CC       a particular physiological process is most active with respect to the
CC       solar day. Transcription and translation of core clock components
CC       (CLOCK, NPAS2, ARNTL/BMAL1, ARNTL2/BMAL2, PER1, PER2, PER3, CRY1 and
CC       CRY2) plays a critical role in rhythm generation, whereas delays
CC       imposed by post-translational modifications (PTMs) are important for
CC       determining the period (tau) of the rhythms (tau refers to the period
CC       of a rhythm and is the length, in time, of one complete cycle). A
CC       diurnal rhythm is synchronized with the day/night cycle, while the
CC       ultradian and infradian rhythms have a period shorter and longer than
CC       24 hours, respectively. Disruptions in the circadian rhythms contribute
CC       to the pathology of cardiovascular diseases, cancer, metabolic
CC       syndromes and aging. A transcription/translation feedback loop (TTFL)
CC       forms the core of the molecular circadian clock mechanism.
CC       Transcription factors, CLOCK or NPAS2 and ARNTL/BMAL1 or ARNTL2/BMAL2,
CC       form the positive limb of the feedback loop, act in the form of a
CC       heterodimer and activate the transcription of core clock genes and
CC       clock-controlled genes (involved in key metabolic processes), harboring
CC       E-box elements (5'-CACGTG-3') within their promoters. The core clock
CC       genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form
CC       the negative limb of the feedback loop and interact with the
CC       CLOCK|NPAS2-ARNTL/BMAL1|ARNTL2/BMAL2 heterodimer inhibiting its
CC       activity and thereby negatively regulating their own expression. This
CC       heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G,
CC       which form a second feedback loop and which activate and repress
CC       ARNTL/BMAL1 transcription, respectively. Regulates circadian target
CC       genes expression at post-transcriptional levels, but may not be
CC       required for the repression at transcriptional level. Controls PER2
CC       protein decay. Represses CRY2 preventing its repression on CLOCK/ARNTL
CC       target genes such as FXYD5 and SCNN1A in kidney and PPARA in liver.
CC       Besides its involvement in the maintenance of the circadian clock, has
CC       an important function in the regulation of several processes.
CC       Participates in the repression of glucocorticoid receptor NR3C1/GR-
CC       induced transcriptional activity by reducing the association of
CC       NR3C1/GR to glucocorticoid response elements (GREs) by ARNTL:CLOCK.
CC       Plays a role in the modulation of the neuroinflammatory state via the
CC       regulation of inflammatory mediators release, such as CCL2 and IL6. In
CC       spinal astrocytes, negatively regulates the MAPK14/p38 and MAPK8/JNK
CC       MAPK cascades as well as the subsequent activation of NFkappaB.
CC       Coordinately regulates the expression of multiple genes that are
CC       involved in the regulation of renal sodium reabsorption. Can act as
CC       gene expression activator in a gene and tissue specific manner, in
CC       kidney enhances WNK1 and SLC12A3 expression in collaboration with
CC       CLOCK. Modulates hair follicle cycling. Represses the CLOCK-ARNTL/BMAL1
CC       induced transcription of BHLHE40/DEC1. {ECO:0000269|PubMed:24005054}.
CC   -!- SUBUNIT: Homodimer (By similarity). Component of the circadian core
CC       oscillator, which includes the CRY proteins, CLOCK or NPAS2,
CC       ARNTL/BMAL1 or ARNTL2/BMAL2, CSNK1D and/or CSNK1E, TIMELESS, and the
CC       PER proteins (By similarity). Interacts directly with TIMELESS, PER2,
CC       PER3, CRY1 and CRY2 (By similarity). Interacts with ARNTL/BMAL1 and
CC       CLOCK (By similarity). Interacts with GPRASP1 (By similarity).
CC       Interacts (phosphorylated) with BTRC and FBXW11; the interactions
CC       trigger proteasomal degradation (PubMed:15917222). Interacts with NONO,
CC       WDR5 and SFPQ (By similarity). Interacts with USP2 (By similarity).
CC       Interacts with HNF4A (PubMed:30530698). {ECO:0000250|UniProtKB:O35973,
CC       ECO:0000250|UniProtKB:Q8CHI5, ECO:0000269|PubMed:15917222,
CC       ECO:0000269|PubMed:30530698}.
CC   -!- INTERACTION:
CC       O15534; Q9R194: Cry2; Xeno; NbExp=3; IntAct=EBI-2557276, EBI-1266619;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Nucleocytoplasmic
CC       shuttling is effected by interaction with other circadian core
CC       oscillator proteins and/or by phosphorylation. Retention of PER1 in the
CC       cytoplasm occurs through PER1-PER2 heterodimer formation. Translocate
CC       to the nucleus after phosphorylation by CSNK1D or CSNK1E. Also
CC       translocated to the nucleus by CRY1 or CRY2 (By similarity).
CC       {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Rigui 4.7;
CC         IsoId=O15534-1; Sequence=Displayed;
CC       Name=Rigui 3.0;
CC         IsoId=O15534-2; Sequence=Not described;
CC       Name=Rigui 6.6; Synonyms=Truncated;
CC         IsoId=O15534-3; Sequence=Not described;
CC       Name=2;
CC         IsoId=O15534-4; Sequence=VSP_056205, VSP_056206, VSP_056207;
CC   -!- TISSUE SPECIFICITY: Widely expressed. Expressed in hair follicles (at
CC       protein level).Found in heart, brain, placenta, lung, liver, skeletal
CC       muscle, pancreas, kidney, spleen, thymus, prostate, testis, ovary and
CC       small intestine. Highest level in skeletal muscle.
CC       {ECO:0000269|PubMed:14750904, ECO:0000269|PubMed:24005054,
CC       ECO:0000269|PubMed:9333243, ECO:0000269|PubMed:9427249}.
CC   -!- INDUCTION: Serum-induced levels in fibroblasts show circadian
CC       oscillations. Maximum levels after 1 hour stimulation, minimum levels
CC       after 12 hours. Another peak is then observed after 20 hours. Protein
CC       levels show maximum levels at 6 hours, decrease to reach minimum levels
CC       at 20 hours, and increase again to reach a second peak after 26 hours.
CC       Levels then decrease slightly and then increase to maximum levels at 32
CC       hours. Levels of phosphorylated form increase between 3 hours and 12
CC       hours. {ECO:0000269|PubMed:14750904}.
CC   -!- PTM: Phosphorylated on serine residues by CSNK1D, CSNK1E and probably
CC       also by CSNK1G2. Phosphorylation by CSNK1D or CSNK1E promotes nuclear
CC       location of PER proteins as well as ubiquitination and subsequent
CC       degradation. May be dephosphorylated by PP1.
CC       {ECO:0000269|PubMed:15917222}.
CC   -!- PTM: Ubiquitinated; requires phosphorylation by CSNK1E and interaction
CC       with BTRC and FBXW11. Deubiquitinated by USP2 (By similarity).
CC       {ECO:0000250|UniProtKB:O35973, ECO:0000269|PubMed:15917222}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC06326.2; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF022991; AAC51765.1; -; mRNA.
DR   EMBL; AB002107; BAA22633.1; -; mRNA.
DR   EMBL; AF102137; AAF15544.1; -; Genomic_DNA.
DR   EMBL; AB030817; BAA94085.1; -; Genomic_DNA.
DR   EMBL; AB088477; BAC06326.2; ALT_INIT; mRNA.
DR   EMBL; AK295410; BAG58361.1; -; mRNA.
DR   EMBL; AC129492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471108; EAW90090.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90091.1; -; Genomic_DNA.
DR   EMBL; BC137346; AAI37347.1; -; mRNA.
DR   CCDS; CCDS11131.1; -. [O15534-1]
DR   PIR; T00018; T00018.
DR   RefSeq; NP_002607.2; NM_002616.2. [O15534-1]
DR   RefSeq; XP_005256746.1; XM_005256689.1. [O15534-1]
DR   PDB; 1UL6; Model; -; A=830-845.
DR   PDBsum; 1UL6; -.
DR   SMR; O15534; -.
DR   BioGrid; 111210; 46.
DR   ComplexPortal; CPX-3221; Cry2-Per1 complex.
DR   ComplexPortal; CPX-3222; Cry1-Per1 complex.
DR   DIP; DIP-56603N; -.
DR   IntAct; O15534; 29.
DR   MINT; O15534; -.
DR   STRING; 9606.ENSP00000314420; -.
DR   iPTMnet; O15534; -.
DR   PhosphoSitePlus; O15534; -.
DR   BioMuta; PER1; -.
DR   EPD; O15534; -.
DR   jPOST; O15534; -.
DR   MassIVE; O15534; -.
DR   PaxDb; O15534; -.
DR   PeptideAtlas; O15534; -.
DR   PRIDE; O15534; -.
DR   ProteomicsDB; 4276; -.
DR   ProteomicsDB; 48743; -. [O15534-1]
DR   Antibodypedia; 24542; 241 antibodies.
DR   Ensembl; ENST00000317276; ENSP00000314420; ENSG00000179094. [O15534-1]
DR   Ensembl; ENST00000354903; ENSP00000346979; ENSG00000179094. [O15534-4]
DR   GeneID; 5187; -.
DR   KEGG; hsa:5187; -.
DR   UCSC; uc002gkd.4; human. [O15534-1]
DR   CTD; 5187; -.
DR   DisGeNET; 5187; -.
DR   GeneCards; PER1; -.
DR   HGNC; HGNC:8845; PER1.
DR   HPA; ENSG00000179094; Low tissue specificity.
DR   MIM; 602260; gene.
DR   neXtProt; NX_O15534; -.
DR   OpenTargets; ENSG00000179094; -.
DR   PharmGKB; PA33184; -.
DR   eggNOG; ENOG410IMRF; Eukaryota.
DR   eggNOG; ENOG410ZBUP; LUCA.
DR   GeneTree; ENSGT00940000159217; -.
DR   HOGENOM; CLU_006667_0_0_1; -.
DR   InParanoid; O15534; -.
DR   KO; K21944; -.
DR   OMA; PGERGCH; -.
DR   OrthoDB; 145617at2759; -.
DR   PhylomeDB; O15534; -.
DR   TreeFam; TF318445; -.
DR   Reactome; R-HSA-400253; Circadian Clock.
DR   SIGNOR; O15534; -.
DR   ChiTaRS; PER1; human.
DR   GeneWiki; PER1; -.
DR   GenomeRNAi; 5187; -.
DR   Pharos; O15534; Tbio.
DR   PRO; PR:O15534; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; O15534; protein.
DR   Bgee; ENSG00000179094; Expressed in right adrenal gland and 223 other tissues.
DR   ExpressionAtlas; O15534; baseline and differential.
DR   Genevisible; O15534; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0031490; F:chromatin DNA binding; ISS:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; IDA:BHF-UCL.
DR   GO; GO:0019900; F:kinase binding; IPI:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:BHF-UCL.
DR   GO; GO:0001222; F:transcription corepressor binding; IBA:GO_Central.
DR   GO; GO:0008134; F:transcription factor binding; IBA:GO_Central.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0097167; P:circadian regulation of translation; ISS:UniProtKB.
DR   GO; GO:0007623; P:circadian rhythm; IEP:UniProtKB.
DR   GO; GO:0009649; P:entrainment of circadian clock; TAS:ProtInc.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0043966; P:histone H3 acetylation; IDA:UniProtKB.
DR   GO; GO:0070932; P:histone H3 deacetylation; ISS:UniProtKB.
DR   GO; GO:0043967; P:histone H4 acetylation; IDA:UniProtKB.
DR   GO; GO:2000323; P:negative regulation of glucocorticoid receptor signaling pathway; ISS:UniProtKB.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; ISS:UniProtKB.
DR   GO; GO:0046329; P:negative regulation of JNK cascade; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; ISS:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0010608; P:posttranscriptional regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:1900015; P:regulation of cytokine production involved in inflammatory response; ISS:UniProtKB.
DR   GO; GO:0042634; P:regulation of hair cycle; IMP:UniProtKB.
DR   GO; GO:1900744; P:regulation of p38MAPK cascade; ISS:UniProtKB.
DR   GO; GO:0002028; P:regulation of sodium ion transport; ISS:UniProtKB.
DR   GO; GO:0051591; P:response to cAMP; IEA:Ensembl.
DR   GO; GO:0009416; P:response to light stimulus; IBA:GO_Central.
DR   CDD; cd00130; PAS; 1.
DR   InterPro; IPR000014; PAS.
DR   InterPro; IPR035965; PAS-like_dom_sf.
DR   InterPro; IPR013655; PAS_fold_3.
DR   InterPro; IPR022728; Period_circadian-like_C.
DR   Pfam; PF08447; PAS_3; 1.
DR   Pfam; PF12114; Period_C; 1.
DR   SMART; SM00091; PAS; 2.
DR   SUPFAM; SSF55785; SSF55785; 1.
DR   PROSITE; PS50112; PAS; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Biological rhythms; Cytoplasm; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome; Repeat; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..1290
FT                   /note="Period circadian protein homolog 1"
FT                   /id="PRO_0000162627"
FT   DOMAIN          208..275
FT                   /note="PAS 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          348..414
FT                   /note="PAS 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00140"
FT   DOMAIN          422..465
FT                   /note="PAC"
FT   REGION          1..151
FT                   /note="Interaction with BTRC"
FT                   /evidence="ECO:0000269|PubMed:15917222"
FT   REGION          596..815
FT                   /note="Required for phosphorylation by CSNK1E"
FT                   /evidence="ECO:0000250"
FT   REGION          1149..1290
FT                   /note="CRY binding domain"
FT                   /evidence="ECO:0000250"
FT   MOTIF           138..147
FT                   /note="Nuclear export signal 1"
FT                   /evidence="ECO:0000250|UniProtKB:O54943"
FT   MOTIF           489..498
FT                   /note="Nuclear export signal 2"
FT                   /evidence="ECO:0000250|UniProtKB:O35973"
FT   MOTIF           827..843
FT                   /note="Nuclear localization signal"
FT                   /evidence="ECO:0000250|UniProtKB:O35973"
FT   MOTIF           982..989
FT                   /note="Nuclear export signal 3"
FT                   /evidence="ECO:0000250|UniProtKB:O54943"
FT   MOTIF           1043..1047
FT                   /note="LXXLL"
FT   COMPBIAS        49..129
FT                   /note="Ser-rich"
FT   COMPBIAS        653..656
FT                   /note="Poly-Ser"
FT   COMPBIAS        848..1013
FT                   /note="Pro-rich"
FT   COMPBIAS        1030..1104
FT                   /note="Ser-rich"
FT   COMPBIAS        1269..1273
FT                   /note="Poly-Glu"
FT   COMPBIAS        1276..1279
FT                   /note="Poly-Ser"
FT   MOD_RES         121
FT                   /note="Phosphothreonine; by CSNK1E"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         122
FT                   /note="Phosphoserine; by CSNK1E"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         126
FT                   /note="Phosphoserine; by CSNK1E"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         661
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35973"
FT   MOD_RES         663
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:O35973"
FT   MOD_RES         704
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         815
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         979
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   MOD_RES         980
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   VAR_SEQ         1..32
FT                   /note="MSGPLEGADGGGDPRPGESFCPGGVPSPGPPQ -> MLEVLEEIWSVRARRA
FT                   (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056205"
FT   VAR_SEQ         822..875
FT                   /note="CHHGPAPPSRRHHCRSKAKRSRHHQNPRAEAPCYVSHPSPVPPSTPWPTPPA
FT                   TT -> SHLGPPGACPLPSLGLDCWGVGLKGGVSAPGTQAGVASTTRPCLGTGPSLASP
FT                   H (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056206"
FT   VAR_SEQ         876..1290
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_056207"
FT   VARIANT         422
FT                   /note="H -> Q (found in a patient with Moyamoya disease;
FT                   unknown pathological significance; dbSNP:rs1464745710)"
FT                   /evidence="ECO:0000269|PubMed:27717682"
FT                   /id="VAR_079176"
FT   VARIANT         696
FT                   /note="E -> Q (in a breast cancer sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036038"
FT   VARIANT         962
FT                   /note="A -> P (in dbSNP:rs2585405)"
FT                   /evidence="ECO:0000269|PubMed:10857746,
FT                   ECO:0000269|PubMed:10940553, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|PubMed:9323128, ECO:0000269|PubMed:9333243,
FT                   ECO:0000269|PubMed:9455484, ECO:0000269|Ref.9"
FT                   /id="VAR_047899"
FT   VARIANT         968
FT                   /note="R -> H (in dbSNP:rs3027193)"
FT                   /id="VAR_047900"
FT   VARIANT         985
FT                   /note="N -> S (in a breast cancer sample; somatic mutation;
FT                   dbSNP:rs1323588262)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036039"
FT   VARIANT         1060
FT                   /note="S -> L (in a colorectal cancer sample; somatic
FT                   mutation; dbSNP:rs761958964)"
FT                   /evidence="ECO:0000269|PubMed:16959974"
FT                   /id="VAR_036040"
FT   MUTAGEN         121..126
FT                   /note="TSGCSS->AAGCSA: Strongly decreases interaction with
FT                   BTRC and FBXW11 and inhibits degradation promoted by
FT                   CSNK1E."
FT   MUTAGEN         210..213
FT                   /note="SEYT->AEYA: No effect on interaction with BTRC and
FT                   FBXW11."
FT                   /evidence="ECO:0000269|PubMed:15917222"
FT   MUTAGEN         714..726
FT                   /note="SVVSVTSQCSFSS->AVVAVTAQCAFAA: No effect on
FT                   interaction with BTRC and FBXW11."
FT                   /evidence="ECO:0000269|PubMed:15917222"
FT   MUTAGEN         794..798
FT                   /note="FLSRF->ALSRA: Strongly decreases interaction with
FT                   BTRC and FBXW11."
FT                   /evidence="ECO:0000269|PubMed:15917222"
SQ   SEQUENCE   1290 AA;  136212 MW;  60B844468EEF4D1B CRC64;
     MSGPLEGADG GGDPRPGESF CPGGVPSPGP PQHRPCPGPS LADDTDANSN GSSGNESNGH
     ESRGASQRSS HSSSSGNGKD SALLETTESS KSTNSQSPSP PSSSIAYSLL SASSEQDNPS
     TSGCSSEQSA RARTQKELMT ALRELKLRLP PERRGKGRSG TLATLQYALA CVKQVQANQE
     YYQQWSLEEG EPCSMDMSTY TLEELEHITS EYTLQNQDTF SVAVSFLTGR IVYISEQAAV
     LLRCKRDVFR GTRFSELLAP QDVGVFYGST APSRLPTWGT GASAGSGLRD FTQEKSVFCR
     IRGGPDRDPG PRYQPFRLTP YVTKIRVSDG APAQPCCLLI AERIHSGYEA PRIPPDKRIF
     TTRHTPSCLF QDVDERAAPL LGYLPQDLLG APVLLFLHPE DRPLMLAIHK KILQLAGQPF
     DHSPIRFCAR NGEYVTMDTS WAGFVHPWSR KVAFVLGRHK VRTAPLNEDV FTPPAPSPAP
     SLDTDIQELS EQIHRLLLQP VHSPSPTGLC GVGAVTSPGP LHSPGSSSDS NGGDAEGPGP
     PAPVTFQQIC KDVHLVKHQG QQLFIESRAR PQSRPRLPAT GTFKAKALPC QSPDPELEAG
     SAPVQAPLAL VPEEAERKEA SSCSYQQINC LDSILRYLES CNLPSTTKRK CASSSSYTTS
     SASDDDRQRT GPVSVGTKKD PPSAALSGEG ATPRKEPVVG GTLSPLALAN KAESVVSVTS
     QCSFSSTIVH VGDKKPPESD IIMMEDLPGL APGPAPSPAP SPTVAPDPAP DAYRPVGLTK
     AVLSLHTQKE EQAFLSRFRD LGRLRGLDSS STAPSALGER GCHHGPAPPS RRHHCRSKAK
     RSRHHQNPRA EAPCYVSHPS PVPPSTPWPT PPATTPFPAV VQPYPLPVFS PRGGPQPLPP
     APTSVPPAAF PAPLVTPMVA LVLPNYLFPT PSSYPYGALQ TPAEGPPTPA SHSPSPSLPA
     LAPSPPHRPD SPLFNSRCSS PLQLNLLQLE ELPRAEGAAV AGGPGSSAGP PPPSAEAAEP
     EARLAEVTES SNQDALSGSS DLLELLLQED SRSGTGSAAS GSLGSGLGSG SGSGSHEGGS
     TSASITRSSQ SSHTSKYFGS IDSSEAEAGA ARGGAEPGDQ VIKYVLQDPI WLLMANADQR
     VMMTYQVPSR DMTSVLKQDR ERLRAMQKQQ PRFSEDQRRE LGAVHSWVRK GQLPRALDVM
     ACVDCGSSTQ DPGHPDDPLF SELDGLGLEP MEEGGGEQGS SGGGSGEGEG CEEAQGGAKA
     SSSQDLAMEE EEEGRSSSSP ALPTAGNCTS
//
ID   PML_HUMAN               Reviewed;         882 AA.
AC   P29590; E9PBR7; P29591; P29592; P29593; Q00755; Q15959; Q59FP9; Q8WUA0;
AC   Q96S41; Q9BPW2; Q9BWP7; Q9BZX6; Q9BZX7; Q9BZX8; Q9BZX9; Q9BZY0; Q9BZY2;
AC   Q9BZY3;
DT   01-APR-1993, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 3.
DT   22-APR-2020, entry version 241.
DE   RecName: Full=Protein PML;
DE   AltName: Full=Promyelocytic leukemia protein;
DE   AltName: Full=RING finger protein 71;
DE   AltName: Full=Tripartite motif-containing protein 19;
GN   Name=PML; Synonyms=MYL, PP8675, RNF71, TRIM19;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-3), AND DISEASE.
RX   PubMed=1652369; DOI=10.1016/0092-8674(91)90113-d;
RA   de The H., Lavau C., Marchio A., Chomienne C., Degos L., Dejean A.;
RT   "The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in
RT   acute promyelocytic leukemia encodes a functionally altered RAR.";
RL   Cell 66:675-684(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PML-1; PML-5 AND PML-8), CHROMOSOMAL
RP   TRANSLOCATION WITH RARA, DISEASE, AND VARIANT LEU-645.
RX   PubMed=1720570; DOI=10.1126/science.1720570;
RA   Goddard A.D., Borrow J., Freemont P.S., Solomon E.;
RT   "Characterization of a zinc finger gene disrupted by the t(15;17) in acute
RT   promyelocytic leukemia.";
RL   Science 254:1371-1374(1991).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-4).
RX   PubMed=1311253; DOI=10.1002/j.1460-2075.1992.tb05095.x;
RA   Kastner P., Perez A., Lutz Y., Rochette-Egly C., Gaub M.P., Durand B.,
RA   Lanotte M., Berger R., Chambon P.;
RT   "Structure, localization and transcriptional properties of two classes of
RT   retinoic acid receptor alpha fusion proteins in acute promyelocytic
RT   leukemia (APL): structural similarities with a new family of
RT   oncoproteins.";
RL   EMBO J. 11:629-642(1992).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-6).
RX   PubMed=1652368; DOI=10.1016/0092-8674(91)90112-c;
RA   Kakizuka A., Miller W.H. Jr., Umenono K., Warrell R.P. Jr., Frankel S.R.,
RA   Murty V.V., Dmitrovsky E., Evans R.M.;
RT   "Chromosomal translocation t(15;17) in human acute promyelocytic leukemia
RT   fuses RAR alpha with a novel putative transcription factor, PML.";
RL   Cell 66:663-674(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS PML-1; PML-2; PML-4; PML-5; PML-6;
RP   PML-7; PML-8; PML-12 AND PML-14), AND VARIANT LEU-645.
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S.,
RA   Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PML-6).
RA   Goddard A.D., Solomon E.;
RL   Submitted (JAN-1992) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PML-13).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (AUG-2003) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PML-11).
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16572171; DOI=10.1038/nature04601;
RA   Zody M.C., Garber M., Sharpe T., Young S.K., Rowen L., O'Neill K.,
RA   Whittaker C.A., Kamal M., Chang J.L., Cuomo C.A., Dewar K.,
RA   FitzGerald M.G., Kodira C.D., Madan A., Qin S., Yang X., Abbasi N.,
RA   Abouelleil A., Arachchi H.M., Baradarani L., Birditt B., Bloom S.,
RA   Bloom T., Borowsky M.L., Burke J., Butler J., Cook A., DeArellano K.,
RA   DeCaprio D., Dorris L. III, Dors M., Eichler E.E., Engels R., Fahey J.,
RA   Fleetwood P., Friedman C., Gearin G., Hall J.L., Hensley G., Johnson E.,
RA   Jones C., Kamat A., Kaur A., Locke D.P., Madan A., Munson G., Jaffe D.B.,
RA   Lui A., Macdonald P., Mauceli E., Naylor J.W., Nesbitt R., Nicol R.,
RA   O'Leary S.B., Ratcliffe A., Rounsley S., She X., Sneddon K.M.B.,
RA   Stewart S., Sougnez C., Stone S.M., Topham K., Vincent D., Wang S.,
RA   Zimmer A.R., Birren B.W., Hood L., Lander E.S., Nusbaum C.;
RT   "Analysis of the DNA sequence and duplication history of human chromosome
RT   15.";
RL   Nature 440:671-675(2006).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PML-13).
RC   TISSUE=Kidney;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 419-466, AND CHROMOSOMAL TRANSLOCATION
RP   WITH RARA.
RX   PubMed=1312695;
RA   Tong J.H., Dong S., Geng J.P., Huang W., Wang Z.Y., Sun G.L., Chen S.J.,
RA   Chen Z., Larsen C.-J., Berger R.;
RT   "Molecular rearrangements of the MYL gene in acute promyelocytic leukemia
RT   (APL, M3) define a breakpoint cluster region as well as some molecular
RT   variants.";
RL   Oncogene 7:311-316(1992).
RN   [12]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 454-503, AND CHROMOSOMAL TRANSLOCATION WITH
RP   RARA.
RX   PubMed=12691149; DOI=10.1080/1042819021000040305;
RA   Fujita K., Oba R., Harada H., Mori H., Niikura H., Isoyama K., Omine M.;
RT   "Cytogenetics, FISH and RT-PCR analysis of acute promyelocytic leukemia:
RT   structure of the fusion point in a case lacking classic t(15;17)
RT   translocation.";
RL   Leuk. Lymphoma 44:111-115(2003).
RN   [13]
RP   SUMOYLATION AT LYS-65; LYS-160 AND LYS-490, MUTAGENESIS OF LYS-65; LYS-133;
RP   LYS-150; LYS-160 AND LYS-490, SUBCELLULAR LOCATION, AND FUNCTION.
RX   PubMed=9756909; DOI=10.1074/jbc.273.41.26675;
RA   Kamitani T., Kito K., Nguyen H.P., Wada H., Fukuda-Kamitani T., Yeh E.T.H.;
RT   "Identification of three major sentrinization sites in PML.";
RL   J. Biol. Chem. 273:26675-26682(1998).
RN   [14]
RP   INTERACTION WITH TRIM27.
RX   PubMed=9570750;
RA   Cao T., Duprez E., Borden K.L., Freemont P.S., Etkin L.D.;
RT   "Ret finger protein is a normal component of PML nuclear bodies and
RT   interacts directly with PML.";
RL   J. Cell Sci. 111:1319-1329(1998).
RN   [15]
RP   INTERACTION WITH LASSA VIRUS Z PROTEIN (MICROBIAL INFECTION).
RX   PubMed=9420283;
RA   Borden K.L., Campbell-Dwyer E.J., Salvato M.S.;
RT   "An arenavirus RING (zinc-binding) protein binds the oncoprotein
RT   promyelocyte leukemia protein (PML) and relocates PML nuclear bodies to the
RT   cytoplasm.";
RL   J. Virol. 72:758-766(1998).
RN   [16]
RP   FUNCTION, AND INTERACTION WITH RARA; RXRA AND TRIM24.
RX   PubMed=10610177; DOI=10.1038/15463;
RA   Zhong S., Delva L., Rachez C., Cenciarelli C., Gandini D., Zhang H.,
RA   Kalantry S., Freedman L.P., Pandolfi P.P.;
RT   "A RA-dependent, tumour-growth suppressive transcription complex is the
RT   target of the PML-RARalpha and T18 oncoproteins.";
RL   Nat. Genet. 23:287-295(1999).
RN   [17]
RP   SUMOYLATION AT LYS-65; LYS-160 AND LYS-490.
RX   PubMed=10779416;
RA   Zhong S., Muller S., Ronchetti S., Freemont P.S., Dejean A., Pandolfi P.P.;
RT   "Role of SUMO-1-modified PML in nuclear body formation.";
RL   Blood 95:2748-2752(2000).
RN   [18]
RP   FUNCTION, AND INTERACTION WITH DAXX.
RX   PubMed=10684855; DOI=10.1084/jem.191.4.631;
RA   Zhong S., Salomoni P., Ronchetti S., Guo A., Ruggero D., Pandolfi P.P.;
RT   "Promyelocytic leukemia protein (PML) and Daxx participate in a novel
RT   nuclear pathway for apoptosis.";
RL   J. Exp. Med. 191:631-640(2000).
RN   [19]
RP   INTERACTION WITH DAXX, AND SUBCELLULAR LOCATION.
RX   PubMed=10669754; DOI=10.1128/mcb.20.5.1784-1796.2000;
RA   Li H., Leo C., Zhu J., Wu X., O'Neil J., Park E.-J., Chen J.D.;
RT   "Sequestration and inhibition of Daxx-mediated transcriptional repression
RT   by PML.";
RL   Mol. Cell. Biol. 20:1784-1796(2000).
RN   [20]
RP   FUNCTION, INTERACTION WITH TP53, AND SUBCELLULAR LOCATION.
RX   PubMed=11025664; DOI=10.1038/35036365;
RA   Guo A., Salomoni P., Luo J., Shih A., Zhong S., Gu W., Pandolfi P.P.;
RT   "The function of PML in p53-dependent apoptosis.";
RL   Nat. Cell Biol. 2:730-736(2000).
RN   [21]
RP   FUNCTION IN HUMAN FOAMY VIRUS RESTRICTION, INTERACTION WITH HUMAN FOAMY
RP   VIRUS BEL1 AND BET (MICROBIAL INFECTION), AND SUBCELLULAR LOCATION.
RX   PubMed=11432836; DOI=10.1093/emboj/20.13.3495;
RA   Regad T., Saib A., Lallemand-Breitenbach V., Pandolfi P.P., de The H.,
RA   Chelbi-Alix M.K.;
RT   "PML mediates the interferon-induced antiviral state against a complex
RT   retrovirus via its association with the viral transactivator.";
RL   EMBO J. 20:3495-3505(2001).
RN   [22]
RP   NOMENCLATURE OF ISOFORMS PML-1 THROUGH PML-7.
RX   PubMed=11704850; DOI=10.1038/sj.onc.1204765;
RA   Jensen K., Shiels C., Freemont P.S.;
RT   "PML protein isoforms and the RBCC/TRIM motif.";
RL   Oncogene 20:7223-7233(2001).
RN   [23]
RP   INTERACTION WITH SIRT1.
RX   PubMed=12006491; DOI=10.1093/emboj/21.10.2383;
RA   Langley E., Pearson M., Faretta M., Bauer U.-M., Frye R.A., Minucci S.,
RA   Pelicci P.G., Kouzarides T.;
RT   "Human SIR2 deacetylates p53 and antagonizes PML/p53-induced cellular
RT   senescence.";
RL   EMBO J. 21:2383-2396(2002).
RN   [24]
RP   SUMOYLATION, AND DESUMOYLATION BY SENP2.
RX   PubMed=12419228; DOI=10.1016/s1097-2765(02)00699-8;
RA   Best J.L., Ganiatsas S., Agarwal S., Changou A., Salomoni P., Shirihai O.,
RA   Meluh P.B., Pandolfi P.P., Zon L.I.;
RT   "SUMO-1 protease-1 regulates gene transcription through PML.";
RL   Mol. Cell 10:843-855(2002).
RN   [25]
RP   FUNCTION IN DNA REPAIR, PHOSPHORYLATION AT SER-117 BY CHEK2, AND
RP   INTERACTION WITH CHEK2.
RX   PubMed=12402044; DOI=10.1038/ncb869;
RA   Yang S., Kuo C., Bisi J.E., Kim M.K.;
RT   "PML-dependent apoptosis after DNA damage is regulated by the checkpoint
RT   kinase hCds1/Chk2.";
RL   Nat. Cell Biol. 4:865-870(2002).
RN   [26]
RP   INTERACTION WITH RABIES VIRUS PHOSPHOPROTEINS, SUBCELLULAR LOCATION, AND
RP   FUNCTION.
RX   PubMed=12439746; DOI=10.1038/sj.onc.1205931;
RA   Blondel D., Regad T., Poisson N., Pavie B., Harper F., Pandolfi P.P.,
RA   De The H., Chelbi-Alix M.K.;
RT   "Rabies virus P and small P products interact directly with PML and
RT   reorganize PML nuclear bodies.";
RL   Oncogene 21:7957-7970(2002).
RN   [27]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CHEK2 AND TP53.
RX   PubMed=12810724; DOI=10.1074/jbc.m301264200;
RA   Louria-Hayon I., Grossman T., Sionov R.V., Alsheich O., Pandolfi P.P.,
RA   Haupt Y.;
RT   "The promyelocytic leukemia protein protects p53 from Mdm2-mediated
RT   inhibition and degradation.";
RL   J. Biol. Chem. 278:33134-33141(2003).
RN   [28]
RP   INTERACTION WITH TOPBP1.
RX   PubMed=12773567; DOI=10.1128/mcb.23.12.4247-4256.2003;
RA   Xu Z.-X., Timanova-Atanasova A., Zhao R.-X., Chang K.-S.;
RT   "PML colocalizes with and stabilizes the DNA damage response protein
RT   TopBP1.";
RL   Mol. Cell. Biol. 23:4247-4256(2003).
RN   [29]
RP   INTERACTION WITH SIAH1, AND DEGRADATION.
RX   PubMed=14645235; DOI=10.1074/jbc.m306407200;
RA   Fanelli M., Fantozzi A., De Luca P., Caprodossi S., Matsuzawa S.,
RA   Lazar M.A., Pelicci P.G., Minucci S.;
RT   "The coiled-coil domain is the structural determinant for mammalian
RT   homologues of Drosophila Sina-mediated degradation of promyelocytic
RT   leukemia protein and other tripartite motif proteins by the proteasome.";
RL   J. Biol. Chem. 279:5374-5379(2004).
RN   [30]
RP   FUNCTION, INTERACTION WITH ELF4, AND SUBCELLULAR LOCATION.
RX   PubMed=14976184; DOI=10.1074/jbc.m312439200;
RA   Suico M.A., Yoshida H., Seki Y., Uchikawa T., Lu Z., Shuto T.,
RA   Matsuzaki K., Nakao M., Li J.-D., Kai H.;
RT   "Myeloid Elf-1-like factor, an ETS transcription factor, up-regulates
RT   lysozyme transcription in epithelial cells through interaction with
RT   promyelocytic leukemia protein.";
RL   J. Biol. Chem. 279:19091-19098(2004).
RN   [31]
RP   INTERACTION WITH ANKRD2.
RX   PubMed=15136035; DOI=10.1016/j.jmb.2004.03.071;
RA   Kojic S., Medeot E., Guccione E., Krmac H., Zara I., Martinelli V.,
RA   Valle G., Faulkner G.;
RT   "The Ankrd2 protein, a link between the sarcomere and the nucleus in
RT   skeletal muscle.";
RL   J. Mol. Biol. 339:313-325(2004).
RN   [32]
RP   FUNCTION, INTERACTION WITH MDM2 AND RPL11, PHOSPHORYLATION BY ATR IN
RP   RESPONSE TO DNA DAMAGE, AND SUBCELLULAR LOCATION.
RX   PubMed=15195100; DOI=10.1038/ncb1147;
RA   Bernardi R., Scaglioni P.P., Bergmann S., Horn H.F., Vousden K.H.,
RA   Pandolfi P.P.;
RT   "PML regulates p53 stability by sequestering Mdm2 to the nucleolus.";
RL   Nat. Cell Biol. 6:665-672(2004).
RN   [33]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH CHFR.
RX   PubMed=15467728; DOI=10.1038/nsmb837;
RA   Daniels M.J., Marson A., Venkitaraman A.R.;
RT   "PML bodies control the nuclear dynamics and function of the CHFR mitotic
RT   checkpoint protein.";
RL   Nat. Struct. Mol. Biol. 11:1114-1121(2004).
RN   [34]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH TGFBR1; TGFBR2; SMAD2;
RP   SMAD3 AND ZFYVE9/SARA.
RX   PubMed=15356634; DOI=10.1038/nature02783;
RA   Lin H.K., Bergmann S., Pandolfi P.P.;
RT   "Cytoplasmic PML function in TGF-beta signalling.";
RL   Nature 431:205-211(2004).
RN   [35]
RP   INTERACTION OF PML-RARALPHA ONCOPROTEIN WITH UBE2I, SUBCELLULAR LOCATION,
RP   SUMOYLATION, AND MUTAGENESIS OF CYS-88 AND PRO-89.
RX   PubMed=15809060; DOI=10.1016/j.bbrc.2005.03.052;
RA   Kim Y.E., Kim D.Y., Lee J.M., Kim S.T., Han T.H., Ahn J.H.;
RT   "Requirement of the coiled-coil domain of PML-RARalpha oncoprotein for
RT   localization, sumoylation, and inhibition of monocyte differentiation.";
RL   Biochem. Biophys. Res. Commun. 330:746-754(2005).
RN   [36]
RP   SUBCELLULAR LOCATION.
RX   PubMed=16778193; DOI=10.1158/0008-5472.can-05-3792;
RA   Condemine W., Takahashi Y., Zhu J., Puvion-Dutilleul F., Guegan S.,
RA   Janin A., de The H.;
RT   "Characterization of endogenous human promyelocytic leukemia isoforms.";
RL   Cancer Res. 66:6192-6198(2006).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; SER-518; SER-527 AND
RP   SER-530, PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-565 (ISOFORM PML-5),
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518; SER-527 AND SER-530
RP   (ISOFORM PML-6), AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [38]
RP   FUNCTION.
RX   PubMed=17030982; DOI=10.1083/jcb.200604009;
RA   Dellaire G., Ching R.W., Ahmed K., Jalali F., Tse K.C., Bristow R.G.,
RA   Bazett-Jones D.P.;
RT   "Promyelocytic leukemia nuclear bodies behave as DNA damage sensors whose
RT   response to DNA double-strand breaks is regulated by NBS1 and the kinases
RT   ATM, Chk2, and ATR.";
RL   J. Cell Biol. 175:55-66(2006).
RN   [39]
RP   FUNCTION IN POLIOVIRUS RESTRICTION.
RX   PubMed=16912307; DOI=10.1128/jvi.00031-06;
RA   Pampin M., Simonin Y., Blondel B., Percherancier Y., Chelbi-Alix M.K.;
RT   "Cross talk between PML and p53 during poliovirus infection: implications
RT   for antiviral defense.";
RL   J. Virol. 80:8582-8592(2006).
RN   [40]
RP   SUBUNIT, SUMOYLATION, SUMO-BINDING MOTIF, MUTAGENESIS OF CYS-57 AND CYS-60,
RP   AND SUBCELLULAR LOCATION.
RX   PubMed=17081985; DOI=10.1016/j.molcel.2006.09.013;
RA   Shen T.H., Lin H.K., Scaglioni P.P., Yung T.M., Pandolfi P.P.;
RT   "The mechanisms of PML-nuclear body formation.";
RL   Mol. Cell 24:331-339(2006).
RN   [41]
RP   INTERACTION WITH PKM, FUNCTION, SUBCELLULAR LOCATION, DOMAIN, AND
RP   MUTAGENESIS OF LYS-487 AND LYS-490.
RX   PubMed=18298799; DOI=10.1111/j.1365-2443.2008.01165.x;
RA   Shimada N., Shinagawa T., Ishii S.;
RT   "Modulation of M2-type pyruvate kinase activity by the cytoplasmic PML
RT   tumor suppressor protein.";
RL   Genes Cells 13:245-254(2008).
RN   [42]
RP   ACETYLATION AT LYS-487 AND LYS-515, AND MUTAGENESIS OF LYS-487 AND LYS-515.
RX   PubMed=18621739; DOI=10.1074/jbc.m802217200;
RA   Hayakawa F., Abe A., Kitabayashi I., Pandolfi P.P., Naoe T.;
RT   "Acetylation of PML is involved in histone deacetylase inhibitor-mediated
RT   apoptosis.";
RL   J. Biol. Chem. 283:24420-24425(2008).
RN   [43]
RP   FUNCTION IN HCMV RESTRICTION.
RX   PubMed=17942542; DOI=10.1128/jvi.01685-07;
RA   Tavalai N., Papior P., Rechter S., Stamminger T.;
RT   "Nuclear domain 10 components promyelocytic leukemia protein and hDaxx
RT   independently contribute to an intrinsic antiviral defense against human
RT   cytomegalovirus infection.";
RL   J. Virol. 82:126-137(2008).
RN   [44]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18716620; DOI=10.1038/nature07290;
RA   Song M.S., Salmena L., Carracedo A., Egia A., Lo-Coco F.,
RA   Teruya-Feldstein J., Pandolfi P.P.;
RT   "The deubiquitinylation and localization of PTEN are regulated by a HAUSP-
RT   PML network.";
RL   Nature 455:813-817(2008).
RN   [45]
RP   POLYUBIQUITINATION AT LYS-380; LYS-400; LYS-401 AND LYS-476 BY RNF4,
RP   PROTEASOMAL DEGRADATION, AND SUMOYLATION.
RX   PubMed=18408734; DOI=10.1038/ncb1716;
RA   Tatham M.H., Geoffroy M.C., Shen L., Plechanovova A., Hattersley N.,
RA   Jaffray E.G., Palvimo J.J., Hay R.T.;
RT   "RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-
RT   induced PML degradation.";
RL   Nat. Cell Biol. 10:538-546(2008).
RN   [46]
RP   FUNCTION, AND INTERACTION WITH SATB1.
RX   PubMed=17173041; DOI=10.1038/ncb1516;
RA   Kumar P.P., Bischof O., Purbey P.K., Notani D., Urlaub H., Dejean A.,
RA   Galande S.;
RT   "Functional interaction between PML and SATB1 regulates chromatin-loop
RT   architecture and transcription of the MHC class I locus.";
RL   Nat. Cell Biol. 9:45-56(2007).
RN   [47]
RP   FUNCTION IN HHV-1 RESTRICTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18509536; DOI=10.1371/journal.pone.0002277;
RA   McNally B.A., Trgovcich J., Maul G.G., Liu Y., Zheng P.;
RT   "A role for cytoplasmic PML in cellular resistance to viral infection.";
RL   PLoS ONE 3:E2277-E2277(2008).
RN   [48]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-403; SER-518; SER-527 AND
RP   SER-530, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [49]
RP   FUNCTION IN INFLUENZA A VIRUS RESTRICTION.
RX   PubMed=19703418; DOI=10.1016/j.bbrc.2009.08.091;
RA   Li W., Wang G., Zhang H., Zhang D., Zeng J., Chen X., Xu Y., Li K.;
RT   "Differential suppressive effect of promyelocytic leukemia protein on the
RT   replication of different subtypes/strains of influenza A virus.";
RL   Biochem. Biophys. Res. Commun. 389:84-89(2009).
RN   [50]
RP   FUNCTION, AND INTERACTION WITH TERT.
RX   PubMed=19567472; DOI=10.1242/jcs.048066;
RA   Oh W., Ghim J., Lee E.W., Yang M.R., Kim E.T., Ahn J.H., Song J.;
RT   "PML-IV functions as a negative regulator of telomerase by interacting with
RT   TERT.";
RL   J. Cell Sci. 122:2613-2622(2009).
RN   [51]
RP   PHOSPHORYLATION AT SER-8 AND SER-38 BY HIPK2, AND INTERACTION WITH HIPK2.
RX   PubMed=19015637; DOI=10.1038/onc.2008.420;
RA   Gresko E., Ritterhoff S., Sevilla-Perez J., Roscic A., Froebius K.,
RA   Kotevic I., Vichalkovski A., Hess D., Hemmings B.A., Schmitz M.L.;
RT   "PML tumor suppressor is regulated by HIPK2-mediated phosphorylation in
RT   response to DNA damage.";
RL   Oncogene 28:698-708(2009).
RN   [52]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-530, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [53]
RP   INTERACTION WITH MORC3, AND SUBCELLULAR LOCATION.
RX   PubMed=20501696; DOI=10.1242/jcs.063586;
RA   Mimura Y., Takahashi K., Kawata K., Akazawa T., Inoue N.;
RT   "Two-step colocalization of MORC3 with PML nuclear bodies.";
RL   J. Cell Sci. 123:2014-2024(2010).
RN   [54]
RP   FUNCTION IN RABIES VIRUS RESTRICTION.
RX   PubMed=20702643; DOI=10.1128/jvi.01286-10;
RA   Blondel D., Kheddache S., Lahaye X., Dianoux L., Chelbi-Alix M.K.;
RT   "Resistance to rabies virus infection conferred by the PMLIV isoform.";
RL   J. Virol. 84:10719-10726(2010).
RN   [55]
RP   INTERACTION OF PML-4 AND PML-5 WITH HADV5 E1B-55K (MICROBIAL INFECTION).
RX   PubMed=20639899; DOI=10.1038/onc.2010.284;
RA   Wimmer P., Schreiner S., Everett R.D., Sirma H., Groitl P., Dobner T.;
RT   "SUMO modification of E1B-55K oncoprotein regulates isoform-specific
RT   binding to the tumour suppressor protein PML.";
RL   Oncogene 29:5511-5522(2010).
RN   [56]
RP   SUMOYLATION, AND UBIQUITINATION.
RX   PubMed=20943951; DOI=10.1091/mbc.e10-05-0449;
RA   Geoffroy M.C., Jaffray E.G., Walker K.J., Hay R.T.;
RT   "Arsenic-induced SUMO-dependent recruitment of RNF4 into PML nuclear
RT   bodies.";
RL   Mol. Biol. Cell 21:4227-4239(2010).
RN   [57]
RP   INTERACTION WITH CSNK2A1 AND CSNK2A3.
RX   PubMed=20625391; DOI=10.1371/journal.pone.0011418;
RA   Hung M.S., Lin Y.C., Mao J.H., Kim I.J., Xu Z., Yang C.T., Jablons D.M.,
RA   You L.;
RT   "Functional polymorphism of the CK2alpha intronless gene plays oncogenic
RT   roles in lung cancer.";
RL   PLoS ONE 5:E11418-E11418(2010).
RN   [58]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518 AND SER-527, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [59]
RP   INTERACTION WITH UBC9, SUBUNIT, UBIQUITINATION, SUMOYLATION, ARSENIC
RP   BINDING, DOMAIN, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=20378816; DOI=10.1126/science.1183424;
RA   Zhang X.W., Yan X.J., Zhou Z.R., Yang F.F., Wu Z.Y., Sun H.B., Liang W.X.,
RA   Song A.X., Lallemand-Breitenbach V., Jeanne M., Zhang Q.Y., Yang H.Y.,
RA   Huang Q.H., Zhou G.B., Tong J.H., Zhang Y., Wu J.H., Hu H.Y., de The H.,
RA   Chen S.J., Chen Z.;
RT   "Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by
RT   directly binding PML.";
RL   Science 328:240-243(2010).
RN   [60]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [61]
RP   FUNCTION, AND INTERACTION WITH WRN.
RX   PubMed=21639834; DOI=10.1134/s000629791105004x;
RA   Liu J., Song Y., Qian J., Liu B., Dong Y., Tian B., Sun Z.;
RT   "Promyelocytic leukemia protein interacts with werner syndrome helicase and
RT   regulates double-strand break repair in gamma-irradiation-induced DNA
RT   damage responses.";
RL   Biochemistry (Mosc.) 76:550-554(2011).
RN   [62]
RP   UBIQUITINATION, PHOSPHORYLATION AT SER-518, AND MUTAGENESIS OF SER-518.
RX   PubMed=21840486; DOI=10.1016/j.ccr.2011.07.008;
RA   Yuan W.C., Lee Y.R., Huang S.F., Lin Y.M., Chen T.Y., Chung H.C.,
RA   Tsai C.H., Chen H.Y., Chiang C.T., Lai C.K., Lu L.T., Chen C.H., Gu D.L.,
RA   Pu Y.S., Jou Y.S., Lu K.P., Hsiao P.W., Shih H.M., Chen R.H.;
RT   "A Cullin3-KLHL20 Ubiquitin ligase-dependent pathway targets PML to
RT   potentiate HIF-1 signaling and prostate cancer progression.";
RL   Cancer Cell 20:214-228(2011).
RN   [63]
RP   REVIEW ON FUNCTION.
RX   PubMed=21475307; DOI=10.1038/cdd.2011.31;
RA   Pinton P., Giorgi C., Pandolfi P.P.;
RT   "The role of PML in the control of apoptotic cell fate: a new key player at
RT   ER-mitochondria sites.";
RL   Cell Death Differ. 18:1450-1456(2011).
RN   [64]
RP   REVIEW ON FUNCTION.
RX   PubMed=21501958; DOI=10.1016/j.ceb.2011.03.011;
RA   Carracedo A., Ito K., Pandolfi P.P.;
RT   "The nuclear bodies inside out: PML conquers the cytoplasm.";
RL   Curr. Opin. Cell Biol. 23:360-366(2011).
RN   [65]
RP   PHOSPHORYLATION AT SER-403; SER-505; SER-518 AND SER-527, AND INTERACTION
RP   WITH PIN1 AND MAPK1.
RX   PubMed=22033920; DOI=10.1074/jbc.m111.289512;
RA   Lim J.H., Liu Y., Reineke E., Kao H.Y.;
RT   "Mitogen-activated protein kinase extracellular signal-regulated kinase 2
RT   phosphorylates and promotes Pin1 protein-dependent promyelocytic leukemia
RT   protein turnover.";
RL   J. Biol. Chem. 286:44403-44411(2011).
RN   [66]
RP   FUNCTION.
RX   PubMed=21172801; DOI=10.1242/jcs.075390;
RA   Cuchet D., Sykes A., Nicolas A., Orr A., Murray J., Sirma H., Heeren J.,
RA   Bartelt A., Everett R.D.;
RT   "PML isoforms I and II participate in PML-dependent restriction of HSV-1
RT   replication.";
RL   J. Cell Sci. 124:280-291(2011).
RN   [67]
RP   REVIEW ON FUNCTION IN ANTIVIRAL DEFENSE.
RX   PubMed=21198351; DOI=10.1089/jir.2010.0111;
RA   Geoffroy M.C., Chelbi-Alix M.K.;
RT   "Role of promyelocytic leukemia protein in host antiviral defense.";
RL   J. Interferon Cytokine Res. 31:145-158(2011).
RN   [68]
RP   FUNCTION IN EMCV RESTRICTION, AND INTERACTION WITH EMCV P3D-POL (MICROBIAL
RP   INFECTION).
RX   PubMed=21994459; DOI=10.1128/jvi.05808-11;
RA   Maroui M.A., Pampin M., Chelbi-Alix M.K.;
RT   "Promyelocytic leukemia isoform IV confers resistance to
RT   encephalomyocarditis virus via the sequestration of 3D polymerase in
RT   nuclear bodies.";
RL   J. Virol. 85:13164-13173(2011).
RN   [69]
RP   SUMOYLATION, AND DESUMOYLATION BY SENP6.
RX   PubMed=21148299; DOI=10.1091/mbc.e10-06-0504;
RA   Hattersley N., Shen L., Jaffray E.G., Hay R.T.;
RT   "The SUMO protease SENP6 is a direct regulator of PML nuclear bodies.";
RL   Mol. Biol. Cell 22:78-90(2011).
RN   [70]
RP   REVIEW ON FUNCTION.
RX   PubMed=21161613; DOI=10.1007/s12035-010-8156-y;
RA   Salomoni P., Betts-Henderson J.;
RT   "The role of PML in the nervous system.";
RL   Mol. Neurobiol. 43:114-123(2011).
RN   [71]
RP   FUNCTION IN VARICELLA ZOSTER RESTRICTION, SUBCELLULAR LOCATION, AND
RP   INTERACTION WITH VZV VP26 (MICROBIAL INFECTION).
RX   PubMed=21304940; DOI=10.1371/journal.ppat.1001266;
RA   Reichelt M., Wang L., Sommer M., Perrino J., Nour A.M., Sen N., Baiker A.,
RA   Zerboni L., Arvin A.M.;
RT   "Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral
RT   host defense against Varicella-Zoster virus.";
RL   PLoS Pathog. 7:E1001266-E1001266(2011).
RN   [72]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-518; SER-527 AND SER-530, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [73]
RP   SUMOYLATION AT LYS-65 AND LYS-160, PHOSPHORYLATION AT SER-565, SUBCELLULAR
RP   LOCATION, AND INTERACTION WITH PIAS1; PIAS2 AND CSNK2A1.
RX   PubMed=22406621; DOI=10.1158/0008-5472.can-11-3159;
RA   Rabellino A., Carter B., Konstantinidou G., Wu S.Y., Rimessi A.,
RA   Byers L.A., Heymach J.V., Girard L., Chiang C.M., Teruya-Feldstein J.,
RA   Scaglioni P.P.;
RT   "The SUMO E3-ligase PIAS1 regulates the tumor suppressor PML and its
RT   oncogenic counterpart PML-RARA.";
RL   Cancer Res. 72:2275-2284(2012).
RN   [74]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MAGEA2.
RX   PubMed=22117195; DOI=10.1038/cdd.2011.173;
RA   Peche L.Y., Scolz M., Ladelfa M.F., Monte M., Schneider C.;
RT   "MageA2 restrains cellular senescence by targeting the function of
RT   PMLIV/p53 axis at the PML-NBs.";
RL   Cell Death Differ. 19:926-936(2012).
RN   [75]
RP   REVIEW ON FUNCTION.
RX   PubMed=22237204; DOI=10.1038/cddis.2011.122;
RA   Salomoni P., Dvorkina M., Michod D.;
RT   "Role of the promyelocytic leukaemia protein in cell death regulation.";
RL   Cell Death Dis. 3:E247-E247(2012).
RN   [76]
RP   FUNCTION, AND INTERACTION WITH TBX2; TBX3; E2F4 AND RBL2.
RX   PubMed=22002537; DOI=10.1038/emboj.2011.370;
RA   Martin N., Benhamed M., Nacerddine K., Demarque M.D., van Lohuizen M.,
RA   Dejean A., Bischof O.;
RT   "Physical and functional interaction between PML and TBX2 in the
RT   establishment of cellular senescence.";
RL   EMBO J. 31:95-109(2012).
RN   [77]
RP   FUNCTION IN CIRCADIAN CLOCK, SUBCELLULAR LOCATION, INTERACTION WITH PER2,
RP   ACETYLATION AT LYS-487, AND DEACETYLATION BY SIRT1.
RX   PubMed=22274616; DOI=10.1038/emboj.2012.1;
RA   Miki T., Xu Z., Chen-Goodspeed M., Liu M., Van Oort-Jansen A., Rea M.A.,
RA   Zhao Z., Lee C.C., Chang K.S.;
RT   "PML regulates PER2 nuclear localization and circadian function.";
RL   EMBO J. 31:1427-1439(2012).
RN   [78]
RP   REVIEW ON PTM.
RX   PubMed=23316480; DOI=10.3389/fonc.2012.00210;
RA   Cheng X., Kao H.Y.;
RT   "Post-translational modifications of PML: consequences and implications.";
RL   Front. Oncol. 2:210-210(2012).
RN   [79]
RP   FUNCTION, SUBCELLULAR LOCATION, SUMOYLATION AT LYS-490, AND INTERACTION
RP   WITH HDAC7; RANBP2 AND CTNNB1-TCF7L2 COMPLEX.
RX   PubMed=22155184; DOI=10.1053/j.gastro.2011.11.041;
RA   Satow R., Shitashige M., Jigami T., Fukami K., Honda K., Kitabayashi I.,
RA   Yamada T.;
RT   "Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor
RT   function in colorectal cancer cells.";
RL   Gastroenterology 142:572-581(2012).
RN   [80]
RP   INTERACTION WITH MOMLV IN AND RT (MICROBIAL INFECTION), AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=22685230; DOI=10.1093/jb/mvs063;
RA   Okino Y., Inayoshi Y., Kojima Y., Kidani S., Kaneoka H., Honkawa A.,
RA   Higuchi H., Nishijima K., Miyake K., Iijima S.;
RT   "Moloney murine leukemia virus integrase and reverse transcriptase interact
RT   with PML proteins.";
RL   J. Biochem. 152:161-169(2012).
RN   [81]
RP   FUNCTION.
RX   PubMed=22589541; DOI=10.1074/jbc.m112.340505;
RA   Cheng X., Liu Y., Chu H., Kao H.Y.;
RT   "Promyelocytic leukemia protein (PML) regulates endothelial cell network
RT   formation and migration in response to tumor necrosis factor alpha
RT   (TNFalpha) and interferon alpha (IFNalpha).";
RL   J. Biol. Chem. 287:23356-23367(2012).
RN   [82]
RP   DOMAIN C-TERMINAL.
RX   PubMed=22773875; DOI=10.1074/jbc.m112.374769;
RA   Geng Y., Monajembashi S., Shao A., Cui D., He W., Chen Z., Hemmerich P.,
RA   Tang J.;
RT   "Contribution of the C-terminal regions of promyelocytic leukemia protein
RT   (PML) isoforms II and V to PML nuclear body formation.";
RL   J. Biol. Chem. 287:30729-30742(2012).
RN   [83]
RP   REVIEW ON UBIQUITINATION.
RX   PubMed=22935031; DOI=10.1186/1423-0127-19-81;
RA   Chen R.H., Lee Y.R., Yuan W.C.;
RT   "The role of PML ubiquitination in human malignancies.";
RL   J. Biomed. Sci. 19:81-81(2012).
RN   [84]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH CIITA.
RX   PubMed=23007646; DOI=10.1083/jcb.201112015;
RA   Ulbricht T., Alzrigat M., Horch A., Reuter N., von Mikecz A., Steimle V.,
RA   Schmitt E., Kraemer O.H., Stamminger T., Hemmerich P.;
RT   "PML promotes MHC class II gene expression by stabilizing the class II
RT   transactivator.";
RL   J. Cell Biol. 199:49-63(2012).
RN   [85]
RP   FUNCTION, AND TISSUE SPECIFICITY.
RX   PubMed=22886304; DOI=10.1172/jci62129;
RA   Carracedo A., Weiss D., Leliaert A.K., Bhasin M., de Boer V.C., Laurent G.,
RA   Adams A.C., Sundvall M., Song S.J., Ito K., Finley L.S., Egia A.,
RA   Libermann T., Gerhart-Hines Z., Puigserver P., Haigis M.C.,
RA   Maratos-Flier E., Richardson A.L., Schafer Z.T., Pandolfi P.P.;
RT   "A metabolic prosurvival role for PML in breast cancer.";
RL   J. Clin. Invest. 122:3088-3100(2012).
RN   [86]
RP   INTERACTION WITH HHV-1 ICP0 (MICROBIAL INFECTION).
RX   PubMed=22875967; DOI=10.1128/jvi.01145-12;
RA   Cuchet-Lourenco D., Vanni E., Glass M., Orr A., Everett R.D.;
RT   "Herpes simplex virus 1 ubiquitin ligase ICP0 interacts with PML isoform I
RT   and induces its SUMO-independent degradation.";
RL   J. Virol. 86:11209-11222(2012).
RN   [87]
RP   INTERACTION WITH TRIM16.
RX   PubMed=22629402; DOI=10.1371/journal.pone.0037470;
RA   Bell J.L., Malyukova A., Holien J.K., Koach J., Parker M.W., Kavallaris M.,
RA   Marshall G.M., Cheung B.B.;
RT   "TRIM16 acts as an E3 ubiquitin ligase and can heterodimerize with other
RT   TRIM family members.";
RL   PLoS ONE 7:E37470-E37470(2012).
RN   [88]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-36; SER-38; SER-48; SER-403;
RP   SER-505; SER-512; SER-518; SER-527; SER-530 AND THR-867, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [89]
RP   SUBCELLULAR LOCATION, AND INTERACTION WITH MDM2 AND MAPK7.
RX   PubMed=22869143; DOI=10.1038/onc.2012.332;
RA   Yang Q., Liao L., Deng X., Chen R., Gray N.S., Yates J.R. III, Lee J.D.;
RT   "BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2
RT   interaction.";
RL   Oncogene 32:3156-3164(2013).
RN   [90]
RP   UBIQUITINATION BY UHRF1.
RX   PubMed=22945642; DOI=10.1038/onc.2012.406;
RA   Guan D., Factor D., Liu Y., Wang Z., Kao H.Y.;
RT   "The epigenetic regulator UHRF1 promotes ubiquitination-mediated
RT   degradation of the tumor-suppressor protein promyelocytic leukemia
RT   protein.";
RL   Oncogene 32:3819-3828(2013).
RN   [91]
RP   SUMOYLATION, INTERACTION WITH RNF4, AND DOMAIN SIM.
RX   PubMed=23028697; DOI=10.1371/journal.pone.0044949;
RA   Maroui M.A., Kheddache-Atmane S., El Asmi F., Dianoux L., Aubry M.,
RA   Chelbi-Alix M.K.;
RT   "Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-
RT   induced degradation of nuclear PML isoforms.";
RL   PLoS ONE 7:E44949-E44949(2012).
RN   [92]
RP   FUNCTION.
RX   PubMed=23219818; DOI=10.1016/j.bbrc.2012.11.108;
RA   Kuroki M., Ariumi Y., Hijikata M., Ikeda M., Dansako H., Wakita T.,
RA   Shimotohno K., Kato N.;
RT   "PML tumor suppressor protein is required for HCV production.";
RL   Biochem. Biophys. Res. Commun. 430:592-597(2013).
RN   [93]
RP   INTERACTION WITH NLRP3.
RX   PubMed=23430110; DOI=10.1182/blood-2012-05-432104;
RA   Lo Y.H., Huang Y.W., Wu Y.H., Tsai C.S., Lin Y.C., Mo S.T., Kuo W.C.,
RA   Chuang Y.T., Jiang S.T., Shih H.M., Lai M.Z.;
RT   "Selective inhibition of the NLRP3 inflammasome by targeting to
RT   promyelocytic leukemia protein in mouse and human.";
RL   Blood 121:3185-3194(2013).
RN   [94]
RP   FUNCTION, AND INTERACTION WITH HUMAN ADENOVIRUS 2 E1A.
RX   PubMed=23135708; DOI=10.1128/jvi.02023-12;
RA   Berscheminski J., Groitl P., Dobner T., Wimmer P., Schreiner S.;
RT   "The adenoviral oncogene E1A-13S interacts with a specific isoform of the
RT   tumor suppressor PML to enhance viral transcription.";
RL   J. Virol. 87:965-977(2013).
RN   [95]
RP   FUNCTION, AND INTERACTION WITH KAT6A.
RX   PubMed=23431171; DOI=10.1073/pnas.1300490110;
RA   Rokudai S., Laptenko O., Arnal S.M., Taya Y., Kitabayashi I., Prives C.;
RT   "MOZ increases p53 acetylation and premature senescence through its complex
RT   formation with PML.";
RL   Proc. Natl. Acad. Sci. U.S.A. 110:3895-3900(2013).
RN   [96]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-8; SER-36; SER-403; SER-518;
RP   SER-527 AND SER-530, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [97]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-380 AND LYS-490, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [98]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-160 AND LYS-490, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [99]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-160; LYS-380; LYS-394;
RP   LYS-478 AND LYS-490, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [100]
RP   INTERACTION OF PML-4 AND PML-5 WITH HADV5 E1B-55K (MICROBIAL INFECTION).
RX   PubMed=25772236; DOI=10.1038/onc.2015.63;
RA   Wimmer P., Berscheminski J., Blanchette P., Groitl P., Branton P.E.,
RA   Hay R.T., Dobner T., Schreiner S.;
RT   "PML isoforms IV and V contribute to adenovirus-mediated oncogenic
RT   transformation by functionally inhibiting the tumor-suppressor p53.";
RL   Oncogene 35:69-82(2016).
RN   [101]
RP   SUMOYLATION AT LYS-160; LYS-380; LYS-400; LYS-490 AND LYS-497, MUTAGENESIS
RP   OF LYS-65; LYS-160; LYS-380; LYS-400; LYS-490 AND LYS-497, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=27211601; DOI=10.1038/srep26509;
RA   Liang Y.C., Lee C.C., Yao Y.L., Lai C.C., Schmitz M.L., Yang W.M.;
RT   "SUMO5, a novel poly-sumo isoform, regulates pml nuclear bodies.";
RL   Sci. Rep. 6:26509-26509(2016).
RN   [102]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-65; LYS-160; LYS-380; LYS-394;
RP   LYS-401; LYS-460; LYS-476; LYS-478; LYS-487; LYS-490 AND LYS-497, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [103]
RP   STRUCTURE BY NMR OF 49-104.
RX   PubMed=7729428; DOI=10.1002/j.1460-2075.1995.tb07139.x;
RA   Borden K.L.B., Boddy M.N., Lally J., O'Reilly N.J., Martin S., Howe K.,
RA   Solomon E., Freemont P.S.;
RT   "The solution structure of the RING finger domain from the acute
RT   promyelocytic leukaemia proto-oncoprotein PML.";
RL   EMBO J. 14:1532-1541(1995).
CC   -!- FUNCTION: Functions via its association with PML-nuclear bodies (PML-
CC       NBs) in a wide range of important cellular processes, including tumor
CC       suppression, transcriptional regulation, apoptosis, senescence, DNA
CC       damage response, and viral defense mechanisms. Acts as the scaffold of
CC       PML-NBs allowing other proteins to shuttle in and out, a process which
CC       is regulated by SUMO-mediated modifications and interactions. Isoform
CC       PML-4 has a multifaceted role in the regulation of apoptosis and growth
CC       suppression: activates RB1 and inhibits AKT1 via interactions with PP1
CC       and PP2A phosphatases respectively, negatively affects the PI3K pathway
CC       by inhibiting MTOR and activating PTEN, and positively regulates
CC       p53/TP53 by acting at different levels (by promoting its acetylation
CC       and phosphorylation and by inhibiting its MDM2-dependent degradation).
CC       Isoform PML-4 also: acts as a transcriptional repressor of TBX2 during
CC       cellular senescence and the repression is dependent on a functional
CC       RBL2/E2F4 repressor complex, regulates double-strand break repair in
CC       gamma-irradiation-induced DNA damage responses via its interaction with
CC       WRN, acts as a negative regulator of telomerase by interacting with
CC       TERT, and regulates PER2 nuclear localization and circadian function.
CC       Isoform PML-6 inhibits specifically the activity of the tetrameric form
CC       of PKM. The nuclear isoforms (isoform PML-1, isoform PML-2, isoform
CC       PML-3, isoform PML-4 and isoform PML-5) in concert with SATB1 are
CC       involved in local chromatin-loop remodeling and gene expression
CC       regulation at the MHC-I locus. Isoform PML-2 is required for efficient
CC       IFN-gamma induced MHC II gene transcription via regulation of CIITA.
CC       Cytoplasmic PML is involved in the regulation of the TGF-beta signaling
CC       pathway. PML also regulates transcription activity of ELF4 and can act
CC       as an important mediator for TNF-alpha- and IFN-alpha-mediated
CC       inhibition of endothelial cell network formation and migration.
CC   -!- FUNCTION: Exhibits antiviral activity against both DNA and RNA viruses.
CC       The antiviral activity can involve one or several isoform(s) and can be
CC       enhanced by the permanent PML-NB-associated protein DAXX or by the
CC       recruitment of p53/TP53 within these structures. Isoform PML-4
CC       restricts varicella zoster virus (VZV) via sequestration of virion
CC       capsids in PML-NBs thereby preventing their nuclear egress and
CC       inhibiting formation of infectious virus particles. The sumoylated
CC       isoform PML-4 restricts rabies virus by inhibiting viral mRNA and
CC       protein synthesis. The cytoplasmic isoform PML-14 can restrict herpes
CC       simplex virus-1 (HHV-1) replication by sequestering the viral E3
CC       ubiquitin-protein ligase ICP0 in the cytoplasm. Isoform PML-6 shows
CC       restriction activity towards human cytomegalovirus (HCMV) and influenza
CC       A virus strains PR8(H1N1) and ST364(H3N2). Sumoylated isoform PML-4 and
CC       isoform PML-12 show antiviral activity against encephalomyocarditis
CC       virus (EMCV) by promoting nuclear sequestration of viral polymerase
CC       (P3D-POL) within PML NBs. Isoform PML-3 exhibits antiviral activity
CC       against poliovirus by inducing apoptosis in infected cells through the
CC       recruitment and the activation of p53/TP53 in the PML-NBs. Isoform PML-
CC       3 represses human foamy virus (HFV) transcription by complexing the HFV
CC       transactivator, bel1/tas, preventing its binding to viral DNA. PML may
CC       positively regulate infectious hepatitis C viral (HCV) production and
CC       isoform PML-2 may enhance adenovirus transcription.
CC   -!- SUBUNIT: Key component of PML bodies. PML bodies are formed by the
CC       interaction of PML homodimers (via SUMO-binding motif) with sumoylated
CC       PML, leading to the assembly of higher oligomers. Several types of PML
CC       bodies have been observed. PML bodies can form hollow spheres that can
CC       sequester target proteins inside. Interacts (via SUMO-binding motif)
CC       with sumoylated proteins. Interacts (via C-terminus) with p53/TP53.
CC       Recruits p53/TP53 and CHEK2 into PML bodies, which promotes p53/TP53
CC       phosphorylation at 'Ser-20' and prevents its proteasomal degradation.
CC       Interacts with MDM2, and sequesters MDM2 in the nucleolus, thereby
CC       preventing ubiquitination of p53/TP53. Interaction with PML-RARA
CC       oncoprotein and certain viral proteins causes disassembly of PML bodies
CC       and abolishes the normal PML function. Interacts with HIPK2, TERT,
CC       SIRT1, TOPBP1, TRIM27 and TRIM69. Interacts with ELF4 (via C-terminus).
CC       Interacts with ITPR3. Interacts (in the cytoplasm) with TGFBR1, TGFBR2
CC       and PKM. Interacts (via the coiled-coil domain and when sumoylated)
CC       with SATB1. Interacts with UBE2I; the interaction is enhanced by
CC       arsenic binding. Interacts (PML-RARA oncoprotein, via the coiled-coil
CC       domain) with UBE2I; the interaction is enhanced by arsenic binding and
CC       is required for PML-RARA oncoprotein sumoylation and inhibition of RARA
CC       transactivational activity. Interacts with RB1, PPP1A, SMAD2, SMAD3,
CC       DAXX, RPL11 and MTOR. Interacts with PPARGC1A and KAT2A. Interacts with
CC       CSNK2A1 and CSNK2A3. Interacts with ANKRD2; the interaction is direct.
CC       Interacts (via SUMO-interacting motif) with sumoylated MORC3
CC       (PubMed:20501696). Isoform PML-1, isoform PML-2, isoform PML-3, isoform
CC       PML-4, isoform PML-5 and isoform PML-6 interact with RNF4. Isoform PML-
CC       1 interacts with NLRP3. Isoform PML-1, isoform PML-2, isoform PML-3,
CC       isoform PML-4 and isoform PML-5 interact with MAGEA2, RBL2, PER2 and
CC       E2F4. Isoform PML-2 interacts with CIITA. Isoform PML-2, isoform PML-3
CC       and isoform PML-4 interact with TBX2. Isoform PML-4 interacts with
CC       RANBP2, HDAC7, KAT6A, WRN, PIN1, TBX3 and phosphorylated MAPK1/ERK2.
CC       Isoform PML-4 interacts with the CTNNB1 and TCF7L2/TCF4 complex.
CC       Isoform PML-4 preferentially interacts with MAPK7/BMK1 although other
CC       isoforms (isoform PML-1, isoform PML-2, isoform PML-3 and isoform PML-
CC       6) also interact with it. Isoform PML-12 interacts with PIAS1, PIAS2
CC       (isoform PIAS2-alpha) and CSNK2A1/CK2. Interacts with TRIM16.
CC       {ECO:0000269|PubMed:10610177, ECO:0000269|PubMed:10669754,
CC       ECO:0000269|PubMed:10684855, ECO:0000269|PubMed:11025664,
CC       ECO:0000269|PubMed:12006491, ECO:0000269|PubMed:12402044,
CC       ECO:0000269|PubMed:12439746, ECO:0000269|PubMed:12773567,
CC       ECO:0000269|PubMed:12810724, ECO:0000269|PubMed:14645235,
CC       ECO:0000269|PubMed:14976184, ECO:0000269|PubMed:15136035,
CC       ECO:0000269|PubMed:15195100, ECO:0000269|PubMed:15356634,
CC       ECO:0000269|PubMed:15467728, ECO:0000269|PubMed:15809060,
CC       ECO:0000269|PubMed:17081985, ECO:0000269|PubMed:17173041,
CC       ECO:0000269|PubMed:18298799, ECO:0000269|PubMed:19015637,
CC       ECO:0000269|PubMed:19567472, ECO:0000269|PubMed:20378816,
CC       ECO:0000269|PubMed:20501696, ECO:0000269|PubMed:20625391,
CC       ECO:0000269|PubMed:21639834, ECO:0000269|PubMed:22002537,
CC       ECO:0000269|PubMed:22033920, ECO:0000269|PubMed:22117195,
CC       ECO:0000269|PubMed:22155184, ECO:0000269|PubMed:22274616,
CC       ECO:0000269|PubMed:22406621, ECO:0000269|PubMed:22629402,
CC       ECO:0000269|PubMed:22869143, ECO:0000269|PubMed:23007646,
CC       ECO:0000269|PubMed:23028697, ECO:0000269|PubMed:23430110,
CC       ECO:0000269|PubMed:23431171, ECO:0000269|PubMed:9570750}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with Lassa virus Z protein and
CC       rabies virus phosphoprotein. {ECO:0000269|PubMed:9420283}.
CC   -!- SUBUNIT: (Microbial infection) Isoform PML-1 interacts with herpes
CC       simplex virus-1/HHV-1 ICP0. {ECO:0000269|PubMed:22875967}.
CC   -!- SUBUNIT: (Microbial infection) Isoform PML-2 interacts with human
CC       adenovirus 2 E1A and this interaction stimulates E1A-dependent
CC       transcriptional activation. {ECO:0000269|PubMed:23135708}.
CC   -!- SUBUNIT: (Microbial infection) Isoform PML-4 interacts with VZV capsid
CC       protein VP26/ORF23 capsid protein. {ECO:0000269|PubMed:21304940}.
CC   -!- SUBUNIT: (Microbial infection) The sumoylated isoform PML-4 interacts
CC       with encephalomyocarditis virus (EMCV) RNA-directed RNA polymerase 3D-
CC       POL (P3D-POL). {ECO:0000269|PubMed:21994459}.
CC   -!- SUBUNIT: (Microbial infection) Isoform PML-6 interacts with moloney
CC       murine leukemia virus (MoMLV) integrase (IN) and reverse transcriptase
CC       (RT). {ECO:0000269|PubMed:22685230}.
CC   -!- SUBUNIT: (Microbial infection) Isoform PML-4 and isoform PML-5 interact
CC       with human adenovirus 5 E1B-55K protein; these interactions promote
CC       efficient subnuclear targeting of E1B-55K to PML nuclear bodies.
CC       {ECO:0000269|PubMed:20639899, ECO:0000269|PubMed:23135708,
CC       ECO:0000269|PubMed:25772236}.
CC   -!- SUBUNIT: (Microbial infection) Isoform PML-3 interacts with human foamy
CC       virus bel1/tas and bet. {ECO:0000269|PubMed:11432836}.
CC   -!- INTERACTION:
CC       P29590; P03243-1; Xeno; NbExp=3; IntAct=EBI-295890, EBI-1927377;
CC       P29590-2; P03243-1; Xeno; NbExp=3; IntAct=EBI-303996, EBI-1927377;
CC       P29590-5; P03243-1; Xeno; NbExp=3; IntAct=EBI-304008, EBI-1927377;
CC       P29590-3; P04489; Xeno; NbExp=4; IntAct=EBI-8099068, EBI-6398911;
CC       P29590-13; P29590-13; NbExp=3; IntAct=EBI-12368281, EBI-12368281;
CC       P29590; PRO_0000037566 [P27958]; Xeno; NbExp=6; IntAct=EBI-295890, EBI-6377335;
CC       P29590-5; PRO_0000039791 [P03304]; Xeno; NbExp=3; IntAct=EBI-304008, EBI-6726189;
CC       P29590; P68400: CSNK2A1; NbExp=2; IntAct=EBI-295890, EBI-347804;
CC       P29590; Q9UER7: DAXX; NbExp=6; IntAct=EBI-295890, EBI-77321;
CC       P29590; P25445: FAS; NbExp=4; IntAct=EBI-295890, EBI-494743;
CC       P29590; Q8UN00: gag-pro-pol; Xeno; NbExp=4; IntAct=EBI-295890, EBI-6692904;
CC       P29590; Q9Y2M5: KLHL20; NbExp=9; IntAct=EBI-295890, EBI-714379;
CC       P29590; Q13164: MAPK7; NbExp=6; IntAct=EBI-295890, EBI-1213983;
CC       P29590; Q00987: MDM2; NbExp=6; IntAct=EBI-295890, EBI-389668;
CC       P29590-5; Q00987: MDM2; NbExp=6; IntAct=EBI-304008, EBI-389668;
CC       P29590; P25788: PSMA3; NbExp=2; IntAct=EBI-295890, EBI-348380;
CC       P29590; P63165: SUMO1; NbExp=6; IntAct=EBI-295890, EBI-80140;
CC       P29590-9; P63165: SUMO1; NbExp=2; IntAct=EBI-6861318, EBI-80140;
CC       P29590; Q13207: TBX2; NbExp=2; IntAct=EBI-295890, EBI-2853051;
CC       P29590-5; O14746: TERT; NbExp=7; IntAct=EBI-304008, EBI-1772203;
CC       P29590; Q6N021: TET2; NbExp=2; IntAct=EBI-295890, EBI-310727;
CC       P29590; Q15583: TGIF1; NbExp=3; IntAct=EBI-295890, EBI-714215;
CC       P29590; P04637: TP53; NbExp=4; IntAct=EBI-295890, EBI-366083;
CC       P29590; Q05516: ZBTB16; NbExp=7; IntAct=EBI-295890, EBI-711925;
CC       P29590-5; Q05516: ZBTB16; NbExp=2; IntAct=EBI-304008, EBI-711925;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Nucleus, nucleoplasm. Cytoplasm
CC       {ECO:0000269|PubMed:27211601}. Nucleus, PML body
CC       {ECO:0000269|PubMed:20501696, ECO:0000269|PubMed:27211601}. Nucleus,
CC       nucleolus. Endoplasmic reticulum membrane {ECO:0000250}; Peripheral
CC       membrane protein {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Early
CC       endosome membrane; Peripheral membrane protein; Cytoplasmic side.
CC       Note=Isoform PML-1 can shuttle between the nucleus and cytoplasm.
CC       Isoform PML-2, isoform PML-3, isoform PML-4, isoform PML-5 and isoform
CC       PML-6 are nuclear isoforms whereas isoform PML-7 and isoform PML-14
CC       lacking the nuclear localization signal are cytoplasmic isoforms.
CC       Detected in the nucleolus after DNA damage. Acetylation at Lys-487 is
CC       essential for its nuclear localization. Within the nucleus, most of PML
CC       is expressed in the diffuse nuclear fraction of the nucleoplasm and
CC       only a small fraction is found in the matrix-associated nuclear bodies
CC       (PML-NBs). The transfer of PML from the nucleoplasm to PML-NBs depends
CC       on its phosphorylation and sumoylation. The B1 box and the RING finger
CC       are also required for the localization in PML-NBs. Also found in
CC       specific membrane structures termed mitochondria-associated membranes
CC       (MAMs) which connect the endoplasmic reticulum (ER) and the
CC       mitochondria. Sequestered in the cytoplasm by interaction with rabies
CC       virus phosphoprotein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=12;
CC       Name=PML-1; Synonyms=PML-I, TRIM19alpha;
CC         IsoId=P29590-1; Sequence=Displayed;
CC       Name=PML-2; Synonyms=PML-II, TRIM19kappa;
CC         IsoId=P29590-8; Sequence=VSP_040595;
CC       Name=PML-3; Synonyms=PML-III;
CC         IsoId=P29590-9; Sequence=VSP_040596, VSP_040597;
CC       Name=PML-4; Synonyms=PML-IV, PML-X, TRIM19zeta;
CC         IsoId=P29590-5; Sequence=VSP_005744, VSP_005745;
CC       Name=PML-5; Synonyms=PML-2, PML-V, TRIM19beta;
CC         IsoId=P29590-2; Sequence=VSP_005739, VSP_005740;
CC       Name=PML-6; Synonyms=PML-3B, PML-VI, TRIM19epsilon;
CC         IsoId=P29590-4; Sequence=VSP_005742, VSP_005743;
CC       Name=PML-7; Synonyms=PML-VII, TRIM19theta;
CC         IsoId=P29590-10; Sequence=VSP_040591, VSP_040594;
CC       Name=PML-8; Synonyms=PML-2G, PML-IIG, TRIM19gamma;
CC         IsoId=P29590-3; Sequence=VSP_005741;
CC       Name=PML-11; Synonyms=PML-1A, PML-IA;
CC         IsoId=P29590-11; Sequence=VSP_040590;
CC       Name=PML-12; Synonyms=PML-4A, PML-IVA, TRIM19lambda;
CC         IsoId=P29590-12; Sequence=VSP_040590, VSP_005744, VSP_005745;
CC       Name=PML-13; Synonyms=PML-2A, PML-IIA;
CC         IsoId=P29590-13; Sequence=VSP_040590, VSP_040595;
CC       Name=PML-14; Synonyms=PML-6B, PML-VIB, TRIM19eta, TRIM19iota;
CC         IsoId=P29590-14; Sequence=VSP_040592, VSP_040593;
CC   -!- INDUCTION: By interferons alpha, beta and gamma. Up-regulated by IRF3
CC       and p53/TP53.
CC   -!- DOMAIN: The coiled-coil domain mediates a strong homo/multidimerization
CC       activity essential for core assembly of PML-NBs. Interacts with PKM via
CC       its coiled-coil domain (PubMed:18298799).
CC       {ECO:0000269|PubMed:18298799}.
CC   -!- DOMAIN: The B box-type zinc binding domain and the coiled-coil domain
CC       mediate its interaction with PIAS1. {ECO:0000269|PubMed:22406621}.
CC   -!- DOMAIN: Binds arsenic via the RING-type zinc finger. The RING-type zinc
CC       finger is essential for its interaction with HFV bel1/tas
CC       (PubMed:11432836). {ECO:0000269|PubMed:11432836}.
CC   -!- DOMAIN: The unique C-terminal domains of isoform PML-2 and isoform PML-
CC       5 play an important role in regulating the localization, assembly
CC       dynamics, and functions of PML-NBs. {ECO:0000269|PubMed:22773875}.
CC   -!- DOMAIN: The Sumo interaction motif (SIM) is required for efficient
CC       ubiquitination, recruitment of proteasome components within PML-NBs and
CC       PML degradation in response to arsenic trioxide.
CC       {ECO:0000269|PubMed:23028697}.
CC   -!- PTM: Ubiquitinated; mediated by RNF4, RNF111, UHRF1, UBE3A/E6AP,
CC       BCR(KLHL20) E3 ubiquitin ligase complex E3 ligase complex, SIAH1 or
CC       SIAH2 and leading to subsequent proteasomal degradation
CC       (PubMed:18408734, PubMed:21840486, PubMed:22033920). Ubiquitination by
CC       BCR(KLHL20) E3 ubiquitin ligase complex E3 ligase complex requires
CC       CDK1/2-mediated phosphorylation at Ser-518 which in turn is recognized
CC       by prolyl-isopeptidase PIN1 and PIN1-catalyzed isomerization further
CC       potentiates PML interaction with KLHL20 (PubMed:21840486,
CC       PubMed:22033920). 'Lys-6'-, 'Lys-11'-, 'Lys-48'- and 'Lys-63'-linked
CC       polyubiquitination by RNF4 is polysumoylation-dependent
CC       (PubMed:18408734). Ubiquitination by RNF111 is polysumoylation-
CC       dependent (By similarity). {ECO:0000250|UniProtKB:Q60953,
CC       ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:21840486,
CC       ECO:0000269|PubMed:22033920}.
CC   -!- PTM: Sumoylation regulates PML's: stability in response to
CC       extracellular or intracellular stimuli, transcription directly and
CC       indirectly, through sequestration of or dissociation of the
CC       transcription factors from PML-NBs, ability to regulate apoptosis and
CC       its anti-viral activities. It is also essential for: maintaining proper
CC       PML nuclear bodies (PML-NBs) structure and normal function, recruitment
CC       of components of PML-NBs, the turnover and retention of PML in PML-NBs
CC       and the integrity of PML-NBs. Undergoes 'Lys-11'-linked sumoylation.
CC       Sumoylation on all three sites (Lys-65, Lys-160 and Lys-490) is
CC       required for nuclear body formation. Sumoylation on Lys-160 is a
CC       prerequisite for sumoylation on Lys-65. Lys-65 and Lys-160 are
CC       sumoylated by PISA1 and PIAS2. PIAS1-mediated sumoylation of PML
CC       promotes its interaction with CSNK2A1/CK2 and phosphorylation at Ser-
CC       565 which in turn triggers its ubiquitin-mediated degradation. PIAS1-
CC       mediated sumoylation of PML-RARA promotes its ubiquitin-mediated
CC       degradation. The PML-RARA fusion protein requires the coiled-coil
CC       domain for sumoylation. Sumoylation at Lys-490 by RANBP2 is essential
CC       for the proper assembly of PML-NBs. SUMO1P1/SUMO5 conjugated PML at
CC       Lys-160, Lys-380, Lys-400, Lys-490 and Lys-497, but Lys-380, Lys-400
CC       and Lys-497 are not key acceptor lysines. SUMO1P1/SUMO5 forms polymeric
CC       chain on Lys-160 of PML by successive conjugation at 'Lys-18';
CC       facilitating recruitment of PML-NB components, which enlarges PML.
CC       SUMO1P1/SUMO5 conjugation of PML increases SUMO2/3 conjugation, which
CC       leads to the recruitment of RNF4 and ubiquitin-dependent disintegration
CC       of PML-NBs. SUMO1P1/SUMO5 monoconjugated Lys-490 (PubMed:27211601). DNA
CC       damage triggers its sumoylation while some but not all viral infections
CC       can abolish sumoylation. Desumoylated by SENP1, SENP2, SENP3, SENP5 and
CC       SENP6 (PubMed:27211601, PubMed:12419228, PubMed:21148299). Arsenic
CC       induces PML and PML-RARA polysumoylation and their subsequent RNF4-
CC       dependent ubiquitination and proteasomal degradation, and is used as
CC       treatment in acute promyelocytic leukemia (APL). The nuclear isoforms
CC       (isoform PML-1, isoform PML-2, isoform PML-3, isoform PML-4, isoform
CC       PML-5 and isoform PML-6) show an increased sumoylation in response to
CC       arsenic trioxide. The cytoplasmic isoform PML-7 is not sumoylated.
CC       {ECO:0000269|PubMed:12419228, ECO:0000269|PubMed:18408734,
CC       ECO:0000269|PubMed:21148299, ECO:0000269|PubMed:22155184,
CC       ECO:0000269|PubMed:22406621, ECO:0000269|PubMed:27211601,
CC       ECO:0000269|PubMed:9756909}.
CC   -!- PTM: Phosphorylation is a major regulatory mechanism that controls PML
CC       protein abundance and the number and size of PML nuclear bodies (PML-
CC       NBs). Phosphorylated in response to DNA damage, probably by ATR. HIPK2-
CC       mediated phosphorylation at Ser-8, Ser-36 and Ser-38 leads to increased
CC       accumulation of PML protein and its sumoylation and is required for the
CC       maximal pro-apoptotic activity of PML after DNA damage. CHEK2-mediated
CC       phosphorylation at Ser-117 is important for PML-mediated apoptosis
CC       following DNA damage. MAPK1-mediated phosphorylations at Ser-403, Ser-
CC       505, Ser-527 and Ser-530 and CDK1/2-mediated phosphorylation at Ser-518
CC       promote PIN1-dependent PML degradation. CK2-mediated phosphorylation at
CC       Ser-565 primes PML ubiquitination via an unidentified ubiquitin ligase.
CC       {ECO:0000269|PubMed:12402044, ECO:0000269|PubMed:15195100,
CC       ECO:0000269|PubMed:18408734, ECO:0000269|PubMed:19015637,
CC       ECO:0000269|PubMed:21840486, ECO:0000269|PubMed:22033920,
CC       ECO:0000269|PubMed:22406621}.
CC   -!- PTM: Acetylation at Lys-487 is essential for its nuclear localization.
CC       Deacetylated at Lys-487 by SIRT1 and this deacetylation promotes PML
CC       control of PER2 nuclear localization. {ECO:0000269|PubMed:18621739,
CC       ECO:0000269|PubMed:22274616}.
CC   -!- DISEASE: Note=A chromosomal aberration involving PML may be a cause of
CC       acute promyelocytic leukemia (APL). Translocation t(15;17)(q21;q21)
CC       with RARA. The PML breakpoints (type A and type B) lie on either side
CC       of an alternatively spliced exon. {ECO:0000269|PubMed:1652369,
CC       ECO:0000269|PubMed:1720570}.
CC   -!- MISCELLANEOUS: [Isoform PML-8]: Non-canonical splice sites. Might
CC       alternatively represent a polymorphic variation. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA60351.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA60352.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA60388.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=AAA60390.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAB62809.1; Type=Miscellaneous discrepancy; Note=Chimeric cDNA.; Evidence={ECO:0000305};
CC       Sequence=BAD92648.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PMLID41.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; S50913; AAB19601.2; -; mRNA.
DR   EMBL; M79462; AAA60388.1; ALT_INIT; mRNA.
DR   EMBL; M79463; AAA60351.1; ALT_INIT; mRNA.
DR   EMBL; M79464; AAA60390.1; ALT_INIT; mRNA.
DR   EMBL; X63131; CAA44841.1; -; mRNA.
DR   EMBL; M73778; AAA60125.1; -; mRNA.
DR   EMBL; M80185; AAA60352.1; ALT_INIT; mRNA.
DR   EMBL; AF230401; AAG50180.1; -; mRNA.
DR   EMBL; AF230402; AAG50181.1; -; mRNA.
DR   EMBL; AF230403; AAG50182.1; -; mRNA.
DR   EMBL; AF230405; AAG50184.1; -; mRNA.
DR   EMBL; AF230406; AAG50185.1; -; mRNA.
DR   EMBL; AF230407; AAG50186.1; -; mRNA.
DR   EMBL; AF230408; AAG50187.1; -; mRNA.
DR   EMBL; AF230409; AAG50188.1; -; mRNA.
DR   EMBL; AF230410; AAG50189.1; -; mRNA.
DR   EMBL; AF230411; AAG50190.1; -; mRNA.
DR   EMBL; BT009911; AAP88913.1; -; mRNA.
DR   EMBL; AB209411; BAD92648.1; ALT_INIT; mRNA.
DR   EMBL; AC013486; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC108137; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC000080; AAH00080.2; -; mRNA.
DR   EMBL; BC020994; AAH20994.1; -; mRNA.
DR   EMBL; X64800; CAA46026.1; -; Genomic_DNA.
DR   EMBL; AB067754; BAB62809.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS10255.1; -. [P29590-1]
DR   CCDS; CCDS10256.1; -. [P29590-10]
DR   CCDS; CCDS10257.1; -. [P29590-8]
DR   CCDS; CCDS10258.1; -. [P29590-13]
DR   CCDS; CCDS45297.1; -. [P29590-5]
DR   CCDS; CCDS45298.1; -. [P29590-2]
DR   CCDS; CCDS45299.1; -. [P29590-4]
DR   CCDS; CCDS45300.1; -. [P29590-14]
DR   CCDS; CCDS58386.1; -. [P29590-12]
DR   PIR; A40044; A40044.
DR   PIR; I38054; I38054.
DR   PIR; S19244; S19244.
DR   PIR; S42516; S42516.
DR   PIR; S44381; S44381.
DR   RefSeq; NP_002666.1; NM_002675.3. [P29590-5]
DR   RefSeq; NP_150241.2; NM_033238.2. [P29590-1]
DR   RefSeq; NP_150242.1; NM_033239.2. [P29590-8]
DR   RefSeq; NP_150243.2; NM_033240.2. [P29590-2]
DR   RefSeq; NP_150247.2; NM_033244.3. [P29590-4]
DR   RefSeq; NP_150249.1; NM_033246.2. [P29590-14]
DR   RefSeq; NP_150250.2; NM_033247.2. [P29590-10]
DR   RefSeq; NP_150252.1; NM_033249.2. [P29590-12]
DR   RefSeq; NP_150253.2; NM_033250.2. [P29590-13]
DR   PDB; 1BOR; NMR; -; A=49-104.
DR   PDB; 2MVW; NMR; -; A/B=120-168.
DR   PDB; 2MWX; NMR; -; A=49-104.
DR   PDB; 4WJN; X-ray; 1.50 A; B=547-573.
DR   PDB; 4WJO; X-ray; 1.46 A; B=547-573.
DR   PDB; 5YUF; X-ray; 1.60 A; A/B/C/D=49-99.
DR   PDB; 6IMQ; X-ray; 2.06 A; A/B/C/D=120-168.
DR   PDB; 6UYO; X-ray; 1.64 A; B/D=547-574.
DR   PDB; 6UYP; X-ray; 1.42 A; B=547-574.
DR   PDB; 6UYQ; X-ray; 1.50 A; B=547-574.
DR   PDB; 6UYR; X-ray; 1.30 A; B=547-574.
DR   PDB; 6UYS; X-ray; 1.59 A; B/D=547-574.
DR   PDB; 6UYT; X-ray; 1.66 A; B=547-574.
DR   PDB; 6UYU; X-ray; 1.66 A; B/D=547-574.
DR   PDB; 6UYV; X-ray; 1.40 A; B=547-574.
DR   PDBsum; 1BOR; -.
DR   PDBsum; 2MVW; -.
DR   PDBsum; 2MWX; -.
DR   PDBsum; 4WJN; -.
DR   PDBsum; 4WJO; -.
DR   PDBsum; 5YUF; -.
DR   PDBsum; 6IMQ; -.
DR   PDBsum; 6UYO; -.
DR   PDBsum; 6UYP; -.
DR   PDBsum; 6UYQ; -.
DR   PDBsum; 6UYR; -.
DR   PDBsum; 6UYS; -.
DR   PDBsum; 6UYT; -.
DR   PDBsum; 6UYU; -.
DR   PDBsum; 6UYV; -.
DR   SMR; P29590; -.
DR   BioGrid; 111384; 270.
DR   CORUM; P29590; -.
DR   DIP; DIP-33053N; -.
DR   IntAct; P29590; 121.
DR   MINT; P29590; -.
DR   STRING; 9606.ENSP00000268058; -.
DR   DrugBank; DB01169; Arsenic trioxide.
DR   iPTMnet; P29590; -.
DR   PhosphoSitePlus; P29590; -.
DR   BioMuta; PML; -.
DR   DMDM; 215274219; -.
DR   EPD; P29590; -.
DR   jPOST; P29590; -.
DR   MassIVE; P29590; -.
DR   MaxQB; P29590; -.
DR   PaxDb; P29590; -.
DR   PeptideAtlas; P29590; -.
DR   PRIDE; P29590; -.
DR   ProteomicsDB; 19281; -.
DR   ProteomicsDB; 54589; -. [P29590-1]
DR   ProteomicsDB; 54590; -. [P29590-10]
DR   ProteomicsDB; 54591; -. [P29590-11]
DR   ProteomicsDB; 54592; -. [P29590-12]
DR   ProteomicsDB; 54593; -. [P29590-13]
DR   ProteomicsDB; 54594; -. [P29590-14]
DR   ProteomicsDB; 54595; -. [P29590-2]
DR   ProteomicsDB; 54596; -. [P29590-3]
DR   ProteomicsDB; 54597; -. [P29590-4]
DR   ProteomicsDB; 54598; -. [P29590-5]
DR   ProteomicsDB; 54599; -. [P29590-8]
DR   ProteomicsDB; 54600; -. [P29590-9]
DR   Antibodypedia; 1737; 565 antibodies.
DR   DNASU; 5371; -.
DR   Ensembl; ENST00000268058; ENSP00000268058; ENSG00000140464. [P29590-1]
DR   Ensembl; ENST00000268059; ENSP00000268059; ENSG00000140464. [P29590-8]
DR   Ensembl; ENST00000354026; ENSP00000315434; ENSG00000140464. [P29590-13]
DR   Ensembl; ENST00000359928; ENSP00000353004; ENSG00000140464. [P29590-14]
DR   Ensembl; ENST00000395132; ENSP00000378564; ENSG00000140464. [P29590-10]
DR   Ensembl; ENST00000395135; ENSP00000378567; ENSG00000140464. [P29590-5]
DR   Ensembl; ENST00000435786; ENSP00000395576; ENSG00000140464. [P29590-2]
DR   Ensembl; ENST00000436891; ENSP00000394642; ENSG00000140464. [P29590-4]
DR   Ensembl; ENST00000564428; ENSP00000457023; ENSG00000140464. [P29590-12]
DR   Ensembl; ENST00000565898; ENSP00000455838; ENSG00000140464. [P29590-11]
DR   Ensembl; ENST00000567543; ENSP00000456277; ENSG00000140464. [P29590-14]
DR   Ensembl; ENST00000569477; ENSP00000455612; ENSG00000140464. [P29590-9]
DR   Ensembl; ENST00000569965; ENSP00000456486; ENSG00000140464. [P29590-4]
DR   GeneID; 5371; -.
DR   KEGG; hsa:5371; -.
DR   UCSC; uc002awk.4; human. [P29590-1]
DR   CTD; 5371; -.
DR   DisGeNET; 5371; -.
DR   GeneCards; PML; -.
DR   HGNC; HGNC:9113; PML.
DR   HPA; ENSG00000140464; Low tissue specificity.
DR   MalaCards; PML; -.
DR   MIM; 102578; gene.
DR   neXtProt; NX_P29590; -.
DR   OpenTargets; ENSG00000140464; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   PharmGKB; PA33439; -.
DR   eggNOG; KOG2177; Eukaryota.
DR   eggNOG; ENOG4111G04; LUCA.
DR   GeneTree; ENSGT00510000048454; -.
DR   HOGENOM; CLU_009136_1_0_1; -.
DR   InParanoid; P29590; -.
DR   KO; K10054; -.
DR   OMA; CCICALL; -.
DR   OrthoDB; 421875at2759; -.
DR   PhylomeDB; P29590; -.
DR   TreeFam; TF336434; -.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-6804758; Regulation of TP53 Activity through Acetylation.
DR   Reactome; R-HSA-877300; Interferon gamma signaling.
DR   Reactome; R-HSA-8934593; Regulation of RUNX1 Expression and Activity.
DR   Reactome; R-HSA-8948747; Regulation of PTEN localization.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9616222; Transcriptional regulation of granulopoiesis. [P29590-4]
DR   SignaLink; P29590; -.
DR   SIGNOR; P29590; -.
DR   ChiTaRS; PML; human.
DR   EvolutionaryTrace; P29590; -.
DR   GeneWiki; Promyelocytic_leukemia_protein; -.
DR   GenomeRNAi; 5371; -.
DR   Pharos; P29590; Tbio.
DR   PRO; PR:P29590; -.
DR   Proteomes; UP000005640; Chromosome 15.
DR   RNAct; P29590; protein.
DR   Bgee; ENSG00000140464; Expressed in left lobe of thyroid gland and 198 other tissues.
DR   ExpressionAtlas; P29590; baseline and differential.
DR   Genevisible; P29590; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; ISS:UniProtKB.
DR   GO; GO:0031901; C:early endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0042406; C:extrinsic component of endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0000792; C:heterochromatin; IEA:Ensembl.
DR   GO; GO:0000784; C:nuclear chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0016363; C:nuclear matrix; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:UniProtKB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0050897; F:cobalt ion binding; IDA:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0046982; F:protein heterodimerization activity; IDA:UniProtKB.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0046332; F:SMAD binding; IBA:GO_Central.
DR   GO; GO:0032183; F:SUMO binding; IPI:UniProtKB.
DR   GO; GO:0003713; F:transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; IDA:UniProtKB.
DR   GO; GO:0060444; P:branching involved in mammary gland duct morphogenesis; IEA:Ensembl.
DR   GO; GO:0007050; P:cell cycle arrest; IDA:UniProtKB.
DR   GO; GO:0045165; P:cell fate commitment; IEA:Ensembl.
DR   GO; GO:0071353; P:cellular response to interleukin-4; IEA:Ensembl.
DR   GO; GO:1990830; P:cellular response to leukemia inhibitory factor; IEA:Ensembl.
DR   GO; GO:0090398; P:cellular senescence; IDA:UniProtKB.
DR   GO; GO:0032922; P:circadian regulation of gene expression; ISS:UniProtKB.
DR   GO; GO:0007182; P:common-partner SMAD protein phosphorylation; IEA:Ensembl.
DR   GO; GO:0051607; P:defense response to virus; IEA:UniProtKB-KW.
DR   GO; GO:0006977; P:DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest; ISS:UniProtKB.
DR   GO; GO:0032469; P:endoplasmic reticulum calcium ion homeostasis; ISS:UniProtKB.
DR   GO; GO:0043153; P:entrainment of circadian clock by photoperiod; ISS:UniProtKB.
DR   GO; GO:0097191; P:extrinsic apoptotic signaling pathway; IEA:Ensembl.
DR   GO; GO:0010761; P:fibroblast migration; IEA:Ensembl.
DR   GO; GO:0045087; P:innate immune response; IDA:UniProtKB.
DR   GO; GO:0060333; P:interferon-gamma-mediated signaling pathway; TAS:Reactome.
DR   GO; GO:0008630; P:intrinsic apoptotic signaling pathway in response to DNA damage; IDA:UniProtKB.
DR   GO; GO:0042771; P:intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator; ISS:UniProtKB.
DR   GO; GO:0070059; P:intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress; IEA:Ensembl.
DR   GO; GO:0008631; P:intrinsic apoptotic signaling pathway in response to oxidative stress; IEA:Ensembl.
DR   GO; GO:0051457; P:maintenance of protein location in nucleus; IDA:MGI.
DR   GO; GO:0030099; P:myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IMP:UniProtKB.
DR   GO; GO:0030308; P:negative regulation of cell growth; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IMP:BHF-UCL.
DR   GO; GO:0050713; P:negative regulation of interleukin-1 beta secretion; IEA:Ensembl.
DR   GO; GO:0045930; P:negative regulation of mitotic cell cycle; IDA:UniProtKB.
DR   GO; GO:0051974; P:negative regulation of telomerase activity; IMP:UniProtKB.
DR   GO; GO:0032211; P:negative regulation of telomere maintenance via telomerase; IMP:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0032938; P:negative regulation of translation in response to oxidative stress; IDA:UniProtKB.
DR   GO; GO:2000059; P:negative regulation of ubiquitin-dependent protein catabolic process; IMP:UniProtKB.
DR   GO; GO:1902187; P:negative regulation of viral release from host cell; IDA:UniProtKB.
DR   GO; GO:0030578; P:PML body organization; IDA:UniProtKB.
DR   GO; GO:0060058; P:positive regulation of apoptotic process involved in mammary gland involution; IDA:UniProtKB.
DR   GO; GO:0002230; P:positive regulation of defense response to virus by host; IMP:UniProtKB.
DR   GO; GO:2001238; P:positive regulation of extrinsic apoptotic signaling pathway; IMP:UniProtKB.
DR   GO; GO:0048146; P:positive regulation of fibroblast proliferation; IEA:Ensembl.
DR   GO; GO:0031065; P:positive regulation of histone deacetylation; IDA:UniProtKB.
DR   GO; GO:1904816; P:positive regulation of protein localization to chromosome, telomeric region; IDA:BHF-UCL.
DR   GO; GO:0032206; P:positive regulation of telomere maintenance; IMP:BHF-UCL.
DR   GO; GO:0043161; P:proteasome-mediated ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   GO; GO:0006606; P:protein import into nucleus; IEA:Ensembl.
DR   GO; GO:0050821; P:protein stabilization; IDA:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IDA:UniProtKB.
DR   GO; GO:0065003; P:protein-containing complex assembly; IDA:UniProtKB.
DR   GO; GO:0010522; P:regulation of calcium ion transport into cytosol; ISS:UniProtKB.
DR   GO; GO:0030155; P:regulation of cell adhesion; IEA:Ensembl.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:2000779; P:regulation of double-strand break repair; IMP:UniProtKB.
DR   GO; GO:0001932; P:regulation of protein phosphorylation; ISS:UniProtKB.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IMP:UniProtKB.
DR   GO; GO:0034097; P:response to cytokine; IDA:BHF-UCL.
DR   GO; GO:0010332; P:response to gamma radiation; IEA:Ensembl.
DR   GO; GO:0001666; P:response to hypoxia; IDA:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IEA:Ensembl.
DR   GO; GO:0048384; P:retinoic acid receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IEA:Ensembl.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR021978; DUF3583.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF12126; DUF3583; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   SMART; SM00336; BBOX; 1.
DR   SMART; SM00184; RING; 1.
DR   PROSITE; PS50119; ZF_BBOX; 2.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Antiviral defense; Apoptosis; Biological rhythms;
KW   Chromosomal rearrangement; Coiled coil; Cytoplasm; DNA-binding;
KW   Endoplasmic reticulum; Endosome; Host-virus interaction; Immunity;
KW   Innate immunity; Isopeptide bond; Membrane; Metal-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Proto-oncogene; Reference proteome; Repeat;
KW   Transcription; Transcription regulation; Tumor suppressor; Ubl conjugation;
KW   Zinc; Zinc-finger.
FT   CHAIN           1..882
FT                   /note="Protein PML"
FT                   /id="PRO_0000056001"
FT   ZN_FING         57..92
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         124..166
FT                   /note="B box-type 1; atypical"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   ZN_FING         183..236
FT                   /note="B box-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   REGION          448..555
FT                   /note="Interaction with PER2"
FT                   /evidence="ECO:0000269|PubMed:22274616"
FT   REGION          556..562
FT                   /note="Sumo interaction motif (SIM)"
FT   COILED          228..253
FT                   /evidence="ECO:0000255"
FT   MOTIF           476..490
FT                   /note="Nuclear localization signal"
FT   COMPBIAS        3..46
FT                   /note="Pro-rich"
FT   METAL           57
FT                   /note="Zinc 1"
FT   METAL           60
FT                   /note="Zinc 1"
FT   METAL           72
FT                   /note="Zinc 2"
FT   METAL           74
FT                   /note="Zinc 2"
FT   METAL           77
FT                   /note="Zinc 1"
FT   METAL           80
FT                   /note="Zinc 1"
FT   METAL           88
FT                   /note="Zinc 2"
FT   METAL           91
FT                   /note="Zinc 2"
FT   SITE            394..395
FT                   /note="Breakpoint for translocation to form PML-RARA
FT                   oncogene in type A APL"
FT   SITE            552..553
FT                   /note="Breakpoint for translocation to form PML-RARA
FT                   oncogene in type B APL"
FT   MOD_RES         8
FT                   /note="Phosphoserine; by HIPK2"
FT                   /evidence="ECO:0000244|PubMed:24275569,
FT                   ECO:0000269|PubMed:19015637"
FT   MOD_RES         36
FT                   /note="Phosphoserine; by HIPK2 and MAPK1"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         38
FT                   /note="Phosphoserine; by HIPK2 and MAPK1"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:19015637"
FT   MOD_RES         48
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         117
FT                   /note="Phosphoserine; by CHEK2"
FT                   /evidence="ECO:0000269|PubMed:12402044"
FT   MOD_RES         403
FT                   /note="Phosphoserine; by MAPK1 and MAPK7"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22033920"
FT   MOD_RES         487
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000269|PubMed:18621739,
FT                   ECO:0000269|PubMed:22274616"
FT   MOD_RES         493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60953"
FT   MOD_RES         504
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q60953"
FT   MOD_RES         505
FT                   /note="Phosphoserine; by MAPK1"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:22033920"
FT   MOD_RES         512
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         515
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000305|PubMed:18621739"
FT   MOD_RES         518
FT                   /note="Phosphoserine; by CDK1 and CDK2"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:21840486,
FT                   ECO:0000269|PubMed:22033920"
FT   MOD_RES         527
FT                   /note="Phosphoserine; by MAPK1"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569, ECO:0000269|PubMed:22033920"
FT   MOD_RES         530
FT                   /note="Phosphoserine; by MAPK1"
FT                   /evidence="ECO:0000244|PubMed:17081983,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         565
FT                   /note="Phosphoserine; by CK2"
FT                   /evidence="ECO:0000269|PubMed:22406621"
FT   MOD_RES         867
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        65
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000269|PubMed:10779416"
FT   CROSSLNK        65
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        160
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000269|PubMed:10779416"
FT   CROSSLNK        160
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1P1/SUMO5); alternate"
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   CROSSLNK        160
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        380
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in /SUMO5); alternate"
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   CROSSLNK        380
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        380
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   CROSSLNK        394
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        400
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1P1/SUMO5); alternate"
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   CROSSLNK        400
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   CROSSLNK        401
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        401
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   CROSSLNK        460
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        476
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        476
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in ubiquitin); alternate"
FT                   /evidence="ECO:0000269|PubMed:18408734"
FT   CROSSLNK        478
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        487
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        490
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000269|PubMed:10779416"
FT   CROSSLNK        490
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1P1/SUMO5); alternate"
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   CROSSLNK        490
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        497
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT   CROSSLNK        497
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1P1/SUMO5); alternate"
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   CROSSLNK        497
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         419..466
FT                   /note="Missing (in isoform PML-11, isoform PML-12 and
FT                   isoform PML-13)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.7,
FT                   ECO:0000303|Ref.8"
FT                   /id="VSP_040590"
FT   VAR_SEQ         419..435
FT                   /note="PEEAERVKAQVQALGLA -> LPPPAHALTGPAQSSTH (in isoform
FT                   PML-7)"
FT                   /evidence="ECO:0000303|PubMed:11331580"
FT                   /id="VSP_040591"
FT   VAR_SEQ         419..423
FT                   /note="PEEAE -> RNALW (in isoform PML-14)"
FT                   /evidence="ECO:0000303|PubMed:11331580"
FT                   /id="VSP_040592"
FT   VAR_SEQ         424..882
FT                   /note="Missing (in isoform PML-14)"
FT                   /evidence="ECO:0000303|PubMed:11331580"
FT                   /id="VSP_040593"
FT   VAR_SEQ         436..882
FT                   /note="Missing (in isoform PML-7)"
FT                   /evidence="ECO:0000303|PubMed:11331580"
FT                   /id="VSP_040594"
FT   VAR_SEQ         553..560
FT                   /note="EERVVVIS -> GRERNALW (in isoform PML-6)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1652368, ECO:0000303|Ref.6"
FT                   /id="VSP_005742"
FT   VAR_SEQ         561..882
FT                   /note="Missing (in isoform PML-6)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1652368, ECO:0000303|Ref.6"
FT                   /id="VSP_005743"
FT   VAR_SEQ         571..882
FT                   /note="SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLVFFDLKIDNETQ
FT                   KISQLAAVNRESKFRVVIQPEAFFSIYSKAVSLEVGLQHFLSFLSSMRRPILACYKLWG
FT                   PGLPNFFRALEDINRLWEFQEAISGFLAALPLIRERVPGASSFKLKNLAQTYLARNMSE
FT                   RSAMAAVLAMRDLCRLLEVSPGPQLAQHVYPFSSLQCFASLQPLVQAAVLPRAEARLLA
FT                   LHNVSFMELLSAHRRDRQGGLKKYSRYLSLQTTTLPPAQPAFNLQALGTYFEGLLEGPA
FT                   LARAEGVSTPLAGRGLAERASQQS -> CMEPMETAEPQSSPAHSSPAHSSPAHSSPVQ
FT                   SLLRAQGASSLPCGTYHPPAWPPHQPAEQAATPDAEPHSEPPDHQERPAVHRGIRYLLY
FT                   RAQRAIRLRHALRLHPQLHRAPIRTWSPHVVQASTPAITGPLNHPANAQEHPAQLQRGI
FT                   SPPHRIRGAVRSRSRSLRGSSHLSQWLNNFFALPFSSMASQLDMSSVVGAGESRAQTLG
FT                   AGVPPGDSVRGSMEASQVQVPLEASPITFPPPCAPERPPISPVPGARQAGL (in
FT                   isoform PML-2 and isoform PML-13)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|Ref.7"
FT                   /id="VSP_040595"
FT   VAR_SEQ         571..882
FT                   /note="SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLVFFDLKIDNETQ
FT                   KISQLAAVNRESKFRVVIQPEAFFSIYSKAVSLEVGLQHFLSFLSSMRRPILACYKLWG
FT                   PGLPNFFRALEDINRLWEFQEAISGFLAALPLIRERVPGASSFKLKNLAQTYLARNMSE
FT                   RSAMAAVLAMRDLCRLLEVSPGPQLAQHVYPFSSLQCFASLQPLVQAAVLPRAEARLLA
FT                   LHNVSFMELLSAHRRDRQGGLKKYSRYLSLQTTTLPPAQPAFNLQALGTYFEGLLEGPA
FT                   LARAEGVSTPLAGRGLAERASQQS -> CMEPMETAEPQSSPAHSSPAHSSPVQSLLRA
FT                   QGASSLPCGTYHPPAWPPHQPAEQAATPDAEPHSEPPDHQERPAVHRGIRYLLYRAQRA
FT                   IRLRHALRLHPQLHRAPIRTWSPHVVQASTPAITGPLNHPANAQEHPAQLQRGISPPHR
FT                   IRGAVRSRSRSLRGSSHLSQWLNNFFALPFSSMASQLDMSSVVGAGESRAQTLGAGVPP
FT                   GDSVRGSMEASQVQVPLEASPITFPPPCAPERPPISPVPGARQAGL (in isoform
FT                   PML-8)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1720570"
FT                   /id="VSP_005741"
FT   VAR_SEQ         571..641
FT                   /note="SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLVFFDLKIDNETQ
FT                   KISQLAAVNRESKFRVVIQ -> VSSSPQSEVLYWKVHGAHGDRRATVLASPLLASPLL
FT                   ASPLLASPVSAESTRSLQPALWHIPPPSLASPPAR (in isoform PML-3)"
FT                   /evidence="ECO:0000303|PubMed:1652369"
FT                   /id="VSP_040596"
FT   VAR_SEQ         571..611
FT                   /note="SSRELDDSSSESSDLQLEGPSTLRVLDENLADPQAEDRPLV -> VSGPEVQ
FT                   PRTPASPHFRSQGAQPQQVTLRLALRLGNFPVRH (in isoform PML-5)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1720570"
FT                   /id="VSP_005739"
FT   VAR_SEQ         612..882
FT                   /note="Missing (in isoform PML-5)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1720570"
FT                   /id="VSP_005740"
FT   VAR_SEQ         621..633
FT                   /note="TQKISQLAAVNRE -> SGFSWGYPHPFLI (in isoform PML-4 and
FT                   isoform PML-12)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1311253"
FT                   /id="VSP_005744"
FT   VAR_SEQ         634..882
FT                   /note="Missing (in isoform PML-4 and isoform PML-12)"
FT                   /evidence="ECO:0000303|PubMed:11331580,
FT                   ECO:0000303|PubMed:1311253"
FT                   /id="VSP_005745"
FT   VAR_SEQ         642..882
FT                   /note="Missing (in isoform PML-3)"
FT                   /evidence="ECO:0000303|PubMed:1652369"
FT                   /id="VSP_040597"
FT   VARIANT         645
FT                   /note="F -> L (in dbSNP:rs5742915)"
FT                   /evidence="ECO:0000269|PubMed:11331580,
FT                   ECO:0000269|PubMed:1720570"
FT                   /id="VAR_052090"
FT   MUTAGEN         57
FT                   /note="C->S: Strongly reduced sumoylation; when associated
FT                   with S-60."
FT                   /evidence="ECO:0000269|PubMed:17081985"
FT   MUTAGEN         60
FT                   /note="C->S: Strongly reduced sumoylation; when associated
FT                   with S-57."
FT                   /evidence="ECO:0000269|PubMed:17081985"
FT   MUTAGEN         65
FT                   /note="K->R: Loss of one sumoylation. No effect on nuclear
FT                   body formation. Loss of 2 sumoylations; when associated
FT                   with R-490 with or without R-133 or R-150. No effect on
FT                   nuclear body formation; when associated with R-490. Loss
FT                   the ability to be conjugated by SUMO1P1/SUMO5 but could be
FT                   conjugated by SUMO1; when associated with R-160 and R-490."
FT                   /evidence="ECO:0000269|PubMed:27211601,
FT                   ECO:0000269|PubMed:9756909"
FT   MUTAGEN         65
FT                   /note="K->R: Loss of one sumoylation. No effect on nuclear
FT                   body formation. Loss of 2 sumoylations; when associated
FT                   with R-490 with or without R-133 or R-150. No effect on
FT                   nuclear body formation; when associated with R-490. No
FT                   sumoylation nor nuclear body formation; when associated
FT                   with R-160 and R-490."
FT                   /evidence="ECO:0000269|PubMed:9756909"
FT   MUTAGEN         68
FT                   /note="K->R: No effect on sumoylation levels."
FT   MUTAGEN         88
FT                   /note="C->S: No nuclear microspeckle location, no
FT                   sumoylation and loss of intrinsic transcriptional repressor
FT                   activity of PML-RARA oncoprotein; when associated with R-
FT                   89."
FT                   /evidence="ECO:0000269|PubMed:15809060"
FT   MUTAGEN         89
FT                   /note="P->R: No nuclear microspeckle location, no
FT                   sumoylation and loss of intrinsic transcriptional repressor
FT                   activity of PML-RARA oncoprotein; when associated with S-
FT                   88."
FT                   /evidence="ECO:0000269|PubMed:15809060"
FT   MUTAGEN         133
FT                   /note="K->R: Loss of 2 sumoylations; when associated with
FT                   R-65 and R-490."
FT                   /evidence="ECO:0000269|PubMed:9756909"
FT   MUTAGEN         150
FT                   /note="K->R: Loss of 2 sumoylations; when associated with
FT                   R-65 and R-490."
FT                   /evidence="ECO:0000269|PubMed:9756909"
FT   MUTAGEN         160
FT                   /note="K->R: Compromised the formation of high molecular
FT                   weight species of SUMO1P1/SUMO5 conjugation on PML. Loss of
FT                   2 sumoylations; when associated with or without R-65. No
FT                   sumoylation nor nuclear body formation; when associated
FT                   with or without R-65 and R-490. Loss the ability to be
FT                   conjugated by SUMO1P1/SUMO5 but could be conjugated by
FT                   SUMO1; when associated with R-65 and R-490."
FT                   /evidence="ECO:0000269|PubMed:27211601,
FT                   ECO:0000269|PubMed:9756909"
FT   MUTAGEN         160
FT                   /note="K->R: Loss of 2 sumoylations; when associated with
FT                   or without R-65. No sumoylation nor nuclear body formation;
FT                   when associated with or without R-65 and R-490."
FT                   /evidence="ECO:0000269|PubMed:9756909"
FT   MUTAGEN         380
FT                   /note="K->R: Does not affect SUMO1P1/SUMO5 conjugation."
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   MUTAGEN         400
FT                   /note="K->R: Does not affect SUMO1P1/SUMO5 conjugation."
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   MUTAGEN         487
FT                   /note="K->A: Loss of nuclear localization; when associated
FT                   with A-490."
FT                   /evidence="ECO:0000269|PubMed:18298799,
FT                   ECO:0000269|PubMed:18621739"
FT   MUTAGEN         487
FT                   /note="K->R: Loss of nuclear localization. Reduced
FT                   acetylation. Further decrease in acetylation; when
FT                   associated with R-515."
FT                   /evidence="ECO:0000269|PubMed:18298799,
FT                   ECO:0000269|PubMed:18621739"
FT   MUTAGEN         490
FT                   /note="K->A: Loss of nuclear localization; when associated
FT                   with A-487."
FT                   /evidence="ECO:0000269|PubMed:18298799,
FT                   ECO:0000269|PubMed:9756909"
FT   MUTAGEN         490
FT                   /note="K->R: Abolished conjugation of one SUMO1P1/SUMO5.
FT                   Loss of 2 sumoylations; when associated with R-65 with or
FT                   without R-133. No effect on nuclear body formation; when
FT                   associated with R-65. No sumoylation nor nuclear body
FT                   formation; when associated with R-65 and R-160. Loss the
FT                   ability to be conjugated by SUMO1P1/SUMO5 but could be
FT                   conjugated by SUMO1; when associated with R-65 and R-160."
FT                   /evidence="ECO:0000269|PubMed:18298799,
FT                   ECO:0000269|PubMed:27211601, ECO:0000269|PubMed:9756909"
FT   MUTAGEN         490
FT                   /note="K->R: Loss of 2 sumoylations; when associated with
FT                   R-65 with or without R-133. No effect on nuclear body
FT                   formation; when associated with R-65. No sumoylation nor
FT                   nuclear body formation; when associated with R-65 and R-
FT                   160."
FT                   /evidence="ECO:0000269|PubMed:18298799,
FT                   ECO:0000269|PubMed:9756909"
FT   MUTAGEN         497
FT                   /note="K->R: Does not affect SUMO1P1/SUMO5 conjugation."
FT                   /evidence="ECO:0000269|PubMed:27211601"
FT   MUTAGEN         515
FT                   /note="K->R: Slightly reduced acetylation. Further decrease
FT                   in acetylation; when associated with R-487."
FT                   /evidence="ECO:0000269|PubMed:18621739"
FT   MUTAGEN         518
FT                   /note="S->A: Abolishes ubiquitination by the BCR(KLHL20) E3
FT                   ubiquitin ligase complex."
FT                   /evidence="ECO:0000269|PubMed:21840486"
FT   MUTAGEN         556..559
FT                   /note="VVVI->AAAS: Abolishes SUMO1 binding."
FT   CONFLICT        224
FT                   /note="E -> D (in Ref. 7; AAP88913 and 10; AAH00080/
FT                   AAH20994)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        419
FT                   /note="P -> A (in Ref. 2; AAA60351/AAA60388/AAA60390, 4;
FT                   AAA60352 and 5; AAG50182/AAG50184/AAG50185)"
FT                   /evidence="ECO:0000305"
FT   STRAND          54..56
FT                   /evidence="ECO:0000244|PDB:5YUF"
FT   TURN            58..60
FT                   /evidence="ECO:0000244|PDB:5YUF"
FT   STRAND          62..66
FT                   /evidence="ECO:0000244|PDB:5YUF"
FT   HELIX           78..82
FT                   /evidence="ECO:0000244|PDB:5YUF"
FT   TURN            89..91
FT                   /evidence="ECO:0000244|PDB:5YUF"
FT   STRAND          93..96
FT                   /evidence="ECO:0000244|PDB:1BOR"
FT   STRAND          121..126
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   TURN            130..132
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   STRAND          138..140
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   TURN            141..144
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   STRAND          145..147
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   HELIX           149..158
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   STRAND          163..165
FT                   /evidence="ECO:0000244|PDB:6IMQ"
FT   STRAND          556..558
FT                   /evidence="ECO:0000244|PDB:6UYR"
FT   MOD_RES         P29590-2:565
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   CONFLICT        P29590-2:578
FT                   /note="P -> A (in Ref. 5; AAG50181)"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P29590-4:518
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   MOD_RES         P29590-4:527
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   MOD_RES         P29590-4:530
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:17081983"
FT   CONFLICT        P29590-10:419
FT                   /note="L -> V (in Ref. 5; AAG50187)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   882 AA;  97551 MW;  D50968A977E34287 CRC64;
     MEPAPARSPR PQQDPARPQE PTMPPPETPS EGRQPSPSPS PTERAPASEE EFQFLRCQQC
     QAEAKCPKLL PCLHTLCSGC LEASGMQCPI CQAPWPLGAD TPALDNVFFE SLQRRLSVYR
     QIVDAQAVCT RCKESADFWC FECEQLLCAK CFEAHQWFLK HEARPLAELR NQSVREFLDG
     TRKTNNIFCS NPNHRTPTLT SIYCRGCSKP LCCSCALLDS SHSELKCDIS AEIQQRQEEL
     DAMTQALQEQ DSAFGAVHAQ MHAAVGQLGR ARAETEELIR ERVRQVVAHV RAQERELLEA
     VDARYQRDYE EMASRLGRLD AVLQRIRTGS ALVQRMKCYA SDQEVLDMHG FLRQALCRLR
     QEEPQSLQAA VRTDGFDEFK VRLQDLSSCI TQGKDAAVSK KASPEAASTP RDPIDVDLPE
     EAERVKAQVQ ALGLAEAQPM AVVQSVPGAH PVPVYAFSIK GPSYGEDVSN TTTAQKRKCS
     QTQCPRKVIK MESEEGKEAR LARSSPEQPR PSTSKAVSPP HLDGPPSPRS PVIGSEVFLP
     NSNHVASGAG EAEERVVVIS SSEDSDAENS SSRELDDSSS ESSDLQLEGP STLRVLDENL
     ADPQAEDRPL VFFDLKIDNE TQKISQLAAV NRESKFRVVI QPEAFFSIYS KAVSLEVGLQ
     HFLSFLSSMR RPILACYKLW GPGLPNFFRA LEDINRLWEF QEAISGFLAA LPLIRERVPG
     ASSFKLKNLA QTYLARNMSE RSAMAAVLAM RDLCRLLEVS PGPQLAQHVY PFSSLQCFAS
     LQPLVQAAVL PRAEARLLAL HNVSFMELLS AHRRDRQGGL KKYSRYLSLQ TTTLPPAQPA
     FNLQALGTYF EGLLEGPALA RAEGVSTPLA GRGLAERASQ QS
//
ID   A0A494C1F9_HUMAN        Unreviewed;       250 AA.
AC   A0A494C1F9;
DT   05-JUN-2019, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 1.
DT   22-APR-2020, entry version 8.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma {ECO:0000256|RuleBase:RU364110};
DE            Short=PPAR-gamma {ECO:0000256|RuleBase:RU364110};
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3 {ECO:0000256|RuleBase:RU364110};
GN   Name=PPARG {ECO:0000256|RuleBase:RU364110,
GN   ECO:0000313|Ensembl:ENSP00000499041};
GN   Synonyms=PPARG1D5 {ECO:0000313|EMBL:VAX75249.1},
GN   PPARG3D5 {ECO:0000313|EMBL:VAX75251.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000499041, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000499041, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [2] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [3] {ECO:0000313|EMBL:VAX75249.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=HEK293 cell line {ECO:0000313|EMBL:VAX75249.1};
RA   Costa V.;
RL   Submitted (SEP-2018) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|Ensembl:ENSP00000499041}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (APR-2019) to UniProtKB.
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators such as
CC       hypolipidemic drugs and fatty acids. Once activated by a ligand, the
CC       nuclear receptor binds to DNA specific PPAR response elements (PPRE)
CC       and modulates the transcription of its target genes, such as acyl-CoA
CC       oxidase. It therefore controls the peroxisomal beta-oxidation pathway
CC       of fatty acids. Key regulator of adipocyte differentiation and glucose
CC       homeostasis. ARF6 acts as a key regulator of the tissue-specific
CC       adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut
CC       homeostasis by suppressing NF-kappa-B-mediated proinflammatory
CC       responses. Plays a role in the regulation of cardiovascular circadian
CC       rhythms by regulating the transcription of ARNTL/BMAL1 in the blood
CC       vessels. {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBUNIT: Heterodimer with other nuclear receptors.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU364110}.
CC       Nucleus {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00586772}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000256|RuleBase:RU364110}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC090947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; LS999978; VAX75249.1; -; mRNA.
DR   EMBL; LS999980; VAX75251.1; -; mRNA.
DR   RefSeq; NP_001317544.1; NM_001330615.1.
DR   RefSeq; XP_011532146.1; XM_011533844.1.
DR   Antibodypedia; 3799; 1044 antibodies.
DR   Ensembl; ENST00000650840; ENSP00000499041; ENSG00000132170.
DR   GeneID; 5468; -.
DR   CTD; 5468; -.
DR   HGNC; HGNC:9236; PPARG.
DR   OpenTargets; ENSG00000132170; -.
DR   GeneTree; ENSGT00940000158273; -.
DR   ChiTaRS; PPARG; human.
DR   Proteomes; UP000005640; Chromosome 3.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00399; ZnF_C4; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|RuleBase:RU364110};
KW   Biological rhythms {ECO:0000256|RuleBase:RU364110};
KW   Cytoplasm {ECO:0000256|RuleBase:RU364110};
KW   DNA-binding {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476383};
KW   Metal-binding {ECO:0000256|RuleBase:RU364110,
KW   ECO:0000256|SAAS:SAAS00476458};
KW   Nucleus {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476518};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:A0A494C1F9,
KW   ECO:0000213|ProteomicsDB:A0A494C1F9};
KW   Receptor {ECO:0000256|RuleBase:RU364110, ECO:0000313|EMBL:VAX75249.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|RuleBase:RU364110,
KW   ECO:0000256|SAAS:SAAS00116499};
KW   Transcription regulation {ECO:0000256|RuleBase:RU364110,
KW   ECO:0000256|SAAS:SAAS00116499};
KW   Zinc {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476458};
KW   Zinc-finger {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476458}.
FT   DOMAIN          108..182
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000259|PROSITE:PS51030"
SQ   SEQUENCE   250 AA;  28535 MW;  F3340CD1975E9AF6 CRC64;
     MTMVDTEMPF WPTNFGISSV DLSVMEDHSH SFDIKPFTTV DFSSISTPHY EDIPFTRTDP
     VVADYKYDLK LQEYQSAIKV EPASPPYYSE KTQLYNKPHE EPSNSLMAIE CRVCGDKASG
     FHYGVHACEG CKGFFRRTIR LKLIYDRCDL NCRIHKKSRN KCQYCRFQKC LAVGMSHNAI
     RFGRMPQAEK EKLLAEISSD IDQLNPESAD LRALAKHLYD SYIKSFPLTK AKARAILTGK
     TTDKSTAQVC
//
ID   D2KUA6_HUMAN            Unreviewed;       477 AA.
AC   D2KUA6;
DT   02-MAR-2010, integrated into UniProtKB/TrEMBL.
DT   02-MAR-2010, sequence version 1.
DT   22-APR-2020, entry version 94.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma {ECO:0000256|RuleBase:RU364110};
DE            Short=PPAR-gamma {ECO:0000256|RuleBase:RU364110};
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3 {ECO:0000256|RuleBase:RU364110};
GN   Name=PPARG {ECO:0000256|RuleBase:RU364110, ECO:0000313|EMBL:BAI63629.1};
GN   Synonyms=NR1C3 {ECO:0000313|EMBL:ADZ17377.1},
GN   PPAR gamma {ECO:0000313|EMBL:BAM71699.1};
GN   ORFNames=hCG_26772 {ECO:0000313|EMBL:EAW64123.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAI63629.1};
RN   [1] {ECO:0000313|EMBL:EAW64123.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW64123.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:BAI63629.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Takahashi S., Inoue I., Seo M., Ikeda M., Katayama S.;
RT   "A promoter in the novel exon of hPPARg6 directs the circadian expression
RT   of PPARg6.";
RL   Submitted (DEC-2008) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAM71699.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Takahashi S., Inoue I.;
RT   "PPAR gamma.";
RL   Submitted (JUN-2010) to the EMBL/GenBank/DDBJ databases.
RN   [5] {ECO:0000313|EMBL:ADZ17377.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Heart {ECO:0000313|EMBL:ADZ17377.1};
RA   Kaighin V.A., Martin A.L., Aronstam R.S.;
RT   "Isolation of cDNA coding for multiple human nuclear receptor clones.";
RL   Submitted (DEC-2010) to the EMBL/GenBank/DDBJ databases.
RN   [6] {ECO:0000313|EMBL:ALQ33725.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators such as
CC       hypolipidemic drugs and fatty acids. Once activated by a ligand, the
CC       nuclear receptor binds to DNA specific PPAR response elements (PPRE)
CC       and modulates the transcription of its target genes, such as acyl-CoA
CC       oxidase. It therefore controls the peroxisomal beta-oxidation pathway
CC       of fatty acids. Key regulator of adipocyte differentiation and glucose
CC       homeostasis. ARF6 acts as a key regulator of the tissue-specific
CC       adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut
CC       homeostasis by suppressing NF-kappa-B-mediated proinflammatory
CC       responses. Plays a role in the regulation of cardiovascular circadian
CC       rhythms by regulating the transcription of ARNTL/BMAL1 in the blood
CC       vessels. {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBUNIT: Heterodimer with other nuclear receptors.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU364110}.
CC       Nucleus {ECO:0000256|RuleBase:RU004334, ECO:0000256|RuleBase:RU364110,
CC       ECO:0000256|SAAS:SAAS01037405}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000256|RuleBase:RU364110}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; HQ692866; ADZ17377.1; -; mRNA.
DR   EMBL; KU178267; ALQ33725.1; -; mRNA.
DR   EMBL; AB472042; BAI63629.1; -; mRNA.
DR   EMBL; AB565476; BAM71699.1; -; mRNA.
DR   EMBL; CH471055; EAW64123.1; -; Genomic_DNA.
DR   RefSeq; NP_005028.4; NM_005037.5.
DR   RefSeq; NP_619725.2; NM_138711.3.
DR   RefSeq; NP_619726.2; NM_138712.3.
DR   RefSeq; XP_011532143.1; XM_011533841.2.
DR   Antibodypedia; 3799; 1044 antibodies.
DR   DNASU; 5468; -.
DR   GeneID; 5468; -.
DR   CTD; 5468; -.
DR   EuPathDB; HostDB:ENSG00000132170.19; -.
DR   PharmGKB; PA281; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   HOGENOM; CLU_007368_4_2_1; -.
DR   ChiTaRS; PPARG; human.
DR   GenomeRNAi; 5468; -.
DR   Bgee; ENSG00000132170; Expressed in subcutaneous adipose tissue and 135 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   2: Evidence at transcript level;
KW   Activator {ECO:0000256|RuleBase:RU364110};
KW   Biological rhythms {ECO:0000256|RuleBase:RU364110};
KW   Cytoplasm {ECO:0000256|RuleBase:RU364110};
KW   DNA-binding {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00476383};
KW   Metal-binding {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS00476458};
KW   Nucleus {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037386};
KW   Receptor {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS01037471,
KW   ECO:0000313|EMBL:BAI63629.1};
KW   Transcription {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS01037387};
KW   Transcription regulation {ECO:0000256|RuleBase:RU004334,
KW   ECO:0000256|SAAS:SAAS01037387};
KW   Zinc {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00476458};
KW   Zinc-finger {ECO:0000256|RuleBase:RU004334, ECO:0000256|SAAS:SAAS00476458}.
FT   DOMAIN          108..182
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000259|PROSITE:PS51030"
FT   DOMAIN          210..475
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000259|PROSITE:PS51843"
SQ   SEQUENCE   477 AA;  54681 MW;  1061C2074B739E0A CRC64;
     MTMVDTEMPF WPTNFGISSV DLSVMEDHSH SFDIKPFTTV DFSSISTPHY EDIPFTRTDP
     VVADYKYDLK LQEYQSAIKV EPASPPYYSE KTQLYNKPHE EPSNSLMAIE CRVCGDKASG
     FHYGVHACEG CKGFFRRTIR LKLIYDRCDL NCRIHKKSRN KCQYCRFQKC LAVGMSHNAI
     RFGRMPQAEK EKLLAEISSD IDQLNPESAD LRALAKHLYD SYIKSFPLTK AKARAILTGK
     TTDKSPFVIY DMNSLMMGED KIKFKHITPL QEQSKEVAIR IFQGCQFRSV EAVQEITEYA
     KSIPGFVNLD LNDQVTLLKY GVHEIIYTML ASLMNKDGVL ISEGQGFMTR EFLKSLRKPF
     GDFMEPKFEF AVKFNALELD DSDLAIFIAV IILSGDRPGL LNVKPIEDIQ DNLLQALELQ
     LKLNHPESSQ LFAKLLQKMT DLRQIVTEHV QLLQVIKKTE TDMSLHPLLQ EIYKDLY
//
ID   E9PFX5_HUMAN            Unreviewed;       248 AA.
AC   E9PFX5; Q4W448;
DT   05-APR-2011, integrated into UniProtKB/TrEMBL.
DT   05-JUN-2019, sequence version 2.
DT   22-APR-2020, entry version 85.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma {ECO:0000256|RuleBase:RU364110};
DE            Short=PPAR-gamma {ECO:0000256|RuleBase:RU364110};
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3 {ECO:0000256|RuleBase:RU364110};
GN   Name=PPARG {ECO:0000256|RuleBase:RU364110, ECO:0000313|EMBL:CAG29019.1,
GN   ECO:0000313|Ensembl:ENSP00000380196};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000380196, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|EMBL:CAG29019.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Colon carcinoma {ECO:0000313|EMBL:CAG29019.1};
RA   Casamassimi A., Migliore C., Ciccodicola A.;
RT   "Human peroxisome proliferative activated receptor gamma.";
RL   Submitted (APR-2004) to the EMBL/GenBank/DDBJ databases.
RN   [2] {ECO:0000313|Ensembl:ENSP00000380196, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [3] {ECO:0000313|Ensembl:ENSP00000380196}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
RN   [4] {ECO:0000213|PubMed:23186163}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=23186163;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators such as
CC       hypolipidemic drugs and fatty acids. Once activated by a ligand, the
CC       nuclear receptor binds to DNA specific PPAR response elements (PPRE)
CC       and modulates the transcription of its target genes, such as acyl-CoA
CC       oxidase. It therefore controls the peroxisomal beta-oxidation pathway
CC       of fatty acids. Key regulator of adipocyte differentiation and glucose
CC       homeostasis. ARF6 acts as a key regulator of the tissue-specific
CC       adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut
CC       homeostasis by suppressing NF-kappa-B-mediated proinflammatory
CC       responses. Plays a role in the regulation of cardiovascular circadian
CC       rhythms by regulating the transcription of ARNTL/BMAL1 in the blood
CC       vessels. {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBUNIT: Heterodimer with other nuclear receptors.
CC       {ECO:0000256|RuleBase:RU364110}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000256|RuleBase:RU364110}.
CC       Nucleus {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00586772}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000256|RuleBase:RU364110}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC090947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ698135; CAG29019.1; -; mRNA.
DR   RefSeq; NP_001317544.1; NM_001330615.1.
DR   ProteomicsDB; 20199; -.
DR   ProteomicsDB; 62370; -.
DR   Antibodypedia; 3799; 1044 antibodies.
DR   Ensembl; ENST00000397000; ENSP00000380196; ENSG00000132170.
DR   GeneID; 5468; -.
DR   UCSC; uc003bwv.4; human.
DR   CTD; 5468; -.
DR   EuPathDB; HostDB:ENSG00000132170.19; -.
DR   HGNC; HGNC:9236; PPARG.
DR   OpenTargets; ENSG00000132170; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00940000158273; -.
DR   ChiTaRS; PPARG; human.
DR   GenomeRNAi; 5468; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   Bgee; ENSG00000132170; Expressed in subcutaneous adipose tissue and 135 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:UniProtKB-SubCell.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0004879; F:nuclear receptor activity; IEA:InterPro.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IEA:InterPro.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00399; ZnF_C4; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   Activator {ECO:0000256|RuleBase:RU364110};
KW   Biological rhythms {ECO:0000256|RuleBase:RU364110};
KW   Cytoplasm {ECO:0000256|RuleBase:RU364110};
KW   DNA-binding {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476383};
KW   Metal-binding {ECO:0000256|RuleBase:RU364110,
KW   ECO:0000256|SAAS:SAAS00476458};
KW   Nucleus {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476518};
KW   Proteomics identification {ECO:0000213|PeptideAtlas:E9PFX5,
KW   ECO:0000213|ProteomicsDB:E9PFX5};
KW   Receptor {ECO:0000256|RuleBase:RU364110, ECO:0000313|EMBL:CAG29019.1};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Transcription {ECO:0000256|RuleBase:RU364110,
KW   ECO:0000256|SAAS:SAAS00116499};
KW   Transcription regulation {ECO:0000256|RuleBase:RU364110,
KW   ECO:0000256|SAAS:SAAS00116499};
KW   Zinc {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476458};
KW   Zinc-finger {ECO:0000256|RuleBase:RU364110, ECO:0000256|SAAS:SAAS00476458}.
FT   DOMAIN          106..180
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000259|PROSITE:PS51030"
SQ   SEQUENCE   248 AA;  28302 MW;  E72235D1B2B56AF6 CRC64;
     MVDTEMPFWP TNFGISSVDL SVMEDHSHSF DIKPFTTVDF SSISTPHYED IPFTRTDPVV
     ADYKYDLKLQ EYQSAIKVEP ASPPYYSEKT QLYNKPHEEP SNSLMAIECR VCGDKASGFH
     YGVHACEGCK GFFRRTIRLK LIYDRCDLNC RIHKKSRNKC QYCRFQKCLA VGMSHNAIRF
     GRMPQAEKEK LLAEISSDID QLNPESADLR ALAKHLYDSY IKSFPLTKAK ARAILTGKTT
     DKSTAQVC
//
ID   PPARG_HUMAN             Reviewed;         505 AA.
AC   P37231; A8K3G6; B5BUA1; O00684; O00710; O14515; Q0QJH8; Q15178; Q15179;
AC   Q15180; Q15832; Q86U60; Q96J12;
DT   01-OCT-1994, integrated into UniProtKB/Swiss-Prot.
DT   27-APR-2001, sequence version 3.
DT   22-APR-2020, entry version 262.
DE   RecName: Full=Peroxisome proliferator-activated receptor gamma;
DE            Short=PPAR-gamma;
DE   AltName: Full=Nuclear receptor subfamily 1 group C member 3;
GN   Name=PPARG; Synonyms=NR1C3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2), FUNCTION, AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Heart;
RX   PubMed=9065481; DOI=10.1074/jbc.272.12.8071;
RA   Mukherjee R., Jow L., Croston G.E., Paterniti J.R. Jr.;
RT   "Identification, characterization, and tissue distribution of human
RT   peroxisome proliferator-activated receptor (PPAR) isoforms PPARgamma2
RT   versus PPARgamma1 and activation with retinoid X receptor agonists and
RT   antagonists.";
RL   J. Biol. Chem. 272:8071-8076(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=8702406; DOI=10.1006/bbrc.1996.1044;
RA   Elbrecht A., Chen Y., Cullinan C.A., Hayes N., Leibowitz M.D., Moller D.E.,
RA   Berger J.;
RT   "Molecular cloning, expression and characterization of human peroxisome
RT   proliferator activated receptors gamma 1 and gamma 2.";
RL   Biochem. Biophys. Res. Commun. 224:431-437(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Adipose tissue;
RX   PubMed=9144532; DOI=10.1006/bbrc.1997.6446;
RA   Yanase T., Yashiro T., Takitani K., Kato S., Taniguchi S., Takayanagi R.,
RA   Nawata H.;
RT   "Differential expression of PPAR gamma1 and gamma2 isoforms in human
RT   adipose tissue.";
RL   Biochem. Biophys. Res. Commun. 233:320-324(1997).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Bone marrow;
RX   PubMed=7787419;
RA   Greene M.E., Blumberg B., McBride O.W., Yi H.F., Kronquist K., Kwan K.,
RA   Hsieh L., Greene G., Nimer S.D.;
RT   "Isolation of the human peroxisome proliferator activated receptor gamma
RT   cDNA: expression in hematopoietic cells and chromosomal mapping.";
RL   Gene Expr. 4:281-299(1995).
RN   [5]
RP   SEQUENCE REVISION TO 36; 37; 213; 214 AND 240.
RA   Greene M.E.;
RL   Submitted (DEC-2001) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=9356045; DOI=10.2337/diab.46.11.1904;
RA   Okazawa H., Mori H., Tamori Y., Araki S., Niki T., Masugi J., Kawanishi M.,
RA   Kubota T., Shinoda H., Kasuga M.;
RT   "No coding mutations are detected in the peroxisome proliferator-activated
RT   receptor-gamma gene in Japanese patients with lipoatrophic diabetes.";
RL   Diabetes 46:1904-1906(1997).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=8706692; DOI=10.1111/j.1432-1033.1996.0001u.x;
RA   Lambe K.G., Tugwood J.D.;
RT   "A human peroxisome-proliferator-activated receptor-gamma is activated by
RT   inducers of adipogenesis, including thiazolidinedione drugs.";
RL   Eur. J. Biochem. 239:1-7(1996).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=16842753; DOI=10.1016/j.bbrc.2006.06.147;
RA   Kim H.J., Woo I.S., Kang E.S., Eun S.Y., Kim H.J., Lee J.H., Chang K.C.,
RA   Kim J.H., Seo H.G.;
RT   "Identification of a truncated alternative splicing variant of human
RT   PPARgamma1 that exhibits dominant negative activity.";
RL   Biochem. Biophys. Res. Commun. 347:698-706(2006).
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [11]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Goshima N., Kawamura Y., Fukumoto A., Miura A., Honma R., Satoh R.,
RA   Wakamatsu A., Yamamoto J., Kimura K., Nishikawa T., Andoh T., Iida Y.,
RA   Ishikawa K., Ito E., Kagawa N., Kaminaga C., Kanehori K., Kawakami B.,
RA   Kenmochi K., Kimura R., Kobayashi M., Kuroita T., Kuwayama H., Maruyama Y.,
RA   Matsuo K., Minami K., Mitsubori M., Mori M., Morishita R., Murase A.,
RA   Nishikawa A., Nishikawa S., Okamoto T., Sakagami N., Sakamoto Y.,
RA   Sasaki Y., Seki T., Sono S., Sugiyama A., Sumiya T., Takayama T.,
RA   Takayama Y., Takeda H., Togashi T., Yahata K., Yamada H., Yanagisawa Y.,
RA   Endo Y., Imamoto F., Kisu Y., Tanaka S., Isogai T., Imai J., Watanabe S.,
RA   Nomura N.;
RT   "Human Protein Factory: an infrastructure to convert the human
RT   transcriptome into the in vitro-expressed human proteome of versatile
RT   utility.";
RL   Submitted (JUL-2008) to the EMBL/GenBank/DDBJ databases.
RN   [12]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ALA-12.
RG   SeattleSNPs variation discovery resource;
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [13]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [14]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [15]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [16]
RP   INTERACTION WITH NCOA6.
RX   PubMed=10681503; DOI=10.1074/jbc.275.8.5308;
RA   Caira F., Antonson P., Pelto-Huikko M., Treuter E., Gustafsson J.-A.;
RT   "Cloning and characterization of RAP250, a nuclear receptor coactivator.";
RL   J. Biol. Chem. 275:5308-5317(2000).
RN   [17]
RP   POSSIBLE INVOLVEMENT IN SUSCEPTIBILITY TO GLIOMA.
RX   PubMed=10851250; DOI=10.1136/jmg.37.6.410;
RA   Zhou X.P., Smith W.M., Gimm O., Mueller E., Gao X., Sarraf P., Prior T.W.,
RA   Plass C., von Deimling A., Black P.M., Yates A.J., Eng C.;
RT   "Over-representation of PPARgamma sequence variants in sporadic cases of
RT   glioblastoma multiforme: preliminary evidence for common low penetrance
RT   modifiers for brain tumour risk in the general population.";
RL   J. Med. Genet. 37:410-414(2000).
RN   [18]
RP   INTERACTION WITH PRMT2.
RX   PubMed=12039952; DOI=10.1074/jbc.m201053200;
RA   Qi C., Chang J., Zhu Y., Yeldandi A.V., Rao S.M., Zhu Y.-J.;
RT   "Identification of protein arginine methyltransferase 2 as a coactivator
RT   for estrogen receptor alpha.";
RL   J. Biol. Chem. 277:28624-28630(2002).
RN   [19]
RP   INTERACTION WITH NOCA7.
RX   PubMed=11971969; DOI=10.1128/mcb.22.10.3358-3372.2002;
RA   Shao W., Halachmi S., Brown M.;
RT   "ERAP140, a conserved tissue-specific nuclear receptor coactivator.";
RL   Mol. Cell. Biol. 22:3358-3372(2002).
RN   [20]
RP   INTERACTION WITH DNTTIP2.
RX   PubMed=15047147; DOI=10.1016/j.bbrc.2004.02.179;
RA   Bu H., Kashireddy P., Chang J., Zhu Y.T., Zhang Z., Zheng W., Rao S.M.,
RA   Zhu Y.-J.;
RT   "ERBP, a novel estrogen receptor binding protein enhancing the activity of
RT   estrogen receptor.";
RL   Biochem. Biophys. Res. Commun. 317:54-59(2004).
RN   [21]
RP   INTERACTION WITH TGFB1I1.
RX   PubMed=15687259; DOI=10.1101/gad.1240705;
RA   Drori S., Girnun G.D., Tou L., Szwaya J.D., Mueller E., Xia K.,
RA   Shivdasani R.A., Spiegelman B.M.;
RT   "Hic-5 regulates an epithelial program mediated by PPARgamma.";
RL   Genes Dev. 19:362-375(2005).
RN   [22]
RP   INTERACTION WITH HELZ2.
RX   PubMed=16239304; DOI=10.1210/en.2005-0450;
RA   Tomaru T., Satoh T., Yoshino S., Ishizuka T., Hashimoto K., Monden T.,
RA   Yamada M., Mori M.;
RT   "Isolation and characterization of a transcriptional cofactor and its novel
RT   isoform that bind the DNA-binding domain of peroxisome proliferator-
RT   activated receptor gamma.";
RL   Endocrinology 147:377-388(2006).
RN   [23]
RP   FUNCTION, INTERACTION WITH PDPK1, AND ACTIVITY REGULATION.
RX   PubMed=16150867; DOI=10.1210/me.2005-0197;
RA   Yin Y., Yuan H., Wang C., Pattabiraman N., Rao M., Pestell R.G.,
RA   Glazer R.I.;
RT   "3-phosphoinositide-dependent protein kinase-1 activates the peroxisome
RT   proliferator-activated receptor-gamma and promotes adipocyte
RT   differentiation.";
RL   Mol. Endocrinol. 20:268-278(2006).
RN   [24]
RP   INTERACTION WITH MAP2K1/MEK1, AND SUBCELLULAR LOCATION.
RX   PubMed=17101779; DOI=10.1128/mcb.00601-06;
RA   Burgermeister E., Chuderland D., Hanoch T., Meyer M., Liscovitch M.,
RA   Seger R.;
RT   "Interaction with MEK causes nuclear export and downregulation of
RT   peroxisome proliferator-activated receptor gamma.";
RL   Mol. Cell. Biol. 27:803-817(2007).
RN   [25]
RP   INTERACTION WITH TACC1.
RX   PubMed=20078863; DOI=10.1186/1471-2199-11-3;
RA   Guyot R., Vincent S., Bertin J., Samarut J., Ravel-Chapuis P.;
RT   "The transforming acidic coiled coil (TACC1) protein modulates the
RT   transcriptional activity of the nuclear receptors TR and RAR.";
RL   BMC Mol. Biol. 11:3-3(2010).
RN   [26]
RP   FUNCTION.
RX   PubMed=20829347; DOI=10.1074/jbc.m110.136259;
RA   Park S.H., Choi H.J., Yang H., Do K.H., Kim J., Lee D.W., Moon Y.;
RT   "Endoplasmic reticulum stress-activated C/EBP homologous protein enhances
RT   nuclear factor-kappaB signals via repression of peroxisome proliferator-
RT   activated receptor gamma.";
RL   J. Biol. Chem. 285:35330-35339(2010).
RN   [27]
RP   INTERACTION WITH ASXL1 AND ASXL2.
RX   PubMed=21047783; DOI=10.1074/jbc.m110.177816;
RA   Park U.H., Yoon S.K., Park T., Kim E.J., Um S.J.;
RT   "Additional sex comb-like (ASXL) proteins 1 and 2 play opposite roles in
RT   adipogenesis via reciprocal regulation of peroxisome proliferator-activated
RT   receptor {gamma}.";
RL   J. Biol. Chem. 286:1354-1363(2011).
RN   [28]
RP   INTERACTION WITH ACTN4.
RX   PubMed=22351778; DOI=10.1074/jbc.m112.345421;
RA   Khurana S., Chakraborty S., Lam M., Liu Y., Su Y.T., Zhao X., Saleem M.A.,
RA   Mathieson P.W., Bruggeman L.A., Kao H.Y.;
RT   "Familial focal segmental glomerulosclerosis (FSGS)-linked alpha-actinin 4
RT   (ACTN4) protein mutants lose ability to activate transcription by nuclear
RT   hormone receptors.";
RL   J. Biol. Chem. 287:12027-12035(2012).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-112, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [30]
RP   FUNCTION, INTERACTION WITH HELZ2 AND THRAP3, AND SUBCELLULAR LOCATION.
RX   PubMed=23525231; DOI=10.1210/me.2012-1332;
RA   Katano-Toki A., Satoh T., Tomaru T., Yoshino S., Ishizuka T., Ishii S.,
RA   Ozawa A., Shibusawa N., Tsuchiya T., Saito T., Shimizu H., Hashimoto K.,
RA   Okada S., Yamada M., Mori M.;
RT   "THRAP3 interacts with HELZ2 and plays a novel role in adipocyte
RT   differentiation.";
RL   Mol. Endocrinol. 27:769-780(2013).
RN   [31]
RP   FUNCTION (MICROBIAL INFECTION), AND INDUCTION (MICROBIAL INFECTION).
RC   TISSUE=Macrophage;
RX   PubMed=25504154; DOI=10.3892/mmr.2014.3070;
RA   Liu L., Liu J., Niu G., Xu Q., Chen Q.;
RT   "Mycobacterium tuberculosis 19-kDa lipoprotein induces Toll-like receptor
RT   2-dependent peroxisome proliferator-activated receptor gamma expression and
RT   promotes inflammatory responses in human macrophages.";
RL   Mol. Med. Report. 11:2921-2926(2015).
RN   [32]
RP   9AATAD MOTIF.
RX   PubMed=30468856; DOI=10.1016/j.jsbmb.2018.11.008;
RA   Piskacek M., Havelka M., Jendruchova K., Knight A.;
RT   "Nuclear hormone receptors: Ancient 9aaTAD and evolutionally gained NCoA
RT   activation pathways.";
RL   J. Steroid Biochem. Mol. Biol. 187:118-123(2019).
RN   [33]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 232-505.
RX   PubMed=9813012; DOI=10.1074/jbc.273.47.31108;
RA   Uppenberg J., Svensson C., Jaki M., Bertilsson G., Jendeberg L.,
RA   Berkenstam A.;
RT   "Crystal structure of the ligand binding domain of the human nuclear
RT   receptor PPARgamma.";
RL   J. Biol. Chem. 273:31108-31112(1998).
RN   [34]
RP   X-RAY CRYSTALLOGRAPHY (2.2 ANGSTROMS) OF 235-504 IN COMPLEXES WITH THE
RP   SYNTHETIC AGONIST ROSIGLITAZONE AND NCOA1, AND SUBUNIT.
RX   PubMed=9744270; DOI=10.1038/25931;
RA   Nolte R.T., Wisely G.B., Westin S., Cobb J.E., Lambert M.H., Kurokawa R.,
RA   Rosenfeld M.G., Willson T.M., Glass C.K., Milburn M.V.;
RT   "Ligand binding and co-activator assembly of the peroxisome proliferator-
RT   activated receptor-gamma.";
RL   Nature 395:137-143(1998).
RN   [35]
RP   X-RAY CRYSTALLOGRAPHY (2.1 ANGSTROMS) IN COMPLEXES WITH RXRA AND SYNTHETIC
RP   AGONISTS.
RX   PubMed=10882139; DOI=10.1016/s1097-2765(00)80448-7;
RA   Gampe R.T. Jr., Montana V.G., Lambert M.H., Miller A.B., Bledsoe R.K.,
RA   Milburn M.V., Kliewer S.A., Willson T.M., Xu H.E.;
RT   "Asymmetry in the PPARgamma/RXRalpha crystal structure reveals the
RT   molecular basis of heterodimerization among nuclear receptors.";
RL   Mol. Cell 5:545-555(2000).
RN   [36]
RP   X-RAY CRYSTALLOGRAPHY (2.3 ANGSTROMS) OF 234-505 IN COMPLEXES WITH
RP   SYNTHETIC AGONIST AND NCOA1.
RX   PubMed=11698662; DOI=10.1073/pnas.241410198;
RA   Xu H.E., Lambert M.H., Montana V.G., Plunket K.D., Moore L.B.,
RA   Collins J.L., Oplinger J.A., Kliewer S.A., Gampe R.T. Jr., McKee D.D.,
RA   Moore J.T., Willson T.M.;
RT   "Structural determinants of ligand binding selectivity between the
RT   peroxisome proliferator-activated receptors.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:13919-13924(2001).
RN   [37]
RP   X-RAY CRYSTALLOGRAPHY (2.35 ANGSTROMS) OF 225-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST.
RX   PubMed=11587644; DOI=10.1016/s0969-2126(01)00634-7;
RA   Cronet P., Petersen J.F.W., Folmer R., Blomberg N., Sjoeblom K.,
RA   Karlsson U., Lindstedt E.-L., Bamberg K.;
RT   "Structure of the PPARalpha and -gamma ligand binding domain in complex
RT   with AZ 242; ligand selectivity and agonist activation in the PPAR
RT   family.";
RL   Structure 9:699-706(2001).
RN   [38]
RP   X-RAY CRYSTALLOGRAPHY (2.65 ANGSTROMS) OF 230-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST.
RX   PubMed=12672231; DOI=10.1021/jm021027r;
RA   Ebdrup S., Pettersson I., Rasmussen H.B., Deussen H.-J., Frost Jensen A.,
RA   Mortensen S.B., Fleckner J., Pridal L., Nygaard L., Sauerberg P.;
RT   "Synthesis and biological and structural characterization of the dual-
RT   acting peroxisome proliferator-activated receptor alpha/gamma agonist
RT   ragaglitazar.";
RL   J. Med. Chem. 46:1306-1317(2003).
RN   [39]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 232-505 IN COMPLEX WITH NCOA2 AND
RP   SYNTHETIC AGONIST.
RX   PubMed=15258145; DOI=10.1074/jbc.m401552200;
RA   Oestberg T., Svensson S., Selen G., Uppenberg J., Thor M., Sundbom M.,
RA   Sydow-Baeckman M., Gustavsson A.-L., Jendeberg L.;
RT   "A new class of peroxisome proliferator-activated receptor agonists with a
RT   novel binding epitope shows antidiabetic effects.";
RL   J. Biol. Chem. 279:41124-41130(2004).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 235-505 IN COMPLEX WITH RXRA;
RP   NCOA1 AND SYNTHETIC AGONIST.
RX   PubMed=15056000; DOI=10.1021/jm030565g;
RA   Haffner C.D., Lenhard J.M., Miller A.B., McDougald D.L., Dwornik K.,
RA   Ittoop O.R., Gampe R.T. Jr., Xu H.E., Blanchard S., Montana V.G.,
RA   Consler T.G., Bledsoe R.K., Ayscue A., Croom D.;
RT   "Structure-based design of potent retinoid X receptor alpha agonists.";
RL   J. Med. Chem. 47:2010-2029(2004).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF 231-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST.
RX   PubMed=15974597; DOI=10.1021/jm0502135;
RA   Shi G.Q., Dropinski J.F., McKeever B.M., Xu S., Becker J.W., Berger J.P.,
RA   MacNaul K.L., Elbrecht A., Zhou G., Doebber T.W., Wang P., Chao Y.-S.,
RA   Forrest M., Heck J.V., Moller D.E., Jones A.B.;
RT   "Design and synthesis of alpha-aryloxyphenylacetic acid derivatives: a
RT   novel class of PPARalpha/gamma dual agonists with potent antihyperglycemic
RT   and lipid modulating activity.";
RL   J. Med. Chem. 48:4457-4468(2005).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) OF 234-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST AND NR0B2.
RX   PubMed=15976031; DOI=10.1073/pnas.0501204102;
RA   Li Y., Choi M., Suino K., Kovach A., Daugherty J., Kliewer S.A., Xu H.E.;
RT   "Structural and biochemical basis for selective repression of the orphan
RT   nuclear receptor liver receptor homolog 1 by small heterodimer partner.";
RL   Proc. Natl. Acad. Sci. U.S.A. 102:9505-9510(2005).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 234-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST AND NCOA1.
RX   PubMed=16919947; DOI=10.1016/j.bmcl.2006.08.003;
RA   Hopkins C.R., O'neil S.V., Laufersweiler M.C., Wang Y., Pokross M.,
RA   Mekel M., Evdokimov A., Walter R., Kontoyianni M., Petrey M.E.,
RA   Sabatakos G., Roesgen J.T., Richardson E., Demuth T.P. Jr.;
RT   "Design and synthesis of novel N-sulfonyl-2-indole carboxamides as potent
RT   PPAR-gamma binding agents with potential application to the treatment of
RT   osteoporosis.";
RL   Bioorg. Med. Chem. Lett. 16:5659-5663(2006).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (2.07 ANGSTROMS) OF 235-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST.
RX   PubMed=16451087; DOI=10.1021/jm0510373;
RA   Mahindroo N., Wang C.-C., Liao C.-C., Huang C.-F., Lu I.-L., Lien T.-W.,
RA   Peng Y.-H., Huang W.-J., Lin Y.-T., Hsu M.-C., Lin C.-H., Tsai C.-H.,
RA   Hsu J.-T., Chen X., Lyu P.-C., Chao Y.-S., Wu S.-Y., Hsieh H.-P.;
RT   "Indol-1-yl acetic acids as peroxisome proliferator-activated receptor
RT   agonists: design, synthesis, structural biology, and molecular docking
RT   studies.";
RL   J. Med. Chem. 49:1212-1216(2006).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (2.54 ANGSTROMS) OF 235-505 IN COMPLEX WITH SYNTHETIC
RP   AGONIST.
RX   PubMed=16640330; DOI=10.1021/jm051129s;
RA   Lu I.-L., Huang C.-F., Peng Y.-H., Lin Y.-T., Hsieh H.-P., Chen C.-T.,
RA   Lien T.-W., Lee H.-J., Mahindroo N., Prakash E., Yueh A., Chen H.-Y.,
RA   Goparaju C.M.V., Chen X., Liao C.-C., Chao Y.-S., Hsu J.-T., Wu S.-Y.;
RT   "Structure-based drug design of a novel family of PPARgamma partial
RT   agonists: virtual screening, X-ray crystallography, and in vitro/in vivo
RT   biological activities.";
RL   J. Med. Chem. 49:2703-2712(2006).
RN   [46]
RP   VARIANT ALA-12.
RX   PubMed=9425261; DOI=10.1006/bbrc.1997.7798;
RA   Yen C.-J., Beamer B.A., Negri C., Silver K., Brown K.A., Yarnall D.P.,
RA   Burns D.K., Roth J., Shuldiner A.R.;
RT   "Molecular scanning of the human peroxisome proliferator activated receptor
RT   gamma (hPPAR-gamma) gene in diabetic Caucasians: identification of a
RT   pro12ala PPAR-gamma-2 missense mutation.";
RL   Biochem. Biophys. Res. Commun. 241:270-274(1997).
RN   [47]
RP   VARIANT OBESITY GLN-113.
RX   PubMed=9753710; DOI=10.1056/nejm199810013391403;
RA   Ristow M., Muller-Wieland D., Pfeiffer A., Krone W., Kahn C.R.;
RT   "Obesity associated with a mutation in a genetic regulator of adipocyte
RT   differentiation.";
RL   N. Engl. J. Med. 339:953-959(1998).
RN   [48]
RP   INVOLVEMENT IN BMIQ1, AND VARIANT ALA-12.
RX   PubMed=9806549; DOI=10.1038/3099;
RA   Deeb S.S., Fajas L., Nemoto M., Pihlajamaeki J., Mykkaenen L., Kuusisto J.,
RA   Laakso M., Fujimoto W., Auwerx J.;
RT   "A Pro12Ala substitution in PPARgamma2 associated with decreased receptor
RT   activity, lower body mass index and improved insulin sensitivity.";
RL   Nat. Genet. 20:284-287(1998).
RN   [49]
RP   VARIANT ALA-12.
RX   PubMed=10407229; DOI=10.1530/eje.0.1410090;
RA   Hamann A., Munzberg H., Buttron P., Busing B., Hinney A., Mayer H.,
RA   Siegfried W., Hebebrand J., Greten H.;
RT   "Missense variants in the human peroxisome proliferator-activated receptor-
RT   gamma2 gene in lean and obese subjects.";
RL   Eur. J. Endocrinol. 141:90-92(1999).
RN   [50]
RP   INVOLVEMENT IN BMIQ1, AND VARIANT ALA-12.
RX   PubMed=10523018; DOI=10.1210/jcem.84.10.6061;
RA   Valve R., Sivenius K., Miettinen R., Pihlajamaeki J., Rissanen A.,
RA   Deeb S.S., Auwerx J., Uusitupa M., Laakso M.;
RT   "Two polymorphisms in the peroxisome proliferator-activated receptor-gamma
RT   gene are associated with severe overweight among obese women.";
RL   J. Clin. Endocrinol. Metab. 84:3708-3712(1999).
RN   [51]
RP   VARIANTS COLON CANCER PRO-314 AND HIS-316, AND VARIANT ALA-12.
RX   PubMed=10394368; DOI=10.1016/s1097-2765(01)80012-5;
RA   Sarraf P., Mueller E., Smith W.M., Wright H.M., Kum J.B., Aaltonen L.A.,
RA   de la Chapelle A., Spiegelman B.M., Eng C.;
RT   "Loss-of-function mutations in PPAR-gamma associated with human colon
RT   cancer.";
RL   Mol. Cell 3:799-804(1999).
RN   [52]
RP   VARIANTS DIABETES MET-318 AND LEU-495.
RX   PubMed=10622252; DOI=10.1038/47254;
RA   Barroso I., Gurnell M., Crowley V.E.F., Agostini M., Schwabel J.W.,
RA   Soos M.A., Masien G.L., Williams T.D.M., Lewis H., Schafer A.J.,
RA   Chatterjee V.K.K., O'Rahilly S.;
RT   "Dominant negative mutations in human PPAR-gamma associated with severe
RT   insulin resistance, diabetes mellitus and hypertension.";
RL   Nature 402:880-883(1999).
RN   [53]
RP   VARIANT FPLD3 LEU-388.
RX   PubMed=12453919; DOI=10.2337/diabetes.51.12.3586;
RA   Hegele R.A., Cao H., Frankowski C., Mathews S.T., Leff T.;
RT   "PPARG F388L, a transactivation-deficient mutant, in familial partial
RT   lipodystrophy.";
RL   Diabetes 51:3586-3590(2002).
RN   [54]
RP   VARIANT FPLD3 CYS-425.
RX   PubMed=11788685; DOI=10.1210/jcem.87.1.8290;
RA   Agarwal A.K., Garg A.;
RT   "A novel heterozygous mutation in peroxisome proliferator-activated
RT   receptor-gamma gene in a patient with familial partial lipodystrophy.";
RL   J. Clin. Endocrinol. Metab. 87:408-411(2002).
RN   [55]
RP   ASSOCIATION OF VARIANT ALA-12 WITH BMI.
RX   PubMed=14569127; DOI=10.1136/jmg.40.10.773;
RA   Masud S., Ye S.;
RT   "Effect of the peroxisome proliferator activated receptor-gamma gene
RT   Pro12Ala variant on body mass index: a meta-analysis.";
RL   J. Med. Genet. 40:773-780(2003).
RN   [56]
RP   ASSOCIATION OF VARIANT ALA-12 WITH CIMT.
RX   PubMed=15356014; DOI=10.1210/jc.2003-032120;
RA   Temelkova-Kurktschiev T., Hanefeld M., Chinetti G., Zawadzki C., Haulon S.,
RA   Kubaszek A., Koehler C., Leonhardt W., Staels B., Laakso M.;
RT   "Ala12Ala genotype of the peroxisome proliferator-activated receptor gamma2
RT   protects against atherosclerosis.";
RL   J. Clin. Endocrinol. Metab. 89:4238-4242(2004).
RN   [57]
RP   VARIANT ALA-12.
RX   PubMed=15562396; DOI=10.1016/j.metabol.2004.06.019;
RA   Kim K.S., Choi S.M., Shin S.U., Yang H.S., Yoon Y.;
RT   "Effects of peroxisome proliferator-activated receptor-gamma 2 Pro12Ala
RT   polymorphism on body fat distribution in female Korean subjects.";
RL   Metabolism 53:1538-1543(2004).
CC   -!- FUNCTION: Nuclear receptor that binds peroxisome proliferators such as
CC       hypolipidemic drugs and fatty acids. Once activated by a ligand, the
CC       nuclear receptor binds to DNA specific PPAR response elements (PPRE)
CC       and modulates the transcription of its target genes, such as acyl-CoA
CC       oxidase. It therefore controls the peroxisomal beta-oxidation pathway
CC       of fatty acids. Key regulator of adipocyte differentiation and glucose
CC       homeostasis. ARF6 acts as a key regulator of the tissue-specific
CC       adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut
CC       homeostasis by suppressing NF-kappa-B-mediated proinflammatory
CC       responses. Plays a role in the regulation of cardiovascular circadian
CC       rhythms by regulating the transcription of ARNTL/BMAL1 in the blood
CC       vessels (By similarity). {ECO:0000250|UniProtKB:P37238,
CC       ECO:0000269|PubMed:16150867, ECO:0000269|PubMed:20829347,
CC       ECO:0000269|PubMed:23525231, ECO:0000269|PubMed:9065481}.
CC   -!- FUNCTION: (Microbial infection) Upon treatment with M.tuberculosis or
CC       its lipoprotein LpqH, phosphorylation of MAPK p38 and IL-6 production
CC       are modulated, probably via this protein.
CC       {ECO:0000269|PubMed:25504154}.
CC   -!- ACTIVITY REGULATION: PDPK1 activates its transcriptional activity
CC       independently of its kinase activity. {ECO:0000269|PubMed:16150867}.
CC   -!- SUBUNIT: Interacts with FOXO1 (acetylated form) (By similarity).
CC       Heterodimer with other nuclear receptors, such as RXRA. The heterodimer
CC       with the retinoic acid receptor RXRA is called adipocyte-specific
CC       transcription factor ARF6. Interacts with NCOA6 coactivator, leading to
CC       a strong increase in transcription of target genes. Interacts with
CC       coactivator PPARBP, leading to a mild increase in transcription of
CC       target genes. Interacts with NOCA7 in a ligand-inducible manner.
CC       Interacts with NCOA1 and NCOA2 LXXLL motifs. Interacts with ASXL1,
CC       ASXL2, DNTTIP2, FAM120B, MAP2K1/MEK1, NR0B2, PDPK1, PRDM16, PRMT2 and
CC       TGFB1I1. Interacts (when activated by agonist) with PPP5C. Interacts
CC       with HELZ2 and THRAP3; the interaction stimulates the transcriptional
CC       activity of PPARG. Interacts with PER2, the interaction is ligand
CC       dependent and blocks PPARG recruitment to target promoters. Interacts
CC       with NOCT. Interacts with ACTN4. Interacts (when in the liganded
CC       conformation) with GPS2 (By similarity). Interacts with CRY1 and CRY2
CC       in a ligand-dependent manner (By similarity). In the absence of
CC       hormonal ligand, interacts with TACC1 (PubMed:20078863).
CC       {ECO:0000250|UniProtKB:P37238, ECO:0000269|PubMed:10681503,
CC       ECO:0000269|PubMed:11587644, ECO:0000269|PubMed:11971969,
CC       ECO:0000269|PubMed:12039952, ECO:0000269|PubMed:12672231,
CC       ECO:0000269|PubMed:15047147, ECO:0000269|PubMed:15056000,
CC       ECO:0000269|PubMed:15258145, ECO:0000269|PubMed:15687259,
CC       ECO:0000269|PubMed:15974597, ECO:0000269|PubMed:15976031,
CC       ECO:0000269|PubMed:16150867, ECO:0000269|PubMed:16239304,
CC       ECO:0000269|PubMed:16451087, ECO:0000269|PubMed:16640330,
CC       ECO:0000269|PubMed:16919947, ECO:0000269|PubMed:17101779,
CC       ECO:0000269|PubMed:20078863, ECO:0000269|PubMed:21047783,
CC       ECO:0000269|PubMed:22351778, ECO:0000269|PubMed:23525231,
CC       ECO:0000269|PubMed:9744270}.
CC   -!- INTERACTION:
CC       P37231; P37231; NbExp=2; IntAct=EBI-781384, EBI-781384;
CC       P37231-1; P37231-1; NbExp=2; IntAct=EBI-15664691, EBI-15664691;
CC       P37231; Q8NFM4: ADCY4; NbExp=3; IntAct=EBI-781384, EBI-2838710;
CC       P37231-2; Q00535: CDK5; NbExp=2; IntAct=EBI-781416, EBI-1041567;
CC       P37231; P10909: CLU; NbExp=3; IntAct=EBI-781384, EBI-1104674;
CC       P37231; O60869: EDF1; NbExp=4; IntAct=EBI-781384, EBI-781301;
CC       P37231; Q9BWX5: GATA5; NbExp=3; IntAct=EBI-781384, EBI-12132270;
CC       P37231; P42858: HTT; NbExp=4; IntAct=EBI-781384, EBI-466029;
CC       P37231; P45984: MAPK9; NbExp=3; IntAct=EBI-781384, EBI-713568;
CC       P37231; P55055-1: NR1H2; NbExp=2; IntAct=EBI-781384, EBI-21458417;
CC       P37231; Q13133: NR1H3; NbExp=2; IntAct=EBI-781384, EBI-781356;
CC       P37231; Q9UBK2: PPARGC1A; NbExp=2; IntAct=EBI-781384, EBI-765486;
CC       P37231; P10276: RARA; NbExp=3; IntAct=EBI-781384, EBI-413374;
CC       P37231-1; P19793: RXRA; NbExp=6; IntAct=EBI-15664691, EBI-78598;
CC       P37231; Q96EB6: SIRT1; NbExp=5; IntAct=EBI-781384, EBI-1802965;
CC       P37231; Q6STE5-1: SMARCD3; NbExp=3; IntAct=EBI-781384, EBI-488506;
CC       P37231; Q6STE5-2: SMARCD3; NbExp=3; IntAct=EBI-781384, EBI-488511;
CC   -!- SUBCELLULAR LOCATION: Nucleus. Cytoplasm. Note=Redistributed from the
CC       nucleus to the cytosol through a MAP2K1/MEK1-dependent manner. NOCT
CC       enhances its nuclear translocation.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=2;
CC         IsoId=P37231-1; Sequence=Displayed;
CC       Name=1; Synonyms=PPARgamma1(wt);
CC         IsoId=P37231-2; Sequence=VSP_003645;
CC       Name=3; Synonyms=PPARgamma1(tr);
CC         IsoId=P37231-3; Sequence=VSP_003645, VSP_043906, VSP_043907;
CC   -!- TISSUE SPECIFICITY: Highest expression in adipose tissue. Lower in
CC       skeletal muscle, spleen, heart and liver. Also detectable in placenta,
CC       lung and ovary. {ECO:0000269|PubMed:9065481}.
CC   -!- INDUCTION: (Microbial infection) Expression increases when incubated
CC       with M.tuberculosis or its lipoprotein LpqH; induction is TLR2-
CC       dependent (at protein level). {ECO:0000269|PubMed:25504154}.
CC   -!- DOMAIN: The 9aaTAD motif is a transactivation domain present in a large
CC       number of yeast and animal transcription factors.
CC       {ECO:0000305|PubMed:30468856}.
CC   -!- PTM: O-GlcNAcylation at Thr-84 reduces transcriptional activity in
CC       adipocytes. {ECO:0000250|UniProtKB:P37238}.
CC   -!- PTM: Phosphorylated in basal conditions and dephosphorylated when
CC       treated with the ligand. May be dephosphorylated by PPP5C. The
CC       phosphorylated form may be inactive and dephosphorylation at Ser-112
CC       induces adipogenic activity (By similarity). {ECO:0000250}.
CC   -!- POLYMORPHISM: Genetic variations in PPARG define the body mass index
CC       quantitative trait locus 1 (BMIQ1) [MIM:606641]. The body max index
CC       (BMI) reflects the amount of fat, lean mass, and body build.
CC       {ECO:0000269|PubMed:10523018, ECO:0000269|PubMed:14569127}.
CC   -!- POLYMORPHISM: Genetic variations in PPARG influence the carotid intimal
CC       medial thickness (CIMT) [MIM:609338]. CIMT is a measure of
CC       atherosclerosis that is independently associated with traditional
CC       atherosclerotic cardiovascular disease risk factors and coronary
CC       atherosclerotic burden. 35 to 45% of the variability in multivariable-
CC       adjusted CIMT is explained by genetic factors.
CC       {ECO:0000269|PubMed:15356014}.
CC   -!- DISEASE: Note=Defects in PPARG can lead to type 2 insulin-resistant
CC       diabetes and hyptertension. PPARG mutations may be associated with
CC       colon cancer. {ECO:0000269|PubMed:10394368}.
CC   -!- DISEASE: Obesity (OBESITY) [MIM:601665]: A condition characterized by
CC       an increase of body weight beyond the limitation of skeletal and
CC       physical requirements, as the result of excessive accumulation of body
CC       fat. {ECO:0000269|PubMed:9753710}. Note=Disease susceptibility may be
CC       associated with variations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Lipodystrophy, familial partial, 3 (FPLD3) [MIM:604367]: A
CC       form of lipodystrophy characterized by marked loss of subcutaneous fat
CC       from the extremities. Facial adipose tissue may be increased, decreased
CC       or normal. Affected individuals show an increased preponderance of
CC       insulin resistance, diabetes mellitus and dyslipidemia.
CC       {ECO:0000269|PubMed:11788685, ECO:0000269|PubMed:12453919}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Glioma 1 (GLM1) [MIM:137800]: Gliomas are benign or malignant
CC       central nervous system neoplasms derived from glial cells. They
CC       comprise astrocytomas and glioblastoma multiforme that are derived from
CC       astrocytes, oligodendrogliomas derived from oligodendrocytes and
CC       ependymomas derived from ependymocytes. {ECO:0000269|PubMed:10851250}.
CC       Note=Disease susceptibility may be associated with variations affecting
CC       the gene represented in this entry. Polymorphic PPARG alleles have been
CC       found to be significantly over-represented among a cohort of American
CC       patients with sporadic glioblastoma multiforme suggesting a possible
CC       contribution to disease susceptibility.
CC   -!- MISCELLANEOUS: [Isoform 3]: Exhibits dominant negative activity over
CC       isoform 1. {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the nuclear hormone receptor family. NR1
CC       subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAN38992.2; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=BAA23354.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC       Sequence=BAF83270.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAA62153.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PPARGID383ch3p25.html";
CC   -!- WEB RESOURCE: Name=Wikipedia; Note=Peroxisome proliferator-activated
CC       receptor entry;
CC       URL="https://en.wikipedia.org/wiki/Peroxisome_proliferator-activated_receptor";
CC   -!- WEB RESOURCE: Name=SeattleSNPs;
CC       URL="http://pga.gs.washington.edu/data/pparg/";
CC   -!- WEB RESOURCE: Name=SHMPD; Note=The Singapore human mutation and
CC       polymorphism database;
CC       URL="http://shmpd.bii.a-star.edu.sg/gene.php?genestart=A&genename=PPARG";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U79012; AAC51248.1; -; mRNA.
DR   EMBL; U63415; AAB04028.1; -; mRNA.
DR   EMBL; D83233; BAA18949.1; -; mRNA.
DR   EMBL; L40904; AAA80314.2; -; mRNA.
DR   EMBL; AB005526; BAA23354.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; X90563; CAA62152.1; -; mRNA.
DR   EMBL; X90563; CAA62153.1; ALT_INIT; mRNA.
DR   EMBL; DQ356894; ABC97372.1; -; mRNA.
DR   EMBL; BT007281; AAP35945.1; -; mRNA.
DR   EMBL; AK290581; BAF83270.1; ALT_INIT; mRNA.
DR   EMBL; AB451337; BAG70151.1; -; mRNA.
DR   EMBL; AB451486; BAG70300.1; -; mRNA.
DR   EMBL; AY157024; AAN38992.2; ALT_INIT; Genomic_DNA.
DR   EMBL; AC090947; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC091492; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC093174; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471055; EAW64124.1; -; Genomic_DNA.
DR   EMBL; BC006811; AAH06811.1; -; mRNA.
DR   CCDS; CCDS2609.1; -. [P37231-1]
DR   CCDS; CCDS2610.2; -. [P37231-2]
DR   PIR; JC4859; JC4859.
DR   PIR; PC4290; PC4290.
DR   PIR; PC4429; PC4429.
DR   RefSeq; NP_005028.4; NM_005037.5. [P37231-2]
DR   RefSeq; NP_056953.2; NM_015869.4. [P37231-1]
DR   RefSeq; NP_619725.2; NM_138711.3. [P37231-2]
DR   RefSeq; NP_619726.2; NM_138712.3. [P37231-2]
DR   RefSeq; XP_011532143.1; XM_011533841.2.
DR   PDB; 1FM6; X-ray; 2.10 A; D/X=234-505.
DR   PDB; 1FM9; X-ray; 2.10 A; D=234-505.
DR   PDB; 1I7I; X-ray; 2.35 A; A/B=225-505.
DR   PDB; 1K74; X-ray; 2.30 A; D=234-505.
DR   PDB; 1KNU; X-ray; 2.50 A; A/B=232-505.
DR   PDB; 1NYX; X-ray; 2.65 A; A/B=230-505.
DR   PDB; 1PRG; X-ray; 2.20 A; A/B=235-504.
DR   PDB; 1RDT; X-ray; 2.40 A; D=235-505.
DR   PDB; 1WM0; X-ray; 2.90 A; X=232-505.
DR   PDB; 1ZEO; X-ray; 2.50 A; A/B=231-505.
DR   PDB; 1ZGY; X-ray; 1.80 A; A=234-505.
DR   PDB; 2ATH; X-ray; 2.28 A; A/B=235-505.
DR   PDB; 2F4B; X-ray; 2.07 A; A/B=235-505.
DR   PDB; 2FVJ; X-ray; 1.99 A; A=235-505.
DR   PDB; 2G0G; X-ray; 2.54 A; A/B=235-505.
DR   PDB; 2G0H; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 2GTK; X-ray; 2.10 A; A=235-505.
DR   PDB; 2HFP; X-ray; 2.00 A; A=234-505.
DR   PDB; 2HWQ; X-ray; 1.97 A; A/B=235-505.
DR   PDB; 2HWR; X-ray; 2.34 A; A/B=235-505.
DR   PDB; 2I4J; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 2I4P; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 2I4Z; X-ray; 2.25 A; A/B=223-504.
DR   PDB; 2OM9; X-ray; 2.80 A; A/B/C/D=232-505.
DR   PDB; 2P4Y; X-ray; 2.25 A; A/B=231-505.
DR   PDB; 2POB; X-ray; 2.30 A; A/B=234-505.
DR   PDB; 2PRG; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 2Q59; X-ray; 2.20 A; A/B=233-505.
DR   PDB; 2Q5P; X-ray; 2.30 A; A/B=233-505.
DR   PDB; 2Q5S; X-ray; 2.05 A; A/B=233-505.
DR   PDB; 2Q61; X-ray; 2.20 A; A/B=233-505.
DR   PDB; 2Q6R; X-ray; 2.41 A; A/B=233-505.
DR   PDB; 2Q6S; X-ray; 2.40 A; A/B=233-505.
DR   PDB; 2Q8S; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 2QMV; NMR; -; A=235-504.
DR   PDB; 2VSR; X-ray; 2.05 A; A/B=232-505.
DR   PDB; 2VST; X-ray; 2.35 A; A/B=232-505.
DR   PDB; 2VV0; X-ray; 2.55 A; A/B=232-505.
DR   PDB; 2VV1; X-ray; 2.20 A; A/B=232-505.
DR   PDB; 2VV2; X-ray; 2.75 A; A/B=232-505.
DR   PDB; 2VV3; X-ray; 2.85 A; A/B=232-505.
DR   PDB; 2VV4; X-ray; 2.35 A; A/B=232-505.
DR   PDB; 2XKW; X-ray; 2.02 A; A/B=232-505.
DR   PDB; 2YFE; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 2ZK0; X-ray; 2.36 A; A/B=223-504.
DR   PDB; 2ZK1; X-ray; 2.61 A; A/B=223-504.
DR   PDB; 2ZK2; X-ray; 2.26 A; A/B=223-504.
DR   PDB; 2ZK3; X-ray; 2.58 A; A/B=223-504.
DR   PDB; 2ZK4; X-ray; 2.57 A; A/B=223-504.
DR   PDB; 2ZK5; X-ray; 2.45 A; A/B=223-504.
DR   PDB; 2ZK6; X-ray; 2.41 A; A/B=223-504.
DR   PDB; 2ZNO; X-ray; 2.40 A; A/B=223-504.
DR   PDB; 2ZVT; X-ray; 1.90 A; A/B=223-504.
DR   PDB; 3ADS; X-ray; 2.25 A; A/B=223-505.
DR   PDB; 3ADT; X-ray; 2.70 A; A/B=223-505.
DR   PDB; 3ADU; X-ray; 2.77 A; A/B=223-505.
DR   PDB; 3ADV; X-ray; 2.27 A; A/B=223-505.
DR   PDB; 3ADW; X-ray; 2.07 A; A/B=223-505.
DR   PDB; 3ADX; X-ray; 1.95 A; A/B=223-505.
DR   PDB; 3AN3; X-ray; 2.30 A; A/B=223-504.
DR   PDB; 3AN4; X-ray; 2.30 A; A/B=223-504.
DR   PDB; 3B0Q; X-ray; 2.10 A; A/B=231-504.
DR   PDB; 3B0R; X-ray; 2.15 A; A/B=231-504.
DR   PDB; 3B1M; X-ray; 1.60 A; A=234-505.
DR   PDB; 3B3K; X-ray; 2.60 A; A/B=223-504.
DR   PDB; 3BC5; X-ray; 2.27 A; A=231-505.
DR   PDB; 3CDP; X-ray; 2.80 A; A/B=223-504.
DR   PDB; 3CDS; X-ray; 2.65 A; A/B=223-504.
DR   PDB; 3CS8; X-ray; 2.30 A; A=234-504.
DR   PDB; 3CWD; X-ray; 2.40 A; A/B=236-505.
DR   PDB; 3D6D; X-ray; 2.40 A; A/B=223-504.
DR   PDB; 3DZU; X-ray; 3.20 A; D=102-505.
DR   PDB; 3DZY; X-ray; 3.10 A; D=102-505.
DR   PDB; 3E00; X-ray; 3.10 A; D=102-505.
DR   PDB; 3ET0; X-ray; 2.40 A; A/B=235-505.
DR   PDB; 3ET3; X-ray; 1.95 A; A=235-505.
DR   PDB; 3FEJ; X-ray; 2.01 A; A=235-505.
DR   PDB; 3FUR; X-ray; 2.30 A; A=234-505.
DR   PDB; 3G9E; X-ray; 2.30 A; A=235-505.
DR   PDB; 3GBK; X-ray; 2.30 A; A/B=235-505.
DR   PDB; 3H0A; X-ray; 2.10 A; D=234-505.
DR   PDB; 3HO0; X-ray; 2.60 A; A/B=223-504.
DR   PDB; 3HOD; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 3IA6; X-ray; 2.31 A; A/B=235-505.
DR   PDB; 3K8S; X-ray; 2.55 A; A/B=234-505.
DR   PDB; 3KMG; X-ray; 2.10 A; A/D=234-505.
DR   PDB; 3LMP; X-ray; 1.90 A; A=234-505.
DR   PDB; 3NOA; X-ray; 1.98 A; A/B=235-505.
DR   PDB; 3OSI; X-ray; 2.70 A; A/B=224-504.
DR   PDB; 3OSW; X-ray; 2.55 A; A/B=224-504.
DR   PDB; 3PBA; X-ray; 2.30 A; A/B=224-505.
DR   PDB; 3PO9; X-ray; 2.35 A; A/B=224-505.
DR   PDB; 3PRG; X-ray; 2.90 A; A=232-505.
DR   PDB; 3QT0; X-ray; 2.50 A; A=235-505.
DR   PDB; 3R5N; X-ray; 2.00 A; A=232-505.
DR   PDB; 3R8A; X-ray; 2.41 A; A/B=235-505.
DR   PDB; 3R8I; X-ray; 2.30 A; A/B=223-505.
DR   PDB; 3S9S; X-ray; 2.55 A; A=234-505.
DR   PDB; 3SZ1; X-ray; 2.30 A; A/B=232-505.
DR   PDB; 3T03; X-ray; 2.10 A; A/B=234-505.
DR   PDB; 3TY0; X-ray; 2.00 A; A/B=231-505.
DR   PDB; 3U9Q; X-ray; 1.52 A; A=236-504.
DR   PDB; 3V9T; X-ray; 1.65 A; A=234-505.
DR   PDB; 3V9V; X-ray; 1.60 A; A=234-505.
DR   PDB; 3V9Y; X-ray; 2.10 A; A=234-505.
DR   PDB; 3VJH; X-ray; 2.22 A; A/B=223-504.
DR   PDB; 3VJI; X-ray; 2.61 A; A/B=223-504.
DR   PDB; 3VN2; X-ray; 2.18 A; A=225-505.
DR   PDB; 3VSO; X-ray; 2.00 A; A/B=223-504.
DR   PDB; 3VSP; X-ray; 2.40 A; A/B=223-504.
DR   PDB; 3WJ4; X-ray; 1.95 A; A/B=235-505.
DR   PDB; 3WJ5; X-ray; 1.89 A; A/B=235-505.
DR   PDB; 3WMH; X-ray; 2.10 A; A/B=223-504.
DR   PDB; 3X1H; X-ray; 2.30 A; A/B=232-505.
DR   PDB; 3X1I; X-ray; 2.40 A; A/B=232-505.
DR   PDB; 4A4V; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 4A4W; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 4CI5; X-ray; 1.77 A; A/B=234-505.
DR   PDB; 4E4K; X-ray; 2.50 A; A/B=223-505.
DR   PDB; 4E4Q; X-ray; 2.50 A; A/B=223-505.
DR   PDB; 4EM9; X-ray; 2.10 A; A/B=235-505.
DR   PDB; 4EMA; X-ray; 2.54 A; A/B=235-505.
DR   PDB; 4F9M; X-ray; 1.90 A; A=234-505.
DR   PDB; 4FGY; X-ray; 2.84 A; A=235-504.
DR   PDB; 4HEE; X-ray; 2.50 A; X=235-505.
DR   PDB; 4JAZ; X-ray; 2.85 A; A/B=223-505.
DR   PDB; 4JL4; X-ray; 2.50 A; A/B=223-505.
DR   PDB; 4L96; X-ray; 2.38 A; A=235-505.
DR   PDB; 4L98; X-ray; 2.28 A; A/B=235-505.
DR   PDB; 4O8F; X-ray; 2.60 A; A/B=223-505.
DR   PDB; 4OJ4; X-ray; 2.30 A; A=232-505.
DR   PDB; 4PRG; X-ray; 2.90 A; A/B/C/D=235-504.
DR   PDB; 4PVU; X-ray; 2.60 A; A/B=223-505.
DR   PDB; 4PWL; X-ray; 2.60 A; A/B=223-505.
DR   PDB; 4R06; X-ray; 2.22 A; A/B=233-505.
DR   PDB; 4R2U; X-ray; 2.30 A; A/D=231-505.
DR   PDB; 4R6S; X-ray; 2.30 A; A/B=231-505.
DR   PDB; 4XLD; X-ray; 2.45 A; A=231-505.
DR   PDB; 4XTA; X-ray; 2.50 A; A/B=232-505.
DR   PDB; 4XUH; X-ray; 2.22 A; A/B=232-505.
DR   PDB; 4XUM; X-ray; 2.40 A; A/B=232-505.
DR   PDB; 4Y29; X-ray; 1.98 A; A=236-504.
DR   PDB; 4YT1; X-ray; 2.20 A; A/B=223-504.
DR   PDB; 5AZV; X-ray; 2.70 A; A/B=232-505.
DR   PDB; 5DSH; X-ray; 2.95 A; A=223-505.
DR   PDB; 5DV3; X-ray; 2.75 A; A=223-505.
DR   PDB; 5DV6; X-ray; 2.80 A; A=223-505.
DR   PDB; 5DV8; X-ray; 2.75 A; A=223-505.
DR   PDB; 5DVC; X-ray; 2.30 A; A=223-505.
DR   PDB; 5DWL; X-ray; 2.20 A; A=223-505.
DR   PDB; 5F9B; X-ray; 2.25 A; A/B=223-505.
DR   PDB; 5GTN; X-ray; 1.85 A; A=223-505.
DR   PDB; 5GTO; X-ray; 2.10 A; A=223-505.
DR   PDB; 5GTP; X-ray; 2.35 A; A=223-505.
DR   PDB; 5HZC; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 5JI0; X-ray; 1.98 A; D=234-505.
DR   PDB; 5LSG; X-ray; 2.00 A; A/B=223-505.
DR   PDB; 5TTO; X-ray; 2.25 A; A/B=233-505.
DR   PDB; 5TWO; X-ray; 1.93 A; A=234-505.
DR   PDB; 5U5L; X-ray; 2.55 A; A/B=233-505.
DR   PDB; 5UGM; X-ray; 2.10 A; A/B=235-505.
DR   PDB; 5WQX; X-ray; 2.29 A; A/B=232-505.
DR   PDB; 5WR0; X-ray; 2.85 A; A/B=232-505.
DR   PDB; 5WR1; X-ray; 2.34 A; A/B=232-505.
DR   PDB; 5Y2O; X-ray; 1.80 A; A/B=235-505.
DR   PDB; 5Y2T; X-ray; 1.70 A; A/B=235-505.
DR   PDB; 5YCN; X-ray; 2.15 A; A=223-505.
DR   PDB; 5YCP; X-ray; 2.00 A; A=223-505.
DR   PDB; 5Z5S; X-ray; 1.80 A; A=234-505.
DR   PDB; 5Z6S; X-ray; 1.80 A; A=234-505.
DR   PDB; 6AD9; X-ray; 2.20 A; A=223-505.
DR   PDB; 6AN1; X-ray; 2.69 A; A/B=224-505.
DR   PDB; 6AUG; X-ray; 2.73 A; A/B=231-505.
DR   PDB; 6AVI; X-ray; 2.29 A; A/B=231-505.
DR   PDB; 6C1I; X-ray; 2.26 A; A/B=231-504.
DR   PDB; 6C5Q; X-ray; 2.40 A; A=235-505.
DR   PDB; 6C5T; X-ray; 2.75 A; A=235-505.
DR   PDB; 6D3E; X-ray; 2.40 A; A/B=235-504.
DR   PDB; 6D8X; X-ray; 1.90 A; A=231-505.
DR   PDB; 6D94; X-ray; 1.90 A; A=231-505.
DR   PDB; 6DBH; X-ray; 2.60 A; A/B=231-505.
DR   PDB; 6DCU; X-ray; 2.95 A; A/B=231-505.
DR   PDB; 6DGL; X-ray; 1.95 A; A/B=231-505.
DR   PDB; 6DGO; X-ray; 3.10 A; A/B=231-505.
DR   PDB; 6DGP; X-ray; 3.10 A; A/B=231-505.
DR   PDB; 6DGQ; X-ray; 2.45 A; A/B=231-505.
DR   PDB; 6DGR; X-ray; 2.15 A; A/B=231-505.
DR   PDB; 6DH9; X-ray; 2.70 A; A/B=235-505.
DR   PDB; 6DHA; X-ray; 1.88 A; A/B=235-505.
DR   PDB; 6E5A; X-ray; 2.40 A; A/B=233-505.
DR   PDB; 6ENQ; X-ray; 2.20 A; A/B=224-505.
DR   PDB; 6F2L; X-ray; 2.10 A; A/B=223-505.
DR   PDB; 6FZF; X-ray; 1.95 A; A/B=231-505.
DR   PDB; 6FZG; X-ray; 2.10 A; A=231-505.
DR   PDB; 6FZJ; X-ray; 2.01 A; A/B=231-505.
DR   PDB; 6FZP; X-ray; 2.30 A; A=231-505.
DR   PDB; 6FZY; X-ray; 3.10 A; A/B=231-505.
DR   PDB; 6ICJ; X-ray; 2.48 A; A=234-505.
DR   PDB; 6IJR; X-ray; 2.85 A; A/C=223-505.
DR   PDB; 6IJS; X-ray; 2.15 A; A=232-505.
DR   PDB; 6ILQ; X-ray; 2.41 A; A=234-505.
DR   PDB; 6IZM; X-ray; 1.80 A; A=234-505.
DR   PDB; 6IZN; X-ray; 1.75 A; A=234-505.
DR   PDB; 6JQ7; X-ray; 2.55 A; A=223-505.
DR   PDB; 6K0T; X-ray; 1.84 A; A/C=223-505.
DR   PDB; 6MCZ; X-ray; 2.10 A; A/B=231-505.
DR   PDB; 6MD0; X-ray; 1.95 A; A/B=231-505.
DR   PDB; 6MD1; X-ray; 2.20 A; A/B=231-505.
DR   PDB; 6MD2; X-ray; 2.20 A; A/B=231-505.
DR   PDB; 6MD4; X-ray; 2.24 A; A/B=231-505.
DR   PDB; 6MS7; X-ray; 1.43 A; A=234-505.
DR   PDB; 6O67; X-ray; 2.52 A; A/B=231-505.
DR   PDB; 6O68; X-ray; 2.78 A; A/B=231-505.
DR   PDB; 6T6B; X-ray; 2.80 A; A=231-505.
DR   PDBsum; 1FM6; -.
DR   PDBsum; 1FM9; -.
DR   PDBsum; 1I7I; -.
DR   PDBsum; 1K74; -.
DR   PDBsum; 1KNU; -.
DR   PDBsum; 1NYX; -.
DR   PDBsum; 1PRG; -.
DR   PDBsum; 1RDT; -.
DR   PDBsum; 1WM0; -.
DR   PDBsum; 1ZEO; -.
DR   PDBsum; 1ZGY; -.
DR   PDBsum; 2ATH; -.
DR   PDBsum; 2F4B; -.
DR   PDBsum; 2FVJ; -.
DR   PDBsum; 2G0G; -.
DR   PDBsum; 2G0H; -.
DR   PDBsum; 2GTK; -.
DR   PDBsum; 2HFP; -.
DR   PDBsum; 2HWQ; -.
DR   PDBsum; 2HWR; -.
DR   PDBsum; 2I4J; -.
DR   PDBsum; 2I4P; -.
DR   PDBsum; 2I4Z; -.
DR   PDBsum; 2OM9; -.
DR   PDBsum; 2P4Y; -.
DR   PDBsum; 2POB; -.
DR   PDBsum; 2PRG; -.
DR   PDBsum; 2Q59; -.
DR   PDBsum; 2Q5P; -.
DR   PDBsum; 2Q5S; -.
DR   PDBsum; 2Q61; -.
DR   PDBsum; 2Q6R; -.
DR   PDBsum; 2Q6S; -.
DR   PDBsum; 2Q8S; -.
DR   PDBsum; 2QMV; -.
DR   PDBsum; 2VSR; -.
DR   PDBsum; 2VST; -.
DR   PDBsum; 2VV0; -.
DR   PDBsum; 2VV1; -.
DR   PDBsum; 2VV2; -.
DR   PDBsum; 2VV3; -.
DR   PDBsum; 2VV4; -.
DR   PDBsum; 2XKW; -.
DR   PDBsum; 2YFE; -.
DR   PDBsum; 2ZK0; -.
DR   PDBsum; 2ZK1; -.
DR   PDBsum; 2ZK2; -.
DR   PDBsum; 2ZK3; -.
DR   PDBsum; 2ZK4; -.
DR   PDBsum; 2ZK5; -.
DR   PDBsum; 2ZK6; -.
DR   PDBsum; 2ZNO; -.
DR   PDBsum; 2ZVT; -.
DR   PDBsum; 3ADS; -.
DR   PDBsum; 3ADT; -.
DR   PDBsum; 3ADU; -.
DR   PDBsum; 3ADV; -.
DR   PDBsum; 3ADW; -.
DR   PDBsum; 3ADX; -.
DR   PDBsum; 3AN3; -.
DR   PDBsum; 3AN4; -.
DR   PDBsum; 3B0Q; -.
DR   PDBsum; 3B0R; -.
DR   PDBsum; 3B1M; -.
DR   PDBsum; 3B3K; -.
DR   PDBsum; 3BC5; -.
DR   PDBsum; 3CDP; -.
DR   PDBsum; 3CDS; -.
DR   PDBsum; 3CS8; -.
DR   PDBsum; 3CWD; -.
DR   PDBsum; 3D6D; -.
DR   PDBsum; 3DZU; -.
DR   PDBsum; 3DZY; -.
DR   PDBsum; 3E00; -.
DR   PDBsum; 3ET0; -.
DR   PDBsum; 3ET3; -.
DR   PDBsum; 3FEJ; -.
DR   PDBsum; 3FUR; -.
DR   PDBsum; 3G9E; -.
DR   PDBsum; 3GBK; -.
DR   PDBsum; 3H0A; -.
DR   PDBsum; 3HO0; -.
DR   PDBsum; 3HOD; -.
DR   PDBsum; 3IA6; -.
DR   PDBsum; 3K8S; -.
DR   PDBsum; 3KMG; -.
DR   PDBsum; 3LMP; -.
DR   PDBsum; 3NOA; -.
DR   PDBsum; 3OSI; -.
DR   PDBsum; 3OSW; -.
DR   PDBsum; 3PBA; -.
DR   PDBsum; 3PO9; -.
DR   PDBsum; 3PRG; -.
DR   PDBsum; 3QT0; -.
DR   PDBsum; 3R5N; -.
DR   PDBsum; 3R8A; -.
DR   PDBsum; 3R8I; -.
DR   PDBsum; 3S9S; -.
DR   PDBsum; 3SZ1; -.
DR   PDBsum; 3T03; -.
DR   PDBsum; 3TY0; -.
DR   PDBsum; 3U9Q; -.
DR   PDBsum; 3V9T; -.
DR   PDBsum; 3V9V; -.
DR   PDBsum; 3V9Y; -.
DR   PDBsum; 3VJH; -.
DR   PDBsum; 3VJI; -.
DR   PDBsum; 3VN2; -.
DR   PDBsum; 3VSO; -.
DR   PDBsum; 3VSP; -.
DR   PDBsum; 3WJ4; -.
DR   PDBsum; 3WJ5; -.
DR   PDBsum; 3WMH; -.
DR   PDBsum; 3X1H; -.
DR   PDBsum; 3X1I; -.
DR   PDBsum; 4A4V; -.
DR   PDBsum; 4A4W; -.
DR   PDBsum; 4CI5; -.
DR   PDBsum; 4E4K; -.
DR   PDBsum; 4E4Q; -.
DR   PDBsum; 4EM9; -.
DR   PDBsum; 4EMA; -.
DR   PDBsum; 4F9M; -.
DR   PDBsum; 4FGY; -.
DR   PDBsum; 4HEE; -.
DR   PDBsum; 4JAZ; -.
DR   PDBsum; 4JL4; -.
DR   PDBsum; 4L96; -.
DR   PDBsum; 4L98; -.
DR   PDBsum; 4O8F; -.
DR   PDBsum; 4OJ4; -.
DR   PDBsum; 4PRG; -.
DR   PDBsum; 4PVU; -.
DR   PDBsum; 4PWL; -.
DR   PDBsum; 4R06; -.
DR   PDBsum; 4R2U; -.
DR   PDBsum; 4R6S; -.
DR   PDBsum; 4XLD; -.
DR   PDBsum; 4XTA; -.
DR   PDBsum; 4XUH; -.
DR   PDBsum; 4XUM; -.
DR   PDBsum; 4Y29; -.
DR   PDBsum; 4YT1; -.
DR   PDBsum; 5AZV; -.
DR   PDBsum; 5DSH; -.
DR   PDBsum; 5DV3; -.
DR   PDBsum; 5DV6; -.
DR   PDBsum; 5DV8; -.
DR   PDBsum; 5DVC; -.
DR   PDBsum; 5DWL; -.
DR   PDBsum; 5F9B; -.
DR   PDBsum; 5GTN; -.
DR   PDBsum; 5GTO; -.
DR   PDBsum; 5GTP; -.
DR   PDBsum; 5HZC; -.
DR   PDBsum; 5JI0; -.
DR   PDBsum; 5LSG; -.
DR   PDBsum; 5TTO; -.
DR   PDBsum; 5TWO; -.
DR   PDBsum; 5U5L; -.
DR   PDBsum; 5UGM; -.
DR   PDBsum; 5WQX; -.
DR   PDBsum; 5WR0; -.
DR   PDBsum; 5WR1; -.
DR   PDBsum; 5Y2O; -.
DR   PDBsum; 5Y2T; -.
DR   PDBsum; 5YCN; -.
DR   PDBsum; 5YCP; -.
DR   PDBsum; 5Z5S; -.
DR   PDBsum; 5Z6S; -.
DR   PDBsum; 6AD9; -.
DR   PDBsum; 6AN1; -.
DR   PDBsum; 6AUG; -.
DR   PDBsum; 6AVI; -.
DR   PDBsum; 6C1I; -.
DR   PDBsum; 6C5Q; -.
DR   PDBsum; 6C5T; -.
DR   PDBsum; 6D3E; -.
DR   PDBsum; 6D8X; -.
DR   PDBsum; 6D94; -.
DR   PDBsum; 6DBH; -.
DR   PDBsum; 6DCU; -.
DR   PDBsum; 6DGL; -.
DR   PDBsum; 6DGO; -.
DR   PDBsum; 6DGP; -.
DR   PDBsum; 6DGQ; -.
DR   PDBsum; 6DGR; -.
DR   PDBsum; 6DH9; -.
DR   PDBsum; 6DHA; -.
DR   PDBsum; 6E5A; -.
DR   PDBsum; 6ENQ; -.
DR   PDBsum; 6F2L; -.
DR   PDBsum; 6FZF; -.
DR   PDBsum; 6FZG; -.
DR   PDBsum; 6FZJ; -.
DR   PDBsum; 6FZP; -.
DR   PDBsum; 6FZY; -.
DR   PDBsum; 6ICJ; -.
DR   PDBsum; 6IJR; -.
DR   PDBsum; 6IJS; -.
DR   PDBsum; 6ILQ; -.
DR   PDBsum; 6IZM; -.
DR   PDBsum; 6IZN; -.
DR   PDBsum; 6JQ7; -.
DR   PDBsum; 6K0T; -.
DR   PDBsum; 6MCZ; -.
DR   PDBsum; 6MD0; -.
DR   PDBsum; 6MD1; -.
DR   PDBsum; 6MD2; -.
DR   PDBsum; 6MD4; -.
DR   PDBsum; 6MS7; -.
DR   PDBsum; 6O67; -.
DR   PDBsum; 6O68; -.
DR   PDBsum; 6T6B; -.
DR   SMR; P37231; -.
DR   BioGrid; 111464; 230.
DR   ComplexPortal; CPX-702; PPARgamma-NCOA2 activated nuclear receptor complex.
DR   ComplexPortal; CPX-711; PPARgamma-NCOA1 activated nuclear receptor complex.
DR   DIP; DIP-35528N; -.
DR   ELM; P37231; -.
DR   IntAct; P37231; 43.
DR   MINT; P37231; -.
DR   STRING; 9606.ENSP00000287820; -.
DR   BindingDB; P37231; -.
DR   ChEMBL; CHEMBL235; -.
DR   DrugBank; DB08760; (2S)-2-(4-chlorophenoxy)-3-phenylpropanoic acid.
DR   DrugBank; DB07842; (2S)-2-(4-ethylphenoxy)-3-phenylpropanoic acid.
DR   DrugBank; DB08121; (2S)-2-(biphenyl-4-yloxy)-3-phenylpropanoic acid.
DR   DrugBank; DB07675; (2S)-2-ETHOXY-3-{4-[2-(10H-PHENOXAZIN-10-YL)ETHOXY]PHENYL}PROPANOIC ACID.
DR   DrugBank; DB06908; (2S)-3-(1-{[2-(2-CHLOROPHENYL)-5-METHYL-1,3-OXAZOL-4-YL]METHYL}-1H-INDOL-5-YL)-2-ETHOXYPROPANOIC ACID.
DR   DrugBank; DB07111; (4S,5E,7Z,10Z,13Z,16Z,19Z)-4-hydroxydocosa-5,7,10,13,16,19-hexaenoic acid.
DR   DrugBank; DB08435; (5E,14E)-11-oxoprosta-5,9,12,14-tetraen-1-oic acid.
DR   DrugBank; DB07172; (5R,6E,8Z,11Z,14Z,17Z)-5-hydroxyicosa-6,8,11,14,17-pentaenoic acid.
DR   DrugBank; DB07208; (8E,10S,12Z)-10-hydroxy-6-oxooctadeca-8,12-dienoic acid.
DR   DrugBank; DB07209; (8R,9Z,12Z)-8-hydroxy-6-oxooctadeca-9,12-dienoic acid.
DR   DrugBank; DB07302; (9S,10E,12Z)-9-hydroxyoctadeca-10,12-dienoic acid.
DR   DrugBank; DB06926; (9Z,11E,13S)-13-hydroxyoctadeca-9,11-dienoic acid.
DR   DrugBank; DB04270; (S)-3-(4-(2-Carbazol-9-Yl-Ethoxy)-Phenyl)-2-Ethoxy-Propionic Acid.
DR   DrugBank; DB08402; 2-[(2,4-DICHLOROBENZOYL)AMINO]-5-(PYRIMIDIN-2-YLOXY)BENZOIC ACID.
DR   DrugBank; DB07863; 2-chloro-5-nitro-N-phenylbenzamide.
DR   DrugBank; DB04689; 2-{5-[3-(6-BENZOYL-1-PROPYLNAPHTHALEN-2-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID.
DR   DrugBank; DB07053; 2-{5-[3-(7-PROPYL-3-TRIFLUOROMETHYLBENZO[D]ISOXAZOL-6-YLOXY)PROPOXY]INDOL-1-YL}ETHANOIC ACID.
DR   DrugBank; DB07723; 3-(5-methoxy-1H-indol-3-yl)propanoic acid.
DR   DrugBank; DB08302; 3-[5-(2-nitropent-1-en-1-yl)furan-2-yl]benzoic acid.
DR   DrugBank; DB08560; 3-FLUORO-N-[1-(4-FLUOROPHENYL)-3-(2-THIENYL)-1H-PYRAZOL-5-YL]BENZENESULFONAMIDE.
DR   DrugBank; DB08915; Aleglitazar.
DR   DrugBank; DB00132; alpha-Linolenic acid.
DR   DrugBank; DB05490; AMG-131.
DR   DrugBank; DB01118; Amiodarone.
DR   DrugBank; DB11811; Arhalofenate.
DR   DrugBank; DB01014; Balsalazide.
DR   DrugBank; DB01393; Bezafibrate.
DR   DrugBank; DB09061; Cannabidiol.
DR   DrugBank; DB03600; Capric acid.
DR   DrugBank; DB09201; Ciglitazone.
DR   DrugBank; DB09006; Clinofibrate.
DR   DrugBank; DB05854; CLX-0921.
DR   DrugBank; DB11672; Curcumin.
DR   DrugBank; DB14635; Curcumin sulfate.
DR   DrugBank; DB14034; Darglitazone.
DR   DrugBank; DB09213; Dexibuprofen.
DR   DrugBank; DB07509; difluoro(5-{2-[(5-octyl-1H-pyrrol-2-yl-kappaN)methylidene]-2H-pyrrol-5-yl-kappaN}pentanoato)boron.
DR   DrugBank; DB03756; Doconexent.
DR   DrugBank; DB05187; Elafibranor.
DR   DrugBank; DB06521; Ertiprotafib.
DR   DrugBank; DB13873; Fenofibric acid.
DR   DrugBank; DB00573; Fenoprofen.
DR   DrugBank; DB13961; Fish oil.
DR   DrugBank; DB02266; Flufenamic acid.
DR   DrugBank; DB01067; Glipizide.
DR   DrugBank; DB01050; Ibuprofen.
DR   DrugBank; DB00159; Icosapent.
DR   DrugBank; DB07724; Indeglitazar.
DR   DrugBank; DB00328; Indomethacin.
DR   DrugBank; DB12007; Isoflavone.
DR   DrugBank; DB09198; Lobeglitazone.
DR   DrugBank; DB14009; Medical Cannabis.
DR   DrugBank; DB00244; Mesalazine.
DR   DrugBank; DB01252; Mitiglinide.
DR   DrugBank; DB06510; Muraglitazar.
DR   DrugBank; DB14011; Nabiximols.
DR   DrugBank; DB00731; Nateglinide.
DR   DrugBank; DB12662; Naveglitazar.
DR   DrugBank; DB04224; Oleic Acid.
DR   DrugBank; DB11133; Omega-3 fatty acids.
DR   DrugBank; DB02746; Phthalic Acid.
DR   DrugBank; DB01132; Pioglitazone.
DR   DrugBank; DB06533; Ragaglitazar.
DR   DrugBank; DB04971; Reglitazar.
DR   DrugBank; DB00912; Repaglinide.
DR   DrugBank; DB02709; Resveratrol.
DR   DrugBank; DB00412; Rosiglitazone.
DR   DrugBank; DB00795; Sulfasalazine.
DR   DrugBank; DB00966; Telmisartan.
DR   DrugBank; DB06536; Tesaglitazar.
DR   DrugBank; DB08604; Triclosan.
DR   DrugBank; DB00197; Troglitazone.
DR   DrugBank; DB00313; Valproic acid.
DR   DrugCentral; P37231; -.
DR   GuidetoPHARMACOLOGY; 595; -.
DR   SwissLipids; SLP:000000396; -.
DR   MoonDB; P37231; Predicted.
DR   iPTMnet; P37231; -.
DR   PhosphoSitePlus; P37231; -.
DR   BioMuta; PPARG; -.
DR   DMDM; 13432234; -.
DR   EPD; P37231; -.
DR   jPOST; P37231; -.
DR   MassIVE; P37231; -.
DR   MaxQB; P37231; -.
DR   PaxDb; P37231; -.
DR   PeptideAtlas; P37231; -.
DR   PRIDE; P37231; -.
DR   ProteomicsDB; 55267; -. [P37231-1]
DR   ProteomicsDB; 55268; -. [P37231-2]
DR   ProteomicsDB; 55269; -. [P37231-3]
DR   Antibodypedia; 3799; 1044 antibodies.
DR   DNASU; 5468; -.
DR   Ensembl; ENST00000287820; ENSP00000287820; ENSG00000132170. [P37231-1]
DR   Ensembl; ENST00000397012; ENSP00000380207; ENSG00000132170. [P37231-2]
DR   Ensembl; ENST00000650650; ENSP00000498420; ENSG00000132170. [P37231-3]
DR   Ensembl; ENST00000650761; ENSP00000498354; ENSG00000132170. [P37231-2]
DR   Ensembl; ENST00000651826; ENSP00000499004; ENSG00000132170. [P37231-2]
DR   GeneID; 5468; -.
DR   KEGG; hsa:5468; -.
DR   UCSC; uc003bwr.4; human. [P37231-1]
DR   CTD; 5468; -.
DR   DisGeNET; 5468; -.
DR   GeneCards; PPARG; -.
DR   HGNC; HGNC:9236; PPARG.
DR   HPA; ENSG00000132170; Tissue enhanced (adipose tissue, breast).
DR   MalaCards; PPARG; -.
DR   MIM; 137800; phenotype.
DR   MIM; 601487; gene.
DR   MIM; 601665; phenotype.
DR   MIM; 604367; phenotype.
DR   MIM; 606641; phenotype.
DR   MIM; 609338; phenotype.
DR   neXtProt; NX_P37231; -.
DR   OpenTargets; ENSG00000132170; -.
DR   Orphanet; 528; Berardinelli-Seip congenital lipodystrophy.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   Orphanet; 251579; Giant cell glioblastoma.
DR   Orphanet; 251576; Gliosarcoma.
DR   Orphanet; 79083; PPARG-related familial partial lipodystrophy.
DR   PharmGKB; PA281; -.
DR   eggNOG; KOG3575; Eukaryota.
DR   eggNOG; ENOG410XRZC; LUCA.
DR   GeneTree; ENSGT00940000158273; -.
DR   HOGENOM; CLU_007368_4_2_1; -.
DR   InParanoid; P37231; -.
DR   KO; K08530; -.
DR   OMA; QRCQFRS; -.
DR   OrthoDB; 1240230at2759; -.
DR   PhylomeDB; P37231; -.
DR   TreeFam; TF316304; -.
DR   Reactome; R-HSA-1989781; PPARA activates gene expression.
DR   Reactome; R-HSA-381340; Transcriptional regulation of white adipocyte differentiation.
DR   Reactome; R-HSA-383280; Nuclear Receptor transcription pathway.
DR   Reactome; R-HSA-4090294; SUMOylation of intracellular receptors.
DR   Reactome; R-HSA-8943724; Regulation of PTEN gene transcription.
DR   Reactome; R-HSA-9022707; MECP2 regulates transcription factors.
DR   SignaLink; P37231; -.
DR   SIGNOR; P37231; -.
DR   ChiTaRS; PPARG; human.
DR   EvolutionaryTrace; P37231; -.
DR   GeneWiki; Peroxisome_proliferator-activated_receptor_gamma; -.
DR   GenomeRNAi; 5468; -.
DR   Pharos; P37231; Tclin.
DR   PRO; PR:P37231; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; P37231; protein.
DR   Bgee; ENSG00000132170; Expressed in subcutaneous adipose tissue and 135 other tissues.
DR   ExpressionAtlas; P37231; baseline and differential.
DR   Genevisible; P37231; HS.
DR   GO; GO:0005829; C:cytosol; ISS:BHF-UCL.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0000790; C:nuclear chromatin; ISA:NTNU_SB.
DR   GO; GO:0005654; C:nucleoplasm; IDA:HPA.
DR   GO; GO:0005634; C:nucleus; IDA:BHF-UCL.
DR   GO; GO:0048471; C:perinuclear region of cytoplasm; IEA:Ensembl.
DR   GO; GO:0032991; C:protein-containing complex; IDA:CAFA.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IDA:BHF-UCL.
DR   GO; GO:0033613; F:activating transcription factor binding; IDA:BHF-UCL.
DR   GO; GO:0051393; F:alpha-actinin binding; IPI:UniProtKB.
DR   GO; GO:0050544; F:arachidonic acid binding; ISS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0050692; F:DNA binding domain binding; IDA:CAFA.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0000981; F:DNA-binding transcription factor activity, RNA polymerase II-specific; ISA:NTNU_SB.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IBA:GO_Central.
DR   GO; GO:0003690; F:double-stranded DNA binding; IMP:CAFA.
DR   GO; GO:0008144; F:drug binding; IDA:BHF-UCL.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0030331; F:estrogen receptor binding; IEA:Ensembl.
DR   GO; GO:0005504; F:fatty acid binding; IBA:GO_Central.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0050693; F:LBD domain binding; IDA:CAFA.
DR   GO; GO:0098531; F:ligand-activated transcription factor activity; IBA:GO_Central.
DR   GO; GO:0008289; F:lipid binding; IBA:GO_Central.
DR   GO; GO:0004879; F:nuclear receptor activity; IDA:BHF-UCL.
DR   GO; GO:0030374; F:nuclear receptor transcription coactivator activity; IDA:UniProtKB.
DR   GO; GO:0042277; F:peptide binding; IDA:CAFA.
DR   GO; GO:0004955; F:prostaglandin receptor activity; TAS:BHF-UCL.
DR   GO; GO:0008022; F:protein C-terminus binding; IDA:CAFA.
DR   GO; GO:0019903; F:protein phosphatase binding; IEA:Ensembl.
DR   GO; GO:0043621; F:protein self-association; IDA:CAFA.
DR   GO; GO:0046965; F:retinoid X receptor binding; IDA:BHF-UCL.
DR   GO; GO:0000977; F:RNA polymerase II regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0001103; F:RNA polymerase II repressing transcription factor binding; IBA:GO_Central.
DR   GO; GO:0038023; F:signaling receptor activity; IBA:GO_Central.
DR   GO; GO:0003707; F:steroid hormone receptor activity; IEA:InterPro.
DR   GO; GO:0008134; F:transcription factor binding; IPI:UniProtKB.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:BHF-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0008270; F:zinc ion binding; IDA:CAFA.
DR   GO; GO:0006919; P:activation of cysteine-type endopeptidase activity involved in apoptotic process; IDA:BHF-UCL.
DR   GO; GO:0031100; P:animal organ regeneration; IEA:Ensembl.
DR   GO; GO:0030154; P:cell differentiation; IBA:GO_Central.
DR   GO; GO:0045165; P:cell fate commitment; ISS:BHF-UCL.
DR   GO; GO:0048469; P:cell maturation; IDA:BHF-UCL.
DR   GO; GO:0071455; P:cellular response to hyperoxia; IEA:Ensembl.
DR   GO; GO:0032869; P:cellular response to insulin stimulus; IMP:BHF-UCL.
DR   GO; GO:0071396; P:cellular response to lipid; IBA:GO_Central.
DR   GO; GO:0071404; P:cellular response to low-density lipoprotein particle stimulus; IDA:BHF-UCL.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEA:Ensembl.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEA:Ensembl.
DR   GO; GO:0071306; P:cellular response to vitamin E; IEA:Ensembl.
DR   GO; GO:0030855; P:epithelial cell differentiation; ISS:BHF-UCL.
DR   GO; GO:0006631; P:fatty acid metabolic process; IBA:GO_Central.
DR   GO; GO:0019395; P:fatty acid oxidation; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; IMP:BHF-UCL.
DR   GO; GO:0007507; P:heart development; IEA:Ensembl.
DR   GO; GO:0009755; P:hormone-mediated signaling pathway; IBA:GO_Central.
DR   GO; GO:0045087; P:innate immune response; TAS:BHF-UCL.
DR   GO; GO:0055088; P:lipid homeostasis; TAS:BHF-UCL.
DR   GO; GO:0006629; P:lipid metabolic process; TAS:ProtInc.
DR   GO; GO:0042953; P:lipoprotein transport; IDA:BHF-UCL.
DR   GO; GO:0015909; P:long-chain fatty acid transport; ISS:BHF-UCL.
DR   GO; GO:0045713; P:low-density lipoprotein particle receptor biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010742; P:macrophage derived foam cell differentiation; IDA:UniProtKB.
DR   GO; GO:0030224; P:monocyte differentiation; IDA:BHF-UCL.
DR   GO; GO:0007275; P:multicellular organism development; IBA:GO_Central.
DR   GO; GO:0002674; P:negative regulation of acute inflammatory response; IEA:Ensembl.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:BHF-UCL.
DR   GO; GO:0043537; P:negative regulation of blood vessel endothelial cell migration; IDA:BHF-UCL.
DR   GO; GO:0030308; P:negative regulation of cell growth; IEA:Ensembl.
DR   GO; GO:0010887; P:negative regulation of cholesterol storage; IDA:BHF-UCL.
DR   GO; GO:0032966; P:negative regulation of collagen biosynthetic process; IEA:Ensembl.
DR   GO; GO:0060965; P:negative regulation of gene silencing by miRNA; IMP:BHF-UCL.
DR   GO; GO:0050728; P:negative regulation of inflammatory response; IBA:GO_Central.
DR   GO; GO:0060336; P:negative regulation of interferon-gamma-mediated signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0010745; P:negative regulation of macrophage derived foam cell differentiation; IDA:BHF-UCL.
DR   GO; GO:2000230; P:negative regulation of pancreatic stellate cell proliferation; IEA:Ensembl.
DR   GO; GO:0010871; P:negative regulation of receptor biosynthetic process; IDA:BHF-UCL.
DR   GO; GO:0010891; P:negative regulation of sequestering of triglyceride; IDA:BHF-UCL.
DR   GO; GO:0048662; P:negative regulation of smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0051974; P:negative regulation of telomerase activity; IEA:Ensembl.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:BHF-UCL.
DR   GO; GO:1905563; P:negative regulation of vascular endothelial cell proliferation; IMP:BHF-UCL.
DR   GO; GO:1904706; P:negative regulation of vascular smooth muscle cell proliferation; IDA:BHF-UCL.
DR   GO; GO:0035357; P:peroxisome proliferator activated receptor signaling pathway; IMP:BHF-UCL.
DR   GO; GO:0001890; P:placenta development; ISS:BHF-UCL.
DR   GO; GO:0043388; P:positive regulation of DNA binding; IMP:CAFA.
DR   GO; GO:0051091; P:positive regulation of DNA-binding transcription factor activity; IDA:BHF-UCL.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; ISS:HGNC-UCL.
DR   GO; GO:0045923; P:positive regulation of fatty acid metabolic process; IBA:GO_Central.
DR   GO; GO:0046321; P:positive regulation of fatty acid oxidation; IEA:Ensembl.
DR   GO; GO:0048714; P:positive regulation of oligodendrocyte differentiation; IEA:Ensembl.
DR   GO; GO:0060100; P:positive regulation of phagocytosis, engulfment; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IDA:UniProtKB.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IMP:CAFA.
DR   GO; GO:1905461; P:positive regulation of vascular associated smooth muscle cell apoptotic process; IMP:BHF-UCL.
DR   GO; GO:0061614; P:pri-miRNA transcription by RNA polymerase II; IDA:BHF-UCL.
DR   GO; GO:0008217; P:regulation of blood pressure; IMP:BHF-UCL.
DR   GO; GO:0060694; P:regulation of cholesterol transporter activity; IC:BHF-UCL.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0019216; P:regulation of lipid metabolic process; IBA:GO_Central.
DR   GO; GO:0006357; P:regulation of transcription by RNA polymerase II; ISS:UniProtKB.
DR   GO; GO:0060850; P:regulation of transcription involved in cell fate commitment; ISS:UniProtKB.
DR   GO; GO:0031000; P:response to caffeine; IEA:Ensembl.
DR   GO; GO:0009409; P:response to cold; IEA:Ensembl.
DR   GO; GO:0043627; P:response to estrogen; IEA:Ensembl.
DR   GO; GO:0035902; P:response to immobilization stress; IEA:Ensembl.
DR   GO; GO:0033993; P:response to lipid; ISS:BHF-UCL.
DR   GO; GO:0009612; P:response to mechanical stimulus; IEA:Ensembl.
DR   GO; GO:1901558; P:response to metformin; IEA:Ensembl.
DR   GO; GO:0007584; P:response to nutrient; TAS:ProtInc.
DR   GO; GO:0031667; P:response to nutrient levels; IBA:GO_Central.
DR   GO; GO:0032526; P:response to retinoic acid; IDA:UniProtKB.
DR   GO; GO:0042594; P:response to starvation; IEA:Ensembl.
DR   GO; GO:0033189; P:response to vitamin A; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; IDA:BHF-UCL.
DR   GO; GO:0006367; P:transcription initiation from RNA polymerase II promoter; TAS:Reactome.
DR   GO; GO:0050872; P:white fat cell differentiation; ISS:HGNC-UCL.
DR   DisProt; DP00718; -.
DR   Gene3D; 1.10.565.10; -; 1.
DR   Gene3D; 3.30.50.10; -; 1.
DR   InterPro; IPR003074; 1Cnucl_rcpt.
DR   InterPro; IPR035500; NHR-like_dom_sf.
DR   InterPro; IPR000536; Nucl_hrmn_rcpt_lig-bd.
DR   InterPro; IPR001723; Nuclear_hrmn_rcpt.
DR   InterPro; IPR003077; PPAR-gamma.
DR   InterPro; IPR022590; PPARgamma_N.
DR   InterPro; IPR001628; Znf_hrmn_rcpt.
DR   InterPro; IPR013088; Znf_NHR/GATA.
DR   Pfam; PF00104; Hormone_recep; 1.
DR   Pfam; PF12577; PPARgamma_N; 1.
DR   Pfam; PF00105; zf-C4; 1.
DR   PRINTS; PR01288; PROXISOMEPAR.
DR   PRINTS; PR01291; PROXISOMPAGR.
DR   PRINTS; PR00398; STRDHORMONER.
DR   PRINTS; PR00047; STROIDFINGER.
DR   SMART; SM00430; HOLI; 1.
DR   SMART; SM00399; ZnF_C4; 1.
DR   SUPFAM; SSF48508; SSF48508; 1.
DR   PROSITE; PS51843; NR_LBD; 1.
DR   PROSITE; PS00031; NUCLEAR_REC_DBD_1; 1.
DR   PROSITE; PS51030; NUCLEAR_REC_DBD_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Activator; Alternative splicing; Biological rhythms;
KW   Cytoplasm; Diabetes mellitus; Disease mutation; DNA-binding; Glycoprotein;
KW   Metal-binding; Nucleus; Obesity; Phosphoprotein; Polymorphism; Receptor;
KW   Reference proteome; Transcription; Transcription regulation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..505
FT                   /note="Peroxisome proliferator-activated receptor gamma"
FT                   /id="PRO_0000053492"
FT   DOMAIN          238..503
FT                   /note="NR LBD"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU01189"
FT   DNA_BIND        136..210
FT                   /note="Nuclear receptor"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         139..159
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   ZN_FING         176..198
FT                   /note="NR C4-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00407"
FT   REGION          205..280
FT                   /note="Interaction with FAM120B"
FT                   /evidence="ECO:0000250"
FT   MOTIF           495..503
FT                   /note="9aaTAD"
FT                   /evidence="ECO:0000269|PubMed:30468856"
FT   BINDING         317
FT                   /note="Synthetic agonist"
FT                   /evidence="ECO:0000269|PubMed:11587644,
FT                   ECO:0000269|PubMed:12672231, ECO:0000269|PubMed:15056000,
FT                   ECO:0000269|PubMed:15258145, ECO:0000269|PubMed:15974597,
FT                   ECO:0000269|PubMed:15976031, ECO:0000269|PubMed:16451087,
FT                   ECO:0000269|PubMed:16640330, ECO:0000269|PubMed:16919947"
FT   BINDING         351
FT                   /note="Synthetic agonist"
FT                   /evidence="ECO:0000269|PubMed:11587644,
FT                   ECO:0000269|PubMed:12672231, ECO:0000269|PubMed:15056000,
FT                   ECO:0000269|PubMed:15258145, ECO:0000269|PubMed:15974597,
FT                   ECO:0000269|PubMed:15976031, ECO:0000269|PubMed:16451087,
FT                   ECO:0000269|PubMed:16640330, ECO:0000269|PubMed:16919947"
FT   BINDING         477
FT                   /note="Synthetic agonist"
FT                   /evidence="ECO:0000269|PubMed:11587644,
FT                   ECO:0000269|PubMed:12672231, ECO:0000269|PubMed:15056000,
FT                   ECO:0000269|PubMed:15258145, ECO:0000269|PubMed:15974597,
FT                   ECO:0000269|PubMed:15976031, ECO:0000269|PubMed:16451087,
FT                   ECO:0000269|PubMed:16640330, ECO:0000269|PubMed:16919947"
FT   BINDING         501
FT                   /note="Synthetic agonist"
FT                   /evidence="ECO:0000269|PubMed:11587644,
FT                   ECO:0000269|PubMed:12672231, ECO:0000269|PubMed:15056000,
FT                   ECO:0000269|PubMed:15258145, ECO:0000269|PubMed:15974597,
FT                   ECO:0000269|PubMed:15976031, ECO:0000269|PubMed:16451087,
FT                   ECO:0000269|PubMed:16640330, ECO:0000269|PubMed:16919947"
FT   MOD_RES         112
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CARBOHYD        84
FT                   /note="O-linked (GlcNAc) threonine"
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         1..28
FT                   /note="Missing (in isoform 1 and isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:15489334, ECO:0000303|PubMed:16842753,
FT                   ECO:0000303|PubMed:7787419, ECO:0000303|PubMed:8702406,
FT                   ECO:0000303|PubMed:8706692, ECO:0000303|PubMed:9065481"
FT                   /id="VSP_003645"
FT   VAR_SEQ         207..213
FT                   /note="AIRFGRM -> EELQKDS (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16842753"
FT                   /id="VSP_043906"
FT   VAR_SEQ         214..504
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:16842753"
FT                   /id="VSP_043907"
FT   VARIANT         12
FT                   /note="P -> A (polymorphism; significant independent
FT                   determinant of CIMT; may protect from early atherosclerosis
FT                   in subject at risk for diabetes; associated with BMI;
FT                   dbSNP:rs1801282)"
FT                   /evidence="ECO:0000269|PubMed:10394368,
FT                   ECO:0000269|PubMed:10407229, ECO:0000269|PubMed:15562396,
FT                   ECO:0000269|PubMed:9425261, ECO:0000269|Ref.12"
FT                   /id="VAR_010723"
FT   VARIANT         40
FT                   /note="P -> A (in dbSNP:rs1805192)"
FT                   /id="VAR_016116"
FT   VARIANT         113
FT                   /note="P -> Q (in obesity; dbSNP:rs1800571)"
FT                   /evidence="ECO:0000269|PubMed:9753710"
FT                   /id="VAR_010724"
FT   VARIANT         314
FT                   /note="Q -> P (in colon cancer; sporadic; somatic mutation;
FT                   loss of ligand-binding; dbSNP:rs121909242)"
FT                   /evidence="ECO:0000269|PubMed:10394368"
FT                   /id="VAR_010725"
FT   VARIANT         316
FT                   /note="R -> H (in colon cancer; sporadic; somatic mutation;
FT                   partial loss of ligand-binding; dbSNP:rs28936407)"
FT                   /evidence="ECO:0000269|PubMed:10394368"
FT                   /id="VAR_010726"
FT   VARIANT         318
FT                   /note="V -> M (in diabetes; dbSNP:rs72551362)"
FT                   /evidence="ECO:0000269|PubMed:10622252"
FT                   /id="VAR_010727"
FT   VARIANT         388
FT                   /note="F -> L (in FPLD3; dbSNP:rs72551363)"
FT                   /evidence="ECO:0000269|PubMed:12453919"
FT                   /id="VAR_022700"
FT   VARIANT         425
FT                   /note="R -> C (in FPLD3; dbSNP:rs72551364)"
FT                   /evidence="ECO:0000269|PubMed:11788685"
FT                   /id="VAR_022701"
FT   VARIANT         495
FT                   /note="P -> L (in diabetes; dbSNP:rs121909244)"
FT                   /evidence="ECO:0000269|PubMed:10622252"
FT                   /id="VAR_010728"
FT   CONFLICT        36..37
FT                   /note="MP -> IA (in Ref. 3; BAA18949)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        213..214
FT                   /note="MP -> IA (in Ref. 3; BAA18949)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        240
FT                   /note="R -> RQ (in Ref. 3; BAA18949)"
FT                   /evidence="ECO:0000305"
FT   STRAND          140..142
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   STRAND          148..150
FT                   /evidence="ECO:0000244|PDB:3DZU"
FT   STRAND          151..154
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   HELIX           157..167
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   TURN            168..170
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   HELIX           186..188
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   HELIX           191..200
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   HELIX           205..207
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   TURN            214..217
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   HELIX           218..220
FT                   /evidence="ECO:0000244|PDB:3DZY"
FT   TURN            226..229
FT                   /evidence="ECO:0000244|PDB:6IJR"
FT   HELIX           234..253
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           258..265
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          266..268
FT                   /evidence="ECO:0000244|PDB:5F9B"
FT   STRAND          269..271
FT                   /evidence="ECO:0000244|PDB:3U9Q"
FT   STRAND          275..277
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           280..290
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          291..293
FT                   /evidence="ECO:0000244|PDB:3NOA"
FT   STRAND          294..296
FT                   /evidence="ECO:0000244|PDB:1ZGY"
FT   HELIX           298..300
FT                   /evidence="ECO:0000244|PDB:6D94"
FT   STRAND          301..303
FT                   /evidence="ECO:0000244|PDB:1FM6"
FT   HELIX           305..329
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           334..336
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           339..360
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          361..363
FT                   /evidence="ECO:0000244|PDB:3DZU"
FT   STRAND          366..369
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   TURN            370..373
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          374..377
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           378..383
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   TURN            385..387
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           388..390
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           393..403
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   HELIX           409..420
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          423..425
FT                   /evidence="ECO:0000244|PDB:3ADT"
FT   HELIX           431..452
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          454..456
FT                   /evidence="ECO:0000244|PDB:3SZ1"
FT   HELIX           459..487
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   STRAND          488..490
FT                   /evidence="ECO:0000244|PDB:6D94"
FT   HELIX           491..493
FT                   /evidence="ECO:0000244|PDB:4L98"
FT   HELIX           495..501
FT                   /evidence="ECO:0000244|PDB:6MS7"
FT   TURN            502..504
FT                   /evidence="ECO:0000244|PDB:6IJS"
SQ   SEQUENCE   505 AA;  57620 MW;  3933EFF36A0E4CAF CRC64;
     MGETLGDSPI DPESDSFTDT LSANISQEMT MVDTEMPFWP TNFGISSVDL SVMEDHSHSF
     DIKPFTTVDF SSISTPHYED IPFTRTDPVV ADYKYDLKLQ EYQSAIKVEP ASPPYYSEKT
     QLYNKPHEEP SNSLMAIECR VCGDKASGFH YGVHACEGCK GFFRRTIRLK LIYDRCDLNC
     RIHKKSRNKC QYCRFQKCLA VGMSHNAIRF GRMPQAEKEK LLAEISSDID QLNPESADLR
     ALAKHLYDSY IKSFPLTKAK ARAILTGKTT DKSPFVIYDM NSLMMGEDKI KFKHITPLQE
     QSKEVAIRIF QGCQFRSVEA VQEITEYAKS IPGFVNLDLN DQVTLLKYGV HEIIYTMLAS
     LMNKDGVLIS EGQGFMTREF LKSLRKPFGD FMEPKFEFAV KFNALELDDS DLAIFIAVII
     LSGDRPGLLN VKPIEDIQDN LLQALELQLK LNHPESSQLF AKLLQKMTDL RQIVTEHVQL
     LQVIKKTETD MSLHPLLQEI YKDLY
//
ID   B4DHC3_HUMAN            Unreviewed;       876 AA.
AC   B4DHC3;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 70.
DE   SubName: Full=cDNA FLJ61254, highly similar to Receptor-type tyrosine-protein phosphatase kappa {ECO:0000313|EMBL:BAG58084.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG58084.1};
RN   [1] {ECO:0000313|EMBL:BAG58084.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAG58084.1};
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK295028; BAG58084.1; -; mRNA.
DR   RefSeq; NP_001278911.1; NM_001291982.1.
DR   RefSeq; NP_001278912.1; NM_001291983.1.
DR   RefSeq; NP_002835.2; NM_002844.3.
DR   PeptideAtlas; B4DHC3; -.
DR   PRIDE; B4DHC3; -.
DR   DNASU; 5796; -.
DR   GeneID; 5796; -.
DR   CTD; 5796; -.
DR   PharmGKB; PA34019; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GenomeRNAi; 5796; -.
DR   Genevisible; B4DHC3; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:BAG58084.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           28..876
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5002803003"
FT   TRANSMEM        754..775
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          34..194
FT                   /note="MAM"
FT                   /evidence="ECO:0000259|PROSITE:PS50060"
FT   DOMAIN          196..281
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          294..389
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          392..488
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          491..595
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
SQ   SEQUENCE   876 AA;  97451 MW;  526727F962ECBF1E CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPGNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAAATEEPEV IPDPAKQTDR VVKIAGISAG ILVFILLLLV VILIVKKRRS
     YYSYSYYLKL AKKRKDAMGN TRQEMTHMVN AMDRSYADQS TLHAEDPLSI TFMDQHNFSP
     RLPNDPLVPT AVLVPITGRK NVYHGDNNSF FAISYL
//
ID   PTPRK_HUMAN             Reviewed;        1439 AA.
AC   Q15262; B2RTQ8; B7ZMG0; Q14763; Q5TG10; Q5TG11;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-MAY-2007, sequence version 2.
DT   22-APR-2020, entry version 198.
DE   RecName: Full=Receptor-type tyrosine-protein phosphatase kappa;
DE            Short=Protein-tyrosine phosphatase kappa;
DE            Short=R-PTP-kappa;
DE            EC=3.1.3.48;
DE   Flags: Precursor;
GN   Name=PTPRK; Synonyms=PTPK;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8663237;
RA   Fuchs M., Mueller T., Lerch M., Ullrich A.;
RT   "Association of human protein-tyrosine phosphatase kappa with members of
RT   the armadillo family.";
RL   J. Biol. Chem. 271:16712-16719(1996).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Foreskin;
RX   PubMed=9047348; DOI=10.1016/s0378-1119(96)00684-1;
RA   Yang Y., Gil M.C., Choi E.Y., Park S.H., Pyun K.H., Ha H.;
RT   "Molecular cloning and chromosomal localization of a human gene homologous
RT   to the murine R-PTP-kappa, a receptor-type protein tyrosine phosphatase.";
RL   Gene 186:77-82(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 3 AND 4).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION IN EGFR REGULATION.
RX   PubMed=19836242; DOI=10.1016/j.cub.2009.09.048;
RA   Tarcic G., Boguslavsky S.K., Wakim J., Kiuchi T., Liu A., Reinitz F.,
RA   Nathanson D., Takahashi T., Mischel P.S., Ng T., Yarden Y.;
RT   "An unbiased screen identifies DEP-1 tumor suppressor as a phosphatase
RT   controlling EGFR endocytosis.";
RL   Curr. Biol. 19:1788-1798(2009).
RN   [7]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [8]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-416.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.95 ANGSTROMS) OF 865-1154.
RX   PubMed=19167335; DOI=10.1016/j.cell.2008.11.038;
RA   Barr A.J., Ugochukwu E., Lee W.H., King O.N.F., Filippakopoulos P.,
RA   Alfano I., Savitsky P., Burgess-Brown N.A., Mueller S., Knapp S.;
RT   "Large-scale structural analysis of the classical human protein tyrosine
RT   phosphatome.";
RL   Cell 136:352-363(2009).
CC   -!- FUNCTION: Regulation of processes involving cell contact and adhesion
CC       such as growth control, tumor invasion, and metastasis. Negative
CC       regulator of EGFR signaling pathway. Forms complexes with beta-catenin
CC       and gamma-catenin/plakoglobin. Beta-catenin may be a substrate for the
CC       catalytic activity of PTPRK/PTP-kappa. {ECO:0000269|PubMed:19836242}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48; Evidence={ECO:0000255|PROSITE-
CC         ProRule:PRU10044};
CC   -!- INTERACTION:
CC       Q15262; P04626: ERBB2; NbExp=2; IntAct=EBI-474052, EBI-641062;
CC       Q15262; P28300: LOX; NbExp=4; IntAct=EBI-474052, EBI-3893481;
CC       Q15262; Q02763: TEK; NbExp=2; IntAct=EBI-474052, EBI-2257090;
CC   -!- SUBCELLULAR LOCATION: Cell junction, adherens junction. Cell membrane;
CC       Single-pass type I membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q15262-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q15262-2; Sequence=VSP_024819;
CC       Name=3;
CC         IsoId=Q15262-3; Sequence=VSP_024819, VSP_042049;
CC       Name=4;
CC         IsoId=Q15262-4; Sequence=VSP_024819, VSP_054480, VSP_042049;
CC   -!- TISSUE SPECIFICITY: High levels in lung, brain and colon; less in
CC       liver, pancreas, stomach, kidney, placenta and mammary carcinoma.
CC   -!- PTM: This protein undergoes proteolytic processing.
CC   -!- SIMILARITY: Belongs to the protein-tyrosine phosphatase family.
CC       Receptor class 2B subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z70660; CAA94519.1; -; mRNA.
DR   EMBL; L77886; AAC37599.1; -; mRNA.
DR   EMBL; AL035470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL034349; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471051; EAW48086.1; -; Genomic_DNA.
DR   EMBL; BC140775; AAI40776.1; -; mRNA.
DR   EMBL; BC144512; AAI44513.1; -; mRNA.
DR   EMBL; BC144513; AAI44514.1; -; mRNA.
DR   CCDS; CCDS47473.1; -. [Q15262-3]
DR   CCDS; CCDS5137.1; -. [Q15262-2]
DR   CCDS; CCDS75517.1; -. [Q15262-1]
DR   CCDS; CCDS78179.1; -. [Q15262-4]
DR   PIR; JC6312; JC6312.
DR   RefSeq; NP_001129120.1; NM_001135648.2. [Q15262-3]
DR   RefSeq; NP_001278910.1; NM_001291981.1. [Q15262-4]
DR   RefSeq; NP_001278913.1; NM_001291984.1. [Q15262-1]
DR   RefSeq; NP_002835.2; NM_002844.3. [Q15262-2]
DR   PDB; 2C7S; X-ray; 1.95 A; A=865-1154.
DR   PDBsum; 2C7S; -.
DR   SMR; Q15262; -.
DR   BioGrid; 111760; 124.
DR   IntAct; Q15262; 96.
DR   MINT; Q15262; -.
DR   STRING; 9606.ENSP00000357196; -.
DR   DEPOD; Q15262; -.
DR   GlyConnect; 1709; -.
DR   iPTMnet; Q15262; -.
DR   PhosphoSitePlus; Q15262; -.
DR   BioMuta; PTPRK; -.
DR   DMDM; 146345496; -.
DR   EPD; Q15262; -.
DR   jPOST; Q15262; -.
DR   MassIVE; Q15262; -.
DR   MaxQB; Q15262; -.
DR   PaxDb; Q15262; -.
DR   PeptideAtlas; Q15262; -.
DR   PRIDE; Q15262; -.
DR   ProteomicsDB; 60503; -. [Q15262-1]
DR   ProteomicsDB; 60504; -. [Q15262-2]
DR   ProteomicsDB; 60505; -. [Q15262-3]
DR   ProteomicsDB; 7258; -.
DR   Antibodypedia; 32782; 48 antibodies.
DR   DNASU; 5796; -.
DR   Ensembl; ENST00000368213; ENSP00000357196; ENSG00000152894. [Q15262-3]
DR   Ensembl; ENST00000368215; ENSP00000357198; ENSG00000152894. [Q15262-1]
DR   Ensembl; ENST00000368226; ENSP00000357209; ENSG00000152894. [Q15262-2]
DR   Ensembl; ENST00000532331; ENSP00000432973; ENSG00000152894. [Q15262-4]
DR   Ensembl; ENST00000618215; ENSP00000484742; ENSG00000273993. [Q15262-3]
DR   Ensembl; ENST00000618924; ENSP00000483766; ENSG00000273993. [Q15262-2]
DR   Ensembl; ENST00000619256; ENSP00000477791; ENSG00000273993. [Q15262-4]
DR   Ensembl; ENST00000628183; ENSP00000486442; ENSG00000273993. [Q15262-1]
DR   GeneID; 5796; -.
DR   KEGG; hsa:5796; -.
DR   UCSC; uc003qbj.4; human. [Q15262-1]
DR   CTD; 5796; -.
DR   DisGeNET; 5796; -.
DR   GeneCards; PTPRK; -.
DR   HGNC; HGNC:9674; PTPRK.
DR   HPA; ENSG00000152894; Low tissue specificity.
DR   MIM; 602545; gene.
DR   neXtProt; NX_Q15262; -.
DR   OpenTargets; ENSG00000152894; -.
DR   PharmGKB; PA34019; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000156249; -.
DR   InParanoid; Q15262; -.
DR   KO; K06776; -.
DR   OrthoDB; 411281at2759; -.
DR   PhylomeDB; Q15262; -.
DR   TreeFam; TF312900; -.
DR   BRENDA; 3.1.3.48; 2681.
DR   Reactome; R-HSA-182971; EGFR downregulation.
DR   SignaLink; Q15262; -.
DR   SIGNOR; Q15262; -.
DR   ChiTaRS; PTPRK; human.
DR   EvolutionaryTrace; Q15262; -.
DR   GeneWiki; PTPRK; -.
DR   GenomeRNAi; 5796; -.
DR   Pharos; Q15262; Tbio.
DR   PRO; PR:Q15262; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   RNAct; Q15262; protein.
DR   Bgee; ENSG00000152894; Expressed in corpus callosum and 231 other tissues.
DR   ExpressionAtlas; Q15262; baseline and differential.
DR   Genevisible; Q15262; HS.
DR   GO; GO:0005912; C:adherens junction; IEA:UniProtKB-SubCell.
DR   GO; GO:0030424; C:axon; IEA:Ensembl.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0009986; C:cell surface; IDA:UniProtKB.
DR   GO; GO:0005911; C:cell-cell junction; IDA:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:Ensembl.
DR   GO; GO:0016021; C:integral component of membrane; NAS:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0031256; C:leading edge membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0001750; C:photoreceptor outer segment; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0008013; F:beta-catenin binding; IPI:UniProtKB.
DR   GO; GO:0045295; F:gamma-catenin binding; IPI:UniProtKB.
DR   GO; GO:0019901; F:protein kinase binding; IPI:UniProtKB.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IDA:UniProtKB.
DR   GO; GO:0005001; F:transmembrane receptor protein tyrosine phosphatase activity; NAS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; IMP:UniProtKB.
DR   GO; GO:0016477; P:cell migration; IMP:UniProtKB.
DR   GO; GO:0034614; P:cellular response to reactive oxygen species; IDA:UniProtKB.
DR   GO; GO:0034644; P:cellular response to UV; IDA:UniProtKB.
DR   GO; GO:0048041; P:focal adhesion assembly; IMP:UniProtKB.
DR   GO; GO:0045786; P:negative regulation of cell cycle; IDA:UniProtKB.
DR   GO; GO:0030336; P:negative regulation of cell migration; IDA:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IDA:UniProtKB.
DR   GO; GO:0010839; P:negative regulation of keratinocyte proliferation; IDA:UniProtKB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0031175; P:neuron projection development; IEA:Ensembl.
DR   GO; GO:0006470; P:protein dephosphorylation; IDA:UniProtKB.
DR   GO; GO:0034394; P:protein localization to cell surface; IDA:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; IDA:UniProtKB.
DR   GO; GO:0007179; P:transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell junction; Cell membrane;
KW   Disulfide bond; Glycoprotein; Hydrolase; Immunoglobulin domain; Membrane;
KW   Phosphoprotein; Protein phosphatase; Receptor; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL          1..26
FT                   /evidence="ECO:0000255"
FT   CHAIN           27..1439
FT                   /note="Receptor-type tyrosine-protein phosphatase kappa"
FT                   /id="PRO_0000025446"
FT   TOPO_DOM        27..752
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        753..774
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        775..1439
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          31..194
FT                   /note="MAM"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00128"
FT   DOMAIN          196..281
FT                   /note="Ig-like C2-type"
FT   DOMAIN          294..389
FT                   /note="Fibronectin type-III 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          392..488
FT                   /note="Fibronectin type-III 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          491..595
FT                   /note="Fibronectin type-III 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          597..680
FT                   /note="Fibronectin type-III 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00316"
FT   DOMAIN          887..1141
FT                   /note="Tyrosine-protein phosphatase 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   DOMAIN          1173..1435
FT                   /note="Tyrosine-protein phosphatase 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00160"
FT   REGION          1082..1088
FT                   /note="Substrate binding"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1082
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   ACT_SITE        1376
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1050
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   BINDING         1126
FT                   /note="Substrate"
FT                   /evidence="ECO:0000250"
FT   SITE            643..644
FT                   /note="Cleavage"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         856
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P35822"
FT   CARBOHYD        101
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        140
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        211
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        416
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        424
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        436
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        462
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        552
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        586
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        590
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        607
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        690
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        216..270
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         732
FT                   /note="A -> AA (in isoform 2, isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:9047348"
FT                   /id="VSP_024819"
FT   VAR_SEQ         831
FT                   /note="Y -> LPNDPLVPTAVLVPITD (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_054480"
FT   VAR_SEQ         946
FT                   /note="I -> IDIWLYR (in isoform 3 and isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_042049"
FT   CONFLICT        9
FT                   /note="L -> V (in Ref. 2; AAC37599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        158
FT                   /note="T -> S (in Ref. 1; CAA94519)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        284
FT                   /note="A -> P (in Ref. 2; AAC37599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        422
FT                   /note="T -> S (in Ref. 2; AAC37599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        672..674
FT                   /note="AEL -> CRT (in Ref. 2; AAC37599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        715
FT                   /note="S -> T (in Ref. 2; AAC37599)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1366
FT                   /note="E -> K (in Ref. 2; AAC37599)"
FT                   /evidence="ECO:0000305"
FT   HELIX           869..871
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           872..879
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          883..885
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           887..892
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           903..906
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           908..913
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           923..925
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           936..939
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          942..948
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          951..958
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           963..965
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           966..976
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          980..983
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          987..989
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1001..1006
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1009..1018
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1020..1031
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1038..1045
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1050..1053
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           1058..1070
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1078..1081
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1083..1086
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           1087..1105
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   STRAND          1106..1108
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           1110..1120
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   HELIX           1128..1144
FT                   /evidence="ECO:0000244|PDB:2C7S"
FT   TURN            1150..1153
FT                   /evidence="ECO:0000244|PDB:2C7S"
SQ   SEQUENCE   1439 AA;  162102 MW;  EE1EA6EA3CCA31ED CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPGNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAATEEPEVI PDPAKQTDRV VKIAGISAGI LVFILLLLVV ILIVKKSKLA
     KKRKDAMGNT RQEMTHMVNA MDRSYADQST LHAEDPLSIT FMDQHNFSPR YENHSATAES
     SRLLDVPRYL CEGTESPYQT GQLHPAIRVA DLLQHINLMK TSDSYGFKEE YESFFEGQSA
     SWDVAKKDQN RAKNRYGNII AYDHSRVILQ PVEDDPSSDY INANYIDGYQ RPSHYIATQG
     PVHETVYDFW RMIWQEQSAC IVMVTNLVEV GRVKCYKYWP DDTEVYGDFK VTCVEMEPLA
     EYVVRTFTLE RRGYNEIREV KQFHFTGWPD HGVPYHATGL LSFIRRVKLS NPPSAGPIVV
     HCSAGAGRTG CYIVIDIMLD MAEREGVVDI YNCVKALRSR RINMVQTEEQ YIFIHDAILE
     ACLCGETAIP VCEFKAAYFD MIRIDSQTNS SHLKDEFQTL NSVTPRLQAE DCSIACLPRN
     HDKNRFMDML PPDRCLPFLI TIDGESSNYI NAALMDSYRQ PAAFIVTQYP LPNTVKDFWR
     LVYDYGCTSI VMLNEVDLSQ GCPQYWPEEG MLRYGPIQVE CMSCSMDCDV INRIFRICNL
     TRPQEGYLMV QQFQYLGWAS HREVPGSKRS FLKLILQVEK WQEECEEGEG RTIIHCLNGG
     GRSGMFCAIG IVVEMVKRQN VVDVFHAVKT LRNSKPNMVE APEQYRFCYD VALEYLESS
//
ID   Q59EZ1_HUMAN            Unreviewed;       742 AA.
AC   Q59EZ1;
DT   26-APR-2005, integrated into UniProtKB/TrEMBL.
DT   26-APR-2005, sequence version 1.
DT   22-APR-2020, entry version 87.
DE   SubName: Full=Protein tyrosine phosphatase, receptor type, K variant {ECO:0000313|EMBL:BAD92907.1};
DE   Flags: Fragment;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAD92907.1};
RN   [1] {ECO:0000313|EMBL:BAD92907.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Brain {ECO:0000313|EMBL:BAD92907.1};
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RT   "Homo sapiens protein coding cDNA.";
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB209670; BAD92907.1; -; mRNA.
DR   RefSeq; NP_001278912.1; NM_001291983.1.
DR   PeptideAtlas; Q59EZ1; -.
DR   PRIDE; Q59EZ1; -.
DR   DNASU; 5796; -.
DR   GeneID; 5796; -.
DR   CTD; 5796; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GenomeRNAi; 5796; -.
DR   Genevisible; Q59EZ1; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   CDD; cd00063; FN3; 2.
DR   Gene3D; 2.60.40.10; -; 4.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS50060; MAM_2; 1.
PE   2: Evidence at transcript level;
KW   Membrane {ECO:0000256|SAM:Phobius}; Receptor {ECO:0000313|EMBL:BAD92907.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712};
KW   Transmembrane {ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAM:Phobius}.
FT   TRANSMEM        606..627
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          17..46
FT                   /note="MAM"
FT                   /evidence="ECO:0000259|PROSITE:PS50060"
FT   DOMAIN          48..133
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          146..241
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          244..340
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          343..447
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   NON_TER         1
FT                   /evidence="ECO:0000313|EMBL:BAD92907.1"
SQ   SEQUENCE   742 AA;  83074 MW;  3D283692BC19A3A7 CRC64;
     CMLVLKSLII YHPRCPKVIF EAEVSGGRSG YIAIDDIQVL SYPCDKSPHF LRLGDVEVNA
     GQNATFQCIA TGRDAVHNKL WLQRRNGEDI PVAQTKNINH RRFAASFRLQ EVTKTDQDLY
     RCVTQSERGS GVSNFAQLIV REPPRPIAPP QLLGVGPTYL LIQLNANSII GDGPIILKEV
     EYRMTSGSWT ETHAVNAPTY KLWHLDPDTE YEIRVLLTRP GEGGTGLPGP PLITRTKCAE
     PMRTPKTLKI AEIQARRIAV DWESLGYNIT RCHTFNVTIC YHYFRGHNES KADCLDMDPK
     APQHVVNHLP PYTNVSLKMI LTNPEGRKES EETIIQTDED VPGPVPVKSL QGTSFENKIF
     LNWKEPLDPN GIITQYEISY SSIRSFDPAV PVAGPPQTVS NLWNSTHHVF MHLHPGTTYQ
     FFIRASTVKG FGPATAINVT TNISAPTLPD YEGVDASLNE TATTITVLLR PAQAKGAPIS
     AYQIVVEELH PHRTKREAGA MECYQVPVTY QNAMSGGAPY YFAAELPPGN LPEPAPFTVG
     DNRTYQGFWN PPLAPRKGYN IYFQAMSSVE KETKTQCVRI ATKAAATEEP EVIPDPAKQT
     DRVVKIAGIS AGILVFILLL LVVILIVKKR YICWRRHICI RNIRRSYYSY SYYLKLAKKR
     KDAMGNTRQE MTHMVNAMDR SYADQSTLHA EDPLSITFMD QHNFSPRLPN DPLVPTAVLV
     PITGRKNVYH GDNNSFFAIS YL
//
ID   Q5TG12_HUMAN            Unreviewed;      1458 AA.
AC   Q5TG12;
DT   21-DEC-2004, integrated into UniProtKB/TrEMBL.
DT   21-DEC-2004, sequence version 1.
DT   22-APR-2020, entry version 149.
DE   SubName: Full=Receptor-type tyrosine-protein phosphatase kappa {ECO:0000313|Ensembl:ENSP00000357193};
GN   Name=PTPRK {ECO:0000313|Ensembl:ENSP00000357193};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000357193, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000357193, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R.,
RA   Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D.,
RA   Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H.,
RA   Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J.,
RA   Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E.,
RA   Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J.,
RA   French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J.,
RA   Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C.,
RA   Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A.,
RA   Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R.,
RA   Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M.,
RA   Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K.,
RA   Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R.,
RA   Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A.,
RA   Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L.,
RA   Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I.,
RA   Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y.,
RA   Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E.,
RA   Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A.,
RA   Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W.,
RA   Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M.,
RA   West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J.,
RA   Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M.,
RA   Bentley D.R., Coulson A., Durbin R., Hubbard T., Sulston J.E., Dunham I.,
RA   Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000357193}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (FEB-2012) to UniProtKB.
RN   [3] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [4] {ECO:0000313|Ensembl:ENSP00000487066}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUN-2015) to UniProtKB.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|SAAS:SAAS01128831};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC212491; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035465; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035470; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL035594; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL357621; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL451073; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL590006; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458278; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF458282; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; XP_011534317.1; XM_011536015.2.
DR   ProteomicsDB; 65091; -.
DR   Antibodypedia; 32782; 48 antibodies.
DR   Ensembl; ENST00000368210; ENSP00000357193; ENSG00000152894.
DR   Ensembl; ENST00000625760; ENSP00000487066; ENSG00000273993.
DR   GeneID; 5796; -.
DR   UCSC; uc010kfd.2; human.
DR   CTD; 5796; -.
DR   EuPathDB; HostDB:ENSG00000152894.14; -.
DR   HGNC; HGNC:9674; PTPRK.
DR   OpenTargets; ENSG00000152894; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   GeneTree; ENSGT00940000156249; -.
DR   HOGENOM; CLU_001645_0_2_1; -.
DR   ChiTaRS; PTPRK; human.
DR   GenomeRNAi; 5796; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000152894; Expressed in corpus callosum and 231 other tissues.
DR   GO; GO:0030054; C:cell junction; IDA:HPA.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0005886; C:plasma membrane; IDA:HPA.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   1: Evidence at protein level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Proteomics identification {ECO:0000213|EPD:Q5TG12,
KW   ECO:0000213|MaxQB:Q5TG12, ECO:0000213|PeptideAtlas:Q5TG12,
KW   ECO:0000213|ProteomicsDB:Q5TG12};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00747680,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           28..1458
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5014586893"
FT   TRANSMEM        754..775
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          34..194
FT                   /note="MAM"
FT                   /evidence="ECO:0000259|PROSITE:PS50060"
FT   DOMAIN          196..281
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          294..389
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          392..488
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          491..595
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          900..1160
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1080..1151
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   DOMAIN          1192..1454
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1368..1445
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   ACT_SITE        1101
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        1395
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
SQ   SEQUENCE   1458 AA;  164203 MW;  2186B2C9AC4F628E CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPGNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAAATEEPEV IPDPAKQTDR VVKIAGISAG ILVFILLLLV VILIVKKSKL
     AKKRKDAMGN TRQEMTHMVN AMDRSYADQS TLHAEDPLSI TFMDQHNFSP RLPNDPLVPT
     AVLDENHSAT AESSRLLDVP RYLCEGTESP YQTGQLHPAI RVADLLQHIN LMKTSDSYGF
     KEEYESFFEG QSASWDVAKK DQNRAKNRYG NIIAYDHSRV ILQPVEDDPS SDYINANYID
     IWLYRDGYQR PSHYIATQGP VHETVYDFWR MIWQEQSACI VMVTNLVEVG RVKCYKYWPD
     DTEVYGDFKV TCVEMEPLAE YVVRTFTLER RGYNEIREVK QFHFTGWPDH GVPYHATGLL
     SFIRRVKLSN PPSAGPIVVH CSAGAGRTGC YIVIDIMLDM AEREGVVDIY NCVKALRSRR
     INMVQTEEQY IFIHDAILEA CLCGETAIPV CEFKAAYFDM IRIDSQTNSS HLKDEFQTLN
     SVTPRLQAED CSIACLPRNH DKNRFMDMLP PDRCLPFLIT IDGESSNYIN AALMDSYRQP
     AAFIVTQYPL PNTVKDFWRL VYDYGCTSIV MLNEVDLSQG CPQYWPEEGM LRYGPIQVEC
     MSCSMDCDVI NRIFRICNLT RPQEGYLMVQ QFQYLGWASH REVPGSKRSF LKLILQVEKW
     QEECEEGEGR TIIHCLNGGG RSGMFCAIGI VVEMVKRQNV VDVFHAVKTL RNSKPNMVEA
     PEQYRFCYDV ALEYLESS
//
ID   Q86WJ2_HUMAN            Unreviewed;      1440 AA.
AC   Q86WJ2;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   22-APR-2020, entry version 123.
DE   SubName: Full=Mutant receptor type protein tyrosine phosphatase K {ECO:0000313|EMBL:AAO49502.1};
DE            EC=3.1.3.48 {ECO:0000313|EMBL:AAO49502.1};
GN   Name=PTPRK {ECO:0000313|EMBL:AAO49502.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAO49502.1};
RN   [1] {ECO:0000313|EMBL:AAO49502.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Melanoma {ECO:0000313|EMBL:AAO49502.1};
RX   PubMed=12794170;
RA   Novellino L., Renkvist N., Rini F., Mazzocchi A., Rivoltini L., Greco A.,
RA   Deho P., Squarcina P., Robbins P.F., Parmiani G., Castelli C.;
RT   "Identification of a mutated receptor-like protein tyrosine phosphatase
RT   kappa as a novel, class II HLA-restricted melanoma antigen.";
RL   J. Immunol. 170:6363-6370(2003).
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H2O + O-phospho-L-tyrosyl-[protein] = L-tyrosyl-[protein] +
CC         phosphate; Xref=Rhea:RHEA:10684, Rhea:RHEA-COMP:10136, Rhea:RHEA-
CC         COMP:10137, ChEBI:CHEBI:15377, ChEBI:CHEBI:43474, ChEBI:CHEBI:46858,
CC         ChEBI:CHEBI:82620; EC=3.1.3.48;
CC         Evidence={ECO:0000256|SAAS:SAAS01128831};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF533875; AAO49502.1; -; mRNA.
DR   RefSeq; NP_002835.2; NM_002844.3.
DR   SMR; Q86WJ2; -.
DR   PRIDE; Q86WJ2; -.
DR   DNASU; 5796; -.
DR   GeneID; 5796; -.
DR   CTD; 5796; -.
DR   PharmGKB; PA34019; -.
DR   eggNOG; KOG4228; Eukaryota.
DR   eggNOG; COG5599; LUCA.
DR   ChiTaRS; PTPRK; human.
DR   GenomeRNAi; 5796; -.
DR   Genevisible; Q86WJ2; HS.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0004725; F:protein tyrosine phosphatase activity; IEA:UniProtKB-EC.
DR   CDD; cd00063; FN3; 2.
DR   CDD; cd06263; MAM; 1.
DR   Gene3D; 2.60.40.10; -; 4.
DR   Gene3D; 3.90.190.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom_sf.
DR   InterPro; IPR003961; FN3_dom.
DR   InterPro; IPR036116; FN3_sf.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR013098; Ig_I-set.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR000998; MAM_dom.
DR   InterPro; IPR029021; Prot-tyrosine_phosphatase-like.
DR   InterPro; IPR000242; PTPase_domain.
DR   InterPro; IPR016130; Tyr_Pase_AS.
DR   InterPro; IPR003595; Tyr_Pase_cat.
DR   InterPro; IPR000387; TYR_PHOSPHATASE_dom.
DR   Pfam; PF00041; fn3; 2.
DR   Pfam; PF07679; I-set; 1.
DR   Pfam; PF00629; MAM; 1.
DR   Pfam; PF00102; Y_phosphatase; 2.
DR   PRINTS; PR00020; MAMDOMAIN.
DR   PRINTS; PR00700; PRTYPHPHTASE.
DR   SMART; SM00060; FN3; 3.
DR   SMART; SM00409; IG; 1.
DR   SMART; SM00137; MAM; 1.
DR   SMART; SM00194; PTPc; 2.
DR   SMART; SM00404; PTPc_motif; 2.
DR   SUPFAM; SSF48726; SSF48726; 1.
DR   SUPFAM; SSF49265; SSF49265; 2.
DR   SUPFAM; SSF49899; SSF49899; 1.
DR   SUPFAM; SSF52799; SSF52799; 2.
DR   PROSITE; PS50853; FN3; 3.
DR   PROSITE; PS50835; IG_LIKE; 1.
DR   PROSITE; PS00740; MAM_1; 1.
DR   PROSITE; PS50060; MAM_2; 1.
DR   PROSITE; PS00383; TYR_PHOSPHATASE_1; 2.
DR   PROSITE; PS50056; TYR_PHOSPHATASE_2; 2.
DR   PROSITE; PS50055; TYR_PHOSPHATASE_PTP; 2.
PE   2: Evidence at transcript level;
KW   Hydrolase {ECO:0000256|SAAS:SAAS01031415};
KW   Membrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Protein phosphatase {ECO:0000256|SAAS:SAAS01031415};
KW   Receptor {ECO:0000313|EMBL:AAO49502.1};
KW   Repeat {ECO:0000256|SAAS:SAAS00923712}; Signal {ECO:0000256|SAM:SignalP};
KW   Transmembrane {ECO:0000256|SAAS:SAAS00747680, ECO:0000256|SAM:Phobius};
KW   Transmembrane helix {ECO:0000256|SAAS:SAAS00747680,
KW   ECO:0000256|SAM:Phobius}.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT   CHAIN           28..1440
FT                   /evidence="ECO:0000256|SAM:SignalP"
FT                   /id="PRO_5004304137"
FT   TRANSMEM        754..775
FT                   /note="Helical"
FT                   /evidence="ECO:0000256|SAM:Phobius"
FT   DOMAIN          34..194
FT                   /note="MAM"
FT                   /evidence="ECO:0000259|PROSITE:PS50060"
FT   DOMAIN          196..281
FT                   /note="Ig-like"
FT                   /evidence="ECO:0000259|PROSITE:PS50835"
FT   DOMAIN          294..389
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          392..488
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          491..595
FT                   /note="Fibronectin type-III"
FT                   /evidence="ECO:0000259|PROSITE:PS50853"
FT   DOMAIN          888..1142
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1062..1133
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   DOMAIN          1174..1436
FT                   /note="Tyrosine-protein phosphatase"
FT                   /evidence="ECO:0000259|PROSITE:PS50055"
FT   DOMAIN          1350..1427
FT                   /note="TYR_PHOSPHATASE_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50056"
FT   ACT_SITE        1083
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
FT   ACT_SITE        1377
FT                   /note="Phosphocysteine intermediate"
FT                   /evidence="ECO:0000256|PROSITE-ProRule:PRU00160"
SQ   SEQUENCE   1440 AA;  162272 MW;  B140BC621878586A CRC64;
     MDTTAAAALP AFVALLLLSP WPLLGSAQGQ FSAGGCTFDD GPGACDYHQD LYDDFEWVHV
     SAQEPHYLPP EMPQGSYMIV DSSDHDPGEK ARLQLPTMKE NDTHCIDFSY LLYSQKGLNP
     GTLNILVRVN KGPLANPIWN VTGFTGRDWL RAELAVSTFW PNEYQVIFEA EVSGGRSGYI
     AIDDIQVLSY PCDKSPHFLR LGDVEVNAGQ NATFQCIATG RDAVHNKLWL QRRNGEDIPV
     AQTKNINHRR FAASFRLQEV TKTDQDLYRC VTQSERGSGV SNFAQLIVRE PPRPIAPPQL
     LGVGPTYLLI QLNANSIIGD GPIILKEVEY RMTSGSWTET HAVNAPTYKL WHLDPDTEYE
     IRVLLTRPGE GGTGLPGPPL ITRTKCAEPM RTPKTLKIAE IQARRIAVDW ESLGYNITRC
     HTFNVTICYH YFRGHNESKA DCLDMDPKAP QHVVNHLPPY TNVSLKMILT NPEGRKESEE
     TIIQTDEDVP GPVPVKSLQG TSFENKIFLN WKEPLDPNGI ITQYEISYSS IRSFDPAVPV
     AGPPQTVSNL WNSTHHVFMH LHPGTTYQFF IRASTVKGFG PATAINVTTN ISAPTLPDYE
     GVDASLNETA TTITVLLRPA QAKGAPISAY QIVVEELHPH RTKREAGAME CYQVPVTYQN
     AMSGGAPYYF AAELPPRNLP EPAPFTVGDN RTYQGFWNPP LAPRKGYNIY FQAMSSVEKE
     TKTQCVRIAT KAAATEEPEV IPDPAKQTDR VVKIAGISAG ILVFILLLLV VILIVKKSKL
     AKKRKDAMGN TRQEMTHMVN AMDRSYADQS TLHAEDPLSI TFMDQHNFSP RYENHSATAE
     SSRLLDVPRY LCEGTESPYQ TGQLHPAIRV ADLLQHINLM KTSDSYGFKE EYESFFEGQS
     ASWDVAKKDQ NRAKNRYGNI IAYDHSRVIL QPVEDDPSSD YINANYIDGY QRPSHYIATQ
     GPVHETVYDF WRMIWQEQSA CIVMVTNLVE VGRVKCYKYW PDDTEVYGDF KVTCVEMEPL
     AEYVVRTFTL ERRGYNEIRE VKQFHFTGWP DHGVPYHATG LLSFIRRVKL SNPPSAGPIV
     VHCSAGAGRT GCYIVIDIML DMAEREGVVD IYNCVKALRS RRINMVQTEE QYIFIHDAIL
     EACLCGETAI PVCEFKAAYF DMIRIDSQTN SSHLKDEFQT LNSVTPRLQA EDCSIACLPR
     NHDKNRFMDM LPPDRCLPFL ITIDGESSNY INAALMDSYR QPAAFIVTQY PLPNTVKDFW
     RLVYDYGCTS IVMLNEVDLS QGCPQYWPEE GMLRYGPIQV ECMSCSMDCD VINRIFRICN
     LTRPQEGYLM VQQFQYLGWA SHREVPGSKR SFLKLILQVE KWQEECEEGE GRTIIHCLNG
     GGRSGMFCAI GIVVEMVKRQ NVVDVFHAVK TLRNSKPNMV EAPEQYRFCY DVALEYLESS
//
ID   A0A024R656_HUMAN        Unreviewed;       350 AA.
AC   A0A024R656;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   11-DEC-2019, entry version 35.
DE   SubName: Full=RAD51-like 1 (S. cerevisiae), isoform CRA_a {ECO:0000313|EMBL:EAW80958.1};
GN   Name=RAD51L1 {ECO:0000313|EMBL:EAW80958.1};
GN   ORFNames=hCG_2036537 {ECO:0000313|EMBL:EAW80958.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW80958.1};
RN   [1] {ECO:0000313|EMBL:EAW80958.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW80958.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471061; EAW80958.1; -; Genomic_DNA.
DR   RefSeq; NP_002868.1; NM_002877.5.
DR   SMR; A0A024R656; -.
DR   PRIDE; A0A024R656; -.
DR   GeneID; 5890; -.
DR   CTD; 5890; -.
DR   eggNOG; KOG1433; Eukaryota.
DR   eggNOG; COG0468; LUCA.
DR   OrthoDB; 1345899at2759; -.
DR   ChiTaRS; RAD51B; human.
DR   GenomeRNAi; 5890; -.
DR   GO; GO:0033063; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro.
DR   CDD; cd01123; Rad51_DMC1_radA; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013632; DNA_recomb/repair_Rad51_C.
DR   InterPro; IPR016467; DNA_recomb/repair_RecA-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033925; Rad51_DMC1_RadA.
DR   InterPro; IPR030548; RAD51B.
DR   InterPro; IPR020588; RecA_ATP-bd.
DR   PANTHER; PTHR46456; PTHR46456; 1.
DR   Pfam; PF08423; Rad51; 1.
DR   PIRSF; PIRSF005856; Rad51; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50162; RECA_2; 1.
PE   4: Predicted;
FT   DOMAIN          79..259
FT                   /note="RECA_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50162"
SQ   SEQUENCE   350 AA;  38257 MW;  CEA992DDC394F3B0 CRC64;
     MGSKKLKRVG LSQELCDRLS RHQILTCQDF LCLSPLELMK VTGLSYRGVH ELLCMVSRAC
     APKMQTAYGI KAQRSADFSP AFLSTTLSAL DEALHGGVAC GSLTEITGPP GCGKTQFCIM
     MSILATLPTN MGGLEGAVVY IDTESAFSAE RLVEIAESRF PRYFNTEEKL LLTSSKVHLY
     RELTCDEVLQ RIESLEEEII SKGIKLVILD SVASVVRKEF DAQLQGNLKE RNKFLAREAS
     SLKYLAEEFS IPVILTNQIT THLSGALASQ ADLVSPADDL SLSEGTSGSS CVIAALGNTW
     SHSVNTRLIL QYLDSERRQI LIAKSPLAPF TSFVYTIKEE GLVLQAYGNS
//
ID   C9JYJ0_HUMAN            Unreviewed;       425 AA.
AC   C9JYJ0;
DT   03-NOV-2009, integrated into UniProtKB/TrEMBL.
DT   03-NOV-2009, sequence version 1.
DT   22-APR-2020, entry version 72.
DE   SubName: Full=DNA repair protein RAD51 homolog 2 {ECO:0000313|Ensembl:ENSP00000419881};
GN   Name=RAD51B {ECO:0000313|Ensembl:ENSP00000419881};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000419881, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000419881, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [2] {ECO:0000313|Ensembl:ENSP00000419881}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL121595; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL133370; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KC877523; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455917; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455919; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; KF455920; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001308750.1; NM_001321821.1.
DR   EPD; C9JYJ0; -.
DR   MaxQB; C9JYJ0; -.
DR   PRIDE; C9JYJ0; -.
DR   ProteomicsDB; 12256; -.
DR   Antibodypedia; 4257; 284 antibodies.
DR   Ensembl; ENST00000487861; ENSP00000419881; ENSG00000182185.
DR   GeneID; 5890; -.
DR   UCSC; uc059csa.1; human.
DR   CTD; 5890; -.
DR   EuPathDB; HostDB:ENSG00000182185.18; -.
DR   HGNC; HGNC:9822; RAD51B.
DR   OpenTargets; ENSG00000182185; -.
DR   GeneTree; ENSGT00940000160169; -.
DR   OrthoDB; 1345899at2759; -.
DR   PhylomeDB; C9JYJ0; -.
DR   ChiTaRS; RAD51B; human.
DR   GenomeRNAi; 5890; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   Bgee; ENSG00000182185; Expressed in corpus callosum and 148 other tissues.
DR   ExpressionAtlas; C9JYJ0; baseline and differential.
DR   GO; GO:0033063; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; IEA:InterPro.
DR   GO; GO:0005524; F:ATP binding; IEA:InterPro.
DR   GO; GO:0003677; F:DNA binding; IEA:InterPro.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IEA:InterPro.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IEA:InterPro.
DR   CDD; cd01123; Rad51_DMC1_radA; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013632; DNA_recomb/repair_Rad51_C.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033925; Rad51_DMC1_RadA.
DR   InterPro; IPR030548; RAD51B.
DR   InterPro; IPR020588; RecA_ATP-bd.
DR   PANTHER; PTHR46456; PTHR46456; 1.
DR   Pfam; PF08423; Rad51; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50162; RECA_2; 1.
PE   1: Evidence at protein level;
KW   Proteomics identification {ECO:0000213|EPD:C9JYJ0,
KW   ECO:0000213|MaxQB:C9JYJ0, ECO:0000213|PeptideAtlas:C9JYJ0,
KW   ECO:0000213|ProteomicsDB:C9JYJ0};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          79..259
FT                   /note="RECA_2"
FT                   /evidence="ECO:0000259|PROSITE:PS50162"
SQ   SEQUENCE   425 AA;  46546 MW;  833D0DC6C1A383C4 CRC64;
     MGSKKLKRVG LSQELCDRLS RHQILTCQDF LCLSPLELMK VTGLSYRGVH ELLCMVSRAC
     APKMQTAYGI KAQRSADFSP AFLSTTLSAL DEALHGGVAC GSLTEITGPP GCGKTQFCIM
     MSILATLPTN MGGLEGAVVY IDTESAFSAE RLVEIAESRF PRYFNTEEKL LLTSSKVHLY
     RELTCDEVLQ RIESLEEEII SKGIKLVILD SVASVVRKEF DAQLQGNLKE RNKFLAREAS
     SLKYLAEEFS IPVILTNQIT THLSGALASQ ADLVSPADDL SLSEGTSGSS CVIAALGNTW
     SHSVNTRLIL QYLDSERRQI LIAKSPLAPF TSFVYTIKEE GLVLQVVRTV ARVSPRSECW
     SAADSHPSPT FLIPDVVLRK TRNPRLLPSV SMCPPQMHST VLSSALPPTN WATGIRTETL
     DEHPV
//
ID   RA51B_HUMAN             Reviewed;         384 AA.
AC   O15315; O60914; O75210; Q3Y4F8; Q6FHX8; Q86SY3; Q86SY4; Q86TR0; Q86U92;
AC   Q86U93; Q86U94; Q8N6H4; Q9UPL5;
DT   15-DEC-1998, integrated into UniProtKB/Swiss-Prot.
DT   07-NOV-2003, sequence version 2.
DT   22-APR-2020, entry version 174.
DE   RecName: Full=DNA repair protein RAD51 homolog 2;
DE            Short=R51H2;
DE   AltName: Full=RAD51 homolog B;
DE            Short=Rad51B;
DE   AltName: Full=RAD51-like protein 1;
GN   Name=RAD51B; Synonyms=RAD51L1, REC2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9207106; DOI=10.1073/pnas.94.14.7417;
RA   Rice M.C., Smith S.T., Bullrich F., Havre P., Kmiec E.B.;
RT   "Isolation of human and mouse genes based on homology to REC2, a
RT   recombinational repair gene from the fungus Ustilago maydis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 94:7417-7422(1997).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=9441753; DOI=10.1006/geno.1997.5062;
RA   Albala J.S., Thelen M.P., Prange C.K., Fan W., Christensen M.,
RA   Thompson L.H., Lennon G.G.;
RT   "Identification of a novel human RAD51 homolog, RAD51B.";
RL   Genomics 46:476-479(1997).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3).
RX   PubMed=9512535; DOI=10.1093/nar/26.7.1653;
RA   Cartwright R., Dunn A.M., Simpson P.J., Tambini C.E., Thacker J.;
RT   "Isolation of novel human and mouse genes of the recA/RAD51 recombination-
RT   repair gene family.";
RL   Nucleic Acids Res. 26:1653-1659(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1; 4 AND 5).
RC   TISSUE=Neuroblastoma;
RA   Li W.B., Gruber C., Jessee J., Polayes D.;
RT   "Full-length cDNA libraries and normalization.";
RL   Submitted (FEB-2003) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS MET-9; CYS-82; TRP-172;
RP   CYS-180; ARG-243 AND ALA-250.
RG   NIEHS SNPs program;
RL   Submitted (AUG-2005) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=12508121; DOI=10.1038/nature01348;
RA   Heilig R., Eckenberg R., Petit J.-L., Fonknechten N., Da Silva C.,
RA   Cattolico L., Levy M., Barbe V., De Berardinis V., Ureta-Vidal A.,
RA   Pelletier E., Vico V., Anthouard V., Rowen L., Madan A., Qin S., Sun H.,
RA   Du H., Pepin K., Artiguenave F., Robert C., Cruaud C., Bruels T.,
RA   Jaillon O., Friedlander L., Samson G., Brottier P., Cure S., Segurens B.,
RA   Aniere F., Samain S., Crespeau H., Abbasi N., Aiach N., Boscus D.,
RA   Dickhoff R., Dors M., Dubois I., Friedman C., Gouyvenoux M., James R.,
RA   Madan A., Mairey-Estrada B., Mangenot S., Martins N., Menard M., Oztas S.,
RA   Ratcliffe A., Shaffer T., Trask B., Vacherie B., Bellemere C., Belser C.,
RA   Besnard-Gonnet M., Bartol-Mavel D., Boutard M., Briez-Silla S.,
RA   Combette S., Dufosse-Laurent V., Ferron C., Lechaplais C., Louesse C.,
RA   Muselet D., Magdelenat G., Pateau E., Petit E., Sirvain-Trukniewicz P.,
RA   Trybou A., Vega-Czarny N., Bataille E., Bluet E., Bordelais I., Dubois M.,
RA   Dumont C., Guerin T., Haffray S., Hammadi R., Muanga J., Pellouin V.,
RA   Robert D., Wunderle E., Gauguet G., Roy A., Sainte-Marthe L., Verdier J.,
RA   Verdier-Discala C., Hillier L.W., Fulton L., McPherson J., Matsuda F.,
RA   Wilson R., Scarpelli C., Gyapay G., Wincker P., Saurin W., Quetier F.,
RA   Waterston R., Hood L., Weissenbach J.;
RT   "The DNA sequence and analysis of human chromosome 14.";
RL   Nature 421:601-607(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 253-310, AND CHROMOSOMAL TRANSLOCATION WITH
RP   HMGA2.
RX   PubMed=12649198;
RA   Quade B.J., Weremowicz S., Neskey D.M., Vanni R., Ladd C., Dal Cin P.,
RA   Morton C.C.;
RT   "Fusion transcripts involving HMGA2 are not a common molecular mechanism in
RT   uterine leiomyomata with rearrangements in 12q15.";
RL   Cancer Res. 63:1351-1358(2003).
RN   [11]
RP   FUNCTION, AND IDENTIFICATION IN THE BCDX2 COMPLEX WITH RAD51C; RAD51D AND
RP   XRCC2.
RX   PubMed=11751635; DOI=10.1101/gad.947001;
RA   Masson J.Y., Tarsounas M.C., Stasiak A.Z., Stasiak A., Shah R.,
RA   McIlwraith M.J., Benson F.E., West S.C.;
RT   "Identification and purification of two distinct complexes containing the
RT   five RAD51 paralogs.";
RL   Genes Dev. 15:3296-3307(2001).
RN   [12]
RP   FUNCTION, AND INTERACTION WITH RAD51C.
RX   PubMed=11751636; DOI=10.1101/gad.935501;
RA   Sigurdsson S., Van Komen S., Bussen W., Schild D., Albala J.S., Sung P.;
RT   "Mediator function of the human Rad51B-Rad51C complex in Rad51/RPA-
RT   catalyzed DNA strand exchange.";
RL   Genes Dev. 15:3308-3318(2001).
RN   [13]
RP   FUNCTION, AND IDENTIFICATION IN A COMPLEX WITH RAD51C; RAD51D AND XRCC2.
RX   PubMed=11842113; DOI=10.1093/nar/30.4.1009;
RA   Liu N., Schild D., Thelen M.P., Thompson L.H.;
RT   "Involvement of Rad51C in two distinct protein complexes of Rad51 paralogs
RT   in human cells.";
RL   Nucleic Acids Res. 30:1009-1015(2002).
RN   [14]
RP   INTERACTION WITH RAD51C, AND SUBUNIT.
RX   PubMed=11744692; DOI=10.1074/jbc.m108306200;
RA   Miller K.A., Yoshikawa D.M., McConnell I.R., Clark R., Schild D.,
RA   Albala J.S.;
RT   "RAD51C interacts with RAD51B and is central to a larger protein complex in
RT   vivo exclusive of RAD51.";
RL   J. Biol. Chem. 277:8406-8411(2002).
RN   [15]
RP   IDENTIFICATION IN A COMPLEX WITH RAD51C; RAD51D AND XRCC2.
RX   PubMed=11842112; DOI=10.1093/nar/30.4.1001;
RA   Wiese C., Collins D.W., Albala J.S., Thompson L.H., Kronenberg A.,
RA   Schild D.;
RT   "Interactions involving the Rad51 paralogs Rad51C and XRCC3 in human
RT   cells.";
RL   Nucleic Acids Res. 30:1001-1008(2002).
RN   [16]
RP   INTERACTION WITH RAD51 AND RAD51C.
RX   PubMed=12427746; DOI=10.1074/jbc.m211038200;
RA   Lio Y.-C., Mazin A.V., Kowalczykowski S.C., Chen D.J.;
RT   "Complex formation by the human Rad51B and Rad51C DNA repair proteins and
RT   their activities in vitro.";
RL   J. Biol. Chem. 278:2469-2478(2003).
RN   [17]
RP   CHROMOSOMAL TRANSLOCATION WITH HMGA2.
RX   PubMed=9892177;
RA   Schoenmakers E.F.P.M., Huysmans C., Van de Ven W.J.M.;
RT   "Allelic knockout of novel splice variants of human recombination repair
RT   gene RAD51B in t(12;14) uterine leiomyomas.";
RL   Cancer Res. 59:19-23(1999).
RN   [18]
RP   CHROMOSOMAL TRANSLOCATION WITH HMGA1.
RX   PubMed=11978964; DOI=10.1159/000057011;
RA   Blank C., Schoenmakers E.F.P.M., Rogalla P., Huys E.H., van Rijk A.A.,
RA   Drieschner N., Bullerdiek J.;
RT   "Intragenic breakpoint within RAD51L1 in a t(6;14)(p21.3;q24) of a
RT   pulmonary chondroid hamartoma.";
RL   Cytogenet. Cell Genet. 95:17-19(2001).
RN   [19]
RP   FUNCTION.
RX   PubMed=12441335; DOI=10.1074/jbc.m210899200;
RA   Yokoyama H., Kurumizaka H., Ikawa S., Yokoyama S., Shibata T.;
RT   "Holliday junction binding activity of the human Rad51B protein.";
RL   J. Biol. Chem. 278:2767-2772(2003).
RN   [20]
RP   INTERACTION WITH RAD51C.
RX   PubMed=14704354; DOI=10.1093/nar/gkg925;
RA   Miller K.A., Sawicka D., Barsky D., Albala J.S.;
RT   "Domain mapping of the Rad51 paralog protein complexes.";
RL   Nucleic Acids Res. 32:169-178(2004).
RN   [21]
RP   PHOSPHORYLATION BY BCR-ABL, AND MUTAGENESIS OF PRO-326.
RX   PubMed=19657362; DOI=10.1038/leu.2009.164;
RA   Slupianek A., Jozwiakowski S.K., Gurdek E., Skorski T.;
RT   "BCR/ABL kinase interacts with and phosphorylates the RAD51 paralog,
RT   RAD51B.";
RL   Leukemia 23:2308-2310(2009).
RN   [22]
RP   INTERACTION WITH SWSAP1.
RX   PubMed=21965664; DOI=10.1074/jbc.m111.271080;
RA   Liu T., Wan L., Wu Y., Chen J., Huang J.;
RT   "hSWS1.SWSAP1 is an evolutionarily conserved complex required for efficient
RT   homologous recombination repair.";
RL   J. Biol. Chem. 286:41758-41766(2011).
RN   [23]
RP   FUNCTION IN MITOTIC CELL PROGRESSION.
RX   PubMed=23108668; DOI=10.1242/jcs.114595;
RA   Rodrigue A., Coulombe Y., Jacquet K., Gagne J.P., Roques C., Gobeil S.,
RA   Poirier G., Masson J.Y.;
RT   "The RAD51 paralogs ensure cellular protection against mitotic defects and
RT   aneuploidy.";
RL   J. Cell Sci. 126:348-359(2013).
RN   [24]
RP   FUNCTION OF THE BCDX2 COMPLEX.
RX   PubMed=23149936; DOI=10.1128/mcb.00465-12;
RA   Chun J., Buechelmaier E.S., Powell S.N.;
RT   "Rad51 paralog complexes BCDX2 and CX3 act at different stages in the
RT   BRCA1-BRCA2-dependent homologous recombination pathway.";
RL   Mol. Cell. Biol. 33:387-395(2013).
RN   [25]
RP   ELECTRON MICROSCOPY OF THE BCDX2 COMPLEX, AND DNA-BINDING OF THE BCDX2
RP   COMPLEX.
RX   PubMed=20207730; DOI=10.1074/jbc.m109.074286;
RA   Compton S.A., Ozgur S., Griffith J.D.;
RT   "Ring-shaped Rad51 paralog protein complexes bind Holliday junctions and
RT   replication forks as visualized by electron microscopy.";
RL   J. Biol. Chem. 285:13349-13356(2010).
CC   -!- FUNCTION: Involved in the homologous recombination repair (HRR) pathway
CC       of double-stranded DNA breaks arising during DNA replication or induced
CC       by DNA-damaging agents. May promote the assembly of presynaptic RAD51
CC       nucleoprotein filaments. Binds single-stranded DNA and double-stranded
CC       DNA and has DNA-dependent ATPase activity. Part of the RAD21 paralog
CC       protein complex BCDX2 which acts in the BRCA1-BRCA2-dependent HR
CC       pathway. Upon DNA damage, BCDX2 acts downstream of BRCA2 recruitment
CC       and upstream of RAD51 recruitment. BCDX2 binds predominantly to the
CC       intersection of the four duplex arms of the Holliday junction and to
CC       junction of replication forks. The BCDX2 complex was originally
CC       reported to bind single-stranded DNA, single-stranded gaps in duplex
CC       DNA and specifically to nicks in duplex DNA. The BCDX2 subcomplex
CC       RAD51B:RAD51C exhibits single-stranded DNA-dependent ATPase activity
CC       suggesting an involvement in early stages of the HR pathway.
CC       {ECO:0000269|PubMed:11751635, ECO:0000269|PubMed:11751636,
CC       ECO:0000269|PubMed:11842113, ECO:0000269|PubMed:12441335,
CC       ECO:0000269|PubMed:23108668, ECO:0000269|PubMed:23149936}.
CC   -!- SUBUNIT: Part of the BCDX2 complex consisting of RAD51B, RAD51C, RAD51D
CC       and XRCC2; the complex has a ring-like structure arranged into a flat
CC       disc around a central channel. The BCDX2 subcomplex RAD51B:RAD51C
CC       interacts with RAD51. Interacts with SWSAP1; involved in homologous
CC       recombination repair. {ECO:0000269|PubMed:11744692,
CC       ECO:0000269|PubMed:11751635, ECO:0000269|PubMed:11751636,
CC       ECO:0000269|PubMed:11842112, ECO:0000269|PubMed:11842113,
CC       ECO:0000269|PubMed:12427746, ECO:0000269|PubMed:14704354,
CC       ECO:0000269|PubMed:21965664}.
CC   -!- INTERACTION:
CC       O15315; Q8IZU0: FAM9B; NbExp=3; IntAct=EBI-2824089, EBI-10175124;
CC       O15315; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-2824089, EBI-16439278;
CC       O15315; O43502: RAD51C; NbExp=12; IntAct=EBI-2824089, EBI-2267048;
CC       O15315; O75771: RAD51D; NbExp=5; IntAct=EBI-2824089, EBI-1055693;
CC       O15315; Q86UA6: RPAIN; NbExp=3; IntAct=EBI-2824089, EBI-3907663;
CC       O15315; Q6NVH7: SWSAP1; NbExp=2; IntAct=EBI-2824089, EBI-5281637;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=5;
CC       Name=1;
CC         IsoId=O15315-3; Sequence=Displayed;
CC       Name=2; Synonyms=RAD51L1a;
CC         IsoId=O15315-1; Sequence=VSP_008819;
CC       Name=3; Synonyms=RAD51L1b;
CC         IsoId=O15315-2; Sequence=VSP_008818;
CC       Name=4;
CC         IsoId=O15315-4; Sequence=VSP_008820;
CC       Name=5;
CC         IsoId=O15315-5; Sequence=VSP_008817, VSP_008818;
CC   -!- TISSUE SPECIFICITY: Expressed in a wide range of tissues.
CC   -!- PTM: Phosphorylated on tyrosine residues by BCR-ABL.
CC       {ECO:0000269|PubMed:19657362}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RAD51B is found in
CC       pulmonary chondroid hamartoma. Translocation t(6;14)(p21;q23-24) with
CC       HMGA1. {ECO:0000269|PubMed:11978964}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RAD51B is found in
CC       uterine leiomyoma. Translocation t(12;14)(q15;q23-24) with HMGA2.
CC       {ECO:0000269|PubMed:12649198, ECO:0000269|PubMed:9892177}.
CC   -!- SIMILARITY: Belongs to the RecA family. RAD51 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=CAD62357.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC       Sequence=CAD66573.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   -!- WEB RESOURCE: Name=NIEHS-SNPs;
CC       URL="http://egp.gs.washington.edu/data/rad51l1/";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U92074; AAB63358.1; -; mRNA.
DR   EMBL; U84138; AAC39723.1; -; mRNA.
DR   EMBL; Y15571; CAA75680.1; -; mRNA.
DR   EMBL; BX161515; CAD61950.1; -; mRNA.
DR   EMBL; BX248061; CAD62357.1; ALT_INIT; mRNA.
DR   EMBL; BX248766; CAD66573.1; ALT_INIT; mRNA.
DR   EMBL; DQ160197; AAZ85144.1; -; Genomic_DNA.
DR   EMBL; AC004518; AAC32426.1; -; Genomic_DNA.
DR   EMBL; AC004518; AAC32425.1; -; Genomic_DNA.
DR   EMBL; CR536560; CAG38797.1; -; mRNA.
DR   EMBL; CH471061; EAW80957.1; -; Genomic_DNA.
DR   EMBL; BC030219; AAH30219.1; -; mRNA.
DR   EMBL; AY138857; AAN60542.1; -; mRNA.
DR   EMBL; AY138858; AAN60543.1; -; mRNA.
DR   EMBL; AY138859; AAN60544.1; -; mRNA.
DR   CCDS; CCDS9789.1; -. [O15315-3]
DR   CCDS; CCDS9790.1; -. [O15315-2]
DR   RefSeq; NP_001308746.1; NM_001321817.1. [O15315-5]
DR   RefSeq; NP_002868.1; NM_002877.5. [O15315-1]
DR   RefSeq; NP_598193.2; NM_133509.3. [O15315-3]
DR   RefSeq; NP_598194.1; NM_133510.3. [O15315-2]
DR   SMR; O15315; -.
DR   BioGrid; 111827; 16.
DR   CORUM; O15315; -.
DR   DIP; DIP-41246N; -.
DR   IntAct; O15315; 15.
DR   MINT; O15315; -.
DR   STRING; 9606.ENSP00000419471; -.
DR   iPTMnet; O15315; -.
DR   PhosphoSitePlus; O15315; -.
DR   BioMuta; RAD51B; -.
DR   jPOST; O15315; -.
DR   MassIVE; O15315; -.
DR   PaxDb; O15315; -.
DR   PeptideAtlas; O15315; -.
DR   PRIDE; O15315; -.
DR   ProteomicsDB; 48575; -. [O15315-3]
DR   ProteomicsDB; 48576; -. [O15315-1]
DR   ProteomicsDB; 48577; -. [O15315-2]
DR   ProteomicsDB; 48578; -. [O15315-4]
DR   ProteomicsDB; 48579; -. [O15315-5]
DR   TopDownProteomics; O15315-2; -. [O15315-2]
DR   Antibodypedia; 4257; 284 antibodies.
DR   DNASU; 5890; -.
DR   Ensembl; ENST00000471583; ENSP00000418859; ENSG00000182185. [O15315-2]
DR   Ensembl; ENST00000487270; ENSP00000419471; ENSG00000182185. [O15315-3]
DR   Ensembl; ENST00000488612; ENSP00000420061; ENSG00000182185. [O15315-4]
DR   GeneID; 5890; -.
DR   KEGG; hsa:5890; -.
DR   UCSC; uc001xkd.4; human. [O15315-3]
DR   CTD; 5890; -.
DR   DisGeNET; 5890; -.
DR   GeneCards; RAD51B; -.
DR   HGNC; HGNC:9822; RAD51B.
DR   HPA; ENSG00000182185; Low tissue specificity.
DR   MIM; 150699; phenotype.
DR   MIM; 602948; gene.
DR   neXtProt; NX_O15315; -.
DR   OpenTargets; ENSG00000182185; -.
DR   PharmGKB; PA34178; -.
DR   eggNOG; KOG1433; Eukaryota.
DR   eggNOG; COG0468; LUCA.
DR   GeneTree; ENSGT00940000160169; -.
DR   HOGENOM; CLU_013059_0_0_1; -.
DR   InParanoid; O15315; -.
DR   KO; K10869; -.
DR   OMA; NRHQIVT; -.
DR   OrthoDB; 1345899at2759; -.
DR   PhylomeDB; O15315; -.
DR   TreeFam; TF101219; -.
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-983231; Factors involved in megakaryocyte development and platelet production.
DR   SIGNOR; O15315; -.
DR   ChiTaRS; RAD51B; human.
DR   GeneWiki; RAD51L1; -.
DR   GenomeRNAi; 5890; -.
DR   Pharos; O15315; Tbio.
DR   PRO; PR:O15315; -.
DR   Proteomes; UP000005640; Chromosome 14.
DR   RNAct; O15315; protein.
DR   Bgee; ENSG00000182185; Expressed in corpus callosum and 148 other tissues.
DR   ExpressionAtlas; O15315; baseline and differential.
DR   Genevisible; O15315; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; TAS:ProtInc.
DR   GO; GO:0033063; C:Rad51B-Rad51C-Rad51D-XRCC2 complex; IDA:UniProtKB.
DR   GO; GO:0005657; C:replication fork; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003677; F:DNA binding; TAS:ProtInc.
DR   GO; GO:0008094; F:DNA-dependent ATPase activity; IDA:UniProtKB.
DR   GO; GO:0003690; F:double-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0003697; F:single-stranded DNA binding; IDA:UniProtKB.
DR   GO; GO:0007596; P:blood coagulation; TAS:Reactome.
DR   GO; GO:0006310; P:DNA recombination; TAS:ProtInc.
DR   GO; GO:0006281; P:DNA repair; TAS:ProtInc.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:UniProtKB.
DR   GO; GO:0010971; P:positive regulation of G2/M transition of mitotic cell cycle; IMP:UniProtKB.
DR   GO; GO:0007131; P:reciprocal meiotic recombination; TAS:ProtInc.
DR   CDD; cd01123; Rad51_DMC1_radA; 1.
DR   InterPro; IPR003593; AAA+_ATPase.
DR   InterPro; IPR013632; DNA_recomb/repair_Rad51_C.
DR   InterPro; IPR016467; DNA_recomb/repair_RecA-like.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR033925; Rad51_DMC1_RadA.
DR   InterPro; IPR030548; RAD51B.
DR   InterPro; IPR020588; RecA_ATP-bd.
DR   PANTHER; PTHR46456; PTHR46456; 1.
DR   Pfam; PF08423; Rad51; 1.
DR   PIRSF; PIRSF005856; Rad51; 1.
DR   SMART; SM00382; AAA; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   PROSITE; PS50162; RECA_2; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Chromosomal rearrangement; DNA damage;
KW   DNA recombination; DNA repair; DNA-binding; Nucleotide-binding; Nucleus;
KW   Phosphoprotein; Polymorphism; Reference proteome.
FT   CHAIN           1..384
FT                   /note="DNA repair protein RAD51 homolog 2"
FT                   /id="PRO_0000122939"
FT   NP_BIND         108..115
FT                   /note="ATP"
FT                   /evidence="ECO:0000255"
FT   REGION          1..75
FT                   /note="Interaction with RAD51C"
FT   SITE            252..253
FT                   /note="Breakpoint for translocation to form HMGA2-RAD51B"
FT   VAR_SEQ         1..119
FT                   /note="Missing (in isoform 5)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_008817"
FT   VAR_SEQ         346..384
FT                   /note="ETTFCSVTQAELNWAPEILPPQPPEQLGLQMCHHTQLIF -> AYGNS (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:9207106,
FT                   ECO:0000303|PubMed:9441753, ECO:0000303|Ref.6"
FT                   /id="VSP_008819"
FT   VAR_SEQ         346..384
FT                   /note="ETTFCSVTQAELNWAPEILPPQPPEQLGLQMCHHTQLIF -> GQEKP (in
FT                   isoform 3 and isoform 5)"
FT                   /evidence="ECO:0000303|PubMed:9512535, ECO:0000303|Ref.4"
FT                   /id="VSP_008818"
FT   VAR_SEQ         347..384
FT                   /note="TTFCSVTQAELNWAPEILPPQPPEQLGLQMCHHTQLIF -> FWHICISGFS
FT                   IQNRLKENES (in isoform 4)"
FT                   /evidence="ECO:0000303|Ref.4"
FT                   /id="VSP_008820"
FT   VARIANT         9
FT                   /note="V -> M (in dbSNP:rs34583846)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025243"
FT   VARIANT         82
FT                   /note="F -> C (in dbSNP:rs35282642)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025244"
FT   VARIANT         172
FT                   /note="L -> W (in dbSNP:rs34094401)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025245"
FT   VARIANT         180
FT                   /note="Y -> C (in dbSNP:rs28910275)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025246"
FT   VARIANT         207
FT                   /note="V -> L (in dbSNP:rs28908168)"
FT                   /id="VAR_035437"
FT   VARIANT         243
FT                   /note="K -> R (in dbSNP:rs34594234)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025247"
FT   VARIANT         250
FT                   /note="S -> A (in dbSNP:rs33929366)"
FT                   /evidence="ECO:0000269|Ref.5"
FT                   /id="VAR_025248"
FT   VARIANT         365
FT                   /note="P -> R (in dbSNP:rs28908468)"
FT                   /id="VAR_051730"
FT   MUTAGEN         326
FT                   /note="P->L: Abolishes interaction with BCR-ABL SH3
FT                   domain."
FT                   /evidence="ECO:0000269|PubMed:19657362"
FT   CONFLICT        281
FT                   /note="S -> P (in Ref. 9; AAN60542/AAN60543/AAN60544)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   384 AA;  42196 MW;  DB0B9AE82F44A52B CRC64;
     MGSKKLKRVG LSQELCDRLS RHQILTCQDF LCLSPLELMK VTGLSYRGVH ELLCMVSRAC
     APKMQTAYGI KAQRSADFSP AFLSTTLSAL DEALHGGVAC GSLTEITGPP GCGKTQFCIM
     MSILATLPTN MGGLEGAVVY IDTESAFSAE RLVEIAESRF PRYFNTEEKL LLTSSKVHLY
     RELTCDEVLQ RIESLEEEII SKGIKLVILD SVASVVRKEF DAQLQGNLKE RNKFLAREAS
     SLKYLAEEFS IPVILTNQIT THLSGALASQ ADLVSPADDL SLSEGTSGSS CVIAALGNTW
     SHSVNTRLIL QYLDSERRQI LIAKSPLAPF TSFVYTIKEE GLVLQETTFC SVTQAELNWA
     PEILPPQPPE QLGLQMCHHT QLIF
//
ID   RBP2_HUMAN              Reviewed;        3224 AA.
AC   P49792; Q13074; Q15280; Q53TE2; Q59FH7;
DT   01-OCT-1996, integrated into UniProtKB/Swiss-Prot.
DT   06-DEC-2005, sequence version 2.
DT   22-APR-2020, entry version 226.
DE   RecName: Full=E3 SUMO-protein ligase RanBP2;
DE            EC=2.3.2.- {ECO:0000269|PubMed:11792325, ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:22194619};
DE   AltName: Full=358 kDa nucleoporin;
DE   AltName: Full=Nuclear pore complex protein Nup358;
DE   AltName: Full=Nucleoporin Nup358;
DE   AltName: Full=Ran-binding protein 2;
DE            Short=RanBP2;
DE   AltName: Full=p270;
GN   Name=RANBP2; Synonyms=NUP358;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], FUNCTION, DOMAIN, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=7775481; DOI=10.1074/jbc.270.23.14209;
RA   Wu J., Matunis M.J., Kraemer D., Blobel G., Coutavas E.;
RT   "Nup358, a cytoplasmically exposed nucleoporin with peptide repeats, Ran-
RT   GTP binding sites, zinc fingers, a cyclophilin A homologous domain, and a
RT   leucine-rich region.";
RL   J. Biol. Chem. 270:14209-14213(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], VARIANT LYS-784, AND SUBCELLULAR LOCATION.
RC   TISSUE=Blood;
RX   PubMed=7603572; DOI=10.1038/376184a0;
RA   Yokoyama N., Hayashi N., Seki T., Nishii K., Hayashida T., Kuma K.,
RA   Miyata T., Fukui M., Nishimoto T., Pante N., Aebi U.;
RT   "A giant nucleopore protein that binds Ran/TC4.";
RL   Nature 376:184-188(1995).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 87-3224.
RC   TISSUE=Brain;
RA   Totoki Y., Toyoda A., Takeda T., Sakaki Y., Tanaka A., Yokoyama S.,
RA   Ohara O., Nagase T., Kikuno R.F.;
RL   Submitted (MAR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2205-2546.
RC   TISSUE=Hippocampus;
RX   PubMed=7724562; DOI=10.1073/pnas.92.8.3328;
RA   Beddow A.L., Richards S.A., Orem N.R., Macara I.G.;
RT   "The Ran/TC4 GTPase-binding domain: identification by expression cloning
RT   and characterization of a conserved sequence motif.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:3328-3332(1995).
RN   [6]
RP   FUNCTION, CATALYTIC ACTIVITY, AND SUMOYLATION.
RX   PubMed=11792325; DOI=10.1016/s0092-8674(01)00633-x;
RA   Pichler A., Gast A., Seeler J.S., Dejean A., Melchior F.;
RT   "The nucleoporin RanBP2 has SUMO1 E3 ligase activity.";
RL   Cell 108:109-120(2002).
RN   [7]
RP   FUNCTION, AND CATALYTIC ACTIVITY.
RX   PubMed=12032081; DOI=10.1093/emboj/21.11.2682;
RA   Kirsh O., Seeler J.-S., Pichler A., Gast A., Mueller S., Miska E.,
RA   Mathieu M., Harel-Bellan A., Kouzarides T., Melchior F., Dejean A.;
RT   "The SUMO E3 ligase RanBP2 promotes modification of the HDAC4
RT   deacetylase.";
RL   EMBO J. 21:2682-2691(2002).
RN   [8]
RP   SUBCELLULAR LOCATION.
RX   PubMed=11839768; DOI=10.1083/jcb.200106046;
RA   Frosst P., Guan T., Subauste C., Hahn K., Gerace L.;
RT   "Tpr is localized within the nuclear basket of the pore complex and has a
RT   role in nuclear protein export.";
RL   J. Cell Biol. 156:617-630(2002).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=15144186; DOI=10.1021/ac035352d;
RA   Brill L.M., Salomon A.R., Ficarro S.B., Mukherji M., Stettler-Gill M.,
RA   Peters E.C.;
RT   "Robust phosphoproteomic profiling of tyrosine phosphorylation sites from
RT   human T cells using immobilized metal affinity chromatography and tandem
RT   mass spectrometry.";
RL   Anal. Chem. 76:2763-2772(2004).
RN   [10]
RP   IDENTIFICATION IN A COMPLEX WITH RANGAP1; NXF1 AND NXT1.
RX   PubMed=14729961; DOI=10.1128/mcb.24.3.1155-1167.2004;
RA   Forler D., Rabut G., Ciccarelli F.D., Herold A., Koecher T., Niggeweg R.,
RA   Bork P., Ellenberg J., Izaurralde E.;
RT   "RanBP2/Nup358 provides a major binding site for NXF1-p15 dimers at the
RT   nuclear pore complex and functions in nuclear mRNA export.";
RL   Mol. Cell. Biol. 24:1155-1167(2004).
RN   [11]
RP   FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH UBE2I, SUMOYLATION AT
RP   LYS-2592, AND MUTAGENESIS OF PRO-2640; LYS-2645; LEU-2651; LYS-2652;
RP   LEU-2653; PRO-2654; PRO-2655; THR-2656; PHE-2657; PHE-2658; CYS-2659;
RP   ASP-2676; PHE-2677 AND TYR-2689.
RX   PubMed=15378033; DOI=10.1038/nsmb834;
RA   Pichler A., Knipscheer P., Saitoh H., Sixma T.K., Melchior F.;
RT   "The RanBP2 SUMO E3 ligase is neither HECT- nor RING-type.";
RL   Nat. Struct. Mol. Biol. 11:984-991(2004).
RN   [12]
RP   INTERACTION WITH SUMOYLATED RANGAP1, AND MUTAGENESIS OF VAL-2632; ILE-2634
RP   AND VAL-2635.
RX   PubMed=15388847; DOI=10.1073/pnas.0403498101;
RA   Song J., Durrin L.K., Wilkinson T.A., Krontiris T.G., Chen Y.;
RT   "Identification of a SUMO-binding motif that recognizes SUMO-modified
RT   proteins.";
RL   Proc. Natl. Acad. Sci. U.S.A. 101:14373-14378(2004).
RN   [13]
RP   INTERACTION WITH SUMO1 AND UBE2I.
RX   PubMed=15608651; DOI=10.1038/nsmb878;
RA   Tatham M.H., Kim S., Jaffray E., Song J., Chen Y., Hay R.T.;
RT   "Unique binding interactions among Ubc9, SUMO and RanBP2 reveal a mechanism
RT   for SUMO paralog selection.";
RL   Nat. Struct. Mol. Biol. 12:67-74(2005).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=16620772; DOI=10.1016/j.abb.2006.03.002;
RA   Li T., Santockyte R., Shen R.-F., Tekle E., Wang G., Yang D.C.H.,
RA   Chock P.B.;
RT   "A general approach for investigating enzymatic pathways and substrates for
RT   ubiquitin-like modifiers.";
RL   Arch. Biochem. Biophys. 453:70-74(2006).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in signaling
RT   networks.";
RL   Cell 127:635-648(2006).
RN   [16]
RP   INTERACTION WITH PRKN, AND UBIQUITINATION.
RX   PubMed=16332688; DOI=10.1074/jbc.m504994200;
RA   Um J.W., Min D.S., Rhim H., Kim J., Paik S.R., Chung K.C.;
RT   "Parkin ubiquitinates and promotes the degradation of RanBP2.";
RL   J. Biol. Chem. 281:3595-3603(2006).
RN   [17]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21 AND THR-1144, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=16964243; DOI=10.1038/nbt1240;
RA   Beausoleil S.A., Villen J., Gerber S.A., Rush J., Gygi S.P.;
RT   "A probability-based approach for high-throughput protein phosphorylation
RT   analysis and site localization.";
RL   Nat. Biotechnol. 24:1285-1292(2006).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [19]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of the
RT   kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-781; SER-948;
RP   SER-955; SER-1110; THR-1144; SER-1160; THR-1396; SER-1443; SER-1456;
RP   SER-1509; SER-1573; SER-1869; SER-2270; THR-2613; SER-2668; SER-2741;
RP   THR-2743 AND SER-2900, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [23]
RP   INTERACTION WITH CDCA8.
RX   PubMed=18946085; DOI=10.1091/mbc.e08-05-0511;
RA   Klein U.R., Haindl M., Nigg E.A., Muller S.;
RT   "RanBP2 and SENP3 function in a mitotic SUMO2/3 conjugation-deconjugation
RT   cycle on Borealin.";
RL   Mol. Biol. Cell 20:410-418(2009).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-955;
RP   SER-1107; THR-1396; SER-1871; SER-2270; SER-2668 AND SER-2900, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [25]
RP   INTERACTION WITH MCM3AP.
RX   PubMed=20005110; DOI=10.1016/j.cub.2009.10.078;
RA   Wickramasinghe V.O., McMurtrie P.I., Mills A.D., Takei Y., Penrhyn-Lowe S.,
RA   Amagase Y., Main S., Marr J., Stewart M., Laskey R.A.;
RT   "mRNA export from mammalian cell nuclei is dependent on GANP.";
RL   Curr. Biol. 20:25-31(2010).
RN   [26]
RP   FUNCTION, INTERACTION WITH BICD2, AND SUBCELLULAR LOCATION.
RX   PubMed=20386726; DOI=10.1371/journal.pbio.1000350;
RA   Splinter D., Tanenbaum M.E., Lindqvist A., Jaarsma D., Flotho A., Yu K.L.,
RA   Grigoriev I., Engelsma D., Haasdijk E.D., Keijzer N., Demmers J.,
RA   Fornerod M., Melchior F., Hoogenraad C.C., Medema R.H., Akhmanova A.;
RT   "Bicaudal D2, dynein, and kinesin-1 associate with nuclear pore complexes
RT   and regulate centrosome and nuclear positioning during mitotic entry.";
RL   PLoS Biol. 8:E1000350-E1000350(2010).
RN   [27]
RP   FUNCTION, AND CAUTION.
RX   PubMed=20676357; DOI=10.1371/journal.pbio.1000439;
RA   Davis T.L., Walker J.R., Campagna-Slater V., Finerty P.J., Paramanathan R.,
RA   Bernstein G., MacKenzie F., Tempel W., Ouyang H., Lee W.H.,
RA   Eisenmesser E.Z., Dhe-Paganon S.;
RT   "Structural and biochemical characterization of the human cyclophilin
RT   family of peptidyl-prolyl isomerases.";
RL   PLoS Biol. 8:E1000439-E1000439(2010).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-19; SER-21; SER-781; SER-837;
RP   SER-948; SER-955; SER-1110; SER-1160; THR-1412; SER-1509; SER-1835;
RP   SER-2900 AND SER-3207, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [29]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1160; SER-1456; SER-2668;
RP   SER-2900 AND SER-3207, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [31]
RP   FUNCTION, AND INTERACTION WITH PML.
RX   PubMed=22155184; DOI=10.1053/j.gastro.2011.11.041;
RA   Satow R., Shitashige M., Jigami T., Fukami K., Honda K., Kitabayashi I.,
RA   Yamada T.;
RT   "Beta-catenin inhibits promyelocytic leukemia protein tumor suppressor
RT   function in colorectal cancer cells.";
RL   Gastroenterology 142:572-581(2012).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-21; THR-779; SER-781;
RP   SER-948; SER-955; THR-1098; SER-1103; SER-1107; SER-1110; THR-1144;
RP   SER-1160; SER-1249; THR-1396; THR-1412; SER-1450; SER-1456; SER-1509;
RP   SER-1520; SER-1573; SER-1833; SER-1835; SER-1869; SER-2270; SER-2526;
RP   THR-2613; TYR-2666; SER-2668; SER-2805 AND SER-3207, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-955; SER-1160; SER-1450;
RP   SER-1456; SER-1509; SER-2668 AND SER-2900, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [34]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-945 AND ARG-1016, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [35]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [36]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1605; LYS-1664; LYS-1723;
RP   LYS-2594 AND LYS-2792, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [37]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [38]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1414; LYS-1605; LYS-1664 AND
RP   LYS-1723, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [39]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-1350; LYS-1414; LYS-1596;
RP   LYS-1605; LYS-1655; LYS-1664; LYS-1714; LYS-1723; LYS-2022; LYS-2522;
RP   LYS-2594; LYS-2612; LYS-2792 AND LYS-2815, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (2.96 ANGSTROMS) OF 1171-1304, AND FUNCTION.
RX   PubMed=10078529; DOI=10.1038/17969;
RA   Vetter I.R., Nowak C., Nishimoto T., Kuhlmann J., Wittinghofer A.;
RT   "Structure of a Ran-binding domain complexed with Ran bound to a GTP
RT   analogue: implications for nuclear transport.";
RL   Nature 398:39-46(1999).
RN   [41]
RP   STRUCTURE BY NMR OF 2028-2154.
RX   PubMed=15826666; DOI=10.1016/j.jmb.2005.02.033;
RA   Geyer J.P., Doker R., Kremer W., Zhao X., Kuhlmann J., Kalbitzer H.R.;
RT   "Solution structure of the Ran-binding domain 2 of RanBP2 and its
RT   interaction with the C terminus of Ran.";
RL   J. Mol. Biol. 348:711-725(2005).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (3.01 ANGSTROMS) OF 2631-2711 IN COMPLEX WITH SUMO1;
RP   RANGAP1 AND UBE2I, FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=15931224; DOI=10.1038/nature03588;
RA   Reverter D., Lima C.D.;
RT   "Insights into E3 ligase activity revealed by a SUMO-RanGAP1-Ubc9-Nup358
RT   complex.";
RL   Nature 435:687-692(2005).
RN   [43]
RP   X-RAY CRYSTALLOGRAPHY (2.29 ANGSTROMS) OF 2631-2695 IN COMPLEX WITH SUMO1;
RP   RANGAP1 AND UBE2I, FUNCTION, CATALYTIC ACTIVITY, AND SUBUNIT.
RX   PubMed=22194619; DOI=10.1074/jbc.m111.321141;
RA   Gareau J.R., Reverter D., Lima C.D.;
RT   "Determinants of small ubiquitin-like modifier 1 (SUMO1) protein
RT   specificity, E3 ligase, and SUMO-RanGAP1 binding activities of nucleoporin
RT   RanBP2.";
RL   J. Biol. Chem. 287:4740-4751(2012).
RN   [44]
RP   X-RAY CRYSTALLOGRAPHY (1.15 ANGSTROMS) OF 1-145, AND TPR REPEATS.
RX   PubMed=22959972; DOI=10.1016/j.jmb.2012.08.026;
RA   Kassube S.A., Stuwe T., Lin D.H., Antonuk C.D., Napetschnig J., Blobel G.,
RA   Hoelz A.;
RT   "Crystal structure of the N-terminal domain of Nup358/RanBP2.";
RL   J. Mol. Biol. 423:752-765(2012).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 3062-3224, FUNCTION, SUBCELLULAR
RP   LOCATION, DOMAIN, AND CAUTION.
RX   PubMed=23353830; DOI=10.1016/j.jmb.2013.01.021;
RA   Lin D.H., Zimmermann S., Stuwe T., Stuwe E., Hoelz A.;
RT   "Structural and functional analysis of the C-terminal domain of
RT   Nup358/RanBP2.";
RL   J. Mol. Biol. 425:1318-1329(2013).
RN   [46]
RP   VARIANTS IIAE3 MET-585; ILE-653 AND VAL-656.
RX   PubMed=19118815; DOI=10.1016/j.ajhg.2008.12.009;
RA   Neilson D.E., Adams M.D., Orr C.M.D., Schelling D.K., Eiben R.M.,
RA   Kerr D.S., Anderson J., Bassuk A.G., Bye A.M., Childs A.-M., Clarke A.,
RA   Crow Y.J., Di Rocco M., Dohna-Schwake C., Dueckers G., Fasano A.E.,
RA   Gika A.D., Gionnis D., Gorman M.P., Grattan-Smith P.J., Hackenberg A.,
RA   Kuster A., Lentschig M.G., Lopez-Laso E., Marco E.J., Mastroyianni S.,
RA   Perrier J., Schmitt-Mechelke T., Servidei S., Skardoutsou A., Uldall P.,
RA   van der Knaap M.S., Goglin K.C., Tefft D.L., Aubin C., de Jager P.,
RA   Hafler D., Warman M.L.;
RT   "Infection-triggered familial or recurrent cases of acute necrotizing
RT   encephalopathy caused by mutations in a component of the nuclear pore,
RT   RANBP2.";
RL   Am. J. Hum. Genet. 84:44-51(2009).
CC   -!- FUNCTION: E3 SUMO-protein ligase which facilitates SUMO1 and SUMO2
CC       conjugation by UBE2I (PubMed:11792325, PubMed:12032081,
CC       PubMed:15378033, PubMed:22194619, PubMed:15931224). Involved in
CC       transport factor (Ran-GTP, karyopherin)-mediated protein import via the
CC       F-G repeat-containing domain which acts as a docking site for
CC       substrates (PubMed:7775481). Binds single-stranded RNA (in vitro)
CC       (PubMed:7775481). May bind DNA (PubMed:7775481). Component of the
CC       nuclear export pathway (PubMed:10078529). Specific docking site for the
CC       nuclear export factor exportin-1 (PubMed:10078529). Sumoylates PML at
CC       'Lys-490' which is essential for the proper assembly of PML-NB
CC       (PubMed:22155184). Recruits BICD2 to the nuclear envelope and
CC       cytoplasmic stacks of nuclear pore complex known as annulate lamellae
CC       during G2 phase of cell cycle (PubMed:20386726). Probable inactive
CC       PPIase with no peptidyl-prolyl cis-trans isomerase activity
CC       (PubMed:20676357, PubMed:23353830). {ECO:0000269|PubMed:11792325,
CC       ECO:0000269|PubMed:12032081, ECO:0000269|PubMed:15378033,
CC       ECO:0000269|PubMed:15931224, ECO:0000269|PubMed:20386726,
CC       ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:22155184,
CC       ECO:0000269|PubMed:22194619, ECO:0000269|PubMed:23353830,
CC       ECO:0000269|PubMed:7775481, ECO:0000303|PubMed:10078529}.
CC   -!- PATHWAY: Protein modification; protein sumoylation.
CC   -!- SUBUNIT: Forms a complex with NXT1, NXF1 and RANGAP1 (PubMed:14729961).
CC       Forms a tight complex with RANBP1 and UBE2I (PubMed:15388847,
CC       PubMed:10078529, PubMed:15826666). Interacts with SUMO1 but not SUMO2
CC       (PubMed:15388847, PubMed:10078529, PubMed:15826666). Interacts with
CC       PRKN (PubMed:16332688). Interacts with sumoylated RANGAP1
CC       (PubMed:15378033, PubMed:10078529, PubMed:15826666). Interacts with
CC       CDCA8 (PubMed:19413330). Interacts with PML (isoform PML-4)
CC       (PubMed:22155184). Interacts with BICD2 (PubMed:20386726). Interacts
CC       with MCM3AP isoform GANP (PubMed:20005110).
CC       {ECO:0000269|PubMed:10078529, ECO:0000269|PubMed:14729961,
CC       ECO:0000269|PubMed:15378033, ECO:0000269|PubMed:15388847,
CC       ECO:0000269|PubMed:15826666, ECO:0000269|PubMed:16332688,
CC       ECO:0000269|PubMed:20005110, ECO:0000269|PubMed:20386726,
CC       ECO:0000269|PubMed:22155184}.
CC   -!- INTERACTION:
CC       P49792; Q8TD16: BICD2; NbExp=2; IntAct=EBI-973138, EBI-2372628;
CC       P49792; Q921C5-1: Bicd2; Xeno; NbExp=4; IntAct=EBI-973138, EBI-642995;
CC       P49792; P04626: ERBB2; NbExp=3; IntAct=EBI-973138, EBI-641062;
CC       P49792; Q53GG5: PDLIM3; NbExp=3; IntAct=EBI-973138, EBI-5658852;
CC       P49792; O60260: PRKN; NbExp=11; IntAct=EBI-973138, EBI-716346;
CC       P49792; P62826: RAN; NbExp=4; IntAct=EBI-973138, EBI-286642;
CC       P49792; P63279: UBE2I; NbExp=3; IntAct=EBI-973138, EBI-80168;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:7775481}. Nucleus
CC       membrane {ECO:0000269|PubMed:11839768}. Nucleus, nuclear pore complex
CC       {ECO:0000269|PubMed:11839768, ECO:0000269|PubMed:20386726,
CC       ECO:0000269|PubMed:23353830, ECO:0000269|PubMed:7603572}. Nucleus
CC       envelope {ECO:0000269|PubMed:20386726}. Note=Detected in diffuse and
CC       discrete intranuclear foci (PubMed:11839768). Cytoplasmic filaments
CC       (PubMed:7775481). {ECO:0000269|PubMed:11839768,
CC       ECO:0000269|PubMed:7775481}.
CC   -!- DOMAIN: Contains FG repeats. FG repeats are interaction sites for
CC       karyopherins (importins, exportins) and form probably an affinity
CC       gradient, guiding the transport proteins unidirectionally with their
CC       cargo through the NPC. FG repeat regions are highly flexible and lack
CC       ordered secondary structure. The overall conservation of FG repeats
CC       regarding exact sequence, spacing, and repeat unit length is limited.
CC       {ECO:0000305}.
CC   -!- DOMAIN: The PPIase cyclophilin-type domain has high structural
CC       similarity with PPIA, but has extremely low and barely detectable
CC       proline isomerase activity (in vitro) (PubMed:23353830). Only about
CC       half of the residues that surround the PPIA active site cleft are
CC       conserved. {ECO:0000269|PubMed:23353830}.
CC   -!- PTM: Polyubiquitinated by PRKN, which leads to proteasomal degradation.
CC       {ECO:0000269|PubMed:16332688}.
CC   -!- PTM: The inner channel of the NPC has a different redox environment
CC       from the cytoplasm and allows the formation of interchain disulfide
CC       bonds between some nucleoporins, the significant increase of these
CC       linkages upon oxidative stress reduces the permeability of the NPC.
CC       {ECO:0000250|UniProtKB:Q9ERU9}.
CC   -!- DISEASE: Encephalopathy, acute, infection-induced, 3 (IIAE3)
CC       [MIM:608033]: A rapidly progressive encephalopathy manifesting in
CC       susceptible individuals with seizures and coma. It can occur within
CC       days in otherwise healthy children after common viral infections such
CC       as influenza and parainfluenza, without evidence of viral infection of
CC       the brain or inflammatory cell infiltration. Brain T2-weighted magnetic
CC       resonance imaging reveals characteristic symmetric lesions present in
CC       the thalami, pons and brainstem. {ECO:0000269|PubMed:19118815}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry. Mutations in the RANBP2 gene predispose to IIAE3, but by
CC       themselves are insufficient to make the phenotype fully penetrant;
CC       additional genetic and environmental factors are required
CC       (PubMed:19118815). {ECO:0000269|PubMed:19118815}.
CC   -!- SIMILARITY: Belongs to the RanBP2 E3 ligase family. {ECO:0000305}.
CC   -!- CAUTION: Despite the presence of a PPIase cyclophilin-type domain, it
CC       has probably no peptidyl-prolyl cis-trans isomerase activity.
CC       {ECO:0000269|PubMed:20676357, ECO:0000269|PubMed:23353830}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RANBP2ID483.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L41840; AAC41758.1; -; Genomic_DNA.
DR   EMBL; D42063; BAA07662.1; -; mRNA.
DR   EMBL; AC010095; AAY14984.1; -; Genomic_DNA.
DR   EMBL; AB209483; BAD92720.1; -; mRNA.
DR   EMBL; U19248; AAA85838.1; -; mRNA.
DR   CCDS; CCDS2079.1; -.
DR   PIR; S58884; S58884.
DR   RefSeq; NP_006258.3; NM_006267.4.
DR   PDB; 1RRP; X-ray; 2.96 A; B/D=1171-1304.
DR   PDB; 1XKE; NMR; -; A=2028-2154.
DR   PDB; 1Z5S; X-ray; 3.01 A; D=2631-2711.
DR   PDB; 2LAS; NMR; -; B=2705-2717.
DR   PDB; 3UIN; X-ray; 2.60 A; D=2629-2695.
DR   PDB; 3UIO; X-ray; 2.60 A; D=2631-2695.
DR   PDB; 3UIP; X-ray; 2.29 A; D=2631-2695.
DR   PDB; 4GA0; X-ray; 1.15 A; A=1-145.
DR   PDB; 4I9Y; X-ray; 1.75 A; A/B/C/D/E/F=3062-3224.
DR   PDB; 4L6E; X-ray; 2.50 A; A=2907-3050.
DR   PDB; 4LQW; X-ray; 1.95 A; A/B=3057-3224.
DR   PDB; 5CLL; X-ray; 2.45 A; B/D=1155-1321.
DR   PDB; 5CLQ; X-ray; 3.20 A; B/D=1155-1321.
DR   PDBsum; 1RRP; -.
DR   PDBsum; 1XKE; -.
DR   PDBsum; 1Z5S; -.
DR   PDBsum; 2LAS; -.
DR   PDBsum; 3UIN; -.
DR   PDBsum; 3UIO; -.
DR   PDBsum; 3UIP; -.
DR   PDBsum; 4GA0; -.
DR   PDBsum; 4I9Y; -.
DR   PDBsum; 4L6E; -.
DR   PDBsum; 4LQW; -.
DR   PDBsum; 5CLL; -.
DR   PDBsum; 5CLQ; -.
DR   SMR; P49792; -.
DR   BioGrid; 111839; 185.
DR   ComplexPortal; CPX-4747; SUMO1 E3 ligase (RANBP2) complex.
DR   ComplexPortal; CPX-4922; SUMO2 E3 ligase (RANBP2) complex.
DR   ComplexPortal; CPX-873; Nuclear pore complex.
DR   DIP; DIP-37654N; -.
DR   IntAct; P49792; 88.
DR   MINT; P49792; -.
DR   STRING; 9606.ENSP00000283195; -.
DR   TCDB; 1.I.1.1.3; the eukaryotic nuclear pore complex (e-npc) family.
DR   iPTMnet; P49792; -.
DR   MetOSite; P49792; -.
DR   PhosphoSitePlus; P49792; -.
DR   SwissPalm; P49792; -.
DR   BioMuta; RANBP2; -.
DR   DMDM; 83305554; -.
DR   OGP; P49792; -.
DR   CPTAC; CPTAC-996; -.
DR   EPD; P49792; -.
DR   jPOST; P49792; -.
DR   MassIVE; P49792; -.
DR   MaxQB; P49792; -.
DR   PaxDb; P49792; -.
DR   PeptideAtlas; P49792; -.
DR   PRIDE; P49792; -.
DR   ProteomicsDB; 56121; -.
DR   Antibodypedia; 33105; 196 antibodies.
DR   Ensembl; ENST00000283195; ENSP00000283195; ENSG00000153201.
DR   GeneID; 5903; -.
DR   KEGG; hsa:5903; -.
DR   UCSC; uc002tem.4; human.
DR   CTD; 5903; -.
DR   DisGeNET; 5903; -.
DR   GeneCards; RANBP2; -.
DR   GeneReviews; RANBP2; -.
DR   HGNC; HGNC:9848; RANBP2.
DR   HPA; ENSG00000153201; Low tissue specificity.
DR   MalaCards; RANBP2; -.
DR   MIM; 601181; gene.
DR   MIM; 608033; phenotype.
DR   neXtProt; NX_P49792; -.
DR   OpenTargets; ENSG00000153201; -.
DR   Orphanet; 263524; Acute necrotizing encephalopathy of childhood.
DR   Orphanet; 88619; Familial acute necrotizing encephalopathy.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   PharmGKB; PA34209; -.
DR   eggNOG; KOG0864; Eukaryota.
DR   eggNOG; KOG0865; Eukaryota.
DR   eggNOG; COG0652; LUCA.
DR   eggNOG; COG5171; LUCA.
DR   GeneTree; ENSGT00940000154389; -.
DR   HOGENOM; CLU_000378_1_0_1; -.
DR   InParanoid; P49792; -.
DR   KO; K12172; -.
DR   OMA; VACQNPR; -.
DR   OrthoDB; 201737at2759; -.
DR   PhylomeDB; P49792; -.
DR   TreeFam; TF314797; -.
DR   Reactome; R-HSA-1169408; ISG15 antiviral mechanism.
DR   Reactome; R-HSA-141444; Amplification of signal from unattached kinetochores via a MAD2 inhibitory signal.
DR   Reactome; R-HSA-159227; Transport of the SLBP independent Mature mRNA.
DR   Reactome; R-HSA-159230; Transport of the SLBP Dependant Mature mRNA.
DR   Reactome; R-HSA-159231; Transport of Mature mRNA Derived from an Intronless Transcript.
DR   Reactome; R-HSA-159236; Transport of Mature mRNA derived from an Intron-Containing Transcript.
DR   Reactome; R-HSA-165054; Rev-mediated nuclear export of HIV RNA.
DR   Reactome; R-HSA-168271; Transport of Ribonucleoproteins into the Host Nucleus.
DR   Reactome; R-HSA-168276; NS1 Mediated Effects on Host Pathways.
DR   Reactome; R-HSA-168325; Viral Messenger RNA Synthesis.
DR   Reactome; R-HSA-168333; NEP/NS2 Interacts with the Cellular Export Machinery.
DR   Reactome; R-HSA-170822; Regulation of Glucokinase by Glucokinase Regulatory Protein.
DR   Reactome; R-HSA-180746; Nuclear import of Rev protein.
DR   Reactome; R-HSA-180910; Vpr-mediated nuclear import of PICs.
DR   Reactome; R-HSA-191859; snRNP Assembly.
DR   Reactome; R-HSA-2467813; Separation of Sister Chromatids.
DR   Reactome; R-HSA-2500257; Resolution of Sister Chromatid Cohesion.
DR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response and repair proteins.
DR   Reactome; R-HSA-3232142; SUMOylation of ubiquitinylation proteins.
DR   Reactome; R-HSA-3301854; Nuclear Pore Complex (NPC) Disassembly.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-4085377; SUMOylation of SUMOylation proteins.
DR   Reactome; R-HSA-4551638; SUMOylation of chromatin organization proteins.
DR   Reactome; R-HSA-4570464; SUMOylation of RNA binding proteins.
DR   Reactome; R-HSA-4615885; SUMOylation of DNA replication proteins.
DR   Reactome; R-HSA-5578749; Transcriptional regulation by small RNAs.
DR   Reactome; R-HSA-5619107; Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC).
DR   Reactome; R-HSA-5663220; RHO GTPases Activate Formins.
DR   Reactome; R-HSA-6784531; tRNA processing in the nucleus.
DR   Reactome; R-HSA-68877; Mitotic Prometaphase.
DR   Reactome; R-HSA-9609690; HCMV Early Events.
DR   Reactome; R-HSA-9610379; HCMV Late Events.
DR   Reactome; R-HSA-9648025; EML4 and NUDC in mitotic spindle formation.
DR   SIGNOR; P49792; -.
DR   UniPathway; UPA00886; -.
DR   ChiTaRS; RANBP2; human.
DR   EvolutionaryTrace; P49792; -.
DR   GeneWiki; RANBP2; -.
DR   GenomeRNAi; 5903; -.
DR   Pharos; P49792; Tbio.
DR   PRO; PR:P49792; -.
DR   Proteomes; UP000005640; Chromosome 2.
DR   RNAct; P49792; protein.
DR   Bgee; ENSG00000153201; Expressed in biceps brachii and 244 other tissues.
DR   ExpressionAtlas; P49792; baseline and differential.
DR   Genevisible; P49792; HS.
DR   GO; GO:0005642; C:annulate lamellae; IDA:UniProtKB.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:1990723; C:cytoplasmic periphery of the nuclear pore complex; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0043657; C:host cell; IEA:GOC.
DR   GO; GO:0043231; C:intracellular membrane-bounded organelle; IDA:HPA.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:Ensembl.
DR   GO; GO:0005635; C:nuclear envelope; IDA:UniProtKB.
DR   GO; GO:0042405; C:nuclear inclusion body; IDA:UniProtKB.
DR   GO; GO:0031965; C:nuclear membrane; IDA:UniProtKB.
DR   GO; GO:0005643; C:nuclear pore; IDA:UniProtKB.
DR   GO; GO:0044614; C:nuclear pore cytoplasmic filaments; IDA:GO_Central.
DR   GO; GO:0044615; C:nuclear pore nuclear basket; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IBA:GO_Central.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0008536; F:Ran GTPase binding; IPI:GO_Central.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0019789; F:SUMO transferase activity; EXP:Reactome.
DR   GO; GO:0051642; P:centrosome localization; IMP:UniProtKB.
DR   GO; GO:0075733; P:intracellular transport of virus; TAS:Reactome.
DR   GO; GO:0006406; P:mRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0006607; P:NLS-bearing protein import into nucleus; IMP:GO_Central.
DR   GO; GO:0033133; P:positive regulation of glucokinase activity; IEA:Ensembl.
DR   GO; GO:0043547; P:positive regulation of GTPase activity; IEA:GOC.
DR   GO; GO:0006457; P:protein folding; IEA:InterPro.
DR   GO; GO:0000413; P:protein peptidyl-prolyl isomerization; IEA:InterPro.
DR   GO; GO:0016925; P:protein sumoylation; IDA:UniProtKB.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0060964; P:regulation of gene silencing by miRNA; TAS:Reactome.
DR   GO; GO:0006111; P:regulation of gluconeogenesis; IEA:Ensembl.
DR   GO; GO:0006110; P:regulation of glycolytic process; TAS:Reactome.
DR   GO; GO:0001975; P:response to amphetamine; IEA:Ensembl.
DR   GO; GO:0006409; P:tRNA export from nucleus; TAS:Reactome.
DR   GO; GO:0016032; P:viral process; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   Gene3D; 1.25.40.10; -; 1.
DR   Gene3D; 2.30.29.30; -; 4.
DR   Gene3D; 2.40.100.10; -; 1.
DR   InterPro; IPR029000; Cyclophilin-like_dom_sf.
DR   InterPro; IPR020892; Cyclophilin-type_PPIase_CS.
DR   InterPro; IPR002130; Cyclophilin-type_PPIase_dom.
DR   InterPro; IPR022011; IR1-M.
DR   InterPro; IPR011993; PH-like_dom_sf.
DR   InterPro; IPR000156; Ran_bind_dom.
DR   InterPro; IPR013026; TPR-contain_dom.
DR   InterPro; IPR011990; TPR-like_helical_dom_sf.
DR   InterPro; IPR019734; TPR_repeat.
DR   InterPro; IPR001876; Znf_RanBP2.
DR   InterPro; IPR036443; Znf_RanBP2_sf.
DR   Pfam; PF12185; IR1-M; 2.
DR   Pfam; PF00160; Pro_isomerase; 1.
DR   Pfam; PF00638; Ran_BP1; 4.
DR   Pfam; PF00641; zf-RanBP; 8.
DR   PRINTS; PR00153; CSAPPISMRASE.
DR   SMART; SM00160; RanBD; 4.
DR   SMART; SM00028; TPR; 1.
DR   SMART; SM00547; ZnF_RBZ; 8.
DR   SUPFAM; SSF48452; SSF48452; 1.
DR   SUPFAM; SSF50891; SSF50891; 1.
DR   SUPFAM; SSF90209; SSF90209; 7.
DR   PROSITE; PS00170; CSA_PPIASE_1; 1.
DR   PROSITE; PS50072; CSA_PPIASE_2; 1.
DR   PROSITE; PS50196; RANBD1; 4.
DR   PROSITE; PS50005; TPR; 1.
DR   PROSITE; PS50293; TPR_REGION; 1.
DR   PROSITE; PS01358; ZF_RANBP2_1; 8.
DR   PROSITE; PS50199; ZF_RANBP2_2; 8.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Disulfide bond; Isopeptide bond; Membrane;
KW   Metal-binding; Methylation; mRNA transport; Nuclear pore complex; Nucleus;
KW   Phosphoprotein; Polymorphism; Protein transport; Reference proteome;
KW   Repeat; RNA-binding; TPR repeat; Transferase; Translocation; Transport;
KW   Ubl conjugation; Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..3224
FT                   /note="E3 SUMO-protein ligase RanBP2"
FT                   /id="PRO_0000204913"
FT   REPEAT          26..59
FT                   /note="TPR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          60..93
FT                   /note="TPR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          94..128
FT                   /note="TPR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          165..201
FT                   /note="TPR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          287..319
FT                   /note="TPR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          583..616
FT                   /note="TPR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          648..681
FT                   /note="TPR 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00339,
FT                   ECO:0000269|PubMed:22959972"
FT   REPEAT          1001..1002
FT                   /note="1"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1101..1102
FT                   /note="2"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1142..1143
FT                   /note="3"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          1171..1307
FT                   /note="RanBD1 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00164"
FT   REPEAT          1459..1460
FT                   /note="4"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1523..1524
FT                   /note="5"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1586..1587
FT                   /note="6"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1852..1853
FT                   /note="7"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1861..1862
FT                   /note="8"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1900..1901
FT                   /note="9"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1938..1939
FT                   /note="10"
FT                   /evidence="ECO:0000305"
FT   REPEAT          1961..1962
FT                   /note="11"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          2012..2148
FT                   /note="RanBD1 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00164"
FT   REPEAT          2260..2261
FT                   /note="12"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          2309..2445
FT                   /note="RanBD1 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00164"
FT   REPEAT          2516..2517
FT                   /note="13"
FT                   /evidence="ECO:0000305"
FT   REPEAT          2535..2536
FT                   /note="14"
FT                   /evidence="ECO:0000305"
FT   REPEAT          2545..2546
FT                   /note="15"
FT                   /evidence="ECO:0000305"
FT   REPEAT          2633..2685
FT                   /note="1"
FT                   /evidence="ECO:0000269|PubMed:22959972"
FT   REPEAT          2711..2761
FT                   /note="2"
FT                   /evidence="ECO:0000269|PubMed:22959972"
FT   REPEAT          2840..2841
FT                   /note="16"
FT                   /evidence="ECO:0000305"
FT   REPEAT          2842..2843
FT                   /note="17"
FT                   /evidence="ECO:0000305"
FT   REPEAT          2863..2864
FT                   /note="18"
FT                   /evidence="ECO:0000305"
FT   REPEAT          2880..2881
FT                   /note="19"
FT                   /evidence="ECO:0000305"
FT   DOMAIN          2911..3046
FT                   /note="RanBD1 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00164"
FT   DOMAIN          3067..3223
FT                   /note="PPIase cyclophilin-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00156"
FT   REPEAT          3106..3107
FT                   /note="20"
FT                   /evidence="ECO:0000305"
FT   REPEAT          3189..3190
FT                   /note="21"
FT                   /evidence="ECO:0000305"
FT   REPEAT          3205..3206
FT                   /note="22"
FT                   /evidence="ECO:0000305"
FT   ZN_FING         1351..1381
FT                   /note="RanBP2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1415..1444
FT                   /note="RanBP2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1479..1508
FT                   /note="RanBP2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1543..1572
FT                   /note="RanBP2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1606..1635
FT                   /note="RanBP2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1665..1694
FT                   /note="RanBP2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1724..1753
FT                   /note="RanBP2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   ZN_FING         1781..1810
FT                   /note="RanBP2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00322"
FT   REGION          1001..3206
FT                   /note="22 X 2 AA repeats of F-G"
FT                   /evidence="ECO:0000305"
FT   REGION          2147..2287
FT                   /note="Interaction with BICD2"
FT                   /evidence="ECO:0000269|PubMed:20386726"
FT   REGION          2631..2635
FT                   /note="Interaction with sumoylated RANGAP1"
FT   REGION          2633..2761
FT                   /note="2 X 50 AA approximate repeats"
FT   REGION          2633..2710
FT                   /note="Required for E3 SUMO-ligase activity"
FT   REGION          2633..2685
FT                   /note="Interaction with UBE2I"
FT   REGION          2686..2761
FT                   /note="Interaction with SUMO1"
FT                   /evidence="ECO:0000269|PubMed:15608651"
FT   MOD_RES         19
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231"
FT   MOD_RES         21
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         779
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         781
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         788
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         837
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231"
FT   MOD_RES         945
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         948
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         955
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1016
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         1016
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         1098
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1103
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1107
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1110
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1144
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:16964243,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1160
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         1249
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1396
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         1412
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1443
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         1450
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1456
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1509
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:23186163,
FT                   ECO:0000244|PubMed:24275569"
FT   MOD_RES         1520
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1573
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1833
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1835
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1869
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         1871
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         1977
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2005
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2008
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2153
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2246
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2251
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2270
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:23186163"
FT   MOD_RES         2280
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2290
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2293
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2297
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2462
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2493
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2510
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q9ERU9"
FT   MOD_RES         2526
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2613
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         2666
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2668
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000244|PubMed:24275569"
FT   MOD_RES         2741
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         2743
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648"
FT   MOD_RES         2805
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         2900
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:19690332, ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:24275569"
FT   MOD_RES         3207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   CROSSLNK        1350
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1414
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1596
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1605
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        1605
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1655
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1664
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        1664
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1714
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1723
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        1723
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2022
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2522
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2592
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO)"
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   CROSSLNK        2594
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        2594
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2612
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2792
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        2815
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VARIANT         548
FT                   /note="V -> L (in dbSNP:rs1057954)"
FT                   /id="VAR_029765"
FT   VARIANT         580
FT                   /note="E -> K (in dbSNP:rs1057956)"
FT                   /id="VAR_029766"
FT   VARIANT         581
FT                   /note="C -> Y (in dbSNP:rs1057957)"
FT                   /id="VAR_029767"
FT   VARIANT         585
FT                   /note="T -> M (in IIAE3; dbSNP:rs121434502)"
FT                   /evidence="ECO:0000269|PubMed:19118815"
FT                   /id="VAR_054997"
FT   VARIANT         653
FT                   /note="T -> I (in IIAE3; dbSNP:rs121434503)"
FT                   /evidence="ECO:0000269|PubMed:19118815"
FT                   /id="VAR_054998"
FT   VARIANT         656
FT                   /note="I -> V (in IIAE3; dbSNP:rs121434504)"
FT                   /evidence="ECO:0000269|PubMed:19118815"
FT                   /id="VAR_054999"
FT   VARIANT         725
FT                   /note="S -> G (in dbSNP:rs17414315)"
FT                   /id="VAR_050575"
FT   VARIANT         784
FT                   /note="R -> K (in dbSNP:rs2912838)"
FT                   /evidence="ECO:0000269|PubMed:7603572"
FT                   /id="VAR_023939"
FT   VARIANT         1870
FT                   /note="P -> L (in dbSNP:rs2889846)"
FT                   /id="VAR_029768"
FT   VARIANT         1892
FT                   /note="P -> A (in dbSNP:rs12770)"
FT                   /id="VAR_014886"
FT   VARIANT         1892
FT                   /note="P -> R (in dbSNP:rs12770)"
FT                   /id="VAR_050576"
FT   MUTAGEN         2632
FT                   /note="V->K: Abolishes interaction with sumoylated
FT                   RANGAP1."
FT                   /evidence="ECO:0000269|PubMed:15388847"
FT   MUTAGEN         2634
FT                   /note="I->K: Abolishes interaction with sumoylated
FT                   RANGAP1."
FT                   /evidence="ECO:0000269|PubMed:15388847"
FT   MUTAGEN         2635
FT                   /note="V->K: Abolishes interaction with sumoylated
FT                   RANGAP1."
FT                   /evidence="ECO:0000269|PubMed:15388847"
FT   MUTAGEN         2640
FT                   /note="P->A: No effect on SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2645
FT                   /note="K->A: No effect on SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2651
FT                   /note="L->A: Abolishes binding to UBE2I and SUMO E3 ligase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2652
FT                   /note="K->A: No effect on SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2653
FT                   /note="L->A: Abolishes binding to UBE2I and SUMO E3 ligase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2654
FT                   /note="P->A: Impairs SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2655
FT                   /note="P->A: No effect on SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2656
FT                   /note="T->A: Impairs SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2657
FT                   /note="F->A: Abolishes binding to UBE2I and SUMO E3 ligase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2658
FT                   /note="F->A: Abolishes binding to UBE2I and SUMO E3 ligase
FT                   activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2659
FT                   /note="C->S,A: Impairs SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2676
FT                   /note="D->A: Impairs SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2677
FT                   /note="F->A: Impairs SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   MUTAGEN         2689
FT                   /note="Y->A: Impairs SUMO E3 ligase activity."
FT                   /evidence="ECO:0000269|PubMed:15378033"
FT   CONFLICT        777
FT                   /note="H -> R (in Ref. 1; AAC41758)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2207
FT                   /note="S -> A (in Ref. 5; AAA85838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2210
FT                   /note="T -> P (in Ref. 5; AAA85838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2216
FT                   /note="E -> V (in Ref. 5; AAA85838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2436
FT                   /note="F -> C (in Ref. 5; AAA85838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2475
FT                   /note="T -> P (in Ref. 5; AAA85838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2531
FT                   /note="K -> N (in Ref. 5; AAA85838)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        2545
FT                   /note="F -> C (in Ref. 5)"
FT                   /evidence="ECO:0000305"
FT   HELIX           5..18
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           22..26
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           29..38
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           42..55
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           60..72
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           76..89
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           94..107
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           112..124
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   HELIX           129..141
FT                   /evidence="ECO:0000244|PDB:4GA0"
FT   STRAND          1191..1205
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   TURN            1206..1209
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          1210..1224
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   TURN            1225..1227
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          1230..1236
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   TURN            1237..1239
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          1242..1247
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          1255..1257
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          1260..1270
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          1277..1284
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   HELIX           1288..1302
FT                   /evidence="ECO:0000244|PDB:5CLL"
FT   STRAND          2028..2030
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2032..2046
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   TURN            2047..2050
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2051..2065
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2071..2077
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   TURN            2078..2081
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2082..2088
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2095..2097
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2105..2111
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2113..2115
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2117..2125
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   HELIX           2129..2145
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   TURN            2146..2148
FT                   /evidence="ECO:0000244|PDB:1XKE"
FT   STRAND          2632..2637
FT                   /evidence="ECO:0000244|PDB:3UIP"
FT   HELIX           2642..2650
FT                   /evidence="ECO:0000244|PDB:3UIP"
FT   HELIX           2657..2661
FT                   /evidence="ECO:0000244|PDB:3UIP"
FT   STRAND          2663..2665
FT                   /evidence="ECO:0000244|PDB:3UIN"
FT   HELIX           2677..2682
FT                   /evidence="ECO:0000244|PDB:3UIP"
FT   TURN            2683..2686
FT                   /evidence="ECO:0000244|PDB:3UIP"
FT   STRAND          2710..2712
FT                   /evidence="ECO:0000244|PDB:2LAS"
FT   TURN            2926..2929
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          2930..2944
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   TURN            2945..2948
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          2949..2963
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   TURN            2964..2967
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          2968..2974
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   TURN            2976..2978
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          2981..2986
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          2994..2996
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          3000..3009
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          3016..3026
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   HELIX           3027..3047
FT                   /evidence="ECO:0000244|PDB:4L6E"
FT   STRAND          3065..3072
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3075..3084
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   TURN            3086..3088
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   HELIX           3090..3101
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   TURN            3102..3104
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3112..3117
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   TURN            3118..3120
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3121..3124
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   TURN            3127..3129
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3130..3133
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3157..3160
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3168..3170
FT                   /evidence="ECO:0000244|PDB:4LQW"
FT   STRAND          3172..3177
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   HELIX           3180..3182
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   TURN            3183..3185
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3188..3194
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   HELIX           3196..3203
FT                   /evidence="ECO:0000244|PDB:4I9Y"
FT   STRAND          3216..3223
FT                   /evidence="ECO:0000244|PDB:4I9Y"
SQ   SEQUENCE   3224 AA;  358199 MW;  4CD9A3D5E77183FB CRC64;
     MRRSKADVER YIASVQGSTP SPRQKSMKGF YFAKLYYEAK EYDLAKKYIC TYINVQERDP
     KAHRFLGLLY ELEENTDKAV ECYRRSVELN PTQKDLVLKI AELLCKNDVT DGRAKYWLER
     AAKLFPGSPA IYKLKEQLLD CEGEDGWNKL FDLIQSELYV RPDDVHVNIR LVEVYRSTKR
     LKDAVAHCHE AERNIALRSS LEWNSCVVQT LKEYLESLQC LESDKSDWRA TNTDLLLAYA
     NLMLLTLSTR DVQESRELLQ SFDSALQSVK SLGGNDELSA TFLEMKGHFY MHAGSLLLKM
     GQHSSNVQWR ALSELAALCY LIAFQVPRPK IKLIKGEAGQ NLLEMMACDR LSQSGHMLLN
     LSRGKQDFLK EIVETFANKS GQSALYDALF SSQSPKDTSF LGSDDIGNID VREPELEDLT
     RYDVGAIRAH NGSLQHLTWL GLQWNSLPAL PGIRKWLKQL FHHLPHETSR LETNAPESIC
     ILDLEVFLLG VVYTSHLQLK EKCNSHHSSY QPLCLPLPVC KQLCTERQKS WWDAVCTLIH
     RKAVPGNVAK LRLLVQHEIN TLRAQEKHGL QPALLVHWAE CLQKTGSGLN SFYDQREYIG
     RSVHYWKKVL PLLKIIKKKN SIPEPIDPLF KHFHSVDIQA SEIVEYEEDA HITFAILDAV
     NGNIEDAVTA FESIKSVVSY WNLALIFHRK AEDIENDALS PEEQEECKNY LRKTRDYLIK
     IIDDSDSNLS VVKKLPVPLE SVKEMLNSVM QELEDYSEGG PLYKNGSLRN ADSEIKHSTP
     SPTRYSLSPS KSYKYSPKTP PRWAEDQNSL LKMICQQVEA IKKEMQELKL NSSNSASPHR
     WPTENYGPDS VPDGYQGSQT FHGAPLTVAT TGPSVYYSQS PAYNSQYLLR PAANVTPTKG
     PVYGMNRLPP QQHIYAYPQQ MHTPPVQSSS ACMFSQEMYG PPALRFESPA TGILSPRGDD
     YFNYNVQQTS TNPPLPEPGY FTKPPIAAHA SRSAESKTIE FGKTNFVQPM PGEGLRPSLP
     TQAHTTQPTP FKFNSNFKSN DGDFTFSSPQ VVTQPPPAAY SNSESLLGLL TSDKPLQGDG
     YSGAKPIPGG QTIGPRNTFN FGSKNVSGIS FTENMGSSQQ KNSGFRRSDD MFTFHGPGKS
     VFGTPTLETA NKNHETDGGS AHGDDDDDGP HFEPVVPLPD KIEVKTGEED EEEFFCNRAK
     LFRFDVESKE WKERGIGNVK ILRHKTSGKI RLLMRREQVL KICANHYISP DMKLTPNAGS
     DRSFVWHALD YADELPKPEQ LAIRFKTPEE AALFKCKFEE AQSILKAPGT NVAMASNQAV
     RIVKEPTSHD NKDICKSDAG NLNFEFQVAK KEGSWWHCNS CSLKNASTAK KCVSCQNLNP
     SNKELVGPPL AETVFTPKTS PENVQDRFAL VTPKKEGHWD CSICLVRNEP TVSRCIACQN
     TKSANKSGSS FVHQASFKFG QGDLPKPINS DFRSVFSTKE GQWDCSACLV QNEGSSTKCA
     ACQNPRKQSL PATSIPTPAS FKFGTSETSK TLKSGFEDMF AKKEGQWDCS SCLVRNEANA
     TRCVACQNPD KPSPSTSVPA PASFKFGTSE TSKAPKSGFE GMFTKKEGQW DCSVCLVRNE
     ASATKCIACQ NPGKQNQTTS AVSTPASSET SKAPKSGFEG MFTKKEGQWD CSVCLVRNEA
     SATKCIACQN PGKQNQTTSA VSTPASSETS KAPKSGFEGM FTKKEGQWDC SVCLVRNEAS
     ATKCIACQCP SKQNQTTAIS TPASSEISKA PKSGFEGMFI RKGQWDCSVC CVQNESSSLK
     CVACDASKPT HKPIAEAPSA FTLGSEMKLH DSSGSQVGTG FKSNFSEKAS KFGNTEQGFK
     FGHVDQENSP SFMFQGSSNT EFKSTKEGFS IPVSADGFKF GISEPGNQEK KSEKPLENGT
     GFQAQDISGQ KNGRGVIFGQ TSSTFTFADL AKSTSGEGFQ FGKKDPNFKG FSGAGEKLFS
     SQYGKMANKA NTSGDFEKDD DAYKTEDSDD IHFEPVVQMP EKVELVTGEE DEKVLYSQRV
     KLFRFDAEVS QWKERGLGNL KILKNEVNGK LRMLMRREQV LKVCANHWIT TTMNLKPLSG
     SDRAWMWLAS DFSDGDAKLE QLAAKFKTPE LAEEFKQKFE ECQRLLLDIP LQTPHKLVDT
     GRAAKLIQRA EEMKSGLKDF KTFLTNDQTK VTEEENKGSG TGAAGASDTT IKPNPENTGP
     TLEWDNYDLR EDALDDSVSS SSVHASPLAS SPVRKNLFRF GESTTGFNFS FKSALSPSKS
     PAKLNQSGTS VGTDEESDVT QEEERDGQYF EPVVPLPDLV EVSSGEENEQ VVFSHRAKLY
     RYDKDVGQWK ERGIGDIKIL QNYDNKQVRI VMRRDQVLKL CANHRITPDM TLQNMKGTER
     VWLWTACDFA DGERKVEHLA VRFKLQDVAD SFKKIFDEAK TAQEKDSLIT PHVSRSSTPR
     ESPCGKIAVA VLEETTRERT DVIQGDDVAD ATSEVEVSST SETTPKAVVS PPKFVFGSES
     VKSIFSSEKS KPFAFGNSSA TGSLFGFSFN APLKSNNSET SSVAQSGSES KVEPKKCELS
     KNSDIEQSSD SKVKNLFASF PTEESSINYT FKTPEKAKEK KKPEDSPSDD DVLIVYELTP
     TAEQKALATK LKLPPTFFCY KNRPDYVSEE EEDDEDFETA VKKLNGKLYL DGSEKCRPLE
     ENTADNEKEC IIVWEKKPTV EEKAKADTLK LPPTFFCGVC SDTDEDNGNG EDFQSELQKV
     QEAQKSQTEE ITSTTDSVYT GGTEVMVPSF CKSEEPDSIT KSISSPSVSS ETMDKPVDLS
     TRKEIDTDST SQGESKIVSF GFGSSTGLSF ADLASSNSGD FAFGSKDKNF QWANTGAAVF
     GTQSVGTQSA GKVGEDEDGS DEEVVHNEDI HFEPIVSLPE VEVKSGEEDE EILFKERAKL
     YRWDRDVSQW KERGVGDIKI LWHTMKNYYR ILMRRDQVFK VCANHVITKT MELKPLNVSN
     NALVWTASDY ADGEAKVEQL AVRFKTKEVA DCFKKTFEEC QQNLMKLQKG HVSLAAELSK
     ETNPVVFFDV CADGEPLGRI TMELFSNIVP RTAENFRALC TGEKGFGFKN SIFHRVIPDF
     VCQGGDITKH DGTGGQSIYG DKFEDENFDV KHTGPGLLSM ANQGQNTNNS QFVITLKKAE
     HLDFKHVVFG FVKDGMDTVK KIESFGSPKG SVCRRITITE CGQI
//
ID   RHOH_HUMAN              Reviewed;         191 AA.
AC   Q15669;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1997, sequence version 1.
DT   22-APR-2020, entry version 189.
DE   RecName: Full=Rho-related GTP-binding protein RhoH;
DE   AltName: Full=GTP-binding protein TTF;
DE   AltName: Full=Translocation three four protein;
DE   Flags: Precursor;
GN   Name=RHOH; Synonyms=ARHH, TTF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=7784061;
RA   Dallery E., Galiegue-Zouitina S., Collyn-D'Hooghe M., Quief S., Denis C.,
RA   Hildebrand M.-P., Lantoine D., Deweindt C., Tilly H., Bastard C.,
RA   Kerckaert J.-P.;
RT   "TTF, a gene encoding a novel small G protein, fuses to the lymphoma-
RT   associated LAZ3 gene by t(3;4) chromosomal translocation.";
RL   Oncogene 10:2171-2178(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Puhl H.L. III, Ikeda S.R., Aronstam R.S.;
RT   "cDNA clones of human proteins involved in signal transduction sequenced by
RT   the Guthrie cDNA resource center (www.cdna.org).";
RL   Submitted (APR-2002) to the EMBL/GenBank/DDBJ databases.
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=B-cell;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, INTERACTION WITH GDI1 AND GDI2, SUBCELLULAR LOCATION, INDUCTION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=11809807; DOI=10.1128/mcb.22.4.1158-1171.2002;
RA   Li X., Bu X., Lu B., Avraham H., Flavell R.A., Lim B.;
RT   "The hematopoiesis-specific GTP-binding protein RhoH is GTPase deficient
RT   and modulates activities of other Rho GTPases by an inhibitory function.";
RL   Mol. Cell. Biol. 22:1158-1171(2002).
RN   [5]
RP   INTERACTION WITH PAK5.
RX   PubMed=17064668; DOI=10.1016/j.bbrc.2006.09.172;
RA   Wu X., Frost J.A.;
RT   "Multiple Rho proteins regulate the subcellular targeting of PAK5.";
RL   Biochem. Biophys. Res. Commun. 351:328-335(2006).
RN   [6]
RP   FUNCTION, SUBCELLULAR LOCATION, TISSUE SPECIFICITY, AND INDUCTION.
RX   PubMed=19414807; DOI=10.4049/jimmunol.0803846;
RA   Daryadel A., Yousefi S., Troi D., Schmid I., Schmidt-Mende J.,
RA   Mordasini C., Dahinden C.A., Ziemiecki A., Simon H.-U.;
RT   "RhoH/TTF negatively regulates leukotriene production in neutrophils.";
RL   J. Immunol. 182:6527-6532(2009).
RN   [7]
RP   FUNCTION, VARIANT EV4 38-TYR--PHE-191 DEL, AND CHARACTERIZATION OF VARIANT
RP   EV4 38-TYR--PHE-191 DEL.
RX   PubMed=22850876; DOI=10.1172/jci62949;
RA   Crequer A., Troeger A., Patin E., Ma C.S., Picard C., Pedergnana V.,
RA   Fieschi C., Lim A., Abhyankar A., Gineau L., Mueller-Fleckenstein I.,
RA   Schmidt M., Taieb A., Krueger J., Abel L., Tangye S.G., Orth G.,
RA   Williams D.A., Casanova J.L., Jouanguy E.;
RT   "Human RHOH deficiency causes T cell defects and susceptibility to EV-HPV
RT   infections.";
RL   J. Clin. Invest. 122:3239-3247(2012).
CC   -!- FUNCTION: Negative regulator of hematopoietic progenitor cell
CC       proliferation, survival and migration. Critical regulator of thymocyte
CC       development and T-cell antigen receptor (TCR) signaling by mediating
CC       recruitment and activation of ZAP70. Required for phosphorylation of
CC       CD3Z, membrane translocation of ZAP70 and subsequent activation of the
CC       ZAP70-mediated pathways. Essential for efficient beta-selection and
CC       positive selection by promoting the ZAP70-dependent phosphorylation of
CC       the LAT signalosome during pre-TCR and TCR signaling. Crucial for
CC       thymocyte maturation during DN3 to DN4 transition and during positive
CC       selection. Plays critical roles in mast cell function by facilitating
CC       phosphorylation of SYK in Fc epsilon RI-mediated signal transduction.
CC       Essential for the phosphorylation of LAT, LCP2, PLCG1 and PLCG2 and for
CC       Ca(2+) mobilization in mast cells (By similarity). Binds GTP but lacks
CC       intrinsic GTPase activity and is resistant to Rho-specific GTPase-
CC       activating proteins. Inhibits the activation of NF-kappa-B by TNF and
CC       IKKB and the activation of CRK/p38 by TNF. Inhibits activities of RAC1,
CC       RHOA and CDC42. Negatively regulates leukotriene production in
CC       neutrophils. {ECO:0000250, ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807, ECO:0000269|PubMed:22850876}.
CC   -!- SUBUNIT: Interacts with ZAP70 (via SH2 domains) and the interaction is
CC       enhanced by its phosphorylation by LCK. Interacts with SYK and the
CC       interaction is enhanced by its phosphorylation by FYN (By similarity).
CC       Interacts with GDI1 and GDI2. Interacts with PAK5 (By similarity).
CC       {ECO:0000250}.
CC   -!- INTERACTION:
CC       Q15669; Q8N9N5-2: BANP; NbExp=3; IntAct=EBI-1244971, EBI-11524452;
CC       Q15669; P51946: CCNH; NbExp=3; IntAct=EBI-1244971, EBI-741406;
CC       Q15669; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-1244971, EBI-6658203;
CC       Q15669; Q8NA54: IQUB; NbExp=3; IntAct=EBI-1244971, EBI-10220600;
CC       Q15669; O14713: ITGB1BP1; NbExp=3; IntAct=EBI-1244971, EBI-2127319;
CC       Q15669; Q63ZY3: KANK2; NbExp=3; IntAct=EBI-1244971, EBI-2556193;
CC       Q15669; O75431: MTX2; NbExp=3; IntAct=EBI-1244971, EBI-7415268;
CC       Q15669; Q6IQ23-2: PLEKHA7; NbExp=3; IntAct=EBI-1244971, EBI-12069346;
CC       Q15669; O94827-4: PLEKHG5; NbExp=3; IntAct=EBI-1244971, EBI-11980215;
CC       Q15669; Q0D2K3: RIPPLY1; NbExp=3; IntAct=EBI-1244971, EBI-10226430;
CC       Q15669; Q9BWG6: SCNM1; NbExp=3; IntAct=EBI-1244971, EBI-748391;
CC       Q15669; Q92673: SORL1; NbExp=3; IntAct=EBI-1244971, EBI-1171329;
CC       Q15669; P51687: SUOX; NbExp=3; IntAct=EBI-1244971, EBI-3921347;
CC       Q15669; Q9Y242: TCF19; NbExp=3; IntAct=EBI-1244971, EBI-7413767;
CC       Q15669; Q9NQW7-3: XPNPEP1; NbExp=3; IntAct=EBI-1244971, EBI-12079490;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807}. Cell membrane {ECO:0000250}; Lipid-anchor
CC       {ECO:0000250}; Cytoplasmic side {ECO:0000250}. Note=Colocalizes
CC       together with ZAP70 in the immunological synapse. {ECO:0000250}.
CC   -!- TISSUE SPECIFICITY: Expressed only in hematopoietic cells. Present at
CC       very high levels in the thymus, less abundant in the spleen, and least
CC       abundant in the bone marrow. Expressed at a higher level in the TH1
CC       subtype of T-helper cells than in the TH2 subpopulation. Expressed in
CC       neutrophils under inflammatory conditions, such as cystic fibrosis,
CC       ulcerative colitis and appendicitis. {ECO:0000269|PubMed:11809807,
CC       ECO:0000269|PubMed:19414807}.
CC   -!- INDUCTION: By CSF2/GM-CSF. Down-regulated by phorbol myristate acetate
CC       (PMA). {ECO:0000269|PubMed:11809807, ECO:0000269|PubMed:19414807}.
CC   -!- DOMAIN: The region involved in interaction with ZAP70 is a non-
CC       canonical immunoreceptor tyrosine-based activation motif (ITAM).
CC       {ECO:0000250}.
CC   -!- PTM: Phosphorylated on tyrosine by LCK. Phosphorylated by FYN.
CC       Phosphorylation enhances the interactions with ZAP70 and SYK and is
CC       critical for its function in thymocyte development (By similarity).
CC       {ECO:0000250}.
CC   -!- DISEASE: Note=A chromosomal aberration involving RHOH is found in a
CC       non-Hodgkin lymphoma cell line. Translocation t(3;4)(q27;p11) with
CC       BCL6.
CC   -!- DISEASE: Epidermodysplasia verruciformis 4 (EV4) [MIM:618307]: A form
CC       of epidermodysplasia verruciformis, a rare genodermatosis associated
CC       with a high risk of skin carcinoma that results from an abnormal
CC       susceptibility to infection by specific human papillomaviruses,
CC       including the oncogenic HPV5. Infection leads to the early development
CC       of disseminated flat wart-like and pityriasis versicolor-like skin
CC       lesions. Cutaneous Bowen's carcinomas in situ and invasive squamous
CC       cell carcinomas develop in about half of the patients, mainly on sun-
CC       exposed skin areas. EV4 patients have decreased number of naive T
CC       cells, increased memory and effector T cells, and impaired T-cell
CC       receptor signaling. EV4 inheritance is autosomal recessive.
CC       {ECO:0000269|PubMed:22850876}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the small GTPase superfamily. Rho family.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/RHOHID93.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z35227; CAA84538.1; -; mRNA.
DR   EMBL; AF498975; AAM21122.1; -; mRNA.
DR   EMBL; BC014261; AAH14261.1; -; mRNA.
DR   CCDS; CCDS3458.1; -.
DR   PIR; I38367; I38367.
DR   RefSeq; NP_001265288.1; NM_001278359.1.
DR   RefSeq; NP_001265289.1; NM_001278360.1.
DR   RefSeq; NP_001265290.1; NM_001278361.1.
DR   RefSeq; NP_001265291.1; NM_001278362.1.
DR   RefSeq; NP_001265292.1; NM_001278363.1.
DR   RefSeq; NP_001265293.1; NM_001278364.1.
DR   RefSeq; NP_001265294.1; NM_001278365.1.
DR   RefSeq; NP_001265295.1; NM_001278366.1.
DR   RefSeq; NP_001265296.1; NM_001278367.1.
DR   RefSeq; NP_001265297.1; NM_001278368.1.
DR   RefSeq; NP_001265298.1; NM_001278369.1.
DR   RefSeq; NP_004301.1; NM_004310.4.
DR   RefSeq; XP_011511994.1; XM_011513692.1.
DR   RefSeq; XP_016863677.1; XM_017008188.1.
DR   RefSeq; XP_016863678.1; XM_017008189.1.
DR   SMR; Q15669; -.
DR   BioGrid; 106892; 9.
DR   IntAct; Q15669; 20.
DR   MINT; Q15669; -.
DR   STRING; 9606.ENSP00000371219; -.
DR   iPTMnet; Q15669; -.
DR   PhosphoSitePlus; Q15669; -.
DR   BioMuta; RHOH; -.
DR   DMDM; 2500200; -.
DR   MassIVE; Q15669; -.
DR   PaxDb; Q15669; -.
DR   PeptideAtlas; Q15669; -.
DR   PRIDE; Q15669; -.
DR   ProteomicsDB; 60699; -.
DR   Antibodypedia; 23555; 237 antibodies.
DR   DNASU; 399; -.
DR   Ensembl; ENST00000381799; ENSP00000371219; ENSG00000168421.
DR   Ensembl; ENST00000505618; ENSP00000425010; ENSG00000168421.
DR   Ensembl; ENST00000610353; ENSP00000480192; ENSG00000168421.
DR   Ensembl; ENST00000613272; ENSP00000480772; ENSG00000168421.
DR   Ensembl; ENST00000614836; ENSP00000478248; ENSG00000168421.
DR   Ensembl; ENST00000615083; ENSP00000480379; ENSG00000168421.
DR   Ensembl; ENST00000615577; ENSP00000481566; ENSG00000168421.
DR   Ensembl; ENST00000617441; ENSP00000482947; ENSG00000168421.
DR   Ensembl; ENST00000619474; ENSP00000481746; ENSG00000168421.
DR   Ensembl; ENST00000622175; ENSP00000481836; ENSG00000168421.
DR   GeneID; 399; -.
DR   KEGG; hsa:399; -.
DR   CTD; 399; -.
DR   DisGeNET; 399; -.
DR   GeneCards; RHOH; -.
DR   HGNC; HGNC:686; RHOH.
DR   HPA; ENSG00000168421; Tissue enhanced (blood, lymphoid tissue).
DR   MalaCards; RHOH; -.
DR   MIM; 602037; gene.
DR   MIM; 618307; phenotype.
DR   neXtProt; NX_Q15669; -.
DR   OpenTargets; ENSG00000168421; -.
DR   Orphanet; 324294; T-cell immunodeficiency with epidermodysplasia verruciformis.
DR   PharmGKB; PA24979; -.
DR   eggNOG; KOG0393; Eukaryota.
DR   eggNOG; COG1100; LUCA.
DR   GeneTree; ENSGT00940000160078; -.
DR   HOGENOM; CLU_041217_21_3_1; -.
DR   InParanoid; Q15669; -.
DR   KO; K07873; -.
DR   OMA; QQVFEYA; -.
DR   OrthoDB; 1091615at2759; -.
DR   PhylomeDB; Q15669; -.
DR   TreeFam; TF331219; -.
DR   BRENDA; 3.6.5.2; 2681.
DR   Reactome; R-HSA-194840; Rho GTPase cycle.
DR   SIGNOR; Q15669; -.
DR   ChiTaRS; RHOH; human.
DR   GeneWiki; RhoH; -.
DR   GenomeRNAi; 399; -.
DR   Pharos; Q15669; Tbio.
DR   PRO; PR:Q15669; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; Q15669; protein.
DR   Bgee; ENSG00000168421; Expressed in leukocyte and 115 other tissues.
DR   ExpressionAtlas; Q15669; baseline and differential.
DR   Genevisible; Q15669; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; TAS:Reactome.
DR   GO; GO:0005525; F:GTP binding; IDA:UniProtKB.
DR   GO; GO:0003924; F:GTPase activity; IBA:GO_Central.
DR   GO; GO:0005095; F:GTPase inhibitor activity; NAS:UniProtKB.
DR   GO; GO:0019210; F:kinase inhibitor activity; IDA:UniProtKB.
DR   GO; GO:0017048; F:Rho GTPase binding; NAS:UniProtKB.
DR   GO; GO:0045576; P:mast cell activation; IEA:Ensembl.
DR   GO; GO:0043124; P:negative regulation of I-kappaB kinase/NF-kappaB signaling; IDA:UniProtKB.
DR   GO; GO:0045582; P:positive regulation of T cell differentiation; IMP:UniProtKB.
DR   GO; GO:0051056; P:regulation of small GTPase mediated signal transduction; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0007266; P:Rho protein signal transduction; IBA:GO_Central.
DR   GO; GO:0030217; P:T cell differentiation; NAS:UniProtKB.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   InterPro; IPR003578; Small_GTPase_Rho.
DR   Pfam; PF00071; Ras; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51420; RHO; 1.
PE   1: Evidence at protein level;
KW   Cell membrane; Chromosomal rearrangement; Cytoplasm; Disease mutation;
KW   GTP-binding; Lipoprotein; Membrane; Methylation; Nucleotide-binding;
KW   Phosphoprotein; Prenylation; Reference proteome.
FT   CHAIN           1..188
FT                   /note="Rho-related GTP-binding protein RhoH"
FT                   /id="PRO_0000198867"
FT   PROPEP          189..191
FT                   /note="Removed in mature form"
FT                   /evidence="ECO:0000250"
FT                   /id="PRO_0000281218"
FT   NP_BIND         11..18
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         58..62
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   NP_BIND         116..119
FT                   /note="GTP"
FT                   /evidence="ECO:0000250"
FT   REGION          73..86
FT                   /note="Interaction with ZAP70"
FT                   /evidence="ECO:0000250"
FT   MOTIF           33..41
FT                   /note="Effector region"
FT                   /evidence="ECO:0000250"
FT   MOD_RES         188
FT                   /note="Cysteine methyl ester"
FT                   /evidence="ECO:0000250"
FT   LIPID           188
FT                   /note="S-geranylgeranyl cysteine"
FT                   /evidence="ECO:0000250"
FT   VARIANT         38..191
FT                   /note="Missing (in EV4; loss-of-function variant resulting
FT                   in impaired T-cell differentiation; unable to rescue T-cell
FT                   lymphopenia in RHOH knockout mice; no protein detected in
FT                   patient cells; results in defective TCR signaling in
FT                   patient cells)"
FT                   /evidence="ECO:0000269|PubMed:22850876"
FT                   /id="VAR_081933"
SQ   SEQUENCE   191 AA;  21331 MW;  C5BF8929AD1E59D0 CRC64;
     MLSSIKCVLV GDSAVGKTSL LVRFTSETFP EAYKPTVYEN TGVDVFMDGI QISLGLWDTA
     GNDAFRSIRP LSYQQADVVL MCYSVANHNS FLNLKNKWIG EIRSNLPCTP VLVVATQTDQ
     REMGPHRASC VNAMEGKKLA QDVRAKGYLE CSALSNRGVQ QVFECAVRTA VNQARRRNRR
     RLFSINECKI F
//
ID   Q6ICP4_HUMAN            Unreviewed;       191 AA.
AC   Q6ICP4; A0A024R9S8;
DT   10-MAY-2005, integrated into UniProtKB/TrEMBL.
DT   10-MAY-2005, sequence version 1.
DT   22-APR-2020, entry version 139.
DE   SubName: Full=ARHH protein {ECO:0000313|EMBL:CAG29345.1};
DE   SubName: Full=Ras homolog gene family, member H, isoform CRA_a {ECO:0000313|EMBL:EAW92960.1};
DE   SubName: Full=cDNA, FLJ94345, Homo sapiens ras homolog gene family, member H (ARHH), mRNA {ECO:0000313|EMBL:BAG36484.1};
DE   Flags: Fragment;
GN   Name=ARHH {ECO:0000313|EMBL:CAG29345.1};
GN   Synonyms=RHOH {ECO:0000313|EMBL:EAW92960.1};
GN   ORFNames=hCG_37394 {ECO:0000313|EMBL:EAW92960.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAG29345.1};
RN   [1] {ECO:0000313|EMBL:EAW92960.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:CAG29345.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (MAY-2004) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:EAW92960.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4] {ECO:0000313|EMBL:BAG36484.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Kaida T., Tsuchiya K., Iida Y.,
RA   Takayama Y., Murakawa K., Kanehori K., Andoh T., Kagawa N., Sato R.,
RA   Kawamura Y., Tanaka S., Kisu Y., Sugano S., Goshima N., Nomura N.,
RA   Isogai T.;
RT   "NEDO functional analysis of protein and research application project.";
RL   Submitted (JAN-2008) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK313744; BAG36484.1; -; mRNA.
DR   EMBL; CR450349; CAG29345.1; -; mRNA.
DR   EMBL; CH471069; EAW92960.1; -; Genomic_DNA.
DR   EMBL; CH471069; EAW92961.1; -; Genomic_DNA.
DR   EMBL; CH471069; EAW92962.1; -; Genomic_DNA.
DR   RefSeq; NP_001265288.1; NM_001278359.1.
DR   RefSeq; NP_001265289.1; NM_001278360.1.
DR   RefSeq; NP_001265290.1; NM_001278361.1.
DR   RefSeq; NP_001265291.1; NM_001278362.1.
DR   RefSeq; NP_001265292.1; NM_001278363.1.
DR   RefSeq; NP_001265293.1; NM_001278364.1.
DR   RefSeq; NP_001265294.1; NM_001278365.1.
DR   RefSeq; NP_001265295.1; NM_001278366.1.
DR   RefSeq; NP_001265296.1; NM_001278367.1.
DR   RefSeq; NP_001265297.1; NM_001278368.1.
DR   RefSeq; NP_001265298.1; NM_001278369.1.
DR   RefSeq; NP_004301.1; NM_004310.4.
DR   RefSeq; XP_011511994.1; XM_011513692.1.
DR   RefSeq; XP_016863677.1; XM_017008188.1.
DR   RefSeq; XP_016863678.1; XM_017008189.1.
DR   IntAct; Q6ICP4; 3.
DR   Antibodypedia; 23555; 237 antibodies.
DR   DNASU; 399; -.
DR   GeneID; 399; -.
DR   KEGG; hsa:399; -.
DR   UCSC; uc003guz.4; human.
DR   CTD; 399; -.
DR   EuPathDB; HostDB:ENSG00000168421.12; -.
DR   PharmGKB; PA24979; -.
DR   eggNOG; KOG0393; Eukaryota.
DR   eggNOG; COG1100; LUCA.
DR   HOGENOM; CLU_041217_21_3_1; -.
DR   KO; K07873; -.
DR   OMA; QQVFEYA; -.
DR   OrthoDB; 1091615at2759; -.
DR   ChiTaRS; RHOH; human.
DR   GenomeRNAi; 399; -.
DR   Bgee; ENSG00000168421; Expressed in leukocyte and 115 other tissues.
DR   GO; GO:0005737; C:cytoplasm; IEA:Ensembl.
DR   GO; GO:0001772; C:immunological synapse; IEA:Ensembl.
DR   GO; GO:0005525; F:GTP binding; IEA:UniProtKB-KW.
DR   GO; GO:0003924; F:GTPase activity; IEA:InterPro.
DR   GO; GO:0045576; P:mast cell activation; IEA:Ensembl.
DR   GO; GO:0007264; P:small GTPase mediated signal transduction; IEA:InterPro.
DR   GO; GO:0030217; P:T cell differentiation; IEA:Ensembl.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR005225; Small_GTP-bd_dom.
DR   InterPro; IPR001806; Small_GTPase.
DR   InterPro; IPR003578; Small_GTPase_Rho.
DR   Pfam; PF00071; Ras; 1.
DR   SUPFAM; SSF52540; SSF52540; 1.
DR   TIGRFAMs; TIGR00231; small_GTP; 1.
DR   PROSITE; PS51420; RHO; 1.
PE   2: Evidence at transcript level;
KW   GTP-binding {ECO:0000256|SAAS:SAAS00466048};
KW   Nucleotide-binding {ECO:0000256|SAAS:SAAS00466048}.
FT   NON_TER         191
FT                   /evidence="ECO:0000313|EMBL:CAG29345.1"
SQ   SEQUENCE   191 AA;  21331 MW;  C5BF8929AD1E59D0 CRC64;
     MLSSIKCVLV GDSAVGKTSL LVRFTSETFP EAYKPTVYEN TGVDVFMDGI QISLGLWDTA
     GNDAFRSIRP LSYQQADVVL MCYSVANHNS FLNLKNKWIG EIRSNLPCTP VLVVATQTDQ
     REMGPHRASC VNAMEGKKLA QDVRAKGYLE CSALSNRGVQ QVFECAVRTA VNQARRRNRR
     RLFSINECKI F
//
ID   RMI2_HUMAN              Reviewed;         147 AA.
AC   Q96E14; B3KVZ6; Q49AE2; Q8TBL0;
DT   21-AUG-2007, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2004, sequence version 2.
DT   22-APR-2020, entry version 131.
DE   RecName: Full=RecQ-mediated genome instability protein 2;
DE            Short=hRMI2;
DE   AltName: Full=BLM-associated protein of 18 kDa;
DE            Short=BLAP18;
GN   Name=RMI2; Synonyms=C16orf75;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15616553; DOI=10.1038/nature03187;
RA   Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G.,
RA   Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E.,
RA   Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J., Buckingham J.M.,
RA   Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C.,
RA   Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M.,
RA   Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M.,
RA   Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D.,
RA   Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L.,
RA   Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E.,
RA   Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H.,
RA   Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y.,
RA   Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J.,
RA   Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D.,
RA   Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S.,
RA   Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A.,
RA   Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M.,
RA   Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H.,
RA   Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A.,
RA   Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J.,
RA   DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J.,
RA   Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M.,
RA   Myers R.M., Rubin E.M., Pennacchio L.A.;
RT   "The sequence and analysis of duplication-rich human chromosome 16.";
RL   Nature 432:988-994(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Lung, Lymph, Skin, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   FUNCTION, IDENTIFICATION IN THE RMI COMPLEX, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LYS-121.
RX   PubMed=18923082; DOI=10.1101/gad.1708608;
RA   Xu D., Guo R., Sobeck A., Bachrati C.Z., Yang J., Enomoto T., Brown G.W.,
RA   Hoatlin M.E., Hickson I.D., Wang W.;
RT   "RMI, a new OB-fold complex essential for Bloom syndrome protein to
RT   maintain genome stability.";
RL   Genes Dev. 22:2843-2855(2008).
RN   [6]
RP   FUNCTION, IDENTIFICATION IN THE RMI COMPLEX, IDENTIFICATION BY MASS
RP   SPECTROMETRY, PHOSPHORYLATION, AND MUTAGENESIS OF LYS-24; TRP-59; LYS-100;
RP   LYS-121 AND TRP-135.
RX   PubMed=18923083; DOI=10.1101/gad.1725108;
RA   Singh T.R., Ali A.M., Busygina V., Raynard S., Fan Q., Du C.-H.,
RA   Andreassen P.R., Sung P., Meetei A.R.;
RT   "BLAP18/RMI2, a novel OB-fold-containing protein, is an essential component
RT   of the Bloom helicase-double Holliday junction dissolvasome.";
RL   Genes Dev. 22:2856-2868(2008).
RN   [7]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, PHOSPHORYLATION [LARGE SCALE
RP   ANALYSIS] AT SER-7, CLEAVAGE OF INITIATOR METHIONINE [LARGE SCALE
RP   ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [8]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, CLEAVAGE OF INITIATOR
RP   METHIONINE [LARGE SCALE ANALYSIS], AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=22814378; DOI=10.1073/pnas.1210303109;
RA   Van Damme P., Lasa M., Polevoda B., Gazquez C., Elosegui-Artola A.,
RA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole K., Larrea E., Timmerman E.,
RA   Prieto J., Arnesen T., Sherman F., Gevaert K., Aldabe R.;
RT   "N-terminal acetylome analyses and functional insights of the N-terminal
RT   acetyltransferase NatB.";
RL   Proc. Natl. Acad. Sci. U.S.A. 109:12449-12454(2012).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-7, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [10]
RP   FUNCTION, AND PROBABLE INVOLVEMENT IN BLOOM-LIKE SYNDROME.
RX   PubMed=27977684; DOI=10.1371/journal.pgen.1006483;
RA   Hudson D.F., Amor D.J., Boys A., Butler K., Williams L., Zhang T.,
RA   Kalitsis P.;
RT   "Loss of RMI2 increases genome instability and causes a Bloom-like
RT   syndrome.";
RL   PLoS Genet. 12:E1006483-E1006483(2016).
CC   -!- FUNCTION: Essential component of the RMI complex, a complex that plays
CC       an important role in the processing of homologous recombination
CC       intermediates. It is required to regulate sister chromatid segregation
CC       and to limit DNA crossover. Essential for the stability, localization,
CC       and function of BLM, TOP3A, and complexes containing BLM. In the RMI
CC       complex, it is required to target BLM to chromatin and stress-induced
CC       nuclear foci and mitotic phosphorylation of BLM.
CC       {ECO:0000269|PubMed:18923082, ECO:0000269|PubMed:18923083,
CC       ECO:0000269|PubMed:27977684}.
CC   -!- SUBUNIT: Component of the RMI complex, containing at least TOP3A, RMI1
CC       and RMI2. The RMI complex interacts with BLM.
CC       {ECO:0000269|PubMed:18923082, ECO:0000269|PubMed:18923083}.
CC   -!- INTERACTION:
CC       Q96E14; Q9H9A7: RMI1; NbExp=4; IntAct=EBI-2555534, EBI-621339;
CC       Q96E14-1; Q9H9A7: RMI1; NbExp=13; IntAct=EBI-15876491, EBI-621339;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:18923082}.
CC       Note=Colocalizes with BLM at nuclear DNA repair foci.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q96E14-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q96E14-2; Sequence=VSP_027287;
CC   -!- PTM: Phosphorylated during mitosis. {ECO:0000269|PubMed:18923083}.
CC   -!- DISEASE: Note=A homozygous deletion of RMI2 has been found in a family
CC       with a Bloom-like syndrome and is probable responsible for the
CC       phenotype. Patients manifest depigmented skin lesions, multiple cafe-
CC       au-lait macules, and growth deficiency. Cells from affected individuals
CC       show a high rate of sister chromatid exchange and increased chromosomal
CC       breaks. {ECO:0000269|PubMed:27977684}.
CC   -!- SIMILARITY: Belongs to the RMI2 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK123764; BAG53958.1; -; mRNA.
DR   EMBL; AC009121; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471112; EAW85155.1; -; Genomic_DNA.
DR   EMBL; BC013040; AAH13040.2; -; mRNA.
DR   EMBL; BC022427; AAH22427.1; -; mRNA.
DR   EMBL; BC031016; AAH31016.1; -; mRNA.
DR   EMBL; BC039361; AAH39361.1; -; mRNA.
DR   CCDS; CCDS10548.1; -. [Q96E14-1]
DR   RefSeq; NP_689521.1; NM_152308.2. [Q96E14-1]
DR   PDB; 3MXN; X-ray; 1.55 A; B=1-147.
DR   PDB; 3NBH; X-ray; 2.00 A; B=6-147.
DR   PDB; 4DAY; X-ray; 3.30 A; B=1-147.
DR   PDBsum; 3MXN; -.
DR   PDBsum; 3NBH; -.
DR   PDBsum; 4DAY; -.
DR   SMR; Q96E14; -.
DR   BioGrid; 125466; 19.
DR   ComplexPortal; CPX-3301; BTR double Holliday Junction dissolution complex.
DR   DIP; DIP-56480N; -.
DR   IntAct; Q96E14; 11.
DR   MINT; Q96E14; -.
DR   STRING; 9606.ENSP00000310356; -.
DR   iPTMnet; Q96E14; -.
DR   PhosphoSitePlus; Q96E14; -.
DR   BioMuta; RMI2; -.
DR   DMDM; 74731517; -.
DR   EPD; Q96E14; -.
DR   jPOST; Q96E14; -.
DR   MassIVE; Q96E14; -.
DR   MaxQB; Q96E14; -.
DR   PaxDb; Q96E14; -.
DR   PeptideAtlas; Q96E14; -.
DR   PRIDE; Q96E14; -.
DR   ProteomicsDB; 76362; -. [Q96E14-1]
DR   ProteomicsDB; 76363; -. [Q96E14-2]
DR   Antibodypedia; 52376; 34 antibodies.
DR   Ensembl; ENST00000312499; ENSP00000310356; ENSG00000175643. [Q96E14-1]
DR   Ensembl; ENST00000572173; ENSP00000461206; ENSG00000175643. [Q96E14-2]
DR   GeneID; 116028; -.
DR   KEGG; hsa:116028; -.
DR   UCSC; uc002daw.2; human. [Q96E14-1]
DR   CTD; 116028; -.
DR   DisGeNET; 116028; -.
DR   GeneCards; RMI2; -.
DR   HGNC; HGNC:28349; RMI2.
DR   HPA; ENSG00000175643; Tissue enhanced (lymphoid tissue, testis).
DR   MalaCards; RMI2; -.
DR   MIM; 612426; gene.
DR   neXtProt; NX_Q96E14; -.
DR   OpenTargets; ENSG00000175643; -.
DR   Orphanet; 508512; Congenital multiple cafe-au-lait macules-increased sister chromatid exchange syndrome.
DR   PharmGKB; PA145149635; -.
DR   eggNOG; ENOG410IXR6; Eukaryota.
DR   eggNOG; ENOG41120UE; LUCA.
DR   GeneTree; ENSGT00390000001653; -.
DR   HOGENOM; CLU_2526905_0_0_1; -.
DR   InParanoid; Q96E14; -.
DR   KO; K15365; -.
DR   OMA; VVWMQGT; -.
DR   OrthoDB; 1604165at2759; -.
DR   PhylomeDB; Q96E14; -.
DR   TreeFam; TF332971; -.
DR   Reactome; R-HSA-5685938; HDR through Single Strand Annealing (SSA).
DR   Reactome; R-HSA-5685942; HDR through Homologous Recombination (HRR).
DR   Reactome; R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent Strand Annealing (SDSA).
DR   Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday Junction Intermediates.
DR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and strand exchange.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   GenomeRNAi; 116028; -.
DR   Pharos; Q96E14; Tbio.
DR   PRO; PR:Q96E14; -.
DR   Proteomes; UP000005640; Chromosome 16.
DR   RNAct; Q96E14; protein.
DR   Bgee; ENSG00000175643; Expressed in placenta and 136 other tissues.
DR   ExpressionAtlas; Q96E14; baseline and differential.
DR   Genevisible; Q96E14; HS.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0006281; P:DNA repair; IBA:GO_Central.
DR   GO; GO:0006260; P:DNA replication; TAS:Reactome.
DR   GO; GO:0043007; P:maintenance of rDNA; IBA:GO_Central.
DR   GO; GO:2000042; P:negative regulation of double-strand break repair via homologous recombination; IBA:GO_Central.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0033045; P:regulation of sister chromatid segregation; IMP:UniProtKB.
DR   InterPro; IPR032245; RMI2.
DR   PANTHER; PTHR33962; PTHR33962; 1.
DR   Pfam; PF16100; RMI2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; DNA replication;
KW   DNA-binding; Nucleus; Phosphoprotein; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:22814378"
FT   CHAIN           2..147
FT                   /note="RecQ-mediated genome instability protein 2"
FT                   /id="PRO_0000297577"
FT   DNA_BIND        44..114
FT                   /note="OB"
FT   MOD_RES         2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:22814378"
FT   MOD_RES         7
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   VAR_SEQ         1..98
FT                   /note="MAAAADSFSGGPAGVRLPRSPPLKVLAEQLRRDAEGGPGAWRLSRAAAGRGP
FT                   LDLAAVWMQGRVVMADRGEARLRDPSGDFSVRGLERVPRGRPCLVP -> MKQTQVGSL
FT                   FSLGIRNPEPGPVSGTAVPRQLAWKS (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_027287"
FT   MUTAGEN         24
FT                   /note="K->A: Abolishes interaction with RMI1, TOP3A and
FT                   BLM."
FT                   /evidence="ECO:0000269|PubMed:18923083"
FT   MUTAGEN         59
FT                   /note="W->A: According to PubMed:18923083, abolishes
FT                   interaction with RMI1, TOP3A and BLM. According to
FT                   PubMed:18923082, does not affects interaction with RMI1 and
FT                   TOP3A."
FT                   /evidence="ECO:0000269|PubMed:18923083"
FT   MUTAGEN         100
FT                   /note="K->A: Does not affect interaction with RMI1, TOP3A
FT                   and BLM."
FT                   /evidence="ECO:0000269|PubMed:18923083"
FT   MUTAGEN         121
FT                   /note="K->A: According to PubMed:18923083, does not affect
FT                   interaction with RMI1, TOP3A and BLM. According to
FT                   PubMed:18923082, affects interaction with BLM and the BMI
FT                   complex."
FT                   /evidence="ECO:0000269|PubMed:18923082,
FT                   ECO:0000269|PubMed:18923083"
FT   MUTAGEN         135
FT                   /note="W->A: Abolishes interaction with RMI1, TOP3A and
FT                   BLM."
FT                   /evidence="ECO:0000269|PubMed:18923083"
FT   HELIX           27..33
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          34..36
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          40..43
FT                   /evidence="ECO:0000244|PDB:3NBH"
FT   TURN            46..49
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          56..68
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          71..76
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          79..84
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   HELIX           86..88
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          92..94
FT                   /evidence="ECO:0000244|PDB:4DAY"
FT   STRAND          101..110
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          112..114
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   STRAND          116..124
FT                   /evidence="ECO:0000244|PDB:3MXN"
FT   HELIX           130..143
FT                   /evidence="ECO:0000244|PDB:3MXN"
SQ   SEQUENCE   147 AA;  15865 MW;  C385825F9AB4439E CRC64;
     MAAAADSFSG GPAGVRLPRS PPLKVLAEQL RRDAEGGPGA WRLSRAAAGR GPLDLAAVWM
     QGRVVMADRG EARLRDPSGD FSVRGLERVP RGRPCLVPGK YVMVMGVVQA CSPEPCLQAV
     KMTDLSDNPI HESMWELEVE DLHRNIP
//
ID   RL22_HUMAN              Reviewed;         128 AA.
AC   P35268; B2R495; Q6IBD1;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   23-JAN-2007, sequence version 2.
DT   22-APR-2020, entry version 194.
DE   RecName: Full=60S ribosomal protein L22;
DE   AltName: Full=EBER-associated protein;
DE            Short=EAP;
DE   AltName: Full=Epstein-Barr virus small RNA-associated protein;
DE   AltName: Full=Heparin-binding protein HBp15;
DE   AltName: Full=Large ribosomal subunit protein eL22 {ECO:0000303|PubMed:24524803};
GN   Name=RPL22;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], AND PROTEIN SEQUENCE OF 2-46 AND 108-125.
RC   TISSUE=Placenta;
RX   PubMed=1846807; DOI=10.1002/j.1460-2075.1991.tb07968.x;
RA   Toczyski D.P.W., Steitz J.A.;
RT   "EAP, a highly conserved cellular protein associated with Epstein-Barr
RT   virus small RNAs (EBERs).";
RL   EMBO J. 10:459-466(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Submandibular gland;
RX   PubMed=8135813; DOI=10.1006/bbrc.1994.1286;
RA   Fujita Y., Okamoto T., Noshiro M., Kato Y., Takada K., Sato J.D., Ozaki T.,
RA   McKeehan W.L., Crabb J.W., Whitney R.G.;
RT   "A novel heparin-binding protein, HBp15, is identified as mammalian
RT   ribosomal protein L22.";
RL   Biochem. Biophys. Res. Commun. 199:706-713(1994).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RA   Ebert L., Schick M., Neubert P., Schatten R., Henze S., Korn B.;
RT   "Cloning of human full open reading frames in Gateway(TM) system entry
RT   vector (pDONR201).";
RL   Submitted (JUN-2004) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   PROTEIN SEQUENCE OF 2-10; 53-65; 70-81 AND 102-113, CLEAVAGE OF INITIATOR
RP   METHIONINE, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RA   Bienvenut W.V., Calvo F., Kolch W.;
RL   Submitted (FEB-2008) to UniProtKB.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain, Cervix, and Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [9]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [10]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-66, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [12]
RP   NOMENCLATURE.
RX   PubMed=24524803; DOI=10.1016/j.sbi.2014.01.002;
RA   Ban N., Beckmann R., Cate J.H.D., Dinman J.D., Dragon F., Ellis S.R.,
RA   Lafontaine D.L.J., Lindahl L., Liljas A., Lipton J.M., McAlear M.A.,
RA   Moore P.B., Noller H.F., Ortega J., Panse V.G., Ramakrishnan V.,
RA   Spahn C.M.T., Steitz T.A., Tchorzewski M., Tollervey D., Warren A.J.,
RA   Williamson J.R., Wilson D., Yonath A., Yusupov M.;
RT   "A new system for naming ribosomal proteins.";
RL   Curr. Opin. Struct. Biol. 24:165-169(2014).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [14]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [15]
RP   STRUCTURE BY ELECTRON MICROSCOPY (5.0 ANGSTROMS).
RX   PubMed=23636399; DOI=10.1038/nature12104;
RA   Anger A.M., Armache J.P., Berninghausen O., Habeck M., Subklewe M.,
RA   Wilson D.N., Beckmann R.;
RT   "Structures of the human and Drosophila 80S ribosome.";
RL   Nature 497:80-85(2013).
CC   -!- INTERACTION:
CC       P35268; P35268; NbExp=3; IntAct=EBI-354533, EBI-354533;
CC       P35268; Q96CW1: AP2M1; NbExp=3; IntAct=EBI-354533, EBI-297683;
CC       P35268; Q8N7W2-2: BEND7; NbExp=5; IntAct=EBI-354533, EBI-10181188;
CC       P35268; Q5HYN5: CT45A1; NbExp=3; IntAct=EBI-354533, EBI-12051833;
CC       P35268; Q96D03: DDIT4L; NbExp=3; IntAct=EBI-354533, EBI-742054;
CC       P35268; Q92914: FGF11; NbExp=3; IntAct=EBI-354533, EBI-11987787;
CC       P35268; U3KQK0: H2BC15; NbExp=3; IntAct=EBI-354533, EBI-12142839;
CC       P35268; P17473: IE; Xeno; NbExp=2; IntAct=EBI-354533, EBI-11702772;
CC       P35268; O00560: SDCBP; NbExp=5; IntAct=EBI-354533, EBI-727004;
CC       P35268; Q9H190: SDCBP2; NbExp=5; IntAct=EBI-354533, EBI-742426;
CC       P35268; Q96MF2: STAC3; NbExp=3; IntAct=EBI-354533, EBI-745680;
CC       P35268; O75683: SURF6; NbExp=3; IntAct=EBI-354533, EBI-2691252;
CC       P35268; Q9NVV9: THAP1; NbExp=3; IntAct=EBI-354533, EBI-741515;
CC       P35268; Q8TBK6: ZCCHC10; NbExp=3; IntAct=EBI-354533, EBI-597063;
CC   -!- MISCELLANEOUS: Binds to Epstein-Barr virus small RNAs and to heparin.
CC   -!- SIMILARITY: Belongs to the eukaryotic ribosomal protein eL22 family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X59357; CAA42007.1; -; mRNA.
DR   EMBL; D17652; BAA04545.1; -; mRNA.
DR   EMBL; AK311749; BAG34692.1; -; mRNA.
DR   EMBL; CR456873; CAG33154.1; -; mRNA.
DR   EMBL; AL031847; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471130; EAW71518.1; -; Genomic_DNA.
DR   EMBL; BC035566; AAH35566.1; -; mRNA.
DR   EMBL; BC058887; AAH58887.1; -; mRNA.
DR   EMBL; BC066314; AAH66314.1; -; mRNA.
DR   CCDS; CCDS58.1; -.
DR   PIR; JC2120; JC2120.
DR   RefSeq; NP_000974.1; NM_000983.3.
DR   PDB; 4UG0; EM; -; LU=1-128.
DR   PDB; 4V6X; EM; 5.00 A; CU=1-128.
DR   PDB; 5AJ0; EM; 3.50 A; AU=1-128.
DR   PDB; 5LKS; EM; 3.60 A; LU=1-128.
DR   PDB; 5T2C; EM; 3.60 A; O=1-128.
DR   PDB; 6EK0; EM; 2.90 A; LU=1-128.
DR   PDB; 6IP5; EM; 3.90 A; 2O=1-128.
DR   PDB; 6IP6; EM; 4.50 A; 2O=1-128.
DR   PDB; 6IP8; EM; 3.90 A; 2O=1-128.
DR   PDB; 6OLE; EM; 3.10 A; V=18-116.
DR   PDB; 6OLF; EM; 3.90 A; V=18-116.
DR   PDB; 6OLG; EM; 3.40 A; AU=18-116.
DR   PDB; 6OLI; EM; 3.50 A; V=18-116.
DR   PDB; 6OLZ; EM; 3.90 A; AU=18-116.
DR   PDB; 6OM0; EM; 3.10 A; V=18-116.
DR   PDB; 6OM7; EM; 3.70 A; V=18-116.
DR   PDB; 6QZP; EM; 2.90 A; LU=17-117.
DR   PDBsum; 4UG0; -.
DR   PDBsum; 4V6X; -.
DR   PDBsum; 5AJ0; -.
DR   PDBsum; 5LKS; -.
DR   PDBsum; 5T2C; -.
DR   PDBsum; 6EK0; -.
DR   PDBsum; 6IP5; -.
DR   PDBsum; 6IP6; -.
DR   PDBsum; 6IP8; -.
DR   PDBsum; 6OLE; -.
DR   PDBsum; 6OLF; -.
DR   PDBsum; 6OLG; -.
DR   PDBsum; 6OLI; -.
DR   PDBsum; 6OLZ; -.
DR   PDBsum; 6OM0; -.
DR   PDBsum; 6OM7; -.
DR   PDBsum; 6QZP; -.
DR   SMR; P35268; -.
DR   BioGrid; 112066; 249.
DR   CORUM; P35268; -.
DR   IntAct; P35268; 88.
DR   MINT; P35268; -.
DR   STRING; 9606.ENSP00000346088; -.
DR   iPTMnet; P35268; -.
DR   PhosphoSitePlus; P35268; -.
DR   SwissPalm; P35268; -.
DR   BioMuta; RPL22; -.
DR   SWISS-2DPAGE; P35268; -.
DR   EPD; P35268; -.
DR   jPOST; P35268; -.
DR   MassIVE; P35268; -.
DR   MaxQB; P35268; -.
DR   PaxDb; P35268; -.
DR   PeptideAtlas; P35268; -.
DR   PRIDE; P35268; -.
DR   ProteomicsDB; 55018; -.
DR   TopDownProteomics; P35268; -.
DR   Antibodypedia; 27215; 178 antibodies.
DR   Ensembl; ENST00000234875; ENSP00000346088; ENSG00000116251.
DR   GeneID; 6146; -.
DR   KEGG; hsa:6146; -.
DR   UCSC; uc001amd.4; human.
DR   CTD; 6146; -.
DR   DisGeNET; 6146; -.
DR   GeneCards; RPL22; -.
DR   HGNC; HGNC:10315; RPL22.
DR   HPA; ENSG00000116251; Low tissue specificity.
DR   MIM; 180474; gene.
DR   neXtProt; NX_P35268; -.
DR   OpenTargets; ENSG00000116251; -.
DR   PharmGKB; PA34688; -.
DR   eggNOG; KOG3434; Eukaryota.
DR   eggNOG; ENOG4111UVJ; LUCA.
DR   GeneTree; ENSGT00940000153314; -.
DR   HOGENOM; CLU_105624_0_1_1; -.
DR   InParanoid; P35268; -.
DR   KO; K02891; -.
DR   OMA; YQLRFYN; -.
DR   OrthoDB; 1594080at2759; -.
DR   PhylomeDB; P35268; -.
DR   TreeFam; TF313018; -.
DR   Reactome; R-HSA-156827; L13a-mediated translational silencing of Ceruloplasmin expression.
DR   Reactome; R-HSA-156902; Peptide chain elongation.
DR   Reactome; R-HSA-1799339; SRP-dependent cotranslational protein targeting to membrane.
DR   Reactome; R-HSA-192823; Viral mRNA Translation.
DR   Reactome; R-HSA-2408557; Selenocysteine synthesis.
DR   Reactome; R-HSA-6791226; Major pathway of rRNA processing in the nucleolus and cytosol.
DR   Reactome; R-HSA-72689; Formation of a pool of free 40S subunits.
DR   Reactome; R-HSA-72706; GTP hydrolysis and joining of the 60S ribosomal subunit.
DR   Reactome; R-HSA-72764; Eukaryotic Translation Termination.
DR   Reactome; R-HSA-9010553; Regulation of expression of SLITs and ROBOs.
DR   Reactome; R-HSA-9633012; Response of EIF2AK4 (GCN2) to amino acid deficiency.
DR   Reactome; R-HSA-975956; Nonsense Mediated Decay (NMD) independent of the Exon Junction Complex (EJC).
DR   Reactome; R-HSA-975957; Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC).
DR   SIGNOR; P35268; -.
DR   ChiTaRS; RPL22; human.
DR   GeneWiki; RPL22; -.
DR   GenomeRNAi; 6146; -.
DR   Pharos; P35268; Tbio.
DR   PRO; PR:P35268; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P35268; protein.
DR   Bgee; ENSG00000116251; Expressed in left ovary and 229 other tissues.
DR   ExpressionAtlas; P35268; baseline and differential.
DR   Genevisible; P35268; HS.
DR   GO; GO:0005737; C:cytoplasm; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0022625; C:cytosolic large ribosomal subunit; HDA:UniProtKB.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:1990904; C:ribonucleoprotein complex; IDA:MGI.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0003735; F:structural constituent of ribosome; TAS:ProtInc.
DR   GO; GO:0002181; P:cytoplasmic translation; IBA:GO_Central.
DR   GO; GO:0000184; P:nuclear-transcribed mRNA catabolic process, nonsense-mediated decay; TAS:Reactome.
DR   GO; GO:0006614; P:SRP-dependent cotranslational protein targeting to membrane; TAS:Reactome.
DR   GO; GO:0006412; P:translation; TAS:ProtInc.
DR   GO; GO:0006413; P:translational initiation; TAS:Reactome.
DR   GO; GO:0019083; P:viral transcription; TAS:Reactome.
DR   Gene3D; 3.30.1360.210; -; 1.
DR   InterPro; IPR002671; Ribosomal_L22e.
DR   InterPro; IPR038526; Ribosomal_L22e_sf.
DR   PANTHER; PTHR10064; PTHR10064; 1.
DR   Pfam; PF01776; Ribosomal_L22e; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Direct protein sequencing; Heparin-binding; Phosphoprotein;
KW   Reference proteome; Ribonucleoprotein; Ribosomal protein; RNA-binding.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000269|PubMed:1846807, ECO:0000269|Ref.5"
FT   CHAIN           2..128
FT                   /note="60S ribosomal protein L22"
FT                   /id="PRO_0000215501"
FT   COMPBIAS        120..128
FT                   /note="Asp/Glu-rich (highly acidic)"
FT   MOD_RES         62
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P67984"
FT   MOD_RES         66
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         69
FT                   /note="N6-succinyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:P67984"
SQ   SEQUENCE   128 AA;  14787 MW;  0F3ED8BE70C9F962 CRC64;
     MAPVKKLVVK GGKKKKQVLK FTLDCTHPVE DGIMDAANFE QFLQERIKVN GKAGNLGGGV
     VTIERSKSKI TVTSEVPFSK RYLKYLTKKY LKKNNLRDWL RVVANSKESY ELRYFQINQD
     EEEEEDED
//
ID   B3KVP3_HUMAN            Unreviewed;       154 AA.
AC   B3KVP3;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 63.
DE   SubName: Full=cDNA FLJ41031 fis, clone DFNES2000146, highly similar to R-spondin-2 {ECO:0000313|EMBL:BAG53855.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG53855.1};
RN   [1] {ECO:0000313|EMBL:BAG53855.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Ninomiya K., Wagatsuma M., Kanda K., Kondo H., Yokoi T., Kodaira H.,
RA   Furuya T., Takahashi M., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Sugiyama T., Irie R.,
RA   Otsuki T., Sato H., Wakamatsu A., Ishii S., Yamamoto J., Isono Y.,
RA   Kawai-Hio Y., Saito K., Nishikawa T., Kimura K., Yamashita H., Matsuo K.,
RA   Nakamura Y., Sekine M., Kikuchi H., Murakawa K., Kanehori K.,
RA   Takahashi-Fujii A., Oshima A., Sugiyama A., Kawakami B., Suzuki Y.,
RA   Sugano S., Nagahari K., Masuho Y., Nagai K., Isogai T.;
RT   "NEDO human cDNA sequencing project.";
RL   Submitted (JUL-2003) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK123027; BAG53855.1; -; mRNA.
DR   RefSeq; NP_001304871.1; NM_001317942.1.
DR   RefSeq; NP_848660.3; NM_178565.4.
DR   SMR; B3KVP3; -.
DR   PRIDE; B3KVP3; -.
DR   GeneID; 340419; -.
DR   KEGG; hsa:340419; -.
DR   CTD; 340419; -.
DR   PharmGKB; PA142670968; -.
DR   eggNOG; ENOG410IMS2; Eukaryota.
DR   eggNOG; ENOG410ZI6H; LUCA.
DR   KO; K23097; -.
DR   OrthoDB; 1441603at2759; -.
DR   GenomeRNAi; 340419; -.
DR   Genevisible; B3KVP3; HS.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IEA:InterPro.
DR   CDD; cd00064; FU; 1.
DR   Gene3D; 2.20.100.10; -; 1.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR042993; RSPO2.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   PANTHER; PTHR23275:SF79; PTHR23275:SF79; 1.
DR   Pfam; PF15913; Furin-like_2; 1.
DR   SMART; SM00261; FU; 1.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   SUPFAM; SSF82895; SSF82895; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   2: Evidence at transcript level;
FT   REGION          115..154
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        115..134
FT                   /note="Basic"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   154 AA;  17916 MW;  7E2A6E14DF6743A8 CRC64;
     MNRCARCRIE NCDSCFSKDF CTKCKVGFYL HRGRCFDECP DGFAPLEETM ECVEGCEVGH
     WSEWGTCSRN NRTCGFKWGL ETRTRQIVKK PVKDTILCPT IAESRRCKMT MRHCPGGKRT
     PKAKEKRNKK KKRKLIERAQ EQHSVFLATD RANQ
//
ID   RSPO2_HUMAN             Reviewed;         243 AA.
AC   Q6UXX9; B3KVP0; Q4G0U4; Q8N6X6;
DT   16-MAY-2006, integrated into UniProtKB/Swiss-Prot.
DT   15-MAY-2007, sequence version 2.
DT   22-APR-2020, entry version 134.
DE   RecName: Full=R-spondin-2;
DE   AltName: Full=Roof plate-specific spondin-2;
DE            Short=hRspo2;
DE   Flags: Precursor;
GN   Name=RSPO2; ORFNames=UNQ9384/PRO34209;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PRO-186.
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1), AND VARIANT PRO-186.
RC   TISSUE=Brain;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16421571; DOI=10.1038/nature04406;
RA   Nusbaum C., Mikkelsen T.S., Zody M.C., Asakawa S., Taudien S., Garber M.,
RA   Kodira C.D., Schueler M.G., Shimizu A., Whittaker C.A., Chang J.L.,
RA   Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., Allen N.R., Anderson S.,
RA   Asakawa T., Blechschmidt K., Bloom T., Borowsky M.L., Butler J., Cook A.,
RA   Corum B., DeArellano K., DeCaprio D., Dooley K.T., Dorris L. III,
RA   Engels R., Gloeckner G., Hafez N., Hagopian D.S., Hall J.L., Ishikawa S.K.,
RA   Jaffe D.B., Kamat A., Kudoh J., Lehmann R., Lokitsang T., Macdonald P.,
RA   Major J.E., Matthews C.D., Mauceli E., Menzel U., Mihalev A.H.,
RA   Minoshima S., Murayama Y., Naylor J.W., Nicol R., Nguyen C., O'Leary S.B.,
RA   O'Neill K., Parker S.C.J., Polley A., Raymond C.K., Reichwald K.,
RA   Rodriguez J., Sasaki T., Schilhabel M., Siddiqui R., Smith C.L.,
RA   Sneddon T.P., Talamas J.A., Tenzin P., Topham K., Venkataraman V., Wen G.,
RA   Yamazaki S., Young S.K., Zeng Q., Zimmer A.R., Rosenthal A., Birren B.W.,
RA   Platzer M., Shimizu N., Lander E.S.;
RT   "DNA sequence and analysis of human chromosome 8.";
RL   Nature 439:331-335(2006).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA], AND VARIANT PRO-186.
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 3), AND VARIANT
RP   PRO-186.
RC   TISSUE=Lung, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   FUNCTION, AND INTERACTION WITH LGR4 AND LGR5.
RX   PubMed=21909076; DOI=10.1038/embor.2011.175;
RA   Glinka A., Dolde C., Kirsch N., Huang Y.L., Kazanskaya O., Ingelfinger D.,
RA   Boutros M., Cruciat C.M., Niehrs C.;
RT   "LGR4 and LGR5 are R-spondin receptors mediating Wnt/beta-catenin and
RT   Wnt/PCP signalling.";
RL   EMBO Rep. 12:1055-1061(2011).
RN   [7]
RP   FUNCTION, AND INTERACTION WITH LGR4; LGR5 AND LGR6.
RX   PubMed=21727895; DOI=10.1038/nature10337;
RA   de Lau W., Barker N., Low T.Y., Koo B.K., Li V.S., Teunissen H., Kujala P.,
RA   Haegebarth A., Peters P.J., van de Wetering M., Stange D.E., van Es J.E.,
RA   Guardavaccaro D., Schasfoort R.B., Mohri Y., Nishimori K., Mohammed S.,
RA   Heck A.J., Clevers H.;
RT   "Lgr5 homologues associate with Wnt receptors and mediate R-spondin
RT   signalling.";
RL   Nature 476:293-297(2011).
RN   [8]
RP   FUNCTION, AND INTERACTION WITH LGR6.
RX   PubMed=22615920; DOI=10.1371/journal.pone.0037137;
RA   Gong X., Carmon K.S., Lin Q., Thomas A., Yi J., Liu Q.;
RT   "LGR6 is a high affinity receptor of R-spondins and potentially functions
RT   as a tumor suppressor.";
RL   PLoS ONE 7:E37137-E37137(2012).
RN   [9]
RP   INVOLVEMENT IN TETAMS2, VARIANTS TETAMS2 70-GLN--GLN-243 DEL AND
RP   137-GLU--GLN-243 DEL, INVOLVEMENT IN HHRRD, VARIANT HHRRD CYS-69,
RP   CHARACTERIZATION OF VARIANT TETAMS2 70-GLN--GLN-243, CHARACTERIZATION OF
RP   VARIANT HHRRD CYS-69, FUNCTION, INTERACTION WITH LGR5; RNF43 AND ZNRF3, AND
RP   MUTAGENESIS OF PHE-105 AND PHE-109.
RX   PubMed=29769720; DOI=10.1038/s41586-018-0118-y;
RA   Szenker-Ravi E., Altunoglu U., Leushacke M., Bosso-Lefevre C., Khatoo M.,
RA   Thi Tran H., Naert T., Noelanders R., Hajamohideen A., Beneteau C.,
RA   de Sousa S.B., Karaman B., Latypova X., Basaran S., Yuecel E.B., Tan T.T.,
RA   Vlaminck L., Nayak S.S., Shukla A., Girisha K.M., Le Caignec C.,
RA   Soshnikova N., Uyguner Z.O., Vleminckx K., Barker N., Kayserili H.,
RA   Reversade B.;
RT   "RSPO2 inhibition of RNF43 and ZNRF3 governs limb development independently
RT   of LGR4/5/6.";
RL   Nature 557:564-569(2018).
CC   -!- FUNCTION: Activator of the canonical Wnt signaling pathway by acting as
CC       a ligand for LGR4-6 receptors. Upon binding to LGR4-6 (LGR4, LGR5 or
CC       LGR6), LGR4-6 associate with phosphorylated LRP6 and frizzled receptors
CC       that are activated by extracellular Wnt receptors, triggering the
CC       canonical Wnt signaling pathway to increase expression of target genes.
CC       Also regulates the canonical Wnt/beta-catenin-dependent pathway and
CC       non-canonical Wnt signaling by acting as an inhibitor of ZNRF3, an
CC       important regulator of the Wnt signaling pathway (PubMed:21909076,
CC       PubMed:21727895, PubMed:22615920). During embryonic development, plays
CC       a crucial role in limb specification, amplifying the Wnt signaling
CC       pathway independently of LGR4-6 receptors, possibly by acting as a
CC       direct antagonistic ligand to RNF43 and ZNRF3, hence governing the
CC       number of limbs an embryo should form (PubMed:29769720).
CC       {ECO:0000269|PubMed:21727895, ECO:0000269|PubMed:21909076,
CC       ECO:0000269|PubMed:22615920, ECO:0000269|PubMed:29769720}.
CC   -!- SUBUNIT: Interacts with WNT1 (By similarity). Binds heparin (By
CC       similarity). Interacts with LGR4, LGR5 and LGR6 (PubMed:21909076,
CC       PubMed:21727895, PubMed:22615920, PubMed:29769720). Interacts with E3
CC       ubiquitin ligases RNF43 and ZNRF3 (PubMed:29769720).
CC       {ECO:0000250|UniProtKB:Q8BFU0, ECO:0000269|PubMed:21727895,
CC       ECO:0000269|PubMed:21909076, ECO:0000269|PubMed:22615920,
CC       ECO:0000269|PubMed:29769720}.
CC   -!- INTERACTION:
CC       Q6UXX9-2; Q8NEC5: CATSPER1; NbExp=3; IntAct=EBI-12009390, EBI-744545;
CC       Q6UXX9-2; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-12009390, EBI-3867333;
CC       Q6UXX9-2; P49639: HOXA1; NbExp=3; IntAct=EBI-12009390, EBI-740785;
CC       Q6UXX9; P60372: KRTAP10-4; NbExp=3; IntAct=EBI-8481036, EBI-10178153;
CC       Q6UXX9-2; P60371: KRTAP10-6; NbExp=3; IntAct=EBI-12009390, EBI-12012928;
CC       Q6UXX9; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-8481036, EBI-10172290;
CC       Q6UXX9-2; P60409: KRTAP10-7; NbExp=3; IntAct=EBI-12009390, EBI-10172290;
CC       Q6UXX9; P60411: KRTAP10-9; NbExp=3; IntAct=EBI-8481036, EBI-10172052;
CC       Q6UXX9-2; P60328: KRTAP12-3; NbExp=3; IntAct=EBI-12009390, EBI-11953334;
CC       Q6UXX9; Q9H8W4: PLEKHF2; NbExp=3; IntAct=EBI-8481036, EBI-742388;
CC       Q6UXX9-2; Q92504: SLC39A7; NbExp=3; IntAct=EBI-12009390, EBI-1051105;
CC       Q6UXX9-2; Q9Y3S2: ZNF330; NbExp=3; IntAct=EBI-12009390, EBI-373456;
CC       Q6UXX9-2; Q96EG3: ZNF837; NbExp=3; IntAct=EBI-12009390, EBI-11962574;
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000250|UniProtKB:Q8BFU0}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q6UXX9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q6UXX9-2; Sequence=VSP_018321;
CC       Name=3;
CC         IsoId=Q6UXX9-3; Sequence=VSP_018322, VSP_018323;
CC   -!- DOMAIN: The FU repeat is required for activation and stabilization of
CC       beta-catenin. {ECO:0000250}.
CC   -!- DISEASE: Tetraamelia syndrome 2 (TETAMS2) [MIM:618021]: A form of
CC       tetraamelia, a rare disease characterized by rudimentary appendages or
CC       complete absence of all four limbs, and other anomalies such as
CC       craniofacial, nervous system, pulmonary, skeletal and urogenital
CC       defects. TETAMS2 patients manifest limb deformities, bilateral agenesis
CC       of the lungs, abnormalities of the pulmonary vasculature, labioscrotal
CC       fold aplasia, and dysmorphic features including bilateral cleft
CC       lip/palate, ankyloglossia, mandibular hypoplasia, and
CC       microretrognathia. TETAMS2 transmission pattern is consistent with
CC       autosomal recessive inheritance. {ECO:0000269|PubMed:29769720}.
CC       Note=The disease is caused by mutations affecting the gene represented
CC       in this entry.
CC   -!- DISEASE: Humerofemoral hypoplasia with radiotibial ray deficiency
CC       (HHRRD) [MIM:618022]: A severe disease characterized by reduction of
CC       all four limbs as well as hypoplasia of the upper limb girdle and
CC       pelvis. Rudimentary finger- or toe-like appendages may be present.
CC       HHRRD transmission pattern is consistent with autosomal recessive
CC       inheritance. {ECO:0000269|PubMed:29769720}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- SIMILARITY: Belongs to the R-spondin family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY358166; AAQ88533.1; -; mRNA.
DR   EMBL; AK123023; BAG53852.1; -; mRNA.
DR   EMBL; AC025508; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AP003479; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471060; EAW91916.1; -; Genomic_DNA.
DR   EMBL; BC027938; AAH27938.1; -; mRNA.
DR   EMBL; BC036554; AAH36554.1; -; mRNA.
DR   CCDS; CCDS6307.1; -. [Q6UXX9-1]
DR   CCDS; CCDS64953.1; -. [Q6UXX9-3]
DR   CCDS; CCDS83314.1; -. [Q6UXX9-2]
DR   RefSeq; NP_001269792.1; NM_001282863.1. [Q6UXX9-3]
DR   RefSeq; NP_001304871.1; NM_001317942.1. [Q6UXX9-2]
DR   RefSeq; NP_848660.3; NM_178565.4. [Q6UXX9-1]
DR   SMR; Q6UXX9; -.
DR   BioGrid; 131049; 12.
DR   IntAct; Q6UXX9; 15.
DR   MINT; Q6UXX9; -.
DR   STRING; 9606.ENSP00000276659; -.
DR   PhosphoSitePlus; Q6UXX9; -.
DR   BioMuta; RSPO2; -.
DR   DMDM; 147744588; -.
DR   PaxDb; Q6UXX9; -.
DR   PeptideAtlas; Q6UXX9; -.
DR   PRIDE; Q6UXX9; -.
DR   ProteomicsDB; 67672; -. [Q6UXX9-1]
DR   ProteomicsDB; 67673; -. [Q6UXX9-2]
DR   ProteomicsDB; 67674; -. [Q6UXX9-3]
DR   Antibodypedia; 26506; 129 antibodies.
DR   Ensembl; ENST00000276659; ENSP00000276659; ENSG00000147655. [Q6UXX9-1]
DR   Ensembl; ENST00000517781; ENSP00000427937; ENSG00000147655. [Q6UXX9-3]
DR   Ensembl; ENST00000517939; ENSP00000428940; ENSG00000147655. [Q6UXX9-2]
DR   GeneID; 340419; -.
DR   KEGG; hsa:340419; -.
DR   UCSC; uc003ymq.4; human. [Q6UXX9-1]
DR   CTD; 340419; -.
DR   DisGeNET; 340419; -.
DR   GeneCards; RSPO2; -.
DR   HGNC; HGNC:28583; RSPO2.
DR   HPA; ENSG00000147655; Tissue enhanced (brain, placenta).
DR   MalaCards; RSPO2; -.
DR   MIM; 610575; gene.
DR   MIM; 618021; phenotype.
DR   MIM; 618022; phenotype.
DR   neXtProt; NX_Q6UXX9; -.
DR   OpenTargets; ENSG00000147655; -.
DR   Orphanet; 3301; Tetraamelia-multiple malformations syndrome.
DR   PharmGKB; PA142670968; -.
DR   eggNOG; ENOG410IMS2; Eukaryota.
DR   eggNOG; ENOG410ZI6H; LUCA.
DR   GeneTree; ENSGT00940000159194; -.
DR   HOGENOM; CLU_064219_1_0_1; -.
DR   InParanoid; Q6UXX9; -.
DR   KO; K23097; -.
DR   OMA; DNGCIRC; -.
DR   OrthoDB; 1441603at2759; -.
DR   PhylomeDB; Q6UXX9; -.
DR   TreeFam; TF331799; -.
DR   Reactome; R-HSA-4641263; Regulation of FZD by ubiquitination.
DR   SIGNOR; Q6UXX9; -.
DR   ChiTaRS; RSPO2; human.
DR   GeneWiki; RSPO2; -.
DR   GenomeRNAi; 340419; -.
DR   Pharos; Q6UXX9; Tbio.
DR   PRO; PR:Q6UXX9; -.
DR   Proteomes; UP000005640; Chromosome 8.
DR   RNAct; Q6UXX9; protein.
DR   Bgee; ENSG00000147655; Expressed in lung and 99 other tissues.
DR   ExpressionAtlas; Q6UXX9; baseline and differential.
DR   Genevisible; Q6UXX9; HS.
DR   GO; GO:0009986; C:cell surface; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0008201; F:heparin binding; IEA:UniProtKB-KW.
DR   GO; GO:0005102; F:signaling receptor binding; IPI:UniProtKB.
DR   GO; GO:0030282; P:bone mineralization; IEA:Ensembl.
DR   GO; GO:0071542; P:dopaminergic neuron differentiation; IEA:Ensembl.
DR   GO; GO:0035115; P:embryonic forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0060441; P:epithelial tube branching involved in lung morphogenesis; IEA:Ensembl.
DR   GO; GO:0060173; P:limb development; IMP:UniProtKB.
DR   GO; GO:0060437; P:lung growth; IEA:Ensembl.
DR   GO; GO:0042489; P:negative regulation of odontogenesis of dentin-containing tooth; IEA:Ensembl.
DR   GO; GO:0001649; P:osteoblast differentiation; IEA:Ensembl.
DR   GO; GO:0090263; P:positive regulation of canonical Wnt signaling pathway; IEA:Ensembl.
DR   GO; GO:0030177; P:positive regulation of Wnt signaling pathway; IDA:UniProtKB.
DR   GO; GO:0060535; P:trachea cartilage morphogenesis; IEA:Ensembl.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   CDD; cd00064; FU; 1.
DR   Gene3D; 2.20.100.10; -; 1.
DR   InterPro; IPR006212; Furin_repeat.
DR   InterPro; IPR009030; Growth_fac_rcpt_cys_sf.
DR   InterPro; IPR042993; RSPO2.
DR   InterPro; IPR000884; TSP1_rpt.
DR   InterPro; IPR036383; TSP1_rpt_sf.
DR   PANTHER; PTHR23275:SF79; PTHR23275:SF79; 1.
DR   Pfam; PF15913; Furin-like_2; 1.
DR   SMART; SM00261; FU; 2.
DR   SMART; SM00209; TSP1; 1.
DR   SUPFAM; SSF57184; SSF57184; 1.
DR   SUPFAM; SSF82895; SSF82895; 1.
DR   PROSITE; PS50092; TSP1; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Developmental protein; Disease mutation;
KW   Disulfide bond; Glycoprotein; Heparin-binding; Polymorphism;
KW   Reference proteome; Secreted; Sensory transduction; Signal;
KW   Wnt signaling pathway.
FT   SIGNAL          1..21
FT                   /evidence="ECO:0000255"
FT   CHAIN           22..243
FT                   /note="R-spondin-2"
FT                   /id="PRO_0000234439"
FT   REPEAT          90..134
FT                   /note="FU"
FT   DOMAIN          144..204
FT                   /note="TSP type-1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   CARBOHYD        160
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        40..46
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        43..52
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        55..74
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        78..93
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        96..104
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        101..110
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        113..124
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        128..141
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        145..187
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        156..163
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   DISULFID        196..203
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00210"
FT   VAR_SEQ         1..67
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018321"
FT   VAR_SEQ         32..95
FT                   /note="ASYVSNPICKGCLSCSKDNGCSRCQQKLFFFLRREGMRQYGECLHSCPSGYY
FT                   GHRAPDMNRCAR -> G (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018322"
FT   VAR_SEQ         143
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_018323"
FT   VARIANT         69
FT                   /note="R -> C (in HHRRD; loss of LGR5-, RNF43- and ZNRF3-
FT                   binding; decreased ability to amplify WNT3A signaling)"
FT                   /evidence="ECO:0000269|PubMed:29769720"
FT                   /id="VAR_081036"
FT   VARIANT         70..243
FT                   /note="Missing (in TETAMS2; loss of LGR5-, RNF43- and
FT                   ZNRF3-binding; complete loss of amplification of WNT3A
FT                   signaling)"
FT                   /evidence="ECO:0000269|PubMed:29769720"
FT                   /id="VAR_081037"
FT   VARIANT         137..243
FT                   /note="Missing (in TETAMS2)"
FT                   /evidence="ECO:0000269|PubMed:29769720"
FT                   /id="VAR_081038"
FT   VARIANT         186
FT                   /note="L -> P (in dbSNP:rs601558)"
FT                   /evidence="ECO:0000269|PubMed:12975309,
FT                   ECO:0000269|PubMed:14702039, ECO:0000269|PubMed:15489334,
FT                   ECO:0000269|Ref.4"
FT                   /id="VAR_026247"
FT   MUTAGEN         105
FT                   /note="F->A: Loss of LGR5-binding, no effect on interaction
FT                   with RNF43 and ZNRF3, no effect on WNT3A signaling; when
FT                   associated with A-109."
FT                   /evidence="ECO:0000269|PubMed:29769720"
FT   MUTAGEN         109
FT                   /note="F->A: Loss of LGR5-binding, no effect on interaction
FT                   with RNF43 and ZNRF3, no effect on WNT3A signaling; when
FT                   associated with A-105."
FT                   /evidence="ECO:0000269|PubMed:29769720"
SQ   SEQUENCE   243 AA;  28315 MW;  96F44F105B21BB52 CRC64;
     MQFRLFSFAL IILNCMDYSH CQGNRWRRSK RASYVSNPIC KGCLSCSKDN GCSRCQQKLF
     FFLRREGMRQ YGECLHSCPS GYYGHRAPDM NRCARCRIEN CDSCFSKDFC TKCKVGFYLH
     RGRCFDECPD GFAPLEETME CVEGCEVGHW SEWGTCSRNN RTCGFKWGLE TRTRQIVKKP
     VKDTILCPTI AESRRCKMTM RHCPGGKRTP KAKEKRNKKK KRKLIERAQE QHSVFLATDR
     ANQ
//
ID   A0A384N5Z8_HUMAN        Unreviewed;       707 AA.
AC   A0A384N5Z8;
DT   05-DEC-2018, integrated into UniProtKB/TrEMBL.
DT   05-DEC-2018, sequence version 1.
DT   22-APR-2020, entry version 11.
DE   SubName: Full=Epididymis secretory sperm binding protein {ECO:0000313|EMBL:ADO22214.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ADO22214.1};
RN   [1] {ECO:0000313|EMBL:ADO22214.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Hoernsten L., Su C., Osbourn A.E., Hellman U., Wernstedt C., Oliw E.H.;
RL   Submitted (SEP-2009) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; GQ891352; ADO22214.1; -; mRNA.
DR   EMBL; GQ900958; ADO22475.1; -; mRNA.
DR   RefSeq; NP_005057.1; NM_005066.2.
DR   RefSeq; XP_005271169.1; XM_005271112.4.
DR   RefSeq; XP_005271170.1; XM_005271113.4.
DR   RefSeq; XP_016857542.1; XM_017002053.1.
DR   RefSeq; XP_016857543.1; XM_017002054.1.
DR   Antibodypedia; 4083; 293 antibodies.
DR   GeneID; 6421; -.
DR   KEGG; hsa:6421; -.
DR   CTD; 6421; -.
DR   KO; K13219; -.
DR   OMA; DMRMGGA; -.
DR   GO; GO:0032839; C:dendrite cytoplasm; IEA:GOC.
DR   GO; GO:0042382; C:paraspeckles; IEA:Ensembl.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; IEA:Ensembl.
DR   GO; GO:0003682; F:chromatin binding; IEA:Ensembl.
DR   GO; GO:0070888; F:E-box binding; IEA:Ensembl.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IEA:Ensembl.
DR   GO; GO:0098963; P:dendritic transport of messenger ribonucleoprotein complex; IEA:Ensembl.
DR   GO; GO:0070932; P:histone H3 deacetylation; IEA:Ensembl.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; IEA:Ensembl.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IEA:Ensembl.
DR   GO; GO:0045876; P:positive regulation of sister chromatid cohesion; IEA:Ensembl.
DR   CDD; cd12948; NOPS_PSF; 1.
DR   CDD; cd12587; RRM1_PSF; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034526; PSF_NOPS.
DR   InterPro; IPR034525; PSF_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          297..369
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          371..452
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   REGION          1..273
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          579..707
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          498..529
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        51..108
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        129..203
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        579..611
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   707 AA;  76149 MW;  6D8D5EA95E235847 CRC64;
     MSRDRFRSRG GGGGGFHRRG GGGGRGGLHD FRSPPPGMGL NQNRGPMGPG PGQSGPKPPI
     PPPPPHQQQQ QPPPQQPPPQ QPPPHQPPPH PQPHQQQQPP PPPQDSSKPV VAQGPGPAPG
     VGSAPPASSS APPATPPTSG APPGSGPGPT PTPPPAVTSA PPGAPPPTPP SSGVPTTPPQ
     AGGPPPPPAA VPGPGPGPKQ GPGPGGPKGG KMPGGPKPGG GPGLSTPGGH PKPPHRGGGE
     PRGGRQHHPP YHQQHHQGPP PGGPGGRSEE KISDSEGFKA NLSLLRRPGE KTYTQRCRLF
     VGNLPADITE DEFKRLFAKY GEPGEVFINK GKGFGFIKLE SRALAEIAKA ELDDTPMRGR
     QLRVRFATHA AALSVRNLSP YVSNELLEEA FSQFGPIERA VVIVDDRGRS TGKGIVEFAS
     KPAARKAFER CSEGVFLLTT TPRPVIVEPL EQLDDEDGLP EKLAQKNPMY QKERETPPRF
     AQHGTFEYEY SQRWKSLDEM EKQQREQVEK NMKDAKDKLE SEMEDAYHEH QANLLRQDLM
     RRQEELRRME ELHNQEMQKR KEMQLRQEEE RRRREEEMMI RQREMEEQMR RQREESYSRM
     GYMDPRERDM RMGGGGAMNM GDPYGSGGQK FPPLGGGGGI GYEANPGVPP ATMSGSMMGS
     DMRTERFGQG GAGPVGGQGP RGMGPGTPAG YGRGREEYEG PNKKPRF
//
ID   SFPQ_HUMAN              Reviewed;         707 AA.
AC   P23246; P30808; Q5SZ71;
DT   01-NOV-1991, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-1996, sequence version 2.
DT   22-APR-2020, entry version 224.
DE   RecName: Full=Splicing factor, proline- and glutamine-rich;
DE   AltName: Full=100 kDa DNA-pairing protein;
DE            Short=hPOMp100;
DE   AltName: Full=DNA-binding p52/p100 complex, 100 kDa subunit;
DE   AltName: Full=Polypyrimidine tract-binding protein-associated-splicing factor {ECO:0000303|PubMed:9848648};
DE            Short=PSF {ECO:0000303|PubMed:8449401};
DE            Short=PTB-associated-splicing factor;
GN   Name=SFPQ; Synonyms=PSF;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], PARTIAL PROTEIN SEQUENCE, ALTERNATIVE SPLICING,
RP   AND FUNCTION.
RC   TISSUE=Fetal brain;
RX   PubMed=8449401; DOI=10.1101/gad.7.3.393;
RA   Patton J.G., Porro E.B., Galceran J., Tempst P., Nadal-Ginard B.;
RT   "Cloning and characterization of PSF, a novel pre-mRNA splicing factor.";
RL   Genes Dev. 7:393-406(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   PROTEIN SEQUENCE OF 33-44; 218-236; 246-267; 272-286; 299-315; 320-330;
RP   350-358; 364-407; 414-425; 431-462; 480-493; 517-536; 549-559; 567-572;
RP   575-581; 600-606; 612-630 AND 667-695, METHYLATION AT LYS-314; ARG-571;
RP   ARG-681 AND ARG-693, AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Ovarian carcinoma;
RA   Bienvenut W.V., Lilla S., von Kriegsheim A., Lempens A., Kolch W.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [5]
RP   PROTEIN SEQUENCE OF 48-68 AND 213-246, BLOCKAGE OF N-TERMINUS, DNA-BINDING,
RP   AND SUBUNIT.
RX   PubMed=8439294; DOI=10.1042/bj2900267;
RA   Zhang W.-W., Zhang L.-X., Busch R.K., Farres J., Busch H.;
RT   "Purification and characterization of a DNA-binding heterodimer of 52 and
RT   100 kDa from HeLa cells.";
RL   Biochem. J. 290:267-272(1993).
RN   [6]
RP   PROTEIN SEQUENCE OF 292-311; 415-421 AND 503-510, AND IDENTIFICATION IN
RP   U5/4/6 SNRNP COMPLEXES.
RX   PubMed=9409622;
RA   Teigelkamp S., Mundt C., Achsel T., Will C.L., Luehrmann R.;
RT   "The human U5 snRNP-specific 100-kD protein is an RS domain-containing,
RT   putative RNA helicase with significant homology to the yeast splicing
RT   factor Prp28p.";
RL   RNA 3:1313-1326(1997).
RN   [7]
RP   PROTEIN SEQUENCE OF 299-314 AND 480-493, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Fetal brain cortex;
RA   Lubec G., Chen W.-Q., Sun Y.;
RL   Submitted (DEC-2008) to UniProtKB.
RN   [8]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 312-707.
RC   TISSUE=Fetal skeletal muscle;
RX   PubMed=2480877;
RA   Gower H.J., Moore S.E., Dickson G., Elsom V.L., Nayak R., Walsh F.S.;
RT   "Cloning and characterization of a myoblast cell surface antigen defined by
RT   24.1D5 monoclonal antibody.";
RL   Development 105:723-731(1989).
RN   [9]
RP   PROTEIN SEQUENCE OF 414-421 AND 427-448, SUBCELLULAR LOCATION, INTERACTION
RP   WITH SNRPA, AND IDENTIFICATION IN A SNRNP-FREE COMPLEX WITH SNRPA.
RX   PubMed=9848648; DOI=10.1017/s1355838298981183;
RA   Lutz C.S., Cooke C., O'Connor J.P., Kobayashi R., Alwine J.C.;
RT   "The snRNP-free U1A (SF-A) complex(es): identification of the largest
RT   subunit as PSF, the polypyrimidine-tract binding protein-associated
RT   splicing factor.";
RL   RNA 4:1493-1499(1998).
RN   [10]
RP   PROTEIN SEQUENCE OF 600-606 AND 667-677, INTERACTION WITH PTBP1, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=10653975;
RX   DOI=10.1002/(sici)1097-4644(20000315)76:4<559::aid-jcb4>3.0.co;2-u;
RA   Meissner M., Dechat T., Gerner C., Grimm R., Foisner R., Sauermann G.;
RT   "Differential nuclear localization and nuclear matrix association of the
RT   splicing factors PSF and PTB.";
RL   J. Cell. Biochem. 76:559-566(2000).
RN   [11]
RP   FUNCTION, INTERACTION WITH PRE-MRNA, AND IDENTIFICATION IN SPLICEOSOME
RP   COMPLEX.
RX   PubMed=8045264; DOI=10.1002/j.1460-2075.1994.tb06638.x;
RA   Gozani O., Patton J.G., Reed R.;
RT   "A novel set of spliceosome-associated proteins and the essential splicing
RT   factor PSF bind stably to pre-mRNA prior to catalytic step II of the
RT   splicing reaction.";
RL   EMBO J. 13:3356-3367(1994).
RN   [12]
RP   CHROMOSOMAL TRANSLOCATION WITH TFE3.
RX   PubMed=9393982; DOI=10.1038/sj.onc.1201394;
RA   Clark J., Lu Y.-J., Sidhar S.K., Parker C., Gill S., Smedley D.,
RA   Hamoudi R., Linehan W.M., Shipley J., Cooper C.S.;
RT   "Fusion of splicing factor genes PSF and NonO (p54nrb) to the TFE3 gene in
RT   papillary renal cell carcinoma.";
RL   Oncogene 15:2233-2239(1997).
RN   [13]
RP   INTERACTION WITH TOP1, AND IDENTIFICATION IN A COMPLEX WITH NONO AND TOP1.
RX   PubMed=9756848; DOI=10.1074/jbc.273.41.26261;
RA   Straub T., Grue P., Uhse A., Lisby M., Knudsen B.R., Tange T.O.,
RA   Westergaard O., Boege F.;
RT   "The RNA-splicing factor PSF/p54 controls DNA-topoisomerase I activity by a
RT   direct interaction.";
RL   J. Biol. Chem. 273:26261-26264(1998).
RN   [14]
RP   FUNCTION IN DNA UNWINDING.
RX   PubMed=10858305; DOI=10.1021/bi992898e;
RA   Straub T., Knudsen B.R., Boege F.;
RT   "PSF/p54(nrb) stimulates 'jumping' of DNA topoisomerase I between separate
RT   DNA helices.";
RL   Biochemistry 39:7552-7558(2000).
RN   [15]
RP   FUNCTION IN TRANSCRIPTION REGULATION, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RX   PubMed=10847580; DOI=10.1210/mend.14.6.0485;
RA   Urban R.J., Bodenburg Y., Kurosky A., Wood T.G., Gasic S.;
RT   "Polypyrimidine tract-binding protein-associated splicing factor is a
RT   negative regulator of transcriptional activity of the porcine p450scc
RT   insulin-like growth factor response element.";
RL   Mol. Endocrinol. 14:774-782(2000).
RN   [16]
RP   FUNCTION IN HOMOLOGOUS DNA PAIRING, AND PHOSPHORYLATION.
RX   PubMed=10931916; DOI=10.1093/nar/28.16.3022;
RA   Akhmedov A.T., Lopez B.S.;
RT   "Human 100-kDa homologous DNA-pairing protein is the splicing factor PSF
RT   and promotes DNA strand invasion.";
RL   Nucleic Acids Res. 28:3022-3030(2000).
RN   [17]
RP   FUNCTION IN NUCLEAR RETENTION OF A-TO-I EDITED RNAS, AND IDENTIFICATION IN
RP   A COMPLEX WITH NONO AND MATR3.
RX   PubMed=11525732; DOI=10.1016/s0092-8674(01)00466-4;
RA   Zhang Z., Carmichael G.G.;
RT   "The fate of dsRNA in the nucleus: a p54(nrb)-containing complex mediates
RT   the nuclear retention of promiscuously A-to-I edited RNAs.";
RL   Cell 106:465-475(2001).
RN   [18]
RP   INTERACTION WITH SNRNP70, AND PHOSPHORYLATION.
RX   PubMed=11514619; DOI=10.1091/mbc.12.8.2328;
RA   Shav-Tal Y., Cohen M., Lapter S., Dye B., Patton J.G., Vandekerckhove J.,
RA   Zipori D.;
RT   "Nuclear relocalization of the pre-mRNA splicing factor PSF during
RT   apoptosis involves hyperphosphorylation, masking of antigenic epitopes, and
RT   changes in protein interactions.";
RL   Mol. Biol. Cell 12:2328-2340(2001).
RN   [19]
RP   FUNCTION IN TRANSCRIPTION REGULATION, AND INTERACTION WITH RXRA; THRA AND
RP   SIN3A.
RX   PubMed=11259580; DOI=10.1128/mcb.21.7.2298-2311.2001;
RA   Mathur M., Tucker P.W., Samuels H.H.;
RT   "PSF is a novel corepressor that mediates its effect through Sin3A and the
RT   DNA binding domain of nuclear hormone receptors.";
RL   Mol. Cell. Biol. 21:2298-2311(2001).
RN   [20]
RP   FUNCTION IN TRANSCRIPTION REGULATION, INTERACTION WITH NR5A1 AND SIN3A, AND
RP   IDENTIFICATION IN A COMPLEX WITH NONO AND NR5A1.
RX   PubMed=11897684; DOI=10.1210/endo.143.4.8748;
RA   Sewer M.B., Nguyen V.Q., Huang C.J., Tucker P.W., Kagawa N., Waterman M.R.;
RT   "Transcriptional activation of human CYP17 in H295R adrenocortical cells
RT   depends on complex formation among p54(nrb)/NonO, protein-associated
RT   splicing factor, and SF-1, a complex that also participates in repression
RT   of transcription.";
RL   Endocrinology 143:1280-1290(2002).
RN   [21]
RP   INTERACTION WITH NONO AND U5 SNRNA, AND IDENTIFICATION IN U5/4/6 SNRNP AND
RP   SPLICEOSOME COMPLEXES.
RX   PubMed=12403470; DOI=10.1017/s1355838202022070;
RA   Peng R., Dye B.T., Perez I., Barnard D.C., Thompson A.B., Patton J.G.;
RT   "PSF and p54nrb bind a conserved stem in U5 snRNA.";
RL   RNA 8:1334-1347(2002).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [23]
RP   FUNCTION IN DNA REPAIR, IDENTIFICATION BY MASS SPECTROMETRY, DNA-BINDING,
RP   AND SUBUNIT.
RX   PubMed=15590677; DOI=10.1074/jbc.m412758200;
RA   Bladen C.L., Udayakumar D., Takeda Y., Dynan W.S.;
RT   "Identification of the polypyrimidine tract binding protein-associated
RT   splicing factor.p54(nrb) complex as a candidate DNA double-strand break
RT   rejoining factor.";
RL   J. Biol. Chem. 280:5205-5210(2005).
RN   [24]
RP   IDENTIFICATION IN A COMPLEX WITH NONO AND WASL.
RX   PubMed=16767080; DOI=10.1038/ncb1433;
RA   Wu X., Yoo Y., Okuhama N.N., Tucker P.W., Liu G., Guan J.L.;
RT   "Regulation of RNA-polymerase-II-dependent transcription by N-WASP and its
RT   nuclear-binding partners.";
RL   Nat. Cell Biol. 8:756-763(2006).
RN   [25]
RP   PHOSPHORYLATION AT TYR-293.
RX   PubMed=17537995; DOI=10.1182/blood-2006-01-028647;
RA   Galietta A., Gunby R.H., Redaelli S., Stano P., Carniti C., Bachi A.,
RA   Tucker P.W., Tartari C.J., Huang C.J., Colombo E., Pulford K., Puttini M.,
RA   Piazza R.G., Ruchatz H., Villa A., Donella-Deana A., Marin O., Perrotti D.,
RA   Gambacorti-Passerini C.;
RT   "NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in
RT   anaplastic large-cell lymphoma.";
RL   Blood 110:2600-2609(2007).
RN   [26]
RP   PHOSPHORYLATION AT SER-8 AND SER-283 BY MKNK2.
RX   PubMed=17965020; DOI=10.1074/jbc.m705286200;
RA   Buxade M., Morrice N., Krebs D.L., Proud C.G.;
RT   "The PSF.p54nrb complex is a novel Mnk substrate that binds the mRNA for
RT   tumor necrosis factor alpha.";
RL   J. Biol. Chem. 283:57-65(2008).
RN   [27]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-687, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D., Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for efficient
RT   phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [28]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-273 AND THR-687, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [29]
RP   INTERACTION WITH RNF43.
RX   PubMed=18655028; DOI=10.1002/pmic.200800083;
RA   Miyamoto K., Sakurai H., Sugiura T.;
RT   "Proteomic identification of a PSF/p54nrb heterodimer as RNF43 oncoprotein-
RT   interacting proteins.";
RL   Proteomics 8:2907-2910(2008).
RN   [30]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [31]
RP   PHOSPHORYLATION, INTERACTION WITH PTK6, AND SUBCELLULAR LOCATION.
RX   PubMed=19439179; DOI=10.1016/j.cellsig.2009.04.008;
RA   Lukong K.E., Huot M.E., Richard S.;
RT   "BRK phosphorylates PSF promoting its cytoplasmic localization and cell
RT   cycle arrest.";
RL   Cell. Signal. 21:1415-1422(2009).
RN   [32]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-379, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [33]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-319; LYS-338; LYS-421 AND
RP   LYS-472, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [34]
RP   FUNCTION, PHOSPHORYLATION AT THR-687, INTERACTION WITH THRAP3, AND
RP   MUTAGENESIS OF THR-687.
RX   PubMed=20932480; DOI=10.1016/j.molcel.2010.09.013;
RA   Heyd F., Lynch K.W.;
RT   "Phosphorylation-dependent regulation of PSF by GSK3 controls CD45
RT   alternative splicing.";
RL   Mol. Cell 40:126-137(2010).
RN   [35]
RP   INTERACTION WITH M.TUBERCULOSIS RV3654C (MICROBIAL INFECTION).
RX   PubMed=20454556; DOI=10.1371/journal.pone.0010474;
RA   Danelishvili L., Yamazaki Y., Selker J., Bermudez L.E.;
RT   "Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins
RT   participate in the suppression of macrophage apoptosis.";
RL   PLoS ONE 5:E10474-E10474(2010).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33 AND SER-626, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [37]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [38]
RP   INTERACTION WITH PQBP1.
RX   PubMed=21933836; DOI=10.1093/hmg/ddr430;
RA   Kunde S.A., Musante L., Grimme A., Fischer U., Mueller E., Wanker E.E.,
RA   Kalscheuer V.M.;
RT   "The X-chromosome-linked intellectual disability protein PQBP1 is a
RT   component of neuronal RNA granules and regulates the appearance of stress
RT   granules.";
RL   Hum. Mol. Genet. 20:4916-4931(2011).
RN   [39]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33; SER-273 AND SER-283, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [40]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-33; SER-273; SER-283;
RP   THR-368; SER-374; SER-496; SER-626; THR-687 AND TYR-691, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [42]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-236; ARG-242; ARG-245; ARG-681;
RP   ARG-693 AND ARG-695, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [43]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-338, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [44]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-338, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [45]
RP   INTERACTION WITH ERCC6.
RX   PubMed=26030138; DOI=10.1371/journal.pone.0128558;
RA   Nicolai S., Filippi S., Caputo M., Cipak L., Gregan J., Ammerer G.,
RA   Frontini M., Willems D., Prantera G., Balajee A.S., Proietti-De-Santis L.;
RT   "Identification of Novel Proteins Co-Purifying with Cockayne Syndrome Group
RT   B (CSB) Reveals Potential Roles for CSB in RNA Metabolism and Chromatin
RT   Dynamics.";
RL   PLoS ONE 10:E0128558-E0128558(2015).
RN   [46]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [47]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH PRKDC; XRCC5; XRCC6;
RP   HEXIM1; NONO; PSPC1; RBM14 AND MATR3.
RX   PubMed=28712728; DOI=10.1016/j.molcel.2017.06.020;
RA   Morchikh M., Cribier A., Raffel R., Amraoui S., Cau J., Severac D.,
RA   Dubois E., Schwartz O., Bennasser Y., Benkirane M.;
RT   "HEXIM1 and NEAT1 Long non-coding RNA form a multi-subunit complex that
RT   regulates DNA-mediated innate immune response.";
RL   Mol. Cell 67:387-399(2017).
RN   [48]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-271; LYS-279 AND LYS-338, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [49]
RP   X-RAY CRYSTALLOGRAPHY (2.05 ANGSTROMS) OF 276-535, COILED COIL, SUBUNIT,
RP   INTERACTION WITH NONO, FUNCTION, DOMAIN, SUBCELLULAR LOCATION, AND
RP   MUTAGENESIS OF LEU-535; LEU-539; LEU-546 AND MET-549.
RX   PubMed=25765647; DOI=10.1093/nar/gkv156;
RA   Lee M., Sadowska A., Bekere I., Ho D., Gully B.S., Lu Y., Iyer K.S.,
RA   Trewhella J., Fox A.H., Bond C.S.;
RT   "The structure of human SFPQ reveals a coiled-coil mediated polymer
RT   essential for functional aggregation in gene regulation.";
RL   Nucleic Acids Res. 43:3826-3840(2015).
CC   -!- FUNCTION: DNA- and RNA binding protein, involved in several nuclear
CC       processes. Essential pre-mRNA splicing factor required early in
CC       spliceosome formation and for splicing catalytic step II, probably as a
CC       heteromer with NONO. Binds to pre-mRNA in spliceosome C complex, and
CC       specifically binds to intronic polypyrimidine tracts. Involved in
CC       regulation of signal-induced alternative splicing. During splicing of
CC       PTPRC/CD45, a phosphorylated form is sequestered by THRAP3 from the
CC       pre-mRNA in resting T-cells; T-cell activation and subsequent reduced
CC       phosphorylation is proposed to lead to release from THRAP3 allowing
CC       binding to pre-mRNA splicing regulatotry elements which represses exon
CC       inclusion. Interacts with U5 snRNA, probably by binding to a purine-
CC       rich sequence located on the 3' side of U5 snRNA stem 1b. May be
CC       involved in a pre-mRNA coupled splicing and polyadenylation process as
CC       component of a snRNP-free complex with SNRPA/U1A. The SFPQ-NONO
CC       heteromer associated with MATR3 may play a role in nuclear retention of
CC       defective RNAs. SFPQ may be involved in homologous DNA pairing; in
CC       vitro, promotes the invasion of ssDNA between a duplex DNA and produces
CC       a D-loop formation. The SFPQ-NONO heteromer may be involved in DNA
CC       unwinding by modulating the function of topoisomerase I/TOP1; in vitro,
CC       stimulates dissociation of TOP1 from DNA after cleavage and enhances
CC       its jumping between separate DNA helices. The SFPQ-NONO heteromer binds
CC       DNA (PubMed:25765647). The SFPQ-NONO heteromer may be involved in DNA
CC       non-homologous end joining (NHEJ) required for double-strand break
CC       repair and V(D)J recombination and may stabilize paired DNA ends; in
CC       vitro, the complex strongly stimulates DNA end joining, binds directly
CC       to the DNA substrates and cooperates with the Ku70/G22P1-Ku80/XRCC5
CC       (Ku) dimer to establish a functional preligation complex. SFPQ is
CC       involved in transcriptional regulation. Functions as transcriptional
CC       activator (PubMed:25765647). Transcriptional repression is mediated by
CC       an interaction of SFPQ with SIN3A and subsequent recruitment of histone
CC       deacetylases (HDACs). The SFPQ-NONO-NR5A1 complex binds to the CYP17
CC       promoter and regulates basal and cAMP-dependent transcriptional
CC       activity. SFPQ isoform Long binds to the DNA binding domains (DBD) of
CC       nuclear hormone receptors, like RXRA and probably THRA, and acts as
CC       transcriptional corepressor in absence of hormone ligands. Binds the
CC       DNA sequence 5'-CTGAGTC-3' in the insulin-like growth factor response
CC       element (IGFRE) and inhibits IGF-I-stimulated transcriptional activity.
CC       Regulates the circadian clock by repressing the transcriptional
CC       activator activity of the CLOCK-ARNTL/BMAL1 heterodimer. Required for
CC       the transcriptional repression of circadian target genes, such as PER1,
CC       mediated by the large PER complex through histone deacetylation (By
CC       similarity). Required for the assembly of nuclear speckles
CC       (PubMed:25765647). Plays a role in the regulation of DNA virus-mediated
CC       innate immune response by assembling into the HDP-RNP complex, a
CC       complex that serves as a platform for IRF3 phosphorylation and
CC       subsequent innate immune response activation through the cGAS-STING
CC       pathway (PubMed:28712728). {ECO:0000250|UniProtKB:Q8VIJ6,
CC       ECO:0000269|PubMed:10847580, ECO:0000269|PubMed:10858305,
CC       ECO:0000269|PubMed:10931916, ECO:0000269|PubMed:11259580,
CC       ECO:0000269|PubMed:11525732, ECO:0000269|PubMed:11897684,
CC       ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:20932480,
CC       ECO:0000269|PubMed:25765647, ECO:0000269|PubMed:28712728,
CC       ECO:0000269|PubMed:8045264, ECO:0000269|PubMed:8449401}.
CC   -!- SUBUNIT: Heterodimer with NONO (PubMed:25765647). Monomer and component
CC       of the SFPQ-NONO complex, which is probably a heterotetramer of two 52
CC       kDa (NONO) and two 100 kDa (SFPQ) subunits (PubMed:8439294,
CC       PubMed:25765647). The coiled coil domain mediates interaction with
CC       NONO, and can also mediate formation of long, linear homooligomers (in
CC       vitro) (PubMed:25765647). SFPQ is a component of spliceosome and U5.4/6
CC       snRNP complexes (PubMed:9409622, PubMed:8045264, PubMed:12403470).
CC       Interacts with SNRPA/U1A (PubMed:9848648). Component of a snRNP-free
CC       complex with SNRPA/U1A (PubMed:9848648). Part of complex consisting of
CC       SFPQ, NONO and MATR3 (PubMed:11525732). Interacts with polypyrimidine
CC       tract-binding protein 1/PTB (PubMed:10653975). Part of a complex
CC       consisting of SFPQ, NONO and NR5A1 (PubMed:11897684). Interacts with
CC       RXRA, probably THRA, and SIN3A (PubMed:11259580). Interacts with TOP1
CC       (PubMed:9756848). Part of a complex consisting of SFPQ, NONO and TOP1
CC       (PubMed:9756848). Interacts with SNRNP70 in apoptotic cells
CC       (PubMed:11514619). Interacts with PSPC1. Interacts with RNF43
CC       (PubMed:18655028). Interacts with PITX3 and NR4A2/NURR1 (By
CC       similarity). Interacts with PTK6 (PubMed:19439179). Interacts with
CC       THRAP3; the interaction is dependent on SFPQ phosphorylation at 'Thr-
CC       687' and inhibits binding of SFPQ to a ESS1 exonic splicing silencer
CC       element-containing RNA (PubMed:20932480). The large PER complex
CC       involved in the histone deacetylation is composed of at least HDAC1,
CC       PER2, SFPQ and SIN3A. Interacts with PER1 and PER2 (By similarity).
CC       Interacts with PQBP1 (PubMed:21933836). Component of a multiprotein
CC       complex with NONO and WASL (PubMed:16767080). Interacts with ERCC6
CC       (PubMed:26030138). {ECO:0000250|UniProtKB:Q8VIJ6,
CC       ECO:0000269|PubMed:10653975, ECO:0000269|PubMed:11259580,
CC       ECO:0000269|PubMed:11514619, ECO:0000269|PubMed:11525732,
CC       ECO:0000269|PubMed:11897684, ECO:0000269|PubMed:12403470,
CC       ECO:0000269|PubMed:15590677, ECO:0000269|PubMed:16767080,
CC       ECO:0000269|PubMed:18655028, ECO:0000269|PubMed:19439179,
CC       ECO:0000269|PubMed:20932480, ECO:0000269|PubMed:21933836,
CC       ECO:0000269|PubMed:25765647, ECO:0000269|PubMed:26030138,
CC       ECO:0000269|PubMed:8045264, ECO:0000269|PubMed:8439294,
CC       ECO:0000269|PubMed:9409622, ECO:0000269|PubMed:9756848,
CC       ECO:0000269|PubMed:9848648}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with M.tuberculosis protein
CC       Rv3654c, which probably leads to the cleavage of PSF, diminishes the
CC       level of caspase-8 in macrophages and suppresses macrophage apoptosis
CC       by blocking the extrinsic pathway. Part of the HDP-RNP complex composed
CC       of at least HEXIM1, PRKDC, XRCC5, XRCC6, paraspeckle proteins (SFPQ,
CC       NONO, PSPC1, RBM14, and MATR3) and NEAT1 RNA.
CC       {ECO:0000269|PubMed:20454556, ECO:0000269|PubMed:28712728}.
CC   -!- INTERACTION:
CC       P23246; Q8AZK7: EBNA-LP; Xeno; NbExp=2; IntAct=EBI-355453, EBI-1185167;
CC       P23246; P41235: HNF4A; NbExp=2; IntAct=EBI-355453, EBI-1049011;
CC       P23246; Q15233: NONO; NbExp=5; IntAct=EBI-355453, EBI-350527;
CC       P23246; P26599: PTBP1; NbExp=2; IntAct=EBI-355453, EBI-350540;
CC       P23246; Q13882: PTK6; NbExp=5; IntAct=EBI-355453, EBI-1383632;
CC       P23246-1; P28700: Rxra; Xeno; NbExp=3; IntAct=EBI-355463, EBI-346715;
CC       P23246; Q96ST3: SIN3A; NbExp=2; IntAct=EBI-355453, EBI-347218;
CC       P23246; P09012: SNRPA; NbExp=4; IntAct=EBI-355453, EBI-607085;
CC       P23246-1; P04625: THRA; Xeno; NbExp=2; IntAct=EBI-355463, EBI-286261;
CC       P23246; Q9Y2W1: THRAP3; NbExp=6; IntAct=EBI-355453, EBI-352039;
CC   -!- SUBCELLULAR LOCATION: Nucleus speckle {ECO:0000269|PubMed:25765647}.
CC       Nucleus matrix {ECO:0000269|PubMed:10653975,
CC       ECO:0000269|PubMed:19439179, ECO:0000269|PubMed:9848648}. Cytoplasm
CC       {ECO:0000269|PubMed:19439179}. Note=Predominantly in nuclear matrix.
CC       {ECO:0000269|PubMed:19439179}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=Long; Synonyms=A;
CC         IsoId=P23246-1; Sequence=Displayed;
CC       Name=Short; Synonyms=F;
CC         IsoId=P23246-2; Sequence=VSP_005855;
CC   -!- DOMAIN: The coiled coil domain mediates interaction with NONO, and can
CC       also mediate formation of long, linear homooligomers (in vitro). The
CC       coiled coil domain is required for optimal DNA binding, and optimal
CC       transcription activation. {ECO:0000269|PubMed:25765647}.
CC   -!- PTM: The N-terminus is blocked.
CC   -!- PTM: Phosphorylated on multiple serine and threonine residues during
CC       apoptosis. In vitro phosphorylated by PKC. Phosphorylation stimulates
CC       binding to DNA and D-loop formation, but inhibits binding to RNA.
CC       Phosphorylation of C-terminal tyrosines promotes its cytoplasmic
CC       localization, impaired its binding to polypyrimidine RNA and led to
CC       cell cycle arrest. In resting T-cells is phosphorylated at Thr-687 by
CC       GSK3B which is proposed to promote association with THRAP and to
CC       prevent binding to PTPRC/CD45 pre-mRNA; T-cell activation leads to
CC       reduced phosphorylation at Thr-687. {ECO:0000269|PubMed:10931916,
CC       ECO:0000269|PubMed:11514619, ECO:0000269|PubMed:17537995,
CC       ECO:0000269|PubMed:17965020, ECO:0000269|PubMed:19439179,
CC       ECO:0000269|PubMed:20932480}.
CC   -!- DISEASE: Note=A chromosomal aberration involving SFPQ may be a cause of
CC       papillary renal cell carcinoma (PRCC). Translocation t(X;1)(p11.2;p34)
CC       with TFE3.
CC   -!- CAUTION: Was originally thought to be myoblast cell surface antigen
CC       24.1D5 and a possible membrane-bound protein ectokinase.
CC       {ECO:0000305|PubMed:2480877}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PSFID167.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X70944; CAA50283.1; -; mRNA.
DR   EMBL; AL590434; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471059; EAX07426.1; -; Genomic_DNA.
DR   EMBL; X16850; CAA34747.1; -; mRNA.
DR   CCDS; CCDS388.1; -. [P23246-1]
DR   PIR; A46302; A46302.
DR   PIR; S29770; S29770.
DR   RefSeq; NP_005057.1; NM_005066.2. [P23246-1]
DR   RefSeq; XP_005271169.1; XM_005271112.4. [P23246-1]
DR   RefSeq; XP_005271170.1; XM_005271113.4. [P23246-1]
DR   RefSeq; XP_005271172.1; XM_005271115.4. [P23246-2]
DR   RefSeq; XP_016857542.1; XM_017002053.1. [P23246-1]
DR   RefSeq; XP_016857543.1; XM_017002054.1. [P23246-1]
DR   PDB; 4WII; X-ray; 2.05 A; A/B=276-535.
DR   PDB; 4WIJ; X-ray; 3.49 A; A/B=276-598.
DR   PDB; 4WIK; X-ray; 3.00 A; A/B=369-598.
DR   PDB; 5WPA; X-ray; 2.29 A; A=276-535.
DR   PDB; 6NCQ; X-ray; 1.90 A; A=276-535.
DR   PDBsum; 4WII; -.
DR   PDBsum; 4WIJ; -.
DR   PDBsum; 4WIK; -.
DR   PDBsum; 5WPA; -.
DR   PDBsum; 6NCQ; -.
DR   SMR; P23246; -.
DR   BioGrid; 112319; 327.
DR   CORUM; P23246; -.
DR   DIP; DIP-31272N; -.
DR   IntAct; P23246; 107.
DR   MINT; P23246; -.
DR   STRING; 9606.ENSP00000349748; -.
DR   DrugBank; DB11638; Artenimol.
DR   DrugBank; DB09130; Copper.
DR   iPTMnet; P23246; -.
DR   MetOSite; P23246; -.
DR   PhosphoSitePlus; P23246; -.
DR   SwissPalm; P23246; -.
DR   BioMuta; SFPQ; -.
DR   DMDM; 1709851; -.
DR   SWISS-2DPAGE; P23246; -.
DR   EPD; P23246; -.
DR   jPOST; P23246; -.
DR   MassIVE; P23246; -.
DR   MaxQB; P23246; -.
DR   PaxDb; P23246; -.
DR   PeptideAtlas; P23246; -.
DR   PRIDE; P23246; -.
DR   ProteomicsDB; 54073; -. [P23246-1]
DR   ProteomicsDB; 54074; -. [P23246-2]
DR   Antibodypedia; 4083; 293 antibodies.
DR   Ensembl; ENST00000357214; ENSP00000349748; ENSG00000116560. [P23246-1]
DR   GeneID; 6421; -.
DR   KEGG; hsa:6421; -.
DR   UCSC; uc001bys.4; human. [P23246-1]
DR   CTD; 6421; -.
DR   DisGeNET; 6421; -.
DR   GeneCards; SFPQ; -.
DR   HGNC; HGNC:10774; SFPQ.
DR   HPA; ENSG00000116560; Low tissue specificity.
DR   MalaCards; SFPQ; -.
DR   MIM; 605199; gene.
DR   neXtProt; NX_P23246; -.
DR   OpenTargets; ENSG00000116560; -.
DR   Orphanet; 319308; MiT family translocation renal cell carcinoma.
DR   PharmGKB; PA35690; -.
DR   eggNOG; KOG0115; Eukaryota.
DR   eggNOG; ENOG410XQA0; LUCA.
DR   GeneTree; ENSGT00940000156221; -.
DR   HOGENOM; CLU_027185_1_0_1; -.
DR   InParanoid; P23246; -.
DR   KO; K13219; -.
DR   OMA; DMRMGGA; -.
DR   OrthoDB; 1274880at2759; -.
DR   PhylomeDB; P23246; -.
DR   TreeFam; TF315795; -.
DR   Reactome; R-HSA-8849468; PTK6 Regulates Proteins Involved in RNA Processing.
DR   Reactome; R-HSA-9635465; Suppression of apoptosis.
DR   SIGNOR; P23246; -.
DR   ChiTaRS; SFPQ; human.
DR   GeneWiki; SFPQ; -.
DR   GenomeRNAi; 6421; -.
DR   Pharos; P23246; Tbio.
DR   PRO; PR:P23246; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P23246; protein.
DR   Bgee; ENSG00000116560; Expressed in oviduct epithelium and 232 other tissues.
DR   ExpressionAtlas; P23246; baseline and differential.
DR   Genevisible; P23246; HS.
DR   GO; GO:0000785; C:chromatin; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0032839; C:dendrite cytoplasm; IEA:GOC.
DR   GO; GO:0016363; C:nuclear matrix; IDA:BHF-UCL.
DR   GO; GO:0016607; C:nuclear speck; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; IDA:BHF-UCL.
DR   GO; GO:0005634; C:nucleus; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0042382; C:paraspeckles; IDA:UniProtKB.
DR   GO; GO:0090575; C:RNA polymerase II transcription factor complex; ISS:BHF-UCL.
DR   GO; GO:0003682; F:chromatin binding; ISS:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IDA:UniProtKB.
DR   GO; GO:0070888; F:E-box binding; ISS:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0003676; F:nucleic acid binding; IBA:GO_Central.
DR   GO; GO:0042803; F:protein homodimerization activity; IPI:UniProtKB.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; ISS:BHF-UCL.
DR   GO; GO:0044212; F:transcription regulatory region DNA binding; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0000976; F:transcription regulatory region sequence-specific DNA binding; ISS:UniProtKB.
DR   GO; GO:0002218; P:activation of innate immune response; IDA:UniProtKB.
DR   GO; GO:0000380; P:alternative mRNA splicing, via spliceosome; IMP:BHF-UCL.
DR   GO; GO:0098963; P:dendritic transport of messenger ribonucleoprotein complex; IEA:Ensembl.
DR   GO; GO:0000724; P:double-strand break repair via homologous recombination; IMP:MGI.
DR   GO; GO:0070932; P:histone H3 deacetylation; ISS:UniProtKB.
DR   GO; GO:0045087; P:innate immune response; IEA:UniProtKB-KW.
DR   GO; GO:0006397; P:mRNA processing; TAS:ProtInc.
DR   GO; GO:0000398; P:mRNA splicing, via spliceosome; IBA:GO_Central.
DR   GO; GO:0042754; P:negative regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; ISS:UniProtKB.
DR   GO; GO:1902177; P:positive regulation of oxidative stress-induced intrinsic apoptotic signaling pathway; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0045876; P:positive regulation of sister chromatid cohesion; IEA:Ensembl.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IMP:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IBA:GO_Central.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0008380; P:RNA splicing; TAS:ProtInc.
DR   CDD; cd12948; NOPS_PSF; 1.
DR   CDD; cd12587; RRM1_PSF; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034526; PSF_NOPS.
DR   InterPro; IPR034525; PSF_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Activator; Alternative splicing;
KW   Biological rhythms; Chromosomal rearrangement; Coiled coil; Cytoplasm;
KW   Direct protein sequencing; DNA damage; DNA recombination; DNA repair;
KW   DNA-binding; Immunity; Innate immunity; Isopeptide bond; Methylation;
KW   mRNA processing; mRNA splicing; Nucleus; Phosphoprotein;
KW   Reference proteome; Repeat; Repressor; RNA-binding; Transcription;
KW   Transcription regulation; Ubl conjugation.
FT   CHAIN           1..707
FT                   /note="Splicing factor, proline- and glutamine-rich"
FT                   /id="PRO_0000081909"
FT   REPEAT          9..11
FT                   /note="1"
FT   REPEAT          19..21
FT                   /note="2"
FT   REPEAT          25..27
FT                   /note="3"
FT   DOMAIN          297..369
FT                   /note="RRM 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   DOMAIN          371..452
FT                   /note="RRM 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00176"
FT   REGION          9..27
FT                   /note="3 X 3 AA repeats of R-G-G"
FT   COILED          497..596
FT                   /evidence="ECO:0000255, ECO:0000269|PubMed:25765647"
FT   COMPBIAS        10..266
FT                   /note="Gln/Glu/Pro-rich"
FT   COMPBIAS        10..15
FT                   /note="Poly-Gly"
FT   COMPBIAS        20..27
FT                   /note="Poly-Gly"
FT   COMPBIAS        56..65
FT                   /note="Poly-Pro"
FT   COMPBIAS        67..71
FT                   /note="Poly-Gln"
FT   COMPBIAS        95..98
FT                   /note="Poly-Gln"
FT   COMPBIAS        99..103
FT                   /note="Poly-Pro"
FT   COMPBIAS        184..188
FT                   /note="Poly-Pro"
FT   COMPBIAS        571..574
FT                   /note="Poly-Arg"
FT   COMPBIAS        613..616
FT                   /note="Poly-Gly"
FT   COMPBIAS        635..641
FT                   /note="Poly-Gly"
FT   SITE            662..663
FT                   /note="Breakpoint for translocation to form SFPQ-TFE3"
FT   MOD_RES         8
FT                   /note="Phosphoserine; by MKNK2"
FT                   /evidence="ECO:0000269|PubMed:17965020"
FT   MOD_RES         9
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIJ6"
FT   MOD_RES         9
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIJ6"
FT   MOD_RES         33
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         208
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q8VIJ6"
FT   MOD_RES         236
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         242
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         245
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         273
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         283
FT                   /note="Phosphoserine; by MKNK2"
FT                   /evidence="ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163, ECO:0000269|PubMed:17965020"
FT   MOD_RES         293
FT                   /note="Phosphotyrosine; by ALK"
FT                   /evidence="ECO:0000269|PubMed:17537995"
FT   MOD_RES         314
FT                   /note="N6,N6-dimethyllysine"
FT                   /evidence="ECO:0000269|Ref.4"
FT   MOD_RES         319
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         338
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         368
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         374
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         379
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:19690332"
FT   MOD_RES         421
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         472
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         496
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         571
FT                   /note="Dimethylated arginine"
FT                   /evidence="ECO:0000269|Ref.4"
FT   MOD_RES         626
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         681
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315, ECO:0000269|Ref.4"
FT   MOD_RES         687
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18220336,
FT                   ECO:0000244|PubMed:18669648, ECO:0000244|PubMed:23186163,
FT                   ECO:0000269|PubMed:20932480"
FT   MOD_RES         691
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         693
FT                   /note="Dimethylated arginine; alternate"
FT                   /evidence="ECO:0000269|Ref.4"
FT   MOD_RES         693
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         695
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   CROSSLNK        271
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        279
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        338
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         663..707
FT                   /note="RTERFGQGGAGPVGGQGPRGMGPGTPAGYGRGREEYEGPNKKPRF -> VRM
FT                   IDVG (in isoform Short)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_005855"
FT   MUTAGEN         535
FT                   /note="L->A: Impairs DNA binding and ability to mediate
FT                   transcriptional activation; when associated with A-539; A-
FT                   546 and A-549."
FT                   /evidence="ECO:0000269|PubMed:25765647"
FT   MUTAGEN         539
FT                   /note="L->A: Impairs DNA binding and ability to mediate
FT                   transcriptional activation; when associated with A-535; A-
FT                   546 and A-549."
FT                   /evidence="ECO:0000269|PubMed:25765647"
FT   MUTAGEN         546
FT                   /note="L->A: Impairs DNA binding and ability to mediate
FT                   transcriptional activation; when associated with A-535; A-
FT                   539 and A-549."
FT                   /evidence="ECO:0000269|PubMed:25765647"
FT   MUTAGEN         549
FT                   /note="M->A: Impairs DNA binding and ability to mediate
FT                   transcriptional activation; when associated with A-535; A-
FT                   539 and A-546."
FT                   /evidence="ECO:0000269|PubMed:25765647"
FT   MUTAGEN         687
FT                   /note="T->A: Abolishes phosphorylation by GSK3B. Impairs
FT                   interaction with THRAP3."
FT                   /evidence="ECO:0000269|PubMed:20932480"
FT   MUTAGEN         687
FT                   /note="T->D: No effect on interaction with THRAP3
FT                   (phosphomimetic)."
FT                   /evidence="ECO:0000269|PubMed:20932480"
FT   CONFLICT        243
FT                   /note="G -> R (in Ref. 5; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           282..285
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           295..297
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          298..303
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           310..316
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           317..320
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          326..329
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   TURN            330..333
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          334..338
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           342..352
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          356..361
FT                   /evidence="ECO:0000244|PDB:4WII"
FT   STRAND          363..366
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          370..376
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           384..391
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           392..394
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          397..404
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          406..408
FT                   /evidence="ECO:0000244|PDB:4WIJ"
FT   STRAND          410..420
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           421..433
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          439..441
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          446..449
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          455..457
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           461..464
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          467..469
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           470..474
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   STRAND          478..480
FT                   /evidence="ECO:0000244|PDB:4WII"
FT   HELIX           486..533
FT                   /evidence="ECO:0000244|PDB:6NCQ"
FT   HELIX           555..588
FT                   /evidence="ECO:0000244|PDB:4WIJ"
SQ   SEQUENCE   707 AA;  76149 MW;  6D8D5EA95E235847 CRC64;
     MSRDRFRSRG GGGGGFHRRG GGGGRGGLHD FRSPPPGMGL NQNRGPMGPG PGQSGPKPPI
     PPPPPHQQQQ QPPPQQPPPQ QPPPHQPPPH PQPHQQQQPP PPPQDSSKPV VAQGPGPAPG
     VGSAPPASSS APPATPPTSG APPGSGPGPT PTPPPAVTSA PPGAPPPTPP SSGVPTTPPQ
     AGGPPPPPAA VPGPGPGPKQ GPGPGGPKGG KMPGGPKPGG GPGLSTPGGH PKPPHRGGGE
     PRGGRQHHPP YHQQHHQGPP PGGPGGRSEE KISDSEGFKA NLSLLRRPGE KTYTQRCRLF
     VGNLPADITE DEFKRLFAKY GEPGEVFINK GKGFGFIKLE SRALAEIAKA ELDDTPMRGR
     QLRVRFATHA AALSVRNLSP YVSNELLEEA FSQFGPIERA VVIVDDRGRS TGKGIVEFAS
     KPAARKAFER CSEGVFLLTT TPRPVIVEPL EQLDDEDGLP EKLAQKNPMY QKERETPPRF
     AQHGTFEYEY SQRWKSLDEM EKQQREQVEK NMKDAKDKLE SEMEDAYHEH QANLLRQDLM
     RRQEELRRME ELHNQEMQKR KEMQLRQEEE RRRREEEMMI RQREMEEQMR RQREESYSRM
     GYMDPRERDM RMGGGGAMNM GDPYGSGGQK FPPLGGGGGI GYEANPGVPP ATMSGSMMGS
     DMRTERFGQG GAGPVGGQGP RGMGPGTPAG YGRGREEYEG PNKKPRF
//
ID   Q86VG2_HUMAN            Unreviewed;       707 AA.
AC   Q86VG2;
DT   01-JUN-2003, integrated into UniProtKB/TrEMBL.
DT   01-JUN-2003, sequence version 1.
DT   22-APR-2020, entry version 100.
DE   SubName: Full=Splicing factor proline/glutamine-rich (Polypyrimidine tract binding protein associated) {ECO:0000313|EMBL:AAH51192.1};
GN   Name=SFPQ {ECO:0000313|EMBL:AAH51192.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAH51192.1};
RN   [1] {ECO:0000313|EMBL:AAH51192.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain {ECO:0000313|EMBL:AAH51192.1};
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RA   Gerhard D.S., Wagner L., Feingold E.A., Shenmen C.M., Grouse L.H.,
RA   Schuler G., Klein S.L., Old S., Rasooly R., Good P., Guyer M., Peck A.M.,
RA   Derge J.G., Lipman D., Collins F.S., Jang W., Sherry S., Feolo M.,
RA   Misquitta L., Lee E., Rotmistrovsky K., Greenhut S.F., Schaefer C.F.,
RA   Buetow K., Bonner T.I., Haussler D., Kent J., Kiekhaus M., Furey T.,
RA   Brent M., Prange C., Schreiber K., Shapiro N., Bhat N.K., Hopkins R.F.,
RA   Hsie F., Driscoll T., Soares M.B., Casavant T.L., Scheetz T.E.,
RA   Brown-stein M.J., Usdin T.B., Toshiyuki S., Carninci P., Piao Y.,
RA   Dudekula D.B., Ko M.S., Kawakami K., Suzuki Y., Sugano S., Gruber C.E.,
RA   Smith M.R., Simmons B., Moore T., Waterman R., Johnson S.L., Ruan Y.,
RA   Wei C.L., Mathavan S., Gunaratne P.H., Wu J., Garcia A.M., Hulyk S.W.,
RA   Fuh E., Yuan Y., Sneed A., Kowis C., Hodgson A., Muzny D.M., McPherson J.,
RA   Gibbs R.A., Fahey J., Helton E., Ketteman M., Madan A., Rodrigues S.,
RA   Sanchez A., Whiting M., Madari A., Young A.C., Wetherby K.D., Granite S.J.,
RA   Kwong P.N., Brinkley C.P., Pearson R.L., Bouffard G.G., Blakesly R.W.,
RA   Green E.D., Dickson M.C., Rodriguez A.C., Grimwood J., Schmutz J.,
RA   Myers R.M., Butterfield Y.S., Griffith M., Griffith O.L., Krzywinski M.I.,
RA   Liao N., Morin R., Morrin R., Palmquist D., Petrescu A.S., Skalska U.,
RA   Smailus D.E., Stott J.M., Schnerch A., Schein J.E., Jones S.J., Holt R.A.,
RA   Baross A., Marra M.A., Clifton S., Makowski K.A., Bosak S., Malek J.;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; BC051192; AAH51192.1; -; mRNA.
DR   RefSeq; NP_005057.1; NM_005066.2.
DR   IntAct; Q86VG2; 2.
DR   PeptideAtlas; Q86VG2; -.
DR   PRIDE; Q86VG2; -.
DR   GeneID; 6421; -.
DR   KEGG; hsa:6421; -.
DR   CTD; 6421; -.
DR   PharmGKB; PA35690; -.
DR   eggNOG; KOG0115; Eukaryota.
DR   eggNOG; ENOG410XQA0; LUCA.
DR   KO; K13219; -.
DR   ChiTaRS; SFPQ; human.
DR   GenomeRNAi; 6421; -.
DR   Genevisible; Q86VG2; HS.
DR   GO; GO:0003723; F:RNA binding; IEA:UniProtKB-UniRule.
DR   CDD; cd12948; NOPS_PSF; 1.
DR   CDD; cd12587; RRM1_PSF; 1.
DR   Gene3D; 3.30.70.330; -; 2.
DR   InterPro; IPR012975; NOPS.
DR   InterPro; IPR012677; Nucleotide-bd_a/b_plait_sf.
DR   InterPro; IPR034526; PSF_NOPS.
DR   InterPro; IPR034525; PSF_RRM1.
DR   InterPro; IPR035979; RBD_domain_sf.
DR   InterPro; IPR000504; RRM_dom.
DR   Pfam; PF08075; NOPS; 1.
DR   Pfam; PF00076; RRM_1; 2.
DR   SMART; SM00360; RRM; 2.
DR   SUPFAM; SSF54928; SSF54928; 1.
DR   PROSITE; PS50102; RRM; 2.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAM:Coils};
KW   RNA-binding {ECO:0000256|PROSITE-ProRule:PRU00176}.
FT   DOMAIN          297..369
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   DOMAIN          371..452
FT                   /note="RRM"
FT                   /evidence="ECO:0000259|PROSITE:PS50102"
FT   REGION          1..273
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          642..707
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          498..529
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          532..595
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        51..108
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        129..203
FT                   /note="Pro-rich"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   707 AA;  76188 MW;  B5C287EF61FD1811 CRC64;
     MSRDRFRSRG GGGGGFHRRG GGGGRGGLHD FRSPPPGMGL NQNRGPMGPG PGQSGPKPPI
     PPPPPHQQQQ QPPPQQPPPQ QPPPHQPPPH PQPHQQQQPP PPPQDSSKPV VAQGPGPAPG
     VGSTPPASSS APPATPPTSG APPGSGPGPT PTPPPAVTSA PPGAPPPTPP SSGVPTTPPQ
     AGGPPPPPAA VPGPGPGPKQ GPGPGGPKGG KMPGGPKPGG GPGLSTPGGH PKPPRRGGGE
     PRGGRQHHPP YHQQHHQGPP PGGPGGRSEE KISDSEGFKA NLSLLRRPGE KTYTQRCRLF
     VGNLPADITE DEFKRLFAKY GEPGEVFINK GKGFGFIKLE SRALAEIAKA ELDDTPMRGR
     QLRVRFATHA AALSVRNLSP YVSNELLEEA FSQFGPIERA VVIVDDRGRS TGKGIVEFAS
     KPAARKAFER CSEGVFLLTT TPRPVIVEPL EQLDDEDGLP EKLAQKNPMY QKERETPTRF
     AQHGTFEYEY SQRWKSLDEM EKQQREQVEK NMKDAKDKLE SEMEDAYHEH QANLLRQDLM
     RRQEELRRME ELHNQEMQKR KEMQLRQEEE RRRREEEMMI RQREMEDQMR RQREESYSRM
     GYMDPRERDM RMGGGGAMNM GDPYGSGGQK FPPLGGGGGI GYEANPGVPP ATMSGSMMGS
     DMRTERFGQG GAGPVGGQGP RGMGPGTPAG YGRGREEYEG PNKKPRF
//
ID   NPT2B_HUMAN             Reviewed;         690 AA.
AC   O95436; A5PL17; Q8N2K2; Q8WYA9; Q9P0V7;
DT   20-DEC-2005, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   22-APR-2020, entry version 149.
DE   RecName: Full=Sodium-dependent phosphate transport protein 2B;
DE            Short=Sodium-phosphate transport protein 2B;
DE   AltName: Full=Na(+)-dependent phosphate cotransporter 2B;
DE   AltName: Full=NaPi3b;
DE   AltName: Full=Sodium/phosphate cotransporter 2B;
DE            Short=Na(+)/Pi cotransporter 2B;
DE            Short=NaPi-2b;
DE   AltName: Full=Solute carrier family 34 member 2;
GN   Name=SLC34A2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), BIOPHYSICOCHEMICAL PROPERTIES,
RP   TISSUE SPECIFICITY, AND VARIANT GLY-634.
RC   TISSUE=Lung, and Small intestine;
RX   PubMed=10329428; DOI=10.1006/bbrc.1999.0666;
RA   Feild J.A., Zhang L., Brun K.A., Brooks D.P., Edwards R.M.;
RT   "Cloning and functional characterization of a sodium-dependent phosphate
RT   transporter expressed in human lung and small intestine.";
RL   Biochem. Biophys. Res. Commun. 258:578-582(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), TISSUE SPECIFICITY, AND VARIANT
RP   GLY-634.
RC   TISSUE=Small intestine;
RX   PubMed=10610722; DOI=10.1006/geno.1999.6009;
RA   Xu H., Bai L., Collins J.F., Ghishan F.K.;
RT   "Molecular cloning, functional characterization, tissue distribution, and
RT   chromosomal localization of a human, small intestinal sodium-phosphate
RT   (Na+-Pi) transporter (SLC34A2).";
RL   Genomics 62:281-284(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15815621; DOI=10.1038/nature03466;
RA   Hillier L.W., Graves T.A., Fulton R.S., Fulton L.A., Pepin K.H., Minx P.,
RA   Wagner-McPherson C., Layman D., Wylie K., Sekhon M., Becker M.C.,
RA   Fewell G.A., Delehaunty K.D., Miner T.L., Nash W.E., Kremitzki C., Oddy L.,
RA   Du H., Sun H., Bradshaw-Cordum H., Ali J., Carter J., Cordes M., Harris A.,
RA   Isak A., van Brunt A., Nguyen C., Du F., Courtney L., Kalicki J.,
RA   Ozersky P., Abbott S., Armstrong J., Belter E.A., Caruso L., Cedroni M.,
RA   Cotton M., Davidson T., Desai A., Elliott G., Erb T., Fronick C., Gaige T.,
RA   Haakenson W., Haglund K., Holmes A., Harkins R., Kim K., Kruchowski S.S.,
RA   Strong C.M., Grewal N., Goyea E., Hou S., Levy A., Martinka S., Mead K.,
RA   McLellan M.D., Meyer R., Randall-Maher J., Tomlinson C.,
RA   Dauphin-Kohlberg S., Kozlowicz-Reilly A., Shah N., Swearengen-Shahid S.,
RA   Snider J., Strong J.T., Thompson J., Yoakum M., Leonard S., Pearman C.,
RA   Trani L., Radionenko M., Waligorski J.E., Wang C., Rock S.M.,
RA   Tin-Wollam A.-M., Maupin R., Latreille P., Wendl M.C., Yang S.-P., Pohl C.,
RA   Wallis J.W., Spieth J., Bieri T.A., Berkowicz N., Nelson J.O., Osborne J.,
RA   Ding L., Meyer R., Sabo A., Shotland Y., Sinha P., Wohldmann P.E.,
RA   Cook L.L., Hickenbotham M.T., Eldred J., Williams D., Jones T.A., She X.,
RA   Ciccarelli F.D., Izaurralde E., Taylor J., Schmutz J., Myers R.M.,
RA   Cox D.R., Huang X., McPherson J.D., Mardis E.R., Clifton S.W., Warren W.C.,
RA   Chinwalla A.T., Eddy S.R., Marra M.A., Ovcharenko I., Furey T.S.,
RA   Miller W., Eichler E.E., Bork P., Suyama M., Torrents D., Waterston R.H.,
RA   Wilson R.K.;
RT   "Generation and annotation of the DNA sequences of human chromosomes 2 and
RT   4.";
RL   Nature 434:724-731(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2), AND VARIANT GLY-634.
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 1-592 (ISOFORM 2), AND INDUCTION.
RC   TISSUE=Intestine;
RX   PubMed=11171583; DOI=10.1152/ajpcell.2001.280.3.c628;
RA   Xu H., Collins J.F., Bai L., Kiela P.R., Ghishan F.K.;
RT   "Regulation of the human sodium-phosphate cotransporter NaPi-IIb gene
RT   promoter by epidermal growth factor.";
RL   Am. J. Physiol. 280:C628-C636(2001).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 266-690, AND VARIANT GLY-634.
RC   TISSUE=Ovarian carcinoma;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [7]
RP   DISEASE, AND CHROMOSOMAL TRANSLOCATION WITH ROS1.
RX   PubMed=12661006; DOI=10.1002/gcc.10207;
RA   Charest A., Lane K., McMahon K., Park J., Preisinger E., Conroy H.,
RA   Housman D.;
RT   "Fusion of FIG to the receptor tyrosine kinase ROS in a glioblastoma with
RT   an interstitial del(6)(q21q21).";
RL   Genes Chromosomes Cancer 37:58-71(2003).
RN   [8]
RP   VARIANT PALM ARG-106.
RX   PubMed=16960801; DOI=10.1086/508263;
RA   Corut A., Senyigit A., Ugur S.A., Altin S., Ozcelik U., Calisir H.,
RA   Yildirim Z., Gocmen A., Tolun A.;
RT   "Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are
RT   possibly associated with testicular microlithiasis.";
RL   Am. J. Hum. Genet. 79:650-656(2006).
CC   -!- FUNCTION: May be involved in actively transporting phosphate into cells
CC       via Na(+) cotransport. It may be the main phosphate transport protein
CC       in the intestinal brush border membrane. May have a role in the
CC       synthesis of surfactant in lungs' alveoli.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       pH dependence:
CC         Optimum pH is 6.6. {ECO:0000269|PubMed:10329428};
CC   -!- INTERACTION:
CC       O95436-2; Q9NVV5-2: AIG1; NbExp=3; IntAct=EBI-12811757, EBI-11957045;
CC       O95436-2; Q9UKR5: ERG28; NbExp=3; IntAct=EBI-12811757, EBI-711490;
CC       O95436-2; Q02747: GUCA2A; NbExp=3; IntAct=EBI-12811757, EBI-12244272;
CC       O95436-2; Q8N5M9: JAGN1; NbExp=3; IntAct=EBI-12811757, EBI-10266796;
CC       O95436-2; Q8TAF8: LHFPL5; NbExp=3; IntAct=EBI-12811757, EBI-2820517;
CC       O95436-2; P26678: PLN; NbExp=3; IntAct=EBI-12811757, EBI-692836;
CC       O95436-2; P54315: PNLIPRP1; NbExp=3; IntAct=EBI-12811757, EBI-8652812;
CC       O95436-2; Q5QGT7: RTP2; NbExp=3; IntAct=EBI-12811757, EBI-10244780;
CC       O95436-2; Q99726: SLC30A3; NbExp=5; IntAct=EBI-12811757, EBI-10294651;
CC       O95436-2; P78382: SLC35A1; NbExp=3; IntAct=EBI-12811757, EBI-12870360;
CC       O95436-2; Q92504: SLC39A7; NbExp=3; IntAct=EBI-12811757, EBI-1051105;
CC       O95436-2; P0DN84: STRIT1; NbExp=3; IntAct=EBI-12811757, EBI-12200293;
CC       O95436-2; Q9Y6I9: TEX264; NbExp=3; IntAct=EBI-12811757, EBI-10329860;
CC       O95436-2; Q5BJH2-2: TMEM128; NbExp=3; IntAct=EBI-12811757, EBI-10694905;
CC       O95436-2; Q8WW34-2: TMEM239; NbExp=3; IntAct=EBI-12811757, EBI-11528917;
CC       O95436-2; Q69YG0: TMEM42; NbExp=3; IntAct=EBI-12811757, EBI-12038591;
CC       O95436-2; Q5TGU0: TSPO2; NbExp=3; IntAct=EBI-12811757, EBI-12195249;
CC       O95436-2; A5PKU2: TUSC5; NbExp=3; IntAct=EBI-12811757, EBI-11988865;
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1; Synonyms=NaPi-3b;
CC         IsoId=O95436-1; Sequence=Displayed;
CC       Name=2; Synonyms=NaPi-2b, NaPi-IIb;
CC         IsoId=O95436-2; Sequence=VSP_016755;
CC   -!- TISSUE SPECIFICITY: Highly expressed in lung. Also detected in
CC       pancreas, kidney, small intestine, ovary, testis, prostate and mammary
CC       gland. In lung, it is found in alveolar type II cells but not in
CC       bronchiolar epithelium. {ECO:0000269|PubMed:10329428,
CC       ECO:0000269|PubMed:10610722}.
CC   -!- INDUCTION: Down-regulated by EGF. {ECO:0000269|PubMed:11171583}.
CC   -!- DISEASE: Pulmonary alveolar microlithiasis (PALM) [MIM:265100]: Rare
CC       disease characterized by the deposition of calcium phosphate microliths
CC       throughout the lungs. Most patients are asymptomatic for several years
CC       or even for decades and generally, the diagnosis is incidental to
CC       clinical investigations unrelated to the disease. Cases with early-
CC       onset or rapid progression are rare. A 'sandstorm-appearing' chest
CC       roentgenogram is a typical diagnostic finding. The onset of this
CC       potentially lethal disease varies from the neonatal period to old age
CC       and the disease follows a long-term, progressive course, resulting in a
CC       slow deterioration of lung functions. Pulmonary alveolar microlithiasis
CC       is a recessive monogenic disease with full penetrance.
CC       {ECO:0000269|PubMed:16960801}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving SLC34A2 is found in a
CC       glioblastoma multiforme cell line U-118MG. Results in the formation of
CC       a SLC34A2-ROS1 chimeric protein that retains a constitutive kinase
CC       activity. {ECO:0000269|PubMed:12661006}.
CC   -!- SIMILARITY: Belongs to the SLC34A transporter family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAC11354.1; Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF111856; AAC98695.1; -; mRNA.
DR   EMBL; AF146796; AAF31328.1; -; mRNA.
DR   EMBL; AC092436; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC142704; AAI42705.1; -; mRNA.
DR   EMBL; BC146666; AAI46667.1; -; mRNA.
DR   EMBL; AH011306; AAL55657.1; -; Genomic_DNA.
DR   EMBL; AK075015; BAC11354.1; ALT_INIT; mRNA.
DR   CCDS; CCDS3435.1; -. [O95436-1]
DR   CCDS; CCDS54750.1; -. [O95436-2]
DR   RefSeq; NP_001171469.1; NM_001177998.1. [O95436-2]
DR   RefSeq; NP_001171470.1; NM_001177999.1.
DR   RefSeq; NP_006415.2; NM_006424.2. [O95436-1]
DR   SMR; O95436; -.
DR   BioGrid; 115819; 15.
DR   IntAct; O95436; 32.
DR   STRING; 9606.ENSP00000371483; -.
DR   DrugBank; DB11348; Calcium Phosphate.
DR   DrugBank; DB14481; Calcium phosphate dihydrate.
DR   DrugBank; DB14502; Sodium phosphate, dibasic.
DR   DrugBank; DB09449; Sodium phosphate, monobasic.
DR   DrugBank; DB14503; Sodium phosphate, monobasic, unspecified form.
DR   TCDB; 2.A.58.1.4; the phosphate:na(+) symporter (pnas) family.
DR   iPTMnet; O95436; -.
DR   PhosphoSitePlus; O95436; -.
DR   BioMuta; SLC34A2; -.
DR   MassIVE; O95436; -.
DR   MaxQB; O95436; -.
DR   PaxDb; O95436; -.
DR   PeptideAtlas; O95436; -.
DR   PRIDE; O95436; -.
DR   ProteomicsDB; 50879; -. [O95436-1]
DR   ProteomicsDB; 50880; -. [O95436-2]
DR   ABCD; O95436; -.
DR   Antibodypedia; 51936; 139 antibodies.
DR   Ensembl; ENST00000382051; ENSP00000371483; ENSG00000157765. [O95436-1]
DR   Ensembl; ENST00000503434; ENSP00000423021; ENSG00000157765. [O95436-2]
DR   Ensembl; ENST00000504570; ENSP00000425501; ENSG00000157765. [O95436-2]
DR   Ensembl; ENST00000645788; ENSP00000494094; ENSG00000157765. [O95436-2]
DR   GeneID; 10568; -.
DR   KEGG; hsa:10568; -.
DR   UCSC; uc003grr.4; human. [O95436-1]
DR   CTD; 10568; -.
DR   DisGeNET; 10568; -.
DR   GeneCards; SLC34A2; -.
DR   HGNC; HGNC:11020; SLC34A2.
DR   HPA; ENSG00000157765; Group enriched (lung, seminal vesicle).
DR   MalaCards; SLC34A2; -.
DR   MIM; 265100; phenotype.
DR   MIM; 604217; gene.
DR   neXtProt; NX_O95436; -.
DR   OpenTargets; ENSG00000157765; -.
DR   Orphanet; 60025; Pulmonary alveolar microlithiasis.
DR   PharmGKB; PA35888; -.
DR   eggNOG; ENOG410IE8P; Eukaryota.
DR   eggNOG; COG1283; LUCA.
DR   GeneTree; ENSGT00950000183177; -.
DR   HOGENOM; CLU_025063_0_0_1; -.
DR   InParanoid; O95436; -.
DR   KO; K14683; -.
DR   OMA; SKCCEDL; -.
DR   OrthoDB; 976094at2759; -.
DR   PhylomeDB; O95436; -.
DR   TreeFam; TF313981; -.
DR   Reactome; R-HSA-427589; Type II Na+/Pi cotransporters.
DR   Reactome; R-HSA-5619045; Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM).
DR   Reactome; R-HSA-5683826; Surfactant metabolism.
DR   Reactome; R-HSA-5687583; Defective SLC34A2 causes pulmonary alveolar microlithiasis (PALM).
DR   SIGNOR; O95436; -.
DR   ChiTaRS; SLC34A2; human.
DR   GeneWiki; SLC34A2; -.
DR   GenomeRNAi; 10568; -.
DR   Pharos; O95436; Tbio.
DR   PRO; PR:O95436; -.
DR   Proteomes; UP000005640; Chromosome 4.
DR   RNAct; O95436; protein.
DR   Bgee; ENSG00000157765; Expressed in right lung and 115 other tissues.
DR   ExpressionAtlas; O95436; baseline and differential.
DR   Genevisible; O95436; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IDA:UniProtKB.
DR   GO; GO:0005903; C:brush border; IBA:GO_Central.
DR   GO; GO:0031526; C:brush border membrane; ISS:UniProtKB.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0016021; C:integral component of membrane; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; NAS:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IBA:GO_Central.
DR   GO; GO:0031982; C:vesicle; HDA:UniProtKB.
DR   GO; GO:0042301; F:phosphate ion binding; IDA:UniProtKB.
DR   GO; GO:0031402; F:sodium ion binding; IDA:UniProtKB.
DR   GO; GO:0015321; F:sodium-dependent phosphate transmembrane transporter activity; IDA:UniProtKB.
DR   GO; GO:0005436; F:sodium:phosphate symporter activity; IDA:UniProtKB.
DR   GO; GO:0030643; P:cellular phosphate ion homeostasis; IDA:UniProtKB.
DR   GO; GO:0044267; P:cellular protein metabolic process; TAS:Reactome.
DR   GO; GO:0001701; P:in utero embryonic development; IEA:Ensembl.
DR   GO; GO:0006817; P:phosphate ion transport; IDA:UniProtKB.
DR   GO; GO:0043627; P:response to estrogen; IEP:UniProtKB.
DR   GO; GO:0044341; P:sodium-dependent phosphate transport; IBA:GO_Central.
DR   InterPro; IPR003841; Na/Pi_transpt.
DR   InterPro; IPR029852; Na/Pi_transpt_2B.
DR   PANTHER; PTHR10010; PTHR10010; 1.
DR   PANTHER; PTHR10010:SF23; PTHR10010:SF23; 1.
DR   Pfam; PF02690; Na_Pi_cotrans; 2.
DR   TIGRFAMs; TIGR01013; 2a58; 1.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease mutation; Disulfide bond; Glycoprotein;
KW   Ion transport; Membrane; Polymorphism; Reference proteome; Sodium;
KW   Sodium transport; Symport; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..690
FT                   /note="Sodium-dependent phosphate transport protein 2B"
FT                   /id="PRO_0000068613"
FT   TOPO_DOM        1..100
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        101..121
FT                   /note="Helical; Name=M1"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        122..135
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        136..156
FT                   /note="Helical; Name=M2"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        157..212
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        213..233
FT                   /note="Helical; Name=M3"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        234..362
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        363..383
FT                   /note="Helical; Name=M4"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        384..407
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        408..428
FT                   /note="Helical; Name=M5"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        429..485
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        486..506
FT                   /note="Helical; Name=M6"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        507..525
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        526..546
FT                   /note="Helical; Name=M7"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        547..552
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        553..573
FT                   /note="Helical; Name=M8"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        574..689
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        464..467
FT                   /note="Poly-Thr"
FT   COMPBIAS        612..644
FT                   /note="Cys-rich"
FT   SITE            126..127
FT                   /note="Breakpoint for translocation to form a SLC34A2-ROS1
FT                   fusion protein"
FT   CARBOHYD        295
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        308
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        313
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        321
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        340
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        303..350
FT                   /evidence="ECO:0000250"
FT   VAR_SEQ         38..39
FT                   /note="TD -> N (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:10610722,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_016755"
FT   VARIANT         45
FT                   /note="V -> A (in dbSNP:rs35426730)"
FT                   /id="VAR_034156"
FT   VARIANT         106
FT                   /note="G -> R (in PALM; dbSNP:rs137853142)"
FT                   /evidence="ECO:0000269|PubMed:16960801"
FT                   /id="VAR_030677"
FT   VARIANT         634
FT                   /note="D -> G (in dbSNP:rs6448389)"
FT                   /evidence="ECO:0000269|PubMed:10329428,
FT                   ECO:0000269|PubMed:10610722, ECO:0000269|PubMed:14702039,
FT                   ECO:0000269|PubMed:15489334"
FT                   /id="VAR_030678"
FT   CONFLICT        228
FT                   /note="V -> L (in Ref. 2; AAF31328 and 5; AAL55657)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        330
FT                   /note="T -> V (in Ref. 6; BAC11354)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        590..595
FT                   /note="Missing (in Ref. 6; BAC11354)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        620
FT                   /note="C -> Y (in Ref. 1; AAC98695)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   690 AA;  75759 MW;  3BDB1920CA92C035 CRC64;
     MAPWPELGDA QPNPDKYLEG AAGQQPTAPD KSKETNKTDN TEAPVTKIEL LPSYSTATLI
     DEPTEVDDPW NLPTLQDSGI KWSERDTKGK ILCFFQGIGR LILLLGFLYF FVCSLDILSS
     AFQLVGGKMA GQFFSNSSIM SNPLLGLVIG VLVTVLVQSS STSTSIVVSM VSSSLLTVRA
     AIPIIMGANI GTSITNTIVA LMQVGDRSEF RRAFAGATVH DFFNWLSVLV LLPVEVATHY
     LEIITQLIVE SFHFKNGEDA PDLLKVITKP FTKLIVQLDK KVISQIAMND EKAKNKSLVK
     IWCKTFTNKT QINVTVPSTA NCTSPSLCWT DGIQNWTMKN VTYKENIAKC QHIFVNFHLP
     DLAVGTILLI LSLLVLCGCL IMIVKILGSV LKGQVATVIK KTINTDFPFP FAWLTGYLAI
     LVGAGMTFIV QSSSVFTSAL TPLIGIGVIT IERAYPLTLG SNIGTTTTAI LAALASPGNA
     LRSSLQIALC HFFFNISGIL LWYPIPFTRL PIRMAKGLGN ISAKYRWFAV FYLIIFFFLI
     PLTVFGLSLA GWRVLVGVGV PVVFIIILVL CLRLLQSRCP RVLPKKLQNW NFLPLWMRSL
     KPWDAVVSKF TGCFQMRCCC CCRVCCRACC LLCDCPKCCR CSKCCEDLEE AQEGQDVPVK
     APETFDNITI SREAQGEVPA SDSKTECTAL
//
ID   A0A087WWU8_HUMAN        Unreviewed;       227 AA.
AC   A0A087WWU8;
DT   29-OCT-2014, integrated into UniProtKB/TrEMBL.
DT   29-OCT-2014, sequence version 1.
DT   22-APR-2020, entry version 35.
DE   SubName: Full=Tropomyosin alpha-3 chain {ECO:0000313|Ensembl:ENSP00000480520};
GN   Name=TPM3 {ECO:0000313|Ensembl:ENSP00000480520};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|Ensembl:ENSP00000480520, ECO:0000313|Proteomes:UP000005640};
RN   [1] {ECO:0000313|Ensembl:ENSP00000480520, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I., Aubin K., Babbage A.K., Bagguley C.L., Bailey J., Beasley H.,
RA   Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J., Buckley D.,
RA   Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y., Clarke G., Clee C.,
RA   Cobley V., Collier R.E., Corby N., Coville G.J., Davies J., Deadman R.,
RA   Dunn M., Earthrowl M., Ellington A.G., Errington H., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Gay L., Ghori M.R.,
RA   Gibson R., Gilby L.M., Gillett W., Glithero R.J., Grafham D.V.,
RA   Griffiths C., Griffiths-Jones S., Grocock R., Hammond S., Harrison E.S.,
RA   Hart E., Haugen E., Heath P.D., Holmes S., Holt K., Howden P.J., Hunt A.R.,
RA   Hunt S.E., Hunter G., Isherwood J., James R., Johnson C., Johnson D.,
RA   Joy A., Kay M., Kershaw J.K., Kibukawa M., Kimberley A.M., King A.,
RA   Knights A.J., Lad H., Laird G., Lawlor S., Leongamornlert D.A., Lloyd D.M.,
RA   Loveland J., Lovell J., Lush M.J., Lyne R., Martin S.,
RA   Mashreghi-Mohammadi M., Matthews L., Matthews N.S., McLaren S., Milne S.,
RA   Mistry S., Moore M.J., Nickerson T., O'Dell C.N., Oliver K., Palmeiri A.,
RA   Palmer S.A., Parker A., Patel D., Pearce A.V., Peck A.I., Pelan S.,
RA   Phelps K., Phillimore B.J., Plumb R., Rajan J., Raymond C., Rouse G.,
RA   Saenphimmachak C., Sehra H.K., Sheridan E., Shownkeen R., Sims S.,
RA   Skuce C.D., Smith M., Steward C., Subramanian S., Sycamore N., Tracey A.,
RA   Tromans A., Van Helmond Z., Wall M., Wallis J.M., White S., Whitehead S.L.,
RA   Wilkinson J.E., Willey D.L., Williams H., Wilming L., Wray P.W., Wu Z.,
RA   Coulson A., Vaudin M., Sulston J.E., Durbin R., Hubbard T., Wooster R.,
RA   Dunham I., Carter N.P., McVean G., Ross M.T., Harrow J., Olson M.V.,
RA   Beck S., Rogers J., Bentley D.R., Banerjee R., Bryant S.P., Burford D.C.,
RA   Burrill W.D., Clegg S.M., Dhami P., Dovey O., Faulkner L.M., Gribble S.M.,
RA   Langford C.F., Pandian R.D., Porter K.M., Prigmore E.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [2] {ECO:0000213|PubMed:18669648}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [3] {ECO:0000213|PubMed:19608861}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [4] {ECO:0000213|PubMed:21269460}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Burckstummer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [5] {ECO:0000213|PubMed:24275569}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [6] {ECO:0000313|Ensembl:ENSP00000480520}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (SEP-2014) to UniProtKB.
RN   [7] {ECO:0000213|PubMed:25944712}
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AL590431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_001265119.1; NM_001278190.1.
DR   SMR; A0A087WWU8; -.
DR   jPOST; A0A087WWU8; -.
DR   PeptideAtlas; A0A087WWU8; -.
DR   PRIDE; A0A087WWU8; -.
DR   Antibodypedia; 1682; 218 antibodies.
DR   Ensembl; ENST00000611659; ENSP00000480520; ENSG00000143549.
DR   GeneID; 7170; -.
DR   UCSC; uc031ppo.1; human.
DR   CTD; 7170; -.
DR   EuPathDB; HostDB:ENSG00000143549.19; -.
DR   HGNC; HGNC:12012; TPM3.
DR   OpenTargets; ENSG00000143549; -.
DR   GeneTree; ENSGT00950000182712; -.
DR   ChiTaRS; TPM3; human.
DR   GenomeRNAi; 7170; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   Bgee; ENSG00000143549; Expressed in muscle of leg and 139 other tissues.
DR   ExpressionAtlas; A0A087WWU8; baseline and differential.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
PE   1: Evidence at protein level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils};
KW   Proteomics identification {ECO:0000213|EPD:A0A087WWU8,
KW   ECO:0000213|MaxQB:A0A087WWU8, ECO:0000213|PeptideAtlas:A0A087WWU8,
KW   ECO:0000213|ProteomicsDB:A0A087WWU8};
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   COILED          7..97
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          105..209
FT                   /evidence="ECO:0000256|SAM:Coils"
SQ   SEQUENCE   227 AA;  26421 MW;  0DE260B63E0F1E4D CRC64;
     MAGITTIEAV KRKIQVLQQQ ADDAEERAER LQREVEGERR AREQAEAEVA SLNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRALK DEEKMELQEI QLKEAKHIAE
     EADRKYEEVA RKLVIIEGDL ERTEERAELA ESRCREMDEQ IRLMDQNLKC LSAAEEKAET
     RAEFAERSVA KLEKTIDDLE DKLKCTKEEH LCTQRMLDQT LLDLNEM
//
ID   A0A0S2Z4G4_HUMAN        Unreviewed;       248 AA.
AC   A0A0S2Z4G4;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 20.
DE   SubName: Full=Tropomyosin 3 isoform 1 {ECO:0000313|EMBL:ALQ33826.1};
DE   Flags: Fragment;
GN   Name=TPM3 {ECO:0000313|EMBL:ALQ33826.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33826.1};
RN   [1] {ECO:0000313|EMBL:ALQ33826.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178368; ALQ33826.1; -; mRNA.
DR   RefSeq; NP_705935.1; NM_153649.3.
DR   SMR; A0A0S2Z4G4; -.
DR   IntAct; A0A0S2Z4G4; 3.
DR   MINT; A0A0S2Z4G4; -.
DR   PRIDE; A0A0S2Z4G4; -.
DR   Antibodypedia; 1682; 218 antibodies.
DR   GeneID; 7170; -.
DR   CTD; 7170; -.
DR   ChiTaRS; TPM3; human.
DR   GenomeRNAi; 7170; -.
DR   ExpressionAtlas; A0A0S2Z4G4; baseline and differential.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils}.
FT   REGION          21..42
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          105..230
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   NON_TER         248
FT                   /evidence="ECO:0000313|EMBL:ALQ33826.1"
SQ   SEQUENCE   248 AA;  29033 MW;  5C049312A337BC19 CRC64;
     MAGITTIEAV KRKIQVLQQQ ADDAEERAER LQREVEGERR AREQAEAEVA SLNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRALK DEEKMELQEI QLKEAKHIAE
     EADRKYEEVA RKLVIIEGDL ERTEERAELA ESRCREMDEQ IRLMDQNLKC LSAAEEKYSQ
     KEDKYEEEIK ILTDKLKEAE TRAEFAERSV AKLEKTIDDL EDKLKCTKEE HLCTQRMLDQ
     TLLDLNEM
//
ID   A0A0S2Z4I4_HUMAN        Unreviewed;       248 AA.
AC   A0A0S2Z4I4;
DT   17-FEB-2016, integrated into UniProtKB/TrEMBL.
DT   17-FEB-2016, sequence version 1.
DT   22-APR-2020, entry version 17.
DE   SubName: Full=Tropomyosin 3 isoform 3 {ECO:0000313|EMBL:ALQ33828.1};
DE   Flags: Fragment;
GN   Name=TPM3 {ECO:0000313|EMBL:ALQ33828.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ALQ33828.1};
RN   [1] {ECO:0000313|EMBL:ALQ33828.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178370; ALQ33828.1; -; mRNA.
DR   RefSeq; NP_001036816.1; NM_001043351.1.
DR   SMR; A0A0S2Z4I4; -.
DR   PRIDE; A0A0S2Z4I4; -.
DR   Antibodypedia; 1682; 218 antibodies.
DR   GeneID; 7170; -.
DR   CTD; 7170; -.
DR   OrthoDB; 1576041at2759; -.
DR   ChiTaRS; TPM3; human.
DR   GenomeRNAi; 7170; -.
DR   ExpressionAtlas; A0A0S2Z4I4; baseline and differential.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils}.
FT   COILED          7..97
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COILED          105..230
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   NON_TER         248
FT                   /evidence="ECO:0000313|EMBL:ALQ33828.1"
SQ   SEQUENCE   248 AA;  28870 MW;  179E2D62BC8993F5 CRC64;
     MAGITTIEAV KRKIQVLQQQ ADDAEERAER LQREVEGERR AREQAEAEVA SLNRRIQLVE
     EELDRAQERL ATALQKLEEA EKAADESERG MKVIENRALK DEEKMELQEI QLKEAKHIAE
     EADRKYEEVA RKLVIIEGDL ERTEERAELA ESKCSELEEE LKNVTNNLKS LEAQAEKYSQ
     KEDKYEEEIK ILTDKLKEAE TRAEFAERSV AKLEKTIDDL EDKLKCTKEE HLCTQRMLDQ
     TLLDLNEM
//
ID   B4DQ80_HUMAN            Unreviewed;       182 AA.
AC   B4DQ80;
DT   23-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   23-SEP-2008, sequence version 1.
DT   22-APR-2020, entry version 39.
DE   SubName: Full=cDNA FLJ50612, highly similar to Rattus norvegicus tropomyosin 3, gamma (Tpm3), transcript variant 2, mRNA {ECO:0000313|EMBL:BAG60842.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG60842.1};
RN   [1] {ECO:0000313|EMBL:BAG60842.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Wakamatsu A., Yamamoto J., Kimura K., Ishii S., Watanabe K., Sugiyama A.,
RA   Murakawa K., Kaida T., Tsuchiya K., Fukuzumi Y., Kumagai A., Oishi Y.,
RA   Yamamoto S., Ono Y., Komori Y., Yamazaki M., Kisu Y., Nishikawa T.,
RA   Sugano S., Nomura N., Isogai T.;
RT   "NEDO human cDNA sequencing project focused on splicing variants.";
RL   Submitted (OCT-2007) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the tropomyosin family.
CC       {ECO:0000256|RuleBase:RU004515}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK298678; BAG60842.1; -; mRNA.
DR   RefSeq; NP_001265117.1; NM_001278188.1.
DR   SMR; B4DQ80; -.
DR   PeptideAtlas; B4DQ80; -.
DR   PRIDE; B4DQ80; -.
DR   GeneID; 7170; -.
DR   CTD; 7170; -.
DR   GenomeRNAi; 7170; -.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   2: Evidence at transcript level;
KW   Coiled coil {ECO:0000256|SAAS:SAAS00134284, ECO:0000256|SAM:Coils}.
FT   REGION          1..31
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COILED          39..164
FT                   /evidence="ECO:0000256|SAM:Coils"
FT   COMPBIAS        9..31
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   182 AA;  21353 MW;  DC4A3CC3AA4CFACE CRC64;
     MMQRSELSAS SEKLREKGGP GNRGMKVIEN RALKDEEKME LQEIQLKEAK HIAEEADRKY
     EEVARKLVII EGDLERTEER AELAESRCRE MDEQIRLMDQ NLKCLSAAEE KYSQKEDKYE
     EEIKILTDKL KEAETRAEFA ERSVAKLEKT IDDLEDKLKC TKEEHLCTQR MLDQTLLDLN
     EM
//
ID   TPM3_HUMAN              Reviewed;         285 AA.
AC   P06753; D3DV71; P12324; Q2QD06; Q5VU58; Q5VU63; Q5VU66; Q5VU71; Q5VU72;
AC   Q8TCG3; Q969Q2; Q9NQH8;
DT   01-JAN-1988, integrated into UniProtKB/Swiss-Prot.
DT   26-JUN-2013, sequence version 2.
DT   22-APR-2020, entry version 225.
DE   RecName: Full=Tropomyosin alpha-3 chain;
DE   AltName: Full=Gamma-tropomyosin;
DE   AltName: Full=Tropomyosin-3;
DE   AltName: Full=Tropomyosin-5;
DE            Short=hTM5;
GN   Name=TPM3;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=3018581; DOI=10.1038/322648a0;
RA   Reinach F.C., McLeod A.R.;
RT   "Tissue-specific expression of the human tropomyosin gene involved in the
RT   generation of the trk oncogene.";
RL   Nature 322:648-650(1986).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RX   PubMed=3024106; DOI=10.1093/nar/14.21.8413;
RA   McLeod A.R., Houlker C., Talbot K.;
RT   "The mRNA and RNA-copy pseudogenes encoding TM30nm, a human cytoskeletal
RT   tropomyosin.";
RL   Nucleic Acids Res. 14:8413-8426(1986).
RN   [3]
RP   NUCLEOTIDE SEQUENCE (ISOFORMS 1 AND 2).
RX   PubMed=3418707; DOI=10.1016/0022-2836(88)90633-x;
RA   Clayton L., Reinach F.C., Chumbley G.M., MacLeod A.R.;
RT   "Organization of the hTMnm gene. Implications for the evolution of muscle
RT   and non-muscle tropomyosins.";
RL   J. Mol. Biol. 201:507-515(1988).
RN   [4]
RP   NUCLEOTIDE SEQUENCE (ISOFORM 3).
RC   TISSUE=Colon cancer;
RA   Lin J.J.-C., Lin J.L.-C., Geng X., Das K.M.;
RT   "Identification and characterization of a novel tropomyosin isoform from a
RT   colon cancer cell line T84.";
RL   Submitted (JUL-2000) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Bone, Kidney, Skeletal muscle, and Uterus;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 2-248 (ISOFORM 2), AND IDENTIFICATION
RP   OF RCTPM3.
RX   PubMed=16201836; DOI=10.1371/journal.pbio.0030357;
RA   Marques A.C., Dupanloup I., Vinckenbosch N., Reymond A., Kaessmann H.;
RT   "Emergence of young human genes after a burst of retroposition in
RT   primates.";
RL   PLoS Biol. 3:E357-E357(2005).
RN   [9]
RP   PROTEIN SEQUENCE OF 93-126; 135-150; 154-168 AND 215-245, PARTIAL PROTEIN
RP   SEQUENCE (ISOFORMS 2/3), CLEAVAGE OF INITIATOR METHIONINE (ISOFORMS 2/3),
RP   ACETYLATION AT ALA-2 (ISOFORMS 2/3), AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=B-cell lymphoma, and Platelet;
RA   Bienvenut W.V., Claeys D.;
RL   Submitted (DEC-2005) to UniProtKB.
RN   [10]
RP   PROTEIN SEQUENCE OF 93-119, PARTIAL PROTEIN SEQUENCE (ISOFORMS 2/3),
RP   CLEAVAGE OF INITIATOR METHIONINE (ISOFORMS 2/3), ACETYLATION AT ALA-2
RP   (ISOFORMS 2/3), AND IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Osteosarcoma;
RA   Bienvenut W.V., Glen H., Brunton V.G., Frame M.C.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [11]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), AND CHROMOSOMAL
RP   TRANSLOCATION WITH NTRK1.
RX   PubMed=2869410; DOI=10.1038/319743a0;
RA   Martin-Zanca D., Hughes S.H., Barbacid M.;
RT   "A human oncogene formed by the fusion of truncated tropomyosin and protein
RT   tyrosine kinase sequences.";
RL   Nature 319:743-748(1986).
RN   [12]
RP   PARTIAL PROTEIN SEQUENCE.
RC   TISSUE=Keratinocyte;
RX   PubMed=1286667; DOI=10.1002/elps.11501301199;
RA   Rasmussen H.H., van Damme J., Puype M., Gesser B., Celis J.E.,
RA   Vandekerckhove J.;
RT   "Microsequences of 145 proteins recorded in the two-dimensional gel protein
RT   database of normal human epidermal keratinocytes.";
RL   Electrophoresis 13:960-969(1992).
RN   [13]
RP   PARTIAL NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 6).
RC   TISSUE=Skeletal muscle;
RX   PubMed=12574106; DOI=10.1161/01.hyp.0000050646.79785.7c;
RA   Dunn S.A., Mohteshamzadeh M., Daly A.K., Thomas T.H.;
RT   "Altered tropomyosin expression in essential hypertension.";
RL   Hypertension 41:347-354(2003).
RN   [14]
RP   INTERACTION WITH TMOD1.
RX   PubMed=8002995; DOI=10.1006/bbrc.1994.1747;
RA   Sung L.A., Lin J.J.-C.;
RT   "Erythrocyte tropomodulin binds to the N-terminus of hTM5, a tropomyosin
RT   isoform encoded by the gamma-tropomyosin gene.";
RL   Biochem. Biophys. Res. Commun. 201:627-634(1994).
RN   [15]
RP   IDENTIFICATION OF RCTPM3 BY MASS SPECTROMETRY.
RC   TISSUE=Mammary cancer;
RA   Ahamed M.E., Ahmed M.E., Eltoum A.M., Altahir G.O., Ahmed K.M., Harbi S.O.,
RA   Stansalas J., Mohamed A.O.;
RT   "Abnormal proteins in primary breast cancer tissues from 25 Sudanese
RT   patients.";
RL   Eur. J. Inflamm. 6:115-121(2008).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [17]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-177 (ISOFORMS 2; 3 AND 6),
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-215 (ISOFORMS 2 AND 5),
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-125 (ISOFORM 7), AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [18]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-88, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [20]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [22]
RP   VARIANT NEM1 ARG-9.
RX   PubMed=7704029; DOI=10.1038/ng0195-75;
RA   Laing N.G., Wilton S.D., Akkari P.A., Dorosz S., Boundy K., Kneebone C.,
RA   Blumbergs P., White S., Watkins H., Love D.R., Haan E.;
RT   "A mutation in the alpha tropomyosin gene TPM3 associated with autosomal
RT   dominant nemaline myopathy.";
RL   Nat. Genet. 9:75-79(1995).
RN   [23]
RP   ERRATUM OF PUBMED:7704029.
RX   PubMed=7663526; DOI=10.1038/ng0695-249;
RA   Laing N.G., Wilton S.D., Akkari P.A., Dorosz S., Boundy K., Kneebone C.,
RA   Blumbergs P., White S., Watkins H., Love D.R., Haan E.;
RL   Nat. Genet. 10:249-249(1995).
RN   [24]
RP   CHARACTERIZATION OF VARIANT NEM1 ARG-9.
RX   PubMed=10587521; DOI=10.1172/jci7842;
RA   Michele D.E., Albayya F.P., Metzger J.M.;
RT   "A nemaline myopathy mutation in alpha-tropomyosin causes defective
RT   regulation of striated muscle force production.";
RL   J. Clin. Invest. 104:1575-1581(1999).
RN   [25]
RP   VARIANT NEM1 HIS-168.
RX   PubMed=17376686; DOI=10.1016/j.nmd.2007.01.017;
RA   Penisson-Besnier I., Monnier N., Toutain A., Dubas F., Laing N.;
RT   "A second pedigree with autosomal dominant nemaline myopathy caused by TPM3
RT   mutation: a clinical and pathological study.";
RL   Neuromuscul. Disord. 17:330-337(2007).
RN   [26]
RP   VARIANTS CFTD MET-100; CYS-168; GLY-168; GLU-169 AND GLY-245, AND VARIANT
RP   CAPM1 HIS-168.
RX   PubMed=18300303; DOI=10.1002/ana.21308;
RA   Clarke N.F., Kolski H., Dye D.E., Lim E., Smith R.L., Patel R., Fahey M.C.,
RA   Bellance R., Romero N.B., Johnson E.S., Labarre-Vila A., Monnier N.,
RA   Laing N.G., North K.N.;
RT   "Mutations in TPM3 are a common cause of congenital fiber type
RT   disproportion.";
RL   Ann. Neurol. 63:329-337(2008).
RN   [27]
RP   VARIANT CAPM1 CYS-168.
RX   PubMed=19487656; DOI=10.1212/wnl.0b013e3181a82659;
RA   Ohlsson M., Fidzianska A., Tajsharghi H., Oldfors A.;
RT   "TPM3 mutation in one of the original cases of cap disease.";
RL   Neurology 72:1961-1963(2009).
RN   [28]
RP   VARIANT CAPM1 HIS-168.
RX   PubMed=19553118; DOI=10.1016/j.nmd.2009.06.365;
RA   De Paula A.M., Franques J., Fernandez C., Monnier N., Lunardi J.,
RA   Pellissier J.F., Figarella-Branger D., Pouget J.;
RT   "A TPM3 mutation causing cap myopathy.";
RL   Neuromuscul. Disord. 19:685-688(2009).
RN   [29]
RP   VARIANTS CFTD VAL-4; PRO-91; HIS-168 AND LYS-241.
RX   PubMed=19953533; DOI=10.1002/humu.21157;
RA   Lawlor M.W., Dechene E.T., Roumm E., Geggel A.S., Moghadaszadeh B.,
RA   Beggs A.H.;
RT   "Mutations of tropomyosin 3 (TPM3) are common and associated with type 1
RT   myofiber hypotrophy in congenital fiber type disproportion.";
RL   Hum. Mutat. 31:176-183(2010).
RN   [30]
RP   VARIANTS CFTD HIS-168 AND ALA-174.
RX   PubMed=20951040; DOI=10.1016/j.nmd.2010.07.274;
RA   Munot P., Lashley D., Jungbluth H., Feng L., Pitt M., Robb S.A., Palace J.,
RA   Jayawant S., Kennet R., Beeson D., Cullup T., Abbs S., Laing N., Sewry C.,
RA   Muntoni F.;
RT   "Congenital fibre type disproportion associated with mutations in the
RT   tropomyosin 3 (TPM3) gene mimicking congenital myasthenia.";
RL   Neuromuscul. Disord. 20:796-800(2010).
RN   [31]
RP   VARIANTS NEM1 PHE-88 AND CYS-168, VARIANTS CAPM1 PHE-88; ALA-151; CYS-168
RP   AND ILE-245, VARIANTS CFTD VAL-100; CYS-168 AND HIS-168, AND VARIANTS
RP   CYS-91 AND LYS-253.
RX   PubMed=24692096; DOI=10.1002/humu.22554;
RA   Marttila M., Lehtokari V.L., Marston S., Nyman T.A., Barnerias C.,
RA   Beggs A.H., Bertini E., Ceyhan-Birsoy O., Cintas P., Gerard M.,
RA   Gilbert-Dussardier B., Hogue J.S., Longman C., Eymard B., Frydman M.,
RA   Kang P.B., Klinge L., Kolski H., Lochmueller H., Magy L., Manel V.,
RA   Mayer M., Mercuri E., North K.N., Peudenier-Robert S., Pihko H.,
RA   Probst F.J., Reisin R., Stewart W., Taratuto A.L., de Visser M.,
RA   Wilichowski E., Winer J., Nowak K., Laing N.G., Winder T.L., Monnier N.,
RA   Clarke N.F., Pelin K., Groenholm M., Wallgren-Pettersson C.;
RT   "Mutation update and genotype-phenotype correlations of novel and
RT   previously described mutations in TPM2 and TPM3 causing congenital
RT   myopathies.";
RL   Hum. Mutat. 35:779-790(2014).
RN   [32]
RP   VARIANT CAPM1 ILE-149.
RX   PubMed=24239060; DOI=10.1016/j.nmd.2013.10.002;
RA   Schreckenbach T., Schroeder J.M., Voit T., Abicht A., Neuen-Jacob E.,
RA   Roos A., Bulst S., Kuhl C., Schulz J.B., Weis J., Claeys K.G.;
RT   "Novel TPM3 mutation in a family with cap myopathy and review of the
RT   literature.";
RL   Neuromuscul. Disord. 24:117-124(2014).
CC   -!- FUNCTION: Binds to actin filaments in muscle and non-muscle cells.
CC       Plays a central role, in association with the troponin complex, in the
CC       calcium dependent regulation of vertebrate striated muscle contraction.
CC       Smooth muscle contraction is regulated by interaction with caldesmon.
CC       In non-muscle cells is implicated in stabilizing cytoskeleton actin
CC       filaments. {ECO:0000250|UniProtKB:P09493}.
CC   -!- SUBUNIT: Homodimer. Heterodimer of an alpha (TPM1, TPM3 or TPM4) and a
CC       beta (TPM2) chain (By similarity). Interacts with TMOD1
CC       (PubMed:8002995). {ECO:0000250|UniProtKB:P04692,
CC       ECO:0000269|PubMed:8002995}.
CC   -!- INTERACTION:
CC       P06753; Q8TAB5: C1orf216; NbExp=4; IntAct=EBI-355607, EBI-747505;
CC       P06753; Q969G5: CAVIN3; NbExp=3; IntAct=EBI-355607, EBI-3893101;
CC       P06753; Q8TD31-3: CCHCR1; NbExp=13; IntAct=EBI-355607, EBI-10175300;
CC       P06753; Q8IZT9: FAM9C; NbExp=8; IntAct=EBI-355607, EBI-2870039;
CC       P06753; P02671-2: FGA; NbExp=3; IntAct=EBI-355607, EBI-9640259;
CC       P06753; Q03933: HSF2; NbExp=10; IntAct=EBI-355607, EBI-2556750;
CC       P06753; Q9ULV5-2: HSF4; NbExp=3; IntAct=EBI-355607, EBI-12056251;
CC       P06753; O14879: IFIT3; NbExp=5; IntAct=EBI-355607, EBI-745127;
CC       P06753; Q9BQD3: KXD1; NbExp=11; IntAct=EBI-355607, EBI-739657;
CC       P06753; O95447: LCA5L; NbExp=4; IntAct=EBI-355607, EBI-8473670;
CC       P06753; Q96LR2: LURAP1; NbExp=4; IntAct=EBI-355607, EBI-741355;
CC       P06753; Q9Y6D9: MAD1L1; NbExp=10; IntAct=EBI-355607, EBI-742610;
CC       P06753; Q7Z3B4: NUP54; NbExp=6; IntAct=EBI-355607, EBI-741048;
CC       P06753; O43482: OIP5; NbExp=12; IntAct=EBI-355607, EBI-536879;
CC       P06753; Q6NSJ2-2: PHLDB3; NbExp=3; IntAct=EBI-355607, EBI-11018958;
CC       P06753; P62195: PSMC5; NbExp=3; IntAct=EBI-355607, EBI-357745;
CC       P06753; O95295: SNAPIN; NbExp=3; IntAct=EBI-355607, EBI-296723;
CC       P06753; Q8N0S2: SYCE1; NbExp=7; IntAct=EBI-355607, EBI-6872807;
CC       P06753; Q9NYJ8: TAB2; NbExp=3; IntAct=EBI-355607, EBI-358708;
CC       P06753; A0A024R4Q5: TFPT; NbExp=6; IntAct=EBI-355607, EBI-11527449;
CC       P06753; P0C1Z6: TFPT; NbExp=7; IntAct=EBI-355607, EBI-1245626;
CC       P06753; P0C1Z6-2: TFPT; NbExp=3; IntAct=EBI-355607, EBI-10178002;
CC       P06753; Q9NVV9: THAP1; NbExp=6; IntAct=EBI-355607, EBI-741515;
CC       P06753; Q9BT49: THAP7; NbExp=3; IntAct=EBI-355607, EBI-741350;
CC       P06753; P19237: TNNI1; NbExp=3; IntAct=EBI-355607, EBI-746692;
CC       P06753; P13805-3: TNNT1; NbExp=3; IntAct=EBI-355607, EBI-12151635;
CC       P06753; P67936: TPM4; NbExp=3; IntAct=EBI-355607, EBI-1642100;
CC       P06753; Q9UJT2: TSKS; NbExp=3; IntAct=EBI-355607, EBI-852101;
CC       P06753; Q8N1B4: VPS52; NbExp=3; IntAct=EBI-355607, EBI-2799833;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytoskeleton {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=7;
CC         Comment=Additional isoforms seem to exist.;
CC       Name=1; Synonyms=Skeletal muscle;
CC         IsoId=P06753-1; Sequence=Displayed;
CC       Name=2; Synonyms=Cytoskeletal, TM30nm;
CC         IsoId=P06753-2; Sequence=VSP_006604, VSP_006605, VSP_006606;
CC       Name=3;
CC         IsoId=P06753-3; Sequence=VSP_006604, VSP_006605, VSP_006607;
CC       Name=4;
CC         IsoId=P06753-4; Sequence=VSP_047302, VSP_047303, VSP_047304,
CC                                  VSP_047305, VSP_047306;
CC       Name=5;
CC         IsoId=P06753-5; Sequence=VSP_047302, VSP_047303, VSP_047304,
CC                                  VSP_006606;
CC       Name=6;
CC         IsoId=P06753-6; Sequence=VSP_006604, VSP_006605;
CC       Name=7;
CC         IsoId=P06753-7; Sequence=VSP_054792, VSP_006606;
CC   -!- DOMAIN: The molecule is in a coiled coil structure that is formed by 2
CC       polypeptide chains. The sequence exhibits a prominent seven-residues
CC       periodicity.
CC   -!- DISEASE: Nemaline myopathy 1 (NEM1) [MIM:609284]: A form of nemaline
CC       myopathy with autosomal dominant or recessive inheritance. Nemaline
CC       myopathies are disorders characterized by muscle weakness of varying
CC       onset and severity, and abnormal thread-like or rod-shaped structures
CC       in muscle fibers on histologic examination. Autosomal dominant NEM1 is
CC       characterized by a moderate phenotype with onset between birth and
CC       early second decade of life. Weakness is diffuse and symmetric with
CC       slow progression often with need for a wheelchair in adulthood. The
CC       autosomal recessive form has onset at birth with moderate to severe
CC       hypotonia and diffuse weakness. In the most severe cases, death can
CC       occur before 2 years. Less severe cases have delayed major motor
CC       milestones, and these patients may walk, but often need a wheelchair
CC       before 10 years. {ECO:0000269|PubMed:10587521,
CC       ECO:0000269|PubMed:17376686, ECO:0000269|PubMed:24692096,
CC       ECO:0000269|PubMed:7704029}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving TPM3 is found in
CC       papillary thyroid carcinomas (PTCs). A rearrangement with NTRK1
CC       generates the TRK fusion transcript by fusing the amino end of isoform
CC       2 of TPM3 to the 3'-end of NTRK1. {ECO:0000269|PubMed:2869410}.
CC   -!- DISEASE: Myopathy, congenital, with fiber-type disproportion (CFTD)
CC       [MIM:255310]: A genetically heterogeneous disorder in which there is
CC       relative hypotrophy of type 1 muscle fibers compared to type 2 fibers
CC       on skeletal muscle biopsy. However, these findings are not specific and
CC       can be found in many different myopathic and neuropathic conditions.
CC       {ECO:0000269|PubMed:18300303, ECO:0000269|PubMed:19953533,
CC       ECO:0000269|PubMed:20951040, ECO:0000269|PubMed:24692096}. Note=The
CC       disease is caused by mutations affecting the gene represented in this
CC       entry.
CC   -!- DISEASE: Cap myopathy 1 (CAPM1) [MIM:609284]: A rare congenital
CC       skeletal muscle disorder characterized by the presence of cap-like
CC       structures which are well demarcated and peripherally located under the
CC       sarcolemma and show abnormal accumulation of sarcomeric proteins.
CC       Clinical features are early onset of hypotonia and slowly progressive
CC       muscle weakness. Respiratory problems are common.
CC       {ECO:0000269|PubMed:18300303, ECO:0000269|PubMed:19487656,
CC       ECO:0000269|PubMed:19553118, ECO:0000269|PubMed:24239060,
CC       ECO:0000269|PubMed:24692096}. Note=The disease is caused by mutations
CC       affecting the gene represented in this entry.
CC   -!- MISCELLANEOUS: [Isoform 2]: Peptides 2-27, 41-55, 132-153, 163-169,
CC       216-225 and 237-248 have been identified and sequenced by MS.
CC       PubMed:16201836 (ABC40673) sequence corresponds to a TPM3 retrocopy
CC       (rcTPM3) on chromosome 16 that is generated by retroposition of
CC       reversed transcribed mRNA back to the genome. rcTPM3 functionality is
CC       uncertain. It has been detected by MS in primary breast cancer tissues.
CC       {ECO:0000269|Ref.10, ECO:0000269|Ref.9, ECO:0000305}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Peptides 2-27, 41-55, 132-153 and 163-169
CC       have been identified and sequenced by MS. {ECO:0000269|Ref.10,
CC       ECO:0000269|Ref.9, ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the tropomyosin family. {ECO:0000305}.
CC   -!- CAUTION: It is uncertain whether Met-1 or Met-2 is the initiator.
CC       {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/TPM3ID225.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X04201; CAA27798.1; -; mRNA.
DR   EMBL; AY004867; AAF87083.1; -; mRNA.
DR   EMBL; X04588; CAB37185.1; -; mRNA.
DR   EMBL; AL590431; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; CH471121; EAW53229.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53230.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53231.1; -; Genomic_DNA.
DR   EMBL; CH471121; EAW53235.1; -; Genomic_DNA.
DR   EMBL; BC000771; AAH00771.1; -; mRNA.
DR   EMBL; BC008407; AAH08407.1; -; mRNA.
DR   EMBL; BC008425; AAH08425.1; -; mRNA.
DR   EMBL; BC015403; AAH15403.1; -; mRNA.
DR   EMBL; BC072428; AAH72428.1; -; mRNA.
DR   EMBL; DQ120714; ABC40673.1; -; Genomic_DNA.
DR   EMBL; X03541; CAA27243.1; ALT_TERM; mRNA.
DR   EMBL; AF474157; AAL84570.1; -; mRNA.
DR   CCDS; CCDS1060.1; -. [P06753-2]
DR   CCDS; CCDS41400.1; -. [P06753-5]
DR   CCDS; CCDS41401.1; -. [P06753-4]
DR   CCDS; CCDS41402.1; -. [P06753-3]
DR   CCDS; CCDS41403.1; -. [P06753-1]
DR   CCDS; CCDS60274.1; -. [P06753-7]
DR   CCDS; CCDS60275.1; -. [P06753-6]
DR   PIR; A25530; A25530.
DR   PIR; S06210; A24199.
DR   RefSeq; NP_001036816.1; NM_001043351.1. [P06753-5]
DR   RefSeq; NP_001036817.1; NM_001043352.1. [P06753-3]
DR   RefSeq; NP_001036818.1; NM_001043353.1. [P06753-4]
DR   RefSeq; NP_001265118.1; NM_001278189.1. [P06753-6]
DR   RefSeq; NP_001265120.1; NM_001278191.1. [P06753-7]
DR   RefSeq; NP_689476.2; NM_152263.3. [P06753-1]
DR   RefSeq; NP_705935.1; NM_153649.3. [P06753-2]
DR   PDB; 6OTN; X-ray; 2.40 A; A/B/C/D=44-117.
DR   PDBsum; 6OTN; -.
DR   SMR; P06753; -.
DR   BioGrid; 113023; 165.
DR   IntAct; P06753; 94.
DR   MINT; P06753; -.
DR   STRING; 9606.ENSP00000357516; -.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   iPTMnet; P06753; -.
DR   MetOSite; P06753; -.
DR   PhosphoSitePlus; P06753; -.
DR   SwissPalm; P06753; -.
DR   BioMuta; TPM3; -.
DR   DMDM; 519668659; -.
DR   DOSAC-COBS-2DPAGE; P06753; -.
DR   SWISS-2DPAGE; P06753; -.
DR   EPD; P06753; -.
DR   jPOST; P06753; -.
DR   MassIVE; P06753; -.
DR   MaxQB; P06753; -.
DR   PaxDb; P06753; -.
DR   PeptideAtlas; P06753; -.
DR   PRIDE; P06753; -.
DR   ProteomicsDB; 51930; -. [P06753-1]
DR   ProteomicsDB; 51931; -. [P06753-2]
DR   ProteomicsDB; 51932; -. [P06753-3]
DR   ProteomicsDB; 65387; -.
DR   ProteomicsDB; 65390; -.
DR   ProteomicsDB; 65392; -.
DR   ProteomicsDB; 65394; -.
DR   Antibodypedia; 1682; 218 antibodies.
DR   Ensembl; ENST00000302206; ENSP00000307712; ENSG00000143549. [P06753-7]
DR   Ensembl; ENST00000323144; ENSP00000357518; ENSG00000143549. [P06753-4]
DR   Ensembl; ENST00000328159; ENSP00000357520; ENSG00000143549. [P06753-6]
DR   Ensembl; ENST00000330188; ENSP00000339035; ENSG00000143549. [P06753-5]
DR   Ensembl; ENST00000341485; ENSP00000341653; ENSG00000143549. [P06753-4]
DR   Ensembl; ENST00000368531; ENSP00000357517; ENSG00000143549. [P06753-3]
DR   Ensembl; ENST00000368533; ENSP00000357521; ENSG00000143549. [P06753-2]
DR   Ensembl; ENST00000651641; ENSP00000498577; ENSG00000143549. [P06753-1]
DR   GeneID; 7170; -.
DR   KEGG; hsa:7170; -.
DR   UCSC; uc001fdy.2; human. [P06753-1]
DR   CTD; 7170; -.
DR   DisGeNET; 7170; -.
DR   GeneCards; TPM3; -.
DR   GeneReviews; TPM3; -.
DR   HGNC; HGNC:12012; TPM3.
DR   HPA; ENSG00000143549; Tissue enhanced (skeletal muscle, tongue).
DR   MalaCards; TPM3; -.
DR   MIM; 164970; gene.
DR   MIM; 191030; gene.
DR   MIM; 255310; phenotype.
DR   MIM; 609284; phenotype.
DR   neXtProt; NX_P06753; -.
DR   OpenTargets; ENSG00000143549; -.
DR   Orphanet; 171881; Cap myopathy.
DR   Orphanet; 171439; Childhood-onset nemaline myopathy.
DR   Orphanet; 2020; Congenital fiber-type disproportion myopathy.
DR   Orphanet; 476406; Congenital generalized hypercontractile muscle stiffness syndrome.
DR   Orphanet; 178342; Inflammatory myofibroblastic tumor.
DR   Orphanet; 171433; Intermediate nemaline myopathy.
DR   PharmGKB; PA36692; -.
DR   eggNOG; KOG1003; Eukaryota.
DR   eggNOG; ENOG410XR5K; LUCA.
DR   GeneTree; ENSGT00950000182712; -.
DR   HOGENOM; CLU_055027_3_0_1; -.
DR   InParanoid; P06753; -.
DR   KO; K09290; -.
DR   OMA; MDKREDY; -.
DR   OrthoDB; 1576041at2759; -.
DR   PhylomeDB; P06753; -.
DR   TreeFam; TF351519; -.
DR   Reactome; R-HSA-390522; Striated Muscle Contraction.
DR   Reactome; R-HSA-445355; Smooth Muscle Contraction.
DR   SIGNOR; P06753; -.
DR   ChiTaRS; TPM3; human.
DR   GeneWiki; Tropomyosin_3; -.
DR   GenomeRNAi; 7170; -.
DR   Pharos; P06753; Tbio.
DR   PRO; PR:P06753; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; P06753; protein.
DR   Bgee; ENSG00000143549; Expressed in muscle of leg and 139 other tissues.
DR   ExpressionAtlas; P06753; baseline and differential.
DR   Genevisible; P06753; HS.
DR   GO; GO:0015629; C:actin cytoskeleton; IDA:HPA.
DR   GO; GO:0005884; C:actin filament; IBA:GO_Central.
DR   GO; GO:0005856; C:cytoskeleton; TAS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005862; C:muscle thin filament tropomyosin; TAS:UniProtKB.
DR   GO; GO:0001725; C:stress fiber; IDA:MGI.
DR   GO; GO:0051015; F:actin filament binding; IBA:GO_Central.
DR   GO; GO:0007015; P:actin filament organization; IBA:GO_Central.
DR   GO; GO:0006936; P:muscle contraction; IBA:GO_Central.
DR   GO; GO:0030049; P:muscle filament sliding; TAS:Reactome.
DR   InterPro; IPR000533; Tropomyosin.
DR   Pfam; PF00261; Tropomyosin; 1.
DR   PRINTS; PR00194; TROPOMYOSIN.
DR   PROSITE; PS00326; TROPOMYOSIN; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Actin-binding; Alternative splicing;
KW   Chromosomal rearrangement; Coiled coil; Cytoplasm; Cytoskeleton;
KW   Direct protein sequencing; Disease mutation; Muscle protein;
KW   Nemaline myopathy; Phosphoprotein; Proto-oncogene; Reference proteome.
FT   INIT_MET        1
FT                   /note="Removed"
FT                   /evidence="ECO:0000250|UniProtKB:P58776"
FT   CHAIN           2..285
FT                   /note="Tropomyosin alpha-3 chain"
FT                   /id="PRO_0000205632"
FT   COILED          1..285
FT                   /evidence="ECO:0000250"
FT   MOD_RES         2
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000250|UniProtKB:P58776"
FT   MOD_RES         54
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P07951"
FT   MOD_RES         62
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58774"
FT   MOD_RES         88
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         109
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P07951"
FT   MOD_RES         207
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P07951"
FT   MOD_RES         216
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P58775"
FT   MOD_RES         253
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P07951"
FT   MOD_RES         262
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P58775"
FT   MOD_RES         272
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21107"
FT   MOD_RES         283
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P07951"
FT   MOD_RES         284
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P21107"
FT   VAR_SEQ         1..127
FT                   /note="Missing (in isoform 7)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_054792"
FT   VAR_SEQ         1..81
FT                   /note="MMEAIKKKMQMLKLDKENALDRAEQAEAEQKQAEERSKQLEDELAAMQKKLK
FT                   GTEDELDKYSEALKDAQEKLELAEKKAAD -> MAGITTIEAVKRKIQVLQQQADDAEE
FT                   RAERLQREVEGERRAREQ (in isoform 2, isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3024106"
FT                   /id="VSP_006604"
FT   VAR_SEQ         1..2
FT                   /note="MM -> MAGITTI (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047302"
FT   VAR_SEQ         5..21
FT                   /note="IKKKMQMLKLDKENALD -> VKRKIQVLQQQADDAEE (in isoform 4
FT                   and isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047303"
FT   VAR_SEQ         25..81
FT                   /note="QAEAEQKQAEERSKQLEDELAAMQKKLKGTEDELDKYSEALKDAQEKLELAE
FT                   KKAAD -> RLQREVEGERRAREQ (in isoform 4 and isoform 5)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047304"
FT   VAR_SEQ         190..212
FT                   /note="KCSELEEELKNVTNNLKSLEAQA -> RCREMDEQIRLMDQNLKCLSAAE
FT                   (in isoform 2, isoform 3 and isoform 6)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3024106"
FT                   /id="VSP_006605"
FT   VAR_SEQ         259..285
FT                   /note="DELYAQKLKYKAISEELDHALNDMTSI -> ERLYSQLERNRLLSNELKLTL
FT                   HDLCD (in isoform 3)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006607"
FT   VAR_SEQ         259..260
FT                   /note="DE -> ER (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047305"
FT   VAR_SEQ         260..285
FT                   /note="ELYAQKLKYKAISEELDHALNDMTSI -> KLKCTKEEHLCTQRMLDQTLLD
FT                   LNEM (in isoform 2, isoform 5 and isoform 7)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:3024106"
FT                   /id="VSP_006606"
FT   VAR_SEQ         263..285
FT                   /note="AQKLKYKAISEELDHALNDMTSI -> SQLERNRLLSNELKLTLHDLCD
FT                   (in isoform 4)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_047306"
FT   VARIANT         4
FT                   /note="A -> V (in CFTD; dbSNP:rs199474711)"
FT                   /evidence="ECO:0000269|PubMed:19953533"
FT                   /id="VAR_071499"
FT   VARIANT         9
FT                   /note="M -> R (in NEM1; decrease in the sensitivity of
FT                   contraction to activating calcium; dbSNP:rs80358247)"
FT                   /evidence="ECO:0000269|PubMed:10587521,
FT                   ECO:0000269|PubMed:7704029"
FT                   /id="VAR_013460"
FT   VARIANT         88
FT                   /note="S -> F (in NEM1 and CAPM1)"
FT                   /evidence="ECO:0000269|PubMed:24692096"
FT                   /id="VAR_071500"
FT   VARIANT         91
FT                   /note="R -> C (probable disease-associated mutation found
FT                   in patients with undefined congenital myopathy)"
FT                   /evidence="ECO:0000269|PubMed:24692096"
FT                   /id="VAR_071501"
FT   VARIANT         91
FT                   /note="R -> P (in CFTD; dbSNP:rs199474713)"
FT                   /evidence="ECO:0000269|PubMed:19953533"
FT                   /id="VAR_071502"
FT   VARIANT         100
FT                   /note="L -> M (in CFTD; dbSNP:rs121964853)"
FT                   /evidence="ECO:0000269|PubMed:18300303"
FT                   /id="VAR_070066"
FT   VARIANT         100
FT                   /note="L -> V (in CFTD)"
FT                   /evidence="ECO:0000269|PubMed:24692096"
FT                   /id="VAR_071503"
FT   VARIANT         149
FT                   /note="L -> I (in CAPM1)"
FT                   /evidence="ECO:0000269|PubMed:24239060"
FT                   /id="VAR_071504"
FT   VARIANT         151
FT                   /note="E -> A (in CAPM1)"
FT                   /evidence="ECO:0000269|PubMed:24692096"
FT                   /id="VAR_071505"
FT   VARIANT         168
FT                   /note="R -> C (in CFTD, CAPM1 and NEM1; also found in
FT                   patients with undefined congenital myopathy;
FT                   dbSNP:rs121964854)"
FT                   /evidence="ECO:0000269|PubMed:18300303,
FT                   ECO:0000269|PubMed:19487656, ECO:0000269|PubMed:24692096"
FT                   /id="VAR_070067"
FT   VARIANT         168
FT                   /note="R -> G (in CFTD; dbSNP:rs121964854)"
FT                   /evidence="ECO:0000269|PubMed:18300303"
FT                   /id="VAR_070068"
FT   VARIANT         168
FT                   /note="R -> H (in NEM1, CAPM1 and CFTD; also found in
FT                   patients with undefined congenital myopathy;
FT                   dbSNP:rs121964852)"
FT                   /evidence="ECO:0000269|PubMed:17376686,
FT                   ECO:0000269|PubMed:18300303, ECO:0000269|PubMed:19553118,
FT                   ECO:0000269|PubMed:19953533, ECO:0000269|PubMed:20951040,
FT                   ECO:0000269|PubMed:24692096"
FT                   /id="VAR_070069"
FT   VARIANT         169
FT                   /note="K -> E (in CFTD; dbSNP:rs199474715)"
FT                   /evidence="ECO:0000269|PubMed:18300303"
FT                   /id="VAR_070070"
FT   VARIANT         174
FT                   /note="E -> A (in CFTD; dbSNP:rs199474716)"
FT                   /evidence="ECO:0000269|PubMed:20951040"
FT                   /id="VAR_071506"
FT   VARIANT         241
FT                   /note="E -> K (in CFTD; dbSNP:rs199474717)"
FT                   /evidence="ECO:0000269|PubMed:19953533"
FT                   /id="VAR_071507"
FT   VARIANT         245
FT                   /note="R -> G (in CFTD; dbSNP:rs199474718)"
FT                   /evidence="ECO:0000269|PubMed:18300303"
FT                   /id="VAR_070071"
FT   VARIANT         245
FT                   /note="R -> I (in CAPM1; dbSNP:rs797046047)"
FT                   /evidence="ECO:0000269|PubMed:24692096"
FT                   /id="VAR_071508"
FT   VARIANT         253
FT                   /note="T -> K (probable disease-associated mutation found
FT                   in patients with undefined congenital myopathy;
FT                   dbSNP:rs1553248515)"
FT                   /evidence="ECO:0000269|PubMed:24692096"
FT                   /id="VAR_071509"
FT   CONFLICT        150
FT                   /note="K -> E (in Ref. 13; CAA27243)"
FT                   /evidence="ECO:0000305"
FT   HELIX           44..110
FT                   /evidence="ECO:0000244|PDB:6OTN"
FT   INIT_MET        P06753-2:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P06753-2:2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P06753-2:177
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         P06753-2:215
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   CONFLICT        P06753-2:33
FT                   /note="R -> Q (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:43
FT                   /note="E -> K (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:66
FT                   /note="A -> P (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:85
FT                   /note="D -> G (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:110
FT                   /note="I -> L (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:135
FT                   /note="I -> T (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:150
FT                   /note="A -> T (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:192
FT                   /note="L -> F (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:196
FT                   /note="L -> P (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        P06753-2:202
FT                   /note="R -> C (in Ref. 8; ABC40673)"
FT                   /evidence="ECO:0000305"
FT   INIT_MET        P06753-3:1
FT                   /note="Removed"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P06753-3:2
FT                   /note="N-acetylalanine"
FT                   /evidence="ECO:0000305"
FT   MOD_RES         P06753-3:177
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         P06753-5:215
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         P06753-6:177
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         P06753-7:125
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
SQ   SEQUENCE   285 AA;  32950 MW;  99EAD24C45460A14 CRC64;
     MMEAIKKKMQ MLKLDKENAL DRAEQAEAEQ KQAEERSKQL EDELAAMQKK LKGTEDELDK
     YSEALKDAQE KLELAEKKAA DAEAEVASLN RRIQLVEEEL DRAQERLATA LQKLEEAEKA
     ADESERGMKV IENRALKDEE KMELQEIQLK EAKHIAEEAD RKYEEVARKL VIIEGDLERT
     EERAELAESK CSELEEELKN VTNNLKSLEA QAEKYSQKED KYEEEIKILT DKLKEAETRA
     EFAERSVAKL EKTIDDLEDE LYAQKLKYKA ISEELDHALN DMTSI
//
ID   B3KN30_HUMAN            Unreviewed;       759 AA.
AC   B3KN30;
DT   02-SEP-2008, integrated into UniProtKB/TrEMBL.
DT   02-SEP-2008, sequence version 1.
DT   26-FEB-2020, entry version 62.
DE   SubName: Full=cDNA FLJ13372 fis, clone PLACE1000706, highly similar to Transcription intermediary factor 1-gamma {ECO:0000313|EMBL:BAG51192.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:BAG51192.1};
RN   [1] {ECO:0000313|EMBL:BAG51192.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Placenta {ECO:0000313|EMBL:BAG51192.1};
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M.,
RA   Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S.,
RA   Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S.,
RA   Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H.,
RA   Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M.,
RA   Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M.,
RA   Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y.,
RA   Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N.,
RA   Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S.,
RA   Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T.,
RA   Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M.,
RA   Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y.,
RA   Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y.,
RA   Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T.,
RA   Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AK023434; BAG51192.1; -; mRNA.
DR   RefSeq; NP_056990.3; NM_015906.3.
DR   RefSeq; NP_148980.2; NM_033020.2.
DR   MaxQB; B3KN30; -.
DR   PeptideAtlas; B3KN30; -.
DR   PRIDE; B3KN30; -.
DR   GeneID; 51592; -.
DR   KEGG; hsa:51592; -.
DR   CTD; 51592; -.
DR   PharmGKB; PA38118; -.
DR   eggNOG; ENOG410ITFN; Eukaryota.
DR   eggNOG; ENOG410Z421; LUCA.
DR   KO; K08883; -.
DR   OrthoDB; 756911at2759; -.
DR   GenomeRNAi; 51592; -.
DR   Genevisible; B3KN30; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF00628; PHD; 1.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00249; PHD; 1.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
PE   2: Evidence at transcript level;
KW   Bromodomain {ECO:0000256|PROSITE-ProRule:PRU00035};
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00146, ECO:0000256|SAAS:SAAS01007077};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00146,
KW   ECO:0000256|SAAS:SAAS01007077}.
FT   DOMAIN          519..566
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50016"
FT   DOMAIN          606..678
FT                   /note="Bromo"
FT                   /evidence="ECO:0000259|PROSITE:PS50014"
FT   REGION          335..431
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          720..759
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        335..406
FT                   /note="Polar"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        738..759
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   759 AA;  83900 MW;  E7C568375BD3DC91 CRC64;
     MKLLQQQNDI TGLSRQVKHV MNFTNWAIAS GSSTALLYSK RLITFQLRHI LKARCDPAPA
     ANGAIRFHCD PTFWAKNVVN LGNLVIESKP APGYTPNVVV GQVPPGTNHI SKTPGQINLA
     QLRLQHMQQQ VYAQKHQQLQ QMRMQQPPAP VPTTTTTTQQ HPRQAAPQML QQQPPRLISV
     QTMQRGNMNC GAFQAHQMRL AQNAARIPGI PRHSGPQYSM MQPHLQRQHS NPGHAGPFPV
     VSVHNTTINP TSPTTATMAN ANRGPTSPSV TAIELIPSVT NPENLPSLPD IPPIQANVVP
     MMHSWYEFGA REKTQDQNVL EDAGSSSLDN LLSRYISGSH LPPQPTSTMN PSPGPSALSP
     GSSGLSNSHT PVRPPSTSST GSRGSCGSSG RTAEKTSLSF KSDQVKVKQE PGTEDEICSF
     SGGVKQEKTE DGRRSACMLS SPESSLTPPL STNLHLESEL DALASLENHV KIEPADMNES
     CKQSGLSSLV NGKSPIRSLM HRSARIGGDG NNKDDDPNED WCAVCQNGGD LLCCEKCPKV
     FHLTCHVPTL LSFPSGDWIC TFCRDIGKPE VEYDCDNLQH SKKGKTAQGL SPVDQRKCER
     LLLYLYCHEL SIEFQEPVPA SIPNYYKIIK KPMDLSTVKK KLQKKHSQHY QIPDDFVADV
     RLIFKNCERF NEMMKVVQVY ADTQEINLKA DSEVAQAGKA VALYFEDKLT EIYSDRTFAP
     LPEFEQEEDD GEVTEDSDED FIQPRRKRLK SDERPVHIK
//
ID   TRI33_HUMAN             Reviewed;        1127 AA.
AC   Q9UPN9; O95855; Q5TG72; Q5TG73; Q5TG74; Q9C017; Q9UJ79;
DT   24-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   22-APR-2020, entry version 197.
DE   RecName: Full=E3 ubiquitin-protein ligase TRIM33;
DE            EC=2.3.2.27;
DE   AltName: Full=Ectodermin homolog;
DE   AltName: Full=RET-fused gene 7 protein;
DE            Short=Protein Rfg7;
DE   AltName: Full=RING-type E3 ubiquitin transferase TRIM33 {ECO:0000305};
DE   AltName: Full=Transcription intermediary factor 1-gamma;
DE            Short=TIF1-gamma;
DE   AltName: Full=Tripartite motif-containing protein 33;
GN   Name=TRIM33; Synonyms=KIAA1113, RFG7, TIF1G;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM ALPHA), FUNCTION, SUBUNIT, AND VARIANT
RP   THR-840.
RX   PubMed=10022127; DOI=10.1038/sj.onc.1202655;
RA   Venturini L., You J., Stadler M., Galien R., Lallemand V., Koken M.H.M.,
RA   Mattei M.-G., Ganser A., Chambon P., Losson R., De The H.;
RT   "TIF1gamma, a novel member of the transcriptional intermediary factor 1
RT   family.";
RL   Oncogene 18:1209-1217(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS ALPHA AND BETA), AND VARIANT THR-840.
RX   PubMed=11331580; DOI=10.1093/emboj/20.9.2140;
RA   Reymond A., Meroni G., Fantozzi A., Merla G., Cairo S., Luzi L.,
RA   Riganelli D., Zanaria E., Messali S., Cainarca S., Guffanti A., Minucci S.,
RA   Pelicci P.G., Ballabio A.;
RT   "The tripartite motif family identifies cell compartments.";
RL   EMBO J. 20:2140-2151(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM ALPHA), AND VARIANT
RP   THR-840.
RC   TISSUE=Brain;
RX   PubMed=10470851; DOI=10.1093/dnares/6.3.197;
RA   Kikuno R., Nagase T., Ishikawa K., Hirosawa M., Miyajima N., Tanaka A.,
RA   Kotani H., Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. XIV. The
RT   complete sequences of 100 new cDNA clones from brain which code for large
RT   proteins in vitro.";
RL   DNA Res. 6:197-205(1999).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16710414; DOI=10.1038/nature04727;
RA   Gregory S.G., Barlow K.F., McLay K.E., Kaul R., Swarbreck D., Dunham A.,
RA   Scott C.E., Howe K.L., Woodfine K., Spencer C.C.A., Jones M.C., Gillson C.,
RA   Searle S., Zhou Y., Kokocinski F., McDonald L., Evans R., Phillips K.,
RA   Atkinson A., Cooper R., Jones C., Hall R.E., Andrews T.D., Lloyd C.,
RA   Ainscough R., Almeida J.P., Ambrose K.D., Anderson F., Andrew R.W.,
RA   Ashwell R.I.S., Aubin K., Babbage A.K., Bagguley C.L., Bailey J.,
RA   Beasley H., Bethel G., Bird C.P., Bray-Allen S., Brown J.Y., Brown A.J.,
RA   Buckley D., Burton J., Bye J., Carder C., Chapman J.C., Clark S.Y.,
RA   Clarke G., Clee C., Cobley V., Collier R.E., Corby N., Coville G.J.,
RA   Davies J., Deadman R., Dunn M., Earthrowl M., Ellington A.G., Errington H.,
RA   Frankish A., Frankland J., French L., Garner P., Garnett J., Gay L.,
RA   Ghori M.R.J., Gibson R., Gilby L.M., Gillett W., Glithero R.J.,
RA   Grafham D.V., Griffiths C., Griffiths-Jones S., Grocock R., Hammond S.,
RA   Harrison E.S.I., Hart E., Haugen E., Heath P.D., Holmes S., Holt K.,
RA   Howden P.J., Hunt A.R., Hunt S.E., Hunter G., Isherwood J., James R.,
RA   Johnson C., Johnson D., Joy A., Kay M., Kershaw J.K., Kibukawa M.,
RA   Kimberley A.M., King A., Knights A.J., Lad H., Laird G., Lawlor S.,
RA   Leongamornlert D.A., Lloyd D.M., Loveland J., Lovell J., Lush M.J.,
RA   Lyne R., Martin S., Mashreghi-Mohammadi M., Matthews L., Matthews N.S.W.,
RA   McLaren S., Milne S., Mistry S., Moore M.J.F., Nickerson T., O'Dell C.N.,
RA   Oliver K., Palmeiri A., Palmer S.A., Parker A., Patel D., Pearce A.V.,
RA   Peck A.I., Pelan S., Phelps K., Phillimore B.J., Plumb R., Rajan J.,
RA   Raymond C., Rouse G., Saenphimmachak C., Sehra H.K., Sheridan E.,
RA   Shownkeen R., Sims S., Skuce C.D., Smith M., Steward C., Subramanian S.,
RA   Sycamore N., Tracey A., Tromans A., Van Helmond Z., Wall M., Wallis J.M.,
RA   White S., Whitehead S.L., Wilkinson J.E., Willey D.L., Williams H.,
RA   Wilming L., Wray P.W., Wu Z., Coulson A., Vaudin M., Sulston J.E.,
RA   Durbin R.M., Hubbard T., Wooster R., Dunham I., Carter N.P., McVean G.,
RA   Ross M.T., Harrow J., Olson M.V., Beck S., Rogers J., Bentley D.R.;
RT   "The DNA sequence and biological annotation of human chromosome 1.";
RL   Nature 441:315-321(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 76-1127 (ISOFORMS ALPHA AND BETA),
RP   CHROMOSOMAL TRANSLOCATION WITH RET, AND VARIANT THR-840.
RC   TISSUE=Thyroid;
RX   PubMed=10439047; DOI=10.1038/sj.onc.1202824;
RA   Klugbauer S., Rabes H.M.;
RT   "The transcription coactivator HTIF1 and a related protein are fused to the
RT   RET receptor tyrosine kinase in childhood papillary thyroid carcinomas.";
RL   Oncogene 18:4388-4393(1999).
RN   [6]
RP   SUBUNIT.
RX   PubMed=12096914; DOI=10.1016/s0022-2836(02)00477-1;
RA   Peng H., Feldman I., Rauscher F.J. III;
RT   "Hetero-oligomerization among the TIF family of RBCC/TRIM domain-containing
RT   nuclear cofactors: a potential mechanism for regulating the switch between
RT   coactivation and corepression.";
RL   J. Mol. Biol. 320:629-644(2002).
RN   [7]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, UBIQUITINATION OF SMAD4,
RP   INTERACTION WITH SMAD4, MUTAGENESIS OF CYS-125 AND CYS-128, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=15820681; DOI=10.1016/j.cell.2005.01.033;
RA   Dupont S., Zacchigna L., Cordenonsi M., Soligo S., Adorno M., Rugge M.,
RA   Piccolo S.;
RT   "Germ-layer specification and control of cell growth by Ectodermin, a Smad4
RT   ubiquitin ligase.";
RL   Cell 121:87-99(2005).
RN   [8]
RP   FUNCTION, IDENTIFICATION IN A COMPLEX WITH SMAD2 AND SMAD3, INTERACTION
RP   WITH SMAD2 AND SMAD3, AND SUBCELLULAR LOCATION.
RX   PubMed=16751102; DOI=10.1016/j.cell.2006.03.045;
RA   He W., Dorn D.C., Erdjument-Bromage H., Tempst P., Moore M.A., Massague J.;
RT   "Hematopoiesis controlled by distinct TIF1gamma and Smad4 branches of the
RT   TGFbeta pathway.";
RL   Cell 125:929-941(2006).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1102 AND SER-1105,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [10]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH SMAD2 AND SMAD4.
RX   PubMed=19135894; DOI=10.1016/j.cell.2008.10.051;
RA   Dupont S., Mamidi A., Cordenonsi M., Montagner M., Zacchigna L., Adorno M.,
RA   Martello G., Stinchfield M.J., Soligo S., Morsut L., Inui M., Moro S.,
RA   Modena N., Argenton F., Newfeld S.J., Piccolo S.;
RT   "FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling,
RT   controls Smad4 monoubiquitination.";
RL   Cell 136:123-135(2009).
RN   [11]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-763; LYS-769 AND LYS-953, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1102 AND SER-1105,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [13]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1102 AND SER-1105,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [15]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-862; THR-1051 AND SER-1119,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [16]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [17]
RP   METHYLATION [LARGE SCALE ANALYSIS] AT ARG-515; ARG-535; ARG-577; ARG-591;
RP   ARG-598 AND ARG-604, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Colon carcinoma;
RX   PubMed=24129315; DOI=10.1074/mcp.o113.027870;
RA   Guo A., Gu H., Zhou J., Mulhern D., Wang Y., Lee K.A., Yang V., Aguiar M.,
RA   Kornhauser J., Jia X., Ren J., Beausoleil S.A., Silva J.C., Vemulapalli V.,
RA   Bedford M.T., Comb M.J.;
RT   "Immunoaffinity enrichment and mass spectrometry analysis of protein
RT   methylation.";
RL   Mol. Cell. Proteomics 13:372-387(2014).
RN   [18]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-334; LYS-763; LYS-769; LYS-776;
RP   LYS-793; LYS-953; LYS-1007 AND LYS-1057, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [19]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-776 AND LYS-793, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25114211; DOI=10.1073/pnas.1413825111;
RA   Impens F., Radoshevich L., Cossart P., Ribet D.;
RT   "Mapping of SUMO sites and analysis of SUMOylation changes induced by
RT   external stimuli.";
RL   Proc. Natl. Acad. Sci. U.S.A. 111:12432-12437(2014).
RN   [20]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-763; LYS-769; LYS-776; LYS-793;
RP   LYS-861; LYS-1057 AND LYS-1118, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=25772364; DOI=10.1016/j.celrep.2015.02.033;
RA   Hendriks I.A., Treffers L.W., Verlaan-de Vries M., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "SUMO-2 orchestrates chromatin modifiers in response to DNA damage.";
RL   Cell Rep. 10:1778-1791(2015).
RN   [21]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-763; LYS-769; LYS-776; LYS-793
RP   AND LYS-1057, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RX   PubMed=25755297; DOI=10.1074/mcp.o114.044792;
RA   Xiao Z., Chang J.G., Hendriks I.A., Sigurdsson J.O., Olsen J.V.,
RA   Vertegaal A.C.;
RT   "System-wide analysis of SUMOylation dynamics in response to replication
RT   stress reveals novel small ubiquitin-like modified target proteins and
RT   acceptor lysines relevant for genome stability.";
RL   Mol. Cell. Proteomics 14:1419-1434(2015).
RN   [22]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-329; LYS-481; LYS-504; LYS-527;
RP   LYS-763; LYS-769; LYS-774; LYS-776; LYS-793; LYS-796; LYS-861; LYS-953;
RP   LYS-1043; LYS-1057 AND LYS-1118, AND IDENTIFICATION BY MASS SPECTROMETRY
RP   [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [23]
RP   VARIANTS [LARGE SCALE ANALYSIS] ILE-580; SER-696; LYS-811; SER-885; MET-961
RP   AND THR-1090.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C., Bignell G.,
RA   Davies H., Teague J., Butler A., Stevens C., Edkins S., O'Meara S.,
RA   Vastrik I., Schmidt E.E., Avis T., Barthorpe S., Bhamra G., Buck G.,
RA   Choudhury B., Clements J., Cole J., Dicks E., Forbes S., Gray K.,
RA   Halliday K., Harrison R., Hills K., Hinton J., Jenkinson A., Jones D.,
RA   Menzies A., Mironenko T., Perry J., Raine K., Richardson D., Shepherd R.,
RA   Small A., Tofts C., Varian J., Webb T., West S., Widaa S., Yates A.,
RA   Cahill D.P., Louis D.N., Goldstraw P., Nicholson A.G., Brasseur F.,
RA   Looijenga L., Weber B.L., Chiew Y.-E., DeFazio A., Greaves M.F.,
RA   Green A.R., Campbell P., Birney E., Easton D.F., Chenevix-Trench G.,
RA   Tan M.-H., Khoo S.K., Teh B.T., Yuen S.T., Leung S.Y., Wooster R.,
RA   Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Acts as an E3 ubiquitin-protein ligase. Promotes SMAD4
CC       ubiquitination, nuclear exclusion and degradation via the ubiquitin
CC       proteasome pathway. According to PubMed:16751102, does not promote a
CC       decrease in the level of endogenous SMAD4. May act as a transcriptional
CC       repressor. Inhibits the transcriptional response to TGF-beta/BMP
CC       signaling cascade. Plays a role in the control of cell proliferation.
CC       Its association with SMAD2 and SMAD3 stimulates erythroid
CC       differentiation of hematopoietic stem/progenitor (By similarity).
CC       Monoubiquitinates SMAD4 and acts as an inhibitor of SMAD4-dependent
CC       TGF-beta/BMP signaling cascade (Monoubiquitination of SMAD4 hampers its
CC       ability to form a stable complex with activated SMAD2/3 resulting in
CC       inhibition of TGF-beta/BMP signaling cascade). {ECO:0000250,
CC       ECO:0000269|PubMed:10022127, ECO:0000269|PubMed:15820681,
CC       ECO:0000269|PubMed:16751102, ECO:0000269|PubMed:19135894}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating enzyme]-L-cysteine +
CC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating enzyme]-L-
CC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;
CC         EC=2.3.2.27;
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Homooligomer and heterooligomer with TRIM24 and TRIM28 family
CC       members. Interacts with SMAD4 in unstimulated cells. Found in a complex
CC       with SMAD2 and SMAD3 upon addition of TGF-beta. Interacts with SMAD2
CC       and SMAD3. Interacts with SMAD4 under basal and induced conditions and,
CC       upon TGF-beta signaling, with activated SMAD2. Forms a ternary complex
CC       with SMAD4 and SMAD2 upon TGF-beta signaling.
CC       {ECO:0000269|PubMed:10022127, ECO:0000269|PubMed:12096914,
CC       ECO:0000269|PubMed:15820681, ECO:0000269|PubMed:16751102,
CC       ECO:0000269|PubMed:19135894}.
CC   -!- INTERACTION:
CC       Q9UPN9; Q15796: SMAD2; NbExp=6; IntAct=EBI-2214398, EBI-1040141;
CC       Q9UPN9; Q13485: SMAD4; NbExp=6; IntAct=EBI-2214398, EBI-347263;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15820681,
CC       ECO:0000269|PubMed:16751102, ECO:0000269|PubMed:19135894}. Note=In
CC       discrete nuclear dots resembling nuclear bodies. {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=Alpha;
CC         IsoId=Q9UPN9-1; Sequence=Displayed;
CC       Name=Beta;
CC         IsoId=Q9UPN9-2; Sequence=VSP_005774;
CC   -!- TISSUE SPECIFICITY: Expressed in stem cells at the bottom of the crypts
CC       of the colon (at protein level). Expressed in colon adenomas and
CC       adenocarcinomas (at protein level). Expressed in brain, lung, liver,
CC       spleen, thymus, prostate, kidney, testis, heart, placenta, pancreas,
CC       small intestine, ovary, colon, skeletal muscle and hematopoietic
CC       progenitors.
CC   -!- PTM: Sumoylated with SUMO1. {ECO:0000250|UniProtKB:Q99PP7}.
CC   -!- DISEASE: Note=A chromosomal aberration involving TRIM33 is found in
CC       papillary thyroid carcinomas (PTCs). Translocation t(1;10)(p13;q11)
CC       with RET. The translocation generates the TRIM33/RET (PTC7) oncogene.
CC       {ECO:0000269|PubMed:10439047}.
CC   -!- SIMILARITY: Belongs to the TRIM/RBCC family. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAD17259.1; Type=Frameshift; Evidence={ECO:0000305};
CC       Sequence=BAA83065.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF119043; AAD17259.1; ALT_FRAME; mRNA.
DR   EMBL; AF220136; AAG53509.1; -; mRNA.
DR   EMBL; AF220137; AAG53510.1; -; mRNA.
DR   EMBL; AB029036; BAA83065.1; ALT_INIT; mRNA.
DR   EMBL; AL035410; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AL390241; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AJ132948; CAB55313.1; -; mRNA.
DR   CCDS; CCDS872.1; -. [Q9UPN9-1]
DR   CCDS; CCDS873.1; -. [Q9UPN9-2]
DR   RefSeq; NP_056990.3; NM_015906.3. [Q9UPN9-1]
DR   RefSeq; NP_148980.2; NM_033020.2. [Q9UPN9-2]
DR   PDB; 3U5M; X-ray; 3.08 A; A/B/C/D/E/F/G/H/I/J/K/L=882-1087.
DR   PDB; 3U5N; X-ray; 1.95 A; A/B=882-1087.
DR   PDB; 3U5O; X-ray; 2.70 A; A/B/C/D/E/F/G/H=882-1087.
DR   PDB; 3U5P; X-ray; 2.80 A; A/B/C/D/E/F/G/H=882-1087.
DR   PDB; 5MR8; X-ray; 1.74 A; A=882-1090.
DR   PDBsum; 3U5M; -.
DR   PDBsum; 3U5N; -.
DR   PDBsum; 3U5O; -.
DR   PDBsum; 3U5P; -.
DR   PDBsum; 5MR8; -.
DR   SMR; Q9UPN9; -.
DR   BioGrid; 119625; 99.
DR   CORUM; Q9UPN9; -.
DR   DIP; DIP-54262N; -.
DR   IntAct; Q9UPN9; 69.
DR   MINT; Q9UPN9; -.
DR   STRING; 9606.ENSP00000351250; -.
DR   BindingDB; Q9UPN9; -.
DR   ChEMBL; CHEMBL2176772; -.
DR   iPTMnet; Q9UPN9; -.
DR   PhosphoSitePlus; Q9UPN9; -.
DR   BioMuta; TRIM33; -.
DR   DMDM; 313104270; -.
DR   EPD; Q9UPN9; -.
DR   jPOST; Q9UPN9; -.
DR   MassIVE; Q9UPN9; -.
DR   PaxDb; Q9UPN9; -.
DR   PeptideAtlas; Q9UPN9; -.
DR   PRIDE; Q9UPN9; -.
DR   ProteomicsDB; 85392; -. [Q9UPN9-1]
DR   ProteomicsDB; 85393; -. [Q9UPN9-2]
DR   Antibodypedia; 1303; 394 antibodies.
DR   Ensembl; ENST00000358465; ENSP00000351250; ENSG00000197323. [Q9UPN9-1]
DR   Ensembl; ENST00000369543; ENSP00000358556; ENSG00000197323. [Q9UPN9-2]
DR   GeneID; 51592; -.
DR   KEGG; hsa:51592; -.
DR   UCSC; uc001eew.3; human. [Q9UPN9-1]
DR   CTD; 51592; -.
DR   DisGeNET; 51592; -.
DR   GeneCards; TRIM33; -.
DR   HGNC; HGNC:16290; TRIM33.
DR   HPA; ENSG00000197323; Low tissue specificity.
DR   MalaCards; TRIM33; -.
DR   MIM; 605769; gene.
DR   neXtProt; NX_Q9UPN9; -.
DR   OpenTargets; ENSG00000197323; -.
DR   Orphanet; 146; Differentiated thyroid carcinoma.
DR   PharmGKB; PA38118; -.
DR   eggNOG; ENOG410ITFN; Eukaryota.
DR   eggNOG; ENOG410Z421; LUCA.
DR   GeneTree; ENSGT00940000156361; -.
DR   InParanoid; Q9UPN9; -.
DR   KO; K08883; -.
DR   OMA; CQLHTQE; -.
DR   OrthoDB; 756911at2759; -.
DR   PhylomeDB; Q9UPN9; -.
DR   TreeFam; TF106455; -.
DR   Reactome; R-HSA-2173795; Downregulation of SMAD2/3:SMAD4 transcriptional activity.
DR   SignaLink; Q9UPN9; -.
DR   SIGNOR; Q9UPN9; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; TRIM33; human.
DR   GeneWiki; TRIM33; -.
DR   GenomeRNAi; 51592; -.
DR   Pharos; Q9UPN9; Tbio.
DR   PRO; PR:Q9UPN9; -.
DR   Proteomes; UP000005640; Chromosome 1.
DR   RNAct; Q9UPN9; protein.
DR   Bgee; ENSG00000197323; Expressed in endometrium epithelium and 241 other tissues.
DR   ExpressionAtlas; Q9UPN9; baseline and differential.
DR   Genevisible; Q9UPN9; HS.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0070410; F:co-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0070412; F:R-SMAD binding; IPI:BHF-UCL.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; TAS:Reactome.
DR   GO; GO:0008270; F:zinc ion binding; IEA:InterPro.
DR   GO; GO:0030514; P:negative regulation of BMP signaling pathway; IDA:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; TAS:Reactome.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; NAS:UniProtKB.
DR   GO; GO:0016567; P:protein ubiquitination; IDA:UniProtKB.
DR   GO; GO:0017015; P:regulation of transforming growth factor beta receptor signaling pathway; IDA:UniProtKB.
DR   CDD; cd00021; BBOX; 1.
DR   Gene3D; 1.20.920.10; -; 1.
DR   Gene3D; 3.30.40.10; -; 2.
DR   InterPro; IPR003649; Bbox_C.
DR   InterPro; IPR001487; Bromodomain.
DR   InterPro; IPR036427; Bromodomain-like_sf.
DR   InterPro; IPR019786; Zinc_finger_PHD-type_CS.
DR   InterPro; IPR027370; Znf-RING_LisH.
DR   InterPro; IPR000315; Znf_B-box.
DR   InterPro; IPR011011; Znf_FYVE_PHD.
DR   InterPro; IPR001965; Znf_PHD.
DR   InterPro; IPR019787; Znf_PHD-finger.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00439; Bromodomain; 1.
DR   Pfam; PF00628; PHD; 1.
DR   Pfam; PF00643; zf-B_box; 1.
DR   Pfam; PF13445; zf-RING_UBOX; 1.
DR   PRINTS; PR00503; BROMODOMAIN.
DR   SMART; SM00502; BBC; 1.
DR   SMART; SM00336; BBOX; 2.
DR   SMART; SM00297; BROMO; 1.
DR   SMART; SM00249; PHD; 2.
DR   SMART; SM00184; RING; 2.
DR   SUPFAM; SSF47370; SSF47370; 1.
DR   SUPFAM; SSF57903; SSF57903; 1.
DR   PROSITE; PS50014; BROMODOMAIN_2; 1.
DR   PROSITE; PS50119; ZF_BBOX; 2.
DR   PROSITE; PS01359; ZF_PHD_1; 1.
DR   PROSITE; PS50016; ZF_PHD_2; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Bromodomain;
KW   Chromosomal rearrangement; Coiled coil; DNA-binding; Isopeptide bond;
KW   Metal-binding; Methylation; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Repeat; Repressor; Transcription;
KW   Transcription regulation; Transferase; Ubl conjugation;
KW   Ubl conjugation pathway; Zinc; Zinc-finger.
FT   CHAIN           1..1127
FT                   /note="E3 ubiquitin-protein ligase TRIM33"
FT                   /id="PRO_0000056395"
FT   DOMAIN          974..1046
FT                   /note="Bromo"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00035"
FT   ZN_FING         125..154
FT                   /note="RING-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00175"
FT   ZN_FING         212..259
FT                   /note="B box-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   ZN_FING         271..312
FT                   /note="B box-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00024"
FT   ZN_FING         887..934
FT                   /note="PHD-type"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00146"
FT   REGION          1..147
FT                   /note="Necessary for E3 ubiquitin-protein ligase activity
FT                   and repression of SMAD4 signaling and transcriptional
FT                   repression"
FT   REGION          299..401
FT                   /note="Necessary for oligomerization"
FT   COILED          299..401
FT                   /evidence="ECO:0000255"
FT   COMPBIAS        13..18
FT                   /note="Poly-Gly"
FT   COMPBIAS        44..49
FT                   /note="Poly-Glu"
FT   COMPBIAS        545..550
FT                   /note="Poly-Thr"
FT   SITE            964..965
FT                   /note="Breakpoint for translocation to form TRIM33-RET
FT                   oncogene"
FT   MOD_RES         515
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         515
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         535
FT                   /note="Omega-N-methylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         577
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         591
FT                   /note="Asymmetric dimethylarginine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99PP7"
FT   MOD_RES         591
FT                   /note="Omega-N-methylarginine; alternate"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         598
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         604
FT                   /note="Asymmetric dimethylarginine"
FT                   /evidence="ECO:0000244|PubMed:24129315"
FT   MOD_RES         763
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         769
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         793
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000250|UniProtKB:Q99PP7"
FT   MOD_RES         803
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99PP7"
FT   MOD_RES         815
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99PP7"
FT   MOD_RES         862
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692,
FT                   ECO:0000244|PubMed:23186163"
FT   MOD_RES         951
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000250|UniProtKB:Q99PP7"
FT   MOD_RES         953
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         1051
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   MOD_RES         1102
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   MOD_RES         1105
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:18669648,
FT                   ECO:0000244|PubMed:20068231, ECO:0000244|PubMed:21406692"
FT   MOD_RES         1119
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:23186163"
FT   CROSSLNK        329
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        334
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        481
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        504
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        527
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        763
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        769
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        774
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        776
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        776
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        793
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO1); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211"
FT   CROSSLNK        793
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25114211,
FT                   ECO:0000244|PubMed:25218447, ECO:0000244|PubMed:25755297,
FT                   ECO:0000244|PubMed:25772364, ECO:0000244|PubMed:28112733"
FT   CROSSLNK        796
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        861
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        953
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1007
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447"
FT   CROSSLNK        1043
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1057
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:25755297, ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   CROSSLNK        1118
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25772364,
FT                   ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1041..1057
FT                   /note="Missing (in isoform Beta)"
FT                   /evidence="ECO:0000303|PubMed:10439047,
FT                   ECO:0000303|PubMed:11331580"
FT                   /id="VSP_005774"
FT   VARIANT         67
FT                   /note="V -> A (in dbSNP:rs6691166)"
FT                   /id="VAR_029494"
FT   VARIANT         580
FT                   /note="M -> I (in a glioblastoma multiforme sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042376"
FT   VARIANT         696
FT                   /note="L -> S (in dbSNP:rs56151583)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042377"
FT   VARIANT         811
FT                   /note="E -> K (in a lung adenocarcinoma sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042378"
FT   VARIANT         840
FT                   /note="I -> T (in dbSNP:rs6537825)"
FT                   /evidence="ECO:0000269|PubMed:10022127,
FT                   ECO:0000269|PubMed:10439047, ECO:0000269|PubMed:10470851,
FT                   ECO:0000269|PubMed:11331580"
FT                   /id="VAR_024616"
FT   VARIANT         885
FT                   /note="P -> S (in a glioblastoma multiforme sample; somatic
FT                   mutation)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042379"
FT   VARIANT         961
FT                   /note="V -> M (in dbSNP:rs55688622)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042380"
FT   VARIANT         1090
FT                   /note="P -> T (in dbSNP:rs55784699)"
FT                   /evidence="ECO:0000269|PubMed:17344846"
FT                   /id="VAR_042381"
FT   MUTAGEN         125
FT                   /note="C->A: Abolishes E3 activity but does not affect
FT                   interaction with SMAD4; when associated with A-128."
FT                   /evidence="ECO:0000269|PubMed:15820681"
FT   MUTAGEN         128
FT                   /note="C->A: Abolishes E3 activity but does not affect
FT                   interaction with SMAD4; when associated with A-125."
FT                   /evidence="ECO:0000269|PubMed:15820681"
FT   CONFLICT        89
FT                   /note="V -> E (in Ref. 5; CAB55313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        451..453
FT                   /note="PAA -> LLH (in Ref. 5; CAB55313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        909
FT                   /note="F -> S (in Ref. 5; CAB55313)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1037
FT                   /note="R -> T (in Ref. 1; AAD17259)"
FT                   /evidence="ECO:0000305"
FT   STRAND          888..890
FT                   /evidence="ECO:0000244|PDB:3U5N"
FT   TURN            891..893
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          897..901
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          903..906
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   TURN            911..913
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          914..916
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          918..920
FT                   /evidence="ECO:0000244|PDB:3U5P"
FT   TURN            929..931
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          934..936
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   HELIX           944..949
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   TURN            950..952
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   HELIX           960..974
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   HELIX           980..982
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   HELIX           993..996
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   HELIX           1003..1009
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          1011..1013
FT                   /evidence="ECO:0000244|PDB:3U5O"
FT   HELIX           1021..1038
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   HELIX           1061..1080
FT                   /evidence="ECO:0000244|PDB:5MR8"
FT   STRAND          1081..1083
FT                   /evidence="ECO:0000244|PDB:3U5O"
SQ   SEQUENCE   1127 AA;  122533 MW;  7A36013799E9933C CRC64;
     MAENKGGGEA ESGGGGSGSA PVTAGAAGPA AQEAEPPLTA VLVEEEEEEG GRAGAEGGAA
     GPDDGGVAAA SSGSAQAASS PAASVGTGVA GGAVSTPAPA PASAPAPGPS AGPPPGPPAS
     LLDTCAVCQQ SLQSRREAEP KLLPCLHSFC LRCLPEPERQ LSVPIPGGSN GDIQQVGVIR
     CPVCRQECRQ IDLVDNYFVK DTSEAPSSSD EKSEQVCTSC EDNASAVGFC VECGEWLCKT
     CIEAHQRVKF TKDHLIRKKE DVSESVGASG QRPVFCPVHK QEQLKLFCET CDRLTCRDCQ
     LLEHKEHRYQ FLEEAFQNQK GAIENLLAKL LEKKNYVHFA ATQVQNRIKE VNETNKRVEQ
     EIKVAIFTLI NEINKKGKSL LQQLENVTKE RQMKLLQQQN DITGLSRQVK HVMNFTNWAI
     ASGSSTALLY SKRLITFQLR HILKARCDPV PAANGAIRFH CDPTFWAKNV VNLGNLVIES
     KPAPGYTPNV VVGQVPPGTN HISKTPGQIN LAQLRLQHMQ QQVYAQKHQQ LQQMRMQQPP
     APVPTTTTTT QQHPRQAAPQ MLQQQPPRLI SVQTMQRGNM NCGAFQAHQM RLAQNAARIP
     GIPRHSGPQY SMMQPHLQRQ HSNPGHAGPF PVVSVHNTTI NPTSPTTATM ANANRGPTSP
     SVTAIELIPS VTNPENLPSL PDIPPIQLED AGSSSLDNLL SRYISGSHLP PQPTSTMNPS
     PGPSALSPGS SGLSNSHTPV RPPSTSSTGS RGSCGSSGRT AEKTSLSFKS DQVKVKQEPG
     TEDEICSFSG GVKQEKTEDG RRSACMLSSP ESSLTPPLST NLHLESELDA LASLENHVKI
     EPADMNESCK QSGLSSLVNG KSPIRSLMHR SARIGGDGNN KDDDPNEDWC AVCQNGGDLL
     CCEKCPKVFH LTCHVPTLLS FPSGDWICTF CRDIGKPEVE YDCDNLQHSK KGKTAQGLSP
     VDQRKCERLL LYLYCHELSI EFQEPVPASI PNYYKIIKKP MDLSTVKKKL QKKHSQHYQI
     PDDFVADVRL IFKNCERFNE MMKVVQVYAD TQEINLKADS EVAQAGKAVA LYFEDKLTEI
     YSDRTFAPLP EFEQEEDDGE VTEDSDEDFI QPRRKRLKSD ERPVHIK
//
ID   WIF1_HUMAN              Reviewed;         379 AA.
AC   Q9Y5W5; Q6UXI1; Q8WVG4;
DT   11-JAN-2001, integrated into UniProtKB/Swiss-Prot.
DT   15-MAR-2005, sequence version 3.
DT   22-APR-2020, entry version 176.
DE   RecName: Full=Wnt inhibitory factor 1;
DE            Short=WIF-1;
DE   Flags: Precursor;
GN   Name=WIF1; ORFNames=UNQ191/PRO217;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=10201374; DOI=10.1038/18899;
RA   Hsieh J.-C., Kodjabachian L., Rebbert M.L., Rattner A., Smallwood P.M.,
RA   Samos C.H., Nusse R., Dawid I.B., Nathans J.;
RT   "A new secreted protein that binds to Wnt proteins and inhibits their
RT   activities.";
RL   Nature 398:431-436(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   INTERACTION WITH MYOC.
RX   PubMed=19188438; DOI=10.1128/mcb.01274-08;
RA   Kwon H.S., Lee H.S., Ji Y., Rubin J.S., Tomarev S.I.;
RT   "Myocilin is a modulator of Wnt signaling.";
RL   Mol. Cell. Biol. 29:2139-2154(2009).
RN   [5]
RP   STRUCTURE BY NMR OF 32-181, AND DISULFIDE BOND.
RX   PubMed=16476441; DOI=10.1016/j.jmb.2006.01.047;
RA   Liepinsh E., Banyai L., Patthy L., Otting G.;
RT   "NMR structure of the WIF domain of the human Wnt-inhibitory factor-1.";
RL   J. Mol. Biol. 357:942-950(2006).
CC   -!- FUNCTION: Binds to WNT proteins and inhibits their activities. May be
CC       involved in mesoderm segmentation.
CC   -!- SUBUNIT: Interacts with MYOC. {ECO:0000269|PubMed:19188438}.
CC   -!- INTERACTION:
CC       Q9Y5W5; A8MQ03: CYSRT1; NbExp=3; IntAct=EBI-3922719, EBI-3867333;
CC       Q9Y5W5; P60410: KRTAP10-8; NbExp=6; IntAct=EBI-3922719, EBI-10171774;
CC       Q9Y5W5; P27467: Wnt3a; Xeno; NbExp=8; IntAct=EBI-3922719, EBI-2899665;
CC       Q9Y5W5; P41221: WNT5A; NbExp=2; IntAct=EBI-3922719, EBI-6594545;
CC       Q9Y5W5; P22725: Wnt5a; Xeno; NbExp=7; IntAct=EBI-3922719, EBI-1570983;
CC       Q9Y5W5; O00755: WNT7A; NbExp=3; IntAct=EBI-3922719, EBI-727198;
CC   -!- SUBCELLULAR LOCATION: Secreted.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/WIF1ID44085ch12q14.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF122922; AAD25402.1; -; mRNA.
DR   EMBL; AY358344; AAQ88710.1; -; mRNA.
DR   EMBL; BC018037; AAH18037.1; -; mRNA.
DR   CCDS; CCDS8971.1; -.
DR   PIR; A59180; A59180.
DR   RefSeq; NP_009122.2; NM_007191.4.
DR   PDB; 2D3J; NMR; -; A=32-181.
DR   PDB; 2YGN; X-ray; 1.85 A; A=35-178.
DR   PDB; 2YGO; X-ray; 1.85 A; A=35-210.
DR   PDB; 2YGP; X-ray; 2.22 A; A=35-210.
DR   PDB; 2YGQ; X-ray; 3.95 A; A=35-346.
DR   PDBsum; 2D3J; -.
DR   PDBsum; 2YGN; -.
DR   PDBsum; 2YGO; -.
DR   PDBsum; 2YGP; -.
DR   PDBsum; 2YGQ; -.
DR   SMR; Q9Y5W5; -.
DR   BioGrid; 116366; 11.
DR   DIP; DIP-59097N; -.
DR   IntAct; Q9Y5W5; 15.
DR   MINT; Q9Y5W5; -.
DR   STRING; 9606.ENSP00000286574; -.
DR   iPTMnet; Q9Y5W5; -.
DR   PhosphoSitePlus; Q9Y5W5; -.
DR   BioMuta; WIF1; -.
DR   DMDM; 61252765; -.
DR   MassIVE; Q9Y5W5; -.
DR   PaxDb; Q9Y5W5; -.
DR   PeptideAtlas; Q9Y5W5; -.
DR   PRIDE; Q9Y5W5; -.
DR   ProteomicsDB; 86517; -.
DR   Antibodypedia; 29209; 481 antibodies.
DR   DNASU; 11197; -.
DR   Ensembl; ENST00000286574; ENSP00000286574; ENSG00000156076.
DR   GeneID; 11197; -.
DR   KEGG; hsa:11197; -.
DR   UCSC; uc001ssk.4; human.
DR   CTD; 11197; -.
DR   DisGeNET; 11197; -.
DR   GeneCards; WIF1; -.
DR   HGNC; HGNC:18081; WIF1.
DR   HPA; ENSG00000156076; Tissue enhanced (brain, lung, retina).
DR   MIM; 605186; gene.
DR   neXtProt; NX_Q9Y5W5; -.
DR   OpenTargets; ENSG00000156076; -.
DR   PharmGKB; PA38291; -.
DR   eggNOG; ENOG410IQQ0; Eukaryota.
DR   eggNOG; ENOG41104IN; LUCA.
DR   GeneTree; ENSGT00940000160401; -.
DR   HOGENOM; CLU_041961_0_0_1; -.
DR   InParanoid; Q9Y5W5; -.
DR   KO; K01691; -.
DR   OMA; INCDKAN; -.
DR   OrthoDB; 1016037at2759; -.
DR   PhylomeDB; Q9Y5W5; -.
DR   Reactome; R-HSA-201681; TCF dependent signaling in response to WNT.
DR   Reactome; R-HSA-3772470; Negative regulation of TCF-dependent signaling by WNT ligand antagonists.
DR   SignaLink; Q9Y5W5; -.
DR   SIGNOR; Q9Y5W5; -.
DR   ChiTaRS; WIF1; human.
DR   EvolutionaryTrace; Q9Y5W5; -.
DR   GeneWiki; WIF1; -.
DR   GenomeRNAi; 11197; -.
DR   Pharos; Q9Y5W5; Tbio.
DR   PRO; PR:Q9Y5W5; -.
DR   Proteomes; UP000005640; Chromosome 12.
DR   RNAct; Q9Y5W5; protein.
DR   Bgee; ENSG00000156076; Expressed in upper lobe of lung and 183 other tissues.
DR   ExpressionAtlas; Q9Y5W5; baseline and differential.
DR   Genevisible; Q9Y5W5; HS.
DR   GO; GO:0009986; C:cell surface; IBA:GO_Central.
DR   GO; GO:0005576; C:extracellular region; IBA:GO_Central.
DR   GO; GO:0005102; F:signaling receptor binding; IBA:GO_Central.
DR   GO; GO:0017147; F:Wnt-protein binding; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0048856; P:anatomical structure development; IBA:GO_Central.
DR   GO; GO:0007275; P:multicellular organism development; IEA:UniProtKB-KW.
DR   GO; GO:0030178; P:negative regulation of Wnt signaling pathway; NAS:ParkinsonsUK-UCL.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IEA:Ensembl.
DR   GO; GO:0007165; P:signal transduction; NAS:ProtInc.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   Gene3D; 2.60.40.2170; -; 1.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR000742; EGF-like_dom.
DR   InterPro; IPR003306; WIF.
DR   InterPro; IPR038677; WIF_sf.
DR   InterPro; IPR013309; Wnt-inh.
DR   Pfam; PF12661; hEGF; 2.
DR   Pfam; PF02019; WIF; 1.
DR   PRINTS; PR01901; WIFPROTEIN.
DR   SMART; SM00181; EGF; 5.
DR   SMART; SM00469; WIF; 1.
DR   PROSITE; PS00022; EGF_1; 5.
DR   PROSITE; PS01186; EGF_2; 4.
DR   PROSITE; PS50026; EGF_3; 5.
DR   PROSITE; PS50814; WIF; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Developmental protein; Disulfide bond; EGF-like domain;
KW   Glycoprotein; Reference proteome; Repeat; Secreted; Signal;
KW   Wnt signaling pathway.
FT   SIGNAL          1..28
FT                   /evidence="ECO:0000255"
FT   CHAIN           29..379
FT                   /note="Wnt inhibitory factor 1"
FT                   /id="PRO_0000007775"
FT   DOMAIN          38..177
FT                   /note="WIF"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00222"
FT   DOMAIN          178..210
FT                   /note="EGF-like 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          211..242
FT                   /note="EGF-like 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          243..271
FT                   /note="EGF-like 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          274..306
FT                   /note="EGF-like 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   DOMAIN          307..338
FT                   /note="EGF-like 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00076"
FT   CARBOHYD        88
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        245
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   DISULFID        140..177
FT                   /evidence="ECO:0000269|PubMed:16476441"
FT   DISULFID        182..192
FT                   /evidence="ECO:0000250"
FT   DISULFID        186..198
FT                   /evidence="ECO:0000250"
FT   DISULFID        200..209
FT                   /evidence="ECO:0000250"
FT   DISULFID        214..224
FT                   /evidence="ECO:0000250"
FT   DISULFID        218..230
FT                   /evidence="ECO:0000250"
FT   DISULFID        232..241
FT                   /evidence="ECO:0000250"
FT   DISULFID        246..256
FT                   /evidence="ECO:0000250"
FT   DISULFID        250..262
FT                   /evidence="ECO:0000250"
FT   DISULFID        278..288
FT                   /evidence="ECO:0000250"
FT   DISULFID        282..294
FT                   /evidence="ECO:0000250"
FT   DISULFID        296..305
FT                   /evidence="ECO:0000250"
FT   DISULFID        310..320
FT                   /evidence="ECO:0000250"
FT   DISULFID        314..326
FT                   /evidence="ECO:0000250"
FT   DISULFID        328..337
FT                   /evidence="ECO:0000250"
FT   CONFLICT        166
FT                   /note="Q -> K (in Ref. 3; AAH18037)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        178
FT                   /note="Q -> L (in Ref. 1; AAD25402)"
FT                   /evidence="ECO:0000305"
FT   STRAND          36..40
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   HELIX           42..49
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          55..59
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   HELIX           65..67
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          68..70
FT                   /evidence="ECO:0000244|PDB:2YGO"
FT   HELIX           74..76
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          85..93
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          95..97
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          99..109
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          111..113
FT                   /evidence="ECO:0000244|PDB:2D3J"
FT   STRAND          118..121
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          123..126
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          131..137
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          146..158
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          163..165
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   STRAND          173..177
FT                   /evidence="ECO:0000244|PDB:2YGN"
FT   TURN            206..209
FT                   /evidence="ECO:0000244|PDB:2YGO"
SQ   SEQUENCE   379 AA;  41528 MW;  32ADFA6644833E9D CRC64;
     MARRSAFPAA ALWLWSILLC LLALRAEAGP PQEESLYLWI DAHQARVLIG FEEDILIVSE
     GKMAPFTHDF RKAQQRMPAI PVNIHSMNFT WQAAGQAEYF YEFLSLRSLD KGIMADPTVN
     VPLLGTVPHK ASVVQVGFPC LGKQDGVAAF EVDVIVMNSE GNTILQTPQN AIFFKTCQQA
     ECPGGCRNGG FCNERRICEC PDGFHGPHCE KALCTPRCMN GGLCVTPGFC ICPPGFYGVN
     CDKANCSTTC FNGGTCFYPG KCICPPGLEG EQCEISKCPQ PCRNGGKCIG KSKCKCSKGY
     QGDLCSKPVC EPGCGAHGTC HEPNKCQCQE GWHGRHCNKR YEASLIHALR PAGAQLRQHT
     PSLKKAEERR DPPESNYIW
//
ID   1433E_HUMAN             Reviewed;         255 AA.
AC   P62258; B3KY71; D3DTH5; P29360; P42655; Q4VJB6; Q53XZ5; Q63631; Q7M4R4;
DT   05-JUL-2004, integrated into UniProtKB/Swiss-Prot.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 186.
DE   RecName: Full=14-3-3 protein epsilon;
DE            Short=14-3-3E;
GN   Name=YWHAE;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=7644510; DOI=10.1073/pnas.92.17.7892;
RA   Conklin D.S., Galaktionov K., Beach D.;
RT   "14-3-3 proteins associate with cdc25 phosphatases.";
RL   Proc. Natl. Acad. Sci. U.S.A. 92:7892-7896(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Liver;
RX   PubMed=8858348; DOI=10.1101/gr.6.8.735;
RA   Chong S.S., Tanigami A., Roschke A.V., Ledbetter D.H.;
RT   "14-3-3 epsilon has no homology to LIS1 and lies telomeric to it on
RT   chromosome 17p13.3 outside the Miller-Dieker syndrome chromosome region.";
RL   Genome Res. 6:735-741(1996).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=8684458; DOI=10.1038/382308a0;
RA   Jin D.-Y., Lyu M.S., Kozak C.A., Jeang K.-T.;
RT   "Function of 14-3-3 proteins.";
RL   Nature 382:308-308(1996).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM SV), AND ALTERNATIVE SPLICING.
RC   TISSUE=Brain;
RX   PubMed=20417184; DOI=10.1016/j.bbrc.2010.04.104;
RA   Han D., Ye G., Liu T., Chen C., Yang X., Wan B., Pan Y., Yu L.;
RT   "Functional identification of a novel 14-3-3 epsilon splicing variant
RT   suggests dimerization is not necessary for 14-3-3 epsilon to inhibit UV-
RT   induced apoptosis.";
RL   Biochem. Biophys. Res. Commun. 396:401-406(2010).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=Heart;
RA   Luk S.C.W., Lee C.Y., Waye M.M.Y.;
RT   "Sequence determination of human epsilon 14-3-3 protein.";
RL   Submitted (JUN-1995) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RA   Tanigami A., Chong S.S., Ledbetter D.H.;
RT   "14-3-3 epsilon genomic sequence.";
RL   Submitted (AUG-1998) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND SV).
RC   TISSUE=Caudate nucleus, Heart, and Subthalamic nucleus;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [10]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Placenta;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [11]
RP   PROTEIN SEQUENCE OF 1-19.
RC   TISSUE=Platelet;
RX   PubMed=12665801; DOI=10.1038/nbt810;
RA   Gevaert K., Goethals M., Martens L., Van Damme J., Staes A., Thomas G.R.,
RA   Vandekerckhove J.;
RT   "Exploring proteomes and analyzing protein processing by mass spectrometric
RT   identification of sorted N-terminal peptides.";
RL   Nat. Biotechnol. 21:566-569(2003).
RN   [12]
RP   PROTEIN SEQUENCE OF 1-56; 62-73; 95-118; 131-193 AND 197-255, INTERACTION
RP   WITH PI4KB; TBC1D22A AND TBC1D22B, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=23572552; DOI=10.1128/mbio.00098-13;
RA   Greninger A.L., Knudsen G.M., Betegon M., Burlingame A.L., DeRisi J.L.;
RT   "ACBD3 interaction with TBC1 domain 22 protein is differentially affected
RT   by enteroviral and kobuviral 3A protein binding.";
RL   MBio 4:E00098-E00098(2013).
RN   [13]
RP   PROTEIN SEQUENCE OF 1-19; 30-50 AND 131-170, ACETYLATION AT MET-1, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=B-cell lymphoma;
RA   Bienvenut W.V.;
RL   Submitted (MAY-2005) to UniProtKB.
RN   [14]
RP   PROTEIN SEQUENCE OF 50-60, AND INTERACTION WITH KSR1.
RX   PubMed=10409742; DOI=10.1128/mcb.19.8.5523;
RA   Stewart S., Sundaram M., Zhang Y., Lee J., Han M., Guan K.L.;
RT   "Kinase suppressor of Ras forms a multiprotein signaling complex and
RT   modulates MEK localization.";
RL   Mol. Cell. Biol. 19:5523-5534(1999).
RN   [15]
RP   PROTEIN SEQUENCE OF 103-108; 120-123; 131-141 AND 143-153.
RC   TISSUE=Histiocytic lymphoma;
RX   PubMed=2026444;
RA   Demeter J., Medzihradszky D., Kha H., Goetzl E.J., Turck C.W.;
RT   "Isolation and partial characterization of the structures of fibroblast
RT   activating factor-related proteins from U937 cells.";
RL   Immunology 72:350-354(1991).
RN   [16]
RP   PROTEIN SEQUENCE OF 131-141 AND 154-190, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY.
RC   TISSUE=Brain, and Cajal-Retzius cell;
RA   Lubec G., Afjehi-Sadat L.;
RL   Submitted (MAR-2007) to UniProtKB.
RN   [17]
RP   INTERACTION WITH HCV CORE PROTEIN (MICROBIAL INFECTION).
RX   PubMed=10644344; DOI=10.1128/jvi.74.4.1736-1741.2000;
RA   Aoki H., Hayashi J., Moriyama M., Arakawa Y., Hino O.;
RT   "Hepatitis C virus core protein interacts with 14-3-3 protein and activates
RT   the kinase Raf-1.";
RL   J. Virol. 74:1736-1741(2000).
RN   [18]
RP   INTERACTION WITH AANAT.
RX   PubMed=11427721; DOI=10.1073/pnas.141118798;
RA   Ganguly S., Gastel J.A., Weller J.L., Schwartz C., Jaffe H.,
RA   Namboodiri M.A., Coon S.L., Hickman A.B., Rollag M., Obsil T.,
RA   Beauverger P., Ferry G., Boutin J.A., Klein D.C.;
RT   "Role of a pineal cAMP-operated arylalkylamine N-acetyltransferase/14-3-3-
RT   binding switch in melatonin synthesis.";
RL   Proc. Natl. Acad. Sci. U.S.A. 98:8083-8088(2001).
RN   [19]
RP   INTERACTION WITH CDKN1B, AND SUBCELLULAR LOCATION.
RX   PubMed=12042314; DOI=10.1074/jbc.m203668200;
RA   Fujita N., Sato S., Katayama K., Tsuruo T.;
RT   "Akt-dependent phosphorylation of p27Kip1 promotes binding to 14-3-3 and
RT   cytoplasmic localization.";
RL   J. Biol. Chem. 277:28706-28713(2002).
RN   [20]
RP   FUNCTION, INTERACTION WITH HSF1, AND SUBCELLULAR LOCATION.
RX   PubMed=12917326; DOI=10.1128/mcb.23.17.6013-6026.2003;
RA   Wang X., Grammatikakis N., Siganou A., Calderwood S.K.;
RT   "Regulation of molecular chaperone gene transcription involves the serine
RT   phosphorylation, 14-3-3 epsilon binding, and cytoplasmic sequestration of
RT   heat shock factor 1.";
RL   Mol. Cell. Biol. 23:6013-6026(2003).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY.
RC   TISSUE=Lymphoblast;
RX   PubMed=14654843; DOI=10.1038/nature02166;
RA   Andersen J.S., Wilkinson C.J., Mayor T., Mortensen P., Nigg E.A., Mann M.;
RT   "Proteomic characterization of the human centrosome by protein correlation
RT   profiling.";
RL   Nature 426:570-574(2003).
RN   [22]
RP   INTERACTION WITH GRB10.
RX   PubMed=15722337; DOI=10.1074/jbc.m501477200;
RA   Urschel S., Bassermann F., Bai R.Y., Munch S., Peschel C., Duyster J.;
RT   "Phosphorylation of grb10 regulates its interaction with 14-3-3.";
RL   J. Biol. Chem. 280:16987-16993(2005).
RN   [23]
RP   INTERACTION WITH ABL1, AND IDENTIFICATION BY MASS SPECTROMETRY.
RX   PubMed=15696159; DOI=10.1038/ncb1228;
RA   Yoshida K., Yamaguchi T., Natsume T., Kufe D., Miki Y.;
RT   "JNK phosphorylation of 14-3-3 proteins regulates nuclear targeting of c-
RT   Abl in the apoptotic response to DNA damage.";
RL   Nat. Cell Biol. 7:278-285(2005).
RN   [24]
RP   INTERACTION WITH YWHAZ.
RX   PubMed=16376338; DOI=10.1016/j.febslet.2005.12.024;
RA   Gu Y.-M., Jin Y.-H., Choi J.-K., Baek K.-H., Yeo C.-Y., Lee K.-Y.;
RT   "Protein kinase A phosphorylates and regulates dimerization of 14-3-3
RT   epsilon.";
RL   FEBS Lett. 580:305-310(2006).
RN   [25]
RP   SUBCELLULAR LOCATION [LARGE SCALE ANALYSIS].
RC   TISSUE=Melanoma;
RX   PubMed=17081065; DOI=10.1021/pr060363j;
RA   Chi A., Valencia J.C., Hu Z.-Z., Watabe H., Yamaguchi H., Mangini N.J.,
RA   Huang H., Canfield V.A., Cheng K.C., Yang F., Abe R., Yamagishi S.,
RA   Shabanowitz J., Hearing V.J., Wu C., Appella E., Hunt D.F.;
RT   "Proteomic and bioinformatic characterization of the biogenesis and
RT   function of melanosomes.";
RL   J. Proteome Res. 5:3135-3144(2006).
RN   [26]
RP   INTERACTION WITH ATP2B1.
RX   PubMed=18029012; DOI=10.1016/j.ceca.2007.09.003;
RA   Linde C.I., Di Leva F., Domi T., Tosatto S.C., Brini M., Carafoli E.;
RT   "Inhibitory interaction of the 14-3-3 proteins with ubiquitous (PMCA1) and
RT   tissue-specific (PMCA3) isoforms of the plasma membrane Ca2+ pump.";
RL   Cell Calcium 43:550-561(2008).
RN   [27]
RP   INTERACTION WITH GAB2.
RX   PubMed=19172738; DOI=10.1038/emboj.2008.159;
RA   Brummer T., Larance M., Herrera Abreu M.T., Lyons R.J., Timpson P.,
RA   Emmerich C.H., Fleuren E.D.G., Lehrbach G.M., Schramek D., Guilhaus M.,
RA   James D.E., Daly R.J.;
RT   "Phosphorylation-dependent binding of 14-3-3 terminates signalling by the
RT   Gab2 docking protein.";
RL   EMBO J. 27:2305-2316(2008).
RN   [28]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=18318008; DOI=10.1002/pmic.200700884;
RA   Han G., Ye M., Zhou H., Jiang X., Feng S., Jiang X., Tian R., Wan D.,
RA   Zou H., Gu J.;
RT   "Large-scale phosphoproteome analysis of human liver tissue by enrichment
RT   and fractionation of phosphopeptides with strong anion exchange
RT   chromatography.";
RL   Proteomics 8:1346-1361(2008).
RN   [29]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J., Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in a
RT   refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [30]
RP   INTERACTION WITH SLITRK1.
RX   PubMed=19640509; DOI=10.1016/j.biopsych.2009.05.033;
RA   Kajiwara Y., Buxbaum J.D., Grice D.E.;
RT   "SLITRK1 binds 14-3-3 and regulates neurite outgrowth in a phosphorylation-
RT   dependent manner.";
RL   Biol. Psychiatry 66:918-925(2009).
RN   [31]
RP   INTERACTION WITH SRPK2.
RX   PubMed=19592491; DOI=10.1074/jbc.m109.026237;
RA   Jang S.W., Liu X., Fu H., Rees H., Yepes M., Levey A., Ye K.;
RT   "Interaction of Akt-phosphorylated SRPK2 with 14-3-3 mediates cell cycle
RT   and cell death in neurons.";
RL   J. Biol. Chem. 284:24512-24525(2009).
RN   [32]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-50; LYS-69; LYS-118 AND LYS-123,
RP   AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19608861; DOI=10.1126/science.1175371;
RA   Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.C.,
RA   Olsen J.V., Mann M.;
RT   "Lysine acetylation targets protein complexes and co-regulates major
RT   cellular functions.";
RL   Science 325:834-840(2009).
RN   [33]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full phosphorylation
RT   site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [35]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21406692; DOI=10.1126/scisignal.2001570;
RA   Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,
RA   Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;
RT   "System-wide temporal characterization of the proteome and phosphoproteome
RT   of human embryonic stem cell differentiation.";
RL   Sci. Signal. 4:RS3-RS3(2011).
RN   [36]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-210, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [37]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-232, AND IDENTIFICATION BY
RP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [38]
RP   INTERACTION WITH DAPK2.
RX   PubMed=26047703; DOI=10.1016/j.bbrc.2015.05.105;
RA   Yuasa K., Ota R., Matsuda S., Isshiki K., Inoue M., Tsuji A.;
RT   "Suppression of death-associated protein kinase 2 by interaction with 14-3-
RT   3 proteins.";
RL   Biochem. Biophys. Res. Commun. 464:70-75(2015).
RN   [39]
RP   INTERACTION WITH DENND1A.
RX   PubMed=26055712; DOI=10.1074/jbc.m115.636712;
RA   Kulasekaran G., Nossova N., Marat A.L., Lund I., Cremer C., Ioannou M.S.,
RA   McPherson P.S.;
RT   "Phosphorylation-dependent regulation of Connecdenn/DENND1 guanine
RT   nucleotide exchange factors.";
RL   J. Biol. Chem. 290:17999-18008(2015).
RN   [40]
RP   INTERACTION WITH RIPOR2.
RX   PubMed=25588844; DOI=10.1242/jcs.161497;
RA   Gao K., Tang W., Li Y., Zhang P., Wang D., Yu L., Wang C., Wu D.;
RT   "Front-signal-dependent accumulation of the RHOA inhibitor FAM65B at
RT   leading edges polarizes neutrophils.";
RL   J. Cell Sci. 128:992-1000(2015).
RN   [41]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [42]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-50, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
RN   [43]
RP   INTERACTION WITH CRTC1; CRTC2 AND CRTC3.
RX   PubMed=30611118; DOI=10.1016/j.isci.2018.12.012;
RA   Sonntag T., Ostojic J., Vaughan J.M., Moresco J.J., Yoon Y.S.,
RA   Yates J.R. III, Montminy M.;
RT   "Mitogenic Signals Stimulate the CREB Coactivator CRTC3 through PP2A
RT   Recruitment.";
RL   IScience 11:134-145(2018).
RN   [44]
RP   INTERACTION WITH KLHL22.
RX   PubMed=29769719; DOI=10.1038/s41586-018-0128-9;
RA   Chen J., Ou Y., Yang Y., Li W., Xu Y., Xie Y., Liu Y.;
RT   "KLHL22 activates amino-acid-dependent mTORC1 signalling to promote
RT   tumorigenesis and ageing.";
RL   Nature 557:585-589(2018).
RN   [45]
RP   X-RAY CRYSTALLOGRAPHY (1.75 ANGSTROMS) OF 1-233, IDENTIFICATION BY MASS
RP   SPECTROMETRY, INTERACTION WITH PHOSPHOSERINE MOTIFS, AND SUBUNIT.
RX   PubMed=17085597; DOI=10.1073/pnas.0605779103;
RA   Yang X., Lee W.H., Sobott F., Papagrigoriou E., Robinson C.V.,
RA   Grossmann J.G., Sundstroem M., Doyle D.A., Elkins J.M.;
RT   "Structural basis for protein-protein interactions in the 14-3-3 protein
RT   family.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:17237-17242(2006).
CC   -!- FUNCTION: Adapter protein implicated in the regulation of a large
CC       spectrum of both general and specialized signaling pathways. Binds to a
CC       large number of partners, usually by recognition of a phosphoserine or
CC       phosphothreonine motif. Binding generally results in the modulation of
CC       the activity of the binding partner (By similarity). Positively
CC       regulates phosphorylated protein HSF1 nuclear export to the cytoplasm
CC       (PubMed:12917326). {ECO:0000250|UniProtKB:P62261,
CC       ECO:0000269|PubMed:12917326}.
CC   -!- SUBUNIT: Homodimer (PubMed:17085597). Heterodimerizes with YWHAZ
CC       (PubMed:16376338). Interacts with PKA-phosphorylated AANAT
CC       (PubMed:11427721). Interacts with ABL1 (phosphorylated form); the
CC       interaction retains it in the cytoplasm (PubMed:15696159). Interacts
CC       with ARHGEF28 (By similarity). Interacts with BEX3 (By similarity).
CC       Weakly interacts with CDKN1B (PubMed:12042314). Interacts with the
CC       'Thr-369' phosphorylated form of DAPK2 (PubMed:26047703). Interacts
CC       with DENND1A (PubMed:26055712). Interacts with GAB2 (PubMed:19172738).
CC       Interacts with phosphorylated GRB10 (PubMed:15722337). Interacts with
CC       KSR1 (PubMed:10409742). Interacts with NDEL1 (By similarity). Interacts
CC       with PI4KB, TBC1D22A and TBC1D22B (PubMed:23572552). Interacts with the
CC       phosphorylated (by AKT1) form of SRPK2 (PubMed:19592491). Interacts
CC       with TIAM2. Interacts with the 'Ser-1134' and 'Ser-1161' phosphorylated
CC       form of SOS1 (By similarity). Interacts with ZFP36 (via phosphorylated
CC       form) (By similarity). Interacts with SLITRK1 (PubMed:19640509).
CC       Interacts with HSF1 (via phosphorylated form); this interaction
CC       promotes HSF1 sequestration in the cytoplasm in a ERK-dependent manner
CC       (PubMed:12917326). Interacts with RIPOR2 isoform 2 (PubMed:25588844).
CC       Interacts with KLHL22; required for the nuclear localization of KLHL22
CC       upon amino acid starvation (PubMed:29769719). Interacts with CRTC1
CC       (PubMed:30611118). Interacts with CRTC2 (probably when phosphorylated
CC       at 'Ser-171') (PubMed:30611118). Interacts with CRTC3 (probably when
CC       phosphorylated at 'Ser-162' and/or 'Ser-273') (PubMed:30611118).
CC       Interacts with ATP2B1; this interaction inhibits calcium-transporting
CC       ATPase activity (PubMed:18029012). {ECO:0000250|UniProtKB:P62259,
CC       ECO:0000250|UniProtKB:P62260, ECO:0000269|PubMed:10409742,
CC       ECO:0000269|PubMed:11427721, ECO:0000269|PubMed:12042314,
CC       ECO:0000269|PubMed:12917326, ECO:0000269|PubMed:15696159,
CC       ECO:0000269|PubMed:15722337, ECO:0000269|PubMed:16376338,
CC       ECO:0000269|PubMed:17085597, ECO:0000269|PubMed:18029012,
CC       ECO:0000269|PubMed:19172738, ECO:0000269|PubMed:19592491,
CC       ECO:0000269|PubMed:19640509, ECO:0000269|PubMed:23572552,
CC       ECO:0000269|PubMed:25588844, ECO:0000269|PubMed:26047703,
CC       ECO:0000269|PubMed:26055712, ECO:0000269|PubMed:29769719,
CC       ECO:0000269|PubMed:30611118}.
CC   -!- SUBUNIT: (Microbial infection) Interacts with HCV core protein.
CC       {ECO:0000269|PubMed:10644344}.
CC   -!- INTERACTION:
CC       P62258; P62258; NbExp=3; IntAct=EBI-356498, EBI-356498;
CC       P62258; PRO_0000278742 [O92972]; Xeno; NbExp=5; IntAct=EBI-356498, EBI-9213553;
CC       P62258; Q96AP0: ACD; NbExp=2; IntAct=EBI-356498, EBI-717666;
CC       P62258; O14727: APAF1; NbExp=2; IntAct=EBI-356498, EBI-446492;
CC       P62258; P10398: ARAF; NbExp=3; IntAct=EBI-356498, EBI-365961;
CC       P62258; Q92934: BAD; NbExp=4; IntAct=EBI-356498, EBI-700771;
CC       P62258; O00257-3: CBX4; NbExp=2; IntAct=EBI-356498, EBI-4392727;
CC       P62258; Q9Y3M2: CBY1; NbExp=3; IntAct=EBI-356498, EBI-947308;
CC       P62258; Q86Z20: CCDC125; NbExp=3; IntAct=EBI-356498, EBI-11977221;
CC       P62258; O94921: CDK14; NbExp=3; IntAct=EBI-356498, EBI-1043945;
CC       P62258; Q9NRI5: DISC1; NbExp=3; IntAct=EBI-356498, EBI-529989;
CC       P62258; P09622: DLD; NbExp=5; IntAct=EBI-356498, EBI-353366;
CC       P62258; P36957: DLST; NbExp=4; IntAct=EBI-356498, EBI-351007;
CC       P62258; Q9UKT5: FBXO4; NbExp=5; IntAct=EBI-356498, EBI-960409;
CC       P62258; P56524: HDAC4; NbExp=4; IntAct=EBI-356498, EBI-308629;
CC       P62258; P56524-2: HDAC4; NbExp=3; IntAct=EBI-356498, EBI-11953488;
CC       P62258; Q14678-2: KANK1; NbExp=3; IntAct=EBI-356498, EBI-6173812;
CC       P62258; Q5S007: LRRK2; NbExp=8; IntAct=EBI-356498, EBI-5323863;
CC       P62258; Q99759: MAP3K3; NbExp=3; IntAct=EBI-356498, EBI-307281;
CC       P62258; O15151: MDM4; NbExp=3; IntAct=EBI-356498, EBI-398437;
CC       P62258; P58340: MLF1; NbExp=3; IntAct=EBI-356498, EBI-721328;
CC       P62258; Q9NXR1: NDE1; NbExp=2; IntAct=EBI-356498, EBI-941227;
CC       P62258; O35244: Prdx6; Xeno; NbExp=2; IntAct=EBI-356498, EBI-915490;
CC       P62258; Q7L804: RAB11FIP2; NbExp=3; IntAct=EBI-356498, EBI-1049676;
CC       P62258; P04049: RAF1; NbExp=5; IntAct=EBI-356498, EBI-365996;
CC       P62258; Q13671: RIN1; NbExp=3; IntAct=EBI-356498, EBI-366017;
CC       P62258; P61588: Rnd3; Xeno; NbExp=2; IntAct=EBI-356498, EBI-6930266;
CC       P62258; Q99469: STAC; NbExp=3; IntAct=EBI-356498, EBI-2652799;
CC       P62258; P21796: VDAC1; NbExp=5; IntAct=EBI-356498, EBI-354158;
CC       P62258; Q9GZV5: WWTR1; NbExp=3; IntAct=EBI-356498, EBI-747743;
CC       P62258; P46937: YAP1; NbExp=5; IntAct=EBI-356498, EBI-1044059;
CC       P62258; P31946: YWHAB; NbExp=6; IntAct=EBI-356498, EBI-359815;
CC       P62258; P61981: YWHAG; NbExp=7; IntAct=EBI-356498, EBI-359832;
CC       P62258; Q04917: YWHAH; NbExp=5; IntAct=EBI-356498, EBI-306940;
CC       P62258; P27348: YWHAQ; NbExp=7; IntAct=EBI-356498, EBI-359854;
CC       P62258; P63104: YWHAZ; NbExp=9; IntAct=EBI-356498, EBI-347088;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:12917326}. Cytoplasm
CC       {ECO:0000269|PubMed:12917326}. Melanosome {ECO:0000269|PubMed:12042314,
CC       ECO:0000269|PubMed:17081065}. Note=Identified by mass spectrometry in
CC       melanosome fractions from stage I to stage IV.
CC       {ECO:0000269|PubMed:12042314, ECO:0000269|PubMed:17081065}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=P62258-1; Sequence=Displayed;
CC       Name=SV;
CC         IsoId=P62258-2; Sequence=VSP_040621;
CC   -!- MISCELLANEOUS: [Isoform SV]: Unable to dimerize with YWHAZ.
CC       {ECO:0000305}.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U20972; AAC50175.1; -; mRNA.
DR   EMBL; U54778; AAC50710.1; -; mRNA.
DR   EMBL; U43399; AAC50625.1; -; mRNA.
DR   EMBL; U43430; AAD00026.1; -; mRNA.
DR   EMBL; U28936; AAA75301.1; -; mRNA.
DR   EMBL; AB017103; BAA32538.1; -; Genomic_DNA.
DR   EMBL; AY883089; AAX68683.1; -; mRNA.
DR   EMBL; AK128785; BAG54733.1; -; mRNA.
DR   EMBL; AK295260; BAG58249.1; -; mRNA.
DR   EMBL; AK316185; BAH14556.1; -; mRNA.
DR   EMBL; BT007161; AAP35825.1; -; mRNA.
DR   EMBL; CH471108; EAW90628.1; -; Genomic_DNA.
DR   EMBL; CH471108; EAW90629.1; -; Genomic_DNA.
DR   EMBL; BC000179; AAH00179.1; -; mRNA.
DR   EMBL; BC001440; AAH01440.1; -; mRNA.
DR   CCDS; CCDS11001.1; -. [P62258-1]
DR   PIR; A61235; A61235.
DR   PIR; I38947; I38947.
DR   RefSeq; NP_006752.1; NM_006761.4. [P62258-1]
DR   PDB; 2BR9; X-ray; 1.75 A; A=1-233.
DR   PDB; 3UAL; X-ray; 1.80 A; A=1-232.
DR   PDB; 3UBW; X-ray; 1.90 A; A=1-234.
DR   PDB; 6EIH; X-ray; 2.70 A; A=3-232.
DR   PDBsum; 2BR9; -.
DR   PDBsum; 3UAL; -.
DR   PDBsum; 3UBW; -.
DR   PDBsum; 6EIH; -.
DR   SMR; P62258; -.
DR   BioGrid; 113363; 522.
DR   CORUM; P62258; -.
DR   DIP; DIP-36676N; -.
DR   ELM; P62258; -.
DR   IntAct; P62258; 264.
DR   MINT; P62258; -.
DR   STRING; 9606.ENSP00000264335; -.
DR   ChEMBL; CHEMBL3329082; -.
DR   DrugBank; DB01780; Fusicoccin.
DR   DrugBank; DB12695; Phenethyl Isothiocyanate.
DR   MoonDB; P62258; Predicted.
DR   iPTMnet; P62258; -.
DR   MetOSite; P62258; -.
DR   PhosphoSitePlus; P62258; -.
DR   SwissPalm; P62258; -.
DR   BioMuta; YWHAE; -.
DR   DMDM; 51702210; -.
DR   OGP; P42655; -.
DR   UCD-2DPAGE; P62258; -.
DR   EPD; P62258; -.
DR   jPOST; P62258; -.
DR   MassIVE; P62258; -.
DR   PaxDb; P62258; -.
DR   PeptideAtlas; P62258; -.
DR   PRIDE; P62258; -.
DR   ProteomicsDB; 57377; -.
DR   ProteomicsDB; 57378; -. [P62258-2]
DR   TopDownProteomics; P62258-1; -. [P62258-1]
DR   Antibodypedia; 1898; 456 antibodies.
DR   DNASU; 7531; -.
DR   Ensembl; ENST00000264335; ENSP00000264335; ENSG00000108953. [P62258-1]
DR   Ensembl; ENST00000571732; ENSP00000461762; ENSG00000108953. [P62258-2]
DR   Ensembl; ENST00000616643; ENSP00000481059; ENSG00000274474. [P62258-2]
DR   Ensembl; ENST00000627231; ENSP00000487356; ENSG00000274474. [P62258-1]
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsk.4; human. [P62258-1]
DR   CTD; 7531; -.
DR   DisGeNET; 7531; -.
DR   GeneCards; YWHAE; -.
DR   HGNC; HGNC:12851; YWHAE.
DR   HPA; ENSG00000108953; Low tissue specificity.
DR   MalaCards; YWHAE; -.
DR   MIM; 605066; gene.
DR   neXtProt; NX_P62258; -.
DR   OpenTargets; ENSG00000108953; -.
DR   Orphanet; 217385; 17p13.3 microduplication syndrome.
DR   Orphanet; 457246; Clear cell sarcoma of kidney.
DR   Orphanet; 261257; Distal 17p13.3 microdeletion syndrome.
DR   Orphanet; 213711; Endometrial stromal sarcoma.
DR   Orphanet; 531; Miller-Dieker syndrome.
DR   PharmGKB; PA37440; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   GeneTree; ENSGT00980000198571; -.
DR   HOGENOM; CLU_058290_0_0_1; -.
DR   InParanoid; P62258; -.
DR   KO; K06630; -.
DR   OMA; YKNATEV; -.
DR   PhylomeDB; P62258; -.
DR   TreeFam; TF102003; -.
DR   Reactome; R-HSA-111447; Activation of BAD and translocation to mitochondria.
DR   Reactome; R-HSA-1445148; Translocation of SLC2A4 (GLUT4) to the plasma membrane.
DR   Reactome; R-HSA-2028269; Signaling by Hippo.
DR   Reactome; R-HSA-205025; NADE modulates death signalling.
DR   Reactome; R-HSA-2565942; Regulation of PLK1 Activity at G2/M Transition.
DR   Reactome; R-HSA-3371453; Regulation of HSF1-mediated heat shock response.
DR   Reactome; R-HSA-3371511; HSF1 activation.
DR   Reactome; R-HSA-380259; Loss of Nlp from mitotic centrosomes.
DR   Reactome; R-HSA-380270; Recruitment of mitotic centrosome proteins and complexes.
DR   Reactome; R-HSA-380284; Loss of proteins required for interphase microtubule organization from the centrosome.
DR   Reactome; R-HSA-380320; Recruitment of NuMA to mitotic centrosomes.
DR   Reactome; R-HSA-5620912; Anchoring of the basal body to the plasma membrane.
DR   Reactome; R-HSA-5625740; RHO GTPases activate PKNs.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-75035; Chk1/Chk2(Cds1) mediated inactivation of Cyclin B:Cdk1 complex.
DR   Reactome; R-HSA-8854518; AURKA Activation by TPX2.
DR   Reactome; R-HSA-8862803; Deregulated CDK5 triggers multiple neurodegenerative pathways in Alzheimer's disease models.
DR   Reactome; R-HSA-8876198; RAB GEFs exchange GTP for GDP on RABs.
DR   SignaLink; P62258; -.
DR   SIGNOR; P62258; -.
DR   ChiTaRS; YWHAE; human.
DR   EvolutionaryTrace; P62258; -.
DR   GeneWiki; YWHAE; -.
DR   GenomeRNAi; 7531; -.
DR   Pharos; P62258; Tbio.
DR   PRO; PR:P62258; -.
DR   Proteomes; UP000005640; Chromosome 17.
DR   RNAct; P62258; protein.
DR   Bgee; ENSG00000108953; Expressed in female gonad and 236 other tissues.
DR   ExpressionAtlas; P62258; baseline and differential.
DR   Genevisible; P62258; HS.
DR   GO; GO:0005623; C:cell; IEA:GOC.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IDA:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005871; C:kinesin complex; IEA:Ensembl.
DR   GO; GO:0042470; C:melanosome; IEA:UniProtKB-SubCell.
DR   GO; GO:0016020; C:membrane; HDA:UniProtKB.
DR   GO; GO:0005739; C:mitochondrion; IEA:GOC.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0045296; F:cadherin binding; HDA:BHF-UCL.
DR   GO; GO:0005246; F:calcium channel regulator activity; IDA:SynGO-UCL.
DR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.
DR   GO; GO:0042826; F:histone deacetylase binding; IPI:BHF-UCL.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0044325; F:ion channel binding; IPI:BHF-UCL.
DR   GO; GO:0023026; F:MHC class II protein complex binding; HDA:UniProtKB.
DR   GO; GO:0051219; F:phosphoprotein binding; IPI:BHF-UCL.
DR   GO; GO:0050815; F:phosphoserine residue binding; IPI:BHF-UCL.
DR   GO; GO:0015459; F:potassium channel regulator activity; IDA:BHF-UCL.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0046982; F:protein heterodimerization activity; IPI:BHF-UCL.
DR   GO; GO:0003723; F:RNA binding; HDA:UniProtKB.
DR   GO; GO:0097110; F:scaffold protein binding; IPI:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:ParkinsonsUK-UCL.
DR   GO; GO:0034605; P:cellular response to heat; IDA:UniProtKB.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0097711; P:ciliary basal body-plasma membrane docking; TAS:Reactome.
DR   GO; GO:0000086; P:G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0035329; P:hippo signaling; TAS:Reactome.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; TAS:ProtInc.
DR   GO; GO:0000165; P:MAPK cascade; IDA:UniProtKB.
DR   GO; GO:0061024; P:membrane organization; TAS:Reactome.
DR   GO; GO:0086013; P:membrane repolarization during cardiac muscle cell action potential; IC:BHF-UCL.
DR   GO; GO:1905913; P:negative regulation of calcium ion export across plasma membrane; IDA:SynGO-UCL.
DR   GO; GO:1901020; P:negative regulation of calcium ion transmembrane transporter activity; IDA:SynGO-UCL.
DR   GO; GO:0043154; P:negative regulation of cysteine-type endopeptidase activity involved in apoptotic process; TAS:Reactome.
DR   GO; GO:1902309; P:negative regulation of peptidyl-serine dephosphorylation; IDA:BHF-UCL.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0046827; P:positive regulation of protein export from nucleus; IDA:UniProtKB.
DR   GO; GO:1900740; P:positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway; TAS:Reactome.
DR   GO; GO:0034504; P:protein localization to nucleus; IMP:UniProtKB.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:1900034; P:regulation of cellular response to heat; TAS:Reactome.
DR   GO; GO:0051480; P:regulation of cytosolic calcium ion concentration; IDA:SynGO-UCL.
DR   GO; GO:0010389; P:regulation of G2/M transition of mitotic cell cycle; TAS:Reactome.
DR   GO; GO:0086091; P:regulation of heart rate by cardiac conduction; IC:BHF-UCL.
DR   GO; GO:0003064; P:regulation of heart rate by hormone; NAS:BHF-UCL.
DR   GO; GO:0060306; P:regulation of membrane repolarization; IDA:BHF-UCL.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IEA:Ensembl.
DR   GO; GO:1901016; P:regulation of potassium ion transmembrane transporter activity; IDA:BHF-UCL.
DR   GO; GO:0021762; P:substantia nigra development; HEP:UniProtKB.
DR   GO; GO:0016032; P:viral process; IEA:UniProtKB-KW.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; Cytoplasm;
KW   Direct protein sequencing; Host-virus interaction; Isopeptide bond;
KW   Nucleus; Phosphoprotein; Reference proteome; Ubl conjugation.
FT   CHAIN           1..255
FT                   /note="14-3-3 protein epsilon"
FT                   /id="PRO_0000058618"
FT   SITE            57
FT                   /note="Interaction with phosphoserine on interacting
FT                   protein"
FT   SITE            130
FT                   /note="Interaction with phosphoserine on interacting
FT                   protein"
FT   MOD_RES         1
FT                   /note="N-acetylmethionine"
FT                   /evidence="ECO:0000244|PubMed:19413330, ECO:0000269|Ref.13"
FT   MOD_RES         50
FT                   /note="N6-acetyllysine; alternate"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         65
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000250|UniProtKB:P62260"
FT   MOD_RES         69
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         118
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         123
FT                   /note="N6-acetyllysine"
FT                   /evidence="ECO:0000244|PubMed:19608861"
FT   MOD_RES         131
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P62260"
FT   MOD_RES         137
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000250|UniProtKB:P62260"
FT   MOD_RES         210
FT                   /note="Phosphoserine"
FT                   /evidence="ECO:0000244|PubMed:20068231,
FT                   ECO:0000244|PubMed:21406692, ECO:0000244|PubMed:23186163"
FT   MOD_RES         232
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000244|PubMed:24275569"
FT   CROSSLNK        50
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2); alternate"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   VAR_SEQ         1..22
FT                   /note="Missing (in isoform SV)"
FT                   /evidence="ECO:0000303|PubMed:14702039,
FT                   ECO:0000303|PubMed:20417184"
FT                   /id="VSP_040621"
FT   CONFLICT        106..107
FT                   /note="KH -> NY (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        143
FT                   /note="E -> F (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        148
FT                   /note="S -> T (in Ref. 15; AA sequence)"
FT                   /evidence="ECO:0000305"
FT   HELIX           4..17
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           20..31
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           39..73
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           76..106
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           108..111
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           115..135
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           138..162
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           168..183
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           188..204
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           205..208
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   TURN            211..213
FT                   /evidence="ECO:0000244|PDB:2BR9"
FT   HELIX           214..231
FT                   /evidence="ECO:0000244|PDB:2BR9"
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   V9HW98_HUMAN            Unreviewed;       255 AA.
AC   V9HW98;
DT   19-MAR-2014, integrated into UniProtKB/TrEMBL.
DT   19-MAR-2014, sequence version 1.
DT   22-APR-2020, entry version 47.
DE   SubName: Full=Epididymis luminal protein 2 {ECO:0000313|EMBL:ACJ13635.1};
GN   Name=HEL2 {ECO:0000313|EMBL:ACJ13635.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:ACJ13635.1};
RN   [1] {ECO:0000313|EMBL:ACJ13635.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Li J.Y., Wang H.Y., Liu F.J., Liu J.;
RL   Submitted (JUN-2008) to the EMBL/GenBank/DDBJ databases.
CC   -!- SIMILARITY: Belongs to the 14-3-3 family.
CC       {ECO:0000256|RuleBase:RU003466, ECO:0000256|SAAS:SAAS00595241}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; EU794581; ACJ13635.1; -; mRNA.
DR   RefSeq; NP_006752.1; NM_006761.4.
DR   SMR; V9HW98; -.
DR   IntAct; V9HW98; 2.
DR   MaxQB; V9HW98; -.
DR   PRIDE; V9HW98; -.
DR   Antibodypedia; 1898; 456 antibodies.
DR   GeneID; 7531; -.
DR   KEGG; hsa:7531; -.
DR   UCSC; uc002fsj.4; human.
DR   CTD; 7531; -.
DR   EuPathDB; HostDB:ENSG00000108953.16; -.
DR   eggNOG; KOG0841; Eukaryota.
DR   eggNOG; COG5040; LUCA.
DR   HOGENOM; CLU_058290_0_0_1; -.
DR   KO; K06630; -.
DR   OMA; YKNATEV; -.
DR   OrthoDB; 1176818at2759; -.
DR   PhylomeDB; V9HW98; -.
DR   ChiTaRS; YWHAE; human.
DR   GenomeRNAi; 7531; -.
DR   Bgee; ENSG00000108953; Expressed in female gonad and 236 other tissues.
DR   ExpressionAtlas; V9HW98; baseline and differential.
DR   GO; GO:0090724; C:central region of growth cone; IEA:Ensembl.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0098978; C:glutamatergic synapse; IEA:Ensembl.
DR   GO; GO:0005871; C:kinesin complex; IEA:Ensembl.
DR   GO; GO:0019899; F:enzyme binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0044877; F:protein-containing complex binding; IEA:Ensembl.
DR   GO; GO:0021987; P:cerebral cortex development; IEA:Ensembl.
DR   GO; GO:0021766; P:hippocampus development; IEA:Ensembl.
DR   GO; GO:0035308; P:negative regulation of protein dephosphorylation; IEA:Ensembl.
DR   GO; GO:0001764; P:neuron migration; IEA:Ensembl.
DR   GO; GO:0006605; P:protein targeting; IEA:Ensembl.
DR   GO; GO:0099072; P:regulation of postsynaptic membrane neurotransmitter receptor levels; IEA:Ensembl.
DR   Gene3D; 1.20.190.20; -; 1.
DR   InterPro; IPR000308; 14-3-3.
DR   InterPro; IPR023409; 14-3-3_CS.
DR   InterPro; IPR036815; 14-3-3_dom_sf.
DR   InterPro; IPR023410; 14-3-3_domain.
DR   PANTHER; PTHR18860; PTHR18860; 1.
DR   Pfam; PF00244; 14-3-3; 1.
DR   PIRSF; PIRSF000868; 14-3-3; 1.
DR   PRINTS; PR00305; 1433ZETA.
DR   SMART; SM00101; 14_3_3; 1.
DR   SUPFAM; SSF48445; SSF48445; 1.
DR   PROSITE; PS00796; 1433_1; 1.
DR   PROSITE; PS00797; 1433_2; 1.
PE   1: Evidence at protein level;
FT   DOMAIN          4..245
FT                   /note="14_3_3"
FT                   /evidence="ECO:0000259|SMART:SM00101"
FT   REGION          234..255
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        238..255
FT                   /note="Polyampholyte"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   255 AA;  29174 MW;  07817CCBD1F75B26 CRC64;
     MDDREDLVYQ AKLAEQAERY DEMVESMKKV AGMDVELTVE ERNLLSVAYK NVIGARRASW
     RIISSIEQKE ENKGGEDKLK MIREYRQMVE TELKLICCDI LDVLDKHLIP AANTGESKVF
     YYKMKGDYHR YLAEFATGND RKEAAENSLV AYKAASDIAM TELPPTHPIR LGLALNFSVF
     YYEILNSPDR ACRLAKAAFD DAIAELDTLS EESYKDSTLI MQLLRDNLTL WTSDMQGDGE
     EQNKEALQDV EDENQ
//
ID   A0A024R3C6_HUMAN        Unreviewed;       673 AA.
AC   A0A024R3C6;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 52.
DE   SubName: Full=Zinc finger and BTB domain containing 16 isoform 1 {ECO:0000313|EMBL:ALQ33858.1};
DE   SubName: Full=Zinc finger and BTB domain containing 16, isoform CRA_a {ECO:0000313|EMBL:EAW67242.1};
GN   Name=ZBTB16 {ECO:0000313|EMBL:EAW67242.1};
GN   ORFNames=hCG_38015 {ECO:0000313|EMBL:EAW67242.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW67242.1};
RN   [1] {ECO:0000313|EMBL:EAW67242.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW67242.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|EMBL:ALQ33858.1}
RP   NUCLEOTIDE SEQUENCE.
RX   PubMed=26871637; DOI=10.1016/j.cell.2016.01.029;
RA   Yang X., Coulombe-Huntington J., Kang S., Sheynkman G.M., Hao T.,
RA   Richardson A., Sun S., Yang F., Shen Y.A., Murray R., Spirohn K.,
RA   Begg B.E., Duran-Frigola M., MacWilliams A., Pevzner S.J., Zhong Q.,
RA   Trigg S.A., Tam S., Ghamsari L., Sahni N., Yi S., Rodriguez M.D.,
RA   Balcha D., Tan G., Costanzo M., Andrews B., Boone C., Zhou X.J.,
RA   Salehi-Ashtiani K., Charloteaux B., Chen A., Calderwood M.A., Aloy P.,
RA   Roth F.P., Hill D.E., Iakoucheva L.M., Xia Y., Vidal M.;
RT   "Widespread Expansion of Protein Interaction Capabilities by Alternative
RT   Splicing.";
RL   Cell 164:805-817(2016).
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; KU178400; ALQ33858.1; -; mRNA.
DR   EMBL; CH471065; EAW67241.1; -; Genomic_DNA.
DR   EMBL; CH471065; EAW67242.1; -; Genomic_DNA.
DR   RefSeq; NP_001018011.1; NM_001018011.1.
DR   RefSeq; NP_005997.2; NM_006006.4.
DR   RefSeq; XP_016873746.1; XM_017018257.1.
DR   RefSeq; XP_016873747.1; XM_017018258.1.
DR   RefSeq; XP_016873748.1; XM_017018259.1.
DR   Antibodypedia; 897; 365 antibodies.
DR   GeneID; 7704; -.
DR   KEGG; hsa:7704; -.
DR   CTD; 7704; -.
DR   EuPathDB; HostDB:ENSG00000109906.13; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   HOGENOM; CLU_026420_0_0_1; -.
DR   KO; K10055; -.
DR   OMA; TAGDHPF; -.
DR   OrthoDB; 1318335at2759; -.
DR   ChiTaRS; ZBTB16; human.
DR   GenomeRNAi; 7704; -.
DR   Bgee; ENSG00000109906; Expressed in upper lobe of lung and 222 other tissues.
DR   GO; GO:0005829; C:cytosol; IEA:Ensembl.
DR   GO; GO:0005634; C:nucleus; IEA:Ensembl.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IEA:Ensembl.
DR   GO; GO:0003690; F:double-stranded DNA binding; IEA:Ensembl.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0007417; P:central nervous system development; IEA:Ensembl.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0035136; P:forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IEA:Ensembl.
DR   GO; GO:0048133; P:male germ-line stem cell asymmetric division; IEA:Ensembl.
DR   GO; GO:0001823; P:mesonephros development; IEA:Ensembl.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; IEA:Ensembl.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0001501; P:skeletal system development; IEA:Ensembl.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 9.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 9.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042}.
FT   DOMAIN          34..96
FT                   /note="BTB"
FT                   /evidence="ECO:0000259|PROSITE:PS50097"
FT   DOMAIN          404..431
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          432..459
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          461..488
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          490..517
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          518..545
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          546..573
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          574..601
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          602..629
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          630..657
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   REGION          215..236
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          249..332
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
SQ   SEQUENCE   673 AA;  74274 MW;  51F8E361FA31239E CRC64;
     MDLTKMGMIQ LQNPSHPTGL LCKANQMRLA GTLCDVVIMV DSQEFHAHRT VLACTSKMFE
     ILFHRNSQHY TLDFLSPKTF QQILEYAYTA TLQAKAEDLD DLLYAAEILE IEYLEEQCLK
     MLETIQASDD NDTEATMADG GAEEEEDRKA RYLKNIFISK HSSEESGYAS VAGQSLPGPM
     VDQSPSVSTS FGLSAMSPTK AAVDSLMTIG QSLLQGTLQP PAGPEEPTLA GGGRHPGVAE
     VKTEMMQVDE VPSQDSPGAA ESSISGGMGD KVEERGKEGP GTPTRSSVIT SARELHYGRE
     ESAEQVPPPA EAGQAPTGRP EHPAPPPEKH LGIYSVLPNH KADAVLSMPS SVTSGLHVQP
     ALAVSMDFST YGGLLPQGFI QRELFSKLGE LAVGMKSESR TIGEQCSVCG VELPDNEAVE
     QHRKLHSGMK TYGCELCGKR FLDSLRLRMH LLAHSAGAKA FVCDQCGAQF SKEDALETHR
     QTHTGTDMAV FCLLCGKRFQ AQSALQQHME VHAGVRSYIC SECNRTFPSH TALKRHLRSH
     TGDHPYECEF CGSCFRDEST LKSHKRIHTG EKPYECNGCG KKFSLKHQLE THYRVHTGEK
     PFECKLCHQR SRDYSAMIKH LRTHNGASPY QCTICTEYCP SLSSMQKHMK GHKPEEIPPD
     WRIEKTYLYL CYV
//
ID   ZBT16_HUMAN             Reviewed;         673 AA.
AC   Q05516; Q8TAL4;
DT   01-NOV-1995, integrated into UniProtKB/Swiss-Prot.
DT   07-MAR-2006, sequence version 2.
DT   22-APR-2020, entry version 216.
DE   RecName: Full=Zinc finger and BTB domain-containing protein 16;
DE   AltName: Full=Promyelocytic leukemia zinc finger protein;
DE   AltName: Full=Zinc finger protein 145;
DE   AltName: Full=Zinc finger protein PLZF;
GN   Name=ZBTB16; Synonyms=PLZF, ZNF145;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM PLZFB), ALTERNATIVE SPLICING, AND
RP   CHROMOSOMAL TRANSLOCATION WITH RARA.
RC   TISSUE=Heart ventricle;
RX   PubMed=8384553; DOI=10.1002/j.1460-2075.1993.tb05757.x;
RA   Chen Z., Brand N.J., Chen A., Chen S.-J., Tong J.-H., Wang Z.-Y.,
RA   Waxman S., Zelent A.;
RT   "Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid
RT   receptor-alpha locus due to a variant t(11;17) translocation associated
RT   with acute promyelocytic leukaemia.";
RL   EMBO J. 12:1161-1167(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].
RX   PubMed=10500192; DOI=10.1073/pnas.96.20.11422;
RA   Zhang T., Xiong H., Kan L.-X., Zhang C.-K., Jiao X.-F., Fu G., Zhang Q.-H.,
RA   Lu L., Tong J.-H., Gu B.-W., Yu M., Liu J.-X., Licht J., Waxman S.,
RA   Zelent A., Chen E., Chen S.-J.;
RT   "Genomic sequence, structural organization, molecular evolution, and
RT   aberrant rearrangement of promyelocytic leukemia zinc finger gene.";
RL   Proc. Natl. Acad. Sci. U.S.A. 96:11422-11427(1999).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM PLZFB).
RC   TISSUE=Brain;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA] OF 424-455.
RX   PubMed=8387545; DOI=10.1172/jci116453;
RA   Chen S.-J., Zelent A., Tong J.-H., Yu H.-Q., Wang Z.-Y., Derre J.,
RA   Berger R., Waxman S., Chen Z.;
RT   "Rearrangements of the retinoic acid receptor alpha and promyelocytic
RT   leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient
RT   with acute promyelocytic leukemia.";
RL   J. Clin. Invest. 91:2260-2267(1993).
RN   [5]
RP   INTERACTION WITH ZBTB32.
RX   PubMed=10572087;
RA   Hoatlin M.E., Zhi Y., Ball H., Silvey K., Melnick A., Stone S., Arai S.,
RA   Hawe N., Owen G., Zelent A., Licht J.D.;
RT   "A novel BTB/POZ transcriptional repressor protein interacts with the
RT   Fanconi anemia group C protein and PLZF.";
RL   Blood 94:3737-3747(1999).
RN   [6]
RP   INTERACTION WITH EPN1.
RX   PubMed=11161217; DOI=10.1126/science.291.5506.1047;
RA   Itoh T., Koshiba S., Kigawa T., Kikuchi A., Yokoyama S., Takenawa T.;
RT   "Role of the ENTH domain in phosphatidylinositol-4,5-bisphosphate binding
RT   and endocytosis.";
RL   Science 291:1047-1051(2001).
RN   [7]
RP   FUNCTION AS AN E3 UBIQUITIN-PROTEIN LIGASE, AND INTERACTION WITH CUL3.
RX   PubMed=14528312; DOI=10.1038/ncb1056;
RA   Furukawa M., He Y.J., Borchers C., Xiong Y.;
RT   "Targeting of protein ubiquitination by BTB-Cullin 3-Roc1 ubiquitin
RT   ligases.";
RL   Nat. Cell Biol. 5:1001-1007(2003).
RN   [8]
RP   INTERACTION WITH ATP7B.
RX   PubMed=16676348; DOI=10.1002/jcb.20980;
RA   Ko J.H., Son W., Bae G.Y., Kang J.H., Oh W., Yoo O.J.;
RT   "A new hepatocytic isoform of PLZF lacking the BTB domain interacts with
RT   ATP7B, the Wilson disease protein, and positively regulates ERK signal
RT   transduction.";
RL   J. Cell. Biochem. 99:719-734(2006).
RN   [9]
RP   FUNCTION, INTERACTION WITH RNF112, AND SUBCELLULAR LOCATION.
RX   PubMed=24359566; DOI=10.1186/1423-0127-20-98;
RA   Lin D.Y., Huang C.C., Hsieh Y.T., Lin H.C., Pao P.C., Tsou J.H., Lai C.Y.,
RA   Hung L.Y., Wang J.M., Chang W.C., Lee Y.C.;
RT   "Analysis of the interaction between Zinc finger protein 179 (Znf179) and
RT   promyelocytic leukemia zinc finger (Plzf).";
RL   J. Biomed. Sci. 20:98-98(2013).
RN   [10]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 6-126.
RX   PubMed=9770450; DOI=10.1073/pnas.95.21.12123;
RA   Ahmad K.F., Engel C.K., Prive G.G.;
RT   "Crystal structure of the BTB domain from PLZF.";
RL   Proc. Natl. Acad. Sci. U.S.A. 95:12123-12128(1998).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.0 ANGSTROMS) OF 7-122.
RX   PubMed=10537309;
RA   Li X., Peng H., Schultz D.C., Lopez-Guisa J.M., Rauscher F.J. III,
RA   Marmorstein R.;
RT   "Structure-function studies of the BTB/POZ transcriptional repression
RT   domain from the promyelocytic leukemia zinc finger oncoprotein.";
RL   Cancer Res. 59:5275-5282(1999).
RN   [12]
RP   VARIANT SGYMR VAL-617.
RX   PubMed=18611983; DOI=10.1136/jmg.2008.059451;
RA   Fischer S., Kohlhase J., Boehm D., Schweiger B., Hoffmann D., Heitmann M.,
RA   Horsthemke B., Wieczorek D.;
RT   "Biallelic loss of function of the promyelocytic leukaemia zinc finger
RT   (PLZF) gene causes severe skeletal defects and genital hypoplasia.";
RL   J. Med. Genet. 45:731-737(2008).
CC   -!- FUNCTION: Acts as a transcriptional repressor (PubMed:24359566). May
CC       play a role in myeloid maturation and in the development and/or
CC       maintenance of other differentiated tissues. Probable substrate-
CC       recognition component of an E3 ubiquitin-protein ligase complex which
CC       mediates the ubiquitination and subsequent proteasomal degradation of
CC       target proteins (PubMed:14528312). {ECO:0000269|PubMed:14528312,
CC       ECO:0000269|PubMed:24359566}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC   -!- SUBUNIT: Binds EPN1 (PubMed:11161217). Interacts with ZBTB32 and CUL3
CC       (PubMed:10572087, PubMed:14528312). Interacts with ATP7B
CC       (PubMed:16676348). Interacts (via C2H2-type zinc finger domains 1 and
CC       2) with RNF112 (PubMed:24359566). {ECO:0000269|PubMed:10572087,
CC       ECO:0000269|PubMed:11161217, ECO:0000269|PubMed:14528312,
CC       ECO:0000269|PubMed:16676348, ECO:0000269|PubMed:24359566}.
CC   -!- INTERACTION:
CC       Q05516; Q05516; NbExp=8; IntAct=EBI-711925, EBI-711925;
CC       Q05516; Q9Y2J4: AMOTL2; NbExp=3; IntAct=EBI-711925, EBI-746752;
CC       Q05516; Q9H2G9: BLZF1; NbExp=3; IntAct=EBI-711925, EBI-2548012;
CC       Q05516; Q9H257-2: CARD9; NbExp=3; IntAct=EBI-711925, EBI-11530605;
CC       Q05516; Q8TD31-3: CCHCR1; NbExp=3; IntAct=EBI-711925, EBI-10175300;
CC       Q05516; Q8NHQ1: CEP70; NbExp=4; IntAct=EBI-711925, EBI-739624;
CC       Q05516; Q9Y2V7: COG6; NbExp=5; IntAct=EBI-711925, EBI-3866319;
CC       Q05516; Q9GZU7: CTDSP1; NbExp=3; IntAct=EBI-711925, EBI-751587;
CC       Q05516; P68104: EEF1A1; NbExp=4; IntAct=EBI-711925, EBI-352162;
CC       Q05516; Q5JST6: EFHC2; NbExp=3; IntAct=EBI-711925, EBI-2349927;
CC       Q05516; Q9NTX9: FAM217B; NbExp=3; IntAct=EBI-711925, EBI-19153639;
CC       Q05516; Q86YD7: FAM90A1; NbExp=3; IntAct=EBI-711925, EBI-6658203;
CC       Q05516; Q5TD97: FHL5; NbExp=3; IntAct=EBI-711925, EBI-750641;
CC       Q05516; O35826: Gne; Xeno; NbExp=2; IntAct=EBI-711925, EBI-7109445;
CC       Q05516; Q08379: GOLGA2; NbExp=8; IntAct=EBI-711925, EBI-618309;
CC       Q05516; A6NEM1: GOLGA6L9; NbExp=3; IntAct=EBI-711925, EBI-5916454;
CC       Q05516; O95872: GPANK1; NbExp=3; IntAct=EBI-711925, EBI-751540;
CC       Q05516; P49639: HOXA1; NbExp=3; IntAct=EBI-711925, EBI-740785;
CC       Q05516; P09022: Hoxa1; Xeno; NbExp=3; IntAct=EBI-711925, EBI-3957603;
CC       Q05516; Q00444: HOXC5; NbExp=3; IntAct=EBI-711925, EBI-11955357;
CC       Q05516; O75031: HSF2BP; NbExp=3; IntAct=EBI-711925, EBI-7116203;
CC       Q05516; P05231: IL6; NbExp=2; IntAct=EBI-711925, EBI-720533;
CC       Q05516; Q9BVG8-5: KIFC3; NbExp=3; IntAct=EBI-711925, EBI-14069005;
CC       Q05516; Q6A162: KRT40; NbExp=9; IntAct=EBI-711925, EBI-10171697;
CC       Q05516; A0A0C4DGV4: LAMTOR5; NbExp=6; IntAct=EBI-711925, EBI-10173304;
CC       Q05516; O95751: LDOC1; NbExp=4; IntAct=EBI-711925, EBI-740738;
CC       Q05516; Q6FHY5: MEOX2; NbExp=3; IntAct=EBI-711925, EBI-16439278;
CC       Q05516; Q9UJV3-2: MID2; NbExp=3; IntAct=EBI-711925, EBI-10172526;
CC       Q05516; Q5JR59-3: MTUS2; NbExp=3; IntAct=EBI-711925, EBI-11522433;
CC       Q05516; Q8WY64: MYLIP; NbExp=3; IntAct=EBI-711925, EBI-6952711;
CC       Q05516; Q8NI38: NFKBID; NbExp=3; IntAct=EBI-711925, EBI-10271199;
CC       Q05516; O00746: NME4; NbExp=3; IntAct=EBI-711925, EBI-744871;
CC       Q05516; Q9H4L5: OSBPL3; NbExp=3; IntAct=EBI-711925, EBI-1051317;
CC       Q05516; O43189: PHF1; NbExp=3; IntAct=EBI-711925, EBI-530034;
CC       Q05516; O75928-2: PIAS2; NbExp=3; IntAct=EBI-711925, EBI-348567;
CC       Q05516; Q4G0R1: PIBF1; NbExp=3; IntAct=EBI-711925, EBI-14066006;
CC       Q05516; P29590: PML; NbExp=7; IntAct=EBI-711925, EBI-295890;
CC       Q05516; P29590-5: PML; NbExp=2; IntAct=EBI-711925, EBI-304008;
CC       Q05516; P31321: PRKAR1B; NbExp=3; IntAct=EBI-711925, EBI-2805516;
CC       Q05516; Q96QF0-7: RAB3IP; NbExp=3; IntAct=EBI-711925, EBI-11984839;
CC       Q05516; Q04864-2: REL; NbExp=3; IntAct=EBI-711925, EBI-10829018;
CC       Q05516; Q6NUQ1: RINT1; NbExp=3; IntAct=EBI-711925, EBI-726876;
CC       Q05516; Q9H788-2: SH2D4A; NbExp=3; IntAct=EBI-711925, EBI-10308083;
CC       Q05516; Q9NYJ8: TAB2; NbExp=3; IntAct=EBI-711925, EBI-358708;
CC       Q05516; Q08117-2: TLE5; NbExp=3; IntAct=EBI-711925, EBI-11741437;
CC       Q05516; Q13077: TRAF1; NbExp=5; IntAct=EBI-711925, EBI-359224;
CC       Q05516; Q12933: TRAF2; NbExp=5; IntAct=EBI-711925, EBI-355744;
CC       Q05516; Q9BUZ4: TRAF4; NbExp=3; IntAct=EBI-711925, EBI-3650647;
CC       Q05516; P19474: TRIM21; NbExp=3; IntAct=EBI-711925, EBI-81290;
CC       Q05516; P36406: TRIM23; NbExp=3; IntAct=EBI-711925, EBI-740098;
CC       Q05516; P14373: TRIM27; NbExp=5; IntAct=EBI-711925, EBI-719493;
CC       Q05516; Q9BYV2: TRIM54; NbExp=6; IntAct=EBI-711925, EBI-2130429;
CC       Q05516; Q5W5X9-3: TTC23; NbExp=3; IntAct=EBI-711925, EBI-9090990;
CC       Q05516; Q7KZS0: UBE2I; NbExp=3; IntAct=EBI-711925, EBI-10180829;
CC       Q05516; Q9NP79: VTA1; NbExp=4; IntAct=EBI-711925, EBI-740160;
CC       Q05516; B2RXF5: ZBTB42; NbExp=3; IntAct=EBI-711925, EBI-12287587;
CC       Q05516; Q9H707: ZNF552; NbExp=3; IntAct=EBI-711925, EBI-2555731;
CC       Q05516; Q6ZNG0: ZNF620; NbExp=3; IntAct=EBI-711925, EBI-4395669;
CC       Q05516; Q8N720: ZNF655; NbExp=3; IntAct=EBI-711925, EBI-625509;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:24359566}. Nucleus,
CC       nuclear body {ECO:0000269|PubMed:24359566}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=PLZFB;
CC         IsoId=Q05516-1; Sequence=Displayed;
CC       Name=PLZFA;
CC         IsoId=Q05516-2; Sequence=VSP_006896;
CC   -!- TISSUE SPECIFICITY: Within the hematopoietic system, PLZF is expressed
CC       in bone marrow, early myeloid cell lines and peripheral blood
CC       mononuclear cells. Also expressed in the ovary, and at lower levels, in
CC       the kidney and lung.
CC   -!- INDUCTION: By retinoic acid.
CC   -!- DISEASE: Skeletal defects, genital hypoplasia, and mental retardation
CC       (SGYMR) [MIM:612447]: A disorder characterized by mental retardation,
CC       craniofacial dysmorphism, microcephaly and short stature. Additional
CC       features include absence of the thumbs, hypoplasia of the radii and
CC       ulnae, additional vertebrae and ribs, retarded bone age and genital
CC       hypoplasia. {ECO:0000269|PubMed:18611983}. Note=The disease is caused
CC       by mutations affecting the gene represented in this entry.
CC   -!- DISEASE: Note=A chromosomal aberration involving ZBTB16 may be a cause
CC       of acute promyelocytic leukemia (APL). Translocation t(11;17)(q32;q21)
CC       with RARA. {ECO:0000269|PubMed:8384553}.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology and
CC       Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/PLZFID37.html";
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; Z19002; CAA79489.1; -; mRNA.
DR   EMBL; AF060568; AAD03619.1; -; Genomic_DNA.
DR   EMBL; BC026902; AAH26902.1; -; mRNA.
DR   EMBL; BC029812; AAH29812.1; -; mRNA.
DR   EMBL; S60093; AAC60590.2; -; Genomic_DNA.
DR   CCDS; CCDS8367.1; -. [Q05516-1]
DR   PIR; S36336; S36336.
DR   RefSeq; NP_001018011.1; NM_001018011.1. [Q05516-1]
DR   RefSeq; NP_005997.2; NM_006006.4. [Q05516-1]
DR   RefSeq; XP_016873746.1; XM_017018257.1.
DR   RefSeq; XP_016873747.1; XM_017018258.1.
DR   RefSeq; XP_016873748.1; XM_017018259.1. [Q05516-1]
DR   PDB; 1BUO; X-ray; 1.90 A; A=6-126.
DR   PDB; 1CS3; X-ray; 2.00 A; A=7-122.
DR   PDBsum; 1BUO; -.
DR   PDBsum; 1CS3; -.
DR   SMR; Q05516; -.
DR   BioGrid; 113498; 128.
DR   DIP; DIP-2654N; -.
DR   IntAct; Q05516; 119.
DR   MINT; Q05516; -.
DR   STRING; 9606.ENSP00000338157; -.
DR   BindingDB; Q05516; -.
DR   ChEMBL; CHEMBL4105726; -.
DR   MoonDB; Q05516; Predicted.
DR   iPTMnet; Q05516; -.
DR   PhosphoSitePlus; Q05516; -.
DR   BioMuta; ZBTB16; -.
DR   DMDM; 90109930; -.
DR   EPD; Q05516; -.
DR   jPOST; Q05516; -.
DR   MassIVE; Q05516; -.
DR   PaxDb; Q05516; -.
DR   PeptideAtlas; Q05516; -.
DR   PRIDE; Q05516; -.
DR   ProteomicsDB; 58332; -. [Q05516-1]
DR   ProteomicsDB; 58333; -. [Q05516-2]
DR   ABCD; Q05516; -.
DR   Antibodypedia; 897; 365 antibodies.
DR   DNASU; 7704; -.
DR   Ensembl; ENST00000335953; ENSP00000338157; ENSG00000109906. [Q05516-1]
DR   Ensembl; ENST00000392996; ENSP00000376721; ENSG00000109906. [Q05516-1]
DR   GeneID; 7704; -.
DR   KEGG; hsa:7704; -.
DR   UCSC; uc001pop.4; human. [Q05516-1]
DR   CTD; 7704; -.
DR   DisGeNET; 7704; -.
DR   GeneCards; ZBTB16; -.
DR   HGNC; HGNC:12930; ZBTB16.
DR   HPA; ENSG00000109906; Low tissue specificity.
DR   MalaCards; ZBTB16; -.
DR   MIM; 176797; gene.
DR   MIM; 612447; phenotype.
DR   neXtProt; NX_Q05516; -.
DR   OpenTargets; ENSG00000109906; -.
DR   Orphanet; 520; Acute promyelocytic leukemia.
DR   Orphanet; 99861; Precursor T-cell acute lymphoblastic leukemia.
DR   PharmGKB; PA37517; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000154616; -.
DR   HOGENOM; CLU_026420_0_0_1; -.
DR   InParanoid; Q05516; -.
DR   KO; K10055; -.
DR   OMA; TAGDHPF; -.
DR   PhylomeDB; Q05516; -.
DR   TreeFam; TF350825; -.
DR   Reactome; R-HSA-8951664; Neddylation.
DR   Reactome; R-HSA-983168; Antigen processing: Ubiquitination & Proteasome degradation.
DR   SignaLink; Q05516; -.
DR   SIGNOR; Q05516; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; ZBTB16; human.
DR   EvolutionaryTrace; Q05516; -.
DR   GeneWiki; Zinc_finger_and_BTB_domain-containing_protein_16; -.
DR   GenomeRNAi; 7704; -.
DR   Pharos; Q05516; Tbio.
DR   PRO; PR:Q05516; -.
DR   Proteomes; UP000005640; Chromosome 11.
DR   RNAct; Q05516; protein.
DR   Bgee; ENSG00000109906; Expressed in upper lobe of lung and 222 other tissues.
DR   ExpressionAtlas; Q05516; baseline and differential.
DR   Genevisible; Q05516; HS.
DR   GO; GO:0005829; C:cytosol; TAS:Reactome.
DR   GO; GO:0016604; C:nuclear body; IDA:UniProtKB.
DR   GO; GO:0016607; C:nuclear speck; IDA:UniProtKB.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0005886; C:plasma membrane; IEA:Ensembl.
DR   GO; GO:0016605; C:PML body; IDA:UniProtKB.
DR   GO; GO:0032991; C:protein-containing complex; IMP:UniProtKB.
DR   GO; GO:0017053; C:transcriptional repressor complex; IDA:MGI.
DR   GO; GO:0003677; F:DNA binding; IDA:MGI.
DR   GO; GO:0003700; F:DNA-binding transcription factor activity; IBA:GO_Central.
DR   GO; GO:0001227; F:DNA-binding transcription repressor activity, RNA polymerase II-specific; IDA:NTNU_SB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0019904; F:protein domain specific binding; IEA:Ensembl.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0000978; F:RNA polymerase II cis-regulatory region sequence-specific DNA binding; IDA:NTNU_SB.
DR   GO; GO:0043565; F:sequence-specific DNA binding; IBA:GO_Central.
DR   GO; GO:0009952; P:anterior/posterior pattern specification; IEA:Ensembl.
DR   GO; GO:0006915; P:apoptotic process; NAS:UniProtKB.
DR   GO; GO:0051216; P:cartilage development; IDA:UniProtKB.
DR   GO; GO:0007417; P:central nervous system development; ISS:UniProtKB.
DR   GO; GO:0042733; P:embryonic digit morphogenesis; IEA:Ensembl.
DR   GO; GO:0035116; P:embryonic hindlimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0009880; P:embryonic pattern specification; IEA:Ensembl.
DR   GO; GO:0035136; P:forelimb morphogenesis; IEA:Ensembl.
DR   GO; GO:0030097; P:hemopoiesis; IDA:UniProtKB.
DR   GO; GO:0048133; P:male germ-line stem cell asymmetric division; IEA:Ensembl.
DR   GO; GO:0001823; P:mesonephros development; ISS:UniProtKB.
DR   GO; GO:0030099; P:myeloid cell differentiation; TAS:UniProtKB.
DR   GO; GO:0008285; P:negative regulation of cell population proliferation; IEA:Ensembl.
DR   GO; GO:0045638; P:negative regulation of myeloid cell differentiation; ISS:UniProtKB.
DR   GO; GO:0000122; P:negative regulation of transcription by RNA polymerase II; IDA:NTNU_SB.
DR   GO; GO:0045892; P:negative regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043065; P:positive regulation of apoptotic process; IEA:Ensembl.
DR   GO; GO:0061036; P:positive regulation of cartilage development; IDA:UniProtKB.
DR   GO; GO:0032332; P:positive regulation of chondrocyte differentiation; IMP:UniProtKB.
DR   GO; GO:0045600; P:positive regulation of fat cell differentiation; IMP:UniProtKB.
DR   GO; GO:0051138; P:positive regulation of NK T cell differentiation; IEA:Ensembl.
DR   GO; GO:0045778; P:positive regulation of ossification; IDA:UniProtKB.
DR   GO; GO:0045944; P:positive regulation of transcription by RNA polymerase II; IBA:GO_Central.
DR   GO; GO:0045893; P:positive regulation of transcription, DNA-templated; IDA:UniProtKB.
DR   GO; GO:0043687; P:post-translational protein modification; TAS:Reactome.
DR   GO; GO:0034504; P:protein localization to nucleus; IEA:Ensembl.
DR   GO; GO:0016567; P:protein ubiquitination; IEA:UniProtKB-UniPathway.
DR   InterPro; IPR000210; BTB/POZ_dom.
DR   InterPro; IPR011333; SKP1/BTB/POZ_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF00651; BTB; 1.
DR   Pfam; PF00096; zf-C2H2; 3.
DR   SMART; SM00225; BTB; 1.
DR   SMART; SM00355; ZnF_C2H2; 9.
DR   SUPFAM; SSF54695; SSF54695; 1.
DR   SUPFAM; SSF57667; SSF57667; 4.
DR   PROSITE; PS50097; BTB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 8.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 9.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Chromosomal rearrangement;
KW   Disease mutation; DNA-binding; Mental retardation; Metal-binding; Nucleus;
KW   Phosphoprotein; Proto-oncogene; Reference proteome; Repeat; Repressor;
KW   Transcription; Transcription regulation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..673
FT                   /note="Zinc finger and BTB domain-containing protein 16"
FT                   /id="PRO_0000047729"
FT   DOMAIN          34..96
FT                   /note="BTB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00037"
FT   ZN_FING         404..426
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         432..454
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         461..483
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         490..512
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         518..540
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         546..568
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         574..596
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         602..624
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         630..652
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   SITE            394..395
FT                   /note="Breakpoint for translocation to form PLZF-RAR-alpha
FT                   oncogene"
FT   MOD_RES         76
FT                   /note="Phosphoserine; by PDPK1"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         184
FT                   /note="Phosphoserine; by PDPK1"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         197
FT                   /note="Phosphoserine; by PDPK1"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         256
FT                   /note="Phosphoserine; by PDPK1"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         282
FT                   /note="Phosphothreonine; by PDPK1"
FT                   /evidence="ECO:0000255"
FT   MOD_RES         628
FT                   /note="Phosphoserine; by PDPK1"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         255..377
FT                   /note="Missing (in isoform PLZFA)"
FT                   /evidence="ECO:0000305"
FT                   /id="VSP_006896"
FT   VARIANT         617
FT                   /note="M -> V (in SGYMR; dbSNP:rs121434606)"
FT                   /evidence="ECO:0000269|PubMed:18611983"
FT                   /id="VAR_054912"
FT   CONFLICT        580
FT                   /note="G -> D (in Ref. 1; CAA79489)"
FT                   /evidence="ECO:0000305"
FT   HELIX           16..30
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   TURN            31..33
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   STRAND          36..42
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   STRAND          44..47
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           49..55
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           57..62
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           63..65
FT                   /evidence="ECO:0000244|PDB:1CS3"
FT   STRAND          68..72
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           77..89
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           96..98
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           99..109
FT                   /evidence="ECO:0000244|PDB:1BUO"
FT   HELIX           112..125
FT                   /evidence="ECO:0000244|PDB:1BUO"
SQ   SEQUENCE   673 AA;  74274 MW;  51F8E361FA31239E CRC64;
     MDLTKMGMIQ LQNPSHPTGL LCKANQMRLA GTLCDVVIMV DSQEFHAHRT VLACTSKMFE
     ILFHRNSQHY TLDFLSPKTF QQILEYAYTA TLQAKAEDLD DLLYAAEILE IEYLEEQCLK
     MLETIQASDD NDTEATMADG GAEEEEDRKA RYLKNIFISK HSSEESGYAS VAGQSLPGPM
     VDQSPSVSTS FGLSAMSPTK AAVDSLMTIG QSLLQGTLQP PAGPEEPTLA GGGRHPGVAE
     VKTEMMQVDE VPSQDSPGAA ESSISGGMGD KVEERGKEGP GTPTRSSVIT SARELHYGRE
     ESAEQVPPPA EAGQAPTGRP EHPAPPPEKH LGIYSVLPNH KADAVLSMPS SVTSGLHVQP
     ALAVSMDFST YGGLLPQGFI QRELFSKLGE LAVGMKSESR TIGEQCSVCG VELPDNEAVE
     QHRKLHSGMK TYGCELCGKR FLDSLRLRMH LLAHSAGAKA FVCDQCGAQF SKEDALETHR
     QTHTGTDMAV FCLLCGKRFQ AQSALQQHME VHAGVRSYIC SECNRTFPSH TALKRHLRSH
     TGDHPYECEF CGSCFRDEST LKSHKRIHTG EKPYECNGCG KKFSLKHQLE THYRVHTGEK
     PFECKLCHQR SRDYSAMIKH LRTHNGASPY QCTICTEYCP SLSSMQKHMK GHKPEEIPPD
     WRIEKTYLYL CYV
//
ID   A0A024R4J5_HUMAN        Unreviewed;       463 AA.
AC   A0A024R4J5;
DT   09-JUL-2014, integrated into UniProtKB/TrEMBL.
DT   09-JUL-2014, sequence version 1.
DT   22-APR-2020, entry version 50.
DE   SubName: Full=Zinc finger protein 331, isoform CRA_a {ECO:0000313|EMBL:EAW72147.1};
GN   Name=ZNF331 {ECO:0000313|EMBL:EAW72147.1};
GN   ORFNames=hCG_2009080 {ECO:0000313|EMBL:EAW72147.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:EAW72147.1};
RN   [1] {ECO:0000313|EMBL:EAW72147.1}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=11181995; DOI=10.1126/science.1058040;
RA   Venter J.C., Adams M.D., Myers E.W., Li P.W., Mural R.J., Sutton G.G.,
RA   Smith H.O., Yandell M., Evans C.A., Holt R.A., Gocayne J.D., Amanatides P.,
RA   Ballew R.M., Huson D.H., Wortman J.R., Zhang Q., Kodira C.D., Zheng X.H.,
RA   Chen L., Skupski M., Subramanian G., Thomas P.D., Zhang J.,
RA   Gabor Miklos G.L., Nelson C., Broder S., Clark A.G., Nadeau J.,
RA   McKusick V.A., Zinder N., Levine A.J., Roberts R.J., Simon M., Slayman C.,
RA   Hunkapiller M., Bolanos R., Delcher A., Dew I., Fasulo D., Flanigan M.,
RA   Florea L., Halpern A., Hannenhalli S., Kravitz S., Levy S., Mobarry C.,
RA   Reinert K., Remington K., Abu-Threideh J., Beasley E., Biddick K.,
RA   Bonazzi V., Brandon R., Cargill M., Chandramouliswaran I., Charlab R.,
RA   Chaturvedi K., Deng Z., Di Francesco V., Dunn P., Eilbeck K.,
RA   Evangelista C., Gabrielian A.E., Gan W., Ge W., Gong F., Gu Z., Guan P.,
RA   Heiman T.J., Higgins M.E., Ji R.R., Ke Z., Ketchum K.A., Lai Z., Lei Y.,
RA   Li Z., Li J., Liang Y., Lin X., Lu F., Merkulov G.V., Milshina N.,
RA   Moore H.M., Naik A.K., Narayan V.A., Neelam B., Nusskern D., Rusch D.B.,
RA   Salzberg S., Shao W., Shue B., Sun J., Wang Z., Wang A., Wang X., Wang J.,
RA   Wei M., Wides R., Xiao C., Yan C., Yao A., Ye J., Zhan M., Zhang W.,
RA   Zhang H., Zhao Q., Zheng L., Zhong F., Zhong W., Zhu S., Zhao S.,
RA   Gilbert D., Baumhueter S., Spier G., Carter C., Cravchik A., Woodage T.,
RA   Ali F., An H., Awe A., Baldwin D., Baden H., Barnstead M., Barrow I.,
RA   Beeson K., Busam D., Carver A., Center A., Cheng M.L., Curry L.,
RA   Danaher S., Davenport L., Desilets R., Dietz S., Dodson K., Doup L.,
RA   Ferriera S., Garg N., Gluecksmann A., Hart B., Haynes J., Haynes C.,
RA   Heiner C., Hladun S., Hostin D., Houck J., Howland T., Ibegwam C.,
RA   Johnson J., Kalush F., Kline L., Koduru S., Love A., Mann F., May D.,
RA   McCawley S., McIntosh T., McMullen I., Moy M., Moy L., Murphy B.,
RA   Nelson K., Pfannkoch C., Pratts E., Puri V., Qureshi H., Reardon M.,
RA   Rodriguez R., Rogers Y.H., Romblad D., Ruhfel B., Scott R., Sitter C.,
RA   Smallwood M., Stewart E., Strong R., Suh E., Thomas R., Tint N.N., Tse S.,
RA   Vech C., Wang G., Wetter J., Williams S., Williams M., Windsor S.,
RA   Winn-Deen E., Wolfe K., Zaveri J., Zaveri K., Abril J.F., Guigo R.,
RA   Campbell M.J., Sjolander K.V., Karlak B., Kejariwal A., Mi H., Lazareva B.,
RA   Hatton T., Narechania A., Diemer K., Muruganujan A., Guo N., Sato S.,
RA   Bafna V., Istrail S., Lippert R., Schwartz R., Walenz B., Yooseph S.,
RA   Allen D., Basu A., Baxendale J., Blick L., Caminha M., Carnes-Stine J.,
RA   Caulk P., Chiang Y.H., Coyne M., Dahlke C., Mays A., Dombroski M.,
RA   Donnelly M., Ely D., Esparham S., Fosler C., Gire H., Glanowski S.,
RA   Glasser K., Glodek A., Gorokhov M., Graham K., Gropman B., Harris M.,
RA   Heil J., Henderson S., Hoover J., Jennings D., Jordan C., Jordan J.,
RA   Kasha J., Kagan L., Kraft C., Levitsky A., Lewis M., Liu X., Lopez J.,
RA   Ma D., Majoros W., McDaniel J., Murphy S., Newman M., Nguyen T., Nguyen N.,
RA   Nodell M., Pan S., Peck J., Peterson M., Rowe W., Sanders R., Scott J.,
RA   Simpson M., Smith T., Sprague A., Stockwell T., Turner R., Venter E.,
RA   Wang M., Wen M., Wu D., Wu M., Xia A., Zandieh A., Zhu X.;
RT   "The sequence of the human genome.";
RL   Science 291:1304-1351(2001).
RN   [2] {ECO:0000313|EMBL:EAW72147.1}
RP   NUCLEOTIDE SEQUENCE.
RA   Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M.,
RA   Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J.,
RA   Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S.,
RA   Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H.,
RA   Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K.,
RA   Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D.,
RA   Hunkapiller M.W., Myers E.W., Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CH471135; EAW72144.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72145.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72146.1; -; Genomic_DNA.
DR   EMBL; CH471135; EAW72147.1; -; Genomic_DNA.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001240727.1; NM_001253798.1.
DR   RefSeq; NP_001240728.1; NM_001253799.1.
DR   RefSeq; NP_001240729.1; NM_001253800.1.
DR   RefSeq; NP_001240730.1; NM_001253801.2.
DR   RefSeq; NP_001304042.1; NM_001317113.1.
DR   RefSeq; NP_001304043.1; NM_001317114.1.
DR   RefSeq; NP_001304044.1; NM_001317115.1.
DR   RefSeq; NP_001304045.1; NM_001317116.1.
DR   RefSeq; NP_001304046.1; NM_001317117.1.
DR   RefSeq; NP_001304047.1; NM_001317118.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   RefSeq; NP_061025.5; NM_018555.5.
DR   RefSeq; XP_011525378.1; XM_011527076.2.
DR   RefSeq; XP_011525380.1; XM_011527078.2.
DR   RefSeq; XP_016882425.1; XM_017026936.1.
DR   RefSeq; XP_016882426.1; XM_017026937.1.
DR   RefSeq; XP_016882427.1; XM_017026938.1.
DR   RefSeq; XP_016882428.1; XM_017026939.1.
DR   RefSeq; XP_016882429.1; XM_017026940.1.
DR   Antibodypedia; 32728; 110 antibodies.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   CTD; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   HOGENOM; CLU_002678_44_0_1; -.
DR   KO; K09228; -.
DR   OMA; WACLDST; -.
DR   OrthoDB; 1318335at2759; -.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   Bgee; ENSG00000130844; Expressed in adenohypophysis and 229 other tissues.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 8.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   4: Predicted;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370}; Repeat {ECO:0000256|SAAS:SAAS00926344};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042, ECO:0000256|SAAS:SAAS00926370};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370}.
FT   DOMAIN          6..78
FT                   /note="KRAB"
FT                   /evidence="ECO:0000259|PROSITE:PS50805"
FT   DOMAIN          131..158
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          159..186
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          187..214
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          215..242
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          243..270
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          271..298
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          299..326
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          327..354
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          355..382
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          383..410
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          411..438
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          439..463
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
SQ   SEQUENCE   463 AA;  53739 MW;  A9DB42D0870A7767 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWICEGTLE RPQRSRGRYV NQMIINYVKR PATREGTPPR
     THQRHHKENS FECKDCGKAF SRGYQLSQHQ KIHTGEKPYE CKECKKAFRW GNQLTQHQKI
     HTGEKPYECK DCGKAFRWGS SLVIHKRIHT GEKPYECKDC GKAFRRGDEL TQHQRFHTGE
     KDYECKDCGK TFSRVYKLIQ HKRIHSGEKP YECKDCGKAF ICGSSLIQHK RIHTGEKPYE
     CQECGKAFTR VNYLTQHQKI HTGEKPHECK ECGKAFRWGS SLVKHERIHT GEKPYKCTEC
     GKAFNCGYHL TQHERIHTGE TPYKCKECGK AFIYGSSLVK HERIHTGVKP YGCTECGKSF
     SHGHQLTQHQ KTHSGAKSYE CKECGKACNH LNHLREHQRI HNS
//
ID   Q68D63_HUMAN            Unreviewed;       463 AA.
AC   Q68D63;
DT   11-OCT-2004, integrated into UniProtKB/TrEMBL.
DT   11-OCT-2004, sequence version 1.
DT   22-APR-2020, entry version 112.
DE   SubName: Full=Uncharacterized protein DKFZp686L0787 {ECO:0000313|EMBL:CAH18357.1};
GN   Name=DKFZp686L0787 {ECO:0000313|EMBL:CAH18357.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:CAH18357.1};
RN   [1] {ECO:0000313|EMBL:CAH18357.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Retina {ECO:0000313|EMBL:CAH18357.1};
RG   The German cDNA Consortium;
RA   Poustka A., Albert R., Moosmayer P., Schupp I., Wellenreuther R.,
RA   Mewes H.W., Weil B., Amid C., Osanger A., Fobo G., Han M., Wiemann S.;
RL   Submitted (AUG-2004) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR749560; CAH18357.1; -; mRNA.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001304042.1; NM_001317113.1.
DR   RefSeq; NP_001304043.1; NM_001317114.1.
DR   RefSeq; NP_001304044.1; NM_001317115.1.
DR   RefSeq; NP_001304045.1; NM_001317116.1.
DR   RefSeq; NP_001304046.1; NM_001317117.1.
DR   RefSeq; NP_001304047.1; NM_001317118.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   RefSeq; NP_061025.5; NM_018555.5.
DR   PeptideAtlas; Q68D63; -.
DR   PRIDE; Q68D63; -.
DR   DNASU; 55422; -.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   CTD; 55422; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   KO; K09228; -.
DR   GenomeRNAi; 55422; -.
DR   Genevisible; Q68D63; HS.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 8.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   2: Evidence at transcript level;
KW   Metal-binding {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370}; Repeat {ECO:0000256|SAAS:SAAS00926344};
KW   Zinc {ECO:0000256|PROSITE-ProRule:PRU00042, ECO:0000256|SAAS:SAAS00926370};
KW   Zinc-finger {ECO:0000256|PROSITE-ProRule:PRU00042,
KW   ECO:0000256|SAAS:SAAS00926370}.
FT   DOMAIN          6..78
FT                   /note="KRAB"
FT                   /evidence="ECO:0000259|PROSITE:PS50805"
FT   DOMAIN          131..158
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          159..186
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          187..214
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          215..242
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          243..270
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          271..298
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          299..326
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          327..354
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          355..382
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          383..410
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          411..438
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
FT   DOMAIN          439..463
FT                   /note="C2H2-type"
FT                   /evidence="ECO:0000259|PROSITE:PS50157"
SQ   SEQUENCE   463 AA;  53667 MW;  DBF942D3325C94D2 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWICEGTLE RPQRSRGRYV NQMIINYVKR PATREGTPPR
     THQRHHKENS FECKDCGKAF SRGYQLSQHQ KIHTGEKPYE CKECKKAFRW GNQLTQHQKI
     HTGEKPYECK DCGKAFRWGS SLVIHKRIHT GEKPYECKDC GKAFRRGDEL TQHQRFHTGE
     KDYECKDCGK TFSRVYKLIQ HKRIHSGEKP YECKDCGKAF ICGSSLIQHK RIHTGEKPYE
     CQECGKAFTR VNYLTQHQKI HTGEKPHECK ECGKAFRWGS SLVKHERIHT GEKPYKCTEC
     GKAFNCGYHL TQHERIHTGG TPYKCKECGK AFIYGSSLVK HERIHTGVKP YGCTECGKSF
     SHGHQLTQHQ KTHSGAKSYE CKECGKACNH LNHLREHQRI HNS
//
ID   Q71QC4_HUMAN            Unreviewed;        63 AA.
AC   Q71QC4;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 62.
DE   SubName: Full=KRAB zinc finger protein {ECO:0000313|EMBL:AAQ03250.1};
DE   Flags: Fragment;
GN   Name=ZNF331 {ECO:0000313|EMBL:AAQ03250.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAQ03250.1};
RN   [1] {ECO:0000313|EMBL:AAQ03250.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03250.1};
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A., Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2] {ECO:0000313|EMBL:AAQ03250.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03250.1};
RA   Meiboom M., Gehrken I., Rippe V., Murua Escobar H., Belge G.,
RA   Bullerdiek J.;
RT   "Further molecular characterization of ZNF331 supports its possible role in
RT   the development of thyroid follicular adenomas.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF412403; AAQ03250.1; -; mRNA.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   PeptideAtlas; Q71QC4; -.
DR   GeneID; 55422; -.
DR   CTD; 55422; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   PROSITE; PS50805; KRAB; 1.
PE   2: Evidence at transcript level;
FT   DOMAIN          6..63
FT                   /note="KRAB"
FT                   /evidence="ECO:0000259|PROSITE:PS50805"
FT   NON_TER         63
FT                   /evidence="ECO:0000313|EMBL:AAQ03250.1"
SQ   SEQUENCE   63 AA;  7211 MW;  355F245688A3518F CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAXRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIH
//
ID   Q71QC5_HUMAN            Unreviewed;        85 AA.
AC   Q71QC5;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 110.
DE   SubName: Full=KRAB zinc finger protein {ECO:0000313|EMBL:AAQ03249.1};
DE   SubName: Full=Zinc finger protein 331 {ECO:0000313|Ensembl:ENSP00000422586};
DE   Flags: Fragment;
GN   Name=ZNF331 {ECO:0000313|EMBL:AAQ03249.1,
GN   ECO:0000313|Ensembl:ENSP00000422586};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAQ03249.1};
RN   [1] {ECO:0000313|EMBL:AAQ03249.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03249.1};
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A., Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2] {ECO:0000313|EMBL:AAQ03249.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03249.1};
RA   Meiboom M., Gehrken I., Rippe V., Murua Escobar H., Belge G.,
RA   Bullerdiek J.;
RT   "Further molecular characterization of ZNF331 supports its possible role in
RT   the development of thyroid follicular adenomas.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
RN   [3] {ECO:0000313|Ensembl:ENSP00000422586, ECO:0000313|Proteomes:UP000005640}
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [4] {ECO:0000313|Ensembl:ENSP00000422586}
RP   IDENTIFICATION.
RG   Ensembl;
RL   Submitted (JUL-2011) to UniProtKB.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AC011487; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AF412400; AAQ03247.1; -; mRNA.
DR   EMBL; AF412402; AAQ03249.1; -; mRNA.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   ProteomicsDB; 68606; -.
DR   Antibodypedia; 32728; 110 antibodies.
DR   DNASU; 55422; -.
DR   Ensembl; ENST00000502616; ENSP00000422586; ENSG00000130844.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   UCSC; uc061ckp.1; human.
DR   CTD; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   HGNC; HGNC:15489; ZNF331.
DR   OpenTargets; ENSG00000130844; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000161267; -.
DR   KO; K09228; -.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   Bgee; ENSG00000130844; Expressed in adenohypophysis and 229 other tissues.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   PROSITE; PS50805; KRAB; 1.
PE   2: Evidence at transcript level;
KW   Reference proteome {ECO:0000313|Proteomes:UP000005640}.
FT   DOMAIN          6..85
FT                   /note="KRAB"
FT                   /evidence="ECO:0000259|PROSITE:PS50805"
FT   NON_TER         85
FT                   /evidence="ECO:0000313|EMBL:AAQ03249.1"
SQ   SEQUENCE   85 AA;  9843 MW;  920E20C81F994C0C CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWIC
//
ID   Q71QC6_HUMAN            Unreviewed;        66 AA.
AC   Q71QC6;
DT   05-JUL-2004, integrated into UniProtKB/TrEMBL.
DT   05-JUL-2004, sequence version 1.
DT   22-APR-2020, entry version 110.
DE   SubName: Full=KRAB zinc finger protein {ECO:0000313|EMBL:AAQ03248.1};
DE   Flags: Fragment;
GN   Name=ZNF331 {ECO:0000313|EMBL:AAQ03248.1};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606 {ECO:0000313|EMBL:AAQ03248.1};
RN   [1] {ECO:0000313|EMBL:AAQ03248.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03248.1};
RX   PubMed=10502321;
RX   DOI=10.1002/(SICI)1098-2264(199911)26:3<229::AID-GCC7>3.3.CO;2-A;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A., Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2] {ECO:0000313|EMBL:AAQ03248.1}
RP   NUCLEOTIDE SEQUENCE.
RC   TISSUE=Testis {ECO:0000313|EMBL:AAQ03248.1};
RA   Meiboom M., Gehrken I., Rippe V., Murua Escobar H., Belge G.,
RA   Bullerdiek J.;
RT   "Further molecular characterization of ZNF331 supports its possible role in
RT   the development of thyroid follicular adenomas.";
RL   Submitted (AUG-2001) to the EMBL/GenBank/DDBJ databases.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF412401; AAQ03248.1; -; mRNA.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   ProteomicsDB; 68607; -.
DR   Antibodypedia; 32728; 110 antibodies.
DR   DNASU; 55422; -.
DR   GeneID; 55422; -.
DR   UCSC; uc061ckq.1; human.
DR   CTD; 55422; -.
DR   EuPathDB; HostDB:ENSG00000130844.16; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   ChiTaRS; ZNF331; human.
DR   GenomeRNAi; 55422; -.
DR   Bgee; ENSG00000130844; Expressed in adenohypophysis and 229 other tissues.
DR   ExpressionAtlas; Q71QC6; baseline and differential.
DR   GO; GO:0003676; F:nucleic acid binding; IEA:InterPro.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   Pfam; PF01352; KRAB; 1.
DR   SMART; SM00349; KRAB; 1.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   PROSITE; PS50805; KRAB; 1.
PE   2: Evidence at transcript level;
FT   NON_TER         66
FT                   /evidence="ECO:0000313|EMBL:AAQ03248.1"
SQ   SEQUENCE   66 AA;  7626 MW;  03CB87D55F245684 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIR
//
ID   ZN331_HUMAN             Reviewed;         463 AA.
AC   Q9NQX6; Q96GJ4;
DT   19-SEP-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2000, sequence version 1.
DT   22-APR-2020, entry version 166.
DE   RecName: Full=Zinc finger protein 331;
DE   AltName: Full=C2H2-like zinc finger protein rearranged in thyroid adenomas;
DE   AltName: Full=Zinc finger protein 361;
DE   AltName: Full=Zinc finger protein 463;
GN   Name=ZNF331; Synonyms=RITA, ZNF361, ZNF463;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=10502321;
RX   DOI=10.1002/(sici)1098-2264(199911)26:3<229::aid-gcc7>3.0.co;2-j;
RA   Rippe V., Belge G., Meiboom M., Kazmierczak B., Fusco A., Bullerdiek J.;
RT   "A KRAB zinc finger protein gene is the potential target of 19q13
RT   translocation in benign thyroid tumors.";
RL   Genes Chromosomes Cancer 26:229-236(1999).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   TISSUE=Testis;
RX   PubMed=11267678; DOI=10.1016/s0167-4781(01)00172-5;
RA   Wu H., Zhang S., Qiu W., Zhang G., Xia Q., Xiao C., Huang X., Huang M.,
RA   Agen P., Fan T., Yang J., Milunsky A.;
RT   "Isolation, characterization, and mapping of a novel human KRAB zinc finger
RT   protein encoding gene ZNF463.";
RL   Biochim. Biophys. Acta 1518:190-193(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Eye;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-400, AND IDENTIFICATION BY MASS
RP   SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25218447; DOI=10.1038/nsmb.2890;
RA   Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,
RA   Vertegaal A.C.;
RT   "Uncovering global SUMOylation signaling networks in a site-specific
RT   manner.";
RL   Nat. Struct. Mol. Biol. 21:927-936(2014).
RN   [5]
RP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-109 AND LYS-400, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=28112733; DOI=10.1038/nsmb.3366;
RA   Hendriks I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,
RA   Nielsen M.L.;
RT   "Site-specific mapping of the human SUMO proteome reveals co-modification
RT   with phosphorylation.";
RL   Nat. Struct. Mol. Biol. 24:325-336(2017).
CC   -!- FUNCTION: May be involved in transcriptional regulation. May play a
CC       role in spermatogenesis.
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000305}.
CC   -!- TISSUE SPECIFICITY: Testis specific.
CC   -!- SIMILARITY: Belongs to the krueppel C2H2-type zinc-finger protein
CC       family. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF272148; AAF78075.1; -; mRNA.
DR   EMBL; AF251515; AAF70179.2; -; mRNA.
DR   EMBL; BC009433; AAH09433.1; -; mRNA.
DR   CCDS; CCDS33102.1; -.
DR   RefSeq; NP_001073375.1; NM_001079906.1.
DR   RefSeq; NP_001073376.1; NM_001079907.1.
DR   RefSeq; NP_001240727.1; NM_001253798.1.
DR   RefSeq; NP_001240728.1; NM_001253799.1.
DR   RefSeq; NP_001240729.1; NM_001253800.1.
DR   RefSeq; NP_001240730.1; NM_001253801.2.
DR   RefSeq; NP_001304042.1; NM_001317113.1.
DR   RefSeq; NP_001304043.1; NM_001317114.1.
DR   RefSeq; NP_001304044.1; NM_001317115.1.
DR   RefSeq; NP_001304045.1; NM_001317116.1.
DR   RefSeq; NP_001304046.1; NM_001317117.1.
DR   RefSeq; NP_001304047.1; NM_001317118.1.
DR   RefSeq; NP_001304048.1; NM_001317119.1.
DR   RefSeq; NP_001304049.1; NM_001317120.1.
DR   RefSeq; NP_001304050.1; NM_001317121.1.
DR   RefSeq; NP_061025.5; NM_018555.5.
DR   RefSeq; XP_011525378.1; XM_011527076.2.
DR   RefSeq; XP_011525380.1; XM_011527078.2.
DR   RefSeq; XP_016882425.1; XM_017026936.1.
DR   RefSeq; XP_016882426.1; XM_017026937.1.
DR   RefSeq; XP_016882427.1; XM_017026938.1.
DR   RefSeq; XP_016882428.1; XM_017026939.1.
DR   RefSeq; XP_016882429.1; XM_017026940.1.
DR   SMR; Q9NQX6; -.
DR   BioGrid; 120663; 63.
DR   IntAct; Q9NQX6; 60.
DR   MINT; Q9NQX6; -.
DR   STRING; 9606.ENSP00000253144; -.
DR   iPTMnet; Q9NQX6; -.
DR   PhosphoSitePlus; Q9NQX6; -.
DR   BioMuta; ZNF331; -.
DR   DMDM; 34925661; -.
DR   EPD; Q9NQX6; -.
DR   jPOST; Q9NQX6; -.
DR   MassIVE; Q9NQX6; -.
DR   PaxDb; Q9NQX6; -.
DR   PeptideAtlas; Q9NQX6; -.
DR   PRIDE; Q9NQX6; -.
DR   ProteomicsDB; 82225; -.
DR   Antibodypedia; 32728; 110 antibodies.
DR   DNASU; 55422; -.
DR   Ensembl; ENST00000253144; ENSP00000253144; ENSG00000130844.
DR   Ensembl; ENST00000411977; ENSP00000393336; ENSG00000130844.
DR   Ensembl; ENST00000449416; ENSP00000393817; ENSG00000130844.
DR   Ensembl; ENST00000504493; ENSP00000425517; ENSG00000130844.
DR   Ensembl; ENST00000511154; ENSP00000421014; ENSG00000130844.
DR   Ensembl; ENST00000511593; ENSP00000427439; ENSG00000130844.
DR   Ensembl; ENST00000512387; ENSP00000421728; ENSG00000130844.
DR   Ensembl; ENST00000513999; ENSP00000423156; ENSG00000130844.
DR   Ensembl; ENST00000648122; ENSP00000496977; ENSG00000130844.
DR   Ensembl; ENST00000648236; ENSP00000497263; ENSG00000130844.
DR   Ensembl; ENST00000648397; ENSP00000497726; ENSG00000130844.
DR   Ensembl; ENST00000648511; ENSP00000497652; ENSG00000130844.
DR   Ensembl; ENST00000649326; ENSP00000498006; ENSG00000130844.
DR   GeneID; 55422; -.
DR   KEGG; hsa:55422; -.
DR   UCSC; uc002qbx.2; human.
DR   CTD; 55422; -.
DR   DisGeNET; 55422; -.
DR   GeneCards; ZNF331; -.
DR   HGNC; HGNC:15489; ZNF331.
DR   HPA; ENSG00000130844; Tissue enhanced (adrenal gland, ovary).
DR   MIM; 606043; gene.
DR   neXtProt; NX_Q9NQX6; -.
DR   OpenTargets; ENSG00000130844; -.
DR   PharmGKB; PA134866703; -.
DR   eggNOG; KOG1721; Eukaryota.
DR   eggNOG; COG5048; LUCA.
DR   GeneTree; ENSGT00940000161267; -.
DR   HOGENOM; CLU_002678_44_0_1; -.
DR   InParanoid; Q9NQX6; -.
DR   KO; K09228; -.
DR   OMA; WACLDST; -.
DR   OrthoDB; 1318335at2759; -.
DR   PhylomeDB; Q9NQX6; -.
DR   TreeFam; TF341817; -.
DR   Reactome; R-HSA-212436; Generic Transcription Pathway.
DR   ChiTaRS; ZNF331; human.
DR   GeneWiki; ZNF331; -.
DR   GenomeRNAi; 55422; -.
DR   Pharos; Q9NQX6; Tbio.
DR   PRO; PR:Q9NQX6; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q9NQX6; protein.
DR   Bgee; ENSG00000130844; Expressed in adenohypophysis and 229 other tissues.
DR   ExpressionAtlas; Q9NQX6; baseline and differential.
DR   Genevisible; Q9NQX6; HS.
DR   GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell.
DR   GO; GO:0003677; F:DNA binding; IEA:UniProtKB-KW.
DR   GO; GO:0008270; F:zinc ion binding; NAS:UniProtKB.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:InterPro.
DR   CDD; cd07765; KRAB_A-box; 1.
DR   InterPro; IPR001909; KRAB.
DR   InterPro; IPR036051; KRAB_dom_sf.
DR   InterPro; IPR036236; Znf_C2H2_sf.
DR   InterPro; IPR013087; Znf_C2H2_type.
DR   Pfam; PF01352; KRAB; 1.
DR   Pfam; PF00096; zf-C2H2; 8.
DR   SMART; SM00349; KRAB; 1.
DR   SMART; SM00355; ZnF_C2H2; 12.
DR   SUPFAM; SSF109640; SSF109640; 1.
DR   SUPFAM; SSF57667; SSF57667; 7.
DR   PROSITE; PS50805; KRAB; 1.
DR   PROSITE; PS00028; ZINC_FINGER_C2H2_1; 12.
DR   PROSITE; PS50157; ZINC_FINGER_C2H2_2; 12.
PE   1: Evidence at protein level;
KW   DNA-binding; Isopeptide bond; Metal-binding; Nucleus; Reference proteome;
KW   Repeat; Transcription; Transcription regulation; Ubl conjugation; Zinc;
KW   Zinc-finger.
FT   CHAIN           1..463
FT                   /note="Zinc finger protein 331"
FT                   /id="PRO_0000047535"
FT   DOMAIN          6..78
FT                   /note="KRAB"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00119"
FT   ZN_FING         131..153
FT                   /note="C2H2-type 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         159..181
FT                   /note="C2H2-type 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         187..209
FT                   /note="C2H2-type 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         215..237
FT                   /note="C2H2-type 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         243..265
FT                   /note="C2H2-type 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         271..293
FT                   /note="C2H2-type 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         299..321
FT                   /note="C2H2-type 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         327..349
FT                   /note="C2H2-type 8"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         355..377
FT                   /note="C2H2-type 9"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         383..405
FT                   /note="C2H2-type 10"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         411..433
FT                   /note="C2H2-type 11"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   ZN_FING         439..461
FT                   /note="C2H2-type 12"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00042"
FT   CROSSLNK        109
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:28112733"
FT   CROSSLNK        400
FT                   /note="Glycyl lysine isopeptide (Lys-Gly) (interchain with
FT                   G-Cter in SUMO2)"
FT                   /evidence="ECO:0000244|PubMed:25218447,
FT                   ECO:0000244|PubMed:28112733"
FT   CONFLICT        59
FT                   /note="E -> K (in Ref. 3; AAH09433)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   463 AA;  53739 MW;  A9DB42D0870A7767 CRC64;
     MAQGLVTFAD VAIDFSQEEW ACLNSAQRDL YWDVMLENYS NLVSLDLESA YENKSLPTEK
     NIHEIRASKR NSDRRSKSLG RNWICEGTLE RPQRSRGRYV NQMIINYVKR PATREGTPPR
     THQRHHKENS FECKDCGKAF SRGYQLSQHQ KIHTGEKPYE CKECKKAFRW GNQLTQHQKI
     HTGEKPYECK DCGKAFRWGS SLVIHKRIHT GEKPYECKDC GKAFRRGDEL TQHQRFHTGE
     KDYECKDCGK TFSRVYKLIQ HKRIHSGEKP YECKDCGKAF ICGSSLIQHK RIHTGEKPYE
     CQECGKAFTR VNYLTQHQKI HTGEKPHECK ECGKAFRWGS SLVKHERIHT GEKPYKCTEC
     GKAFNCGYHL TQHERIHTGE TPYKCKECGK AFIYGSSLVK HERIHTGVKP YGCTECGKSF
     SHGHQLTQHQ KTHSGAKSYE CKECGKACNH LNHLREHQRI HNS
//
